Citrus Sinensis ID: 046595

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360---
Protein Sequence
MLCCGGQEEEPQPPASQTTAPPRSGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGPEAQA
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccEEccccccEEEEEEEccccEEEEEEccccccccccHHHHHHHHHHHccccccccccEEEEcccccEEEEEEEcccccHHHHHccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHcccccccccccccHHHHHHHHHHHcccccccccccccccHHHccccccccccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccccc
Secondary Structure Prediction (SSPRO)
ccEEEcccccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHcccccccccEEEEEEcccccEEEEEEEccccccccHHHHHHHHHHHHHHHcccHHEEEEEEEccccEEEEEEEcccccHHHHHccccccccccccccccHHHHHHHHHHHHHHHHHHHHHccccEEEEcccHcHEEccccccccHcHccHHEEcccccccEEEEEEEEccccccHHHHHHccccHHHHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHHHcccHHHHccccccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHccccccccccccc
Coil and Loop (DISEMBL)
mlccggqeeepqppasqttapprsgntqpggsargeprtnvvktgtpqkalpieipqiKLDELNrltsnfgtkaligegsyGRVFYAkltdgtpaaikkldtssapepesdfAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGslhdvlhgrkgvqgaepgpvltwnQRVKVAYGAAKGLEflhekvqppivhrdvrssnvllfddfkskiadfnltnqssdtaaRLHSTRVLgtfgyhapeyamtgqitqksdvYSFGVVLLELLtgrkpvdhtmpkgqqslvtwatprlsedkvkqcvdpklnndyppKAIAKLAAVAALCVQYEADFRPNMTIVVKALQpllnskpagpeaqa
Flexible Loop (DISEMBL)
mlccggqeeepqppasqttapprsgntqpggsargeprtnvvktgtpqkalpieipQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGaepgpvltwnQRVKVAYGAAKGLEFLhekvqppivhrdvrSSNVLLFDDFKSKIADFnltnqssdtaarlHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTgrkpvdhtmpkgqqslvtwatprlseDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQpllnskpagpeaqa
Low Complexity Region (SEG)
MLCCGGQEEEpqppasqttapprsGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPkaiaklaavaalCVQYEADFRPNMTIVVKALQPLLNSKPAGPEAQA
Disordered region (IsUnstruct)
**************************************************LPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTP*******************AQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDH*******SLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL************
Disordered Region (DISOPRED)
*L*****************************************************PQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKAL***************
Disordered Region (DISEMBL)
****************************************VVKTGTPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKL***********FAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN**********
Disordered Region (DISPRO)
MLCCGGQE*******************************************PIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL***********
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLCCGGQEEEPQPPASQTTAPPRSGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGPEAQA
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	363	2.2.26 [Sep-21-2011]
P93749	365	Probable protein kinase A	yes	no	0.997	0.991	0.827	1e-172
Q8H1G6	361	PTI1-like tyrosine-protei	no	no	0.942	0.947	0.684	1e-137
B9DFG5	408	PTI1-like tyrosine-protei	no	no	0.975	0.867	0.684	1e-136
O49339	366	PTI1-like tyrosine-protei	no	no	0.961	0.953	0.663	1e-136
O80719	365	Probable receptor-like pr	no	no	0.983	0.978	0.646	1e-130
Q41328	354	Pto-interacting protein 1	N/A	no	0.823	0.844	0.750	1e-130
Q9SGY7	718	Putative proline-rich rec	no	no	0.853	0.431	0.452	6e-76
Q9FFW5	681	Proline-rich receptor-lik	no	no	0.776	0.414	0.444	1e-71
Q8RWW0	744	Receptor-like serine/thre	no	no	0.796	0.388	0.447	2e-70
Q9ZUE0	720	Proline-rich receptor-lik	no	no	0.853	0.430	0.416	5e-70

>sp|P93749|Y2197_ARATH Probable protein kinase At2g41970 OS=Arabidopsis thaliana GN=At2g41970 PE=2 SV=1

 Score =  604 bits (1558), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 303/366 (82%), Positives = 326/366 (89%), Gaps = 4/366 (1%)

Query: 1   MLCCGGQEEEPQ-PPASQTTAPP-RSGNTQPGGSARGEPRT-NVVKTGTPQKALPIEIPQ 57
           M CCGG +EEP  PPA+Q  APP ++GN   GG  RGEPR  N  ++G P K LPIEIP 
Sbjct: 1   MFCCGGADEEPAGPPANQYAAPPNKAGNPNFGGGNRGEPRNPNAPRSGAPAKVLPIEIPS 60

Query: 58  IKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLS 117
           + LDELNR+  NFG KALIGEGSYGRVF  K   G   AIKKLD SS+ EP+SDF +QLS
Sbjct: 61  VALDELNRMAGNFGNKALIGEGSYGRVFCGKFK-GEAVAIKKLDASSSEEPDSDFTSQLS 119

Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV 177
           VVSRLKH+HFVELLGYC+E+NNRIL+YQFAT GSLHDVLHGRKGVQGAEPGPVL WNQRV
Sbjct: 120 VVSRLKHDHFVELLGYCLEANNRILIYQFATKGSLHDVLHGRKGVQGAEPGPVLNWNQRV 179

Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
           K+AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF +K+ADFNLTN SSDTAARLHST
Sbjct: 180 KIAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFVAKMADFNLTNASSDTAARLHST 239

Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR 297
           RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR
Sbjct: 240 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR 299

Query: 298 LSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA 357
           LSEDKVKQC+DPKLNND+PPKA+AKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA
Sbjct: 300 LSEDKVKQCIDPKLNNDFPPKAVAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA 359

Query: 358 GPEAQA 363
           GPE+ +
Sbjct: 360 GPESTS 365

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q8H1G6|PTI11_ARATH PTI1-like tyrosine-protein kinase 1 OS=Arabidopsis thaliana GN=PTI11 PE=1 SV=1

 Score =  486 bits (1252), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 243/355 (68%), Positives = 292/355 (82%), Gaps = 13/355 (3%)

Query: 2   LCCGGQ----EEEPQPPASQTTAPPRSGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQ 57
           +CC  Q     EE Q  +SQ  +     N++P   A+ E +         ++ALPIE+P 
Sbjct: 5   ICCTCQIEDSNEEQQLKSSQQQSDANHKNSKPAPVAKHEVK---------KEALPIEVPP 55

Query: 58  IKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLS 117
           + LDE+   T NFG+KALIGEGSYGRV+YA L DG   A+KKLD +   E +++F +Q+S
Sbjct: 56  LSLDEVKEKTENFGSKALIGEGSYGRVYYATLNDGVAVALKKLDVAPEAETDTEFLSQVS 115

Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV 177
           +VSRLKHE+ ++LLG+C++ N R+L Y+FATMGSLHD+LHGRKGVQGA+PGP L W  RV
Sbjct: 116 MVSRLKHENLIQLLGFCVDGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWITRV 175

Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
           K+A  AA+GLE+LHEK QPP++HRD+RSSNVLLF+D+K+KIADFNL+NQ+ D AARLHST
Sbjct: 176 KIAVEAARGLEYLHEKSQPPVIHRDIRSSNVLLFEDYKAKIADFNLSNQAPDNAARLHST 235

Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR 297
           RVLGTFGYHAPEYAMTGQ+TQKSDVYSFGVVLLELLTGRKPVDHTMP+GQQSLVTWATPR
Sbjct: 236 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 295

Query: 298 LSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL 352
           LSEDKVKQC+DPKL  DYPPKA+AKLAAVAALCVQYEA+FRPNM+IVVKALQPLL
Sbjct: 296 LSEDKVKQCIDPKLKADYPPKAVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 350

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|B9DFG5|PTI13_ARATH PTI1-like tyrosine-protein kinase 3 OS=Arabidopsis thaliana GN=PTI13 PE=1 SV=1

 Score =  486 bits (1251), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 245/358 (68%), Positives = 287/358 (80%), Gaps = 4/358 (1%)

Query: 2   LCCGGQEEEP-QPPASQTTAPPRSGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKL 60
           LCC    EEP     ++    P+  N    G    +P+   VK    ++   I++P + L
Sbjct: 47  LCCACHVEEPYHSSENEHLRSPKHHND--FGHHTRKPQA-AVKPDALKEPPSIDVPALSL 103

Query: 61  DELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVS 120
           DEL   T NFG+K+LIGEGSYGR +YA L DG   A+KKLD ++ PE   +F  Q+S VS
Sbjct: 104 DELKEKTDNFGSKSLIGEGSYGRAYYATLKDGKAVAVKKLDNAAEPESNVEFLTQVSRVS 163

Query: 121 RLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
           +LKH++FVEL GYC+E N RIL Y+FATMGSLHD+LHGRKGVQGA+PGP L W QRV++A
Sbjct: 164 KLKHDNFVELFGYCVEGNFRILAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIQRVRIA 223

Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
             AA+GLE+LHEKVQP ++HRD+RSSNVLLF+DFK+KIADFNL+NQS D AARLHSTRVL
Sbjct: 224 VDAARGLEYLHEKVQPAVIHRDIRSSNVLLFEDFKAKIADFNLSNQSPDMAARLHSTRVL 283

Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE 300
           GTFGYHAPEYAMTGQ+TQKSDVYSFGVVLLELLTGRKPVDHTMP+GQQSLVTWATPRLSE
Sbjct: 284 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSE 343

Query: 301 DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAG 358
           DKVKQCVDPKL  +YPPKA+AKLAAVAALCVQYE++FRPNM+IVVKALQPLL S  A 
Sbjct: 344 DKVKQCVDPKLKGEYPPKAVAKLAAVAALCVQYESEFRPNMSIVVKALQPLLRSSTAA 401

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|O49339|PTI12_ARATH PTI1-like tyrosine-protein kinase 2 OS=Arabidopsis thaliana GN=PTI12 PE=1 SV=1

 Score =  485 bits (1248), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 233/351 (66%), Positives = 289/351 (82%), Gaps = 2/351 (0%)

Query: 2   LCCGGQEEEPQPPASQTTAPPRSGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLD 61
           +CCG ++ +      +        N++   + + +    VVK    ++ALPIE+P + +D
Sbjct: 5   ICCGDKKGDSDLSNEEVHLKSPWQNSE--ANQKNQKPQAVVKPEAQKEALPIEVPPLSVD 62

Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSR 121
           E+   T NFG+K+LIGEGSYGRV+YA L DG   A+KKLD +   E  ++F  Q+S+VSR
Sbjct: 63  EVKEKTDNFGSKSLIGEGSYGRVYYATLNDGKAVALKKLDVAPEAETNTEFLNQVSMVSR 122

Query: 122 LKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY 181
           LKHE+ ++L+GYC++ N R+L Y+FATMGSLHD+LHGRKGVQGA+PGP L W  RVK+A 
Sbjct: 123 LKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWLTRVKIAV 182

Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG 241
            AA+GLE+LHEKVQPP++HRD+RSSNVLLF+D+++K+ADFNL+NQ+ D AARLHSTRVLG
Sbjct: 183 EAARGLEYLHEKVQPPVIHRDIRSSNVLLFEDYQAKVADFNLSNQAPDNAARLHSTRVLG 242

Query: 242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED 301
           TFGYHAPEYAMTGQ+TQKSDVYSFGVVLLELLTGRKPVDHTMP+GQQSLVTWATPRLSED
Sbjct: 243 TFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED 302

Query: 302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL 352
           KVKQCVDPKL  +YPPK++AKLAAVAALCVQYE++FRPNM+IVVKALQPLL
Sbjct: 303 KVKQCVDPKLKGEYPPKSVAKLAAVAALCVQYESEFRPNMSIVVKALQPLL 353

Probable tyrosine-protein kinase involved in oxidative burst-mediated signaling leading to specific genes expression.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|O80719|Y2706_ARATH Probable receptor-like protein kinase At2g47060 OS=Arabidopsis thaliana GN=At2g47060 PE=2 SV=1

 Score =  466 bits (1198), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 234/362 (64%), Positives = 289/362 (79%), Gaps = 5/362 (1%)

Query: 1   MLC--CGGQEEEPQPPASQTTAPPRSGNTQPGGSARGEPRTNVVKTGTPQKAL-PIEIPQ 57
           M C  C G++++    A       ++ +  PG  AR    +   + G P   L PIE+P 
Sbjct: 1   MSCFGCCGEDDDMHKTADYGGRHNQAKHFPPGNDARHHQASETAQKGPPVVKLQPIEVPI 60

Query: 58  IKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLS 117
           I   EL   T +FG+ +LIGEGSYGRV+Y  L +  P+AIKKLD++   +P+++F AQ+S
Sbjct: 61  IPFSELKEATDDFGSNSLIGEGSYGRVYYGVLNNDLPSAIKKLDSNK--QPDNEFLAQVS 118

Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV 177
           +VSRLKH++FV+LLGYC++ N+RIL Y+FA  GSLHD+LHGRKGV+GA+PGPVL+W QRV
Sbjct: 119 MVSRLKHDNFVQLLGYCVDGNSRILSYEFANNGSLHDILHGRKGVKGAQPGPVLSWYQRV 178

Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
           K+A GAA+GLE+LHEK  P I+HRD++SSNVLLF+D  +KIADF+L+NQ+ D AARLHST
Sbjct: 179 KIAVGAARGLEYLHEKANPHIIHRDIKSSNVLLFEDDVAKIADFDLSNQAPDMAARLHST 238

Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR 297
           RVLGTFGYHAPEYAMTGQ+  KSDVYSFGVVLLELLTGRKPVDH +P+GQQSLVTWATP+
Sbjct: 239 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHRLPRGQQSLVTWATPK 298

Query: 298 LSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA 357
           LSEDKVKQCVD +L  DYPPKA+AKLAAVAALCVQYEADFRPNM+IVVKALQPLLN++  
Sbjct: 299 LSEDKVKQCVDARLGGDYPPKAVAKLAAVAALCVQYEADFRPNMSIVVKALQPLLNARAV 358

Query: 358 GP 359
            P
Sbjct: 359 AP 360

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q41328|PTI1_SOLLC Pto-interacting protein 1 OS=Solanum lycopersicum GN=PTI1 PE=1 SV=2

 Score =  465 bits (1197), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 226/301 (75%), Positives = 265/301 (88%), Gaps = 2/301 (0%)

Query: 52  PIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESD 111
           PI +P I +DEL  +T NFG+KALIGEGSYGRV++  L  G  AAIKKLD+S   +P+ +
Sbjct: 50  PIAVPSIAVDELKDITDNFGSKALIGEGSYGRVYHGVLKSGRAAAIKKLDSSK--QPDRE 107

Query: 112 FAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVL 171
           F AQ+S+VSRLK E+ VELLGYC++   R+L Y++A  GSLHD+LHGRKGV+GA+PGPVL
Sbjct: 108 FLAQVSMVSRLKDENVVELLGYCVDGGFRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVL 167

Query: 172 TWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTA 231
           +W QRVK+A GAAKGLE+LHEK QP I+HRD++SSN+LLFDD  +KIADF+L+NQ+ D A
Sbjct: 168 SWAQRVKIAVGAAKGLEYLHEKAQPHIIHRDIKSSNILLFDDDVAKIADFDLSNQAPDMA 227

Query: 232 ARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLV 291
           ARLHSTRVLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+P+GQQSLV
Sbjct: 228 ARLHSTRVLGTFGYHAPEYAMTGQLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287

Query: 292 TWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL 351
           TWATPRLSEDKVKQCVD +LN DYPPKAIAK+AAVAALCVQYEADFRPNM+IVVKALQPL
Sbjct: 288 TWATPRLSEDKVKQCVDARLNTDYPPKAIAKMAAVAALCVQYEADFRPNMSIVVKALQPL 347

Query: 352 L 352
           L
Sbjct: 348 L 348

A serine-threonine kinase involved in the hypersensitive response (HR)-mediated signaling cascade.

Solanum lycopersicum (taxid: 4081)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2

 Score =  284 bits (727), Expect = 6e-76,   Method: Compositional matrix adjust.
 Identities = 149/329 (45%), Positives = 213/329 (64%), Gaps = 19/329 (5%)

Query: 26  NTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKL--DELNRLTSNFGTKALIGEGSYGR 83
           N+ P  ++ G P+      GTP  A+ I   +I    +EL+++T  F    ++GEG +G 
Sbjct: 328 NSSPDTNSLGNPKHG---RGTPDSAV-IGTSKIHFTYEELSQITEGFCKSFVVGEGGFGC 383

Query: 84  VFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV 143
           V+   L +G P AIK+L + SA E   +F A++ ++SR+ H H V L+GYC+   +R L+
Sbjct: 384 VYKGILFEGKPVAIKQLKSVSA-EGYREFKAEVEIISRVHHRHLVSLVGYCISEQHRFLI 442

Query: 144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDV 203
           Y+F    +L   LHG+         PVL W++RV++A GAAKGL +LHE   P I+HRD+
Sbjct: 443 YEFVPNNTLDYHLHGKNL-------PVLEWSRRVRIAIGAAKGLAYLHEDCHPKIIHRDI 495

Query: 204 RSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVY 263
           +SSN+LL D+F++++ADF L  + +DTA    STRV+GTFGY APEYA +G++T +SDV+
Sbjct: 496 KSSNILLDDEFEAQVADFGLA-RLNDTAQSHISTRVMGTFGYLAPEYASSGKLTDRSDVF 554

Query: 264 SFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE----DKVKQCVDPKLNNDYPPKA 319
           SFGVVLLEL+TGRKPVD + P G++SLV WA PRL E      + + VDP+L NDY    
Sbjct: 555 SFGVVLLELITGRKPVDTSQPLGEESLVEWARPRLIEAIEKGDISEVVDPRLENDYVESE 614

Query: 320 IAKLAAVAALCVQYEADFRPNMTIVVKAL 348
           + K+   AA CV++ A  RP M  VV+AL
Sbjct: 615 VYKMIETAASCVRHSALKRPRMVQVVRAL 643

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1

 Score =  270 bits (690), Expect = 1e-71,   Method: Compositional matrix adjust.
 Identities = 132/297 (44%), Positives = 196/297 (65%), Gaps = 15/297 (5%)

Query: 61  DELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVS 120
           DEL+++TS F  K L+GEG +G V+   L+DG   A+K+L    + + E +F A++ ++S
Sbjct: 330 DELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGS-QGEREFKAEVEIIS 388

Query: 121 RLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPG-PVLTWNQRVKV 179
           R+ H H V L+GYC+   +R+LVY +    +LH  LH         PG PV+TW  RV+V
Sbjct: 389 RVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHA--------PGRPVMTWETRVRV 440

Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH-STR 238
           A GAA+G+ +LHE   P I+HRD++SSN+LL + F++ +ADF L   + +     H STR
Sbjct: 441 AAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTR 500

Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL 298
           V+GTFGY APEYA +G++++K+DVYS+GV+LLEL+TGRKPVD + P G +SLV WA P L
Sbjct: 501 VMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLL 560

Query: 299 SE----DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL 351
            +    ++  + VDP+L  ++ P  + ++   AA CV++ A  RP M+ VV+AL  L
Sbjct: 561 GQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTL 617

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1

 Score =  266 bits (681), Expect = 2e-70,   Method: Compositional matrix adjust.
 Identities = 135/302 (44%), Positives = 195/302 (64%), Gaps = 13/302 (4%)

Query: 53  IEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDF 112
           + +    L EL + T  F  K ++GEG +GRV+   + DGT  A+K L T      + +F
Sbjct: 332 LSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLL-TRDNQNRDREF 390

Query: 113 AAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLT 172
            A++ ++SRL H + V+L+G C+E   R L+Y+    GS+   LH     +G      L 
Sbjct: 391 IAEVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLH-----EG-----TLD 440

Query: 173 WNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA 232
           W+ R+K+A GAA+GL +LHE   P ++HRD ++SNVLL DDF  K++DF L  ++++ + 
Sbjct: 441 WDARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 500

Query: 233 RLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT 292
            + STRV+GTFGY APEYAMTG +  KSDVYS+GVVLLELLTGR+PVD + P G+++LVT
Sbjct: 501 HI-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVT 559

Query: 293 WATPRLS-EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL 351
           WA P L+  + ++Q VDP L   Y    +AK+AA+A++CV  E   RP M  VV+AL+ +
Sbjct: 560 WARPLLANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALKLI 619

Query: 352 LN 353
            N
Sbjct: 620 YN 621

Required during the differentiation of the protoderm into shoots epidermis and cuticle.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2

 Score =  265 bits (676), Expect = 5e-70,   Method: Compositional matrix adjust.
 Identities = 135/324 (41%), Positives = 202/324 (62%), Gaps = 14/324 (4%)

Query: 30  GGSARGEPRTNVVKTGTPQKA-LPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAK 88
           G +  G P   +  +GTP  A L         +EL  +T  F  K ++GEG +G V+   
Sbjct: 330 GTAGGGYPHHQMQSSGTPDSAILGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGT 389

Query: 89  LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFAT 148
           L DG   A+K+L   S  + + +F A++ ++SR+ H H V L+GYC+   +R+L+Y++ +
Sbjct: 390 LQDGKVVAVKQLKAGSG-QGDREFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVS 448

Query: 149 MGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNV 208
             +L   LHG KG+      PVL W++RV++A G+AKGL +LHE   P I+HRD++S+N+
Sbjct: 449 NQTLEHHLHG-KGL------PVLEWSKRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANI 501

Query: 209 LLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVV 268
           LL D++++++ADF L  + +DT     STRV+GTFGY APEYA +G++T +SDV+SFGVV
Sbjct: 502 LLDDEYEAQVADFGLA-RLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVV 560

Query: 269 LLELLTGRKPVDHTMPKGQQSLVTWATPRL----SEDKVKQCVDPKLNNDYPPKAIAKLA 324
           LLEL+TGRKPVD T P G++SLV WA P L        + + +D +L   Y    + ++ 
Sbjct: 561 LLELVTGRKPVDQTQPLGEESLVEWARPLLLKAIETGDLSELIDTRLEKRYVEHEVFRMI 620

Query: 325 AVAALCVQYEADFRPNMTIVVKAL 348
             AA CV++    RP M  VV+AL
Sbjct: 621 ETAAACVRHSGPKRPRMVQVVRAL 644

Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	363
356570526	365	PREDICTED: probable protein kinase At2g4	1.0	0.994	0.846	0.0
224088180	363	predicted protein [Populus trichocarpa]	0.994	0.994	0.873	1e-180
255587729	365	Serine/threonine-protein kinase PBS1, pu	0.997	0.991	0.862	1e-179
224139898	368	predicted protein [Populus trichocarpa]	1.0	0.986	0.864	1e-178
38488407	365	protein kinase 1 [Nicotiana tabacum]	0.994	0.989	0.849	1e-176
449437557	366	PREDICTED: probable protein kinase At2g4	0.991	0.983	0.857	1e-173
356503493	366	PREDICTED: probable protein kinase At2g4	1.0	0.991	0.849	1e-172
356533109	365	PREDICTED: probable protein kinase At2g4	0.980	0.975	0.840	1e-172
38488409	369	protein kinase 2 [Nicotiana tabacum]	0.997	0.981	0.832	1e-171
225441501	364	PREDICTED: probable protein kinase At2g4	0.997	0.994	0.846	1e-170

>gi|356570526|ref|XP_003553436.1| PREDICTED: probable protein kinase At2g41970-like [Glycine max]

 Score =  651 bits (1679), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 309/365 (84%), Positives = 341/365 (93%), Gaps = 2/365 (0%)

Query: 1   MLCCGGQEEEPQ-PPASQT-TAPPRSGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQI 58
           MLCCGG EEE   PPA+Q  TAPPR G+T  GG+ RGEPR NV K+G PQK LPIEIP +
Sbjct: 1   MLCCGGAEEESSGPPANQYPTAPPRGGSTYGGGNDRGEPRGNVAKSGAPQKVLPIEIPSM 60

Query: 59  KLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSV 118
            LDELNRLT NFGTKA IGEGSYGRV+YAKL+DGT AAIKKLDTSS+ EP+SDFAAQLS+
Sbjct: 61  PLDELNRLTGNFGTKAFIGEGSYGRVYYAKLSDGTDAAIKKLDTSSSAEPDSDFAAQLSI 120

Query: 119 VSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK 178
           VSRLKH++FVEL+GYC+E++NR+LVYQ+A++GSLHDVLHGRKGVQGAEPGPVL+W+QR K
Sbjct: 121 VSRLKHDNFVELIGYCLEADNRLLVYQYASLGSLHDVLHGRKGVQGAEPGPVLSWSQRAK 180

Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
           +A+GAAKGLEFLHEKVQP IVHRDVRSSNVLLF+D+++KIADF+LTNQSSDTAARLHSTR
Sbjct: 181 IAFGAAKGLEFLHEKVQPSIVHRDVRSSNVLLFNDYEAKIADFSLTNQSSDTAARLHSTR 240

Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL 298
           VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL
Sbjct: 241 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL 300

Query: 299 SEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAG 358
           SEDKVKQCVDPKLNNDYPPKAIAKL AVAALCVQYEADFRPNMTIVVKALQPLLN+KPAG
Sbjct: 301 SEDKVKQCVDPKLNNDYPPKAIAKLGAVAALCVQYEADFRPNMTIVVKALQPLLNAKPAG 360

Query: 359 PEAQA 363
           P++ A
Sbjct: 361 PDSHA 365

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224088180|ref|XP_002308358.1| predicted protein [Populus trichocarpa] gi|222854334|gb|EEE91881.1| predicted protein [Populus trichocarpa]

 Score =  635 bits (1638), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 319/365 (87%), Positives = 336/365 (92%), Gaps = 4/365 (1%)

Query: 1   MLCCGGQEEEPQ-PPASQTTAPPRSGNTQPGGSARGEPRT-NVVKTGTPQKALPIEIPQI 58
           M CCG +EEEP  PPA+Q TAPPR GN  P GS RGEPR+ N  + G PQK LPIEIP I
Sbjct: 1   MFCCGDKEEEPHGPPANQYTAPPRGGN--PYGSGRGEPRSANPARNGAPQKVLPIEIPAI 58

Query: 59  KLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSV 118
            LDELNR+T NFGTKALIGEGSYGRVFYAKL+DG  AAIKKLDTSS+ EP+SDFAAQLSV
Sbjct: 59  PLDELNRMTGNFGTKALIGEGSYGRVFYAKLSDGMRAAIKKLDTSSSQEPDSDFAAQLSV 118

Query: 119 VSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK 178
           VSRLKHEHFVEL GYC+++NNRILVYQFA MGSLHDVLHGRKGVQGAEPGPVL WNQRVK
Sbjct: 119 VSRLKHEHFVELTGYCLDANNRILVYQFAVMGSLHDVLHGRKGVQGAEPGPVLNWNQRVK 178

Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
           +AYGAAKGLE+LHEKVQPPIVHRDVRSSNVLLFDDF S+IADFNL+N  SDTAARLHSTR
Sbjct: 179 IAYGAAKGLEYLHEKVQPPIVHRDVRSSNVLLFDDFMSRIADFNLSNAHSDTAARLHSTR 238

Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL 298
           VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL
Sbjct: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL 298

Query: 299 SEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAG 358
           SEDKVKQCVDPKLNNDYPPKA+AKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAG
Sbjct: 299 SEDKVKQCVDPKLNNDYPPKAVAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAG 358

Query: 359 PEAQA 363
           P+A A
Sbjct: 359 PDAHA 363

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255587729|ref|XP_002534374.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223525414|gb|EEF28012.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis]

 Score =  633 bits (1632), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 314/364 (86%), Positives = 335/364 (92%), Gaps = 2/364 (0%)

Query: 1   MLCCGGQEEEPQ-PPASQTTAPPRSGNTQPGGSARGEPRTNV-VKTGTPQKALPIEIPQI 58
           MLCCGG EEE   PPA+Q TAPP+ GN   GG  R EPR+N   K+GTPQK LPIE+P +
Sbjct: 1   MLCCGGAEEELDGPPANQYTAPPKGGNNYAGGGERAEPRSNNPAKSGTPQKVLPIEVPAL 60

Query: 59  KLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSV 118
            LDELNRLT NFGTKALIGEGSYGRVFYAKL +G  AAIKKLDTS++ EP+SDFAAQLSV
Sbjct: 61  SLDELNRLTGNFGTKALIGEGSYGRVFYAKLNNGEEAAIKKLDTSTSQEPDSDFAAQLSV 120

Query: 119 VSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK 178
           VSRLKHEHFVEL+GYC+E+NNRIL+YQFATMGSLHDVLHGRKGVQGAEPGP L+WNQRV 
Sbjct: 121 VSRLKHEHFVELIGYCLEANNRILIYQFATMGSLHDVLHGRKGVQGAEPGPALSWNQRVI 180

Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
           VAYGAAKGLE+LHEKVQP +VHRDVRSSNVLLFDDF SKIADFNL++ SSDTAARLHSTR
Sbjct: 181 VAYGAAKGLEYLHEKVQPSVVHRDVRSSNVLLFDDFTSKIADFNLSSASSDTAARLHSTR 240

Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL 298
           VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL
Sbjct: 241 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL 300

Query: 299 SEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAG 358
           SEDKVKQCVDPKLNNDYPPKA+AKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAG
Sbjct: 301 SEDKVKQCVDPKLNNDYPPKAVAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAG 360

Query: 359 PEAQ 362
           PE+ 
Sbjct: 361 PESH 364

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139898|ref|XP_002323330.1| predicted protein [Populus trichocarpa] gi|222867960|gb|EEF05091.1| predicted protein [Populus trichocarpa]

 Score =  631 bits (1627), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 318/368 (86%), Positives = 334/368 (90%), Gaps = 5/368 (1%)

Query: 1   MLCCGGQEEEPQ-PPASQTTAPPRSGNT---QPGGSARGEPR-TNVVKTGTPQKALPIEI 55
           M CCGG EEEP  PPA+Q TAPP+  N        SARGEPR  N  ++G PQK LPIEI
Sbjct: 1   MFCCGGNEEEPHGPPANQYTAPPKGANIYGGGGSSSARGEPRGANQARSGAPQKVLPIEI 60

Query: 56  PQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQ 115
           P I LDELNR+T NFGTKALIGEGSYGRVFYAKL DG PAAIKKLDTSS+ EP+SDF AQ
Sbjct: 61  PSIPLDELNRMTGNFGTKALIGEGSYGRVFYAKLKDGMPAAIKKLDTSSSQEPDSDFEAQ 120

Query: 116 LSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQ 175
           LSVVSRLKHEHFVEL GYC+E+NNRILVYQFA MGSLHDVLHGRKGV+GAEPGPVL WNQ
Sbjct: 121 LSVVSRLKHEHFVELTGYCLEANNRILVYQFAVMGSLHDVLHGRKGVEGAEPGPVLNWNQ 180

Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
           RVK+AYGAAKGLE+LHEKVQP IVHRDVRSSNVLLFDDF SKIADFNL+N +SDTAARLH
Sbjct: 181 RVKIAYGAAKGLEYLHEKVQPSIVHRDVRSSNVLLFDDFLSKIADFNLSNANSDTAARLH 240

Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT 295
           STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT
Sbjct: 241 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT 300

Query: 296 PRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK 355
           PRLSEDKVKQCVDPKLNNDYPPKA+AKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK
Sbjct: 301 PRLSEDKVKQCVDPKLNNDYPPKAVAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK 360

Query: 356 PAGPEAQA 363
           PAGPE+QA
Sbjct: 361 PAGPESQA 368

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|38488407|emb|CAE55203.1| protein kinase 1 [Nicotiana tabacum]

 Score =  623 bits (1606), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 310/365 (84%), Positives = 332/365 (90%), Gaps = 4/365 (1%)

Query: 1   MLCCGGQEEEPQ---PPASQTTAPPRSGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQ 57
           M CCGG EE+     PP++Q TAPPR+GN   G S RGEP     KTGTPQK LPIEIP 
Sbjct: 1   MSCCGGGEEDVYSGGPPSNQNTAPPRAGNPYGGASDRGEPGGGA-KTGTPQKVLPIEIPV 59

Query: 58  IKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLS 117
           + LDELN+LT NFG KALIGEGSYGRVF+AKL+DG  AAIKKLDTSS+ EP+SDF AQLS
Sbjct: 60  VSLDELNKLTGNFGQKALIGEGSYGRVFFAKLSDGQQAAIKKLDTSSSSEPDSDFTAQLS 119

Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV 177
           +VS LKHEHFV L+GYC+E+NNRILVY+FA MGSLHDVLHGRKGVQGAEPGPVLTWN+RV
Sbjct: 120 MVSALKHEHFVTLMGYCLEANNRILVYEFAAMGSLHDVLHGRKGVQGAEPGPVLTWNERV 179

Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
           K+AYGAAKGLE+LHEKVQPPIVHRDVRSSNVLLFDDF +KIADFNLTNQSSDTAARLHST
Sbjct: 180 KIAYGAAKGLEYLHEKVQPPIVHRDVRSSNVLLFDDFTAKIADFNLTNQSSDTAARLHST 239

Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR 297
           RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR
Sbjct: 240 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR 299

Query: 298 LSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA 357
           LSEDKVKQCVDPKLNNDYP KAIAK+AAVAALCVQYEADFRPNMTIVVKALQPLLN+KPA
Sbjct: 300 LSEDKVKQCVDPKLNNDYPAKAIAKMAAVAALCVQYEADFRPNMTIVVKALQPLLNAKPA 359

Query: 358 GPEAQ 362
           GPE+ 
Sbjct: 360 GPESN 364

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449437557|ref|XP_004136558.1| PREDICTED: probable protein kinase At2g41970-like [Cucumis sativus]

 Score =  612 bits (1579), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 313/365 (85%), Positives = 333/365 (91%), Gaps = 5/365 (1%)

Query: 1   MLCCGGQEEEP-QPPASQTTAPPRSGNTQPGGSARGEPRT-NVVKTGTPQKALPIEIPQI 58
           M CCGG EEE    P+SQ TAPPR GNT  GGS RGEPRT NVV++G PQ+ LPIE P I
Sbjct: 1   MFCCGGVEEENFGAPSSQYTAPPR-GNTY-GGSERGEPRTSNVVRSGAPQQVLPIETPVI 58

Query: 59  KLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSV 118
            LDELNRLT NFGTK+ IGEGSYGRV+YA L  G  AAIKKLDTSS+PEP++DFAAQLS 
Sbjct: 59  PLDELNRLTGNFGTKSFIGEGSYGRVYYATLKSGQAAAIKKLDTSSSPEPDTDFAAQLSS 118

Query: 119 VSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK 178
           VSRLK E+F+EL+GYC+E+NNRILVYQFA MGSLHD+LHGRKGVQGAEPGPVL WNQRVK
Sbjct: 119 VSRLKQENFLELIGYCLEANNRILVYQFAKMGSLHDILHGRKGVQGAEPGPVLAWNQRVK 178

Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
           +AYGAAKGLE+LHEKVQP IVHRD+RSSNVLLFDDF +KIADFNLTNQSSDTAARLHSTR
Sbjct: 179 IAYGAAKGLEYLHEKVQPSIVHRDIRSSNVLLFDDFLAKIADFNLTNQSSDTAARLHSTR 238

Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL 298
           VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL
Sbjct: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL 298

Query: 299 SEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN-SKPA 357
           SEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN SKP 
Sbjct: 299 SEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSSKPP 358

Query: 358 GPEAQ 362
           GPE+Q
Sbjct: 359 GPESQ 363

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356503493|ref|XP_003520542.1| PREDICTED: probable protein kinase At2g41970-like [Glycine max]

 Score =  612 bits (1578), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 311/366 (84%), Positives = 340/366 (92%), Gaps = 3/366 (0%)

Query: 1   MLCCGGQEEEPQ-PPASQT-TAPPRSGNTQPGGSA-RGEPRTNVVKTGTPQKALPIEIPQ 57
           MLCCGG EEE    PA+Q  TAPPR GNT  GG   RGEPR NV K+G PQK LPIEIP 
Sbjct: 1   MLCCGGAEEESTGSPANQYPTAPPRGGNTYGGGGNDRGEPRGNVAKSGAPQKVLPIEIPS 60

Query: 58  IKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLS 117
           + LDELNRLT NFGTKA IGEGSYGRVFYAKL+DGT AAIKKLDTSS+PEP+SDFAAQLS
Sbjct: 61  MPLDELNRLTGNFGTKAFIGEGSYGRVFYAKLSDGTDAAIKKLDTSSSPEPDSDFAAQLS 120

Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV 177
           +VSR+KH++FVEL+GYC+E++NR+LVYQ+A++GSLHDVLHGRKGVQGAEPGPVL+WNQR 
Sbjct: 121 IVSRMKHDNFVELIGYCLEADNRLLVYQYASLGSLHDVLHGRKGVQGAEPGPVLSWNQRA 180

Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
           K+A+GAAKGLEFLHEKVQP IVHRDVRSSNVLLF+D+++KIADF+LTNQSSDTAARLHST
Sbjct: 181 KIAFGAAKGLEFLHEKVQPSIVHRDVRSSNVLLFNDYEAKIADFSLTNQSSDTAARLHST 240

Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR 297
           RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR
Sbjct: 241 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR 300

Query: 298 LSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA 357
           LSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN+KP+
Sbjct: 301 LSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNAKPS 360

Query: 358 GPEAQA 363
           GP+  A
Sbjct: 361 GPDPHA 366

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356533109|ref|XP_003535110.1| PREDICTED: probable protein kinase At2g41970-like [Glycine max]

 Score =  609 bits (1570), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 301/358 (84%), Positives = 329/358 (91%), Gaps = 2/358 (0%)

Query: 1   MLCCGGQEEE-PQPPASQTTAPPRSGNTQPGGSA-RGEPRTNVVKTGTPQKALPIEIPQI 58
           MLCCGG EE+   PP +Q  A P+ GN   GG   RGEPR NVVK G PQK LPIEIP I
Sbjct: 1   MLCCGGAEEDFGIPPGNQYNASPKKGNAYNGGGGDRGEPRGNVVKNGAPQKTLPIEIPAI 60

Query: 59  KLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSV 118
            LDEL+RLTSNF T+ALIGEGSYG+V+YAKL+DG  AAIKKLDTSS+P+P+SDFAAQLS+
Sbjct: 61  SLDELDRLTSNFSTEALIGEGSYGKVYYAKLSDGMEAAIKKLDTSSSPDPDSDFAAQLSI 120

Query: 119 VSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK 178
           VSRLK+EHFVEL+GYC+E N RILVYQ+A++GSLHDVLHGRKGVQGAEPGP+L W+QR+K
Sbjct: 121 VSRLKNEHFVELMGYCLEENYRILVYQYASLGSLHDVLHGRKGVQGAEPGPILNWSQRIK 180

Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
           +A+GAAKGLEFLHEK QP IVHRDVRSSNVLLF+D++SK+ADFNLTNQSSDTAARLHSTR
Sbjct: 181 IAFGAAKGLEFLHEKCQPSIVHRDVRSSNVLLFNDYESKVADFNLTNQSSDTAARLHSTR 240

Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL 298
           VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL
Sbjct: 241 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL 300

Query: 299 SEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP 356
           SEDKVKQCVDPKLNN+YPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP
Sbjct: 301 SEDKVKQCVDPKLNNEYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP 358

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|38488409|emb|CAE55204.1| protein kinase 2 [Nicotiana tabacum]

 Score =  608 bits (1568), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 308/370 (83%), Positives = 332/370 (89%), Gaps = 8/370 (2%)

Query: 1   MLCCGGQEEEPQ---PPASQTTAPPRSGN----TQPGGSARGEPRTNVVKTGTPQKALPI 53
           M CCGG EE+     PP++Q TAPPR+GN       G S RGEPR+   + G PQK LPI
Sbjct: 1   MSCCGGGEEDVYSGGPPSNQNTAPPRAGNPYGGGTGGASERGEPRS-AARGGAPQKVLPI 59

Query: 54  EIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFA 113
           E P   LDELNRLT NFG KAL+GEGSYGRVF AKL++G  AAIKKLDTSS+PEP+SDFA
Sbjct: 60  EAPVFTLDELNRLTGNFGQKALVGEGSYGRVFCAKLSNGQQAAIKKLDTSSSPEPDSDFA 119

Query: 114 AQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTW 173
           AQLS+VS LKHEHF+ L+GYC+E NNRILVY+FAT GSLHDVLHGRKGVQGAEPGPVLTW
Sbjct: 120 AQLSMVSALKHEHFMTLMGYCLEGNNRILVYEFATKGSLHDVLHGRKGVQGAEPGPVLTW 179

Query: 174 NQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAAR 233
           N+RVK+AYG+AKGLE+LHEKVQPPIVHRDVRSSNVLLFDDF +KIADFN++NQSS TAAR
Sbjct: 180 NERVKIAYGSAKGLEYLHEKVQPPIVHRDVRSSNVLLFDDFTAKIADFNISNQSSATAAR 239

Query: 234 LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTW 293
           LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTW
Sbjct: 240 LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTW 299

Query: 294 ATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN 353
           ATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN
Sbjct: 300 ATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN 359

Query: 354 SKPAGPEAQA 363
           SKPAGPE+QA
Sbjct: 360 SKPAGPESQA 369

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225441501|ref|XP_002275867.1| PREDICTED: probable protein kinase At2g41970 [Vitis vinifera] gi|297739815|emb|CBI29997.3| unnamed protein product [Vitis vinifera]

 Score =  605 bits (1560), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 309/365 (84%), Positives = 333/365 (91%), Gaps = 3/365 (0%)

Query: 1   MLCCGGQEEEPQ-PPASQTTAPPRSGNTQPGGSARGEPR-TNVVKTGTPQKALPIEIPQI 58
           M CCGG+EEE    PA+Q TAPPR GN   GG   GEPR +N  K+G PQK LPIE P +
Sbjct: 1   MFCCGGEEEENHGQPANQYTAPPRGGNAY-GGGGTGEPRNSNTAKSGAPQKILPIETPAM 59

Query: 59  KLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSV 118
            LDELNRLTSNFG+KALIGEGSYGRVFYAKL+ G  AAIKKLDTSS+ EP+SDFAAQLS+
Sbjct: 60  SLDELNRLTSNFGSKALIGEGSYGRVFYAKLSSGEGAAIKKLDTSSSQEPDSDFAAQLSI 119

Query: 119 VSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK 178
           VSRL HE+FV LLGYC+E++N+ILVYQFATMGSLHD+LHGRKGVQGAEPGPVL+WNQRVK
Sbjct: 120 VSRLTHENFVGLLGYCLEADNKILVYQFATMGSLHDMLHGRKGVQGAEPGPVLSWNQRVK 179

Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
           +AYGAAKGLE+LHEKVQP IVHRDVRSSNVLLFDDF +KIADFNL+NQSSDTAARLHSTR
Sbjct: 180 IAYGAAKGLEYLHEKVQPSIVHRDVRSSNVLLFDDFLAKIADFNLSNQSSDTAARLHSTR 239

Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL 298
           VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL
Sbjct: 240 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL 299

Query: 299 SEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAG 358
           SEDKVKQCVDPKLNNDYP KAIAK+AAVAALCVQYEADFRPNMTIVVKALQPLLN KPAG
Sbjct: 300 SEDKVKQCVDPKLNNDYPAKAIAKMAAVAALCVQYEADFRPNMTIVVKALQPLLNPKPAG 359

Query: 359 PEAQA 363
           P++ A
Sbjct: 360 PDSNA 364

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	363
TAIR|locus:2064557	365	AT2G41970 [Arabidopsis thalian	0.991	0.986	0.780	3.7e-151
TAIR|locus:2009115	361	AT1G06700 [Arabidopsis thalian	0.889	0.894	0.693	1.5e-124
TAIR|locus:2054502	366	AT2G30740 [Arabidopsis thalian	0.975	0.967	0.634	2.4e-124
TAIR|locus:2081277	408	AT3G59350 [Arabidopsis thalian	0.975	0.867	0.651	2.1e-123
TAIR|locus:2088990	364	AT3G17410 [Arabidopsis thalian	0.969	0.967	0.608	9.1e-116
TAIR|locus:2098083	361	AT3G62220 [Arabidopsis thalian	0.914	0.919	0.643	8.2e-115
TAIR|locus:2054492	338	AT2G30730 [Arabidopsis thalian	0.865	0.928	0.636	5.3e-111
TAIR|locus:2023767	363	AT1G48210 [Arabidopsis thalian	0.845	0.845	0.653	8.7e-111
TAIR|locus:2023752	364	AT1G48220 [Arabidopsis thalian	0.845	0.843	0.583	5.2e-97
TAIR|locus:2019938	718	PERK11 "proline-rich extensin-	0.853	0.431	0.449	3.5e-68

TAIR|locus:2064557 AT2G41970 [Arabidopsis thaliana (taxid:3702)]

 Score = 1475 (524.3 bits), Expect = 3.7e-151, P = 3.7e-151
 Identities = 284/364 (78%), Positives = 302/364 (82%)

Query:     1 MLCCGGQEEEXXXXXXXXXXX--XXXGNTQPGGSARGEPRT-NVVKTGTPQKALPIEIPQ 57
             M CCGG +EE                GN   GG  RGEPR  N  ++G P K LPIEIP 
Sbjct:     1 MFCCGGADEEPAGPPANQYAAPPNKAGNPNFGGGNRGEPRNPNAPRSGAPAKVLPIEIPS 60

Query:    58 IKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLS 117
             + LDELNR+  NFG KALIGEGSYGRVF  K   G   AIKKLD SS+ EP+SDF +QLS
Sbjct:    61 VALDELNRMAGNFGNKALIGEGSYGRVFCGKFK-GEAVAIKKLDASSSEEPDSDFTSQLS 119

Query:   118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV 177
             VVSRLKH+HFVELLGYC+E+NNRIL+YQFAT GSLHDVLHGRKGVQGAEPGPVL WNQRV
Sbjct:   120 VVSRLKHDHFVELLGYCLEANNRILIYQFATKGSLHDVLHGRKGVQGAEPGPVLNWNQRV 179

Query:   178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
             K+AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF +K+ADFNLTN SSDTAARLHST
Sbjct:   180 KIAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFVAKMADFNLTNASSDTAARLHST 239

Query:   238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR 297
             RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR
Sbjct:   240 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR 299

Query:   298 LSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKPA 357
             LSEDKVKQC+DPKLNND+PP            CVQYEADFRPNMTIVVKALQPLLNSKPA
Sbjct:   300 LSEDKVKQCIDPKLNNDFPPKAVAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA 359

Query:   358 GPEA 361
             GPE+
Sbjct:   360 GPES 363

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

TAIR|locus:2009115 AT1G06700 [Arabidopsis thaliana (taxid:3702)]

 Score = 1224 (435.9 bits), Expect = 1.5e-124, P = 1.5e-124
 Identities = 224/323 (69%), Positives = 267/323 (82%)

Query:    41 VVKTGTPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKL 100
             V K    ++ALPIE+P + LDE+   T NFG+KALIGEGSYGRV+YA L DG   A+KKL
Sbjct:    39 VAKHEVKKEALPIEVPPLSLDEVKEKTENFGSKALIGEGSYGRVYYATLNDGVAVALKKL 98

Query:   101 DTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRK 160
             D +   E +++F +Q+S+VSRLKHE+ ++LLG+C++ N R+L Y+FATMGSLHD+LHGRK
Sbjct:    99 DVAPEAETDTEFLSQVSMVSRLKHENLIQLLGFCVDGNLRVLAYEFATMGSLHDILHGRK 158

Query:   161 GVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD 220
             GVQGA+PGP L W  RVK+A  AA+GLE+LHEK QPP++HRD+RSSNVLLF+D+K+KIAD
Sbjct:   159 GVQGAQPGPTLDWITRVKIAVEAARGLEYLHEKSQPPVIHRDIRSSNVLLFEDYKAKIAD 218

Query:   221 FNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
             FNL+NQ+ D AARLHSTRVLGTFGYHAPEYAMTGQ+TQKSDVYSFGVVLLELLTGRKPVD
Sbjct:   219 FNLSNQAPDNAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 278

Query:   281 HTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPN 340
             HTMP+GQQSLVTWATPRLSEDKVKQC+DPKL  DYPP            CVQYEA+FRPN
Sbjct:   279 HTMPRGQQSLVTWATPRLSEDKVKQCIDPKLKADYPPKAVAKLAAVAALCVQYEAEFRPN 338

Query:   341 MTIVVKALQPLLNSKPAGPEAQA 363
             M+IVVKALQPLL    A P  ++
Sbjct:   339 MSIVVKALQPLLKPPAAAPAPES 361

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IPI

GO:0005886 "plasma membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2054502 AT2G30740 [Arabidopsis thaliana (taxid:3702)]

 Score = 1222 (435.2 bits), Expect = 2.4e-124, P = 2.4e-124
 Identities = 227/358 (63%), Positives = 279/358 (77%)

Query:     2 LCCGGQEEEXXXXXXXXXXXXXXGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLD 61
             +CCG ++ +               N++       +P+  VVK    ++ALPIE+P + +D
Sbjct:     5 ICCGDKKGDSDLSNEEVHLKSPWQNSE-ANQKNQKPQA-VVKPEAQKEALPIEVPPLSVD 62

Query:    62 ELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSR 121
             E+   T NFG+K+LIGEGSYGRV+YA L DG   A+KKLD +   E  ++F  Q+S+VSR
Sbjct:    63 EVKEKTDNFGSKSLIGEGSYGRVYYATLNDGKAVALKKLDVAPEAETNTEFLNQVSMVSR 122

Query:   122 LKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY 181
             LKHE+ ++L+GYC++ N R+L Y+FATMGSLHD+LHGRKGVQGA+PGP L W  RVK+A 
Sbjct:   123 LKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWLTRVKIAV 182

Query:   182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG 241
              AA+GLE+LHEKVQPP++HRD+RSSNVLLF+D+++K+ADFNL+NQ+ D AARLHSTRVLG
Sbjct:   183 EAARGLEYLHEKVQPPVIHRDIRSSNVLLFEDYQAKVADFNLSNQAPDNAARLHSTRVLG 242

Query:   242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED 301
             TFGYHAPEYAMTGQ+TQKSDVYSFGVVLLELLTGRKPVDHTMP+GQQSLVTWATPRLSED
Sbjct:   243 TFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED 302

Query:   302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKPAGP 359
             KVKQCVDPKL  +YPP            CVQYE++FRPNM+IVVKALQPLL  KP  P
Sbjct:   303 KVKQCVDPKLKGEYPPKSVAKLAAVAALCVQYESEFRPNMSIVVKALQPLL--KPPAP 358

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2081277 AT3G59350 [Arabidopsis thaliana (taxid:3702)]

 Score = 1213 (432.1 bits), Expect = 2.1e-123, P = 2.1e-123
 Identities = 232/356 (65%), Positives = 271/356 (76%)

Query:     2 LCCGGQEEEXXXXXXXXXXXXXXGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLD 61
             LCC    EE               +   G   R +P+   VK    ++   I++P + LD
Sbjct:    47 LCCACHVEEPYHSSENEHLRSPKHHNDFGHHTR-KPQA-AVKPDALKEPPSIDVPALSLD 104

Query:    62 ELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSR 121
             EL   T NFG+K+LIGEGSYGR +YA L DG   A+KKLD ++ PE   +F  Q+S VS+
Sbjct:   105 ELKEKTDNFGSKSLIGEGSYGRAYYATLKDGKAVAVKKLDNAAEPESNVEFLTQVSRVSK 164

Query:   122 LKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY 181
             LKH++FVEL GYC+E N RIL Y+FATMGSLHD+LHGRKGVQGA+PGP L W QRV++A 
Sbjct:   165 LKHDNFVELFGYCVEGNFRILAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIQRVRIAV 224

Query:   182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG 241
              AA+GLE+LHEKVQP ++HRD+RSSNVLLF+DFK+KIADFNL+NQS D AARLHSTRVLG
Sbjct:   225 DAARGLEYLHEKVQPAVIHRDIRSSNVLLFEDFKAKIADFNLSNQSPDMAARLHSTRVLG 284

Query:   242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED 301
             TFGYHAPEYAMTGQ+TQKSDVYSFGVVLLELLTGRKPVDHTMP+GQQSLVTWATPRLSED
Sbjct:   285 TFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED 344

Query:   302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKPA 357
             KVKQCVDPKL  +YPP            CVQYE++FRPNM+IVVKALQPLL S  A
Sbjct:   345 KVKQCVDPKLKGEYPPKAVAKLAAVAALCVQYESEFRPNMSIVVKALQPLLRSSTA 400

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IPI

GO:0005886 "plasma membrane" evidence=IDA

GO:0010200 "response to chitin" evidence=RCA

TAIR|locus:2088990 AT3G17410 [Arabidopsis thaliana (taxid:3702)]

 Score = 1141 (406.7 bits), Expect = 9.1e-116, P = 9.1e-116
 Identities = 218/358 (60%), Positives = 267/358 (74%)

Query:     3 CCGGQEEEXXXXXXXXXXXXXXGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLDE 62
             CCGG E+               G    G   R +P  N+       +  PI +  I  DE
Sbjct:     6 CCGGGEDFRRVSETGPKPVHNTGGYNGGHHQRADPPKNLPVI----QMQPISVAAIPADE 61

Query:    63 LNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
             L  +T N+G+K+LIGEGSYGRVFY  L  G  AAIKKLD+S   +P+ +F AQ+S+VSRL
Sbjct:    62 LRDITDNYGSKSLIGEGSYGRVFYGILKSGKAAAIKKLDSSK--QPDQEFLAQVSMVSRL 119

Query:   123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
             + E+ V LLGYC++   R+L Y++A  GSLHD+LHGRKGV+GA+PGPVL+W+QRVK+A G
Sbjct:   120 RQENVVALLGYCVDGPLRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWHQRVKIAVG 179

Query:   183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
             AA+GLE+LHEK  P ++HRD++SSNVLLFDD  +KIADF+L+NQ+ D AARLHSTRVLGT
Sbjct:   180 AARGLEYLHEKANPHVIHRDIKSSNVLLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239

Query:   243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK 302
             FGYHAPEYAMTG ++ KSDVYSFGVVLLELLTGRKPVDHT+P+GQQS+VTWATP+LSEDK
Sbjct:   240 FGYHAPEYAMTGTLSTKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSVVTWATPKLSEDK 299

Query:   303 VKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKPAGPE 360
             VKQCVD +LN +YPP            CVQYEADFRPNM+IVVKALQPLLN   + P+
Sbjct:   300 VKQCVDARLNGEYPPKAVAKLAAVAALCVQYEADFRPNMSIVVKALQPLLNPPRSAPQ 357

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0016036 "cellular response to phosphate starvation" evidence=RCA

GO:0019375 "galactolipid biosynthetic process" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042631 "cellular response to water deprivation" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

TAIR|locus:2098083 AT3G62220 [Arabidopsis thaliana (taxid:3702)]

 Score = 1132 (403.5 bits), Expect = 8.2e-115, P = 8.2e-115
 Identities = 217/337 (64%), Positives = 267/337 (79%)

Query:    28 QPGGSARGEPRTNVVKTGTPQ-KALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFY 86
             Q GG+      +   + G    K  PIE+  I  DEL   T++FGT +LIGEGSY RV++
Sbjct:    26 QSGGNDGRRNGSETAQKGAQSVKVQPIEVAAILADELIEATNDFGTNSLIGEGSYARVYH 85

Query:    87 AKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF 146
               L +G  AAIKKLD++   +P  +F AQ+S+VSRLKH +FVELLGY ++ N+RILV++F
Sbjct:    86 GVLKNGQRAAIKKLDSNK--QPNEEFLAQVSMVSRLKHVNFVELLGYSVDGNSRILVFEF 143

Query:   147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSS 206
             A  GSLHD+LHGRKGV+GA+PGP+L+W+QRVK+A GAA+GLE+LHEK  P ++HRD++SS
Sbjct:   144 AQNGSLHDILHGRKGVKGAKPGPLLSWHQRVKIAVGAARGLEYLHEKANPHVIHRDIKSS 203

Query:   207 NVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFG 266
             NVL+FD+  +KIADF+L+NQ+ D AARLHSTRVLGTFGYHAPEYAMTGQ++ KSDVYSFG
Sbjct:   204 NVLIFDNDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLSAKSDVYSFG 263

Query:   267 VVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPXXXXXXXXX 326
             VVLLELLTGRKPVDHT+P+GQQSLVTWATP+LSEDKVKQCVD +L  DYPP         
Sbjct:   264 VVLLELLTGRKPVDHTLPRGQQSLVTWATPKLSEDKVKQCVDSRLGGDYPPKAVAKLAAV 323

Query:   327 XXXCVQYEADFRPNMTIVVKALQPLLNSK--PAGPEA 361
                CVQYEADFRPNM+IVVKALQPLLN++  PAG  A
Sbjct:   324 AALCVQYEADFRPNMSIVVKALQPLLNARTGPAGEGA 360

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2054492 AT2G30730 [Arabidopsis thaliana (taxid:3702)]

 Score = 1096 (390.9 bits), Expect = 5.3e-111, P = 5.3e-111
 Identities = 200/314 (63%), Positives = 251/314 (79%)

Query:    47 PQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAP 106
             P++ LPI +P + +DE+N  T NFG  +LIGEGSYGRV+YA L DG   A+KKLD +   
Sbjct:    24 PKEILPIIVPSLSVDEVNEQTDNFGPNSLIGEGSYGRVYYATLNDGKAVALKKLDLAPED 83

Query:   107 EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE 166
             E  ++F +Q+S+VSRLKHE+ ++L+GYC++ N R+L Y+FATMGSLHD+LHGRKGVQ A 
Sbjct:    84 ETNTEFLSQVSMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQDAL 143

Query:   167 PGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ 226
             PGP L W  RVK+A  AA+GLE+LHEKVQP ++HRD+RSSN+LLFDD+++KIADFNL+NQ
Sbjct:   144 PGPTLDWITRVKIAVEAARGLEYLHEKVQPQVIHRDIRSSNILLFDDYQAKIADFNLSNQ 203

Query:   227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKG 286
             S D AARL STRVLG+FGY++PEYAMTG++T KSDVY FGVVLLELLTGRKPVDHTMP+G
Sbjct:   204 SPDNAARLQSTRVLGSFGYYSPEYAMTGELTHKSDVYGFGVVLLELLTGRKPVDHTMPRG 263

Query:   287 QQSLVTWATPRLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVK 346
             QQSLVTWATP+LSED V++CVDPKL  +Y P            CVQYE++ RP M+ VVK
Sbjct:   264 QQSLVTWATPKLSEDTVEECVDPKLKGEYSPKSVAKLAAVAALCVQYESNCRPKMSTVVK 323

Query:   347 ALQPLLNSKPAGPE 360
             ALQ LL +  + P+
Sbjct:   324 ALQQLLIATGSIPQ 337

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2023767 AT1G48210 [Arabidopsis thaliana (taxid:3702)]

 Score = 1094 (390.2 bits), Expect = 8.7e-111, P = 8.7e-111
 Identities = 202/309 (65%), Positives = 248/309 (80%)

Query:    52 PIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESD 111
             PI +P I +DEL  +T N+G+K LIGEGSYGRVFY  L  G  AAIKKLD+S   +P+ +
Sbjct:    50 PISVPAIPVDELRDITDNYGSKTLIGEGSYGRVFYGVLKSGGAAAIKKLDSSK--QPDQE 107

Query:   112 FAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVL 171
             F +Q+S+VSRL+H++   L+GYC++   R+L Y+FA  GSLHD LHG+KG +GA  GPV+
Sbjct:   108 FLSQISMVSRLRHDNVTALMGYCVDGPLRVLAYEFAPKGSLHDTLHGKKGAKGALRGPVM 167

Query:   172 TWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTA 231
             TW QRVK+A GAA+GLE+LHEKV P ++HRD++SSNVLLFDD  +KI DF+L++Q+ D A
Sbjct:   168 TWQQRVKIAVGAARGLEYLHEKVSPQVIHRDIKSSNVLLFDDDVAKIGDFDLSDQAPDMA 227

Query:   232 ARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLV 291
             ARLHSTRVLGTFGYHAPEYAMTG ++ KSDVYSFGVVLLELLTGRKPVDHT+P+GQQSLV
Sbjct:   228 ARLHSTRVLGTFGYHAPEYAMTGTLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287

Query:   292 TWATPRLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPL 351
             TWATP+LSEDKVKQCVD +L  +YPP            CVQYEA+FRPNM+IVVKALQPL
Sbjct:   288 TWATPKLSEDKVKQCVDARLLGEYPPKAVGKLAAVAALCVQYEANFRPNMSIVVKALQPL 347

Query:   352 LNSKPAGPE 360
             LN   + P+
Sbjct:   348 LNPPRSAPQ 356

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2023752 AT1G48220 [Arabidopsis thaliana (taxid:3702)]

 Score = 964 (344.4 bits), Expect = 5.2e-97, P = 5.2e-97
 Identities = 181/310 (58%), Positives = 235/310 (75%)

Query:    52 PIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESD 111
             PI +P I +DEL  +T NF ++ L+G+GSYGRVFY  L  G  AAIKKL  +   +P+ +
Sbjct:    50 PIAVPAIPVDELEDITENFSSEVLVGKGSYGRVFYGVLKSGKEAAIKKLYPTK--QPDQE 107

Query:   112 FAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVL 171
             F +Q+S+VSRL HE+ V L+ YC++   R+L Y+FAT G+LHDVLHG+ GV GA  GPV+
Sbjct:   108 FLSQVSMVSRLHHENVVALMAYCVDGPLRVLAYEFATYGTLHDVLHGQTGVIGALQGPVM 167

Query:   172 TWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTA 231
             TW +RVK+A GAA+GLE+LH+KV P ++HRD+++SN+LLFDD  +KI DF+L +Q+ + A
Sbjct:   168 TWQRRVKIALGAARGLEYLHKKVNPQVIHRDIKASNILLFDDDIAKIGDFDLYDQAPNMA 227

Query:   232 ARLHSTRV-LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSL 290
              RLHS R+ LG    H PE+AMTG +T KSDVYSFGVVLLELLTGRKPVD T+P+GQQ+L
Sbjct:   228 GRLHSCRMALGASRSHCPEHAMTGILTTKSDVYSFGVVLLELLTGRKPVDRTLPRGQQNL 287

Query:   291 VTWATPRLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQP 350
             VTWATP+LS+DKVKQCVD +L  +YPP            CV Y+ DFRP+M+IVVKALQP
Sbjct:   288 VTWATPKLSKDKVKQCVDARLLGEYPPKAVAKLAAVSARCVHYDPDFRPDMSIVVKALQP 347

Query:   351 LLNSKPAGPE 360
             LLNS  + P+
Sbjct:   348 LLNSSRSSPQ 357

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019938 PERK11 "proline-rich extensin-like receptor kinase 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 692 (248.7 bits), Expect = 3.5e-68, P = 3.5e-68
 Identities = 148/329 (44%), Positives = 211/329 (64%)

Query:    26 NTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKL--DELNRLTSNFGTKALIGEGSYGR 83
             N+ P  ++ G P+      GTP  A+ I   +I    +EL+++T  F    ++GEG +G 
Sbjct:   328 NSSPDTNSLGNPKHG---RGTPDSAV-IGTSKIHFTYEELSQITEGFCKSFVVGEGGFGC 383

Query:    84 VFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV 143
             V+   L +G P AIK+L + SA E   +F A++ ++SR+ H H V L+GYC+   +R L+
Sbjct:   384 VYKGILFEGKPVAIKQLKSVSA-EGYREFKAEVEIISRVHHRHLVSLVGYCISEQHRFLI 442

Query:   144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDV 203
             Y+F    +L   LHG K +      PVL W++RV++A GAAKGL +LHE   P I+HRD+
Sbjct:   443 YEFVPNNTLDYHLHG-KNL------PVLEWSRRVRIAIGAAKGLAYLHEDCHPKIIHRDI 495

Query:   204 RSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVY 263
             +SSN+LL D+F++++ADF L  + +DTA    STRV+GTFGY APEYA +G++T +SDV+
Sbjct:   496 KSSNILLDDEFEAQVADFGLA-RLNDTAQSHISTRVMGTFGYLAPEYASSGKLTDRSDVF 554

Query:   264 SFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE--DK--VKQCVDPKLNNDYPPXX 319
             SFGVVLLEL+TGRKPVD + P G++SLV WA PRL E  +K  + + VDP+L NDY    
Sbjct:   555 SFGVVLLELITGRKPVDTSQPLGEESLVEWARPRLIEAIEKGDISEVVDPRLENDYVESE 614

Query:   320 XXXXXXXXXXCVQYEADFRPNMTIVVKAL 348
                       CV++ A  RP M  VV+AL
Sbjct:   615 VYKMIETAASCVRHSALKRPRMVQVVRAL 643

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q41328	PTI1_SOLLC	2, ., 7, ., 1, 1, ., 1	0.7508	0.8236	0.8446	N/A	no
P93749	Y2197_ARATH	2, ., 7, ., 1, 1, ., -	0.8278	0.9972	0.9917	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.991
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: gw1.VI.2327.1 hypothetical protein (359 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	363
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-49
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-48
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-48
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-48
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-48
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	7e-41
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-38
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-33
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-31
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-29
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-29
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	8e-28
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-27
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-26
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-26
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	7e-26
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-25
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-25
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-25
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-24
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-23
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-23
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-23
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-23
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-22
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	8e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-22
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-21
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-21
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-21
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-21
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-21
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-21
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-21
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	9e-21
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-20
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-20
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-20
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-20
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-20
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-20
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-20
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-20
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-20
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	8e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	9e-20
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-19
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-19
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-19
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-19
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-19
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-19
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-19
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-19
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	7e-19
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	7e-19
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-19
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-18
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-18
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-18
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-18
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	9e-18
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-17
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-17
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-17
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-17
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-17
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-17
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-17
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-17
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-17
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-17
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-17
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	6e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-17
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-17
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-16
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-16
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-16
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-16
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-16
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-16
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-16
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-16
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-16
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	8e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-15
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-15
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-15
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-15
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-15
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-15
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-15
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-15
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-15
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-15
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-15
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	8e-15
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	9e-15
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-14
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-14
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-14
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-14
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-14
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	8e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	8e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-13
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-13
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-13
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-13
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-13
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-13
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-13
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-13
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-13
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-13
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-12
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-12
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-12
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-12
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	7e-12
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	8e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-11
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-11
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	8e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	9e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-10
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-10
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-10
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-10
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-10
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-10
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-10
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-10
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-10
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-10
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	7e-10
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	9e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-09
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-09
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-09
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-09
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	7e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	9e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-08
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-08
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-08
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-08
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-08
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	6e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	7e-08
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-08
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	8e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	9e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-07
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-07
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-07
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-07
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-07
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-07
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-07
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-06
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-06
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-06
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-06
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	8e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-05
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-05
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-05
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-05
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-05
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	9e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-04
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-04
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-04
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-04
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	7e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	9e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	0.001
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	0.001
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	0.001
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	0.001
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	0.002
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	0.003
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  164 bits (418), Expect = 2e-49
 Identities = 60/200 (30%), Positives = 101/200 (50%), Gaps = 16/200 (8%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           +GEG +G V+ A+    G   AIK +    +     +   ++ ++ +L H + V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            + N+  LV ++   GSL D+L         E    L+ ++ +++     +GLE+LH   
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLK--------ENEGKLSEDEILRILLQILEGLEYLHSN- 111

Query: 195 QPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE-YAM 252
              I+HRD++  N+LL  D    K+ADF L+   +   + L +    GT  Y APE    
Sbjct: 112 --GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLG 167

Query: 253 TGQITQKSDVYSFGVVLLEL 272
            G  ++KSD++S GV+L EL
Sbjct: 168 KGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  164 bits (417), Expect = 1e-48
 Identities = 80/284 (28%), Positives = 127/284 (44%), Gaps = 43/284 (15%)

Query: 76  IGEGSYGRVFYAKLTD-----GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +GEG++G V+   L        T  A+K L   ++ E   +F  + S++ +L H + V L
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
           LG C +     +V ++   G L D L         + G  LT    +++A   AKG+E+L
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLR--------KHGEKLTLKDLLQMALQIAKGMEYL 118

Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ-SSDTAARLHSTRVLGTFGYHAPE 249
             K     VHRD+ + N L+ ++   KI+DF L+     D   R      L      APE
Sbjct: 119 ESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM-APE 174

Query: 250 YAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD 308
               G+ T KSDV+SFGV+L E+ T G +P                 P +S ++V +   
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPY----------------PGMSNEEVLE--- 215

Query: 309 PKLNNDY----PPKAIAKLAAVAALCVQYEADFRPNMTIVVKAL 348
             L + Y    P     +L  +   C  Y+ + RP  + +V+ L
Sbjct: 216 -LLEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  164 bits (417), Expect = 1e-48
 Identities = 72/280 (25%), Positives = 126/280 (45%), Gaps = 36/280 (12%)

Query: 76  IGEGSYGRVFYAKLTDGTPA-----AIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +GEG++G V+  KL           A+K L   ++ +   +F  +  ++ +L H + V+L
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
           LG C E     +V ++   G L   L   +        P L+ +  +  A   A+G+E+L
Sbjct: 67  LGVCTEEEPLYIVMEYMEGGDLLSYLRKNR--------PKLSLSDLLSFALQIARGMEYL 118

Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT-NQSSDTAARLHSTRVLGTFGYHAPE 249
             K     +HRD+ + N L+ ++   KI+DF L+ +   D   R    ++     + APE
Sbjct: 119 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPE 173

Query: 250 YAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD 308
               G+ T KSDV+SFGV+L E+ T G +P                 P +S ++V + + 
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPY----------------PGMSNEEVLEYLK 217

Query: 309 PKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKAL 348
                  PP    +L  +   C   + + RP  + +V+ L
Sbjct: 218 NGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  163 bits (415), Expect = 3e-48
 Identities = 85/290 (29%), Positives = 126/290 (43%), Gaps = 46/290 (15%)

Query: 76  IGEGSYGRVFYAKLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
           +GEG++G V+  KL       T  A+K L   ++ E   DF  +  V+ +L H + V LL
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62

Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G C E     LV ++   G L D L   + V  +     L+    +  A   AKG+E+L 
Sbjct: 63  GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122

Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT-------NQSSDTAARLHSTRVLGTFG 244
            K     VHRD+ + N L+ +D   KI+DF L+            T  +L   R +    
Sbjct: 123 SK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLP-IRWM---- 174

Query: 245 YHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKV 303
             APE    G  T KSDV+SFGV+L E+ T G  P                 P LS ++V
Sbjct: 175 --APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY----------------PGLSNEEV 216

Query: 304 KQCVDPKLNNDY----PPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ 349
            +     L   Y    P     +L  +   C Q + + RP  + +V+ L+
Sbjct: 217 LE----YLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  162 bits (412), Expect = 7e-48
 Identities = 70/280 (25%), Positives = 126/280 (45%), Gaps = 35/280 (12%)

Query: 76  IGEGSYGRVFYAKLTDG-----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +GEG++G V+   L           A+K L   ++ +   +F  +  ++ +L H + V+L
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
           LG C E    ++V ++   G L D L   +          L+ +  +  A   A+G+E+L
Sbjct: 67  LGVCTEEEPLMIVMEYMPGGDLLDYLRKNR-------PKELSLSDLLSFALQIARGMEYL 119

Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT-NQSSDTAARLHSTRVLGTFGYHAPE 249
             K     +HRD+ + N L+ ++   KI+DF L+ +   D   ++   ++     + APE
Sbjct: 120 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPE 174

Query: 250 YAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD 308
               G+ T KSDV+SFGV+L E+ T G +P                 P +S  +V + + 
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEEP----------------YPGMSNAEVLEYLK 218

Query: 309 PKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKAL 348
                  PP    +L  +   C   + + RP  + +V+ L
Sbjct: 219 KGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  144 bits (365), Expect = 7e-41
 Identities = 68/219 (31%), Positives = 107/219 (48%), Gaps = 17/219 (7%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQ-LSVVSRLKHEHFVELLGY 133
           +G GS+G V+ AK    G   A+K L   S    +   A + + ++ RL H + V L+  
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             + ++  LV ++   G L D L              L+ ++  K+A    +GLE+LH  
Sbjct: 67  FEDKDHLYLVMEYCEGGDLFDYLSRGG---------PLSEDEAKKIALQILRGLEYLHSN 117

Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               I+HRD++  N+LL ++   KIADF L  +   +++ L +   +GT  Y APE  + 
Sbjct: 118 ---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLG 172

Query: 254 GQ-ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLV 291
           G     K DV+S GV+L ELLTG+ P        Q  L+
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLI 211

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  137 bits (348), Expect = 2e-38
 Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 16/205 (7%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
            +GEGS+G+V+ A+    G   AIK +      +       ++ ++ +LKH + V L   
Sbjct: 6   KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65

Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             + +   LV ++   G L D+L  R           L+ ++           LE+LH K
Sbjct: 66  FEDEDKLYLVMEYCEGGDLFDLLKKRGR---------LSEDEARFYLRQILSALEYLHSK 116

Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               IVHRD++  N+LL +D   K+ADF L  Q         +T V GT  Y APE  + 
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPG--EKLTTFV-GTPEYMAPEVLLG 170

Query: 254 GQITQKSDVYSFGVVLLELLTGRKP 278
               +  D++S GV+L ELLTG+ P
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  125 bits (315), Expect = 1e-33
 Identities = 63/204 (30%), Positives = 104/204 (50%), Gaps = 16/204 (7%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG+G +G V+ A+    G   AIK +   S  + +     ++ ++ + KH + V+  G  
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEK-KEKIINEIQILKKCKHPNIVKYYGSY 66

Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
           ++ +   +V +F + GSL D+L              LT +Q   V     KGLE+LH   
Sbjct: 67  LKKDELWIVMEFCSGGSLKDLLKSTNQT--------LTESQIAYVCKELLKGLEYLHSN- 117

Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              I+HRD++++N+LL  D + K+ DF L+ Q SDT AR     ++GT  + APE     
Sbjct: 118 --GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR---NTMVGTPYWMAPEVINGK 172

Query: 255 QITQKSDVYSFGVVLLELLTGRKP 278
               K+D++S G+  +EL  G+ P
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  119 bits (301), Expect = 1e-31
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 30/215 (13%)

Query: 75  LIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESD-FAAQLSVVSRLKHEHFVELLG 132
           L+G GS+G V+ A   D G   A+K ++ S   E E +    ++ ++S L+H + V   G
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66

Query: 133 YCMESN--NRILVYQ-FATMGSLHDVLHGRKGVQGAEP------GPVLTWNQRVKVAYGA 183
                   N + ++  + + GSL  +L     +   EP        +L            
Sbjct: 67  -SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP--EPVIRKYTRQIL------------ 111

Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
            +GL +LH      IVHRD++ +N+L+  D   K+ADF    +  D      +  V GT 
Sbjct: 112 -EGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTP 167

Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            + APE     +  + +D++S G  ++E+ TG+ P
Sbjct: 168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  114 bits (288), Expect = 1e-29
 Identities = 67/223 (30%), Positives = 112/223 (50%), Gaps = 31/223 (13%)

Query: 76  IGEGSYGRVFYAKLTDGTP------AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +GEG++G+VF  +     P       A+K L  +++ +   DF  +  +++  +HE+ V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 130 LLGYCMESNNRILVYQFATMGSLHDVL--HGRKGV----QGAEPGPVLTWNQRVKVAYGA 183
             G C E +  I+V+++   G L+  L  HG          +  G  LT +Q +++A   
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE-LTLSQLLQIAVQI 131

Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST---RVL 240
           A G+ +L  +     VHRD+ + N L+  D   KI DF +   S D    +++T   RV 
Sbjct: 132 ASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGM---SRD----VYTTDYYRVG 181

Query: 241 GT----FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
           G       +  PE  M  + T +SDV+SFGVVL E+ T G++P
Sbjct: 182 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  115 bits (289), Expect = 3e-29
 Identities = 63/255 (24%), Positives = 110/255 (43%), Gaps = 30/255 (11%)

Query: 75  LIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESD--FAAQLSVVSRLKHE-HFVELL 131
            +GEGS+G V+ A+  D    A+K L      + +    F  ++ +++ L H  + V+L 
Sbjct: 7   KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
            +  +  +  LV ++   GSL D+L              L+ ++ + +       LE+LH
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIG------RKGPLSESEALFILAQILSALEYLH 118

Query: 192 EKVQPPIVHRDVRSSNVLL-FDDFKSKIADF----NLTNQSSDTAARLHSTRVLGTFGYH 246
            K    I+HRD++  N+LL  D    K+ DF     L +  S ++     +  +GT GY 
Sbjct: 119 SK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 247 APEYAM---TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV 303
           APE  +       +  SD++S G+ L ELLTG  P         +     +    +   +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP--------FEGEKNSSATSQTLKII 227

Query: 304 KQCVDPKLNNDYPPK 318
            +   P L +   P 
Sbjct: 228 LELPTPSLASPLSPS 242

Length = 384

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 8e-28
 Identities = 70/210 (33%), Positives = 109/210 (51%), Gaps = 25/210 (11%)

Query: 73  KALIGEGSYGRVFYAKLTDGTPAAIKKL-DTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
            A IG+G +G V       G   A+K L D S+A +    F A+ SV++ L+H + V+LL
Sbjct: 11  GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ---AFLAEASVMTTLRHPNLVQLL 66

Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G  ++ N   +V ++   GSL D L  R G        V+T  Q++  A    +G+E+L 
Sbjct: 67  GVVLQGNPLYIVTEYMAKGSLVDYLRSR-GRA------VITLAQQLGFALDVCEGMEYLE 119

Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPE 249
           EK     VHRD+ + NVL+ +D  +K++DF L  ++S            G     + APE
Sbjct: 120 EK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-------SGKLPVKWTAPE 169

Query: 250 YAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
                + + KSDV+SFG++L E+ + GR P
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  107 bits (269), Expect = 7e-27
 Identities = 74/282 (26%), Positives = 118/282 (41%), Gaps = 40/282 (14%)

Query: 76  IGEGSYGRVF---YAKLTDGTPA--AIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +GEG +G+V    Y  L D T    A+K L+ S   +  SDF  ++ ++  L HE+ V+ 
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71

Query: 131 LGYCMESNNRI--LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C +   R   L+ ++   GSL D L   +     +        + +  +    KG++
Sbjct: 72  KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK--------RLLLFSSQICKGMD 123

Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT---NQSSDTAARLHSTRVLGTFGY 245
           +L  +     +HRD+ + N+L+  +   KI+DF L     +  D    +        F Y
Sbjct: 124 YLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYY-YVKEPGESPIFWY 179

Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLT-GRK-------PVDHTMPKGQQSLVTWATPR 297
            APE   T + +  SDV+SFGV L EL T G          +        Q +VT     
Sbjct: 180 -APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238

Query: 298 LSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP 339
           L E         +L    PP    ++  +  LC + E   RP
Sbjct: 239 LKE-------GERLPR--PPSCPDEVYDLMKLCWEAEPQDRP 271

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  105 bits (265), Expect = 1e-26
 Identities = 72/236 (30%), Positives = 112/236 (47%), Gaps = 44/236 (18%)

Query: 54  EIP--QIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSS-APEPES 110
           EIP   +KL+   +L          G G +G V+       T  A+K L   + +PE   
Sbjct: 2   EIPRESLKLER--KL----------GAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE--- 46

Query: 111 DFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPV 170
            F  +  ++ +L+H+  V+L   C E     +V ++ + GSL D L           G  
Sbjct: 47  AFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKS-------GEGKK 99

Query: 171 LTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT 230
           L   Q V +A   A+G+ +L  +     +HRD+ + N+L+ ++   KIADF L       
Sbjct: 100 LRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGL------- 149

Query: 231 AARL-----HSTRVLGTF--GYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
            ARL     ++ R    F   + APE A  G+ T KSDV+SFG++L E++T GR P
Sbjct: 150 -ARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  104 bits (261), Expect = 7e-26
 Identities = 60/252 (23%), Positives = 108/252 (42%), Gaps = 36/252 (14%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQ-LSVVSRLKHEHFVELLG 132
            IG+GS+G+V+  +  +DG    +K++D S+  E E + A   + ++ +L H + ++   
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66

Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
              E     +V ++A  G L   +  +K     + G      Q +         L++LH 
Sbjct: 67  SFEEKGKLCIVMEYADGGDLSQKIKKQK-----KEGKPFPEEQILDWFVQLCLALKYLHS 121

Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE--- 249
           +    I+HRD++  N+ L  +   K+ DF ++   S T     +  V+GT  Y +PE   
Sbjct: 122 R---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPELCQ 176

Query: 250 ---YAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC 306
              Y        KSD++S G VL EL T + P +         L           K+ + 
Sbjct: 177 NKPY------NYKSDIWSLGCVLYELCTLKHPFEGE---NLLELAL---------KILKG 218

Query: 307 VDPKLNNDYPPK 318
             P + + Y  +
Sbjct: 219 QYPPIPSQYSSE 230

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  104 bits (261), Expect = 7e-26
 Identities = 63/219 (28%), Positives = 109/219 (49%), Gaps = 21/219 (9%)

Query: 76  IGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +GEG++G+V+  +LT        T  AIK L  ++ P+ + +F  +  ++S L+H + V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRK-------GVQGAEPGPVLTWNQRVKVAYG 182
           LLG C +     +++++   G LH+ L                     L  +  + +A  
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ--SSDTAARLHSTRVL 240
            A G+E+L        VHRD+ + N L+ +    KI+DF L+    S+D   R+ S  +L
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY-YRVQSKSLL 188

Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
               +  PE  + G+ T +SD++SFGVVL E+ + G +P
Sbjct: 189 -PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  103 bits (259), Expect = 2e-25
 Identities = 83/299 (27%), Positives = 136/299 (45%), Gaps = 31/299 (10%)

Query: 69  NFGTKALIGEGSYGRVFYAKLTDGTP------AAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           N   K  +GEG++G+VF A+  +  P       A+K L  +S      DF  +  +++ L
Sbjct: 6   NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNL 64

Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVL--HGRKGVQGAEPGPV--LTWNQRVK 178
           +HEH V+  G C+E +  I+V+++   G L+  L  HG   V  AE      LT +Q + 
Sbjct: 65  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124

Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
           +A   A G+ +L  +     VHRD+ + N L+ ++   KI DF ++     T        
Sbjct: 125 IAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181

Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPR 297
            +    +  PE  M  + T +SDV+S GVVL E+ T G++P              W   +
Sbjct: 182 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP--------------WY--Q 225

Query: 298 LSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP 356
           LS ++V +C+        P     ++  +   C Q E   R N+  +   LQ L  + P
Sbjct: 226 LSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 3e-25
 Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 20/214 (9%)

Query: 69  NFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPE-SDFAAQLSVVSRLKHEH 126
           N+    LIG G++G V+    L  G   AIK++      E        ++ ++  LKH +
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVL--HGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            V+ +G    S++  ++ ++A  GSL  ++   G               +      Y   
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP-----------FPESLVAVYVYQVL 109

Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
           +GL +LHE+    ++HRD++++N+L   D   K+ADF +  + +D +    S  V+GT  
Sbjct: 110 QGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPY 164

Query: 245 YHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           + APE       +  SD++S G  ++ELLTG  P
Sbjct: 165 WMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  102 bits (255), Expect = 4e-25
 Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 13/199 (6%)

Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V+     +    AIK L +    + + DF  ++  + RL+H+H + L   C 
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQ-DFQKEVQALKRLRHKHLISLFAVCS 72

Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
                 ++ +    GSL   L        +  G VL     + +A   A+G+ +L E+  
Sbjct: 73  VGEPVYIITELMEKGSLLAFL-------RSPEGQVLPVASLIDMACQVAEGMAYLEEQ-- 123

Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQ 255
              +HRD+ + N+L+ +D   K+ADF L     +        ++   + + APE A  G 
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGT 180

Query: 256 ITQKSDVYSFGVVLLELLT 274
            + KSDV+SFG++L E+ T
Sbjct: 181 FSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 99.1 bits (247), Expect = 4e-24
 Identities = 72/276 (26%), Positives = 119/276 (43%), Gaps = 30/276 (10%)

Query: 69  NFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAA-QLSVVSRLKHEH 126
           +F     IG+GS+G VF   +  D    A+K++D S     E + A  +  V+++L   +
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKG 186
            +      ++     +V ++A  G LH +L         + G  L  +Q  +       G
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLK-------MQRGRPLPEDQVWRFFIQILLG 113

Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           L  LH K    I+HRD++S N+ L      KI D  +    SD      +  ++GT  Y 
Sbjct: 114 LAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NFANTIVGTPYYL 168

Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC 306
           +PE        +KSDV++ GVVL E  TG+ P D      Q +L+          K+ + 
Sbjct: 169 SPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD---ANNQGALIL---------KIIRG 216

Query: 307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMT 342
           V P ++  Y      +LA +   C+  +   RP+  
Sbjct: 217 VFPPVSQMYSQ----QLAQLIDQCLTKDYRQRPDTF 248

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 97.8 bits (244), Expect = 2e-23
 Identities = 73/258 (28%), Positives = 112/258 (43%), Gaps = 31/258 (12%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           +G G+ G V        G   A+K +        +     +L ++ +    + V   G  
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
             + +  +  ++   GSL  +L   K VQG  P  +L      K+A    KGL +LHEK 
Sbjct: 69  YNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILG-----KIAVAVLKGLTYLHEKH 120

Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
           +  I+HRDV+ SN+L+    + K+ DF ++ Q  ++ A+   T V GT  Y APE     
Sbjct: 121 K--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK---TFV-GTSSYMAPERIQGN 174

Query: 255 QITQKSDVYSFGVVLLELLTGRKPV-----DHTMPKGQ-QSLVTWATPRLSEDK------ 302
             + KSD++S G+ L+EL TGR P               Q +V    PRL   K      
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQ 234

Query: 303 --VKQCV--DPKLNNDYP 316
             V  C+  DP+    Y 
Sbjct: 235 DFVNLCLIKDPRERPSYK 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 96.3 bits (240), Expect = 4e-23
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 19/211 (9%)

Query: 75  LIGEGSYGRVFYAKLTDGT----PAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
            +G+GS+G V   + +       P A+K L +    +   DF  + +++  L HE+ + L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
            G  +     ++V + A +GSL D L  RK   G      L  +  V++A     G+ +L
Sbjct: 62  YGVVLTHP-LMMVTELAPLGSLLDRL--RKDALGHFLISTL-CDYAVQIA----NGMRYL 113

Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ--SSDTAARLHSTRVLGTFGYHAP 248
             K     +HRD+ + N+LL  D K KI DF L      ++    +     +  F + AP
Sbjct: 114 ESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAP 169

Query: 249 EYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
           E   T   +  SDV+ FGV L E+ T G +P
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 96.3 bits (240), Expect = 6e-23
 Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 18/213 (8%)

Query: 74  ALIGEGSYGRVFYAKLT-DG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
            ++G G++G V+      +G     P AIK L   ++P+   +   +  V++ + H H V
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 129 ELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            LLG C+ S+   L+ Q   +G L D +   K   G++   +L W  ++      AKG+ 
Sbjct: 73  RLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQY--LLNWCVQI------AKGMS 123

Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +L EK    +VHRD+ + NVL+      KI DF L           H+        + A 
Sbjct: 124 YLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180

Query: 249 EYAMTGQITQKSDVYSFGVVLLELLT-GRKPVD 280
           E  +    T KSDV+S+GV + EL+T G KP +
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 96.2 bits (239), Expect = 9e-23
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 19/217 (8%)

Query: 76  IGEGSYGRVFYAKLTDGTP------AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +GEG++G+VF A+  +  P       A+K L  +S      DF  +  +++ L+H+H V 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE-SARQDFQREAELLTVLQHQHIVR 71

Query: 130 LLGYCMESNNRILVYQFATMGSLHDVL--HGR-----KGVQGAEPGPVLTWNQRVKVAYG 182
             G C E    ++V+++   G L+  L  HG       G +   PG  LT  Q + +A  
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQ-LTLGQMLAIASQ 130

Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            A G+ +L        VHRD+ + N L+      KI DF ++     T       R +  
Sbjct: 131 IASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187

Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
             +  PE  +  + T +SD++SFGVVL E+ T G++P
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 95.2 bits (237), Expect = 2e-22
 Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 19/215 (8%)

Query: 75  LIGEGSYGRVFYA------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHF 127
            +GEG++G+V  A         + +  A+K L   +  +  SD  +++ ++  + KH++ 
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGR-------KGVQGAEPGPVLTWNQRVKVA 180
           + LLG C +     +V ++A  G+L D L  R              P   LT    V  A
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           Y  A+G+EFL  K     +HRD+ + NVL+ +D   KIADF L            +T   
Sbjct: 139 YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 241 GTFGYHAPEYAMTGQI-TQKSDVYSFGVVLLELLT 274
               + APE A+  ++ T +SDV+SFGV+L E+ T
Sbjct: 196 LPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 93.6 bits (233), Expect = 4e-22
 Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 28/211 (13%)

Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V+     + TP A+K L   +  +P+ DF A+  ++ +L+H   ++L   C 
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPK-DFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
                 +V +    GSL + L G  G         L   Q + +A   A G+ +L  +  
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRA-------LKLPQLIDMAAQVASGMAYLEAQ-- 122

Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARL-----HSTRVLGTF--GYHAP 248
              +HRD+ + NVL+ ++   K+ADF L        AR+     +  R    F   + AP
Sbjct: 123 -NYIHRDLAARNVLVGENNICKVADFGL--------ARVIKEDIYEAREGAKFPIKWTAP 173

Query: 249 EYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
           E A+  + + KSDV+SFG++L E++T GR P
Sbjct: 174 EAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 93.3 bits (232), Expect = 6e-22
 Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 34/278 (12%)

Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPE-SDFAAQLSVVSRLKHEH 126
           +F     +G+GSYG V+  K L+D    A+K++D  S  + E  D   ++ +++ + H +
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPV-LTWNQRVKVAYGAAK 185
            +      ++ N   +V ++A  G L   +   K  +  +  P    W   +++     +
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAI--SKRKKKRKLIPEQEIWRIFIQLL----R 114

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           GL+ LHE+    I+HRD++S+N+LL  +   KI D  ++       A+      +GT  Y
Sbjct: 115 GLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK----TQIGTPHY 167

Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD-HTMPKGQQSLVTWATPRLSEDKVK 304
            APE       + KSD++S G +L E+ T   P +  +M   +  +     P +      
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI------ 221

Query: 305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMT 342
                      PP     L       +Q +   RPN  
Sbjct: 222 -----------PPIYSQDLQNFIRSMLQVKPKLRPNCD 248

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 93.2 bits (231), Expect = 8e-22
 Identities = 82/268 (30%), Positives = 127/268 (47%), Gaps = 37/268 (13%)

Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G+G +G V+       T  AIK L   +   PE+ F  +  V+ +L+HE  V+L  Y +
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEA-FLQEAQVMKKLRHEKLVQL--YAV 69

Query: 136 ESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            S   I +V ++ + GSL D L G       E G  L   Q V +A   A G+ ++ E++
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYV-ERM 121

Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAM 252
               VHRD+R++N+L+ ++   K+ADF L     D     ++ R    F   + APE A+
Sbjct: 122 N--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 176

Query: 253 TGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKL 311
            G+ T KSDV+SFG++L EL T GR P                 P +   +V   V+   
Sbjct: 177 YGRFTIKSDVWSFGILLTELTTKGRVPY----------------PGMVNREVLDQVERGY 220

Query: 312 NNDYPPKAIAKLAAVAALCVQYEADFRP 339
               PP+    L  +   C + E + RP
Sbjct: 221 RMPCPPECPESLHDLMCQCWRKEPEERP 248

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 92.7 bits (231), Expect = 8e-22
 Identities = 65/250 (26%), Positives = 119/250 (47%), Gaps = 29/250 (11%)

Query: 75  LIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
            +GEGSYG V+ A     G   AIK +      +   +   ++S++ +    + V+  G 
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ---EIIKEISILKQCDSPYIVKYYGS 66

Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             ++ +  +V ++   GS+ D++              LT  +   + Y   KGLE+LH  
Sbjct: 67  YFKNTDLWIVMEYCGAGSVSDIMKIT--------NKTLTEEEIAAILYQTLKGLEYLHSN 118

Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
                +HRD+++ N+LL ++ ++K+ADF ++ Q +DT A+ ++  V+GT  + APE    
Sbjct: 119 ---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQE 173

Query: 254 GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLV-TWATPRLSE---------DKV 303
                K+D++S G+  +E+  G+ P     P     ++     P LS+         D V
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFV 233

Query: 304 KQC--VDPKL 311
           K+C   DP+ 
Sbjct: 234 KKCLVKDPEE 243

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 91.9 bits (228), Expect = 2e-21
 Identities = 72/279 (25%), Positives = 133/279 (47%), Gaps = 41/279 (14%)

Query: 74  ALIGEGSYGRVFYAKLTDGTPAAIK--KLDTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
            +IGEG +G V   + T G   A+K  K D ++       F  + +V+++L H++ V LL
Sbjct: 12  EIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA-----FLEETAVMTKLHHKNLVRLL 65

Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G  +  N   +V +  + G+L + L  R   +           Q ++ +   A+G+E+L 
Sbjct: 66  GVILH-NGLYIVMELMSKGNLVNFLRTRG--RALVSVI-----QLLQFSLDVAEGMEYLE 117

Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA 251
            K    +VHRD+ + N+L+ +D  +K++DF L    S     + ++++     + APE  
Sbjct: 118 SK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---VDNSKL--PVKWTAPEAL 169

Query: 252 MTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPK 310
              + + KSDV+S+GV+L E+ + GR P                 P++S  +VK+CV+  
Sbjct: 170 KHKKFSSKSDVWSYGVLLWEVFSYGRAPY----------------PKMSLKEVKECVEKG 213

Query: 311 LNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ 349
              + P    A +  +   C + E   RP+   + + L+
Sbjct: 214 YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 91.8 bits (228), Expect = 2e-21
 Identities = 66/283 (23%), Positives = 127/283 (44%), Gaps = 42/283 (14%)

Query: 75  LIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
            IG+G++G V+   L   T  A+K   ++  P+ +  F  +  ++ +  H + V+L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
           ++     +V +    GSL   L  +K          LT  + ++++  AA G+E+L  K 
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKN--------RLTVKKLLQMSLDAAAGMEYLESK- 112

Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
               +HRD+ + N L+ ++   KI+DF ++ +       +          + APE    G
Sbjct: 113 --NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYG 170

Query: 255 QITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD----- 308
           + T +SDV+S+G++L E  + G  P                 P +S  + ++ ++     
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPY----------------PGMSNQQTRERIESGYRM 214

Query: 309 --PKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ 349
             P+L     P+ I +L      C  Y+ + RP+ + +   LQ
Sbjct: 215 PAPQLC----PEEIYRL---MLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 91.6 bits (228), Expect = 2e-21
 Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 26/213 (12%)

Query: 76  IGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
           IG G +G V   +L          AIK L   S+ +   DF  + S++ +  H + + L 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G   +S   +++ ++   GSL   L    G          T  Q V +  G A G+++L 
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLRENDG--------KFTVGQLVGMLRGIASGMKYLS 123

Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR-----VLGTFGYH 246
           E      VHRD+ + N+L+  +   K++DF L+ +  D+ A  ++T+     +  T    
Sbjct: 124 EMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT-YTTKGGKIPIRWT---- 175

Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
           APE     + T  SDV+SFG+V+ E+++ G +P
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 91.4 bits (227), Expect = 3e-21
 Identities = 67/276 (24%), Positives = 110/276 (39%), Gaps = 35/276 (12%)

Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V   K       AIK +   +  E   DF  +  V+ +L H + V+L G C 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE--DDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           +     +V ++   G L + L  RKG  G E          + +     + +E+L     
Sbjct: 70  KQRPIFIVTEYMANGCLLNYLRERKGKLGTE--------WLLDMCSDVCEAMEYLESN-- 119

Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT---FGYHAPEYAM 252
              +HRD+ + N L+ +D   K++DF L     D       T   GT     +  PE   
Sbjct: 120 -GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD----QYTSSQGTKFPVKWAPPEVFD 174

Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLN 312
             + + KSDV+SFGV++ E+ +  K     MP            R S  +V + V     
Sbjct: 175 YSRFSSKSDVWSFGVLMWEVFSEGK-----MP----------YERFSNSEVVESVSAGYR 219

Query: 313 NDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKAL 348
              P  A  ++  +   C   + + RP    ++  L
Sbjct: 220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 91.4 bits (227), Expect = 3e-21
 Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 14/215 (6%)

Query: 68  SNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSR 121
           SN      +G G +G VF AK          T   +K L  +     +S+F  +L +  +
Sbjct: 5   SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64

Query: 122 LKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY 181
           L H++ V LLG C E+    ++ ++  +G L   L   K        P L+  Q+V +  
Sbjct: 65  LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124

Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAAR--LHSTRV 239
             A G++ L        VHRD+ + N L+    + K++  +L+    D            
Sbjct: 125 QIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK---DVYNSEYYKLRNA 178

Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
           L    + APE       + KSDV+SFGV++ E+ T
Sbjct: 179 LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 91.3 bits (227), Expect = 4e-21
 Identities = 76/283 (26%), Positives = 120/283 (42%), Gaps = 27/283 (9%)

Query: 76  IGEGSYGRVF--YAK--LTD--GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G+GS+G V+   AK  +     T  AIK ++ +++     +F  + SV+      H V 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHG-RKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
           LLG        ++V +    G L   L   R   +        T  + +++A   A G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +L  K     VHRD+ + N ++ +D   KI DF +T    +T       + L    + AP
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 249 EYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCV 307
           E    G  T KSDV+SFGVVL E+ T   +P                   LS ++V + V
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY----------------QGLSNEEVLKFV 234

Query: 308 DPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQP 350
               + D P     KL  +  +C QY    RP    +V +L+ 
Sbjct: 235 IDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 90.7 bits (226), Expect = 5e-21
 Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 30/220 (13%)

Query: 68  SNFGTKALIGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE 125
           S+     ++G+GS G V+    K T G   A+KK+      E       +L  +   +  
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPT-GKIYALKKIHVDGDEEFRKQLLRELKTLRSCESP 59

Query: 126 HFVELLG-YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
           + V+  G +  E    I V ++   GSL D+L     +    P PVL       +A    
Sbjct: 60  YVVKCYGAFYKEGEISI-VLEYMDGGSLADLLKKVGKI----PEPVLA-----YIARQIL 109

Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
           KGL++LH K    I+HRD++ SN+L+    + KIADF ++    +T  +  +T V GT  
Sbjct: 110 KGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-CNTFV-GTVT 165

Query: 245 YHAPE------YAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           Y +PE      Y+        +D++S G+ LLE   G+ P
Sbjct: 166 YMSPERIQGESYSY------AADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 90.6 bits (225), Expect = 8e-21
 Identities = 70/238 (29%), Positives = 111/238 (46%), Gaps = 32/238 (13%)

Query: 59  KLDELNRLTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLS 117
           K+ EL+RL          GEG+ G V   +L   G   A+K + T   P+ +     +L 
Sbjct: 2   KIVELSRL----------GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELE 51

Query: 118 VVSRLKHEHFVELLGYCM-ESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQ 175
           +    K  + V+  G  + ES++ I +  ++   GSL D ++ +   +G   G      +
Sbjct: 52  INKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIG------E 104

Query: 176 RV--KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAAR 233
           +V  K+A    KGL +LH +    I+HRD++ SN+LL    + K+ DF +   S +    
Sbjct: 105 KVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGV---SGELVNS 158

Query: 234 LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLV 291
           L  T   GT  Y APE       +  SDV+S G+ LLE+   R P     P+G+  L 
Sbjct: 159 LAGTFT-GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP---PEGEPPLG 212

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 90.1 bits (223), Expect = 9e-21
 Identities = 74/229 (32%), Positives = 114/229 (49%), Gaps = 31/229 (13%)

Query: 54  EIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFA 113
           EIP+  L  + +L          G G +G V+       T  A+K L   +   PES F 
Sbjct: 2   EIPRESLQLIKKL----------GNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPES-FL 49

Query: 114 AQLSVVSRLKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLT 172
            +  ++ +L+H+  V+L  Y + S   I +V ++ + GSL D L   +G     P     
Sbjct: 50  EEAQIMKKLRHDKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLP----- 102

Query: 173 WNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA 232
               V +A   A G+ ++ E++    +HRD+RS+N+L+ D    KIADF L     D   
Sbjct: 103 --NLVDMAAQVAAGMAYI-ERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE- 156

Query: 233 RLHSTRVLGTF--GYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
             ++ R    F   + APE A+ G+ T KSDV+SFG++L EL+T GR P
Sbjct: 157 --YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 90.1 bits (223), Expect = 1e-20
 Identities = 68/258 (26%), Positives = 126/258 (48%), Gaps = 38/258 (14%)

Query: 75  LIGEGSYGRVFYAKLT-DGTP--AAIKKLDTSSAPEPESDFAAQLSVVSRLKHE-HFVEL 130
           +IGEG++G+V  A++  DG    AAIK++   ++ +   DFA +L V+ +L H  + + L
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQ-----GAEPGPVLTWNQR--VKVAYGA 183
           LG C       L  ++A  G+L D L   + ++             T + +  +  A   
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
           A+G+++L +K     +HRD+ + N+L+ +++ +KIADF L+         ++  + +G  
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRL 173

Query: 244 G--YHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP--------VDHTMPKGQQSLVT 292
              + A E       T  SDV+S+GV+L E+++ G  P        +   +P+G +    
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR---- 229

Query: 293 WATPRLSEDKV----KQC 306
              P   +D+V    +QC
Sbjct: 230 LEKPLNCDDEVYDLMRQC 247

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 90.5 bits (224), Expect = 1e-20
 Identities = 68/213 (31%), Positives = 109/213 (51%), Gaps = 21/213 (9%)

Query: 75  LIGEGSYGRVFYAKLT-DGTP--AAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVEL 130
           +IGEG++G+V  A +  DG    AAIK L   ++     DFA +L V+ +L  H + + L
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68

Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQ-----GAEPG--PVLTWNQRVKVAYGA 183
           LG C       +  ++A  G+L D L   + ++       E G    LT  Q ++ A   
Sbjct: 69  LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128

Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
           A G+++L EK     +HRD+ + NVL+ ++  SKIADF L+         ++  + +G  
Sbjct: 129 ATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVKKTMGRL 180

Query: 244 G--YHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
              + A E       T KSDV+SFGV+L E+++
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 89.9 bits (223), Expect = 1e-20
 Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 36/289 (12%)

Query: 75  LIGEGSYGRVFYAKLTD----GT---PAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
            +G G++G V+    TD    G+     A+K L   +  + + +F  +  ++S   H + 
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61

Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
           V+LLG C+ +  + ++ +    G L   L  R         P+LT  + + +    AKG 
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYL--RDARVERFGPPLLTLKELLDICLDVAKGC 119

Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKS-----KIADFNLTNQ--SSDTAARLHSTRVL 240
            +L    Q   +HRD+ + N L+ +         KI DF L      SD   R     +L
Sbjct: 120 VYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY-YRKEGEGLL 175

Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE 300
               + APE  + G+ T +SDV+SFGV++ E+LT           GQQ       P L+ 
Sbjct: 176 -PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT----------LGQQPY-----PALNN 219

Query: 301 DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ 349
            +V Q V        P     K+  +   C   +   RP    + + LQ
Sbjct: 220 QEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 89.3 bits (222), Expect = 2e-20
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 29/214 (13%)

Query: 76  IGEGSYGRVF--YAKLTDGT--PAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
           +G G++G V      +  G     A+K L        + +F  + SV+++L H   V L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G C +    +LV + A +G L   L  R+ +  ++   +     +V      A G+ +L 
Sbjct: 63  GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSD---LKELAHQV------AMGMAYLE 112

Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG------Y 245
            K     VHRD+ + NVLL +  ++KI+DF ++      A    S     T        +
Sbjct: 113 SK---HFVHRDLAARNVLLVNRHQAKISDFGMSR-----ALGAGSDYYRATTAGRWPLKW 164

Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
           +APE    G+ + KSDV+S+GV L E  + G KP
Sbjct: 165 YAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 89.9 bits (224), Expect = 2e-20
 Identities = 55/210 (26%), Positives = 100/210 (47%), Gaps = 26/210 (12%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAA--QLSVVSRLKHEHFVELLG 132
           IGEG+YG+V+ A+    G   A+KK+   +  E      A  ++ ++ +L+H + V L  
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKE-GFPITAIREIKLLQKLRHPNIVRLKE 65

Query: 133 YC--MESNNRILVYQFATMGSLHDV--LHGRKGVQGAEPGPVLTWNQRVK-VAYGAAKGL 187
                   +  +V+++      HD+  L     V+  E         ++K       +GL
Sbjct: 66  IVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTES--------QIKCYMKQLLEGL 113

Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           ++LH      I+HRD++ SN+L+ +D   K+ADF L    +   +  ++ RV+ T  Y  
Sbjct: 114 QYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRP 169

Query: 248 PEYAM-TGQITQKSDVYSFGVVLLELLTGR 276
           PE  +   +   + D++S G +L EL  G+
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 88.5 bits (219), Expect = 3e-20
 Identities = 65/275 (23%), Positives = 117/275 (42%), Gaps = 27/275 (9%)

Query: 76  IGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG G++G VF  +L  D TP A+K    +  P+ ++ F  +  ++ +  H + V L+G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            +     +V +    G     L           GP L   + +++   AA G+E+L  K 
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTE--------GPRLKVKELIQMVENAAAGMEYLESKH 114

Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
               +HRD+ + N L+ +    KI+DF ++ +  D               + APE    G
Sbjct: 115 ---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYG 171

Query: 255 QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNND 314
           + + +SDV+SFG++L E                 SL       LS  + ++ ++  +   
Sbjct: 172 RYSSESDVWSFGILLWEAF---------------SLGAVPYANLSNQQTREAIEQGVRLP 216

Query: 315 YPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ 349
            P      +  +   C +Y+   RP+ + V + LQ
Sbjct: 217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 89.3 bits (221), Expect = 3e-20
 Identities = 60/238 (25%), Positives = 111/238 (46%), Gaps = 25/238 (10%)

Query: 76  IGEGSYGRVFYAKLTD------GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +GEG +G+V  A           T  A+K L  +++     D  ++ +++ ++ H H ++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGP---------------VLTWN 174
           L G C +    +L+ ++A  GSL   L   + V  +  G                 LT  
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 175 QRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARL 234
             +  A+  ++G+++L E     +VHRD+ + NVL+ +  K KI+DF L+    +  + +
Sbjct: 128 DLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 235 HSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLV 291
             ++      + A E       T +SDV+SFGV+L E++T G  P     P+   +L+
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLL 242

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 88.8 bits (220), Expect = 3e-20
 Identities = 74/288 (25%), Positives = 129/288 (44%), Gaps = 26/288 (9%)

Query: 76  IGEGSYGRVF---YAKLTDGTP--AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +GEG +G+V    Y    DGT    A+K L      +  S +  +++++  L HE+ V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 131 LGYCMESNNRI--LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C E   +   L+ ++  +GSL D L          P   L   Q +  A    +G+ 
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYL----------PKHKLNLAQLLLFAQQICEGMA 121

Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG---TFGY 245
           +LH +     +HRD+ + NVLL +D   KI DF L  ++       +  R  G    F Y
Sbjct: 122 YLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA-KAVPEGHEYYRVREDGDSPVFWY 177

Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ 305
            A E     + +  SDV+SFGV L ELLT       + PK  + ++     +++  ++ +
Sbjct: 178 -AVECLKENKFSYASDVWSFGVTLYELLTHCDS-KQSPPKKFEEMIGPKQGQMTVVRLIE 235

Query: 306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN 353
            ++  +    P     ++  +   C + EA FRP    ++  L+ + +
Sbjct: 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 88.3 bits (219), Expect = 5e-20
 Identities = 61/220 (27%), Positives = 108/220 (49%), Gaps = 32/220 (14%)

Query: 75  LIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK---------- 123
           LIG+G+YGRV+ A  +T G   A+K+++   A       + Q  +V  L+          
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELP-ATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 124 HEHFVELLGYCMESNNRILVY-QFATMGSLHDVL--HGRKGVQGAEPGPVLTWNQRVKVA 180
           H + V+ LG    +   + ++ ++   GS+   L  +GR      E   V  + ++V   
Sbjct: 67  HLNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGR-----FEEQLVRFFTEQV--- 117

Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
               +GL +LH K    I+HRD+++ N+L+  D   KI+DF ++ +S D      +  + 
Sbjct: 118 ---LEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ 171

Query: 241 GTFGYHAPEYAMTGQ--ITQKSDVYSFGVVLLELLTGRKP 278
           G+  + APE   +     + K D++S G V+LE+  GR+P
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 88.3 bits (219), Expect = 6e-20
 Identities = 77/304 (25%), Positives = 126/304 (41%), Gaps = 38/304 (12%)

Query: 56  PQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLT--DGTPA----AIKKLDTSSAPEPE 109
           P++  D +  L      +AL G G++G V+       DG       A+K L  S + + E
Sbjct: 1   PEVPRDSITLL------RAL-GHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDE 53

Query: 110 SDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGP 169
           SDF  +  ++S+  H++ V L+G   E   R ++ +    G L   L  R+     E   
Sbjct: 54  SDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFL--RENRPRPERPS 111

Query: 170 VLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD---DFKSKIADFNLTNQ 226
            LT    +  A   AKG ++L E      +HRD+ + N LL        +KIADF +   
Sbjct: 112 SLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARD 168

Query: 227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPK 285
               +      R +    +  PE  + G  T K+DV+SFGV+L E+ + G  P       
Sbjct: 169 IYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY------ 222

Query: 286 GQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVV 345
                     P  +  +V + V      D P      +  +   C Q+  + RPN   ++
Sbjct: 223 ----------PGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATIL 272

Query: 346 KALQ 349
           + +Q
Sbjct: 273 ERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 87.4 bits (216), Expect = 8e-20
 Identities = 82/278 (29%), Positives = 130/278 (46%), Gaps = 37/278 (13%)

Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G+G +G V+       T  AIK L   +   PE+ F  +  ++ +L+H+  V L  Y +
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEA-FLQEAQIMKKLRHDKLVPL--YAV 69

Query: 136 ESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            S   I +V +F   GSL D L  ++G      G  L   Q V +A   A G+ ++ E++
Sbjct: 70  VSEEPIYIVTEFMGKGSLLDFL--KEG-----DGKYLKLPQLVDMAAQIADGMAYI-ERM 121

Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAM 252
               +HRD+R++N+L+ D+   KIADF L     D     ++ R    F   + APE A+
Sbjct: 122 N--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 176

Query: 253 TGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKL 311
            G+ T KSDV+SFG++L EL+T GR P                 P +   +V + V+   
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPY----------------PGMVNREVLEQVERGY 220

Query: 312 NNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ 349
               P      L  +  LC + + D RP    +   L+
Sbjct: 221 RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 88.1 bits (218), Expect = 8e-20
 Identities = 81/314 (25%), Positives = 130/314 (41%), Gaps = 37/314 (11%)

Query: 54  EIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTD---GTP---AAIKKLDTSSAPE 107
           E+ + K+  L  L          G+GS+G V+     D   G      A+K ++ S++  
Sbjct: 2   EVSREKITLLREL----------GQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR 51

Query: 108 PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEP 167
              +F  + SV+      H V LLG   +    ++V +    G L   L   +      P
Sbjct: 52  ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 111

Query: 168 G-PVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ 226
           G P  T  + +++A   A G+ +L+ K     VHRD+ + N ++  DF  KI DF +T  
Sbjct: 112 GRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRD 168

Query: 227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKG 286
             +T       + L    + APE    G  T  SD++SFGVVL E+              
Sbjct: 169 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI-------------- 214

Query: 287 QQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK 346
             SL       LS ++V + V      D P     ++  +  +C Q+    RP    +V 
Sbjct: 215 -TSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273

Query: 347 ALQPLLNSKPAGPE 360
            L+  L+  P+ PE
Sbjct: 274 LLKDDLH--PSFPE 285

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 87.9 bits (218), Expect = 9e-20
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 22/210 (10%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELL-GY 133
           +G+G++G+V+ A+    G  AA K +   S  E E DF  ++ ++S  KH + V L   Y
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELE-DFMVEIDILSECKHPNIVGLYEAY 71

Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             E+   IL+ +F   G+L  ++         E    LT  Q   V     + L FLH  
Sbjct: 72  FYENKLWILI-EFCDGGALDSIM--------LELERGLTEPQIRYVCRQMLEALNFLHSH 122

Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               ++HRD+++ N+LL  D   K+ADF ++ ++  T  +  +   +GT  + APE    
Sbjct: 123 K---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVAC 177

Query: 254 GQITQ-----KSDVYSFGVVLLELLTGRKP 278
                     K+D++S G+ L+EL     P
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 87.8 bits (217), Expect = 1e-19
 Identities = 77/297 (25%), Positives = 133/297 (44%), Gaps = 32/297 (10%)

Query: 73  KALIGEGSYGRVFYAKLTDGTPAAIKKL-DTSSAPEP----ESDFAAQLSVVSRLKHEHF 127
           K  +GEG++G+VF A+  + +P   K L    +  +P      DF  +  +++ L+HEH 
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69

Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVL--HGRKGVQGAEPGPV-----LTWNQRVKVA 180
           V+  G C + +  I+V+++   G L+  L  HG   +   +  P      L  +Q + +A
Sbjct: 70  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
              A G+ +L  +     VHRD+ + N L+  +   KI DF ++     T         +
Sbjct: 130 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLS 299
               +  PE  M  + T +SDV+SFGV+L E+ T G++P              W   +LS
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--------------WF--QLS 230

Query: 300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP 356
             +V +C+      + P     ++  +   C Q E   R N+  + K L  L  + P
Sbjct: 231 NTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 86.7 bits (215), Expect = 1e-19
 Identities = 50/211 (23%), Positives = 100/211 (47%), Gaps = 14/211 (6%)

Query: 76  IGEGSYGR-VFYAKLTDGTPAAIKKLDTSSAPEPESDFAA-QLSVVSRLKHEHFVELLGY 133
           +G+G++G    Y +  D +    K+++ +   E E   A  ++ ++S L+H + +    +
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
            M+ N  ++  ++A  G+L+D +  +KG    E          +   +     + ++H+ 
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEE-------EMVLWYLFQIVSAVSYIHKA 120

Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               I+HRD+++ N+ L      K+ DF ++           +  V+GT  Y +PE    
Sbjct: 121 ---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE--YSMAETVVGTPYYMSPELCQG 175

Query: 254 GQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
            +   KSD+++ G VL ELLT ++  D T P
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRTFDATNP 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 87.1 bits (215), Expect = 2e-19
 Identities = 74/283 (26%), Positives = 123/283 (43%), Gaps = 36/283 (12%)

Query: 76  IGEGSYGRVFYAKLTDGTP---AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           IG+GS+G VF  K  D       AIK +D   A +   D   +++V+S+    +  +  G
Sbjct: 12  IGKGSFGEVF--KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
             ++     ++ ++   GS  D+L         EPGP L   Q   +     KGL++LH 
Sbjct: 70  SYLKDTKLWIIMEYLGGGSALDLL---------EPGP-LDETQIATILREILKGLDYLHS 119

Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           + +   +HRD++++NVLL +  + K+ADF +  Q +DT  ++     +GT  + APE   
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QIKRNTFVGTPFWMAPEVIK 174

Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLN 312
                 K+D++S G+  +EL  G  P     P     L+    P            P L 
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP------------PTLE 222

Query: 313 NDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK 355
            +Y       L      C+  E  FRP    ++K    +  +K
Sbjct: 223 GNYS----KPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK 261

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 87.4 bits (216), Expect = 2e-19
 Identities = 62/214 (28%), Positives = 111/214 (51%), Gaps = 23/214 (10%)

Query: 75  LIGEGSYGRVFYAKL-TDG--TPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVEL 130
           +IGEG++G+V  A++  DG    AAIK++   ++ +   DFA +L V+ +L  H + + L
Sbjct: 14  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73

Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPG--------PVLTWNQRVKVAYG 182
           LG C       L  ++A  G+L D L   + V   +P           L+  Q +  A  
Sbjct: 74  LGACEHRGYLYLAIEYAPHGNLLDFLRKSR-VLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            A+G+++L +K     +HRD+ + N+L+ +++ +KIADF L+         ++  + +G 
Sbjct: 133 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGR 184

Query: 243 FG--YHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
               + A E       T  SDV+S+GV+L E+++
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 86.4 bits (214), Expect = 2e-19
 Identities = 57/218 (26%), Positives = 111/218 (50%), Gaps = 25/218 (11%)

Query: 74  ALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESD--------FAAQLSVVSRLKH 124
           ALIG GS+G V+     + G   A+K+++  S      D         A +++++  L+H
Sbjct: 6   ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65

Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
           E+ V+ LG  +++++  +  ++   GS+  +L+      GA    ++    R  +     
Sbjct: 66  ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQIL----- 116

Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ----SSDTAARLHSTRVL 240
           KGL +LH +    I+HRD++ +N+L+ +    KI+DF ++ +    S  T        + 
Sbjct: 117 KGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ 173

Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           G+  + APE       T+K+D++S G +++E+LTG+ P
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 86.9 bits (215), Expect = 2e-19
 Identities = 62/229 (27%), Positives = 106/229 (46%), Gaps = 32/229 (13%)

Query: 73  KALIGEGSYGRV---------------FYAKLTDGTP--AAIKKLDTSSAPEPESDFAAQ 115
           K  +GEG +G V               F   +  G P   A+K L   +     +DF  +
Sbjct: 10  KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKE 69

Query: 116 LSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVL----------HGRKGVQGA 165
           + ++SRLK  + + LLG C++ +   ++ ++   G L+  L          +G   V  A
Sbjct: 70  VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129

Query: 166 EPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT- 224
              P ++++  + VA   A G+++L        VHRD+ + N L+ ++   KIADF ++ 
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSR 186

Query: 225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELL 273
           N  +    R+    VL    + A E  + G+ T  SDV++FGV L E+L
Sbjct: 187 NLYAGDYYRIQGRAVL-PIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 2e-19
 Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 37/223 (16%)

Query: 75  LIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLG 132
           +IGEG+YG+V+ A+    G   AIK +D     + E +   + +++ +   H +     G
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIKIMD--IIEDEEEEIKEEYNILRKYSNHPNIATFYG 70

Query: 133 YCMESNNRI------LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK---VAY-- 181
             ++ N         LV +    GS+ D+      V+G     +    +R+K   +AY  
Sbjct: 71  AFIKKNPPGNDDQLWLVMELCGGGSVTDL------VKG-----LRKKGKRLKEEWIAYIL 119

Query: 182 -GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
               +GL +LHE     ++HRD++  N+LL  + + K+ DF ++ Q   T  R ++   +
Sbjct: 120 RETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT--FI 174

Query: 241 GTFGYHAPE-----YAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           GT  + APE              +SDV+S G+  +EL  G+ P
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 88.4 bits (219), Expect = 5e-19
 Identities = 77/297 (25%), Positives = 134/297 (45%), Gaps = 30/297 (10%)

Query: 63  LNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKL-DTSSAPEPESDFAAQLSVVS 120
           +N + S+   + +I  G  G  +  K + +G    +K++ D +S P  E      ++ + 
Sbjct: 685 INDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSE------IADMG 738

Query: 121 RLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
           +L+H + V+L+G C       L++++    +L +VL              L+W +R K+A
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------------LSWERRRKIA 786

Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
            G AK L FLH +  P +V  ++    +++    +  +         +DT   + S    
Sbjct: 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISS---- 842

Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE 300
               Y APE   T  IT+KSD+Y FG++L+ELLTG+ P D        S+V WA    S+
Sbjct: 843 ---AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSD 898

Query: 301 DKVKQCVDPKLNNDYP--PKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK 355
             +   +DP +  D       I ++  +A  C   +   RP    V+K L+    S 
Sbjct: 899 CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955

Length = 968

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 84.7 bits (209), Expect = 6e-19
 Identities = 70/276 (25%), Positives = 121/276 (43%), Gaps = 31/276 (11%)

Query: 75  LIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           L+G+G++G VF   L D TP A+K        E +  F ++  ++ +  H + V+L+G C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            +     +V +    G     L  +K          L   Q VK A  AA G+ +L  K 
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKK--------DELKTKQLVKFALDAAAGMAYLESK- 112

Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT--FGYHAPEYAM 252
               +HRD+ + N L+ ++   KI+DF ++ Q  D    ++S+  L      + APE   
Sbjct: 113 --NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG---IYSSSGLKQIPIKWTAPEALN 167

Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLN 312
            G+ + +SDV+S+G++L E                 SL     P ++  + ++ V+    
Sbjct: 168 YGRYSSESDVWSYGILLWETF---------------SLGVCPYPGMTNQQAREQVEKGYR 212

Query: 313 NDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKAL 348
              P K    +  V   C  Y+ + RP  + + K L
Sbjct: 213 MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 85.8 bits (212), Expect = 7e-19
 Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 21/229 (9%)

Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYA--------KLTDGTPAAIKKLDTSSAPEPESDFA 113
           EL+R     G    +GEG +G+V  A        K       A+K L   +  +  SD  
Sbjct: 8   ELSRTRLTLGKP--LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLV 65

Query: 114 AQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRK--GVQGA----- 165
           +++ ++  + KH++ + LLG C +     ++ ++A+ G+L + L  R+  G+  +     
Sbjct: 66  SEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125

Query: 166 EPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN 225
            P   LT+   V  AY  A+G+E+L  +     +HRD+ + NVL+ +D   KIADF L  
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Query: 226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
              +      +T       + APE       T +SDV+SFGV+L E+ T
Sbjct: 183 DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 84.6 bits (209), Expect = 7e-19
 Identities = 70/249 (28%), Positives = 118/249 (47%), Gaps = 35/249 (14%)

Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           IG+G +G V       G   A+K +   +  +    F A+ SV+++L+H + V+LLG  +
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69

Query: 136 ESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
           E    + +V ++   GSL D L  R          VL  +  +K +    + +E+L    
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEAN- 121

Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT--AARLHSTRVLGTFGYHAPEYAM 252
               VHRD+ + NVL+ +D  +K++DF LT ++S T    +L          + APE   
Sbjct: 122 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-------PVKWTAPEALR 172

Query: 253 TGQITQKSDVYSFGVVLLELLT------GRKPVDHTMP---KGQQSLVTWATPRLSEDKV 303
             + + KSDV+SFG++L E+ +       R P+   +P   KG +       P +  D +
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVM 232

Query: 304 KQC--VDPK 310
           KQC  +D  
Sbjct: 233 KQCWHLDAA 241

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 85.4 bits (211), Expect = 8e-19
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 19/215 (8%)

Query: 76  IGEGSYGRVFYA--------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEH 126
           +GEG +G+V  A        K    T  A+K L + +  +  SD  +++ ++  + KH++
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRK--GVQ-----GAEPGPVLTWNQRVKV 179
            + LLG C +     ++ ++A+ G+L + L  R+  G++        P   L++   V  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
           AY  A+G+E+L  K     +HRD+ + NVL+ +D   KIADF L            +T  
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                + APE       T +SDV+SFGV+L E+ T
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 84.1 bits (208), Expect = 1e-18
 Identities = 71/229 (31%), Positives = 114/229 (49%), Gaps = 31/229 (13%)

Query: 54  EIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFA 113
           E+P+  L  + +L          G G +G V+       T  AIK L   S   PE+ F 
Sbjct: 2   EVPRETLKLVKKL----------GAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEA-FL 49

Query: 114 AQLSVVSRLKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLT 172
           A+ +++ +L+H   V L  Y + +   I ++ ++   GSL D L   +G++       LT
Sbjct: 50  AEANLMKQLQHPRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPEGIK-------LT 100

Query: 173 WNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA 232
            N+ + +A   A+G+ F+  K     +HRD+R++N+L+ +    KIADF L     D   
Sbjct: 101 INKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE- 156

Query: 233 RLHSTRVLGTF--GYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
             ++ R    F   + APE    G  T KSDV+SFG++L E++T GR P
Sbjct: 157 --YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 83.5 bits (206), Expect = 2e-18
 Identities = 58/216 (26%), Positives = 112/216 (51%), Gaps = 17/216 (7%)

Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVV--SRLKHE 125
            +     IGEGS+G+++ AK  +D     IK++D +  P  E + A++  V+  +++KH 
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKE-ASKKEVILLAKMKHP 59

Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
           + V       E+    +V ++   G L   ++ ++GV  +E   +L+W  ++ +      
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSE-DQILSWFVQISL------ 112

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFK-SKIADFNLTNQSSDTAARLHSTRVLGTFG 244
           GL+ +H++    I+HRD++S N+ L  +   +K+ DF +  Q +D+    ++   +GT  
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPY 167

Query: 245 YHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
           Y +PE         K+D++S G VL EL T + P +
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 83.6 bits (207), Expect = 2e-18
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 15/214 (7%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG G+   V+ A  L +    AIK++D         +   ++  +S+  H + V+     
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
           +  +   LV  + + GSL D+      ++ + P   L       V     KGLE+LH   
Sbjct: 69  VVGDELWLVMPYLSGGSLLDI------MKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122

Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR--VLGTFGYHAPEYAM 252
           Q   +HRD+++ N+LL +D   KIADF ++   +D   R    R   +GT  + APE  M
Sbjct: 123 Q---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VM 178

Query: 253 TGQ--ITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
                   K+D++SFG+  +EL TG  P     P
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 82.8 bits (204), Expect = 4e-18
 Identities = 69/282 (24%), Positives = 119/282 (42%), Gaps = 27/282 (9%)

Query: 76  IGEGSYGRVFYAKLTDG-------TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           +G+GS+G V Y  +  G       T  AIK ++ +++     +F  + SV+      H V
Sbjct: 14  LGQGSFGMV-YEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 129 ELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVL-TWNQRVKVAYGAAKGL 187
            LLG   +    +++ +  T G L   L   +      P     +  + +++A   A G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
            +L+       VHRD+ + N ++ +DF  KI DF +T    +T       + L    + +
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189

Query: 248 PEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCV 307
           PE    G  T  SDV+SFGVVL E+ T               L       +S ++V + V
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGMSNEQVLRFV 234

Query: 308 DPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ 349
                 D P      L  +  +C QY    RP+   ++ +++
Sbjct: 235 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 81.8 bits (203), Expect = 6e-18
 Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 31/216 (14%)

Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQL------SVVSRLKHEHFV 128
           +G+GS+G+V   +  D G   A+K L                      +++SR+ H   V
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI----IKRKEVEHTLTERNILSRINHPFIV 56

Query: 129 ELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA--AK 185
           +L  Y  ++  ++ LV ++A  G L   L  ++G    E         R +  Y A    
Sbjct: 57  KLH-YAFQTEEKLYLVLEYAPGGELFSHLS-KEGRFSEE---------RARF-YAAEIVL 104

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
            LE+LH      I++RD++  N+LL  D   K+ DF L  + S   +R ++    GT  Y
Sbjct: 105 ALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEY 159

Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDH 281
            APE  +     +  D +S GV+L E+LTG+ P   
Sbjct: 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 81.6 bits (201), Expect = 9e-18
 Identities = 73/239 (30%), Positives = 119/239 (49%), Gaps = 29/239 (12%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAA---QLSVVSRLKHEHFVELL 131
           IG G+YG V+ A+ +  G  AAIK +      EP  DFA    ++ ++   KH + V   
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKL----EPGEDFAVVQQEIIMMKDCKHSNIVAYF 72

Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G  +  +   +  +F   GSL D+ H          GP L+ +Q   V+    +GL +LH
Sbjct: 73  GSYLRRDKLWICMEFCGGGSLQDIYH--------VTGP-LSESQIAYVSRETLQGLYYLH 123

Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA 251
            K +   +HRD++ +N+LL D+   K+ADF ++ Q + T A+  S   +GT  + APE A
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEVA 178

Query: 252 MT---GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT---WATPRLSEDKVK 304
                G   Q  D+++ G+  +EL   + P+    P     L+T   +  P+L +DK+K
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKL-KDKMK 236

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 60/219 (27%), Positives = 105/219 (47%), Gaps = 21/219 (9%)

Query: 76  IGEGSYGRVFYAKL-----TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +GE ++G+++   L           AIK L   + P+   +F  + S+++ L H + V L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 131 LGYCMESNNRILVYQFATMGSLHDVL-----HGRKGVQGAEPGPV---LTWNQRVKVAYG 182
           LG   +     +++++   G LH+ L     H   G    E G V   L     + +A  
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ--SSDTAARLHSTRVL 240
            A G+E+L        VH+D+ + N+L+ +    KI+D  L+ +  S+D   R+    +L
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADY-YRVQPKSLL 188

Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
               +  PE  M G+ +  SD++SFGVVL E+ + G +P
Sbjct: 189 -PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 64/238 (26%), Positives = 113/238 (47%), Gaps = 23/238 (9%)

Query: 54  EIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYA--------KLTDGTPAAIKKLDTSSA 105
           E+P+    E +R     G    +GEG +G+V  A        K  +    A+K L   + 
Sbjct: 3   ELPEDPRWEFSRDKLTLGKP--LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT 60

Query: 106 PEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQG 164
            +  SD  +++ ++  + KH++ + LLG C +     ++ ++A+ G+L + L  R+   G
Sbjct: 61  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP-G 119

Query: 165 AE--------PGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS 216
            E        P   +T+   V   Y  A+G+E+L  +     +HRD+ + NVL+ ++   
Sbjct: 120 MEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVM 176

Query: 217 KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
           KIADF L    ++      +T       + APE       T +SDV+SFGV++ E+ T
Sbjct: 177 KIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 81.3 bits (201), Expect = 1e-17
 Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 21/210 (10%)

Query: 75  LIGEGSYGRVFYA-KLTDGTPAAIKK----LDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           L+G GS+G V+    L DG   A+K+     D  +  E       +++++S+L+H + V+
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
            LG   E +N  +  +    GSL  +L       G+ P PV+    R  +      GLE+
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLYTRQIL-----LGLEY 117

Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE 249
           LH++     VHRD++ +N+L+  +   K+ADF +  Q  + +    +    G+  + APE
Sbjct: 118 LHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF---AKSFKGSPYWMAPE 171

Query: 250 YAM-TGQITQKSDVYSFGVVLLELLTGRKP 278
                G     +D++S G  +LE+ TG+ P
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 64/237 (27%), Positives = 103/237 (43%), Gaps = 33/237 (13%)

Query: 52  PIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAK---LTDGTPA---AIKKLDTSSA 105
           P ++P     E  R   +FG    +G G++G+V  A    L+        A+K L  ++ 
Sbjct: 21  PTQLPYDLKWEFPRNNLSFGK--TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH 78

Query: 106 PEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQG 164
                   ++L ++S L  HE+ V LLG C      +++ ++   G L + L  ++    
Sbjct: 79  SSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRES-- 136

Query: 165 AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL- 223
                 LT    +  +Y  AKG+ FL  K     +HRD+ + NVLL      KI DF L 
Sbjct: 137 -----FLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLA 188

Query: 224 ------TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                 +N      ARL          + APE       T +SDV+S+G++L E+ +
Sbjct: 189 RDIMNDSNYVVKGNARL-------PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 53/205 (25%), Positives = 102/205 (49%), Gaps = 16/205 (7%)

Query: 75  LIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
            IG+GS+G V+ A         AIK +D   A +   D   ++  +S+ +  +  +  G 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
            ++ +   ++ ++   GS  D+L         +PG  L       +      GLE+LHE+
Sbjct: 68  FLKGSKLWIIMEYCGGGSCLDLL---------KPGK-LDETYIAFILREVLLGLEYLHEE 117

Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
            +   +HRD++++N+LL ++   K+ADF ++ Q + T ++ ++   +GT  + APE    
Sbjct: 118 GK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF--VGTPFWMAPEVIKQ 172

Query: 254 GQITQKSDVYSFGVVLLELLTGRKP 278
               +K+D++S G+  +EL  G  P
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 80.7 bits (199), Expect = 2e-17
 Identities = 67/277 (24%), Positives = 124/277 (44%), Gaps = 35/277 (12%)

Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V Y K       AIK +   S  E E  F  +  V+ +L HE  V+L G C 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE--FIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           +     +V ++ + G L + L  R+  +  +P      +Q +++     +G+ +L  K  
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYL--REHGKRFQP------SQLLEMCKDVCEGMAYLESK-- 119

Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAMT 253
              +HRD+ + N L+ D    K++DF L+    D     +++ V   F   +  PE  + 
Sbjct: 120 -QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLLY 175

Query: 254 GQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLN 312
            + + KSDV++FGV++ E+ + G+ P +                R +  +  + V   L 
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYSLGKMPYE----------------RFNNSETVEKVSQGLR 219

Query: 313 NDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ 349
              P  A  K+ A+   C   +A+ RP    ++ +++
Sbjct: 220 LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 79.9 bits (197), Expect = 4e-17
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 24/206 (11%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFA-AQLSVVSRLKHEHFVELLGY 133
           IGEGS+G+    K   DG    IK+++ S     E + +  +++V+S +KH + V+    
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67

Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             E+ N  +V  +   G L+  ++ ++GV   E   +L W  ++ +A      L+ +H++
Sbjct: 68  FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPED-QILDWFVQICLA------LKHVHDR 120

Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL-----GTFGYHAP 248
               I+HRD++S N+ L  D   K+ DF +       A  L+ST  L     GT  Y +P
Sbjct: 121 ---KILHRDIKSQNIFLTKDGTIKLGDFGI-------ARVLNSTVELARTCIGTPYYLSP 170

Query: 249 EYAMTGQITQKSDVYSFGVVLLELLT 274
           E         KSD+++ G VL E+ T
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 80.8 bits (199), Expect = 4e-17
 Identities = 58/220 (26%), Positives = 104/220 (47%), Gaps = 29/220 (13%)

Query: 76  IGEGSYGRVFYAKLTDGTP--------AAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEH 126
           +GEG +G+V  A+               A+K L  ++  +  +D  +++ ++  + KH++
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGP------------VLTWN 174
            + LLG C +     ++ ++A  G+L + L  R+      PGP             L++ 
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARR-----PPGPDYTFDITKVPEEQLSFK 134

Query: 175 QRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARL 234
             V  AY  A+G+E+L  +     +HRD+ + NVL+ +D   KIADF L     D     
Sbjct: 135 DLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191

Query: 235 HSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
            ++       + APE       T +SDV+SFG+++ E+ T
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 80.3 bits (198), Expect = 4e-17
 Identities = 59/224 (26%), Positives = 108/224 (48%), Gaps = 25/224 (11%)

Query: 76  IGEGSYGRVFYAK---LTDGTP---AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           IG+G++GRVF A+   L    P    A+K L   ++ + ++DF  + ++++   H + V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGR-------------KGVQGAEPGPVLTWNQR 176
           LLG C       L++++   G L++ L  R                +       L+  ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT-NQSSDTAARLH 235
           + +A   A G+ +L E+     VHRD+ + N L+ ++   KIADF L+ N  S    +  
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
               +    +  PE     + T +SDV+++GVVL E+ + G +P
Sbjct: 190 ENDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 80.2 bits (198), Expect = 5e-17
 Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 27/210 (12%)

Query: 76  IGEGSYGRVFYAKLT-DGTPAAIKKLDTS--SAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           IG GS+G V++A+        AIKK+  S   + E   D   ++  + +L+H + +E  G
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 133 YCMESNNRILVYQFATMGSLHDVLH-GRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
             +  +   LV ++  +GS  D+L   +K +Q  E            + +GA +GL +LH
Sbjct: 83  CYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIA---------AICHGALQGLAYLH 132

Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE-- 249
              +   +HRD+++ N+LL +    K+ADF     S+   +  +S   +GT  + APE  
Sbjct: 133 SHER---IHRDIKAGNILLTEPGTVKLADFG----SASLVSPANS--FVGTPYWMAPEVI 183

Query: 250 YAM-TGQITQKSDVYSFGVVLLELLTGRKP 278
            AM  GQ   K DV+S G+  +E L  RKP
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIE-LAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 80.1 bits (197), Expect = 5e-17
 Identities = 76/273 (27%), Positives = 121/273 (44%), Gaps = 38/273 (13%)

Query: 75  LIGEGSYGRVFYAKL-----TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           ++G G++G V+         T   P AIK L+ ++ P+   +F  +  +++ + H H V 
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           LLG C+    + LV Q    G L D +H  K   G++   +L W  ++      AKG+ +
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQ--LLLNWCVQI------AKGMMY 124

Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE 249
           L E+    +VHRD+ + NVL+      KI DF L           ++        + A E
Sbjct: 125 LEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 181

Query: 250 YAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSE--DKVKQC 306
                + T +SDV+S+GV + EL+T G KP D         + T   P L E  +++ Q 
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD--------GIPTREIPDLLEKGERLPQ- 232

Query: 307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP 339
                    PP     +  V   C   +AD RP
Sbjct: 233 ---------PPICTIDVYMVMVKCWMIDADSRP 256

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 79.2 bits (195), Expect = 6e-17
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 21/210 (10%)

Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           IG G +G V+     +    AIK +   +  E   DF  +  V+ +L H   V+L G C 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE--EDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           E +   LV++F   G L D L  ++G    E          + +     +G+ +L     
Sbjct: 70  ERSPICLVFEFMEHGCLSDYLRAQRGKFSQE--------TLLGMCLDVCEGMAYLESSN- 120

Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT---FGYHAPEYAM 252
             ++HRD+ + N L+ ++   K++DF +T    D       T   GT     + +PE   
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD----QYTSSTGTKFPVKWSSPEVFS 174

Query: 253 TGQITQKSDVYSFGVVLLELLT-GRKPVDH 281
             + + KSDV+SFGV++ E+ + G+ P ++
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 79.8 bits (197), Expect = 6e-17
 Identities = 68/213 (31%), Positives = 100/213 (46%), Gaps = 30/213 (14%)

Query: 75  LIGEGSYGRV---FYAKLTDGTPA--AIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
            +G+G++G V    Y  L D T    A+KKL  S+  E   DF  ++ ++  L+H++ V+
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVK 69

Query: 130 LLGYC--MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
             G C      N  LV ++   GSL D L   +          L   + +  A    KG+
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR--------ERLDHRKLLLYASQICKGM 121

Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN---QSSDTAARLHSTRVLG--- 241
           E+L  K     VHRD+ + N+L+  + + KI DF LT    Q  +     +  R  G   
Sbjct: 122 EYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE----YYKVREPGESP 174

Query: 242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
            F Y APE     + +  SDV+SFGVVL EL T
Sbjct: 175 IFWY-APESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 79.3 bits (196), Expect = 6e-17
 Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 28/212 (13%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIK--KLDTSSAPEPESDFAA---QLSVVSRLKHEHFVE 129
           IG G+YG V+ A+ +  G   AIK  KL      EP  DF     ++S++   +H + V 
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKL------EPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
             G  +  +   +V ++   GSL D+           P   L+  Q   V     KGL +
Sbjct: 65  YFGSYLRRDKLWIVMEYCGGGSLQDIYQ-----VTRGP---LSELQIAYVCRETLKGLAY 116

Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE 249
           LHE  +   +HRD++ +N+LL +D   K+ADF ++ Q + T A+  S   +GT  + APE
Sbjct: 117 LHETGK---IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWMAPE 171

Query: 250 YA---MTGQITQKSDVYSFGVVLLELLTGRKP 278
            A     G    K D+++ G+  +EL   + P
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 67/275 (24%), Positives = 123/275 (44%), Gaps = 35/275 (12%)

Query: 76  IGEGSYGRV---FYAKLTDGTPAAIKKL-DTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
           +G G++G V    Y         A+K L + ++ P  + +   + +V+ +L + + V ++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G C E+ + +LV + A +G L+  L   K V         T     ++ +  + G+++L 
Sbjct: 63  GIC-EAESWMLVMELAELGPLNKFLQKNKHV---------TEKNITELVHQVSMGMKYLE 112

Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ-SSDTAARLHSTRVLGTFGYHAPEY 250
           E      VHRD+ + NVLL     +KI+DF L+    +D       T       ++APE 
Sbjct: 113 ET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169

Query: 251 AMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDP 309
               + + KSDV+SFGV++ E  + G+KP                   +  ++V Q ++ 
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQKPYK----------------GMKGNEVTQMIES 213

Query: 310 KLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIV 344
               + P +   ++  +  LC  Y  D RP   +V
Sbjct: 214 GERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVV 248

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 78.5 bits (193), Expect = 1e-16
 Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 20/203 (9%)

Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           +G+G++G+V+ A+  + G  AA K +DT S  E E D+  ++ +++   H + V+LL   
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELE-DYMVEIDILASCDHPNIVKLLDAF 71

Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
              NN  ++ +F   G++  V+         E    LT  Q   V     + L +LHE  
Sbjct: 72  YYENNLWILIEFCAGGAVDAVM--------LELERPLTEPQIRVVCKQTLEALNYLHEN- 122

Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              I+HRD+++ N+L   D   K+ADF ++ +++ T  R  S   +GT  + APE  M  
Sbjct: 123 --KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCE 178

Query: 255 QITQ-----KSDVYSFGVVLLEL 272
                    K+DV+S G+ L+E+
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 78.0 bits (193), Expect = 2e-16
 Identities = 55/242 (22%), Positives = 92/242 (38%), Gaps = 66/242 (27%)

Query: 75  LIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL--- 130
           +IGEGS+  V  AK        AIK LD                 + + K   +V++   
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQ--------------LIKEKKVKYVKIEKE 53

Query: 131 -------------LGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
                        L Y  +    +  V ++A  G L   +     +           +++
Sbjct: 54  VLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSL-----------DEK 102

Query: 177 VKVAYGA--AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADF--------NLTNQ 226
               Y A     LE+LH K    I+HRD++  N+LL  D   KI DF        N + +
Sbjct: 103 CTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159

Query: 227 SSDTAARLHSTR----------VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGR 276
           S+   A    ++           +GT  Y +PE        + SD+++ G ++ ++LTG+
Sbjct: 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Query: 277 KP 278
            P
Sbjct: 220 PP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 77.8 bits (192), Expect = 2e-16
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 35/220 (15%)

Query: 74  ALIGEGSYGRVFYA-KLTDGTPAAIK-----KLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
             IG G++G+V+ A  L  G   A+K       D  +  E       ++ V+  LKH + 
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIAD----EMKVLELLKHPNL 61

Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA--K 185
           V+  G  +      +  ++ + G+L ++L           G +L  ++ V   Y     +
Sbjct: 62  VKYYGVEVHREKVYIFMEYCSGGTLEELLEH---------GRIL--DEHVIRVYTLQLLE 110

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN----LTNQSSDTAARLHSTRVLG 241
           GL +LH      IVHRD++ +N+ L  +   K+ DF     L N ++     + S    G
Sbjct: 111 GLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA--G 165

Query: 242 TFGYHAPEYAMTGQITQK---SDVYSFGVVLLELLTGRKP 278
           T  Y APE    G+       +D++S G V+LE+ TG++P
Sbjct: 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 77.6 bits (191), Expect = 2e-16
 Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 21/213 (9%)

Query: 75  LIGEGSYGRVFYAKLTDGTPAAIKK--LDTSSAPEPESDFAA---QLSVVSRLKHEHFVE 129
           ++G+G+YG V+      G   A+K+  LDTS+    E ++     ++ ++  LKH + V+
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
            LG C++ N   +  +F   GS+  +L+      G  P PV       K       G+ +
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRF----GPLPEPVFC-----KYTKQILDGVAY 117

Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL----GTFGY 245
           LH      +VHRD++ +NV+L  +   K+ DF    + +        + +L    GT  +
Sbjct: 118 LHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174

Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            APE        +KSD++S G  + E+ TG+ P
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 77.8 bits (191), Expect = 3e-16
 Identities = 66/245 (26%), Positives = 114/245 (46%), Gaps = 22/245 (8%)

Query: 76  IGEGSYGRVFYAKLTDGTP--AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           IG+GS+G V Y  + + T    AIK +D   A +   D   +++V+S+    +     G 
Sbjct: 12  IGKGSFGEV-YKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70

Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
            ++     ++ ++   GS  D+L         +PGP L       +     KGL++LH +
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLL---------KPGP-LEETYIATILREILKGLDYLHSE 120

Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
            +   +HRD++++NVLL +    K+ADF +  Q +DT  ++     +GT  + APE    
Sbjct: 121 RK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKRNTFVGTPFWMAPEVIKQ 175

Query: 254 GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK----VKQCVDP 309
                K+D++S G+  +EL  G  P     P     L+   +P   E +     K+ V+ 
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEA 235

Query: 310 KLNND 314
            LN D
Sbjct: 236 CLNKD 240

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 77.6 bits (191), Expect = 3e-16
 Identities = 71/290 (24%), Positives = 119/290 (41%), Gaps = 43/290 (14%)

Query: 75  LIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +IG G +G V   +L          AIK L +    +   DF ++ S++ +  H + + L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
            G   +S   +++ +F   G+L   L    G          T  Q V +  G A G+++L
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYL 122

Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG---TFGYHA 247
            E      VHRD+ + N+L+  +   K++DF L+    D  +    T  LG      + A
Sbjct: 123 SEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179

Query: 248 PEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC 306
           PE     + T  SDV+S+G+V+ E+++ G +P              W       D   Q 
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY-------------W-------DMSNQD 219

Query: 307 VDPKLNNDY----PPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL 352
           V   +  DY    P      L  +   C Q + + RP    +V  L  ++
Sbjct: 220 VINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 77.3 bits (191), Expect = 4e-16
 Identities = 64/253 (25%), Positives = 110/253 (43%), Gaps = 36/253 (14%)

Query: 76  IGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IGEG+ G V+ A     G   AIKK+      + +     ++ ++   KH + V+     
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRK--QNKELIINEILIMKDCKHPNIVDYYD-S 83

Query: 135 MESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA---KGLEFL 190
               + + +V ++   GSL D++  +  V+  EP          ++AY      +GLE+L
Sbjct: 84  YLVGDELWVVMEYMDGGSLTDIIT-QNFVRMNEP----------QIAYVCREVLQGLEYL 132

Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEY 250
           H +    ++HRD++S N+LL  D   K+ADF    Q   T  +     V+GT  + APE 
Sbjct: 133 HSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL--TKEKSKRNSVVGTPYWMAPEV 187

Query: 251 AMTGQITQKSDVYSFGVVLLELLTGRKP-VDHTMPKGQQSLVTWATPRLSE--------- 300
                   K D++S G++ +E+  G  P +     +    + T   P L           
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFK 247

Query: 301 DKVKQC--VDPKL 311
           D + +C   DP+ 
Sbjct: 248 DFLNKCLVKDPEK 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 77.0 bits (189), Expect = 4e-16
 Identities = 68/254 (26%), Positives = 116/254 (45%), Gaps = 24/254 (9%)

Query: 76  IGEGSYGRVFYAKLTDG---TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           IG+GS+G VF  K  D       AIK +D   A +   D   +++V+S+    +  +  G
Sbjct: 12  IGKGSFGEVF--KGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
             ++     ++ ++   GS  D+L           GP   + Q   +     KGL++LH 
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLRA---------GPFDEF-QIATMLKEILKGLDYLHS 119

Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           + +   +HRD++++NVLL +    K+ADF +  Q +DT  ++     +GT  + APE   
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKRNTFVGTPFWMAPEVIQ 174

Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLV-TWATPRLSED---KVKQCVD 308
                 K+D++S G+  +EL  G  P     P     L+     P L+ +     K+ +D
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFID 234

Query: 309 PKLNNDYPPKAIAK 322
             LN D   +  AK
Sbjct: 235 ACLNKDPSFRPTAK 248

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 76.9 bits (190), Expect = 5e-16
 Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 18/205 (8%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPE--PESDFAAQLSVVSRLKHEHFVELLG 132
           IGEG++G VF AK    G   A+KK+         P      ++  +   +H + V+LL 
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQ-ALREIKALQACQHPYVVKLLD 66

Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
                +  +LV ++     L +VL         E  P L   Q         KG+ ++H 
Sbjct: 67  VFPHGSGFVLVMEY-MPSDLSEVLR-------DEERP-LPEAQVKSYMRMLLKGVAYMHA 117

Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
                I+HRD++ +N+L+  D   KIADF L    S+   RL+S +V  T  Y APE   
Sbjct: 118 N---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLY 173

Query: 253 TGQ-ITQKSDVYSFGVVLLELLTGR 276
             +      D+++ G +  ELL G 
Sbjct: 174 GARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 77.3 bits (190), Expect = 5e-16
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)

Query: 73  KALIGEGSYGRVFYAKLT-------------DGTP--AAIKKLDTSSAPEPESDFAAQLS 117
           K  +GEG +G V   +               DG P   A+K L         +DF  ++ 
Sbjct: 10  KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK 69

Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRK---GVQGAEPGPVLTWN 174
           ++SRLK+ + + LLG C+  +   ++ ++   G L+  L  R+       A   P ++  
Sbjct: 70  IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129

Query: 175 QRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT-NQSSDTAAR 233
             + +A   A G+++L        VHRD+ + N L+ + +  KIADF ++ N  S    R
Sbjct: 130 NLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYR 186

Query: 234 LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
           +    VL    + A E  + G+ T  SDV++FGV L E+ T
Sbjct: 187 IQGRAVL-PIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 77.0 bits (189), Expect = 5e-16
 Identities = 67/241 (27%), Positives = 116/241 (48%), Gaps = 28/241 (11%)

Query: 58  IKLDELNRLTSNFGTKALIGEGSYGRVF-YAKLTDGTPAAIKKLDTSSAPEPESDFAAQL 116
           + L+ L   T  +     IG+G+YG+V+      DG+ AA+K LD  S  + + +  A+ 
Sbjct: 12  LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEY 69

Query: 117 SVVSRL-KHEHFVELLGYCMESNNRI-----LVYQFATMGSLHDVLHG--RKGVQGAEPG 168
           +++  L  H + V+  G   +++  +     LV +    GS+ +++ G    G +  E  
Sbjct: 70  NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEA- 128

Query: 169 PVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS 228
            ++++     + YGA  GL+ LH      I+HRDV+ +N+LL  +   K+ DF ++ Q  
Sbjct: 129 -MISY-----ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQL- 178

Query: 229 DTAARLHSTRVLGTFGYHAPEYAMTGQITQKS-----DVYSFGVVLLELLTGRKPVDHTM 283
            T+ RL     +GT  + APE     Q    S     DV+S G+  +EL  G  P+    
Sbjct: 179 -TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237

Query: 284 P 284
           P
Sbjct: 238 P 238

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 76.5 bits (188), Expect = 6e-16
 Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 17/209 (8%)

Query: 76  IGEGSYGRVFYAKLTDGTPAA---IKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           IG G +G+V   +   G   A   +K+L  S+ P+ +  F  ++     L H + ++ LG
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
            C+ES   +LV +F  +G L + L   +G+        +   QR  +A   A GL +LH 
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVL--QR--MACEVASGLLWLH- 117

Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA- 251
             Q   +H D+   N  L  D   KI D+ L  +       +          + APE   
Sbjct: 118 --QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175

Query: 252 ------MTGQITQKSDVYSFGVVLLELLT 274
                 +    T+KS+++S GV + EL T
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 77.1 bits (190), Expect = 7e-16
 Identities = 41/146 (28%), Positives = 71/146 (48%), Gaps = 6/146 (4%)

Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
           K++    +GL +L EK +  I+HRDV+ SN+L+    + K+ DF ++ Q  D+ A     
Sbjct: 103 KISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 156

Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR 297
             +GT  Y +PE       T +SD++S G+ L+E+  GR P+     K  +++       
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSE 216

Query: 298 LSEDKVKQCVDPKLNNDYPPKAIAKL 323
               +  + V     +   P AI +L
Sbjct: 217 GEAKESHRPVSGHPPDSPRPMAIFEL 242

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 76.6 bits (188), Expect = 8e-16
 Identities = 58/204 (28%), Positives = 106/204 (51%), Gaps = 22/204 (10%)

Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           +G+G++G+V+ AK  + G  AA K ++T S  E E D+  ++ +++   H + V+LLG  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYMVEIEILATCNHPYIVKLLGAF 78

Query: 135 MESNNRILVYQFATMGSLHDV-LHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
                  ++ +F   G++  + L   +G+   EP   +   Q ++        L++LH  
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRGLT--EPQIQVICRQMLE-------ALQYLHSM 129

Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               I+HRD+++ NVLL  D   K+ADF ++ ++  T  R  S   +GT  + APE  M 
Sbjct: 130 ---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMC 184

Query: 254 GQITQ-----KSDVYSFGVVLLEL 272
             +       K+D++S G+ L+E+
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 62/219 (28%), Positives = 105/219 (47%), Gaps = 18/219 (8%)

Query: 68  SNFGTKALIGEGSYGRVFYAK-LTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++G G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 7   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66

Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 67  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI----- 118

Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L E+    +VHRD+ + NVL+      KI DF L           H+      
Sbjct: 119 -AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174

Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVD 280
             + A E  +    T +SDV+S+GV + EL+T G KP D
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 18/206 (8%)

Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V+     + T  A+K L   +       F  + +++  L+H+  V L     
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV--QAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           +     ++ ++   GSL D L   +G +   P       + +  +   A+G+ ++  K  
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP-------KLIDFSAQIAEGMAYIERK-- 122

Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAMT 253
              +HRD+R++NVL+ +    KIADF L     D     ++ R    F   + APE    
Sbjct: 123 -NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINF 178

Query: 254 GQITQKSDVYSFGVVLLELLT-GRKP 278
           G  T KSDV+SFG++L E++T G+ P
Sbjct: 179 GSFTIKSDVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 76.0 bits (187), Expect = 1e-15
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 24/210 (11%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           +G G+ G V   K +  GT  A K +   +          +L ++   +  + V   G  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
           +  NN  +  +F   GSL  +   +KG      GP +      K+A    +GL +L+   
Sbjct: 73  LNENNICMCMEFMDCGSLDRIY--KKG------GP-IPVEILGKIAVAVVEGLTYLYNVH 123

Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADF----NLTNQSSDTAARLHSTRVLGTFGYHAPEY 250
           +  I+HRD++ SN+L+    + K+ DF     L N  +DT         +GT  Y +PE 
Sbjct: 124 R--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT--------FVGTSTYMSPER 173

Query: 251 AMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
              G+ T KSDV+S G+ ++EL  G+ P  
Sbjct: 174 IQGGKYTVKSDVWSLGISIIELALGKFPFA 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 51/210 (24%), Positives = 87/210 (41%), Gaps = 26/210 (12%)

Query: 75  LIGEGSYGRVFYAKLTD-GTPAAIKK-LDTSSAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           ++GEG+YG V   +    G   AIKK  ++    + +     ++ V+ +L+HE+ V L  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPV--LTWNQRVKVAYGAAKGLEFL 190
                    LV+++    +L ++L    G  G  P  V    W           + + + 
Sbjct: 68  AFRRKGRLYLVFEYVER-TLLELLEASPG--GLPPDAVRSYIWQ--------LLQAIAYC 116

Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE- 249
           H      I+HRD++  N+L+ +    K+ DF          A    T  + T  Y APE 
Sbjct: 117 HSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPEL 172

Query: 250 ---YAMTGQITQKSDVYSFGVVLLELLTGR 276
                  G   +  DV++ G ++ ELL G 
Sbjct: 173 LVGDTNYG---KPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 75.5 bits (186), Expect = 1e-15
 Identities = 51/156 (32%), Positives = 82/156 (52%), Gaps = 23/156 (14%)

Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
           K+A    K LE+LH K+   ++HRDV+ SNVL+  + + K+ DF ++    D+ A+   T
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK---T 161

Query: 238 RVLGTFGYHAPEYAMTGQITQ-----KSDVYSFGVVLLELLTGRKPVD--HTMPKGQQSL 290
              G   Y APE  +  ++ Q     KSDV+S G+ ++EL TGR P D   T  +  + +
Sbjct: 162 IDAGCKPYMAPE-RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV 220

Query: 291 VTWATPRLSEDK--------VKQCV--DPKLNNDYP 316
           V   +P+L  +K        V +C+  + K   +YP
Sbjct: 221 VEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYP 256

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 66/238 (27%), Positives = 101/238 (42%), Gaps = 47/238 (19%)

Query: 57  QIKLDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQ 115
              L++L  L         IG G+ G+V+  +    G   A+K++  +   E        
Sbjct: 11  PADLNDLENL-------GEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMD 63

Query: 116 LSVVSRLKHE--HFVELLGY---------CMESNNRILVYQFATMGSLHDVLHGRKGVQG 164
           L VV    H+  + V+  GY         CME            M +  D L   K +QG
Sbjct: 64  LDVVL-KSHDCPYIVKCYGYFITDSDVFICME-----------LMSTCLDKL--LKRIQG 109

Query: 165 AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT 224
             P  +L      K+     K L +L EK    ++HRDV+ SN+LL      K+ DF ++
Sbjct: 110 PIPEDILG-----KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS 162

Query: 225 NQSSDTAARLHSTRVLGTFGYHAPEY----AMTGQITQKSDVYSFGVVLLELLTGRKP 278
            +  D+ A+   TR  G   Y APE         +   ++DV+S G+ L+EL TG+ P
Sbjct: 163 GRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 21/208 (10%)

Query: 76  IGEGSYGRVFYAKL-----TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +GEG +G+V   +        G   A+K L   S     +D   ++ ++  L HE+ V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 131 LGYCMESNNR--ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C E       L+ +F   GSL + L   K          +   Q++K A    KG++
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK--------INLKQQLKYAVQICKGMD 123

Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN--QSSDTAARLHSTRVLGTFGYH 246
           +L  +     VHRD+ + NVL+  + + KI DF LT   ++      +        F Y 
Sbjct: 124 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY- 179

Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT 274
           APE  +  +    SDV+SFGV L ELLT
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 75.1 bits (185), Expect = 3e-15
 Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 25/208 (12%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQ----LSVVSRLKHEHFVEL 130
           IGEG+YG V+ A+    G   AIKK+                   + ++  L H + ++L
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKI---KLRFESEGIPKTALREIKLLKELNHPNIIKL 63

Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK-VAYGAAKGLEF 189
           L       +  LV++F        +   ++G+              +K   Y   +GL F
Sbjct: 64  LDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLP----------ESLIKSYLYQLLQGLAF 113

Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE 249
            H      I+HRD++  N+L+  +   K+ADF L  +S  +  R ++  V+ T  Y APE
Sbjct: 114 CH---SHGILHRDLKPENLLINTEGVLKLADFGLA-RSFGSPVRPYTHYVV-TRWYRAPE 168

Query: 250 YAMT-GQITQKSDVYSFGVVLLELLTGR 276
             +     +   D++S G +  ELL+ R
Sbjct: 169 LLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 74.7 bits (183), Expect = 3e-15
 Identities = 72/280 (25%), Positives = 123/280 (43%), Gaps = 34/280 (12%)

Query: 75  LIGEGSYGRVFYAK-LTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           ++G G++G V+    + DG     P AIK L  +++P+   +   +  V++ +   +   
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           LLG C+ S  + LV Q    G L D +   K   G++   +L W  ++      AKG+ +
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQD--LLNWCVQI------AKGMSY 124

Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE 249
           L E+V+  +VHRD+ + NVL+      KI DF L           H+        + A E
Sbjct: 125 L-EEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181

Query: 250 YAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD 308
             +  + T +SDV+S+GV + EL+T G KP D  +P  +   +     RL +        
Sbjct: 182 SILHRRFTHQSDVWSYGVTVWELMTFGAKPYD-GIPAREIPDLLEKGERLPQ-------- 232

Query: 309 PKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKAL 348
                  PP     +  +   C   +++ RP    +V   
Sbjct: 233 -------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEF 265

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 74.3 bits (182), Expect = 3e-15
 Identities = 69/281 (24%), Positives = 127/281 (45%), Gaps = 28/281 (9%)

Query: 68  SNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKL---DTSSAPEPESDFAAQLSVVSRLK 123
           +NF  +  IG G +  V+ A  L DG P A+KK+   D   A +  +D   ++ ++ +L 
Sbjct: 2   ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDA-KARADCIKEIDLLKQLN 60

Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           H + ++     +E N   +V + A  G L  ++   K  +   P   + W   V++    
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV-WKYFVQLC--- 116

Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
              LE +H +    ++HRD++ +NV +      K+ D  L    S      HS  ++GT 
Sbjct: 117 -SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTP 170

Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV 303
            Y +PE         KSD++S G +L E+   + P        + +L +         K+
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSLCK------KI 220

Query: 304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIV 344
           +QC  P L +D+  + + +L     +C+  + + RP++T V
Sbjct: 221 EQCDYPPLPSDHYSEELRQL---VNMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 74.2 bits (182), Expect = 4e-15
 Identities = 72/293 (24%), Positives = 123/293 (41%), Gaps = 37/293 (12%)

Query: 68  SNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK 123
           S    + +IG G +G V   +L        P AIK L      +   DF ++ S++ +  
Sbjct: 4   SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD 63

Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           H + + L G   +S   ++V ++   GSL   L    G          T  Q V +  G 
Sbjct: 64  HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG--------QFTVIQLVGMLRGI 115

Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG-- 241
           A G+++L +      VHRD+ + N+L+  +   K++DF L+    D     ++TR  G  
Sbjct: 116 ASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR--GGK 170

Query: 242 -TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLS 299
               + APE     + T  SDV+S+G+V+ E+++ G +P              W    +S
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY-------------W---EMS 214

Query: 300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL 352
              V + ++       P    A L  +   C Q + + RP    +V  L  L+
Sbjct: 215 NQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 74.2 bits (182), Expect = 4e-15
 Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 18/210 (8%)

Query: 75  LIGEGSYGRVFYAK-LTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           L+G G +G V     + +G     P AIK +   S  +   +    +  +  L H + V 
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           LLG C  ++ + LV Q + +GSL D +   +      P  +L W  ++      AKG+ +
Sbjct: 74  LLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLD--PQRLLNWCVQI------AKGMYY 124

Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE 249
           L E     +VHR++ + N+LL  D   +IADF + +       +   +       + A E
Sbjct: 125 LEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181

Query: 250 YAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
             + G+ T +SDV+S+GV + E+++ G +P
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 74.0 bits (182), Expect = 5e-15
 Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 18/211 (8%)

Query: 73  KALIGEGSYGRV----FYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
              IGEG +G V    + +   +    A+K     ++P     F  +  ++ +  H H V
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 129 ELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
           +L+G   E+   I V + A +G L   L   K         + +    +  +Y  +  L 
Sbjct: 71  KLIGVITENPVWI-VMELAPLGELRSYLQVNK-----YSLDLASL---ILYSYQLSTALA 121

Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +L  K     VHRD+ + NVL+      K+ DF L+    D +    +++      + AP
Sbjct: 122 YLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY-YKASKGKLPIKWMAP 177

Query: 249 EYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
           E     + T  SDV+ FGV + E+L  G KP
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 74.7 bits (183), Expect = 5e-15
 Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 31/212 (14%)

Query: 76  IGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPE--SDFAAQLSVVSRLKHEHFVELLG 132
           IG GS+G V++A         A+KK+  S     E   D   ++  + +LKH + +E  G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA---YGAAKGLEF 189
             ++ +   LV ++  +GS  D+L   K        P+    Q V++A   +GA +GL +
Sbjct: 89  CYLKEHTAWLVMEYC-LGSASDLLEVHKK-------PL----QEVEIAAITHGALQGLAY 136

Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE 249
           LH      ++HRD+++ N+LL +  + K+ADF   ++SS       +   +GT  + APE
Sbjct: 137 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPE 187

Query: 250 YAMT---GQITQKSDVYSFGVVLLELLTGRKP 278
             +    GQ   K DV+S G+  +E L  RKP
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIE-LAERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 73.7 bits (181), Expect = 5e-15
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 25/216 (11%)

Query: 74  ALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQ-----LSVVSRLKHEHF 127
             +G G++   + A+ +  GT  A+K++        E +   +     + +++RL H H 
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY--GAAK 185
           + +LG   E ++  L  ++   GS+  +L         + G    + + V + Y     +
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLS--------KYGA---FKEAVIINYTEQLLR 114

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQ--SSDTAARLHSTRVLGT 242
           GL +LHE     I+HRDV+ +N+L+    +  +IADF    +  +  T A     ++LGT
Sbjct: 115 GLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGT 171

Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
             + APE     Q  +  DV+S G V++E+ T + P
Sbjct: 172 IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 74.4 bits (182), Expect = 6e-15
 Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 26/211 (12%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPE--SDFAAQLSVVSRLKHEHFVELLG 132
           IG GS+G V++A+ +      AIKK+  S     E   D   ++  + R+KH + +E  G
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 133 YCMESNNRILVYQFATMGSLHDVLH-GRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
             +  +   LV ++  +GS  D+L   +K +Q  E            + +GA +GL +LH
Sbjct: 93  CYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIA---------AITHGALQGLAYLH 142

Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA 251
                 ++HRD+++ N+LL +  + K+ADF   + +S       +   +GT  + APE  
Sbjct: 143 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVI 193

Query: 252 MT---GQITQKSDVYSFGVVLLELLTGRKPV 279
           +    GQ   K DV+S G+  +EL   + P+
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 73.6 bits (181), Expect = 7e-15
 Identities = 70/286 (24%), Positives = 122/286 (42%), Gaps = 36/286 (12%)

Query: 67  TSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLK 123
             NF  +  IG+G +  V+ A  L DG   A+KK+        +   D   ++ ++ +L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSL-HDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
           H + ++ L   +E+N   +V + A  G L   + H +K  Q         W   V++   
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKK--QKRLIPERTIWKYFVQLC-- 116

Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
               LE +H K    I+HRD++ +NV +      K+ D  L    S      HS  ++GT
Sbjct: 117 --SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169

Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ----SLVTWATPRL 298
             Y +PE         KSD++S G +L E+   + P       G +    SL        
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLYSLC------- 217

Query: 299 SEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIV 344
              K+++C  P L  D+      +L  + + C+  + + RP+++ V
Sbjct: 218 --KKIEKCDYPPLPADHYS---EELRDLVSRCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 73.3 bits (180), Expect = 8e-15
 Identities = 60/219 (27%), Positives = 106/219 (48%), Gaps = 24/219 (10%)

Query: 75  LIGEGSYGRVFYAKLT--DGTP--AAIK--KLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           ++GEG +G V   +L+  DG+    A+K  KLD  +  E E +F ++ + +    H + +
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIE-EFLSEAACMKDFDHPNVM 64

Query: 129 ELLGYCMESNNR------ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
           +L+G C E+++       +++  F   G LH  L   +     E  P+ T    +K    
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTL---LKFMVD 121

Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ--SSDTAARLHSTRVL 240
            A G+E+L  +     +HRD+ + N +L +D    +ADF L+ +  S D   +    ++ 
Sbjct: 122 IALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM- 177

Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
               + A E       T KSDV++FGV + E+ T G+ P
Sbjct: 178 -PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 72.9 bits (179), Expect = 9e-15
 Identities = 66/219 (30%), Positives = 98/219 (44%), Gaps = 42/219 (19%)

Query: 75  LIGEGSYGRVFYAKLTDGTP----AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +IG+G +G V++  L D        A+K L+  +  E    F  +  ++    H + + L
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61

Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHG--RKGVQGAEPGPVLTWNQRVK--VAYG--AA 184
           LG C+ S    LV        L  + HG  R  ++     P       VK  + +G   A
Sbjct: 62  LGICLPSEGSPLVV-------LPYMKHGDLRNFIRSETHNPT------VKDLIGFGLQVA 108

Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD---------TAARLH 235
           KG+E+L  K     VHRD+ + N +L + F  K+ADF L     D         T A+L 
Sbjct: 109 KGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL- 164

Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                    + A E   T + T KSDV+SFGV+L EL+T
Sbjct: 165 ------PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 72.2 bits (177), Expect = 1e-14
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 15/204 (7%)

Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V   K       AIK ++  +  E   DF  +  V+ +L H   V+L G C 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE--EDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           +     +V +F   G L + L  R+G    +   +L+  Q V       +G+E+L    +
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLRQRQGKLSKD--MLLSMCQDV------CEGMEYLE---R 118

Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQ 255
              +HRD+ + N L+      K++DF +T    D      S+       +  PE     +
Sbjct: 119 NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD-EYTSSSGAKFPVKWSPPEVFNFSK 177

Query: 256 ITQKSDVYSFGVVLLELLT-GRKP 278
            + KSDV+SFGV++ E+ T G+ P
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 25/211 (11%)

Query: 76  IGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFA---AQLSVVSRLKHEHFVELL 131
           +G G+YG V+ A  L  G  AA+K +      EP  DF+    ++ +V   KH + V   
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKL----EPGDDFSLIQQEIFMVKECKHCNIVAYF 72

Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G  +      +  ++   GSL D+ H          GP L+  Q   V     +GL +LH
Sbjct: 73  GSYLSREKLWICMEYCGGGSLQDIYH--------VTGP-LSELQIAYVCRETLQGLAYLH 123

Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA 251
            K +   +HRD++ +N+LL D+   K+ADF +  + + T A+  S   +GT  + APE A
Sbjct: 124 SKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEVA 178

Query: 252 M---TGQITQKSDVYSFGVVLLELLTGRKPV 279
                G   Q  D+++ G+  +EL   + P+
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 49/169 (28%), Positives = 75/169 (44%), Gaps = 25/169 (14%)

Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
           K+A    K L +L E+++  I+HRDV+ SN+LL  +   K+ DF ++ Q  D+ A+   T
Sbjct: 111 KIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---T 165

Query: 238 RVLGTFGYHAPEYAMTGQITQ---KSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWA 294
           R  G   Y APE            +SDV+S G+ L E+ TG+ P              W 
Sbjct: 166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP-----------KWN 214

Query: 295 TPRLSEDKVKQCVD---PKLNNDYPPKAIAKLAAVAALCVQYEADFRPN 340
           +     D++ Q V    P L+N    +          LC+  +   RP 
Sbjct: 215 SVF---DQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPK 260

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 72.6 bits (178), Expect = 2e-14
 Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 24/222 (10%)

Query: 73  KALIGEGSYGRV-----------------FYAKLTDGTPAAIKKLDTSSAPEPESDFAAQ 115
           K  +GEG +G V                            A+K L   +     +DF  +
Sbjct: 10  KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKE 69

Query: 116 LSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVL--HGRKGVQGAEPGPVLTW 173
           + ++SRLK  + + LL  C+ S+   ++ ++   G L+  L  H  +          +++
Sbjct: 70  IKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129

Query: 174 NQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT-NQSSDTAA 232
           +  + +A   A G+++L        VHRD+ + N L+  ++  KIADF ++ N  S    
Sbjct: 130 STLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186

Query: 233 RLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
           R+    VL    + + E  + G+ T  SDV++FGV L E+LT
Sbjct: 187 RIQGRAVL-PIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 71/291 (24%), Positives = 123/291 (42%), Gaps = 47/291 (16%)

Query: 75  LIGEGSYGRVFYAKL-TDG---TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +IG G +G VF   L   G      AIK L      +   DF ++ S++ +  H + + L
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
            G   +    +++ ++   G+L   L    G    E        Q V +  G A G+++L
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRDHDG----EFSSY----QLVGMLRGIAAGMKYL 123

Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG-----Y 245
            +      VHRD+ + N+L+  + + K++DF L+    D     ++T    + G     +
Sbjct: 124 SDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT----SGGKIPIRW 176

Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVK 304
            APE     + T  SDV+SFG+V+ E+++ G +P              W    +S  +V 
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY-------------W---DMSNHEVM 220

Query: 305 QCVDPKLNNDYP---PKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL 352
           + ++       P   P A+ +L      C Q +   RP    +V  L  LL
Sbjct: 221 KAINDGFRLPAPMDCPSAVYQL---MLQCWQQDRARRPRFVDIVNLLDKLL 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 72.2 bits (177), Expect = 2e-14
 Identities = 64/225 (28%), Positives = 109/225 (48%), Gaps = 34/225 (15%)

Query: 67  TSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQL----SVVSR 121
               G + ++G+G+YG V+ A+ L+     AIK++     PE +S +   L    ++ S 
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEI-----PERDSRYVQPLHEEIALHSY 61

Query: 122 LKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY 181
           LKH + V+ LG   E+    +  +    GSL  +L  + G       P L  N++  + Y
Sbjct: 62  LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWG-------P-LKDNEQTIIFY 113

Query: 182 GAA--KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS--KIADFNLTNQSSDTAARLH-- 235
                +GL++LH+     IVHRD++  NVL+ + +    KI+DF     +S   A ++  
Sbjct: 114 TKQILEGLKYLHDN---QIVHRDIKGDNVLV-NTYSGVVKISDFG----TSKRLAGINPC 165

Query: 236 STRVLGTFGYHAPEYAMTGQ--ITQKSDVYSFGVVLLELLTGRKP 278
           +    GT  Y APE    G       +D++S G  ++E+ TG+ P
Sbjct: 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 27/210 (12%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPE--SDFAAQLSVVSRLKHEHFVELLG 132
           IG GS+G V++A+ + +    AIKK+  S     E   D   ++  + +L+H + ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 133 YCMESNNRILVYQFATMGSLHDVLH-GRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
             +  +   LV ++  +GS  D+L   +K +Q  E            V +GA +GL +LH
Sbjct: 83  CYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIA---------AVTHGALQGLAYLH 132

Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA 251
                 ++HRDV++ N+LL +    K+ DF     S+   A  +    +GT  + APE  
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANX--FVGTPYWMAPEVI 183

Query: 252 MT---GQITQKSDVYSFGVVLLELLTGRKP 278
           +    GQ   K DV+S G+  +E L  RKP
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIE-LAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 71.9 bits (176), Expect = 3e-14
 Identities = 60/227 (26%), Positives = 103/227 (45%), Gaps = 18/227 (7%)

Query: 76  IGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG+G+ G V+ A  +  G   AIK+++    P+ E     ++ V+   KH + V  L   
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL-IINEILVMRENKHPNIVNYLDSY 85

Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
           +  +   +V ++   GSL DV+      +G          Q   V     + LEFLH   
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTETCMDEG----------QIAAVCRECLQALEFLHSN- 134

Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              ++HRD++S N+LL  D   K+ DF    Q +   ++   + ++GT  + APE     
Sbjct: 135 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRK 190

Query: 255 QITQKSDVYSFGVVLLELLTGRKPVDHTMP-KGQQSLVTWATPRLSE 300
               K D++S G++ +E++ G  P  +  P +    + T  TP L  
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN 237

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 71.5 bits (175), Expect = 3e-14
 Identities = 55/210 (26%), Positives = 104/210 (49%), Gaps = 21/210 (10%)

Query: 76  IGEGSYGRV---FYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           +G G++G V    Y         AIK L   +      +   +  ++ +L + + V ++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
            C E+   +LV + A+ G L+  L G+K          +T +  V++ +  + G+++L  
Sbjct: 63  VC-EAEALMLVMEMASGGPLNKFLSGKK--------DEITVSNVVELMHQVSMGMKYLEG 113

Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ-SSDTAARLHSTRVLGTF--GYHAPE 249
           K     VHRD+ + NVLL +   +KI+DF L+    +D +   +  R  G +   ++APE
Sbjct: 114 K---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS--YYKARSAGKWPLKWYAPE 168

Query: 250 YAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
                + + +SDV+S+G+ + E  + G+KP
Sbjct: 169 CINFRKFSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 71.6 bits (175), Expect = 3e-14
 Identities = 64/239 (26%), Positives = 109/239 (45%), Gaps = 35/239 (14%)

Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPA------AIKKLDTSSAPEPESDFAAQ 115
           E+N  T  F  +  +GE  +G+V+   L    P       AIK L   +      +F  +
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 116 LSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGR------------KGVQ 163
             + SRL+H + V LLG   +     +++ + +   LH+ L  R            K V+
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 164 GA-EPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN 222
              EP   +       +    A G+EFL       +VH+D+ + NVL+FD    KI+D  
Sbjct: 119 STLEPADFV------HIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLG 169

Query: 223 LTNQ--SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
           L  +  ++D    + ++  L    + +PE  M G+ +  SD++S+GVVL E+ + G +P
Sbjct: 170 LFREVYAADYYKLMGNS--LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 71.3 bits (175), Expect = 5e-14
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 19/213 (8%)

Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEH 126
           S       IGEGS G V  A   + G   A+KK+D       E  F  ++ ++   +H +
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN-EVVIMRDYQHPN 77

Query: 127 FVELLGYCMESNNRILVYQFATMGSLHD-VLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
            VE+    +  +   +V +F   G+L D V H R           +   Q   V     K
Sbjct: 78  IVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIATVCLAVLK 126

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
            L FLH +    ++HRD++S ++LL  D + K++DF    Q S    R  S  ++GT  +
Sbjct: 127 ALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYW 181

Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            APE         + D++S G++++E++ G  P
Sbjct: 182 MAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 70.6 bits (173), Expect = 6e-14
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 18/215 (8%)

Query: 62  ELNRLTSNFGTKALIGEGSYGRVF--YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVV 119
           E+ R  ++   K  +G G YG V+    K    T  A+K L   +    E  F  + +V+
Sbjct: 2   EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLT-VAVKTLKEDTMEVEE--FLKEAAVM 56

Query: 120 SRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKV 179
             +KH + V+LLG C       ++ +F T G+L D L  R+  +      VL     + +
Sbjct: 57  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVL-----LYM 109

Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
           A   +  +E+L +K     +HRD+ + N L+ ++   K+ADF L+   +      H+   
Sbjct: 110 ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 166

Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                + APE     + + KSDV++FGV+L E+ T
Sbjct: 167 F-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 70.7 bits (174), Expect = 6e-14
 Identities = 60/225 (26%), Positives = 94/225 (41%), Gaps = 47/225 (20%)

Query: 76  IGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEH-------- 126
           I +G+YGRVF A K + G   AIK +        ++D   + + V ++  E         
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVI-------KKADMIRK-NQVDQVLTERDILSQAQS 52

Query: 127 -FVELLGYCMES-NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA- 183
            +V  L Y  +   N  LV ++   G L  +L             V + ++ V   Y A 
Sbjct: 53  PYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLEN-----------VGSLDEDVARIYIAE 101

Query: 184 -AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL---------TNQSSDTAAR 233
               LE+LH      I+HRD++  N+L+  +   K+ DF L          N + D    
Sbjct: 102 IVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK-- 156

Query: 234 LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
               R++GT  Y APE  +    ++  D +S G +L E L G  P
Sbjct: 157 -EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 70.8 bits (173), Expect = 8e-14
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 19/205 (9%)

Query: 76  IGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IGEGS G V  A + + G   A+KK+D       E  F  ++ ++   +HE+ VE+    
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHENVVEMYNSY 86

Query: 135 MESNNRILVYQFATMGSLHDVL-HGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
           +  +   +V +F   G+L D++ H R           +   Q   V     K L  LH +
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIAAVCLAVLKALSVLHAQ 135

Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               ++HRD++S ++LL  D + K++DF    Q S    R  S  ++GT  + APE    
Sbjct: 136 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISR 190

Query: 254 GQITQKSDVYSFGVVLLELLTGRKP 278
                + D++S G++++E++ G  P
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 70.4 bits (172), Expect = 8e-14
 Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 19/206 (9%)

Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V+ A     T  A+K +   S       F A+ +V+  L+H+  V+L     
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV--EAFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           +    I+  +F   GSL D L   +G    +P P L     +  +   A+G+ F+ ++  
Sbjct: 72  KEPIYIIT-EFMAKGSLLDFLKSDEG--SKQPLPKL-----IDFSAQIAEGMAFIEQR-- 121

Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAMT 253
              +HRD+R++N+L+      KIADF L     D     ++ R    F   + APE    
Sbjct: 122 -NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINF 177

Query: 254 GQITQKSDVYSFGVVLLELLT-GRKP 278
           G  T KSDV+SFG++L+E++T GR P
Sbjct: 178 GSFTIKSDVWSFGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 67/221 (30%), Positives = 102/221 (46%), Gaps = 27/221 (12%)

Query: 65  RLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSR 121
           R  + F     IGEG+YG V+ A+  T G   A+KK  +D      P S    +++++  
Sbjct: 4   RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLN 62

Query: 122 LKHEHFVELL----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV 177
           L+H + VEL     G  ++S   ++ Y    + SL D +          P P  + +Q  
Sbjct: 63  LRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM----------PTP-FSESQVK 111

Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
            +     +GL++LHE     I+HRD++ SN+LL D    KIADF L       A     T
Sbjct: 112 CLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK--PMT 166

Query: 238 RVLGTFGYHAPE--YAMTGQITQKSDVYSFGVVLLELLTGR 276
             + T  Y APE     T   T   D+++ G +L ELL  +
Sbjct: 167 PKVVTLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 69.8 bits (171), Expect = 1e-13
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 28/215 (13%)

Query: 75  LIGEGSYGRVFYAKLTD-GTPAAIKKLDTS-SAPEPESDFAA---QLSVVSRLKHEHFVE 129
           L+G+G++GRV+     D G   A+K++     +PE + +  A   ++ ++  L+HE  V+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 130 LLGYCMESNNRILVY-QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
             G C+  +  + ++ ++   GS+ D L           G  LT     K      +G+E
Sbjct: 69  YYG-CLRDDETLSIFMEYMPGGSVKDQL--------KAYGA-LTETVTRKYTRQILEGVE 118

Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ-----SSDTAARLHSTRVLGTF 243
           +LH  +   IVHRD++ +N+L       K+ DF  + +     SS T  +     V GT 
Sbjct: 119 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMK----SVTGTP 171

Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            + +PE        +K+DV+S G  ++E+LT + P
Sbjct: 172 YWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 68/284 (23%), Positives = 124/284 (43%), Gaps = 34/284 (11%)

Query: 68  SNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES--DFAAQLSVVSRLKH 124
           +NF  +  IG G +  V+ A  L D  P A+KK+      + ++  D   ++ ++ +L H
Sbjct: 2   ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61

Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            + ++ L   +E N   +V + A  G L  ++   K  +   P   + W   V++     
Sbjct: 62  PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV-WKYFVQLC---- 116

Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
             +E +H +    ++HRD++ +NV +      K+ D  L    S      HS  ++GT  
Sbjct: 117 SAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPY 171

Query: 245 YHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK 304
           Y +PE         KSD++S G +L E+   + P        + +L +         K++
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLFSLC------QKIE 221

Query: 305 QCVDPKLNNDYPP----KAIAKLAAVAALCVQYEADFRPNMTIV 344
           QC       DYPP        KL  + ++C+  + D RP++  V
Sbjct: 222 QC-------DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 56/240 (23%), Positives = 116/240 (48%), Gaps = 35/240 (14%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKH---EHFVEL 130
           LIG G+YG V+  K +  G   A+K ++  +  +  SD   +++++S+L+     +  + 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGP-------VLTWNQRVKVAYGA 183
            G  ++     ++ ++A  GS+  ++         + GP       V+   + V VA   
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLM---------KAGPIAEKYISVII--REVLVA--- 113

Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
              L+++H+     ++HRD++++N+L+ +    K+ DF +    +  +++  ST V GT 
Sbjct: 114 ---LKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK-RSTFV-GTP 165

Query: 244 GYHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGRKPV-DHTMPKGQQSLVTWATPRLSED 301
            + APE    G+    K+D++S G+ + E+ TG  P  D    +    +     PRL ++
Sbjct: 166 YWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDN 225

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 69.2 bits (169), Expect = 2e-13
 Identities = 85/284 (29%), Positives = 129/284 (45%), Gaps = 41/284 (14%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQ-LSVVSRLKHEHFVELL-G 132
           +G+GSYG V   +  TDG    IKKL+  +A   E   A Q   ++S+LKH + V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           +  E     +V  F   G L+  L  +KG        +L  NQ V+     A  L++LHE
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKG-------KLLPENQVVEWFVQIAMALQYLHE 120

Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFN----LTNQSSDTAARLHSTRVLGTFGYHAP 248
           K    I+HRD+++ NV L      K+ D      L NQ  D A+ L     +GT  Y +P
Sbjct: 121 K---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DMASTL-----IGTPYYMSP 171

Query: 249 EYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD 308
           E         KSDV++ G  + E+ T +   +    K   SLV     R+ E K+     
Sbjct: 172 ELFSNKPYNYKSDVWALGCCVYEMATLKHAFN---AKDMNSLVY----RIIEGKL----- 219

Query: 309 PKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL 352
           P +  DY P+    +A +  L  + E   RP++  +++  QP +
Sbjct: 220 PPMPKDYSPELGELIATM--LSKRPEK--RPSVKSILR--QPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 69.4 bits (169), Expect = 3e-13
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 18/225 (8%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG+G+ G VF A  +  G   AIK+++    P+ E     ++ V+  LK+ + V  L   
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL-IINEILVMKELKNPNIVNFLDSF 85

Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
           +  +   +V ++   GSL DV+              +   Q   V     + LEFLH   
Sbjct: 86  LVGDELFVVMEYLAGGSLTDVV----------TETCMDEAQIAAVCRECLQALEFLHAN- 134

Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              ++HRD++S NVLL  D   K+ DF    Q +   ++   + ++GT  + APE     
Sbjct: 135 --QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRK 190

Query: 255 QITQKSDVYSFGVVLLELLTGRKPVDHTMP-KGQQSLVTWATPRL 298
               K D++S G++ +E++ G  P  +  P +    + T  TP L
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 68.7 bits (168), Expect = 3e-13
 Identities = 69/270 (25%), Positives = 112/270 (41%), Gaps = 50/270 (18%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLG-- 132
           +G+G+YG V+       G   A+K++         +    +L ++ +    + V+  G  
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 133 -------YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
                   CME         +   GSL D L+         P  VL      ++ Y   K
Sbjct: 69  FIEGAVYMCME---------YMDAGSL-DKLYAGGVATEGIPEDVLR-----RITYAVVK 113

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           GL+FL E+    I+HRDV+ +NVL+  + + K+ DF +   S +  A L  T + G   Y
Sbjct: 114 GLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGV---SGNLVASLAKTNI-GCQSY 167

Query: 246 HAPEYAMTGQITQ------KSDVYSFGVVLLELLTGRKP----VDHTMPKGQQSLVTWAT 295
            APE   +G   Q      +SDV+S G+ +LE+  GR P        +     ++V    
Sbjct: 168 MAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP 227

Query: 296 PRL-------SEDKVKQCV--DPKLNNDYP 316
           P L       ++D V +C+   P     Y 
Sbjct: 228 PTLPSGYSDDAQDFVAKCLNKIPNRRPTYA 257

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 68.7 bits (169), Expect = 3e-13
 Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 49/220 (22%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPE--PESDFAA--QLSVVSRLKHEHFVEL 130
           +GEG+YG V+ A+    G   A+KK+   +  E  P +   A  ++S++  LKH + V+L
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPST---ALREISLLKELKHPNIVKL 63

Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK-VAYGAAKGLEF 189
           L          LV+++  M  L   L  R G         L+ N  +K + Y   +GL +
Sbjct: 64  LDVIHTERKLYLVFEYCDM-DLKKYLDKRPG--------PLSPNL-IKSIMYQLLRGLAY 113

Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS------TRVLGTF 243
            H      I+HRD++  N+L+  D   K+ADF L        AR         T  + T 
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGL--------ARAFGIPLRTYTHEVVTL 162

Query: 244 GYHAPE-------YAMTGQITQKSDVYSFGVVLLELLTGR 276
            Y APE       Y  +  +    D++S G +  E++TG+
Sbjct: 163 WYRAPEILLGSKHY--STAV----DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 67.9 bits (166), Expect = 4e-13
 Identities = 76/285 (26%), Positives = 125/285 (43%), Gaps = 42/285 (14%)

Query: 76  IGEGSYGRVFYAK---LTDG-----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           +G+G++ ++F      + D      T   +K LD S     ES F A  S++S+L H+H 
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAA-SMMSQLSHKHL 61

Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
           V   G C+  +  I+V ++   GSL   L   K +         +W  +++VA   A  L
Sbjct: 62  VLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINI------SW--KLEVAKQLAWAL 113

Query: 188 EFLHEKVQPPIVHRDVRSSNVLLF--DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
            FL +K    + H +V + NVLL   +D K+    F   +    +   L    +L    +
Sbjct: 114 HFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPW 170

Query: 246 HAPEYAMTGQ-ITQKSDVYSFGVVLLELLTG-RKPVDHTMPKGQQSLVTWATPRLSEDKV 303
             PE     Q ++  +D +SFG  L E+ +G  KP+       Q+ L      +  ED+ 
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--QKKL------QFYEDR- 221

Query: 304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKAL 348
            Q   PK           +LA +   C+ YE DFRP+   +++ L
Sbjct: 222 HQLPAPKW---------TELANLINQCMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 68.5 bits (168), Expect = 4e-13
 Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 30/234 (12%)

Query: 72  TKALIGEGSYGRVFYAKLTDGTPA------------------AIKKLDTSSAPEPESDFA 113
               +GEG +G V   +  DG                     A+K L   ++     DF 
Sbjct: 9   FVEKLGEGQFGEVHLCE-ADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67

Query: 114 AQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEP--GPVL 171
            ++ ++SRL   +   LLG C       ++ ++   G L+  L                L
Sbjct: 68  KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127

Query: 172 TWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ--SSD 229
           +++  + +A   A G+ +L        VHRD+ + N L+  ++  KIADF ++    SSD
Sbjct: 128 SFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184

Query: 230 TAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT--GRKPVDH 281
              R+     L    + A E  + G+ T KSDV++FGV L E+LT    +P +H
Sbjct: 185 YY-RVQGRAPL-PIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 68.2 bits (167), Expect = 5e-13
 Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 18/210 (8%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPE--PESDFAAQLSVVSRLKHEHFVELLG 132
           IGEG+YG V+  +    G   A+KK+   S  E  P S    ++S++  L+H + V L  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVP-STAIREISLLKELQHPNIVCLQD 66

Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
             M+ +   L+++F +M  L   L      Q  +   V ++       Y   +G+ F H 
Sbjct: 67  VLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSY------LYQILQGILFCHS 119

Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           +    ++HRD++  N+L+ +    K+ADF L  ++     R+++  V+ T  Y APE  +
Sbjct: 120 R---RVLHRDLKPQNLLIDNKGVIKLADFGLA-RAFGIPVRVYTHEVV-TLWYRAPEVLL 174

Query: 253 TGQ-ITQKSDVYSFGVVLLELLTGRKPVDH 281
                +   D++S G +  E+ T +KP+ H
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMAT-KKPLFH 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 67.7 bits (166), Expect = 5e-13
 Identities = 32/93 (34%), Positives = 46/93 (49%), Gaps = 6/93 (6%)

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
            LE+LH K    I+HRD++  N+LL +     I DFN+   ++       +T   GT GY
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNI---ATKVTPDTLTTSTSGTPGY 165

Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            APE       +   D +S GV   E L G++P
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 5e-13
 Identities = 58/233 (24%), Positives = 99/233 (42%), Gaps = 63/233 (27%)

Query: 76  IGEGSYGRVFYAKL---TDGTPAAIKKLDTSSAPEPESDFAA----QLSVVSRLKHEHFV 128
           IG G+YGRV+ AK     DG   AIKK       E  +  +     +++++  LKHE+ V
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGD--KEQYTGISQSACREIALLRELKHENVV 65

Query: 129 ELLGYCMESNNRI--LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTW---NQRVKVAYGA 183
            L+   +E  ++   L++ +A     HD+              ++ +    +RV +    
Sbjct: 66  SLVEVFLEHADKSVYLLFDYAE----HDLWQ------------IIKFHRQAKRVSIPPSM 109

Query: 184 AK--------GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS----KIADFNLTNQSSDTA 231
            K        G+ +LH      ++HRD++ +N+L+  +       KI D  L        
Sbjct: 110 VKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGL-------- 158

Query: 232 ARL---------HSTRVLGTFGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLT 274
           ARL             V+ T  Y APE  +  +  T+  D+++ G +  ELLT
Sbjct: 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 68.2 bits (166), Expect = 5e-13
 Identities = 65/245 (26%), Positives = 112/245 (45%), Gaps = 34/245 (13%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKH-EHFVELLG 132
           L+G G+YG+V+  + +  G  AAIK +D +   + E +   +++++ +  H  +     G
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYG 70

Query: 133 YCMESN------NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY---GA 183
             ++ N         LV +F   GS+ D++   KG    E      W     +AY     
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE-----EW-----IAYICREI 120

Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
            +GL  LH   Q  ++HRD++  NVLL ++ + K+ DF ++ Q   T  R ++   +GT 
Sbjct: 121 LRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTP 175

Query: 244 GYHAPEYAMTGQITQ-----KSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTW-ATPR 297
            + APE     +        KSD++S G+  +E+  G  P+    P     L+     PR
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR 235

Query: 298 LSEDK 302
           L   K
Sbjct: 236 LKSKK 240

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 67.7 bits (165), Expect = 6e-13
 Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 18/217 (8%)

Query: 76  IGEGSYGRVFYAKLTDG-TPA--AIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           IG G +G+V   ++  G TPA   +K+L  S++ + +  F  +      L+H + ++ LG
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
            C E    +LV +F  +G L   L   +  +   P P     QR  +A   A GL  LH+
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTL--QR--MACEIALGLLHLHK 118

Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA- 251
                 +H D+   N LL  D   KI D+ L++        +   ++     + APE   
Sbjct: 119 N---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175

Query: 252 ------MTGQITQKSDVYSFGVVLLELLT-GRKPVDH 281
                 +    T++S+V+S GV + EL   G +P  H
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 27/244 (11%)

Query: 76  IGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG+G+ G V+ A  +  G   AI++++    P+ E     ++ V+   K+ + V  L   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIVNYLDSY 86

Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
           +  +   +V ++   GSL DV+      +G          Q   V     + LEFLH   
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEG----------QIAAVCRECLQALEFLHSN- 135

Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              ++HRD++S N+LL  D   K+ DF    Q +   ++   + ++GT  + APE     
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRK 191

Query: 255 QITQKSDVYSFGVVLLELLTGRKPVDHTMP-KGQQSLVTWATPRLS---------EDKVK 304
               K D++S G++ +E++ G  P  +  P +    + T  TP L           D + 
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251

Query: 305 QCVD 308
           +C+D
Sbjct: 252 RCLD 255

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 66.8 bits (163), Expect = 1e-12
 Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 21/204 (10%)

Query: 76  IGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           +G G+ G V+ A  L      A+K +      E +    ++L ++ +    + +   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
              N   +  +F   GSL         V    P  VL      ++A    KGL +L    
Sbjct: 69  FVENRISICTEFMDGGSLD--------VYRKIPEHVLG-----RIAVAVVKGLTYLWSL- 114

Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              I+HRDV+ SN+L+    + K+ DF ++ Q  ++ A+ +    +GT  Y APE     
Sbjct: 115 --KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY----VGTNAYMAPERISGE 168

Query: 255 QITQKSDVYSFGVVLLELLTGRKP 278
           Q    SDV+S G+  +EL  GR P
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 66.3 bits (161), Expect = 2e-12
 Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 18/225 (8%)

Query: 76  IGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG+G+ G V+ A  +  G   AIK+++    P+ E     ++ V+   K+ + V  L   
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL-IINEILVMRENKNPNIVNYLDSY 85

Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
           +  +   +V ++   GSL DV+      +G          Q   V     + L+FLH   
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTETCMDEG----------QIAAVCRECLQALDFLHSN- 134

Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              ++HRD++S N+LL  D   K+ DF    Q +   ++   + ++GT  + APE     
Sbjct: 135 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRK 190

Query: 255 QITQKSDVYSFGVVLLELLTGRKPVDHTMP-KGQQSLVTWATPRL 298
               K D++S G++ +E++ G  P  +  P +    + T  TP L
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)

Query: 76  IGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IGEGS G V  A +   G   A+KK+D       E  F  ++ ++    HE+ V++    
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN-EVVIMRDYHHENVVDMYNSY 88

Query: 135 MESNNRILVYQFATMGSLHDVL-HGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
           +  +   +V +F   G+L D++ H R           +   Q   V     + L +LH +
Sbjct: 89  LVGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIATVCLSVLRALSYLHNQ 137

Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               ++HRD++S ++LL  D + K++DF    Q S    +  S  ++GT  + APE    
Sbjct: 138 ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISR 192

Query: 254 GQITQKSDVYSFGVVLLELLTGRKPVDHTMP-KGQQSLVTWATPRLSE 300
                + D++S G++++E++ G  P  +  P +  + +     PR+ +
Sbjct: 193 LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKD 240

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 61/223 (27%), Positives = 108/223 (48%), Gaps = 28/223 (12%)

Query: 76  IGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVELLGY 133
           IG+G+YG+VF      +G+ AA+K LD     + + +  A+ +++  L  H + V+  G 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILD--PIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83

Query: 134 CMESNNRI-----LVYQFATMGSLHDVLHG--RKGVQGAEPGPVLTWNQRVKVAYGAAKG 186
             + + +      LV +    GS+ D++ G  ++G +  EP  ++ +     + + A  G
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP--IIAY-----ILHEALMG 136

Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           L+ LH       +HRDV+ +N+LL  +   K+ DF ++ Q + T  RL     +GT  + 
Sbjct: 137 LQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST--RLRRNTSVGTPFWM 191

Query: 247 APEYAMTGQ-----ITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
           APE     Q        + DV+S G+  +EL  G  P+    P
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 65.7 bits (161), Expect = 5e-12
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 21/211 (9%)

Query: 74  ALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPES--DFAA--QLSVVSRLKHEHFV 128
             +GEG+Y  V+ A+    G   AIKK+      E +   +F A  ++ ++  LKH + +
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 129 ELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            LL      +N  LV++F     L  V+  +  V    P  + ++           +GLE
Sbjct: 66  GLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLT--PADIKSYMLM------TLRGLE 116

Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +LH      I+HRD++ +N+L+  D   K+ADF L         ++ + +V+ T  Y AP
Sbjct: 117 YLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM-THQVV-TRWYRAP 171

Query: 249 EYAM-TGQITQKSDVYSFGVVLLELLTGRKP 278
           E            D++S G +  ELL  R P
Sbjct: 172 ELLFGARHYGVGVDMWSVGCIFAELLL-RVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 64.8 bits (158), Expect = 7e-12
 Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 18/212 (8%)

Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKHE 125
           NF     IGEG+YG V+ A+    G   A+KK  LDT +   P S    ++S++  L H 
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP-STAIREISLLKELNHP 59

Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
           + V+LL      N   LV++F     LH  L   K    A P   +         +   +
Sbjct: 60  NIVKLLDVIHTENKLYLVFEF-----LHQDL---KKFMDASPLSGIPLPLIKSYLFQLLQ 111

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R ++  V+ T  Y
Sbjct: 112 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV-TLWY 166

Query: 246 HAPEYAMTGQI-TQKSDVYSFGVVLLELLTGR 276
            APE  +  +  +   D++S G +  E++T R
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 64.4 bits (157), Expect = 8e-12
 Identities = 55/213 (25%), Positives = 86/213 (40%), Gaps = 30/213 (14%)

Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSR----LKHEHFVEL 130
           +G+G +G V   ++   G   A KKLD     + + +   Q+++  +         F+  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGE---QMALNEKKILEKVSSRFIVS 57

Query: 131 LGYCMESNNRI-LVYQFATMGSLHDVL--HGRKGVQGAEPGPVLTWNQRVKVAYGA--AK 185
           L Y  E+ + + LV      G L   +   G  G   A             + Y A    
Sbjct: 58  LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEAR-----------AIFYAAQIIC 106

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           GLE LH++    IV+RD++  NVLL D    +I+D  L   + +           GT GY
Sbjct: 107 GLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGL---AVELKGGKKIKGRAGTPGY 160

Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            APE           D ++ G  L E++ GR P
Sbjct: 161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 63.7 bits (155), Expect = 1e-11
 Identities = 54/210 (25%), Positives = 99/210 (47%), Gaps = 18/210 (8%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFA-AQLSVVSRLKHEHFVELLG 132
           ++G G++G V   +   D     IK++      + E   A  +  V+  L H + +E   
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
             +E    ++V ++A  G+L + +  R      E   +L +  ++ +A      L  +H 
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDED-TILHFFVQILLA------LHHVHT 119

Query: 193 KVQPPIVHRDVRSSNVLLFDDFKS--KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEY 250
           K+   I+HRD+++ N+LL D  K   KI DF ++   S  +    +  V+GT  Y +PE 
Sbjct: 120 KL---ILHRDLKTQNILL-DKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPEL 172

Query: 251 AMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
                  QKSD+++ G VL EL + ++  +
Sbjct: 173 CEGKPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 66/215 (30%), Positives = 104/215 (48%), Gaps = 31/215 (14%)

Query: 75  LIGEGSYGRVFYAKLTDGTPA----AIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           ++G+GS+G+VF  +   G  A    A+K L             A L V  R++ +   ++
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKK-----------ATLKVRDRVRTKMERDI 51

Query: 131 LGYCMESNNRILV---YQFATMGSLHDVLHGRKG--VQGAEPGPVLTWNQRVKVAYGA-- 183
           L    E N+  +V   Y F T G L+ +L   +G  +       V+   + VK  Y A  
Sbjct: 52  L---AEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAEL 107

Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
           A  L+ LH      I++RD++  N+LL ++   K+ DF L+ +S D   + +S    GT 
Sbjct: 108 ALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTV 162

Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            Y APE       TQ +D +SFGV++ E+LTG  P
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 36/214 (16%)

Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAA----QLSVVSRLKHEHFVEL 130
           +G G+YG+V  A  T  G   AIKKL   S P   +  A     +L ++  + HE+ + L
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKL---SRPFQSAIHAKRTYRELRLLKHMDHENVIGL 79

Query: 131 LG-YCMESNNR-----ILVYQFATMGS-LHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           L  +   S+        LV     MG+ L++++  +K          L+ +    + Y  
Sbjct: 80  LDVFTPASSLEDFQDVYLVTHL--MGADLNNIVKCQK----------LSDDHIQFLVYQI 127

Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
            +GL+++H      I+HRD++ SN+ + +D + KI DF L   + D       T  + T 
Sbjct: 128 LRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM-----TGYVATR 179

Query: 244 GYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGR 276
            Y APE  +      Q  D++S G ++ ELLTG+
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 33/217 (15%)

Query: 74  ALIGEGSYGRVFYA--KLTDGTPA--AIKKLDTSSAPEPESDFAAQ--LSVVSRLKHEHF 127
           A++G G +G+V  A  K T    A  A+KK D  +  E ES    +      +  +H   
Sbjct: 5   AVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFL 64

Query: 128 VELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK- 185
           V L   C ++ + +  V ++A  G L  ++H    V          +++   V Y A   
Sbjct: 65  VNLFA-CFQTEDHVCFVMEYAAGGDL--MMHIHTDV----------FSEPRAVFYAACVV 111

Query: 186 -GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS---SDTAARLHSTRVLG 241
            GL++LHE     IV+RD++  N+LL  +   KIADF L  +     D      ST   G
Sbjct: 112 LGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT----ST-FCG 163

Query: 242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           T  + APE       T+  D +  GV++ E+L G  P
Sbjct: 164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 37/102 (36%), Positives = 58/102 (56%), Gaps = 6/102 (5%)

Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
           KV+    +GL +L EK Q  I+HRDV+ SN+L+    + K+ DF ++ Q  D+ A     
Sbjct: 107 KVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 160

Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPV 279
             +GT  Y +PE       + +SD++S G+ L+EL  GR P+
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 62.4 bits (151), Expect = 4e-11
 Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 29/220 (13%)

Query: 76  IGEGSYGRVFYAKLTDGT---PAAIKKLDTSSAPEPE-SDFAAQLSVVSRLKHEHFVELL 131
           +GEG +G V   +L         A+K +  +     E  DF ++   +    H + + L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 132 GYCMESNNR------ILVYQFATMGSLHD-VLHGRKGVQGAEPGPVLTWNQR-VKVAYGA 183
           G C+++         +++  F   G LH  +L+ R G       P     Q  VK     
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDC-----PQYLPTQMLVKFMTDI 121

Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT----NQSSDTAARLHSTRV 239
           A G+E+L  K     +HRD+ + N +L ++    +ADF L+    N       R+    V
Sbjct: 122 ASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178

Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
                + A E       T KSDV+SFGV + E+ T G+ P
Sbjct: 179 ----KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 62.4 bits (152), Expect = 5e-11
 Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 38/220 (17%)

Query: 75  LIGEGSYGRVFYAKLTDGTP-----AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           L+ EG++GR+FY  L D  P       +K +   ++    +    +  ++  L H++ + 
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72

Query: 130 LLGYCMESNNRILV-YQFATMGSLHDVLHGRKGVQGAEPGP-VLTWNQRVKVAYGAAKGL 187
           +L  C+E      V Y +   G+L   L  ++   G    P  L+  Q V +A   A G+
Sbjct: 73  ILHVCIEDGEPPFVLYPYMNWGNLKLFL--QQCRLGEANNPQALSTQQLVHMAIQIACGM 130

Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH- 246
            +LH++    ++H+D+ + N ++ ++ + KI D  L             +R L    YH 
Sbjct: 131 SYLHKR---GVIHKDIAARNCVIDEELQVKITDNAL-------------SRDLFPMDYHC 174

Query: 247 ------------APEYAMTGQITQKSDVYSFGVVLLELLT 274
                       A E  +  + +  SDV+SFGV+L EL+T
Sbjct: 175 LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 62.5 bits (152), Expect = 6e-11
 Identities = 63/214 (29%), Positives = 95/214 (44%), Gaps = 27/214 (12%)

Query: 75  LIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAA---QLSVVSRLKHEHFVEL 130
           +IG+GSYG V  A  T  G   AIKK++     E  SD      ++ ++  L+H   VE+
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKIN--DVFEHVSDATRILREIKLLRLLRHPDIVEI 64

Query: 131 LGYCMESNNR----ILVYQFATMGS-LHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
               +  + R    I V  F  M S LH V+              LT        Y   +
Sbjct: 65  KHIMLPPSRREFKDIYVV-FELMESDLHQVIKANDD---------LTPEHHQFFLYQLLR 114

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS-SDTAARLHSTRVLGTFG 244
            L+++H      + HRD++  N+L   D K KI DF L   + +DT   +  T  + T  
Sbjct: 115 ALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171

Query: 245 YHAPEY--AMTGQITQKSDVYSFGVVLLELLTGR 276
           Y APE   +   + T   D++S G +  E+LTG+
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 62.3 bits (151), Expect = 8e-11
 Identities = 36/93 (38%), Positives = 52/93 (55%), Gaps = 5/93 (5%)

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           GL+FLH K    IV+RD++  N+LL  D   KIADF +  ++    A+  +    GT  Y
Sbjct: 108 GLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDY 162

Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            APE  +  +     D +SFGV+L E+L G+ P
Sbjct: 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 61.8 bits (150), Expect = 9e-11
 Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 26/214 (12%)

Query: 75  LIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSV--VSRLKHEH-FVEL 130
           ++G+GS+G+V  A+L   G   A+K L      + + D    ++   +  L   H F+  
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQ-DDDVECTMTEKRILSLARNHPFLTQ 60

Query: 131 LGYCMESNNRIL-VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK---G 186
           L  C ++ +R+  V +F   G L  + H +K  +  E           +  + AA+    
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEA----------RARFYAAEITSA 108

Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           L FLH+K    I++RD++  NVLL  +   K+ADF +  +         ++   GT  Y 
Sbjct: 109 LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYI 163

Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
           APE           D ++ GV+L E+L G  P +
Sbjct: 164 APEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 51/204 (25%), Positives = 95/204 (46%), Gaps = 17/204 (8%)

Query: 76  IGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IGEGS G V  A+    G   A+K +D       E  F  ++ ++   +H++ VE+    
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN-EVVIMRDYQHQNVVEMYKSY 87

Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
           +      ++ +F   G+L D++   +          L   Q   V     + L +LH + 
Sbjct: 88  LVGEELWVLMEFLQGGALTDIVSQTR----------LNEEQIATVCESVLQALCYLHSQ- 136

Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              ++HRD++S ++LL  D + K++DF    Q S    +  S  ++GT  + APE     
Sbjct: 137 --GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRT 192

Query: 255 QITQKSDVYSFGVVLLELLTGRKP 278
               + D++S G++++E++ G  P
Sbjct: 193 PYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 50/236 (21%), Positives = 99/236 (41%), Gaps = 41/236 (17%)

Query: 115 QLSVVSRLKHEHFVELLGYCMESNNR----ILVYQFATMGSLHDVLHGRKGVQGAEPGPV 170
           ++  + R+   + +++ G+ ++  +      L+ ++ T G L +VL   K          
Sbjct: 68  EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD--------- 118

Query: 171 LTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT 230
           L++  ++ +A    KGL  L++    P  ++++ S + L+ +++K KI    L    S  
Sbjct: 119 LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSP 176

Query: 231 AARLHSTRVLGTFGYHAPEYAMTGQI----TQKSDVYSFGVVLLELLTGRKPVDHTMPKG 286
                   V     Y + +  M   I    T K D+YS GVVL E+ TG+ P ++   K 
Sbjct: 177 P----FKNV-NFMVYFSYK--MLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE 229

Query: 287 QQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMT 342
              L+           + +    KL  D P     ++  +   C  +++  RPN+ 
Sbjct: 230 IYDLI-----------INKNNSLKLPLDCP----LEIKCIVEACTSHDSIKRPNIK 270

Length = 283

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 64/225 (28%), Positives = 99/225 (44%), Gaps = 32/225 (14%)

Query: 73  KALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSV--------VSRLK 123
             ++G G+ G V  AK ++DG P A+K +D     E + +  AQ  V         S +K
Sbjct: 37  SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKN-RAQAEVCCLLNCDFFSIVK 95

Query: 124 -HEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY 181
            HE F +      E+   I LV  +A  G L   +  R                R    +
Sbjct: 96  CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTN------------RTFREH 143

Query: 182 GAAKGLEFL------HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
            A  GL F+      H      ++HRD++S+N+LL  +   K+ DF  +   + T +   
Sbjct: 144 EA--GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV 201

Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
                GT  Y APE       ++K+D++S GV+L ELLT ++P D
Sbjct: 202 GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 61.1 bits (149), Expect = 1e-10
 Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 27/216 (12%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESD-FAAQLSVVSRLKHEHFVELLGY 133
           IG+GS+G V   +  +DG     K++D  +  E E     ++++++  LKH + V    Y
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV---RY 64

Query: 134 C----MESNNRI-LVYQFATMGSLHDVL-HGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  SN  + +V ++   G L  ++   +K  +  E   +       ++       L
Sbjct: 65  YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW------RILTQLLLAL 118

Query: 188 EFLHEKVQPP--IVHRDVRSSNVLLFDDFKSKIADFNLT---NQSSDTAARLHSTRVLGT 242
              H +  P   ++HRD++ +N+ L  +   K+ DF L       S  A     T V GT
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA----KTYV-GT 173

Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
             Y +PE        +KSD++S G ++ EL     P
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 35/212 (16%)

Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAA--QLSVVSRLKHEHFVELLG 132
           IGEGSYG VF  +  + G   AIKK    S  +P     A  ++ ++ +LKH + V L+ 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKF-VESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 133 YCMESNNRILVYQFATMGSLHDVLHG-RKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
                    LV+++      H VL+   K  +G     +       K+ +   + + F H
Sbjct: 68  VFRRKRKLHLVFEYCD----HTVLNELEKNPRGVPEHLI------KKIIWQTLQAVNFCH 117

Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS------TRVLGTFGY 245
              +   +HRDV+  N+L+    + K+ DF          AR+ +      T  + T  Y
Sbjct: 118 ---KHNCIHRDVKPENILITKQGQIKLCDFGF--------ARILTGPGDDYTDYVATRWY 166

Query: 246 HAPEYAMTG--QITQKSDVYSFGVVLLELLTG 275
            APE  + G  Q     DV++ G V  ELLTG
Sbjct: 167 RAPEL-LVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 61/224 (27%), Positives = 95/224 (42%), Gaps = 42/224 (18%)

Query: 76  IGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEH-------- 126
           I +G++G V+ A K + G   AIK L        +SD  A  + V+ +K E         
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVL-------KKSDMIA-KNQVTNVKAERAIMMIQGE 55

Query: 127 --FVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
             +V  L Y  +S + + LV ++   G    ++       G  P     W ++    Y A
Sbjct: 56  SPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIK----TLGGLP---EDWAKQ----YIA 104

Query: 184 --AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG 241
               G+E LH   Q  I+HRD++  N+L+      K+ DF L+         L + + +G
Sbjct: 105 EVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSR------NGLENKKFVG 155

Query: 242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPK 285
           T  Y APE  +     + SD +S G V+ E L G  P     P 
Sbjct: 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD 199

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 61.1 bits (149), Expect = 1e-10
 Identities = 67/221 (30%), Positives = 95/221 (42%), Gaps = 37/221 (16%)

Query: 74  ALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPE--PESDF--AAQLSVVSRLKHEHFV 128
           A IGEG+YG V+ A+ L  G   A+KK+    + E  P S     A L  +   +H + V
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 129 ELLGYC--MESNNRI---LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
            LL  C    ++  +   LV++      L   L          P P L       +    
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLS-------KCPKPGLPPETIKDLMRQL 116

Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
            +G++FLH      IVHRD++  N+L+  D + KIADF L    S   A    T V+ T 
Sbjct: 117 LRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL---TSVVVTL 170

Query: 244 GYHAPE------YAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            Y APE      YA         D++S G +  EL   R+P
Sbjct: 171 WYRAPEVLLQSSYATP------VDMWSVGCIFAELFR-RRP 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 60/243 (24%), Positives = 109/243 (44%), Gaps = 33/243 (13%)

Query: 58  IKLDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQL 116
           I L  L      F    ++G G+YG+V+  + +  G  AAIK +D +   + E +   ++
Sbjct: 6   IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEI 63

Query: 117 SVVSRLKHEHFVELL--GYCMES-----NNRILVYQFATMGSLHDVLHGRKGVQGAEPGP 169
           +++ +  H   +      +  +S     +   LV +F   GS+ D++   KG    E   
Sbjct: 64  NMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE--- 120

Query: 170 VLTWNQRVKVAY---GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ 226
              W     +AY      +GL  LH      ++HRD++  NVLL ++ + K+ DF ++ Q
Sbjct: 121 --DW-----IAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170

Query: 227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQ-----ITQKSDVYSFGVVLLELLTGRKPVDH 281
              T  R ++   +GT  + APE     +        +SD++S G+  +E+  G  P+  
Sbjct: 171 LDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228

Query: 282 TMP 284
             P
Sbjct: 229 MHP 231

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 37/95 (38%), Positives = 53/95 (55%), Gaps = 9/95 (9%)

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL--TNQSSDTAARLHSTRVLGTF 243
           GL+FLH+K    I++RD++  NVLL  D   KIADF +   N + +  A    +   GT 
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA----STFCGTP 160

Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            Y APE     +  +  D +SFGV+L E+L G+ P
Sbjct: 161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 36/102 (35%), Positives = 58/102 (56%), Gaps = 6/102 (5%)

Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
           KV+    KGL +L EK +  I+HRDV+ SN+L+    + K+ DF ++ Q  D+ A     
Sbjct: 107 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 160

Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPV 279
             +GT  Y +PE       + +SD++S G+ L+E+  GR P+
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 20/217 (9%)

Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPA-AIKKLDTSSAPEPESDFAAQLSVVSRLKHE 125
           +F    ++G+GS+G+V  A  K TD   A  I K D     +       +  V++     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 126 HFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            F+  L  C ++ +R+  V ++   G L  + H ++  +  EP       Q V  A   +
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEP-------QAVFYAAEIS 111

Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL-GTF 243
            GL FLH +    I++RD++  NV+L  +   KIADF +  +         +TR   GT 
Sbjct: 112 VGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV---TTRTFCGTP 165

Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
            Y APE        +  D +++GV+L E+L G+ P D
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 24/221 (10%)

Query: 68  SNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLD-TSSAPEPESDFAA---QLSVVSRL 122
           +N+    L+G+G++GRV+     D G   A+K++     +PE   +  A   ++ ++  L
Sbjct: 2   TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61

Query: 123 KHEHFVELLGYCMESNNRIL--VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
            HE  V+  G   +   R L    +    GS+ D L       GA     LT N   K  
Sbjct: 62  LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKS----YGA-----LTENVTRKYT 112

Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST--- 237
               +G+ +LH  +   IVHRD++ +N+L       K+ DF  + +       L  T   
Sbjct: 113 RQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC--LSGTGMK 167

Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            V GT  + +PE        +K+D++S G  ++E+LT + P
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 65/256 (25%), Positives = 111/256 (43%), Gaps = 19/256 (7%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           +GEG+Y  V+  +  T G   A+K++   +     S    ++S++  LKHE+ V L    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
              N  +LV+++     L   +    GV+GA     L  N      Y   KG+ F HE  
Sbjct: 68  HTENKLMLVFEYMD-KDLKKYMDTH-GVRGA-----LDPNTVKSFTYQLLKGIAFCHEN- 119

Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              ++HRD++  N+L+    + K+ADF L  ++        S  V+ T  Y AP+  +  
Sbjct: 120 --RVLHRDLKPQNLLINKRGELKLADFGLA-RAFGIPVNTFSNEVV-TLWYRAPDVLLGS 175

Query: 255 QITQKS-DVYSFGVVLLELLTGRKPVDHTMPKGQ--QSLVTWATPRLSEDKVKQCVD-PK 310
           +    S D++S G ++ E++TGR     T  + Q  +      TP  +E         P+
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTP--TESTWPGISQLPE 233

Query: 311 LNNDYPPKAIAKLAAV 326
               +P      L  +
Sbjct: 234 YKPTFPRYPPQDLQQL 249

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 59.8 bits (145), Expect = 3e-10
 Identities = 60/237 (25%), Positives = 101/237 (42%), Gaps = 36/237 (15%)

Query: 117 SVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
           S++S+L H+H V+L G C+   N I+V ++   G L   LH  K          L W  +
Sbjct: 53  SLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKN------NVSLHW--K 103

Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL--FDDFKSKIADFNLTNQSSDTAARL 234
           + VA   A  L +L +K    +VH +V   N+L+  +   +  +    L++         
Sbjct: 104 LDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS 160

Query: 235 HSTRVLGTFGYHAPEYAMTGQ--ITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLV 291
              RV     + APE    GQ  +T  +D +SFG  LLE+ + G +P+            
Sbjct: 161 REERVERI-PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPL------------ 207

Query: 292 TWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKAL 348
             +T   SE +       +  +  P    A+LA +   C  Y+   RP+   +++ L
Sbjct: 208 --STLSSSEKERFY----QDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 31/209 (14%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVELLG- 132
           IGEG++  V  A+    G   AIK +        + +   ++  + RL  H + + L+  
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66

Query: 133 -YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK-VAYGAAKGLEFL 190
            +  ++    LV++   M +L++++ GRK      P P     +RVK   Y   K L+ +
Sbjct: 67  LFDRKTGRLALVFELMDM-NLYELIKGRK-----RPLP----EKRVKSYMYQLLKSLDHM 116

Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS----TRVLGTFGYH 246
           H      I HRD++  N+L+ DD   K+ADF        +   ++S    T  + T  Y 
Sbjct: 117 HRN---GIFHRDIKPENILIKDD-ILKLADFG-------SCRGIYSKPPYTEYISTRWYR 165

Query: 247 APEYAMT-GQITQKSDVYSFGVVLLELLT 274
           APE  +T G    K D+++ G V  E+L+
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 61.4 bits (149), Expect = 4e-10
 Identities = 57/196 (29%), Positives = 89/196 (45%), Gaps = 25/196 (12%)

Query: 96  AIKKLDTSSAPEPESDFA---AQLSVVSRLKHEHFVELLGYCMESNNRIL-VYQFATMGS 151
           AIK L T  APE E   A    + ++ +RL H + V LL         +  V+++    +
Sbjct: 7   AIKLLRTD-APEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65

Query: 152 LHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF 211
           L +VL     +   E G ++    +V  A   A      H +    IVHRD++  N+++ 
Sbjct: 66  LREVLAADGALPAGETGRLML---QVLDALACA------HNQ---GIVHRDLKPQNIMVS 113

Query: 212 ---DDFKSKIADFNLTNQSSDT--AARLHSTR---VLGTFGYHAPEYAMTGQITQKSDVY 263
                  +K+ DF +         A     TR   VLGT  Y APE      +T  SD+Y
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173

Query: 264 SFGVVLLELLTGRKPV 279
           ++G++ LE LTG++ V
Sbjct: 174 AWGLIFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 59.7 bits (144), Expect = 4e-10
 Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 20/212 (9%)

Query: 75  LIGEGSYGRVFYAKLTD-GTPAAIKKLD-TSSAPEPESDFAA---QLSVVSRLKHEHFVE 129
           L+G+G++GRV+     D G   A K++     +PE   + +A   ++ ++  L+HE  V+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 130 LLGYCMESNNRILV--YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
             G   +   + L    ++   GS+ D L       GA     LT +   K      +G+
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA----YGA-----LTESVTRKYTRQILEGM 119

Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR-VLGTFGYH 246
            +LH  +   IVHRD++ +N+L       K+ DF  + +           R V GT  + 
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176

Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           +PE        +K+DV+S G  ++E+LT + P
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 60.1 bits (145), Expect = 4e-10
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 32/212 (15%)

Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAA----QLSVVSRLKHEHFVEL 130
           +G G+YG V  A  T  G   A+KKL   S P      A     +L ++  +KHE+ + L
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLLKHMKHENVIGL 81

Query: 131 L-----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
           L        +E  N + +        L++++  +K          LT +    + Y   +
Sbjct: 82  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILR 131

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           GL+++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y
Sbjct: 132 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 183

Query: 246 HAPEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
            APE  +      Q  D++S G ++ ELLTGR
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 59.7 bits (145), Expect = 4e-10
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 42/197 (21%)

Query: 74  ALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFA-AQLSVVSRLKHEHFVELL 131
           A IG+G++G VF A+        A+KK+   +  E     A  ++ ++  LKHE+ V L+
Sbjct: 18  AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77

Query: 132 GYC-----MESNNR---ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
             C       +  +    LV++F      HD L G            L  N+ VK     
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFCE----HD-LAG------------LLSNKNVKFTLSE 120

Query: 184 AK--------GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL---TNQSSDTAA 232
            K        GL ++H      I+HRD++++N+L+  D   K+ADF L    + S ++  
Sbjct: 121 IKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKP 177

Query: 233 RLHSTRVLGTFGYHAPE 249
             ++ RV+ T  Y  PE
Sbjct: 178 NRYTNRVV-TLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 59.4 bits (144), Expect = 5e-10
 Identities = 63/229 (27%), Positives = 107/229 (46%), Gaps = 29/229 (12%)

Query: 65  RLTSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAA-QLSVVSRL 122
           R    F     IGEG+YG+V+ A+  D G   A+KK+   +  E     A  ++ ++ +L
Sbjct: 4   RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL 63

Query: 123 KHEHFVEL----------LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLT 172
            H + V L          L +  +     LV+++      HD++    G+   E G V  
Sbjct: 64  NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD----HDLM----GL--LESGLVHF 113

Query: 173 WNQRVKVAYGA-AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTA 231
               +K       +GL + H+K     +HRD++ SN+LL +  + K+ADF L    +   
Sbjct: 114 SEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170

Query: 232 ARLHSTRVLGTFGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGRKPV 279
           +R ++ +V+ T  Y  PE  +  +      DV+S G +L EL T +KP+
Sbjct: 171 SRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 36/93 (38%), Positives = 52/93 (55%), Gaps = 5/93 (5%)

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           GL+FLH K    I++RD++  NV+L  D   KIADF +  ++     R  ++   GT  Y
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDY 162

Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            APE     + T   D +SFGV+L E+L G+ P
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 59.0 bits (143), Expect = 7e-10
 Identities = 59/232 (25%), Positives = 102/232 (43%), Gaps = 25/232 (10%)

Query: 69  NFGTKALIGEGSYGRVFYA-KLT---DGTPAAIKKLDTSSAPEPESDFA---AQLSVVSR 121
           NF    ++G G+YG+VF   K+     G   A+K L  ++  +          +  V+  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 122 LKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
           ++   F+  L Y  +++ ++ L+  +   G L   L+ R+    +E   V  +   + +A
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESE---VRVYIAEIVLA 117

Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ-SSDTAARLHSTRV 239
                 L+ LH   Q  I++RD++  N+LL  +    + DF L+ +  ++   R +S   
Sbjct: 118 ------LDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS--F 166

Query: 240 LGTFGYHAPEYAMTGQITQKS--DVYSFGVVLLELLTGRKPVDHTMPKGQQS 289
            GT  Y APE    G        D +S GV+  ELLTG  P      +  QS
Sbjct: 167 CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS 218

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 59.1 bits (144), Expect = 7e-10
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 36/218 (16%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESD--FAAQ----LSVVSRLKHEHF 127
            IG G+YG V  A     G   AIKK+          D   A +    + ++  L+HE+ 
Sbjct: 7   PIGSGAYGVVCSAVDKRTGRKVAIKKI-----SNVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 128 VELL-----GYCMESNNRILVYQFATMGS-LHDVLHGRKGVQGAEPGPVLTWNQRVK-VA 180
           + LL         + N+  +V +   M + LH V+   +          LT +  ++   
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTEL--METDLHKVIKSPQ---------PLT-DDHIQYFL 109

Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS-SDTAARLHSTRV 239
           Y   +GL++LH      ++HRD++ SN+L+  +   KI DF L      D   +   T  
Sbjct: 110 YQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166

Query: 240 LGTFGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGR 276
           + T  Y APE  ++    T+  D++S G +  ELLT +
Sbjct: 167 VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 58.6 bits (142), Expect = 9e-10
 Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 37/214 (17%)

Query: 75  LIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSV-----VSRLKHEHFV 128
           L+GEGSYG V   K  + G   AIKK   S     +     ++++     + +L+HE+ V
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLES----EDDKMVKKIAMREIRMLKQLRHENLV 63

Query: 129 ELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            L+          LV++F     L D+     G         L  ++  K  +   +G+E
Sbjct: 64  NLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---------LDESRVRKYLFQILRGIE 114

Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS-----TRVLGTF 243
           F H      I+HRD++  N+L+      K+ DF         A  L +     T  + T 
Sbjct: 115 FCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF-------ARTLAAPGEVYTDYVATR 164

Query: 244 GYHAPEYAMTGQIT--QKSDVYSFGVVLLELLTG 275
            Y APE  + G     +  D+++ G ++ E+LTG
Sbjct: 165 WYRAPEL-LVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 47/187 (25%), Positives = 81/187 (43%), Gaps = 15/187 (8%)

Query: 94  PAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLH 153
           P AI  L    + +    F A+   + +  H + V L G     N  ++V ++ + G+L 
Sbjct: 35  PVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALD 94

Query: 154 DVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD 213
             L   +G         L   Q + +  G A G+++L E      VH+ + +  VL+  D
Sbjct: 95  SFLRKHEG--------QLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSD 143

Query: 214 FKSKIADFN-LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLEL 272
              KI+ F  L    S+      S +      + APE       +  SDV+SFG+V+ E+
Sbjct: 144 LVCKISGFRRLQEDKSEAIYTTMSGKSPVL--WAAPEAIQYHHFSSASDVWSFGIVMWEV 201

Query: 273 LT-GRKP 278
           ++ G +P
Sbjct: 202 MSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 36/224 (16%)

Query: 68  SNFGTKALIGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAA----QLSVVSR 121
             +   + IGEG+YG V  A  K T G   AIKK+    +P     F      ++ ++ R
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPT-GVKVAIKKI----SPFEHQTFCQRTLREIKILRR 59

Query: 122 LKHEHFVELLGY----CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV 177
            KHE+ + +L        ES N + + Q      L+ ++  +           L+ N  +
Sbjct: 60  FKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH----------LS-NDHI 108

Query: 178 K-VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL---TNQSSDTAAR 233
           +   Y   +GL+++H      ++HRD++ SN+LL  +   KI DF L    +   D    
Sbjct: 109 QYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF 165

Query: 234 LHSTRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
           L  T  + T  Y APE  +  +   K+ D++S G +L E+L+ R
Sbjct: 166 L--TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 63/246 (25%), Positives = 105/246 (42%), Gaps = 47/246 (19%)

Query: 75  LIGEGSYGRVFYAKLTDGTPA----AIKKLDTSSAPEPESDFA---AQLSVVSRLKHEHF 127
           ++G+G YG+VF  +   G       A+K L  ++    + D A   A+ +++  +KH   
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQR-------VKVA 180
           V+L            +Y F T G L+ +L    G      G +    +R           
Sbjct: 63  VDL------------IYAFQTGGKLYLILEYLSG------GELFMHLEREGIFMEDTACF 104

Query: 181 YGA--AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
           Y +  +  LE LH++    I++RD++  N+LL      K+ DF L  +S       H+  
Sbjct: 105 YLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-- 159

Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTG--------RKPVDHTMPKGQQSL 290
             GT  Y APE  M     +  D +S G ++ ++LTG        RK     + KG+ +L
Sbjct: 160 FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219

Query: 291 VTWATP 296
             + TP
Sbjct: 220 PPYLTP 225

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 65/222 (29%), Positives = 100/222 (45%), Gaps = 39/222 (17%)

Query: 76  IGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAA----QLSVVSRLKHEHFVEL 130
           +G G+YG V  A     G   AIKKL     P     FA     +L ++  +KHE+ + L
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKL---YRPFQSELFAKRAYRELRLLKHMKHENVIGL 79

Query: 131 LGYCMES------NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK-VAYGA 183
           L            ++  LV  F  MG+  D+    K  + +E         R++ + Y  
Sbjct: 80  LDVFTPDLSLDRFHDFYLVMPF--MGT--DLGKLMKHEKLSE--------DRIQFLVYQM 127

Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
            KGL+++H      I+HRD++  N+ + +D + KI DF L  Q+         TR     
Sbjct: 128 LKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR----- 179

Query: 244 GYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGR---KPVDH 281
            Y APE  +     TQ  D++S G ++ E+LTG+   K  DH
Sbjct: 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH 221

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 5/92 (5%)

Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           L +LH++ +  IVHRD+  +N++L +D K  I DF L  Q    +     T V+GT  Y 
Sbjct: 126 LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYS 180

Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            PE        +K+DV++FG +L ++ T + P
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 35/106 (33%), Positives = 50/106 (47%), Gaps = 3/106 (2%)

Query: 169 PVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS 228
           P L++   V  +Y  A G+EFL  K     VHRD+ + NVL+ +    KI DF L     
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIM 290

Query: 229 DTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
             +  +          + APE       T  SDV+SFG++L E+ T
Sbjct: 291 RDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 26/216 (12%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIK--KLDTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
           L+G+G++G+V   +    G   A+K  K +   A +  +    +  V+   +H  F+  L
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHP-FLTAL 60

Query: 132 GYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA--AKGLE 188
            Y  ++++R+  V ++A  G L    H  +    +E         R +  YGA     L 
Sbjct: 61  KYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSED--------RARF-YGAEIVSALG 109

Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +LH      +V+RD++  N++L  D   KI DF L  +     A + +    GT  Y AP
Sbjct: 110 YLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAP 164

Query: 249 EYAMTGQITQKSDVYSFGVVLLELLTGRKPV---DH 281
           E        +  D +  GVV+ E++ GR P    DH
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 24/213 (11%)

Query: 75  LIGEGSYGRVFYA--KLTDGTPA-AIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
           ++G+GS+G+V  A  K TD   A  I K D     +       +  V++      F+  L
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66

Query: 132 GYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA--AKGLE 188
             C ++ +R+  V ++   G L  + H ++  +  EP           V Y A  A GL 
Sbjct: 67  HSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKFKEP---------HAVFYAAEIAIGLF 115

Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL-GTFGYHA 247
           FLH K    I++RD++  NV+L  +   KIADF +  ++        +TR   GT  Y A
Sbjct: 116 FLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK---TTRTFCGTPDYIA 169

Query: 248 PEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
           PE        +  D ++FGV+L E+L G+ P D
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 30/217 (13%)

Query: 74  ALIGEGSYGRVFYA--KLTDGTPA--AIKKLDTSSAPEPESDFAAQ--LSVVSRLKHEHF 127
            ++G+GS+G+V  A  K TD   A   +KK       + E     +  L++  +  H   
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK--HPFL 58

Query: 128 VELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA--A 184
            +L   C ++ +R+  V ++   G L  + H ++  +  EP             Y A   
Sbjct: 59  TQLHS-CFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEP---------RARFYAAEIV 106

Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
            GL+FLHE+    I++RD++  NVLL  +   KIADF +  +         ++   GT  
Sbjct: 107 LGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPD 161

Query: 245 YHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVD 280
           Y APE  ++ Q    + D ++ GV+L E+L G+ P +
Sbjct: 162 YIAPE-ILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 56.9 bits (138), Expect = 3e-09
 Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 23/209 (11%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           IGEG+YG V+ A+    G   A+KK  L+T     P S    ++S++  L H + V LL 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVP-STAIREISLLKELNHPNIVRLLD 65

Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV--KVAYGAAKGLEFL 190
                N   LV++F  +    D+             P+   +  +     Y   +G+ + 
Sbjct: 66  VVHSENKLYLVFEFLDL----DLKKYMDSS------PLTGLDPPLIKSYLYQLLQGIAYC 115

Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEY 250
           H      ++HRD++  N+L+  +   K+ADF L  ++     R ++  V+ T  Y APE 
Sbjct: 116 HSH---RVLHRDLKPQNLLIDREGALKLADFGLA-RAFGVPVRTYTHEVV-TLWYRAPEI 170

Query: 251 AMTG-QITQKSDVYSFGVVLLELLTGRKP 278
            +   Q +   D++S G +  E++  R+P
Sbjct: 171 LLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 57/233 (24%), Positives = 93/233 (39%), Gaps = 46/233 (19%)

Query: 74  ALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESD-----------FAA--QLSVV 119
           A +GEG+YG+V  A  T  G   AIKK+         +            F    +L ++
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 120 SRLKHEHFVELLG-YCMESNNRILVYQFATMGSLHDVLHG--RKGVQGAEPGPVLTWNQR 176
           + +KHE+ + L+  Y       +++          D++    +K V   +    LT +Q 
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVM----------DIMASDLKKVV---DRKIRLTESQV 121

Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL------------T 224
             +      GL  LH+      +HRD+  +N+ +      KIADF L             
Sbjct: 122 KCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178

Query: 225 NQSSDTAARLHSTRVLGTFGYHAPEYAM-TGQITQKSDVYSFGVVLLELLTGR 276
           ++      R   T  + T  Y APE  M   +     D++S G +  ELLTG+
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 56.7 bits (137), Expect = 4e-09
 Identities = 46/219 (21%), Positives = 83/219 (37%), Gaps = 30/219 (13%)

Query: 68  SNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPE-----PESDFAAQLSVVSR 121
            +      +G G++GRV   +        A+K +   + PE      E     +  V+  
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVM---AIPEVIRLKQEQHVHNEKRVLKE 57

Query: 122 LKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY 181
           + H   + L     +     ++ ++   G L   L                ++    + Y
Sbjct: 58  VSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG-----------RFSNSTGLFY 106

Query: 182 GA--AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
            +     LE+LH K    IV+RD++  N+LL  +   K+ DF    +  D    L     
Sbjct: 107 ASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL----- 158

Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            GT  Y APE   +    +  D ++ G+++ E+L G  P
Sbjct: 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 32/216 (14%)

Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQL---SVVSRLKHEHFVELL 131
           IG G+YG V  AK ++     AIKK+  ++A +   D    L    ++  L HE+ + + 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKI--ANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70

Query: 132 GYCMESNNR------ILVYQFATMGS-LHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
              M   +R       +VY+   M + LH ++   +  Q       L+ +      Y   
Sbjct: 71  D-IMPPPHREAFNDVYIVYEL--MDTDLHQII---RSSQ------TLSDDHCQYFLYQLL 118

Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
           +GL+++H      ++HRD++ SN+LL  +   KI DF L   +S+    +  T  + T  
Sbjct: 119 RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM--TEYVVTRW 173

Query: 245 YHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPV 279
           Y APE  +   + T   DV+S G +  ELL GRKP+
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 56.1 bits (135), Expect = 5e-09
 Identities = 50/206 (24%), Positives = 94/206 (45%), Gaps = 15/206 (7%)

Query: 75  LIGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           ++GEGS+GR        +D    A+K++    +     D   +  +++++KH + V    
Sbjct: 7   VVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65

Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
                 +  +V ++   G L   +  ++G    E   +L W  ++ +      G++ +HE
Sbjct: 66  SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPED-TILQWFVQMCL------GVQHIHE 118

Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++S N+ L  + K K+ DF      +   A  ++   +GT  Y  PE   
Sbjct: 119 K---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWE 173

Query: 253 TGQITQKSDVYSFGVVLLELLTGRKP 278
                 KSD++S G +L EL T + P
Sbjct: 174 NMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 56.2 bits (135), Expect = 6e-09
 Identities = 64/218 (29%), Positives = 95/218 (43%), Gaps = 28/218 (12%)

Query: 74  ALIGEGSYGRVFYAK--LTDGTPAAIKKLDTSSAPE--PESDF--AAQLSVVSRLKHEHF 127
           A IGEG+YG+VF A+     G   A+K++   +  E  P S     A L  +   +H + 
Sbjct: 7   AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66

Query: 128 VELLGYCMESNNR-----ILVYQFATMGSLHDVLHGRKGVQGAEPG-PVLTWNQRVKVAY 181
           V L   C  S         LV++      L   L      +  EPG P  T      + +
Sbjct: 67  VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLD-----KVPEPGVPTETIKD---MMF 117

Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG 241
              +GL+FLH      +VHRD++  N+L+    + K+ADF L    S   A    T V+ 
Sbjct: 118 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVV 171

Query: 242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPV 279
           T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 56.2 bits (136), Expect = 7e-09
 Identities = 75/300 (25%), Positives = 129/300 (43%), Gaps = 45/300 (15%)

Query: 76  IGEGSYGRVFYAKLT-DGTPAAIKKL-DTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           IG G+YG V  A  T  G   AIKK+      P        +L ++   KH++ + +   
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72

Query: 134 CM-ESNNRILVYQ-FATMGS-LHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
                 +   VY     M S LH ++H        +P   LT        Y   +GL+++
Sbjct: 73  LRPPGADFKDVYVVMDLMESDLHHIIHSD------QP---LTEEHIRYFLYQLLRGLKYI 123

Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN--QSSDTAARLHSTRVLGTFGYHAP 248
           H      ++HRD++ SN+L+ +D + +I DF +     SS T  +   T  + T  Y AP
Sbjct: 124 HSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180

Query: 249 EYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMP----KGQQSLVTW--ATP----- 296
           E  ++  + T   D++S G +  E+L GR+ +    P      Q  L+     +P     
Sbjct: 181 ELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL---FPGKNYVHQLKLILSVLGSPSEEVL 236

Query: 297 -RLSEDKVKQCV------DPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ 349
            R+  D+V++ +       P   +   PKA  +   + +  +Q++ + R     V +ALQ
Sbjct: 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT---VEQALQ 293

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 56.4 bits (136), Expect = 7e-09
 Identities = 59/215 (27%), Positives = 91/215 (42%), Gaps = 22/215 (10%)

Query: 68  SNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKH 124
           S+F     +G GS+GRV  AK    G   AIK L        +     A + S++  L H
Sbjct: 18  SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH 77

Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLT-WNQRVKVAYGA 183
              V ++    + N    + +F   G L    H RK   G  P  V   ++  + +A+  
Sbjct: 78  PFIVNMMCSFQDENRVYFLLEFVVGGELFT--HLRKA--GRFPNDVAKFYHAELVLAF-- 131

Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
               E+LH K    I++RD++  N+LL +    K+ DF    +  D    L      GT 
Sbjct: 132 ----EYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL-----CGTP 179

Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            Y APE   +    +  D ++ GV+L E + G  P
Sbjct: 180 EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 56.6 bits (136), Expect = 9e-09
 Identities = 29/81 (35%), Positives = 49/81 (60%)

Query: 198 IVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQIT 257
           ++HRD++S+N+ L      K+ DF  + Q SD+ +   ++   GT  Y APE     + +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249

Query: 258 QKSDVYSFGVVLLELLTGRKP 278
           +K+D++S GV+L ELLT  +P
Sbjct: 250 KKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 46/210 (21%), Positives = 92/210 (43%), Gaps = 22/210 (10%)

Query: 76  IGEGSYGRVFYAKL---TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           IG G +G+V  +++   T      +K+L  +++ + +++F  Q      L+H + ++ LG
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
            C+E+   +LV+++  +G L   L   +  +      +L      ++A   A G+  +H+
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-----RMACEIAAGVTHMHK 117

Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNL--TNQSSDTAARLHSTRVLGTFGYHAPEY 250
                 +H D+   N  L  D   K+ D+ +  +    D               + APE 
Sbjct: 118 H---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET--EDDKCVPLRWLAPEL 172

Query: 251 A-------MTGQITQKSDVYSFGVVLLELL 273
                   +T + T+ S+V++ GV L EL 
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 37/228 (16%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKL-DTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +G G++G V  A+    G   AIKK+    S P        +L ++  L+HE+ + L   
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77

Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK-VAYGAAKGLEFLHE 192
            +     I          LH +L  R      E        Q ++   Y   +GL+++H 
Sbjct: 78  FISPLEDIYFVTELLGTDLHRLLTSRP----LEK-------QFIQYFLYQILRGLKYVHS 126

Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG---TFGYHAPE 249
                +VHRD++ SN+L+ ++   KI DF L        AR+   ++ G   T  Y APE
Sbjct: 127 A---GVVHRDLKPSNILINENCDLKICDFGL--------ARIQDPQMTGYVSTRYYRAPE 175

Query: 250 YAMTGQ-ITQKSDVYSFGVVLLELLTGRKPV----DHTMPKGQQSLVT 292
             +T Q    + D++S G +  E+L G KP+    DH     Q S++T
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLFPGKDHV---NQFSIIT 219

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 25/221 (11%)

Query: 69  NFGTKALIGEGSYGRVFYAKLTDGTPAA-------IKKLDTSSAPEPESDFAAQLSVVSR 121
           NF    ++G G+YG+VF  +   G  +        +KK       +       +  V+  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 122 LKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
           ++   F+  L Y  +++ ++ L+  +   G L   L  R+  +  E   V  ++  + +A
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQE---VQIYSGEIVLA 117

Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ-SSDTAARLHSTRV 239
                 LE LH   +  I++RD++  N+LL  +    + DF L+ +   D   R +S   
Sbjct: 118 ------LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS--F 166

Query: 240 LGTFGYHAPEYAMTGQITQKS--DVYSFGVVLLELLTGRKP 278
            GT  Y AP+    G        D +S GV++ ELLTG  P
Sbjct: 167 CGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 55.3 bits (134), Expect = 1e-08
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 30/214 (14%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESD-FAA----QLSVVSRLKHEHFVE 129
           I EG+YG V+ A+    G   A+KKL      E E + F      +++++ +L+H + V 
Sbjct: 13  IEEGTYGVVYRARDKKTGEIVALKKLKM----EKEKEGFPITSLREINILLKLQHPNIVT 68

Query: 130 LLGYCMESN-NRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK-VAYGAAKG 186
           +    + SN ++I +V ++        V H  K +      P L     VK +      G
Sbjct: 69  VKEVVVGSNLDKIYMVMEY--------VEHDLKSLMETMKQPFLQ--SEVKCLMLQLLSG 118

Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           +  LH+     I+HRD+++SN+LL +    KI DF L  +          T+++ T  Y 
Sbjct: 119 VAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQLVVTLWYR 173

Query: 247 APEYAM-TGQITQKSDVYSFGVVLLELLTGRKPV 279
           APE  +   + +   D++S G +  ELLT +KP+
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 64/242 (26%), Positives = 106/242 (43%), Gaps = 36/242 (14%)

Query: 61  DELNR----LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAA- 114
           +E+N+    L   + +   +G G+YG V  A     G   AIKKL   S P     FA  
Sbjct: 4   EEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL---SRPFQSEIFAKR 60

Query: 115 ---QLSVVSRLKHEHFVELLGYCMESNNRILVYQF-ATMGSLHDVLHGRKGVQGAEPGPV 170
              +L+++  ++HE+ + LL     + +      F   M  +   L    G   +E    
Sbjct: 61  AYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSE---- 116

Query: 171 LTWNQRVK-VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD 229
                +V+ + Y    GL+++H      I+HRD++  N+ + +D + KI DF L      
Sbjct: 117 ----DKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARH--- 166

Query: 230 TAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ 288
             A    T  + T  Y APE  +      Q  D++S G ++ E+LTG+     T+ KG+ 
Sbjct: 167 --ADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK-----TLFKGKD 219

Query: 289 SL 290
            L
Sbjct: 220 YL 221

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 44/233 (18%)

Query: 69  NFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPE--PESDFAAQLSVVSRLKHE 125
               K  +GEG++G V+ A ++  G   A+KK+   +  +  P +    ++ ++ +LKH 
Sbjct: 11  EILGK--LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHP 67

Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVL----HGRKGVQGAEPGPVLTWNQRVKVAY 181
           + V L+   +E  ++         GS++ V     H   G+           N  VK+  
Sbjct: 68  NVVPLIDMAVERPDKSK----RKRGSVYMVTPYMDHDLSGLLE---------NPSVKLTE 114

Query: 182 GAAK--------GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL---------T 224
              K        G+ +LHE     I+HRD++++N+L+ +    KIADF L          
Sbjct: 115 SQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171

Query: 225 NQSSDTAARLHSTRVLGTFGYHAPEYAM-TGQITQKSDVYSFGVVLLELLTGR 276
            +          T ++ T  Y  PE  +   + T   D++  G V  E+ T R
Sbjct: 172 PKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 23/219 (10%)

Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G+YG V+ AK  DG       L              +++++  LKH + + L    +
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 136 ESNNR--ILVYQFATMGSLHDVLHGRK--GVQGAEPGPVLTWNQRVK-VAYGAAKGLEFL 190
              +R   L++ +A     HD+ H  K      A   PV      VK + Y    G+ +L
Sbjct: 69  SHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 191 HEKVQPPIVHRDVRSSNVLLFDD----FKSKIADFN---LTNQSSDTAARLHSTRVLGTF 243
           H      ++HRD++ +N+L+  +     + KIAD     L N      A L    V+ TF
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP--VVVTF 179

Query: 244 GYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGRKPVDH 281
            Y APE  +  +  T+  D+++ G +  ELLT  +P+ H
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 23/210 (10%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKL--DTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
           L+G+G++G+V   +    G   A+K L  +   A +  +    +  V+   +H  F+  L
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP-FLTAL 60

Query: 132 GYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA--AKGLE 188
            Y  ++++R+  V ++A  G L   L   +         V T  +R +  YGA     LE
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHLSRER---------VFT-EERARF-YGAEIVSALE 109

Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +LH +    +V+RD++  N++L  D   KI DF L  +     A + +    GT  Y AP
Sbjct: 110 YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAP 164

Query: 249 EYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           E        +  D +  GVV+ E++ GR P
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 58/219 (26%), Positives = 104/219 (47%), Gaps = 24/219 (10%)

Query: 75  LIGEGSYGRVFYA--KLTDGT--PAAIK--KLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           ++G+G +G V  A  K  DG+    A+K  K D  S+ + E +F  + + +    H + +
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIE-EFLREAACMKEFDHPNVI 64

Query: 129 ELLGYCMESNNR------ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
           +L+G  + S  +      +++  F   G LH  L   +   G EP   L     V+    
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSR--IGEEPF-TLPLQTLVRFMID 121

Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ--SSDTAARLHSTRVL 240
            A G+E+L  K     +HRD+ + N +L ++    +ADF L+ +  S D   +  ++++ 
Sbjct: 122 IASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL- 177

Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
               + A E       T  SDV++FGV + E++T G+ P
Sbjct: 178 -PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 54.7 bits (131), Expect = 3e-08
 Identities = 61/300 (20%), Positives = 121/300 (40%), Gaps = 55/300 (18%)

Query: 10  EPQPPASQTTAPPRSGNT------QPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLDEL 63
           E   PA +   P  + +        P G+   +          P  A P+ + Q KL   
Sbjct: 84  EDAAPAGELLVPRSNADLFASAGDGPSGAEDSDASHLDFDEAPPDAAGPVPLAQAKLKHD 143

Query: 64  NRLTSNFGTKALIGEGSYGRVFYAKL--TDGTPAAIKKLDTSSAPEPESD---------- 111
           +   ++F     +  G++G++F   L  +     A + +++++  +P+ +          
Sbjct: 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAG 203

Query: 112 --FAAQLS----VVSRLKHEHFV---ELLGYCMESNNRILV--YQFATMGSLHDVLHGRK 160
              A QL      + RL HE+ +   E+L    E+N  ++   Y F     ++D      
Sbjct: 204 SRAAIQLENEILALGRLNHENILKIEEILRS--EANTYMITQKYDFDLYSFMYD------ 255

Query: 161 GVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD 220
                +  P+L   + +      A  +E++H+K    ++HRD++  N+ L  D K  + D
Sbjct: 256 EAFDWKDRPLLKQTRAIMKQLLCA--VEYIHDKK---LIHRDIKLENIFLNCDGKIVLGD 310

Query: 221 FNLTNQSSDTAARLHSTRV------LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
           F        TA      R       +GT   ++PE        + +D++S G++LL++L+
Sbjct: 311 FG-------TAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 52/211 (24%), Positives = 91/211 (43%), Gaps = 15/211 (7%)

Query: 68  SNFGTKALIGEGSYGRVFYAKLTDGTP-AAIKKL-DTSSAPEPESDFAAQLSVVSRLKHE 125
           + F    ++GEG+YG V   +  +     AIKK  D+    E +     +L ++  LK E
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
           + VEL           LV+++     L  +    +   G  P  V ++       Y   K
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVRSY------IYQLIK 111

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
            + + H+     IVHRD++  N+L+  +   K+ DF      S+  +  + T  + T  Y
Sbjct: 112 AIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE-GSNANYTEYVATRWY 167

Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLTGR 276
            +PE  +     +  D++S G +L EL  G+
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 25/211 (11%)

Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPE--PESDFAAQLSVVSRLKHEHFVELLG 132
           IGEG+YG VF AK  +     A+K++      E  P S    ++ ++  LKH++ V L  
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLYD 66

Query: 133 YCMESNNRILVYQFAT--MGSLHDVLHGRKGVQGAEPGPVLTWNQRVK-VAYGAAKGLEF 189
                    LV+++    +    D  +G       +  P     + VK   +   KGL F
Sbjct: 67  VLHSDKKLTLVFEYCDQDLKKYFDSCNG-------DIDP-----EIVKSFMFQLLKGLAF 114

Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE 249
            H      ++HRD++  N+L+  + + K+ADF L  ++     R +S  V+ T  Y  P+
Sbjct: 115 CHSH---NVLHRDLKPQNLLINKNGELKLADFGLA-RAFGIPVRCYSAEVV-TLWYRPPD 169

Query: 250 YAMTGQITQKS-DVYSFGVVLLELLTGRKPV 279
                ++   S D++S G +  EL    +P+
Sbjct: 170 VLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 23/219 (10%)

Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G+YG V+ AK  DG       L              +++++  LKH + + L    +
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 136 ESNNR--ILVYQFATMGSLHDVLHGRK--GVQGAEPGPVLTWNQRVK-VAYGAAKGLEFL 190
             ++R   L++ +A     HD+ H  K      A   P+      VK + Y    G+ +L
Sbjct: 69  SHSDRKVWLLFDYAE----HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124

Query: 191 HEKVQPPIVHRDVRSSNVLLFDD----FKSKIADFN---LTNQSSDTAARLHSTRVLGTF 243
           H      ++HRD++ +N+L+  +     + KIAD     L N      A L    V+ TF
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP--VVVTF 179

Query: 244 GYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGRKPVDH 281
            Y APE  +  +  T+  D+++ G +  ELLT  +P+ H
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 53.5 bits (128), Expect = 6e-08
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 36/214 (16%)

Query: 76  IGEGSYGRV---FYAKLTDGTPAAIKKLDTSSAPEPESDFAA----QLSVVSRLKHEHFV 128
           +G G+YG V   +  +L      A+KKL   S P      A     +L ++  +KHE+ +
Sbjct: 23  VGSGAYGSVCSAYDTRLRQ--KVAVKKL---SRPFQSLIHARRTYRELRLLKHMKHENVI 77

Query: 129 ELL-----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
            LL        +E+ N + +        L++++  +K          L+      + Y  
Sbjct: 78  GLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK----------LSDEHVQFLIYQL 127

Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
            +GL+++H      I+HRD++ SNV + +D + +I DF L  Q+ D      +TR     
Sbjct: 128 LRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR----- 179

Query: 244 GYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
            Y APE  +      Q  D++S G ++ ELL G+
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 53.0 bits (127), Expect = 6e-08
 Identities = 63/263 (23%), Positives = 109/263 (41%), Gaps = 39/263 (14%)

Query: 75  LIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAA-----QLSVVSRLKHEHFV 128
           +IG G +G V+  +  D G   A+K LD       + +  A      LS+VS      F+
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST-GDCPFI 59

Query: 129 ELLGYCMESNNRI-LVYQFATMGSLHDVL--HGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
             + Y   + +++  +      G LH  L  HG           V +  +    A     
Sbjct: 60  VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-----------VFSEAEMRFYAAEIIL 108

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           GLE +H +    +V+RD++ +N+LL +    +I+D  L    S    + H++  +GT GY
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHAS--VGTHGY 161

Query: 246 HAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK 304
            APE    G     S D +S G +L +LL G  P      K +  +          D++ 
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----------DRMT 211

Query: 305 QCVDPKLNNDYPPKAIAKLAAVA 327
             +  +L + + P+  + L  + 
Sbjct: 212 LTMAVELPDSFSPELRSLLEGLL 234

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 53.0 bits (127), Expect = 7e-08
 Identities = 59/235 (25%), Positives = 105/235 (44%), Gaps = 26/235 (11%)

Query: 69  NFGTKALIGEGSYGRVFYAKLTDGTPA----AIKKLDTSSAPEPESDFA---AQLSVVSR 121
           NF    ++G G+YG+VF  +   G       A+K L  ++  +          + +V+  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 122 LKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
           ++   F+  L Y  ++  ++ L+  + + G +   L+ R      E   V  ++  + +A
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDE---VRFYSGEIILA 117

Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS-SDTAARLHSTRV 239
                 LE LH   +  IV+RD++  N+LL  +    + DF L+ +  S+   R +S   
Sbjct: 118 ------LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS--F 166

Query: 240 LGTFGYHAPEY--AMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT 292
            GT  Y APE      G   +  D +S G+++ ELLTG  P      +  QS V+
Sbjct: 167 CGTIEYMAPEIIRGKGGH-GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS 220

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 52.9 bits (128), Expect = 7e-08
 Identities = 59/219 (26%), Positives = 92/219 (42%), Gaps = 30/219 (13%)

Query: 68  SNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPE--PESDFAAQLSVVSRLKH 124
            +F     +G GS+GRV   +    G   A+K L  +   +         +  ++  ++H
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA- 183
              V L G   + +N  LV ++   G L   L  RK   G  P PV  +       Y A 
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL--RKS--GRFPEPVARF-------YAAQ 109

Query: 184 -AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR---V 239
               LE+LH      IV+RD++  N+LL  D   KI DF          A+    R   +
Sbjct: 110 VVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGF--------AKRVKGRTYTL 158

Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            GT  Y APE  ++    +  D ++ G+++ E+L G  P
Sbjct: 159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 53.0 bits (128), Expect = 8e-08
 Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 45/221 (20%)

Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKL-DTSSAPEPESDFAAQ-----LSVVSRLK-HEH 126
           +G+G+YG V+ A  + T     A+KK+ D   A    +D  AQ     +  +  L  H +
Sbjct: 15  LGKGAYGIVWKAIDRRT-KEVVALKKIFD---AFRNATD--AQRTFREIMFLQELGDHPN 68

Query: 127 FVELLGYCMESNNRILVYQFATMGS-LHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
            V+LL      N++ +   F  M + LH V+  R  +        L    +  + Y   K
Sbjct: 69  IVKLLNVIKAENDKDIYLVFEYMETDLHAVI--RANI--------LEDVHKRYIMYQLLK 118

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT---NQSSDTAARLHSTRVLGT 242
            L+++H      ++HRD++ SN+LL  D + K+ADF L    ++  +       T  + T
Sbjct: 119 ALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175

Query: 243 FGYHAPEYAMTGQITQKSDVYSFGV-------VLLELLTGR 276
             Y APE      I   S  Y+ GV       +L E+L G+
Sbjct: 176 RWYRAPE------ILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 52.7 bits (126), Expect = 9e-08
 Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 22/218 (10%)

Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAA-IKKLDTSSAPEPESDFAAQLSVVSRLKHE 125
           +F    ++G+GS+G+V  A  K TD   A  I K D     +       +  V++     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 126 HFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA- 183
            F+  L  C ++ +R+  V ++   G L  +   ++  +  EP  V          Y A 
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYQIQQVGRFKEPHAVF---------YAAE 109

Query: 184 -AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            A GL FLH K    I++RD++  NV+L  +   KIADF +  +  +    + +    GT
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NMWDGVTTKTFCGT 164

Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
             Y APE        +  D ++FGV+L E+L G+ P +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 22/210 (10%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIK--KLDTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
           L+G+G++G+V   K    G   A+K  K +   A +  +    +  V+   +H  F+  L
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP-FLTAL 60

Query: 132 GYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA--AKGLE 188
            Y  ++++R+  V ++A  G L   L  R+ V   +         R +  YGA     L+
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSED---------RARF-YGAEIVSALD 109

Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +LH +    +V+RD++  N++L  D   KI DF L  +     A + +    GT  Y AP
Sbjct: 110 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAP 165

Query: 249 EYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           E        +  D +  GVV+ E++ GR P
Sbjct: 166 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 29/211 (13%)

Query: 76  IGEGSYGRVFYAKLTDGT--PAAIKKLDTSSA-PEPESDFA-AQLSVVSRLKHEHFVELL 131
           +G GS+GRV  A   +    P AIK+ + S    + + D   ++  +++ + H   V L 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G   + +   LV +F   G     L   K            +   V   Y A   L F  
Sbjct: 98  GSFKDESYLYLVLEFVIGGEFFTFLRRNK-----------RFPNDVGCFYAAQIVLIF-- 144

Query: 192 EKVQP-PIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR---VLGTFGYHA 247
           E +Q   IV+RD++  N+LL  D   K+ DF          A++  TR   + GT  Y A
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGF--------AKVVDTRTYTLCGTPEYIA 196

Query: 248 PEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           PE  +     + +D ++ G+ + E+L G  P
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 66/253 (26%), Positives = 105/253 (41%), Gaps = 26/253 (10%)

Query: 76  IGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSV-VSRLKHEHFVELLGY 133
           +G+G +G V   ++   G   A KKLD     +   +  A L   +    +  F+  L Y
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 134 CMESNNRI-LVYQFATMGSL-HDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
             ES   + LV      G L + + +   G +G E   V+ ++ ++        G+  LH
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYN--VGERGLEMERVIHYSAQI------TCGILHLH 112

Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA 251
                 IV+RD++  NVLL D    +++D  L  +  D       T+  GT GY APE  
Sbjct: 113 SM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEIL 166

Query: 252 MTGQITQKSDVYSFGVVLLELLTGRKPV-DHTMPKGQQSLVTWATPRLSEDKVKQCVDPK 310
                +   D ++ G  + E++ GR P  DH     ++ L      R  ED+VK      
Sbjct: 167 KEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR----RTLEDEVKFEHQ-- 220

Query: 311 LNNDYPPKAIAKL 323
            N     K I +L
Sbjct: 221 -NFTEESKDICRL 232

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 52.4 bits (125), Expect = 1e-07
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 23/210 (10%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIK--KLDTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
           L+G+G++G+V   +    G   A+K  K +   A +  +    +  V+   +H  F+  L
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHP-FLTSL 60

Query: 132 GYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA--AKGLE 188
            Y  ++ +R+  V ++   G L   L   +            +++     YGA     L+
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLSRER-----------VFSEDRTRFYGAEIVSALD 109

Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +LH      IV+RD++  N++L  D   KI DF L  +    AA + +    GT  Y AP
Sbjct: 110 YLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAP 164

Query: 249 EYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           E        +  D +  GVV+ E++ GR P
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 43/129 (33%), Positives = 60/129 (46%), Gaps = 10/129 (7%)

Query: 177 VKV-AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN-QSSDTAARL 234
           VKV  Y   +GL++LH      I+HRD++  N+L+  +   KI DF L   +  D     
Sbjct: 105 VKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE--SK 159

Query: 235 HSTRVLGTFGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT- 292
           H T+ + T  Y APE  M  +  T   D++S G +  ELL  R       P  Q  L+T 
Sbjct: 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITD 219

Query: 293 -WATPRLSE 300
              TP L  
Sbjct: 220 LLGTPSLEA 228

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 57/268 (21%), Positives = 96/268 (35%), Gaps = 81/268 (30%)

Query: 76  IGEGSYGRVFYA------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE-HFV 128
           +G G++G+V  A      K       A+K L   +          +L ++  + H  + V
Sbjct: 15  LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74

Query: 129 ELLGYCMESNNRILV-YQFATMGSLHDVLHGR---------KGVQGAEPGPVLTWNQR-- 176
            LLG C +    ++V  ++   G+L + L  +         K  +  E        QR  
Sbjct: 75  NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134

Query: 177 -----------------------------------------VKVAYGAAKGLEFLHEKVQ 195
                                                    +  ++  A+G+EFL  +  
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR-- 192

Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTN---------QSSDTAARLHSTRVLGTFGYH 246
              +HRD+ + N+LL ++   KI DF L           +  D  ARL          + 
Sbjct: 193 -KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD--ARL-------PLKWM 242

Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT 274
           APE       T +SDV+SFGV+L E+ +
Sbjct: 243 APESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 7/97 (7%)

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARL--HSTRVLGTF 243
           GL+++H      ++HRD++  N+L+  D + KI DF L    S+         T  + T 
Sbjct: 117 GLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173

Query: 244 GYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPV 279
            Y APE  ++ Q   K+ DV+S G +L ELL GRKPV
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 29/214 (13%)

Query: 75  LIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAA-----QLSVVSRLKHEHFV 128
           +IG G +G V+  +  D G   A+K LD       + +  A      LS+VS      F+
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST-GDCPFI 59

Query: 129 ELLGYCMESNNRI-LVYQFATMGSLHDVL--HGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
             + Y   + +++  +      G LH  L  HG           V +  +    A     
Sbjct: 60  VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-----------VFSEKEMRFYATEIIL 108

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           GLE +H +    +V+RD++ +N+LL +    +I+D  L    S    + H++  +GT GY
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHAS--VGTHGY 161

Query: 246 HAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKP 278
            APE    G     S D +S G +L +LL G  P
Sbjct: 162 MAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 59/265 (22%), Positives = 116/265 (43%), Gaps = 26/265 (9%)

Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV---ELL 131
           +G GS G VF A  +D     A+KK+  +     +     ++ ++ RL H++ V   E+L
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALR-EIKIIRRLDHDNIVKVYEVL 71

Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQG-----AEPGPVLTWNQRVKVAYGAAKG 186
           G     +   L     ++  L+ V   ++ ++       E GP+   + R+   Y   +G
Sbjct: 72  G----PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARL-FMYQLLRG 126

Query: 187 LEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTN-QSSDTAARLHSTRVLGTFG 244
           L+++H      ++HRD++ +NV +  +D   KI DF L        + + + +  L T  
Sbjct: 127 LKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183

Query: 245 YHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRK--PVDHTMPKGQQSLVTWATPRLSED 301
           Y +P   ++    T+  D+++ G +  E+LTG+      H + + Q  L +    R  + 
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDR 243

Query: 302 KVKQCVDP---KLNNDYPPKAIAKL 323
                V P   + +   P + +  L
Sbjct: 244 NELLNVIPSFVRNDGGEPRRPLRDL 268

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 30/216 (13%)

Query: 75  LIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDF---AAQLSVVSRLKHEHFVELL 131
           +IG GSY +V   +L         K+        + D      +  V  +     F+  L
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 132 GYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK---GL 187
             C ++ +R+ LV ++   G L  + H ++  +  E              + AA+    L
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEE----------HARFYAAEICIAL 109

Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS---SDTAARLHSTRVLGTFG 244
            FLHE+    I++RD++  NVLL  D   K+ D+ +  +     DT     ++   GT  
Sbjct: 110 NFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT-----TSTFCGTPN 161

Query: 245 YHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
           Y APE     +     D ++ GV++ E++ GR P D
Sbjct: 162 YIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 51.4 bits (123), Expect = 2e-07
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 19/209 (9%)

Query: 76  IGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLS--VVSRLKHEHFVELLG 132
           +G+G +G V   ++   G   A KKL+     + +    A +   +++++ H  F+  L 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59

Query: 133 YCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA--KGLEF 189
           Y  ++   + LV      G   D+ +    V    PG    + +     Y A    GLE 
Sbjct: 60  YAFQTKTDLCLVMTIMNGG---DLRYHIYNVDEENPG----FPEPRACFYTAQIISGLEH 112

Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE 249
           LH   Q  I++RD++  NVLL +D   +I+D  L  +  D  ++  +    GT G+ APE
Sbjct: 113 LH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPE 167

Query: 250 YAMTGQITQKSDVYSFGVVLLELLTGRKP 278
                +     D ++ GV L E++  R P
Sbjct: 168 LLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 52/214 (24%), Positives = 86/214 (40%), Gaps = 28/214 (13%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK----HEHFVEL 130
           IGEG+YG+V+ A+    G   A+KK  T    + E      L  +S L+      + V L
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKK--TRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66

Query: 131 LG--YCMESNNRI---LVYQF--ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           L   +  E N +    LV+++  + +    D  +GR   +      +          Y  
Sbjct: 67  LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMD-SNGRGPGRPLPAKTI------KSFMYQL 119

Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDD-FKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            KG+   H+     ++HRD++  N+L+       KIAD  L    S        T  + T
Sbjct: 120 LKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVT 174

Query: 243 FGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTG 275
             Y APE  +     +   D++S G +  E+   
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 28/213 (13%)

Query: 75  LIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAA--QLSVVSRLKHEHFVELL 131
           ++G+G +G V   ++   G   A KKL+     + + +  A  +  ++ ++ +  FV  L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSL 65

Query: 132 GYCMESNNRI-LVYQFATMGSL--HDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK--- 185
            Y  E+ + + LV      G L  H    G  G +              +  + AA+   
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEG------------RAVFYAAEICC 113

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           GLE LH   Q  IV+RD++  N+LL D    +I+D  L     +   +    RV GT GY
Sbjct: 114 GLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRV-GTVGY 167

Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            APE     + T   D ++ G +L E++ G+ P
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 51.0 bits (123), Expect = 3e-07
 Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 49/220 (22%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQL-SVVSRLK---HEHFVEL 130
           +G+G++G V+ A+    G   AIKK+        E      L  V S  K   H + V+L
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEE---CMNLREVKSLRKLNEHPNIVKL 63

Query: 131 LGYCMESNNRILVYQFATM-GSLHDVLHGRKGVQGAEPGPVLTWNQRVK-VAYGAAKGLE 188
                E++    V+++  M G+L+ ++  RKG   +E          ++ + Y   +GL 
Sbjct: 64  KEVFRENDELYFVFEY--MEGNLYQLMKDRKGKPFSES--------VIRSIIYQILQGLA 113

Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAAR-LHS----TRVLGTF 243
            +H+       HRD++  N+L+      KIADF L        AR + S    T  + T 
Sbjct: 114 HIHKH---GFFHRDLKPENLLVSGPEVVKIADFGL--------AREIRSRPPYTDYVSTR 162

Query: 244 GYHAPEYAMTGQITQKSDVYS-------FGVVLLELLTGR 276
            Y APE      I  +S  YS        G ++ EL T R
Sbjct: 163 WYRAPE------ILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 34/101 (33%), Positives = 48/101 (47%), Gaps = 24/101 (23%)

Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR----VLGT 242
            E+LH +    I++RD++  N+LL  +   K+ DF         A +L S +      GT
Sbjct: 106 FEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFG-------FAKKLKSGQKTWTFCGT 155

Query: 243 FGYHAPEYAMTGQITQK-----SDVYSFGVVLLELLTGRKP 278
             Y APE      I  K      D +S G++L ELLTGR P
Sbjct: 156 PEYVAPE-----IILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 53/222 (23%), Positives = 98/222 (44%), Gaps = 28/222 (12%)

Query: 69  NFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKL----DTSSAPEPESDFAAQLSVVSRLK 123
           N+    L+G G++G V+     D G   A+K++    D+    +  +    ++ ++  L+
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 124 HEHFVELLGYCMESNNRIL--VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY 181
           H+  V+  G   +   + L    ++   GS+ D L       GA     LT N   +   
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA----YGA-----LTENVTRRYTR 113

Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ-----SSDTAARLHS 236
              +G+ +LH  +   IVHRD++ +N+L       K+ DF  + +      S T  +   
Sbjct: 114 QILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIK--- 167

Query: 237 TRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
             V GT  + +PE        +K+DV+S    ++E+LT + P
Sbjct: 168 -SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 35/110 (31%), Positives = 53/110 (48%), Gaps = 4/110 (3%)

Query: 170 VLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD 229
           VLT    +  ++  AKG+EFL  +     +HRD+ + N+LL ++   KI DF L      
Sbjct: 175 VLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYK 231

Query: 230 TAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
               +          + APE       T +SDV+SFGV+L E+ + G  P
Sbjct: 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 50.3 bits (120), Expect = 5e-07
 Identities = 60/221 (27%), Positives = 91/221 (41%), Gaps = 35/221 (15%)

Query: 74  ALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPE--PESDF--AAQLSVVSRLKHEHFV 128
           A IG G+YG V+ A+    G   A+K +   +  +  P S     A L  +    H + V
Sbjct: 6   AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65

Query: 129 ELLGYCMESNNR-----ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
            L+  C  S         LV++         V    +      P P L       +    
Sbjct: 66  RLMDVCATSRTDRETKVTLVFE--------HVDQDLRTYLDKVPPPGLPAETIKDLMRQF 117

Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS-----TR 238
            +GL+FLH      IVHRD++  N+L+    + K+ADF L        AR++S     T 
Sbjct: 118 LRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL--------ARIYSCQMALTP 166

Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPV 279
           V+ T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 167 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 33/104 (31%), Positives = 47/104 (45%), Gaps = 3/104 (2%)

Query: 171 LTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT 230
           LT    +   Y  A+G+EFL  K     VHRD+ + NVLL      KI DF L       
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290

Query: 231 AARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
           +  +          + APE       T  SDV+S+G++L E+ +
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 50.4 bits (121), Expect = 6e-07
 Identities = 59/240 (24%), Positives = 93/240 (38%), Gaps = 52/240 (21%)

Query: 75  LIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFA---AQLSVVSRLKHEHFVEL 130
           L+G+G  GRVF  +L   G   A+K LD        +       +  +++ L H     L
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM-IKRNKVKRVLTEQEILATLDHPFLPTL 66

Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA-YGAAK---G 186
                      LV  +   G L  +L  +       PG  L+     +VA + AA+    
Sbjct: 67  YASFQTETYLCLVMDYCPGGELFRLLQRQ-------PGKCLS----EEVARFYAAEVLLA 115

Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAAR------------- 233
           LE+LH      IV+RD++  N+LL +     ++DF+L+ QS                   
Sbjct: 116 LEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172

Query: 234 ----LHSTRV----------LGTFGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGRKP 278
                  T            +GT  Y APE  ++G       D ++ G++L E+L G  P
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 50.2 bits (120), Expect = 7e-07
 Identities = 40/136 (29%), Positives = 61/136 (44%), Gaps = 18/136 (13%)

Query: 151 SLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL 210
           S        K  +  E    L  +  ++ +   A+G++FL  K     +HRDV + NVLL
Sbjct: 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLL 245

Query: 211 FDDFKSKIADFNL-------TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVY 263
            D   +KI DF L       +N      ARL          + APE       T +SDV+
Sbjct: 246 TDGRVAKICDFGLARDIMNDSNYVVKGNARL-------PVKWMAPESIFDCVYTVQSDVW 298

Query: 264 SFGVVLLELLT-GRKP 278
           S+G++L E+ + G+ P
Sbjct: 299 SYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 22/205 (10%)

Query: 76  IGEGSYGRVFYAKLTDGTPA-AIKKLDTSSAPE--PESDFAAQL--SVVSRLKHEHFVEL 130
           +G+GS+G V+  K         +K L      E  P     A     ++S+L H   V+ 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67

Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
               +E +   ++ ++     L   L   K       G  L+ NQ  +       G+ ++
Sbjct: 68  HASFLERDAFCIITEYCEGRDLDCKLEELK-----HTGKTLSENQVCEWFIQLLLGVHYM 122

Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN---QSSDTAARLHSTRVLGTFGYHA 247
           H++    I+HRD+++ N+ L ++   KI DF ++     S D A     T   GT  Y +
Sbjct: 123 HQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLA-----TTFTGTPYYMS 173

Query: 248 PEYAMTGQITQKSDVYSFGVVLLEL 272
           PE         KSD++S G +L E+
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 35/105 (33%), Positives = 52/105 (49%), Gaps = 10/105 (9%)

Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
           VA     G+ +LH +    IVHRD++ SN+L+      KIADF ++   + T    +S+ 
Sbjct: 173 VARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS- 228

Query: 239 VLGTFGYHAPEYAMTGQITQK-----SDVYSFGVVLLELLTGRKP 278
            +GT  Y +PE   T            D++S GV +LE   GR P
Sbjct: 229 -VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 47/204 (23%), Positives = 93/204 (45%), Gaps = 18/204 (8%)

Query: 76  IGEGSYGRVF--YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +GEG+Y  VF   +KLT+    A+K++              ++S++  LKH + V L   
Sbjct: 13  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
                   LV+++        + +          G +++ +      +   +GL + H++
Sbjct: 72  IHTERCLTLVFEYLDSDLKQYLDNC---------GNLMSMHNVKIFMFQLLRGLSYCHKR 122

Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM- 252
               I+HRD++  N+L+ +  + K+ADF L    S    + +S  V+ T  Y  P+  + 
Sbjct: 123 ---KILHRDLKPQNLLINEKGELKLADFGLARAKS-VPTKTYSNEVV-TLWYRPPDVLLG 177

Query: 253 TGQITQKSDVYSFGVVLLELLTGR 276
           + + +   D++  G +L E+ TGR
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 58/216 (26%), Positives = 85/216 (39%), Gaps = 36/216 (16%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSS--APEPESDFAAQLSV-VSRLKHEHFVELL 131
           IG+GS+G+V  AK   DG   A+K L   +    + +    A+ +V +  +KH   V L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKV-------AYGA- 183
                       Y F T   L+ VL    G      G +    QR +         Y A 
Sbjct: 63  ------------YSFQTADKLYFVLDYVNG------GELFFHLQRERSFPEPRARFYAAE 104

Query: 184 -AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            A  L +LH      I++RD++  N+LL       + DF L  +         ++   GT
Sbjct: 105 IASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGT 159

Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
             Y APE        +  D +  G VL E+L G  P
Sbjct: 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 36/111 (32%), Positives = 55/111 (49%), Gaps = 8/111 (7%)

Query: 171 LTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ--SS 228
           LT    +  ++  A+G+EFL  +     +HRD+ + N+LL ++   KI DF L       
Sbjct: 171 LTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKD 227

Query: 229 DTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
               R  S R+     + APE       T +SDV+SFGV+L E+ + G  P
Sbjct: 228 PDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 46/204 (22%), Positives = 94/204 (46%), Gaps = 18/204 (8%)

Query: 76  IGEGSYGRVF--YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +GEG+Y  VF   +KLT+    A+K++              ++S++  LKH + V L   
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
                +  LV+++     L   +         + G +++ +      Y   +GL + H +
Sbjct: 73  VHTDKSLTLVFEYLDK-DLKQYMD--------DCGNIMSMHNVKIFLYQILRGLAYCHRR 123

Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM- 252
               ++HRD++  N+L+ +  + K+ADF L    S    + +S  V+ T  Y  P+  + 
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLARAKS-VPTKTYSNEVV-TLWYRPPDVLLG 178

Query: 253 TGQITQKSDVYSFGVVLLELLTGR 276
           + + + + D++  G +  E+ +GR
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 28/84 (33%), Positives = 40/84 (47%), Gaps = 5/84 (5%)

Query: 199 VHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT----G 254
           +HRDV+  N+LL      K+ADF  T    D    +     +GT  Y +PE   +    G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFG-TCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDG 222

Query: 255 QITQKSDVYSFGVVLLELLTGRKP 278
              ++ D +S GV L E+L G  P
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 62/214 (28%), Positives = 90/214 (42%), Gaps = 30/214 (14%)

Query: 75  LIGEGSYGRVFYAKLT-DGTPAAIKKLDTS---SAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +IG+GS+G+V  AK   DG   A+K L      +  E +   A +  ++  +KH   V L
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 131 LGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA--AKGL 187
             Y  ++  ++  V  F   G L    H ++     EP        R +  Y A  A  L
Sbjct: 62  -HYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEP--------RARF-YAAEIASAL 109

Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS---SDTAARLHSTRVLGTFG 244
            +LH      IV+RD++  N+LL       + DF L  +    SDT     +T   GT  
Sbjct: 110 GYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT-----TTTFCGTPE 161

Query: 245 YHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           Y APE           D +  G VL E+L G  P
Sbjct: 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 6/93 (6%)

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           GLE LH   +   V+RD++  N+LL D    +I+D  L  +  +        RV GT GY
Sbjct: 114 GLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE--GESIRGRV-GTVGY 167

Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            APE     + T   D +  G ++ E++ G+ P
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 51/213 (23%), Positives = 95/213 (44%), Gaps = 24/213 (11%)

Query: 75  LIGEGSYGRVFYAKL--TDGTPA-AIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
           +IG GSY +V   +L  T+   A  + K +  +  E       +  V  +  +  F+  L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 132 GYCMESNNRIL-VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
             C ++ +R+  V ++   G L  + H ++  +  E      ++  + +A      L +L
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARF-YSAEISLA------LNYL 112

Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS---SDTAARLHSTRVLGTFGYHA 247
           HE+    I++RD++  NVLL  +   K+ D+ +  +     DT     ++   GT  Y A
Sbjct: 113 HER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-----TSTFCGTPNYIA 164

Query: 248 PEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
           PE           D ++ GV++ E++ GR P D
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 55/264 (20%), Positives = 108/264 (40%), Gaps = 41/264 (15%)

Query: 76  IGEGSYGRVF--YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +GEG+Y  V+   +KLTD    A+K++              ++S++  LKH + V L   
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
                +  LV+++     L   L         + G  +  +      +   +GL + H +
Sbjct: 73  IHTEKSLTLVFEYLDK-DLKQYLD--------DCGNSINMHNVKLFLFQLLRGLNYCHRR 123

Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM- 252
               ++HRD++  N+L+ +  + K+ADF L    S    + +S  V+ T  Y  P+  + 
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYSNEVV-TLWYRPPDILLG 178

Query: 253 TGQITQKSDVYSFGVVLLELLTGR--------------------KPVDHTMPK--GQQSL 290
           +   + + D++  G +  E+ TGR                     P + T P     +  
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238

Query: 291 VTWATPRLSEDKVKQCVDPKLNND 314
            ++  P+   D +     P+L++D
Sbjct: 239 KSYNYPKYRADCLHNHA-PRLDSD 261

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 47.0 bits (111), Expect = 6e-06
 Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)

Query: 76  IGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAA--QLSVVSRLKHEHFVELLG 132
           +GEGSY  V+  K   +G   A+K +      E  + F A  + S++  LKH + V L  
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKHANIVLLHD 70

Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
                    LV+++     L   +    G  G  P  V  +       +   +GL ++H+
Sbjct: 71  IIHTKETLTLVFEYVHT-DLCQYMDKHPG--GLHPENVKLF------LFQLLRGLSYIHQ 121

Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           +    I+HRD++  N+L+ D  + K+ADF L    S   +  +S  V+ T  Y  P+  +
Sbjct: 122 RY---ILHRDLKPQNLLISDTGELKLADFGLARAKS-VPSHTYSNEVV-TLWYRPPDVLL 176

Query: 253 -TGQITQKSDVYSFGVVLLELLTG 275
            + + +   D++  G + +E++ G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 47.1 bits (112), Expect = 6e-06
 Identities = 30/97 (30%), Positives = 47/97 (48%), Gaps = 11/97 (11%)

Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS---SDTAARLHSTRVLGTF 243
           L FLHE+    I++RD++  NVLL  +   K+ D+ +  +     DT +        GT 
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTF-----CGTP 160

Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
            Y APE           D ++ GV++ E++ GR P D
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 47.2 bits (112), Expect = 8e-06
 Identities = 35/107 (32%), Positives = 51/107 (47%), Gaps = 18/107 (16%)

Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL-------TNQSSDTAA 232
           +Y  AKG+ FL  K     +HRD+ + N+LL     +KI DF L       +N      A
Sbjct: 220 SYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNA 276

Query: 233 RLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
           RL          + APE       T +SDV+S+G++L E+ + G  P
Sbjct: 277 RL-------PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 6/93 (6%)

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           GLE LH +    IV+RD++  N+LL D    +I+D  L  +  +        RV GT GY
Sbjct: 114 GLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE--GETIRGRV-GTVGY 167

Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            APE     + T   D +  G ++ E++ G+ P
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 43/169 (25%), Positives = 63/169 (37%), Gaps = 57/169 (33%)

Query: 199 VHRDVRSSNVLLFDDFKSKIADFNLTN-----------QSSD------------------ 229
           +HRD++  N+L+  D   K+ DF L             QS D                  
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 230 ------------TAARLH----STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELL 273
                        AAR H    +  ++GT  Y APE  +    TQ  D +S GV+L E+L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 274 TGRKPVDHTMP-KGQQSLVTWAT-----------PRLSEDKVKQCVDPK 310
            G+ P     P + Q  ++ W T           P  S+  +K C  P+
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPE 291

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 22/210 (10%)

Query: 75  LIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAA--QLSVVSRLKHEHFVELL 131
           ++G+G +G V   ++   G   A KKL+     + + +  A  +  ++ ++ +  FV  L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSL 65

Query: 132 GYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK--GLE 188
            Y  E+ + + LV      G L   ++         PG    ++++  + Y A    GLE
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNM-----GNPG----FDEQRAIFYAAELCCGLE 116

Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
            L  +    IV+RD++  N+LL D    +I+D  L  Q  +        RV GT GY AP
Sbjct: 117 DLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPE--GETVRGRV-GTVGYMAP 170

Query: 249 EYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           E     + T   D +  G ++ E++ G+ P
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 28/109 (25%), Positives = 51/109 (46%), Gaps = 19/109 (17%)

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLL--FDD----------FKSKIADFNLTNQSSDTAAR 233
            +E++H K    ++HRD++  N+LL  F +          FK    +  L     +    
Sbjct: 125 TIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181

Query: 234 LHST----RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
             S     +++GT  Y APE  +    ++ +D+Y+ GV+L ++LT   P
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 22/211 (10%)

Query: 74  ALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSS--APEPESDFAAQLSVVSR-LKHEHFVE 129
            +IG+GS+G+V  AK  +DG+  A+K L   +    + ++   A+ +V+ + LKH   V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 130 LLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKV-AYGAAKGL 187
            L Y  ++  ++  V  +   G L    H ++     EP        R +  A   A  +
Sbjct: 61  -LHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEP--------RARFYAAEVASAI 109

Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
            +LH      I++RD++  N+LL       + DF L  +  +      ++   GT  Y A
Sbjct: 110 GYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLA 164

Query: 248 PEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           PE        +  D +  G VL E+L G  P
Sbjct: 165 PEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 51/225 (22%), Positives = 90/225 (40%), Gaps = 41/225 (18%)

Query: 75  LIGEGSYGR--VFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSR-LKHEHFVEL 130
           LIG+       V  AK     T  A+KK++  S  + +     Q  + SR L+H + +  
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64

Query: 131 LGYCMESNNRILVYQFATMGSLHDVL--HGRKGVQGAEPGPVLTWNQRVKVAY---GAAK 185
           +   +  +   +V      GS  D+L  H  +G+              + +A+       
Sbjct: 65  VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP------------ELAIAFILKDVLN 112

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAAR---------LHS 236
            L+++H K     +HR V++S++LL  D K  ++     + S     +           S
Sbjct: 113 ALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLR-YSVSMIKHGKRQRVVHDFPKSS 168

Query: 237 TRVLGTFGYHAPEY---AMTGQITQKSDVYSFGVVLLELLTGRKP 278
            + L    + +PE     + G   +KSD+YS G+   EL  G  P
Sbjct: 169 VKNLP---WLSPEVLQQNLQG-YNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 28/94 (29%), Positives = 45/94 (47%), Gaps = 16/94 (17%)

Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR-----V 239
           +GL +LH      I+HRDV++ N+ + D  +  I D          AA+          +
Sbjct: 168 EGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLG--------AAQFPVVAPAFLGL 216

Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELL 273
            GT   +APE     +   K+D++S G+VL E+L
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 28/85 (32%), Positives = 41/85 (48%), Gaps = 5/85 (5%)

Query: 198 IVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT---- 253
           ++HRDV+  N+LL      K+ADF  T    D    +     +GT  Y +PE   +    
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFG-TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGD 221

Query: 254 GQITQKSDVYSFGVVLLELLTGRKP 278
           G   ++ D +S GV L E+L G  P
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 44.1 bits (104), Expect = 4e-05
 Identities = 48/171 (28%), Positives = 72/171 (42%), Gaps = 18/171 (10%)

Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
           + V L  Y +  ++  LV Q A  G L    H  K +   E   V  W   + VA     
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWS--HISKFLNIPE-ECVKRWAAEMVVA----- 97

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
            L+ LH +    IV RD+  +N+LL D    ++  F+  ++  D+        +     Y
Sbjct: 98  -LDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----Y 148

Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATP 296
            APE     + T+  D +S G +L ELLTG K +    P G  +  T   P
Sbjct: 149 CAPEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSGINTHTTLNIP 198

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 54/218 (24%), Positives = 85/218 (38%), Gaps = 32/218 (14%)

Query: 76  IGEGSYGRVFYAKLTD-GTPAAIK--------KLDTSSAPEPESDFAAQLSVVSRLKHEH 126
           +G+G YG+VF AK  D G   A+K        KL+       E D      +++  K E 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERD------ILTTTKSEW 62

Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKG 186
            V+LL    +     L  ++   G    +L+            VL+ +      +  A+ 
Sbjct: 63  LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG---------VLSEDH---ARFYMAEM 110

Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
            E +    +   +HRD++  N L+      K+ DF L   S       +S  V+G+  Y 
Sbjct: 111 FEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGL---SKGIVTYANS--VVGSPDYM 165

Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
           APE           D +S G +L E L G  P   + P
Sbjct: 166 APEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 44.4 bits (105), Expect = 5e-05
 Identities = 63/226 (27%), Positives = 94/226 (41%), Gaps = 35/226 (15%)

Query: 69  NFGTKALIGEGSYG--RVFYAKLTDGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKH 124
           +F  K+L+G G +G  +V   K T G   A+K +  S   A E  S F  +  ++S    
Sbjct: 2   DFDVKSLVGRGHFGEVQVVREKAT-GDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
               +L     + +N  LV ++   G L  +L+ R   Q  E              +  A
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLN-RYEDQFDED----------MAQFYLA 109

Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH------STR 238
           + +  +H   Q   VHRD++  NVL+      K+ADF        +AARL       S  
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFG-------SAARLTANKMVNSKL 162

Query: 239 VLGTFGYHAPEYAMTGQITQKS------DVYSFGVVLLELLTGRKP 278
            +GT  Y APE   T     K       D +S GV+  E++ GR P
Sbjct: 163 PVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 43.8 bits (103), Expect = 8e-05
 Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 26/225 (11%)

Query: 76  IGEGSYGRVFYAKLTDGTP----AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
           IG+GS+G+V   +  D         I+K    S  E     A + +V++++    F+  L
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAER-TVLAQVNCP-FIVPL 58

Query: 132 GYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
            +  +S  ++ LV  F   G L   L           G       R   A      LE L
Sbjct: 59  KFSFQSPEKLYLVLAFINGGELFHHLQ--------REGRFDLSRARFYTAE-LLCALENL 109

Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIA--DFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           H+     +++RD++  N+LL  D++  IA  DF L   +     + ++    GT  Y AP
Sbjct: 110 HKF---NVIYRDLKPENILL--DYQGHIALCDFGLCKLNMKDDDKTNT--FCGTPEYLAP 162

Query: 249 EYAMTGQITQKSDVYSFGVVLLELLTGRKPV-DHTMPKGQQSLVT 292
           E  +    T+  D ++ GV+L E+LTG  P  D  + +  + ++ 
Sbjct: 163 ELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ 207

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 43.7 bits (103), Expect = 9e-05
 Identities = 26/92 (28%), Positives = 47/92 (51%), Gaps = 5/92 (5%)

Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           L FLH   +  +++RD++  N+LL  +   K+ADF +  +       + +T   GT  Y 
Sbjct: 109 LMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEG--ILNGVTTTTFCGTPDYI 163

Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           APE     +     D ++ GV++ E++ G+ P
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 27/90 (30%), Positives = 44/90 (48%), Gaps = 6/90 (6%)

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           G++ LH      I+HRD++ SN+++  D   KI DF L   +         T  + T  Y
Sbjct: 135 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPYVVTRYY 188

Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLTG 275
            APE  +     +  D++S G ++ EL+ G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 54/210 (25%), Positives = 88/210 (41%), Gaps = 22/210 (10%)

Query: 112 FAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVL 171
           F    S++ ++ H+H V L G C+     I+V +F   G L D+   RK         VL
Sbjct: 51  FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL-DLFMHRK-------SDVL 102

Query: 172 TWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF-DDFKSKIADFNLTNQSSDT 230
           T   + KVA   A  L +L +K    +VH +V + N+LL  +    +   F   +     
Sbjct: 103 TTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159

Query: 231 AARLHSTRVLGTFGYHAPEYAM-TGQITQKSDVYSFGVVLLEL-LTGRKPV-DHTMPKGQ 287
              L     +    + APE    +  ++  +D +SFG  L E+   G  P+ D T+ + +
Sbjct: 160 ITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE 219

Query: 288 Q---SLVTWATPRLSE--DKVKQCV--DPK 310
           +         TP   E  D +  C+  DP 
Sbjct: 220 RFYEGQCMLVTPSCKELADLMTHCMNYDPN 249

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 27/117 (23%), Positives = 49/117 (41%), Gaps = 6/117 (5%)

Query: 162 VQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADF 221
           V  + P P+    Q + +     + L +LH +    I+HRDV++ N+ L +   + + DF
Sbjct: 176 VDRSGPLPL---EQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDF 229

Query: 222 NLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
               +              GT   ++PE         K+D++S G+VL E+      
Sbjct: 230 GAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 27/107 (25%), Positives = 39/107 (36%), Gaps = 27/107 (25%)

Query: 199 VHRDVRSSNVLLFDDFKSKIADFNL-----------------TNQSSDTAARLHSTR--- 238
           +HRD++  N+L+  D   K+ADF L                  N        +       
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182

Query: 239 -------VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
                   +GT  Y APE         + D +S GV+L E+L G  P
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 37/140 (26%), Positives = 50/140 (35%), Gaps = 44/140 (31%)

Query: 199 VHRDVRSSNVLLFDDFKSKIADFNLTN-----------QSSD------------------ 229
           +HRD++  N+L+  D   K+ DF L             Q  D                  
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 230 --------TAARLHSTRVL-----GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGR 276
                      R H  R L     GT  Y APE  +    TQ  D +S GV+L E+L G+
Sbjct: 183 CRLKPLERRRKRQH-QRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241

Query: 277 KPVDHTMPKG-QQSLVTWAT 295
            P     P   Q  ++ W T
Sbjct: 242 PPFLADTPAETQLKVINWET 261

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 61/245 (24%), Positives = 104/245 (42%), Gaps = 42/245 (17%)

Query: 112 FAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPV- 170
           F    S++S++ H H   + G C+  +  I+V +F   G L DV   +      E G V 
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCLRK------EKGRVP 115

Query: 171 LTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD-----FNLTN 225
           + W  ++ VA   A  L +L +K    +VH +V + N+LL    +  +A+       L++
Sbjct: 116 VAW--KITVAQQLASALSYLEDK---NLVHGNVCAKNILL---ARLGLAEGTSPFIKLSD 167

Query: 226 QSSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLEL-LTGRKPVDHTM 283
                 A     RV     + APE    G  ++  +D +SFG  LLE+   G  P+    
Sbjct: 168 PGVSFTALSREERV-ERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226

Query: 284 PKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTI 343
           P  ++        R  E K +           P  +  +LA + + C+ YE   RP+   
Sbjct: 227 PSEKE--------RFYEKKHR----------LPEPSCKELATLISQCLTYEPTQRPSFRT 268

Query: 344 VVKAL 348
           +++ L
Sbjct: 269 ILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 41.7 bits (98), Expect = 3e-04
 Identities = 55/210 (26%), Positives = 100/210 (47%), Gaps = 27/210 (12%)

Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAA-QLSVVSRLKHEHFVELLG 132
           IGEG+YG V+ A  ++T+ T  A+KK+      E     A  ++S++  ++H + V L  
Sbjct: 10  IGEGTYGVVYKARDRVTNET-IALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 133 YCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQR-VKV-AYGAAKGLEF 189
             + S  R+ LV+++         L  +K +  +   P    N R +K   Y   +G+ +
Sbjct: 69  -VVHSEKRLYLVFEYLD-------LDLKKHMDSS---PDFAKNPRLIKTYLYQILRGIAY 117

Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKS--KIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
            H      ++HRD++  N LL D   +  K+ADF L  ++     R  +  V+ T  Y A
Sbjct: 118 CHSH---RVLHRDLKPQN-LLIDRRTNALKLADFGLA-RAFGIPVRTFTHEVV-TLWYRA 171

Query: 248 PEYAM-TGQITQKSDVYSFGVVLLELLTGR 276
           PE  + +   +   D++S G +  E++  +
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 6/94 (6%)

Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE 249
           +H   Q   VHRD++  NVLL  +   ++ADF    + +     + S+  +GT  Y +PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPE 173

Query: 250 Y--AM---TGQITQKSDVYSFGVVLLELLTGRKP 278
              AM    G+   + D +S GV + E+L G  P
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 28/93 (30%), Positives = 45/93 (48%), Gaps = 6/93 (6%)

Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           LE LH+     IV+RD++  N+LL       + DF L+   ++      +    GT  Y 
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYL 163

Query: 247 APEYAMTGQ-ITQKSDVYSFGVVLLELLTGRKP 278
           APE  +  +  T+  D +S GV++ E+  G  P
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 41.2 bits (97), Expect = 5e-04
 Identities = 51/219 (23%), Positives = 97/219 (44%), Gaps = 48/219 (21%)

Query: 76  IGEGSYGRVF--YAKLTDGTPAAIKKLDTSSAPEPESDFAA--QLSVVSRLKHEHFVELL 131
           +GEGSY  V+   +KLT     A+K++      E  + F A  + S++  LKH + V   
Sbjct: 13  LGEGSYATVYKGRSKLTGQL-VALKEI--RLEHEEGAPFTAIREASLLKDLKHANIV--- 66

Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGV------------QGAEPGPVLTWNQRVKV 179
                              +LHD++H +K +            Q  +          V++
Sbjct: 67  -------------------TLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRL 107

Query: 180 -AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
             +   +GL + H++    ++HRD++  N+L+ +  + K+ADF L    S   ++ +S  
Sbjct: 108 FLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKS-VPSKTYSNE 163

Query: 239 VLGTFGYHAPEYAM-TGQITQKSDVYSFGVVLLELLTGR 276
           V+ T  Y  P+  + + + +   D++  G +  E+ TGR
Sbjct: 164 VV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 40.6 bits (96), Expect = 7e-04
 Identities = 41/161 (25%), Positives = 69/161 (42%), Gaps = 27/161 (16%)

Query: 123 KHEHFVELLGYCMESNNR-ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY 181
            + +F++L  Y + +    +L+  +   G L D+L     +  AE           K+  
Sbjct: 67  DNPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEV---------KKIIR 116

Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI--ADFNLTNQSSDTAARLHSTRV 239
              + L  LH+     I+H D++  NVL +D  K +I   D+ L          + +   
Sbjct: 117 QLVEALNDLHKH---NIIHNDIKLENVL-YDRAKDRIYLCDYGL-------CKIIGTPSC 165

Query: 240 L-GTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKP 278
             GT  Y +PE  + G     S D ++ GV+  ELLTG+ P
Sbjct: 166 YDGTLDYFSPE-KIKGHNYDVSFDWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 40.5 bits (95), Expect = 7e-04
 Identities = 34/106 (32%), Positives = 48/106 (45%), Gaps = 18/106 (16%)

Query: 187 LEFLHEKVQPPIVHRDVRSSNVLL-------FDDFK-SKIADFNLT------NQSSDTAA 232
           LE+LH      IVHRD++  N+L+         DF  SKI   +LT      +   DT  
Sbjct: 114 LEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDT-R 169

Query: 233 RLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
                +V GT  Y APE  +     +  D ++ G++L E L G  P
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 40.4 bits (94), Expect = 9e-04
 Identities = 27/91 (29%), Positives = 48/91 (52%), Gaps = 6/91 (6%)

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           G++ LH      I+HRD++ SN+++  D   KI DF L  +++ T+  +    V  T  Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTSFMMTPYVV--TRYY 191

Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLTGR 276
            APE  +     +  D++S G ++ E++ G 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 26/91 (28%), Positives = 45/91 (49%), Gaps = 6/91 (6%)

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           G++ LH      I+HRD++ SN+++  D   KI DF L   +  +      T  + T  Y
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYY 183

Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLTGR 276
            APE  +     +  D++S G ++ E++ G 
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 33/120 (27%), Positives = 52/120 (43%), Gaps = 13/120 (10%)

Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN----LTNQSSDTAARL 234
           + +GA +GL +LH   Q   +HR++++S++L+  D    ++  +    L           
Sbjct: 106 ILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162

Query: 235 H----STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSL 290
                ST VL           + G    KSD+YS G+   EL TGR P    M + Q  L
Sbjct: 163 DFPQFSTSVLPWLSPELLRQDLYG-YNVKSDIYSVGITACELATGRVPF-QDMLRTQMLL 220

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 48/219 (21%)

Query: 76  IGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAA--QLSVVSRLKHEHFVELLG 132
           +GEGSY  V+      +G   A+K +   +  E    F A  + S++  LKH + V    
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLKHANIV---- 66

Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGV--------------QGAEPGPVLTWNQRVK 178
                              LHD++H ++ +                  PG +  +N R+ 
Sbjct: 67  ------------------LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL- 107

Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
             +   +GL ++H +    I+HRD++  N+L+    + K+ADF L    S   ++ +S+ 
Sbjct: 108 FMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKS-IPSQTYSSE 163

Query: 239 VLGTFGYHAPEYAM-TGQITQKSDVYSFGVVLLELLTGR 276
           V+ T  Y  P+  +     +   D++  G + +E+L G+
Sbjct: 164 VV-TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 27/84 (32%), Positives = 40/84 (47%), Gaps = 5/84 (5%)

Query: 199 VHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT----G 254
           +HRDV+  N+LL      K+ADF  T    +    +     +GT  Y +PE   +    G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFG-TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 222

Query: 255 QITQKSDVYSFGVVLLELLTGRKP 278
              ++ D +S GV L E+L G  P
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 39.7 bits (92), Expect = 0.002
 Identities = 29/102 (28%), Positives = 47/102 (46%), Gaps = 12/102 (11%)

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           G++ LH      I+HRD++ SN+++  D   KI DF L   +  +      T  + T  Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYY 184

Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLE------LLTGRKPVDH 281
            APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 39.0 bits (91), Expect = 0.003
 Identities = 28/85 (32%), Positives = 42/85 (49%), Gaps = 6/85 (7%)

Query: 199 VHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEY--AM---T 253
           VHRD++  NVLL  +   ++ADF  +         + S   +GT  Y +PE   AM    
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182

Query: 254 GQITQKSDVYSFGVVLLELLTGRKP 278
           G+   + D +S GV + E+L G  P
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 38.4 bits (89), Expect = 0.004
 Identities = 24/93 (25%), Positives = 42/93 (45%), Gaps = 6/93 (6%)

Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD-TAARLHSTRVLGTF 243
           + +++LHE     I+HRD+++ N+ +       + DF       D  A + +     GT 
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA--GTI 247

Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGR 276
             +APE           D++S G+VL E+ T  
Sbjct: 248 ATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	363
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.97
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.94
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.91
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.9
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.9
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
PRK12274	218	serine/threonine protein kinase; Provisional	99.9
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.87
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.86
PRK10345	210	hypothetical protein; Provisional	99.86
smart00090	237	RIO RIO-like kinase.	99.84
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.84
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.82
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.8
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.8
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.8
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.78
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.75
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.73
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.71
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.67
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.6
KOG1243	690	consensus Protein kinase [General function predict	99.55
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.5
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.49
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.49
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.47
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.39
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.39
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.37
COG4248	637	Uncharacterized protein with protein kinase and he	99.33
KOG3087	229	consensus Serine/threonine protein kinase [General	99.3
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.29
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.2
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.18
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.11
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.08
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.98
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.96
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.96
PRK09902	216	hypothetical protein; Provisional	98.92
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.81
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.81
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.75
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.65
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.54
PLN02876	822	acyl-CoA dehydrogenase	98.53
PF01636	239	APH: Phosphotransferase enzyme family This family	98.51
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.5
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.5
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.4
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.4
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.26
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.19
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	98.15
PRK10593	297	hypothetical protein; Provisional	98.14
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.12
PRK05231	319	homoserine kinase; Provisional	98.11
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.08
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	98.07
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.03
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.84
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.72
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.64
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.6
KOG2270	520	consensus Serine/threonine protein kinase involved	97.55
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.52
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.43
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.36
PLN02756	418	S-methyl-5-thioribose kinase	97.34
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.28
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.25
PLN02236	344	choline kinase	97.16
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.16
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.12
PRK11768	325	serine/threonine protein kinase; Provisional	97.1
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	97.07
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.98
COG2334	331	Putative homoserine kinase type II (protein kinase	96.94
PRK12396	409	5-methylribose kinase; Reviewed	96.73
PRK06148	1013	hypothetical protein; Provisional	96.63
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.56
PTZ00384	383	choline kinase; Provisional	96.06
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.84
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	95.5
PTZ00296	442	choline kinase; Provisional	95.21

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-55  Score=376.68  Aligned_cols=251  Identities=23%  Similarity=0.364  Sum_probs=212.8

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCe-eEEEEec
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNN-RILVYQF  146 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~  146 (363)
                      +.+..+.||+|..|+||+++++ +++.+|+|++.....+...+++.+|+++++..+|||||.+|+.|..... ..++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            4455677999999999999876 6888999999776666667899999999999999999999999999985 9999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-cCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE-KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |++|+|.+++...+         .+++..+-.|+.++++||.|||+ +   +||||||||+||||+..|+|||||||.+.
T Consensus       160 MDgGSLd~~~k~~g---------~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~  227 (364)
T KOG0581|consen  160 MDGGSLDDILKRVG---------RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSG  227 (364)
T ss_pred             cCCCCHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccH
Confidence            99999999998654         28999999999999999999996 6   89999999999999999999999999987


Q ss_pred             CCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      ...+.    ..+.++||..|||||.+.+..|+.++||||||++++|+.+|+.||....+..           .....+..
T Consensus       228 ~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-----------~~~~~Ll~  292 (364)
T KOG0581|consen  228 ILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-----------LDIFELLC  292 (364)
T ss_pred             Hhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC-----------CCHHHHHH
Confidence            76655    3467899999999999999999999999999999999999999997541110           01111112


Q ss_pred             ccCCcCCCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          306 CVDPKLNNDYPPK-AIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       306 ~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .+-.+....+|.. ++.+++.++..||+.||.+||++.++++
T Consensus       293 ~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  293 AIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             HHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            2222223344554 7888999999999999999999999987

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-53  Score=383.23  Aligned_cols=291  Identities=48%  Similarity=0.887  Sum_probs=255.8

Q ss_pred             CCCccCHHHHHHHhcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeE
Q 046595           54 EIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY  133 (363)
Q Consensus        54 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~  133 (363)
                      ....+.++++...+++|.....||+|+||.||+|...++..||||++....... ..+|..|+.++.+++|||+|+++||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence            566789999999999999999999999999999999989999999887654432 4569999999999999999999999


Q ss_pred             EEeCC-eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC
Q 046595          134 CMESN-NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD  212 (363)
Q Consensus       134 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~  212 (363)
                      |.+.+ ..+||+||+.+|+|.+.|......       .++|..+++|+.++++||+|||..+.+.|||||||++|||+|+
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~-------~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~  212 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-------PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE  212 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCC-------CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC
Confidence            99998 499999999999999999876531       3899999999999999999999987777999999999999999


Q ss_pred             CCceEEeeeccCCCCCccccccccccc-ccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchh
Q 046595          213 DFKSKIADFNLTNQSSDTAARLHSTRV-LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLV  291 (363)
Q Consensus       213 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~  291 (363)
                      +.+.||+|||+|+.......  ..... .||.+|+|||++..+..+.++||||||++|.||++|+.+.+...+.....+.
T Consensus       213 ~~~aKlsDFGLa~~~~~~~~--~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~  290 (361)
T KOG1187|consen  213 DFNAKLSDFGLAKLGPEGDT--SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLV  290 (361)
T ss_pred             CCCEEccCccCcccCCcccc--ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHH
Confidence            99999999999965543111  11122 7999999999999999999999999999999999999999876666666689


Q ss_pred             hhccccccccccccccCCcCC-CCCCH-HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          292 TWATPRLSEDKVKQCVDPKLN-NDYPP-KAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                      .|..+.+....+.+++|+.+. ..++. .....+..+..+|++.+|++||+|.+|++.|+.+...
T Consensus       291 ~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  291 EWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            999888888899999999987 66665 6777899999999999999999999999999766544

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.9e-54  Score=388.00  Aligned_cols=248  Identities=25%  Similarity=0.411  Sum_probs=216.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      .+|...+.||+|||+.||.++. .+|+.||+|++.+..  .....+.+.+|+++.+.|+|||||+++++|++.++.|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4799999999999999999987 789999999998754  4445678999999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      |+|..++|..+++.++         .+++.++..+++||+.||.|||++   +|+|||||..|+|++++.+|||+|||||
T Consensus        98 ELC~~~sL~el~Krrk---------~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLA  165 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRK---------PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLA  165 (592)
T ss_pred             EecCCccHHHHHHhcC---------CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEeccccee
Confidence            9999999999998554         399999999999999999999999   9999999999999999999999999999


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      ........+  ....+|||.|.|||++....++..+||||+||+||-||.|++||+...-.+....+.            
T Consensus       166 t~le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik------------  231 (592)
T KOG0575|consen  166 TQLEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK------------  231 (592)
T ss_pred             eeecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH------------
Confidence            887755333  456899999999999999999999999999999999999999997543322222211            


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                         ...  -.+|...+.+..+||.++|+.||.+|||+++|+.
T Consensus       232 ---~~~--Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  232 ---LNE--YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ---hcC--cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               111  2335567778999999999999999999999986

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-53  Score=369.61  Aligned_cols=252  Identities=21%  Similarity=0.344  Sum_probs=207.9

Q ss_pred             HhcCCCCCCeeeccCCceEEEEE-eCCCCeEEEEEccCCCCCC------chHHHHHHHHHHhcCCCCccceeeeEEEeCC
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPE------PESDFAAQLSVVSRLKHEHFVELLGYCMESN  138 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~avK~~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  138 (363)
                      +.+.|.+.+.||+|+||.|-+|. .++|+.||||.+.......      ....+.+|+++|++|+|||||++++++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            55678999999999999999996 5579999999998754332      2234679999999999999999999999999


Q ss_pred             eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCC---Cc
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD---FK  215 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~---~~  215 (363)
                      ..||||||+.||+|.+++-..+.         +.+.....+++|++.|+.|||++   ||+||||||+|||+..+   ..
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~---------l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~l  317 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKY---------LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCL  317 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccc---------cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceE
Confidence            99999999999999999987764         78888899999999999999999   99999999999999765   88


Q ss_pred             eEEeeeccCCCCCcccccccccccccccCCCCccccccCC---CCccCceehhHHHHHHHHhCCCCCCCCCCccccchhh
Q 046595          216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQ---ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT  292 (363)
Q Consensus       216 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~  292 (363)
                      +||+|||+|+......   ....++||+.|.|||++.+..   +..++|+||+||+||-+|+|.+||........  +  
T Consensus       318 lKItDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l--  390 (475)
T KOG0615|consen  318 LKITDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--L--  390 (475)
T ss_pred             EEecccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--H--
Confidence            9999999998876432   246689999999999998653   34588999999999999999999975433210  0  


Q ss_pred             hccccccccccccccCCcCC--CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          293 WATPRLSEDKVKQCVDPKLN--NDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                                ..++....+.  ...-.+.+++..++|.+||..||++|||+.++++
T Consensus       391 ----------~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  391 ----------KEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             ----------HHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence                      0111111111  1222467888999999999999999999999775

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-52  Score=373.92  Aligned_cols=260  Identities=30%  Similarity=0.501  Sum_probs=217.2

Q ss_pred             CCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeCC-eeEEEEeccc
Q 046595           71 GTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESN-NRILVYQFAT  148 (363)
Q Consensus        71 ~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~  148 (363)
                      .+.+.||+|+||+||.+.+.....||||.+...... .....|.+|+.+|.+++|||||+++|++.+.. .+.+||||+.
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            344559999999999999985555999999764422 22568999999999999999999999999887 7899999999


Q ss_pred             CCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCC-eEEecccCCceeecCCC-ceEEeeeccCCC
Q 046595          149 MGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPP-IVHRDVRSSNVLLFDDF-KSKIADFNLTNQ  226 (363)
Q Consensus       149 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-ivH~Dlkp~Nill~~~~-~vkl~Dfg~a~~  226 (363)
                      +|+|.+++.....       ..+++..++.++.+|+.|+.|||++   + ||||||||+|||++.++ ++||+|||+++.
T Consensus       124 ~GsL~~~l~~~~~-------~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  124 GGSLSVLLHKKRK-------RKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSRE  193 (362)
T ss_pred             CCcHHHHHhhccc-------CCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence            9999999987411       1399999999999999999999999   8 99999999999999997 999999999976


Q ss_pred             CCcccccccccccccccCCCCccccc--cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAM--TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      .....  ...+...||+.|||||++.  ...|+.++||||||++||||+||+.||....+..               -+.
T Consensus       194 ~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~---------------~~~  256 (362)
T KOG0192|consen  194 KVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ---------------VAS  256 (362)
T ss_pred             ecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH---------------HHH
Confidence            55432  1233468999999999999  5689999999999999999999999998664411               111


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCC
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA  357 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~  357 (363)
                      .+.....+...+..++..+..++++||+.||..||++.+|+..|+.+......
T Consensus       257 ~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  257 AVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             HHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence            22233444555666888999999999999999999999999999998876553

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-54  Score=356.01  Aligned_cols=260  Identities=22%  Similarity=0.358  Sum_probs=211.2

Q ss_pred             cCCCCCCeeeccCCceEEEEE-eCCCCeEEEEEccCCCCCC-chHHHHHHHHHHhcCCCCccceeee-EEEeCCe-eEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLG-YCMESNN-RILV  143 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~-~~lv  143 (363)
                      .+|+++++||+|.||.||++. ..+|..+|.|.+....... ..+.+..|+.+|++|+||||+++++ .+.++.. +++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            468889999999999999995 5689999999998654333 3478899999999999999999998 4444444 8899


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCC-CCeEEecccCCceeecCCCceEEeeec
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ-PPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ||||.+|+|...|+..+..     ...+++..+|.++.|++.||.++|++-. .-|+||||||.||+|+.+|.|||+|||
T Consensus        99 mE~c~~GDLsqmIk~~K~q-----kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQ-----KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             HHhhcccCHHHHHHHHHhc-----cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence            9999999999999876532     2359999999999999999999999311 139999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      +++.+......  ....+|||.||+||.+.+..|+.++||||+||++|||+.-++||.+..   ...             
T Consensus       174 L~r~l~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n---~~~-------------  235 (375)
T KOG0591|consen  174 LGRFLSSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN---LLS-------------  235 (375)
T ss_pred             hHhHhcchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc---HHH-------------
Confidence            99987765443  456899999999999999999999999999999999999999997541   111             


Q ss_pred             cccccCCcCCCCCC-HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 046595          303 VKQCVDPKLNNDYP-PKAIAKLAAVAALCVQYEADFRPNMTIVVKALQP  350 (363)
Q Consensus       303 ~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~  350 (363)
                      +...+.++-...+| ..++..+..||..|+.+||+.||+.-.++..+..
T Consensus       236 L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  236 LCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             HHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            11111222222334 5678899999999999999999996555555443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1e-52  Score=360.66  Aligned_cols=242  Identities=23%  Similarity=0.308  Sum_probs=206.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC--chHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE--PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|++.++||+|+||.||+++.+ +++.+|+|++++....+  ..+....|..+|..++||+||.++-.|++.+++|||+
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl  104 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL  104 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence            47999999999999999999755 58999999998765433  3578899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      +|+.||.|...|+..+.         |++..+.-++..|+.||.|||++   |||||||||+|||+|.+|+++|+|||++
T Consensus       105 d~~~GGeLf~hL~~eg~---------F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~  172 (357)
T KOG0598|consen  105 DYLNGGELFYHLQREGR---------FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLC  172 (357)
T ss_pred             eccCCccHHHHHHhcCC---------cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccc
Confidence            99999999999987664         99999999999999999999999   9999999999999999999999999999


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      +........  ...++||+.|||||++.+..|+..+|.||||+++|||++|.+||...+......               
T Consensus       173 k~~~~~~~~--t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~---------------  235 (357)
T KOG0598|consen  173 KEDLKDGDA--TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYD---------------  235 (357)
T ss_pred             hhcccCCCc--cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHH---------------
Confidence            865444332  455899999999999999999999999999999999999999997654322111               


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCC
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP  339 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP  339 (363)
                      .+. ..-....+.-.+.+..+++.++|..||++|.
T Consensus       236 ~I~-~~k~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  236 KIL-KGKLPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             HHh-cCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence            111 1111222334667899999999999999995

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-52  Score=373.76  Aligned_cols=257  Identities=27%  Similarity=0.459  Sum_probs=226.1

Q ss_pred             CCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccC
Q 046595           70 FGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATM  149 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  149 (363)
                      +++.+.||+|.||.||+|.+.....||+|.++..  ....+.|.+|+++|+.|+|+|||+++++|..++.++|||||+..
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~--~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~  285 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG--SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK  285 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEecc--ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence            3445569999999999999988889999999874  33446889999999999999999999999998899999999999


Q ss_pred             CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCc
Q 046595          150 GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       150 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      |+|.++|+....       ..+...+.+.++.||++|++||+++   ++|||||..+||||++++.+||+|||||+...+
T Consensus       286 GsLl~yLr~~~~-------~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d  355 (468)
T KOG0197|consen  286 GSLLDYLRTREG-------GLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGD  355 (468)
T ss_pred             CcHHHHhhhcCC-------CccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCC
Confidence            999999987322       2389999999999999999999999   999999999999999999999999999996555


Q ss_pred             ccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccccccC
Q 046595          230 TAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD  308 (363)
Q Consensus       230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (363)
                      ..+... ....-...|.|||.+..+.++.+|||||||++||||+| |+.||.                ..++.++.+.++
T Consensus       356 ~~Y~~~-~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~----------------~msn~ev~~~le  418 (468)
T KOG0197|consen  356 DEYTAS-EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP----------------GMSNEEVLELLE  418 (468)
T ss_pred             Cceeec-CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC----------------CCCHHHHHHHHh
Confidence            444322 22234678999999999999999999999999999999 888885                455677788888


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccC
Q 046595          309 PKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK  355 (363)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~  355 (363)
                      ++.+...|..||.++.+|+..||+.+|++|||++.+...|+++....
T Consensus       419 ~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  419 RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence            99999999999999999999999999999999999999999887643

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-52  Score=359.89  Aligned_cols=204  Identities=29%  Similarity=0.454  Sum_probs=183.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC-CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS-APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ..+|.+.+.||+|+||+||+|+++ ++..||||.+.... .....+.+..|+.+|+.++|||||.+++++..++.+||||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            357999999999999999999865 58999999998754 4444567889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCC------CceEE
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD------FKSKI  218 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~------~~vkl  218 (363)
                      |||+||+|.+||+..+.         +++..+..+..||+.||++||++   +||||||||+||||+..      ..+||
T Consensus        89 EyC~gGDLs~yi~~~~~---------l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKI  156 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGR---------LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKI  156 (429)
T ss_pred             EeCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEe
Confidence            99999999999998763         99999999999999999999999   99999999999999764      56899


Q ss_pred             eeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCc
Q 046595          219 ADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPK  285 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~  285 (363)
                      +|||+|+.......   ....+|++-|||||++....|+.|+|+||+|++||++++|+.||+.....
T Consensus       157 ADFGfAR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~  220 (429)
T KOG0595|consen  157 ADFGFARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK  220 (429)
T ss_pred             cccchhhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence            99999998875433   45679999999999999999999999999999999999999999865443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-51  Score=368.69  Aligned_cols=253  Identities=23%  Similarity=0.321  Sum_probs=214.5

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCC--CCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCee
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSA--PEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNR  140 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  140 (363)
                      +...+|.+++.||+|+|++|++|+. .+++.||||++.+...  +.....+.+|..+|.+| .||.|+++|..|.+...+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            4456899999999999999999964 4799999999976542  22335677899999999 799999999999999999


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEee
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD  220 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D  220 (363)
                      |+|+||+++|+|.++|++.+.         |++.....++.+|+.||+|||++   |||||||||+||||++++++||+|
T Consensus       150 YFvLe~A~nGdll~~i~K~Gs---------fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITD  217 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKYGS---------FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITD  217 (604)
T ss_pred             EEEEEecCCCcHHHHHHHhCc---------chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEee
Confidence            999999999999999998864         99999999999999999999999   999999999999999999999999


Q ss_pred             eccCCCCCccccc---------ccc--cccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccc
Q 046595          221 FNLTNQSSDTAAR---------LHS--TRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQS  289 (363)
Q Consensus       221 fg~a~~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~  289 (363)
                      ||.|+.+......         ...  ..++||..|.+||+|.....+..+|||+|||+||+|+.|.+||....+-..-+
T Consensus       218 FGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq  297 (604)
T KOG0592|consen  218 FGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ  297 (604)
T ss_pred             ccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH
Confidence            9999876543222         111  45899999999999999999999999999999999999999997654321111


Q ss_pred             hhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          290 LVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                                  ++.     .+.-.++...++...+||+++|..||.+|+|.++|.+
T Consensus       298 ------------kI~-----~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  298 ------------KIQ-----ALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             ------------HHH-----HhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence                        111     1223456666788999999999999999999999887

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.5e-51  Score=343.26  Aligned_cols=265  Identities=23%  Similarity=0.307  Sum_probs=215.5

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCch-HHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPE-SDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      ++|+.+.++|+|+||.||+|+++ +|+.||||++..+.+.... .-..+|+++|++++|+|+|.++++|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            36788889999999999999876 5999999999876553333 456899999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      ||+. ++.+-+.....        .++...+..+++|++.|+.|+|++   ++|||||||+||||+.+|.+||||||+|+
T Consensus        82 ~~dh-TvL~eLe~~p~--------G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR  149 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPN--------GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFAR  149 (396)
T ss_pred             ecch-HHHHHHHhccC--------CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhH
Confidence            9998 66666665543        288999999999999999999999   99999999999999999999999999998


Q ss_pred             CCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccc---
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED---  301 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~---  301 (363)
                      .......  ..+..+.|.+|.|||.+.| ..|+..+||||+||++.||++|.+-|.+.++.++...+......+...   
T Consensus       150 ~L~~pgd--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~  227 (396)
T KOG0593|consen  150 TLSAPGD--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQS  227 (396)
T ss_pred             hhcCCcc--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHH
Confidence            8774322  2566789999999999987 589999999999999999999999999888887776664333322221   


Q ss_pred             ------ccccccCCcCC-----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          302 ------KVKQCVDPKLN-----NDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       302 ------~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                            ....+.-+...     ..--+.....+.++++.||+.||.+|++.++++.
T Consensus       228 iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  228 IFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             HhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence                  11111111111     1111244567899999999999999999999874

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.2e-50  Score=378.88  Aligned_cols=273  Identities=28%  Similarity=0.470  Sum_probs=236.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRI  141 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  141 (363)
                      .+....+.||+|.||.||+|+..      +...||||.++........++|++|++++..++|||||+++|+|.+++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            34556777999999999999643      356699999988666556789999999999999999999999999999999


Q ss_pred             EEEecccCCChhhhhcCCCCCCCCC-C----CCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCce
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGAE-P----GPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS  216 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~~-~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v  216 (363)
                      ||+|||..|+|.+||.......... .    ...++..+.+.|+.||+.|+.||.++   .+|||||-.+|+||.++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence            9999999999999998654333222 2    33499999999999999999999999   99999999999999999999


Q ss_pred             EEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcc
Q 046595          217 KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       217 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      ||+||||++.....++........-..+|||||.+..+.++.+|||||+||+|||+++ |..||.+              
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~g--------------  708 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYG--------------  708 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccc--------------
Confidence            9999999988776666554445556789999999999999999999999999999999 8899864              


Q ss_pred             ccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCCCC
Q 046595          296 PRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGP  359 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~~~  359 (363)
                        ++++++.+.+..+-....|..||.++..|+..||+.+|.+||++++|...|+...++.+.-.
T Consensus       709 --lSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~~  770 (774)
T KOG1026|consen  709 --LSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKYS  770 (774)
T ss_pred             --cchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcccc
Confidence              45566666666666688899999999999999999999999999999999998887766543

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-49  Score=356.37  Aligned_cols=269  Identities=28%  Similarity=0.484  Sum_probs=218.5

Q ss_pred             HHHHHhcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCC-CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCee
Q 046595           62 ELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSS-APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNR  140 (363)
Q Consensus        62 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  140 (363)
                      +.+...+.+.+...||+|.||+||+|+|..  .||||++.... .++..+.|+.|+.+++.-+|.||+-+.|+|..... 
T Consensus       386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-  462 (678)
T KOG0193|consen  386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-  462 (678)
T ss_pred             ccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence            344445667788999999999999999873  59999998754 33345889999999999999999999999998877 


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEee
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD  220 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D  220 (363)
                      .+|+.+|.|-+|+.+|+....        .|.......|+.||++|+.|||.+   +|||||||..||++.+++.|||+|
T Consensus       463 AIiTqwCeGsSLY~hlHv~et--------kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgD  531 (678)
T KOG0193|consen  463 AIITQWCEGSSLYTHLHVQET--------KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGD  531 (678)
T ss_pred             eeeehhccCchhhhhccchhh--------hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEec
Confidence            999999999999999987652        299999999999999999999999   999999999999999999999999


Q ss_pred             eccCCCCCcccccccccccccccCCCCcccccc---CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccc
Q 046595          221 FNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT---GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR  297 (363)
Q Consensus       221 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~  297 (363)
                      ||++................|...|||||++..   .+|+..+||||||+++|||++|..||. ....++   +.|....
T Consensus       532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dq---IifmVGr  607 (678)
T KOG0193|consen  532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQ---IIFMVGR  607 (678)
T ss_pred             ccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhh---eEEEecc
Confidence            999876555444433445568889999999874   479999999999999999999999997 222111   1111100


Q ss_pred             ccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCC
Q 046595          298 LSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP  356 (363)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~  356 (363)
                             ..+.+.+ .....+++.++.+|+..||..++++||.+.+|+..|++++..++
T Consensus       608 -------G~l~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~p  658 (678)
T KOG0193|consen  608 -------GYLMPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLP  658 (678)
T ss_pred             -------cccCccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccc
Confidence                   0000111 12234678899999999999999999999999999999988663

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-49  Score=348.91  Aligned_cols=266  Identities=22%  Similarity=0.282  Sum_probs=213.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCC-CCCchHHHHHHHHHHhcCCCCccceeeeEEEeC--CeeEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSS-APEPESDFAAQLSVVSRLKHEHFVELLGYCMES--NNRILV  143 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv  143 (363)
                      ..|+.++.||+|.||.||+|+. .+|+.||+|++.... .++......+|+.||++|+||||+++.+...+.  ..+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            4577888899999999999974 579999999998866 334456788999999999999999999998876  689999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      +|||+. +|..++....        -.|++.++..++.||+.||+|||++   ||+|||||.+|||||++|.+||+||||
T Consensus       197 FeYMdh-DL~GLl~~p~--------vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGL  264 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPG--------VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGL  264 (560)
T ss_pred             Eecccc-hhhhhhcCCC--------cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccc
Confidence            999998 9999987643        2399999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      |+++...... ..+..+-|.+|.|||+|.|. .|+.++|+||+||||.||++|++.|.+.....+...+...-.......
T Consensus       265 Ar~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~  343 (560)
T KOG0600|consen  265 ARFYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY  343 (560)
T ss_pred             eeeccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc
Confidence            9976554332 25667889999999999876 799999999999999999999999988776665555432222211111


Q ss_pred             cc--ccc---CCcCCCCC-------CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          303 VK--QCV---DPKLNNDY-------PPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       303 ~~--~~~---~~~~~~~~-------~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ..  .+.   .-.....+       ....+....+|+..+|..||++|.|+.++++
T Consensus       344 W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  344 WPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            11  000   00000111       1234566889999999999999999999886

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-49  Score=328.09  Aligned_cols=237  Identities=24%  Similarity=0.338  Sum_probs=205.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC--CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP--EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|+..+.||.|+||.|.+++.+ +|..+|+|++.+...-  ...+...+|..+|+.+.||+++++++.+.+.++++|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            46888999999999999999855 6899999999775422  23466788999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.||.|..++++.+.         |++..+..++.||+.||+|||++   +|++|||||+|||||.+|.+||+|||+|
T Consensus       124 eyv~GGElFS~Lrk~~r---------F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFA  191 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGR---------FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFA  191 (355)
T ss_pred             eccCCccHHHHHHhcCC---------CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccce
Confidence            99999999999998764         99999999999999999999999   9999999999999999999999999999


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      +.....     .-..+|||.|+|||++....|+.++|.||||+++|||+.|.+||....+......              
T Consensus       192 K~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~K--------------  252 (355)
T KOG0616|consen  192 KRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEK--------------  252 (355)
T ss_pred             EEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHH--------------
Confidence            776543     3457999999999999999999999999999999999999999986655322221              


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCC
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFR  338 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R  338 (363)
                       ++...  ..+|.-....+.+|+..+|++|-.+|
T Consensus       253 -I~~~~--v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  253 -ILEGK--VKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             -HHhCc--ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence             11111  34566777889999999999999888

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-50  Score=351.35  Aligned_cols=268  Identities=21%  Similarity=0.337  Sum_probs=217.9

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-CCccceeeeEEEeCC-eeE
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVELLGYCMESN-NRI  141 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~~  141 (363)
                      .+..+|.+++.||.|+||.||+|+. .+|+.||||+++...-.-....-++|++.|++|+ ||||+++.+++.+.+ .++
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            3456899999999999999999964 5699999999987554333334578999999998 999999999999887 999


Q ss_pred             EEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeee
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADF  221 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df  221 (363)
                      +|||||+. +|.++++.+..        .|++..+..|++||++||+|+|.+   |+.|||+||+|||+.....|||+||
T Consensus        87 fVfE~Md~-NLYqLmK~R~r--------~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDF  154 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDRNR--------LFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADF  154 (538)
T ss_pred             eeHHhhhh-hHHHHHhhcCC--------cCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccc
Confidence            99999987 99999988743        499999999999999999999999   9999999999999998889999999


Q ss_pred             ccCCCCCcccccccccccccccCCCCccccc-cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccc
Q 046595          222 NLTNQSSDTAARLHSTRVLGTFGYHAPEYAM-TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE  300 (363)
Q Consensus       222 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  300 (363)
                      |+|+.......   .++.+.|.+|.|||++. .+.|+.+.||||+||+++|+++-++-|.+.+..++...+..+......
T Consensus       155 GLARev~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~  231 (538)
T KOG0661|consen  155 GLAREVRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDK  231 (538)
T ss_pred             ccccccccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcc
Confidence            99987665433   56788999999999876 568999999999999999999999999887777666554333222221


Q ss_pred             cccc------cccCCcCC-------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          301 DKVK------QCVDPKLN-------NDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       301 ~~~~------~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                      ....      ..+.-.+.       ..+.+.++.+..++|..|++.||++|||+.+.++.
T Consensus       232 ~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  232 DSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             ccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            1111      11111110       11223477889999999999999999999999984

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-48  Score=351.34  Aligned_cols=249  Identities=25%  Similarity=0.407  Sum_probs=216.0

Q ss_pred             cCCCCCCeeeccCCceEEEEE-eCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      ..|.....||+|+.|.||.++ ..+++.||||++..... ...+-+.+|+.+|+..+|+|||.+++.+...+.+|.||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q-~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ-PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC-CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            358888899999999999995 55789999999987543 3456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      ++||+|.+.+....          +++.++..|++.++.||+|||.+   ||+|||||.+|||++.+|.+||+|||++..
T Consensus       352 m~ggsLTDvVt~~~----------~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaq  418 (550)
T KOG0578|consen  352 MEGGSLTDVVTKTR----------MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQ  418 (550)
T ss_pred             cCCCchhhhhhccc----------ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeec
Confidence            99999999998875          99999999999999999999999   999999999999999999999999999876


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      ......  .....+||+.|||||++....|+.++||||||++++||+-|++||-...+.....++.-.            
T Consensus       419 i~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n------------  484 (550)
T KOG0578|consen  419 ISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN------------  484 (550)
T ss_pred             cccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc------------
Confidence            655443  245578999999999999999999999999999999999999999765554333332211            


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                        .......+..++..|.+++.+||+.|+++|+++.++|+
T Consensus       485 --g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  485 --GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             --CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence              12223445677888999999999999999999999997

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-48  Score=341.45  Aligned_cols=256  Identities=25%  Similarity=0.399  Sum_probs=207.2

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCC--eeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESN--NRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~  144 (363)
                      .+|...+.||+|+||.||++... +|+..|||.+....... .+.+.+|+.+|.+++|||||+++|......  .++++|
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            46888899999999999999765 48999999998763333 667899999999999999999999754444  688999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC-CCceEEeeecc
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD-DFKSKIADFNL  223 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~  223 (363)
                      ||+.+|+|.+++...+.        .+++..+..++.|+++||.|||++   ||+|+||||+|||++. ++.+||+|||+
T Consensus        96 Ey~~~GsL~~~~~~~g~--------~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~  164 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGG--------KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGL  164 (313)
T ss_pred             eccCCCcHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcc
Confidence            99999999999987653        289999999999999999999999   9999999999999999 79999999999


Q ss_pred             CCCCCc-ccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccc
Q 046595          224 TNQSSD-TAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       224 a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      +..... ...........||+.|||||++.++ ....++|||||||++.||+||..||...  .....            
T Consensus       165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~------------  230 (313)
T KOG0198|consen  165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAE------------  230 (313)
T ss_pred             ccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHH------------
Confidence            876653 1111223357899999999999963 3445999999999999999999999753  00000            


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ  349 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~  349 (363)
                      .+...........+|..++.+..+++.+|+..||++|||++++++..-
T Consensus       231 ~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  231 ALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             HHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence            011111111223556678888999999999999999999999998544

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.7e-48  Score=318.44  Aligned_cols=265  Identities=25%  Similarity=0.307  Sum_probs=216.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCch-HHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPE-SDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      .+|...++||+|.||.||+|++ .+|+.||||+++.....+.. ....+|++.|+.++|+||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            3688888999999999999964 57999999999886544433 568899999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |++. +|...|++...        .++..++..++.++++||+|||++   .|+||||||+|+||+.+|.+||+|||+++
T Consensus        82 fm~t-dLe~vIkd~~i--------~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr  149 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNI--------ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLAR  149 (318)
T ss_pred             eccc-cHHHHhccccc--------ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchh
Confidence            9988 99999987653        499999999999999999999999   99999999999999999999999999999


Q ss_pred             CCCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc-
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV-  303 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  303 (363)
                      .+........  ..+-|.+|.|||.+.|. .|+..+|+||.||++.||+.|.+-|.+.++.++...+--+......+.. 
T Consensus       150 ~f~~p~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP  227 (318)
T KOG0659|consen  150 FFGSPNRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWP  227 (318)
T ss_pred             ccCCCCcccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCc
Confidence            8876655432  23789999999999875 7999999999999999999999888877766655544222211111111 


Q ss_pred             --ccccC--------CcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          304 --KQCVD--------PKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       304 --~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                        ..+-+        ......+.+.++....+++..+|..||.+|++++|.++
T Consensus       228 ~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~  280 (318)
T KOG0659|consen  228 EMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK  280 (318)
T ss_pred             cccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence              11100        11111234456677899999999999999999999987

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-48  Score=350.42  Aligned_cols=251  Identities=23%  Similarity=0.328  Sum_probs=208.2

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCC----CchHHHHHHHHHHhcCC-CCccceeeeEEEeCC
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAP----EPESDFAAQLSVVSRLK-HEHFVELLGYCMESN  138 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~  138 (363)
                      ...++|.+++.||+|+||.|+.|.+ .+++.||+|++......    ...+.+.+|+.++++++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3456899999999999999999965 46899999977664211    23456778999999998 999999999999999


Q ss_pred             eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCC-CceE
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD-FKSK  217 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-~~vk  217 (363)
                      ..++||||+.||+|.+++...+         .+.+.++..++.|++.|++|||++   ||+||||||+|||++.+ +++|
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g---------~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~K  161 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKG---------RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLK  161 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcC---------CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEE
Confidence            9999999999999999998844         388999999999999999999999   99999999999999999 9999


Q ss_pred             EeeeccCCCCCcccccccccccccccCCCCccccccCC-CC-ccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 046595          218 IADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQ-IT-QKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       218 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      |+|||++.....  ........+||+.|+|||++.+.. |+ .++||||+|++||.|++|..||+..........     
T Consensus       162 l~DFG~s~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k-----  234 (370)
T KOG0583|consen  162 LSDFGLSAISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK-----  234 (370)
T ss_pred             EeccccccccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH-----
Confidence            999999987641  112245679999999999999877 86 889999999999999999999986322111100     


Q ss_pred             ccccccccccccCCcCCCCCCHHH-HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          296 PRLSEDKVKQCVDPKLNNDYPPKA-IAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                                +..  -.-.+|..+ +.++..++.+||..||.+|+++.+|+.
T Consensus       235 ----------i~~--~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  235 ----------IRK--GEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             ----------Hhc--CCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence                      011  012233334 778999999999999999999999993

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-48  Score=337.36  Aligned_cols=263  Identities=24%  Similarity=0.340  Sum_probs=213.7

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      .+.|++..+||.|..++||+|+. ..++.||||++...........+.+|+..++.++||||++++..|..++.+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            35799999999999999999964 56899999999887766667899999999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      ||.+|++.+++...-...       +.+..+..|++++++||.|||.+   |.||||||+.||||+.+|.|||+|||.+.
T Consensus       105 fMa~GS~ldIik~~~~~G-------l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa  174 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDG-------LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSA  174 (516)
T ss_pred             hhcCCcHHHHHHHHcccc-------ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeee
Confidence            999999999998654322       89999999999999999999999   99999999999999999999999999875


Q ss_pred             CCCccccccc--ccccccccCCCCcccccc--CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccc
Q 046595          226 QSSDTAARLH--STRVLGTFGYHAPEYAMT--GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       226 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      ...+...+..  ...++||++|||||++..  ..|+.|+||||||++..||.+|..||....+.....+..-..+..   
T Consensus       175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~---  251 (516)
T KOG0582|consen  175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPT---  251 (516)
T ss_pred             eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCC---
Confidence            5443332221  145789999999999654  479999999999999999999999998665432211111000000   


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                          .....+..+........+.+++..||+.||++|||++++++
T Consensus       252 ----~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  252 ----LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             ----cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                00111112222345568999999999999999999999987

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.1e-48  Score=351.84  Aligned_cols=269  Identities=24%  Similarity=0.414  Sum_probs=209.2

Q ss_pred             cCCCCCCeeeccCCceEEEEEe------CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCC-e
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL------TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESN-N  139 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~  139 (363)
                      ++|++.+.||+|+||.||+|.+      .+++.||+|++...........+.+|+.++..+ +||||+++++++.... .
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP   86 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence            4799999999999999999963      235679999987644444456789999999999 8999999999887644 5


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCC-----------------------------------------------------CC
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQG-----------------------------------------------------AE  166 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~-----------------------------------------------------~~  166 (363)
                      .+++|||+++|+|.+++........                                                     ..
T Consensus        87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (338)
T cd05102          87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL  166 (338)
T ss_pred             eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence            7899999999999999975421100                                                     00


Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCcccccccccccccccCCC
Q 046595          167 PGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH  246 (363)
Q Consensus       167 ~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  246 (363)
                      ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++...............++..|+
T Consensus       167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~  243 (338)
T cd05102         167 WKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM  243 (338)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence            012488899999999999999999999   99999999999999999999999999987643322222223345678899


Q ss_pred             CccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHH
Q 046595          247 APEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAA  325 (363)
Q Consensus       247 aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  325 (363)
                      |||++.+..++.++|||||||+||||++ |..||........  ..             ..+........+..++..+.+
T Consensus       244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~-------------~~~~~~~~~~~~~~~~~~l~~  308 (338)
T cd05102         244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FC-------------QRLKDGTRMRAPENATPEIYR  308 (338)
T ss_pred             CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HH-------------HHHhcCCCCCCCCCCCHHHHH
Confidence            9999999999999999999999999997 9999975432110  00             000001111223345667999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          326 VAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       326 li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                      ++.+||+.||++|||+.+|++.|+.++.+
T Consensus       309 li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         309 IMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            99999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-47  Score=351.40  Aligned_cols=243  Identities=24%  Similarity=0.346  Sum_probs=207.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCC-CCccceeeeEEEeCCeeEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLK-HEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l  142 (363)
                      ..+|.+.++||+|+||.|+++..+ +++.+|||++++..  ..+..+....|..|+...+ ||+++.++..|.+.+++|+
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            468999999999999999999755 68899999998865  3445678888988888885 9999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ||||+.||++...++...          |++..+..++..++.||.|||++   ||||||||.+|||+|.+|.+||+|||
T Consensus       447 vmey~~Ggdm~~~~~~~~----------F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFG  513 (694)
T KOG0694|consen  447 VMEYVAGGDLMHHIHTDV----------FSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFG  513 (694)
T ss_pred             EEEecCCCcEEEEEeccc----------ccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccc
Confidence            999999999666665443          99999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      +++.......  ..+.++|||.|||||++.+..|+.++|.|||||+|||||.|..||.+.+.++.-.-+           
T Consensus       514 lcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI-----------  580 (694)
T KOG0694|consen  514 LCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI-----------  580 (694)
T ss_pred             cccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-----------
Confidence            9986553332  367799999999999999999999999999999999999999999865432211111           


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNM  341 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~  341 (363)
                          +.  -...+|..++.+...|++++|..+|++|.-+
T Consensus       581 ----~~--d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  581 ----VN--DEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ----hc--CCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence                10  1134577888899999999999999999865

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=8.7e-47  Score=346.01  Aligned_cols=249  Identities=23%  Similarity=0.308  Sum_probs=197.2

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      .+|+..+.||+|+||.||++++. +++.||||++...........+.+|+.+++.++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            35677888999999999999765 68999999986644433456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|.+...             ..+..+..++.|++.||.|||++   +|+||||||+|||+++++.+||+|||++..
T Consensus       154 ~~~~~L~~~~~-------------~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~  217 (353)
T PLN00034        154 MDGGSLEGTHI-------------ADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRI  217 (353)
T ss_pred             CCCCccccccc-------------CCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccccccee
Confidence            99999865321             56778889999999999999999   999999999999999999999999999876


Q ss_pred             CCcccccccccccccccCCCCcccccc-----CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMT-----GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      .......  .....||..|+|||++..     ...+.++|||||||++|||++|+.||......+.......        
T Consensus       218 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~--------  287 (353)
T PLN00034        218 LAQTMDP--CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA--------  287 (353)
T ss_pred             ccccccc--ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH--------
Confidence            5432211  234579999999998753     2345689999999999999999999973322111111000        


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                           .........+..++.++.++|.+||+.||++||++.+|++.
T Consensus       288 -----~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        288 -----ICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             -----HhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 00011122234556779999999999999999999999984

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-47  Score=350.14  Aligned_cols=248  Identities=24%  Similarity=0.318  Sum_probs=210.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      +-|++++.||.|+.|.|-+|++ .+|+.+|||++.+..  .......+.+|+-+|+.+.||||+.+|++|++..++|+|+
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            5699999999999999999975 479999999998753  2223467899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+++|.|++++...+.         +++.++.+++.||+.|+.|+|..   +|+||||||+|+||+..+++||+|||+|
T Consensus        92 Eyv~gGELFdylv~kG~---------l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMA  159 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGP---------LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMA  159 (786)
T ss_pred             EecCCchhHHHHHhhCC---------CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeecccee
Confidence            99999999999977653         99999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCC-ccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQIT-QKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      ..-....   .....||++.|++||++.|..|+ .++||||+|||||.||+|+.||++..-   ..+..           
T Consensus       160 sLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi---r~LLl-----------  222 (786)
T KOG0588|consen  160 SLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI---RVLLL-----------  222 (786)
T ss_pred             ecccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH---HHHHH-----------
Confidence            5432221   13456899999999999999885 789999999999999999999973321   11111           


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                        .+..+ .-..|.+.+.+.++|+.+||.+||.+|.|+++|++.
T Consensus       223 --KV~~G-~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  223 --KVQRG-VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             --HHHcC-cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence              11111 123466778889999999999999999999999873

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.6e-48  Score=332.77  Aligned_cols=249  Identities=22%  Similarity=0.369  Sum_probs=213.5

Q ss_pred             HhcCCCCCCeeeccCCceEEEEE-eCCCCeEEEEEccCCCCCCch--HHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPE--SDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~avK~~~~~~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      +..+|++.+.||+|.||.|-+|. ...|+.||||.+++....+..  -.+.+|++||..|+||||+.+|++|++.+...+
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            44589999999999999999996 467999999999887655443  467899999999999999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ||||..+|.|.+|+..+..         +++.+...+++||+.|+.|+|.+   +++|||||.+|||+|.++++||.|||
T Consensus       131 vMEYaS~GeLYDYiSer~~---------LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFG  198 (668)
T KOG0611|consen  131 VMEYASGGELYDYISERGS---------LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFG  198 (668)
T ss_pred             EEEecCCccHHHHHHHhcc---------ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccc
Confidence            9999999999999988764         99999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCC-CccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      ++..+.+...   ...++|++.|.+||+++|.+| ++.+|-||||++||-|+.|..||++.+-.               .
T Consensus       199 LSNly~~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---------------~  260 (668)
T KOG0611|consen  199 LSNLYADKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---------------R  260 (668)
T ss_pred             hhhhhccccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---------------H
Confidence            9877665433   467899999999999999988 47899999999999999999999865321               1


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                      .++++-...+.   .++.+....-||.|||.+||+.|.|+.+|...
T Consensus       261 lvrQIs~GaYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  261 LVRQISRGAYR---EPETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             HHHHhhccccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence            12222222221   22345567889999999999999999999874

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6e-47  Score=338.28  Aligned_cols=252  Identities=20%  Similarity=0.293  Sum_probs=205.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|+++++||+|+||.||+|+.+ +|..+|+|+++++.  ..+....+..|-.+|...++|+||++|-.|.+.+++||||
T Consensus       141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM  220 (550)
T KOG0605|consen  141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM  220 (550)
T ss_pred             ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence            46999999999999999999755 69999999998764  2334577889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||++||++..+|....         .+++..+..++.+++.|++.||+.   |+|||||||+|+|||..|++||+||||+
T Consensus       221 EylPGGD~mTLL~~~~---------~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs  288 (550)
T KOG0605|consen  221 EYLPGGDMMTLLMRKD---------TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLS  288 (550)
T ss_pred             EecCCccHHHHHHhcC---------cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeecccccc
Confidence            9999999999998765         499999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCc----------------------cccc------c-----------------cccccccccCCCCccccccCCCCcc
Q 046595          225 NQSSD----------------------TAAR------L-----------------HSTRVLGTFGYHAPEYAMTGQITQK  259 (363)
Q Consensus       225 ~~~~~----------------------~~~~------~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~  259 (363)
                      .-...                      ....      .                 .....+|||.|+|||++.+..|+..
T Consensus       289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~  368 (550)
T KOG0605|consen  289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE  368 (550)
T ss_pred             chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc
Confidence            42211                      0000      0                 0122579999999999999999999


Q ss_pred             CceehhHHHHHHHHhCCCCCCCCCCccccc-hhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCC
Q 046595          260 SDVYSFGVVLLELLTGRKPVDHTMPKGQQS-LVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFR  338 (363)
Q Consensus       260 ~DvwslG~~l~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R  338 (363)
                      +|.||||||+||||.|.+||....+..... .+.|...              +...-...+..+..+||.+|+. ||++|
T Consensus       369 cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~--------------l~fP~~~~~s~eA~DLI~rll~-d~~~R  433 (550)
T KOG0605|consen  369 CDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET--------------LKFPEEVDLSDEAKDLITRLLC-DPENR  433 (550)
T ss_pred             ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh--------------ccCCCcCcccHHHHHHHHHHhc-CHHHh
Confidence            999999999999999999998776654333 2222211              1111112334678999999999 99999


Q ss_pred             CC---HHHHHH
Q 046595          339 PN---MTIVVK  346 (363)
Q Consensus       339 Ps---~~~vl~  346 (363)
                      -.   ++||.+
T Consensus       434 LG~~G~~EIK~  444 (550)
T KOG0605|consen  434 LGSKGAEEIKK  444 (550)
T ss_pred             cCcccHHHHhc
Confidence            65   666654

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-48  Score=336.37  Aligned_cols=248  Identities=25%  Similarity=0.412  Sum_probs=214.9

Q ss_pred             CCCCCCeeeccCCceEEEEE-eCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           69 NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      .|+....||+|.||.||+|. ..+++.||+|++..........++..|+.++..++++||.++|+.+..+..++++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            57777899999999999996 45799999999999888888899999999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      .||++.+.+....         .+.+.++.-++++++.||.|||.+   +.+|||||+.|||+..+|.|||+|||++-..
T Consensus        94 ~gGsv~~lL~~~~---------~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql  161 (467)
T KOG0201|consen   94 GGGSVLDLLKSGN---------ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQL  161 (467)
T ss_pred             cCcchhhhhccCC---------CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeee
Confidence            9999999998765         257888889999999999999999   9999999999999999999999999998766


Q ss_pred             CcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCV  307 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (363)
                      ......  ...++||+.|||||++....|+.++||||||++.+||.+|.+|+....+.....++                
T Consensus       162 ~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI----------------  223 (467)
T KOG0201|consen  162 TNTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI----------------  223 (467)
T ss_pred             echhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec----------------
Confidence            655444  36789999999999999889999999999999999999999999876653222221                


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          308 DPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      -......+...++..+.+++..||+.||+.||++.++++
T Consensus       224 pk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  224 PKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             cCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            111112222345566999999999999999999999987

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-47  Score=369.54  Aligned_cols=267  Identities=27%  Similarity=0.424  Sum_probs=225.9

Q ss_pred             CCCCCCeeeccCCceEEEEEeCC--CC----eEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           69 NFGTKALIGEGSYGRVFYAKLTD--GT----PAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~~--~~----~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      ...+.+.||+|.||.||.|...+  +.    .||||.+....+......|.+|..+|+.++|||||+++|++.+....++
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            45667889999999999997543  43    3899999887777778899999999999999999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ++|||.+|+|..||++.+.....  ...++..+++.++.+|++|+.||+++   ++|||||..+|+||+....|||+|||
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~--~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQ--PSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCC--CCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence            99999999999999987543322  23499999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      +|+...+..+........-...|||||.+..+.++.++|||||||+|||++| |..||....                +.
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~----------------n~  911 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS----------------NF  911 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc----------------hH
Confidence            9985554444333333344578999999999999999999999999999999 889996543                33


Q ss_pred             cccc-ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCC
Q 046595          302 KVKQ-CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA  357 (363)
Q Consensus       302 ~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~  357 (363)
                      ++.. ++..+ +.+.|..|+..+.+++..||+.+|++||++..|++.+.++++..-.
T Consensus       912 ~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~  967 (1025)
T KOG1095|consen  912 EVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG  967 (1025)
T ss_pred             HHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence            3333 22233 6677889999999999999999999999999999999988876543

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.2e-47  Score=343.60  Aligned_cols=247  Identities=27%  Similarity=0.362  Sum_probs=210.5

Q ss_pred             cCCCCCCeeeccCCceEEEEE-eCCCCeEEEEEccCCCCCC-chHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           68 SNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      ++|.+.+.||+|+||.||+|+ ..+.+.||+|.+.+....+ ....+.+|+++++.++||||+.++++|+...+.++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            468888899999999999996 4578999999998765443 45678999999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.| +|..+|.....         +++..+..++.+++.||.|||++   +|+|||+||.|||++..|.+|+||||+|+
T Consensus        82 ~a~g-~L~~il~~d~~---------lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar  148 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGK---------LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLAR  148 (808)
T ss_pred             hhhh-hHHHHHHhccC---------CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhh
Confidence            9988 99999987653         99999999999999999999999   99999999999999999999999999998


Q ss_pred             CCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      ......  ...+...|||.|||||++.+..|+..+|+|||||++||+++|++||-...-.   .++            ..
T Consensus       149 ~m~~~t--~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~---~Lv------------~~  211 (808)
T KOG0597|consen  149 AMSTNT--SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT---QLV------------KS  211 (808)
T ss_pred             hcccCc--eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH---HHH------------HH
Confidence            765532  2355678999999999999999999999999999999999999999533111   111            01


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      +...  ...+|...+..+..+++..|..||..|.+-.+++.
T Consensus       212 I~~d--~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  212 ILKD--PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             HhcC--CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            1100  12335577888999999999999999999998875

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.5e-46  Score=336.22  Aligned_cols=271  Identities=23%  Similarity=0.375  Sum_probs=207.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCC-----------------CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCcccee
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTD-----------------GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL  130 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~-----------------~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~  130 (363)
                      ++|++.+.||+|+||.||+|.+.+                 +..||+|.+...........+.+|+.++..++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            579999999999999999997532                 336999998764433345678999999999999999999


Q ss_pred             eeEEEeCCeeEEEEecccCCChhhhhcCCCCCCC----------CCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEE
Q 046595          131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQG----------AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVH  200 (363)
Q Consensus       131 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~----------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH  200 (363)
                      ++++.+....++||||+.+++|.+++........          ......+++..++.++.|++.||.|||+.   +|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence            9999999999999999999999999865432111          11123478899999999999999999999   9999


Q ss_pred             ecccCCceeecCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh--CCCC
Q 046595          201 RDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT--GRKP  278 (363)
Q Consensus       201 ~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~--g~~p  278 (363)
                      |||||+|||++.++.+||+|||++................++..|+|||++.++.++.++||||||+++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999876543322222333456789999999988899999999999999999987  5677


Q ss_pred             CCCCCCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 046595          279 VDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQP  350 (363)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~  350 (363)
                      |........   ..........      .........+..++..+.+++.+||+.||++|||+.+|.+.|++
T Consensus       242 ~~~~~~~~~---~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         242 YGELTDEQV---IENAGEFFRD------QGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCcCCHHHH---HHHHHHHhhh------ccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            765432211   1100000000      00011112233556789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.4e-46  Score=345.25  Aligned_cols=266  Identities=23%  Similarity=0.371  Sum_probs=208.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEe------CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCee
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL------TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNR  140 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  140 (363)
                      ++|++.+.||+|+||.||+|.+      .++..||+|+++..........+.+|+.++..+ +||||+++++++......
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            4789999999999999999963      236689999987654444456788999999999 899999999999999999


Q ss_pred             EEEEecccCCChhhhhcCCCCCCC--------------------------------------------------------
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQG--------------------------------------------------------  164 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~--------------------------------------------------------  164 (363)
                      ++||||+++|+|.+++........                                                        
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            999999999999999965321000                                                        


Q ss_pred             ----------CCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCcccccc
Q 046595          165 ----------AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARL  234 (363)
Q Consensus       165 ----------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~  234 (363)
                                ......+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++..........
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                      00122478899999999999999999999   99999999999999999999999999987654332211


Q ss_pred             cccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccccccCCcCCC
Q 046595          235 HSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNN  313 (363)
Q Consensus       235 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (363)
                      ......++..|+|||++.+..++.++|||||||++|||++ |..||.......  ...             ..+......
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~-------------~~~~~~~~~  336 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFY-------------KMIKEGYRM  336 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHH-------------HHHHhCccC
Confidence            1222345678999999999999999999999999999998 888986432211  111             111111111


Q ss_pred             CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 046595          314 DYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL  351 (363)
Q Consensus       314 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l  351 (363)
                      ..+...+.++.+|+.+||+.||++||++.+|++.|++.
T Consensus       337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            12223456799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.8e-46  Score=344.46  Aligned_cols=267  Identities=24%  Similarity=0.420  Sum_probs=209.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCee
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNR  140 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  140 (363)
                      .+|.+.+.||+|+||.||+|.+.      ++..||+|.+...........+.+|+.+++.+ +|+||+++++++......
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            47899999999999999998642      24579999997655444456788999999999 899999999999999999


Q ss_pred             EEEEecccCCChhhhhcCCCCC----------------------------------------------------------
Q 046595          141 ILVYQFATMGSLHDVLHGRKGV----------------------------------------------------------  162 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~----------------------------------------------------------  162 (363)
                      ++||||+.+|+|.+++......                                                          
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            9999999999999998643210                                                          


Q ss_pred             ---CCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCccccccccccc
Q 046595          163 ---QGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV  239 (363)
Q Consensus       163 ---~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~  239 (363)
                         ........+++..++.++.|++.||.|||++   +|+||||||+|||+++++.+||+|||++...............
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence               0001123478899999999999999999999   9999999999999999999999999998755433221112223


Q ss_pred             ccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccccccCCcCCCCCCHH
Q 046595          240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPK  318 (363)
Q Consensus       240 ~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (363)
                      .++..|+|||++.+..++.++|||||||++|||++ |..||........               +............+..
T Consensus       275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~---------------~~~~~~~~~~~~~~~~  339 (374)
T cd05106         275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK---------------FYKMVKRGYQMSRPDF  339 (374)
T ss_pred             CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH---------------HHHHHHcccCccCCCC
Confidence            45678999999988899999999999999999997 9999975432111               0011111111122223


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccc
Q 046595          319 AIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL  352 (363)
Q Consensus       319 ~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~  352 (363)
                      .+.++.+++.+||+.||++|||+.+|++.|++++
T Consensus       340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            4567999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6.6e-46  Score=330.04  Aligned_cols=265  Identities=26%  Similarity=0.427  Sum_probs=212.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCC------CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTD------GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRI  141 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  141 (363)
                      ++|++.+.||+|+||.||+|....      ...+++|.+...........+.+|+.+++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468889999999999999997542      25799999876544444567889999999999999999999999999999


Q ss_pred             EEEecccCCChhhhhcCCCCCCCC-------CCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGA-------EPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF  214 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~-------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~  214 (363)
                      ++|||+.+++|.+++.........       .....+++..++.++.|++.||.|||++   +++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence            999999999999999764322211       1113488999999999999999999999   999999999999999999


Q ss_pred             ceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhh
Q 046595          215 KSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTW  293 (363)
Q Consensus       215 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~  293 (363)
                      .++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||......+       
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-------  234 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-------  234 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence            999999999875443322222334467889999999988899999999999999999998 999997543321       


Q ss_pred             ccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 046595          294 ATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL  351 (363)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l  351 (363)
                               +...+........+..++.++.+|+.+||+.||.+||++.+|++.|+.+
T Consensus       235 ---------~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         235 ---------VIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             ---------HHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence                     1111111222233556778899999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-47  Score=307.74  Aligned_cols=268  Identities=22%  Similarity=0.334  Sum_probs=214.1

Q ss_pred             HhcCCCCCCeeeccCCceEEEEE-eCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCe-----
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNN-----  139 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----  139 (363)
                      ..++|++.+.||+|||+-||+++ ..++..||+|++.... .+..+...+|++..++++||||++++++...+..     
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            35789999999999999999997 5679999999998855 4566788999999999999999999988765444     


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEe
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA  219 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~  219 (363)
                      .|+++.|...|+|.+.++..+..     +..+++.+++.|+.++++||++||+... .+.||||||.|||+++++.++|+
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~k-----g~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~  171 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIK-----GNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLM  171 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhc-----CCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEE
Confidence            89999999999999999876532     3359999999999999999999999822 39999999999999999999999


Q ss_pred             eeccCCCCCccccc-------ccccccccccCCCCccccc---cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccc
Q 046595          220 DFNLTNQSSDTAAR-------LHSTRVLGTFGYHAPEYAM---TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQS  289 (363)
Q Consensus       220 Dfg~a~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~  289 (363)
                      |||.+....-....       ........|..|.|||.+.   +...++++|||||||+||.|+.|..||+..-.....-
T Consensus       172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl  251 (302)
T KOG2345|consen  172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL  251 (302)
T ss_pred             eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence            99998654322111       1112345799999999886   4467899999999999999999999997543322111


Q ss_pred             hhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccc
Q 046595          290 LVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN  353 (363)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~  353 (363)
                      .             ..+.+..+...-....++.+.++|++|+++||.+||++.+++..+.++++
T Consensus       252 a-------------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li~  302 (302)
T KOG2345|consen  252 A-------------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLIA  302 (302)
T ss_pred             E-------------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhcC
Confidence            1             11112222222223377889999999999999999999999999998763

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-46  Score=353.53  Aligned_cols=265  Identities=22%  Similarity=0.344  Sum_probs=217.1

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCC-CeEEEEEccCCCCCCchHHHHHHHHHHhcCC-CCccceeeeE-EEe------CC
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDG-TPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVELLGY-CME------SN  138 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~-~~~------~~  138 (363)
                      -++++.++|.+|||+.||+|....+ ..||+|++... +....+.+.+|+.+|+.|. |+|||.+++. ...      .-
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            4678899999999999999987665 99999999775 5566788999999999996 9999999993 221      23


Q ss_pred             eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEE
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI  218 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl  218 (363)
                      +.+|+||||.||.|.+++..+...       .|++.++++|++++++|+.+||.. ++.|||||||-+||||+.+|..||
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~-------~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KL  187 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQT-------RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKL  187 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhc-------cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEe
Confidence            567999999999999999866532       299999999999999999999997 446999999999999999999999


Q ss_pred             eeeccCCCCCcccccc-------cccccccccCCCCcccc---ccCCCCccCceehhHHHHHHHHhCCCCCCCCCCcccc
Q 046595          219 ADFNLTNQSSDTAARL-------HSTRVLGTFGYHAPEYA---MTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ  288 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~  288 (363)
                      ||||.+..........       ..-...-|+.|+|||++   .+..+++|+|||+|||+||-|+....||+.....   
T Consensus       188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---  264 (738)
T KOG1989|consen  188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---  264 (738)
T ss_pred             CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---
Confidence            9999986443322110       01112469999999986   4678999999999999999999999999754331   


Q ss_pred             chhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCCCCC
Q 046595          289 SLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGPE  360 (363)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~~~~  360 (363)
                                      .+++..+...-.+.++..|.+||..||+.||++||++-+|++.+-++.+..+.-++
T Consensus       265 ----------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~  320 (738)
T KOG1989|consen  265 ----------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPD  320 (738)
T ss_pred             ----------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccc
Confidence                            22333333333468889999999999999999999999999999999988776554

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.5e-46  Score=316.03  Aligned_cols=265  Identities=22%  Similarity=0.258  Sum_probs=213.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCch-HHHHHHHHHHhcCCCCccceeeeEEEe--CCeeEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPE-SDFAAQLSVVSRLKHEHFVELLGYCME--SNNRILV  143 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv  143 (363)
                      +.|+.+..|++|+||.||+|++ ++++.||+|+++.....+.. ...++|+.+|.+++|||||.+-.+.+.  -+..|||
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            4688888899999999999975 47999999999876533332 467899999999999999999887654  4678999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      ||||+. +|..++...+        +.|...++..+..|+++||+|||++   .|+|||||++|+|+++.|.+||+|||+
T Consensus       156 Me~~Eh-DLksl~d~m~--------q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGL  223 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMK--------QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGL  223 (419)
T ss_pred             HHHHHh-hHHHHHHhcc--------CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccch
Confidence            999998 9999998765        2499999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccc--
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE--  300 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--  300 (363)
                      |+.+......  .+..+-|.+|.|||.+.+. .|+.+.|+||+|||+.||+++++-|.+.+..++.+.+.-.......  
T Consensus       224 AR~ygsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~i  301 (419)
T KOG0663|consen  224 AREYGSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAI  301 (419)
T ss_pred             hhhhcCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcccc
Confidence            9988876443  4567889999999998875 7999999999999999999999999888777666554222111111  


Q ss_pred             ------ccc------ccccCCcCCCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          301 ------DKV------KQCVDPKLNNDYPPK-AIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       301 ------~~~------~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                            -..      .......+...+... .++.-.+|+..+|..||.+|.|+.+.++
T Consensus       302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence                  100      011111122222222 4567889999999999999999999886

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-46  Score=335.88  Aligned_cols=252  Identities=22%  Similarity=0.382  Sum_probs=216.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCc-hHHHHHHHHHHhcCCCCccceeeeEEEeCCe-eEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEP-ESDFAAQLSVVSRLKHEHFVELLGYCMESNN-RILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~  144 (363)
                      .+|..++.+|+|+||.+++++++ ++..+++|.+......+. ......|+.+++++.||||+.+.+.|++++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            47899999999999999999755 688999999987654333 3467899999999999999999999999888 89999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      +|++||+|.+.|...+..       .|++..++.++.|++.|+.|||++   .|+|||||+.|||++.++.|+|+|||+|
T Consensus        84 ~Y~eGg~l~~~i~~~k~~-------~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGla  153 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGV-------LFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLA  153 (426)
T ss_pred             eecCCCCHHHHHHHHhhc-------cccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhh
Confidence            999999999999876632       399999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      +........  ....+||+.||.||++.+.+|+.++|||||||++|||++-+.+|...+...   ++             
T Consensus       154 K~l~~~~~~--a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li-------------  215 (426)
T KOG0589|consen  154 KILNPEDSL--ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LI-------------  215 (426)
T ss_pred             hhcCCchhh--hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HH-------------
Confidence            987766522  456789999999999999999999999999999999999999997653321   11             


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                      .-+.+......+..+..++..+|+.|++.+|+.||++.+++..
T Consensus       216 ~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  216 LKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            1111222345567788899999999999999999999999986

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-45  Score=325.36  Aligned_cols=258  Identities=25%  Similarity=0.360  Sum_probs=203.6

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC-------------CchHHHHHHHHHHhcCCCCcccee
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP-------------EPESDFAAQLSVVSRLKHEHFVEL  130 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~  130 (363)
                      ...++|++++.||+|.||.|-+|+.. +++.||||++.+....             ...+...+|+.+|++++|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            44568999999999999999999754 6999999998653211             123578999999999999999999


Q ss_pred             eeEEEe--CCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCce
Q 046595          131 LGYCME--SNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNV  208 (363)
Q Consensus       131 ~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Ni  208 (363)
                      +++..+  .+++|||+|||..|.+...-...         ..+++.+++.++.+++.||+|||.+   |||||||||+|+
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~---------~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNL  241 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDK---------PELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNL  241 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCCCc---------ccccHHHHHHHHHHHHHHHHHHHhc---Ceeccccchhhe
Confidence            999876  46889999999988774433222         1289999999999999999999999   999999999999


Q ss_pred             eecCCCceEEeeeccCCCCCccc---ccccccccccccCCCCccccccCC----CCccCceehhHHHHHHHHhCCCCCCC
Q 046595          209 LLFDDFKSKIADFNLTNQSSDTA---ARLHSTRVLGTFGYHAPEYAMTGQ----ITQKSDVYSFGVVLLELLTGRKPVDH  281 (363)
Q Consensus       209 ll~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~~l~ell~g~~p~~~  281 (363)
                      ||+++|+|||+|||.+..+....   ........+|||.|+|||...++.    .+.+.||||+||+||.|+.|+.||..
T Consensus       242 Ll~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~  321 (576)
T KOG0585|consen  242 LLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD  321 (576)
T ss_pred             EEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence            99999999999999987653221   111123368999999999887632    35788999999999999999999975


Q ss_pred             CCCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 046595          282 TMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ  349 (363)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~  349 (363)
                      .....               -...+++..+...-.++..+.+.+||.++|..||+.|.++.+|.....
T Consensus       322 ~~~~~---------------l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw  374 (576)
T KOG0585|consen  322 DFELE---------------LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW  374 (576)
T ss_pred             chHHH---------------HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence            42211               112223333333333467788999999999999999999999987554

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.3e-45  Score=326.27  Aligned_cols=247  Identities=19%  Similarity=0.313  Sum_probs=201.0

Q ss_pred             CeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCc--hHHHHHHHHHHhcCCCCccceeeeEEEe----CCeeEEEEecc
Q 046595           74 ALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELLGYCME----SNNRILVYQFA  147 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~  147 (363)
                      ..||+|++|.||+|.. +|+.||||++........  .+.+.+|+.++++++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            5799999999999988 588999999976432221  3567899999999999999999999876    35678999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      .+|+|.+++....         .+++...+.++.+++.||.|||+..  +++||||||+||++++++.+||+|||+++..
T Consensus       105 ~~g~L~~~l~~~~---------~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~  173 (283)
T PHA02988        105 TRGYLREVLDKEK---------DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKIL  173 (283)
T ss_pred             CCCcHHHHHhhCC---------CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence            9999999997653         2889999999999999999999732  7889999999999999999999999998754


Q ss_pred             CcccccccccccccccCCCCcccccc--CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMT--GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      ....     ....|+..|+|||++.+  ..++.++|||||||++|||++|..||..........               .
T Consensus       174 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~---------------~  233 (283)
T PHA02988        174 SSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYD---------------L  233 (283)
T ss_pred             cccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHH---------------H
Confidence            3321     23468899999999876  689999999999999999999999997543221111               1


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccc
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL  352 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~  352 (363)
                      ..........+..++..+.+++.+||+.||++|||+++|++.|+.+.
T Consensus       234 i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        234 IINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             HHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            11111122234456778999999999999999999999999998764

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-46  Score=332.37  Aligned_cols=266  Identities=25%  Similarity=0.385  Sum_probs=223.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      .+...+++.||+|.||.|.+|....+..||||.++..........|.+|+++|.+|+||||++++++|..++.+++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            35677889999999999999998878999999999877767778999999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +++|+|.+|+......       .+.....+.|+.||+.|++||.+.   ++|||||.++|+|++.++++||+|||+++.
T Consensus       617 mEnGDLnqFl~aheap-------t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~  686 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELP-------TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRN  686 (807)
T ss_pred             HhcCcHHHHHHhccCc-------ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccc
Confidence            9999999999876432       145566778999999999999999   999999999999999999999999999998


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh--CCCCCCCCCCccccchhhhccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT--GRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      .....+.......+-..+|||+|.+..++++.++|+|+||+++||+++  ...||....+++..   +-........   
T Consensus       687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv---en~~~~~~~~---  760 (807)
T KOG1094|consen  687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV---ENAGEFFRDQ---  760 (807)
T ss_pred             cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH---HhhhhhcCCC---
Confidence            777766666666778899999999999999999999999999999876  77899755443211   1111111110   


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL  351 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l  351 (363)
                         ........|.-|+..+.+++..||..+-++||+++++...|++.
T Consensus       761 ---~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  761 ---GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ---CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence               11112344678899999999999999999999999999988765

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.6e-45  Score=324.60  Aligned_cols=256  Identities=23%  Similarity=0.370  Sum_probs=207.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC----CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      .+|++.+.||+|+||.||+|.+.    .+..||+|.++..........+.+|+.+++.++||||+++++++......++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46889999999999999999643    36689999988754444456788999999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.+|+|.+++.....        .+++..++.++.|++.||+|||++   +++||||||+||+++.++.++++|||.
T Consensus        85 ~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~  153 (266)
T cd05064          85 TEYMSNGALDSFLRKHEG--------QLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRR  153 (266)
T ss_pred             EEeCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcc
Confidence            999999999999975431        388999999999999999999999   999999999999999999999999998


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      +........ .......++..|+|||.+.+..++.++|||||||++||+++ |..||.........              
T Consensus       154 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~--------------  218 (266)
T cd05064         154 LQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI--------------  218 (266)
T ss_pred             cccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH--------------
Confidence            755322211 11112345678999999999999999999999999999875 99999754322110              


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL  351 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l  351 (363)
                        ..+........+..++..+.+++..||+.+|++||++.+|++.|+.+
T Consensus       219 --~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         219 --KAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             --HHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence              11111111223445677899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1e-45  Score=334.76  Aligned_cols=242  Identities=21%  Similarity=0.306  Sum_probs=198.1

Q ss_pred             CeeeccCCceEEEEEe-CCCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCC
Q 046595           74 ALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMG  150 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g  150 (363)
                      +.||+|+||.||+|+. .+++.||+|++....  .......+..|+.++++++||||+++++++...+..++||||+.++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999975 468999999987532  2223456788999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCcc
Q 046595          151 SLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT  230 (363)
Q Consensus       151 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~  230 (363)
                      +|.+++....         .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~  148 (323)
T cd05571          81 ELFFHLSRER---------VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD  148 (323)
T ss_pred             cHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC
Confidence            9999987644         388999999999999999999999   9999999999999999999999999998653222


Q ss_pred             cccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCc
Q 046595          231 AARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPK  310 (363)
Q Consensus       231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (363)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+               ... 
T Consensus       149 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~---------------~~~-  210 (323)
T cd05571         149 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI---------------LME-  210 (323)
T ss_pred             CC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH---------------HcC-
Confidence            11  123467999999999999999999999999999999999999999643221110000               000 


Q ss_pred             CCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046595          311 LNNDYPPKAIAKLAAVAALCVQYEADFRP-----NMTIVVK  346 (363)
Q Consensus       311 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  346 (363)
                       ...++...+.++.+++.+||+.||++||     ++.++++
T Consensus       211 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         211 -EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             -CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence             1123445567799999999999999999     7999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-46  Score=331.18  Aligned_cols=245  Identities=20%  Similarity=0.281  Sum_probs=202.9

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC--CCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA--PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      +|++.+.||+|+||.||+|... +++.||+|++.....  ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            6889999999999999999765 689999999865321  2234568889999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+|+|.+++....         .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.
T Consensus        82 ~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~  149 (291)
T cd05612          82 YVPGGELFSYLRNSG---------RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAK  149 (291)
T ss_pred             CCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcch
Confidence            999999999997654         288999999999999999999999   99999999999999999999999999987


Q ss_pred             CCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      .....     .....|++.|+|||++.+..++.++|||||||++|+|++|+.||...........+              
T Consensus       150 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i--------------  210 (291)
T cd05612         150 KLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI--------------  210 (291)
T ss_pred             hccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------------
Confidence            55332     22356899999999999889999999999999999999999999754322111100              


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPN-----MTIVVKA  347 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~~vl~~  347 (363)
                       ...  ...++...+..+.+++.+||+.||.+||+     +.++++.
T Consensus       211 -~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         211 -LAG--KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             -HhC--CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence             000  01223344667999999999999999995     8888764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-46  Score=333.32  Aligned_cols=242  Identities=27%  Similarity=0.458  Sum_probs=208.9

Q ss_pred             CCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCCCh
Q 046595           73 KALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSL  152 (363)
Q Consensus        73 ~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g~L  152 (363)
                      ++-||+|+.|.||+|+.+ ++.||||+++...        ..+++.|++|+|+||+.+.|+|...-.++||||||..|-|
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL  199 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence            445999999999999987 6889999986522        3468899999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCcccc
Q 046595          153 HDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA  232 (363)
Q Consensus       153 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~  232 (363)
                      ..+|+...         .++....+.|..+|+.|+.|||.+   .|||||||.-||||..+..|||+|||-++...+...
T Consensus       200 ~~VLka~~---------~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST  267 (904)
T KOG4721|consen  200 YEVLKAGR---------PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST  267 (904)
T ss_pred             HHHHhccC---------ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhh
Confidence            99998765         488999999999999999999999   999999999999999999999999999877666532


Q ss_pred             cccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCC
Q 046595          233 RLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLN  312 (363)
Q Consensus       233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (363)
                         ...+.||..|||||++.+.+.++++|||||||+|||||||..||.+.+..    .+.|           .+-...+.
T Consensus       268 ---kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AIIw-----------GVGsNsL~  329 (904)
T KOG4721|consen  268 ---KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AIIW-----------GVGSNSLH  329 (904)
T ss_pred             ---hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeEE-----------eccCCccc
Confidence               35689999999999999999999999999999999999999999744321    1112           12233455


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccc
Q 046595          313 NDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN  353 (363)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~  353 (363)
                      ...|..|+.-+.-|++.||+..|+.||++.+|+..|.-.-.
T Consensus       330 LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p  370 (904)
T KOG4721|consen  330 LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP  370 (904)
T ss_pred             ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence            66788899999999999999999999999999998875443

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.9e-45  Score=339.19  Aligned_cols=269  Identities=23%  Similarity=0.378  Sum_probs=211.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-CCccceeeeEEEeCCe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVELLGYCMESNN  139 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~  139 (363)
                      .++|.+++.||+|+||.||+|.+.      .+..||||++.........+.+.+|+.+++++. ||||+++++++.+...
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            357889999999999999999753      234699999976544444568899999999996 9999999999999999


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCC-------------------------------------------------------
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQG-------------------------------------------------------  164 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~-------------------------------------------------------  164 (363)
                      .++||||+.+|+|.+++........                                                       
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            9999999999999999865321000                                                       


Q ss_pred             --------------------------------CCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC
Q 046595          165 --------------------------------AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD  212 (363)
Q Consensus       165 --------------------------------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~  212 (363)
                                                      ......+++..++.++.|++.||.|||+.   +|+|+||||+||+++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence                                            00112478889999999999999999999   9999999999999999


Q ss_pred             CCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchh
Q 046595          213 DFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLV  291 (363)
Q Consensus       213 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~  291 (363)
                      ++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||........    
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~----  348 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST----  348 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH----
Confidence            99999999999875543322222233457788999999998899999999999999999997 9999864322110    


Q ss_pred             hhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccc
Q 046595          292 TWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN  353 (363)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~  353 (363)
                                 +...+........+..++..+.+++.+||+.||++||++.+|.+.|+.+++
T Consensus       349 -----------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         349 -----------FYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             -----------HHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence                       000111111122334566789999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.5e-45  Score=334.51  Aligned_cols=245  Identities=23%  Similarity=0.307  Sum_probs=202.2

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      .+|.+.+.||+|+||.||+|++. +++.||+|++....  .......+.+|+.++++++||||+++++++...+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            47899999999999999999865 58899999986532  2233467889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+|+|.+++....         .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        98 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~  165 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG---------RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFA  165 (329)
T ss_pred             cCCCCChHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCc
Confidence            9999999999997653         278899999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      ......     .....||+.|+|||++.+..++.++|||||||++|+|++|..||....+.....               
T Consensus       166 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---------------  225 (329)
T PTZ00263        166 KKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYE---------------  225 (329)
T ss_pred             eEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHH---------------
Confidence            755332     123579999999999999999999999999999999999999996543211100               


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPN-----MTIVVK  346 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~~vl~  346 (363)
                      ......  ..++...+..+.+++.+||+.||.+||+     +++++.
T Consensus       226 ~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        226 KILAGR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             HHhcCC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            001111  1123334567899999999999999997     677774

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=4.8e-45  Score=324.80  Aligned_cols=251  Identities=22%  Similarity=0.293  Sum_probs=201.9

Q ss_pred             CCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCC--CCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           70 FGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSA--PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      |+..+.||+|+||.||++.. .+++.||+|.+.....  ......+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            67788999999999999975 5789999999865332  22234678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+|+|.+++.....       ..+++..++.++.|++.||.|||++   +|+||||||+|||+++++.++|+|||++..
T Consensus        82 ~~~g~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~  151 (285)
T cd05631          82 MNGGDLKFHIYNMGN-------PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQ  151 (285)
T ss_pred             cCCCcHHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEE
Confidence            999999988864321       1388999999999999999999999   999999999999999999999999999865


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      ......   .....||..|+|||++.+..++.++|||||||++|+|++|+.||............            ...
T Consensus       152 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~------------~~~  216 (285)
T cd05631         152 IPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV------------DRR  216 (285)
T ss_pred             cCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH------------HHH
Confidence            432211   23457899999999999999999999999999999999999999754322111100            000


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPN-----MTIVVK  346 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~~vl~  346 (363)
                      + ......++...+..+.+|+.+||+.||++||+     ++++++
T Consensus       217 ~-~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         217 V-KEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             h-hcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            0 01112234455677999999999999999997     788886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.8e-44  Score=311.73  Aligned_cols=254  Identities=22%  Similarity=0.282  Sum_probs=209.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCC-CCeEEEEEccCCCCC--CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAP--EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~avK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      +.|++++.||.|..|+||+|+.++ +..+|+|++.+....  ....+...|.+||..++||.++.+|..++.+...+++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            457788889999999999998764 689999999875432  22356778999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      |||.||+|..+++++..       ..|++..+..++..++-||+|||..   |||+|||||+||||.++|+|.|+||.|+
T Consensus       157 eyCpGGdL~~LrqkQp~-------~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS  226 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPG-------KRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLS  226 (459)
T ss_pred             ecCCCccHHHHHhhCCC-------CccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeecccc
Confidence            99999999999988664       3599999999999999999999999   9999999999999999999999999986


Q ss_pred             CCCCc---------------------------------ccc---------------------cccccccccccCCCCccc
Q 046595          225 NQSSD---------------------------------TAA---------------------RLHSTRVLGTFGYHAPEY  250 (363)
Q Consensus       225 ~~~~~---------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~  250 (363)
                      .....                                 ...                     ......++||-.|+|||+
T Consensus       227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv  306 (459)
T KOG0610|consen  227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV  306 (459)
T ss_pred             ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence            43210                                 000                     012334789999999999


Q ss_pred             cccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhc
Q 046595          251 AMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALC  330 (363)
Q Consensus       251 ~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  330 (363)
                      +.|...+.++|.|+||++||||+.|..||.+.........               ++.+.+.-.-.+..+..+.+||+++
T Consensus       307 I~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~N---------------Iv~~~l~Fp~~~~vs~~akDLIr~L  371 (459)
T KOG0610|consen  307 IRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRN---------------IVGQPLKFPEEPEVSSAAKDLIRKL  371 (459)
T ss_pred             eecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHH---------------HhcCCCcCCCCCcchhHHHHHHHHH
Confidence            9999999999999999999999999999987655433222               2222222221235667799999999


Q ss_pred             cCCCCCCCCC----HHHHHH
Q 046595          331 VQYEADFRPN----MTIVVK  346 (363)
Q Consensus       331 l~~~p~~RPs----~~~vl~  346 (363)
                      |..||.+|..    ++||.+
T Consensus       372 LvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  372 LVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             hccChhhhhccccchHHhhc
Confidence            9999999998    888765

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.6e-45  Score=327.07  Aligned_cols=265  Identities=19%  Similarity=0.322  Sum_probs=203.1

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      ++|.+.+.||.|+||.||+|... ++..||+|++...........+.+|+.+++.++||||+++++++......++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46999999999999999999754 68999999987654444455778999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+ +|.+++.....        .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++..
T Consensus        85 ~~~-~l~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~  152 (288)
T cd07871          85 LDS-DLKQYLDNCGN--------LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARA  152 (288)
T ss_pred             CCc-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceee
Confidence            986 99998865432        278899999999999999999999   999999999999999999999999999865


Q ss_pred             CCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc-------
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL-------  298 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~-------  298 (363)
                      .......  .....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.......       
T Consensus       153 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07871         153 KSVPTKT--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG  230 (288)
T ss_pred             ccCCCcc--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhc
Confidence            4322211  233568999999998875 568999999999999999999999997654332221111000000       


Q ss_pred             --cccccccccCCcCCC----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          299 --SEDKVKQCVDPKLNN----DYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       299 --~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                        ..........+....    ......+.++.+++.+||+.||.+|||++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         231 ITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             cccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence              000111111111000    001123567899999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.9e-45  Score=330.19  Aligned_cols=260  Identities=25%  Similarity=0.428  Sum_probs=207.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCC----eEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGT----PAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      .+|++.+.||+|+||.||+|.+. ++.    .||+|.+...........+..|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            47999999999999999999754 333    38999987644444456788999999999999999999998764 5779


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      +++|+.+|+|.+++.....        .+++..++.++.|++.||+|||++   +|+||||||+||++++++.+||+|||
T Consensus        86 v~e~~~~g~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG  154 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFG  154 (316)
T ss_pred             eeecCCCCCHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccc
Confidence            9999999999999976432        278899999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      +++...............++..|+|||.+.+..++.++||||||+++|||++ |..||........              
T Consensus       155 ~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~--------------  220 (316)
T cd05108         155 LAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--------------  220 (316)
T ss_pred             ccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH--------------
Confidence            9976554332222222335678999999999999999999999999999998 9999975422111              


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccC
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK  355 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~  355 (363)
                        ............+..++..+.+++.+||+.+|.+||++.+|+..|..+.+..
T Consensus       221 --~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         221 --SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             --HHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence              1111111111223344567899999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-46  Score=320.06  Aligned_cols=268  Identities=25%  Similarity=0.336  Sum_probs=217.5

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCC-CCCchHHHHHHHHHHhcCCCCccceeeeEEEe-----CC
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSS-APEPESDFAAQLSVVSRLKHEHFVELLGYCME-----SN  138 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~  138 (363)
                      +...|...+.||.|++|.|..+.. .+|+.||||++.... .....++..+|+++|++++|+||+.+++++..     -.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            445677788999999999999965 479999999997433 23345788999999999999999999998765     35


Q ss_pred             eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEE
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI  218 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl  218 (363)
                      ..|+|+|+|+. +|...++....         ++...+..+.+|++.||+|+|+.   +|+||||||.|++++.++.+||
T Consensus       100 DvYiV~elMet-DL~~iik~~~~---------L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI  166 (359)
T KOG0660|consen  100 DVYLVFELMET-DLHQIIKSQQD---------LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKI  166 (359)
T ss_pred             eeEEehhHHhh-HHHHHHHcCcc---------ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEe
Confidence            67999999955 99999987653         89999999999999999999999   9999999999999999999999


Q ss_pred             eeeccCCCCCcccccccccccccccCCCCccccc-cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccc
Q 046595          219 ADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM-TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR  297 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~  297 (363)
                      ||||+|+...........++.+-|.+|.|||++. ...|+...||||+||++.||++|+.-|.+.+...+..++....+.
T Consensus       167 ~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGt  246 (359)
T KOG0660|consen  167 CDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGT  246 (359)
T ss_pred             ccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCC
Confidence            9999998775432233346678899999999875 468999999999999999999999999988777777776655555


Q ss_pred             ccccccccccCCcC-----------CCC---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          298 LSEDKVKQCVDPKL-----------NND---YPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       298 ~~~~~~~~~~~~~~-----------~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .+.+.+..+.....           ...   ..+.......+|+++||..||.+|+|+++.++
T Consensus       247 P~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  247 PSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             CCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            54443333221110           011   11245677899999999999999999999887

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-46  Score=337.63  Aligned_cols=261  Identities=31%  Similarity=0.471  Sum_probs=217.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC--CC---CeEEEEEccCC--CCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCee
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT--DG---TPAAIKKLDTS--SAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNR  140 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~--~~---~~~avK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  140 (363)
                      ++..+.+.||+|+||.||.|+.+  ++   ..||+|..+..  ...+....+..|+++++.++||||+++||++.....+
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence            34566789999999999999654  22   22899998752  2344567899999999999999999999999999999


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEee
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD  220 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D  220 (363)
                      ++|||+|.||+|.++|++.+.        .++..+.+.++.+.+.||+|||++   +++||||-.+|+|++.++.+||+|
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~~--------~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISD  305 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNKK--------SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISD  305 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCc
Confidence            999999999999999998763        289999999999999999999999   999999999999999999999999


Q ss_pred             eccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccc
Q 046595          221 FNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       221 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      ||+++.......  ......-...|+|||.+..+.|+.++|||||||++||+++ |..||.+....              
T Consensus       306 FGLs~~~~~~~~--~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------------  369 (474)
T KOG0194|consen  306 FGLSRAGSQYVM--KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------------  369 (474)
T ss_pred             cccccCCcceee--ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--------------
Confidence            999876541111  1111234679999999999999999999999999999999 78899754322              


Q ss_pred             cccccccc-CCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCC
Q 046595          300 EDKVKQCV-DPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA  357 (363)
Q Consensus       300 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~  357 (363)
                        .+...+ ....+...+...+.++..++..||..+|++||+|.++.+.|+.+......
T Consensus       370 --~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  370 --EVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             --HHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence              233333 44555666678888999999999999999999999999999988877654

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=9e-45  Score=319.87  Aligned_cols=258  Identities=26%  Similarity=0.424  Sum_probs=209.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCC----CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTD----GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      ++|++.+.||+|+||.||+|.+..    ...|++|.+...........+..|+.+++.++|+||+++++++......+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            468899999999999999997642    4578999987655444556788999999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.+++|.+++.....        .+++..++.++.|++.||.|||++   +|+|+||||+||++++++.++|+|||+
T Consensus        84 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~  152 (266)
T cd05033          84 TEYMENGSLDKFLRENDG--------KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGL  152 (266)
T ss_pred             EEcCCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccch
Confidence            999999999999975432        388999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      +................++..|+|||.+.+..++.++||||||+++|+|++ |..||........               
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~---------------  217 (266)
T cd05033         153 SRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV---------------  217 (266)
T ss_pred             hhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH---------------
Confidence            987652222211222345678999999998899999999999999999998 9999864322111               


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccc
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL  352 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~  352 (363)
                       ...+........+..++..+.+++.+||+.+|++||++.+|++.|++++
T Consensus       218 -~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~  266 (266)
T cd05033         218 -IKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI  266 (266)
T ss_pred             -HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence             1111111111223345667999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.1e-44  Score=329.24  Aligned_cols=265  Identities=22%  Similarity=0.317  Sum_probs=205.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      ++|++.+.||+|+||.||+++.. ++..+|+|.+...........+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            58999999999999999999765 68889999987644333456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +++++|.+++....         .+++..+..++.|++.||.|||+..  +|+||||||+||+++.++.+||+|||++..
T Consensus        85 ~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  153 (331)
T cd06649          85 MDGGSLDQVLKEAK---------RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  153 (331)
T ss_pred             CCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccc
Confidence            99999999997643         2889999999999999999999852  599999999999999999999999999865


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhh------------c
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTW------------A  294 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~------------~  294 (363)
                      .....    .....|+..|+|||++.+..++.++|||||||++|||++|+.||..............            .
T Consensus       154 ~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (331)
T cd06649         154 LIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSI  229 (331)
T ss_pred             ccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCcccc
Confidence            53321    2345789999999999988999999999999999999999999965432111000000            0


Q ss_pred             cccc------------------ccccccccc-CCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          295 TPRL------------------SEDKVKQCV-DPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       295 ~~~~------------------~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                      .+..                  ........+ ............+.++.+|+.+||+.||++|||+.+|++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         230 SPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             CcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0000                  000000000 0000000112356679999999999999999999999874

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=5.1e-45  Score=323.80  Aligned_cols=264  Identities=26%  Similarity=0.430  Sum_probs=210.1

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRI  141 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  141 (363)
                      ++|.+.+.||+|+||.||+|...      ++..|++|.+......+....+.+|+++++.++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            46888899999999999999753      347899999876544444578999999999999999999999999999999


Q ss_pred             EEEecccCCChhhhhcCCCCCCC-----CCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCce
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQG-----AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS  216 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~-----~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v  216 (363)
                      ++|||+.+++|.+++........     ......+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence            99999999999999976432110     11223488999999999999999999999   99999999999999999999


Q ss_pred             EEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcc
Q 046595          217 KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       217 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      +|+|||++................++..|+|||++.+..++.++||||||+++|||++ |..||........   ..   
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~---  235 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IE---  235 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HH---
Confidence            9999999865433222112233456788999999999999999999999999999998 9999865432211   11   


Q ss_pred             ccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 046595          296 PRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQP  350 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~  350 (363)
                                ..........+...+..+.+++.+||+.||++||++.+|++.|++
T Consensus       236 ----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         236 ----------CITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             ----------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence                      011111122233456779999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-45  Score=331.49  Aligned_cols=254  Identities=20%  Similarity=0.282  Sum_probs=205.5

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC--CCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA--PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|++.+.||+|+||.||+|++. +++.||+|++.....  ......+..|+.++..++||||+++++++......++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36899999999999999999865 588999999875321  223456888999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+++|.+++....         .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        81 e~~~g~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a  148 (333)
T cd05600          81 EYVPGGDFRTLLNNLG---------VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLS  148 (333)
T ss_pred             eCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCC
Confidence            9999999999997543         288999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      .....     ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+...         .
T Consensus       149 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---------~  214 (333)
T cd05600         149 KGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW---------K  214 (333)
T ss_pred             ccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc---------c
Confidence            75543     234467999999999999999999999999999999999999999755432211111000         0


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                      ...............+.++.+++.+||..+|++||++.++++.
T Consensus       215 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         215 ETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0000000000012446679999999999999999999999964

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.6e-44  Score=321.17  Aligned_cols=271  Identities=24%  Similarity=0.383  Sum_probs=209.1

Q ss_pred             cCC-CCCCeeeccCCceEEEEEe-----CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeC--Ce
Q 046595           68 SNF-GTKALIGEGSYGRVFYAKL-----TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMES--NN  139 (363)
Q Consensus        68 ~~y-~~~~~lg~G~~g~V~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~  139 (363)
                      ++| .+.+.||+|+||.||++..     .++..||+|.+...........+.+|+.+++.++||||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            345 8889999999999988642     357889999987654333456788999999999999999999987654  35


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEe
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA  219 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~  219 (363)
                      .+++|||+.+++|.+++....          +++.+++.++.|++.||.|||++   +|+|+||||+||+++.++.++|+
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~~----------l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~  149 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKHK----------LNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIG  149 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHcC----------CCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEe
Confidence            789999999999999997543          89999999999999999999999   99999999999999999999999


Q ss_pred             eeccCCCCCccccccc-ccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 046595          220 DFNLTNQSSDTAARLH-STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL  298 (363)
Q Consensus       220 Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  298 (363)
                      |||++........... .....++..|+|||.+.+..++.++||||||+++|||++|..||....... ...........
T Consensus       150 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~  228 (283)
T cd05080         150 DFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQM  228 (283)
T ss_pred             ecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhccccccc
Confidence            9999876543222111 112345667999999988899999999999999999999999986543211 11111111111


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccc
Q 046595          299 SEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL  352 (363)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~  352 (363)
                      ....+....+.......+..++..+.+++..||+.+|++|||+++|++.|+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         229 TVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             chhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            111222222222223334456678999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.3e-45  Score=323.67  Aligned_cols=265  Identities=21%  Similarity=0.264  Sum_probs=202.6

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      +|++.+.||+|+||.||+|++. +++.||+|++...... .....+.+|+.+++.++|+||+++++++...+..++||||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY   81 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence            6899999999999999999875 5888999998764332 2346788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.++.|..+.....         .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        82 ~~~~~l~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  149 (287)
T cd07848          82 VEKNMLELLEEMPN---------GVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARN  149 (287)
T ss_pred             CCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccc
Confidence            99876655543221         288999999999999999999999   999999999999999999999999999876


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccc-----
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED-----  301 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----  301 (363)
                      ....... ......|++.|+|||++.+..++.++|||||||++|||++|+.||......+...............     
T Consensus       150 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (287)
T cd07848         150 LSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLF  228 (287)
T ss_pred             ccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhh
Confidence            5432221 1234568999999999998899999999999999999999999997643322111111100000000     


Q ss_pred             ----ccccccCCcC------CCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          302 ----KVKQCVDPKL------NNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       302 ----~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                          .......+..      ...+....+..+.+++.+||+.||++|||++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         229 YSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                0000000000      01111235667999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.3e-44  Score=322.89  Aligned_cols=267  Identities=25%  Similarity=0.436  Sum_probs=210.5

Q ss_pred             CCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      +|++.+.||+|+||.||+|...      ....+++|.+...........+.+|+.+++.++||||+++++.+......++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4788899999999999999643      2356888888754433344678899999999999999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCC---------------CCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCc
Q 046595          143 VYQFATMGSLHDVLHGRKGVQ---------------GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSN  207 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~---------------~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~N  207 (363)
                      ++||+.+++|.+++.......               .......+++..++.++.|++.||.|||++   +++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence            999999999999987543211               011123488999999999999999999999   99999999999


Q ss_pred             eeecCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCcc
Q 046595          208 VLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKG  286 (363)
Q Consensus       208 ill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~  286 (363)
                      |++++++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||....+..
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999875543322211223346778999999988889999999999999999998 999996543221


Q ss_pred             ccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          287 QQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                         ..             ...........+..++..+.+++.+||+.+|++||++.++++.|++++.+
T Consensus       238 ---~~-------------~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         238 ---LF-------------NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             ---HH-------------HHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence               11             11111122222344556799999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.1e-44  Score=328.63  Aligned_cols=243  Identities=22%  Similarity=0.305  Sum_probs=198.4

Q ss_pred             CeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCC
Q 046595           74 ALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMG  150 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g  150 (363)
                      +.||+|+||.||+++.. +++.||+|++....  .......+.+|+.+++.++||||+++++++...+..++||||+.+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999754 68999999987542  2233467788999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCcc
Q 046595          151 SLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT  230 (363)
Q Consensus       151 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~  230 (363)
                      +|..++....         .+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus        81 ~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~  148 (328)
T cd05593          81 ELFFHLSRER---------VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD  148 (328)
T ss_pred             CHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc
Confidence            9999886543         288999999999999999999999   9999999999999999999999999998653322


Q ss_pred             cccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCc
Q 046595          231 AARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPK  310 (363)
Q Consensus       231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (363)
                      ..  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........               ...  
T Consensus       149 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~---------------~~~--  209 (328)
T cd05593         149 AA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL---------------ILM--  209 (328)
T ss_pred             cc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH---------------hcc--
Confidence            11  12345799999999999988999999999999999999999999965422111100               000  


Q ss_pred             CCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 046595          311 LNNDYPPKAIAKLAAVAALCVQYEADFRP-----NMTIVVKA  347 (363)
Q Consensus       311 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~~  347 (363)
                      ....++...+.++.+++.+||+.||++|+     ++.++++.
T Consensus       210 ~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         210 EDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            01123344566799999999999999997     89998863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-45  Score=328.09  Aligned_cols=240  Identities=20%  Similarity=0.250  Sum_probs=194.8

Q ss_pred             eeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCCCh
Q 046595           76 IGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSL  152 (363)
Q Consensus        76 lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g~L  152 (363)
                      ||+|+||.||+|+.. +++.||+|++....  .......+..|+.+++.++||||+++++++......++||||+.+|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999765 58899999986532  223345678899999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCcccc
Q 046595          153 HDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA  232 (363)
Q Consensus       153 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~  232 (363)
                      .+++....         .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++........
T Consensus        81 ~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~  148 (312)
T cd05585          81 FHHLQREG---------RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD  148 (312)
T ss_pred             HHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC
Confidence            99997543         288999999999999999999999   999999999999999999999999999875432221


Q ss_pred             cccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCC
Q 046595          233 RLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLN  312 (363)
Q Consensus       233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (363)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ..            ......  .
T Consensus       149 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~---~~------------~~~~~~--~  209 (312)
T cd05585         149 --KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE---MY------------RKILQE--P  209 (312)
T ss_pred             --ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH---HH------------HHHHcC--C
Confidence              1234579999999999999999999999999999999999999997432211   00            001110  1


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 046595          313 NDYPPKAIAKLAAVAALCVQYEADFRPN---MTIVVK  346 (363)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~~p~~RPs---~~~vl~  346 (363)
                      ..++...+..+.+++.+||+.||.+||+   +.+++.
T Consensus       210 ~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         210 LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            1234455677999999999999999985   555554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=9.9e-45  Score=329.86  Aligned_cols=269  Identities=22%  Similarity=0.393  Sum_probs=208.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeC-Ce
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMES-NN  139 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~~  139 (363)
                      ++|++.+.||+|+||.||+|...      +++.||+|++...........+..|+.++.++ +|+||+++++++... ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            47999999999999999999532      35789999987644333445678899999999 899999999988654 56


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCC----------------------------------------------------CCC
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQG----------------------------------------------------AEP  167 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~----------------------------------------------------~~~  167 (363)
                      .+++|||+.+++|.+++........                                                    ...
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            7899999999999999864321100                                                    000


Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCcccccccccccccccCCCC
Q 046595          168 GPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA  247 (363)
Q Consensus       168 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  247 (363)
                      ...+++..+..++.|++.||.|||++   +|+||||||+||++++++.++|+|||++................++..|+|
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence            12588999999999999999999999   999999999999999999999999999876543322222233456778999


Q ss_pred             ccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHH
Q 046595          248 PEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAV  326 (363)
Q Consensus       248 PE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  326 (363)
                      ||++.+..++.++|||||||++|||++ |..||......+.  +.             ..+........+...+.++.++
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~-------------~~~~~~~~~~~~~~~~~~~~~l  308 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FC-------------RRLKEGTRMRAPEYATPEIYSI  308 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HH-------------HHHhccCCCCCCccCCHHHHHH
Confidence            999999999999999999999999998 9999965322110  00             0011111112233445679999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          327 AALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       327 i~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                      +.+||+.+|++||++.+|++.|+.+++.
T Consensus       309 ~~~cl~~~p~~RPs~~ell~~l~~~~~~  336 (337)
T cd05054         309 MLDCWHNNPEDRPTFSELVEILGDLLQE  336 (337)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            9999999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=8.2e-45  Score=328.83  Aligned_cols=242  Identities=23%  Similarity=0.321  Sum_probs=197.2

Q ss_pred             CeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCC
Q 046595           74 ALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMG  150 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g  150 (363)
                      +.||+|+||.||+++.. +|..||+|++....  .......+.+|+.+++.++||||+++++++...+..++||||+.+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999754 68999999987532  2223456778999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCcc
Q 046595          151 SLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT  230 (363)
Q Consensus       151 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~  230 (363)
                      +|..++....         .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus        81 ~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  148 (323)
T cd05595          81 ELFFHLSRER---------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  148 (323)
T ss_pred             cHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCC
Confidence            9999887543         288999999999999999999999   9999999999999999999999999998653222


Q ss_pred             cccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCc
Q 046595          231 AARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPK  310 (363)
Q Consensus       231 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (363)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||............               ....
T Consensus       149 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~---------------~~~~  211 (323)
T cd05595         149 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI---------------LMEE  211 (323)
T ss_pred             CC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH---------------hcCC
Confidence            11  123457999999999999999999999999999999999999999754322111100               0000


Q ss_pred             CCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046595          311 LNNDYPPKAIAKLAAVAALCVQYEADFRP-----NMTIVVK  346 (363)
Q Consensus       311 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  346 (363)
                        ..++...+..+.+++.+||+.||++||     ++.++++
T Consensus       212 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         212 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             --CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence              122344566799999999999999998     8888876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6.6e-45  Score=331.12  Aligned_cols=246  Identities=22%  Similarity=0.277  Sum_probs=202.2

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCC--CCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTD--GTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      ++|.+.+.||+|+||.||+|.+.+  +..||+|++....  .......+.+|+.+++.++||||+++++++.+....++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            469999999999999999997543  3689999886432  223346788999999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.+|+|.+++....         .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       110 ~Ey~~~g~L~~~i~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~  177 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRNK---------RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGF  177 (340)
T ss_pred             EeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCC
Confidence            99999999999997654         288999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      +......     .....||+.|+|||++.+..++.++|||||||++|||++|..||....+......             
T Consensus       178 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~-------------  239 (340)
T PTZ00426        178 AKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK-------------  239 (340)
T ss_pred             CeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH-------------
Confidence            8754322     2345799999999999988899999999999999999999999975433211110             


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP-----NMTIVVKA  347 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~~  347 (363)
                        .....  ..++...+..+.+++.+||+.||.+|+     +++++++.
T Consensus       240 --i~~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        240 --ILEGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             --HhcCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence              00000  122334456689999999999999995     89988764

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.9e-44  Score=315.24  Aligned_cols=249  Identities=25%  Similarity=0.458  Sum_probs=199.8

Q ss_pred             CeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCCCh
Q 046595           74 ALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSL  152 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g~L  152 (363)
                      +.||+|+||.||+|... +++.+++|.+......+....+.+|+++++.++|+||+++++++......++||||+.+++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            35999999999999764 68899999886544334456789999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCcccc
Q 046595          153 HDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA  232 (363)
Q Consensus       153 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~  232 (363)
                      .+++....        ..+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~~~--------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  149 (252)
T cd05084          81 LTFLRTEG--------PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY  149 (252)
T ss_pred             HHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccc
Confidence            99986432        1378999999999999999999999   999999999999999999999999999865433211


Q ss_pred             cccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccccccCCcC
Q 046595          233 RLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKL  311 (363)
Q Consensus       233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (363)
                      ........++..|+|||.+.+..++.++||||||+++|||++ |..||........                ...+....
T Consensus       150 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~----------------~~~~~~~~  213 (252)
T cd05084         150 ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT----------------REAIEQGV  213 (252)
T ss_pred             cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH----------------HHHHHcCC
Confidence            111111223457999999998899999999999999999998 8888864322111                11111112


Q ss_pred             CCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 046595          312 NNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ  349 (363)
Q Consensus       312 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~  349 (363)
                      ....+..++..+.+++.+||+.+|++|||+.+|++.|+
T Consensus       214 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         214 RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            22334455678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-45  Score=298.80  Aligned_cols=249  Identities=23%  Similarity=0.334  Sum_probs=210.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCC--CCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSA--PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|++++.||+|.||.||+|+. +++-.||+|++.+...  ......+.+|+++-..|+||||+++|+++.+....|+++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            4799999999999999999975 4688899999976542  222357889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||...|+|...|......       .+++.....+..|++.||.|+|.+   +|+||||||+|+|++..+.+||+|||.+
T Consensus       102 Eya~~gel~k~L~~~~~~-------~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGws  171 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEGRMK-------RFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWS  171 (281)
T ss_pred             EecCCchHHHHHHhcccc-------cccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCce
Confidence            999999999999865432       388999999999999999999999   9999999999999999999999999987


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      .....    ......+||..|.+||+..+..++..+|+|++|++.||++.|..||...........+             
T Consensus       172 V~~p~----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI-------------  234 (281)
T KOG0580|consen  172 VHAPS----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRI-------------  234 (281)
T ss_pred             eecCC----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHH-------------
Confidence            54331    1235578999999999999999999999999999999999999999865432222111             


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                        .  .....+|...+....++|..|+..+|.+|.+..++++.
T Consensus       235 --~--k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  235 --R--KVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             --H--HccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence              1  11234456677789999999999999999999999863

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.5e-44  Score=327.41  Aligned_cols=245  Identities=24%  Similarity=0.347  Sum_probs=196.8

Q ss_pred             CCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHH---hcCCCCccceeeeEEEeCCeeEEE
Q 046595           70 FGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVV---SRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      |++.+.||+|+||.||+|.+. +++.||||++....  .......+..|+.++   +.++||||+++++++......++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            677889999999999999754 68999999987532  122345666676554   566899999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.+++|..++....          +++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        81 ~E~~~~~~L~~~~~~~~----------l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~  147 (324)
T cd05589          81 MEYAAGGDLMMHIHTDV----------FSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGL  147 (324)
T ss_pred             EcCCCCCcHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccC
Confidence            99999999998886532          89999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      +........  ......|++.|+|||.+.+..++.++|||||||++|||++|+.||...........             
T Consensus       148 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~-------------  212 (324)
T cd05589         148 CKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS-------------  212 (324)
T ss_pred             CccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH-------------
Confidence            864332211  12346799999999999999999999999999999999999999975432211110             


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP-----NMTIVVK  346 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  346 (363)
                        ....  ...++...+..+.+++.+||+.||.+||     ++.++++
T Consensus       213 --i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         213 --IVND--EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             --HHhC--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence              0000  0123344567789999999999999999     5777766

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.3e-44  Score=316.34  Aligned_cols=255  Identities=24%  Similarity=0.380  Sum_probs=207.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      ++|++.+.||+|+||.||+|...++..|++|.+...  ....+.+.+|+.+++.++|+||+++++.+...+..+++|||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG--TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC--chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            478899999999999999998878888999987653  223568899999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      .+++|.+++.....       ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++...
T Consensus        84 ~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  153 (261)
T cd05072          84 AKGSLLDFLKSDEG-------GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVI  153 (261)
T ss_pred             CCCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceec
Confidence            99999999975321       1378899999999999999999999   9999999999999999999999999998765


Q ss_pred             CcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      ....... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||..........   ..            
T Consensus       154 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~---~~------------  217 (261)
T cd05072         154 EDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMS---AL------------  217 (261)
T ss_pred             CCCceec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHH---HH------------
Confidence            4332211 122345678999999988889999999999999999998 999996543221111   00            


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL  351 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l  351 (363)
                       ...........++..+.+++.+||+.+|++||++++|++.|+++
T Consensus       218 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         218 -QRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             -HcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence             00111111223456799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.3e-44  Score=314.48  Aligned_cols=252  Identities=25%  Similarity=0.395  Sum_probs=203.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      ++|++.+.||+|+||.||++++.++..+++|.+...  ......+..|+.++++++||||+++++++......+++|||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG--AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC--CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            357888999999999999999888888999987643  233567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      .+|+|.+++.....        .+++..++.++.|++.||.|||++   +++|+||||+||++++++.+||+|||++...
T Consensus        82 ~~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~  150 (256)
T cd05114          82 ENGCLLNYLRQRQG--------KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYV  150 (256)
T ss_pred             CCCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCcccc
Confidence            99999999875431        278999999999999999999999   9999999999999999999999999998765


Q ss_pred             CcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      ...... ......++..|+|||.+.+..++.++|+||||+++|||++ |+.||..........   ....          
T Consensus       151 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~---~i~~----------  216 (256)
T cd05114         151 LDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVE---MISR----------  216 (256)
T ss_pred             CCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH---HHHC----------
Confidence            432221 1122345668999999988889999999999999999999 899996543211111   1000          


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ  349 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~  349 (363)
                         ......+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       217 ---~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         217 ---GFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ---CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence               0001112223457999999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3e-44  Score=318.71  Aligned_cols=261  Identities=24%  Similarity=0.408  Sum_probs=204.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCC----eEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGT----PAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      .+|++.+.||+|+||.||+|.+. +++    .+++|.+...........+..|+.++.+++||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            46888899999999999999764 344    477787754333233456778888999999999999999875 456789


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ++||+.+|+|.+++.....        .+++..++.++.|++.||.|||++   +++|+||||+||++++++.+||+|||
T Consensus        86 i~e~~~~gsL~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg  154 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRD--------SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFG  154 (279)
T ss_pred             EEEeCCCCcHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCc
Confidence            9999999999999975432        388999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      +++...............++..|+|||.+.+..++.++||||||+++|||++ |..||....+......           
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-----------  223 (279)
T cd05111         155 VADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL-----------  223 (279)
T ss_pred             cceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-----------
Confidence            9876543322222334557788999999998899999999999999999998 9999975432211111           


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCC
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP  356 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~  356 (363)
                           +........+..++..+..++.+||..||.+|||+.++++.|..+.++.+
T Consensus       224 -----~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~  273 (279)
T cd05111         224 -----LEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPP  273 (279)
T ss_pred             -----HHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCc
Confidence                 11111111122234568889999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.7e-44  Score=320.02  Aligned_cols=266  Identities=24%  Similarity=0.388  Sum_probs=206.7

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCe
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNN  139 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  139 (363)
                      ..++|++.+.||+|+||.||.|.+.      ++..||+|++...........+.+|+.+++.++|+||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3467999999999999999998643      3567999988653333334568899999999999999999999999999


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCC-CCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEE
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGA-EPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI  218 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl  218 (363)
                      .++||||+.+++|.+++......... .....+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence            99999999999999999754321111 1122467889999999999999999999   9999999999999999999999


Q ss_pred             eeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccc
Q 046595          219 ADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPR  297 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~  297 (363)
                      +|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||............      
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~------  234 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV------  234 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH------
Confidence            99999875543322222222345788999999998899999999999999999999 78888654321111000      


Q ss_pred             ccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 046595          298 LSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQP  350 (363)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~  350 (363)
                               .. ......+..++..+.+++.+||+.||++|||+.++++.|+.
T Consensus       235 ---------~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         235 ---------ME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             ---------Hc-CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence                     00 00111233455679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.7e-44  Score=322.83  Aligned_cols=265  Identities=19%  Similarity=0.290  Sum_probs=199.5

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      .+|.+.+.||+|+||.||+|+.. +++.||+|++...........+.+|+.+++.++||||+++++++.+....++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            57999999999999999999865 68899999987654444445678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+ +|.+++.....        .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++..
T Consensus        85 ~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  152 (303)
T cd07869          85 VHT-DLCQYMDKHPG--------GLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARA  152 (303)
T ss_pred             CCc-CHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCccee
Confidence            964 88888765421        278899999999999999999999   999999999999999999999999999864


Q ss_pred             CCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCcccc-chhhhccccccccc--
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ-SLVTWATPRLSEDK--  302 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~--  302 (363)
                      ......  ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||....+.... ..............  
T Consensus       153 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (303)
T cd07869         153 KSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWP  230 (303)
T ss_pred             ccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhcc
Confidence            332211  1234568999999998875 45889999999999999999999999754321110 00000000000000  


Q ss_pred             ----cccccCCcCCCCCCH---------HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          303 ----VKQCVDPKLNNDYPP---------KAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       303 ----~~~~~~~~~~~~~~~---------~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                          .............+.         ..+..+.+++.+||+.||++|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                000000000000000         12346889999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.3e-44  Score=319.20  Aligned_cols=264  Identities=23%  Similarity=0.373  Sum_probs=207.1

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-----CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-----TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      .+|++.+.||+|+||.||+|.+     .++..+++|.+...........+.+|+.+++.++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            3678889999999999999974     24678999998764433334678899999999999999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCC--------CCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC
Q 046595          143 VYQFATMGSLHDVLHGRKGVQ--------GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF  214 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~--------~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~  214 (363)
                      +|||+.+++|.+++.......        .......+++..++.++.|++.||.|||++   +++|+||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence            999999999999986432110        011123478999999999999999999999   999999999999999999


Q ss_pred             ceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhh
Q 046595          215 KSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTW  293 (363)
Q Consensus       215 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~  293 (363)
                      .+||+|||++................++..|+|||++.+..++.++||||||+++|||++ |..||....+....     
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~-----  236 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI-----  236 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-----
Confidence            999999999876543322222233456778999999988889999999999999999998 88998643321111     


Q ss_pred             ccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 046595          294 ATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQP  350 (363)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~  350 (363)
                                 +.+........+..++..+.+++.+||+.||.+||++.+|++.|..
T Consensus       237 -----------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         237 -----------EMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             -----------HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                       1111111112233456679999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.5e-44  Score=325.80  Aligned_cols=242  Identities=22%  Similarity=0.339  Sum_probs=196.4

Q ss_pred             CeeeccCCceEEEEEe----CCCCeEEEEEccCCC---CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           74 ALIGEGSYGRVFYAKL----TDGTPAAIKKLDTSS---APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~----~~~~~~avK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      +.||+|+||.||+++.    .+++.||+|++....   .......+..|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999974    357889999987532   122335677899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|.+++....         .+.+..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  149 (323)
T cd05584          82 LSGGELFMHLEREG---------IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKE  149 (323)
T ss_pred             CCCchHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence            99999999997544         278889999999999999999999   999999999999999999999999999864


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      ......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........               ..
T Consensus       150 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~---------------~~  212 (323)
T cd05584         150 SIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID---------------KI  212 (323)
T ss_pred             cccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHH---------------HH
Confidence            332221  1234579999999999998889999999999999999999999997543211100               01


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP-----NMTIVVK  346 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  346 (363)
                      ...  ...++...+..+.+++.+||+.||++||     ++.++++
T Consensus       213 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         213 LKG--KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             HcC--CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            111  1122334556799999999999999999     7888876

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.9e-44  Score=316.78  Aligned_cols=255  Identities=25%  Similarity=0.442  Sum_probs=210.5

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      .+|++.+.||.|+||.||+|...++..+++|.+.... ......+..|+.+++.++|+||+++++++......++||||+
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            4688999999999999999998889999999987632 223567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      .+++|.+++.....       ..+++..+..++.|++.||.|||++   +++|+||||+||++++++.+||+|||++...
T Consensus        85 ~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~  154 (261)
T cd05148          85 EKGSLLAFLRSPEG-------QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLI  154 (261)
T ss_pred             ccCCHHHHHhcCCC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhc
Confidence            99999999976432       1388999999999999999999999   9999999999999999999999999998765


Q ss_pred             CcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      ......  .....++..|+|||.+.+..++.++||||||+++|+|++ |..||..........                .
T Consensus       155 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~----------------~  216 (261)
T cd05148         155 KEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYD----------------Q  216 (261)
T ss_pred             CCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHH----------------H
Confidence            433222  123346778999999988899999999999999999998 899996543211111                1


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL  351 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l  351 (363)
                      .........+..++..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         217 ITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             HHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            111122233445667899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.6e-44  Score=321.40  Aligned_cols=267  Identities=28%  Similarity=0.438  Sum_probs=210.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNN  139 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~  139 (363)
                      .++|++.+.||+|+||.||++...      +...+++|.+...........+.+|+.+++++ +|+||+++++++.....
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   90 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP   90 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence            357889999999999999999753      23678999987644434446788999999999 79999999999999999


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCC-------CCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQG-------AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD  212 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~  212 (363)
                      .+++|||+.+|+|.+++........       ......+++..++.++.|++.||.|||++   +|+|+||||+||++++
T Consensus        91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~  167 (293)
T cd05053          91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE  167 (293)
T ss_pred             eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence            9999999999999999975421110       01233589999999999999999999999   9999999999999999


Q ss_pred             CCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchh
Q 046595          213 DFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLV  291 (363)
Q Consensus       213 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~  291 (363)
                      ++.+||+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||........    
T Consensus       168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~----  243 (293)
T cd05053         168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL----  243 (293)
T ss_pred             CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH----
Confidence            99999999999876544322211222345678999999988899999999999999999998 8899864322111    


Q ss_pred             hhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccc
Q 046595          292 TWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL  352 (363)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~  352 (363)
                                  ............+..++..+.+++.+||+.||++|||+.+|++.|++++
T Consensus       244 ------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         244 ------------FKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             ------------HHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                        1111111112233445667999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-44  Score=314.50  Aligned_cols=256  Identities=27%  Similarity=0.431  Sum_probs=207.7

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      .++|++.+.||+|++|.||+|...+++.|++|.+....  .....+.+|+.++++++|+||+++++++...+..+++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            35789999999999999999987777889999986532  2356788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|.+++.....       ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus        83 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~  152 (261)
T cd05068          83 MKYGSLLEYLQGGAG-------RALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARV  152 (261)
T ss_pred             ccCCcHHHHHhccCC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEE
Confidence            999999999976431       2388999999999999999999999   999999999999999999999999999876


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      ....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.........                .
T Consensus       153 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~----------------~  215 (261)
T cd05068         153 IKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL----------------Q  215 (261)
T ss_pred             ccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH----------------H
Confidence            5432211 1111223457999999988899999999999999999999 99999654221110                0


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL  351 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l  351 (363)
                      .+........+...+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         216 QVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             HHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            1111111122334567799999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6.8e-44  Score=324.08  Aligned_cols=265  Identities=23%  Similarity=0.306  Sum_probs=204.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      .++|++.+.||+|+||.||++.+. ++..+++|.+...........+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            358999999999999999999765 6888999988764443444678999999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+++|.+++....         .+++..+..++.|++.||.|||+..  +|+|+||||+|||++.++.+||+|||++.
T Consensus        84 ~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~  152 (333)
T cd06650          84 HMDGGSLDQVLKKAG---------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSG  152 (333)
T ss_pred             cCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcch
Confidence            999999999997543         2788999999999999999999742  69999999999999999999999999986


Q ss_pred             CCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhh------hcccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT------WATPRLS  299 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~------~~~~~~~  299 (363)
                      ......    .....|+..|+|||++.+..++.++|||||||++|+|++|+.||.............      +......
T Consensus       153 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (333)
T cd06650         153 QLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETS  228 (333)
T ss_pred             hhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccC
Confidence            543321    234578999999999998899999999999999999999999997543221110000      0000000


Q ss_pred             ----------------------ccccccccCCcCCCCCC-HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          300 ----------------------EDKVKQCVDPKLNNDYP-PKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       300 ----------------------~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                                            ...+...+........+ ...+.++.+|+.+||+.||++|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         229 PRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             cccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                                  00000000000000000 123567899999999999999999999976

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.6e-44  Score=320.05  Aligned_cols=265  Identities=22%  Similarity=0.340  Sum_probs=197.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC--CCCeEEEEEccCCCCCC-chHHHHHHHHHHhcC---CCCccceeeeEEE-----e
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT--DGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRL---KHEHFVELLGYCM-----E  136 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~  136 (363)
                      ++|++.+.||+|+||.||+|+..  ++..||+|.+....... ....+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            37999999999999999999763  46789999987644332 234566777777665   6999999999885     2


Q ss_pred             CCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCce
Q 046595          137 SNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS  216 (363)
Q Consensus       137 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v  216 (363)
                      ....++||||+.+ +|.+++.....       ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+
T Consensus        81 ~~~~~lv~e~~~~-~l~~~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~  149 (290)
T cd07862          81 ETKLTLVFEHVDQ-DLTTYLDKVPE-------PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQI  149 (290)
T ss_pred             CCcEEEEEccCCC-CHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCE
Confidence            4568899999975 99999875432       1388999999999999999999999   99999999999999999999


Q ss_pred             EEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccc
Q 046595          217 KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATP  296 (363)
Q Consensus       217 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~  296 (363)
                      ||+|||++......   .......|++.|+|||++.+..++.++|||||||++|||++|..||......+....+.....
T Consensus       150 kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~  226 (290)
T cd07862         150 KLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG  226 (290)
T ss_pred             EEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC
Confidence            99999998654332   123345789999999999888999999999999999999999999986544322111110000


Q ss_pred             ccccccc-------ccccCCcCC---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          297 RLSEDKV-------KQCVDPKLN---NDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       297 ~~~~~~~-------~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .......       ...+.....   ....+..+..+.+++.+||+.||++|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            0000000       000000000   0111234567899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.6e-44  Score=317.73  Aligned_cols=268  Identities=22%  Similarity=0.381  Sum_probs=213.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCC-----CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEe-CCee
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTD-----GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCME-SNNR  140 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~  140 (363)
                      .++|.+.+.||+|+||.||+|.+.+     +..|++|.+...........+.+|+.+++.++|+||+++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            3578999999999999999998654     688999988754444445778899999999999999999998776 4678


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEee
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD  220 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D  220 (363)
                      +++++|+.+++|.+++........ .....+++..++.++.|++.||.|||++   +++|+||||+||++++++.+||+|
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEA-NNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhcccccc-ccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence            899999999999999976532211 1123489999999999999999999999   999999999999999999999999


Q ss_pred             eccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccc
Q 046595          221 FNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       221 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      ||+++...............++..|+|||.+.+..++.++||||||+++||+++ |+.||....+..   ...+      
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~------  231 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAY------  231 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHH------
Confidence            999876544332222233456778999999988889999999999999999999 999997543221   1111      


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                             +........+..++..+.+++.+||+.+|++|||+.++++.|+.+..+
T Consensus       232 -------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         232 -------LKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             -------HHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence                   111111122234566799999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.2e-45  Score=322.37  Aligned_cols=251  Identities=30%  Similarity=0.522  Sum_probs=196.0

Q ss_pred             CCCeeeccCCceEEEEEeC-----CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           72 TKALIGEGSYGRVFYAKLT-----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        72 ~~~~lg~G~~g~V~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      +.+.||.|.||.||+|.+.     .+..|+||.+...........+.+|++.+++++||||+++++++......++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4568999999999999765     36679999996643333467899999999999999999999999988889999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+|+|.+++.....       ..+++..++.|+.|++.||.|||++   +++|+||+++||+++.++.+||+|||++..
T Consensus        83 ~~~g~L~~~L~~~~~-------~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~  152 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNK-------EPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRP  152 (259)
T ss_dssp             -TTEBHHHHHHHTCT-------TTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEE
T ss_pred             ccccccccccccccc-------ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence            999999999987621       1389999999999999999999999   999999999999999999999999999876


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      ..............+...|+|||.+.+..++.++||||||+++|||++ |+.||.......                +..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~----------------~~~  216 (259)
T PF07714_consen  153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE----------------IIE  216 (259)
T ss_dssp             TTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH----------------HHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----------------ccc
Confidence            532222222333457789999999999999999999999999999999 678886542211                111


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKAL  348 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l  348 (363)
                      .+........+..++..+.+++..||+.||++||++.+|++.|
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  217 KLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            1111112223445667799999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.2e-44  Score=322.99  Aligned_cols=270  Identities=27%  Similarity=0.422  Sum_probs=211.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC--------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCC
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT--------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESN  138 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~  138 (363)
                      .+|.+.+.||+|+||.||++++.        +...+|+|.+...........+..|+.+++.+ +|+||+++++++....
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            47999999999999999999642        23469999987644344456788899999999 7999999999999999


Q ss_pred             eeEEEEecccCCChhhhhcCCCCCC-------CCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQ-------GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF  211 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~  211 (363)
                      ..++||||+.+++|.+++.......       .......+++.+++.++.|++.||.|||++   +++|+||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence            9999999999999999997643211       011223488999999999999999999999   999999999999999


Q ss_pred             CCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccch
Q 046595          212 DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSL  290 (363)
Q Consensus       212 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~  290 (363)
                      .++.+||+|||++................++..|+|||.+.+..++.++|+||||+++|||++ |..||.......    
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~----  250 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----  250 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH----
Confidence            999999999999875543221111122234568999999998899999999999999999998 888886432211    


Q ss_pred             hhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCC
Q 046595          291 VTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP  356 (363)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~  356 (363)
                                  +...+........+...+..+.+++.+||+.+|++||++.+|++.|++++....
T Consensus       251 ------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~  304 (307)
T cd05098         251 ------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS  304 (307)
T ss_pred             ------------HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence                        111111111123344556789999999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.5e-44  Score=314.36  Aligned_cols=256  Identities=23%  Similarity=0.379  Sum_probs=207.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      .+|.+.+.||+|+||.||+|.+. +++.+++|.+...  ......+.+|+.++++++|+||+++++++......+++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            35788899999999999999754 5888999988642  23356788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|.+++.....       ..+++..++.++.|++.||.|||++   +++|+||||+||++++++.+||+|||++..
T Consensus        84 ~~~~~L~~~~~~~~~-------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~  153 (263)
T cd05052          84 MTYGNLLDYLRECNR-------QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL  153 (263)
T ss_pred             CCCCcHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccc
Confidence            999999999965432       1388999999999999999999999   999999999999999999999999999876


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      ........ .....++..|+|||.+.+..++.++||||||+++|||++ |..||........                ..
T Consensus       154 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~----------------~~  216 (263)
T cd05052         154 MTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----------------YE  216 (263)
T ss_pred             cccceeec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH----------------HH
Confidence            54432211 112234668999999998899999999999999999998 8999864322111                01


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccc
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL  352 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~  352 (363)
                      .+........+..++..+.+++.+||+.+|++||++.++++.|+.++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  263 (263)
T cd05052         217 LLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF  263 (263)
T ss_pred             HHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence            11111222334455678999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.8e-44  Score=326.01  Aligned_cols=252  Identities=21%  Similarity=0.306  Sum_probs=199.7

Q ss_pred             CCCCCCeeeccCCceEEEEEe----CCCCeEEEEEccCCC---CCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCee
Q 046595           69 NFGTKALIGEGSYGRVFYAKL----TDGTPAAIKKLDTSS---APEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNR  140 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~----~~~~~~avK~~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  140 (363)
                      +|++.+.||+|+||.||+++.    .+++.||+|++....   .......+..|+.+++.+ +|+||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478899999999999999964    358899999986532   222345678899999999 599999999999999999


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEee
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD  220 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D  220 (363)
                      ++||||+.+|+|.+++....         .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~D  148 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD---------NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTD  148 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEee
Confidence            99999999999999997543         288999999999999999999999   999999999999999999999999


Q ss_pred             eccCCCCCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc
Q 046595          221 FNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       221 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      ||++......... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.............       
T Consensus       149 fG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~-------  220 (332)
T cd05614         149 FGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS-------  220 (332)
T ss_pred             CcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH-------
Confidence            9998754332221 12345799999999998865 47899999999999999999999996432221111000       


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP-----NMTIVVK  346 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  346 (363)
                          ....  .....++...+..+.+++.+||+.||++||     +++++++
T Consensus       221 ----~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         221 ----RRIL--KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             ----HHHh--cCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence                0000  011223344566789999999999999999     7778875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.4e-44  Score=321.65  Aligned_cols=269  Identities=25%  Similarity=0.423  Sum_probs=212.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC--------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeC
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT--------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMES  137 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  137 (363)
                      ..+|.+.+.||+|+||.||+|+..        ++..+++|.+...........+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            357889999999999999999631        24468999887544444456789999999999 899999999999999


Q ss_pred             CeeEEEEecccCCChhhhhcCCCCCCC-------CCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceee
Q 046595          138 NNRILVYQFATMGSLHDVLHGRKGVQG-------AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL  210 (363)
Q Consensus       138 ~~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill  210 (363)
                      ...+++|||+.+++|.+++........       ......+++..++.++.|++.||.|||++   +++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence            999999999999999999976432110       01223588999999999999999999999   99999999999999


Q ss_pred             cCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccc
Q 046595          211 FDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQS  289 (363)
Q Consensus       211 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~  289 (363)
                      +.++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||......... 
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-  249 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF-  249 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH-
Confidence            9999999999999876544332222233346678999999988889999999999999999998 78888643221111 


Q ss_pred             hhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          290 LVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                                     ..+........+..++..+.+++.+||+.+|.+||++.+|++.|++++.-
T Consensus       250 ---------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         250 ---------------KLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             ---------------HHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence                           11111111222345667899999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.8e-44  Score=319.61  Aligned_cols=263  Identities=24%  Similarity=0.350  Sum_probs=206.7

Q ss_pred             CCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      +|.+.+.||+|+||.||+|...      ++..||+|++...........+..|+.++..++||||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4677788999999999999753      2577999998764433334668889999999999999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCC-------CCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCc
Q 046595          143 VYQFATMGSLHDVLHGRKGVQ-------GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK  215 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~  215 (363)
                      +++|+.+++|.+++.......       .......+++..++.++.|++.||.|||++   +|+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence            999999999999986432110       011123488899999999999999999999   9999999999999999999


Q ss_pred             eEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhc
Q 046595          216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWA  294 (363)
Q Consensus       216 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~  294 (363)
                      +||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..||.........      
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~------  236 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI------  236 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH------
Confidence            99999999876544332222233456789999999988889999999999999999998 88888654321111      


Q ss_pred             cccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 046595          295 TPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQP  350 (363)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~  350 (363)
                                ..+.......++..++..+.+++..||+.+|++||++++|+..|+.
T Consensus       237 ----------~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 ----------EMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             ----------HHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                      1111111122344567779999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5e-44  Score=317.01  Aligned_cols=262  Identities=25%  Similarity=0.378  Sum_probs=206.5

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRI  141 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  141 (363)
                      ++|.+.+.||+|++|.||+|.+.      .+..|++|.+...........+..|+.+++.++|+||+++++++.+....+
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF   85 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence            56889999999999999999764      356789998865444444567889999999999999999999999999999


Q ss_pred             EEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC---ceEE
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF---KSKI  218 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~---~vkl  218 (363)
                      +||||+.+++|.+++........  ....+++..++.++.|++.||.|||++   +++|+||||+||+++.++   .+||
T Consensus        86 lv~e~~~g~~L~~~i~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          86 ILLELMAGGDLKSFLRENRPRPE--RPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             EEEecCCCCCHHHHHHHhCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence            99999999999999976542211  122489999999999999999999999   999999999999998654   6899


Q ss_pred             eeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccc
Q 046595          219 ADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPR  297 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~  297 (363)
                      +|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||..........        
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~--------  232 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME--------  232 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--------
Confidence            99999876533222111222334568999999998899999999999999999997 999997543221111        


Q ss_pred             ccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 046595          298 LSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQP  350 (363)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~  350 (363)
                              .+........+..++..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       233 --------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         233 --------FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             --------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence                    111111122344556779999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2e-44  Score=342.34  Aligned_cols=257  Identities=21%  Similarity=0.330  Sum_probs=205.4

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEeCC-----
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCMESN-----  138 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----  138 (363)
                      ..++|.+.+.||+|+||.||+|+. .+++.||||++..... ......+.+|+.++..++|+||+++++.+....     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            346899999999999999999975 4799999999876432 223456788999999999999999987765432     


Q ss_pred             ---eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCc
Q 046595          139 ---NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK  215 (363)
Q Consensus       139 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~  215 (363)
                         ..++||||+.+|+|.+++......     ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~-----~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~  181 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKT-----NRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGL  181 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCC
Confidence               367999999999999999754321     12489999999999999999999999   9999999999999999999


Q ss_pred             eEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 046595          216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       216 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      +||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||........   ..   
T Consensus       182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~---~~---  255 (496)
T PTZ00283        182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV---MH---  255 (496)
T ss_pred             EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH---HH---
Confidence            999999998765443332223456799999999999999999999999999999999999999974322110   00   


Q ss_pred             ccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          296 PRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                               ... .......+..++.++.+++.+||+.||.+||++.+++.
T Consensus       256 ---------~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        256 ---------KTL-AGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             ---------HHh-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence                     000 01112234456678999999999999999999999876

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.3e-45  Score=312.56  Aligned_cols=268  Identities=22%  Similarity=0.287  Sum_probs=209.5

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCC-----eeEE
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESN-----NRIL  142 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l  142 (363)
                      .|...+++|+|+||.||.|... +++.||||+.-....     --.+|+++|+.+.|||||++.-++....     ...+
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            5778899999999999999754 579999999866433     2347999999999999999988876532     2348


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCC-CceEEeee
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD-FKSKIADF  221 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~Df  221 (363)
                      ||||++. +|.++++.....+     ..++.-.+.-+.+||++||.|||+.   +|+||||||.|+|+|.+ |.+|||||
T Consensus       100 VleymP~-tL~~~~r~~~~~~-----~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDF  170 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRAN-----QRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDF  170 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcC-----CCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccC
Confidence            9999998 9999998642111     2378888899999999999999998   99999999999999965 99999999


Q ss_pred             ccCCCCCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccc
Q 046595          222 NLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE  300 (363)
Q Consensus       222 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  300 (363)
                      |.|+........   .....|..|.|||.+.|. .|+.+.||||.||++.||+.|++-|.+.+..++...+.-.....+.
T Consensus       171 GSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~  247 (364)
T KOG0658|consen  171 GSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR  247 (364)
T ss_pred             CcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH
Confidence            999877655442   345678999999998875 7999999999999999999999999987777666555444334433


Q ss_pred             cccccccCC------------cCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhccccc
Q 046595          301 DKVKQCVDP------------KLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPLLN  353 (363)
Q Consensus       301 ~~~~~~~~~------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l~~  353 (363)
                      +++..+.-.            ....-+....+.+..+++.++|+.+|.+|.++.+++.  .+.++..
T Consensus       248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~  314 (364)
T KOG0658|consen  248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD  314 (364)
T ss_pred             HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence            333222211            1111134456778999999999999999999999886  4444443

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7.2e-44  Score=318.27  Aligned_cols=269  Identities=26%  Similarity=0.412  Sum_probs=211.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRI  141 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  141 (363)
                      ++|.+.+.||+|+||.||++...      ++..+++|.+.... ......+.+|+.++++++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            46888899999999999999642      34568888875422 222357889999999999999999999999999999


Q ss_pred             EEEecccCCChhhhhcCCCCCC-------CCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQ-------GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF  214 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~  214 (363)
                      +||||+.+++|.+++.......       .......+++..++.++.|++.||.|||++   +|+||||||+||+++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence            9999999999999997543110       011122488999999999999999999999   999999999999999999


Q ss_pred             ceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhh
Q 046595          215 KSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTW  293 (363)
Q Consensus       215 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~  293 (363)
                      .++|+|||++................|+..|+|||.+.+..++.++||||||+++|||++ |..||.......   ....
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~  237 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIEC  237 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH
Confidence            999999999875544332222334557889999999998999999999999999999999 999986543321   1110


Q ss_pred             ccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCC
Q 046595          294 ATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP  356 (363)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~  356 (363)
                                   .........+..++..+.+++.+||+.+|++||++.+|++.|+++....+
T Consensus       238 -------------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~  287 (291)
T cd05094         238 -------------ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP  287 (291)
T ss_pred             -------------HhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence                         11111111223356679999999999999999999999999999977654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.4e-44  Score=340.50  Aligned_cols=253  Identities=20%  Similarity=0.275  Sum_probs=202.8

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-C-CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-D-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~-~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      .|.+.+.||+|+||.||+|... + +..|++|.+... .......+..|+.+++.++||||+++++++...+..++||||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN-DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            4899999999999999999643 4 677888876542 223345677899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+|+|.+++.....     ....+++.++..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++..
T Consensus       147 ~~gg~L~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~  218 (478)
T PTZ00267        147 GSGGDLNKQIKQRLK-----EHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQ  218 (478)
T ss_pred             CCCCCHHHHHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCcee
Confidence            999999998864321     112388999999999999999999999   999999999999999999999999999976


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      .............+||+.|+|||++.+..++.++|||||||++|||++|+.||..........               ..
T Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~---------------~~  283 (478)
T PTZ00267        219 YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQ---------------QV  283 (478)
T ss_pred             cCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---------------HH
Confidence            554332222345679999999999999999999999999999999999999996432211100               00


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .. ......+..++..+.++|.+||+.||++||++.+++.
T Consensus       284 ~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        284 LY-GKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             Hh-CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            00 0011223345567999999999999999999999864

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.7e-44  Score=327.20  Aligned_cols=243  Identities=22%  Similarity=0.309  Sum_probs=196.7

Q ss_pred             CeeeccCCceEEEEEe-CCCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCC
Q 046595           74 ALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMG  150 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g  150 (363)
                      +.||+|+||.||++.. .+++.||+|++....  .......+..|+.+++.++||||+++++++......++||||+.+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999975 468999999987532  2223456778999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-cCCCCeEEecccCCceeecCCCceEEeeeccCCCCCc
Q 046595          151 SLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE-KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       151 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      +|..++....         .+++..+..++.|++.||.|||+ +   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 ~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~  148 (325)
T cd05594          81 ELFFHLSRER---------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  148 (325)
T ss_pred             cHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCC
Confidence            9999887543         28899999999999999999997 7   999999999999999999999999999864322


Q ss_pred             ccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCC
Q 046595          230 TAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDP  309 (363)
Q Consensus       230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (363)
                      ...  ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.               ..
T Consensus       149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~---------------~~  211 (325)
T cd05594         149 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL---------------ME  211 (325)
T ss_pred             CCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh---------------cC
Confidence            211  1233569999999999999999999999999999999999999996543211111100               00


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 046595          310 KLNNDYPPKAIAKLAAVAALCVQYEADFRP-----NMTIVVKA  347 (363)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~~  347 (363)
                        ...++...+.++.+++.+||+.||++|+     ++.++++.
T Consensus       212 --~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         212 --EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             --CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence              0122334556799999999999999996     89998863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-44  Score=316.65  Aligned_cols=264  Identities=27%  Similarity=0.398  Sum_probs=208.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRI  141 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  141 (363)
                      ++|.+.+.||+|+||.||++...      ++..|++|.+...........+.+|+.+++.++|+||+++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            47889999999999999999754      246799999865443334467889999999999999999999999999999


Q ss_pred             EEEecccCCChhhhhcCCCCCCCC-CCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEee
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGA-EPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD  220 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D  220 (363)
                      +||||+.+++|.+++......... .....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~d  162 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECC
Confidence            999999999999999754321111 1122478899999999999999999999   999999999999999999999999


Q ss_pred             eccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccc
Q 046595          221 FNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       221 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      ||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...........         
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~---------  233 (277)
T cd05032         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF---------  233 (277)
T ss_pred             cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHH---------
Confidence            999875543322212233456789999999988889999999999999999998 8999865432211110         


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQP  350 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~  350 (363)
                             .........+..++..+.+++.+||+.+|++|||+.+|++.|++
T Consensus       234 -------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         234 -------VIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             -------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence                   01111122233446789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-44  Score=319.55  Aligned_cols=251  Identities=19%  Similarity=0.318  Sum_probs=215.8

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCC-chHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      ++.+-|.+.+.||+|.|+.|-+|++ -+|+.||||++.+....+ ....+..|+..|+.++|||||++|++......+||
T Consensus        15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL   94 (864)
T KOG4717|consen   15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL   94 (864)
T ss_pred             ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence            3456799999999999999999975 489999999998866443 34678999999999999999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec-CCCceEEeee
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF-DDFKSKIADF  221 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~-~~~~vkl~Df  221 (363)
                      |+|.-++|+|++||-+...        .+.+....+++.||+.|+.|+|+.   .+|||||||+||.+- .-|-|||+||
T Consensus        95 iLELGD~GDl~DyImKHe~--------Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDF  163 (864)
T KOG4717|consen   95 ILELGDGGDLFDYIMKHEE--------GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDF  163 (864)
T ss_pred             EEEecCCchHHHHHHhhhc--------cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeec
Confidence            9999999999999976643        289999999999999999999999   999999999998775 6789999999


Q ss_pred             ccCCCCCcccccccccccccccCCCCccccccCCCC-ccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccc
Q 046595          222 NLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQIT-QKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE  300 (363)
Q Consensus       222 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  300 (363)
                      |++..+.....   .+..+|+..|.|||++.|..|+ +++|||||||+||.|++|+.||+...+.....           
T Consensus       164 GFSNkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT-----------  229 (864)
T KOG4717|consen  164 GFSNKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT-----------  229 (864)
T ss_pred             cccccCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh-----------
Confidence            99877665543   4567999999999999999998 67899999999999999999998655433222           


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          301 DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                          .++|..  -..|...+.+..+||..||..||++|.+.++|..
T Consensus       230 ----mImDCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  230 ----MIMDCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             ----hhhccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence                222322  2457788899999999999999999999999986

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=8.4e-44  Score=329.39  Aligned_cols=253  Identities=23%  Similarity=0.255  Sum_probs=198.0

Q ss_pred             CCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           69 NFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      .|.+.+.||+|+||.||+|+. .+++.||+|++....  .......+..|+.+++.++|+||+++++++.+....++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            588899999999999999975 468899999987533  22334678899999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+|+|.+++....         .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.
T Consensus        82 ~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~  149 (381)
T cd05626          82 YIPGGDMMSLLIRME---------VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCT  149 (381)
T ss_pred             cCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCc
Confidence            999999999997643         288999999999999999999999   99999999999999999999999999975


Q ss_pred             CCCcccc---------------------------------------------cccccccccccCCCCccccccCCCCccC
Q 046595          226 QSSDTAA---------------------------------------------RLHSTRVLGTFGYHAPEYAMTGQITQKS  260 (363)
Q Consensus       226 ~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~  260 (363)
                      .......                                             .......+||+.|+|||++.+..++.++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~  229 (381)
T cd05626         150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC  229 (381)
T ss_pred             ccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcc
Confidence            3311000                                             0001235799999999999988999999


Q ss_pred             ceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHh--ccCCCCCCC
Q 046595          261 DVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAAL--CVQYEADFR  338 (363)
Q Consensus       261 DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~~p~~R  338 (363)
                      |||||||++|||++|..||....+......+            ... ...+........+.++.+++.+  |+..++..|
T Consensus       230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i------------~~~-~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R  296 (381)
T cd05626         230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKV------------INW-ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGR  296 (381)
T ss_pred             ceeehhhHHHHHHhCCCCCcCCCHHHHHHHH------------Hcc-ccccCCCCCCCCCHHHHHHHHHHccCcccccCC
Confidence            9999999999999999999754432211100            000 0001111111345567788877  556677779


Q ss_pred             CCHHHHHH
Q 046595          339 PNMTIVVK  346 (363)
Q Consensus       339 Ps~~~vl~  346 (363)
                      |++.+|+.
T Consensus       297 ~~~~~~l~  304 (381)
T cd05626         297 NGADDIKA  304 (381)
T ss_pred             CCHHHHhc
Confidence            99999987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=9.6e-44  Score=311.57  Aligned_cols=252  Identities=25%  Similarity=0.391  Sum_probs=203.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      ++|++.+.||+|+||.||++++.++..+|+|.+....  .....+.+|+.++++++||||+++++++......+++|||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            3588889999999999999988777779999886532  23467899999999999999999999999888999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      .+++|.+++.....        .+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++...
T Consensus        82 ~~~~l~~~i~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~  150 (256)
T cd05113          82 SNGCLLNYLREHGK--------RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYV  150 (256)
T ss_pred             CCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceec
Confidence            99999999975432        288999999999999999999999   9999999999999999999999999998755


Q ss_pred             CcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      ...... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..........   .             
T Consensus       151 ~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~---~-------------  213 (256)
T cd05113         151 LDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVE---K-------------  213 (256)
T ss_pred             CCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH---H-------------
Confidence            432211 1122345678999999988889999999999999999998 999986443211100   0             


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ  349 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~  349 (363)
                      .........+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       214 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         214 VSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            0001111112234567999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=8.6e-44  Score=317.31  Aligned_cols=268  Identities=27%  Similarity=0.411  Sum_probs=209.5

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRI  141 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  141 (363)
                      .+|.+.+.||+|+||.||++...      ++..+++|.+.... ......+.+|+.++++++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            46889999999999999999642      34568888886532 233467889999999999999999999999999999


Q ss_pred             EEEecccCCChhhhhcCCCCCCC----CCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceE
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQG----AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSK  217 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~----~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk  217 (363)
                      ++|||+.+++|.+++........    ......+++..++.++.|++.||+|||++   +++||||||+||++++++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence            99999999999999975432111    11112489999999999999999999999   999999999999999999999


Q ss_pred             EeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccc
Q 046595          218 IADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATP  296 (363)
Q Consensus       218 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~  296 (363)
                      |+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||...........+     
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i-----  235 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI-----  235 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----
Confidence            999999875543322222233446788999999998899999999999999999998 89998654322111000     


Q ss_pred             cccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccC
Q 046595          297 RLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK  355 (363)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~  355 (363)
                                 ........+...+..+.+++.+||+.||.+|||+.+|++.|+++....
T Consensus       236 -----------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~  283 (288)
T cd05093         236 -----------TQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS  283 (288)
T ss_pred             -----------HcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence                       000001112234456999999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.8e-44  Score=306.46  Aligned_cols=272  Identities=24%  Similarity=0.294  Sum_probs=209.3

Q ss_pred             CCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCC-chHHHHHHHHHHhcCCCCc-cceeeeEEEeCC------e
Q 046595           69 NFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEH-FVELLGYCMESN------N  139 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~------~  139 (363)
                      .|...+.||+|+||.||+|+. .+|+.||+|++......+ .-....+|+.++++++|+| |+.+++++...+      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            455666799999999999974 478999999998865533 2356789999999999999 999999998877      7


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEe
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA  219 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~  219 (363)
                      +++|+||++. +|..++.......     ..++...+..+..||+.||+|||++   +|+||||||+||||+++|.+||+
T Consensus        92 l~lvfe~~d~-DL~~ymd~~~~~~-----~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKla  162 (323)
T KOG0594|consen   92 LYLVFEFLDR-DLKKYMDSLPKKP-----QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLA  162 (323)
T ss_pred             EEEEEEeecc-cHHHHHHhccccc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeee
Confidence            8999999987 9999998765321     1266789999999999999999999   99999999999999999999999


Q ss_pred             eeccCCCCCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 046595          220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL  298 (363)
Q Consensus       220 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  298 (363)
                      |||+|+...-....  .+..++|.+|.|||++.+. .|+...||||+||++.||++++.-|.+.+..++...+--.....
T Consensus       163 DFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP  240 (323)
T KOG0594|consen  163 DFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP  240 (323)
T ss_pred             ccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC
Confidence            99999865533322  4556889999999999986 79999999999999999999999998776654433321111111


Q ss_pred             ccc---ccccccCCc--C-----CCCCCH---HHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hccc
Q 046595          299 SED---KVKQCVDPK--L-----NNDYPP---KAIAKLAAVAALCVQYEADFRPNMTIVVKA--LQPL  351 (363)
Q Consensus       299 ~~~---~~~~~~~~~--~-----~~~~~~---~~~~~l~~li~~cl~~~p~~RPs~~~vl~~--l~~l  351 (363)
                      ...   .+....+-.  .     ...+..   .......+++.+||+.+|.+|.|+...++.  +..+
T Consensus       241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence            110   001000000  0     011111   122478899999999999999999999885  4444

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=9.6e-44  Score=315.53  Aligned_cols=260  Identities=25%  Similarity=0.405  Sum_probs=206.1

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCC----eEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGT----PAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      .+|++.+.||+|+||.||+|.+. ++.    .||+|++...........+.+|+.++..++|+||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            47888999999999999999753 444    4799998765444445678899999999999999999998875 45789


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      +++|+++|+|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+||++++++.+||+|||
T Consensus        86 ~~~~~~~g~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG  154 (279)
T cd05109          86 VTQLMPYGCLLDYVRENKD--------RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFG  154 (279)
T ss_pred             EEEcCCCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCC
Confidence            9999999999999975431        388999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      +++...............++..|+|||.+.+..++.++|||||||++|||++ |..||........              
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--------------  220 (279)
T cd05109         155 LARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI--------------  220 (279)
T ss_pred             ceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH--------------
Confidence            9876543322211222345678999999998899999999999999999998 8999864322111              


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccC
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK  355 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~  355 (363)
                        ...+........+..++..+.+++.+||+.||++||++.++++.|+.+....
T Consensus       221 --~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         221 --PDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             --HHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence              1111111111223345567999999999999999999999999998875543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.5e-43  Score=311.00  Aligned_cols=255  Identities=27%  Similarity=0.412  Sum_probs=206.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      ..+|++.++||+|+||.||+|...+++.+++|.+....  .....+.+|+.++++++|+||+++++++. .+..+++|||
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS--MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC--CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            45799999999999999999998889999999987533  33567899999999999999999999864 5678999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|.+++.....       ..+++.+++.++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++..
T Consensus        82 ~~~~~L~~~~~~~~~-------~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  151 (260)
T cd05067          82 MENGSLVDFLKTPEG-------IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARL  151 (260)
T ss_pred             CCCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceee
Confidence            999999999865432       1388999999999999999999999   999999999999999999999999999865


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      ....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..........                
T Consensus       152 ~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~----------------  214 (260)
T cd05067         152 IEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ----------------  214 (260)
T ss_pred             cCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH----------------
Confidence            5422211 1123346778999999998899999999999999999999 999997543211110                


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL  351 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l  351 (363)
                      .+........+...+.++.+++.+||+.+|++||+++++++.|+++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         215 NLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence            0111111122334456799999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-44  Score=329.50  Aligned_cols=254  Identities=20%  Similarity=0.288  Sum_probs=204.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|++....  .......+..|+.++..++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36889999999999999999765 68999999987532  2234467888999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+++|.+++....         .+++..+..++.|++.||.|||++   ||+||||||+||+++.++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~  148 (350)
T cd05573          81 EYMPGGDLMNLLIRKD---------VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLC  148 (350)
T ss_pred             cCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCC
Confidence            9999999999997653         288999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCccc---------------------------ccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCC
Q 046595          225 NQSSDTA---------------------------ARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRK  277 (363)
Q Consensus       225 ~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~  277 (363)
                      .......                           .........||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~  228 (350)
T cd05573         149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP  228 (350)
T ss_pred             ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCC
Confidence            7654332                           0011234569999999999999999999999999999999999999


Q ss_pred             CCCCCCCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 046595          278 PVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPN-MTIVVKA  347 (363)
Q Consensus       278 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~~vl~~  347 (363)
                      ||...........            +..+. ..+.......++..+.++|..||. ||.+||+ +.++++.
T Consensus       229 Pf~~~~~~~~~~~------------i~~~~-~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         229 PFYSDTLQETYNK------------IINWK-ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCCCCHHHHHHH------------HhccC-CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            9975542211110            00000 001111111246779999999998 9999999 9999873

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=8.8e-44  Score=317.23  Aligned_cols=268  Identities=25%  Similarity=0.403  Sum_probs=208.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCee
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNR  140 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  140 (363)
                      ..+|++.+.||+|+||.||+|..+      .+..||+|.+...........+.+|+.+++.++|+||+++++++.+....
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT   84 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            457999999999999999999643      24579999886543333345678899999999999999999999999999


Q ss_pred             EEEEecccCCChhhhhcCCCCCCC-CCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEe
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQG-AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA  219 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~  219 (363)
                      ++||||+.+|+|.+++........ .......+...+..++.|++.||.|||++   +|+||||||+||+++.++.++|+
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~  161 (288)
T cd05061          85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG  161 (288)
T ss_pred             EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEEC
Confidence            999999999999999975432111 11123467788999999999999999999   99999999999999999999999


Q ss_pred             eeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccc
Q 046595          220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRL  298 (363)
Q Consensus       220 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~  298 (363)
                      |||+++...............++..|+|||.+.+..++.++|+|||||++|||++ |..||......+..   ..     
T Consensus       162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~---~~-----  233 (288)
T cd05061         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL---KF-----  233 (288)
T ss_pred             cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH-----
Confidence            9999875443322222223345778999999998899999999999999999999 78898654322111   00     


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccc
Q 046595          299 SEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN  353 (363)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~  353 (363)
                             ..+ ......+..++..+.+++.+||+.||++|||+.++++.|+..+.
T Consensus       234 -------~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  280 (288)
T cd05061         234 -------VMD-GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH  280 (288)
T ss_pred             -------HHc-CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence                   000 00111223345679999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.7e-43  Score=311.00  Aligned_cols=256  Identities=28%  Similarity=0.452  Sum_probs=205.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      .++|++.+.||+|+||.||+|.+.++..|++|.+....  .....+.+|+.+++.++|+||+++++++. ....++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY   81 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc--cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence            35799999999999999999987776779999987532  23457889999999999999999999875 4567899999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|.+++.....       ..+++..++.++.|++.||.|||+.   +++|+||||+||++++++.++|+|||.+..
T Consensus        82 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~  151 (262)
T cd05071          82 MSKGSLLDFLKGEMG-------KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL  151 (262)
T ss_pred             CCCCcHHHHHhhccc-------cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceee
Confidence            999999999975321       1378999999999999999999999   999999999999999999999999999865


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      ....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..........                
T Consensus       152 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~----------------  214 (262)
T cd05071         152 IEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD----------------  214 (262)
T ss_pred             ccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHH----------------
Confidence            5433221 1122346778999999988899999999999999999999 888886543221110                


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccc
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL  352 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~  352 (363)
                      ..........+..++..+.+++.+||+.+|++||++.++++.|++.+
T Consensus       215 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         215 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             HHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            00011111223456678999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.9e-44  Score=326.81  Aligned_cols=265  Identities=24%  Similarity=0.353  Sum_probs=197.4

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEeC-----CeeE
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCMES-----NNRI  141 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~  141 (363)
                      +|++.+.||+|+||.||+|... ++..||||++..... ......+.+|+.+++.++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5888999999999999999754 689999999875322 22345688999999999999999999987543     2479


Q ss_pred             EEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeee
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADF  221 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df  221 (363)
                      +||||+. ++|.+++....         .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        81 lv~e~~~-~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Df  147 (338)
T cd07859          81 VVFELME-SDLHQVIKAND---------DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDF  147 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc---------cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccC
Confidence            9999996 58999887543         288999999999999999999999   9999999999999999999999999


Q ss_pred             ccCCCCCcccc-cccccccccccCCCCcccccc--CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 046595          222 NLTNQSSDTAA-RLHSTRVLGTFGYHAPEYAMT--GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL  298 (363)
Q Consensus       222 g~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  298 (363)
                      |+++....... ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||...........+.......
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~  227 (338)
T cd07859         148 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTP  227 (338)
T ss_pred             ccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99875432211 111234579999999998875  678999999999999999999999997543321111110000000


Q ss_pred             c--------ccccccc---cCCcCCCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          299 S--------EDKVKQC---VDPKLNNDY---PPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       299 ~--------~~~~~~~---~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .        .......   +.......+   .+..+..+.+++.+||+.||++|||+.++++
T Consensus       228 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             CHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            0        0000000   000000000   0123456889999999999999999999997

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-43  Score=312.20  Aligned_cols=261  Identities=22%  Similarity=0.368  Sum_probs=203.3

Q ss_pred             CCCCCeeeccCCceEEEEEeCC----CCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeCCe-----
Q 046595           70 FGTKALIGEGSYGRVFYAKLTD----GTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESNN-----  139 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~~~----~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----  139 (363)
                      |.+.+.||+|+||.||.|....    +..||+|.+...... .....+..|+..++.++|+||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999997542    467999998754322 223578899999999999999999998866554     


Q ss_pred             -eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEE
Q 046595          140 -RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI  218 (363)
Q Consensus       140 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl  218 (363)
                       .++++||+.+++|..++.......   ....+++..+..++.|++.||.|||+.   +++|+||||+||++++++.+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl  154 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGG---LPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCV  154 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccC---CcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEE
Confidence             789999999999999986543211   112489999999999999999999999   9999999999999999999999


Q ss_pred             eeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccc
Q 046595          219 ADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPR  297 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~  297 (363)
                      +|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.......   ...+    
T Consensus       155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~----  227 (273)
T cd05035         155 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDY----  227 (273)
T ss_pred             CCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----
Confidence            99999876543322111222335678999999988899999999999999999999 889986543211   1111    


Q ss_pred             ccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccc
Q 046595          298 LSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL  352 (363)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~  352 (363)
                               +........+..++..+.+++.+||+.||++||++.+|++.|++++
T Consensus       228 ---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~  273 (273)
T cd05035         228 ---------LRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL  273 (273)
T ss_pred             ---------HHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence                     1111112223455678999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=320.81  Aligned_cols=253  Identities=19%  Similarity=0.282  Sum_probs=213.8

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC--chHHHHHHHHHHhcCC-CCccceeeeEEEeCCeeE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE--PESDFAAQLSVVSRLK-HEHFVELLGYCMESNNRI  141 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~  141 (363)
                      +...|.+.+.||+|.||.||.|+.+ +|+.+|+|.+.+.....  ....+.+|+.+|+++. ||||+.+++++++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            4568999999999999999999765 59999999998765433  3478999999999998 999999999999999999


Q ss_pred             EEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC----CCceE
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD----DFKSK  217 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~----~~~vk  217 (363)
                      +|||++.||.|.+.+....          +++..+..++.|++.++.|||+.   ||+||||||+|+|+..    ++.+|
T Consensus       113 lvmEL~~GGeLfd~i~~~~----------~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik  179 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKKH----------YSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIK  179 (382)
T ss_pred             EEEEecCCchHHHHHHHcc----------CCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEE
Confidence            9999999999999998761          89999999999999999999999   9999999999999963    35799


Q ss_pred             EeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccc
Q 046595          218 IADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR  297 (363)
Q Consensus       218 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~  297 (363)
                      ++|||++.....   .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||...........+...   
T Consensus       180 ~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~---  253 (382)
T KOG0032|consen  180 LIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG---  253 (382)
T ss_pred             EeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC---
Confidence            999999987766   22356689999999999999999999999999999999999999999866433222211100   


Q ss_pred             ccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          298 LSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                                +.......-...+....++|..++..||.+|+|+.++++.
T Consensus       254 ----------~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  254 ----------DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             ----------CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                      0122233334567889999999999999999999999984

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.1e-43  Score=318.64  Aligned_cols=260  Identities=25%  Similarity=0.409  Sum_probs=207.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCee
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNR  140 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  140 (363)
                      .+|.+.+.||+|+||.||++...      ++..+|+|.+.........+.+.+|+.+++++ +|+||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            47899999999999999999641      34579999887654444456788999999999 799999999999999999


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEee
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD  220 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D  220 (363)
                      +++|||+.+++|.+++.....       ..+++.++..++.|++.||.|||++   +++|+||||+||+++.++.++|+|
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~d  184 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRE-------SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICD  184 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECC
Confidence            999999999999999975432       1278999999999999999999999   999999999999999999999999


Q ss_pred             eccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccc
Q 046595          221 FNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       221 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      ||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||........            
T Consensus       185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~------------  252 (302)
T cd05055         185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------------  252 (302)
T ss_pred             CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH------------
Confidence            999875543322111223456788999999998899999999999999999998 9999864422110            


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccc
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL  352 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~  352 (363)
                         .............+...+..+.+++.+||+.+|++||++.+|++.|.+++
T Consensus       253 ---~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~  302 (302)
T cd05055         253 ---FYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL  302 (302)
T ss_pred             ---HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence               00111111111222334567999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=7.9e-44  Score=329.51  Aligned_cols=267  Identities=27%  Similarity=0.436  Sum_probs=210.1

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-CCccceeeeEEEeCCee
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVELLGYCMESNNR  140 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~  140 (363)
                      ++|.+.+.||+|+||.||+|++.      .++.||+|++...........+..|+.++.++. ||||+++++++......
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            46778899999999999999753      346799999986544444567889999999997 99999999999999999


Q ss_pred             EEEEecccCCChhhhhcCCCCCC---------------------------------------------------------
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQ---------------------------------------------------------  163 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~---------------------------------------------------------  163 (363)
                      ++||||+.+|+|.+++.......                                                         
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            99999999999999997543100                                                         


Q ss_pred             --------------------------------CCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec
Q 046595          164 --------------------------------GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF  211 (363)
Q Consensus       164 --------------------------------~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~  211 (363)
                                                      .......+++..++.++.|++.||.|||+.   +++||||||+|||++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~  273 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLIC  273 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEe
Confidence                                            001123478888999999999999999999   999999999999999


Q ss_pred             CCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccch
Q 046595          212 DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSL  290 (363)
Q Consensus       212 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~  290 (363)
                      +++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||........   
T Consensus       274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~---  350 (401)
T cd05107         274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ---  350 (401)
T ss_pred             CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH---
Confidence            999999999999875433222111223457789999999998889999999999999999998 8899864322111   


Q ss_pred             hhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccc
Q 046595          291 VTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL  352 (363)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~  352 (363)
                                  ....+........+..++.++.+++.+||..+|.+||++++|++.|++++
T Consensus       351 ------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         351 ------------FYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             ------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                        00111111112233445678999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.2e-43  Score=318.47  Aligned_cols=267  Identities=26%  Similarity=0.426  Sum_probs=207.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCC--eEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGT--PAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~--~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      ++|++.+.||+|+||.||+|.+. ++.  .+++|.+...........+.+|+.++.++ +|+||+++++++...+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            36888999999999999999764 444  35777765433333446788899999999 899999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCC-------CCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCce
Q 046595          144 YQFATMGSLHDVLHGRKGVQG-------AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS  216 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v  216 (363)
                      |||+.+++|.+++........       ......+++..++.++.|++.||.|||++   +++||||||+|||++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence            999999999999976532111       11223589999999999999999999999   99999999999999999999


Q ss_pred             EEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcc
Q 046595          217 KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       217 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      ||+|||++........   .....++..|+|||.+.+..++.++||||||+++|||++ |..||.......   ..... 
T Consensus       164 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~-  236 (303)
T cd05088         164 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKL-  236 (303)
T ss_pred             EeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---HHHHH-
Confidence            9999999864321111   111234667999999988889999999999999999998 999996443211   11100 


Q ss_pred             ccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCC
Q 046595          296 PRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP  356 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~  356 (363)
                                  ........+...+..+.+++.+||+.+|++||++.++++.|+++++...
T Consensus       237 ------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         237 ------------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             ------------hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence                        0111111222345678999999999999999999999999998877664

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.5e-44  Score=322.54  Aligned_cols=237  Identities=22%  Similarity=0.308  Sum_probs=192.2

Q ss_pred             CeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEEEEecccC
Q 046595           74 ALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATM  149 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~  149 (363)
                      +.||+|+||.||+|+.. +++.||+|++....  .......+..|..++..+ +||||+++++++...+..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999765 58899999987532  233445677888888776 699999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCc
Q 046595          150 GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       150 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      |+|.+++....         .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 g~L~~~i~~~~---------~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~  148 (320)
T cd05590          81 GDLMFHIQKSR---------RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF  148 (320)
T ss_pred             chHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc
Confidence            99999987654         288999999999999999999999   999999999999999999999999999865322


Q ss_pred             ccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCC
Q 046595          230 TAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDP  309 (363)
Q Consensus       230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (363)
                      ...  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........               +...
T Consensus       149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~---------------i~~~  211 (320)
T cd05590         149 NGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA---------------ILND  211 (320)
T ss_pred             CCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH---------------HhcC
Confidence            211  12345799999999999988999999999999999999999999975432211110               0000


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 046595          310 KLNNDYPPKAIAKLAAVAALCVQYEADFRPNM  341 (363)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~  341 (363)
                      .  ..++...+.++.+++.+||+.||++||++
T Consensus       212 ~--~~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         212 E--VVYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             C--CCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            0  12233456678999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=9.8e-44  Score=320.81  Aligned_cols=242  Identities=23%  Similarity=0.296  Sum_probs=192.5

Q ss_pred             CeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhc-CCCCccceeeeEEEeCCeeEEEEecccC
Q 046595           74 ALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSR-LKHEHFVELLGYCMESNNRILVYQFATM  149 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~  149 (363)
                      ++||+|+||.||+|+.. +++.||+|++....  .......+..|..++.. .+||||+++++++......++||||+.+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999765 58889999987532  22233455666666664 4899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCc
Q 046595          150 GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       150 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      |+|..++....         .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        81 g~L~~~~~~~~---------~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~  148 (316)
T cd05592          81 GDLMFHIQSSG---------RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN  148 (316)
T ss_pred             CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCC
Confidence            99999987543         288999999999999999999999   999999999999999999999999999865432


Q ss_pred             ccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCC
Q 046595          230 TAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDP  309 (363)
Q Consensus       230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (363)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|..||...........               +.. 
T Consensus       149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~---------------i~~-  210 (316)
T cd05592         149 GE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS---------------ILN-  210 (316)
T ss_pred             CC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHH---------------HHc-
Confidence            22  123446799999999999998999999999999999999999999975432111000               000 


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 046595          310 KLNNDYPPKAIAKLAAVAALCVQYEADFRPNMT-IVVK  346 (363)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~-~vl~  346 (363)
                       ....++...+.++.+++.+||+.||.+||++. ++++
T Consensus       211 -~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         211 -DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence             01223344566789999999999999999875 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.8e-43  Score=320.91  Aligned_cols=249  Identities=21%  Similarity=0.286  Sum_probs=196.1

Q ss_pred             CeeeccCCceEEEEEeC-CCCeEEEEEccCCCC--CCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEEEEecccC
Q 046595           74 ALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA--PEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATM  149 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~  149 (363)
                      ++||+|+||.||++++. +++.||+|+++....  ......+..|..++..+ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999764 688999999976432  22345678899999888 799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCc
Q 046595          150 GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       150 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      |+|.+++....         .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        81 g~L~~~~~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  148 (329)
T cd05588          81 GDLMFHMQRQR---------KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR  148 (329)
T ss_pred             CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccccc
Confidence            99999886543         289999999999999999999999   999999999999999999999999999864322


Q ss_pred             ccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCcc--ccchhhhcccccccccccccc
Q 046595          230 TAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKG--QQSLVTWATPRLSEDKVKQCV  307 (363)
Q Consensus       230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  307 (363)
                      ...  ......||+.|+|||++.+..++.++|+|||||++|+|++|+.||.......  ......+..        ....
T Consensus       149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~--------~~~~  218 (329)
T cd05588         149 PGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLF--------QVIL  218 (329)
T ss_pred             CCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHH--------HHHH
Confidence            111  1234579999999999999999999999999999999999999996432211  000000000        0011


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCC------HHHHHH
Q 046595          308 DPKLNNDYPPKAIAKLAAVAALCVQYEADFRPN------MTIVVK  346 (363)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs------~~~vl~  346 (363)
                      ...  ..++...+..+.+++.+||+.||.+|++      +.++++
T Consensus       219 ~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         219 EKQ--IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             cCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            111  1233445667999999999999999997      667764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.2e-44  Score=325.57  Aligned_cols=239  Identities=23%  Similarity=0.317  Sum_probs=194.2

Q ss_pred             CeeeccCCceEEEEEe----CCCCeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEeccc
Q 046595           74 ALIGEGSYGRVFYAKL----TDGTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFAT  148 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~----~~~~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  148 (363)
                      +.||+|+||.||+++.    .+++.||+|++..... ......+..|+.++++++||||+++++++......++||||+.
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999864    3588999999875332 2233567789999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCC
Q 046595          149 MGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS  228 (363)
Q Consensus       149 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~  228 (363)
                      +|+|.+++....         .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++....
T Consensus        82 ~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  149 (318)
T cd05582          82 GGDLFTRLSKEV---------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESI  149 (318)
T ss_pred             CCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccC
Confidence            999999996543         289999999999999999999999   99999999999999999999999999987543


Q ss_pred             cccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccC
Q 046595          229 DTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD  308 (363)
Q Consensus       229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (363)
                      ....  ......|++.|+|||.+.+..++.++|||||||++|||++|+.||..........               ....
T Consensus       150 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~---------------~i~~  212 (318)
T cd05582         150 DHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT---------------MILK  212 (318)
T ss_pred             CCCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHH---------------HHHc
Confidence            3211  1234579999999999998889999999999999999999999997543211110               0000


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 046595          309 PKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTI  343 (363)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~  343 (363)
                      .  ...++...+..+.+++.+||+.||++||++.+
T Consensus       213 ~--~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         213 A--KLGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             C--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            0  11233445667999999999999999999444

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7.7e-44  Score=322.78  Aligned_cols=247  Identities=23%  Similarity=0.275  Sum_probs=198.2

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCC-CccceeeeEEEeCCeeEEEE
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKH-EHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~  144 (363)
                      +|++.+.||+|+||.||+|+.. +++.||+|++....  .......+..|..++..+.| ++|+.+++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788999999999999999765 57889999987532  22344677889999999976 56888999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+|+|.+++....         .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        81 E~~~~g~L~~~~~~~~---------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~  148 (324)
T cd05587          81 EYVNGGDLMYHIQQVG---------KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMC  148 (324)
T ss_pred             cCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcc
Confidence            9999999999987543         278999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      ........  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........              
T Consensus       149 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~--------------  212 (324)
T cd05587         149 KENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS--------------  212 (324)
T ss_pred             eecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH--------------
Confidence            64322111  12345799999999999999999999999999999999999999975432111110              


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNM-----TIVVK  346 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~~vl~  346 (363)
                       ...  ....++...+..+.+++.+||+.||.+|++.     .++++
T Consensus       213 -i~~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  256 (324)
T cd05587         213 -IME--HNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE  256 (324)
T ss_pred             -HHc--CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence             000  0122333456678999999999999999976     56654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-43  Score=310.22  Aligned_cols=251  Identities=24%  Similarity=0.377  Sum_probs=203.3

Q ss_pred             CCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEeccc
Q 046595           69 NFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFAT  148 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  148 (363)
                      +|++.+.||+|+||.||++.+.++..+++|.+....  .....+..|+.+++.++|+||+++++++......++||||++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            588889999999999999988777889999986432  234578889999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCC
Q 046595          149 MGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS  228 (363)
Q Consensus       149 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~  228 (363)
                      +++|.+++.....        .+++..++.++.|++.||.|||+.   +++|+||||+||++++++.+||+|||+++...
T Consensus        83 ~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~  151 (256)
T cd05059          83 NGCLLNYLRERKG--------KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVL  151 (256)
T ss_pred             CCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecc
Confidence            9999999975432        388999999999999999999999   99999999999999999999999999987554


Q ss_pred             cccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccccccccc
Q 046595          229 DTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCV  307 (363)
Q Consensus       229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (363)
                      ...... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||....+.....                .+
T Consensus       152 ~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~----------------~~  214 (256)
T cd05059         152 DDQYTS-SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE----------------SV  214 (256)
T ss_pred             cccccc-cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH----------------HH
Confidence            322111 111224457999999998899999999999999999999 899997543221111                01


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 046595          308 DPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ  349 (363)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~  349 (363)
                      ........+..++..+.+++.+||..+|++|||+.+|++.|.
T Consensus       215 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         215 SAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            111112223345678999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.8e-43  Score=316.59  Aligned_cols=267  Identities=27%  Similarity=0.404  Sum_probs=207.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCC-CC--eEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTD-GT--PAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~-~~--~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      ++|++.++||+|+||.||+|...+ +.  .+++|.++........+.+.+|+.++.++ +||||+++++++......+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            478999999999999999997643 33  46888876433333446788999999999 799999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCC-------CCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCce
Q 046595          144 YQFATMGSLHDVLHGRKGVQG-------AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS  216 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v  216 (363)
                      +||+++++|.+++........       ......+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence            999999999999975432110       01123488999999999999999999999   99999999999999999999


Q ss_pred             EEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcc
Q 046595          217 KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       217 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      ||+|||++........   ......+..|+|||.+.+..++.++|||||||++|||++ |..||........   ..   
T Consensus       159 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~---~~---  229 (297)
T cd05089         159 KIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL---YE---  229 (297)
T ss_pred             EECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH---
Confidence            9999999864322111   111223557999999988889999999999999999997 9999965432111   10   


Q ss_pred             ccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCC
Q 046595          296 PRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP  356 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~  356 (363)
                                ..........+..++..+.+++.+||+.+|.+||++.+|++.|+++++...
T Consensus       230 ----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~  280 (297)
T cd05089         230 ----------KLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK  280 (297)
T ss_pred             ----------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence                      011111222233456679999999999999999999999999998887653

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1e-43  Score=321.61  Aligned_cols=243  Identities=19%  Similarity=0.272  Sum_probs=195.6

Q ss_pred             CeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEEEEecccC
Q 046595           74 ALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATM  149 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~  149 (363)
                      ++||+|+||.||+|+.. +++.||+|++....  .......+..|..++..+ +||||+++++++......++||||+.+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999765 58899999987532  223345677888888866 799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCc
Q 046595          150 GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       150 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      ++|..++....         .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~  148 (321)
T cd05591          81 GDLMFQIQRSR---------KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL  148 (321)
T ss_pred             CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceeccc
Confidence            99999987544         288999999999999999999999   999999999999999999999999999865332


Q ss_pred             ccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCC
Q 046595          230 TAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDP  309 (363)
Q Consensus       230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (363)
                      ...  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........               ....
T Consensus       149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~---------------i~~~  211 (321)
T cd05591         149 NGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES---------------ILHD  211 (321)
T ss_pred             CCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH---------------HHcC
Confidence            221  12345799999999999988999999999999999999999999975432211110               0000


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccCCCCCCCC-------CHHHHHHH
Q 046595          310 KLNNDYPPKAIAKLAAVAALCVQYEADFRP-------NMTIVVKA  347 (363)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-------s~~~vl~~  347 (363)
                      .  ..++...+.++.+++..||+.||++||       ++.++++.
T Consensus       212 ~--~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         212 D--VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             C--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            0  112233456789999999999999999       78888753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.2e-43  Score=318.52  Aligned_cols=268  Identities=26%  Similarity=0.430  Sum_probs=209.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC--------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCC
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT--------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESN  138 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~  138 (363)
                      .+|.+.+.||+|+||.||+++..        ....+++|.+...........+..|+.+++.+ +||||+++++++....
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            47889999999999999999642        24568999887644444456788999999999 6999999999999989


Q ss_pred             eeEEEEecccCCChhhhhcCCCCCC-------CCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQ-------GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF  211 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~  211 (363)
                      ..+++|||+.+|+|.+++.......       .......+++.++..++.|++.||.|||++   |++|+||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence            9999999999999999997643210       011123489999999999999999999999   999999999999999


Q ss_pred             CCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccch
Q 046595          212 DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSL  290 (363)
Q Consensus       212 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~  290 (363)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||...........
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~  248 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL  248 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999999999999876543322111122234567999999998899999999999999999999 8889864432111110


Q ss_pred             hhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          291 VTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                                      .........+..++..+.+++.+||+.+|++||++.++++.|.++...
T Consensus       249 ----------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         249 ----------------LREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             ----------------HHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence                            011111122344566799999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.1e-43  Score=312.10  Aligned_cols=261  Identities=23%  Similarity=0.366  Sum_probs=199.7

Q ss_pred             CCCCCeeeccCCceEEEEEeCC-CC--eEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEeC------Ce
Q 046595           70 FGTKALIGEGSYGRVFYAKLTD-GT--PAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCMES------NN  139 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~~~-~~--~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~  139 (363)
                      |.+.+.||+|+||.||+|.+.+ +.  .+|+|.++.... ......+..|+.+++.++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567889999999999998654 32  589998876432 22346788899999999999999999987532      24


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEe
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA  219 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~  219 (363)
                      .+++|||+.+|+|.+++......   .....+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~  154 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLG---DCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVA  154 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhccc---CCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEEC
Confidence            68999999999999988533211   1112388999999999999999999999   99999999999999999999999


Q ss_pred             eeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccc
Q 046595          220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRL  298 (363)
Q Consensus       220 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~  298 (363)
                      |||++................+++.|++||.+.+..++.++||||||+++|||++ |..||........   ....    
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~~----  227 (272)
T cd05075         155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI---YDYL----  227 (272)
T ss_pred             CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH----
Confidence            9999876543322111222346778999999998899999999999999999999 7899865332111   1000    


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccc
Q 046595          299 SEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL  352 (363)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~  352 (363)
                               ...-....+..++..+.+++.+||+.||++|||+.+|++.|++++
T Consensus       228 ---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~  272 (272)
T cd05075         228 ---------RQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL  272 (272)
T ss_pred             ---------HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence                     000001122345567999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.2e-43  Score=308.93  Aligned_cols=253  Identities=26%  Similarity=0.431  Sum_probs=204.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      ++|++.+.||+|+||.||+|...++..+++|.+.....  ....+.+|+.++++++|+||+++++++. ....+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            47899999999999999999888888899999876332  3457899999999999999999999875 45688999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      .+++|.+++.....       ..+++..++.++.|++.||.|||++   +++|+||||+||++++++.++|+|||++...
T Consensus        83 ~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~  152 (260)
T cd05070          83 SKGSLLDFLKDGEG-------RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLI  152 (260)
T ss_pred             CCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeec
Confidence            99999999975321       1388999999999999999999999   9999999999999999999999999998655


Q ss_pred             CcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      ....... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.........   .             .
T Consensus       153 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~---~-------------~  215 (260)
T cd05070         153 EDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL---E-------------Q  215 (260)
T ss_pred             cCccccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH---H-------------H
Confidence            4322111 122345678999999988899999999999999999999 88999643221111   1             1


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQP  350 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~  350 (363)
                      +........+...+..+.+++.+||..+|++|||+.++++.|++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         216 VERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            11111222344556779999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5.4e-44  Score=330.40  Aligned_cols=254  Identities=22%  Similarity=0.269  Sum_probs=199.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....  .......+.+|+.++++++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36899999999999999999754 68999999986432  1223456889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+|+|.+++....         .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        81 E~~~~g~L~~~i~~~~---------~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a  148 (376)
T cd05598          81 DYIPGGDMMSLLIRLG---------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLC  148 (376)
T ss_pred             eCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCC
Confidence            9999999999997643         278899999999999999999999   9999999999999999999999999997


Q ss_pred             CCCCccc-----------------------------------------ccccccccccccCCCCccccccCCCCccCcee
Q 046595          225 NQSSDTA-----------------------------------------ARLHSTRVLGTFGYHAPEYAMTGQITQKSDVY  263 (363)
Q Consensus       225 ~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw  263 (363)
                      ..+....                                         .........||+.|+|||++.+..++.++|||
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw  228 (376)
T cd05598         149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW  228 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeee
Confidence            5321000                                         00001235799999999999999999999999


Q ss_pred             hhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCC---C
Q 046595          264 SFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP---N  340 (363)
Q Consensus       264 slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---s  340 (363)
                      ||||++|||++|+.||....+......+.            .+ ...+........+..+.+++.+|+ .+|.+|+   +
T Consensus       229 SlGvilyell~G~~Pf~~~~~~~~~~~i~------------~~-~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t  294 (376)
T cd05598         229 SVGVILYEMLVGQPPFLADTPAETQLKVI------------NW-ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNG  294 (376)
T ss_pred             eccceeeehhhCCCCCCCCCHHHHHHHHh------------cc-CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCC
Confidence            99999999999999997654322111100            00 001111111234556778888876 4999999   8


Q ss_pred             HHHHHHH
Q 046595          341 MTIVVKA  347 (363)
Q Consensus       341 ~~~vl~~  347 (363)
                      +.++++.
T Consensus       295 ~~ell~h  301 (376)
T cd05598         295 ADEIKAH  301 (376)
T ss_pred             HHHHhCC
Confidence            8998864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-44  Score=328.09  Aligned_cols=253  Identities=20%  Similarity=0.279  Sum_probs=200.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|++.+.||+|+||.||+|+.. +++.||||++....  .......+.+|+.+++.++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            36889999999999999999765 68999999987532  1223456788999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+|+|.+++....         .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.++|+|||++
T Consensus        81 E~~~~g~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~  148 (364)
T cd05599          81 EYLPGGDMMTLLMKKD---------TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLC  148 (364)
T ss_pred             CCCCCcHHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccc
Confidence            9999999999997543         289999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCccccc------------------------------------ccccccccccCCCCccccccCCCCccCceehhHHH
Q 046595          225 NQSSDTAAR------------------------------------LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVV  268 (363)
Q Consensus       225 ~~~~~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~  268 (363)
                      .........                                    ......+||+.|+|||++.+..++.++|||||||+
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i  228 (364)
T cd05599         149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI  228 (364)
T ss_pred             eeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhH
Confidence            643221100                                    00112469999999999998899999999999999


Q ss_pred             HHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCC---HHHHH
Q 046595          269 LLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPN---MTIVV  345 (363)
Q Consensus       269 l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs---~~~vl  345 (363)
                      +|||++|..||....+......+            ..+ ...+........+..+.++|.+|+. +|.+|++   +.+++
T Consensus       229 l~el~~G~~Pf~~~~~~~~~~~i------------~~~-~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll  294 (364)
T cd05599         229 MYEMLVGYPPFCSDNPQETYRKI------------INW-KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIK  294 (364)
T ss_pred             HHHhhcCCCCCCCCCHHHHHHHH------------HcC-CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHh
Confidence            99999999999754332111100            000 0000001111235678899999997 9999998   88887


Q ss_pred             H
Q 046595          346 K  346 (363)
Q Consensus       346 ~  346 (363)
                      +
T Consensus       295 ~  295 (364)
T cd05599         295 S  295 (364)
T ss_pred             c
Confidence            6

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.4e-43  Score=325.97  Aligned_cols=252  Identities=19%  Similarity=0.268  Sum_probs=199.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      .++|++.+.||+|+||.||+++.. +++.+|+|++....  .......+.+|+.+++.++||||+++++++.+....++|
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            467999999999999999999865 58889999986422  222345678899999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.+|+|.+++....          +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       122 ~Ey~~gg~L~~~l~~~~----------~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~  188 (370)
T cd05621         122 MEYMPGGDLVNLMSNYD----------VPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGT  188 (370)
T ss_pred             EcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccc
Confidence            99999999999997543          78899999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccC----CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTG----QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      +........ .......||+.|+|||++.+.    .++.++|||||||++|+|++|..||.........           
T Consensus       189 a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~-----------  256 (370)
T cd05621         189 CMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY-----------  256 (370)
T ss_pred             ceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH-----------
Confidence            876533211 112345799999999998754    3789999999999999999999999754321111           


Q ss_pred             ccccccccCCcCCCCCC--HHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 046595          300 EDKVKQCVDPKLNNDYP--PKAIAKLAAVAALCVQYEADF--RPNMTIVVKA  347 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~--RPs~~~vl~~  347 (363)
                          ..+.+......++  ...+..+.+++..||..++..  |+++.++++.
T Consensus       257 ----~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         257 ----SKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ----HHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                1111111111112  234667889999999855543  8899999884

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.4e-43  Score=319.96  Aligned_cols=249  Identities=20%  Similarity=0.286  Sum_probs=195.1

Q ss_pred             CeeeccCCceEEEEEeC-CCCeEEEEEccCCCC--CCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEEEEecccC
Q 046595           74 ALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA--PEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATM  149 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~  149 (363)
                      +.||+|+||.||+++.. +++.||+|++.....  ......+..|+.++.++ +||||+++++++......++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            36999999999999764 688999999876432  22335677888888776 799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCc
Q 046595          150 GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       150 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      |+|..++....         .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~L~~~~~~~~---------~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~  148 (329)
T cd05618          81 GDLMFHMQRQR---------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  148 (329)
T ss_pred             CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccC
Confidence            99998886543         288999999999999999999999   999999999999999999999999999865322


Q ss_pred             ccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCcccc--chhhhcccccccccccccc
Q 046595          230 TAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ--SLVTWATPRLSEDKVKQCV  307 (363)
Q Consensus       230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  307 (363)
                      ...  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........  ....+..        ....
T Consensus       149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~--------~~i~  218 (329)
T cd05618         149 PGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF--------QVIL  218 (329)
T ss_pred             CCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHH--------HHHh
Confidence            211  123467999999999999999999999999999999999999999632211100  0000000        0001


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCC------HHHHHH
Q 046595          308 DPKLNNDYPPKAIAKLAAVAALCVQYEADFRPN------MTIVVK  346 (363)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs------~~~vl~  346 (363)
                      ..  ...++...+..+.+++.+||+.||++||+      +.++++
T Consensus       219 ~~--~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         219 EK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             cC--CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence            11  12234455677899999999999999998      456654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-43  Score=316.20  Aligned_cols=271  Identities=22%  Similarity=0.345  Sum_probs=205.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCC---------------CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeee
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTD---------------GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLG  132 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~---------------~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~  132 (363)
                      .+|++.+.||+|+||.||+|...+               ...|++|.+...........+.+|++++++++|+||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            479999999999999999986532               22489999876444444567899999999999999999999


Q ss_pred             EEEeCCeeEEEEecccCCChhhhhcCCCCCC---CCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCcee
Q 046595          133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQ---GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVL  209 (363)
Q Consensus       133 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil  209 (363)
                      ++......++||||+.+++|.+++.......   .......+++..++.++.|++.||.|||++   +++|+||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence            9999999999999999999999996532111   011112378899999999999999999999   9999999999999


Q ss_pred             ecCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh--CCCCCCCCCCccc
Q 046595          210 LFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT--GRKPVDHTMPKGQ  287 (363)
Q Consensus       210 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~--g~~p~~~~~~~~~  287 (363)
                      +++++.+||+|||++................++..|+|||.+.+..++.++|+||||+++|+|++  +..||........
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            99999999999999875543322222233445778999999988899999999999999999998  6678764432211


Q ss_pred             cchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 046595          288 QSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQP  350 (363)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~  350 (363)
                      ...   .....      ...........+...+..+.+++.+||+.||++||++.+|++.|++
T Consensus       242 ~~~---~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         242 IEN---TGEFF------RNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHH---HHHhh------hhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            100   00000      0000011111122345679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.6e-43  Score=318.72  Aligned_cols=279  Identities=19%  Similarity=0.322  Sum_probs=209.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      .+|.+.+.||+|+||.||+|+.. +++.||+|.+...........+.+|+.++++++|+||+++++++......++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            46999999999999999999765 68889999987655444455678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+ +|.+++.....        .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++..
T Consensus        86 ~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  153 (309)
T cd07872          86 LDK-DLKQYMDDCGN--------IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARA  153 (309)
T ss_pred             CCC-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcccccee
Confidence            986 88888865432        378899999999999999999999   999999999999999999999999999865


Q ss_pred             CCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccc----
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED----  301 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~----  301 (363)
                      .......  .....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||......+...............    
T Consensus       154 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (309)
T cd07872         154 KSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG  231 (309)
T ss_pred             cCCCccc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Confidence            4332211  223467899999998865 468999999999999999999999997654432221111110000000    


Q ss_pred             -----ccccccCCcCC----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HhccccccCCCCCC
Q 046595          302 -----KVKQCVDPKLN----NDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPLLNSKPAGPE  360 (363)
Q Consensus       302 -----~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l~~~~~~~~~  360 (363)
                           .......+...    .......+.++.+++.+||+.||.+|||+.++++  .++.+..+...-||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~  301 (309)
T cd07872         232 ISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRIHSLPE  301 (309)
T ss_pred             hcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcccccccCCc
Confidence                 00000000000    0011234567899999999999999999999998  55555544333333

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-44  Score=329.28  Aligned_cols=253  Identities=20%  Similarity=0.243  Sum_probs=197.6

Q ss_pred             CCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           69 NFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      +|.+.+.||+|+||.||++.. .+++.||||++....  .......+.+|+.+++.++||||+++++++.+....++|||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E   81 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME   81 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence            688999999999999999975 468999999986532  22234568889999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+|+|.+++....         .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        82 ~~~gg~L~~~l~~~~---------~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~  149 (377)
T cd05629          82 FLPGGDLMTMLIKYD---------TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLST  149 (377)
T ss_pred             CCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccc
Confidence            999999999997543         288999999999999999999999   99999999999999999999999999986


Q ss_pred             CCCccccc---------------------------------------------ccccccccccCCCCccccccCCCCccC
Q 046595          226 QSSDTAAR---------------------------------------------LHSTRVLGTFGYHAPEYAMTGQITQKS  260 (363)
Q Consensus       226 ~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~  260 (363)
                      ........                                             ......+||+.|+|||++.+..++.++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  229 (377)
T cd05629         150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC  229 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCce
Confidence            33211000                                             000124699999999999988999999


Q ss_pred             ceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCC--
Q 046595          261 DVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFR--  338 (363)
Q Consensus       261 DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R--  338 (363)
                      |||||||++|||++|..||...........+  .          .+. ..+...-....+.++.+++.+||. +|.+|  
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i--~----------~~~-~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~  295 (377)
T cd05629         230 DWWSLGAIMFECLIGWPPFCSENSHETYRKI--I----------NWR-ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLG  295 (377)
T ss_pred             eeEecchhhhhhhcCCCCCCCCCHHHHHHHH--H----------ccC-CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCC
Confidence            9999999999999999999754332111100  0          000 000000011234568899999997 67665  


Q ss_pred             -CCHHHHHHH
Q 046595          339 -PNMTIVVKA  347 (363)
Q Consensus       339 -Ps~~~vl~~  347 (363)
                       +++.+++..
T Consensus       296 r~~~~~~l~h  305 (377)
T cd05629         296 RGGAHEIKSH  305 (377)
T ss_pred             CCCHHHHhcC
Confidence             599998874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.2e-43  Score=320.23  Aligned_cols=241  Identities=23%  Similarity=0.301  Sum_probs=192.7

Q ss_pred             CeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEEEEecccC
Q 046595           74 ALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATM  149 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~  149 (363)
                      +.||+|+||.||+|++. +++.||+|++....  ..........|..++..+ +||||+++++++.+.+..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999765 68899999987532  123345567777777654 899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCc
Q 046595          150 GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       150 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      |+|..++....         .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++|+|||++.....
T Consensus        81 g~L~~~i~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~  148 (316)
T cd05620          81 GDLMFHIQDKG---------RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF  148 (316)
T ss_pred             CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeeccc
Confidence            99999987543         288999999999999999999999   999999999999999999999999999864322


Q ss_pred             ccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCC
Q 046595          230 TAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDP  309 (363)
Q Consensus       230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (363)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|..||............            .   . 
T Consensus       149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~------------~---~-  210 (316)
T cd05620         149 GDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI------------R---V-  210 (316)
T ss_pred             CCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------------H---h-
Confidence            111  133467999999999999999999999999999999999999999754321110000            0   0 


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 046595          310 KLNNDYPPKAIAKLAAVAALCVQYEADFRPNMT-IVV  345 (363)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~-~vl  345 (363)
                       ....++...+.++.+++.+||+.||++||++. +++
T Consensus       211 -~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         211 -DTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence             01122333456789999999999999999984 565

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.5e-43  Score=319.49  Aligned_cols=242  Identities=26%  Similarity=0.320  Sum_probs=193.5

Q ss_pred             CeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhc-CCCCccceeeeEEEeCCeeEEEEecccC
Q 046595           74 ALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSR-LKHEHFVELLGYCMESNNRILVYQFATM  149 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~  149 (363)
                      +.||+|+||.||+|+.. +++.||+|++....  ..........|..++.. ++||||+++++++.+.+..++||||+.+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999865 57899999987542  12334556677777776 4899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCc
Q 046595          150 GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       150 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      |+|.+++....         .+++.++..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 g~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  148 (316)
T cd05619          81 GDLMFHIQSCH---------KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENML  148 (316)
T ss_pred             CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCC
Confidence            99999997543         288999999999999999999999   999999999999999999999999999864322


Q ss_pred             ccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCC
Q 046595          230 TAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDP  309 (363)
Q Consensus       230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (363)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+..                
T Consensus       149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~----------------  210 (316)
T cd05619         149 GDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM----------------  210 (316)
T ss_pred             CCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------------
Confidence            111  12345799999999999988999999999999999999999999975432111110000                


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 046595          310 KLNNDYPPKAIAKLAAVAALCVQYEADFRPNMT-IVVK  346 (363)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~-~vl~  346 (363)
                       ....++...+..+.+++.+||+.||++||++. ++++
T Consensus       211 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         211 -DNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             -CCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence             00112334556789999999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.2e-43  Score=321.37  Aligned_cols=247  Identities=23%  Similarity=0.283  Sum_probs=198.1

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEEEE
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      +|.+.+.||+|+||.||+|+.. +++.||+|++....  .......+..|..++..+ +|++|+.+++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788899999999999999765 57899999987532  122334566777887777 5899999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+|+|.+++....         .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        81 E~~~~g~L~~~~~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~  148 (323)
T cd05616          81 EYVNGGDLMYQIQQVG---------RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC  148 (323)
T ss_pred             cCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCc
Confidence            9999999999987543         288999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      ........  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........              
T Consensus       149 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~--------------  212 (323)
T cd05616         149 KENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS--------------  212 (323)
T ss_pred             eecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHH--------------
Confidence            64322111  12346799999999999999999999999999999999999999975432211110              


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNM-----TIVVK  346 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~~vl~  346 (363)
                       +...  ...++...+.++.+++.+||+.||.+|++.     .++++
T Consensus       213 -i~~~--~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~  256 (323)
T cd05616         213 -IMEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  256 (323)
T ss_pred             -HHhC--CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence             0010  112344556779999999999999999984     56553

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=7e-43  Score=307.81  Aligned_cols=261  Identities=22%  Similarity=0.349  Sum_probs=210.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|++.+.||+|+||.||+|... +++.|++|.++...  .......+.+|++++++++|+||+++++++...+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            47899999999999999999765 79999999886432  2233567889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+++|.+++.....     ....+++..++.++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        82 e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~  153 (267)
T cd08224          82 ELADAGDLSRMIKHFKK-----QKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             ecCCCCCHHHHHHHhcc-----cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEecccee
Confidence            99999999999865321     112388999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      .........  .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||......    ..          .+.
T Consensus       154 ~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~----------~~~  217 (267)
T cd08224         154 RFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LY----------SLC  217 (267)
T ss_pred             eeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HH----------HHH
Confidence            654332211  23356889999999998888999999999999999999999998643211    00          001


Q ss_pred             cccCCcCCCCCCH-HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccc
Q 046595          305 QCVDPKLNNDYPP-KAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL  352 (363)
Q Consensus       305 ~~~~~~~~~~~~~-~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~  352 (363)
                      ...........+. ..+..+.+++.+||..+|++|||+.+|++.|+.+.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         218 KKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             hhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            1111111122222 55678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3e-43  Score=308.61  Aligned_cols=248  Identities=25%  Similarity=0.422  Sum_probs=198.3

Q ss_pred             eeeccCCceEEEEEe---CCCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCC
Q 046595           75 LIGEGSYGRVFYAKL---TDGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMG  150 (363)
Q Consensus        75 ~lg~G~~g~V~~~~~---~~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g  150 (363)
                      .||+|+||.||+|.+   .++..+++|++...... ...+.+..|+.+++.++|+||+++++++. .+..++||||+.++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999964   35788999998754322 23467889999999999999999999875 45678999999999


Q ss_pred             ChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCcc
Q 046595          151 SLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT  230 (363)
Q Consensus       151 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~  230 (363)
                      +|.+++....         .+++..+..++.|++.||.|||++   +|+|+||||.||+++.++.+||+|||++......
T Consensus        81 ~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~  148 (257)
T cd05116          81 PLNKFLQKNK---------HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGAD  148 (257)
T ss_pred             cHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence            9999996543         288999999999999999999999   9999999999999999999999999998765433


Q ss_pred             ccccc-ccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccccccC
Q 046595          231 AARLH-STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD  308 (363)
Q Consensus       231 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (363)
                      ..... .....++..|+|||.+.+..++.++|+||||+++|||++ |..||........                ...++
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~----------------~~~i~  212 (257)
T cd05116         149 ENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV----------------TQMIE  212 (257)
T ss_pred             CCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------HHHHH
Confidence            22111 112234678999999988889999999999999999998 9999975432211                11111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 046595          309 PKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL  351 (363)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l  351 (363)
                      .......+..++.++.++|.+||+.||++||++.+|.+.|++.
T Consensus       213 ~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         213 SGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            2222233445677899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.8e-43  Score=309.62  Aligned_cols=261  Identities=22%  Similarity=0.335  Sum_probs=208.5

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC--CCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA--PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|++.+.||+|+||.||+|+.. +++.|++|.+.....  ......+..|+.+++.++||||+++++++......++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            47999999999999999999754 689999998765322  223456888999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+++|.+++......     ...+++..++.++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++
T Consensus        82 e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~  153 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQ-----KRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             EecCCCcHHHHHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccc
Confidence            999999999988643211     11378899999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      .........  .....|+..|+|||.+.+..++.++|+||||+++|||++|+.||....... ......         +.
T Consensus       154 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~---------~~  221 (267)
T cd08228         154 RFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQK---------IE  221 (267)
T ss_pred             eeccchhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHH---------Hh
Confidence            765433221  223468899999999988889999999999999999999999986432211 011000         00


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL  351 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l  351 (363)
                         ............+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       222 ---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         222 ---QCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             ---cCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence               00111112234567899999999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.5e-43  Score=325.67  Aligned_cols=253  Identities=21%  Similarity=0.279  Sum_probs=196.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|++.+.||+|+||.||+|... +++.||+|++....  .......+..|+.++..++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            36889999999999999999754 68899999986532  1223356788999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+++|+|.+++....         .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        81 E~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla  148 (363)
T cd05628          81 EFLPGGDMMTLLMKKD---------TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLC  148 (363)
T ss_pred             cCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCc
Confidence            9999999999997643         289999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCccccc---------------------------------ccccccccccCCCCccccccCCCCccCceehhHHHHHH
Q 046595          225 NQSSDTAAR---------------------------------LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLE  271 (363)
Q Consensus       225 ~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~e  271 (363)
                      +........                                 ......+||+.|+|||++.+..++.++|||||||++||
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e  228 (363)
T cd05628         149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE  228 (363)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHH
Confidence            654321100                                 00123579999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCCccccchhhhccccccccccccccCCcCCCCCCH--HHHHHHHHHHHhccC--CCCCCCCCHHHHHHH
Q 046595          272 LLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPP--KAIAKLAAVAALCVQ--YEADFRPNMTIVVKA  347 (363)
Q Consensus       272 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~--~~p~~RPs~~~vl~~  347 (363)
                      |++|..||...........+.            ... ..  ..++.  ..+.++.+++.+++.  .++..||++.+|++.
T Consensus       229 ll~G~~Pf~~~~~~~~~~~i~------------~~~-~~--~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         229 MLIGYPPFCSETPQETYKKVM------------NWK-ET--LIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             HHhCCCCCCCCCHHHHHHHHH------------cCc-Cc--ccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            999999997543322111100            000 00  00111  133456777766443  334457899999874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.3e-43  Score=308.91  Aligned_cols=251  Identities=21%  Similarity=0.331  Sum_probs=205.4

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      +|++.+.||.|+||.||++... ++..+++|.+.........+.+..|+.+++.++|+||+++++.+......+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4788899999999999999754 688999999876444445577889999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      ++++|.+++.....       ..+++..++.++.|++.||.|||++   +++|+||||+||++++++.++|+|||++...
T Consensus        81 ~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  150 (255)
T cd08219          81 DGGDLMQKIKLQRG-------KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLL  150 (255)
T ss_pred             CCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceee
Confidence            99999998865332       1378999999999999999999999   9999999999999999999999999998655


Q ss_pred             CcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCV  307 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (363)
                      .....  ......|+..|+|||++.+..++.++|+||||+++|+|++|..||..........               . +
T Consensus       151 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~---------------~-~  212 (255)
T cd08219         151 TSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL---------------K-V  212 (255)
T ss_pred             ccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHH---------------H-H
Confidence            43221  1234568999999999998889999999999999999999999997432211100               0 0


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          308 DPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                      ........+...+..+.+++.+||+.||++||++.+|+..
T Consensus       213 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         213 CQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             hcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            0011112234456679999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-43  Score=307.23  Aligned_cols=257  Identities=30%  Similarity=0.453  Sum_probs=207.4

Q ss_pred             CeeeccCCceEEEEEeCC----CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccC
Q 046595           74 ALIGEGSYGRVFYAKLTD----GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATM  149 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~----~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  149 (363)
                      +.||+|+||.||+|....    +..+++|.+...........+..|+.+++.++|+||+++++++......+++|||+.+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            369999999999997653    7889999998755444467889999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCc
Q 046595          150 GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       150 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      ++|.+++..............+++..++.++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            99999998752111011112489999999999999999999999   999999999999999999999999999876654


Q ss_pred             ccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccccccC
Q 046595          230 TAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD  308 (363)
Q Consensus       230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (363)
                      ...........++..|+|||.+.+..++.++||||||+++|+|++ |..||........   .             ..+.
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~-------------~~~~  221 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV---L-------------EYLR  221 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH---H-------------HHHH
Confidence            332222334567889999999988899999999999999999999 6999975522111   1             1111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 046595          309 PKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ  349 (363)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~  349 (363)
                      .......+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus       222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         222 KGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             cCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            11122334455778999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.4e-43  Score=326.31  Aligned_cols=252  Identities=19%  Similarity=0.258  Sum_probs=201.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      ..+|++.+.||+|+||.||+++.. +++.||+|++....  .......+..|+.+++.++||||+++++++.+....++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            357999999999999999999765 68899999986432  122334577899999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.+|+|.+++....          +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       122 ~Ey~~gg~L~~~l~~~~----------l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~  188 (370)
T cd05596         122 MEYMPGGDLVNLMSNYD----------IPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT  188 (370)
T ss_pred             EcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccc
Confidence            99999999999997543          78889999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccC----CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTG----QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      +........ .......||+.|+|||++.+.    .++.++|||||||++|||++|..||.........           
T Consensus       189 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-----------  256 (370)
T cd05596         189 CMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY-----------  256 (370)
T ss_pred             eeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH-----------
Confidence            865432211 112345799999999988653    4789999999999999999999999754321111           


Q ss_pred             ccccccccCCcCCCCCC--HHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 046595          300 EDKVKQCVDPKLNNDYP--PKAIAKLAAVAALCVQYEADF--RPNMTIVVKA  347 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~--RPs~~~vl~~  347 (363)
                          ..+........++  ...+.++.+++.+||+.+|++  |+++.++++.
T Consensus       257 ----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         257 ----SKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             ----HHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                1111111011111  234677999999999999987  9999999763

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.5e-43  Score=313.92  Aligned_cols=271  Identities=22%  Similarity=0.349  Sum_probs=206.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-----------------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCcccee
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-----------------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL  130 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-----------------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~  130 (363)
                      ++|++.+.||+|+||.||++.+.                 +...+++|++...........+.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            47999999999999999998532                 2346899998764444445678999999999999999999


Q ss_pred             eeEEEeCCeeEEEEecccCCChhhhhcCCCCCCC--CCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCce
Q 046595          131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQG--AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNV  208 (363)
Q Consensus       131 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Ni  208 (363)
                      ++++...+..+++|||+.+++|.+++........  ......+++..++.++.|++.||.|||++   +++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence            9999999999999999999999999976542211  11223488899999999999999999999   999999999999


Q ss_pred             eecCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh--CCCCCCCCCCcc
Q 046595          209 LLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT--GRKPVDHTMPKG  286 (363)
Q Consensus       209 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~--g~~p~~~~~~~~  286 (363)
                      +++.++.++|+|||++................++..|++||...++.++.++|+|||||++|||++  |..||.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999875543322111223345678999999888899999999999999999998  778886443221


Q ss_pred             ccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 046595          287 QQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQP  350 (363)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~  350 (363)
                      ...   ......     .. .........+..++..+.+++.+||+.||++||++.+|++.|++
T Consensus       242 ~~~---~~~~~~-----~~-~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         242 VIE---NTGEFF-----RD-QGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHH---HHHHHH-----hh-ccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            110   000000     00 00000111123455779999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.4e-43  Score=311.36  Aligned_cols=258  Identities=25%  Similarity=0.417  Sum_probs=205.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCC-C---CeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTD-G---TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~-~---~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      +.|++.+.||+|+||.||+|.... +   ..|++|.+...........+..|+.+++.++||||+++++++......++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            357889999999999999997643 3   359999987644444456889999999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.+++|.+++.....        .+++.+++.++.|++.||.|||++   +++|+||||+||+++.++.++|+|||+
T Consensus        84 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~  152 (269)
T cd05065          84 TEFMENGALDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGL  152 (269)
T ss_pred             EecCCCCcHHHHHhhCCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcc
Confidence            999999999999975432        288999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccc-cc--cccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccc
Q 046595          224 TNQSSDTAARLHSTR-VL--GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       224 a~~~~~~~~~~~~~~-~~--gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      +.............. ..  ++..|+|||.+.+..++.++||||||+++|||++ |..||.......   ...+.     
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i-----  224 (269)
T cd05065         153 SRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAI-----  224 (269)
T ss_pred             ccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHH-----
Confidence            865543222111111 11  2457999999998899999999999999999886 999996543221   11111     


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccc
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL  352 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~  352 (363)
                              ........+..++..+.+++..||+.+|.+||++.+|+..|+.++
T Consensus       225 --------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  269 (269)
T cd05065         225 --------EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI  269 (269)
T ss_pred             --------HcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence                    011111223345667999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.1e-43  Score=307.74  Aligned_cols=249  Identities=24%  Similarity=0.413  Sum_probs=198.6

Q ss_pred             eeeccCCceEEEEEeC---CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCCC
Q 046595           75 LIGEGSYGRVFYAKLT---DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGS  151 (363)
Q Consensus        75 ~lg~G~~g~V~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g~  151 (363)
                      .||+|+||.||+|.+.   ++..||+|++.........+.+.+|+.++++++|+||+++++++. ....++||||+.+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999653   355699999876544344567899999999999999999999875 457889999999999


Q ss_pred             hhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCccc
Q 046595          152 LHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTA  231 (363)
Q Consensus       152 L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~  231 (363)
                      |.+++.....        .+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++.......
T Consensus        81 L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  149 (257)
T cd05115          81 LNKFLSGKKD--------EITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD  149 (257)
T ss_pred             HHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCc
Confidence            9999875331        389999999999999999999999   99999999999999999999999999987543322


Q ss_pred             cccc-ccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccccccCC
Q 046595          232 ARLH-STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDP  309 (363)
Q Consensus       232 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (363)
                      .... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.......                +...+..
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----------------~~~~~~~  213 (257)
T cd05115         150 SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE----------------VMSFIEQ  213 (257)
T ss_pred             cceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH----------------HHHHHHC
Confidence            1111 111223578999999988889999999999999999996 999997543221                1111112


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 046595          310 KLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL  351 (363)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l  351 (363)
                      ......+..++.++.+++..||+.+|++||++.+|++.|+.+
T Consensus       214 ~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         214 GKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            222334455677899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.1e-43  Score=314.87  Aligned_cols=271  Identities=23%  Similarity=0.371  Sum_probs=208.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCC-----------------CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCcccee
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTD-----------------GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL  130 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~-----------------~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~  130 (363)
                      ++|++.+.||+|+||.||+|...+                 +..|++|.+...........+.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            579999999999999999986542                 245899998765444445678899999999999999999


Q ss_pred             eeEEEeCCeeEEEEecccCCChhhhhcCCCCCCC--CCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCce
Q 046595          131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQG--AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNV  208 (363)
Q Consensus       131 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Ni  208 (363)
                      ++++......+++|||+.+++|.+++........  ......+++..++.++.|++.||.|||++   +++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni  161 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence            9999999999999999999999999976542111  01122489999999999999999999999   999999999999


Q ss_pred             eecCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh--CCCCCCCCCCcc
Q 046595          209 LLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT--GRKPVDHTMPKG  286 (363)
Q Consensus       209 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~--g~~p~~~~~~~~  286 (363)
                      +++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|||++  +..||.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ  241 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence            999999999999999875543322222334456788999999988889999999999999999998  677886433211


Q ss_pred             ccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 046595          287 QQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQP  350 (363)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~  350 (363)
                         ...........      .........+..++.++.+++.+||+.||.+|||+.+|++.|++
T Consensus       242 ---~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         242 ---VIENAGHFFRD------DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             ---HHHHHHhcccc------ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence               11110000000      00111112233455789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-43  Score=313.17  Aligned_cols=252  Identities=23%  Similarity=0.317  Sum_probs=202.2

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC--CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP--EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      .|++.++||+|+||.||++... +++.||+|++......  .....+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999754 6899999998653321  223456789999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+|+|.+++.....       ..+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++.
T Consensus        81 ~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~  150 (285)
T cd05605          81 LMNGGDLKFHIYNMGN-------PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAV  150 (285)
T ss_pred             ccCCCcHHHHHHhcCc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCce
Confidence            9999999988864321       1388999999999999999999999   99999999999999999999999999986


Q ss_pred             CCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      .......   .....|+..|+|||++.+..++.++||||||+++|||++|..||..........            .+..
T Consensus       151 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~------------~~~~  215 (285)
T cd05605         151 EIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE------------EVER  215 (285)
T ss_pred             ecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH------------HHHH
Confidence            5432211   233578999999999998899999999999999999999999997532211100            0111


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP-----NMTIVVK  346 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  346 (363)
                      .+. .....++...+..+.+++.+||+.||.+||     ++.++++
T Consensus       216 ~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         216 RVK-EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             Hhh-hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            111 111233445677799999999999999999     8888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.1e-43  Score=325.41  Aligned_cols=258  Identities=16%  Similarity=0.237  Sum_probs=197.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      .+|.+.+.||+|+||.||+|.. .+++.||+|....       ..+.+|+.++++++||||+++++++......++|+|+
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            5799999999999999999975 4688999997532       3467899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +. ++|..++....         .+++.+++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++..
T Consensus       165 ~~-~~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~  231 (391)
T PHA03212        165 YK-TDLYCYLAAKR---------NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF  231 (391)
T ss_pred             CC-CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence            96 58988886543         288999999999999999999999   999999999999999999999999999865


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCcccc-----ch--h-hhccc--
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ-----SL--V-TWATP--  296 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~-----~~--~-~~~~~--  296 (363)
                      ...... .......||+.|+|||++.+..++.++|||||||++|||++|..||......+..     .+  + .....  
T Consensus       232 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p  310 (391)
T PHA03212        232 PVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHP  310 (391)
T ss_pred             cccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCCh
Confidence            332211 1123467999999999999899999999999999999999999887543221110     00  0 00000  


Q ss_pred             -cc---ccccccccc---------CCcCCCCC--CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          297 -RL---SEDKVKQCV---------DPKLNNDY--PPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       297 -~~---~~~~~~~~~---------~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                       ..   ....+....         .+.....+  ....+.++.+|+.+||+.||.+|||+.++++
T Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        311 NEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence             00   000000000         00000000  1235668999999999999999999999996

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.7e-43  Score=327.64  Aligned_cols=252  Identities=21%  Similarity=0.261  Sum_probs=196.2

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC--CCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA--PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      +|.+.+.||+|+||.||+|+.. +++.||+|++.....  ......+.+|+.+++.++|+||+++++.+.+....++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999754 688999999865321  2234578889999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+|+|.+++....         .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.
T Consensus        82 ~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~  149 (382)
T cd05625          82 YIPGGDMMSLLIRMG---------IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCT  149 (382)
T ss_pred             CCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCc
Confidence            999999999997543         278899999999999999999999   99999999999999999999999999975


Q ss_pred             CCCccc---------------------------------------------ccccccccccccCCCCccccccCCCCccC
Q 046595          226 QSSDTA---------------------------------------------ARLHSTRVLGTFGYHAPEYAMTGQITQKS  260 (363)
Q Consensus       226 ~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  260 (363)
                      ......                                             ........+||+.|+|||++.+..++.++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~  229 (382)
T cd05625         150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC  229 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCee
Confidence            321000                                             00001234699999999999999999999


Q ss_pred             ceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCC
Q 046595          261 DVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPN  340 (363)
Q Consensus       261 DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs  340 (363)
                      |||||||++|||++|+.||....+......+.            .+ ...+........+.+..++|.+++. +|.+|++
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~------------~~-~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~  295 (382)
T cd05625         230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVI------------NW-QTSLHIPPQAKLSPEASDLIIKLCR-GPEDRLG  295 (382)
T ss_pred             eEEechHHHHHHHhCCCCCCCCCHHHHHHHHH------------cc-CCCcCCCCcccCCHHHHHHHHHHcc-CHhHcCC
Confidence            99999999999999999997543321111000            00 0001111112345567787877764 9999997


Q ss_pred             ---HHHHHH
Q 046595          341 ---MTIVVK  346 (363)
Q Consensus       341 ---~~~vl~  346 (363)
                         +.+++.
T Consensus       296 ~~~~~ei~~  304 (382)
T cd05625         296 KNGADEIKA  304 (382)
T ss_pred             CCCHHHHhc
Confidence               887765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.2e-43  Score=322.20  Aligned_cols=269  Identities=24%  Similarity=0.393  Sum_probs=206.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEe------CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeC-Ce
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL------TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMES-NN  139 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~~  139 (363)
                      ++|++.+.||+|+||.||+|.+      .+++.||||.++..........+.+|+.++.++ +|+||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            4799999999999999999963      347889999997644444456788999999999 689999999987654 45


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCC-------------------------------------------------------
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQG-------------------------------------------------------  164 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~-------------------------------------------------------  164 (363)
                      .+++|||+.+|+|.+++........                                                       
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            7899999999999999865321000                                                       


Q ss_pred             ---CCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCccccccccccccc
Q 046595          165 ---AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG  241 (363)
Q Consensus       165 ---~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~g  241 (363)
                         ......+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++................+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence               00012378889999999999999999999   999999999999999999999999999876533222111222345


Q ss_pred             ccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccccccCCcCCCCCCHHHH
Q 046595          242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAI  320 (363)
Q Consensus       242 t~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (363)
                      +..|+|||.+.+..++.++||||||+++|+|++ |..||........  ..             ..+........+...+
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~-------------~~~~~~~~~~~~~~~~  308 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC-------------RRLKEGTRMRAPDYTT  308 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HH-------------HHHhccCCCCCCCCCC
Confidence            678999999988899999999999999999997 8999864322110  00             0000011111122234


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          321 AKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       321 ~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                      ..+.+++..||+.||++||++.+|++.|+.+++.
T Consensus       309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            5689999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=5.1e-43  Score=305.81  Aligned_cols=248  Identities=27%  Similarity=0.446  Sum_probs=200.1

Q ss_pred             CeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCCChh
Q 046595           74 ALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLH  153 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g~L~  153 (363)
                      ++||+|+||.||++...++..+++|.+...........+.+|+.+++.++||||+++++++......++||||+.+++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999887889999999876543333457889999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCccccc
Q 046595          154 DVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAAR  233 (363)
Q Consensus       154 ~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~  233 (363)
                      +++.....        .+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++.........
T Consensus        81 ~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  149 (250)
T cd05085          81 SFLRKKKD--------ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS  149 (250)
T ss_pred             HHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccc
Confidence            99865331        278999999999999999999999   9999999999999999999999999998654332211


Q ss_pred             ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccccccCCcCC
Q 046595          234 LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLN  312 (363)
Q Consensus       234 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (363)
                      . .....++..|+|||++.+..++.++||||||+++|+|++ |..||..........                .......
T Consensus       150 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~----------------~~~~~~~  212 (250)
T cd05085         150 S-SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE----------------QVEKGYR  212 (250)
T ss_pred             c-CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH----------------HHHcCCC
Confidence            1 112234567999999998899999999999999999998 999996442211100                0111111


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 046595          313 NDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ  349 (363)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~  349 (363)
                      ...+..++..+.+++.+||+.+|++||++.++++.|.
T Consensus       213 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         213 MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            2223345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.8e-43  Score=319.49  Aligned_cols=242  Identities=22%  Similarity=0.298  Sum_probs=196.1

Q ss_pred             CeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEEEEecccC
Q 046595           74 ALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATM  149 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~  149 (363)
                      +.||+|+||.||+|+.. +++.||+|++....  .......+..|..+++.+ +||||+++++++...+..++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999765 58899999987532  223345677888888887 699999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCc
Q 046595          150 GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       150 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      |+|..++....         .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~L~~~~~~~~---------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  148 (318)
T cd05570          81 GDLMFHIQRSG---------RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL  148 (318)
T ss_pred             CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCc
Confidence            99999887653         289999999999999999999999   999999999999999999999999999864322


Q ss_pred             ccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCC
Q 046595          230 TAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDP  309 (363)
Q Consensus       230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (363)
                      ...  ......|++.|+|||++.+..++.++|||||||++|+|++|+.||........   ..            .....
T Consensus       149 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~---~~------------~i~~~  211 (318)
T cd05570         149 GGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL---FQ------------SILED  211 (318)
T ss_pred             CCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH---HH------------HHHcC
Confidence            111  12345789999999999999999999999999999999999999975432111   00            00000


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 046595          310 KLNNDYPPKAIAKLAAVAALCVQYEADFRPNM-----TIVVK  346 (363)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~~vl~  346 (363)
                        ...++...+..+.+++.+||+.||.+||++     .++++
T Consensus       212 --~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         212 --EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             --CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence              112233456679999999999999999999     88775

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=6.7e-44  Score=324.09  Aligned_cols=253  Identities=21%  Similarity=0.258  Sum_probs=201.1

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC--CCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA--PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|.+.+.||+|+||.||+++.. +++.||+|++.....  ......+..|+.+++.++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36889999999999999999754 689999999876432  223456788999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+++|+|.+++.....        .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a  149 (330)
T cd05601          81 EYQPGGDLLSLLNRYED--------QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSA  149 (330)
T ss_pred             CCCCCCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCC
Confidence            99999999999976521        288999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCccccc------cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAM------TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL  298 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  298 (363)
                      ......... ......||+.|+|||++.      +..++.++|||||||++|||++|..||...........        
T Consensus       150 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~--------  220 (330)
T cd05601         150 ARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNN--------  220 (330)
T ss_pred             eECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHH--------
Confidence            755432221 123356899999999986      45678999999999999999999999975432111100        


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          299 SEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                          +... ...+........+..+.+++.+||+ +|.+||++.+++.
T Consensus       221 ----i~~~-~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         221 ----IMNF-QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             ----HHcC-CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence                0000 0000011112345678999999998 9999999999985

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.9e-43  Score=313.94  Aligned_cols=264  Identities=25%  Similarity=0.398  Sum_probs=206.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRI  141 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  141 (363)
                      .+|++.+.||+|+||.||++...      ++..+++|.+...........+.+|+.+++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~   84 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC   84 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence            47899999999999999999753      467899999876443334467889999999999999999999999999999


Q ss_pred             EEEecccCCChhhhhcCCCCCCCC-------------CCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCce
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGA-------------EPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNV  208 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~-------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Ni  208 (363)
                      ++|||+.+++|.+++.........             .....+++..++.++.|++.||.|||++   +++||||||+||
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ni  161 (288)
T cd05050          85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNC  161 (288)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhhe
Confidence            999999999999999754321110             1123478999999999999999999999   999999999999


Q ss_pred             eecCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccc
Q 046595          209 LLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQ  287 (363)
Q Consensus       209 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~  287 (363)
                      +++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus       162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~  241 (288)
T cd05050         162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV  241 (288)
T ss_pred             EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999999865433221111222345667999999988899999999999999999998 8888864322111


Q ss_pred             cchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 046595          288 QSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQP  350 (363)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~  350 (363)
                         ..            ...+.. ....+..++.++.+++.+||+.+|++|||+.+|++.|++
T Consensus       242 ---~~------------~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         242 ---IY------------YVRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ---HH------------HHhcCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence               00            000001 111233456779999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.8e-43  Score=312.73  Aligned_cols=263  Identities=25%  Similarity=0.394  Sum_probs=205.2

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRI  141 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  141 (363)
                      ++|.+.+.||+|+||.||++...      ++..+++|.+... .......+.+|+++++.++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            46888999999999999999632      3567888887653 2233467899999999999999999999999999999


Q ss_pred             EEEecccCCChhhhhcCCCCCC------CCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCc
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQ------GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK  215 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~  215 (363)
                      ++|||+.+++|.+++.......      .......+++..++.++.|++.||.|||+.   +++|+||||+||++++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence            9999999999999997543210      011123488999999999999999999999   9999999999999999999


Q ss_pred             eEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhc
Q 046595          216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWA  294 (363)
Q Consensus       216 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~  294 (363)
                      +||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||...........    
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----  236 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC----  236 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH----
Confidence            99999999865433222111223345788999999998999999999999999999998 8999864432211110    


Q ss_pred             cccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 046595          295 TPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQP  350 (363)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~  350 (363)
                                  .........+..++..+.+++.+||+.||.+||++.+|++.|+.
T Consensus       237 ------------~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         237 ------------ITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             ------------HHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence                        00111112223455679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.2e-43  Score=309.41  Aligned_cols=258  Identities=26%  Similarity=0.412  Sum_probs=205.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-C---CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-D---GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~---~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      .+|++.+.||+|+||.||+|.+. +   +..+++|.+...........+..|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            47889999999999999999753 2   3368999987644434456788999999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+++++|.+++.....        .+++.+++.++.|++.||.|||++   +++|+||||+||+++.++.++|+|||+
T Consensus        84 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~  152 (267)
T cd05066          84 TEYMENGSLDAFLRKHDG--------QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGL  152 (267)
T ss_pred             EEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCc
Confidence            999999999999975431        378999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccc-cccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccc
Q 046595          224 TNQSSDTAARL-HSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       224 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      +.......... ......++..|+|||.+.+..++.++|+||||+++||+++ |..||........   .....      
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~~------  223 (267)
T cd05066         153 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAIE------  223 (267)
T ss_pred             ccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHHh------
Confidence            87654322211 1112233568999999998899999999999999999887 9999975433211   11000      


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccc
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL  352 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~  352 (363)
                             .......+..++..+.+++.+||+.+|.+||++.++++.|++++
T Consensus       224 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  267 (267)
T cd05066         224 -------EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI  267 (267)
T ss_pred             -------CCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence                   01111122345667899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=9.2e-43  Score=306.05  Aligned_cols=253  Identities=28%  Similarity=0.442  Sum_probs=203.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      .+|.+...||+|++|.||++...++..+++|.+....  ...+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            4688999999999999999988777789999876532  23467889999999999999999998875 45688999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      .+++|.+++.....       ..+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++...
T Consensus        83 ~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~  152 (260)
T cd05069          83 GKGSLLDFLKEGDG-------KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLI  152 (260)
T ss_pred             CCCCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEc
Confidence            99999999975431       2378999999999999999999999   9999999999999999999999999998655


Q ss_pred             CcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      ...... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....+....   ..             
T Consensus       153 ~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~-------------  215 (260)
T cd05069         153 EDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL---EQ-------------  215 (260)
T ss_pred             cCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH-------------
Confidence            332211 1122346678999999988899999999999999999999 89999754321110   00             


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQP  350 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~  350 (363)
                      .........+...+..+.+++.+||+.||++||++++|++.|++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         216 VERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             HHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            11111122334556789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.3e-43  Score=319.58  Aligned_cols=238  Identities=22%  Similarity=0.297  Sum_probs=189.5

Q ss_pred             CeeeccCCceEEEEEeC-CCCeEEEEEccCCCC--CCchHHHHHHHH-HHhcCCCCccceeeeEEEeCCeeEEEEecccC
Q 046595           74 ALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA--PEPESDFAAQLS-VVSRLKHEHFVELLGYCMESNNRILVYQFATM  149 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  149 (363)
                      +.||+|+||.||+|... +++.||+|++.....  ......+..|.. +++.++||||+++++.+...+..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999765 689999999865321  122334455544 56789999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCc
Q 046595          150 GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       150 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      |+|..++....         .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 g~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~  148 (323)
T cd05575          81 GELFFHLQRER---------SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE  148 (323)
T ss_pred             CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccccc
Confidence            99999987543         288999999999999999999999   999999999999999999999999999865322


Q ss_pred             ccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCC
Q 046595          230 TAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDP  309 (363)
Q Consensus       230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (363)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|..||..........               .....
T Consensus       149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~---------------~i~~~  211 (323)
T cd05575         149 HSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD---------------NILNK  211 (323)
T ss_pred             CCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH---------------HHHcC
Confidence            211  1334579999999999999999999999999999999999999997542211100               00011


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 046595          310 KLNNDYPPKAIAKLAAVAALCVQYEADFRPNMT  342 (363)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~  342 (363)
                      .  ...+...+..+.+++.+||+.||.+||++.
T Consensus       212 ~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         212 P--LRLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             C--CCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            0  112233466799999999999999999884

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.6e-43  Score=320.80  Aligned_cols=239  Identities=21%  Similarity=0.277  Sum_probs=189.3

Q ss_pred             CeeeccCCceEEEEEeC-CCCeEEEEEccCCCC--CCchHHHHHHH-HHHhcCCCCccceeeeEEEeCCeeEEEEecccC
Q 046595           74 ALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA--PEPESDFAAQL-SVVSRLKHEHFVELLGYCMESNNRILVYQFATM  149 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  149 (363)
                      +.||+|+||.||+|+.. +++.||+|++.....  ......+..|. .+++.++|+||+++++++...+..++||||+.+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999765 578899999865321  12223444444 456788999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCc
Q 046595          150 GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       150 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      ++|.+++....         .+.+..+..++.|++.||.|||++   ||+||||||+|||++.++.+||+|||++.....
T Consensus        81 ~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~  148 (325)
T cd05602          81 GELFYHLQRER---------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  148 (325)
T ss_pred             CcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccccc
Confidence            99999997643         278889999999999999999999   999999999999999999999999999865332


Q ss_pred             ccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCC
Q 046595          230 TAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDP  309 (363)
Q Consensus       230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (363)
                      ...  ......||+.|+|||++.+..++.++|||||||++|+|++|..||........   ..            .....
T Consensus       149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~------------~i~~~  211 (325)
T cd05602         149 HNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YD------------NILNK  211 (325)
T ss_pred             CCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---HH------------HHHhC
Confidence            211  13346799999999999999999999999999999999999999975432111   00            00000


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 046595          310 KLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTI  343 (363)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~  343 (363)
                        ...++...+..+.+++.+||+.||.+||++.+
T Consensus       212 --~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~  243 (325)
T cd05602         212 --PLQLKPNITNSARHLLEGLLQKDRTKRLGAKD  243 (325)
T ss_pred             --CcCCCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence              01123345667999999999999999998874

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-42  Score=325.31  Aligned_cols=261  Identities=18%  Similarity=0.219  Sum_probs=195.1

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      ..|.+.+.||+|+||.||++.+. +++.|+||....       ..+.+|+.++++++|+||+++++++......++||++
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            36999999999999999999765 578899996432       2457899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +. ++|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+||||+.++.+||+|||+++.
T Consensus       242 ~~-~~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~  309 (461)
T PHA03211        242 YR-SDLYTYLGARLR--------PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACF  309 (461)
T ss_pred             cC-CCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCcee
Confidence            96 589888865321        389999999999999999999999   999999999999999999999999999876


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccc-----cch---hhhccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQ-----QSL---VTWATPRL  298 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~-----~~~---~~~~~~~~  298 (363)
                      ..............||..|+|||++.+..++.++|||||||+||||++|..|+........     ..+   +.......
T Consensus       310 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~  389 (461)
T PHA03211        310 ARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV  389 (461)
T ss_pred             cccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc
Confidence            5433222222345799999999999999999999999999999999998866532211110     000   11000000


Q ss_pred             cc------cccc-cccC---CcCCC-----CCC--HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          299 SE------DKVK-QCVD---PKLNN-----DYP--PKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       299 ~~------~~~~-~~~~---~~~~~-----~~~--~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                      ..      ..+. ....   .....     .+.  ......+.+||.+||+.||.+|||+.|+++.
T Consensus       390 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        390 DEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             ccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00      0000 0000   00000     000  0223468899999999999999999999874

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.1e-43  Score=310.77  Aligned_cols=272  Identities=24%  Similarity=0.390  Sum_probs=205.1

Q ss_pred             CCCCCCeeeccCCceEEEEEe-----CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeC--CeeE
Q 046595           69 NFGTKALIGEGSYGRVFYAKL-----TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMES--NNRI  141 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~  141 (363)
                      .|++.+.||+|+||.||+++.     .++..|++|.+...........+.+|+.+++.++|+||+++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            478889999999999999963     357889999987654444456789999999999999999999988775  5678


Q ss_pred             EEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeee
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADF  221 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df  221 (363)
                      +||||+++++|.+++.....        .+++..++.++.|++.||.|||++   +++||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~g~~L~~~l~~~~~--------~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~df  153 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKN--------KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDF  153 (284)
T ss_pred             EEEEccCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCC
Confidence            99999999999999865421        288999999999999999999999   9999999999999999999999999


Q ss_pred             ccCCCCCccccc-ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccc
Q 046595          222 NLTNQSSDTAAR-LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE  300 (363)
Q Consensus       222 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  300 (363)
                      |++......... .......|+..|+|||.+.+..++.++||||||+++|||+++..|+.............. ......
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~-~~~~~~  232 (284)
T cd05079         154 GLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPT-HGQMTV  232 (284)
T ss_pred             ccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccc-cccccH
Confidence            998765432221 112234567789999999888899999999999999999998766532211000000000 000000


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccc
Q 046595          301 DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL  352 (363)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~  352 (363)
                      ...............+..++..+.+++.+||+.+|++||++.+|++.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~  284 (284)
T cd05079         233 TRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL  284 (284)
T ss_pred             HHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence            0000011111111223345678999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-43  Score=306.55  Aligned_cols=255  Identities=27%  Similarity=0.447  Sum_probs=207.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      .++|.+.+.||+|+||.||++...++..+++|.+...  ......+.+|+.+++.++|+||+++++++......+++|||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG--TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC--ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            4579999999999999999998877888999998753  23456789999999999999999999999988999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|.+++.....       ..+++..+..++.|++.||.|||++   +++|+||||+||++++++.++|+|||++..
T Consensus        83 ~~~~~L~~~i~~~~~-------~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~  152 (261)
T cd05034          83 MSKGSLLDFLKSGEG-------KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARL  152 (261)
T ss_pred             cCCCCHHHHHhcccc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECcccccee
Confidence            999999999976432       2388999999999999999999999   999999999999999999999999999876


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      ....... ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||........   ...            
T Consensus       153 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~------------  216 (261)
T cd05034         153 IEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV---LEQ------------  216 (261)
T ss_pred             ccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH------------
Confidence            5432111 1112234678999999998889999999999999999999 9999964422111   110            


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQP  350 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~  350 (363)
                       .........+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus       217 -~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         217 -VERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -HHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence             01111112223346679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-43  Score=317.71  Aligned_cols=253  Identities=21%  Similarity=0.349  Sum_probs=206.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCC-CCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEEEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSS-APEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      .+.|++.+.||+||.+.||++...+.+.||+|++.... +......|..|+.+|.+| .|.+|+++++|-..++.+||||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            35699999999999999999998888888888776543 333457899999999999 4999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||-+. +|..+|.+....        +..-.+..++.|++.|+.++|++   ||||.||||.|+|+- .|.+||+|||+|
T Consensus       440 E~Gd~-DL~kiL~k~~~~--------~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA  506 (677)
T KOG0596|consen  440 ECGDI-DLNKILKKKKSI--------DPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIA  506 (677)
T ss_pred             ecccc-cHHHHHHhccCC--------CchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechh
Confidence            98766 999999887642        33237889999999999999999   999999999999995 569999999999


Q ss_pred             CCCCcccccccccccccccCCCCccccccCC-----------CCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhh
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQ-----------ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTW  293 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~  293 (363)
                      ...............+||+.||+||.+....           .+.++|||||||+||+|+.|+.||.....         
T Consensus       507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---------  577 (677)
T KOG0596|consen  507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---------  577 (677)
T ss_pred             cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---------
Confidence            8887766666667789999999999986432           56789999999999999999999974321         


Q ss_pred             ccccccccccccccCCcCCCCCCHHHHH-HHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          294 ATPRLSEDKVKQCVDPKLNNDYPPKAIA-KLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                           ...++..+.++.-...|+.--.. ++.++++.||+.||++||++.++|+
T Consensus       578 -----~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  578 -----QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             -----HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence                 11233444455444444432222 2999999999999999999999987

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.8e-43  Score=310.63  Aligned_cols=248  Identities=21%  Similarity=0.293  Sum_probs=196.2

Q ss_pred             eeccCCceEEEEEeC-CCCeEEEEEccCCCCC--CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCCCh
Q 046595           76 IGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP--EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSL  152 (363)
Q Consensus        76 lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g~L  152 (363)
                      ||+|+||.||++... +++.||+|.+......  .....+..|+.+++.++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999754 6889999998653322  1235677899999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCcccc
Q 046595          153 HDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA  232 (363)
Q Consensus       153 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~  232 (363)
                      ..++.....     ....+++..++.++.|++.||.|||++   +|+||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~~~~-----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  152 (280)
T cd05608          81 RYHIYNVDE-----ENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS  152 (280)
T ss_pred             HHHHHhccc-----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc
Confidence            988754221     112389999999999999999999999   999999999999999999999999999865443222


Q ss_pred             cccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCC
Q 046595          233 RLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLN  312 (363)
Q Consensus       233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (363)
                      .  .....||+.|+|||++.+..++.++||||||+++|||++|+.||............           .......  .
T Consensus       153 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~-----------~~~~~~~--~  217 (280)
T cd05608         153 K--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL-----------KQRILND--S  217 (280)
T ss_pred             c--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH-----------HHhhccc--C
Confidence            1  23457899999999999999999999999999999999999999753221110000           0000010  1


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046595          313 NDYPPKAIAKLAAVAALCVQYEADFRP-----NMTIVVK  346 (363)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  346 (363)
                      ..++...+..+.+++.+||+.||++||     +++++++
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         218 VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            123445667799999999999999999     7788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.7e-43  Score=317.30  Aligned_cols=244  Identities=21%  Similarity=0.283  Sum_probs=193.3

Q ss_pred             CeeeccCCceEEEEEeC-CCCeEEEEEccCCCC--CCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEEEEecccC
Q 046595           74 ALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA--PEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATM  149 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~  149 (363)
                      +.||+|+||.||+|... +++.||+|++.....  ......+..|+.++.++ +|+||+.+++++......++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999764 578899999976432  22345678899998888 699999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCc
Q 046595          150 GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       150 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      |+|..++....         .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 ~~L~~~~~~~~---------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~  148 (327)
T cd05617          81 GDLMFHMQRQR---------KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG  148 (327)
T ss_pred             CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccC
Confidence            99999886543         289999999999999999999999   999999999999999999999999999864322


Q ss_pred             ccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCC
Q 046595          230 TAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDP  309 (363)
Q Consensus       230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (363)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|..||.............+....        ....
T Consensus       149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~--------~~~~  218 (327)
T cd05617         149 PGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV--------ILEK  218 (327)
T ss_pred             CCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH--------HHhC
Confidence            111  123467999999999999999999999999999999999999999644322211111111000        0011


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 046595          310 KLNNDYPPKAIAKLAAVAALCVQYEADFRPNM  341 (363)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~  341 (363)
                        ...++...+..+.+++.+||+.||++|+++
T Consensus       219 --~~~~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         219 --PIRIPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             --CCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence              112344456678999999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=6.1e-43  Score=308.50  Aligned_cols=258  Identities=24%  Similarity=0.421  Sum_probs=205.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CC---CeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DG---TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~---~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      .+|+..+.||+|+||.||+|... ++   ..+++|.+.........+.+..|+.+++.++|+||+++++++...+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            46788899999999999999764 33   368999987654444456788999999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.+++|.+++.....        .+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+
T Consensus        85 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~  153 (268)
T cd05063          85 TEYMENGALDKYLRDHDG--------EFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGL  153 (268)
T ss_pred             EEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCcc
Confidence            999999999999965321        388999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCccccccc-ccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccc
Q 046595          224 TNQSSDTAARLH-STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       224 a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      +........... ......+..|+|||.+.+..++.++||||||+++|||++ |..||...........           
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~-----------  222 (268)
T cd05063         154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKA-----------  222 (268)
T ss_pred             ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH-----------
Confidence            865543222111 111223457999999988889999999999999999998 9999965432211110           


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccc
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL  352 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~  352 (363)
                           +........+..++..+.+++.+||+.+|++||++.+|++.|++++
T Consensus       223 -----i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         223 -----INDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             -----HhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence                 1111111222345667999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=5.6e-43  Score=331.96  Aligned_cols=268  Identities=17%  Similarity=0.243  Sum_probs=194.2

Q ss_pred             HHHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC------CCccceeeeEEEe
Q 046595           64 NRLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK------HEHFVELLGYCME  136 (363)
Q Consensus        64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~  136 (363)
                      ....++|++.+.||+|+||.||+|.+. +++.||||+++...  ........|+.+++.++      |.+++.+++++..
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            334578999999999999999999754 58889999986422  22334556777766664      4568888888876


Q ss_pred             C-CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-cCCCCeEEecccCCceeecCCC
Q 046595          137 S-NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE-KVQPPIVHRDVRSSNVLLFDDF  214 (363)
Q Consensus       137 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~  214 (363)
                      . ...++||+++ +++|.+++....         .+++..+..++.||+.||.|||+ .   +|+||||||+|||++.++
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~---------~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~  269 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHG---------PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSD  269 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCC
Confidence            4 4678899887 668998886543         28899999999999999999997 6   899999999999998765


Q ss_pred             ----------------ceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCC
Q 046595          215 ----------------KSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP  278 (363)
Q Consensus       215 ----------------~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p  278 (363)
                                      .+||+|||++......     .....||+.|+|||++.+..|+.++|||||||++|||++|+.|
T Consensus       270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p  344 (467)
T PTZ00284        270 TVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL  344 (467)
T ss_pred             cccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence                            4999999987543221     2346799999999999999999999999999999999999999


Q ss_pred             CCCCCCccccchhhhccccccc--------cccccccCC--cCCCCC---------------CHHHHHHHHHHHHhccCC
Q 046595          279 VDHTMPKGQQSLVTWATPRLSE--------DKVKQCVDP--KLNNDY---------------PPKAIAKLAAVAALCVQY  333 (363)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~--~~~~~~---------------~~~~~~~l~~li~~cl~~  333 (363)
                      |...........+.........        .....+.+.  .+....               .......+.+||.+||+.
T Consensus       345 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  424 (467)
T PTZ00284        345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY  424 (467)
T ss_pred             CCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCc
Confidence            9765443222221111100000        000000000  000000               001235688999999999


Q ss_pred             CCCCCCCHHHHHH--Hhccc
Q 046595          334 EADFRPNMTIVVK--ALQPL  351 (363)
Q Consensus       334 ~p~~RPs~~~vl~--~l~~l  351 (363)
                      ||++|||+.|+++  +|...
T Consensus       425 dP~~R~ta~e~L~Hp~~~~~  444 (467)
T PTZ00284        425 DRQKRLNARQMTTHPYVLKY  444 (467)
T ss_pred             ChhhCCCHHHHhcCcccccc
Confidence            9999999999997  55543

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.5e-43  Score=314.07  Aligned_cols=277  Identities=19%  Similarity=0.289  Sum_probs=209.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|.+...........+.+|+.+++.++|+||+++++++......++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            46999999999999999999764 68899999987655444455778899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+ +|.+++.....        .+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++..
T Consensus        86 ~~~-~l~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  153 (301)
T cd07873          86 LDK-DLKQYLDDCGN--------SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARA  153 (301)
T ss_pred             ccc-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhc
Confidence            975 89988865432        278999999999999999999999   999999999999999999999999999865


Q ss_pred             CCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc-------
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL-------  298 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~-------  298 (363)
                      .......  .....+++.|+|||++.+. .++.++||||||+++|+|++|+.||...................       
T Consensus       154 ~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (301)
T cd07873         154 KSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG  231 (301)
T ss_pred             cCCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchh
Confidence            4322211  2234578899999988754 57889999999999999999999997554322111110000000       


Q ss_pred             --cccccccccCCcCCC----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HhccccccCCCC
Q 046595          299 --SEDKVKQCVDPKLNN----DYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPLLNSKPAG  358 (363)
Q Consensus       299 --~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l~~~~~~~  358 (363)
                        ..........+....    .....++..+.++|.+||+.||.+|||+.++++  .++.+.++...-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~~~~  299 (301)
T cd07873         232 ILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIHKL  299 (301)
T ss_pred             hhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchhhcC
Confidence              000000000011100    011234567899999999999999999999998  666666554443

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-42  Score=303.86  Aligned_cols=249  Identities=24%  Similarity=0.436  Sum_probs=201.3

Q ss_pred             CeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCCChh
Q 046595           74 ALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLH  153 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g~L~  153 (363)
                      +.||.|+||.||++...+++.|++|.+...........+..|+.+++.++|+||+++++++......++||||+.+++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            36899999999999876699999999876544334567889999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCccccc
Q 046595          154 DVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAAR  233 (363)
Q Consensus       154 ~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~  233 (363)
                      +++.....        .+++..++.++.+++.||.|||++   +++||||||+||+++.++.++|+|||++.........
T Consensus        81 ~~l~~~~~--------~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  149 (251)
T cd05041          81 TFLRKKKN--------RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT  149 (251)
T ss_pred             HHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcce
Confidence            99865321        278999999999999999999999   9999999999999999999999999998755432221


Q ss_pred             ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccccccCCcCC
Q 046595          234 LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLN  312 (363)
Q Consensus       234 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (363)
                      .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........                +.....
T Consensus       150 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~----------------~~~~~~  213 (251)
T cd05041         150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER----------------IESGYR  213 (251)
T ss_pred             eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH----------------HhcCCC
Confidence            11122234567999999988899999999999999999999 8888865432211111                111111


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 046595          313 NDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ  349 (363)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~  349 (363)
                      ...+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus       214 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         214 MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            2223445678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=9.9e-43  Score=305.13  Aligned_cols=249  Identities=29%  Similarity=0.453  Sum_probs=201.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEE-eCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM-ESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~  146 (363)
                      .+|.+.+.||+|+||.||++... +..+++|.+...   .....+.+|+.++++++|+|++++++++. .....+++|||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC---chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            47889999999999999999765 788999988642   33567889999999999999999999764 45678999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|.+++.....       ..+++..++.++.|++.||.|||++   +++||||||+||++++++.+||+|||++..
T Consensus        82 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~  151 (256)
T cd05082          82 MAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE  151 (256)
T ss_pred             CCCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCcccee
Confidence            999999999975432       1378999999999999999999999   999999999999999999999999999864


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      .....     ....++..|+|||++.+..++.++||||||+++|+|++ |+.||.......   .             ..
T Consensus       152 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~-------------~~  210 (256)
T cd05082         152 ASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---V-------------VP  210 (256)
T ss_pred             ccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---H-------------HH
Confidence            33221     22344668999999988899999999999999999998 999986432211   0             01


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL  351 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l  351 (363)
                      .+........+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         211 RVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            1111122233345567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.1e-43  Score=309.27  Aligned_cols=261  Identities=26%  Similarity=0.423  Sum_probs=208.2

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCC----eEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGT----PAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      .+|++.+.||+|+||.||+|.+. +++    .+++|.+...........+.+|+.++++++|+||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            46888999999999999999754 333    5899988765443344678899999999999999999999887 78899


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      +|||+.+|+|.+++.....        .+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||
T Consensus        86 v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg  154 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKD--------NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFG  154 (279)
T ss_pred             EEecCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCc
Confidence            9999999999999975432        288999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      ++................++..|+|||.+....++.++|+||||+++||+++ |..||.........             
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------------  221 (279)
T cd05057         155 LAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP-------------  221 (279)
T ss_pred             ccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH-------------
Confidence            9876553322211222234568999999988899999999999999999998 99999754322111             


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCC
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP  356 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~  356 (363)
                         ..+........+..++..+.+++.+||..+|.+||++.++++.|..+.+..+
T Consensus       222 ---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (279)
T cd05057         222 ---DLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ  273 (279)
T ss_pred             ---HHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence               1111111112223344568999999999999999999999999999877544

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-42  Score=306.74  Aligned_cols=258  Identities=26%  Similarity=0.434  Sum_probs=200.0

Q ss_pred             CeeeccCCceEEEEEeCC-CC--eEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEEEEecccC
Q 046595           74 ALIGEGSYGRVFYAKLTD-GT--PAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATM  149 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~-~~--~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~  149 (363)
                      +.||+|+||.||+|...+ +.  .+++|.+...........+..|+.++.++ +||||+++++++......+++|||+.+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            358999999999998653 43  46888876544344456788999999999 799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCC-------CCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          150 GSLHDVLHGRKGVQG-------AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       150 g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ++|.+++........       ......+++..++.++.|++.||+|||++   +++|+||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            999999976432110       11123488999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      ++........   ......+..|+|||++.+..++.++||||||+++|||++ |..||.......   ....        
T Consensus       158 l~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~--------  223 (270)
T cd05047         158 LSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEK--------  223 (270)
T ss_pred             Cccccchhhh---ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHHH--------
Confidence            9753221111   111234567999999988889999999999999999997 999996432211   1110        


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccc
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN  353 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~  353 (363)
                           +........+...+..+.+++.+||+.+|.+|||+.+++..|+++++
T Consensus       224 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~  270 (270)
T cd05047         224 -----LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  270 (270)
T ss_pred             -----HhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence                 01111112223445679999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=7.1e-43  Score=317.86  Aligned_cols=268  Identities=26%  Similarity=0.423  Sum_probs=209.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCC--------CCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCC
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTD--------GTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESN  138 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~  138 (363)
                      .+|.+.+.||+|+||.||+|+...        ...+++|.+...........+.+|+.+++++ +|+||+++++++....
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            479999999999999999996421        2368999887644444457889999999999 7999999999999999


Q ss_pred             eeEEEEecccCCChhhhhcCCCCCCC-------CCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQG-------AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF  211 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~  211 (363)
                      ..++++||+.+|+|.+++........       ......+++..++.++.|++.||.|||++   +++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence            99999999999999999975432110       01223488999999999999999999999   999999999999999


Q ss_pred             CCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccch
Q 046595          212 DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSL  290 (363)
Q Consensus       212 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~  290 (363)
                      .++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.......... 
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~-  247 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK-  247 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH-
Confidence            999999999999875543222111222334567999999998999999999999999999998 888886442211111 


Q ss_pred             hhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          291 VTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                                     .+........+..++..+.+++.+||+.+|.+||++.+|++.|++++..
T Consensus       248 ---------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~  296 (334)
T cd05100         248 ---------------LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV  296 (334)
T ss_pred             ---------------HHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence                           1111111222334566799999999999999999999999999988743

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6.7e-43  Score=309.73  Aligned_cols=246  Identities=20%  Similarity=0.262  Sum_probs=192.5

Q ss_pred             eeccCCceEEEEEeC-CCCeEEEEEccCCCCC--CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCCCh
Q 046595           76 IGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP--EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSL  152 (363)
Q Consensus        76 lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g~L  152 (363)
                      ||+|+||.||+++.. +|+.||+|.+......  .....+..|+++++.++||||+++++++......++||||+.+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999754 6899999998653221  1233456799999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCcccc
Q 046595          153 HDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA  232 (363)
Q Consensus       153 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~  232 (363)
                      .+++......       .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~  150 (277)
T cd05607          81 KYHIYNVGER-------GLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT  150 (277)
T ss_pred             HHHHHhcccc-------CCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce
Confidence            9888644321       278899999999999999999999   999999999999999999999999999865543221


Q ss_pred             cccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCC
Q 046595          233 RLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLN  312 (363)
Q Consensus       233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (363)
                         .....|+..|+|||++.+..++.++|||||||++|||++|..||...........+           ..........
T Consensus       151 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~-----------~~~~~~~~~~  216 (277)
T cd05607         151 ---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL-----------KRRTLEDEVK  216 (277)
T ss_pred             ---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH-----------HHHhhccccc
Confidence               23356899999999999888999999999999999999999999643221110000           0000111110


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          313 NDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      . .....+.++.+++.+||+.||++||++.++++
T Consensus       217 ~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         217 F-EHQNFTEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             c-ccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence            0 01234567999999999999999999976553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.1e-42  Score=305.43  Aligned_cols=255  Identities=24%  Similarity=0.413  Sum_probs=205.7

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      .++|++.+.||+|+||.||++...++..+++|.+...  ......+.+|+.+++.++|+||+++++++.. ...+++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            4689999999999999999998777788999988653  2234678899999999999999999999887 778999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|.+++.....       ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++..
T Consensus        82 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~  151 (260)
T cd05073          82 MAKGSLLDFLKSDEG-------SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV  151 (260)
T ss_pred             CCCCcHHHHHHhCCc-------cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceee
Confidence            999999999976432       1378899999999999999999999   999999999999999999999999999865


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      ....... ......++..|+|||.+.+..++.++|+||||+++|++++ |..||.........   .             
T Consensus       152 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~-------------  214 (260)
T cd05073         152 IEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---R-------------  214 (260)
T ss_pred             ccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH---H-------------
Confidence            5432211 1122345678999999988889999999999999999999 89999754321111   1             


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL  351 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l  351 (363)
                      .+........+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         215 ALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             HHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence            0111111122334556799999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-45  Score=297.70  Aligned_cols=254  Identities=21%  Similarity=0.286  Sum_probs=206.7

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCC-CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSS-APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      .+...|.+.++||+|.|+.|+++.+ .+|+.+++|.+.... .....+.+.+|+.+-+.|+||||+++.+.+.+....||
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            3456788889999999999999954 579999999886543 33456789999999999999999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec---CCCceEEe
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIA  219 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~---~~~~vkl~  219 (363)
                      |+|++.|++|..-|-.+.         .+++..+-....||+++|.|+|.+   +|||||+||+|+++.   ..--+||+
T Consensus        88 vFe~m~G~dl~~eIV~R~---------~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~  155 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVARE---------FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLA  155 (355)
T ss_pred             EEecccchHHHHHHHHHH---------HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeec
Confidence            999999999976665442         388899999999999999999999   999999999999995   34568999


Q ss_pred             eeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc
Q 046595          220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       220 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      |||+|....+..   ....+.|||.|||||+++..+|+..+|||+.||+||-|+.|.+||.+.+.......+.-..    
T Consensus       156 ~FGvAi~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~----  228 (355)
T KOG0033|consen  156 DFGLAIEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGA----  228 (355)
T ss_pred             ccceEEEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccc----
Confidence            999998776332   2456789999999999999999999999999999999999999997643322211111000    


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                               -.+....-....++..+|+.+||..||.+|.|+.|.+.
T Consensus       229 ---------yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  229 ---------YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             ---------cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                     01112222355677999999999999999999998764

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-42  Score=305.05  Aligned_cols=253  Identities=22%  Similarity=0.332  Sum_probs=204.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCC----chHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPE----PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      ++|.+.+.||+|++|.||.+.. .+++.+++|.+.......    ....+.+|+.++++++||||+++++++......++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4689999999999999999975 468999999986543221    23568889999999999999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ++||+.+++|.+++....         .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||
T Consensus        82 v~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg  149 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG---------ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG  149 (263)
T ss_pred             EEEECCCCcHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence            999999999999987543         278899999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCccccccc-ccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccc
Q 046595          223 LTNQSSDTAARLH-STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       223 ~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      ++........... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||.........             
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-------------  216 (263)
T cd06625         150 ASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI-------------  216 (263)
T ss_pred             cceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH-------------
Confidence            9865433221111 12356788999999999888999999999999999999999999644221110             


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                        ...........++...+..+.+++..||..+|.+|||+.++++.
T Consensus       217 --~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         217 --FKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             --HHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence              00111111223344566779999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-42  Score=304.44  Aligned_cols=250  Identities=30%  Similarity=0.483  Sum_probs=206.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      ++|++.+.||.|+||.||+|... ++.|++|.+.....  ....+.+|+.+++.++|+||+++++++......++||||+
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            47889999999999999999875 78899999976433  4568899999999999999999999999899999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      .+++|.+++.....       ..+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++...
T Consensus        83 ~~~~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~  152 (256)
T cd05039          83 AKGSLVDYLRSRGR-------AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEA  152 (256)
T ss_pred             CCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccc
Confidence            99999999975432       1389999999999999999999999   9999999999999999999999999998765


Q ss_pred             CcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      .....     ...++..|+|||.+.+..++.++||||||+++|+|++ |..||.......                +...
T Consensus       153 ~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----------------~~~~  211 (256)
T cd05039         153 SQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----------------VVPH  211 (256)
T ss_pred             ccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH----------------HHHH
Confidence            32211     2234667999999988889999999999999999998 999986442211                1111


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL  351 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l  351 (363)
                      +........+...+..+.+++.+||..+|++||++.++++.|+.+
T Consensus       212 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         212 VEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             HhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            111111222334567799999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=320.72  Aligned_cols=262  Identities=29%  Similarity=0.467  Sum_probs=226.5

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCC---C--CeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTD---G--TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~---~--~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      ....+.+.||.|.||.||.|...+   |  -.||||+.+....++..+.|..|..+|+.++||||++++|+|.+ ...|+
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi  467 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI  467 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence            345567789999999999996432   2  34899999988888888999999999999999999999999986 46799


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      |||.++.|.|..|++..+.        .++......+++||+.||.|||+.   .+|||||..+|||+...--|||+|||
T Consensus       468 vmEL~~~GELr~yLq~nk~--------sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFG  536 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNKD--------SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFG  536 (974)
T ss_pred             EEecccchhHHHHHHhccc--------cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccc
Confidence            9999999999999988764        388999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      +++...+..+-. .+...-...|||||.++-..++.++|||-|||.+||++. |..||.+-                .+.
T Consensus       537 LSR~~ed~~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv----------------kNs  599 (974)
T KOG4257|consen  537 LSRYLEDDAYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV----------------KNS  599 (974)
T ss_pred             hhhhccccchhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc----------------ccc
Confidence            999887765532 222334678999999999999999999999999999988 89999743                344


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCCC
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAG  358 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~~  358 (363)
                      .+...++.+-+...|+.||..|..|+.+||..+|.+||++++|...|.++++.....
T Consensus       600 DVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~  656 (974)
T KOG4257|consen  600 DVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKIN  656 (974)
T ss_pred             ceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhh
Confidence            555566677778889999999999999999999999999999999999998855443

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-44  Score=324.95  Aligned_cols=265  Identities=24%  Similarity=0.393  Sum_probs=231.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCC-CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      .+.....+||-|.||.||.|.|+. ...||||.++.  +......|+.|+.+|+.++|||+|+++++|..+..+|||+||
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE--DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf  344 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF  344 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhh--cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence            456677889999999999999874 67799999876  345578999999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      |..|+|.+||+.+....       ++.-.++.++.||..|++||..+   ++|||||..+|+|+.++..||+.|||+++.
T Consensus       345 M~yGNLLdYLRecnr~e-------v~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  345 MCYGNLLDYLRECNRSE-------VPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             ccCccHHHHHHHhchhh-------cchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhh
Confidence            99999999998876432       77778899999999999999999   999999999999999999999999999988


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      .....+..+. ...-...|.|||-+....++.++|||+|||+|||+.| |-.||.+                +....+..
T Consensus       415 MtgDTYTAHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG----------------idlSqVY~  477 (1157)
T KOG4278|consen  415 MTGDTYTAHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG----------------IDLSQVYG  477 (1157)
T ss_pred             hcCCceeccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC----------------ccHHHHHH
Confidence            7665544322 2234678999999999999999999999999999999 7788853                34455677


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCCCCCC
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGPEA  361 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~~~~~  361 (363)
                      +++.+++.+-|..|++.+.+|+..||+.+|.+||++.+|.+.|+.++.+...+.|.
T Consensus       478 LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSisdEV  533 (1157)
T KOG4278|consen  478 LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSISDEV  533 (1157)
T ss_pred             HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccccHHH
Confidence            78888889999999999999999999999999999999999999999887766553

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.1e-43  Score=316.57  Aligned_cols=242  Identities=22%  Similarity=0.292  Sum_probs=194.9

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCC-CCccceeeeEEEeCCeeEEEE
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLK-HEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      +|+..+.||+|+||.||+|... +++.||+|++....  .......+..|..++..+. |++|+++++++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3677889999999999999754 68899999987532  2233456778888888885 578888999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+|+|.+++....         .+++.+++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        81 Ey~~~g~L~~~i~~~~---------~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~  148 (323)
T cd05615          81 EYVNGGDLMYHIQQVG---------KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMC  148 (323)
T ss_pred             cCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccc
Confidence            9999999999987543         289999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      ........  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..........               
T Consensus       149 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~---------------  211 (323)
T cd05615         149 KEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQ---------------  211 (323)
T ss_pred             cccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHH---------------
Confidence            65322211  1234569999999999998899999999999999999999999997543211110               


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNM  341 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~  341 (363)
                      .+...  ...++...+..+.+++.+||+.+|.+|++.
T Consensus       212 ~i~~~--~~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         212 SIMEH--NVSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             HHHhC--CCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            01110  112334456678999999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=6.4e-43  Score=321.82  Aligned_cols=253  Identities=18%  Similarity=0.233  Sum_probs=198.8

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      ..++|++.+.||+|+||.||+|+.. +++.+|+|++....  .......+.+|+.+++.++||||+++++.+.+....++
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM  120 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            3468999999999999999999765 68889999986422  12223557789999999999999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ||||+.+|+|.+++....          +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus       121 v~Ey~~gg~L~~~~~~~~----------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG  187 (371)
T cd05622         121 VMEYMPGGDLVNLMSNYD----------VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG  187 (371)
T ss_pred             EEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCC
Confidence            999999999999997543          78889999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccC----CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG----QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL  298 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  298 (363)
                      ++........ .......||+.|+|||++.+.    .++.++|||||||++|||++|..||..........         
T Consensus       188 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~---------  257 (371)
T cd05622         188 TCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS---------  257 (371)
T ss_pred             ceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHH---------
Confidence            9875543211 112345799999999998754    37899999999999999999999997543211111         


Q ss_pred             cccccccccCCc--CCCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 046595          299 SEDKVKQCVDPK--LNNDYPPKAIAKLAAVAALCVQYEADF--RPNMTIVVKA  347 (363)
Q Consensus       299 ~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~~vl~~  347 (363)
                            .+....  +........+..+.++|..||..++.+  |+++.+|++.
T Consensus       258 ------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         258 ------KIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             ------HHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence                  111100  111111245667899999999844432  7799988874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.4e-42  Score=303.90  Aligned_cols=251  Identities=26%  Similarity=0.383  Sum_probs=204.7

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC-CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS-APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      +|.+.+.||+|++|.||++... +++.|++|.+.... .......+..|+.+++.++||||+++++++......++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778889999999999999764 68999999986532 233456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|.+++.....       ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus        81 ~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~  150 (256)
T cd08529          81 AENGDLHKLLKMQRG-------RPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKL  150 (256)
T ss_pred             CCCCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEccccccee
Confidence            999999999976421       2388999999999999999999999   999999999999999999999999999875


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      .......  .....|++.|+|||++.+..++.++|+||||+++|+|++|+.||.......   ...            ..
T Consensus       151 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~------------~~  213 (256)
T cd08529         151 LSDNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LIL------------KI  213 (256)
T ss_pred             ccCccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHH------------HH
Confidence            5433221  233568899999999998889999999999999999999999997543211   000            00


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                      . .......+..++..+.+++.+||+.+|++||++.++++.
T Consensus       214 ~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         214 I-RGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             H-cCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            0 111122233556779999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1e-42  Score=309.67  Aligned_cols=272  Identities=25%  Similarity=0.364  Sum_probs=201.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-----CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEe--CCee
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-----TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCME--SNNR  140 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~  140 (363)
                      .+|++.+.||+|+||.||.+..     .++..|++|.+.... ......+.+|+.+++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            4788899999999999999963     257889999986532 2334678899999999999999999998754  3467


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEee
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD  220 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D  220 (363)
                      ++|+||+.+++|.+++.....        .+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+|
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~d  151 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHRE--------RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGD  151 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcCc--------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECC
Confidence            899999999999999965421        288999999999999999999999   999999999999999999999999


Q ss_pred             eccCCCCCccccccc-ccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc
Q 046595          221 FNLTNQSSDTAARLH-STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       221 fg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      ||++........... .....++..|+|||.+.+..++.++||||||+++|||++|..++....................
T Consensus       152 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd05081         152 FGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMI  231 (284)
T ss_pred             CcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccc
Confidence            999876543221111 1112234569999999988999999999999999999998876643211100000000000000


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL  351 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l  351 (363)
                      ...+.+.+........+..++..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             hHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            0001111111111222334567799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.3e-42  Score=319.26  Aligned_cols=263  Identities=21%  Similarity=0.269  Sum_probs=198.3

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEeCC-----
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCMESN-----  138 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----  138 (363)
                      +.++|++.+.||+|+||.||++... ++..||+|++..... ......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999999999754 689999999875432 233467789999999999999999999886543     


Q ss_pred             -eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceE
Q 046595          139 -NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSK  217 (363)
Q Consensus       139 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk  217 (363)
                       ..++||||+.+ +|.+.+...           +++..+..++.|++.||.|||++   +|+||||||+||+++.++.+|
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~k  163 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHME-----------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK  163 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhcc-----------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEE
Confidence             46899999976 677766431           78889999999999999999999   999999999999999999999


Q ss_pred             EeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhc---
Q 046595          218 IADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWA---  294 (363)
Q Consensus       218 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~---  294 (363)
                      |+|||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.............-.   
T Consensus       164 l~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  240 (359)
T cd07876         164 ILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGT  240 (359)
T ss_pred             EecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999986543221   123457899999999999999999999999999999999999999765332111000000   


Q ss_pred             -----------------c--ccccccccccccCCcC---CCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          295 -----------------T--PRLSEDKVKQCVDPKL---NNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       295 -----------------~--~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                                       .  +........+......   ........+..+.+++.+||+.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         241 PSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             CcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence                             0  0000000000000000   00011123466899999999999999999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.8e-43  Score=329.76  Aligned_cols=269  Identities=20%  Similarity=0.267  Sum_probs=197.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeC--------
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMES--------  137 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------  137 (363)
                      .++|.+.+.||+|+||.||+|... +++.||||++....     ....+|+.+++.++|+||+++++++...        
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            357999999999999999999764 68899999885421     2345799999999999999998876432        


Q ss_pred             CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC-ce
Q 046595          138 NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF-KS  216 (363)
Q Consensus       138 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~v  216 (363)
                      ..+++||||+.+ +|.+++.....     ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++ .+
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~-----~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~v  210 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYAR-----NNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTL  210 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhh-----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCce
Confidence            246689999986 78777753221     112388999999999999999999999   999999999999998654 79


Q ss_pred             EEeeeccCCCCCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 046595          217 KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       217 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      ||+|||+++.......   .....||+.|+|||++.+. .++.++|||||||++|||++|..||...........+....
T Consensus       211 kL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~  287 (440)
T PTZ00036        211 KLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVL  287 (440)
T ss_pred             eeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            9999999976543221   2345789999999988764 68999999999999999999999997654322211111000


Q ss_pred             cccccccc------------ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhcccc
Q 046595          296 PRLSEDKV------------KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPLL  352 (363)
Q Consensus       296 ~~~~~~~~------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l~  352 (363)
                      .....+.+            .......+...++...+.++.+|+.+||+.||.+|||+.++++  .+..+.
T Consensus       288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence            00000000            0000111111223345668999999999999999999999985  555443

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.5e-43  Score=317.37  Aligned_cols=238  Identities=22%  Similarity=0.298  Sum_probs=188.9

Q ss_pred             CeeeccCCceEEEEEeC-CCCeEEEEEccCCCC--CCchHHHHHHH-HHHhcCCCCccceeeeEEEeCCeeEEEEecccC
Q 046595           74 ALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA--PEPESDFAAQL-SVVSRLKHEHFVELLGYCMESNNRILVYQFATM  149 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  149 (363)
                      ++||+|+||.||+|+.. +++.||+|++.....  ......+..|. .+++.++||||+++++++.+.+..++||||+.+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999865 688999999865321  12233455555 467889999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCc
Q 046595          150 GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       150 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      ++|...+....         .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  148 (321)
T cd05603          81 GELFFHLQRER---------CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE  148 (321)
T ss_pred             CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCC
Confidence            99998886543         278899999999999999999999   999999999999999999999999999865322


Q ss_pred             ccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCC
Q 046595          230 TAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDP  309 (363)
Q Consensus       230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (363)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|..||.......   ...            .+...
T Consensus       149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~------------~i~~~  211 (321)
T cd05603         149 PEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---MYD------------NILHK  211 (321)
T ss_pred             CCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---HHH------------HHhcC
Confidence            221  1334579999999999998899999999999999999999999997542211   100            00000


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 046595          310 KLNNDYPPKAIAKLAAVAALCVQYEADFRPNMT  342 (363)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~  342 (363)
                        ...++...+..+.+++.+||+.||.+||+..
T Consensus       212 --~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         212 --PLQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence              1122334456799999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.1e-42  Score=305.31  Aligned_cols=257  Identities=23%  Similarity=0.371  Sum_probs=194.4

Q ss_pred             CeeeccCCceEEEEEeC---CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCC
Q 046595           74 ALIGEGSYGRVFYAKLT---DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMG  150 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g  150 (363)
                      +.||+|+||.||+|.+.   ++..+++|.+...........+.+|+.++++++||||+++++++.+....++||||+.+|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            35899999999999754   345789998876544334457888999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCcc
Q 046595          151 SLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT  230 (363)
Q Consensus       151 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~  230 (363)
                      +|.+++.......    ....++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++......
T Consensus        81 ~L~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~  153 (269)
T cd05087          81 DLKGYLRSCRKAE----LMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE  153 (269)
T ss_pred             cHHHHHHHhhhcc----cccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCc
Confidence            9999997543211    11256778889999999999999999   9999999999999999999999999998654433


Q ss_pred             cccccccccccccCCCCccccccC-------CCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccc
Q 046595          231 AARLHSTRVLGTFGYHAPEYAMTG-------QITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       231 ~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      ..........|+..|+|||++.+.       .++.++|+||||+++|||++ |..||........... .+.      ..
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~-~~~------~~  226 (269)
T cd05087         154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY-TVR------EQ  226 (269)
T ss_pred             ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH-Hhh------cc
Confidence            322223345678899999988642       35789999999999999996 9999965433211110 000      00


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ  349 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~  349 (363)
                      ......+.+    ....+..+.+++..|| .+|++|||+++|+..|+
T Consensus       227 ~~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         227 QLKLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cCCCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            011111111    1223456888999999 58999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-42  Score=304.08  Aligned_cols=250  Identities=25%  Similarity=0.412  Sum_probs=198.9

Q ss_pred             CeeeccCCceEEEEEeCC----CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccC
Q 046595           74 ALIGEGSYGRVFYAKLTD----GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATM  149 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~----~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  149 (363)
                      +.||+|+||.||+|.+..    +..+++|.+...........+..|+.+++.++|+||+++++++. ....++||||+.+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999996432    26899999876554444567889999999999999999999876 4567999999999


Q ss_pred             CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCc
Q 046595          150 GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       150 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      ++|.+++....         .+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.....
T Consensus        80 ~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~  147 (257)
T cd05060          80 GPLLKYLKKRR---------EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGA  147 (257)
T ss_pred             CcHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeec
Confidence            99999997654         288999999999999999999999   999999999999999999999999999875543


Q ss_pred             cccccc-ccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccccccccc
Q 046595          230 TAARLH-STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCV  307 (363)
Q Consensus       230 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (363)
                      ...... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ...+..            
T Consensus       148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~------------  212 (257)
T cd05060         148 GSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLE------------  212 (257)
T ss_pred             CCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHH------------
Confidence            222111 111223567999999998899999999999999999998 999997543211   111111            


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccc
Q 046595          308 DPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL  352 (363)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~  352 (363)
                       .......+..++..+.+++.+||+.+|++||++.+|++.|+++.
T Consensus       213 -~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         213 -SGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             -cCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence             11111223345567999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.7e-42  Score=338.78  Aligned_cols=273  Identities=19%  Similarity=0.261  Sum_probs=210.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC--chHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE--PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++.......  ...++.+|+.+++.++||||+++++++.+.+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57999999999999999999765 58999999987543222  2457889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCC--CCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          145 QFATMGSLHDVLHGRKGVQG--AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ||++|++|.+++........  ......+++..++.++.|++.||.|||++   +|+||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            99999999999864321110  11112367788899999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccc----------------cccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCcc
Q 046595          223 LTNQSSDTAA----------------RLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKG  286 (363)
Q Consensus       223 ~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~  286 (363)
                      ++........                ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9876521100                001123569999999999999999999999999999999999999996532211


Q ss_pred             ccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhccccccCCC
Q 046595          287 QQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP-NMTIVVKALQPLLNSKPA  357 (363)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~~vl~~l~~l~~~~~~  357 (363)
                      ....    .         ....+ .........+..+.+++.+||+.||++|| +++++++.|+..++..+.
T Consensus       239 i~~~----~---------~i~~P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~  296 (932)
T PRK13184        239 ISYR----D---------VILSP-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPE  296 (932)
T ss_pred             hhhh----h---------hccCh-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCcc
Confidence            1000    0         00000 00000124456789999999999999995 678888888888776544

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.2e-42  Score=306.97  Aligned_cols=259  Identities=25%  Similarity=0.401  Sum_probs=206.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCC----CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTD----GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      .+|.+.+.||+|+||.||+|.+.+    ...+++|...........+.+.+|+.+++.++|+||+++++++.+ ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            468889999999999999997543    246899988764433445678999999999999999999998875 557899


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.+++|.+++.....        .+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+
T Consensus        85 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~  153 (270)
T cd05056          85 MELAPLGELRSYLQVNKY--------SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGL  153 (270)
T ss_pred             EEcCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCce
Confidence            999999999999975431        288999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      +......... ......++..|+|||.+....++.++||||||+++|||++ |..||............           
T Consensus       154 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~-----------  221 (270)
T cd05056         154 SRYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI-----------  221 (270)
T ss_pred             eeecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-----------
Confidence            8655433211 1122334568999999988889999999999999999996 99999754322111100           


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccC
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK  355 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~  355 (363)
                           ........+..++..+.+++.+||..+|++|||+.++++.|.++.++.
T Consensus       222 -----~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~  269 (270)
T cd05056         222 -----ENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE  269 (270)
T ss_pred             -----HcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence                 011111223455678999999999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.1e-42  Score=307.00  Aligned_cols=255  Identities=25%  Similarity=0.415  Sum_probs=201.9

Q ss_pred             eeeccCCceEEEEEeCC-------CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           75 LIGEGSYGRVFYAKLTD-------GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        75 ~lg~G~~g~V~~~~~~~-------~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      .||+|+||.||+|...+       +..+++|.+...........+.+|+.+++.++||||+++++++......+++|||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            58999999999997542       25789998866444445667889999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC-----ceEEeeec
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF-----KSKIADFN  222 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-----~vkl~Dfg  222 (363)
                      .+++|.+++.......  .....+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++     .++|+|||
T Consensus        82 ~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          82 EGGDLLSYLRDARVER--FGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             CCCcHHHHHHHhhhcc--cCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            9999999997543211  0123478999999999999999999999   999999999999999877     89999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      ++................++..|+|||.+.+..++.++||||||+++|+|++ |..||........   ..         
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~---~~---------  224 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV---LQ---------  224 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH---HH---------
Confidence            9875543322222233456788999999999999999999999999999998 9999964322111   11         


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQP  350 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~  350 (363)
                          .+........+...+..+.+++.+||+.+|.+||++.+|++.|++
T Consensus       225 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         225 ----HVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ----HHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                011111122334566789999999999999999999999998864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.2e-42  Score=310.00  Aligned_cols=263  Identities=22%  Similarity=0.320  Sum_probs=203.0

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      +|++.+.||+|+||.||++.+. ++..+++|.+...........+.+|++++++++||||+++++.+...+..+++|||+
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~   81 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM   81 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence            6889999999999999999765 578889998875433333456889999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      ++++|.+++....         .+++..+..++.|++.||.|||+..  +++|+||||+||+++.++.++|+|||++...
T Consensus        82 ~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (308)
T cd06615          82 DGGSLDQVLKKAG---------RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  150 (308)
T ss_pred             CCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccc
Confidence            9999999997643         2889999999999999999999732  8999999999999999999999999998654


Q ss_pred             CcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc-----
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK-----  302 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----  302 (363)
                      ....    .....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.......................     
T Consensus       151 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (308)
T cd06615         151 IDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV  226 (308)
T ss_pred             cccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence            3321    2345789999999999888899999999999999999999999964432221111110000000000     


Q ss_pred             ----------------cccccCCcCCCCCC-HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          303 ----------------VKQCVDPKLNNDYP-PKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       303 ----------------~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                                      ....... .....+ ..++.++.+++.+||+.+|++||++.+|++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         227 SGHPPDSPRPMAIFELLDYIVNE-PPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             cCCCCCccchhhHHHHHHHHhcC-CCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                            0000000 000111 1245679999999999999999999999885

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.6e-42  Score=304.38  Aligned_cols=254  Identities=25%  Similarity=0.381  Sum_probs=201.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      ++|++.+.||+|+||.||+|.. .+++.|++|++.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            4799999999999999999975 468899999986532 23345678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|.+++....         .+++..+..++.|++.||.|||+.   +|+|+||+|+||+++.++.++|+|||++..
T Consensus        88 ~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~  155 (267)
T cd06646          88 CGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAK  155 (267)
T ss_pred             CCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCcccee
Confidence            99999999986543         288999999999999999999999   999999999999999999999999999875


Q ss_pred             CCcccccccccccccccCCCCccccc---cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAM---TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      .......  .....|+..|+|||.+.   ...++.++|+|||||++|||++|+.||....+.......  .....     
T Consensus       156 ~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--~~~~~-----  226 (267)
T cd06646         156 ITATIAK--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--SKSNF-----  226 (267)
T ss_pred             ecccccc--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--ecCCC-----
Confidence            5322211  23356889999999875   345788999999999999999999998644322111100  00000     


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKAL  348 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l  348 (363)
                         .....  ......+..+.+++.+||+.+|++||++++|++.|
T Consensus       227 ---~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         227 ---QPPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ---CCCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence               00000  01123456799999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-43  Score=288.36  Aligned_cols=247  Identities=23%  Similarity=0.363  Sum_probs=197.8

Q ss_pred             CCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-CCccceeeeEEEeCCeeEEEEeccc
Q 046595           71 GTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVELLGYCMESNNRILVYQFAT  148 (363)
Q Consensus        71 ~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~  148 (363)
                      ..+..||+|+-|.|++++.+ +|...|||.+......+...++++.+.++...+ .|+||+.+|+|......++.||.|.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs  174 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS  174 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence            34556999999999999865 588999999998777777788888888877765 8999999999999999999999886


Q ss_pred             CCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCC
Q 046595          149 MGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS  228 (363)
Q Consensus       149 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~  228 (363)
                      . -+..++.....        ++++..+-++...+++||.||.+++  +|+|||+||+|||+|+.|++||||||++....
T Consensus       175 ~-C~ekLlkrik~--------piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlv  243 (391)
T KOG0983|consen  175 T-CAEKLLKRIKG--------PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLV  243 (391)
T ss_pred             H-HHHHHHHHhcC--------CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceee
Confidence            4 45555543321        3889999999999999999999886  99999999999999999999999999987766


Q ss_pred             cccccccccccccccCCCCcccccc---CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccc
Q 046595          229 DTAARLHSTRVLGTFGYHAPEYAMT---GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       229 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      +...   .+...|.+.|||||.+..   ..|+.++||||||++|+||.||+.||.....+....              ..
T Consensus       244 dSkA---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~l--------------tk  306 (391)
T KOG0983|consen  244 DSKA---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVL--------------TK  306 (391)
T ss_pred             cccc---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHH--------------HH
Confidence            5544   345579999999999864   369999999999999999999999998653322111              11


Q ss_pred             ccCCcCCCCCC--HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          306 CVDPKLNNDYP--PKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       306 ~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      +++. ....++  ...+..+++++..||+.|+.+||.+.++++
T Consensus       307 vln~-ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  307 VLNE-EPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             HHhc-CCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            1110 001111  125677999999999999999999999876

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.7e-42  Score=313.85  Aligned_cols=191  Identities=22%  Similarity=0.321  Sum_probs=163.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      ..+|.+.+.||+|+||.||+|... +++.||+|+....       ....|+.++++++|+||+++++++......++||+
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            357999999999999999999765 5778999975432       23568999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      ++.+ +|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.
T Consensus       138 ~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~  205 (357)
T PHA03209        138 HYSS-DLYTYLTKRSR--------PLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ  205 (357)
T ss_pred             ccCC-cHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccc
Confidence            9965 88888865321        389999999999999999999999   99999999999999999999999999986


Q ss_pred             CCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCC
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPV  279 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~  279 (363)
                      ......   ......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus       206 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        206 FPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            433221   123456899999999999999999999999999999999966554

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.9e-42  Score=306.01  Aligned_cols=250  Identities=22%  Similarity=0.311  Sum_probs=199.5

Q ss_pred             CCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           69 NFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      +|++.+.||+|+||.||+|.+ .++..|++|.+...........+.+|+.++++++||||+++++++......++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            578889999999999999975 4688999999876443344567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      .+++|..+..             +++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++...
T Consensus        82 ~~~~l~~~~~-------------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~  145 (279)
T cd06619          82 DGGSLDVYRK-------------IPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL  145 (279)
T ss_pred             CCCChHHhhc-------------CCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceec
Confidence            9999865531             77888999999999999999999   9999999999999999999999999998654


Q ss_pred             CcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCV  307 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (363)
                      ....    .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||............         .......
T Consensus       146 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~---------~~~~~~~  212 (279)
T cd06619         146 VNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP---------LQLLQCI  212 (279)
T ss_pred             cccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch---------HHHHHHH
Confidence            3321    23457899999999999889999999999999999999999999653322111100         0000000


Q ss_pred             CCcCCCCC-CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          308 DPKLNNDY-PPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       308 ~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                      ........ ....+.++.+++.+||+.+|++||++.++++.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         213 VDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             hccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            00000111 12244568999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.3e-42  Score=311.90  Aligned_cols=260  Identities=26%  Similarity=0.433  Sum_probs=204.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCC----eEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGT----PAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      ++|+..+.||+|+||.||++.+. ++.    .+++|.+...........+.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            46788899999999999999753 444    47888886544333345688999999999999999999988754 4679


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      +++|+.+|+|.+++.....        .+++..++.++.|++.||.|||++   +|+|+||||+||++++++.+||+|||
T Consensus        86 v~e~~~~g~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg  154 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKD--------NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFG  154 (303)
T ss_pred             eehhcCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccc
Confidence            9999999999999875432        278899999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      ++................++..|+|||.+.+..++.++||||||+++|||++ |..||........   ..+        
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~---~~~--------  223 (303)
T cd05110         155 LARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI---PDL--------  223 (303)
T ss_pred             ccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH--------
Confidence            9976543322222223345778999999998899999999999999999997 8999964422111   111        


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccC
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK  355 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~  355 (363)
                           +........+..++..+.+++..||..+|++||++.++++.|+.+.+..
T Consensus       224 -----~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         224 -----LEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             -----HHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence                 1111111112234557899999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.4e-42  Score=308.00  Aligned_cols=263  Identities=23%  Similarity=0.323  Sum_probs=195.7

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC-chHHHHHHHHHHhcC---CCCccceeeeEEEe-----CC
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRL---KHEHFVELLGYCME-----SN  138 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~  138 (363)
                      +|++.+.||+|+||.||+|... +++.||+|.+....... ....+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5888999999999999999765 68899999987643222 234566777777665   79999999998764     24


Q ss_pred             eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEE
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI  218 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl  218 (363)
                      ..+++|||+.+ +|.+++.....       ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl  149 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPP-------PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKL  149 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence            57899999986 89888875432       1288999999999999999999999   9999999999999999999999


Q ss_pred             eeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchh-hhcccc
Q 046595          219 ADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLV-TWATPR  297 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~-~~~~~~  297 (363)
                      +|||++........   .....|+..|+|||++.+..++.++|||||||++|+|++|..||......+....+ ..... 
T Consensus       150 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~-  225 (288)
T cd07863         150 ADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL-  225 (288)
T ss_pred             CccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCC-
Confidence            99999876543221   23356899999999999889999999999999999999999999654332211110 00000 


Q ss_pred             ccccccc-------cccCCc---CCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          298 LSEDKVK-------QCVDPK---LNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       298 ~~~~~~~-------~~~~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .......       ......   ......+..+..+.+++.+||+.||++|||+.+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         226 PPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             CChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000000       000000   001112245667899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.3e-42  Score=304.99  Aligned_cols=256  Identities=23%  Similarity=0.378  Sum_probs=191.1

Q ss_pred             eeeccCCceEEEEEeCC---CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCCC
Q 046595           75 LIGEGSYGRVFYAKLTD---GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGS  151 (363)
Q Consensus        75 ~lg~G~~g~V~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g~  151 (363)
                      .||+|+||.||+|...+   ...+++|.+...........+.+|+.+++.++|+||+++++.+......++||||+.+|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999996433   446788877654333334567889999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCccc
Q 046595          152 LHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTA  231 (363)
Q Consensus       152 L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~  231 (363)
                      |.+++.......    ....++..++.++.|++.||.|||++   +|+||||||+||++++++.+||+|||++.......
T Consensus        82 L~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          82 LKNYLRSNRGMV----AQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED  154 (269)
T ss_pred             HHHHHHhccccc----cccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccch
Confidence            999997654211    11256788899999999999999999   99999999999999999999999999986543322


Q ss_pred             ccccccccccccCCCCcccccc-------CCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccccc
Q 046595          232 ARLHSTRVLGTFGYHAPEYAMT-------GQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       232 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      .........++..|+|||++..       ..++.++|||||||++|||++ |..||....+.......  .     ....
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~--~-----~~~~  227 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV--V-----REQD  227 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH--h-----hccC
Confidence            2111233446778999998743       356889999999999999999 77888644321110000  0     0000


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ  349 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~  349 (363)
                      .....    ...+...+..+.+++..|| .||++|||+++|++.|.
T Consensus       228 ~~~~~----~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         228 IKLPK----PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             ccCCC----CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            01111    1123345566788899999 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.8e-42  Score=307.82  Aligned_cols=250  Identities=23%  Similarity=0.354  Sum_probs=204.6

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      ..+|++.+.||+|+||.||++.. .++..+++|.+..... .....+.+|+.+++.++|+||+++++.+......++|||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e   97 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence            35899999999999999999975 4688999999876433 334678899999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+++|.+++....          +++.++..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++.
T Consensus        98 ~~~~~~L~~~~~~~~----------~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~  164 (296)
T cd06654          98 YLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (296)
T ss_pred             ccCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccch
Confidence            999999999986532          78999999999999999999999   99999999999999999999999999886


Q ss_pred             CCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      ........  .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+....  ..+.           
T Consensus       165 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~~~-----------  229 (296)
T cd06654         165 QITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLIA-----------  229 (296)
T ss_pred             hccccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HHHh-----------
Confidence            54332211  23346889999999998888999999999999999999999999754332111  0000           


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                       .........+...+..+.+++.+||..+|++||++.+|++
T Consensus       230 -~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         230 -TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             -cCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence             0000011223455677999999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3e-42  Score=303.94  Aligned_cols=262  Identities=22%  Similarity=0.350  Sum_probs=208.1

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCC--CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAP--EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      .+|.+.+.||+|+||.||++.. .+++.++||.+......  .....+.+|+.+++.++|+||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            3688889999999999999975 47899999987653322  22357889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+++|.+++.....     ....+++..++.++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++
T Consensus        82 e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~  153 (267)
T cd08229          82 ELADAGDLSRMIKHFKK-----QKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             EecCCCCHHHHHHHhhc-----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhh
Confidence            99999999998864221     112388999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      .........  .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||........ ...         ..+.
T Consensus       154 ~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~---------~~~~  221 (267)
T cd08229         154 RFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLC---------KKIE  221 (267)
T ss_pred             hccccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-HHh---------hhhh
Confidence            655432221  2235688999999999888899999999999999999999999964322100 000         0000


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccc
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL  352 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~  352 (363)
                         ............+..+.+++.+||+.||++|||+.+|++.++++.
T Consensus       222 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         222 ---QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             ---cCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence               001111112346678999999999999999999999999988763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=8.4e-43  Score=319.58  Aligned_cols=261  Identities=21%  Similarity=0.266  Sum_probs=203.6

Q ss_pred             cCCCCCCeeeccCCceEEEEE-eCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-C-----CccceeeeEEEeCCee
Q 046595           68 SNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-H-----EHFVELLGYCMESNNR  140 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~~~~~~~~~~  140 (363)
                      .+|.+.++||+|+||.|.+|. ..+++.||||+++..  ......-..|+.+|..|+ |     -|+|++++++...++.
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~--k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl  263 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK--KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL  263 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC--hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence            357889999999999999995 557999999999873  334456778999999996 4     3899999999999999


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC--CCceEE
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD--DFKSKI  218 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~--~~~vkl  218 (363)
                      |||+|.+.. +|.++|+...-.       .++...+..++.||+.||.+||+.   +|||+||||+||||.+  ...|||
T Consensus       264 ciVfELL~~-NLYellK~n~f~-------Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKV  332 (586)
T KOG0667|consen  264 CIVFELLST-NLYELLKNNKFR-------GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKV  332 (586)
T ss_pred             eeeehhhhh-hHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeE
Confidence            999999977 999999876543       399999999999999999999999   9999999999999974  347999


Q ss_pred             eeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 046595          219 ADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL  298 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  298 (363)
                      +|||.|........     ...-+..|.|||++.|.+|+.+.||||||||+.||++|.+-|.+.+..++...+.......
T Consensus       333 IDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~P  407 (586)
T KOG0667|consen  333 IDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLP  407 (586)
T ss_pred             EecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCC
Confidence            99999987655443     2345778999999999999999999999999999999988887765554433331111000


Q ss_pred             cc----------------------ccccc-----------------ccCCcC-------CCCCCHHHHHHHHHHHHhccC
Q 046595          299 SE----------------------DKVKQ-----------------CVDPKL-------NNDYPPKAIAKLAAVAALCVQ  332 (363)
Q Consensus       299 ~~----------------------~~~~~-----------------~~~~~~-------~~~~~~~~~~~l~~li~~cl~  332 (363)
                      ..                      .....                 ..+.+.       ...........+.+++.+||.
T Consensus       408 p~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~  487 (586)
T KOG0667|consen  408 PPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLE  487 (586)
T ss_pred             CHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhc
Confidence            00                      00000                 000000       001111334578999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 046595          333 YEADFRPNMTIVVK  346 (363)
Q Consensus       333 ~~p~~RPs~~~vl~  346 (363)
                      .||.+|+|..+.++
T Consensus       488 ~dP~~R~tp~qal~  501 (586)
T KOG0667|consen  488 WDPAERITPAQALN  501 (586)
T ss_pred             cCchhcCCHHHHhc
Confidence            99999999999987

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.2e-42  Score=307.61  Aligned_cols=251  Identities=23%  Similarity=0.311  Sum_probs=200.0

Q ss_pred             CCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC--chHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           70 FGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE--PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      |+..+.||+|+||.||++.+. +++.||+|.+.......  ....+..|+.++++++|+||+.+++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677788999999999999754 68899999986543222  234567899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|.+++.....       ..+++..++.++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++..
T Consensus        82 ~~g~~L~~~l~~~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~  151 (285)
T cd05630          82 MNGGDLKFHIYHMGE-------AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVH  151 (285)
T ss_pred             cCCCcHHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceee
Confidence            999999998864332       1288999999999999999999999   999999999999999999999999999865


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      ......   .....|+..|+|||++.+..++.++||||||+++|+|++|..||..........            .....
T Consensus       152 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~------------~~~~~  216 (285)
T cd05630         152 VPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE------------EVERL  216 (285)
T ss_pred             cCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH------------HHHhh
Confidence            432211   123478999999999998899999999999999999999999997532211000            00000


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPN-----MTIVVK  346 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~~vl~  346 (363)
                      . ......++...+..+.+++.+||+.||++|||     +.++++
T Consensus       217 ~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         217 V-KEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             h-hhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            0 01111223345567999999999999999999     888887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.1e-42  Score=319.17  Aligned_cols=265  Identities=19%  Similarity=0.247  Sum_probs=199.2

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeC-----
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMES-----  137 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----  137 (363)
                      .+.++|++.+.||+|+||.||++... +++.||+|++...... .....+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            35578999999999999999999754 6889999998764322 2345778899999999999999999987643     


Q ss_pred             -CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCce
Q 046595          138 -NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS  216 (363)
Q Consensus       138 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v  216 (363)
                       ...++||||+.+ +|.+.+...           +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~~-----------l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~  158 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTL  158 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCE
Confidence             346899999976 777776532           78899999999999999999999   99999999999999999999


Q ss_pred             EEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhh----
Q 046595          217 KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT----  292 (363)
Q Consensus       217 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~----  292 (363)
                      ||+|||+++.......   .....||..|+|||++.+..++.++|||||||++|+|++|+.||.............    
T Consensus       159 kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (355)
T cd07874         159 KILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG  235 (355)
T ss_pred             EEeeCcccccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            9999999875443221   234578999999999999899999999999999999999999997543211110000    


Q ss_pred             ----------------hcc--ccccccccccccCCcC---CCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          293 ----------------WAT--PRLSEDKVKQCVDPKL---NNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       293 ----------------~~~--~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                                      +..  +..............+   ........+..+.+++.+||+.||++|||+.++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             CCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                            000  0000000000000000   001112234578999999999999999999999983

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.1e-43  Score=323.33  Aligned_cols=264  Identities=22%  Similarity=0.314  Sum_probs=199.7

Q ss_pred             CCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEeCC-----eeE
Q 046595           69 NFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCMESN-----NRI  141 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~  141 (363)
                      +|++.+.||+|+||.||++.. .+++.||+|++..... ......+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478889999999999999975 4789999999865322 223457889999999999999999999998776     789


Q ss_pred             EEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeee
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADF  221 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df  221 (363)
                      +|+||+.+ +|.+++....         .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Df  147 (372)
T cd07853          81 VVTELMQS-DLHKIIVSPQ---------PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDF  147 (372)
T ss_pred             EEeecccc-CHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccc
Confidence            99999975 8888876543         389999999999999999999999   9999999999999999999999999


Q ss_pred             ccCCCCCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccc
Q 046595          222 NLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE  300 (363)
Q Consensus       222 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  300 (363)
                      |++......... ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||....+......+.........
T Consensus       148 g~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~  226 (372)
T cd07853         148 GLARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL  226 (372)
T ss_pred             cceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence            998754332211 12334688999999998874 5799999999999999999999999765543322211110000000


Q ss_pred             ccc-------cccc-CCcCC-------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          301 DKV-------KQCV-DPKLN-------NDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       301 ~~~-------~~~~-~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ..+       ...+ .....       .......+.++.+++.+||+.||++|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            000       0000 00000       0111233567899999999999999999999987

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.1e-42  Score=319.06  Aligned_cols=262  Identities=18%  Similarity=0.264  Sum_probs=200.0

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC---CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT---DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      +..+|.+.+.||+|+||.||+|...   .+..|++|.+...      ....+|+.+++.++||||+++++++......++
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l  163 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM  163 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence            4467999999999999999999643   3677999987542      235689999999999999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      +|+++. ++|.+++....         .+++.+++.++.|++.||.|||++   +|+||||||+|||++.++.++|+|||
T Consensus       164 v~e~~~-~~l~~~l~~~~---------~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG  230 (392)
T PHA03207        164 VMPKYK-CDLFTYVDRSG---------PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFG  230 (392)
T ss_pred             EehhcC-CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCc
Confidence            999996 48988885432         389999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccc-----
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR-----  297 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~-----  297 (363)
                      ++................||+.|+|||++.+..++.++|||||||++|||++|+.||..................     
T Consensus       231 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~  310 (392)
T PHA03207        231 AACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHP  310 (392)
T ss_pred             cccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCc
Confidence            987655433322233567999999999999999999999999999999999999999754432211100000000     


Q ss_pred             --ccc---c----ccccccCCcCCCCC--C-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          298 --LSE---D----KVKQCVDPKLNNDY--P-----PKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       298 --~~~---~----~~~~~~~~~~~~~~--~-----~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                        ...   .    ..... .......+  +     ...+..+.++|.+||..||++||++.+++..
T Consensus       311 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        311 LEFPQNGSTNLCKHFKQY-AIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             cccCCccchhHHHHHHhh-cccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence              000   0    00000 00000000  0     1234568899999999999999999999874

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.6e-43  Score=317.26  Aligned_cols=238  Identities=24%  Similarity=0.285  Sum_probs=188.9

Q ss_pred             CeeeccCCceEEEEEeC-CCCeEEEEEccCCCC--CCchHHHHHHHH-HHhcCCCCccceeeeEEEeCCeeEEEEecccC
Q 046595           74 ALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA--PEPESDFAAQLS-VVSRLKHEHFVELLGYCMESNNRILVYQFATM  149 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  149 (363)
                      +.||+|+||.||+|+.. +++.+|+|++.....  ......+..|.. +++.++||||+++++++...+..++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999754 689999999865321  222344555554 56778999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCc
Q 046595          150 GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       150 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      |+|..++....         .+++..+..++.||+.||.|||++   ||+||||||+|||++.++.+||+|||++.....
T Consensus        81 ~~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~  148 (325)
T cd05604          81 GELFFHLQRER---------SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA  148 (325)
T ss_pred             CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCC
Confidence            99998886543         288999999999999999999999   999999999999999999999999999865322


Q ss_pred             ccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCC
Q 046595          230 TAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDP  309 (363)
Q Consensus       230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (363)
                      ...  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........               ......
T Consensus       149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~---------------~~~~~~  211 (325)
T cd05604         149 QSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY---------------DNILHK  211 (325)
T ss_pred             CCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH---------------HHHHcC
Confidence            211  123457999999999999999999999999999999999999999754321110               001111


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 046595          310 KLNNDYPPKAIAKLAAVAALCVQYEADFRPNMT  342 (363)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~  342 (363)
                      .  ...++..+..+.+++.+||+.+|.+||++.
T Consensus       212 ~--~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~  242 (325)
T cd05604         212 P--LVLRPGASLTAWSILEELLEKDRQRRLGAK  242 (325)
T ss_pred             C--ccCCCCCCHHHHHHHHHHhccCHHhcCCCC
Confidence            1  111223456688999999999999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.3e-42  Score=304.06  Aligned_cols=249  Identities=24%  Similarity=0.370  Sum_probs=207.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      ..|+..+.||.|+||.||.|.+. ++..|++|.+...........+.+|+.+++.++|+||+++++.+.+....++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            46778889999999999999765 58899999987644444456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|.+++....          +++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        84 ~~~~~L~~~i~~~~----------l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~  150 (277)
T cd06640          84 LGGGSALDLLRAGP----------FDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQ  150 (277)
T ss_pred             CCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEccccccee
Confidence            99999999987533          78899999999999999999999   999999999999999999999999999865


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      ......  ......++..|+|||.+.+..++.++|+||||+++|||++|..||....+.....                .
T Consensus       151 ~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~----------------~  212 (277)
T cd06640         151 LTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF----------------L  212 (277)
T ss_pred             ccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh----------------h
Confidence            543221  1233467889999999988889999999999999999999999997543321111                1


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                      ............++..+.+++.+||+.+|++||++.+++..
T Consensus       213 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         213 IPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            11112233455677889999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=7.5e-43  Score=320.81  Aligned_cols=250  Identities=20%  Similarity=0.289  Sum_probs=197.0

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      +|++.+.||+|+||.||++... +++.||+|++....  .......+..|+.++..++|+||+++++.+.+....++|||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            6888999999999999999764 68999999986432  22334678889999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+|+|.+++....         .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.++|+|||++.
T Consensus        82 ~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~  149 (360)
T cd05627          82 FLPGGDMMTLLMKKD---------TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCT  149 (360)
T ss_pred             CCCCccHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCc
Confidence            999999999997643         288999999999999999999999   99999999999999999999999999986


Q ss_pred             CCCccccc---------------------------------ccccccccccCCCCccccccCCCCccCceehhHHHHHHH
Q 046595          226 QSSDTAAR---------------------------------LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLEL  272 (363)
Q Consensus       226 ~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el  272 (363)
                      ........                                 ......+||+.|+|||++.+..++.++|||||||++|||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel  229 (360)
T cd05627         150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM  229 (360)
T ss_pred             ccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeec
Confidence            44221100                                 001134799999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCCccccchhhhccccccccccccccCCcCCCCCC--HHHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 046595          273 LTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYP--PKAIAKLAAVAALCVQYEADFRPN---MTIVVK  346 (363)
Q Consensus       273 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~RPs---~~~vl~  346 (363)
                      ++|..||....+......+            .... ..  ..++  ...+.++.++|.+++. ||.+|++   +.++++
T Consensus       230 ~tG~~Pf~~~~~~~~~~~i------------~~~~-~~--~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~  292 (360)
T cd05627         230 LIGYPPFCSETPQETYRKV------------MNWK-ET--LVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS  292 (360)
T ss_pred             ccCCCCCCCCCHHHHHHHH------------HcCC-Cc--eecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence            9999999755432211110            0000 00  0111  1234568888888774 9999985   666665

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-44  Score=332.17  Aligned_cols=259  Identities=26%  Similarity=0.444  Sum_probs=230.4

Q ss_pred             CCCCCCeeeccCCceEEEEEeC----CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ...+.++||.|.||.|++|+.+    ....||||.++....+....+|+.|+.||-+++||||+++.|+........+|+
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            4567889999999999999865    245699999999888888899999999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      |||++|+|..||+....        .|+.-+++.+++.|+.|++||.+.   ++|||||..+|||++.+..+|++|||++
T Consensus       710 EyMENGsLDsFLR~~DG--------qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLS  778 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQNDG--------QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLS  778 (996)
T ss_pred             hhhhCCcHHHHHhhcCC--------ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccce
Confidence            99999999999987653        289999999999999999999999   9999999999999999999999999999


Q ss_pred             CCCCccccccccccccc--ccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccc
Q 046595          225 NQSSDTAARLHSTRVLG--TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      +...+.... ..+..-|  ..+|.|||.+....++.++||||+|++|||.++ |..||.                .+++.
T Consensus       779 Rvledd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW----------------dmSNQ  841 (996)
T KOG0196|consen  779 RVLEDDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW----------------DMSNQ  841 (996)
T ss_pred             eecccCCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc----------------ccchH
Confidence            977654421 1222222  468999999999999999999999999999888 999985                45677


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccC
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK  355 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~  355 (363)
                      ++...++.+++..-|.+||..|.+|+..||+.|-.+||.+.+|+..|.++++..
T Consensus       842 dVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  842 DVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             HHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            778888888888889999999999999999999999999999999999988753

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.1e-42  Score=303.00  Aligned_cols=253  Identities=25%  Similarity=0.402  Sum_probs=194.1

Q ss_pred             CeeeccCCceEEEEEeC----CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEE-eCCeeEEEEeccc
Q 046595           74 ALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM-ESNNRILVYQFAT  148 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~  148 (363)
                      +.||+|+||.||+|.+.    +...+++|.+...........+..|+.+++.++||||+++++++. .....+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            35899999999999753    245689998765333334567888999999999999999999775 4556789999999


Q ss_pred             CCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCC
Q 046595          149 MGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS  228 (363)
Q Consensus       149 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~  228 (363)
                      +++|.+++.....        ..++..++.++.|++.||.|||+.   +++||||||+||++++++.+||+|||++....
T Consensus        81 ~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~  149 (262)
T cd05058          81 HGDLRNFIRSETH--------NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIY  149 (262)
T ss_pred             CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCcccccccc
Confidence            9999999975432        257788899999999999999999   99999999999999999999999999987543


Q ss_pred             ccccc--ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhC-CCCCCCCCCccccchhhhcccccccccccc
Q 046595          229 DTAAR--LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTG-RKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       229 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      .....  .......++..|+|||.+.+..++.++||||||+++|||++| ..||.......   ....            
T Consensus       150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~------------  214 (262)
T cd05058         150 DKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVY------------  214 (262)
T ss_pred             CCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH------------
Confidence            32111  111223467789999999888999999999999999999995 55664322111   1100            


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccc
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN  353 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~  353 (363)
                       +........+...+..+.+++..||+.+|++||++.+|++.|+++++
T Consensus       215 -~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         215 -LLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             -HhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence             00011111122345679999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-42  Score=304.52  Aligned_cols=247  Identities=24%  Similarity=0.382  Sum_probs=205.1

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      +|.+.+.||.|++|.||++... +++.+++|.+...........+.+|+.+++.++|+||+++++++.+....++|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            6888899999999999999765 688999999876544445567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      .+++|.+++....          +++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++...
T Consensus        82 ~~~~L~~~~~~~~----------~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  148 (274)
T cd06609          82 GGGSCLDLLKPGK----------LDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQL  148 (274)
T ss_pred             CCCcHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceee
Confidence            9999999997642          89999999999999999999999   9999999999999999999999999998765


Q ss_pred             CcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCV  307 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (363)
                      .....  ......|+..|+|||.+.+..++.++||||||+++|+|++|..||....+......            +.   
T Consensus       149 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~------------~~---  211 (274)
T cd06609         149 TSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL------------IP---  211 (274)
T ss_pred             ccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH------------hh---
Confidence            54321  13345688899999999988899999999999999999999999975432211100            00   


Q ss_pred             CCcCCCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          308 DPKLNNDYPPK-AIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       308 ~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                       .......+.. ++..+.+++.+||..+|++||+++++++
T Consensus       212 -~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         212 -KNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             -hcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence             0111111112 5667999999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.9e-43  Score=291.00  Aligned_cols=255  Identities=22%  Similarity=0.328  Sum_probs=208.1

Q ss_pred             HHHHHhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCC---ch----HHHHHHHHHHhcC-CCCccceeee
Q 046595           62 ELNRLTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPE---PE----SDFAAQLSVVSRL-KHEHFVELLG  132 (363)
Q Consensus        62 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~---~~----~~~~~e~~~l~~l-~h~~i~~~~~  132 (363)
                      .-..+..+|.-.+.||.|..+.|.++.+ .+|..+|+|++.......   ..    +.-..|+.+|+++ .||+|+.+.+
T Consensus        11 aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D   90 (411)
T KOG0599|consen   11 AAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD   90 (411)
T ss_pred             hHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence            3445677899999999999999999864 468889999987543221   12    3456789999998 5999999999


Q ss_pred             EEEeCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC
Q 046595          133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD  212 (363)
Q Consensus       133 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~  212 (363)
                      +++.....++|+|.|+.|.|.+++...-         ++++++...|..|+.+|++|||.+   +||||||||+|||+++
T Consensus        91 ~yes~sF~FlVFdl~prGELFDyLts~V---------tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILldd  158 (411)
T KOG0599|consen   91 VYESDAFVFLVFDLMPRGELFDYLTSKV---------TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDD  158 (411)
T ss_pred             eccCcchhhhhhhhcccchHHHHhhhhe---------eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeecc
Confidence            9999999999999999999999998654         499999999999999999999999   9999999999999999


Q ss_pred             CCceEEeeeccCCCCCcccccccccccccccCCCCcccccc------CCCCccCceehhHHHHHHHHhCCCCCCCCCCcc
Q 046595          213 DFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT------GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKG  286 (363)
Q Consensus       213 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~  286 (363)
                      +-++||+|||+++....+..   ....+|||+|+|||.+.-      ..|+..+|+|++||+||-|+.|.+||....+.-
T Consensus       159 n~~i~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml  235 (411)
T KOG0599|consen  159 NMNIKISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML  235 (411)
T ss_pred             ccceEEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH
Confidence            99999999999988776544   467899999999998852      368899999999999999999999996542211


Q ss_pred             ccchhhhccccccccccccccCCcCCCCC--CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          287 QQSLVTWATPRLSEDKVKQCVDPKLNNDY--PPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .               ++.+....+.-.-  =.+.+....+||.+||++||.+|.|++|++.
T Consensus       236 M---------------LR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  236 M---------------LRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             H---------------HHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            1               1111111111111  1345667899999999999999999999986

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.6e-42  Score=316.81  Aligned_cols=263  Identities=20%  Similarity=0.242  Sum_probs=198.6

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEeC------
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCMES------  137 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------  137 (363)
                      +.++|.+.+.||+|+||.||++... .++.||||++..... ......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4568999999999999999999754 688999999875432 23346788899999999999999999887543      


Q ss_pred             CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceE
Q 046595          138 NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSK  217 (363)
Q Consensus       138 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk  217 (363)
                      ...++||||+.+ +|.+.+...           +++..+..++.|++.||.|||++   +|+||||||+||+++.++.+|
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~k  166 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK  166 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHhc-----------CCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEE
Confidence            357899999976 787777532           78899999999999999999999   999999999999999999999


Q ss_pred             EeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccc-
Q 046595          218 IADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATP-  296 (363)
Q Consensus       218 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~-  296 (363)
                      |+|||+++.......   .....||..|+|||++.+..++.++|||||||++|+|++|+.||...........+..... 
T Consensus       167 L~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  243 (364)
T cd07875         167 ILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT  243 (364)
T ss_pred             EEeCCCccccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            999999876543221   2345789999999999999999999999999999999999999975443221111100000 


Q ss_pred             ---------------------cccccccccccCCcC---CCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          297 ---------------------RLSEDKVKQCVDPKL---NNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       297 ---------------------~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                                           ...............   ...........+.+++.+||+.||.+|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         244 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             CCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                                 000000000000000   00111122456899999999999999999999988

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.7e-42  Score=309.75  Aligned_cols=203  Identities=22%  Similarity=0.395  Sum_probs=163.1

Q ss_pred             CCeeeccCCceEEEEEeC---CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEe--CCeeEEEEecc
Q 046595           73 KALIGEGSYGRVFYAKLT---DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCME--SNNRILVYQFA  147 (363)
Q Consensus        73 ~~~lg~G~~g~V~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~  147 (363)
                      .+.||+|+||.||+|+..   +++.+|+|.+....   ....+.+|+.++++++||||+++++++..  ....+++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            457999999999999754   46789999986532   23457889999999999999999998854  45678999998


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceee----cCCCceEEeeecc
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL----FDDFKSKIADFNL  223 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill----~~~~~vkl~Dfg~  223 (363)
                      .+ +|.+++..............+++..+..++.|++.||.|||++   +|+||||||+|||+    +.++.+||+|||+
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            65 8988876443222222223488999999999999999999999   99999999999999    4567899999999


Q ss_pred             CCCCCccccc-ccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCC
Q 046595          224 TNQSSDTAAR-LHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHT  282 (363)
Q Consensus       224 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~  282 (363)
                      +......... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            9765433221 112346789999999998764 6899999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-41  Score=300.40  Aligned_cols=250  Identities=22%  Similarity=0.418  Sum_probs=202.5

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCc--------hHHHHHHHHHHhcCCCCccceeeeEEEeCCe
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEP--------ESDFAAQLSVVSRLKHEHFVELLGYCMESNN  139 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  139 (363)
                      +|.+.+.||.|++|.||.|... +++.+++|.+........        ...+.+|+.+++.++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4788899999999999999754 588999998865432221        2457789999999999999999999999999


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEe
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA  219 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~  219 (363)
                      .++++||+.+++|.+++....         .+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~  148 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG---------AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKIS  148 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc---------CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEec
Confidence            999999999999999997643         278899999999999999999999   99999999999999999999999


Q ss_pred             eeccCCCCCccccc----ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 046595          220 DFNLTNQSSDTAAR----LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       220 Dfg~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      |||+++........    .......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||........  ..    
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~----  222 (267)
T cd06628         149 DFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA--IF----  222 (267)
T ss_pred             ccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH--HH----
Confidence            99998765422111    111234588899999999988899999999999999999999999975322110  00    


Q ss_pred             ccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          296 PRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                            .+..    ......+...+..+.+++.+||+.||.+||++.+|++
T Consensus       223 ------~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         223 ------KIGE----NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ------HHhc----cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                  0001    1112334456677999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.6e-42  Score=300.52  Aligned_cols=247  Identities=27%  Similarity=0.467  Sum_probs=200.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      ++|++.+.||+|+||.||++.. +++.+++|.+...   .....+.+|+.++++++|+||+++++++... ..+++|||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD---VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc---chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            4689999999999999999875 5788999998652   2346788999999999999999999988654 579999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      .+++|.+++.....       ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++...
T Consensus        81 ~~~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~  150 (254)
T cd05083          81 SKGNLVNFLRTRGR-------ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVG  150 (254)
T ss_pred             CCCCHHHHHHhcCc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceec
Confidence            99999999975432       1378999999999999999999999   9999999999999999999999999998654


Q ss_pred             CcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      ...     ......+..|+|||.+.+..++.++|+||||+++|+|++ |..||........                ...
T Consensus       151 ~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~----------------~~~  209 (254)
T cd05083         151 SMG-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV----------------KEC  209 (254)
T ss_pred             ccc-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH----------------HHH
Confidence            322     122334568999999988899999999999999999998 9999965432211                111


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQP  350 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~  350 (363)
                      .........+..++..+.+++.+||+.+|++||++.+|++.|++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         210 VEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             HhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            11112222233456779999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.2e-42  Score=305.00  Aligned_cols=272  Identities=23%  Similarity=0.380  Sum_probs=208.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-----CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEe--CCee
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCME--SNNR  140 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~  140 (363)
                      +.|++.+.||+|+||.||++.+.     ++..+|+|++...........+.+|+.+++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            36778899999999999999753     3678999998764433245689999999999999999999999877  5578


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEee
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD  220 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D  220 (363)
                      +++|||+.+++|.+++.....        .+++..++.++.|++.||.|||++   +++|+||||+||+++.++.++|+|
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~--------~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d  152 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRD--------QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISD  152 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCcc--------ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcc
Confidence            999999999999999976442        388999999999999999999999   999999999999999999999999


Q ss_pred             eccCCCCCcccccc-cccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc
Q 046595          221 FNLTNQSSDTAARL-HSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       221 fg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      ||++.......... ......++..|++||.+.+..++.++||||||+++|||++|..||............. ......
T Consensus       153 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~  231 (284)
T cd05038         153 FGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMI  231 (284)
T ss_pred             cccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-cccccc
Confidence            99987655322111 1112234567999999988899999999999999999999999986432211000000 000000


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL  351 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l  351 (363)
                      ...+...+........+..++.++.+++.+||+.+|++||++.+|++.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         232 VTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1111112222222223345567899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6.2e-42  Score=300.01  Aligned_cols=251  Identities=24%  Similarity=0.438  Sum_probs=201.6

Q ss_pred             CCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEeccc
Q 046595           69 NFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFAT  148 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  148 (363)
                      +|++.+.||+|+||.||++.+.++..+++|.+....  .....+..|+++++.++||||+++++++......+++|||+.
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA--MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC--CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            678889999999999999987778889999886532  234578899999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCC
Q 046595          149 MGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS  228 (363)
Q Consensus       149 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~  228 (363)
                      +++|.+++.....        .+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        83 ~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  151 (256)
T cd05112          83 HGCLSDYLRAQRG--------KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVL  151 (256)
T ss_pred             CCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecc
Confidence            9999999875431        278899999999999999999999   99999999999999999999999999886543


Q ss_pred             cccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccccccccc
Q 046595          229 DTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCV  307 (363)
Q Consensus       229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (363)
                      ..... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.......   ....             +
T Consensus       152 ~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~-------------~  214 (256)
T cd05112         152 DDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVET-------------I  214 (256)
T ss_pred             cCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHH-------------H
Confidence            32111 1122335678999999988899999999999999999998 999996433211   1100             0


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 046595          308 DPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ  349 (363)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~  349 (363)
                      ........+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       215 ~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         215 NAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             hCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            001111112223567999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.8e-42  Score=302.97  Aligned_cols=263  Identities=26%  Similarity=0.420  Sum_probs=206.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRI  141 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  141 (363)
                      ++|.+.+.||+|+||.||+|+.+      +...+++|.+...........+.+|+.++++++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            47889999999999999999754      246689998866433334567899999999999999999999999989999


Q ss_pred             EEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeee
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADF  221 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df  221 (363)
                      +||||+.+++|.+++..............+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999997654222212222489999999999999999999999   9999999999999999999999999


Q ss_pred             ccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccc
Q 046595          222 NLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSE  300 (363)
Q Consensus       222 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~  300 (363)
                      |++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||........   ...       
T Consensus       162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~---~~~-------  230 (275)
T cd05046         162 SLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV---LNR-------  230 (275)
T ss_pred             ccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH---HHH-------
Confidence            998644322111 1233456778999999988889999999999999999999 7889864332111   110       


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 046595          301 DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ  349 (363)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~  349 (363)
                           ..........+..++..+.+++.+||+.+|.+||++.+++..|+
T Consensus       231 -----~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         231 -----LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             -----HHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                 00011111122345567999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.6e-42  Score=306.05  Aligned_cols=247  Identities=24%  Similarity=0.368  Sum_probs=202.7

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      .|...+.||+|+||.||+|.+. ++..|++|.+...........+.+|+.+++.++|+||+++++++......++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4666678999999999999754 578899999876544444567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      .+++|.+++....          +++..+..++.|++.||.|||++   +++|+||+|+||++++++.++|+|||++...
T Consensus        85 ~~~~L~~~~~~~~----------~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06642          85 GGGSALDLLKPGP----------LEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQL  151 (277)
T ss_pred             CCCcHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccc
Confidence            9999999986532          88999999999999999999999   9999999999999999999999999998765


Q ss_pred             CcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCV  307 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (363)
                      .....  ......|+..|+|||.+.+..++.++|+||||+++|||++|..||....+.....                ..
T Consensus       152 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~----------------~~  213 (277)
T cd06642         152 TDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF----------------LI  213 (277)
T ss_pred             cCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh----------------hh
Confidence            43221  1233468889999999998889999999999999999999999986443221110                01


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          308 DPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ............+..+.+++.+||+.+|++||++.+|+.
T Consensus       214 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         214 PKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             hcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            111111223345667999999999999999999999997

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.7e-42  Score=304.61  Aligned_cols=251  Identities=22%  Similarity=0.293  Sum_probs=199.1

Q ss_pred             CCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC--CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           70 FGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP--EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      |+..+.||+|+||.||++.+. +++.+|+|.+......  .....+.+|+.+++.++|+||+.+++.+...+..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667788999999999999754 6889999998654322  2234577899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|.+++.....       ..+++..+..++.|++.||.|||++   +|+||||||+||++++++.++|+|||++..
T Consensus        82 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~  151 (285)
T cd05632          82 MNGGDLKFHIYNMGN-------PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVK  151 (285)
T ss_pred             ccCccHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCccee
Confidence            999999988864321       1389999999999999999999999   999999999999999999999999998865


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      ......   .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||..............        .+.  
T Consensus       152 ~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~--------~~~--  218 (285)
T cd05632         152 IPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR--------RVL--  218 (285)
T ss_pred             cCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH--------hhh--
Confidence            432211   2234689999999999988999999999999999999999999975432111111100        000  


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPN-----MTIVVK  346 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~~vl~  346 (363)
                         .....++...+..+.+|+..||+.||++||+     +.+++.
T Consensus       219 ---~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         219 ---ETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ---ccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence               0011223345567899999999999999999     677776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1e-41  Score=305.10  Aligned_cols=250  Identities=23%  Similarity=0.365  Sum_probs=205.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      .++|++.+.||+|+||.||++.. .+++.|++|.+..... .....+.+|+.+++.++|+||+++++++......++|||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            46899999999999999999975 4799999999875432 334668889999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+++++|.+++....          +++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus        97 ~~~~~~L~~~~~~~~----------~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~  163 (297)
T cd06656          97 YLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA  163 (297)
T ss_pred             ccCCCCHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccce
Confidence            999999999986543          78899999999999999999999   99999999999999999999999999986


Q ss_pred             CCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      ........  .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||....+.......              
T Consensus       164 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~--------------  227 (297)
T cd06656         164 QITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--------------  227 (297)
T ss_pred             EccCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee--------------
Confidence            54332211  23346889999999999888999999999999999999999999654332111100              


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ..........+...+..+.+++.+||+.+|++||++.+|++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         228 ATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             ccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00001111123445667899999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.1e-41  Score=300.10  Aligned_cols=252  Identities=22%  Similarity=0.361  Sum_probs=202.4

Q ss_pred             CCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCC-----chHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           69 NFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPE-----PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      +|.+.+.||.|+||.||+|...+++.+|+|.+.......     ....+.+|+.+++.++|+||+++++++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            488899999999999999988789999999887543211     124688899999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      +||+.+++|.+++....         .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+
T Consensus        81 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~  148 (265)
T cd06631          81 MEFVPGGSISSILNRFG---------PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGC  148 (265)
T ss_pred             EecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchh
Confidence            99999999999997543         278999999999999999999999   999999999999999999999999998


Q ss_pred             CCCCCccc----ccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc
Q 046595          224 TNQSSDTA----ARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       224 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      +.......    .........|+..|+|||.+.+..++.++|+||||+++|+|++|..||..........  ....    
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~--~~~~----  222 (265)
T cd06631         149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF--YIGA----  222 (265)
T ss_pred             hHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH--Hhhh----
Confidence            86542211    1111223568899999999998889999999999999999999999996432211100  0000    


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                              ........+...+..+.+++.+||+.+|.+||++.++++
T Consensus       223 --------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         223 --------HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             --------ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                    000111223345667999999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.4e-41  Score=297.87  Aligned_cols=252  Identities=26%  Similarity=0.437  Sum_probs=203.3

Q ss_pred             CCCCCeeeccCCceEEEEEeCC-----CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           70 FGTKALIGEGSYGRVFYAKLTD-----GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      +++.+.||.|+||.||++.+.+     +..+++|.+...........+..|+.+++.++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567889999999999997653     37899999976544445678899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+++|.+++......       .+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++
T Consensus        81 e~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~  150 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPK-------ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLS  150 (258)
T ss_pred             eccCCCCHHHHHHhhhhc-------cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCc
Confidence            999999999999764321       178999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      .......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||........   ..           
T Consensus       151 ~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~---~~-----------  215 (258)
T smart00219      151 RDLYDDDYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV---LE-----------  215 (258)
T ss_pred             eecccccccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH-----------
Confidence            7655432211 112336789999999988889999999999999999998 7888864322111   11           


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKAL  348 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l  348 (363)
                        ..........+...+..+.+++.+||..+|++|||+.++++.|
T Consensus       216 --~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      216 --YLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --HHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence              0111111222334667799999999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.9e-42  Score=304.00  Aligned_cols=253  Identities=23%  Similarity=0.372  Sum_probs=202.5

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      +|++.+.||+|+||.||++.+. ++..|++|.+...........+.+|+.++++++|+||+++++.+......++||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            6888999999999999999865 689999998876433334567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      ++++|..++.....      ...+++..+..++.|++.||.|||+..  +|+|+||||+||+++.++.++|+|||++...
T Consensus        82 ~~~~l~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  153 (286)
T cd06622          82 DAGSLDKLYAGGVA------TEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL  153 (286)
T ss_pred             CCCCHHHHHHhccc------cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99999999875321      113899999999999999999999632  8999999999999999999999999998654


Q ss_pred             CcccccccccccccccCCCCccccccC------CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTG------QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      ....    .....|+..|+|||.+.+.      .++.++|+|||||++|+|++|..||..........            
T Consensus       154 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~------------  217 (286)
T cd06622         154 VASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA------------  217 (286)
T ss_pred             cCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH------------
Confidence            3321    2234678899999988654      35889999999999999999999996432211100            


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .+..... ......+..++.++.+++.+||+.+|++||++.+++.
T Consensus       218 ~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         218 QLSAIVD-GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             HHHHHhh-cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            0011111 1112334557788999999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-42  Score=315.64  Aligned_cols=263  Identities=22%  Similarity=0.328  Sum_probs=196.5

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeC-----
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMES-----  137 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----  137 (363)
                      .+.++|.+.+.||+|+||.||+|.. .+++.||+|++...... .....+.+|+.+++.++|+||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            4567899999999999999999975 46889999998753322 2235677899999999999999999877543     


Q ss_pred             -CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCce
Q 046595          138 -NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS  216 (363)
Q Consensus       138 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v  216 (363)
                       ...+++++++ +++|.+++....          +++..+..++.|++.||.|||++   +|+||||||+||+++.++.+
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~  157 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKCQK----------LSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCEL  157 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCE
Confidence             3468899987 669988886433          89999999999999999999999   99999999999999999999


Q ss_pred             EEeeeccCCCCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhh-hc
Q 046595          217 KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT-WA  294 (363)
Q Consensus       217 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~-~~  294 (363)
                      ||+|||++......     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............. ..
T Consensus       158 kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  232 (343)
T cd07878         158 RILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVV  232 (343)
T ss_pred             EEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh
Confidence            99999998754332     234578999999999876 578999999999999999999999996543221111000 00


Q ss_pred             cc-------cccccccccccCC--cCC-C---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          295 TP-------RLSEDKVKQCVDP--KLN-N---DYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       295 ~~-------~~~~~~~~~~~~~--~~~-~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ..       .............  ... .   .........+.+++.+||+.||.+|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         233 GTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             CCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00       0000000000000  000 0   000112345789999999999999999999996

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-42  Score=310.15  Aligned_cols=256  Identities=20%  Similarity=0.224  Sum_probs=195.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|++.+.||+|+||.||+++.. +++.||+|++....  .......+..|+.++..++|+||+.+++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            36899999999999999999765 58999999986421  2223456788999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+|+|.+++.....        .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        81 e~~~g~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~  149 (331)
T cd05597          81 DYYVGGDLLTLLSKFED--------RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSC  149 (331)
T ss_pred             ecCCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCce
Confidence            99999999999965321        288999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCcccccc-----CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMT-----GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      ......... ......||+.|+|||++.+     ..++.++|||||||++|+|++|+.||...........+      ..
T Consensus       150 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i------~~  222 (331)
T cd05597         150 LRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI------MN  222 (331)
T ss_pred             eecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHH------Hc
Confidence            654332211 1223469999999999863     45788999999999999999999999754321111000      00


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCC--CCCCCCCHHHHHHH
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQY--EADFRPNMTIVVKA  347 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--~p~~RPs~~~vl~~  347 (363)
                      .....     .+ .......+..+.+++.+|+..  ++..|+++.++++.
T Consensus       223 ~~~~~-----~~-~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         223 HKEHF-----QF-PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CCCcc-----cC-CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            00000     00 011122456688888887754  33347899988874

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-42  Score=305.37  Aligned_cols=253  Identities=28%  Similarity=0.467  Sum_probs=198.0

Q ss_pred             CCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCch-HHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           70 FGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPE-SDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      |++.+.||+|+||.||+++.. +++.+|+|.+......... ....+|+.++++++|+||+++++++......+++|+|+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            667889999999999999866 4668999999875432222 23356999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      .+++|.+++....         .+++..++.++.|+++||.+||++   +++|+||||+||+++.++.++|+|||.+...
T Consensus        81 ~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~  148 (260)
T PF00069_consen   81 PGGSLQDYLQKNK---------PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKL  148 (260)
T ss_dssp             TTEBHHHHHHHHS---------SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred             ccccccccccccc---------cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence            9999999998332         289999999999999999999999   9999999999999999999999999998643


Q ss_pred             CcccccccccccccccCCCCccccc-cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAM-TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      ..  .........++..|+|||++. +..++.++||||||+++|+|++|..||..................    .....
T Consensus       149 ~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~----~~~~~  222 (260)
T PF00069_consen  149 SE--NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR----PLPSS  222 (260)
T ss_dssp             TS--TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT----HHHHH
T ss_pred             cc--cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc----ccccc
Confidence            11  111234567899999999998 788999999999999999999999999754111111111000000    00000


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                            ..........+.+++.+||+.||++||++.++++
T Consensus       223 ------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  223 ------SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             ------TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ------ccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  0000011267999999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=9.5e-42  Score=305.17  Aligned_cols=249  Identities=24%  Similarity=0.384  Sum_probs=204.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      .+|++.+.||.|++|.||++.. .+++.|++|.+.... ......+.+|+.+++.++|+||+++++++......++|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            4699999999999999999975 568999999987543 33456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|..++....          +++.++..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++..
T Consensus        98 ~~~~~L~~~~~~~~----------l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~  164 (296)
T cd06655          98 LAGGSLTDVVTETC----------MDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ  164 (296)
T ss_pred             cCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchh
Confidence            99999999987543          88999999999999999999999   999999999999999999999999999865


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      .......  .....|+..|+|||.+.+..++.++|+|||||++|+|++|..||....+........  .           
T Consensus       165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~--~-----------  229 (296)
T cd06655         165 ITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--T-----------  229 (296)
T ss_pred             ccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--h-----------
Confidence            4332211  233468899999999998889999999999999999999999997654322111100  0           


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                       ........+..++..+.++|.+||..||++||++.+|+.
T Consensus       230 -~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         230 -NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             -cCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence             000001123345567999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=6.8e-42  Score=301.68  Aligned_cols=252  Identities=27%  Similarity=0.396  Sum_probs=199.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      ++|.+.+.||+|+||.||+|... +++.|++|+++... ......+.+|+.+++.++||||+++++.+......+++|||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            36888889999999999999754 68899999987542 23345678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|.+++....         .+++.+++.++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++..
T Consensus        88 ~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~  155 (267)
T cd06645          88 CGGGSLQDIYHVTG---------PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQ  155 (267)
T ss_pred             cCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeE
Confidence            99999999987543         288999999999999999999999   999999999999999999999999999865


Q ss_pred             CCcccccccccccccccCCCCccccc---cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAM---TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      ......  ......|+..|+|||++.   ...++.++|+|||||++|+|++|..||....+........  .....    
T Consensus       156 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~--~~~~~----  227 (267)
T cd06645         156 ITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT--KSNFQ----  227 (267)
T ss_pred             ccCccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh--ccCCC----
Confidence            432211  123457899999999874   4568899999999999999999999986443221111000  00000    


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                          ....  .....++..+.+++.+||+.+|++||++.+|++
T Consensus       228 ----~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         228 ----PPKL--KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ----CCcc--cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence                0000  001123456899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=8.5e-42  Score=301.82  Aligned_cols=251  Identities=25%  Similarity=0.439  Sum_probs=198.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeC------C
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMES------N  138 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~------~  138 (363)
                      .+.|++.+.||+|+||.||+|... +++.+++|.+...  ......+..|+.+++++ +|+||+++++++...      .
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC--CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            457888899999999999999754 5888999998653  23456788999999998 699999999998753      4


Q ss_pred             eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEE
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI  218 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl  218 (363)
                      ..+++|||+.+++|.+++.....       ..+++..+..++.|++.||.|||++   +|+|+||||+||++++++.++|
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l  152 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKG-------NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKL  152 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEE
Confidence            57899999999999999976432       1388999999999999999999999   9999999999999999999999


Q ss_pred             eeeccCCCCCcccccccccccccccCCCCccccc-----cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhh
Q 046595          219 ADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM-----TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTW  293 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~  293 (363)
                      +|||++........  ......|+..|+|||++.     +..++.++|||||||++|||++|..||....+.......  
T Consensus       153 ~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~--  228 (272)
T cd06637         153 VDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI--  228 (272)
T ss_pred             ccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH--
Confidence            99999865433221  123456899999999886     346888999999999999999999999644322111100  


Q ss_pred             ccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          294 ATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                        .           ...........++..+.+++.+||..+|.+|||+.+|++
T Consensus       229 --~-----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         229 --P-----------RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             --h-----------cCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence              0           000001112234567999999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.3e-41  Score=298.05  Aligned_cols=250  Identities=26%  Similarity=0.393  Sum_probs=199.6

Q ss_pred             CeeeccCCceEEEEEeCC--CC--eEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccC
Q 046595           74 ALIGEGSYGRVFYAKLTD--GT--PAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATM  149 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~--~~--~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  149 (363)
                      +.||+|++|.||+|.+.+  ++  .+++|.+...........+..|+.++++++|+||+++++++.. ...++++||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            368999999999997643  33  5899998775443445688999999999999999999999888 888999999999


Q ss_pred             CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCc
Q 046595          150 GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       150 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      ++|.+++.....       ..+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++.....
T Consensus        80 ~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~  149 (257)
T cd05040          80 GSLLDRLRKDAL-------GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQ  149 (257)
T ss_pred             CcHHHHHHhccc-------ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccc
Confidence            999999976431       1388999999999999999999999   999999999999999999999999999876544


Q ss_pred             ccccc-cccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccccccccc
Q 046595          230 TAARL-HSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCV  307 (363)
Q Consensus       230 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (363)
                      ..... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+......               
T Consensus       150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~---------------  214 (257)
T cd05040         150 NEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID---------------  214 (257)
T ss_pred             cccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---------------
Confidence            22211 1122456788999999998899999999999999999998 999996443221111000               


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 046595          308 DPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ  349 (363)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~  349 (363)
                      ........+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus       215 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         215 KEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             hcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            000111122345667999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.2e-42  Score=338.24  Aligned_cols=263  Identities=18%  Similarity=0.296  Sum_probs=200.2

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeC--Cee
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMES--NNR  140 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~  140 (363)
                      ....+|.+.+.||+|+||.||+|.+. ++..+++|++...... .....+..|+.+++.++||||+++++++...  ..+
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            44568999999999999999999765 5778899988754322 2346788999999999999999999988653  568


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCC----CCeEEecccCCceeecC----
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ----PPIVHRDVRSSNVLLFD----  212 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~----~~ivH~Dlkp~Nill~~----  212 (363)
                      +|||||+.+++|.++|......     ...+++..++.|+.||+.||.|||+...    .+|+||||||+||||+.    
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~-----~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~  164 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKM-----FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH  164 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence            9999999999999999753211     1138999999999999999999998510    15999999999999964    


Q ss_pred             -------------CCceEEeeeccCCCCCcccccccccccccccCCCCcccccc--CCCCccCceehhHHHHHHHHhCCC
Q 046595          213 -------------DFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT--GQITQKSDVYSFGVVLLELLTGRK  277 (363)
Q Consensus       213 -------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~  277 (363)
                                   .+.+||+|||++........   .....||+.|+|||++.+  ..++.++|||||||+||||++|..
T Consensus       165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~  241 (1021)
T PTZ00266        165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT  241 (1021)
T ss_pred             cccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence                         34589999999875533221   234579999999999864  458899999999999999999999


Q ss_pred             CCCCCCCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhccc
Q 046595          278 PVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPL  351 (363)
Q Consensus       278 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l  351 (363)
                      ||.......  .+...             +....... ....+..+.+||..||+.+|.+||++.+++.  .+..+
T Consensus       242 PF~~~~~~~--qli~~-------------lk~~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        242 PFHKANNFS--QLISE-------------LKRGPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             CCCcCCcHH--HHHHH-------------HhcCCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            996432211  11100             00000000 1123567999999999999999999999984  44433

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.8e-42  Score=324.86  Aligned_cols=274  Identities=16%  Similarity=0.259  Sum_probs=191.2

Q ss_pred             HHHhcCCCCCCeeeccCCceEEEEEeC--CCCeEEEEEcc--------------CC--CCCCchHHHHHHHHHHhcCCCC
Q 046595           64 NRLTSNFGTKALIGEGSYGRVFYAKLT--DGTPAAIKKLD--------------TS--SAPEPESDFAAQLSVVSRLKHE  125 (363)
Q Consensus        64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~avK~~~--------------~~--~~~~~~~~~~~e~~~l~~l~h~  125 (363)
                      ..+.++|++.+.||+|+||.||+|..+  ++...++|.+.              ..  ........+.+|+.++++++|+
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence            345679999999999999999998643  22222222111              00  1112234678999999999999


Q ss_pred             ccceeeeEEEeCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccC
Q 046595          126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRS  205 (363)
Q Consensus       126 ~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp  205 (363)
                      ||+++++++...+..+++++++.+ +|.+++.......    ........+..++.|++.||.|||++   +|+||||||
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~----~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP  295 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDW----KDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKL  295 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccc----cccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence            999999999999999999999865 7888775433211    01134667888999999999999999   999999999


Q ss_pred             CceeecCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCC-CCCCCC
Q 046595          206 SNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP-VDHTMP  284 (363)
Q Consensus       206 ~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p-~~~~~~  284 (363)
                      +|||++.++.+||+|||++......... ......||..|+|||++.+..++.++|||||||++|||++|..+ |.....
T Consensus       296 ~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~  374 (501)
T PHA03210        296 ENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG  374 (501)
T ss_pred             HHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC
Confidence            9999999999999999999765433221 12346799999999999999999999999999999999998854 433222


Q ss_pred             ccccchhhhcc------ccccc--cccccccCCc-C---CCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          285 KGQQSLVTWAT------PRLSE--DKVKQCVDPK-L---NNDYP-----PKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       285 ~~~~~~~~~~~------~~~~~--~~~~~~~~~~-~---~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .....+.....      .....  ..+...++.. +   ....+     ...+..+.+++.+||+.||.+|||+.|++.
T Consensus       375 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        375 KPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             CHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            21111111000      00000  0000000000 0   00000     012345788899999999999999999986

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-42  Score=314.18  Aligned_cols=241  Identities=19%  Similarity=0.226  Sum_probs=187.0

Q ss_pred             eeccCCceEEEEEeC-CCCeEEEEEccCCCC--CCchHHHHHHHHHHhcC---CCCccceeeeEEEeCCeeEEEEecccC
Q 046595           76 IGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA--PEPESDFAAQLSVVSRL---KHEHFVELLGYCMESNNRILVYQFATM  149 (363)
Q Consensus        76 lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~  149 (363)
                      ||+|+||.||+|+.. +++.||+|++.....  ......+..|..++..+   +||||+.+++++......++||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999765 689999999864321  11223455566666655   699999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCc
Q 046595          150 GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       150 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      |+|..++....         .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 g~L~~~l~~~~---------~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~  148 (330)
T cd05586          81 GELFWHLQKEG---------RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLT  148 (330)
T ss_pred             ChHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCC
Confidence            99999987543         288999999999999999999999   999999999999999999999999999865332


Q ss_pred             ccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccC
Q 046595          230 TAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD  308 (363)
Q Consensus       230 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (363)
                      ...  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+       ...      .
T Consensus       149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i-------~~~------~  213 (330)
T cd05586         149 DNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI-------AFG------K  213 (330)
T ss_pred             CCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH-------HcC------C
Confidence            221  12346799999999998764 5899999999999999999999999654221110000       000      0


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccCCCCCCCC----CHHHHHH
Q 046595          309 PKLNNDYPPKAIAKLAAVAALCVQYEADFRP----NMTIVVK  346 (363)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP----s~~~vl~  346 (363)
                      ..+.   ....+..+.+++.+||+.||.+||    ++.++++
T Consensus       214 ~~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         214 VRFP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CCCC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            0000   112456788999999999999998    5677665

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-41  Score=296.61  Aligned_cols=253  Identities=25%  Similarity=0.397  Sum_probs=204.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      ++|++.+.||.|+||.||+|... +++.+++|.+..... .....+.+|+.+++.++||||+++++++......+++|||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch-hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            47889999999999999999764 578899999876433 2457889999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|.+++.....        .+++..+..++.|++.||.|||++   +++|+||+|+||++++++.++|+|||++..
T Consensus        82 ~~~~~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~  150 (262)
T cd06613          82 CGGGSLQDIYQVTRG--------PLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQ  150 (262)
T ss_pred             CCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchh
Confidence            999999999876421        288999999999999999999999   999999999999999999999999999865


Q ss_pred             CCcccccccccccccccCCCCccccccC---CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTG---QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      .......  .....++..|+|||.+.+.   .++.++|+||||+++|+|++|..||....+........  .     .  
T Consensus       151 ~~~~~~~--~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~--~-----~--  219 (262)
T cd06613         151 LTATIAK--RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS--K-----S--  219 (262)
T ss_pred             hhhhhhc--cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--h-----c--
Confidence            5432211  2335688899999998776   88999999999999999999999997544322111100  0     0  


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                       ..  ...........+.++.+++.+||+.+|.+|||+.+|+.
T Consensus       220 -~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         220 -NF--PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             -cC--CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             00  00011123455678999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.8e-41  Score=296.88  Aligned_cols=249  Identities=25%  Similarity=0.442  Sum_probs=204.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCC-CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      ++|++.+.||+|+||.||++.+.+ +..+++|.+.....   ...+.+|+.+++.++|+||+++++++......++++||
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            478899999999999999998764 78999999865322   67899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|.+++.....        .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        80 ~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~  148 (256)
T cd06612          80 CGAGSVSDIMKITNK--------TLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQ  148 (256)
T ss_pred             CCCCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchh
Confidence            999999999965331        389999999999999999999999   999999999999999999999999999876


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      ......  ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||....+.......            .. 
T Consensus       149 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~------------~~-  213 (256)
T cd06612         149 LTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI------------PN-  213 (256)
T ss_pred             cccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh------------cc-
Confidence            544321  123345888999999999889999999999999999999999999754332111100            00 


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                       ........+...+..+.+++.+||+.||++|||+.+|++
T Consensus       214 -~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         214 -KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             -CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence             000011123345677999999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.4e-41  Score=298.42  Aligned_cols=255  Identities=21%  Similarity=0.350  Sum_probs=189.9

Q ss_pred             eeeccCCceEEEEEeCCC---CeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCCC
Q 046595           75 LIGEGSYGRVFYAKLTDG---TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGS  151 (363)
Q Consensus        75 ~lg~G~~g~V~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g~  151 (363)
                      .||+|+||.||++...++   ..+++|.+...........+.+|+.+++.++||||+++++.+......++||||+.+|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999975433   34566766554433445688999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCccc
Q 046595          152 LHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTA  231 (363)
Q Consensus       152 L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~  231 (363)
                      |.+++......     ...+....+..++.|++.||.|||+.   +++|+||||+|||++.++.++|+|||++.......
T Consensus        82 L~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~  153 (268)
T cd05086          82 LKSYLSQEQWH-----RRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED  153 (268)
T ss_pred             HHHHHHhhhcc-----cccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcch
Confidence            99999764321     11266778889999999999999999   99999999999999999999999999975432222


Q ss_pred             ccccccccccccCCCCcccccc-------CCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccccc
Q 046595          232 ARLHSTRVLGTFGYHAPEYAMT-------GQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       232 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      .........|+..|+|||++..       ..++.++||||||+++|||++ |..||....+.......      . ....
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~------~-~~~~  226 (268)
T cd05086         154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV------I-KDQQ  226 (268)
T ss_pred             hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------H-hhcc
Confidence            1122234568899999998743       245789999999999999997 56787543321111100      0 0111


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ  349 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~  349 (363)
                      ....++.+    .......+.+++..|| .+|++||++++|++.|.
T Consensus       227 ~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         227 VKLFKPQL----ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cccCCCcc----CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            11122222    2224456888999999 67999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.1e-41  Score=296.69  Aligned_cols=252  Identities=21%  Similarity=0.342  Sum_probs=205.3

Q ss_pred             CCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCC-CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           69 NFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSS-APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      +|+..++||.|+||.||.++. .+++.+++|.+.... .......+.+|+.++++++|+||+++++++.+....+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            588899999999999999974 468899999886543 334456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|.+++.....       ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++..
T Consensus        81 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~  150 (256)
T cd08221          81 ANGGTLYDKIVRQKG-------QLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKI  150 (256)
T ss_pred             cCCCcHHHHHHhccc-------cCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEE
Confidence            999999999976431       2388999999999999999999999   999999999999999999999999999865


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      ......  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..........               ..
T Consensus       151 ~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~---------------~~  213 (256)
T cd08221         151 LGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV---------------KI  213 (256)
T ss_pred             cccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH---------------HH
Confidence            543321  1234568999999999988889999999999999999999999996433211110               00


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKAL  348 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l  348 (363)
                      ..... ...+...+..+.+++.+||+.+|++||++.++++.+
T Consensus       214 ~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         214 VQGNY-TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             HcCCC-CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            00111 111234566799999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=284.04  Aligned_cols=249  Identities=18%  Similarity=0.264  Sum_probs=198.6

Q ss_pred             HhcCCCCC-CeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEe----CC
Q 046595           66 LTSNFGTK-ALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCME----SN  138 (363)
Q Consensus        66 ~~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~  138 (363)
                      ++++|.+. .+||-|-.|.|..|.++ +++.+|+|++...      ....+|+++.-.. .|||||.+++++.+    ..
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk  132 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK  132 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence            45677764 47999999999999654 7999999998653      2456777765555 69999999998764    34


Q ss_pred             eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec---CCCc
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF---DDFK  215 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~---~~~~  215 (363)
                      .+.+|||.++||.|++.++.++..       .|++.++..|..||..|+.|||+.   +|.||||||+|+|..   .+..
T Consensus       133 cLLiVmE~meGGeLfsriq~~g~~-------afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~  202 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDRGDQ-------AFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAP  202 (400)
T ss_pred             eeEeeeecccchHHHHHHHHcccc-------cchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcc
Confidence            567999999999999999987753       399999999999999999999999   999999999999996   4567


Q ss_pred             eEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 046595          216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       216 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      +||+|||+|+.......   ....+.|+.|+|||++....|+...|+||+||++|-|++|.+||-.....          
T Consensus       203 lKLtDfGFAK~t~~~~~---L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~----------  269 (400)
T KOG0604|consen  203 LKLTDFGFAKETQEPGD---LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----------  269 (400)
T ss_pred             eEecccccccccCCCcc---ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc----------
Confidence            99999999987654222   34567899999999999999999999999999999999999999644321          


Q ss_pred             ccccccccccccCCcCCCCCC----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          296 PRLSEDKVKQCVDPKLNNDYP----PKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                       .++.+.-..+....  -.||    ...++...++|+.+|..+|.+|.|+.+++.
T Consensus       270 -aispgMk~rI~~gq--y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  270 -AISPGMKRRIRTGQ--YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             -cCChhHHhHhhccC--ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence             12222111221111  1223    256778999999999999999999999876

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-41  Score=302.72  Aligned_cols=262  Identities=23%  Similarity=0.324  Sum_probs=205.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      .+|++.+.||+|+||.||++... ++..|++|++...........+.+|+++++.++||||+++++++......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            46888889999999999999765 68889999887654444457889999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|.+++....         .+++..+..++.+++.||.|||+..  +++|+||+|+||++++++.++|+|||++..
T Consensus        85 ~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~  153 (284)
T cd06620          85 MDCGSLDRIYKKGG---------PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGE  153 (284)
T ss_pred             CCCCCHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccc
Confidence            99999999987643         2889999999999999999999632  899999999999999999999999998764


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      .....    .....|+..|+|||++.+..++.++|+|||||++|+|++|..||............    +......+...
T Consensus       154 ~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~----~~~~~~~~~~~  225 (284)
T cd06620         154 LINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD----PMGILDLLQQI  225 (284)
T ss_pred             hhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhh----hhHHHHHHHHH
Confidence            42221    22357899999999998889999999999999999999999999754332110000    00000000111


Q ss_pred             cCCcCCCCCC-HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 046595          307 VDPKLNNDYP-PKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ  349 (363)
Q Consensus       307 ~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~  349 (363)
                      ..... ...+ ...+.++.+++.+||+.||++|||+.++++...
T Consensus       226 ~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~  268 (284)
T cd06620         226 VQEPP-PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP  268 (284)
T ss_pred             hhccC-CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence            11111 1111 235677999999999999999999999998643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.1e-41  Score=309.50  Aligned_cols=252  Identities=19%  Similarity=0.219  Sum_probs=195.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|.+.+.||+|+||.||+++.. +++.||+|++....  .......+..|..++..++|+||+.+++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36889999999999999999765 58889999986522  1222345778899999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+|+|.+++.....        .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        81 Ey~~gg~L~~~l~~~~~--------~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a  149 (331)
T cd05624          81 DYYVGGDLLTLLSKFED--------RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSC  149 (331)
T ss_pred             eCCCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccce
Confidence            99999999999975321        288999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCcccccc-----CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMT-----GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      ......... ......||+.|+|||++.+     ..++.++||||||++||+|++|+.||...........         
T Consensus       150 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~---------  219 (331)
T cd05624         150 LKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK---------  219 (331)
T ss_pred             eeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHH---------
Confidence            654432211 1233569999999998875     4688999999999999999999999975432111100         


Q ss_pred             ccccccccCCcCCCCC---CHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 046595          300 EDKVKQCVDPKLNNDY---PPKAIAKLAAVAALCVQYEADF--RPNMTIVVK  346 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~--RPs~~~vl~  346 (363)
                            .........+   ....+.++.+++.+|+..++++  |++++++++
T Consensus       220 ------i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         220 ------IMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             ------HHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence                  0000000011   1234567889999999865544  467888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3e-41  Score=299.20  Aligned_cols=247  Identities=26%  Similarity=0.391  Sum_probs=203.4

Q ss_pred             CCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           69 NFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      -|++.+.||+|+||.||+|.+ .++..+|+|.+...........+.+|+.++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            477888999999999999975 4688999999876444444567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      .+++|.+++....          +++..+..++.|++.++.|||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        85 ~~~~l~~~i~~~~----------~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06641          85 GGGSALDLLEPGP----------LDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL  151 (277)
T ss_pred             CCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceec
Confidence            9999999986532          88999999999999999999999   9999999999999999999999999998654


Q ss_pred             CcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCV  307 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (363)
                      .....  ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...........                +
T Consensus       152 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~----------------~  213 (277)
T cd06641         152 TDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL----------------I  213 (277)
T ss_pred             ccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH----------------H
Confidence            43221  12334688899999999888899999999999999999999999964432111110                0


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          308 DPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .......++..++..+.+++.+||+.+|.+||++.++++
T Consensus       214 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         214 PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             hcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            001111223345677999999999999999999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3e-41  Score=301.53  Aligned_cols=251  Identities=24%  Similarity=0.377  Sum_probs=199.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      +.|++.+.||.|+||.||+++.. ++..+++|.+... .......+.+|+.+++.++|+||+++++.+......++||||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            57999999999999999999765 5889999998653 233346788899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|..++.....        .+++..+..++.|++.+|.|||++   +++|+||||+||+++.++.++|+|||++..
T Consensus        91 ~~~~~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~  159 (292)
T cd06644          91 CPGGAVDAIMLELDR--------GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAK  159 (292)
T ss_pred             CCCCcHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCcccee
Confidence            999999888754321        288999999999999999999999   999999999999999999999999998765


Q ss_pred             CCcccccccccccccccCCCCccccc-----cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAM-----TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      ......  ......++..|+|||++.     ...++.++|+|||||++|+|++|..||........  ......      
T Consensus       160 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~~------  229 (292)
T cd06644         160 NVKTLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAK------  229 (292)
T ss_pred             cccccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HHHHhc------
Confidence            332211  123456889999999884     34578899999999999999999999965432110  000000      


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                          ...+  ....+...+..+.+++.+||+.+|++||++.+|++
T Consensus       230 ----~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         230 ----SEPP--TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ----CCCc--cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                0000  01123345567999999999999999999999987

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2e-41  Score=301.51  Aligned_cols=266  Identities=21%  Similarity=0.282  Sum_probs=199.1

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC-chHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      +|++.+.||+|++|.||+|+.. ++..|++|++....... ....+.+|+.+++.++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788899999999999999764 68999999987643322 345788899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +. ++|.+++.....      +..+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++..
T Consensus        81 ~~-~~l~~~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  150 (285)
T cd07861          81 LS-MDLKKYLDSLPK------GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARA  150 (285)
T ss_pred             CC-CCHHHHHhcCCC------CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceee
Confidence            97 489888865331      12389999999999999999999999   999999999999999999999999999865


Q ss_pred             CCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchh--hhcccc---cc-
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLV--TWATPR---LS-  299 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~--~~~~~~---~~-  299 (363)
                      ......  ......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||............  .+..+.   +. 
T Consensus       151 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (285)
T cd07861         151 FGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG  228 (285)
T ss_pred             cCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhc
Confidence            433211  12234678899999988754 5789999999999999999999999754322111000  000000   00 


Q ss_pred             ---ccccccccCC---cCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          300 ---EDKVKQCVDP---KLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       300 ---~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                         ..........   ..........+.++.++|.+||+.||++|||+.+|++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         229 VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             chhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence               0000000000   0000111234567889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.3e-41  Score=296.47  Aligned_cols=250  Identities=24%  Similarity=0.348  Sum_probs=200.3

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEe-CCeeEEEEe
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCME-SNNRILVYQ  145 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e  145 (363)
                      +|++.+.||.|++|.||.+... +++.+++|.+..... ......+..|+.++++++|+|++++++.+.. ....+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4888999999999999999754 578899999865332 2234568889999999999999999988764 446789999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+++|.+++.....       ..+++.+++.++.+++.||.|||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus        81 ~~~~~~l~~~l~~~~~-------~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~  150 (257)
T cd08223          81 FCEGGDLYHKLKEQKG-------KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIAR  150 (257)
T ss_pred             ccCCCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceE
Confidence            9999999999975321       1388999999999999999999999   99999999999999999999999999986


Q ss_pred             CCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      .......  ......|++.|+|||++.+..++.++|+||||+++|+|++|+.||..........               .
T Consensus       151 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~---------------~  213 (257)
T cd08223         151 VLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY---------------R  213 (257)
T ss_pred             EecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH---------------H
Confidence            5433211  1234568999999999998899999999999999999999999996432211000               0


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ... ......+...+..+.+++.+||+.+|++||++.++++
T Consensus       214 ~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         214 IIE-GKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             HHh-cCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            000 1111234456678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.8e-41  Score=308.16  Aligned_cols=253  Identities=19%  Similarity=0.228  Sum_probs=195.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|.+.+.||+|+||.||+++.. +++.+|+|++....  .......+..|+.++..++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36889999999999999999865 57889999986421  1222345788999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+|+|.+++.....        .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        81 ey~~~g~L~~~l~~~~~--------~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a  149 (332)
T cd05623          81 DYYVGGDLLTLLSKFED--------RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSC  149 (332)
T ss_pred             eccCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchh
Confidence            99999999999975321        288999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCccccc-----cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAM-----TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      ........ .......||+.|+|||++.     ...++.++|||||||++|||++|+.||...........+        
T Consensus       150 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i--------  220 (332)
T cd05623         150 LKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI--------  220 (332)
T ss_pred             eecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHH--------
Confidence            65432211 1123357999999999886     346889999999999999999999999754322111110        


Q ss_pred             ccccccccCCcCC---CCCCHHHHHHHHHHHHhccCCCCC--CCCCHHHHHHH
Q 046595          300 EDKVKQCVDPKLN---NDYPPKAIAKLAAVAALCVQYEAD--FRPNMTIVVKA  347 (363)
Q Consensus       300 ~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~--~RPs~~~vl~~  347 (363)
                             ......   ......++..+.+++.+|+..+++  .|+++.++++.
T Consensus       221 -------~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         221 -------MNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             -------hCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                   000000   111123466788899998865443  36889998875

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-43  Score=293.68  Aligned_cols=250  Identities=21%  Similarity=0.280  Sum_probs=205.6

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      .++|..+++||+|.||.|.+|+. .+++.||+|++++..  ..+....-..|-.+|+..+||.+..+.-.+...+.+++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            35788999999999999999975 479999999998753  223345667788999999999999999899999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||.+||.|.-.|...+         .+++.....+...|+.||.|||++   +||+||||.+|+|+|.+|++||+|||+
T Consensus       247 MeyanGGeLf~HLsrer---------~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGL  314 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER---------VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGL  314 (516)
T ss_pred             EEEccCceEeeehhhhh---------cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeeccc
Confidence            99999999988887654         388999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      ++.-...  ......++|||.|+|||++....|+.++|.|.+||++|||++|+.||...+....-.++.           
T Consensus       315 CKE~I~~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl-----------  381 (516)
T KOG0690|consen  315 CKEEIKY--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL-----------  381 (516)
T ss_pred             chhcccc--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH-----------
Confidence            8753322  223567899999999999999999999999999999999999999997543221111111           


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCC--CHHHHHHH
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP--NMTIVVKA  347 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP--s~~~vl~~  347 (363)
                        .    -...+|...+++...|+..+|..||.+|.  ...+..+.
T Consensus       382 --~----ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi  421 (516)
T KOG0690|consen  382 --M----EDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEI  421 (516)
T ss_pred             --h----hhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHH
Confidence              0    01345667778899999999999999995  33444443

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.4e-41  Score=305.87  Aligned_cols=263  Identities=18%  Similarity=0.268  Sum_probs=194.7

Q ss_pred             CCCeeecc--CCceEEEEEe-CCCCeEEEEEccCCCCCC-chHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           72 TKALIGEG--SYGRVFYAKL-TDGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        72 ~~~~lg~G--~~g~V~~~~~-~~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      +.++||+|  +|++||++.. .+|+.||+|.+....... ....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45679999  6889999965 478999999987643322 2356778999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      ++|+|.+++......       .+++..++.++.|++.||.|||++   +|+||||||+||+++.++.++++||+.+...
T Consensus        82 ~~~~l~~~~~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~  151 (327)
T cd08227          82 AYGSAKDLICTHFMD-------GMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM  151 (327)
T ss_pred             CCCcHHHHHHhhccC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcc
Confidence            999999999654211       288999999999999999999999   9999999999999999999999999865332


Q ss_pred             Cccccc-----ccccccccccCCCCcccccc--CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc--
Q 046595          228 SDTAAR-----LHSTRVLGTFGYHAPEYAMT--GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL--  298 (363)
Q Consensus       228 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~--  298 (363)
                      ......     .......++..|+|||++.+  ..++.++|||||||++|||++|+.||........  .........  
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~  229 (327)
T cd08227         152 INHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPC  229 (327)
T ss_pred             ccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCccc
Confidence            211110     01122356778999999876  4689999999999999999999999975322110  000000000  


Q ss_pred             -------ccccc-------------cc---------ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          299 -------SEDKV-------------KQ---------CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       299 -------~~~~~-------------~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                             .....             ..         .........+....+..+.+++.+||+.||++|||++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                   00000             00         00000001122345668999999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-42  Score=316.30  Aligned_cols=255  Identities=26%  Similarity=0.390  Sum_probs=212.4

Q ss_pred             CCCCCCeeeccCCceEEEEEeC--CCCe--EEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT--DGTP--AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~--~~~~--~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      +..+.++||+|.||.|++|.|.  +|+.  ||||.+..........+|++|+.+|.+|+|+|++++||+..+ ....|||
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            3445567999999999999876  3554  799999876544456899999999999999999999999887 6778999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      |.+..|+|.+.|++...       ..|....+..++.||+.|+.||.++   ++|||||..+|+|+.....|||+||||+
T Consensus       190 ELaplGSLldrLrka~~-------~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLm  259 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRKAKK-------AILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLM  259 (1039)
T ss_pred             hhcccchHHHHHhhccc-------cceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccce
Confidence            99999999999987322       2388889999999999999999999   9999999999999999999999999999


Q ss_pred             CCCCccccccccc-ccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccc
Q 046595          225 NQSSDTAARLHST-RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       225 ~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      +.+.......... ...-...|+|||.++...++.++|||++||+||||++ |+.||-+...                -.
T Consensus       260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----------------~q  323 (1039)
T KOG0199|consen  260 RALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----------------IQ  323 (1039)
T ss_pred             eccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH----------------HH
Confidence            8776554433222 2234568999999999999999999999999999999 7789865433                23


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQP  350 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~  350 (363)
                      +.+.+|.+-+...+..|++.+++++..||..+|.+|||+..|.+.+-.
T Consensus       324 IL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  324 ILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             HHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence            445555555566688999999999999999999999999999865543

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-41  Score=304.74  Aligned_cols=253  Identities=23%  Similarity=0.322  Sum_probs=203.0

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC--chHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE--PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      +|++.+.||+|++|.||+|... +++.+++|.+.......  ....+..|+++++.++|+||+++++.+......+++||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            6888999999999999999765 58999999997644332  34578889999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+++|.+++.....       ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus        82 ~~~~~~L~~~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~  151 (316)
T cd05574          82 YCPGGELFRLLQRQPG-------KCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSK  151 (316)
T ss_pred             ecCCCCHHHHHHhCCC-------CccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhh
Confidence            9999999999875432       2389999999999999999999999   99999999999999999999999999876


Q ss_pred             CCCccccc---------------------------ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCC
Q 046595          226 QSSDTAAR---------------------------LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP  278 (363)
Q Consensus       226 ~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p  278 (363)
                      ........                           .......|+..|+|||++.+..++.++||||||+++|+|++|..|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~p  231 (316)
T cd05574         152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP  231 (316)
T ss_pred             cccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCC
Confidence            54321110                           011234688999999999988899999999999999999999999


Q ss_pred             CCCCCCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCC----HHHHHH
Q 046595          279 VDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPN----MTIVVK  346 (363)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs----~~~vl~  346 (363)
                      |........  +             ................+..+.+++.+||+.||++||+    +.+++.
T Consensus       232 f~~~~~~~~--~-------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         232 FKGSNRDET--F-------------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CCCCchHHH--H-------------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            975432211  1             0111111111111225678999999999999999999    777777

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.9e-41  Score=300.08  Aligned_cols=254  Identities=24%  Similarity=0.397  Sum_probs=199.2

Q ss_pred             HHHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEe-----
Q 046595           64 NRLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCME-----  136 (363)
Q Consensus        64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-----  136 (363)
                      ....+.|++.+.||.|+||.||+|... +++.+++|++...  ......+..|+.+++++ +|+||+++++++..     
T Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   89 (282)
T cd06636          12 RDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG   89 (282)
T ss_pred             cChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC--hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence            334568999999999999999999764 6889999988653  23345688899999998 79999999998853     


Q ss_pred             -CCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCc
Q 046595          137 -SNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK  215 (363)
Q Consensus       137 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~  215 (363)
                       ....+++|||+.+|+|.+++.....       ..+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.
T Consensus        90 ~~~~~~iv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~  159 (282)
T cd06636          90 HDDQLWLVMEFCGAGSVTDLVKNTKG-------NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE  159 (282)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHccC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence             4578999999999999999975432       1378888999999999999999999   9999999999999999999


Q ss_pred             eEEeeeccCCCCCcccccccccccccccCCCCccccc-----cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccch
Q 046595          216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM-----TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSL  290 (363)
Q Consensus       216 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~  290 (363)
                      ++|+|||++........  ......|+..|+|||.+.     +..++.++|+|||||++|||++|..||....+......
T Consensus       160 ~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~  237 (282)
T cd06636         160 VKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL  237 (282)
T ss_pred             EEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh
Confidence            99999999865432211  123456899999999875     34688899999999999999999999965432211110


Q ss_pred             hhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          291 VTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                                     .............++..+.++|.+||+.||.+||++.+|++
T Consensus       238 ---------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         238 ---------------IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             ---------------HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                           00000111112245667999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.8e-41  Score=304.37  Aligned_cols=203  Identities=22%  Similarity=0.392  Sum_probs=162.3

Q ss_pred             CCeeeccCCceEEEEEeC---CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEe--CCeeEEEEecc
Q 046595           73 KALIGEGSYGRVFYAKLT---DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCME--SNNRILVYQFA  147 (363)
Q Consensus        73 ~~~lg~G~~g~V~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~  147 (363)
                      ...||+|+||.||+|+..   ++..||+|.+....   ....+.+|+.+++.++||||+++++++..  ....+++|||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence            357999999999999854   35789999886532   23467889999999999999999998854  45778999998


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceee----cCCCceEEeeecc
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL----FDDFKSKIADFNL  223 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill----~~~~~vkl~Dfg~  223 (363)
                      .+ +|.+++..............+++..+..++.|++.||.|||++   +|+||||||+||++    +.++.+||+|||+
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            76 8888876433221112223488999999999999999999999   99999999999999    4667999999999


Q ss_pred             CCCCCccccc-ccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCC
Q 046595          224 TNQSSDTAAR-LHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHT  282 (363)
Q Consensus       224 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~  282 (363)
                      ++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            9765433221 11234578999999999876 45899999999999999999999999744

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2e-41  Score=298.22  Aligned_cols=252  Identities=23%  Similarity=0.347  Sum_probs=204.7

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      +|++.+.||+|++|.||++.+. +++.+++|.+...........+.+|++++++++||||+++++.+......++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5778889999999999999765 688999999877554455567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-cCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE-KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      .+++|.+++....        ..+++..+..++.|++.||.|||+ .   +++|+||||+||++++++.++|+|||.+..
T Consensus        82 ~~~~L~~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~  150 (265)
T cd06605          82 DGGSLDKILKEVQ--------GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQ  150 (265)
T ss_pred             CCCcHHHHHHHcc--------CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchh
Confidence            9999999997643        138899999999999999999999 8   999999999999999999999999998765


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      ......    ....|+..|+|||.+.+..++.++||||||+++|+|++|..||.......... ..         .+...
T Consensus       151 ~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~---------~~~~~  216 (265)
T cd06605         151 LVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI-FE---------LLQYI  216 (265)
T ss_pred             hHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH-HH---------HHHHH
Confidence            433221    12678899999999998899999999999999999999999996542211100 00         01111


Q ss_pred             cCCcCCCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          307 VDPKLNNDYPPK-AIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       307 ~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ... .....+.. .+..+.++|..||..+|++|||+.+++.
T Consensus       217 ~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         217 VNE-PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             hcC-CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            111 11122222 6677999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7.8e-41  Score=294.67  Aligned_cols=258  Identities=26%  Similarity=0.361  Sum_probs=206.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      ++|++.+.||.|+||.||+|... ++..+++|++...........+.+|+.+++.++|+||+++++.+......++++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            36899999999999999999754 68889999987655444567899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|.+++.....      ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++..
T Consensus        81 ~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~  151 (267)
T cd06610          81 LSGGSLLDIMKSSYP------RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSAS  151 (267)
T ss_pred             cCCCcHHHHHHHhcc------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHH
Confidence            999999999975421      11388999999999999999999999   999999999999999999999999999865


Q ss_pred             CCcccccc--cccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          227 SSDTAARL--HSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       227 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      ........  ......|+..|+|||.+... .++.++|+||||+++|+|++|+.||........  .......       
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~-------  222 (267)
T cd06610         152 LADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTLQN-------  222 (267)
T ss_pred             hccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHhcC-------
Confidence            54432221  12334689999999998876 789999999999999999999999975433211  1110000       


Q ss_pred             ccccCCcCCCCC-CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          304 KQCVDPKLNNDY-PPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       304 ~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                         ....+.... ....+..+.+++.+||+.||++||++.+|++
T Consensus       223 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         223 ---DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             ---CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence               000111111 1245677999999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.2e-41  Score=299.07  Aligned_cols=251  Identities=26%  Similarity=0.386  Sum_probs=198.9

Q ss_pred             CCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEeccc
Q 046595           70 FGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFAT  148 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  148 (363)
                      |++.+.||+|+||.||++... ++..+++|.+.... ......+.+|+.+++.++|+||+++++++......++|+||+.
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            677888999999999999765 57788888886532 2334678889999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCC
Q 046595          149 MGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS  228 (363)
Q Consensus       149 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~  228 (363)
                      +++|..++.....        .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        86 ~~~l~~~~~~~~~--------~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  154 (282)
T cd06643          86 GGAVDAVMLELER--------PLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT  154 (282)
T ss_pred             CCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccc
Confidence            9999988764221        388999999999999999999999   99999999999999999999999999986543


Q ss_pred             cccccccccccccccCCCCccccc-----cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          229 DTAARLHSTRVLGTFGYHAPEYAM-----TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       229 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      ....  ......|+..|+|||++.     +..++.++|+|||||++|+|++|+.||....+...  ......        
T Consensus       155 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~~--------  222 (282)
T cd06643         155 RTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLKIAK--------  222 (282)
T ss_pred             cccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHHHhh--------
Confidence            3221  123456899999999874     34678899999999999999999999975432111  010000        


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKAL  348 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l  348 (363)
                        ..  ......+...+.++.+++.+||+.||.+||++.++++.-
T Consensus       223 --~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         223 --SE--PPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             --cC--CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence              00  001112334566799999999999999999999998643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=295.25  Aligned_cols=248  Identities=25%  Similarity=0.398  Sum_probs=212.3

Q ss_pred             CCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEeccc
Q 046595           70 FGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFAT  148 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  148 (363)
                      |.++..||+|+||.||++.++ +|..+|||.+..   ....+.+..|+.+++++..+++|++||.+.....+++|||||-
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV---~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV---DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc---cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            556667999999999999655 699999999876   4457889999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCC
Q 046595          149 MGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS  228 (363)
Q Consensus       149 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~  228 (363)
                      .|+..+.++.+..        +++++++..++...++||+|||..   .-+|||||..|||++.+|+.||.|||.|..+.
T Consensus       112 AGSiSDI~R~R~K--------~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT  180 (502)
T KOG0574|consen  112 AGSISDIMRARRK--------PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLT  180 (502)
T ss_pred             CCcHHHHHHHhcC--------CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhh
Confidence            9999999986652        599999999999999999999999   88999999999999999999999999997776


Q ss_pred             cccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccC
Q 046595          229 DTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD  308 (363)
Q Consensus       229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (363)
                      +....  .+...||+-|||||++..-.|+.++||||||++..||.-|++||.+..+.....++.-..             
T Consensus       181 DTMAK--RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~P-------------  245 (502)
T KOG0574|consen  181 DTMAK--RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKP-------------  245 (502)
T ss_pred             hhHHh--hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCC-------------
Confidence            65443  456789999999999999999999999999999999999999998766543333221111             


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          309 PKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                       -..-..|...+.++.+++++||-.+|++|-|+.++++.
T Consensus       246 -PPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  246 -PPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             -CCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence             01112255667889999999999999999999998763

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=8.9e-41  Score=294.41  Aligned_cols=250  Identities=23%  Similarity=0.368  Sum_probs=197.5

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC----CchHHHHHHHHHHhcCCCCccceeeeEEEe--CCeeE
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP----EPESDFAAQLSVVSRLKHEHFVELLGYCME--SNNRI  141 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~  141 (363)
                      +|...+.||+|+||.||++... ++..|++|.+......    .....+.+|+.+++.++|+||+++++++.+  ....+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            6889999999999999999754 6889999988653321    123467889999999999999999998875  35678


Q ss_pred             EEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeee
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADF  221 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df  221 (363)
                      +++||+.+++|.+++....         .+++..++.++.|++.||.|||+.   +|+|+||+|+||+++.++.++|+||
T Consensus        83 l~~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~df  150 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYG---------ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDF  150 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccC
Confidence            9999999999999997543         278899999999999999999999   9999999999999999999999999


Q ss_pred             ccCCCCCccccc-ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccc
Q 046595          222 NLTNQSSDTAAR-LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE  300 (363)
Q Consensus       222 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  300 (363)
                      |++......... .......++..|+|||.+.+..++.++||||||+++|||++|+.||.......              
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~--------------  216 (266)
T cd06651         151 GASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA--------------  216 (266)
T ss_pred             CCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH--------------
Confidence            998654322111 11123458899999999998889999999999999999999999997442211              


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          301 DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                       .+...........++......+.+++ .||..+|++||++.+|++
T Consensus       217 -~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         217 -AIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             -HHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence             01111111112333445566788888 677789999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.9e-41  Score=294.97  Aligned_cols=251  Identities=23%  Similarity=0.366  Sum_probs=203.7

Q ss_pred             CCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCC-CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           69 NFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSS-APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      +|++.+.||+|+||.||.+.. .+++.|++|.+.... .......+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            588899999999999999975 468899999986532 223345788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|.+++.....       ..+++..++.++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ~~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~  150 (256)
T cd08218          81 CEGGDLYKKINAQRG-------VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARV  150 (256)
T ss_pred             CCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceee
Confidence            999999999875432       1278999999999999999999999   999999999999999999999999999865


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      .......  .....|+..|+|||++.+..++.++|+||||+++|+|++|..||........               +...
T Consensus       151 ~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~---------------~~~~  213 (256)
T cd08218         151 LNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL---------------VLKI  213 (256)
T ss_pred             cCcchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH---------------HHHH
Confidence            5433221  2234688899999999888899999999999999999999999964322110               0000


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                      .. ......+...+..+.+++.+||+.+|.+||++.+|++.
T Consensus       214 ~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         214 IR-GSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             hc-CCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            00 11112234556779999999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-41  Score=296.00  Aligned_cols=274  Identities=27%  Similarity=0.416  Sum_probs=215.7

Q ss_pred             CCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcC--CCCccceeeeEEEeCC----eeEE
Q 046595           69 NFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL--KHEHFVELLGYCMESN----NRIL  142 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~~----~~~l  142 (363)
                      ...+..+||+|.||.||+|... ++.||||++..    ...+.|..|.+|....  .|+||+++++.-....    .++|
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc-CceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            4456677999999999999986 59999999865    3457888888887764  7999999998765554    7899


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccC------CCCeEEecccCCceeecCCCce
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV------QPPIVHRDVRSSNVLLFDDFKS  216 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~------~~~ivH~Dlkp~Nill~~~~~v  216 (363)
                      |++|.+.|+|.++|..+.          ++|.+..+|+..+++||+|||+..      +++|+|||||..||||.+|++.
T Consensus       286 Vt~fh~kGsL~dyL~~nt----------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc  355 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKANT----------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC  355 (534)
T ss_pred             EeeeccCCcHHHHHHhcc----------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence            999999999999999875          999999999999999999999764      5689999999999999999999


Q ss_pred             EEeeeccCCCCCcccccccccccccccCCCCccccccCC-C-----CccCceehhHHHHHHHHhCCCCCC-CCCCccccc
Q 046595          217 KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQ-I-----TQKSDVYSFGVVLLELLTGRKPVD-HTMPKGQQS  289 (363)
Q Consensus       217 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-----~~~~DvwslG~~l~ell~g~~p~~-~~~~~~~~~  289 (363)
                      .|+|||+|..+............+||.+|||||++.+.. .     -.+.||||+|.+||||++.-.-+. +..+.-+..
T Consensus       356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlp  435 (534)
T KOG3653|consen  356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLP  435 (534)
T ss_pred             EeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCc
Confidence            999999998776554444444578999999999998642 2     246899999999999999765543 333333333


Q ss_pred             hhhhcccccccccccccc-CCcCCCCCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCC
Q 046595          290 LVTWATPRLSEDKVKQCV-DPKLNNDYPP-----KAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA  357 (363)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~  357 (363)
                      +...+....+.+++...+ ..+.+..++.     .....+++.++.||++|++.|.|+.=+.+++.++....+.
T Consensus       436 fe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  436 FEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             hhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence            333444444444444333 3333333333     3456799999999999999999999999999988877664

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=5.5e-41  Score=296.81  Aligned_cols=260  Identities=22%  Similarity=0.352  Sum_probs=199.0

Q ss_pred             CCCCCeeeccCCceEEEEEeC----CCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeCC------
Q 046595           70 FGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESN------  138 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------  138 (363)
                      |.+.+.||+|+||.||+|...    ++..+++|++...... ...+.+.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999643    3688999998764322 23457889999999999999999999886542      


Q ss_pred             eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEE
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI  218 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl  218 (363)
                      ..+++++|+.+|+|.+++........   ...+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl  154 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEE---PFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCV  154 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEE
Confidence            23688999999999988753221110   11378899999999999999999999   9999999999999999999999


Q ss_pred             eeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccc
Q 046595          219 ADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPR  297 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~  297 (363)
                      +|||+++...............++..|++||.+.+..++.++||||||+++|+|++ |..||.......   ...+..  
T Consensus       155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~--  229 (273)
T cd05074         155 ADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLI--  229 (273)
T ss_pred             CcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHH--
Confidence            99999876543222111223345678999999988889999999999999999999 888886443211   111100  


Q ss_pred             ccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 046595          298 LSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL  351 (363)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l  351 (363)
                       .          ......+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       230 -~----------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         230 -K----------GNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             -c----------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             0          000111223456799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.8e-41  Score=296.09  Aligned_cols=255  Identities=23%  Similarity=0.377  Sum_probs=199.9

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC--C-------chHHHHHHHHHHhcCCCCccceeeeEEEeCC
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP--E-------PESDFAAQLSVVSRLKHEHFVELLGYCMESN  138 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  138 (363)
                      +|.+.+.||.|+||.||+|... +++.+++|.+......  .       ..+.+..|+.+++.++|+||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            5788899999999999999754 6889999987642211  1       1245778999999999999999999999999


Q ss_pred             eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEE
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI  218 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl  218 (363)
                      ..++||||+.+++|.+++....         .+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l  149 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG---------RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKI  149 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEE
Confidence            9999999999999999997653         288899999999999999999999   9999999999999999999999


Q ss_pred             eeeccCCCCCcccccccccccccccCCCCccccccCC--CCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccc
Q 046595          219 ADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQ--ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATP  296 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~  296 (363)
                      +|||++................|+..|+|||.+....  ++.++|+||||+++|++++|..||.......  ....... 
T Consensus       150 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~-  226 (272)
T cd06629         150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA--AMFKLGN-  226 (272)
T ss_pred             eeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH--HHHHhhc-
Confidence            9999987654332222223456889999999887654  8899999999999999999999996332210  0000000 


Q ss_pred             cccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          297 RLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                              ..............++..+.+++.+||+.+|++||++.+|++
T Consensus       227 --------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         227 --------KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             --------cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence                    000011111222345678999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.2e-41  Score=300.35  Aligned_cols=262  Identities=23%  Similarity=0.365  Sum_probs=200.8

Q ss_pred             HHHHHHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEE---
Q 046595           61 DELNRLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCM---  135 (363)
Q Consensus        61 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~---  135 (363)
                      +.+....++|++.+.||+|+||.||++... +++.+++|++...  ......+..|+.+++.+ +|+||+++++++.   
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI--HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc--cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            444556679999999999999999999754 5889999987542  22235678899999999 6999999999874   


Q ss_pred             --eCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCC
Q 046595          136 --ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD  213 (363)
Q Consensus       136 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~  213 (363)
                        .....++||||+++++|.+++......     ...+++..+..++.|++.||.|||++   +++||||||+||+++.+
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~  160 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKR-----GERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTE  160 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhcc-----CccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCC
Confidence              345689999999999999987642211     12388999999999999999999999   99999999999999999


Q ss_pred             CceEEeeeccCCCCCcccccccccccccccCCCCcccccc-----CCCCccCceehhHHHHHHHHhCCCCCCCCCCcccc
Q 046595          214 FKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-----GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ  288 (363)
Q Consensus       214 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~  288 (363)
                      +.++|+|||++........  ......|+..|+|||.+..     ..++.++|||||||++|||++|+.||....+....
T Consensus       161 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~  238 (286)
T cd06638         161 GGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL  238 (286)
T ss_pred             CCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH
Confidence            9999999999865433211  1233468999999998753     45789999999999999999999999754321111


Q ss_pred             chhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 046595          289 SLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKAL  348 (363)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l  348 (363)
                      .  ..          .....  .....+...+..+.+++.+||+.||++|||+.+|++.+
T Consensus       239 ~--~~----------~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         239 F--KI----------PRNPP--PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             h--hc----------cccCC--CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            0  00          00000  00011222345699999999999999999999998753

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.6e-41  Score=294.54  Aligned_cols=239  Identities=23%  Similarity=0.403  Sum_probs=186.7

Q ss_pred             eeeccCCceEEEEEeCC-------------CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeE
Q 046595           75 LIGEGSYGRVFYAKLTD-------------GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRI  141 (363)
Q Consensus        75 ~lg~G~~g~V~~~~~~~-------------~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  141 (363)
                      .||+|+||.||+|...+             ...+++|++.... ......+..|+.+++.++||||+++++++......+
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            58999999999997432             2257888876532 233457788899999999999999999999999999


Q ss_pred             EEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCc------
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK------  215 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~------  215 (363)
                      ++|||+.+++|..++.....        .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.      
T Consensus        81 lv~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~  149 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSD--------VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGP  149 (262)
T ss_pred             EEEecccCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCc
Confidence            99999999999988864321        388999999999999999999999   9999999999999987664      


Q ss_pred             -eEEeeeccCCCCCcccccccccccccccCCCCccccc-cCCCCccCceehhHHHHHHHH-hCCCCCCCCCCccccchhh
Q 046595          216 -SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM-TGQITQKSDVYSFGVVLLELL-TGRKPVDHTMPKGQQSLVT  292 (363)
Q Consensus       216 -vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell-~g~~p~~~~~~~~~~~~~~  292 (363)
                       ++++|||++......      ....|+..|+|||.+. +..++.++|||||||++|||+ .|..||...........  
T Consensus       150 ~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~--  221 (262)
T cd05077         150 FIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF--  221 (262)
T ss_pred             eeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH--
Confidence             899999987654321      2345788999999886 467899999999999999998 48888764322111000  


Q ss_pred             hccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 046595          293 WATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ  349 (363)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~  349 (363)
                                    ......  .....+.++.+|+.+||+.||++||++.+|++.|+
T Consensus       222 --------------~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         222 --------------YEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             --------------HhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence                          000000  01122456899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.2e-41  Score=292.98  Aligned_cols=238  Identities=25%  Similarity=0.448  Sum_probs=189.2

Q ss_pred             CeeeccCCceEEEEEeCCCC-----------eEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           74 ALIGEGSYGRVFYAKLTDGT-----------PAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~~~-----------~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      +.||+|+||.||++...+..           .+++|.+......  ...+.+|+.+++.++|+||+++++++.. ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence            36899999999999875432           4677776543222  5788899999999999999999999888 77899


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC-------c
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF-------K  215 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-------~  215 (363)
                      ||||+.+|+|.+++.....        .+++..++.++.|++.||.|||++   +|+|+||||+||+++.++       .
T Consensus        78 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~  146 (259)
T cd05037          78 VEEYVKFGPLDVFLHREKN--------NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPF  146 (259)
T ss_pred             EEEcCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCcee
Confidence            9999999999999976542        288999999999999999999999   999999999999999887       7


Q ss_pred             eEEeeeccCCCCCcccccccccccccccCCCCccccccC--CCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhh
Q 046595          216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG--QITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVT  292 (363)
Q Consensus       216 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~  292 (363)
                      +||+|||++.....      .....++..|+|||++.+.  .++.++||||||+++|+|++ |..||.............
T Consensus       147 ~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~  220 (259)
T cd05037         147 IKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ  220 (259)
T ss_pred             EEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh
Confidence            99999999875433      1234567889999998876  78999999999999999999 577776543221111110


Q ss_pred             hccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 046595          293 WATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ  349 (363)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~  349 (363)
                        ..            ...    +......+.+++.+||..+|.+||++.+|++.|+
T Consensus       221 --~~------------~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 --DQ------------HRL----PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             --cC------------CCC----CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence              00            000    0011167999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.5e-41  Score=293.68  Aligned_cols=248  Identities=23%  Similarity=0.365  Sum_probs=202.0

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC----CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP----EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      +|+..+.||+|++|.||+|... +++.|++|.+......    .....+.+|+.+++.++|+||+++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4788899999999999999765 7899999998653321    2345788999999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      +||+++++|.+++....         .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||+
T Consensus        81 ~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~  148 (258)
T cd06632          81 LELVPGGSLAKLLKKYG---------SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGM  148 (258)
T ss_pred             EEecCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCcc
Confidence            99999999999997543         278999999999999999999999   999999999999999999999999998


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCC-CCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      +.......   ......|+..|++||.+.... ++.++|+||||+++|+|++|+.||....+...  ...+.        
T Consensus       149 ~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~--------  215 (258)
T cd06632         149 AKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--VFKIG--------  215 (258)
T ss_pred             ceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--HHHHH--------
Confidence            86543322   123456889999999987766 89999999999999999999999975432111  00000        


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                           ........+...+..+.+++.+||+.+|.+||++.+++.
T Consensus       216 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         216 -----RSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             -----hcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                 000111223345677899999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=6.5e-41  Score=294.67  Aligned_cols=252  Identities=19%  Similarity=0.308  Sum_probs=202.9

Q ss_pred             CCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEe--CCeeEEEE
Q 046595           69 NFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCME--SNNRILVY  144 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~  144 (363)
                      +|++.+.||.|+||.||++.. .++..+++|.+...... ...+.+..|+.+++.++|+||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            478889999999999999965 46889999998754322 234568889999999999999999997754  45678999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh-----ccCCCCeEEecccCCceeecCCCceEEe
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH-----EKVQPPIVHRDVRSSNVLLFDDFKSKIA  219 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-----~~~~~~ivH~Dlkp~Nill~~~~~vkl~  219 (363)
                      ||+.+++|.+++.....     ....+++..++.++.|++.||.|||     +.   +++|+||+|+||++++++.+||+
T Consensus        81 e~~~~~~L~~~l~~~~~-----~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~  152 (265)
T cd08217          81 EYCEGGDLAQLIQKCKK-----ERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLG  152 (265)
T ss_pred             hhccCCCHHHHHHHHhh-----cccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEe
Confidence            99999999999975421     1124889999999999999999999     77   99999999999999999999999


Q ss_pred             eeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc
Q 046595          220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       220 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      |||++.........  .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||......   ..         
T Consensus       153 d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~---------  218 (265)
T cd08217         153 DFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QL---------  218 (265)
T ss_pred             cccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HH---------
Confidence            99998765443221  23356899999999999888999999999999999999999999754311   11         


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                          .+..........+...+..+.+++.+||+.+|++||++.+|++
T Consensus       219 ----~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         219 ----ASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             ----HHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                1111112223344566678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-41  Score=300.24  Aligned_cols=252  Identities=25%  Similarity=0.379  Sum_probs=201.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      ++|++.+.||.|+||.||++... ++..+++|.+... .......+..|+.+++.++|+||+++++++......++||||
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            46888999999999999999764 6889999998653 223346788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|.+++.....        .+++..++.++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++..
T Consensus        84 ~~~~~L~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~  152 (280)
T cd06611          84 CDGGALDSIMLELER--------GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAK  152 (280)
T ss_pred             cCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchh
Confidence            999999999875431        389999999999999999999999   999999999999999999999999998765


Q ss_pred             CCcccccccccccccccCCCCccccc-----cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAM-----TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      ......  ......|+..|+|||.+.     +..++.++|+||||+++|+|++|+.||........  ...+.       
T Consensus       153 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~~~~-------  221 (280)
T cd06611         153 NKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLKIL-------  221 (280)
T ss_pred             hccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HHHHh-------
Confidence            433221  123456899999999875     34578899999999999999999999975432111  00000       


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                         ...  ......+..++..+.+++..||+.+|++||++.+|++.
T Consensus       222 ---~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         222 ---KSE--PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             ---cCC--CCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence               000  00111233455679999999999999999999999873

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-41  Score=295.94  Aligned_cols=247  Identities=20%  Similarity=0.364  Sum_probs=201.1

Q ss_pred             CCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC---CCccceeeeEEEeCCeeEEEE
Q 046595           69 NFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK---HEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      .|++.+.||+|+||.||+|.+ .+++.+++|.+...........+.+|+.+++.++   |+|++++++++......+++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477888999999999999975 4689999999876544555677889999999986   999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+++|.+++....          +++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        82 e~~~~~~L~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~  148 (277)
T cd06917          82 EYAEGGSVRTLMKAGP----------IAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVA  148 (277)
T ss_pred             ecCCCCcHHHHHHccC----------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCce
Confidence            9999999999986542          88999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      .........  .....|+..|+|||.+.++ .++.++|+||||+++|+|++|..||...........   .         
T Consensus       149 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~---~---------  214 (277)
T cd06917         149 ALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML---I---------  214 (277)
T ss_pred             eecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc---c---------
Confidence            765443321  2335689999999988754 578999999999999999999999975432211100   0         


Q ss_pred             ccccCCcCCCCCCH-HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          304 KQCVDPKLNNDYPP-KAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       304 ~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ..    .....++. ..+.++.+++.+||+.||++||++.+++.
T Consensus       215 ~~----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         215 PK----SKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             cc----CCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            00    00011111 14567999999999999999999999987

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.9e-41  Score=299.82  Aligned_cols=244  Identities=22%  Similarity=0.309  Sum_probs=201.9

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC--CCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA--PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      +|++.+.||+|+||.||++.+. +++.+++|++.....  ......+.+|++++++++||||+++++++......++|||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            6889999999999999999765 689999999865332  2234678899999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+++|.+++....         .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++.
T Consensus        82 ~~~~~~L~~~~~~~~---------~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~  149 (290)
T cd05580          82 YVPGGELFSHLRKSG---------RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAK  149 (290)
T ss_pred             cCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCcc
Confidence            999999999997653         288999999999999999999999   99999999999999999999999999987


Q ss_pred             CCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      .....     .....|++.|+|||.+.+..++.++||||||+++|+|++|..||...........               
T Consensus       150 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---------------  209 (290)
T cd05580         150 RVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK---------------  209 (290)
T ss_pred             ccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---------------
Confidence            65443     2345689999999999888899999999999999999999999975432110000               


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP-----NMTIVVK  346 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  346 (363)
                      ...  ....++...+..+.+++.+||..||.+|+     +++++++
T Consensus       210 ~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         210 ILE--GKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             Hhc--CCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            000  01122334467799999999999999999     7777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=8.8e-41  Score=297.48  Aligned_cols=265  Identities=23%  Similarity=0.310  Sum_probs=200.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      ++|++.+.||+|+||.||+++.. +++.|++|++...... .....+.+|+.+++.++|+||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            36889999999999999999865 5899999998654322 233567899999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+++++|..++....         .+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus        81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~  148 (286)
T cd07847          81 YCDHTVLNELEKNPR---------GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFAR  148 (286)
T ss_pred             ccCccHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccce
Confidence            999988887765432         288999999999999999999999   99999999999999999999999999987


Q ss_pred             CCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc------
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL------  298 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~------  298 (363)
                      ........  .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......+............      
T Consensus       149 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (286)
T cd07847         149 ILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQ  226 (286)
T ss_pred             ecCCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            65443211  223457889999998876 468899999999999999999999997554322111110000000      


Q ss_pred             --cc-cccccccCCcCCCC-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          299 --SE-DKVKQCVDPKLNND-----YPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       299 --~~-~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                        .. ........+.....     .....+..+.+++.+||+.+|++||++.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         227 IFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             hcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence              00 00000000000000     01123567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=6e-41  Score=298.86  Aligned_cols=265  Identities=21%  Similarity=0.327  Sum_probs=202.6

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      +|++.+.||+|+||.||+|.+. +++.|++|++..... ......+.+|+++++.++|+||+++++++...+..+++|||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            6889999999999999999765 588999999876432 23346789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.++.|..++....         .+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++..
T Consensus        82 ~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~  149 (288)
T cd07833          82 VERTLLELLEASPG---------GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARA  149 (288)
T ss_pred             CCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccc
Confidence            99866666554432         288999999999999999999999   999999999999999999999999999876


Q ss_pred             CCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc------
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS------  299 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~------  299 (363)
                      ....... ......++..|+|||++.+. .++.++|+||||+++|+|++|..||......+.............      
T Consensus       150 ~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (288)
T cd07833         150 LRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQEL  228 (288)
T ss_pred             cCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhh
Confidence            5543321 12345688999999999887 889999999999999999999999975432211110000000000      


Q ss_pred             ---ccccc-----cccCC-cCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          300 ---EDKVK-----QCVDP-KLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       300 ---~~~~~-----~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                         .....     ..... .....++..++.++.+++.+||..+|++||++++|++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence               00000     00000 0001123334778999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.3e-40  Score=293.57  Aligned_cols=254  Identities=22%  Similarity=0.380  Sum_probs=204.3

Q ss_pred             CCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCC-----chHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           69 NFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPE-----PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      +|+..+.||+|++|.||++.. .+++.+++|++.......     ....+..|+.++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            478889999999999999975 568999999987543211     23578899999999999999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC-ceEEeee
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF-KSKIADF  221 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Df  221 (363)
                      |+||+.+++|.+++....         .+++..+..++.|++.||.|||++   +++|+||+|+||+++.++ .++|+||
T Consensus        81 v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~df  148 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG---------AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADF  148 (268)
T ss_pred             EEeccCCCcHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccc
Confidence            999999999999997543         288999999999999999999999   999999999999998765 6999999


Q ss_pred             ccCCCCCccccc--ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc
Q 046595          222 NLTNQSSDTAAR--LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       222 g~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      |++.........  .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...........         
T Consensus       149 g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---------  219 (268)
T cd06630         149 GAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---------  219 (268)
T ss_pred             ccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---------
Confidence            998665433211  112234688999999999888899999999999999999999999964332111111         


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                         +............+...+..+.+++.+||+.+|.+||++.+++.
T Consensus       220 ---~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         220 ---IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ---HHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence               01111111223445567788999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1e-41  Score=293.60  Aligned_cols=273  Identities=21%  Similarity=0.315  Sum_probs=235.2

Q ss_pred             HHHHHHHhcCCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeE
Q 046595           60 LDELNRLTSNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY  133 (363)
Q Consensus        60 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~  133 (363)
                      ..++..-..++++..++.+|.||.||.|.|.      +.+.|.+|.++....+-....+..|.-++..+.|||++.+.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            3445555567889999999999999999554      3455788888887666667889999999999999999999998


Q ss_pred             EEeC-CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC
Q 046595          134 CMES-NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD  212 (363)
Q Consensus       134 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~  212 (363)
                      +.+. ...+.++.++..|+|..|+..++.. .....+.++..+.+.++.|++.|++|||++   +|||.||..+|++|++
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~-~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGD-DPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD  431 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccC-CCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence            8654 5677888999999999999866532 233445688999999999999999999999   9999999999999999


Q ss_pred             CCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchh
Q 046595          213 DFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLV  291 (363)
Q Consensus       213 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~  291 (363)
                      ..+|||+|=.+++..-..++++..+.......||+||.+.+..|+.++|+|||||+||||+| |+.|+...+|       
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP-------  504 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP-------  504 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH-------
Confidence            99999999999999888888887777778889999999999999999999999999999999 8999975544       


Q ss_pred             hhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccc
Q 046595          292 TWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL  352 (363)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~  352 (363)
                               .++...+..+++...|.+||.+|..++..||...|++||++++++..|.+..
T Consensus       505 ---------fEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  505 ---------FEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             ---------HHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence                     4455556667777888999999999999999999999999999999998754

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1e-40  Score=296.67  Aligned_cols=252  Identities=26%  Similarity=0.374  Sum_probs=195.1

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHH-HhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSV-VSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      +|++.+.||+|+||.||++.+. +++.||+|++...........+..|+.+ ++.++||||+++++++......+++|||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~   81 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV   81 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence            6888999999999999999765 6999999998765433344556666665 5667899999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +++ +|.+++......     ...+++..++.++.|++.||.|||++.  +++||||||+||+++.++.+||+|||++..
T Consensus        82 ~~~-~l~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~  153 (283)
T cd06617          82 MDT-SLDKFYKKVYDK-----GLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGY  153 (283)
T ss_pred             hcc-cHHHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccc
Confidence            974 888887653211     124899999999999999999999853  799999999999999999999999999876


Q ss_pred             CCcccccccccccccccCCCCcccccc----CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMT----GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      ......   .....|+..|+|||.+.+    ..++.++|+||||+++|+|++|+.||....... ..             
T Consensus       154 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~-------------  216 (283)
T cd06617         154 LVDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQ-------------  216 (283)
T ss_pred             cccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HH-------------
Confidence            533211   233568889999998865    456889999999999999999999996422110 00             


Q ss_pred             cccccCCcCCCCCC-HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          303 VKQCVDPKLNNDYP-PKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       303 ~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      +...... .....+ ..++..+.+++.+||..+|++||++.+|++
T Consensus       217 ~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         217 LKQVVEE-PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             HHHHHhc-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0111110 011111 234667999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=9.2e-41  Score=292.45  Aligned_cols=249  Identities=20%  Similarity=0.337  Sum_probs=201.7

Q ss_pred             CCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCC-CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           69 NFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSS-APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      +|++.+.||+|+||.||++.. .++..+++|.+.... .......+..|+.++++++|+||+++++.+......++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            588889999999999999975 468889999987643 223356788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCC-CceEEeeeccCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD-FKSKIADFNLTN  225 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~Dfg~a~  225 (363)
                      +.+++|.+++.....       ..+++..+..++.+++.+|.|||++   +++|+||+|+||+++.+ +.++|+|||++.
T Consensus        81 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~  150 (256)
T cd08220          81 APGGTLAEYIQKRCN-------SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISK  150 (256)
T ss_pred             CCCCCHHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCce
Confidence            999999999976432       2388999999999999999999999   99999999999999854 468999999987


Q ss_pred             CCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      .......   .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||..........               .
T Consensus       151 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~---------------~  212 (256)
T cd08220         151 ILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL---------------K  212 (256)
T ss_pred             ecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHH---------------H
Confidence            6543321   223568899999999998889999999999999999999999996543211110               0


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ... ......+...+..+.+++.+||+.+|++|||+.++++
T Consensus       213 ~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         213 IMS-GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             HHh-cCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            000 1111223345667999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-41  Score=298.47  Aligned_cols=264  Identities=21%  Similarity=0.323  Sum_probs=197.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      ++|++.+.||+|++|.||+|... +++.|++|.+...........+.+|+.+++.++|+||+++++++.+....++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57899999999999999999765 68999999987644333345577899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+ +|.+++.....        .+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||++..
T Consensus        85 ~~~-~L~~~~~~~~~--------~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  152 (291)
T cd07844          85 LDT-DLKQYMDDCGG--------GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARA  152 (291)
T ss_pred             CCC-CHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccc
Confidence            986 99998875432        278999999999999999999999   999999999999999999999999999864


Q ss_pred             CCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCcc-ccchhhhcccccccccc-
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKG-QQSLVTWATPRLSEDKV-  303 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~-  303 (363)
                      ......  ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||....... ................. 
T Consensus       153 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (291)
T cd07844         153 KSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP  230 (291)
T ss_pred             cCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhh
Confidence            332111  1122356889999998875 458899999999999999999999996543111 00000000000000000 


Q ss_pred             --------cccc-----CCcCCCCCCHHH--HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          304 --------KQCV-----DPKLNNDYPPKA--IAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       304 --------~~~~-----~~~~~~~~~~~~--~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                              ....     ...+.... ...  ...+.+++.+||+.+|++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         231 GVSSNPEFKPYSFPFYPPRPLINHA-PRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hhhhccccccccccccCChhHHHhC-cCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                    0000     00000000 011  256889999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=314.93  Aligned_cols=250  Identities=24%  Similarity=0.376  Sum_probs=204.0

Q ss_pred             CCCCCCeeeccCCceEEEEEeCCCC-eEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           69 NFGTKALIGEGSYGRVFYAKLTDGT-PAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      .|.++..||.|+||.||+|..++.. ..|.|++.. ...+..+++.-|++||..+.||+|+++++.|...+.++|++|||
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet-kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET-KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc-cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            4778888999999999999876544 456666654 44566789999999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      .||-...++-.-..        .+++.++.-+++|++.||.|||++   +|||||||..|||++-+|.++|+|||.+-..
T Consensus       112 ~GGAVDaimlEL~r--------~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn  180 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGR--------VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKN  180 (1187)
T ss_pred             CCchHhHHHHHhcc--------ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccc
Confidence            99999887765432        499999999999999999999999   9999999999999999999999999987443


Q ss_pred             CcccccccccccccccCCCCccccc-----cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAM-----TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      ..  .....+.+.|||.|||||++.     ..+|+.++||||||++|.||.-+.+|-....+......+....|      
T Consensus       181 ~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSeP------  252 (1187)
T KOG0579|consen  181 KS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP------  252 (1187)
T ss_pred             hh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCC------
Confidence            32  233456789999999999864     56899999999999999999999999865544221111110000      


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                              ...-.|......+.+++..||..||+.||++.++++
T Consensus       253 --------PTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  253 --------PTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             --------CcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                    001224566778999999999999999999999987

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=312.33  Aligned_cols=275  Identities=23%  Similarity=0.340  Sum_probs=214.1

Q ss_pred             CCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCC------eeE
Q 046595           69 NFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESN------NRI  141 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~  141 (363)
                      .|...+.||+|+||.||++++ .+|+.||||.+.........+..-+|+++|++++|+|||+++++=++..      ...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            456677899999999999985 4799999999998777777889999999999999999999998755433      457


Q ss_pred             EEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec--CCC--ceE
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF--DDF--KSK  217 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~--~~~--~vk  217 (363)
                      ++||||.||+|...++...+..      .+++.+++.++.+++.||.|||++   ||+||||||.||++-  .+|  .-|
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~------GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyK  164 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAY------GLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYK  164 (732)
T ss_pred             EEEeecCCCcHHHHhcCccccc------CCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEe
Confidence            9999999999999998765433      399999999999999999999999   999999999999984  333  469


Q ss_pred             EeeeccCCCCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccc
Q 046595          218 IADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATP  296 (363)
Q Consensus       218 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~  296 (363)
                      |+|||.|+...+..   ....+.||..|.+||++.. +.|+..+|.|||||++|+..||..||.......-..-+.|...
T Consensus       165 LtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~  241 (732)
T KOG4250|consen  165 LTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHII  241 (732)
T ss_pred             eecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhh
Confidence            99999999877665   3567899999999999884 8899999999999999999999999975443322122223222


Q ss_pred             cccccccccccCCcC------------CCCCCHHHHHHHHHHHHhccCCCCCCCC--CHHHHHHHhccccccC
Q 046595          297 RLSEDKVKQCVDPKL------------NNDYPPKAIAKLAAVAALCVQYEADFRP--NMTIVVKALQPLLNSK  355 (363)
Q Consensus       297 ~~~~~~~~~~~~~~~------------~~~~~~~~~~~l~~li~~cl~~~p~~RP--s~~~vl~~l~~l~~~~  355 (363)
                      ......+.-...+..            ...........+...+..+|..+|++|-  .+.+....+..|++..
T Consensus       242 tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~  314 (732)
T KOG4250|consen  242 TKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK  314 (732)
T ss_pred             ccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence            221111111111111            1122234555677888889999999998  7777777777777643

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4.8e-41  Score=298.97  Aligned_cols=264  Identities=20%  Similarity=0.287  Sum_probs=196.8

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      +|++.+.||+|+||.||+|+.. +|+.+++|.+...... .....+.+|+.++++++|+||+++++++.+....++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999764 6899999998754322 2235677899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+ +|.+++.....        .+++..++.++.|+++||.|||++   +++|+||||+||+++.++.++|+|||++..
T Consensus        81 ~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~  148 (284)
T cd07839          81 CDQ-DLKKYFDSCNG--------DIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARA  148 (284)
T ss_pred             CCC-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhc
Confidence            975 88888764321        289999999999999999999999   999999999999999999999999999875


Q ss_pred             CCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCcccc-chh----------hhc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ-SLV----------TWA  294 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~-~~~----------~~~  294 (363)
                      .......  .....++..|+|||++.+. .++.++|||||||++|+|++|..||......... ...          .|.
T Consensus       149 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (284)
T cd07839         149 FGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP  226 (284)
T ss_pred             cCCCCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhH
Confidence            4332211  2234678899999988764 4789999999999999999999886433221100 000          000


Q ss_pred             cc-cccccccccccCCcC-CCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          295 TP-RLSEDKVKQCVDPKL-NNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       295 ~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .. ............... ........+.++.+++.+||+.||.+|||++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00 000000000000000 01112235677899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.1e-40  Score=291.91  Aligned_cols=251  Identities=22%  Similarity=0.348  Sum_probs=198.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC----CchHHHHHHHHHHhcCCCCccceeeeEEEeC--Cee
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP----EPESDFAAQLSVVSRLKHEHFVELLGYCMES--NNR  140 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~  140 (363)
                      .+|++.+.||+|+||.||.+... ++..|++|.+......    .....+.+|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            36889999999999999999764 5899999988643211    1235778899999999999999999988763  467


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEee
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD  220 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D  220 (363)
                      +++|||+.+++|.+++....         .+++..++.++.|++.||.|||++   +++|+||||+||+++.++.++|+|
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~D  149 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG---------ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGD  149 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECc
Confidence            89999999999999987543         278889999999999999999999   999999999999999999999999


Q ss_pred             eccCCCCCccccc-ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc
Q 046595          221 FNLTNQSSDTAAR-LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       221 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      ||++......... .......|+..|+|||++.+..++.++|+||||+++|+|++|+.||........            
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------------  217 (265)
T cd06652         150 FGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA------------  217 (265)
T ss_pred             CccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH------------
Confidence            9998754322111 112234688999999999888899999999999999999999999964321110            


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                         +............+......+.+++.+||. +|++||++++|++
T Consensus       218 ---~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         218 ---IFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             ---HHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence               011111111233455666778899999995 9999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-42  Score=309.91  Aligned_cols=245  Identities=27%  Similarity=0.408  Sum_probs=200.6

Q ss_pred             CCCCCeeeccCCceEEEEE-eCCCCeEEEEEccCCCC--CCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           70 FGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSA--PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~-~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      |.-++.||.|+||.||.++ ..+.+.||||++..+-.  .+..+++..|+..|+.++|||++.+-+.+..+...||||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            5556679999999999997 45789999999976543  33457899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      |-| +-.+++.-.+.        ++.+.++..|..+.+.||.|||++   +.||||||..|||+++.|.|||+|||.|..
T Consensus       108 ClG-SAsDlleVhkK--------plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi  175 (948)
T KOG0577|consen  108 CLG-SASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASI  175 (948)
T ss_pred             Hhc-cHHHHHHHHhc--------cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhh
Confidence            977 77777754432        388999999999999999999999   999999999999999999999999998754


Q ss_pred             CCcccccccccccccccCCCCccccc---cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAM---TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      ...      .+.++|||.|||||++.   .+.|+-++||||||++..||.-.++|+.....  ...++..+.        
T Consensus       176 ~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA--MSALYHIAQ--------  239 (948)
T KOG0577|consen  176 MAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQ--------  239 (948)
T ss_pred             cCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH--HHHHHHHHh--------
Confidence            433      46689999999999875   47899999999999999999999999754321  111111111        


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                        .-.+.+.   ..+.+..++.++..||+.-|.+|||.++++..
T Consensus       240 --NesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  240 --NESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             --cCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence              0011111   34667789999999999999999999998763

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4.6e-41  Score=300.14  Aligned_cols=249  Identities=22%  Similarity=0.379  Sum_probs=198.8

Q ss_pred             CCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           69 NFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      .|.....||+|+||.||++.. .++..|+||.+.... ......+.+|+.+++.++|+||+++++.+...+..++||||+
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            344456699999999999975 468899999886532 233456889999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      .+++|.+++....          +++..+..++.|++.||.|||++   +|+||||||+||++++++.++|+|||++...
T Consensus       102 ~~~~L~~~~~~~~----------l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~  168 (292)
T cd06658         102 EGGALTDIVTHTR----------MNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQV  168 (292)
T ss_pred             CCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence            9999999886432          78999999999999999999999   9999999999999999999999999998654


Q ss_pred             CcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCV  307 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (363)
                      .....  ......|+..|+|||.+.+..++.++|+||||+++|||++|..||....+......            +....
T Consensus       169 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~------------~~~~~  234 (292)
T cd06658         169 SKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR------------IRDNL  234 (292)
T ss_pred             ccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------------HHhcC
Confidence            33221  12335689999999999888899999999999999999999999975432111000            00011


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          308 DPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                      .....  .....+..+.+++.+||..||.+|||+.++++.
T Consensus       235 ~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         235 PPRVK--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             CCccc--cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            11110  112345578999999999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.4e-40  Score=295.72  Aligned_cols=250  Identities=24%  Similarity=0.368  Sum_probs=203.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      ++|.+.+.||+|+||.||++.. .++..+++|.+.... ....+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            5799999999999999999975 468889999986532 23346788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|.+++....          +++.++..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||++..
T Consensus        98 ~~~~~L~~~~~~~~----------l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~  164 (293)
T cd06647          98 LAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ  164 (293)
T ss_pred             CCCCcHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceec
Confidence            99999999997543          78999999999999999999999   999999999999999999999999998765


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      ......  ......|++.|++||.+.+..++.++|+||||+++|++++|..||....+.......  .            
T Consensus       165 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~--~------------  228 (293)
T cd06647         165 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--A------------  228 (293)
T ss_pred             cccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh--h------------
Confidence            443222  123346888999999998888999999999999999999999999754332211100  0            


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                      .........+...+..+.+++..||+.+|++||++.+++..
T Consensus       229 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         229 TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00001111233456679999999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.9e-40  Score=291.69  Aligned_cols=251  Identities=23%  Similarity=0.352  Sum_probs=207.3

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      +|++.+.||+|++|.||+|... +++.+++|.+...........+..|+..+.+++|+||+++++++......++++||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            5888899999999999999765 599999999877544344578899999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-cCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE-KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      .+++|.+++....         .+++..++.++.|++.||.|||+ .   +++|+||+|+||+++.++.++|+|||++..
T Consensus        82 ~~~~L~~~l~~~~---------~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~  149 (264)
T cd06623          82 DGGSLADLLKKVG---------KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKV  149 (264)
T ss_pred             CCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCcccee
Confidence            9999999997642         38999999999999999999999 8   999999999999999999999999999876


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      .......  .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...............            
T Consensus       150 ~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~------------  215 (264)
T cd06623         150 LENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI------------  215 (264)
T ss_pred             cccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH------------
Confidence            5433221  12456889999999999889999999999999999999999999765431111111111            


Q ss_pred             cCCcCCCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          307 VDPKLNNDYPPK-AIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       307 ~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      . .......+.. .+..+.+++..||+.+|++||++.++++
T Consensus       216 ~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         216 C-DGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             h-cCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            1 1111222333 5678999999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-43  Score=288.47  Aligned_cols=264  Identities=23%  Similarity=0.311  Sum_probs=201.2

Q ss_pred             CCCccCHHHHHHHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceee
Q 046595           54 EIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELL  131 (363)
Q Consensus        54 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~  131 (363)
                      ..-.+..+.++.+       ..||.|+||+|++..++ .|+..|||+++.........+++.|.+...+- +.||||++|
T Consensus        57 ~~~~F~~~~Lqdl-------g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfy  129 (361)
T KOG1006|consen   57 HLHTFTSDNLQDL-------GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFY  129 (361)
T ss_pred             cccccccchHHHH-------HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHh
Confidence            3334554555444       34999999999999755 69999999999877767778899998766555 789999999


Q ss_pred             eEEEeCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec
Q 046595          132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF  211 (363)
Q Consensus       132 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~  211 (363)
                      |.+..++..|+.||.|+- +|..+...--..+    ...++++.+-.|...+++||.||....  .|||||+||+|||++
T Consensus       130 Ga~F~EGdcWiCMELMd~-SlDklYk~vy~vq----~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILld  202 (361)
T KOG1006|consen  130 GALFSEGDCWICMELMDI-SLDKLYKRVYSVQ----KSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLD  202 (361)
T ss_pred             hhhhcCCceeeeHHHHhh-hHHHHHHHHHHHH----hccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEe
Confidence            999999999999999976 6655432111000    012889999999999999999999775  799999999999999


Q ss_pred             CCCceEEeeeccCCCCCcccccccccccccccCCCCcccccc--CCCCccCceehhHHHHHHHHhCCCCCCCCCCcc-cc
Q 046595          212 DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT--GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKG-QQ  288 (363)
Q Consensus       212 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~-~~  288 (363)
                      ..|.|||||||++....+...   .+...|...|||||.+..  ..|+.++||||||++|||+.||..|+...+... +.
T Consensus       203 r~G~vKLCDFGIcGqLv~SiA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql  279 (361)
T KOG1006|consen  203 RHGDVKLCDFGICGQLVDSIA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQL  279 (361)
T ss_pred             cCCCEeeecccchHhHHHHHH---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHH
Confidence            999999999999876655443   244578999999999864  469999999999999999999999997654321 11


Q ss_pred             chhhhccccccccccccccCCcCCCCC-CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          289 SLVTWATPRLSEDKVKQCVDPKLNNDY-PPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ..+....+.+            +..+. ..+.+..+.++|..||..|-.+||.+.++++
T Consensus       280 ~~Vv~gdpp~------------l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  280 CQVVIGDPPI------------LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             HHHHcCCCCe------------ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            1111111111            11111 1245667999999999999999999999886

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.1e-40  Score=299.80  Aligned_cols=255  Identities=19%  Similarity=0.253  Sum_probs=199.7

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC--CCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA--PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      +|.+.+.||+|+||.||++... +++.|++|.+.....  ......+..|+.+++.++||||+++++.+......++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            6888999999999999999765 578899998875432  2234567889999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+++|.+++....         .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||+++
T Consensus        82 ~~~g~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~  149 (305)
T cd05609          82 YVEGGDCATLLKNIG---------ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSK  149 (305)
T ss_pred             cCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCcc
Confidence            999999999996543         288999999999999999999999   99999999999999999999999999876


Q ss_pred             CCCcccc-------------cccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhh
Q 046595          226 QSSDTAA-------------RLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT  292 (363)
Q Consensus       226 ~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~  292 (363)
                      .......             ........|+..|+|||.+.+..++.++|+||||+++|||++|..||...........  
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~--  227 (305)
T cd05609         150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ--  227 (305)
T ss_pred             ccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--
Confidence            3211100             0011124578899999999888899999999999999999999999964322110000  


Q ss_pred             hccccccccccccccCCcC-CCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 046595          293 WATPRLSEDKVKQCVDPKL-NNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQP  350 (363)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~  350 (363)
                                   ...... ........+..+.+++.+||+.+|++||+..++.+.|+.
T Consensus       228 -------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         228 -------------VISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             -------------HHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence                         000000 001112356679999999999999999996666555543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.6e-40  Score=293.30  Aligned_cols=256  Identities=22%  Similarity=0.360  Sum_probs=200.1

Q ss_pred             CCCCCCeeeccCCceEEEEEeCC--CCeEEEEEccCCC---------CCCchHHHHHHHHHHhc-CCCCccceeeeEEEe
Q 046595           69 NFGTKALIGEGSYGRVFYAKLTD--GTPAAIKKLDTSS---------APEPESDFAAQLSVVSR-LKHEHFVELLGYCME  136 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~avK~~~~~~---------~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~  136 (363)
                      .|++.+.||+|+||.||++....  ++.+++|.+....         .......+..|+.++.. ++|+||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788899999999999998654  7889999876432         11123456778887765 799999999999999


Q ss_pred             CCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-cCCCCeEEecccCCceeecCCCc
Q 046595          137 SNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE-KVQPPIVHRDVRSSNVLLFDDFK  215 (363)
Q Consensus       137 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~  215 (363)
                      .+..+++|||+.+++|.+++......     ...+++..++.++.|++.||.|||+ .   +++|+||+|+||+++.++.
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~  152 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEK-----KQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDK  152 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCc
Confidence            99999999999999999988542211     1238899999999999999999996 5   8999999999999999999


Q ss_pred             eEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 046595          216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       216 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      ++|+|||++.......   ......|+..|++||.+.+..++.++|+||||+++|+|++|..||..........      
T Consensus       153 ~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~------  223 (269)
T cd08528         153 VTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT------  223 (269)
T ss_pred             EEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHH------
Confidence            9999999987654432   2344568999999999998889999999999999999999999996432211000      


Q ss_pred             ccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 046595          296 PRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQP  350 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~  350 (363)
                               ...+...........+..+.+++.+||+.||++||++.++.+.+++
T Consensus       224 ---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         224 ---------KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             ---------HHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence                     0000111110111345679999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.6e-41  Score=295.70  Aligned_cols=239  Identities=25%  Similarity=0.427  Sum_probs=185.8

Q ss_pred             eeeccCCceEEEEEeCC-------------------------CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccce
Q 046595           75 LIGEGSYGRVFYAKLTD-------------------------GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE  129 (363)
Q Consensus        75 ~lg~G~~g~V~~~~~~~-------------------------~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~  129 (363)
                      .||+|+||.||+|....                         ...|++|.+.... ......+.+|+.+++.++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence            59999999999986321                         1347888876432 222356788899999999999999


Q ss_pred             eeeEEEeCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCcee
Q 046595          130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVL  209 (363)
Q Consensus       130 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil  209 (363)
                      +++++......++||||+++|+|..++.....        .+++..++.++.|++.||.|||++   +|+||||||+||+
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nil  149 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--------RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNIL  149 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEE
Confidence            99999999999999999999999999865321        378999999999999999999999   9999999999999


Q ss_pred             ecCCC-------ceEEeeeccCCCCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHH-hCCCCCC
Q 046595          210 LFDDF-------KSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELL-TGRKPVD  280 (363)
Q Consensus       210 l~~~~-------~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell-~g~~p~~  280 (363)
                      ++..+       .+|++|||++......      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||.
T Consensus       150 l~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~  223 (274)
T cd05076         150 LARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLK  223 (274)
T ss_pred             EeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcc
Confidence            97643       4899999987543221      22357788999998875 56899999999999999995 6899997


Q ss_pred             CCCCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 046595          281 HTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ  349 (363)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~  349 (363)
                      ...+.......                ...  ...+......+.+++.+||+.+|++|||+.+|++.|.
T Consensus       224 ~~~~~~~~~~~----------------~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         224 ERTPSEKERFY----------------EKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ccChHHHHHHH----------------Hhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            54332111110                000  0111122346899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=9.8e-41  Score=298.77  Aligned_cols=247  Identities=21%  Similarity=0.325  Sum_probs=198.1

Q ss_pred             CCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEeccc
Q 046595           70 FGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFAT  148 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  148 (363)
                      |.....||+|+||.||++... +++.|++|.+.... ......+.+|+.+++.++||||+++++++...+..++++||++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            334446999999999999754 68999999986533 2335678899999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCC
Q 046595          149 MGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS  228 (363)
Q Consensus       149 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~  228 (363)
                      +++|..++....          +++..++.++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++....
T Consensus       102 ~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~  168 (297)
T cd06659         102 GGALTDIVSQTR----------LNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS  168 (297)
T ss_pred             CCCHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcc
Confidence            999999886532          88999999999999999999999   99999999999999999999999999986443


Q ss_pred             cccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccC
Q 046595          229 DTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD  308 (363)
Q Consensus       229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (363)
                      .....  .....|+..|+|||.+.+..++.++||||||+++|||++|+.||....+.......   ....         .
T Consensus       169 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~~---------~  234 (297)
T cd06659         169 KDVPK--RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL---RDSP---------P  234 (297)
T ss_pred             ccccc--ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---hccC---------C
Confidence            32211  23356899999999999889999999999999999999999999754322111110   0000         0


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          309 PKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                        .........+..+.+++.+||+.+|.+||++.+|++
T Consensus       235 --~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         235 --PKLKNAHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             --CCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence              000111234456899999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.8e-41  Score=294.79  Aligned_cols=239  Identities=26%  Similarity=0.470  Sum_probs=187.8

Q ss_pred             eeeccCCceEEEEEeCC--------CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           75 LIGEGSYGRVFYAKLTD--------GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        75 ~lg~G~~g~V~~~~~~~--------~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      .||+|+||.||+|....        ...+++|.+.... ....+.+..|+.+++.++||||+++++++......++||||
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            59999999999996532        2347777765422 22345778899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCc--------eEE
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK--------SKI  218 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~--------vkl  218 (363)
                      +.+|+|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+||+++.++.        +++
T Consensus        81 ~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l  149 (258)
T cd05078          81 VKFGSLDTYLKKNKN--------LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKL  149 (258)
T ss_pred             CCCCcHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEe
Confidence            999999999976542        278999999999999999999999   9999999999999987765        699


Q ss_pred             eeeccCCCCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCC-CCCCCCCCccccchhhhccc
Q 046595          219 ADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGR-KPVDHTMPKGQQSLVTWATP  296 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~-~p~~~~~~~~~~~~~~~~~~  296 (363)
                      +|||++.....      .....++..|+|||++.+ ..++.++||||||+++|+|++|. .||....+.......     
T Consensus       150 ~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-----  218 (258)
T cd05078         150 SDPGISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-----  218 (258)
T ss_pred             cccccccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-----
Confidence            99998764432      123467889999999876 45899999999999999999985 565433221111000     


Q ss_pred             cccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 046595          297 RLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ  349 (363)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~  349 (363)
                                 ..  ...++.....++.+++.+||+.||++|||+++|++.|+
T Consensus       219 -----------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         219 -----------ED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -----------Hc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                       00  01122233456999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.8e-40  Score=289.92  Aligned_cols=251  Identities=22%  Similarity=0.381  Sum_probs=202.0

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      +|.+.+.||+|+||.||++... +++.+++|.+...... .....+..|+.++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5888999999999999999754 6889999998765432 2457889999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|.+++....         .+++..+..++.+++.||.|||+.   +++|+||+|+||++++++.+||+|||++..
T Consensus        81 ~~~~~L~~~~~~~~---------~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~  148 (264)
T cd06626          81 CSGGTLEELLEHGR---------ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVK  148 (264)
T ss_pred             CCCCcHHHHHhhcC---------CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccc
Confidence            99999999997643         278899999999999999999999   999999999999999999999999999876


Q ss_pred             CCccccccc--ccccccccCCCCccccccCC---CCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccc
Q 046595          227 SSDTAARLH--STRVLGTFGYHAPEYAMTGQ---ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       227 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      .........  .....++..|+|||.+.+..   ++.++||||||+++|+|++|..||...........   ..      
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~---~~------  219 (264)
T cd06626         149 LKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF---HV------  219 (264)
T ss_pred             cCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHH---HH------
Confidence            544322211  12346788999999988766   88999999999999999999999975432111000   00      


Q ss_pred             ccccccCCcCCCCCCH--HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          302 KVKQCVDPKLNNDYPP--KAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                        ..    ......+.  ..+..+.+++.+||+.+|++||++.+++.
T Consensus       220 --~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         220 --GA----GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             --hc----CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence              00    00111122  23667899999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=7.1e-41  Score=298.11  Aligned_cols=264  Identities=23%  Similarity=0.354  Sum_probs=200.0

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC-chHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      +|++.+.||+|+||.||+|.+. +++.|++|++....... ....+.+|+++++.++||||+++++++......++|+||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            6888999999999999999875 58999999986643332 345678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|..+.....         .+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++..
T Consensus        82 ~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~  149 (286)
T cd07846          82 VDHTVLDDLEKYPN---------GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFART  149 (286)
T ss_pred             CCccHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeee
Confidence            99988887765432         288999999999999999999999   999999999999999999999999999865


Q ss_pred             CCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccc-----
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE-----  300 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-----  300 (363)
                      ......  ......++..|+|||.+.+ ..++.++||||||+++|||++|..||.....................     
T Consensus       150 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (286)
T cd07846         150 LAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI  227 (286)
T ss_pred             ccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHH
Confidence            433321  1233568899999998875 35788999999999999999999999644321110000000000000     


Q ss_pred             ---ccc-ccccCCcCC-----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          301 ---DKV-KQCVDPKLN-----NDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       301 ---~~~-~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                         ..+ .....+...     ....+..+..+.+++.+||+.+|++||++.+|++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence               000 000000000     0011244677999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.5e-41  Score=303.29  Aligned_cols=249  Identities=23%  Similarity=0.323  Sum_probs=209.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCc-hHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEP-ESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ...|.+.+.||+|.|+.|.++++. ++..||||.+.+...... .+.+.+|+++|..++||||++++.+......+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            457999999999999999999754 699999999988654333 366899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+|.+++++.+...         +.+.++..++.|++.|++|||++   +|+|||||.+||||+.+-++||+|||++
T Consensus       135 eya~~ge~~~yl~~~gr---------~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS  202 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHGR---------MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFS  202 (596)
T ss_pred             EeccCchhHHHHHhccc---------chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccc
Confidence            99999999999988764         66688899999999999999999   9999999999999999999999999999


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCC-CccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      ..+....   ....++|++.|.|||++.+..| ++.+|+||+|++||-|+.|..||++..-..-           ..   
T Consensus       203 ~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-----------r~---  265 (596)
T KOG0586|consen  203 TFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-----------RP---  265 (596)
T ss_pred             eeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-----------cc---
Confidence            8776433   2456899999999999998876 4889999999999999999999975422111           00   


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                       .++...+  ..+.-...+..++|+++|-.+|.+|+++++|.+.
T Consensus       266 -rvl~gk~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  266 -RVLRGKY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             -hheeeee--cccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence             1111111  1223345568899999999999999999999874

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-41  Score=309.76  Aligned_cols=245  Identities=25%  Similarity=0.375  Sum_probs=202.6

Q ss_pred             eeeccCCceEEEEEeCC-CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCCChh
Q 046595           75 LIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLH  153 (363)
Q Consensus        75 ~lg~G~~g~V~~~~~~~-~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g~L~  153 (363)
                      +||+|.||+||.|++.+ ....|||.+.... ....+-+..|+.+.++|+|.|||+++|.+.+.+.+-+.||-++||+|.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd-sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD-SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccccc-chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            69999999999998765 5567999887643 344567899999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCCCCCc--CHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec-CCCceEEeeeccCCCCCcc
Q 046595          154 DVLHGRKGVQGAEPGPVL--TWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF-DDFKSKIADFNLTNQSSDT  230 (363)
Q Consensus       154 ~~l~~~~~~~~~~~~~~~--~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~-~~~~vkl~Dfg~a~~~~~~  230 (363)
                      ++++..-+        ++  .+...-.+.+||++||.|||++   .|||||||-+||||+ -.|.+||+|||-++.....
T Consensus       661 sLLrskWG--------PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi  729 (1226)
T KOG4279|consen  661 SLLRSKWG--------PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI  729 (1226)
T ss_pred             HHHHhccC--------CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC
Confidence            99976532        13  6778888999999999999999   999999999999997 5789999999998776543


Q ss_pred             cccccccccccccCCCCccccccC--CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccC
Q 046595          231 AARLHSTRVLGTFGYHAPEYAMTG--QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD  308 (363)
Q Consensus       231 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (363)
                      ..  ....+.||..|||||++-.+  .|+.++|||||||++.||.||++||-.......              .+.++--
T Consensus       730 nP--~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------------AMFkVGm  793 (1226)
T KOG4279|consen  730 NP--CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------------AMFKVGM  793 (1226)
T ss_pred             Cc--cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------------hhhhhcc
Confidence            22  24567899999999999765  699999999999999999999999964422111              1111111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          309 PKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                      -+.....|.+.+.+...+|.+|+.+||.+||++.++++.
T Consensus       794 yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  794 YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence            233467788999999999999999999999999999873

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-41  Score=305.24  Aligned_cols=274  Identities=22%  Similarity=0.318  Sum_probs=202.3

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCC-----e
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESN-----N  139 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~  139 (363)
                      +.++|.+.+.||+|+||.||+|.+ .+++.||+|++...........+..|+.+++.++|+||+++++++....     .
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            356899999999999999999975 4689999999865433344567888999999999999999998866543     5


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEe
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA  219 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~  219 (363)
                      .++++||+.+ +|.+++....          +++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+
T Consensus        83 ~~lv~e~~~~-~l~~~~~~~~----------l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~  148 (336)
T cd07849          83 VYIVQELMET-DLYKLIKTQH----------LSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKIC  148 (336)
T ss_pred             EEEEehhccc-CHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEC
Confidence            7899999975 8888886543          89999999999999999999999   99999999999999999999999


Q ss_pred             eeccCCCCCcccccc-cccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccc
Q 046595          220 DFNLTNQSSDTAARL-HSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR  297 (363)
Q Consensus       220 Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~  297 (363)
                      |||++.......... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||..................
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~  228 (336)
T cd07849         149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT  228 (336)
T ss_pred             cccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence            999986544322111 1223568999999998654 56899999999999999999999999653221111000000000


Q ss_pred             ccccccccccCC-----------cCCCC---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hccccc
Q 046595          298 LSEDKVKQCVDP-----------KLNND---YPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA--LQPLLN  353 (363)
Q Consensus       298 ~~~~~~~~~~~~-----------~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~--l~~l~~  353 (363)
                      ...+.+......           .....   ..+..+..+.+++.+||+.+|++|||+.++++.  ++....
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence            000000000000           00000   011235679999999999999999999999985  665543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.6e-40  Score=294.41  Aligned_cols=265  Identities=23%  Similarity=0.289  Sum_probs=201.3

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      +|++.+.||+|++|.||+|.+. ++..|++|++..... ......+.+|+.++++++|+||+++++++......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            5888999999999999999764 689999999876543 23346788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      + +++|.+++....        ..+++.+++.++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++..
T Consensus        81 ~-~~~L~~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~  148 (286)
T cd07832          81 M-PSDLSEVLRDEE--------RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARL  148 (286)
T ss_pred             c-CCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeeccc
Confidence            9 999999986543        1389999999999999999999999   999999999999999999999999999876


Q ss_pred             CCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhh--c------ccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTW--A------TPR  297 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~--~------~~~  297 (363)
                      ...... .......|+..|+|||.+.+. .++.++||||||+++|||++|..+|....+.........  .      .+.
T Consensus       149 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (286)
T cd07832         149 FSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPG  227 (286)
T ss_pred             ccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhh
Confidence            544321 112335689999999988654 468999999999999999999888864432211100000  0      000


Q ss_pred             ccc-cccccccCCcC----CCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          298 LSE-DKVKQCVDPKL----NNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       298 ~~~-~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ... ...........    ......+.+..+.+++.+||+.+|++||++++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            000 00000000000    00111234578999999999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.3e-40  Score=292.03  Aligned_cols=248  Identities=22%  Similarity=0.289  Sum_probs=203.8

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC--CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP--EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      +|++.+.||.|+||.||+|... ++..|++|.+......  .....+.+|++++++++||||+++++.+......++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788899999999999999765 6899999998754322  345688899999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+++|.+++....         .+++..+..++.|+++||.|||++   +++|+||+|+||++++++.++|+|||++.
T Consensus        81 ~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~  148 (258)
T cd05578          81 LLLGGDLRYHLSQKV---------KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIAT  148 (258)
T ss_pred             CCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeeccccc
Confidence            999999999997652         288999999999999999999999   99999999999999999999999999987


Q ss_pred             CCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      ......   ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||............             .
T Consensus       149 ~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------------~  212 (258)
T cd05578         149 KVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR-------------A  212 (258)
T ss_pred             ccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH-------------H
Confidence            654332   123456888999999998888999999999999999999999999755432111111             0


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH--HHHH
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNM--TIVV  345 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~--~~vl  345 (363)
                      .... .....+...+..+.+++.+||+.||.+||++  ++++
T Consensus       213 ~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         213 KQET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             Hhcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            0000 1123344556789999999999999999999  6554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.5e-40  Score=290.91  Aligned_cols=250  Identities=24%  Similarity=0.363  Sum_probs=195.9

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      .+.....||+|+||.||+|.+. ++..|++|.+.... ......+.+|+.++++++|+||+++++++...+..++++||+
T Consensus         9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   87 (268)
T cd06624           9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV   87 (268)
T ss_pred             cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence            3444557999999999999754 57889999876532 223467889999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCc--CHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC-CCceEEeeeccC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVL--TWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD-DFKSKIADFNLT  224 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~--~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~a  224 (363)
                      .+++|.+++.....        .+  ++..+..++.|++.||.|||++   +|+|+||||+||+++. ++.++|+|||++
T Consensus        88 ~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~  156 (268)
T cd06624          88 PGGSLSALLRSKWG--------PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTS  156 (268)
T ss_pred             CCCCHHHHHHHhcc--------cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence            99999999975421        13  7888899999999999999999   9999999999999976 679999999998


Q ss_pred             CCCCcccccccccccccccCCCCccccccC--CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTG--QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      ........  ......|+..|+|||.+.+.  .++.++|+||||+++|+|++|..||.........   .+.        
T Consensus       157 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~--------  223 (268)
T cd06624         157 KRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFK--------  223 (268)
T ss_pred             eecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhh--------
Confidence            65432211  12234588999999988654  3789999999999999999999999643211100   000        


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                         .........++...+.++.+++.+||+.+|.+|||+.+|++
T Consensus       224 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         224 ---VGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             ---hhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence               00001112334456677999999999999999999999986

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-41  Score=309.42  Aligned_cols=245  Identities=22%  Similarity=0.378  Sum_probs=196.4

Q ss_pred             CCCeeeccCCceEEEEEeC-CCCeEE---EEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCe--eEEEEe
Q 046595           72 TKALIGEGSYGRVFYAKLT-DGTPAA---IKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNN--RILVYQ  145 (363)
Q Consensus        72 ~~~~lg~G~~g~V~~~~~~-~~~~~a---vK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~lv~e  145 (363)
                      ...+||+|+|-+||+|.+. +|-.||   ||.-.....++..++|..|+.+|+.|+|+||+++|++|.+..+  ..+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            4456999999999999653 466654   3433444456666899999999999999999999999998766  679999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec-CCCceEEeeeccC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF-DDFKSKIADFNLT  224 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~-~~~~vkl~Dfg~a  224 (363)
                      .+..|+|..|+.+.+.         ++.+.+..|++||++||.|||++ .++|+|||||.+||+|+ ..|.|||+|+|||
T Consensus       124 L~TSGtLr~Y~kk~~~---------vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLA  193 (632)
T KOG0584|consen  124 LFTSGTLREYRKKHRR---------VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLA  193 (632)
T ss_pred             cccCCcHHHHHHHhcc---------CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHH
Confidence            9999999999998874         88999999999999999999998 45899999999999997 5699999999999


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      ........    ....|||.|||||+.. ..|+..+||||||+.+.||.|+..||.......+  .+..+........+.
T Consensus       194 tl~r~s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ--IYKKV~SGiKP~sl~  266 (632)
T KOG0584|consen  194 TLLRKSHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ--IYKKVTSGIKPAALS  266 (632)
T ss_pred             HHhhcccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH--HHHHHHcCCCHHHhh
Confidence            77655443    3478999999999666 8999999999999999999999999975433211  111111111111111


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .            --..++.++|.+||.. ..+|||+.|+|.
T Consensus       267 k------------V~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  267 K------------VKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             c------------cCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            1            1134699999999999 899999999987

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.7e-40  Score=295.16  Aligned_cols=260  Identities=27%  Similarity=0.425  Sum_probs=200.3

Q ss_pred             HHHHHHhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeC-
Q 046595           61 DELNRLTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMES-  137 (363)
Q Consensus        61 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-  137 (363)
                      .++....++|.+.+.||+|+||.||++.. .+++.+++|++....  .....+..|+.+++++ +||||+++++++... 
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~   92 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD   92 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence            33444567899999999999999999976 468899999986532  2345677899999998 799999999998754 


Q ss_pred             ----CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCC
Q 046595          138 ----NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD  213 (363)
Q Consensus       138 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~  213 (363)
                          ...++||||+.+++|.+++......     ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.+
T Consensus        93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~  164 (291)
T cd06639          93 KLVGGQLWLVLELCNGGSVTELVKGLLIC-----GQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTE  164 (291)
T ss_pred             ccCCCeeEEEEEECCCCcHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCC
Confidence                3579999999999999988642211     12388999999999999999999999   99999999999999999


Q ss_pred             CceEEeeeccCCCCCcccccccccccccccCCCCccccccC-----CCCccCceehhHHHHHHHHhCCCCCCCCCCcccc
Q 046595          214 FKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG-----QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ  288 (363)
Q Consensus       214 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~  288 (363)
                      +.+||+|||++.........  .....|+..|+|||.+...     .++.++|||||||++|||++|+.||....+... 
T Consensus       165 ~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-  241 (291)
T cd06639         165 GGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-  241 (291)
T ss_pred             CCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-
Confidence            99999999998754432211  2334688999999987643     368999999999999999999999975432111 


Q ss_pred             chhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          289 SLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                       ...+..     ..       ......+......+.+++.+||+.+|++||++.++++
T Consensus       242 -~~~~~~-----~~-------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         242 -LFKIPR-----NP-------PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             -HHHHhc-----CC-------CCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence             110000     00       0001112334567999999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-40  Score=291.61  Aligned_cols=254  Identities=26%  Similarity=0.435  Sum_probs=199.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCC------
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESN------  138 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~------  138 (363)
                      .++|++.+.||+|++|.||+|... +++.+++|++....  .....+.+|+.+++++ +|+||+++++++....      
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            468999999999999999999864 57889999987533  2346788999999999 7999999999987644      


Q ss_pred             eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEE
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI  218 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl  218 (363)
                      ..++||||+.+++|.+++......     ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l  154 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKK-----GKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKL  154 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEE
Confidence            489999999999999998653210     12388999999999999999999999   9999999999999999999999


Q ss_pred             eeeccCCCCCcccccccccccccccCCCCcccccc-----CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhh
Q 046595          219 ADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-----GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTW  293 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~  293 (363)
                      +|||++.........  .....|+..|+|||.+..     ..++.++||||||+++|+|++|..||..........  . 
T Consensus       155 ~d~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~-  229 (275)
T cd06608         155 VDFGVSAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF--K-  229 (275)
T ss_pred             CCCccceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH--H-
Confidence            999998654332221  234568999999998753     346789999999999999999999996432211110  0 


Q ss_pred             ccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          294 ATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                               +....  ......+...+..+.+++.+||..||++|||+.+|++
T Consensus       230 ---------~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         230 ---------IPRNP--PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             ---------hhccC--CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                     00000  0011112345678999999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=6.3e-40  Score=292.84  Aligned_cols=265  Identities=18%  Similarity=0.243  Sum_probs=197.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      ++|.+.+.||+|+||.||+|.. .++..|++|.+...........+.+|+.+++.++|+||+++++++......++||||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            5799999999999999999975 468899999987654444445678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +. ++|.+++.....        .+.+..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++..
T Consensus        85 ~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~  152 (291)
T cd07870          85 MH-TDLAQYMIQHPG--------GLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARA  152 (291)
T ss_pred             cc-CCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccc
Confidence            96 578777654321        267888999999999999999999   999999999999999999999999999865


Q ss_pred             CCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccc-----
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE-----  300 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-----  300 (363)
                      .......  .....++..|+|||.+.+. .++.++||||||+++|+|++|..||....+........|.......     
T Consensus       153 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (291)
T cd07870         153 KSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP  230 (291)
T ss_pred             cCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence            4332211  2334578999999988754 5788999999999999999999999754332111000000000000     


Q ss_pred             -----cc-cccccCCcCCCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          301 -----DK-VKQCVDPKLNNDY-----PPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       301 -----~~-~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                           .. .............     ....+..+.+++.+|+..||.+|||+.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                 00 0000000000000     0012456889999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.5e-39  Score=334.57  Aligned_cols=267  Identities=26%  Similarity=0.487  Sum_probs=211.0

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      .+...|...++||+|+||.||+|.. .++..||+|++.....     ....|++++++++||||+++++++.+....++|
T Consensus       687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv  761 (968)
T PLN00113        687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI  761 (968)
T ss_pred             HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence            3445688888999999999999986 4789999999865322     123468899999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+++|+|.+++..            +++..+..++.|++.||+|||..+..+|+||||||+||+++.++..++. ||.
T Consensus       762 ~Ey~~~g~L~~~l~~------------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~  828 (968)
T PLN00113        762 HEYIEGKNLSEVLRN------------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL  828 (968)
T ss_pred             EeCCCCCcHHHHHhc------------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecc
Confidence            999999999999963            7899999999999999999995444499999999999999998888775 665


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      ......      .....|+..|+|||++.+..++.++|||||||++|||++|+.||+..... ......|..........
T Consensus       829 ~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~  901 (968)
T PLN00113        829 PGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHL  901 (968)
T ss_pred             cccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccch
Confidence            433211      12236889999999999999999999999999999999999999543221 22333444333333334


Q ss_pred             ccccCCcCCC--CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCC
Q 046595          304 KQCVDPKLNN--DYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP  356 (363)
Q Consensus       304 ~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~  356 (363)
                      ..+.++.+..  ....+...++.+++.+||+.||++||++.+|++.|+++.+..+
T Consensus       902 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~  956 (968)
T PLN00113        902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS  956 (968)
T ss_pred             hheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence            4444554433  2345666778999999999999999999999999999877543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6e-41  Score=323.80  Aligned_cols=255  Identities=23%  Similarity=0.371  Sum_probs=192.2

Q ss_pred             HHHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCC----
Q 046595           64 NRLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESN----  138 (363)
Q Consensus        64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----  138 (363)
                      .+...+|+...+||+||||.||+++++ ||+.||||++...........+.+|+.++.+|+|||||+++..|.+..    
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            345568889999999999999999876 899999999988665555678999999999999999998875442111    


Q ss_pred             --------------------------------------------------------------------------------
Q 046595          139 --------------------------------------------------------------------------------  138 (363)
Q Consensus       139 --------------------------------------------------------------------------------  138 (363)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------------------eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHH
Q 046595          139 -----------------------------------NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA  183 (363)
Q Consensus       139 -----------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i  183 (363)
                                                         .+||-||||+..+|.+++......        -..+..++++++|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--------~~~d~~wrLFreI  706 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--------SQRDEAWRLFREI  706 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--------hhhHHHHHHHHHH
Confidence                                               135667777776666666554310        1478899999999


Q ss_pred             HHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCC----------------cccccccccccccccCCCC
Q 046595          184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS----------------DTAARLHSTRVLGTFGYHA  247 (363)
Q Consensus       184 ~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~----------------~~~~~~~~~~~~gt~~y~a  247 (363)
                      ++||.|+|++   |||||||||.||+++.++.|||+|||+|....                ........+..+||.-|+|
T Consensus       707 lEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA  783 (1351)
T KOG1035|consen  707 LEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVA  783 (1351)
T ss_pred             HHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeec
Confidence            9999999999   99999999999999999999999999997621                0111113456789999999


Q ss_pred             ccccccC---CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCCC--CCCHHHHHH
Q 046595          248 PEYAMTG---QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNN--DYPPKAIAK  322 (363)
Q Consensus       248 PE~~~~~---~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  322 (363)
                      ||++.+.   .|+.|+|+||||++|+||+.   ||...+...              ..+..+.+..+..  .+..+....
T Consensus       784 PEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa--------------~iL~~LR~g~iP~~~~f~~~~~~~  846 (1351)
T KOG1035|consen  784 PELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA--------------SILTNLRKGSIPEPADFFDPEHPE  846 (1351)
T ss_pred             HHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHH--------------HHHHhcccCCCCCCcccccccchH
Confidence            9998764   49999999999999999986   454322110              0011111112211  223344455


Q ss_pred             HHHHHHhccCCCCCCCCCHHHHHH
Q 046595          323 LAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       323 l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      -..+|.+++++||.+|||+.++|.
T Consensus       847 e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  847 EASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHHHHHhcCCCccCCCHHHHhh
Confidence            788999999999999999999885

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=5.1e-40  Score=288.88  Aligned_cols=243  Identities=19%  Similarity=0.292  Sum_probs=199.1

Q ss_pred             eeccCCceEEEEEeC-CCCeEEEEEccCCCCC--CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCCCh
Q 046595           76 IGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP--EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSL  152 (363)
Q Consensus        76 lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g~L  152 (363)
                      ||.|++|.||+++.. +++.+++|++......  .....+.+|+.+++.++|+||+++++++.+....++++||+.+++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999865 5899999998764322  3346789999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCcccc
Q 046595          153 HDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA  232 (363)
Q Consensus       153 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~  232 (363)
                      .+++....         .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~~l~~~~---------~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-  147 (262)
T cd05572          81 WTILRDRG---------LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-  147 (262)
T ss_pred             HHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-
Confidence            99997653         278999999999999999999999   99999999999999999999999999987654432 


Q ss_pred             cccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCC
Q 046595          233 RLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLN  312 (363)
Q Consensus       233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (363)
                        ......|+..|++||.+.+..++.++|+||||+++|+|++|..||........ ..            ..........
T Consensus       148 --~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~------------~~~~~~~~~~  212 (262)
T cd05572         148 --KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM-EI------------YNDILKGNGK  212 (262)
T ss_pred             --ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH-HH------------HHHHhccCCC
Confidence              12334688999999999888899999999999999999999999975532110 00            1111111122


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 046595          313 NDYPPKAIAKLAAVAALCVQYEADFRPN-----MTIVVK  346 (363)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~~vl~  346 (363)
                      ..++...+.++.+++.+||+.+|++||+     +.++++
T Consensus       213 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         213 LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            3334445778999999999999999999     888877

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.5e-40  Score=292.60  Aligned_cols=266  Identities=24%  Similarity=0.357  Sum_probs=205.4

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeC--CeeEEEEe
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMES--NNRILVYQ  145 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e  145 (363)
                      +|...+.||.|++|.||++... +++.+++|.+...........+.+|++++++++|+||+++++++...  ...++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            5778889999999999999864 58889999987654444456789999999999999999999988653  46899999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+++|.+++......     ...++...+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.
T Consensus        82 ~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~  153 (287)
T cd06621          82 YCEGGSLDSIYKKVKKR-----GGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSG  153 (287)
T ss_pred             ecCCCCHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccc
Confidence            99999999887542211     12378899999999999999999999   99999999999999999999999999986


Q ss_pred             CCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCc--cccchhhhcccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPK--GQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~  303 (363)
                      ......    .....++..|+|||.+.+..++.++||||||+++|+|++|..||......  .......+...       
T Consensus       154 ~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------  222 (287)
T cd06621         154 ELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-------  222 (287)
T ss_pred             cccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-------
Confidence            543221    12345788999999999889999999999999999999999999755321  11111111110       


Q ss_pred             ccccCCcCCCCCC--HHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HhccccccC
Q 046595          304 KQCVDPKLNNDYP--PKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPLLNSK  355 (363)
Q Consensus       304 ~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l~~~~  355 (363)
                        .....+.....  ...+..+.+++.+||+.+|.+|||+.+|++  .+.....++
T Consensus       223 --~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~  276 (287)
T cd06621         223 --MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKK  276 (287)
T ss_pred             --CCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccch
Confidence              00001111111  134567999999999999999999999998  555555443

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.6e-40  Score=294.73  Aligned_cols=264  Identities=23%  Similarity=0.281  Sum_probs=200.1

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC----CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP----EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      +|.+.+.||+|++|.||+|... +++.|++|.+......    .....+..|+.++++++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4788889999999999999764 6899999999765432    1234567899999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+ +++|.+++....        ..+++..++.++.|+++||.|||++   +++|+||+|+||+++.++.++|+|||+
T Consensus        81 ~e~~-~~~L~~~i~~~~--------~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~  148 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--------IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGL  148 (298)
T ss_pred             Eccc-CCCHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEcccee
Confidence            9999 889999997543        1389999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchh-hhcc-ccc--
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLV-TWAT-PRL--  298 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~-~~~~-~~~--  298 (363)
                      +.........  .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..+|....+....... .... +..  
T Consensus       149 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (298)
T cd07841         149 ARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEEN  226 (298)
T ss_pred             eeeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhh
Confidence            8765443211  223456788999998865 46789999999999999999998887654332111100 0000 000  


Q ss_pred             -c-ccccccccCCcCCC-----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          299 -S-EDKVKQCVDPKLNN-----DYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       299 -~-~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                       . ..............     ......+..+.+++.+||+.+|++|||+.+|++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence             0 00000000000001     111234677999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=7.9e-40  Score=291.46  Aligned_cols=251  Identities=24%  Similarity=0.356  Sum_probs=204.8

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ....|...+.||+|++|.||.+.+. ++..+++|++.....  ....+..|+.+++.++|+||+++++.+......++++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            3457888899999999999999765 688999999876433  4567889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+++|.+++....        ..+++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||++
T Consensus        95 e~~~~~~L~~~l~~~~--------~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~  163 (286)
T cd06614          95 EYMDGGSLTDIITQNF--------VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFA  163 (286)
T ss_pred             eccCCCcHHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchh
Confidence            9999999999998753        1389999999999999999999999   9999999999999999999999999987


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      ........  ......++..|++||.+.+..++.++|+||||+++|+|++|..||....+.....  ...          
T Consensus       164 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~--~~~----------  229 (286)
T cd06614         164 AQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF--LIT----------  229 (286)
T ss_pred             hhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHH----------
Confidence            65433221  1233457889999999988889999999999999999999999997443221100  000          


Q ss_pred             cccCCcC-CCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          305 QCVDPKL-NNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       305 ~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                         .... .......++..+.+++.+||+.+|.+||++.+|++
T Consensus       230 ---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         230 ---TKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             ---hcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence               0000 01112235677999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.6e-40  Score=294.02  Aligned_cols=262  Identities=16%  Similarity=0.192  Sum_probs=186.7

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeCC----CCeEEEEEccCCCCCCchH----------HHHHHHHHHhcCCCCccceee
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLTD----GTPAAIKKLDTSSAPEPES----------DFAAQLSVVSRLKHEHFVELL  131 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~avK~~~~~~~~~~~~----------~~~~e~~~l~~l~h~~i~~~~  131 (363)
                      ..++|.+.+.||+|+||.||+|.+.+    +..+++|+..........+          ....+...+..++|+||+.++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            34689999999999999999998654    4456666544322111111          112233455667899999999


Q ss_pred             eEEEeCC----eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCc
Q 046595          132 GYCMESN----NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSN  207 (363)
Q Consensus       132 ~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~N  207 (363)
                      +.+....    ..+++++++.. ++.+.+....         ..++..+..++.|++.||.|||++   +|+||||||+|
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~N  156 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK---------CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPEN  156 (294)
T ss_pred             EeeeEecCCceEEEEEEehhcc-CHHHHHHhhc---------cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence            8765543    34677787654 6666665432         156788899999999999999999   99999999999


Q ss_pred             eeecCCCceEEeeeccCCCCCccccc-----ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCC
Q 046595          208 VLLFDDFKSKIADFNLTNQSSDTAAR-----LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHT  282 (363)
Q Consensus       208 ill~~~~~vkl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~  282 (363)
                      ||++.++.++|+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus       157 ill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~  236 (294)
T PHA02882        157 IMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF  236 (294)
T ss_pred             EEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence            99999999999999998765322111     1122346999999999999999999999999999999999999999755


Q ss_pred             CCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 046595          283 MPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ  349 (363)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~  349 (363)
                      ......  .....    .+.+.......+   ....++..+.+++..||+.+|++||++++|++.|+
T Consensus       237 ~~~~~~--~~~~~----~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        237 GHNGNL--IHAAK----CDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             ccchHH--HHHhH----HHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            321110  00000    000011111111   11234677999999999999999999999998774

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7e-40  Score=291.60  Aligned_cols=248  Identities=23%  Similarity=0.375  Sum_probs=199.0

Q ss_pred             CCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           69 NFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      .|...+.||+|++|.||++.. .+++.+++|++.... ......+.+|+.+++.++|+||+++++++...+..++++||+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~   98 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL   98 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence            345557899999999999975 468899999886532 233456889999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      .+++|.+++....          +++..+..++.|++.||.|||++   +++||||+|+||+++.++.++|+|||++...
T Consensus        99 ~~~~L~~~~~~~~----------~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~  165 (285)
T cd06648          99 EGGALTDIVTHTR----------MNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQV  165 (285)
T ss_pred             CCCCHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhh
Confidence            9999999987632          88999999999999999999999   9999999999999999999999999987654


Q ss_pred             CcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCV  307 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (363)
                      ......  .....|+..|+|||.+.+..++.++||||||+++|+|++|..||....+.......            ....
T Consensus       166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~------------~~~~  231 (285)
T cd06648         166 SKEVPR--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI------------RDNL  231 (285)
T ss_pred             ccCCcc--cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH------------HhcC
Confidence            332211  22356899999999998888999999999999999999999999654321111100            0000


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          308 DPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ...  ...+...+..+.+++.+||+.+|++||++.++++
T Consensus       232 ~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         232 PPK--LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CCC--CcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            000  0112234567999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=7.3e-40  Score=291.29  Aligned_cols=266  Identities=22%  Similarity=0.317  Sum_probs=202.1

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      +|++.+.||.|++|.||+|+.. ++..|++|++...........+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788899999999999999865 688999999987655555567788999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      .+ +|.+++.....      ...+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++...
T Consensus        81 ~~-~l~~~~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~  150 (284)
T cd07836          81 DK-DLKKYMDTHGV------RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAF  150 (284)
T ss_pred             Cc-cHHHHHHhcCC------CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhh
Confidence            86 89888865431      12389999999999999999999999   9999999999999999999999999998654


Q ss_pred             CcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      .....  ......++..|++||.+.+. .++.++||||||+++|+|++|..||......+......-............+
T Consensus       151 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07836         151 GIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGI  228 (284)
T ss_pred             cCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHH
Confidence            33211  12334578899999988654 5789999999999999999999999765432211110000000000000000


Q ss_pred             -----cCCcC-------CCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          307 -----VDPKL-------NNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       307 -----~~~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                           .....       ...+.+..+..+.+++.+||+.||.+||++.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         229 SQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                 00000       01112234667899999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=5.6e-40  Score=293.47  Aligned_cols=265  Identities=22%  Similarity=0.318  Sum_probs=200.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC-chHHHHHHHHHHhcCCCCccceeeeEEEeC--CeeEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLGYCMES--NNRILV  143 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv  143 (363)
                      ++|++.+.||.|+||.||+|... +++.+++|.++...... ....+.+|+.++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888999999999999999865 58899999987643322 234567899999999999999999998877  889999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      +||+.+ +|.+++.....        .+++..++.++.|++.||.|||++   +++|+||||+||+++.++.++|+|||+
T Consensus        85 ~e~~~~-~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~  152 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQ--------PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGL  152 (293)
T ss_pred             ehhcCc-CHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCc
Confidence            999985 99998875432        389999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhh----------
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT----------  292 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~----------  292 (363)
                      +.........  .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.............          
T Consensus       153 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  230 (293)
T cd07843         153 AREYGSPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKI  230 (293)
T ss_pred             eeeccCCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHH
Confidence            8765443211  2334578899999988754 46899999999999999999999997544322111000          


Q ss_pred             hcc----ccccccccccccCCcCCCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          293 WAT----PRLSEDKVKQCVDPKLNNDYPPK-AIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       293 ~~~----~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      |..    +..............+...++.. .+..+.++|.+||+.+|++|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         231 WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             HHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            000    00000000001111111222222 4667899999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.2e-40  Score=293.68  Aligned_cols=264  Identities=21%  Similarity=0.307  Sum_probs=198.4

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      +|++.+.||.|++|.||+|+.. ++..|++|.+...... .....+..|++++++++||||+++++++.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999764 6899999998754322 2335788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +. ++|.+++.....       ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++..
T Consensus        81 ~~-~~l~~~~~~~~~-------~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~  149 (284)
T cd07860          81 LH-QDLKKFMDASPL-------SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARA  149 (284)
T ss_pred             cc-cCHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhh
Confidence            96 589888865432       1388999999999999999999999   999999999999999999999999999865


Q ss_pred             CCcccccccccccccccCCCCccccccCC-CCccCceehhHHHHHHHHhCCCCCCCCCCccccc-hhhhcccccc-----
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQS-LVTWATPRLS-----  299 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~-----  299 (363)
                      .......  .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||.......... ..........     
T Consensus       150 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (284)
T cd07860         150 FGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG  227 (284)
T ss_pred             cccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Confidence            4332211  22345788999999887644 6889999999999999999999997543221110 0000000000     


Q ss_pred             -------ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          300 -------EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       300 -------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                             ......+....+ .......+..+.++|.+||+.||.+||++.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         228 VTSLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhHHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                   000000000000 0111234566889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=8e-40  Score=300.01  Aligned_cols=264  Identities=20%  Similarity=0.258  Sum_probs=199.5

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC-CCCchHHHHHHHHHHhcCCCCccceeeeEEEeC-----
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS-APEPESDFAAQLSVVSRLKHEHFVELLGYCMES-----  137 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----  137 (363)
                      .+.++|++.+.||+|+||.||+|... +++.||+|.+.... .......+.+|+.++++++|+||+++++++...     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            35678999999999999999999754 68999999986532 222345677899999999999999999987643     


Q ss_pred             -CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCce
Q 046595          138 -NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS  216 (363)
Q Consensus       138 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v  216 (363)
                       ...++||||+.+ +|.+.+...           ++...+..++.|++.||.|||++   +|+||||||+||+++.++.+
T Consensus        93 ~~~~~lv~e~~~~-~l~~~~~~~-----------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~  157 (353)
T cd07850          93 FQDVYLVMELMDA-NLCQVIQMD-----------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTL  157 (353)
T ss_pred             cCcEEEEEeccCC-CHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCE
Confidence             356899999975 888887532           78889999999999999999999   99999999999999999999


Q ss_pred             EEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhh----
Q 046595          217 KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT----  292 (363)
Q Consensus       217 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~----  292 (363)
                      ||+|||++........   .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...........+.    
T Consensus       158 kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  234 (353)
T cd07850         158 KILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLG  234 (353)
T ss_pred             EEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999999876543221   233468899999999999999999999999999999999999997543211110000    


Q ss_pred             ----------------hcccc--ccccccccccCC----cCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          293 ----------------WATPR--LSEDKVKQCVDP----KLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       293 ----------------~~~~~--~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                                      +....  ............    ..........+..+.+++.+||+.||++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         235 TPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             CCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                            00000  000000000000    0001112234667899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-41  Score=296.53  Aligned_cols=249  Identities=22%  Similarity=0.306  Sum_probs=204.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC--CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP--EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      +.|+.-++||+||||.|+-|+.+ +|+-||+|.+.+....  ......+.|..+|.+++.++||.+--.+++.+.+++||
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            45788889999999999999754 6999999988654322  22345678999999999999999988899999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ..|+||+|.-.|.....       +.|++..++.++.+|+.||++||+.   +||+|||||+|||+|+.|+|+|+|+|+|
T Consensus       265 tlMNGGDLkfHiyn~g~-------~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLA  334 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGN-------PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLA  334 (591)
T ss_pred             EeecCCceeEEeeccCC-------CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceE
Confidence            99999999888876543       2399999999999999999999999   9999999999999999999999999999


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      .........   ...+||.+|||||++.++.|+...|.|||||+||||+.|+.||......            ...+++.
T Consensus       335 vei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK------------vk~eEvd  399 (591)
T KOG0986|consen  335 VEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK------------VKREEVD  399 (591)
T ss_pred             EecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh------------hhHHHHH
Confidence            877665443   4458999999999999999999999999999999999999999644221            1112222


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMT  342 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~  342 (363)
                      .... .-...++...+++..+|.+..|+.||.+|....
T Consensus       400 rr~~-~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  400 RRTL-EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             HHHh-cchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            1111 112455667788899999999999999996543

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.7e-39  Score=283.40  Aligned_cols=249  Identities=30%  Similarity=0.465  Sum_probs=203.4

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      +|.+.+.||+|++|.||++... +++.+++|++..... .....+.+|+.+++.++|+||+++++++......++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence            4778889999999999999865 688999999876433 34578899999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      .+++|.+++....        ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||.+...
T Consensus        80 ~~~~L~~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~  148 (253)
T cd05122          80 SGGSLKDLLKSTN--------QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQL  148 (253)
T ss_pred             CCCcHHHHHhhcC--------CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccc
Confidence            9999999997653        1389999999999999999999998   9999999999999999999999999998765


Q ss_pred             CcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCV  307 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (363)
                      .....   .....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.............            ...
T Consensus       149 ~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~------------~~~  213 (253)
T cd05122         149 SDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA------------TNG  213 (253)
T ss_pred             ccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH------------hcC
Confidence            44321   234568899999999988889999999999999999999999997543211111000            000


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          308 DPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ....  ......+..+.+++..||+.||++|||+.++++
T Consensus       214 ~~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         214 PPGL--RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             CCCc--CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0000  011123567999999999999999999999985

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.5e-39  Score=284.93  Aligned_cols=252  Identities=23%  Similarity=0.350  Sum_probs=206.7

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEeC--CeeEEEE
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCMES--NNRILVY  144 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~  144 (363)
                      +|.+.+.||+|++|.||+|... +++.+++|++..... ......+.+|+.++++++|+||+++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778889999999999999866 688999999876432 23356788999999999999999999999988  8899999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+++|.+++....         .+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+
T Consensus        81 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~  148 (260)
T cd06606          81 EYVSGGSLSSLLKKFG---------KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCA  148 (260)
T ss_pred             EecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccE
Confidence            9999999999997654         289999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      ................++..|+|||.+.+..++.++||||||+++|+|++|..||......  ..            .+.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~------------~~~  214 (260)
T cd06606         149 KRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP--MA------------ALY  214 (260)
T ss_pred             EecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HH------------HHH
Confidence            7655443211123456889999999998888999999999999999999999999755411  00            001


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ...........+...+..+.+++.+||+.+|++||++.+++.
T Consensus       215 ~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         215 KIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             hccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            111112223344455778999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=7.5e-40  Score=294.86  Aligned_cols=266  Identities=24%  Similarity=0.306  Sum_probs=198.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC-chHHHHHHHHHHhcCCCCccceeeeEEEeC--CeeEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLGYCMES--NNRIL  142 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l  142 (363)
                      ..+|++.+.||+|+||.||+|... +++.||+|++....... ....+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            357999999999999999999764 68999999987543222 223567899999999999999999998755  56899


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ||||+.+ +|.+++....        ..+++.++..++.|++.||.|||+.   +++|+||||+||++++++.+||+|||
T Consensus        86 v~e~~~~-~l~~~l~~~~--------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg  153 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMP--------TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFG  153 (309)
T ss_pred             EEecCCC-CHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccc
Confidence            9999975 8888887543        1389999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      ++.........  .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||....+......+.-........
T Consensus       154 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  231 (309)
T cd07845         154 LARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNES  231 (309)
T ss_pred             eeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            98765433211  222345788999998875 468999999999999999999999997654432221111100000000


Q ss_pred             cc---c-----ccc--CCcCCCC---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          302 KV---K-----QCV--DPKLNND---YPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       302 ~~---~-----~~~--~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ..   .     ...  .......   .....+..+.++|.+||+.||++|||+.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         232 IWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00   0     000  0000000   00123567889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=9.9e-40  Score=292.09  Aligned_cols=268  Identities=21%  Similarity=0.256  Sum_probs=196.9

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC-chHHHHHHHHHHhcCC-CCccceeeeEEEeCCe-----e
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLK-HEHFVELLGYCMESNN-----R  140 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~-----~  140 (363)
                      +|++.+.||+|+||.||+|.+. +++.|++|.+....... ....+.+|+.+++.+. |+||+++++++.....     .
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            6889999999999999999765 68999999987643322 3356788999999995 6999999999887665     7


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC-CCceEEe
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD-DFKSKIA  219 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~  219 (363)
                      +++|||+.+ +|.+++......    ....+++..++.++.|++.||.|||++   +|+||||+|+||+++. ++.+||+
T Consensus        82 ~lv~e~~~~-~l~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~  153 (295)
T cd07837          82 YLVFEYLDS-DLKKFMDSNGRG----PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIA  153 (295)
T ss_pred             EEEeeccCc-CHHHHHHHhccc----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEe
Confidence            999999986 898888654321    112489999999999999999999999   9999999999999998 8999999


Q ss_pred             eeccCCCCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 046595          220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL  298 (363)
Q Consensus       220 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  298 (363)
                      |||++.........  .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||....+........-.....
T Consensus       154 dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~  231 (295)
T cd07837         154 DLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTP  231 (295)
T ss_pred             ecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99998754332211  122356889999998865 457899999999999999999999997543221111000000000


Q ss_pred             ccc---ccccccC--------CcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          299 SED---KVKQCVD--------PKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       299 ~~~---~~~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ...   .......        +.......+..+..+.++|.+||+.||.+||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000   0000000        00000111235677999999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.2e-39  Score=291.51  Aligned_cols=247  Identities=26%  Similarity=0.365  Sum_probs=197.1

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC--CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP--EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      +.|.+.+.||+|+||.||++... +++.|++|.+......  .....+.+|+.+++.++||||+++++++......++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            46889999999999999999764 6899999988653322  22356889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+ +|.+++.....        .+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++
T Consensus        95 e~~~g-~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~  162 (307)
T cd06607          95 EYCLG-SASDILEVHKK--------PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSA  162 (307)
T ss_pred             HhhCC-CHHHHHHHccc--------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcc
Confidence            99975 78777753321        388999999999999999999999   9999999999999999999999999988


Q ss_pred             CCCCcccccccccccccccCCCCccccc---cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAM---TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      ......      ....|+..|+|||++.   ...++.++||||||+++|||++|..||.............         
T Consensus       163 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~---------  227 (307)
T cd06607         163 SLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---------  227 (307)
T ss_pred             eecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh---------
Confidence            654321      2346788999999874   3568899999999999999999999996443211110000         


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                            ............+..+.+++.+||+.+|++||++.+|+..
T Consensus       228 ------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         228 ------QNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             ------cCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                  0000111123456779999999999999999999999873

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.1e-40  Score=300.48  Aligned_cols=267  Identities=23%  Similarity=0.361  Sum_probs=200.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEe----CCee
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCME----SNNR  140 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~  140 (363)
                      ..+|.+.+.||.|+||.||+|... +++.|++|++..... ......+.+|+.+++.++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            468999999999999999999754 699999999876432 2334677889999999999999999987753    3567


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEee
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD  220 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D  220 (363)
                      ++||||+. ++|.+++....         .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~d  150 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ---------PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGD  150 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecc
Confidence            99999996 58999886543         289999999999999999999999   999999999999999999999999


Q ss_pred             eccCCCCCccccc--ccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccc
Q 046595          221 FNLTNQSSDTAAR--LHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR  297 (363)
Q Consensus       221 fg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~  297 (363)
                      ||++.........  .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||..................
T Consensus       151 fg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~  230 (334)
T cd07855         151 FGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGS  230 (334)
T ss_pred             cccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCC
Confidence            9998654332211  11124578999999998865 46899999999999999999999999754332211111110000


Q ss_pred             cc--------ccccccccCC-cCCCC-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          298 LS--------EDKVKQCVDP-KLNND-----YPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       298 ~~--------~~~~~~~~~~-~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ..        ...+...... .....     .....+..+.+++.+||+.+|++||++.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            00        0001110000 00011     11234678999999999999999999999887

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.5e-40  Score=294.04  Aligned_cols=257  Identities=25%  Similarity=0.344  Sum_probs=194.7

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-CCccceeeeEEEeCCeeEEEEec
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      +|...+.||+|+||.||++... +++.+++|.+...........+..|+.++.++. |+||+++++++......+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4556678999999999999754 589999999876544444567889999999996 99999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.. +|.++......    .....+++..+..++.|++.||+|||+..  +++||||||+||+++.++.++|+|||++..
T Consensus        85 ~~~-~l~~l~~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  157 (288)
T cd06616          85 MDI-SLDKFYKYVYE----VLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQ  157 (288)
T ss_pred             ccC-CHHHHHHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence            865 66554321100    00113899999999999999999999632  899999999999999999999999999865


Q ss_pred             CCcccccccccccccccCCCCccccccC---CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTG---QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      ......   .....|+..|+|||.+.+.   .++.++||||||+++|+|++|+.||....... .....          +
T Consensus       158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~----------~  223 (288)
T cd06616         158 LVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF-DQLTQ----------V  223 (288)
T ss_pred             hccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH-HHHhh----------h
Confidence            433221   1234688899999998766   68999999999999999999999996432100 00000          0


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .....+.+.......++..+.+++.+||+.+|++|||+.+|++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         224 VKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             cCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000011112222346677999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.3e-39  Score=289.24  Aligned_cols=261  Identities=23%  Similarity=0.308  Sum_probs=194.6

Q ss_pred             CCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-CCccceeeeEEEeC--CeeEEEEe
Q 046595           70 FGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVELLGYCMES--NNRILVYQ  145 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e  145 (363)
                      |++.+.||+|+||.||++... +++.+++|++.............+|+.++.++. |+||+++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            667888999999999999754 688999999876543333344567888888885 99999999999987  88999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+ +|.+++.....        .+++.++..++.|++.||.|||+.   +++|+||+|+||+++. +.+||+|||++.
T Consensus        81 ~~~~-~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~  147 (282)
T cd07831          81 LMDM-NLYELIKGRKR--------PLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCR  147 (282)
T ss_pred             cCCc-cHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccc
Confidence            9975 88888865321        389999999999999999999999   9999999999999999 999999999987


Q ss_pred             CCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccc----
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE----  300 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~----  300 (363)
                      .......   .....++..|+|||.+.. ..++.++|||||||++|||++|..||......+..............    
T Consensus       148 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (282)
T cd07831         148 GIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLK  224 (282)
T ss_pred             ccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            6543221   123467899999997654 56789999999999999999999999754332211100000000000    


Q ss_pred             ----cccccccCCcC-C---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          301 ----DKVKQCVDPKL-N---NDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       301 ----~~~~~~~~~~~-~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                          ........+.. .   .......+..+.+++.+||+.+|++||++.++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         225 KFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             hhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence                00000000000 0   0011245678999999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=6.4e-40  Score=287.29  Aligned_cols=251  Identities=23%  Similarity=0.398  Sum_probs=200.9

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      +|.+.+.||+|+||.||++... ++..+++|.+..... ......+.+|+.+++.++|+||+++++.+......++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788899999999999999765 588899999866432 22345788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC-ceEEeeeccCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF-KSKIADFNLTN  225 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Dfg~a~  225 (363)
                      +.+++|.+++.....       ..+++..+..++.|++.||.|||+.   +++|+||||+||++++++ .++|+|||.+.
T Consensus        81 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~  150 (257)
T cd08225          81 CDGGDLMKRINRQRG-------VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIAR  150 (257)
T ss_pred             CCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccch
Confidence            999999999975432       1378999999999999999999999   999999999999999875 56999999987


Q ss_pred             CCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      ........  .....|++.|+|||++.+..++.++|+||||+++|+|++|..||........   .            ..
T Consensus       151 ~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~------------~~  213 (257)
T cd08225         151 QLNDSMEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL---V------------LK  213 (257)
T ss_pred             hccCCccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---H------------HH
Confidence            65432211  2234588999999999888899999999999999999999999964322110   0            00


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                      ..... ........+..+.+++.+||+.+|++|||+.+|+..
T Consensus       214 ~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         214 ICQGY-FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             Hhccc-CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            00101 111223445679999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.2e-39  Score=289.10  Aligned_cols=243  Identities=23%  Similarity=0.304  Sum_probs=189.4

Q ss_pred             eeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCc--hHHHHHHHHH---HhcCCCCccceeeeEEEeCCeeEEEEeccc
Q 046595           75 LIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEP--ESDFAAQLSV---VSRLKHEHFVELLGYCMESNNRILVYQFAT  148 (363)
Q Consensus        75 ~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~--~~~~~~e~~~---l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  148 (363)
                      .||+|+||.||++... +++.+|+|.+........  ...+.+|..+   +...+|+||+.+++++...+..++||||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999764 588999998865432221  2233444433   333479999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCC
Q 046595          149 MGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS  228 (363)
Q Consensus       149 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~  228 (363)
                      +++|.+++....         .+++..+..++.|++.||.|||++   +|+|+||||+||++++++.++|+|||++....
T Consensus        81 ~~~L~~~i~~~~---------~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~  148 (279)
T cd05633          81 GGDLHYHLSQHG---------VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS  148 (279)
T ss_pred             CCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence            999999987543         289999999999999999999999   99999999999999999999999999986543


Q ss_pred             cccccccccccccccCCCCccccc-cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccccc
Q 046595          229 DTAARLHSTRVLGTFGYHAPEYAM-TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCV  307 (363)
Q Consensus       229 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (363)
                      ...    .....|+..|+|||.+. +..++.++|+|||||++|+|++|..||............             .. 
T Consensus       149 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~-------------~~-  210 (279)
T cd05633         149 KKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-------------RM-  210 (279)
T ss_pred             ccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHH-------------HH-
Confidence            221    22346899999999886 456899999999999999999999999754322111100             00 


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 046595          308 DPKLNNDYPPKAIAKLAAVAALCVQYEADFRP-----NMTIVVKA  347 (363)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~~  347 (363)
                      .......++...+.++.+++.+||+.||.+||     +++++++.
T Consensus       211 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         211 TLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             hhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            00112233455677899999999999999999     69999883

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=5.5e-40  Score=299.25  Aligned_cols=269  Identities=23%  Similarity=0.320  Sum_probs=200.8

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC-CCCchHHHHHHHHHHhcC-CCCccceeeeEEEeC--Ce
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS-APEPESDFAAQLSVVSRL-KHEHFVELLGYCMES--NN  139 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~  139 (363)
                      .+.++|.+.+.||+|+||.||+|... +++.+++|++.... .......+.+|+.+++++ +|+||+++++++...  ..
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            34568999999999999999999765 68899999886432 223345677899999999 999999999987653  46


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEe
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA  219 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~  219 (363)
                      .++||||+.+ +|..++....          +.+..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+
T Consensus        84 ~~lv~e~~~~-~L~~~~~~~~----------~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~  149 (337)
T cd07852          84 IYLVFEYMET-DLHAVIRANI----------LEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLA  149 (337)
T ss_pred             EEEEeccccc-CHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEe
Confidence            7999999975 9999887542          78899999999999999999999   99999999999999999999999


Q ss_pred             eeccCCCCCccccc---ccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 046595          220 DFNLTNQSSDTAAR---LHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       220 Dfg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      |||++.........   .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||....+...........
T Consensus       150 d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~  229 (337)
T cd07852         150 DFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI  229 (337)
T ss_pred             eccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            99998765433221   11233568999999998765 467899999999999999999999997554332211111110


Q ss_pred             ccccccc--------cccccC----C--cCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          296 PRLSEDK--------VKQCVD----P--KLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       296 ~~~~~~~--------~~~~~~----~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                      .......        ....++    .  ..........+..+.+++.+||+.||++|||+.++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         230 GPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             CCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            0000000        000000    0  00011112256779999999999999999999999973

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-40  Score=290.82  Aligned_cols=264  Identities=22%  Similarity=0.272  Sum_probs=198.4

Q ss_pred             CCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC-chHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           70 FGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      |++.+.||.|++|.||+|... +|..|++|++....... ....+.+|+.+++.++|+||+++++++.+....+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            677889999999999999754 79999999987643222 2356888999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      . ++|.+++.....       ..+++..++.++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||++...
T Consensus        81 ~-~~l~~~~~~~~~-------~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~  149 (283)
T cd07835          81 D-LDLKKYMDSSPL-------TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAF  149 (283)
T ss_pred             C-cCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeeccccccc
Confidence            6 589999876542       1389999999999999999999999   9999999999999999999999999998654


Q ss_pred             CcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchh-hhccccc-------
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLV-TWATPRL-------  298 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~-~~~~~~~-------  298 (363)
                      ......  .....++..|+|||++.+. .++.++|+||||+++|+|++|..||....+....... .......       
T Consensus       150 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (283)
T cd07835         150 GVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV  227 (283)
T ss_pred             CCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhh
Confidence            322211  2233568899999988764 5789999999999999999999999754332111100 0000000       


Q ss_pred             -cccccccccC---CcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          299 -SEDKVKQCVD---PKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       299 -~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                       ..........   ...........+..+.+++.+||+.+|.+|||++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         228 TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence             0000000000   00001112234467999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.7e-39  Score=288.04  Aligned_cols=245  Identities=24%  Similarity=0.314  Sum_probs=194.5

Q ss_pred             eeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCCCh
Q 046595           76 IGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSL  152 (363)
Q Consensus        76 lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g~L  152 (363)
                      ||+|+||.||+|... +++.+++|.+....  .......+..|+.+++.++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999654 68999999986532  122344667899999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCcccc
Q 046595          153 HDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA  232 (363)
Q Consensus       153 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~  232 (363)
                      .+++.....       ..+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~~l~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~-  149 (277)
T cd05577          81 KYHIYNVGE-------PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-  149 (277)
T ss_pred             HHHHHHcCc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC-
Confidence            999975442       1388999999999999999999999   99999999999999999999999999886543311 


Q ss_pred             cccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCC
Q 046595          233 RLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLN  312 (363)
Q Consensus       233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (363)
                        ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||..........            .+..... ...
T Consensus       150 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------------~~~~~~~-~~~  214 (277)
T cd05577         150 --KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE------------ELKRRTL-EMA  214 (277)
T ss_pred             --ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH------------HHHhccc-ccc
Confidence              1233467889999999988889999999999999999999999996543211110            0000000 011


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046595          313 NDYPPKAIAKLAAVAALCVQYEADFRP-----NMTIVVK  346 (363)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  346 (363)
                      ..++...+..+.+++.+||+.+|.+||     ++.+++.
T Consensus       215 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         215 VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            223344567799999999999999999     7777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.7e-39  Score=284.38  Aligned_cols=252  Identities=23%  Similarity=0.393  Sum_probs=205.8

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      +|.+.+.||.|+||.||++.+. ++..+++|++...... .....+..|+++++.++|+|++++++.+......++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4788899999999999999765 6889999998764432 3456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +++++|.+++.....     ....+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~  152 (258)
T cd08215          81 ADGGDLSQKIKKQKK-----EGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKV  152 (258)
T ss_pred             cCCCcHHHHHHHhhc-----cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceee
Confidence            999999999976431     112489999999999999999999999   999999999999999999999999999876


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      ......  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.......   ...            ..
T Consensus       153 ~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~------------~~  215 (258)
T cd08215         153 LSSTVD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LAL------------KI  215 (258)
T ss_pred             cccCcc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HHH------------HH
Confidence            544321  1234568899999999988889999999999999999999999996543211   000            00


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      . .......+...+..+.+++.+||..+|++||++.++++
T Consensus       216 ~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         216 L-KGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             h-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0 11112223345667999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1e-39  Score=285.73  Aligned_cols=250  Identities=24%  Similarity=0.384  Sum_probs=204.9

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      +|++.+.||+|++|.||++... +++.+++|.+..... ......+..|+.+++.++|+||+++++++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788899999999999999654 688999999876432 23345678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +++++|.+++.....     ....+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++..
T Consensus        81 ~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~  152 (256)
T cd08530          81 APFGDLSKAISKRKK-----KRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKV  152 (256)
T ss_pred             cCCCCHHHHHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhh
Confidence            999999999876321     112388999999999999999999999   999999999999999999999999999876


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      .....    .....|+..|++||.+.+..++.++|+||||+++|+|++|+.||........                ...
T Consensus       153 ~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~----------------~~~  212 (256)
T cd08530         153 LKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL----------------RYK  212 (256)
T ss_pred             hccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----------------HHH
Confidence            55431    2234678899999999988899999999999999999999999975432111                111


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .........+...+.++.+++.+||+.+|++||++.++++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         213 VQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             HhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            1112222334466778999999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-39  Score=284.41  Aligned_cols=251  Identities=20%  Similarity=0.321  Sum_probs=200.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC----CCCchHHHHHHHHHHhcCCCCccceeeeEEEeC--Cee
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS----APEPESDFAAQLSVVSRLKHEHFVELLGYCMES--NNR  140 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~  140 (363)
                      .+|.+.+.||+|+||.||++... ++..|++|.+....    .......+.+|+.++++++|+||+++++.+.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            36899999999999999999754 68999999875422    122335788999999999999999999988764  457


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEee
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD  220 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D  220 (363)
                      ++++||+.+++|.+++....         .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~d  149 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG---------ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGD  149 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECc
Confidence            89999999999999987543         278899999999999999999999   999999999999999999999999


Q ss_pred             eccCCCCCccccc-ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc
Q 046595          221 FNLTNQSSDTAAR-LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       221 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      ||++......... .......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.......             
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------------  216 (264)
T cd06653         150 FGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-------------  216 (264)
T ss_pred             cccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-------------
Confidence            9998765322111 11223568899999999998889999999999999999999999996432111             


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                        .+...........++......+.+++..||+ +|..||+..+++.
T Consensus       217 --~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         217 --AIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             --HHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence              1111111222234456677789999999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-39  Score=292.22  Aligned_cols=270  Identities=21%  Similarity=0.307  Sum_probs=197.9

Q ss_pred             CCCCCCeeeccCCceEEEEEeC---CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeC--CeeE
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT---DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMES--NNRI  141 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~  141 (363)
                      +|.+.+.||+|+||.||+|...   ++..||+|.+....  .......+.+|+.+++.++||||+++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788899999999999999764   47899999987643  122335678899999999999999999999988  8899


Q ss_pred             EEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC----CCceE
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD----DFKSK  217 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~----~~~vk  217 (363)
                      +||||+.+ +|.+++.......    ...+++..++.++.|++.||.|||++   +++||||||+||+++.    ++.+|
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~k  152 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAK----RVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVK  152 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCC----CcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEE
Confidence            99999976 7877775433211    12488999999999999999999999   9999999999999999    99999


Q ss_pred             EeeeccCCCCCcccc-cccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccc------
Q 046595          218 IADFNLTNQSSDTAA-RLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQS------  289 (363)
Q Consensus       218 l~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~------  289 (363)
                      |+|||++........ ........++..|+|||.+.+. .++.++||||||+++|+|++|+.||..........      
T Consensus       153 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~  232 (316)
T cd07842         153 IGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD  232 (316)
T ss_pred             ECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHH
Confidence            999999876543322 1122345678999999987764 58899999999999999999999997554322000      


Q ss_pred             -hh---hhccccc--------ccccccc----ccCCcCC-CCCCH------HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          290 -LV---TWATPRL--------SEDKVKQ----CVDPKLN-NDYPP------KAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       290 -~~---~~~~~~~--------~~~~~~~----~~~~~~~-~~~~~------~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                       +.   .......        .......    ....... .....      ..+..+.+++.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         233 QLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence             00   0000000        0000000    0000000 00000      23456899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=5.8e-39  Score=290.04  Aligned_cols=252  Identities=26%  Similarity=0.370  Sum_probs=199.3

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC--CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP--EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      .|...+.||+|+||.||++... ++..+++|.+......  +....+..|+.+++.++|+|++++++++......++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            4777888999999999999754 6889999998654322  233578889999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+ +|.+.+.....        .+++.++..++.|++.||.|||++   +|+|+||+|+||+++.++.++|+|||++.
T Consensus       106 ~~~g-~l~~~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~  173 (317)
T cd06635         106 YCLG-SASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSAS  173 (317)
T ss_pred             CCCC-CHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCcc
Confidence            9975 88777754321        388999999999999999999999   99999999999999999999999999876


Q ss_pred             CCCcccccccccccccccCCCCccccc---cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAM---TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      ....      .....|+..|+|||.+.   ++.++.++|||||||++|+|++|..||..........             
T Consensus       174 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~-------------  234 (317)
T cd06635         174 IASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------------  234 (317)
T ss_pred             ccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH-------------
Confidence            5432      23346889999999874   4568899999999999999999999986432211111             


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccc
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN  353 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~  353 (363)
                        ...............+..+.+++.+||+.+|.+||++.+|++.+..+..
T Consensus       235 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         235 --HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             --HHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence              0001111111122455679999999999999999999999986554443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.2e-39  Score=291.86  Aligned_cols=268  Identities=22%  Similarity=0.299  Sum_probs=195.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC-chHHHHHHHHHHhcCCCCccceeeeEEEeCC------
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLGYCMESN------  138 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------  138 (363)
                      .++|++.+.||+|+||.||+|... +++.||+|.+....... ....+.+|+.++++++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            357999999999999999999764 68999999886543222 2345678999999999999999999887654      


Q ss_pred             --eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCce
Q 046595          139 --NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS  216 (363)
Q Consensus       139 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v  216 (363)
                        ..++||||+.+ +|.+++.....        .+++.+++.++.|++.||.|||++   +++|+||||+||+++.++.+
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~  158 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKNV--------KFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGIL  158 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcE
Confidence              34899999975 88888765421        289999999999999999999999   99999999999999999999


Q ss_pred             EEeeeccCCCCCccccc--ccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhh
Q 046595          217 KIADFNLTNQSSDTAAR--LHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTW  293 (363)
Q Consensus       217 kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~  293 (363)
                      ||+|||++.........  .......++..|+|||.+.+. .++.++||||||+++|+|++|..||..............
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~  238 (310)
T cd07865         159 KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQ  238 (310)
T ss_pred             EECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99999998765432221  112234578899999988764 478899999999999999999999975543222111111


Q ss_pred             cccccccccccc-----ccC-CcCCCCC---------CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          294 ATPRLSEDKVKQ-----CVD-PKLNNDY---------PPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       294 ~~~~~~~~~~~~-----~~~-~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ............     ..+ ..+....         .......+.++|.+||+.||.+|||++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         239 LCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             HhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            110000000000     000 0000000         0012345789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8.7e-40  Score=297.86  Aligned_cols=270  Identities=23%  Similarity=0.337  Sum_probs=200.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCC-CCCchHHHHHHHHHHhcCCCCccceeeeEEEeC-----Ce
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSS-APEPESDFAAQLSVVSRLKHEHFVELLGYCMES-----NN  139 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~  139 (363)
                      ..+|.+.+.||+|+||.||++.. .+++.|++|.+.... .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45799999999999999999975 468999999987532 222345677899999999999999999987644     34


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEe
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA  219 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~  219 (363)
                      .++++||+. ++|.+++....         .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~  150 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ---------TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKIC  150 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEC
Confidence            799999996 58998886543         289999999999999999999999   99999999999999999999999


Q ss_pred             eeccCCCCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhh-hcc--
Q 046595          220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT-WAT--  295 (363)
Q Consensus       220 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~-~~~--  295 (363)
                      |||++........  ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||............. ...  
T Consensus       151 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  228 (337)
T cd07858         151 DFGLARTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSP  228 (337)
T ss_pred             cCccccccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence            9999876543321  1234568899999998765 468999999999999999999999996543211110000 000  


Q ss_pred             -----ccccccccccccCC---cCC---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hccc
Q 046595          296 -----PRLSEDKVKQCVDP---KLN---NDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA--LQPL  351 (363)
Q Consensus       296 -----~~~~~~~~~~~~~~---~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~--l~~l  351 (363)
                           ..............   ...   ......++.++.+++.+||+.+|++|||++++++.  +..+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         229 SEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             ChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                 00000011100000   000   01112456778999999999999999999999975  5443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.6e-39  Score=289.28  Aligned_cols=266  Identities=18%  Similarity=0.264  Sum_probs=196.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      ++|++.+.||+|++|.||+|... +++.|++|.+...... .....+.+|+.++++++|+||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46889999999999999999765 6889999998764332 223567889999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC-CCceEEeeeccC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD-DFKSKIADFNLT  224 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~a  224 (363)
                      |+.+ +|.+++......       .+++..+..++.|++.||.|||++   +++|+||+|+||+++. ++.+||+|||++
T Consensus        82 ~~~~-~l~~~~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~  150 (294)
T PLN00009         82 YLDL-DLKKHMDSSPDF-------AKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLA  150 (294)
T ss_pred             cccc-cHHHHHHhCCCC-------CcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccc
Confidence            9965 888887543321       267888899999999999999999   9999999999999985 567999999998


Q ss_pred             CCCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc-
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK-  302 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-  302 (363)
                      ........  ......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||......+................ 
T Consensus       151 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  228 (294)
T PLN00009        151 RAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW  228 (294)
T ss_pred             cccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence            65433211  1223467889999998866 4578999999999999999999999975433211110000000000000 


Q ss_pred             -----cccc---c---CCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          303 -----VKQC---V---DPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       303 -----~~~~---~---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                           +...   .   ............+.++.+++.+|++.+|++||++.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 0000   0   000000011234566899999999999999999999986

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-39  Score=284.10  Aligned_cols=244  Identities=20%  Similarity=0.252  Sum_probs=188.9

Q ss_pred             CeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC--CchHHHHHHHHH-HhcCCCCccceeeeEEEeCCeeEEEEecccC
Q 046595           74 ALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP--EPESDFAAQLSV-VSRLKHEHFVELLGYCMESNNRILVYQFATM  149 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  149 (363)
                      +.||+|+||.||+|... +++.||+|.+......  .....+..|..+ ....+|+||+++++++...+..++++||+.+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46999999999999764 5889999998653211  112234455444 3455899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCc
Q 046595          150 GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       150 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      ++|.+++....         .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 ~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  149 (260)
T cd05611          82 GDCASLIKTLG---------GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE  149 (260)
T ss_pred             CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc
Confidence            99999997543         288999999999999999999999   999999999999999999999999998765432


Q ss_pred             ccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCC
Q 046595          230 TAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDP  309 (363)
Q Consensus       230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (363)
                            .....|+..|+|||.+.+..++.++||||||+++|+|++|..||............  ..     .      ..
T Consensus       150 ------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~-----~------~~  210 (260)
T cd05611         150 ------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI--LS-----R------RI  210 (260)
T ss_pred             ------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--Hh-----c------cc
Confidence                  23356889999999998888999999999999999999999999654321110000  00     0      00


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 046595          310 KLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKAL  348 (363)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l  348 (363)
                      .........++..+.+++.+||+.+|++||++.++.+.|
T Consensus       211 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         211 NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            011112224567799999999999999999776555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-41  Score=328.12  Aligned_cols=255  Identities=22%  Similarity=0.311  Sum_probs=209.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      .-+|.-...||.|.||.||.|.. .+|+..|+|.+...... .....+.+|..++..++|||+|++||+=.+.+..+|.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            34688888999999999999964 56899999988765433 22356789999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      |||.+|+|.+++...+.         .++.....+..|++.|+.|||++   |||||||||.||+++.+|.+|++|||.|
T Consensus      1314 EyC~~GsLa~ll~~gri---------~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRI---------EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred             HHhccCcHHHHHHhcch---------hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccce
Confidence            99999999999987653         56666677888999999999999   9999999999999999999999999998


Q ss_pred             CCCCccccc--ccccccccccCCCCccccccC---CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc
Q 046595          225 NQSSDTAAR--LHSTRVLGTFGYHAPEYAMTG---QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       225 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      .........  ......+||+.|||||++.+.   ....++|||||||++.||+||+.||...+..-             
T Consensus      1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~------------- 1448 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW------------- 1448 (1509)
T ss_pred             eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh-------------
Confidence            766544211  112346899999999999753   46788999999999999999999997554321             


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKAL  348 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l  348 (363)
                        .+...+..+-...+|...+.+=.++++.||+.||+.|.++.|+++.=
T Consensus      1449 --aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1449 --AIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             --HHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence              22222333344566777888999999999999999999999888753

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3e-39  Score=288.36  Aligned_cols=243  Identities=24%  Similarity=0.395  Sum_probs=195.7

Q ss_pred             CeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCCCh
Q 046595           74 ALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSL  152 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g~L  152 (363)
                      ..||+|+||.||++.. .+++.|++|++... .......+.+|+.+++.++|+||+++++.+...+..+++|||+.+++|
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            5699999999999976 46899999988643 223456788999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCcccc
Q 046595          153 HDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA  232 (363)
Q Consensus       153 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~  232 (363)
                      .+++....          +++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus       105 ~~~~~~~~----------~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~  171 (292)
T cd06657         105 TDIVTHTR----------MNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  171 (292)
T ss_pred             HHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc
Confidence            99886433          78999999999999999999999   999999999999999999999999998765433221


Q ss_pred             cccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCC
Q 046595          233 RLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLN  312 (363)
Q Consensus       233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (363)
                        ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||............            .......+.
T Consensus       172 --~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~------------~~~~~~~~~  237 (292)
T cd06657         172 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI------------RDNLPPKLK  237 (292)
T ss_pred             --cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------------HhhCCcccC
Confidence              123356889999999998888999999999999999999999999753221111100            000000110


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          313 NDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                        .....+..+.+++.+||+.+|.+||++.++++
T Consensus       238 --~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         238 --NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             --CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence              11234556899999999999999999999988

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-39  Score=280.67  Aligned_cols=248  Identities=26%  Similarity=0.435  Sum_probs=203.4

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      +|.+.+.||+|++|.||++... +++.|++|.+...... .....+.+|++++++++|+|++++++++.+....+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4788899999999999999765 5889999998765422 2346788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|.+++....         .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ~~~~~L~~~~~~~~---------~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~  148 (254)
T cd06627          81 AENGSLRQIIKKFG---------PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATK  148 (254)
T ss_pred             CCCCcHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEecccccee
Confidence            99999999987643         289999999999999999999999   999999999999999999999999999876


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      .......  .....|+..|+|||.+.+..++.++||||||+++|+|++|..||........  ...  .        .  
T Consensus       149 ~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~--~~~--~--------~--  212 (254)
T cd06627         149 LNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA--LFR--I--------V--  212 (254)
T ss_pred             cCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH--HHH--H--------h--
Confidence            5443221  2335688899999999888899999999999999999999999974432110  000  0        0  


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                        .......+...+..+.+++.+||..+|++||++.+++.
T Consensus       213 --~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         213 --QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             --ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence              01112223345677999999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-39  Score=286.62  Aligned_cols=263  Identities=22%  Similarity=0.289  Sum_probs=201.2

Q ss_pred             CCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           70 FGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      |.+.+.||+|++|.||++... +++.+++|.+...... .....+..|+.++++++|+||+++++++......++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567788999999999999764 6889999998764432 33467888999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      .+ +|.+++.....        .+++..+..++.|++.||.|||++   +|+|+||||+||+++.++.++|+|||.+...
T Consensus        81 ~~-~l~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~  148 (283)
T cd05118          81 DT-DLYKLIKDRQR--------GLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSF  148 (283)
T ss_pred             CC-CHHHHHHhhcc--------cCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEec
Confidence            76 88888876421        389999999999999999999999   9999999999999999999999999988665


Q ss_pred             CcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      .....  ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+....................
T Consensus       149 ~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (283)
T cd05118         149 GSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKF  226 (283)
T ss_pred             CCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccc
Confidence            44321  12234578899999988776 7899999999999999999999999755432211111000000000000000


Q ss_pred             cC-------------CcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          307 VD-------------PKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       307 ~~-------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .+             ...........+.++.++|..||+.||.+||++.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            00             00001122346778999999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.9e-39  Score=288.57  Aligned_cols=268  Identities=21%  Similarity=0.286  Sum_probs=198.8

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEeCC----
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCMESN----  138 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----  138 (363)
                      ...++|++.+.||+|+||.||+|... +++.|++|++..... ......+.+|+.++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34568999999999999999999865 588999999875432 223356778999999999999999999887654    


Q ss_pred             ------eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC
Q 046595          139 ------NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD  212 (363)
Q Consensus       139 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~  212 (363)
                            ..++++||+.+ +|.+++....        ..+++..++.++.|++.||.|||+.   +|+|+||||+||++++
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~  151 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGL--------VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNN  151 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence                  78999999987 7777776432        1389999999999999999999999   9999999999999999


Q ss_pred             CCceEEeeeccCCCCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchh
Q 046595          213 DFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLV  291 (363)
Q Consensus       213 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~  291 (363)
                      ++.+||+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+
T Consensus       152 ~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~  230 (302)
T cd07864         152 KGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI  230 (302)
T ss_pred             CCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            999999999998765433221 1122346788999998865 35789999999999999999999999754332211111


Q ss_pred             hhccccccccccccc--------------cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          292 TWATPRLSEDKVKQC--------------VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       292 ~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ...............              ........ ....+..+.+++..||+.+|.+||++.+|++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHHhCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            100000000000000              00000000 1123567999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.2e-39  Score=284.91  Aligned_cols=245  Identities=23%  Similarity=0.323  Sum_probs=196.3

Q ss_pred             eeccCCceEEEEEeC-CCCeEEEEEccCCCCC--CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCCCh
Q 046595           76 IGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP--EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSL  152 (363)
Q Consensus        76 lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g~L  152 (363)
                      ||.|+||.||++... +++.+++|.+......  .....+.+|+.++++++|+||+++++.+......++++||+.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999876 4999999998654321  3346788899999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCcccc
Q 046595          153 HDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA  232 (363)
Q Consensus       153 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~  232 (363)
                      .+++....         .+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~l~~~~---------~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~  148 (265)
T cd05579          81 ASLLENVG---------SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQ  148 (265)
T ss_pred             HHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcc
Confidence            99997643         289999999999999999999999   999999999999999999999999999865433211


Q ss_pred             ------cccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          233 ------RLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       233 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                            ........++..|++||.+.+..++.++|+||||+++|+|++|..||...........               .
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~---------------~  213 (265)
T cd05579         149 INLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQN---------------I  213 (265)
T ss_pred             cccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---------------H
Confidence                  1112345678899999999888899999999999999999999999975432211100               0


Q ss_pred             cCCcCCCCCCHH--HHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 046595          307 VDPKLNNDYPPK--AIAKLAAVAALCVQYEADFRPNMTIVVKALQ  349 (363)
Q Consensus       307 ~~~~~~~~~~~~--~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~  349 (363)
                      ....  ...+..  .+..+.+++.+||+.+|++|||+..+.+.|+
T Consensus       214 ~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         214 LNGK--IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             hcCC--cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            0000  111122  3677999999999999999999966666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=9e-39  Score=288.50  Aligned_cols=255  Identities=20%  Similarity=0.286  Sum_probs=188.8

Q ss_pred             CCceEEEEEeC-CCCeEEEEEccCC-CCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCCChhhhhc
Q 046595           80 SYGRVFYAKLT-DGTPAAIKKLDTS-SAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLH  157 (363)
Q Consensus        80 ~~g~V~~~~~~-~~~~~avK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~  157 (363)
                      ++|.||.++.. +++.||+|++... ........+..|+.+++.++|+||+++++++.+.+..+++|||+.+++|.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            34445555432 6899999998764 233445789999999999999999999999999999999999999999999997


Q ss_pred             CCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCcccc-----
Q 046595          158 GRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA-----  232 (363)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~-----  232 (363)
                      .....       .+++..+..++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||.+........     
T Consensus        92 ~~~~~-------~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          92 THFPE-------GLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             Hhccc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            64321       278899999999999999999999   999999999999999999999999998764432111     


Q ss_pred             cccccccccccCCCCcccccc--CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc---ccc-c-------
Q 046595          233 RLHSTRVLGTFGYHAPEYAMT--GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT---PRL-S-------  299 (363)
Q Consensus       233 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~---~~~-~-------  299 (363)
                      ........++..|+|||++..  ..++.++|+||||+++|||++|..||........  ......   +.. .       
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  239 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLY  239 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhh
Confidence            111223457788999999875  3588999999999999999999999975432111  000000   000 0       


Q ss_pred             cccccc--------ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          300 EDKVKQ--------CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       300 ~~~~~~--------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ...+..        .................+.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            000000        00001111223355678999999999999999999999998

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=8.3e-39  Score=290.39  Aligned_cols=267  Identities=18%  Similarity=0.301  Sum_probs=195.4

Q ss_pred             eeecc--CCceEEEEEeC-CCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCC
Q 046595           75 LIGEG--SYGRVFYAKLT-DGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMG  150 (363)
Q Consensus        75 ~lg~G--~~g~V~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g  150 (363)
                      .||+|  +||+||++.+. +++.||+|.+...... ...+.+.+|+.+++.++||||+++++++......++|+||+.++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            46666  99999999764 7999999998764322 23467888999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCcc
Q 046595          151 SLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT  230 (363)
Q Consensus       151 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~  230 (363)
                      +|.+++......       .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||+.+......
T Consensus        85 ~l~~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~  154 (328)
T cd08226          85 SANSLLKTYFPE-------GMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRN  154 (328)
T ss_pred             CHHHHHHhhccc-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhcc
Confidence            999998764321       288999999999999999999999   9999999999999999999999999864322211


Q ss_pred             cccc-----cccccccccCCCCccccccC--CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc-ccc----
Q 046595          231 AARL-----HSTRVLGTFGYHAPEYAMTG--QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT-PRL----  298 (363)
Q Consensus       231 ~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~~----  298 (363)
                      ....     ......++..|+|||++.+.  .++.++|||||||++|+|++|..||.........  ..... +..    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~  232 (328)
T cd08226         155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLD  232 (328)
T ss_pred             CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCcc
Confidence            1100     01112346679999998764  4789999999999999999999999754321110  00000 000    


Q ss_pred             ----------------------ccccc-----ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhc
Q 046595          299 ----------------------SEDKV-----KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQ  349 (363)
Q Consensus       299 ----------------------~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~  349 (363)
                                            .....     .......+.......++..+.+++.+||+.||++|||+.++++  .++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~  312 (328)
T cd08226         233 ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK  312 (328)
T ss_pred             ccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHH
Confidence                                  00000     0001111122223456778999999999999999999999975  444


Q ss_pred             cccc
Q 046595          350 PLLN  353 (363)
Q Consensus       350 ~l~~  353 (363)
                      .+.+
T Consensus       313 ~~~~  316 (328)
T cd08226         313 QVKE  316 (328)
T ss_pred             HHHH
Confidence            4433

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.1e-39  Score=287.63  Aligned_cols=250  Identities=24%  Similarity=0.340  Sum_probs=204.1

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC--CCchHHHHHHHHHHhcCC-CCccceeeeEEEeCCeeEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA--PEPESDFAAQLSVVSRLK-HEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv  143 (363)
                      ++|.+.+.||+|+||.||++... ++..|++|++.....  ......+..|+.++++++ |+||+++++++......+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36889999999999999999765 689999999876332  223456788999999998 99999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.+++|.+++....         .+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+
T Consensus        81 ~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~  148 (280)
T cd05581          81 LEYAPNGELLQYIRKYG---------SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGT  148 (280)
T ss_pred             EcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCcc
Confidence            99999999999997654         389999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCccccc------------------ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCc
Q 046595          224 TNQSSDTAAR------------------LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPK  285 (363)
Q Consensus       224 a~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~  285 (363)
                      +.........                  .......|+..|+|||.+.+..++.++|+||||+++|++++|..||......
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  228 (280)
T cd05581         149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY  228 (280)
T ss_pred             ccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence            8765433211                  1123356789999999998888999999999999999999999999754321


Q ss_pred             cccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH----HHHHH
Q 046595          286 GQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNM----TIVVK  346 (363)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~----~~vl~  346 (363)
                      ...               ....  .....++...+..+.+++.+||+.+|.+||++    .+++.
T Consensus       229 ~~~---------------~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         229 LTF---------------QKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHH---------------HHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            100               0000  11123344557779999999999999999999    77764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-39  Score=285.39  Aligned_cols=264  Identities=20%  Similarity=0.297  Sum_probs=198.9

Q ss_pred             CCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC-CCCchHHHHHHHHHHhcCCCCccceeeeEEEeC--CeeEEEEe
Q 046595           70 FGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS-APEPESDFAAQLSVVSRLKHEHFVELLGYCMES--NNRILVYQ  145 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e  145 (363)
                      |.+.+.||+|++|.||+|... +++.+++|.+.... .......+.+|+.+++.++|+|++++++++...  ...++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567888999999999999865 58899999998754 223345788999999999999999999999888  88999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+ +|.+++....        ..+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.
T Consensus        81 ~~~~-~l~~~~~~~~--------~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~  148 (287)
T cd07840          81 YMDH-DLTGLLDSPE--------VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR  148 (287)
T ss_pred             cccc-cHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEcccccee
Confidence            9986 8988886542        1389999999999999999999999   99999999999999999999999999987


Q ss_pred             CCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      ........ ......++..|+|||.+.+ ..++.++||||||+++|||++|..||.........................
T Consensus       149 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (287)
T cd07840         149 PYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP  227 (287)
T ss_pred             eccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcc
Confidence            65443211 1223456889999998765 467899999999999999999999997554322111110000000000000


Q ss_pred             ---c-----------ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          305 ---Q-----------CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       305 ---~-----------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                         .           .....+...+...++..+.+++.+||+.+|++||++.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             ccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence               0           00000000111113667999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.8e-39  Score=287.82  Aligned_cols=252  Identities=24%  Similarity=0.395  Sum_probs=194.5

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCC-CCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-CCccceeeeEEEeCCeeEEEEe
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      ++|.+.+.||+|+||.||+|.+.+ ++.|+||.+...........+..|+.++.++. |+||+++++++.+....+++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            468899999999999999998764 88999999876544444456677777676664 9999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-cCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE-KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      |+.+ +|.+++.....        .+++..+..++.|++.||.|||+ .   +|+|+||+|+||++++++.+||+|||++
T Consensus        95 ~~~~-~l~~l~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~  162 (296)
T cd06618          95 LMST-CLDKLLKRIQG--------PIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGIS  162 (296)
T ss_pred             ccCc-CHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccc
Confidence            9865 77777754321        38899999999999999999997 5   8999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCccccccCC----CCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQ----ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE  300 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  300 (363)
                      ........   .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||....... ..+.......   
T Consensus       163 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~---  235 (296)
T cd06618         163 GRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVLTKILQEE---  235 (296)
T ss_pred             hhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HHHHHHhcCC---
Confidence            65433222   12335788999999987553    7899999999999999999999996432110 0000000000   


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          301 DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                             ....  .....++.++.+++.+||+.||++||++.++++.
T Consensus       236 -------~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         236 -------PPSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             -------CCCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                   0000  0111245679999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.5e-38  Score=280.27  Aligned_cols=249  Identities=19%  Similarity=0.269  Sum_probs=193.5

Q ss_pred             HHHHHHhcCCCCCCee--eccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEe
Q 046595           61 DELNRLTSNFGTKALI--GEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCME  136 (363)
Q Consensus        61 ~~~~~~~~~y~~~~~l--g~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~  136 (363)
                      .+.....++|.+.+.+  |+|+||.||++.. .++..+++|.+.......      .|+.....+ +|+||+++++.+..
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEec
Confidence            3445556678877776  9999999999975 468889999986532111      122222222 79999999999999


Q ss_pred             CCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC-c
Q 046595          137 SNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF-K  215 (363)
Q Consensus       137 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~  215 (363)
                      .+..++||||+++++|.+++....         .+++.++..++.|++.||.|||+.   +++|+||||+||+++.++ .
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~  148 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKEG---------KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDR  148 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCe
Confidence            999999999999999999997653         289999999999999999999999   999999999999999988 9


Q ss_pred             eEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 046595          216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       216 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      ++|+|||++......      ....|+..|+|||++.+..++.++|+||||+++|+|++|..||......... ...   
T Consensus       149 ~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~---  218 (267)
T PHA03390        149 IYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD-LES---  218 (267)
T ss_pred             EEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh-HHH---
Confidence            999999988654322      2346889999999999889999999999999999999999999744322110 000   


Q ss_pred             ccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 046595          296 PRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPN-MTIVVK  346 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~~vl~  346 (363)
                             +.....  .........+..+.+++.+||+.+|.+||+ ++++++
T Consensus       219 -------~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        219 -------LLKRQQ--KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             -------HHHhhc--ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                   000010  011223356778999999999999999995 688874

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-39  Score=294.24  Aligned_cols=271  Identities=23%  Similarity=0.321  Sum_probs=205.2

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEeCC-----eeE
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCMESN-----NRI  141 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~  141 (363)
                      +|.+.+.||.|++|.||+|... ++..+++|++..... ......+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5888999999999999999865 589999999876432 334567889999999999999999999988775     789


Q ss_pred             EEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeee
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADF  221 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df  221 (363)
                      ++|+|+.+ +|.+++....         .+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.++|+||
T Consensus        81 lv~e~~~~-~l~~~l~~~~---------~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~df  147 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQ---------PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDF  147 (330)
T ss_pred             EEecchhh-hHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccc
Confidence            99999985 8988887543         389999999999999999999999   9999999999999999999999999


Q ss_pred             ccCCCCCccccc-ccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccc--
Q 046595          222 NLTNQSSDTAAR-LHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR--  297 (363)
Q Consensus       222 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~--  297 (363)
                      |++......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+.-....  
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  227 (330)
T cd07834         148 GLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS  227 (330)
T ss_pred             CceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCC
Confidence            998765443210 112345678999999999887 8999999999999999999999999755432111111000000  


Q ss_pred             ------ccccccccccCC-cCC-----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhcccc
Q 046595          298 ------LSEDKVKQCVDP-KLN-----NDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPLL  352 (363)
Q Consensus       298 ------~~~~~~~~~~~~-~~~-----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l~  352 (363)
                            .........+.. ...     .......+..+.+++..||+.+|++||++.+++.  .++.+.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence                  000001111000 000     0111234677999999999999999999999997  354433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.4e-38  Score=282.15  Aligned_cols=242  Identities=24%  Similarity=0.318  Sum_probs=188.6

Q ss_pred             eeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCc--hHHHHHHH---HHHhcCCCCccceeeeEEEeCCeeEEEEeccc
Q 046595           75 LIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEP--ESDFAAQL---SVVSRLKHEHFVELLGYCMESNNRILVYQFAT  148 (363)
Q Consensus        75 ~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~--~~~~~~e~---~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  148 (363)
                      +||+|+||.||++... +++.||+|.+........  ...+..|.   ..++...||+|+.+++++......++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999754 588999999876432211  12233333   34455689999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCC
Q 046595          149 MGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS  228 (363)
Q Consensus       149 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~  228 (363)
                      +++|..++....         .+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++....
T Consensus        81 g~~L~~~l~~~~---------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~  148 (278)
T cd05606          81 GGDLHYHLSQHG---------VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS  148 (278)
T ss_pred             CCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence            999999886543         389999999999999999999999   99999999999999999999999999986543


Q ss_pred             cccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccccc
Q 046595          229 DTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCV  307 (363)
Q Consensus       229 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (363)
                      ...    .....|+..|+|||.+.++ .++.++||||+|+++|+|++|+.||............ .         ..   
T Consensus       149 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-~---------~~---  211 (278)
T cd05606         149 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-R---------MT---  211 (278)
T ss_pred             ccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-H---------Hh---
Confidence            321    2234689999999998754 6899999999999999999999999754322111100 0         00   


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046595          308 DPKLNNDYPPKAIAKLAAVAALCVQYEADFRP-----NMTIVVK  346 (363)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  346 (363)
                       ......++...+..+.+++.+||..+|.+||     ++.++++
T Consensus       212 -~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         212 -LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             -hccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence             0011222334467799999999999999999     9999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-39  Score=283.47  Aligned_cols=275  Identities=24%  Similarity=0.360  Sum_probs=212.5

Q ss_pred             HHHHhcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcC--CCCccceeeeEEEeCC--
Q 046595           63 LNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL--KHEHFVELLGYCMESN--  138 (363)
Q Consensus        63 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~~--  138 (363)
                      ..++.++..+.+.||+|.||.||+|+|+ |+.||||++..    ..+..+.+|.++++..  +|+||+.+++.-..+.  
T Consensus       206 QRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs  280 (513)
T KOG2052|consen  206 QRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGS  280 (513)
T ss_pred             HHhhhheeEEEEEecCccccceeecccc-CCceEEEEecc----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence            3456778899999999999999999997 89999999865    3456788999988864  9999999998755443  


Q ss_pred             --eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcc-----CCCCeEEecccCCceeec
Q 046595          139 --NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK-----VQPPIVHRDVRSSNVLLF  211 (363)
Q Consensus       139 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-----~~~~ivH~Dlkp~Nill~  211 (363)
                        .++||++|.+.|+|+|||....          ++....++++..++.||++||..     +++.|.|||||..|||+.
T Consensus       281 ~TQLwLvTdYHe~GSL~DyL~r~t----------v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK  350 (513)
T KOG2052|consen  281 WTQLWLVTDYHEHGSLYDYLNRNT----------VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK  350 (513)
T ss_pred             eEEEEEeeecccCCcHHHHHhhcc----------CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc
Confidence              5789999999999999998764          99999999999999999999965     366899999999999999


Q ss_pred             CCCceEEeeeccCCCCCcc--cccccccccccccCCCCccccccC------CCCccCceehhHHHHHHHHhCCCCCCCCC
Q 046595          212 DDFKSKIADFNLTNQSSDT--AARLHSTRVLGTFGYHAPEYAMTG------QITQKSDVYSFGVVLLELLTGRKPVDHTM  283 (363)
Q Consensus       212 ~~~~vkl~Dfg~a~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~ell~g~~p~~~~~  283 (363)
                      .+|...|+|+|||......  ......+..+||.+|||||++...      .--..+||||||+++||+...-.- .+..
T Consensus       351 kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~-ggi~  429 (513)
T KOG2052|consen  351 KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCES-GGIV  429 (513)
T ss_pred             cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhc-CCEe
Confidence            9999999999998654332  222334567899999999998643      122468999999999999873110 0111


Q ss_pred             Cccccchhhhcccccccccccccc-CCcCCCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccc
Q 046595          284 PKGQQSLVTWATPRLSEDKVKQCV-DPKLNNDYP-----PKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN  353 (363)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~  353 (363)
                      ..-+..+++++....+.+++++.+ .++++...|     .++...+.++++.||..||..|-|+--|.+.|.++.+
T Consensus       430 eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  430 EEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             hhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            111222233444444444554443 333444333     3667789999999999999999999999999999886

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-38  Score=281.09  Aligned_cols=263  Identities=24%  Similarity=0.340  Sum_probs=196.1

Q ss_pred             CCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCc-hHHHHHHHHHHhcC---CCCccceeeeEEEeCCe-----
Q 046595           70 FGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEP-ESDFAAQLSVVSRL---KHEHFVELLGYCMESNN-----  139 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~-~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~-----  139 (363)
                      |++.+.||+|+||.||++.+. ++..+++|.+........ ...+.+|+.+++++   +|+||+++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            667889999999999999876 489999999975433222 24566777776665   69999999999988776     


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEe
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA  219 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~  219 (363)
                      .+++|||+.+ +|.+++.....       ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~-------~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~  149 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPK-------PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIA  149 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEe
Confidence            8999999975 89988865432       1388999999999999999999999   99999999999999999999999


Q ss_pred             eeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhh-hcc-c-
Q 046595          220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT-WAT-P-  296 (363)
Q Consensus       220 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~-~~~-~-  296 (363)
                      |||++........   .....++..|+|||.+.+..++.++|+||||+++|+|++|..||......+....+. ... + 
T Consensus       150 dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (287)
T cd07838         150 DFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPS  226 (287)
T ss_pred             ccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCC
Confidence            9999866533221   123457889999999998899999999999999999999999997543322111000 000 0 


Q ss_pred             --cccccc--cccccCCcCC---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          297 --RLSEDK--VKQCVDPKLN---NDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       297 --~~~~~~--~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                        .+....  ..........   .......+..+.+++.+||+.||++||++.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence              000000  0000000000   1112345677899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.3e-39  Score=285.93  Aligned_cols=257  Identities=22%  Similarity=0.289  Sum_probs=200.6

Q ss_pred             CCCCCCeeeccCCceEEEEEe----CCCCeEEEEEccCCCC---CCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCee
Q 046595           69 NFGTKALIGEGSYGRVFYAKL----TDGTPAAIKKLDTSSA---PEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNR  140 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~----~~~~~~avK~~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  140 (363)
                      +|.+.+.||+|++|.||++..    .+++.|++|++.....   ......+..|+.++.++ +|+||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            377888999999999999864    3578899999865321   22235678899999999 599999999999999999


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEee
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD  220 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D  220 (363)
                      ++||||+.+++|.+++....         .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~d  148 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE---------HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTD  148 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC---------CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEE
Confidence            99999999999999987543         288999999999999999999999   999999999999999999999999


Q ss_pred             eccCCCCCcccccccccccccccCCCCccccccCC--CCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 046595          221 FNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQ--ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL  298 (363)
Q Consensus       221 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  298 (363)
                      ||++......... ......|+..|+|||.+.+..  .+.++|+||||+++|+|++|..||...........  .     
T Consensus       149 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~--~-----  220 (288)
T cd05583         149 FGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSE--I-----  220 (288)
T ss_pred             Ccccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHH--H-----
Confidence            9998664433211 122346889999999987654  78899999999999999999999964322111000  0     


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 046595          299 SEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL  351 (363)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l  351 (363)
                      .    .....  .....+...+..+.+++.+||+.||++|||+.++.+.|+..
T Consensus       221 ~----~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         221 S----RRILK--SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             H----HHHHc--cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence            0    00000  01122334556789999999999999999998888777644

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.2e-38  Score=284.48  Aligned_cols=252  Identities=22%  Similarity=0.317  Sum_probs=197.3

Q ss_pred             CCCCCCeeeccCCceEEEEEe----CCCCeEEEEEccCCCC---CCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCee
Q 046595           69 NFGTKALIGEGSYGRVFYAKL----TDGTPAAIKKLDTSSA---PEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNR  140 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~----~~~~~~avK~~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  140 (363)
                      +|++.+.||.|+||.||.++.    .+|+.||+|++.....   ......+.+|+.+++++ +|+||+.+++.+......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            478889999999999999975    3688999999865321   22235678899999999 599999999999998999


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEee
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD  220 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D  220 (363)
                      ++|+||+.+++|.+++....         .+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.+||+|
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~d  148 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE---------RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTD  148 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEee
Confidence            99999999999999997543         278899999999999999999999   999999999999999999999999


Q ss_pred             eccCCCCCcccccccccccccccCCCCccccccC--CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 046595          221 FNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG--QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL  298 (363)
Q Consensus       221 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  298 (363)
                      ||++......... ......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||..........  .+     
T Consensus       149 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~--~~-----  220 (290)
T cd05613         149 FGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA--EI-----  220 (290)
T ss_pred             Cccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHH--HH-----
Confidence            9998764332211 12235688999999988753  47889999999999999999999996432211100  00     


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046595          299 SEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP-----NMTIVVK  346 (363)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  346 (363)
                           ...... ....++...+..+.+++.+||+.||++||     +..+++.
T Consensus       221 -----~~~~~~-~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         221 -----SRRILK-SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             -----HHHhhc-cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                 000000 01122344567799999999999999997     7777766

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.1e-40  Score=275.92  Aligned_cols=206  Identities=24%  Similarity=0.394  Sum_probs=176.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-C--C--CCeEEEEEccCCCCCCch-HHHHHHHHHHhcCCCCccceeeeEEEe-CCee
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-T--D--GTPAAIKKLDTSSAPEPE-SDFAAQLSVVSRLKHEHFVELLGYCME-SNNR  140 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-~--~--~~~~avK~~~~~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~  140 (363)
                      ..|+..+.||+|.||.||+|.- .  +  +..+|+|+++...+.... ...-+|+.+++.++||||+.+..++.+ +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            3699999999999999999942 2  2  336899999876554443 567899999999999999999998877 7889


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCC----Cce
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD----FKS  216 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~----~~v  216 (363)
                      +|++||.+. +|+..|+..+....    ..++...+..|+.||++|+.|||++   =|+||||||.|||+..+    |.|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~----~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~V  175 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKA----KQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRV  175 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchh----ccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCee
Confidence            999999998 99999987654322    3589999999999999999999999   79999999999999877    999


Q ss_pred             EEeeeccCCCCCcccccc-cccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCC
Q 046595          217 KIADFNLTNQSSDTAARL-HSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDH  281 (363)
Q Consensus       217 kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~  281 (363)
                      ||+|||+++.+....... ..+..+-|.+|.|||.+.|. .|+.+.||||+||++.||++-++-|..
T Consensus       176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            999999999887765543 34556789999999999875 699999999999999999998888864

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-39  Score=311.15  Aligned_cols=267  Identities=27%  Similarity=0.437  Sum_probs=219.2

Q ss_pred             CCCCCCeeeccCCceEEEEEeC----C----CCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCe
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT----D----GTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNN  139 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~----~----~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~  139 (363)
                      +..+.+.||+|.||.|++|...    .    ...||||.++..........+..|+++|+.+ .|+||+.+++.|.....
T Consensus       297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~  376 (609)
T KOG0200|consen  297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP  376 (609)
T ss_pred             hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence            4456668999999999999632    1    4568999998877776778999999999999 59999999999999999


Q ss_pred             eEEEEecccCCChhhhhcCCC-CCCCCCCC------CCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC
Q 046595          140 RILVYQFATMGSLHDVLHGRK-GVQGAEPG------PVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD  212 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~  212 (363)
                      .++|+||+..|+|.++++..+ .......+      ..++..+++.++.||+.|++||++.   ++|||||-.+|||+..
T Consensus       377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~  453 (609)
T KOG0200|consen  377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITK  453 (609)
T ss_pred             eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecC
Confidence            999999999999999998877 11111111      2489999999999999999999999   9999999999999999


Q ss_pred             CCceEEeeeccCCCCCcccccc-cccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccch
Q 046595          213 DFKSKIADFNLTNQSSDTAARL-HSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSL  290 (363)
Q Consensus       213 ~~~vkl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~  290 (363)
                      +..+||+|||+|+......... ..+...-...|||||.+....|+.++||||||++||||++ |..||.+...      
T Consensus       454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~------  527 (609)
T KOG0200|consen  454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP------  527 (609)
T ss_pred             CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc------
Confidence            9999999999998544432221 1111112456999999999999999999999999999999 8899864210      


Q ss_pred             hhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccc
Q 046595          291 VTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN  353 (363)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~  353 (363)
                               ...+.+.+..+.+...|..+..++.++++.||+.+|++||++.++.+.|...+.
T Consensus       528 ---------~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  528 ---------TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             ---------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence                     222334566677778888999999999999999999999999999999998654

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-40  Score=305.12  Aligned_cols=257  Identities=26%  Similarity=0.426  Sum_probs=224.5

Q ss_pred             CCCCCeeeccCCceEEEEEeC-C----CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           70 FGTKALIGEGSYGRVFYAKLT-D----GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~~-~----~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      .+..++||+|+||+||+|.|- .    .-+||+|++........-..+.+|+.+|..++|||++++++++.... .-||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            445778999999999999653 3    44689999988777777789999999999999999999999998765 77999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      +|+++|+|.++++..+.        .+..+..+.|.+||++|+.|||.+   .++||||-.+|||+.....|||+|||++
T Consensus       777 q~mP~G~LlDyvr~hr~--------~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla  845 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRD--------NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLA  845 (1177)
T ss_pred             HhcccchHHHHHHHhhc--------cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchh
Confidence            99999999999987664        388899999999999999999999   9999999999999999999999999999


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      +...............-.+.|||-|.+....|+.++|||||||++||++| |..|++..                +-+++
T Consensus       846 ~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi----------------~~~eI  909 (1177)
T KOG1025|consen  846 KLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI----------------PAEEI  909 (1177)
T ss_pred             hccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC----------------CHHHh
Confidence            88776655544444445678999999999999999999999999999999 99998743                44567


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                      .++++.+.+...|+.++.++..++.+||..|+..||+++++...+....++
T Consensus       910 ~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  910 PDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             hHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence            777777777888999999999999999999999999999999988876654

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.2e-38  Score=290.19  Aligned_cols=267  Identities=25%  Similarity=0.284  Sum_probs=197.2

Q ss_pred             hcCCCC-CCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCc-------------hHHHHHHHHHHhcCCCCccceee
Q 046595           67 TSNFGT-KALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEP-------------ESDFAAQLSVVSRLKHEHFVELL  131 (363)
Q Consensus        67 ~~~y~~-~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~-------------~~~~~~e~~~l~~l~h~~i~~~~  131 (363)
                      .++|.. .+.||.|+||.||+|... +++.||+|++........             ...+.+|+.+++.++|+||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            456764 577999999999999754 689999999865432220             12467899999999999999999


Q ss_pred             eEEEeCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec
Q 046595          132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF  211 (363)
Q Consensus       132 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~  211 (363)
                      +++...+..+++|||+.+ +|.+++....         .+++..+..++.|++.||.|||+.   +++|+||+|+||+++
T Consensus        87 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~---------~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~  153 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMAS-DLKKVVDRKI---------RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFIN  153 (335)
T ss_pred             EEEecCCcEEEEEecccc-CHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEEC
Confidence            999999999999999975 9999986543         288999999999999999999999   999999999999999


Q ss_pred             CCCceEEeeeccCCCCCccc------------ccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCC
Q 046595          212 DDFKSKIADFNLTNQSSDTA------------ARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKP  278 (363)
Q Consensus       212 ~~~~vkl~Dfg~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p  278 (363)
                      .++.++|+|||++.......            .........++..|+|||.+.+. .++.++|+||||+++|+|++|..|
T Consensus       154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p  233 (335)
T PTZ00024        154 SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL  233 (335)
T ss_pred             CCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            99999999999986554111            01111223568899999988764 478999999999999999999999


Q ss_pred             CCCCCCccccchhhhccccccccccccc--------cCCcCC---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          279 VDHTMPKGQQSLVTWATPRLSEDKVKQC--------VDPKLN---NDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      |....+......+...............        ......   .......+..+.+++.+||+.+|++||++.+++.
T Consensus       234 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        234 FPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            9755432211111000000000000000        000000   0011233567899999999999999999999997

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-38  Score=282.06  Aligned_cols=263  Identities=21%  Similarity=0.313  Sum_probs=197.5

Q ss_pred             CCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-CCccceeeeEEEeCCeeEEEEecc
Q 046595           70 FGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      |.+.+.||+|++|.||+|... +++.|++|++.............+|+..+++++ |+||+++++++......++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            667889999999999999875 578899999876443333345567899999998 999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                       +++|.+++.....       ..+++..++.++.|++.+|.|||++   +++|+||+|+||++++++.++|+|||++...
T Consensus        81 -~~~l~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~  149 (283)
T cd07830          81 -EGNLYQLMKDRKG-------KPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREI  149 (283)
T ss_pred             -CCCHHHHHHhccc-------ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceec
Confidence             7799998876431       1389999999999999999999999   9999999999999999999999999998654


Q ss_pred             CcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhh-hccc---------
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT-WATP---------  296 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~-~~~~---------  296 (363)
                      .....   .....|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||......+...... +...         
T Consensus       150 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (283)
T cd07830         150 RSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG  226 (283)
T ss_pred             cCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhH
Confidence            43221   233567889999998754 468999999999999999999999996554322211110 0000         


Q ss_pred             cccccccccccCCcCC---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          297 RLSEDKVKQCVDPKLN---NDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       297 ~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ......+...+.....   .......+..+.+++.+||+.+|++||++.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         227 YKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            0000000000000000   0001112467999999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.2e-39  Score=294.69  Aligned_cols=265  Identities=21%  Similarity=0.298  Sum_probs=195.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeC--------
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMES--------  137 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------  137 (363)
                      .++|.+.+.||.|+||.||+|... ++..|++|.+..... .....+.+|+.+++.++||||+++++++...        
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            468999999999999999999754 688999999866433 4456788999999999999999999766543        


Q ss_pred             ------CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec
Q 046595          138 ------NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF  211 (363)
Q Consensus       138 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~  211 (363)
                            ...++||||+.+ +|.+++....          +++..+..++.|++.||.|||+.   +|+||||||+||+++
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~----------l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~  148 (342)
T cd07854          83 GSLTELNSVYIVQEYMET-DLANVLEQGP----------LSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFIN  148 (342)
T ss_pred             ccccccceEEEEeecccc-cHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEc
Confidence                  357899999975 8988886432          88999999999999999999999   999999999999997


Q ss_pred             -CCCceEEeeeccCCCCCcccccc-cccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCcccc
Q 046595          212 -DDFKSKIADFNLTNQSSDTAARL-HSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ  288 (363)
Q Consensus       212 -~~~~vkl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~  288 (363)
                       +++.++|+|||++.......... ......|+..|+|||.+.. ..++.++|||||||++|+|++|+.||....+....
T Consensus       149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~  228 (342)
T cd07854         149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM  228 (342)
T ss_pred             CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence             55678999999986543321111 1122357889999998754 56889999999999999999999999755432211


Q ss_pred             chhhhcccccccccccc-------ccC-CcCCC-----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          289 SLVTWATPRLSEDKVKQ-------CVD-PKLNN-----DYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       289 ~~~~~~~~~~~~~~~~~-------~~~-~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .......+.........       ... .....     ......+.++.+++.+||+.||++|||+.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         229 QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            11111000000000000       000 00000     011234567889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=281.21  Aligned_cols=242  Identities=24%  Similarity=0.303  Sum_probs=200.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      .+|..+.+||+|+||.|.++.-+ +.+.+|||++++..  ..+..+.-..|..+|... +-|.++++...+...+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            47888999999999999999644 57889999998753  223334455677777766 468899999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.||+|.-.|++.+.         +.+..++.++..|+-||-|||++   ||++||||.+||+++.+|++||+|||+
T Consensus       429 MEyvnGGDLMyhiQQ~Gk---------FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGm  496 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGK---------FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGM  496 (683)
T ss_pred             EEEecCchhhhHHHHhcc---------cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccc
Confidence            999999999999987664         78888899999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      ++.-....  .....++|||.|+|||++...+|+.++|.||+||+||||+.|+.||++.+....-.              
T Consensus       497 cKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~--------------  560 (683)
T KOG0696|consen  497 CKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ--------------  560 (683)
T ss_pred             ccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH--------------
Confidence            87543332  23567899999999999999999999999999999999999999998654322111              


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCC
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPN  340 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs  340 (363)
                       .+.+  -...+|...+.+...+....|..+|.+|..
T Consensus       561 -aI~e--hnvsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  561 -AIME--HNVSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             -HHHH--ccCcCcccccHHHHHHHHHHhhcCCccccC
Confidence             1111  124567788888999999999999999853

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-39  Score=251.06  Aligned_cols=264  Identities=22%  Similarity=0.289  Sum_probs=211.7

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCch-HHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPE-SDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      +|...+.||+|.+|+||+++.+ +++.||+|.++...+.+.. ....+|+-+++.+.|.||++++++.-.+..+.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4566678999999999999865 5889999999886655544 6788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      |.. +|..+......        .++...+..+..|+++||.|+|++   +++|||+||.|+||+.+|++||.|||+++.
T Consensus        83 cdq-dlkkyfdslng--------~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglara  150 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNG--------DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARA  150 (292)
T ss_pred             hhH-HHHHHHHhcCC--------cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhh
Confidence            987 89988876543        288999999999999999999999   999999999999999999999999999987


Q ss_pred             CCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccc---
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED---  301 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~---  301 (363)
                      +.-...  ..+..+-|.+|.+|.++.+. -|+.+.|+||.||++.|+.. |++-|.+.+..++...+.|.......+   
T Consensus       151 fgipvr--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wp  228 (292)
T KOG0662|consen  151 FGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWP  228 (292)
T ss_pred             cCCceE--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCC
Confidence            664432  23445679999999999876 58999999999999999998 566676666655555555544433332   


Q ss_pred             ccccccCCcCCCCCCH---------HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          302 KVKQCVDPKLNNDYPP---------KAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~---------~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .+.++-+-.....++.         .....=.+++++.+.-+|..|.+++..++
T Consensus       229 s~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  229 SMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             ccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            2333334333333332         33445678899999999999999998775

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.4e-39  Score=292.33  Aligned_cols=263  Identities=26%  Similarity=0.350  Sum_probs=197.0

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCC-chHHHHHHHHHHhcCCCCccceeeeEEEeCC----
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLGYCMESN----  138 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----  138 (363)
                      .+.++|.+.+.||+|+||.||++.. .++..||+|++....... ....+.+|+.+++.++|+||+++++++....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            4567899999999999999999974 478999999986533222 2356789999999999999999999887554    


Q ss_pred             --eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCce
Q 046595          139 --NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS  216 (363)
Q Consensus       139 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v  216 (363)
                        ..++||+|+ +++|.+++....          +++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~~~----------l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~  157 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKHEK----------LSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCEL  157 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCE
Confidence              358999998 669988886432          88999999999999999999999   99999999999999999999


Q ss_pred             EEeeeccCCCCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 046595          217 KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       217 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      +|+|||++......     .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.............-..
T Consensus       158 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~  232 (343)
T cd07880         158 KILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVT  232 (343)
T ss_pred             EEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            99999998754332     223467899999998876 468899999999999999999999997543211110000000


Q ss_pred             cc--------ccccccccccC--CcC----CCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          296 PR--------LSEDKVKQCVD--PKL----NNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       296 ~~--------~~~~~~~~~~~--~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ..        +..........  +..    .......++..+.+++.+|++.||++|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         233 GTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             CCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00        00000000000  000    00111234556899999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.8e-38  Score=285.68  Aligned_cols=251  Identities=25%  Similarity=0.373  Sum_probs=197.1

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      .|...+.||+|+||.||+|+.. ++..+++|.+....  .......+.+|+.+++.++|+|++++++++......++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            4677788999999999999864 57889999886432  22233567889999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+. |+|.+.+.....        .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.
T Consensus        96 ~~~-~~l~~~~~~~~~--------~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~  163 (308)
T cd06634          96 YCL-GSASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSAS  163 (308)
T ss_pred             ccC-CCHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccce
Confidence            997 488887753321        278999999999999999999999   99999999999999999999999999876


Q ss_pred             CCCcccccccccccccccCCCCccccc---cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAM---TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      ....      .....|+..|+|||.+.   ...++.++|||||||++|+|++|..||..........             
T Consensus       164 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-------------  224 (308)
T cd06634         164 IMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------------  224 (308)
T ss_pred             eecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH-------------
Confidence            5432      22346889999999874   3568889999999999999999999986432211100             


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccc
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL  352 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~  352 (363)
                        ...............+..+.++|.+||+.+|++||++.+++.....+.
T Consensus       225 --~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         225 --HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             --HHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence              000011111112345667999999999999999999999998654443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5.3e-38  Score=283.19  Aligned_cols=245  Identities=26%  Similarity=0.390  Sum_probs=193.9

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC--CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP--EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      .|...+.||+|+||.||+|+.. ++..|++|++......  .....+..|+.+++.++|+|++++++++.+....++|||
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  101 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME  101 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence            3666778999999999999754 6889999998654322  223567889999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+ +|.+++.....        .+++.+++.++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||++.
T Consensus       102 ~~~~-~l~~~l~~~~~--------~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~  169 (313)
T cd06633         102 YCLG-SASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSAS  169 (313)
T ss_pred             cCCC-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCc
Confidence            9965 88887754321        388999999999999999999999   99999999999999999999999999875


Q ss_pred             CCCcccccccccccccccCCCCccccc---cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAM---TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      ....      .....|+..|+|||++.   +..++.++||||||+++|+|++|..||.............          
T Consensus       170 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~----------  233 (313)
T cd06633         170 KSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----------  233 (313)
T ss_pred             ccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH----------
Confidence            4322      23456889999999874   4568899999999999999999999986543211111000          


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                           ............+..+.+++.+||+.+|.+||++.+++.
T Consensus       234 -----~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         234 -----QNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             -----hcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 000001111233456899999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.2e-38  Score=287.08  Aligned_cols=268  Identities=22%  Similarity=0.310  Sum_probs=195.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC-chHHHHHHHHHHhcCCCCccceeeeEEEeCC------
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLGYCMESN------  138 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------  138 (363)
                      .++|.+.+.||+|+||.||+|.+. +++.+++|++....... ....+.+|+++++.++|+||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            358999999999999999999764 68899999886543222 2346778999999999999999998875443      


Q ss_pred             --eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCce
Q 046595          139 --NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS  216 (363)
Q Consensus       139 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v  216 (363)
                        ..++|++|+.+ +|...+....        ..+++..+..++.|+++||.|||++   +++|+||||+||++++++.+
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~--------~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~  154 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPS--------VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGIL  154 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccc--------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence              46899999976 7777776432        1389999999999999999999999   99999999999999999999


Q ss_pred             EEeeeccCCCCCcccccc---------cccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCcc
Q 046595          217 KIADFNLTNQSSDTAARL---------HSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKG  286 (363)
Q Consensus       217 kl~Dfg~a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~  286 (363)
                      +|+|||++..........         ......|++.|+|||.+.+. .++.++||||||+++|||++|..||.......
T Consensus       155 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~  234 (311)
T cd07866         155 KIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID  234 (311)
T ss_pred             EECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999999987544322111         11234578899999987654 58899999999999999999999997544322


Q ss_pred             ccchhhhccccccc------cccccccCCcCCCCCC-------HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          287 QQSLVTWATPRLSE------DKVKQCVDPKLNNDYP-------PKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       287 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ....+.........      ..+....+.......+       ......+.+++.+||+.||++|||+.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            11111000000000      0000000000000011       122356899999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=7.4e-39  Score=290.43  Aligned_cols=264  Identities=22%  Similarity=0.330  Sum_probs=198.0

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEe-CCeeE
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCME-SNNRI  141 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~  141 (363)
                      .+..+|.+.+.||.|+||.||++... +++.|++|++..... ......+..|+.+++.++||||+++++++.. ....+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            45678999999999999999999754 799999998865332 2334677889999999999999999998865 56788


Q ss_pred             EEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeee
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADF  221 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df  221 (363)
                      +++||+. ++|.+++....          +++..+..++.|++.||.|||++   +|+|+||+|+||++++++.++|+||
T Consensus        87 lv~e~~~-~~L~~~~~~~~----------~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~df  152 (328)
T cd07856          87 FVTELLG-TDLHRLLTSRP----------LEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDF  152 (328)
T ss_pred             EEeehhc-cCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcc
Confidence            9999984 58988886543          78888899999999999999999   9999999999999999999999999


Q ss_pred             ccCCCCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchh-hhccc---
Q 046595          222 NLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLV-TWATP---  296 (363)
Q Consensus       222 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~-~~~~~---  296 (363)
                      |++......     .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||............ .....   
T Consensus       153 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~  227 (328)
T cd07856         153 GLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD  227 (328)
T ss_pred             ccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            998643221     123467889999998765 57899999999999999999999999654321111000 00000   


Q ss_pred             ----ccccccccccc-CCcCCCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          297 ----RLSEDKVKQCV-DPKLNNDYP-----PKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       297 ----~~~~~~~~~~~-~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                          ........... ........+     ...+..+.++|.+||+.+|++||++.+++..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                00000000000 000011111     1245679999999999999999999998764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.3e-38  Score=279.72  Aligned_cols=251  Identities=20%  Similarity=0.316  Sum_probs=195.7

Q ss_pred             CCCCCCeeeccCCceEEEEEeCC-CCeEEEEEccCCC----CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           69 NFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSS----APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~avK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      +|.+.+.||+|+||.||++.+.. +..+++|.++...    .......+..|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            58888999999999999997643 4445555554322    122234567789999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      +||+.+++|.+++......     ...+++..++.++.|++.||.|||+.   +++|+||+|+||++++ +.++|+|||+
T Consensus        81 ~e~~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~  151 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHT-----GKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGV  151 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhc-----ccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCc
Confidence            9999999999988643211     12389999999999999999999999   9999999999999975 5799999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      +.........  .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.......   ...           
T Consensus       152 ~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---~~~-----------  215 (260)
T cd08222         152 SRLLMGSCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS---VVL-----------  215 (260)
T ss_pred             eeecCCCccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHH-----------
Confidence            8655432221  233467889999999888889999999999999999999999996332110   000           


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                       . .........+..++.++.+++.+||+.+|++||++.++++
T Consensus       216 -~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         216 -R-IVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             -H-HHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence             0 0011122334566778999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.1e-39  Score=292.27  Aligned_cols=268  Identities=24%  Similarity=0.336  Sum_probs=198.6

Q ss_pred             HHHHHHhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEeC-
Q 046595           61 DELNRLTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCMES-  137 (363)
Q Consensus        61 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-  137 (363)
                      .++..+.++|.+.+.||+|+||.||++.. .+++.||+|++..... ......+.+|+.++++++|+||+++++++... 
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            44556778999999999999999999974 5789999999875322 22245678899999999999999999987643 


Q ss_pred             -----CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC
Q 046595          138 -----NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD  212 (363)
Q Consensus       138 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~  212 (363)
                           ...+++++++ +++|.+++....          +++..+..++.|++.||.|||++   +|+||||||+||+++.
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~  155 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE  155 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcC
Confidence                 3357777776 679988886543          88999999999999999999999   9999999999999999


Q ss_pred             CCceEEeeeccCCCCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchh
Q 046595          213 DFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLV  291 (363)
Q Consensus       213 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~  291 (363)
                      ++.+||+|||++......     .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||............
T Consensus       156 ~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~  230 (345)
T cd07877         156 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI  230 (345)
T ss_pred             CCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999998654322     233568899999998866 56889999999999999999999999644322111100


Q ss_pred             -hhcc-------cccccccc---ccccCCcCCCC---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          292 -TWAT-------PRLSEDKV---KQCVDPKLNND---YPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       292 -~~~~-------~~~~~~~~---~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                       ....       ........   ...........   .....+..+.++|..||+.||.+||++.+++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence             0000       00000000   00000000000   011235568999999999999999999999873

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-40  Score=314.96  Aligned_cols=255  Identities=21%  Similarity=0.259  Sum_probs=207.4

Q ss_pred             HHHHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCe
Q 046595           63 LNRLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNN  139 (363)
Q Consensus        63 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  139 (363)
                      +..-..+|.++++||+|+||.|.+++++ +++.||+|++.+-.  .......|+.|-.+|..-+.+=|+.+.-.|.+..+
T Consensus        70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~  149 (1317)
T KOG0612|consen   70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY  149 (1317)
T ss_pred             HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence            3334568999999999999999999875 58899999987622  11223578889999999999999999999999999


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEe
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA  219 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~  219 (363)
                      +||||||++||+|..++.+..         .+++.-+..++..|+.||.-||+.   |+|||||||+|||||..|++||+
T Consensus       150 LYlVMdY~pGGDlltLlSk~~---------~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLA  217 (1317)
T KOG0612|consen  150 LYLVMDYMPGGDLLTLLSKFD---------RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLA  217 (1317)
T ss_pred             eEEEEecccCchHHHHHhhcC---------CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeec
Confidence            999999999999999998875         289999999999999999999999   99999999999999999999999


Q ss_pred             eeccCCCCCcccccccccccccccCCCCccccc----c-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhc
Q 046595          220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM----T-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWA  294 (363)
Q Consensus       220 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~  294 (363)
                      |||.+-..... ........+|||.|.+||++.    + +.|+..+|.||+||++|||+.|..||....-...       
T Consensus       218 DFGsClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveT-------  289 (1317)
T KOG0612|consen  218 DFGSCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVET-------  289 (1317)
T ss_pred             cchhHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHH-------
Confidence            99987655432 223356678999999999985    3 5799999999999999999999999964432222       


Q ss_pred             cccccccccccccCCcCCCCCC--HHHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 046595          295 TPRLSEDKVKQCVDPKLNNDYP--PKAIAKLAAVAALCVQYEADFRPN---MTIVVK  346 (363)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~RPs---~~~vl~  346 (363)
                              +..+.+-.-...+|  ...+.+..+||+..+. +|+.|-.   +.++..
T Consensus       290 --------Y~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  290 --------YGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             --------HHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence                    22222222223444  4577889999998887 6778877   777764

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.9e-39  Score=291.44  Aligned_cols=269  Identities=23%  Similarity=0.333  Sum_probs=198.5

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEeCC----
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCMESN----  138 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----  138 (363)
                      .+..+|.+.+.||+|+||.||+|... +++.||+|++..... ......+.+|+.+++.++|+||+++++++....    
T Consensus        12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~   91 (342)
T cd07879          12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE   91 (342)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence            34578999999999999999999754 689999999875432 223356789999999999999999999886543    


Q ss_pred             --eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCce
Q 046595          139 --NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS  216 (363)
Q Consensus       139 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v  216 (363)
                        ..++|++|+.. +|..++..           .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+
T Consensus        92 ~~~~~lv~e~~~~-~l~~~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~  156 (342)
T cd07879          92 FQDFYLVMPYMQT-DLQKIMGH-----------PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCEL  156 (342)
T ss_pred             CceEEEEeccccc-CHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence              45899999865 77766532           288999999999999999999999   99999999999999999999


Q ss_pred             EEeeeccCCCCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 046595          217 KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       217 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      +|+|||++......     .....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||................
T Consensus       157 kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~  231 (342)
T cd07879         157 KILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT  231 (342)
T ss_pred             EEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            99999998654321     223467889999998876 468999999999999999999999997543221111110000


Q ss_pred             cccccc--------ccccccC---CcCCCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhccccc
Q 046595          296 PRLSED--------KVKQCVD---PKLNNDY---PPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPLLN  353 (363)
Q Consensus       296 ~~~~~~--------~~~~~~~---~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l~~  353 (363)
                      +.....        .......   .......   .+..+..+.+++..||+.||.+||++.+++.  .++.+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         232 GVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             CCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            000000        0000000   0000000   0123456899999999999999999999995  4665543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-39  Score=270.89  Aligned_cols=255  Identities=22%  Similarity=0.352  Sum_probs=200.7

Q ss_pred             CeeeccCCceEEEEE-eCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-CCccceeeeEEEeCCeeEEEEecccCCC
Q 046595           74 ALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVELLGYCMESNNRILVYQFATMGS  151 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~g~  151 (363)
                      +.||+|+++.|--|. ..+|..||||++.+. ......++.+|++++...+ |+||++++++|+++.++|||||-+.||+
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            469999999999985 668999999999875 3345678999999999984 9999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC---ceEEeeeccCCCCC
Q 046595          152 LHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF---KSKIADFNLTNQSS  228 (363)
Q Consensus       152 L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~---~vkl~Dfg~a~~~~  228 (363)
                      |...|.+++.         |++.++-++..+|+.||.|||.+   ||.||||||+|||.....   -||||||.+..-..
T Consensus       163 lLshI~~~~~---------F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k  230 (463)
T KOG0607|consen  163 LLSHIQKRKH---------FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIK  230 (463)
T ss_pred             HHHHHHHhhh---------ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccc
Confidence            9999988774         99999999999999999999999   999999999999997654   47999998864221


Q ss_pred             c-----ccccccccccccccCCCCccccc---c--CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 046595          229 D-----TAARLHSTRVLGTFGYHAPEYAM---T--GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL  298 (363)
Q Consensus       229 ~-----~~~~~~~~~~~gt~~y~aPE~~~---~--~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  298 (363)
                      .     ..........+|+..|||||++.   +  ..|+.+.|+|||||+||-||+|..||.+....+..    |.....
T Consensus       231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG----WdrGe~  306 (463)
T KOG0607|consen  231 LNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG----WDRGEV  306 (463)
T ss_pred             cCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC----ccCCCc
Confidence            1     11111223467999999999764   2  36899999999999999999999999876554322    222111


Q ss_pred             c---ccccccccCCcCCCCCCH----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          299 S---EDKVKQCVDPKLNNDYPP----KAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       299 ~---~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .   ..++.+.+..+. -++|.    ..+.+..+++..+|..|+.+|-++.+++.
T Consensus       307 Cr~CQ~~LFesIQEGk-YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  307 CRVCQNKLFESIQEGK-YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             cHHHHHHHHHHHhccC-CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            1   112222222222 23343    35677889999999999999999999887

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.3e-38  Score=287.98  Aligned_cols=265  Identities=21%  Similarity=0.274  Sum_probs=192.3

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-C--CCeEEEEEccCCCCC-CchHHHHHHHHHHhcC-CCCccceeeeEEEeC----Ce
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-D--GTPAAIKKLDTSSAP-EPESDFAAQLSVVSRL-KHEHFVELLGYCMES----NN  139 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~--~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~----~~  139 (363)
                      +|++.+.||+|+||.||+++.. +  +..||+|++...... .....+.+|+.+++++ +|+||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4788889999999999999764 3  778999998653322 2345678899999999 599999999875432    45


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEe
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA  219 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~  219 (363)
                      .+++++|+. ++|.+++....         .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~  147 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ---------PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKIC  147 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeC
Confidence            678888886 58999886543         388999999999999999999999   99999999999999999999999


Q ss_pred             eeccCCCCCccccc--ccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccc
Q 046595          220 DFNLTNQSSDTAAR--LHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATP  296 (363)
Q Consensus       220 Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~  296 (363)
                      |||++.........  .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||.................
T Consensus       148 Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  227 (332)
T cd07857         148 DFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG  227 (332)
T ss_pred             cCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC
Confidence            99998754432211  11233568999999998765 4689999999999999999999999975432111100000000


Q ss_pred             cccccccccc-----------cCCcCCC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          297 RLSEDKVKQC-----------VDPKLNN---DYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       297 ~~~~~~~~~~-----------~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ......+..+           .......   ......+..+.+++.+||+.||.+|||+.+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         228 TPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             CCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000000           0000000   001123567999999999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=290.02  Aligned_cols=240  Identities=19%  Similarity=0.286  Sum_probs=196.2

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      +...|.+...+|.|+|+.|-.+.. .+++..++|++.....     ...+|+.++... +||||+++.+.+.+..+.|+|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v  394 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV  394 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc-----ccccccchhhhhcCCCcceeecceecCCceeeee
Confidence            356788888899999999999965 4688899999977522     234566555555 799999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceee-cCCCceEEeeec
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFN  222 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill-~~~~~vkl~Dfg  222 (363)
                      ||.+.|+-|.+.+...+.         +. .++..|+.+|+.|+.|||++   |||||||||+|||+ ++.++++|+|||
T Consensus       395 ~e~l~g~ell~ri~~~~~---------~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG  461 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSKPE---------FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFG  461 (612)
T ss_pred             ehhccccHHHHHHHhcch---------hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEec
Confidence            999999999888876552         33 77888999999999999999   99999999999999 699999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      .++.....     ....+-|..|+|||++....|++++|+||||++||+||+|+.||......               ..
T Consensus       462 ~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---------------~e  521 (612)
T KOG0603|consen  462 FWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---------------IE  521 (612)
T ss_pred             hhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---------------HH
Confidence            98776654     22345688999999999999999999999999999999999999744221               01


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      +..   ......+....+....+|+.+||+.||.+||++.++..
T Consensus       522 i~~---~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  522 IHT---RIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             HHH---hhcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            111   11112233566778999999999999999999999876

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8e-39  Score=292.17  Aligned_cols=263  Identities=23%  Similarity=0.349  Sum_probs=198.3

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC-CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCe---
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS-APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNN---  139 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---  139 (363)
                      .+.++|.+.+.||+|++|.||+|+.. ++..|++|++.... .......+.+|+.+++.++|+||+++.+++.....   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            35678999999999999999999865 58899999886532 22233567789999999999999999987766554   


Q ss_pred             ---eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCce
Q 046595          140 ---RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS  216 (363)
Q Consensus       140 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v  216 (363)
                         .++|+||+ +++|.+++....          +++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~~~----------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~  157 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKCQK----------LSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCEL  157 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCE
Confidence               89999998 559999987532          89999999999999999999999   99999999999999999999


Q ss_pred             EEeeeccCCCCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 046595          217 KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       217 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      +|+|||++......     .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.............-..
T Consensus       158 kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~  232 (343)
T cd07851         158 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLV  232 (343)
T ss_pred             EEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Confidence            99999998765432     233467889999998865 367899999999999999999999997543321111100000


Q ss_pred             c--------cccccccccc---cCCcCCCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          296 P--------RLSEDKVKQC---VDPKLNNDY---PPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       296 ~--------~~~~~~~~~~---~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .        ..........   ........+   ....+..+.+++.+||+.+|++|||+.+|++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            0        0000000000   000000011   1123567999999999999999999999986

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-38  Score=278.10  Aligned_cols=262  Identities=24%  Similarity=0.361  Sum_probs=199.4

Q ss_pred             CCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           70 FGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      |++.+.||+|++|.||+|... +++.+++|.+..... ......+..|+.+++.++|+||+++++++......++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566788999999999999765 589999999987542 223467788999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      .+ +|.+++....        ..+++..+..++.|++.||.|||++   +|+|+||+|+||++++++.++|+|||++...
T Consensus        81 ~~-~l~~~i~~~~--------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~  148 (282)
T cd07829          81 DM-DLKKYLDKRP--------GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAF  148 (282)
T ss_pred             Cc-CHHHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCccccc
Confidence            85 9999997652        1289999999999999999999999   9999999999999999999999999998765


Q ss_pred             CcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhh----------hccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT----------WATP  296 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~----------~~~~  296 (363)
                      .....  ......++..|+|||.+.+. .++.++||||||+++|||++|..||.............          |...
T Consensus       149 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (282)
T cd07829         149 GIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV  226 (282)
T ss_pred             CCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhh
Confidence            43322  12234567889999998766 88999999999999999999999997543221110000          0000


Q ss_pred             -cc--cccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          297 -RL--SEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       297 -~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                       ..  ............. ....+..+..+.+++..||+.+|++||++.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         227 TKLPDYKPTFPKFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccccccccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence             00  0000000000000 0111123667999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-40  Score=292.84  Aligned_cols=242  Identities=20%  Similarity=0.292  Sum_probs=207.7

Q ss_pred             CCCCCCeeeccCCceEEEEEeCCCC-eEEEEEccCCCCCC--chHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           69 NFGTKALIGEGSYGRVFYAKLTDGT-PAAIKKLDTSSAPE--PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~avK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      +++.+..||-|+||.|=+++..... .+|+|.+++....+  ..+.+..|..+|..++.|+||++|-.+.+..+.||+||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            4566778999999999999765433 48888887765433  44678889999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      -|-||.|+..+++++.         |+......++..+++|++|||++   |||+|||||+|++++.+|-+||.|||+|+
T Consensus       501 aClGGElWTiLrdRg~---------Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAK  568 (732)
T KOG0614|consen  501 ACLGGELWTILRDRGS---------FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAK  568 (732)
T ss_pred             hhcCchhhhhhhhcCC---------cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHH
Confidence            9999999999998874         88888899999999999999999   99999999999999999999999999998


Q ss_pred             CCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      .......   .-.++||+.|.|||++.+...+.++|.||||+++|||++|.+||...++.....++.....         
T Consensus       569 ki~~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid---------  636 (732)
T KOG0614|consen  569 KIGSGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID---------  636 (732)
T ss_pred             HhccCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh---------
Confidence            8766544   3468999999999999999999999999999999999999999998777655544321111         


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCC
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPN  340 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs  340 (363)
                            ...+|...+....++|++++..+|.+|..
T Consensus       637 ------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  637 ------KIEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ------hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence                  13456677778899999999999999976

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=270.13  Aligned_cols=250  Identities=20%  Similarity=0.279  Sum_probs=199.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l  142 (363)
                      .++|.++.+||+|+|+.|.+++++ +.+.||+|++++..  ..+...-.+.|..+.... +||.+|.+...+..+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            357999999999999999999854 68889999987653  333445667788887776 79999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      |.||++||+|.=.++..+.         +++..+..+...|+.||.|||++   ||++||||.+|+|++..|++||+|+|
T Consensus       329 vieyv~ggdlmfhmqrqrk---------lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdyg  396 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYG  396 (593)
T ss_pred             EEEEecCcceeeehhhhhc---------CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccc
Confidence            9999999999776665542         88999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCc-cccchhhhcccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPK-GQQSLVTWATPRLSED  301 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~-~~~~~~~~~~~~~~~~  301 (363)
                      +++.-.....  ..+.++|||.|.|||++.+..|+.++|.|+|||+++||+.|+.||+--... ......++.-+.+   
T Consensus       397 mcke~l~~gd--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi---  471 (593)
T KOG0695|consen  397 MCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI---  471 (593)
T ss_pred             hhhcCCCCCc--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH---
Confidence            9876443332  256789999999999999999999999999999999999999999732211 1111111111111   


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCC
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPN  340 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs  340 (363)
                           +++  +...|...+-....+++..|..||.+|..
T Consensus       472 -----lek--qiriprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  472 -----LEK--QIRIPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             -----hhh--cccccceeehhhHHHHHHhhcCCcHHhcC
Confidence                 111  12334555556778888999999999853

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-39  Score=275.05  Aligned_cols=265  Identities=17%  Similarity=0.273  Sum_probs=203.7

Q ss_pred             HHHhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-C-C----ccceeeeEEEe
Q 046595           64 NRLTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-H-E----HFVELLGYCME  136 (363)
Q Consensus        64 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-h-~----~i~~~~~~~~~  136 (363)
                      +.+..+|.+.+.+|+|.||.|..+-+ ..+..||+|+++...  ...+.-.-|+++++++. + |    -++++.+++..
T Consensus        85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy  162 (415)
T KOG0671|consen   85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD--KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY  162 (415)
T ss_pred             cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH--HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence            35578999999999999999999954 357899999997632  23345667899999993 2 2    37888888999


Q ss_pred             CCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC----
Q 046595          137 SNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD----  212 (363)
Q Consensus       137 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~----  212 (363)
                      .++.++|+|.+ |-++.+++..+...       +++...+..|++|++++++|||+.   +++|-||||+|||+.+    
T Consensus       163 rghiCivfell-G~S~~dFlk~N~y~-------~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~  231 (415)
T KOG0671|consen  163 RGHICIVFELL-GLSTFDFLKENNYI-------PFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYF  231 (415)
T ss_pred             cCceEEEEecc-ChhHHHHhccCCcc-------ccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceE
Confidence            99999999988 44999999876532       389999999999999999999999   9999999999999942    


Q ss_pred             ----------------CCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCC
Q 046595          213 ----------------DFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGR  276 (363)
Q Consensus       213 ----------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~  276 (363)
                                      +..|+|+|||.|......     .+..+-|..|.|||++.+-.++..+||||+||||+|+++|.
T Consensus       232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~  306 (415)
T KOG0671|consen  232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGE  306 (415)
T ss_pred             EEeccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccc
Confidence                            345899999998764433     35567899999999999999999999999999999999999


Q ss_pred             CCCCCCCCccccchhhhccccccccccccc-----cCCc-C-----------------------CCCCCHHHHHHHHHHH
Q 046595          277 KPVDHTMPKGQQSLVTWATPRLSEDKVKQC-----VDPK-L-----------------------NNDYPPKAIAKLAAVA  327 (363)
Q Consensus       277 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~-~-----------------------~~~~~~~~~~~l~~li  327 (363)
                      .-|...+...+..+.+-....+....+...     +..+ +                       ...........|.+|+
T Consensus       307 ~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl  386 (415)
T KOG0671|consen  307 TLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL  386 (415)
T ss_pred             eecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence            999866554443333322222222111111     0000 0                       0011124456799999


Q ss_pred             HhccCCCCCCCCCHHHHHH
Q 046595          328 ALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       328 ~~cl~~~p~~RPs~~~vl~  346 (363)
                      ++||..||.+|+|+.|++.
T Consensus       387 ~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  387 RRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHccCccccccHHHHhc
Confidence            9999999999999999986

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=272.02  Aligned_cols=237  Identities=24%  Similarity=0.315  Sum_probs=193.7

Q ss_pred             eeccCCceEEEEEeC-CCCeEEEEEccCCCCCC--chHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCCCh
Q 046595           76 IGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE--PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSL  152 (363)
Q Consensus        76 lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g~L  152 (363)
                      ||.|+||.||.+... +++.+++|.+.......  ....+..|+.+++.++|+||+++++.+......+++|||+.+++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999765 58899999987643322  346788999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCcccc
Q 046595          153 HDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA  232 (363)
Q Consensus       153 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~  232 (363)
                      .+++....         .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~  148 (250)
T cd05123          81 FSHLSKEG---------RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS  148 (250)
T ss_pred             HHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC
Confidence            99997653         288999999999999999999998   999999999999999999999999999865443211


Q ss_pred             cccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCC
Q 046595          233 RLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLN  312 (363)
Q Consensus       233 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (363)
                        ......++..|++||.+.+..++.++|+||||+++|+|++|..||......   ....            ....  ..
T Consensus       149 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~------------~~~~--~~  209 (250)
T cd05123         149 --RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EIYE------------KILK--DP  209 (250)
T ss_pred             --cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHH------------HHhc--CC
Confidence              123456888999999998888999999999999999999999999654321   1000            0000  11


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 046595          313 NDYPPKAIAKLAAVAALCVQYEADFRPNMTI  343 (363)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~  343 (363)
                      ..++...+..+.+++.+||..||++||++.+
T Consensus       210 ~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         210 LRFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            2233344677999999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=283.52  Aligned_cols=244  Identities=22%  Similarity=0.290  Sum_probs=197.3

Q ss_pred             CCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCc-hHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCC
Q 046595           73 KALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEP-ESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMG  150 (363)
Q Consensus        73 ~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g  150 (363)
                      .++||+|.||+||-|++ ++|+.||||++.+...+.. ...+..|+.||+.+.||.||.+...|+..+..+.|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            56899999999999975 4799999999988765443 467889999999999999999999999999999999999774


Q ss_pred             ChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec---CCCceEEeeeccCCCC
Q 046595          151 SLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQS  227 (363)
Q Consensus       151 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~---~~~~vkl~Dfg~a~~~  227 (363)
                      -|.-.|...+.        .+++..-..++.||+.||.|||.+   +|+|+||||+|||+.   ...++||||||+|+..
T Consensus       649 MLEMILSsEkg--------RL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiI  717 (888)
T KOG4236|consen  649 MLEMILSSEKG--------RLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARII  717 (888)
T ss_pred             HHHHHHHhhcc--------cchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeec
Confidence            44444444332        388898999999999999999999   999999999999996   4468999999999987


Q ss_pred             CcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccc-cchhhhccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQ-QSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  306 (363)
                      .....+   ...+||+.|+|||++.+..|...-|+||+||++|--++|..||....+... -+...+.            
T Consensus       718 gEksFR---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFM------------  782 (888)
T KOG4236|consen  718 GEKSFR---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFM------------  782 (888)
T ss_pred             chhhhh---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccc------------
Confidence            765443   557899999999999999999999999999999999999999975432211 0000000            


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                          +...-=.+...+..+||...|++.-++|-|.+.-+.
T Consensus       783 ----yPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  783 ----YPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             ----cCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence                111111356667889999999999999988876543

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.1e-37  Score=303.90  Aligned_cols=146  Identities=23%  Similarity=0.352  Sum_probs=130.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC--CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP--EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|.+.+.||+|+||.||+|.+. +++.||||++......  .....+..|+.++..++|+||+++++++......++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57999999999999999999765 6899999998754322  22357888999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+++|.+++....         .+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|||++
T Consensus        84 Ey~~g~~L~~li~~~~---------~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls  151 (669)
T cd05610          84 EYLIGGDVKSLLHIYG---------YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLS  151 (669)
T ss_pred             eCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCC
Confidence            9999999999997543         278899999999999999999999   9999999999999999999999999987


Q ss_pred             C
Q 046595          225 N  225 (363)
Q Consensus       225 ~  225 (363)
                      +
T Consensus       152 ~  152 (669)
T cd05610         152 K  152 (669)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=4.3e-37  Score=266.24  Aligned_cols=219  Identities=21%  Similarity=0.232  Sum_probs=176.6

Q ss_pred             cCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCCChhhhhc
Q 046595           79 GSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLH  157 (363)
Q Consensus        79 G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~  157 (363)
                      |.+|.||++.+ .+++.||+|.+....      ....|...+....||||+++++++......+++|||+.+|+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            89999999975 468999999987632      22334445555679999999999999999999999999999999987


Q ss_pred             CCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCccccccccc
Q 046595          158 GRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST  237 (363)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~  237 (363)
                      ...         .+++..+..++.|++.||.|||++   +|+|+||||+||+++.++.++++|||.+......     ..
T Consensus        78 ~~~---------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~  140 (237)
T cd05576          78 KFL---------NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CD  140 (237)
T ss_pred             Hhc---------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cc
Confidence            543         288999999999999999999999   9999999999999999999999999987554332     12


Q ss_pred             ccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCCCCCCH
Q 046595          238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPP  317 (363)
Q Consensus       238 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (363)
                      ...++..|+|||.+.+..++.++|+||+|+++|||++|..||......                 +.    .......+.
T Consensus       141 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----------------~~----~~~~~~~~~  199 (237)
T cd05576         141 GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----------------IN----THTTLNIPE  199 (237)
T ss_pred             cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----------------cc----cccccCCcc
Confidence            235677899999998888999999999999999999999887532110                 00    000112233


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCH
Q 046595          318 KAIAKLAAVAALCVQYEADFRPNM  341 (363)
Q Consensus       318 ~~~~~l~~li~~cl~~~p~~RPs~  341 (363)
                      ..+..+.+++.+||+.||++||++
T Consensus       200 ~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         200 WVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             cCCHHHHHHHHHHccCCHHHhcCC
Confidence            456679999999999999999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-37  Score=282.87  Aligned_cols=208  Identities=24%  Similarity=0.326  Sum_probs=176.2

Q ss_pred             CCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           70 FGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      |..++.||-|+||.|.+++. .+...||+|.+.+..  .......++.|..||...+++-||++|-.|.+.+++|+||+|
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY  710 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY  710 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence            66788899999999999964 457779999987643  222345678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      ++||++..+|-..+         .|.+..+..++..+..|+++.|..   |+|||||||+|||||.+|++||+||||+.-
T Consensus       711 IPGGDmMSLLIrmg---------IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTG  778 (1034)
T KOG0608|consen  711 IPGGDMMSLLIRMG---------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTG  778 (1034)
T ss_pred             cCCccHHHHHHHhc---------cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccccc
Confidence            99999999997665         388888888999999999999999   999999999999999999999999999853


Q ss_pred             CCccc----------------------------------------ccccccccccccCCCCccccccCCCCccCceehhH
Q 046595          227 SSDTA----------------------------------------ARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFG  266 (363)
Q Consensus       227 ~~~~~----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG  266 (363)
                      +....                                        .+......+||+.|+|||++....|+..+|.||.|
T Consensus       779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~g  858 (1034)
T KOG0608|consen  779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVG  858 (1034)
T ss_pred             ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhh
Confidence            32100                                        00112235799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCccccc
Q 046595          267 VVLLELLTGRKPVDHTMPKGQQS  289 (363)
Q Consensus       267 ~~l~ell~g~~p~~~~~~~~~~~  289 (363)
                      |+||||+.|+.||....+.....
T Consensus       859 vil~em~~g~~pf~~~tp~~tq~  881 (1034)
T KOG0608|consen  859 VILYEMLVGQPPFLADTPGETQY  881 (1034)
T ss_pred             HHHHHHhhCCCCccCCCCCccee
Confidence            99999999999998877765443

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.3e-39  Score=261.21  Aligned_cols=267  Identities=24%  Similarity=0.351  Sum_probs=200.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEe--------C
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCME--------S  137 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~  137 (363)
                      +.|.-...+|+|.||.||+|+.+ +|+.|++|++...... .--....+|+++|..+.|+|++.+++.|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            45666778999999999999765 5778888876553322 223567899999999999999999887753        2


Q ss_pred             CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceE
Q 046595          138 NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSK  217 (363)
Q Consensus       138 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk  217 (363)
                      ..+|+||.+|+. +|..++....-        .++..++..+..++++||.|+|+.   .|+|||+|+.|+||+.+|.+|
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~v--------r~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilk  164 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKV--------RFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILK  164 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccc--------cccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEE
Confidence            347899999988 99999976532        389999999999999999999999   999999999999999999999


Q ss_pred             EeeeccCCCCCccccc--ccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhc
Q 046595          218 IADFNLTNQSSDTAAR--LHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWA  294 (363)
Q Consensus       218 l~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~  294 (363)
                      |+|||+++.+......  ...+..+-|.+|.+||.+.|. .|+.+.|||..||++.||+++.+-|.+.....+..++.-.
T Consensus       165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L  244 (376)
T KOG0669|consen  165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL  244 (376)
T ss_pred             eeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence            9999999765433222  223456679999999988864 7999999999999999999999888766554444333211


Q ss_pred             c--------ccccccccccccCCc-CCCCCCHH---------HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          295 T--------PRLSEDKVKQCVDPK-LNNDYPPK---------AIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       295 ~--------~~~~~~~~~~~~~~~-~~~~~~~~---------~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      -        |...+-.+.+.+... +....-..         -..+..+|++.++..||.+|+++.+++.
T Consensus       245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            1        111111111111100 10000001         1235779999999999999999999875

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-38  Score=274.47  Aligned_cols=260  Identities=24%  Similarity=0.378  Sum_probs=201.1

Q ss_pred             HhcCCCCCCeeeccCCceEEEEE-eCCCCeEEEEEccCCCCCCch------HHHHHHHHHHhcCCCCccceeeeEEEe-C
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPE------SDFAAQLSVVSRLKHEHFVELLGYCME-S  137 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~avK~~~~~~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~-~  137 (363)
                      +.++|-++.+||+|||+.||++. ....+.||||+-.....+...      ...-+|..|.+.|+||.||++|+++.- .
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            45678889999999999999995 556888999987665443322      345679999999999999999999864 5


Q ss_pred             CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec---CCC
Q 046595          138 NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF---DDF  214 (363)
Q Consensus       138 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~---~~~  214 (363)
                      +.++-|+|||+|.+|.=||...+.         +++.++..|+.||+.||.||... +++|||-||||.|||+-   .-|
T Consensus       541 dsFCTVLEYceGNDLDFYLKQhkl---------mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacG  610 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQHKL---------MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACG  610 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhhhh---------hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccc
Confidence            677899999999999999987764         89999999999999999999987 45899999999999995   458


Q ss_pred             ceEEeeeccCCCCCccccc-----ccccccccccCCCCccccccC----CCCccCceehhHHHHHHHHhCCCCCCCCCCc
Q 046595          215 KSKIADFNLTNQSSDTAAR-----LHSTRVLGTFGYHAPEYAMTG----QITQKSDVYSFGVVLLELLTGRKPVDHTMPK  285 (363)
Q Consensus       215 ~vkl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~ell~g~~p~~~~~~~  285 (363)
                      .+||+|||+++...+....     ...+...||.+|++||.+.-+    .++.++||||+||++|..+.|+.||......
T Consensus       611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ  690 (775)
T KOG1151|consen  611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ  690 (775)
T ss_pred             eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH
Confidence            8999999999877654433     223456799999999988533    5789999999999999999999999854221


Q ss_pred             cccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          286 GQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                        .....+.       .+...  ....-..-+-+..+..++|++||+.--++|....++..
T Consensus       691 --QdILqeN-------TIlkA--tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  691 --QDILQEN-------TILKA--TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             --HHHHhhh-------chhcc--eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence              1111110       00000  01111112345667899999999999999998887754

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-39  Score=263.52  Aligned_cols=265  Identities=22%  Similarity=0.332  Sum_probs=205.1

Q ss_pred             CCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeCC-----eeEE
Q 046595           70 FGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESN-----NRIL  142 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l  142 (363)
                      .+-.+.||-|+||.||.+.+ ++|+.|++|++...... ....++.+|+++|..++|.|++..++...-..     ++|.
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            44456799999999999965 57999999998653311 22467899999999999999999988765432     4567


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ++|.+.. +|.+.|-...         .++.+.+.-+++||++||+|||+.   +|+||||||.|+|++.+..+||||||
T Consensus       135 ~TELmQS-DLHKIIVSPQ---------~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFG  201 (449)
T KOG0664|consen  135 LTELMQS-DLHKIIVSPQ---------ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFG  201 (449)
T ss_pred             HHHHHHh-hhhheeccCC---------CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccc
Confidence            8888866 8988887554         388889999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      +++..... .....+..+-|..|.|||+++|. .|+.+.||||+||++.||+..+.-|....+..+..++.......+.+
T Consensus       202 LARvee~d-~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~E  280 (449)
T KOG0664|consen  202 LARTWDQR-DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQE  280 (449)
T ss_pred             cccccchh-hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHH
Confidence            99865433 33344556779999999999975 69999999999999999999999999888877777665444444433


Q ss_pred             ccccc--------cCCcCCC---------CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 046595          302 KVKQC--------VDPKLNN---------DYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKAL  348 (363)
Q Consensus       302 ~~~~~--------~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l  348 (363)
                      .++..        ++...+.         .-+.....+-..++.+++..||++|.+.++.+..+
T Consensus       281 aMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  281 AMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            32221        1111111         11123445677888999999999999998877643

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=278.83  Aligned_cols=251  Identities=25%  Similarity=0.450  Sum_probs=207.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEe-----CCee
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCME-----SNNR  140 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-----~~~~  140 (363)
                      ..|++..+||.|.+|.||+++. ++++..|+|+.....  +..+.+..|.++++.+ .|||++.+++++..     ++.+
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~--d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL   96 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE--DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL   96 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc--cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence            4688999999999999999974 478889999887643  3445677888898888 69999999999864     5789


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEee
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD  220 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D  220 (363)
                      |||||||.+|+..++++....       ..+.|..+..|++.++.||.+||.+   .++|||||-.|||++.++.|||+|
T Consensus        97 WLVMEfC~gGSVTDLVKn~~g-------~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvD  166 (953)
T KOG0587|consen   97 WLVMEFCGGGSVTDLVKNTKG-------NRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVD  166 (953)
T ss_pred             EEEeeccCCccHHHHHhhhcc-------cchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEee
Confidence            999999999999999987652       3489999999999999999999999   999999999999999999999999


Q ss_pred             eccCCCCCcccccccccccccccCCCCcccccc-----CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 046595          221 FNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-----GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       221 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      ||++.........  .....||+.|||||++.-     ..|+..+|+||||++..||--|.+|+-+..+......+.   
T Consensus       167 FGvSaQldsT~gr--RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip---  241 (953)
T KOG0587|consen  167 FGVSAQLDSTVGR--RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP---  241 (953)
T ss_pred             eeeeeeeeccccc--ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC---
Confidence            9998765554433  456789999999999863     357899999999999999999999997665533222211   


Q ss_pred             ccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          296 PRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                                 .++......+..-.+++.++|..||..|.+.||++.++++
T Consensus       242 -----------RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  242 -----------RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             -----------CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                       1222223335677889999999999999999999999886

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=240.91  Aligned_cols=200  Identities=27%  Similarity=0.384  Sum_probs=168.5

Q ss_pred             CCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEEEEecccCC
Q 046595           73 KALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATMG  150 (363)
Q Consensus        73 ~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~g  150 (363)
                      +..||+|++|.|=+.++. +|...|+|.+..........++++|+.+..+. .+|++|.+||........++.||.|+. 
T Consensus        51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-  129 (282)
T KOG0984|consen   51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-  129 (282)
T ss_pred             hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-
Confidence            345999999999888754 79999999998866655667888999887766 699999999999999999999999977 


Q ss_pred             ChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCcc
Q 046595          151 SLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT  230 (363)
Q Consensus       151 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~  230 (363)
                      +|..+-.+--.     .+..+++..+-+|+..++.||.|||++.  .++|||+||+||||+.+|+||+||||++....+.
T Consensus       130 Sldkfy~~v~~-----~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS  202 (282)
T KOG0984|consen  130 SLDKFYRKVLK-----KGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS  202 (282)
T ss_pred             hHHHHHHHHHh-----cCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence            88777654321     1234889999999999999999999986  7999999999999999999999999998776655


Q ss_pred             cccccccccccccCCCCcccccc----CCCCccCceehhHHHHHHHHhCCCCCCCCC
Q 046595          231 AARLHSTRVLGTFGYHAPEYAMT----GQITQKSDVYSFGVVLLELLTGRKPVDHTM  283 (363)
Q Consensus       231 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~~l~ell~g~~p~~~~~  283 (363)
                      ...   +-..|...|||||.+..    ..|+.++||||||++++||.+++.||+...
T Consensus       203 iAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  203 IAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             hHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            442   33468889999998864    379999999999999999999999997543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=3.1e-35  Score=254.73  Aligned_cols=237  Identities=27%  Similarity=0.393  Sum_probs=193.0

Q ss_pred             CCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCCChhhhhcC
Q 046595           80 SYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHG  158 (363)
Q Consensus        80 ~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  158 (363)
                      +||.||+|... +++.+++|++...........+.+|+..+++++|+||+++++++......++++||+.+++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999876 48999999987754433367899999999999999999999999999999999999999999999976


Q ss_pred             CCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCcccccccccc
Q 046595          159 RKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR  238 (363)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~  238 (363)
                      ...         +++..++.++.+++.++.|||+.   +++|+||+|+||++++++.++|+|||.+.......   ....
T Consensus        81 ~~~---------~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~  145 (244)
T smart00220       81 RGR---------LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTT  145 (244)
T ss_pred             ccC---------CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---cccc
Confidence            432         78999999999999999999999   99999999999999999999999999987654432   1234


Q ss_pred             cccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCCCCCCH-
Q 046595          239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPP-  317 (363)
Q Consensus       239 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  317 (363)
                      ..++..|++||.+.+..++.++|+||||+++|+|++|..||......  .....             ............ 
T Consensus       146 ~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~-------------~~~~~~~~~~~~~  210 (244)
T smart00220      146 FVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFK-------------KIGKPKPPFPPPE  210 (244)
T ss_pred             ccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHH-------------HHhccCCCCcccc
Confidence            56888999999998888999999999999999999999999653111  11111             010010000001 


Q ss_pred             -HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          318 -KAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       318 -~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                       .++..+.+++.+||..+|++||++.++++
T Consensus       211 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      211 WKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             ccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence             15567999999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3.3e-35  Score=281.76  Aligned_cols=267  Identities=17%  Similarity=0.197  Sum_probs=169.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-C----CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeE------EE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-D----GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY------CM  135 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~----~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~------~~  135 (363)
                      .++|.+.+.||+|+||.||+|.+. +    +..||+|++....   ..+....+  .++...+.++..++..      ..
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~---~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG---AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc---hhHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            457999999999999999999765 4    6889999875422   11111111  1222222222222111      24


Q ss_pred             eCCeeEEEEecccCCChhhhhcCCCCCC-----------CCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEeccc
Q 046595          136 ESNNRILVYQFATMGSLHDVLHGRKGVQ-----------GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVR  204 (363)
Q Consensus       136 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~-----------~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlk  204 (363)
                      .....++|+||+.+++|.+++.......           ............+..++.|++.||.|||++   +|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence            5667899999999999999987543110           000111123455678999999999999999   99999999


Q ss_pred             CCceeecC-CCceEEeeeccCCCCCcccccccccccccccCCCCccccccC----------------------CCCccCc
Q 046595          205 SSNVLLFD-DFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG----------------------QITQKSD  261 (363)
Q Consensus       205 p~Nill~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D  261 (363)
                      |+|||++. ++.+||+|||++........ .......|++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999985 68999999999975433222 123456789999999976422                      2345679


Q ss_pred             eehhHHHHHHHHhCCCCCCCCCCccccchhh-hccccccccccccccCCcCCCC------CCHHHHHHHHHHHHhccCCC
Q 046595          262 VYSFGVVLLELLTGRKPVDHTMPKGQQSLVT-WATPRLSEDKVKQCVDPKLNND------YPPKAIAKLAAVAALCVQYE  334 (363)
Q Consensus       262 vwslG~~l~ell~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~  334 (363)
                      ||||||+||||+++..+++....    .+.. .....................+      ..........+|+.+||+.|
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~----~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d  437 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLI----QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK  437 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHH----HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence            99999999999998776542110    0000 0000000000000111110000      00011224558999999999


Q ss_pred             CCCCCCHHHHHH
Q 046595          335 ADFRPNMTIVVK  346 (363)
Q Consensus       335 p~~RPs~~~vl~  346 (363)
                      |++|||+.++++
T Consensus       438 P~kR~ta~e~L~  449 (566)
T PLN03225        438 GRQRISAKAALA  449 (566)
T ss_pred             cccCCCHHHHhC
Confidence            999999999998

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-34  Score=252.52  Aligned_cols=132  Identities=17%  Similarity=0.309  Sum_probs=111.8

Q ss_pred             cCCCCCCeeeccCCceEEEEE-eCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-----C---CccceeeeEEEe--
Q 046595           68 SNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-----H---EHFVELLGYCME--  136 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~i~~~~~~~~~--  136 (363)
                      ++|.+.++||.|.|++||+|. ..+.+.||+|+.+..  ....+.-..|+++|++++     |   .+||++++.|..  
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            789999999999999999995 456889999998763  223356778999999883     2   379999998864  


Q ss_pred             --CCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec
Q 046595          137 --SNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF  211 (363)
Q Consensus       137 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~  211 (363)
                        +.+.+||+|++ |.+|..+|.......       ++...+.+|++|++.||.|||..|  ||||-||||+|||+.
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~YrG-------lpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRG-------LPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCCC-------CcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence              56889999998 559999998765433       899999999999999999999998  999999999999983

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6e-34  Score=266.78  Aligned_cols=272  Identities=19%  Similarity=0.237  Sum_probs=180.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe-----------------CCCCeEEEEEccCCCCCC-------------chHHHHHHH
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKL-----------------TDGTPAAIKKLDTSSAPE-------------PESDFAAQL  116 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~-----------------~~~~~~avK~~~~~~~~~-------------~~~~~~~e~  116 (363)
                      .++|.+.++||+|+||.||+|..                 .+++.||||++.......             ..+....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            45899999999999999999853                 235679999986532211             111233466


Q ss_pred             HHHhcCCCCcc-----ceeeeEEEe--------CCeeEEEEecccCCChhhhhcCCCCC---------------CCCCCC
Q 046595          117 SVVSRLKHEHF-----VELLGYCME--------SNNRILVYQFATMGSLHDVLHGRKGV---------------QGAEPG  168 (363)
Q Consensus       117 ~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~---------------~~~~~~  168 (363)
                      .++.+++|.++     +++++++..        ....++|+||+.+++|.+++......               ......
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            66667765544     566666543        35679999999999999998753211               001112


Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCcccccccccccccccCCCCc
Q 046595          169 PVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP  248 (363)
Q Consensus       169 ~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  248 (363)
                      ..+++..+..++.|++.+|.|||+.   +|+||||||+||+++.++.+||+|||++......... ......+++.|+||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP  379 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP  379 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence            2367888999999999999999999   9999999999999999999999999998654332111 11122357899999


Q ss_pred             cccccCC--------------------CC--ccCceehhHHHHHHHHhCCC-CCCCCCCccccchhhhcccccccccccc
Q 046595          249 EYAMTGQ--------------------IT--QKSDVYSFGVVLLELLTGRK-PVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       249 E~~~~~~--------------------~~--~~~DvwslG~~l~ell~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      |.+....                    |+  .+.|+||+||++|+|++|.. ||.......... ..+ .  ......+.
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~-~~~-~--~~~~~~r~  455 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTEL-RQY-D--NDLNRWRM  455 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHH-hhc-c--chHHHHHh
Confidence            9875322                    11  24799999999999999885 765321111100 000 0  00000000


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCC---CCCCCHHHHHH
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEA---DFRPNMTIVVK  346 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p---~~RPs~~~vl~  346 (363)
                      ..............+....+++.++|..+|   .+|+|++++++
T Consensus       456 ~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        456 YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            111111111223456678899999998765   78999999986

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=4.5e-35  Score=260.70  Aligned_cols=268  Identities=21%  Similarity=0.260  Sum_probs=205.3

Q ss_pred             HHHHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC------CCccceeeeEEE
Q 046595           63 LNRLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK------HEHFVELLGYCM  135 (363)
Q Consensus        63 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~  135 (363)
                      .+.+..+|.+....|.|-|++|..|.+. -|..||||++...  +.....=+.|+++|++|+      --|.++++-.|.
T Consensus       427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN--E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~  504 (752)
T KOG0670|consen  427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN--EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK  504 (752)
T ss_pred             hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc--hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence            3456789999999999999999999754 4779999999763  233455578999999995      347999999999


Q ss_pred             eCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCC-C
Q 046595          136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD-F  214 (363)
Q Consensus       136 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-~  214 (363)
                      ...++|||+|.+.. +|.++|.+.+..-      .+....+..++.|+.-||..|...   ||+|.||||+|||+++. .
T Consensus       505 hknHLClVFE~Lsl-NLRevLKKyG~nv------GL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~  574 (752)
T KOG0670|consen  505 HKNHLCLVFEPLSL-NLREVLKKYGRNV------GLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKN  574 (752)
T ss_pred             hcceeEEEehhhhc-hHHHHHHHhCccc------ceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcc
Confidence            99999999999876 9999998876432      288899999999999999999998   99999999999999865 5


Q ss_pred             ceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhc
Q 046595          215 KSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWA  294 (363)
Q Consensus       215 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~  294 (363)
                      .+||||||.|........    +...-+.-|.|||++.|..|+...|+||+||+||||+||+..|.+........+.+-.
T Consensus       575 iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~  650 (752)
T KOG0670|consen  575 ILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL  650 (752)
T ss_pred             eeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence            789999999866554332    2234456799999999999999999999999999999999999766554333333222


Q ss_pred             ccccccccc--------------------------------ccccCC------cCCC--CCC---HHHHHHHHHHHHhcc
Q 046595          295 TPRLSEDKV--------------------------------KQCVDP------KLNN--DYP---PKAIAKLAAVAALCV  331 (363)
Q Consensus       295 ~~~~~~~~~--------------------------------~~~~~~------~~~~--~~~---~~~~~~l~~li~~cl  331 (363)
                      ...+.+..+                                ...+.+      .+..  .++   ......|.+|+..||
T Consensus       651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml  730 (752)
T KOG0670|consen  651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML  730 (752)
T ss_pred             cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence            222221110                                000010      0000  122   234557999999999


Q ss_pred             CCCCCCCCCHHHHHH
Q 046595          332 QYEADFRPNMTIVVK  346 (363)
Q Consensus       332 ~~~p~~RPs~~~vl~  346 (363)
                      ..||++|.|..+.|.
T Consensus       731 ~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  731 ILDPEKRITVNQALK  745 (752)
T ss_pred             ccChhhcCCHHHHhc
Confidence            999999999999875

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=2.5e-34  Score=231.55  Aligned_cols=256  Identities=16%  Similarity=0.267  Sum_probs=194.8

Q ss_pred             cCCCCCCeeeccCCceEEEEE-eCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-CCccceeeeEEEeCC--eeEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVELLGYCMESN--NRILV  143 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~~~lv  143 (363)
                      .+|++.+.+|+|.++.||.|. ..+++.++||+++..    ....+.+|+.+|+.|. ||||++++++..+..  ...||
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccCCCceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            478999999999999999996 567899999998653    3567899999999997 999999999987654  45699


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC-CCceEEeeec
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD-DFKSKIADFN  222 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg  222 (363)
                      +||+++.+...+...            ++..++...+.+++.||.|+|+.   ||+|||+||.|++|+. ...++|+|||
T Consensus       114 FE~v~n~Dfk~ly~t------------l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWG  178 (338)
T KOG0668|consen  114 FEYVNNTDFKQLYPT------------LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWG  178 (338)
T ss_pred             hhhhccccHHHHhhh------------hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecc
Confidence            999999777666543            78889999999999999999999   9999999999999984 5679999999


Q ss_pred             cCCCCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc---
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL---  298 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~---  298 (363)
                      +|.++.....   .+-.+.+..|--||.+-. ..|+.+-|+|||||+|..|+..+.||-...+.. .+++..+.-.-   
T Consensus       179 LAEFYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~-DQLVkIakVLGt~e  254 (338)
T KOG0668|consen  179 LAEFYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVKIAKVLGTDE  254 (338)
T ss_pred             hHhhcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH-HHHHHHHHHhChHH
Confidence            9987765433   234566788999998875 578999999999999999999999986554432 11221110000   


Q ss_pred             -----------cccccccccCCcCCCCCC--------HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          299 -----------SEDKVKQCVDPKLNNDYP--------PKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       299 -----------~~~~~~~~~~~~~~~~~~--------~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                                 .+.....++....+..+.        .-...+..+++.+.|..|-.+|+|++|.+.
T Consensus       255 l~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  255 LYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                       011111111111111110        112357889999999999999999999875

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=5e-34  Score=256.91  Aligned_cols=197  Identities=21%  Similarity=0.347  Sum_probs=168.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC-------CchHHHHHHHHHHhcCC---CCccceeeeEEEe
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP-------EPESDFAAQLSVVSRLK---HEHFVELLGYCME  136 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-------~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~  136 (363)
                      .+|..++.||+|+||.|++|.++ +...|+||.+.+.+.-       ...-.+-.|+.||..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            35899999999999999999765 4667889988764311       11123456999999997   9999999999999


Q ss_pred             CCeeEEEEecc-cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCc
Q 046595          137 SNNRILVYQFA-TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK  215 (363)
Q Consensus       137 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~  215 (363)
                      ++++||+||-. +|-+|+++|....+         +++.++..|+.|++.|+++||++   ||||||||-+||.++.+|-
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp~---------m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~  708 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKPR---------MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGF  708 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccCc---------cchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCe
Confidence            99999999975 45599999987654         99999999999999999999999   9999999999999999999


Q ss_pred             eEEeeeccCCCCCcccccccccccccccCCCCccccccCCC-CccCceehhHHHHHHHHhCCCCCC
Q 046595          216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGRKPVD  280 (363)
Q Consensus       216 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~p~~  280 (363)
                      +||+|||.+.......    ...++||..|.|||++.|..| +..-|||+||++||-++....||-
T Consensus       709 ~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  709 VKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999999886554432    356899999999999999887 566899999999999999988874

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-34  Score=266.07  Aligned_cols=247  Identities=23%  Similarity=0.357  Sum_probs=186.9

Q ss_pred             CCCCCeeeccCCce-EEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEEEEecc
Q 046595           70 FGTKALIGEGSYGR-VFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        70 y~~~~~lg~G~~g~-V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      |.-.+++|.|+-|+ ||+|.. +++.||||.+-.    +-.....+|+..|+.- +||||+++|+.-.+....|+..|.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhh----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            44566789998776 678877 488999998854    2334678999999998 5999999999988899999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC---C--CceEEeeec
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD---D--FKSKIADFN  222 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~--~~vkl~Dfg  222 (363)
                      .. +|.+++.... .....    ...-..+.+..|+++||++||+.   +||||||||.||||+.   +  ..++|+|||
T Consensus       586 ~~-sL~dlie~~~-~d~~~----~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfg  656 (903)
T KOG1027|consen  586 AC-SLQDLIESSG-LDVEM----QSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFG  656 (903)
T ss_pred             hh-hHHHHHhccc-cchhh----cccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccc
Confidence            87 9999998741 11000    11134567889999999999998   9999999999999975   3  578999999


Q ss_pred             cCCCCCccccc-ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhC-CCCCCCCCCccccchhhhccccccc
Q 046595          223 LTNQSSDTAAR-LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTG-RKPVDHTMPKGQQSLVTWATPRLSE  300 (363)
Q Consensus       223 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~~  300 (363)
                      +++........ .......||-+|+|||++.....+.++|||||||++|+.++| ..||+..-..+..-    ....   
T Consensus       657 lsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI----l~~~---  729 (903)
T KOG1027|consen  657 LSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI----LTGN---  729 (903)
T ss_pred             cccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh----hcCc---
Confidence            99877654333 224556799999999999998888899999999999999996 89997542211100    0000   


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          301 DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ..+..       .....++  +..+||..|++++|..||++.+|+.
T Consensus       730 ~~L~~-------L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  730 YTLVH-------LEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             cceee-------eccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            00000       0101122  7889999999999999999999873

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=8.8e-32  Score=227.76  Aligned_cols=212  Identities=29%  Similarity=0.521  Sum_probs=183.5

Q ss_pred             eeccCCceEEEEEeCC-CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCCChhh
Q 046595           76 IGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHD  154 (363)
Q Consensus        76 lg~G~~g~V~~~~~~~-~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~  154 (363)
                      ||+|.+|.||++...+ ++.+++|++...........+.+|+..++.+.|++|+++++++......++++|++.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999998754 899999998764433235689999999999999999999999999899999999999999999


Q ss_pred             hhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC-CCceEEeeeccCCCCCccccc
Q 046595          155 VLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD-DFKSKIADFNLTNQSSDTAAR  233 (363)
Q Consensus       155 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~a~~~~~~~~~  233 (363)
                      ++....        ..++...++.++.+++.+|.+||+.   +++|+||+|.||+++. ++.++|+|||.+........ 
T Consensus        81 ~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-  148 (215)
T cd00180          81 LLKENE--------GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-  148 (215)
T ss_pred             HHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-
Confidence            997652        1288999999999999999999999   9999999999999999 89999999999865543321 


Q ss_pred             ccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCC
Q 046595          234 LHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLN  312 (363)
Q Consensus       234 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (363)
                       ......+...|++||.+... .++.++|+|+||+++++|                                        
T Consensus       149 -~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------  187 (215)
T cd00180         149 -LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------  187 (215)
T ss_pred             -hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------
Confidence             12334578899999998877 888999999999999999                                        


Q ss_pred             CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 046595          313 NDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKAL  348 (363)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l  348 (363)
                              ..+.+++..|++.+|++||++.++++.+
T Consensus       188 --------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 --------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             --------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                    3589999999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-33  Score=231.03  Aligned_cols=253  Identities=23%  Similarity=0.358  Sum_probs=191.3

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeE-EEeCCeeEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGY-CMESNNRIL  142 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~-~~~~~~~~l  142 (363)
                      +...|.+.+.||+|.||.+-+|+++ +...+++|.+...  .....+|.+|...--.| .|.||+.-|++ |+..+.+++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p--~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF   99 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP--QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF   99 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc--hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence            4568999999999999999999887 4778899988763  34567899999877677 58999998875 566678889


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec--CCCceEEee
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF--DDFKSKIAD  220 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~--~~~~vkl~D  220 (363)
                      ++||++.|+|.+-+...+          +.+.-...++.|+++||.|||++   ++||||||.+||||-  +.-+|||||
T Consensus       100 ~qE~aP~gdL~snv~~~G----------igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcD  166 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVEAAG----------IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCD  166 (378)
T ss_pred             eeccCccchhhhhcCccc----------ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeee
Confidence            999999999999998755          88999999999999999999999   999999999999994  456899999


Q ss_pred             eccCCCCCcccccccccccccccCCCCcccccc---C--CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 046595          221 FNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT---G--QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       221 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      ||+.+........     ..-+..|.+||....   +  ...+.+|+|.||+++|.+++|..||+..... ...++.|..
T Consensus       167 FG~t~k~g~tV~~-----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~-d~~Y~~~~~  240 (378)
T KOG1345|consen  167 FGLTRKVGTTVKY-----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM-DKPYWEWEQ  240 (378)
T ss_pred             cccccccCceehh-----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-CchHHHHHH
Confidence            9997655433222     223567999997542   2  3468899999999999999999999844332 233333332


Q ss_pred             ccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          296 PRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                      ...  ++..     .+... ....++.+.+++++-|.+++++|--..++.+.
T Consensus       241 w~~--rk~~-----~~P~~-F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  241 WLK--RKNP-----ALPKK-FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             Hhc--ccCc-----cCchh-hcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence            111  1111     11111 12345668899999999999999655555543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=4.9e-33  Score=254.31  Aligned_cols=252  Identities=24%  Similarity=0.360  Sum_probs=204.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      .+|.+...+|+|.+|.||++++ .+++..|+|+++... .+....+..|+-+++..+|+||+.+++.+...+.+++.|||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep-~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP-GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccC-CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            3788999999999999999975 479999999998744 34456778899999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      |.+|+|.+.-+...         .+++.++..+.+..+.||+|||+.   +-+|||||-.||++++.|.||+.|||.+-.
T Consensus        94 cgggslQdiy~~Tg---------plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaq  161 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQ  161 (829)
T ss_pred             cCCCcccceeeecc---------cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhh
Confidence            99999999877654         389999999999999999999999   899999999999999999999999998765


Q ss_pred             CCcccccccccccccccCCCCccccc---cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAM---TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      +.....  ....+.||+.|||||+-.   .+.|...+|||++|++..|+---+.|.....+.....+...-.        
T Consensus       162 itati~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~--------  231 (829)
T KOG0576|consen  162 ITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSG--------  231 (829)
T ss_pred             hhhhhh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccC--------
Confidence            544333  245689999999999763   5689999999999999999988888876554433222221111        


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                         .++--. .-...-.+.+.++++.|+..+|++||+++.+++
T Consensus       232 ---~qpp~l-kDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  232 ---FQPPTL-KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ---CCCCcc-cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence               111000 112244567999999999999999999998765

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=3.4e-32  Score=229.36  Aligned_cols=260  Identities=20%  Similarity=0.239  Sum_probs=194.8

Q ss_pred             cCCCCCCeeeccCCceEEEEE-eCCCCeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEeC------Ce
Q 046595           68 SNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCMES------NN  139 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~  139 (363)
                      .+|.-++.+|.|.- .|..+. .-.++.|++|++..... .....+..+|..++..++|+||++++.++.-.      ..
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            47777888899988 555553 34689999998865432 22345778999999999999999999988644      35


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEe
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA  219 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~  219 (363)
                      .|+|||++.. +|...+.-.           ++-..+..|+.|++.|+.|||+.   +|+||||||+||++..++.+||.
T Consensus        96 ~y~v~e~m~~-nl~~vi~~e-----------lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~  160 (369)
T KOG0665|consen   96 VYLVMELMDA-NLCQVILME-----------LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKIL  160 (369)
T ss_pred             HHHHHHhhhh-HHHHHHHHh-----------cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeec
Confidence            6899999987 999988732           67788889999999999999999   99999999999999999999999


Q ss_pred             eeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc
Q 046595          220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       220 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      |||+++.....   ...+..+.|..|.|||++.+-.|.+.+||||+||++.||++|..-|.+.+..++...+.-......
T Consensus       161 dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd  237 (369)
T KOG0665|consen  161 DFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPD  237 (369)
T ss_pred             cchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCC
Confidence            99998754333   235567889999999999988899999999999999999999998875543333222211111111


Q ss_pred             ccccc----------------------cc-cCCcCCC--CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          300 EDKVK----------------------QC-VDPKLNN--DYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       300 ~~~~~----------------------~~-~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ...+.                      +. -|.....  +.+........+++.+||-.||++|-+++++|.
T Consensus       238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  238 PSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            10000                      00 0000000  111123456889999999999999999999987

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=2.2e-30  Score=221.89  Aligned_cols=200  Identities=31%  Similarity=0.450  Sum_probs=171.8

Q ss_pred             CCCCCeeeccCCceEEEEEeCC-CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEeccc
Q 046595           70 FGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFAT  148 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~~~-~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  148 (363)
                      |.+.+.||+|++|.||++...+ ++.+++|.+...........+.+|+..+++++|+|++++++++......++++|++.
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5677889999999999998764 889999999864432246788899999999999999999999999899999999999


Q ss_pred             CCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCC
Q 046595          149 MGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS  228 (363)
Q Consensus       149 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~  228 (363)
                      +++|.+++.....        .+++..+..++.+++.+|.+||+.   +++|+||+|.||+++.++.++|+|||++....
T Consensus        81 ~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~  149 (225)
T smart00221       81 GGDLFDYLRKKGG--------KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIH  149 (225)
T ss_pred             CCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEec
Confidence            9999999976531        167899999999999999999999   99999999999999999999999999887654


Q ss_pred             cccccccccccccccCCCCcccc-ccCCCCccCceehhHHHHHHHHhCCCCCCC
Q 046595          229 DTAARLHSTRVLGTFGYHAPEYA-MTGQITQKSDVYSFGVVLLELLTGRKPVDH  281 (363)
Q Consensus       229 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~~l~ell~g~~p~~~  281 (363)
                      ..... ......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus       150 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      150 RDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             Ccccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            43211 12345678899999988 666788899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.97  E-value=1e-30  Score=221.53  Aligned_cols=265  Identities=19%  Similarity=0.248  Sum_probs=211.9

Q ss_pred             cCCCCCCeeeccCCceEEEEE-eCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-CCccceeeeEEEeCCeeEEEEe
Q 046595           68 SNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      -.|+++++||+|+||.+|.|+ .-++++||||......   ....+..|....+.|. .++|..+|-+...+.+..||+|
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS---~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS---EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC---CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            479999999999999999996 4589999999876643   3446788988888884 7999999999998888999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC-----CCceEEee
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD-----DFKSKIAD  220 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-----~~~vkl~D  220 (363)
                      .+ |-+|.++..-+.+        .|+.+.++.++.|++.-++|+|++   .+|+|||||+|+||..     ...|.|+|
T Consensus       105 LL-GPSLEDLFD~CgR--------~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiD  172 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLCGR--------RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIID  172 (449)
T ss_pred             hh-CcCHHHHHHHhcC--------cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEe
Confidence            87 6699998876654        399999999999999999999999   9999999999999974     34689999


Q ss_pred             eccCCCCCccccccc-----ccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 046595          221 FNLTNQSSDTAARLH-----STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       221 fg~a~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      ||+|+.+.+.....+     .....||.+||+-....|.+.+.+.|+-|||-+++++|-|..||.+.....-....+.  
T Consensus       173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK--  250 (449)
T KOG1165|consen  173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK--  250 (449)
T ss_pred             ccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH--
Confidence            999998887665533     2346799999999999999999999999999999999999999987643322222211  


Q ss_pred             ccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCC
Q 046595          296 PRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP  356 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~  356 (363)
                             +.+.........+-...|.++..-+.-.-..+-.+-|.++-+...+..++.+..
T Consensus       251 -------IGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g  304 (449)
T KOG1165|consen  251 -------IGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG  304 (449)
T ss_pred             -------hccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence                   111111111112223456778877777778888899999999998888877654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.97  E-value=4.3e-31  Score=214.53  Aligned_cols=265  Identities=19%  Similarity=0.262  Sum_probs=212.2

Q ss_pred             HhcCCCCCCeeeccCCceEEEEE-eCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCC-CccceeeeEEEeCCeeEEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKH-EHFVELLGYCMESNNRILV  143 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv  143 (363)
                      ..++|.+++.||+|+||.+|++. ..+|+.||||+......   ...+..|..+.+.|++ ..|..+..++.+.....+|
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~---hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK---HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC---CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            35689999999999999999995 56899999999865332   3467889999999974 7888888888899999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec---CCCceEEee
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIAD  220 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~---~~~~vkl~D  220 (363)
                      |+.+ |.+|.++..-+..        .++..+++.++-|++.-++|+|.+   +++||||||+|+|..   ....+.|+|
T Consensus        90 MdLL-GPsLEdLfnfC~R--------~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LID  157 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNFCSR--------RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLID  157 (341)
T ss_pred             eecc-CccHHHHHHHHhh--------hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEe
Confidence            9987 6699998876543        399999999999999999999999   999999999999996   345789999


Q ss_pred             eccCCCCCccccccc-----ccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 046595          221 FNLTNQSSDTAARLH-----STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       221 fg~a~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      ||+|+.+.+.....+     .....||.+|.+-..+.+.+.+.+.|+-|+|.+|.++.-|..||++.......+..+.. 
T Consensus       158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI-  236 (341)
T KOG1163|consen  158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI-  236 (341)
T ss_pred             ccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH-
Confidence            999988766544322     33467999999999998899999999999999999999999999877554433332211 


Q ss_pred             ccccccccccccCCcCCC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCC
Q 046595          296 PRLSEDKVKQCVDPKLNN---DYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA  357 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~  357 (363)
                                 .+..+..   .+-...|.++.-.+..|-..--++-|++.-+.+.+.-|++..+.
T Consensus       237 -----------~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~  290 (341)
T KOG1163|consen  237 -----------SEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNH  290 (341)
T ss_pred             -----------HHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccc
Confidence                       1111111   11123466788888899999999999999999988888776654

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=2.5e-30  Score=225.75  Aligned_cols=266  Identities=22%  Similarity=0.311  Sum_probs=198.0

Q ss_pred             HHHHhcCCCCCCeeeccCCceEEEEEeC----CCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeC
Q 046595           63 LNRLTSNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMES  137 (363)
Q Consensus        63 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  137 (363)
                      +..+...|.+++.||+|.|++||++...    ..+.||+|.+.....+   .++..|+++|..+ .+.||+++.+.+...
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccC
Confidence            3455678999999999999999999532    4788999999875544   4688999999999 599999999999999


Q ss_pred             CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec-CCCce
Q 046595          138 NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF-DDFKS  216 (363)
Q Consensus       138 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~-~~~~v  216 (363)
                      +...+|++|++.....++...            ++..++..+++.++.||.++|.+   |||||||||+|+|.+ ..+.-
T Consensus       108 d~v~ivlp~~~H~~f~~l~~~------------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg  172 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYRS------------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRG  172 (418)
T ss_pred             CeeEEEecccCccCHHHHHhc------------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCc
Confidence            999999999999999999875            77899999999999999999999   999999999999998 45778


Q ss_pred             EEeeeccCCCCCcc-------c-----------------------------------ccccccccccccCCCCcccccc-
Q 046595          217 KIADFNLTNQSSDT-------A-----------------------------------ARLHSTRVLGTFGYHAPEYAMT-  253 (363)
Q Consensus       217 kl~Dfg~a~~~~~~-------~-----------------------------------~~~~~~~~~gt~~y~aPE~~~~-  253 (363)
                      .|+|||+|......       .                                   .........||++|.|||++.. 
T Consensus       173 ~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~  252 (418)
T KOG1167|consen  173 VLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC  252 (418)
T ss_pred             eEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc
Confidence            99999998611000       0                                   0000112459999999999875 


Q ss_pred             CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchh---------------------hhc-cccccccccccccCC--
Q 046595          254 GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLV---------------------TWA-TPRLSEDKVKQCVDP--  309 (363)
Q Consensus       254 ~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~---------------------~~~-~~~~~~~~~~~~~~~--  309 (363)
                      ...+.++||||.|+++.-+++++.||-...++......                     .|. .......++...++.  
T Consensus       253 ~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~  332 (418)
T KOG1167|consen  253 PRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLH  332 (418)
T ss_pred             cCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccC
Confidence            46788999999999999999999999654333111000                     000 000000000000000  


Q ss_pred             ---cCC--------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          310 ---KLN--------NDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       310 ---~~~--------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                         ...        .......+..+.+++.+|+..||.+|.|+++.|+
T Consensus       333 ~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  333 IESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             hhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence               000        1111223457899999999999999999999876

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-29  Score=226.96  Aligned_cols=264  Identities=19%  Similarity=0.264  Sum_probs=201.4

Q ss_pred             CCCCCCeeeccCCceEEEEEeCC--CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCC----CccceeeeEE-EeCCeeE
Q 046595           69 NFGTKALIGEGSYGRVFYAKLTD--GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKH----EHFVELLGYC-MESNNRI  141 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h----~~i~~~~~~~-~~~~~~~  141 (363)
                      +|.+.+.||+|+||.||.|...+  ...+|+|........... .+..|..++..+..    .++..+++.+ ......+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            79999999999999999998654  357899888764433322 67888888888863    6899999998 4777889


Q ss_pred             EEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCC-----Cce
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD-----FKS  216 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-----~~v  216 (363)
                      +||+.+ |.+|.++......       ..++...++.|+.|++.+|++||+.   |++||||||+|+++...     ..+
T Consensus        98 iVM~l~-G~sL~dl~~~~~~-------~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~  166 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNPP-------GRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTL  166 (322)
T ss_pred             EEEecc-CccHHHHHHhCCC-------CCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceE
Confidence            999977 6699998865441       2399999999999999999999999   99999999999999854     469


Q ss_pred             EEeeeccCC--CCCccccc------ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCcccc
Q 046595          217 KIADFNLTN--QSSDTAAR------LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ  288 (363)
Q Consensus       217 kl~Dfg~a~--~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~  288 (363)
                      +|.|||+++  .+......      .....+.||..|+++.+..+...+.+.|+||++.++.+++.|..||.........
T Consensus       167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~  246 (322)
T KOG1164|consen  167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK  246 (322)
T ss_pred             EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH
Confidence            999999998  33222211      1123466999999999999999999999999999999999999999655432211


Q ss_pred             chhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCC
Q 046595          289 SLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP  356 (363)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~  356 (363)
                      ...            ...........+....+.++.++...+-..+..++|.+..+...|+.+.....
T Consensus       247 ~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~  302 (322)
T KOG1164|consen  247 SKF------------EKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEG  302 (322)
T ss_pred             HHH------------HHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcC
Confidence            111            11111111111223345567777777777999999999999999988877653

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=2e-30  Score=260.51  Aligned_cols=196  Identities=18%  Similarity=0.198  Sum_probs=136.9

Q ss_pred             cCCC-CccceeeeEE-------EeCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc
Q 046595          121 RLKH-EHFVELLGYC-------MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE  192 (363)
Q Consensus       121 ~l~h-~~i~~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~  192 (363)
                      .++| .||..+++++       ......++++|++ +++|.++|....        ..+++.+++.++.||+.||.|||+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH~   98 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--------RSVDAFECFHVFRQIVEIVNAAHS   98 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--------ccccHHHHHHHHHHHHHHHHHHHh
Confidence            4455 5777787776       3334567788887 459999997432        138999999999999999999999


Q ss_pred             cCCCCeEEecccCCceeecCCCc-------------------eEEeeeccCCCCCcccc--------------ccccccc
Q 046595          193 KVQPPIVHRDVRSSNVLLFDDFK-------------------SKIADFNLTNQSSDTAA--------------RLHSTRV  239 (363)
Q Consensus       193 ~~~~~ivH~Dlkp~Nill~~~~~-------------------vkl~Dfg~a~~~~~~~~--------------~~~~~~~  239 (363)
                      +   ||+||||||+||||+..+.                   +||+|||+++.......              .......
T Consensus        99 ~---gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (793)
T PLN00181         99 Q---GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILA  175 (793)
T ss_pred             C---CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccccccc
Confidence            9   9999999999999965444                   55555555543211000              0001123


Q ss_pred             ccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCCCCCCHHH
Q 046595          240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKA  319 (363)
Q Consensus       240 ~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (363)
                      .||+.|+|||++.+..|+.++|||||||+||||++|..|+.....    .......         ..    +.... ...
T Consensus       176 ~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~---------~~----~~~~~-~~~  237 (793)
T PLN00181        176 MEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRH---------RV----LPPQI-LLN  237 (793)
T ss_pred             CCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHH---------hh----cChhh-hhc
Confidence            588999999999999999999999999999999999888752211    0000000         00    00000 111


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          320 IAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       320 ~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ......++.+||+.+|.+||++.+|++
T Consensus       238 ~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        238 WPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             CHHHHHHHHHhCCCChhhCcChHHHhh
Confidence            234567888999999999999999986

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=7.9e-29  Score=204.47  Aligned_cols=169  Identities=22%  Similarity=0.212  Sum_probs=126.7

Q ss_pred             CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCc
Q 046595          150 GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       150 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      |+|.+++.....        .+++.+++.++.|++.||.|||++   +      ||+||+++.++.+|+  ||++.....
T Consensus         1 GsL~~~l~~~~~--------~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~   61 (176)
T smart00750        1 VSLADILEVRGR--------PLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTP   61 (176)
T ss_pred             CcHHHHHHHhCC--------CCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecc
Confidence            689999975431        389999999999999999999999   6      999999999999999  998765433


Q ss_pred             ccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCC
Q 046595          230 TAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDP  309 (363)
Q Consensus       230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (363)
                      .       ...||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...+... .     ... ..
T Consensus        62 ~-------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~-~~~~~~~-~-----~~~-~~  126 (176)
T smart00750       62 E-------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI-LEILLNG-M-----PAD-DP  126 (176)
T ss_pred             c-------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH-HHHHHHH-h-----ccC-Cc
Confidence            2       126899999999999999999999999999999999999999644321110 0000000 0     000 00


Q ss_pred             cCCCCCCHHHHH--HHHHHHHhccCCCCCCCCCHHHHHHHhccccc
Q 046595          310 KLNNDYPPKAIA--KLAAVAALCVQYEADFRPNMTIVVKALQPLLN  353 (363)
Q Consensus       310 ~~~~~~~~~~~~--~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~  353 (363)
                      . ....+.....  .+.+++.+||+.+|++||++.++++.+..+..
T Consensus       127 ~-~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      127 R-DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             c-ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            0 0011223333  69999999999999999999999998876643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=4e-27  Score=211.99  Aligned_cols=176  Identities=19%  Similarity=0.206  Sum_probs=133.2

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC--CCCeEEEEEccCCC----CCCchHHHHHHHHHHhcCCCCccce-eeeEEEeC
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT--DGTPAAIKKLDTSS----APEPESDFAAQLSVVSRLKHEHFVE-LLGYCMES  137 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~avK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~  137 (363)
                      .+..+|.+.+.||+|+||.||+|.+.  +++.+|||++....    .......+.+|+++|+.++|+|++. +++    .
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----T   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----c
Confidence            45678999999999999999999754  57778999875321    1122456899999999999999985 443    2


Q ss_pred             CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecc-cCCceeecCCCce
Q 046595          138 NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDV-RSSNVLLFDDFKS  216 (363)
Q Consensus       138 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dl-kp~Nill~~~~~v  216 (363)
                      ...++||||+.|++|... ..            ..   ...++.+++++|.|||++   ||+|||| ||+|||++.++.+
T Consensus        91 ~~~~LVmE~~~G~~L~~~-~~------------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~i  151 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLA-RP------------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEA  151 (365)
T ss_pred             CCcEEEEEccCCCCHHHh-Cc------------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCE
Confidence            457999999999999632 11            11   135788999999999999   9999999 9999999999999


Q ss_pred             EEeeeccCCCCCccccccc------ccccccccCCCCccccccCC------CCccCcee
Q 046595          217 KIADFNLTNQSSDTAARLH------STRVLGTFGYHAPEYAMTGQ------ITQKSDVY  263 (363)
Q Consensus       217 kl~Dfg~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~~~~~Dvw  263 (363)
                      ||+|||+|+..........      .....+++.|+|||.+....      .+..+|-|
T Consensus       152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            9999999986654321111      13456888999999886432      23445666

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=4e-28  Score=232.36  Aligned_cols=255  Identities=18%  Similarity=0.231  Sum_probs=191.4

Q ss_pred             CCCCeeeccCCceEEEEEe-CCCCeEEEEEccC----CCCCCch-HHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           71 GTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDT----SSAPEPE-SDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        71 ~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~----~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ....++|.|++|.|+.+.. ...+.+..|....    ....... ..+..|+.+-..+.|+|++..+....+.....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            4567899999998887743 3344455554431    1111111 12566777788889999988887776666666669


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      |||++ +|..++....         .+...++..++.|++.|+.|||+.   ||.|||+|++|++++.+|.+||+|||.+
T Consensus       401 E~~~~-Dlf~~~~~~~---------~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~  467 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG---------KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAA  467 (601)
T ss_pred             hcccH-HHHHHHhccc---------ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcc
Confidence            99999 9999998762         288899999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCccccc--ccccccccccCCCCccccccCCCCc-cCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccc
Q 046595          225 NQSSDTAAR--LHSTRVLGTFGYHAPEYAMTGQITQ-KSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       225 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      ..+.-....  ......+|+..|+|||++.+..|+. ..||||.|++++.|.+|+.||......+......        .
T Consensus       468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~--------~  539 (601)
T KOG0590|consen  468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN--------N  539 (601)
T ss_pred             eeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh--------c
Confidence            765544443  4566789999999999999999985 5799999999999999999998665544332000        0


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ...+.....-.......++.....+|.++|++||.+|.|+++|++
T Consensus       540 ~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  540 YSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            000000000011223466778999999999999999999999986

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=6.4e-27  Score=193.62  Aligned_cols=251  Identities=22%  Similarity=0.364  Sum_probs=196.0

Q ss_pred             CCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccC
Q 046595           71 GTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATM  149 (363)
Q Consensus        71 ~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  149 (363)
                      .+..+|.+...|..|+|+|. |..+++|++..... .....+|..|.-.|+.+.||||+.+++.|....++.++..|++.
T Consensus       193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            34445889999999999997 55566777765432 22336788999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCc
Q 046595          150 GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       150 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      |+|+..++.....       ..+..++++++.++++|+.|||+... -|.--.|....++||++.+.+|. .+-.++...
T Consensus       272 gslynvlhe~t~v-------vvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltaris-mad~kfsfq  342 (448)
T KOG0195|consen  272 GSLYNVLHEQTSV-------VVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQ  342 (448)
T ss_pred             hHHHHHHhcCccE-------EEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhhee-cccceeeee
Confidence            9999999876542       47788999999999999999999852 24445688999999999887774 111111111


Q ss_pred             ccccccccccccccCCCCccccccCCC---CccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          230 TAARLHSTRVLGTFGYHAPEYAMTGQI---TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                            .....-.+.||+||.+...+-   -.++|+|||+++||||.|...||....+.+....               +
T Consensus       343 ------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk---------------i  401 (448)
T KOG0195|consen  343 ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK---------------I  401 (448)
T ss_pred             ------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh---------------h
Confidence                  112234788999999986543   3678999999999999999999987766443332               2


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccc
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL  352 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~  352 (363)
                      .-.+++...|+..+..+.+|+.-|...||.+||.+..|+-+|+...
T Consensus       402 aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  402 ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            2345666778888889999999999999999999999999888653

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=1.1e-24  Score=197.18  Aligned_cols=262  Identities=24%  Similarity=0.359  Sum_probs=199.4

Q ss_pred             CCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCc--hHHHHHHHHHHhcCCCC-ccceeeeEEEeCCeeEEEEec
Q 046595           70 FGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHE-HFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      |.+.+.||.|+||.||.+...  ..+++|.+........  ...+.+|+.++..+.|+ +|+.+++.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            677788999999999999876  7889999887665543  67899999999999988 799999999777778999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC-ceEEeeeccCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF-KSKIADFNLTN  225 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Dfg~a~  225 (363)
                      +.+++|.+++......      ..+.......+..|++.++.|+|+.   +++|||+||+||+++..+ .++++|||++.
T Consensus        80 ~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~  150 (384)
T COG0515          80 VDGGSLEDLLKKIGRK------GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAK  150 (384)
T ss_pred             CCCCcHHHHHHhcccc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcce
Confidence            9999999777654311      1388999999999999999999999   999999999999999988 79999999987


Q ss_pred             CCCcccccc----cccccccccCCCCcccccc---CCCCccCceehhHHHHHHHHhCCCCCCCCCCc-cccchhhhcccc
Q 046595          226 QSSDTAARL----HSTRVLGTFGYHAPEYAMT---GQITQKSDVYSFGVVLLELLTGRKPVDHTMPK-GQQSLVTWATPR  297 (363)
Q Consensus       226 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~-~~~~~~~~~~~~  297 (363)
                      .........    ......|+..|++||.+.+   ..++...|+||+|++++++++|..||...... ............
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  230 (384)
T COG0515         151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL  230 (384)
T ss_pred             ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc
Confidence            554433221    2356789999999999987   57899999999999999999999997654321 000000000000


Q ss_pred             ccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          298 LSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                      ...     .................+.+++..++..+|..|.+..+....
T Consensus       231 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         231 PTP-----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             CCc-----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            000     000000001012233568899999999999999999887664

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=4.8e-25  Score=184.93  Aligned_cols=173  Identities=15%  Similarity=0.188  Sum_probs=134.5

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCch--HH------HHHHHHHHhcCCCCccceeeeEEEe
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPE--SD------FAAQLSVVSRLKHEHFVELLGYCME  136 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~--~~------~~~e~~~l~~l~h~~i~~~~~~~~~  136 (363)
                      .+.++|++.++||.|+||.||++.. ++..+++|++.........  ..      +.+|+..+.++.|++|..+.+++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            4678999999999999999999766 5778999999754332221  22      5789999999999999999988664


Q ss_pred             C--------CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCce
Q 046595          137 S--------NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNV  208 (363)
Q Consensus       137 ~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Ni  208 (363)
                      .        ...+++|||++|.+|.++..             ++.    ....+++.+|..||+.   |++|||+||+||
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Ni  166 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNF  166 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh-------------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHE
Confidence            3        35789999999999988732             332    2456889999999999   999999999999


Q ss_pred             eecCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHH
Q 046595          209 LLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELL  273 (363)
Q Consensus       209 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell  273 (363)
                      +++.+| ++|+|||...........   .           ..+....|+.++|+||||+++..+.
T Consensus       167 li~~~g-i~liDfg~~~~~~e~~a~---d-----------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        167 IVSKNG-LRIIDLSGKRCTAQRKAK---D-----------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEeCCC-EEEEECCCcccccchhhH---H-----------HHHHHhHhcccccccceeEeehHHH
Confidence            999988 999999987554322111   0           0244456778999999999987654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=3.2e-24  Score=178.02  Aligned_cols=141  Identities=19%  Similarity=0.164  Sum_probs=108.1

Q ss_pred             CCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCC-c-------h-----------------HHHHHHHHHHhcCCCCcc
Q 046595           73 KALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPE-P-------E-----------------SDFAAQLSVVSRLKHEHF  127 (363)
Q Consensus        73 ~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~-~-------~-----------------~~~~~e~~~l~~l~h~~i  127 (363)
                      ...||+|+||.||+|...+|+.||||+++...... .       .                 .....|+.++.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            45799999999999987789999999997643211 1       0                 122348999999987776


Q ss_pred             ceeeeEEEeCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHh-hccCCCCeEEecccCC
Q 046595          128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL-HEKVQPPIVHRDVRSS  206 (363)
Q Consensus       128 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l-H~~~~~~ivH~Dlkp~  206 (363)
                      .....+..  ...+|||||+.+++|...+....         .++...+..++.|++.+|.|+ |+.   ||+||||||+
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~---------~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~  147 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDA---------PLSESKARELYLQVIQIMRILYQDC---RLVHADLSEY  147 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcC---------CCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHH
Confidence            44333222  23489999999977765432221         288899999999999999999 688   9999999999


Q ss_pred             ceeecCCCceEEeeeccCCCCC
Q 046595          207 NVLLFDDFKSKIADFNLTNQSS  228 (363)
Q Consensus       207 Nill~~~~~vkl~Dfg~a~~~~  228 (363)
                      ||+++ ++.++|+|||+|....
T Consensus       148 NIli~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147         148 NLLYH-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             HEEEE-CCcEEEEEccccccCC
Confidence            99998 4789999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.91  E-value=4.4e-25  Score=212.62  Aligned_cols=250  Identities=18%  Similarity=0.207  Sum_probs=184.6

Q ss_pred             CCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHH---HHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           69 NFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFA---AQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~---~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      .|...+.||++.|=.|.+|++++|. |+||++.+....-....+.   .|++ ...++|||.+.+.-+-+.....|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            6778889999999999999998877 8999987654333334443   3444 555689999999888888888899999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |... +|+|.|..+.         ++..-+..-|+.|++.||.-+|..   ||+|||||.+||||+.=+=+.|+||..-+
T Consensus       102 yvkh-nLyDRlSTRP---------FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFK  168 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTRP---------FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFK  168 (1431)
T ss_pred             HHhh-hhhhhhccch---------HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccC
Confidence            9988 9999998765         488888899999999999999999   99999999999999998889999998654


Q ss_pred             CCCc-ccccccccccc----cccCCCCccccccC----------C-CCccCceehhHHHHHHHHh-CCCCCCCCCCcccc
Q 046595          226 QSSD-TAARLHSTRVL----GTFGYHAPEYAMTG----------Q-ITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQ  288 (363)
Q Consensus       226 ~~~~-~~~~~~~~~~~----gt~~y~aPE~~~~~----------~-~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~  288 (363)
                      ...- .+.....+.+.    .-..|.|||.+...          . .+++.||||+||++.||++ |+++|.-.      
T Consensus       169 PtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------  242 (1431)
T KOG1240|consen  169 PTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------  242 (1431)
T ss_pred             CccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------
Confidence            3221 11111111122    23479999988541          1 4678999999999999999 67888521      


Q ss_pred             chhhhccc-cccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 046595          289 SLVTWATP-RLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQP  350 (363)
Q Consensus       289 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~  350 (363)
                      ++..|... ....+.+.+.+           ....++.++..|++.||.+|.++++.|+....
T Consensus       243 QL~aYr~~~~~~~e~~Le~I-----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  243 QLLAYRSGNADDPEQLLEKI-----------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             HHHhHhccCccCHHHHHHhC-----------cCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence            22222221 11111111111           11248999999999999999999999988543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.90  E-value=5.7e-25  Score=201.78  Aligned_cols=233  Identities=24%  Similarity=0.306  Sum_probs=188.2

Q ss_pred             eeeccCCceEEEEEe----CCCCeEEEEEccCCCCCCc-hHHHHHHHHHHhcCC-CCccceeeeEEEeCCeeEEEEeccc
Q 046595           75 LIGEGSYGRVFYAKL----TDGTPAAIKKLDTSSAPEP-ESDFAAQLSVVSRLK-HEHFVELLGYCMESNNRILVYQFAT  148 (363)
Q Consensus        75 ~lg~G~~g~V~~~~~----~~~~~~avK~~~~~~~~~~-~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~  148 (363)
                      ++|.|.||.|++++.    ..+..+++|+......... ......|..++...+ ||.++++.-.+..+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999998843    3477789998876542221 225566788888886 9999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCC
Q 046595          149 MGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS  228 (363)
Q Consensus       149 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~  228 (363)
                      +|.|...+.+...         +.+.........++-+++++|+.   +++|||+|++||+++.+|++++.|||+++...
T Consensus        81 gg~lft~l~~~~~---------f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v  148 (612)
T KOG0603|consen   81 GGDLFTRLSKEVM---------FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAV  148 (612)
T ss_pred             cchhhhccccCCc---------hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhH
Confidence            9999998887653         77778888888899999999999   99999999999999999999999999987654


Q ss_pred             cccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccC
Q 046595          229 DTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD  308 (363)
Q Consensus       229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (363)
                      ....      .+||..|||||+++  ....++|.||||++++||++|..||...                   .+..+. 
T Consensus       149 ~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~-------------------~~~~Il-  200 (612)
T KOG0603|consen  149 KEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD-------------------TMKRIL-  200 (612)
T ss_pred             hhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH-------------------HHHHHh-
Confidence            4332      28999999999988  6788899999999999999999999741                   111111 


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH--HHHHHHh
Q 046595          309 PKLNNDYPPKAIAKLAAVAALCVQYEADFRPNM--TIVVKAL  348 (363)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~--~~vl~~l  348 (363)
                       +.....|.+......+++..++..+|..|--.  ..+.++.
T Consensus       201 -~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik  241 (612)
T KOG0603|consen  201 -KAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK  241 (612)
T ss_pred             -hhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence             12245577888889999999999999999755  3444443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=1.1e-23  Score=206.09  Aligned_cols=250  Identities=21%  Similarity=0.235  Sum_probs=184.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC---CCccceeeeEEEeCCeeEEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK---HEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv  143 (363)
                      ...|.+.+.||+|+||.||+|...+++.||+|+-+....++-..    -.+++.||+   -+.|+.+...+.-.+..++|
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI----~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv  772 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI----CLQVMERLKPQMLPSIMHISSAHVFQNASVLV  772 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee----hHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence            45688999999999999999998889999999988766555431    123344443   23455666556667778899


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec-------CCCce
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF-------DDFKS  216 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~-------~~~~v  216 (363)
                      +||.+.|+|.+++...+         .+++..++.++.|++..++.||..   +|||+||||+|+||.       +...+
T Consensus       773 ~ey~~~Gtlld~~N~~~---------~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l  840 (974)
T KOG1166|consen  773 SEYSPYGTLLDLINTNK---------VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGL  840 (974)
T ss_pred             eeccccccHHHhhccCC---------CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccce
Confidence            99999999999998544         389999999999999999999999   999999999999995       23468


Q ss_pred             EEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccc
Q 046595          217 KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATP  296 (363)
Q Consensus       217 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~  296 (363)
                      +|+|||.+-...--.........++|-.+-.+|+..|..++..+|.|.|+.+++-||.|+.-=            .|...
T Consensus       841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------~~~g~  908 (974)
T KOG1166|consen  841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------VKNGS  908 (974)
T ss_pred             EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------hcCCc
Confidence            999999875433222222345677899999999999999999999999999999999998421            01110


Q ss_pred             cccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          297 RLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                      .+       .++..+..-+..+   .+.+++..+|..|-..=|...++...|+..+++
T Consensus       909 ~~-------~~~~~~~Ry~~~~---~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~  956 (974)
T KOG1166|consen  909 SW-------MVKTNFPRYWKRD---MWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE  956 (974)
T ss_pred             ce-------eccccchhhhhHH---HHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence            00       0111111111112   255666777777777778888888888876653

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.90  E-value=9.4e-24  Score=182.39  Aligned_cols=238  Identities=18%  Similarity=0.225  Sum_probs=150.3

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC--CchHHHHHHHHHHhcCC----------CCccceeeeEEE
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP--EPESDFAAQLSVVSRLK----------HEHFVELLGYCM  135 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~~~e~~~l~~l~----------h~~i~~~~~~~~  135 (363)
                      .+..+..||.|+++.||.+++. +++.+++|++......  ...+.+.+|.-....+.          |-.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3455778999999999999865 5899999998664422  23456666665544432          222333233221


Q ss_pred             ---------eCC--------eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCe
Q 046595          136 ---------ESN--------NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPI  198 (363)
Q Consensus       136 ---------~~~--------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i  198 (363)
                               ...        +.+++|.-+.+ +|.+++..-......  ...+.....+.+..|+++.+++||++   |+
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~--~~~l~~~arl~lT~Q~I~lvA~Lh~~---Gl  166 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQT--HSPLAFAARLSLTVQMIRLVANLHSY---GL  166 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTT--SHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccc--cchhHHHHHHHHHHHHHHHHHHHhhc---ce
Confidence                     111        33567777754 888876531111100  11244555667779999999999999   99


Q ss_pred             EEecccCCceeecCCCceEEeeeccCCCCCcccccccccccccccCCCCcccccc--------CCCCccCceehhHHHHH
Q 046595          199 VHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT--------GQITQKSDVYSFGVVLL  270 (363)
Q Consensus       199 vH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~~l~  270 (363)
                      +|+||+|+|++++.+|.++|+||+...........     ...+..|.+||....        ..++.+.|.|+||+++|
T Consensus       167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly  241 (288)
T PF14531_consen  167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY  241 (288)
T ss_dssp             EEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred             EecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence            99999999999999999999999976554443221     234578999997643        24788999999999999


Q ss_pred             HHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCC
Q 046595          271 ELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFR  338 (363)
Q Consensus       271 ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R  338 (363)
                      .|.++..||+...+......                    ....+. +.++.+..||..+|+.||++|
T Consensus       242 ~lWC~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  242 SLWCGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999999975433211110                    113445 788899999999999999988

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=6.9e-23  Score=170.66  Aligned_cols=141  Identities=19%  Similarity=0.164  Sum_probs=110.4

Q ss_pred             CCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCC--------------------c-----hHHHHHHHHHHhcCCCCcc
Q 046595           73 KALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPE--------------------P-----ESDFAAQLSVVSRLKHEHF  127 (363)
Q Consensus        73 ~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~--------------------~-----~~~~~~e~~~l~~l~h~~i  127 (363)
                      .+.||+|+||.||+|...+|+.||||++.......                    .     ...+..|...+.++.|++|
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            46799999999999987789999999987642110                    0     1123578899999999887


Q ss_pred             ceeeeEEEeCCeeEEEEecccCCChhhh-hcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-cCCCCeEEecccC
Q 046595          128 VELLGYCMESNNRILVYQFATMGSLHDV-LHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE-KVQPPIVHRDVRS  205 (363)
Q Consensus       128 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp  205 (363)
                      .....+...  ..+|||||+.|+++... +...          .++...+..++.|++.+|.++|+ .   ||+||||||
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~----------~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP  146 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV----------PLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSE  146 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhhc----------cCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCCh
Confidence            554443332  34899999998755443 3322          26788999999999999999999 8   999999999


Q ss_pred             CceeecCCCceEEeeeccCCCCCc
Q 046595          206 SNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       206 ~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      +||+++ ++.++|+|||++.....
T Consensus       147 ~NIll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         147 YNILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             hhEEEE-CCCEEEEEcccceecCC
Confidence            999998 88999999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=5.5e-23  Score=168.84  Aligned_cols=187  Identities=13%  Similarity=0.097  Sum_probs=140.3

Q ss_pred             CCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCc---hHHHHHHHHHHhcCC-CCccceeeeEEEeCCeeEEEEec
Q 046595           71 GTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEP---ESDFAAQLSVVSRLK-HEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        71 ~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      .+...|++|+||+|+++.. .+.+++.+.+........   ...+.+|+++|++|. |++|++++++    ...+++|+|
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3456799999999998866 678888777766443222   235789999999995 5889999886    346899999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecc-cCCceeecCCCceEEeeeccCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDV-RSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dl-kp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      +.|.+|...+..                ....++.|++.+|.++|++   ||+|||| ||+|||++.++.++|+|||++.
T Consensus        80 I~G~~L~~~~~~----------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~  140 (218)
T PRK12274         80 LAGAAMYQRPPR----------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAV  140 (218)
T ss_pred             ecCccHHhhhhh----------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCce
Confidence            999888654321                1134778999999999999   9999999 7999999999999999999997


Q ss_pred             CCCccccc----c-------cccccccccCCCCccccccC-CCC-ccCceehhHHHHHHHHhCCCCCCC
Q 046595          226 QSSDTAAR----L-------HSTRVLGTFGYHAPEYAMTG-QIT-QKSDVYSFGVVLLELLTGRKPVDH  281 (363)
Q Consensus       226 ~~~~~~~~----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~~l~ell~g~~p~~~  281 (363)
                      ........    .       ...-...++.|++|+...-. ..+ ...+.++.|+-+|.++|++.++..
T Consensus       141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            54433210    0       00112367888888754432 333 567889999999999999988643

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=5.7e-22  Score=172.49  Aligned_cols=198  Identities=19%  Similarity=0.235  Sum_probs=142.6

Q ss_pred             CCCccceeeeEEEe---------------------------CCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHH
Q 046595          123 KHEHFVELLGYCME---------------------------SNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQ  175 (363)
Q Consensus       123 ~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~  175 (363)
                      .||||+.+.++|.+                           ...+|+||..++. +|..++..+.          .+...
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----------~s~r~  342 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----------RSYRT  342 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----------CchHH
Confidence            59999999876642                           2356899998877 9999998765          66777


Q ss_pred             HHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec--CCC--ceEEeeeccCCCCCc----ccccccccccccccCCCC
Q 046595          176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF--DDF--KSKIADFNLTNQSSD----TAARLHSTRVLGTFGYHA  247 (363)
Q Consensus       176 ~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~--~~~--~vkl~Dfg~a~~~~~----~~~~~~~~~~~gt~~y~a  247 (363)
                      ..-++.|+++|+.|||++   ||.|||+|.+|||+.  +|+  .+.|.|||.+-....    .......-...|...-||
T Consensus       343 ~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmA  419 (598)
T KOG4158|consen  343 GRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMA  419 (598)
T ss_pred             HHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecc
Confidence            778999999999999999   999999999999993  443  568899997643222    111111222457888999


Q ss_pred             ccccccCC------CCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCCCCCCHHHHH
Q 046595          248 PEYAMTGQ------ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIA  321 (363)
Q Consensus       248 PE~~~~~~------~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (363)
                      ||+....+      --.++|.|+.|.+.||++....||-..... .          ++...+.+    .-...++..++.
T Consensus       420 PEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~----------L~~r~Yqe----~qLPalp~~vpp  484 (598)
T KOG4158|consen  420 PEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-L----------LDTRTYQE----SQLPALPSRVPP  484 (598)
T ss_pred             hhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-e----------echhhhhh----hhCCCCcccCCh
Confidence            99876432      236899999999999999999999642110 0          00011111    111344567778


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 046595          322 KLAAVAALCVQYEADFRPNMTIVVKALQ  349 (363)
Q Consensus       322 ~l~~li~~cl~~~p~~RPs~~~vl~~l~  349 (363)
                      .+.+++...|+.||.+|++..-....|+
T Consensus       485 ~~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  485 VARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHHHHHHhcCCccccCCccHHHhHHH
Confidence            8999999999999999999876555443

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.86  E-value=2e-21  Score=178.32  Aligned_cols=219  Identities=23%  Similarity=0.378  Sum_probs=163.2

Q ss_pred             HhcCCCCccceeeeEEEeCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCe
Q 046595          119 VSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPI  198 (363)
Q Consensus       119 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i  198 (363)
                      |+.+.|.|+.+++|.+.++...+.|.+||.-|+|.+.+.....        .+++.....+.++++.||.|||..   .|
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~--------~~d~~F~~s~~rdi~~Gl~ylh~s---~i   69 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI--------KLDYFFILSFIRDISKGLAYLHNS---PI   69 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc--------CccHHHHHHHHHHHHHHHHHHhcC---cc
Confidence            4578999999999999999999999999999999999987332        388889999999999999999988   55


Q ss_pred             -EEecccCCceeecCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCC-------CCccCceehhHHHHH
Q 046595          199 -VHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQ-------ITQKSDVYSFGVVLL  270 (363)
Q Consensus       199 -vH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~~l~  270 (363)
                       .|+.++..|++++..-.+||+|||+.................-...|.|||.+.+..       .+.+.|+||||++++
T Consensus        70 ~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~  149 (484)
T KOG1023|consen   70 GYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMY  149 (484)
T ss_pred             eeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHH
Confidence             999999999999999999999999976654311111111122345799999987641       467799999999999


Q ss_pred             HHHhCCCCCCCCCCcccc-chhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 046595          271 ELLTGRKPVDHTMPKGQQ-SLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ  349 (363)
Q Consensus       271 ell~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~  349 (363)
                      |+++.+.||......... ..+....    . .-...+.+.+...  .+.++.+..++..||..+|.+||++++|...++
T Consensus       150 ei~~r~~~~~~~~~~~~~~eii~~~~----~-~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~  222 (484)
T KOG1023|consen  150 EILFRSGPFDLRNLVEDPDEIILRVK----K-GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLL  222 (484)
T ss_pred             HHHhccCccccccccCChHHHHHHHH----h-cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhh
Confidence            999999999754322211 1111100    0 0001111111111  144557999999999999999999999999998


Q ss_pred             cccccC
Q 046595          350 PLLNSK  355 (363)
Q Consensus       350 ~l~~~~  355 (363)
                      .+....
T Consensus       223 ~~~~~~  228 (484)
T KOG1023|consen  223 TINKGG  228 (484)
T ss_pred             hhcccc
Confidence            877653

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=6.1e-21  Score=159.76  Aligned_cols=135  Identities=13%  Similarity=0.169  Sum_probs=104.2

Q ss_pred             CCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-----CCCccceeeeEEEeCC---eeE-E
Q 046595           72 TKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-----KHEHFVELLGYCMESN---NRI-L  142 (363)
Q Consensus        72 ~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~~~-l  142 (363)
                      -...||+|+||.||.  +......+||++.... ......+.+|+.+++.+     +||||+++++++.+..   ..+ +
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCeEEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            356799999999995  4433334789886632 23456789999999999     5799999999998874   333 7


Q ss_pred             EEec--ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHH-HHhhccCCCCeEEecccCCceeecC----CCc
Q 046595          143 VYQF--ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL-EFLHEKVQPPIVHRDVRSSNVLLFD----DFK  215 (363)
Q Consensus       143 v~e~--~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l-~~lH~~~~~~ivH~Dlkp~Nill~~----~~~  215 (363)
                      |+||  +.+++|.+++....          +++.  ..++.+++.++ +|||++   +|+||||||+|||++.    ++.
T Consensus        83 I~e~~G~~~~tL~~~l~~~~----------~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~  147 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQCR----------YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVI  147 (210)
T ss_pred             EecCCCCcchhHHHHHHccc----------ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCc
Confidence            8999  55789999997532          4444  35677888777 999999   9999999999999974    347


Q ss_pred             eEEeeeccC
Q 046595          216 SKIADFNLT  224 (363)
Q Consensus       216 vkl~Dfg~a  224 (363)
                      ++|+||+.+
T Consensus       148 ~~LiDg~G~  156 (210)
T PRK10345        148 PVVCDNIGE  156 (210)
T ss_pred             EEEEECCCC
Confidence            999995543

>smart00090 RIO RIO-like kinase

Probab=99.84  E-value=1.8e-20  Score=160.79  Aligned_cols=144  Identities=17%  Similarity=0.127  Sum_probs=111.8

Q ss_pred             CCCCCCeeeccCCceEEEEE--eCCCCeEEEEEccCCCCCC-----------------------chHHHHHHHHHHhcCC
Q 046595           69 NFGTKALIGEGSYGRVFYAK--LTDGTPAAIKKLDTSSAPE-----------------------PESDFAAQLSVVSRLK  123 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~--~~~~~~~avK~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~  123 (363)
                      -|.+.+.||+|+||.||+|.  ..+|+.||+|++.......                       ....+..|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999998  5689999999987542110                       0123568999999997


Q ss_pred             CC--ccceeeeEEEeCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCC-eEE
Q 046595          124 HE--HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPP-IVH  200 (363)
Q Consensus       124 h~--~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-ivH  200 (363)
                      +.  .+.+++++    ...++||||+.+.+|........         .+...++..++.|++.+|.+||++   | |+|
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH  172 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---------EPEEEEEFELYDDILEEMRKLYKE---GELVH  172 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---------CcchHHHHHHHHHHHHHHHHHHhc---CCEEe
Confidence            53  34455543    23589999999988876543221         155667789999999999999999   9 999


Q ss_pred             ecccCCceeecCCCceEEeeeccCCCCCc
Q 046595          201 RDVRSSNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       201 ~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      +||||+||+++ ++.++|+|||.+.....
T Consensus       173 ~Dikp~NIli~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      173 GDLSEYNILVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             CCCChhhEEEE-CCCEEEEEChhhhccCC
Confidence            99999999999 88999999998765433

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.84  E-value=7.3e-22  Score=178.11  Aligned_cols=173  Identities=22%  Similarity=0.325  Sum_probs=129.2

Q ss_pred             eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEE
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI  218 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl  218 (363)
                      .+++.|++|...+|.++|......      ...++...+.++.|++.|++|   +   +.+|+|+||.||+...+..+||
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~------e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kI  397 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTG------EERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKI  397 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcc------cccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhh
Confidence            578999999999999999765432      236788899999999999999   6   8999999999999999999999


Q ss_pred             eeeccCCCCCccc----ccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhh
Q 046595          219 ADFNLTNQSSDTA----ARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTW  293 (363)
Q Consensus       219 ~Dfg~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~  293 (363)
                      .|||+........    .....+...||.+||+||++.+..|+.++||||||++|+|++. =...|...           
T Consensus       398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~-----------  466 (516)
T KOG1033|consen  398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI-----------  466 (516)
T ss_pred             hhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-----------
Confidence            9999976554433    2223556789999999999999999999999999999999998 23333211           


Q ss_pred             ccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 046595          294 ATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMT  342 (363)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~  342 (363)
                             ..+.++.+..+...+..+. +.-..|+.+++...|.+||++.
T Consensus       467 -------~t~~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~  507 (516)
T KOG1033|consen  467 -------ATLTDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAI  507 (516)
T ss_pred             -------HhhhhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHH
Confidence                   0111111111111111112 2345788999999999999443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.82  E-value=5.6e-21  Score=184.28  Aligned_cols=208  Identities=23%  Similarity=0.322  Sum_probs=142.1

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCC-CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      .+|..++.+-.|++|.||+++++. .+.+|+| +.+..      .+.+.  ++....+|.+|                  
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~------lilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN------LILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccc------hhhhc--cccccCCccee------------------
Confidence            478899999999999999998774 5667773 33211      11111  33333444444                  


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                         |+=...+...+.         ++        .+++.+++|||+.   +|+|||+||+|.+|+.-|++|++|||+++.
T Consensus       136 ---gDc~tllk~~g~---------lP--------vdmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~  192 (1205)
T KOG0606|consen  136 ---GDCATLLKNIGP---------LP--------VDMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKK  192 (1205)
T ss_pred             ---chhhhhcccCCC---------Cc--------chhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhh
Confidence               233333332211         21        1227899999999   999999999999999999999999998753


Q ss_pred             CCcc------------ccccc-ccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhh
Q 046595          227 SSDT------------AARLH-STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTW  293 (363)
Q Consensus       227 ~~~~------------~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~  293 (363)
                      ....            ..+.. ....+||+.|.|||++....|+..+|+|++|+++||.+-|..||.+..+......+. 
T Consensus       193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi-  271 (1205)
T KOG0606|consen  193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI-  271 (1205)
T ss_pred             hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh-
Confidence            2211            11111 233589999999999999999999999999999999999999998775532111110 


Q ss_pred             ccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCC
Q 046595          294 ATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP  339 (363)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP  339 (363)
                           .  ....+      .+-....+.+..+++..+|+.+|..|-
T Consensus       272 -----s--d~i~w------pE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  272 -----S--DDIEW------PEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             -----h--hhccc------cccCcCCCHHHHHHHHHHHHhChHhhc
Confidence                 0  00001      111234456799999999999999995

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=1.5e-19  Score=153.52  Aligned_cols=135  Identities=21%  Similarity=0.298  Sum_probs=112.6

Q ss_pred             CeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCc-------hHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           74 ALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEP-------ESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      +.||+|++|.||+|.+ ++..+++|+.........       ...+.+|+.++..+.|++|.....++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5699999999999987 577899998654322111       13577899999999999988777777777888999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      ++|++|.+++...            .. ....++.+++.+|.++|+.   +++|+|++|.||+++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~------------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999998642            12 7889999999999999999   999999999999999 78999999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.80  E-value=4.2e-19  Score=149.31  Aligned_cols=131  Identities=22%  Similarity=0.303  Sum_probs=106.0

Q ss_pred             eeeccCCceEEEEEeCCCCeEEEEEccCCCCCC-c------hHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           75 LIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPE-P------ESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        75 ~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~-~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      .||+|+||.||++.+ ++..+++|+........ .      ..++.+|+.+++.+.|+++.....++......+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999985 57889999865432111 1      245678999999998887665555555667779999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +|++|.+++....          .      .++.+++.+|.+||+.   +++|+|++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~----------~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN----------D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH----------H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999998875421          1      7889999999999999   999999999999999 88999999998754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.80  E-value=3.7e-19  Score=149.44  Aligned_cols=140  Identities=19%  Similarity=0.153  Sum_probs=109.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCC---------------------CchHHHHHHHHHHhcCCCC-
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAP---------------------EPESDFAAQLSVVSRLKHE-  125 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~---------------------~~~~~~~~e~~~l~~l~h~-  125 (363)
                      ..|.+.+.||+|+||.||++...+|+.|+||++......                     ........|+.++..+.|. 
T Consensus        15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            348889999999999999998888999999987653210                     0012356788888888776 


Q ss_pred             -ccceeeeEEEeCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEeccc
Q 046595          126 -HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVR  204 (363)
Q Consensus       126 -~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlk  204 (363)
                       .+...++    ....+++|||+.|++|......               .....++.+++.++.++|+.   +|+|+|||
T Consensus        95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~  152 (198)
T cd05144          95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------------EDPEEVLDEILEEIVKAYKH---GIIHGDLS  152 (198)
T ss_pred             CCCCceee----cCCceEEEEEeCCcchhhcccc---------------ccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence             4444444    2345899999999998765431               22457888999999999999   99999999


Q ss_pred             CCceeecCCCceEEeeeccCCCCCc
Q 046595          205 SSNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       205 p~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      |+||++++++.++|+|||++.....
T Consensus       153 p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         153 EFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             cccEEEcCCCcEEEEECCccccCCC
Confidence            9999999999999999999855443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.80  E-value=4.2e-19  Score=170.89  Aligned_cols=138  Identities=20%  Similarity=0.241  Sum_probs=110.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEc-cCCCCCC------chHHHHHHHHHHhcCCCCccceeeeEEEeCCe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKL-DTSSAPE------PESDFAAQLSVVSRLKHEHFVELLGYCMESNN  139 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~-~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  139 (363)
                      ...|...+.||+|+||.||++.+.+.. +++|+. .......      ...++.+|+.+++.++|++++....++.....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            345677889999999999999876443 444432 2211111      12467899999999999999988877777778


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEe
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA  219 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~  219 (363)
                      .++||||+++++|.+++.                 ....++.+++.+|.+||+.   +++||||||+||++ +++.++|+
T Consensus       411 ~~lv~E~~~g~~L~~~l~-----------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~li  469 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE-----------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLI  469 (535)
T ss_pred             CEEEEEecCCCcHHHHHH-----------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEE
Confidence            899999999999998875                 2357889999999999999   99999999999999 67899999


Q ss_pred             eeccCCC
Q 046595          220 DFNLTNQ  226 (363)
Q Consensus       220 Dfg~a~~  226 (363)
                      |||+++.
T Consensus       470 DFGla~~  476 (535)
T PRK09605        470 DFGLGKY  476 (535)
T ss_pred             eCccccc
Confidence            9999864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=5.8e-20  Score=176.39  Aligned_cols=255  Identities=20%  Similarity=0.280  Sum_probs=190.8

Q ss_pred             CCCCCCeeeccCCceEEEEEeCC--CCeEEEEEccCCC-CCCchHHHHHHHHHHhcCC-CCccceeeeEEEeCCeeEEEE
Q 046595           69 NFGTKALIGEGSYGRVFYAKLTD--GTPAAIKKLDTSS-APEPESDFAAQLSVVSRLK-HEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~avK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      .|.+.+.||+|+|+.|-......  ...+++|.+.... ..........|..+-..+. |.|++.+++...+.+..++++
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            56677779999999999886533  4445665554432 2222344555777777776 999999999999999999999


Q ss_pred             ecccCCChhhhhc-CCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh-ccCCCCeEEecccCCceeecCCC-ceEEeee
Q 046595          145 QFATMGSLHDVLH-GRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH-EKVQPPIVHRDVRSSNVLLFDDF-KSKIADF  221 (363)
Q Consensus       145 e~~~~g~L~~~l~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Df  221 (363)
                      +|..|+++.+.+. ....        ..+....-..+.|+..++.|+| ..   ++.|+||||+|.+++..+ .+++.||
T Consensus       101 ~~s~g~~~f~~i~~~~~~--------~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df  169 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPDST--------GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADF  169 (601)
T ss_pred             CcccccccccccccCCcc--------CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCc
Confidence            9999999999884 3220        1556667788999999999999 87   999999999999999999 9999999


Q ss_pred             ccCCCCCc-cccccccccccc-ccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 046595          222 NLTNQSSD-TAARLHSTRVLG-TFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL  298 (363)
Q Consensus       222 g~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  298 (363)
                      |+|..+.. ..........+| ++.|+|||.+.+. ......|+||.|+++.-+++|..||......+... ..|.... 
T Consensus       170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-~~~~~~~-  247 (601)
T KOG0590|consen  170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-SSWKSNK-  247 (601)
T ss_pred             hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-eeecccc-
Confidence            99987776 333334455678 9999999998874 55788999999999999999999998665544221 1111111 


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          299 SEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                                ................+++.+++..+|..|.+.+++..
T Consensus       248 ----------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  248 ----------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ----------cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence                      00001112233445788888999999999999988764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.75  E-value=7.8e-18  Score=140.14  Aligned_cols=138  Identities=21%  Similarity=0.226  Sum_probs=98.6

Q ss_pred             CCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCc-hHH----------------------HHHHHHHHhcCCCC--cc
Q 046595           73 KALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEP-ESD----------------------FAAQLSVVSRLKHE--HF  127 (363)
Q Consensus        73 ~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~-~~~----------------------~~~e~~~l~~l~h~--~i  127 (363)
                      .+.||+|+||.||+|...+++.||||++........ ...                      ...|...+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            567999999999999887899999999865321111 111                      13455555555433  24


Q ss_pred             ceeeeEEEeCCeeEEEEecccCCChhhh-hcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-cCCCCeEEecccC
Q 046595          128 VELLGYCMESNNRILVYQFATMGSLHDV-LHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE-KVQPPIVHRDVRS  205 (363)
Q Consensus       128 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp  205 (363)
                      .+.++.    ...+++|||+.++++... +....          . ..+...++.+++.++.++|. .   +|+|+||||
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----------~-~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p  143 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----------L-LEDPEELYDQILELMRKLYREA---GLVHGDLSE  143 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh----------h-cccHHHHHHHHHHHHHHHhhcc---CcCcCCCCh
Confidence            444443    346899999999654321 21111          1 15677899999999999999 8   999999999


Q ss_pred             CceeecCCCceEEeeeccCCCCCc
Q 046595          206 SNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       206 ~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      +||+++ ++.++|+|||.+.....
T Consensus       144 ~Nili~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         144 YNILVD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             hhEEEE-CCcEEEEECcccccccC
Confidence            999999 89999999999865443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.73  E-value=4.7e-17  Score=139.94  Aligned_cols=137  Identities=13%  Similarity=0.172  Sum_probs=104.8

Q ss_pred             CCeee-ccCCceEEEEEeCCCCeEEEEEccCCC------------CCCchHHHHHHHHHHhcCCCCcc--ceeeeEEEeC
Q 046595           73 KALIG-EGSYGRVFYAKLTDGTPAAIKKLDTSS------------APEPESDFAAQLSVVSRLKHEHF--VELLGYCMES  137 (363)
Q Consensus        73 ~~~lg-~G~~g~V~~~~~~~~~~~avK~~~~~~------------~~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~  137 (363)
                      ...|| .||.|+||.+... +..+++|.+....            ......++.+|+.++.++.|++|  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            34687 8999999999875 7788998875311            01223567889999999988775  6666664433


Q ss_pred             Ce----eEEEEecccC-CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC
Q 046595          138 NN----RILVYQFATM-GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD  212 (363)
Q Consensus       138 ~~----~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~  212 (363)
                      ..    .++|||+++| .+|.+++....          ++..    .+.+++.+|.+||+.   ||+|+||||+|||++.
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~----------l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~  177 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEAP----------LSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDP  177 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcCC----------CCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcC
Confidence            22    2599999997 68988886432          4433    356889999999999   9999999999999999


Q ss_pred             CCceEEeeeccCCCC
Q 046595          213 DFKSKIADFNLTNQS  227 (363)
Q Consensus       213 ~~~vkl~Dfg~a~~~  227 (363)
                      ++.++|+|||.+...
T Consensus       178 ~~~v~LIDfg~~~~~  192 (239)
T PRK01723        178 DGKFWLIDFDRGELR  192 (239)
T ss_pred             CCCEEEEECCCcccC
Confidence            899999999987653

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.71  E-value=1.4e-16  Score=127.57  Aligned_cols=135  Identities=18%  Similarity=0.195  Sum_probs=111.4

Q ss_pred             CCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCC--CccceeeeEEEeCCeeEEEEecccC
Q 046595           72 TKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKH--EHFVELLGYCMESNNRILVYQFATM  149 (363)
Q Consensus        72 ~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~  149 (363)
                      +.+.||+|.++.||++...+ ..+++|.......   ...+..|+.+++.++|  .++++++.+....+..+++|||+.+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            35679999999999998754 7899998865432   4578899999999976  5899999888877889999999998


Q ss_pred             CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          150 GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       150 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+..+                +......++.+++.+|.+||.....+++|+|++|+||+++..+.++++|||.+..
T Consensus        78 ~~~~~~----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             eecccC----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            777544                2345567888999999999986323699999999999999999999999998754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.67  E-value=3.9e-16  Score=143.82  Aligned_cols=251  Identities=23%  Similarity=0.266  Sum_probs=182.6

Q ss_pred             hcCCCCCCeeec--cCCceEEEEEe---CCCCeEEEEEccCCCCCC-chHHHHHHHHHHhcC-CCCccceeeeEEEeCCe
Q 046595           67 TSNFGTKALIGE--GSYGRVFYAKL---TDGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRL-KHEHFVELLGYCMESNN  139 (363)
Q Consensus        67 ~~~y~~~~~lg~--G~~g~V~~~~~---~~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~  139 (363)
                      ...+.+.+.+|.  |.+|.||.+..   .++..+++|.-+...... ...+-.+|+.....+ .|++.++.+..+...+.
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence            456778888999  99999999965   367888988854432221 122344566666666 49999999999999999


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHH----HHHHhhccCCCCeEEecccCCceeecCC-C
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK----GLEFLHEKVQPPIVHRDVRSSNVLLFDD-F  214 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~----~l~~lH~~~~~~ivH~Dlkp~Nill~~~-~  214 (363)
                      .++-+|++. .+|..+......        .+....++..+.+...    ||.++|+.   +++|-|+||.||++..+ .
T Consensus       193 lfiqtE~~~-~sl~~~~~~~~~--------~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~  260 (524)
T KOG0601|consen  193 LFIQTELCG-ESLQSYCHTPCN--------FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWT  260 (524)
T ss_pred             ceeeecccc-chhHHhhhcccc--------cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccc
Confidence            999999986 588888876543        2677788888888888    99999999   99999999999999998 8


Q ss_pred             ceEEeeeccCCCCCcccccc---cccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchh
Q 046595          215 KSKIADFNLTNQSSDTAARL---HSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLV  291 (363)
Q Consensus       215 ~vkl~Dfg~a~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~  291 (363)
                      ..+++|||+...........   ......|...|++||.+ .+.++...|+|++|.++.+..++.......-      ..
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~------~~  333 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGK------NS  333 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCC------CC
Confidence            89999999987665443221   11223688899999954 4788999999999999999999876543210      00


Q ss_pred             hhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          292 TWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .|..       ++..   .+..++-.....++...+..+++.+|..|++.+.+..
T Consensus       334 ~W~~-------~r~~---~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  334 SWSQ-------LRQG---YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             Cccc-------cccc---cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            0111       1111   1222222233445666899999999999999887654

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.60  E-value=5.6e-15  Score=137.88  Aligned_cols=143  Identities=22%  Similarity=0.249  Sum_probs=97.4

Q ss_pred             CCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCc-------------------------h--------------HHHH
Q 046595           73 KALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEP-------------------------E--------------SDFA  113 (363)
Q Consensus        73 ~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~-------------------------~--------------~~~~  113 (363)
                      .+.||+|++|.||+|+.++|+.||||+.+......-                         .              -++.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            357999999999999999999999999864321000                         0              0133


Q ss_pred             HHHHHHhcC----CCCccceeeeEE-EeCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHH-HH
Q 046595          114 AQLSVVSRL----KHEHFVELLGYC-MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK-GL  187 (363)
Q Consensus       114 ~e~~~l~~l----~h~~i~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~-~l  187 (363)
                      +|+..+.++    .|.+-+.+-.++ ......++||||++|++|.++......        ...   ...++..++. .+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--------~~~---~~~ia~~~~~~~l  270 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--------GLD---RKALAENLARSFL  270 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--------CCC---HHHHHHHHHHHHH
Confidence            455444444    222222222222 223457899999999999887653211        022   2345555555 46


Q ss_pred             HHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCc
Q 046595          188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       188 ~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      ..+|..   |++|+|++|.||+++.++.++|+|||++.....
T Consensus       271 ~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       271 NQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            788988   999999999999999999999999999876553

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.55  E-value=5.5e-14  Score=131.14  Aligned_cols=168  Identities=20%  Similarity=0.275  Sum_probs=128.9

Q ss_pred             EeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCCChhhhhcCCCCCCCCCC
Q 046595           88 KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEP  167 (363)
Q Consensus        88 ~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~  167 (363)
                      +..++.+|.|+..+.... +......+-++.|+.++||||+++++.++.....|+|+|.+.  .|..++..         
T Consensus        33 ~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~---------  100 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE---------  100 (690)
T ss_pred             eeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH---------
Confidence            445788899998877554 444567788899999999999999999999999999999985  57777765         


Q ss_pred             CCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCcccccccccccccccCCCC
Q 046595          168 GPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA  247 (363)
Q Consensus       168 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  247 (363)
                         +....+...+.||+.||.|||+.+  +++|++|.-+.|+++..|..||++|.++.........  .....--..|..
T Consensus       101 ---l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~~  173 (690)
T KOG1243|consen  101 ---LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFDD  173 (690)
T ss_pred             ---hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhcccC
Confidence               446677778899999999999665  8999999999999999999999999987543332210  011111224556


Q ss_pred             ccccccCCCCccCceehhHHHHHHHHhCC
Q 046595          248 PEYAMTGQITQKSDVYSFGVVLLELLTGR  276 (363)
Q Consensus       248 PE~~~~~~~~~~~DvwslG~~l~ell~g~  276 (363)
                      |+.+-...  ...|.|-||++++|++.|.
T Consensus       174 P~~~~~s~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  174 PEEIDPSE--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             hhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence            65332222  4569999999999999993

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.50  E-value=3.8e-14  Score=133.85  Aligned_cols=148  Identities=16%  Similarity=0.195  Sum_probs=94.0

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeCC-CCeEEEEEccCCCCC---------------------C------------chHH
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAP---------------------E------------PESD  111 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~avK~~~~~~~~---------------------~------------~~~~  111 (363)
                      +...|.. +.||+|++|.||.|+.++ |+.||||+.+.....                     .            ....
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            3445776 689999999999999887 999999998753100                     0            0011


Q ss_pred             ------HHHHHHHHhcC----CCCccceeeeEEEe-CCeeEEEEecccCCChhhhh--cCCCCCCCCCCCCCcCHHHHHH
Q 046595          112 ------FAAQLSVVSRL----KHEHFVELLGYCME-SNNRILVYQFATMGSLHDVL--HGRKGVQGAEPGPVLTWNQRVK  178 (363)
Q Consensus       112 ------~~~e~~~l~~l----~h~~i~~~~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~~~~~~~~~~~~~  178 (363)
                            +.+|+..+.++    .+.+.+.+-.++.+ ....+|||||+.|+.|.++-  ...+.     ....+....+..
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~-----d~~~la~~~v~~  271 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGT-----DMKLLAERGVEV  271 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCC-----CHHHHHHHHHHH
Confidence                  23344333333    23333333333222 45678999999999997742  22110     000133333444


Q ss_pred             HHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC----ceEEeeeccCCCCCc
Q 046595          179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF----KSKIADFNLTNQSSD  229 (363)
Q Consensus       179 i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~----~vkl~Dfg~a~~~~~  229 (363)
                      ++.|++       ..   |++|+|+||.||+++.+|    .++++|||++.....
T Consensus       272 ~~~Qif-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        272 FFTQVF-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHH-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            444443       45   999999999999999888    999999999876544

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.49  E-value=1.6e-14  Score=123.62  Aligned_cols=204  Identities=21%  Similarity=0.298  Sum_probs=139.4

Q ss_pred             HHHhcCCCCccceeeeEEEeCC-----eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh
Q 046595          117 SVVSRLKHEHFVELLGYCMESN-----NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH  191 (363)
Q Consensus       117 ~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH  191 (363)
                      .-+-.+.|-||+++..||.+..     ...+++||+..|+|..+|+..+..+     ..+......+|+-||+.||.|||
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-----~a~~~~~wkkw~tqIlsal~yLh  193 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-----KALFQKAWKKWCTQILSALSYLH  193 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-----hhhhHHHHHHHHHHHHhhhhhhh
Confidence            3444557999999999886543     4679999999999999998755332     23778888899999999999999


Q ss_pred             ccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCccc---ccccccccccccCCCCccccccCCCCccCceehhHHH
Q 046595          192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTA---ARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVV  268 (363)
Q Consensus       192 ~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~  268 (363)
                      +. .+.|+|+.+..+.|++..+|-+|+.- +.-.......   .........+-++|.+||.-.....+..+|||+||+.
T Consensus       194 s~-~PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmc  271 (458)
T KOG1266|consen  194 SC-DPPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMC  271 (458)
T ss_pred             cc-CCccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHH
Confidence            96 55899999999999999998888742 2111111110   1111222356789999997666677889999999999


Q ss_pred             HHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          269 LLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       269 l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ..+|..+..--........        .......+...+...+           -..++.+|++..|..||++.+++.
T Consensus       272 AlemailEiq~tnseS~~~--------~ee~ia~~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  272 ALEMAILEIQSTNSESKVE--------VEENIANVIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HHHHHHheeccCCCcceee--------hhhhhhhheeeccCcc-----------ccCcCcccccCCCCCCcchhhhhc
Confidence            9999988753221111000        0000011111111122           345678999999999999998765

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.49  E-value=1.8e-13  Score=111.85  Aligned_cols=130  Identities=13%  Similarity=0.096  Sum_probs=94.5

Q ss_pred             CeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCcc-ceeeeEEEeCCeeEEEEecccCCCh
Q 046595           74 ALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF-VELLGYCMESNNRILVYQFATMGSL  152 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~g~L  152 (363)
                      +.|+.|.++.||+++.. +..+++|.......  ....+..|+.+++.+.+.++ .+++.+.  ....++||||++|.++
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            45889999999999875 77899998765322  22346789999988865444 4455443  3345899999999887


Q ss_pred             hhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccC--CCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          153 HDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV--QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       153 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      ...-              ..   ...++.+++.+|..||...  ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~~--------------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED--------------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc--------------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            5430              11   1235678999999999981  11259999999999999 67899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.47  E-value=1e-12  Score=108.22  Aligned_cols=138  Identities=20%  Similarity=0.211  Sum_probs=98.7

Q ss_pred             CCeeeccCCceEEEEEeCC-------CCeEEEEEccCCCC---------------------CCchHHHH----HHHHHHh
Q 046595           73 KALIGEGSYGRVFYAKLTD-------GTPAAIKKLDTSSA---------------------PEPESDFA----AQLSVVS  120 (363)
Q Consensus        73 ~~~lg~G~~g~V~~~~~~~-------~~~~avK~~~~~~~---------------------~~~~~~~~----~e~~~l~  120 (363)
                      ...||.|--+.||.|...+       +..+|||+.+....                     ......+.    +|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3568999999999997543       47899998753210                     01112222    7888998


Q ss_pred             cCCC--CccceeeeEEEeCCeeEEEEecccCCChhh-hhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHh-hccCCC
Q 046595          121 RLKH--EHFVELLGYCMESNNRILVYQFATMGSLHD-VLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL-HEKVQP  196 (363)
Q Consensus       121 ~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l-H~~~~~  196 (363)
                      ++..  -++...+++    ..-++||||+.+..+.. .+...          .++..+...+..+++.+|..| |+.   
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----------~~~~~~~~~i~~~i~~~l~~l~H~~---  144 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----------KLNDEEMKNAYYQVLSMMKQLYKEC---  144 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----------ccCHHHHHHHHHHHHHHHHHHHHhC---
Confidence            8853  456666654    45689999997754422 22221          145556777889999999999 888   


Q ss_pred             CeEEecccCCceeecCCCceEEeeeccCCCCC
Q 046595          197 PIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS  228 (363)
Q Consensus       197 ~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~  228 (363)
                      +|+|+||++.||+++ ++.++|+|||.+....
T Consensus       145 glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         145 NLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            999999999999997 4689999999875443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.39  E-value=5e-12  Score=108.01  Aligned_cols=143  Identities=20%  Similarity=0.252  Sum_probs=106.7

Q ss_pred             CeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCC--CccceeeeEEEeCC---eeEEEEeccc
Q 046595           74 ALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKH--EHFVELLGYCMESN---NRILVYQFAT  148 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~---~~~lv~e~~~  148 (363)
                      +.|+.|..+.||++...+|+.+++|.............+..|+.+++.+.+  ..+.+++.+.....   ..++||||+.
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            458999999999998776789999997654332234578899999999965  44677777765532   5689999999


Q ss_pred             CCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccC----------------------------------
Q 046595          149 MGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV----------------------------------  194 (363)
Q Consensus       149 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~----------------------------------  194 (363)
                      |.+|.+.+...          .++......++.+++.+|..||+..                                  
T Consensus        84 G~~l~~~~~~~----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (223)
T cd05154          84 GRVLRDRLLRP----------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE  153 (223)
T ss_pred             CEecCCCCCCC----------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence            98887765321          1556666677777777777777421                                  


Q ss_pred             -------------------CCCeEEecccCCceeecC--CCceEEeeeccCCC
Q 046595          195 -------------------QPPIVHRDVRSSNVLLFD--DFKSKIADFNLTNQ  226 (363)
Q Consensus       195 -------------------~~~ivH~Dlkp~Nill~~--~~~vkl~Dfg~a~~  226 (363)
                                         ...++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                               126799999999999998  67789999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.39  E-value=6.1e-12  Score=100.15  Aligned_cols=132  Identities=19%  Similarity=0.289  Sum_probs=97.6

Q ss_pred             CeeeccCCceEEEEEeCCCCeEEEEEcc-CCCCCCc------hHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           74 ALIGEGSYGRVFYAKLTDGTPAAIKKLD-TSSAPEP------ESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~~~~~avK~~~-~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      ..+++|+-+.++.+.+. |..+++|.-. +......      ..+..+|+.++..+.--.|..-+-+..+.....++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999775 4446666432 2221111      13567789999888654554444455667778899999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.|..|.+++....                ..++..+-.-+.-||..   ||+|+||.++||++..++ +.++|||++..
T Consensus        81 I~G~~lkd~l~~~~----------------~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEAR----------------PDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhcc----------------hHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99988888887531                34666777778899999   999999999999998765 99999999764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.37  E-value=4.9e-13  Score=123.56  Aligned_cols=246  Identities=19%  Similarity=0.183  Sum_probs=173.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe--CCCCeEEEEEccCCCCCCch-HHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKL--TDGTPAAIKKLDTSSAPEPE-SDFAAQLSVVSRL-KHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~~avK~~~~~~~~~~~-~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l  142 (363)
                      ..+|.++..||.|.|+.|+.+..  .++..|++|........... ..-..|+-+...+ .|.+++..+..|..-+..++
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i  343 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI  343 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence            34688889999999999999853  46888999987664422222 2223455555555 58889998888888888889


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCC-CceEEeee
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD-FKSKIADF  221 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~Df  221 (363)
                      =.||++++++...+.-..         .+.+...+.+..|++.++.++|+.   .++|+|+||+||++..+ +.-++.||
T Consensus       344 p~e~~~~~s~~l~~~~~~---------~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~  411 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRSVTSQ---------MLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDF  411 (524)
T ss_pred             chhhhcCcchhhhhHHHH---------hcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccc
Confidence            999999998877663221         378889999999999999999999   99999999999999876 77899999


Q ss_pred             ccCCCCCcccccccccccccccCCC--CccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc
Q 046595          222 NLTNQSSDTAARLHSTRVLGTFGYH--APEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       222 g~a~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      |.+..+....     ......-++.  +++......+..+.|++|||..+.+..++..--....        .|      
T Consensus       412 ~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~------  472 (524)
T KOG0601|consen  412 GCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QS------  472 (524)
T ss_pred             ccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------cc------
Confidence            9875422111     1112233344  5555556688899999999999999999874321110        00      


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ  349 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~  349 (363)
                          .. +..+.....+ .....+..+.+.+...++..||.+.++.....
T Consensus       473 ----~~-i~~~~~p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  473 ----LT-IRSGDTPNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             ----ee-eecccccCCC-chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence                00 0111111112 22266888888899999999999888765443

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.33  E-value=1.4e-10  Score=103.17  Aligned_cols=266  Identities=16%  Similarity=0.172  Sum_probs=160.4

Q ss_pred             CCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeee------EEEeC-CeeEEE
Q 046595           71 GTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLG------YCMES-NNRILV  143 (363)
Q Consensus        71 ~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~------~~~~~-~~~~lv  143 (363)
                      ..+..||+|+-+.+|-.-.-  ...+.|+.....-. ...+  .-..+..--.||-+..=+.      +.-+. ...-++
T Consensus        14 ~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa-~~aq--k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPA-AQAQ--KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecchh--hchhheeecCCCch-HHHH--HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            45667999999999966322  12355666542211 1111  1111222224554332111      11122 225677


Q ss_pred             EecccCC-ChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          144 YQFATMG-SLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       144 ~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      |..+.+. ....++...   .....-+...|...+++++.++.+...||..   |.+-+|+.++|+|+.+++.|.|.|=.
T Consensus        89 mP~v~g~~pI~~~y~p~---tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsD  162 (637)
T COG4248          89 MPKVSGKEPIHMIYSPA---TRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSD  162 (637)
T ss_pred             cccCCCccchhhhcCch---hhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccc
Confidence            8877764 223333221   2223334589999999999999999999999   99999999999999999999999744


Q ss_pred             cCCCCCcccccccccccccccCCCCccccc-----cCCCCccCceehhHHHHHHHHhC-CCCCCCCCCcccc--chhhhc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAM-----TGQITQKSDVYSFGVVLLELLTG-RKPVDHTMPKGQQ--SLVTWA  294 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g-~~p~~~~~~~~~~--~~~~~~  294 (363)
                      .-.....   ....-..+|...|.+||.-.     +..-+...|.|.||+++|+++.| +.||.+.......  .+.   
T Consensus       163 sfqi~~n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---  236 (637)
T COG4248         163 SFQINAN---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---  236 (637)
T ss_pred             ceeeccC---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---
Confidence            3211111   11123457899999999654     34567889999999999999997 8999754221110  000   


Q ss_pred             cccccccccccccC--CcC---CCCCC-HHHHHHHHHHHHhccCC--CCCCCCCHHHHHHHhcccccc
Q 046595          295 TPRLSEDKVKQCVD--PKL---NNDYP-PKAIAKLAAVAALCVQY--EADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       295 ~~~~~~~~~~~~~~--~~~---~~~~~-~~~~~~l~~li~~cl~~--~p~~RPs~~~vl~~l~~l~~~  354 (363)
                       ..+..+.....-+  .++   ....| .-.+..+..++.+|+..  ++.-|||++.++..|..+..+
T Consensus       237 -~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         237 -TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             -hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence             0011111111111  111   11222 24567788999999853  467899999999988776554

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.30  E-value=4.1e-11  Score=95.07  Aligned_cols=144  Identities=17%  Similarity=0.204  Sum_probs=103.4

Q ss_pred             CCCeeeccCCceEEEEEeCCCCeEEEEEccCCC-CCC------chHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           72 TKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSS-APE------PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        72 ~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~-~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ....+-+|+-+.|+.+.+. |+.++||.-.... ...      ...+..+|+.++.++.--.|.--.-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4567899999999999885 7887777543221 111      1246778999988886445544444556666778999


Q ss_pred             ecccC-CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC---ceEEee
Q 046595          145 QFATM-GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF---KSKIAD  220 (363)
Q Consensus       145 e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~---~vkl~D  220 (363)
                      ||++| .++.+++...-...       ........++..+-+.+.-||..   +|+|+||..+||++..++   .+.++|
T Consensus        90 E~~~g~~~vk~~i~~~~~~~-------~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lId  159 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE-------SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILID  159 (229)
T ss_pred             EeccchhHHHHHHHHHccCc-------ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEe
Confidence            99987 47788886543221       22222367888889999999999   999999999999997554   348999


Q ss_pred             eccCCC
Q 046595          221 FNLTNQ  226 (363)
Q Consensus       221 fg~a~~  226 (363)
                      ||++..
T Consensus       160 fgls~~  165 (229)
T KOG3087|consen  160 FGLSSV  165 (229)
T ss_pred             ecchhc
Confidence            999743

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.29  E-value=9.8e-13  Score=128.10  Aligned_cols=247  Identities=19%  Similarity=0.195  Sum_probs=163.3

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC--CCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA--PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      .+.+.+-+-+|.++.++.+.-. .|...++|+......  ....+....+-.++-...+|.++...-.+.-....+++++
T Consensus       805 ~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~  884 (1205)
T KOG0606|consen  805 GFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGH  884 (1205)
T ss_pred             cceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhH
Confidence            4555556888888888887543 243334443322110  0111222233333333455666665555555678899999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+++|...++....         .+..-.......+..+++|||..   .+.|+|++|.|+++..+|..++.|||...
T Consensus       885 ~~~~~~~~Skl~~~~~---------~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~  952 (1205)
T KOG0606|consen  885 YLNGGDLPSKLHNSGC---------LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLS  952 (1205)
T ss_pred             HhccCCchhhhhcCCC---------cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccc
Confidence            9999999999987652         22223334455677899999998   79999999999999999999999998432


Q ss_pred             CCCcc-----------------------------cccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCC
Q 046595          226 QSSDT-----------------------------AARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGR  276 (363)
Q Consensus       226 ~~~~~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~  276 (363)
                      .....                             ..........||+.|.+||.+.+......+|.|++|++++|.++|.
T Consensus       953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen  953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred             ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence            11100                             0000122356899999999999999999999999999999999999


Q ss_pred             CCCCCCCCccccchhhhccccccccccccccCCcC-CCCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 046595          277 KPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKL-NNDYPPKAIAKLAAVAALCVQYEADFRPNMT  342 (363)
Q Consensus       277 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~  342 (363)
                      .||....+.....-               +..... ...-+...+.+..+++...+..+|.+|-.+.
T Consensus      1033 pp~na~tpq~~f~n---------------i~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQIFEN---------------ILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCcchhhhhhc---------------cccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            99986654322111               111000 1122334556688888899999999987665

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.20  E-value=1.6e-10  Score=94.98  Aligned_cols=126  Identities=21%  Similarity=0.211  Sum_probs=81.8

Q ss_pred             eEEEEEeCCCCeEEEEEccCCCCC------------C---------c----hHHHHHHHHHHhcCCCC--ccceeeeEEE
Q 046595           83 RVFYAKLTDGTPAAIKKLDTSSAP------------E---------P----ESDFAAQLSVVSRLKHE--HFVELLGYCM  135 (363)
Q Consensus        83 ~V~~~~~~~~~~~avK~~~~~~~~------------~---------~----~~~~~~e~~~l~~l~h~--~i~~~~~~~~  135 (363)
                      .||.|...+|..+|+|..+.....            .         .    .....+|...|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            489999888999999987542110            0         0    12356799999999755  566666542 


Q ss_pred             eCCeeEEEEeccc--CCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHH-hhccCCCCeEEecccCCceeecC
Q 046595          136 ESNNRILVYQFAT--MGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF-LHEKVQPPIVHRDVRSSNVLLFD  212 (363)
Q Consensus       136 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~-lH~~~~~~ivH~Dlkp~Nill~~  212 (363)
                         ...+||||+.  |..+..+....           ++......++.+++..+.. +|..   ||+|+||.+.||++++
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~-----------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~  142 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD-----------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDD  142 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG-----------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEET
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc-----------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeec
Confidence               3479999998  65554443322           2234455677778775555 5788   9999999999999988


Q ss_pred             CCceEEeeeccCCCC
Q 046595          213 DFKSKIADFNLTNQS  227 (363)
Q Consensus       213 ~~~vkl~Dfg~a~~~  227 (363)
                      + .+.|+|||.+...
T Consensus       143 ~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  143 G-KVYIIDFGQAVDS  156 (188)
T ss_dssp             T-CEEE--GTTEEET
T ss_pred             c-eEEEEecCcceec
Confidence            7 9999999987543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.18  E-value=5.2e-10  Score=97.39  Aligned_cols=141  Identities=16%  Similarity=0.094  Sum_probs=99.1

Q ss_pred             CeeeccCCceEEEEEeCCCCeEEEEEccCCCCC----------CchHHHHHHHHHHhcCCCCc--cceeeeEEEe-----
Q 046595           74 ALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAP----------EPESDFAAQLSVVSRLKHEH--FVELLGYCME-----  136 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~-----  136 (363)
                      +.+-.-....|+.+.. +|+.|.||........          .....+.+|...+.+|..-+  ++..+++++.     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3444444455667655 5788999976432211          11124778888888884333  3444555543     


Q ss_pred             CCeeEEEEecccCC-ChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC---
Q 046595          137 SNNRILVYQFATMG-SLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD---  212 (363)
Q Consensus       137 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---  212 (363)
                      ....+||+|++.+. +|.+++......       ..+......++.+++..+.-||+.   ||+|+|+++.|||++.   
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~-------~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~  176 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATN-------PPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFP  176 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhccc-------CCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEecccc
Confidence            23467999999986 798888532110       145677788999999999999999   9999999999999975   


Q ss_pred             ----CCceEEeeeccCC
Q 046595          213 ----DFKSKIADFNLTN  225 (363)
Q Consensus       213 ----~~~vkl~Dfg~a~  225 (363)
                          +..+.|+||+.+.
T Consensus       177 ~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        177 GREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             CCCCCceEEEEECCccc
Confidence                4689999999874

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.11  E-value=5.7e-10  Score=94.35  Aligned_cols=138  Identities=17%  Similarity=0.154  Sum_probs=99.1

Q ss_pred             CCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCC---------------------CchHHHHHHHHHHhcCCCC--c
Q 046595           70 FGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAP---------------------EPESDFAAQLSVVSRLKHE--H  126 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~---------------------~~~~~~~~e~~~l~~l~h~--~  126 (363)
                      +.++..||-|.-+.||.|...+|..++||.-+.....                     -......+|.++|++|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            4577889999999999999999999999964322110                     0112356799999999654  6


Q ss_pred             cceeeeEEEeCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCC
Q 046595          127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSS  206 (363)
Q Consensus       127 i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~  206 (363)
                      |.+.+++    +.-.+|||+++|..|...--              +....-.++..|++-+.-+-..   ||||+|+++-
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~--------------~~en~~~il~~il~~~~~~~~~---GiVHGDlSef  231 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLRL--------------DVENPDEILDKILEEVRKAYRR---GIVHGDLSEF  231 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeecccC--------------cccCHHHHHHHHHHHHHHHHHc---CccccCCchh
Confidence            7777764    44579999999976655431              1112223444455555555566   9999999999


Q ss_pred             ceeecCCCceEEeeeccCCCCC
Q 046595          207 NVLLFDDFKSKIADFNLTNQSS  228 (363)
Q Consensus       207 Nill~~~~~vkl~Dfg~a~~~~  228 (363)
                      ||+++++|.+.++||-.+....
T Consensus       232 NIlV~~dg~~~vIDwPQ~v~~~  253 (304)
T COG0478         232 NILVTEDGDIVVIDWPQAVPIS  253 (304)
T ss_pred             eEEEecCCCEEEEeCcccccCC
Confidence            9999999999999998765433

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.08  E-value=2.8e-09  Score=97.25  Aligned_cols=221  Identities=14%  Similarity=0.152  Sum_probs=147.9

Q ss_pred             CceEEEEE-eCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEE----eCCeeEEEEecccC-CChhh
Q 046595           81 YGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM----ESNNRILVYQFATM-GSLHD  154 (363)
Q Consensus        81 ~g~V~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~-g~L~~  154 (363)
                      -.+.|++. ..||..|++|++........ .....-++.++++.|.|||++.+++.    .+..+++|++|.++ ++|.+
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~-nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQST-NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCc-ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            35678884 55899999999944332211 12234567899999999999988776    34577899999875 47766


Q ss_pred             hhcCCCCCC------CCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCC
Q 046595          155 VLHGRKGVQ------GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS  228 (363)
Q Consensus       155 ~l~~~~~~~------~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~  228 (363)
                      +--......      ....+...++..+|.++.|+..||.++|+.   |+..+-|.+.+|+++.+.+++|..+|......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence            553322111      122334588999999999999999999999   99999999999999999999999888764433


Q ss_pred             cccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccC
Q 046595          229 DTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD  308 (363)
Q Consensus       229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (363)
                      ...              .+|  +.   --.+-|.=.||.+++.|.||..--...+. .+                 +.. 
T Consensus       445 ~d~--------------~~~--le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~-~~-----------------~s~-  486 (655)
T KOG3741|consen  445 EDP--------------TEP--LE---SQQQNDLRDLGLLLLALATGTENSNRTDS-TQ-----------------SSH-  486 (655)
T ss_pred             CCC--------------Ccc--hh---HHhhhhHHHHHHHHHHHhhcccccccccc-hH-----------------HHH-
Confidence            221              001  11   12345888999999999998632110000 00                 000 


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          309 PKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                         ........+.++.+++......++++ -++.+++..
T Consensus       487 ---~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  487 ---LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             ---HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence               01112345566778888888888776 666666553

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.98  E-value=1.5e-10  Score=108.85  Aligned_cols=151  Identities=19%  Similarity=0.283  Sum_probs=103.8

Q ss_pred             HHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCccccccc-------ccccccccCCCCcccccc
Q 046595          181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH-------STRVLGTFGYHAPEYAMT  253 (363)
Q Consensus       181 ~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~  253 (363)
                      .+.++|+.|+|...  ++||+.|.|++|.++..+.+||+.|+++...........       ..-..-...|.|||.+.+
T Consensus       106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            34458999999875  899999999999999999999999998754433111000       000113457999999999


Q ss_pred             CCCCccCceehhHHHHHHHHhCC-CCCCCCCCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccC
Q 046595          254 GQITQKSDVYSFGVVLLELLTGR-KPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQ  332 (363)
Q Consensus       254 ~~~~~~~DvwslG~~l~ell~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  332 (363)
                      ...+.++|+||+|+++|.+..|. .-+..........             .....+..-...+..+.+.++.+=+.+++.
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-------------~~~~~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-------------FSRNLLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhh-------------hhhcccccccccccccCcHHHHHHHHHHhc
Confidence            88899999999999999999544 4343221111110             001111111122345677889999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 046595          333 YEADFRPNMTIVVK  346 (363)
Q Consensus       333 ~~p~~RPs~~~vl~  346 (363)
                      .+..-||++..+..
T Consensus       251 ~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLS  264 (700)
T ss_pred             CCcccCcchhhhhc
Confidence            99999998777653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.96  E-value=4.8e-09  Score=88.38  Aligned_cols=124  Identities=22%  Similarity=0.192  Sum_probs=91.2

Q ss_pred             CCCeEEEEEccCCCC------CCchHHHHHHHHHHhcCC--CCccceeeeEEEeCC----eeEEEEecccCC-Chhhhhc
Q 046595           91 DGTPAAIKKLDTSSA------PEPESDFAAQLSVVSRLK--HEHFVELLGYCMESN----NRILVYQFATMG-SLHDVLH  157 (363)
Q Consensus        91 ~~~~~avK~~~~~~~------~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~----~~~lv~e~~~~g-~L~~~l~  157 (363)
                      .++.+.+|.......      .-...+..+|...+.+|.  .-.+.+.+++.+...    ..++|+|++++. +|.+++.
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~  110 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ  110 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence            356666665432111      123456788888888774  334556666665532    347999999884 7999987


Q ss_pred             CCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC---ceEEeeeccCCC
Q 046595          158 GRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF---KSKIADFNLTNQ  226 (363)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~---~vkl~Dfg~a~~  226 (363)
                      ....         .+......++.+++..+.-||..   ||+|+|+++.|||++.++   .+.|+||+.++.
T Consensus       111 ~~~~---------~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  111 QWEQ---------LDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             hhcc---------cchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            6332         45566778999999999999999   999999999999999887   899999997654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.96  E-value=3e-09  Score=100.20  Aligned_cols=144  Identities=17%  Similarity=0.187  Sum_probs=92.3

Q ss_pred             CeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCc-----------------------------h----H------HHHH
Q 046595           74 ALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEP-----------------------------E----S------DFAA  114 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~-----------------------------~----~------~~~~  114 (363)
                      .-|+.++.|.||.|+.++|+.||||+.+..-...-                             .    +      ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            46899999999999999999999999754221100                             0    0      1234


Q ss_pred             HHHHHhcC-----CCCccceeeeEEEeCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHH
Q 046595          115 QLSVVSRL-----KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF  189 (363)
Q Consensus       115 e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~  189 (363)
                      |...+.++     +.++|.--.=++.-.....|+|||++|-.+.+.......        .++.+.+.....++.  +..
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--------g~d~k~ia~~~~~~f--~~q  280 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--------GIDRKELAELLVRAF--LRQ  280 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--------CCCHHHHHHHHHHHH--HHH
Confidence            44444444     123322212223335667899999999988888432221        145444443333332  122


Q ss_pred             hhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCcc
Q 046595          190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT  230 (363)
Q Consensus       190 lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~  230 (363)
                      +-..   |++|.|.+|.||+++.+|++.+.|||+.......
T Consensus       281 ~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         281 LLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             HHhc---CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            2223   8999999999999999999999999998765543

>PRK09902 hypothetical protein; Provisional

Probab=98.92  E-value=4.7e-08  Score=80.86  Aligned_cols=143  Identities=11%  Similarity=0.041  Sum_probs=103.5

Q ss_pred             CCeeeccCCceEEEEEeCCCCeEEEEEccCCC-----CCCchHHHHHHHHHHhcCCC--CccceeeeEEEeC----CeeE
Q 046595           73 KALIGEGSYGRVFYAKLTDGTPAAIKKLDTSS-----APEPESDFAAQLSVVSRLKH--EHFVELLGYCMES----NNRI  141 (363)
Q Consensus        73 ~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~----~~~~  141 (363)
                      .---|+||.+-|+..... |..+.+|.-....     .+.....|.+|+..+++|..  -.+.++.......    ...+
T Consensus        23 ~pN~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~  101 (216)
T PRK09902         23 EPNYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRAL  101 (216)
T ss_pred             CCCcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEE
Confidence            334577999999998764 4578888765211     14456789999999999853  2244544222111    2356


Q ss_pred             EEEecccC-CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCc--eEE
Q 046595          142 LVYQFATM-GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK--SKI  218 (363)
Q Consensus       142 lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~--vkl  218 (363)
                      ||+|-+.+ -+|.+++......       ..+......++.+++..+.-||+.   |+.|+|+.+.||+++.++.  +++
T Consensus       102 LVTe~L~g~~~L~~~l~~~~~~-------~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~l  171 (216)
T PRK09902        102 LVTEDMAGFISIADWYAQHAVS-------PYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGF  171 (216)
T ss_pred             EEEEeCCCCccHHHHHhcCCcC-------CcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEE
Confidence            99997764 3888888654311       256777789999999999999999   9999999999999986667  999


Q ss_pred             eeeccCCC
Q 046595          219 ADFNLTNQ  226 (363)
Q Consensus       219 ~Dfg~a~~  226 (363)
                      +||.-++.
T Consensus       172 IDlEk~r~  179 (216)
T PRK09902        172 LDLEKSRR  179 (216)
T ss_pred             EEhhccch
Confidence            99986543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.81  E-value=1.2e-07  Score=80.81  Aligned_cols=72  Identities=10%  Similarity=0.111  Sum_probs=54.0

Q ss_pred             CeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCc--cceeeeEEEeCCeeEEEEecccCCC
Q 046595           74 ALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEH--FVELLGYCMESNNRILVYQFATMGS  151 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~g~  151 (363)
                      ..||.|..+.||+.   .+..+++|.....   .....+.+|.++++.+..-+  +.+++++....+...+||++++|.+
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~---~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPG---FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCC---CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            35899999999984   2556788887542   23456789999999886433  5777888777777889999999963

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.81  E-value=8.4e-08  Score=79.68  Aligned_cols=138  Identities=15%  Similarity=0.211  Sum_probs=90.3

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHH---------HHHHHHHhcCCC---Cccceeee
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDF---------AAQLSVVSRLKH---EHFVELLG  132 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~---------~~e~~~l~~l~h---~~i~~~~~  132 (363)
                      .+..+|...+++-......|.+... +|..+++|...... ....+.+         .+.+..+.++..   -.+..++.
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~-~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl  105 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREEN-RRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL  105 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhh-hhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence            3456888888888887777777766 47889999876532 1111111         223333333322   22222222


Q ss_pred             E-----EEeCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCc
Q 046595          133 Y-----CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSN  207 (363)
Q Consensus       133 ~-----~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~N  207 (363)
                      +     +......+|+|||++|..|.+...             ++.    .++..+.+++.-||+.   |++|+|.+|.|
T Consensus       106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgN  165 (229)
T PF06176_consen  106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED-------------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGN  165 (229)
T ss_pred             eeeeeeccceeEEEEEEEEecCeecccchh-------------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCc
Confidence            2     222345568999999988876643             222    2445677889999999   99999999999


Q ss_pred             eeecCCCceEEeeeccCC
Q 046595          208 VLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       208 ill~~~~~vkl~Dfg~a~  225 (363)
                      +++++++ ++++||+..+
T Consensus       166 Flv~~~~-i~iID~~~k~  182 (229)
T PF06176_consen  166 FLVSNNG-IRIIDTQGKR  182 (229)
T ss_pred             EEEECCc-EEEEECcccc
Confidence            9998654 9999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.75  E-value=1.8e-07  Score=78.58  Aligned_cols=155  Identities=21%  Similarity=0.212  Sum_probs=101.4

Q ss_pred             ccCHHHHHHHhcCCCCCCeee---ccCCceEEEEEeCCCCeEEEEEccCCCCCCc------------------hH-----
Q 046595           57 QIKLDELNRLTSNFGTKALIG---EGSYGRVFYAKLTDGTPAAIKKLDTSSAPEP------------------ES-----  110 (363)
Q Consensus        57 ~~~~~~~~~~~~~y~~~~~lg---~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~------------------~~-----  110 (363)
                      ..+...+..+.++..+....|   +|.-+.||+|...++..+|+|++........                  ..     
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~  113 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA  113 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence            344555666666666655544   5666789999888899999999865321110                  00     


Q ss_pred             HHHHHHHHHhcCC--CCccceeeeEEEeCCeeEEEEecccCC-ChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHH
Q 046595          111 DFAAQLSVVSRLK--HEHFVELLGYCMESNNRILVYQFATMG-SLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL  187 (363)
Q Consensus       111 ~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l  187 (363)
                      -...|+..|+++.  +-.+.+-+++.    +..|||||+... .-.-.|..-          .+...+...+..++++.+
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv----------~~e~~e~~~~~~~~v~~~  179 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV----------PLELEEAEGLYEDVVEYM  179 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC----------CcCchhHHHHHHHHHHHH
Confidence            1235667777763  34455555442    346999998653 111122211          133336777788888888


Q ss_pred             HHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCC
Q 046595          188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS  228 (363)
Q Consensus       188 ~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~  228 (363)
                      .-|-..+  ++||+||+.-|||+. ++.+.|+|||.|....
T Consensus       180 ~~l~~~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         180 RRLYKEA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HHHHHhc--CcccccchhhheEEE-CCeEEEEECccccccC
Confidence            8777632  999999999999999 8899999999875544

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.65  E-value=2e-07  Score=87.80  Aligned_cols=139  Identities=20%  Similarity=0.202  Sum_probs=90.7

Q ss_pred             CeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCc------------------------------------hHHHHHHHH
Q 046595           74 ALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEP------------------------------------ESDFAAQLS  117 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~------------------------------------~~~~~~e~~  117 (363)
                      +.||..+.|.||+|+.++|+.||||+-+..-....                                    +-+|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            46899999999999999999999998654321110                                    001334443


Q ss_pred             HHhcC----CCCc------cceeeeEEEeCCeeEEEEecccCCChhhh--hcCCCCCCCCCCCCCcCHHHHHHHHHHHHH
Q 046595          118 VVSRL----KHEH------FVELLGYCMESNNRILVYQFATMGSLHDV--LHGRKGVQGAEPGPVLTWNQRVKVAYGAAK  185 (363)
Q Consensus       118 ~l~~l----~h~~------i~~~~~~~~~~~~~~lv~e~~~~g~L~~~--l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~  185 (363)
                      ...+.    .|-+      |.+++-  .-.....|+|||++|..+.+.  +.+.+          ++...+..-+.+...
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~g----------i~~~~i~~~l~~~~~  314 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRG----------ISPHDILNKLVEAYL  314 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcC----------CCHHHHHHHHHHHHH
Confidence            33322    3444      444443  223567899999999877654  33333          666655554444432


Q ss_pred             HHHHhhccCCCCeEEecccCCceeec----CCCceEEeeeccCCCCCc
Q 046595          186 GLEFLHEKVQPPIVHRDVRSSNVLLF----DDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       186 ~l~~lH~~~~~~ivH~Dlkp~Nill~----~~~~vkl~Dfg~a~~~~~  229 (363)
                      -.-+.|     |++|+|-+|.||++.    .++.+.+.|||+......
T Consensus       315 ~qIf~~-----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  315 EQIFKT-----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHHhc-----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            222222     899999999999998    367899999999765544

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.54  E-value=1.3e-06  Score=75.75  Aligned_cols=75  Identities=11%  Similarity=0.096  Sum_probs=53.0

Q ss_pred             eeccCC-ceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-CCccceeeeEEEeCCeeEEEEecccCCChh
Q 046595           76 IGEGSY-GRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVELLGYCMESNNRILVYQFATMGSLH  153 (363)
Q Consensus        76 lg~G~~-g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~g~L~  153 (363)
                      |..|.. ..||+.... +..+++|......    ...+.+|+.+++.+. +--+.+++++....+..++||++++|.+|.
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            444554 788988764 4678888875432    335678888888873 444667787777666788999999998776


Q ss_pred             hh
Q 046595          154 DV  155 (363)
Q Consensus       154 ~~  155 (363)
                      ..
T Consensus        81 ~~   82 (244)
T cd05150          81 AL   82 (244)
T ss_pred             Hh
Confidence            43

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.53  E-value=1.6e-06  Score=87.98  Aligned_cols=80  Identities=11%  Similarity=0.263  Sum_probs=58.2

Q ss_pred             CCeeeccCCceEEEEEeCCC---CeEEEEEccCCCCCCchHHHHHHHHHHhcCC-CCcc--ceeeeEEEeC---CeeEEE
Q 046595           73 KALIGEGSYGRVFYAKLTDG---TPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHF--VELLGYCMES---NNRILV  143 (363)
Q Consensus        73 ~~~lg~G~~g~V~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~~lv  143 (363)
                      ...|+.|.++.+|+....++   ..+++|+............+.+|+.+++.+. |.+|  .+++.++.+.   ...|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            45688899999999876553   4677777654333333457889999999995 6654  7778877654   467899


Q ss_pred             EecccCCCh
Q 046595          144 YQFATMGSL  152 (363)
Q Consensus       144 ~e~~~~g~L  152 (363)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999998653

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.51  E-value=1.2e-06  Score=75.20  Aligned_cols=77  Identities=14%  Similarity=0.203  Sum_probs=55.3

Q ss_pred             CeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCC--ccceeeeEEE---eCCeeEEEEeccc
Q 046595           74 ALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE--HFVELLGYCM---ESNNRILVYQFAT  148 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~---~~~~~~lv~e~~~  148 (363)
                      +.|+.|..+.||.+...+ ..+++|.....   .....+..|..+++.+...  .+.+++.+..   .....+++|++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            468999999999999876 68999986542   3346778888888888432  3556665432   2335689999999


Q ss_pred             CCChhh
Q 046595          149 MGSLHD  154 (363)
Q Consensus       149 ~g~L~~  154 (363)
                      |..+..
T Consensus        79 g~~~~~   84 (239)
T PF01636_consen   79 GRPLDD   84 (239)
T ss_dssp             SEEHHH
T ss_pred             cccccc
Confidence            987777

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.50  E-value=9.5e-07  Score=70.29  Aligned_cols=129  Identities=16%  Similarity=0.197  Sum_probs=90.7

Q ss_pred             CCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccc-eeeeEEEeCCeeEEEEecccC
Q 046595           71 GTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV-ELLGYCMESNNRILVYQFATM  149 (363)
Q Consensus        71 ~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~  149 (363)
                      ++.+.|++|.+|.||++.+. |..+|+|+-..   +.....+..|+++|..+.-.++. ++|.+..    .++.|||+.|
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~---ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G   96 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRR---DSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDG   96 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecC---CcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcC
Confidence            45667999999999999997 55788887654   44466789999999998766554 4555433    3456999999


Q ss_pred             CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEeccc-CCceeecCCCceEEeeeccCCC
Q 046595          150 GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVR-SSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       150 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlk-p~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      -.|.+.-...            +.+.+.    .+++.---|-..   ||-|+.|. |...+|..++.+.|+||.-|..
T Consensus        97 ~~L~~~~~~~------------~rk~l~----~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          97 RPLGKLEIGG------------DRKHLL----RVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             cchhhhhhcc------------cHHHHH----HHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            8887766531            223333    334443444455   89999987 5555666666999999998763

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.50  E-value=4.2e-08  Score=91.95  Aligned_cols=181  Identities=18%  Similarity=0.137  Sum_probs=130.9

Q ss_pred             CeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCc-cceeeeEEEeCCeeEEEEecccCC-C
Q 046595           74 ALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEH-FVELLGYCMESNNRILVYQFATMG-S  151 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~g-~  151 (363)
                      ..+++|+++.+++.+-.-.+....+.+...      .....++++|.+++||| .+..++.+..+...++.++++.++ +
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs  321 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS  321 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence            347889999999887544444445554432      34556889999999999 777777777778888999999876 2


Q ss_pred             hhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCccc
Q 046595          152 LHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTA  231 (363)
Q Consensus       152 L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~  231 (363)
                      -.......        ...+..-+...+.+.-.++++++|+.   .=+|+|    ||+..+ +.++..||+....+.+..
T Consensus       322 ~~~~~~~s--------e~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~  385 (829)
T KOG0576|consen  322 SALEMTVS--------EIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM  385 (829)
T ss_pred             ccccCChh--------hHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc
Confidence            21111100        00134444555666677899999987   558888    777655 688999999887666554


Q ss_pred             ccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCC
Q 046595          232 ARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPV  279 (363)
Q Consensus       232 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~  279 (363)
                         ......+++.++|||+...+.+....|+|++|+--.++--|.+|-
T Consensus       386 ---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  386 ---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             ---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence               245567999999999999999999999999998777777776664

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.40  E-value=9.4e-06  Score=67.34  Aligned_cols=129  Identities=19%  Similarity=0.201  Sum_probs=90.2

Q ss_pred             CCeeeccCCceEEEEEeCCCCeEEEEEccCCC---------------CCCchHHHHHHHHHHhcCC------CCccceee
Q 046595           73 KALIGEGSYGRVFYAKLTDGTPAAIKKLDTSS---------------APEPESDFAAQLSVVSRLK------HEHFVELL  131 (363)
Q Consensus        73 ~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~---------------~~~~~~~~~~e~~~l~~l~------h~~i~~~~  131 (363)
                      ...||+|+.-.||.  +.++....||+.....               .........+|+.-...+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            44699999988884  4455667888876644               0112345666766555554      78999999


Q ss_pred             eEEEeCCeeEEEEecccC------CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccC
Q 046595          132 GYCMESNNRILVYQFATM------GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRS  205 (363)
Q Consensus       132 ~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp  205 (363)
                      |+.++.....+|+|.+..      -+|.+++....          ++. ...   ..+-+-..||-+.   +|+.+|++|
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----------~~~-~~~---~~L~~f~~~l~~~---~Iv~~dl~~  146 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----------LTE-ELR---QALDEFKRYLLDH---HIVIRDLNP  146 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----------ccH-HHH---HHHHHHHHHHHHc---CCeecCCCc
Confidence            999999999999998643      27888886543          544 333   3344455677777   899999999


Q ss_pred             CceeecCC--C--ceEEee
Q 046595          206 SNVLLFDD--F--KSKIAD  220 (363)
Q Consensus       206 ~Nill~~~--~--~vkl~D  220 (363)
                      .||++...  +  .+.|+|
T Consensus       147 ~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  147 HNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             ccEEEEecCCCceEEEEEe
Confidence            99999632  2  577777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.40  E-value=1.8e-06  Score=71.25  Aligned_cols=100  Identities=28%  Similarity=0.304  Sum_probs=79.8

Q ss_pred             HHHHHHHhcCCC-CccceeeeEEEeCCeeEEEEecccCCChhhh---hcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHH
Q 046595          113 AAQLSVVSRLKH-EHFVELLGYCMESNNRILVYQFATMGSLHDV---LHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE  188 (363)
Q Consensus       113 ~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~---l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~  188 (363)
                      ..|.-+++.+++ +++++++|+|-    .+++.||...+++...   +....         ..+|..+.+|+.++++.++
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~---------~~~w~~R~~iA~~lL~~l~   73 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFL---------QSPWEQRAKIALQLLELLE   73 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccccccc---------ccCHHHHHHHHHHHHHHHH
Confidence            357788888865 69999999983    3688999987766432   11111         1689999999999999999


Q ss_pred             HhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       189 ~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      +++......+.-.|++++|+-+++++++|++|...+.
T Consensus        74 ~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   74 ELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             HHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence            9998644368889999999999999999999998754

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.26  E-value=9.4e-06  Score=69.95  Aligned_cols=73  Identities=14%  Similarity=0.124  Sum_probs=45.3

Q ss_pred             CeeeccCCc-eEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCC---ccceeeeEEEeC---CeeEEEEec
Q 046595           74 ALIGEGSYG-RVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE---HFVELLGYCMES---NNRILVYQF  146 (363)
Q Consensus        74 ~~lg~G~~g-~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~---~~~~lv~e~  146 (363)
                      ..|+.|+.. .||+.    +..+++|....   ......+.+|.++++.+...   .+.++++.....   ...+++|++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~---~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA---AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc---cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            346767666 48876    23467776443   22345788999998887531   344555444332   234789999


Q ss_pred             ccCCChh
Q 046595          147 ATMGSLH  153 (363)
Q Consensus       147 ~~~g~L~  153 (363)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.19  E-value=2.7e-05  Score=67.06  Aligned_cols=73  Identities=14%  Similarity=0.140  Sum_probs=47.6

Q ss_pred             CeeeccCCceEEEEEeCC--CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCc-cceeeeEEEeCCeeEEEEecccCC
Q 046595           74 ALIGEGSYGRVFYAKLTD--GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEH-FVELLGYCMESNNRILVYQFATMG  150 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~--~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~g  150 (363)
                      +.|..|-...+|++...+  +..|++|+.....  .......+|+.+++.+...+ ..+++....    ..++|||++|.
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~--~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~   77 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT--ELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR   77 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCc--cceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence            357778888999998664  6788899765421  11223457888888885333 344544322    24899999987


Q ss_pred             Ch
Q 046595          151 SL  152 (363)
Q Consensus       151 ~L  152 (363)
                      ++
T Consensus        78 ~l   79 (235)
T cd05157          78 TL   79 (235)
T ss_pred             cC
Confidence            65

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=98.15  E-value=2.8e-05  Score=69.44  Aligned_cols=160  Identities=15%  Similarity=0.179  Sum_probs=88.5

Q ss_pred             HHHHHhcCCCC-----CCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCC--ccceeeeE-
Q 046595           62 ELNRLTSNFGT-----KALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE--HFVELLGY-  133 (363)
Q Consensus        62 ~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~-  133 (363)
                      ++..+..+|.+     .+.|..|....+|+....+ ..+++|+...    .....+..|+.++..+.+-  .+.+++.. 
T Consensus         3 ~l~~~l~~y~~~~~~~i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~   77 (296)
T cd05153           3 ELASFLADYDLGELLSFEGISAGIENTNYFVTTDS-GRYVLTLFEK----VSAEELPFFLALLDHLAERGLPVPRPIADR   77 (296)
T ss_pred             HHHHHHHHcCCCchhheecccCccccceEEEEeCC-CcEEEEEcCC----CChHhccHHHHHHHHHHHCCCCCCccccCC
Confidence            44555556654     3346667778999987644 4688888754    2234566777777777432  24444331 


Q ss_pred             -----EEeCCeeEEEEecccCCChhh-----------h---hcCCC-CCCCC-CCCCCcCHHHHH----------HHHHH
Q 046595          134 -----CMESNNRILVYQFATMGSLHD-----------V---LHGRK-GVQGA-EPGPVLTWNQRV----------KVAYG  182 (363)
Q Consensus       134 -----~~~~~~~~lv~e~~~~g~L~~-----------~---l~~~~-~~~~~-~~~~~~~~~~~~----------~i~~~  182 (363)
                           ....+..++++++++|..+..           .   ++... ..... .......|....          .....
T Consensus        78 ~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  157 (296)
T cd05153          78 DGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRAL  157 (296)
T ss_pred             CCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHH
Confidence                 223456689999999876532           0   01000 00000 000001111110          01111


Q ss_pred             HHHHHHHhhc----cCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          183 AAKGLEFLHE----KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       183 i~~~l~~lH~----~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +..++.++..    ....+++|+|+.|.||++++++.+.|+||+.+..
T Consensus       158 ~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         158 LADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             HHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            2233444432    1123799999999999999987789999997643

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK10593 hypothetical protein; Provisional

Probab=98.14  E-value=5.3e-05  Score=67.57  Aligned_cols=78  Identities=12%  Similarity=0.044  Sum_probs=56.4

Q ss_pred             CCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCC---CccceeeeEEEe---CCeeEEEE
Q 046595           71 GTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKH---EHFVELLGYCME---SNNRILVY  144 (363)
Q Consensus        71 ~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~---~~~~~lv~  144 (363)
                      .-.+.||.|..+.||.....++ .+++|..+.   ......+..|...++.+..   -.+.++++++..   .+..+|||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~---~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQG-NPMPLMARS---FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             heeeecCCccceeEEEEEcCCC-CEEEEEecc---cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            3345699999999999977655 466676432   1123478899998888842   467888887754   35689999


Q ss_pred             ecccCCCh
Q 046595          145 QFATMGSL  152 (363)
Q Consensus       145 e~~~~g~L  152 (363)
                      |++++.++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998765

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.12  E-value=3.5e-05  Score=67.33  Aligned_cols=142  Identities=11%  Similarity=0.077  Sum_probs=77.7

Q ss_pred             eeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCcc-ceeeeEEEeCCeeEEEEecccCCChhh
Q 046595           76 IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF-VELLGYCMESNNRILVYQFATMGSLHD  154 (363)
Q Consensus        76 lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~g~L~~  154 (363)
                      +..|-.+.+|+... ++..+++|........-. .....|..+++.+..-.+ .+++...  .  .++|++|++|..+..
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALG-VDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL   77 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCccccccc-CcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence            45677888998874 567888887654222111 235778888888854333 3444432  1  368999999866532


Q ss_pred             h--------------hcCCCCCCCCCCCCCcCHHH-HHHHHHHH---------HHHHHHhhcc-----CCCCeEEecccC
Q 046595          155 V--------------LHGRKGVQGAEPGPVLTWNQ-RVKVAYGA---------AKGLEFLHEK-----VQPPIVHRDVRS  205 (363)
Q Consensus       155 ~--------------l~~~~~~~~~~~~~~~~~~~-~~~i~~~i---------~~~l~~lH~~-----~~~~ivH~Dlkp  205 (363)
                      .              +.+-....  ..+..++... +.....++         ...+..+-..     ....++|+|+.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~--~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~  155 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQP--RFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA  155 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence            1              11000000  0111122221 11111111         1111111111     112589999999


Q ss_pred             CceeecCCCceEEeeeccCCC
Q 046595          206 SNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       206 ~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      .||++++++ +.|+||..+..
T Consensus       156 ~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       156 YNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CcEEEeCCC-CEEEeccccCc
Confidence            999999877 78999998754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=98.11  E-value=6.7e-05  Score=67.83  Aligned_cols=164  Identities=18%  Similarity=0.199  Sum_probs=85.2

Q ss_pred             cCHHHHHHHhcCCCC-----CCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCC--cccee
Q 046595           58 IKLDELNRLTSNFGT-----KALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE--HFVEL  130 (363)
Q Consensus        58 ~~~~~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~  130 (363)
                      +...++..+...|.+     .+.|+.|....+|+....+| .+++|+.. ..   ....+..|..++..|...  .+.++
T Consensus         7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~~---~~~~l~~~~~~l~~L~~~glpvP~~   81 (319)
T PRK05231          7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE-RL---TAEDLPFFLGLMQHLAARGVPVPAP   81 (319)
T ss_pred             CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec-cC---ChHHhHHHHHHHHHHHHCCCCCCcc
Confidence            444556666667765     23456677788999987655 68888865 21   123344455555555211  13333


Q ss_pred             ee------EEEeCCeeEEEEecccCCChh-----------hhhc---CCCC-CCCCCC-CCCc-CHHHHHH---------
Q 046595          131 LG------YCMESNNRILVYQFATMGSLH-----------DVLH---GRKG-VQGAEP-GPVL-TWNQRVK---------  178 (363)
Q Consensus       131 ~~------~~~~~~~~~lv~e~~~~g~L~-----------~~l~---~~~~-~~~~~~-~~~~-~~~~~~~---------  178 (363)
                      +.      +....+..+++++|++|..+.           ..+.   .... ...... ...+ .+.....         
T Consensus        82 i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (319)
T PRK05231         82 VARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADE  161 (319)
T ss_pred             eeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChh
Confidence            32      122355678999999986431           1111   1000 000000 0001 1111111         


Q ss_pred             ---HHHH-HHHHHHHhhcc----CCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          179 ---VAYG-AAKGLEFLHEK----VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       179 ---i~~~-i~~~l~~lH~~----~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                         ...+ +...+..+...    ...++||+|+.+.||+++++...-|+||+.+..
T Consensus       162 ~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        162 QAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             HHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence               1111 11122222210    233899999999999999776668999998754

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.08  E-value=0.00011  Score=67.65  Aligned_cols=76  Identities=14%  Similarity=0.143  Sum_probs=54.9

Q ss_pred             CeeeccCCceEEEEEeCCC-CeEEEEEccCC-----C-CCCchHHHHHHHHHHhcCC---CCccceeeeEEEeCCeeEEE
Q 046595           74 ALIGEGSYGRVFYAKLTDG-TPAAIKKLDTS-----S-APEPESDFAAQLSVVSRLK---HEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~~-~~~avK~~~~~-----~-~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv  143 (363)
                      +.||.|.+..||++...+| +.++||.-...     . .+....+...|.+.|+.+.   ..++.+++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            4689999999999988776 48999985421     1 1234567788888888763   3467788876  34557899


Q ss_pred             EecccCCC
Q 046595          144 YQFATMGS  151 (363)
Q Consensus       144 ~e~~~~g~  151 (363)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=98.07  E-value=0.00015  Score=65.16  Aligned_cols=163  Identities=14%  Similarity=0.192  Sum_probs=88.5

Q ss_pred             CHHHHHHHhcCCCCC-----CeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCC--ccceee
Q 046595           59 KLDELNRLTSNFGTK-----ALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE--HFVELL  131 (363)
Q Consensus        59 ~~~~~~~~~~~y~~~-----~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~  131 (363)
                      ..+++..+.+.|.+.     +.++.|....+|++...++ .+++|+.....   ....+..|..++..|...  .+.+++
T Consensus         8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~---~~~~i~~e~~~l~~L~~~g~pvp~~i   83 (307)
T TIGR00938         8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV---KAEELPFFLALTTHLAARGLPVPKPV   83 (307)
T ss_pred             CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC---CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            345666666667553     4566777789999876544 57788765421   233455667777766322  234443


Q ss_pred             eE------EEeCCeeEEEEecccCCChhh-----------h---hcCCCCC-CCCCCC--CCcCHHHHH-----------
Q 046595          132 GY------CMESNNRILVYQFATMGSLHD-----------V---LHGRKGV-QGAEPG--PVLTWNQRV-----------  177 (363)
Q Consensus       132 ~~------~~~~~~~~lv~e~~~~g~L~~-----------~---l~~~~~~-~~~~~~--~~~~~~~~~-----------  177 (363)
                      ..      ....+..+++++|++|..+..           .   ++..... ......  ..-.|....           
T Consensus        84 ~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~  163 (307)
T TIGR00938        84 KSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLE  163 (307)
T ss_pred             cCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccC
Confidence            31      122456789999998854321           1   1111000 000000  001111100           


Q ss_pred             -HHHHHHHHHHHHhhc----cCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          178 -KVAYGAAKGLEFLHE----KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       178 -~i~~~i~~~l~~lH~----~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                       .....+...++++..    ....+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       164 ~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       164 AHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence             001112234444432    112389999999999999998877899999864

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.03  E-value=2e-05  Score=79.33  Aligned_cols=198  Identities=15%  Similarity=0.173  Sum_probs=138.6

Q ss_pred             HHHHHHHHhcCCCCccceeeeEEEeCCeeE----EEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHH
Q 046595          112 FAAQLSVVSRLKHEHFVELLGYCMESNNRI----LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL  187 (363)
Q Consensus       112 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~----lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l  187 (363)
                      ...|+..+..+.|+|++.++.|..+....-    +..+++...++...+..-.         .++...++.+..++.+||
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---------~i~~~~~r~~~~~~~~GL  299 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---------SIPLETLRILHQKLLEGL  299 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---------ccCHHHHHHHHHHHhhhH
Confidence            345667788889999999999876654332    4456777778877776554         378888999999999999


Q ss_pred             HHhhccCCCCeEEecccCC---ceeecCCCceEEe--eeccCCCCCcccccccccccccccCCCCccccccCCCC--ccC
Q 046595          188 EFLHEKVQPPIVHRDVRSS---NVLLFDDFKSKIA--DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQIT--QKS  260 (363)
Q Consensus       188 ~~lH~~~~~~ivH~Dlkp~---Nill~~~~~vkl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~  260 (363)
                      .|+|+.   .+.|.-+...   +.-.+..+.+.++  ||+.+....+....   ....-+..+.++|......++  ...
T Consensus       300 ~~~h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~  373 (1351)
T KOG1035|consen  300 AYLHSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLT  373 (1351)
T ss_pred             HHHHHh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhh
Confidence            999998   6777766665   5555667777777  99987766554332   223446678888877766554  447


Q ss_pred             ceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCC
Q 046595          261 DVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPN  340 (363)
Q Consensus       261 DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs  340 (363)
                      |+|.+|..+..+..|..+-....                  ....++        +......+.+....|+..++++|++
T Consensus       374 dL~~lgll~~~~~~~~~i~~~~~------------------~~~~~l--------~~~~~~~~~d~~~~~~~~~~~~Rl~  427 (1351)
T KOG1035|consen  374 DLWCLGLLLLQLSQGEDISEKSA------------------VPVSLL--------DVLSTSELLDALPKCLDEDSEERLS  427 (1351)
T ss_pred             HHHHHHHHHhhhhhcCccccccc------------------chhhhh--------ccccchhhhhhhhhhcchhhhhccc
Confidence            99999999999998875432110                  000000        0111115788889999999999999


Q ss_pred             HHHHHHHhcc
Q 046595          341 MTIVVKALQP  350 (363)
Q Consensus       341 ~~~vl~~l~~  350 (363)
                      ..+++...-.
T Consensus       428 ~~~ll~~~f~  437 (1351)
T KOG1035|consen  428 ALELLTHPFL  437 (1351)
T ss_pred             hhhhhhchhc
Confidence            9999885443

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.84  E-value=0.00015  Score=65.00  Aligned_cols=73  Identities=22%  Similarity=0.204  Sum_probs=47.2

Q ss_pred             eeeccCCceEEEEEeCC-------CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCc-cceeeeEEEeCCeeEEEEec
Q 046595           75 LIGEGSYGRVFYAKLTD-------GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEH-FVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        75 ~lg~G~~g~V~~~~~~~-------~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~  146 (363)
                      .|..|-...+|++...+       ++.+++|+.....  .......+|..++..+...+ ..+++.++.    -.+|++|
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~   78 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV--ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF   78 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC--cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence            45667777899987654       5788999865532  22345678888888875333 334555443    2368999


Q ss_pred             ccCCChh
Q 046595          147 ATMGSLH  153 (363)
Q Consensus       147 ~~~g~L~  153 (363)
                      ++|..+.
T Consensus        79 i~G~~l~   85 (302)
T cd05156          79 IPSRTLT   85 (302)
T ss_pred             eCCCcCC
Confidence            9887664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.72  E-value=4.6e-05  Score=66.74  Aligned_cols=135  Identities=16%  Similarity=0.152  Sum_probs=93.8

Q ss_pred             CCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCC----------------Cc-----hHHHHHHHHHHhcCC-CC-c
Q 046595           70 FGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAP----------------EP-----ESDFAAQLSVVSRLK-HE-H  126 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~----------------~~-----~~~~~~e~~~l~~l~-h~-~  126 (363)
                      +.+++.||-|.-+.||.+-..+|+..++|.-+.....                ..     .-...+|+..|+.|. |- -
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            6788899999999999999988999998864322110                00     112346777777774 32 3


Q ss_pred             cceeeeEEEeCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCC
Q 046595          127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSS  206 (363)
Q Consensus       127 i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~  206 (363)
                      +.+.+++    +.-++|||++.|..|...-+-.            +..   .+...++.-+--|..+   |+||+|+.-=
T Consensus       174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~------------d~~---~ly~~lm~~Iv~la~~---GlIHgDFNEF  231 (465)
T KOG2268|consen  174 VPKPIDH----NRHCVVMELVDGYPLRQVRHVE------------DPP---TLYDDLMGLIVRLANH---GLIHGDFNEF  231 (465)
T ss_pred             CCCcccc----cceeeHHHhhcccceeeeeecC------------ChH---HHHHHHHHHHHHHHHc---Cceecccchh
Confidence            4555554    3457899999988776654321            122   3344445555666777   9999999999


Q ss_pred             ceeecCCCceEEeeeccCCC
Q 046595          207 NVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       207 Nill~~~~~vkl~Dfg~a~~  226 (363)
                      ||++.+++.++++||-.+..
T Consensus       232 Nimv~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  232 NIMVKDDDKIVVIDFPQMVS  251 (465)
T ss_pred             eeEEecCCCEEEeechHhhc
Confidence            99999999999999986543

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.64  E-value=0.00013  Score=60.20  Aligned_cols=126  Identities=25%  Similarity=0.368  Sum_probs=83.9

Q ss_pred             cCCCCCCeeeccCC-ceEEEEEeCCCCeEEEEEccC---CCCC-----------------CchHHHHHHHHHHhcC---C
Q 046595           68 SNFGTKALIGEGSY-GRVFYAKLTDGTPAAIKKLDT---SSAP-----------------EPESDFAAQLSVVSRL---K  123 (363)
Q Consensus        68 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~avK~~~~---~~~~-----------------~~~~~~~~e~~~l~~l---~  123 (363)
                      .+++..+.||.|.- |.||+++.. |+.||+|++..   ....                 .....|..|.....+|   .
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            57788889999999 999999985 77999999322   1100                 0112466677666666   4


Q ss_pred             CCcc--ceeeeEEEeCC------------------eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHH
Q 046595          124 HEHF--VELLGYCMESN------------------NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA  183 (363)
Q Consensus       124 h~~i--~~~~~~~~~~~------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i  183 (363)
                      +.++  ++++||..-..                  ...||.||.....                  .+....    +.++
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------------~~~~~~----~~~~  173 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------------PLQIRD----IPQM  173 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------------ccchhH----HHHH
Confidence            5566  88888864321                  1134555544322                  123333    4456


Q ss_pred             HHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       184 ~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      .+-+..+|..   ||+-+|+++.|..     .-+|+|||.+
T Consensus       174 ~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  174 LRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            6777889999   9999999999975     2489999864

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.60  E-value=0.0011  Score=58.96  Aligned_cols=155  Identities=17%  Similarity=0.207  Sum_probs=83.7

Q ss_pred             CCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCC--CccceeeeEEEeCC--eeEEEEecc
Q 046595           72 TKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKH--EHFVELLGYCMESN--NRILVYQFA  147 (363)
Q Consensus        72 ~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~--~~~lv~e~~  147 (363)
                      +.+.+..|..-.+|..... ++.+++..-.............+|+.+++.+.-  --+...++.|.++.  ..++||+|+
T Consensus        29 ~v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v  107 (321)
T COG3173          29 IVEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV  107 (321)
T ss_pred             eeeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence            3444434444445555544 777888722222333445677888888888753  23445566666655  668999999


Q ss_pred             cCCChhhhhcCCCC---------------------CCCCCCCC--CcCHHHHHHHHHHH--------------HHHHHHh
Q 046595          148 TMGSLHDVLHGRKG---------------------VQGAEPGP--VLTWNQRVKVAYGA--------------AKGLEFL  190 (363)
Q Consensus       148 ~~g~L~~~l~~~~~---------------------~~~~~~~~--~~~~~~~~~i~~~i--------------~~~l~~l  190 (363)
                      .|..+.+.+.....                     ......+.  .....++..+..+.              ..-..+|
T Consensus       108 eGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl  187 (321)
T COG3173         108 EGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWL  187 (321)
T ss_pred             cceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHH
Confidence            98533322221110                     00000000  00001111111111              1122233


Q ss_pred             hccC-----CCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          191 HEKV-----QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       191 H~~~-----~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      +.+.     ...++|+|+.+.|++++.++-+-++||+++..-
T Consensus       188 ~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         188 EANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             HhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            3221     136999999999999999888999999998653

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.55  E-value=0.00061  Score=60.92  Aligned_cols=142  Identities=22%  Similarity=0.225  Sum_probs=94.2

Q ss_pred             CCCCeeeccCCceEEEEEeCCCCeEEEEEccCCC-----------------------CCCchHH--HHHHHHHHhcCCCC
Q 046595           71 GTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSS-----------------------APEPESD--FAAQLSVVSRLKHE  125 (363)
Q Consensus        71 ~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~-----------------------~~~~~~~--~~~e~~~l~~l~h~  125 (363)
                      .+-..|..|.-+.||.|...+|..+|||+++.+-                       .+...-.  ...|+.-|.+|+.-
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            3455678899999999999999999999875321                       0000011  23466777777654


Q ss_pred             ccceeeeEEEeCCeeEEEEecccCCC-hhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEeccc
Q 046595          126 HFVELLGYCMESNNRILVYQFATMGS-LHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVR  204 (363)
Q Consensus       126 ~i~~~~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlk  204 (363)
                      .|.----+..  ..-.|||+++.... -.-.|...          .++...+..+-.+++.-+.-|.+.|  ++||.||.
T Consensus       227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~----------~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLS  292 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDA----------SLSTSKARELYQQCVRIMRRLYQKC--RLVHADLS  292 (520)
T ss_pred             CCCCCCceee--ecceEeeeeccCCCCcCcccccc----------cCChHHHHHHHHHHHHHHHHHHHHh--ceeccchh
Confidence            4332111111  23368999985321 11222222          2777788888888888888888777  89999999


Q ss_pred             CCceeecCCCceEEeeeccCCCC
Q 046595          205 SSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       205 p~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      --|+|+. +|.+.|+|.+.+...
T Consensus       293 EfN~Lyh-dG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  293 EFNLLYH-DGKLYIIDVSQSVEH  314 (520)
T ss_pred             hhhheEE-CCEEEEEEccccccC
Confidence            9999985 568999999876443

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.52  E-value=0.0014  Score=59.21  Aligned_cols=80  Identities=16%  Similarity=0.153  Sum_probs=52.3

Q ss_pred             eeeccCCceEEEEEeCCC-CeEEEEEccC------CCCCCchHHHHHHHHHHhcCC--CC-ccceeeeEEEeCCeeEEEE
Q 046595           75 LIGEGSYGRVFYAKLTDG-TPAAIKKLDT------SSAPEPESDFAAQLSVVSRLK--HE-HFVELLGYCMESNNRILVY  144 (363)
Q Consensus        75 ~lg~G~~g~V~~~~~~~~-~~~avK~~~~------~~~~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~lv~  144 (363)
                      .||.|....||++...++ +.++||.-..      ...+-...+...|...|+...  -| .+.++|.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            479999999999987654 5799987431      122444567777888887763  23 56666644  445567999


Q ss_pred             ecccCC-Chhhhh
Q 046595          145 QFATMG-SLHDVL  156 (363)
Q Consensus       145 e~~~~g-~L~~~l  156 (363)
                      |+++.. .|.+.+
T Consensus        80 EdL~~~~ilR~~L   92 (370)
T TIGR01767        80 EDLSHHKIARKGL   92 (370)
T ss_pred             hhCccchHHHHHH
Confidence            998543 343444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.43  E-value=0.0015  Score=57.52  Aligned_cols=30  Identities=20%  Similarity=0.445  Sum_probs=25.2

Q ss_pred             CeEEecccCCceeecCCCc-eEEeeeccCCC
Q 046595          197 PIVHRDVRSSNVLLFDDFK-SKIADFNLTNQ  226 (363)
Q Consensus       197 ~ivH~Dlkp~Nill~~~~~-vkl~Dfg~a~~  226 (363)
                      .++|+|+++.||++++++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            5899999999999997555 56999998754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.36  E-value=8.2e-06  Score=83.95  Aligned_cols=162  Identities=10%  Similarity=0.006  Sum_probs=115.8

Q ss_pred             HHHHHHHHhcCCCCccceeeeEEEe--CCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHH
Q 046595          112 FAAQLSVVSRLKHEHFVELLGYCME--SNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF  189 (363)
Q Consensus       112 ~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~  189 (363)
                      ...|..-++.+.|+++...+.-...  ....+..++|+.+|.+.+.|.+...     ..+.+...-+...-.+.+.+..-
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~e-----e~~~ld~~~v~~~~kvsvl~~~~ 1350 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLE-----ESPDLDRSPVHLRHKVSVLNRNV 1350 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccc-----cCCcchhchHHHHHHHHHhccch
Confidence            3445556666788888776654432  2345788999999999999976542     12234444444343343667777


Q ss_pred             hhccCC--CCeEEecccCCceeecCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHH
Q 046595          190 LHEKVQ--PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGV  267 (363)
Q Consensus       190 lH~~~~--~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~  267 (363)
                      +|+..+  .-.+|+++|+-|.+|..+-.||+.++|+.+......  ...+...+++.|+.+++.+.-.++.++|+|..|+
T Consensus      1351 ~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~ 1428 (2724)
T KOG1826|consen 1351 ILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSL 1428 (2724)
T ss_pred             hhhcccCCccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHH
Confidence            776632  236899999999999999999999999987322211  1234467888999999888888999999999999


Q ss_pred             HHHHHHhCCCCCC
Q 046595          268 VLLELLTGRKPVD  280 (363)
Q Consensus       268 ~l~ell~g~~p~~  280 (363)
                      .+|+...|..+|-
T Consensus      1429 ~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1429 SLYLRSDGNAYFI 1441 (2724)
T ss_pred             HHHHHhcccHHHH
Confidence            9999998887773

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.34  E-value=0.0047  Score=56.95  Aligned_cols=81  Identities=12%  Similarity=0.103  Sum_probs=53.8

Q ss_pred             CCeeeccCCceEEEEEeCCCCeEEEEEccCCC------CCCchHHHHHHHHHHhcCC---CCccceeeeEEEeCCeeEEE
Q 046595           73 KALIGEGSYGRVFYAKLTDGTPAAIKKLDTSS------APEPESDFAAQLSVVSRLK---HEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        73 ~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~------~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv  143 (363)
                      .+.||.|....||+.... +..++||.-....      .+....+-..|...|+.+.   ..++.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            446899999999999874 5568898765211      1123445556677666653   357888988876  446789


Q ss_pred             EecccC--CChhhhh
Q 046595          144 YQFATM--GSLHDVL  156 (363)
Q Consensus       144 ~e~~~~--g~L~~~l  156 (363)
                      ||++++  ..+.+.+
T Consensus       114 ME~L~~~~~ilr~~L  128 (418)
T PLN02756        114 MRYLEPPHIILRKGL  128 (418)
T ss_pred             EeecCCcceehhhhh
Confidence            999977  2444444

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.28  E-value=0.0023  Score=56.54  Aligned_cols=73  Identities=15%  Similarity=0.251  Sum_probs=47.3

Q ss_pred             CCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcC---CCCccceeeeEEEeCCeeEEEEecccC
Q 046595           73 KALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL---KHEHFVELLGYCMESNNRILVYQFATM  149 (363)
Q Consensus        73 ~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~  149 (363)
                      .+.++-|....+|..+ .+++.+.||+-..    .....|..|..-|+.|   .--.+.+++++....+..+|+|||++.
T Consensus        22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~   96 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSE----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM   96 (288)
T ss_dssp             EEEE--SSSSEEEEEE-TTS-EEEEEEEEG----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred             eEecCCCChhheEEEE-CCCccEEEEecCh----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence            4468888899999888 5688899998752    2234677888777777   345688999998888888999999987


Q ss_pred             C
Q 046595          150 G  150 (363)
Q Consensus       150 g  150 (363)
                      +
T Consensus        97 ~   97 (288)
T PF03881_consen   97 G   97 (288)
T ss_dssp             -
T ss_pred             C
Confidence            6

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.25  E-value=0.0098  Score=53.47  Aligned_cols=28  Identities=29%  Similarity=0.421  Sum_probs=24.9

Q ss_pred             CeEEecccCCceeecCCCceEEeeeccCC
Q 046595          197 PIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       197 ~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      +++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            7999999999999987 678999999654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02236 choline kinase

Probab=97.16  E-value=0.0036  Score=57.14  Aligned_cols=143  Identities=17%  Similarity=0.221  Sum_probs=78.4

Q ss_pred             eeeccCCceEEEEEeCC-----CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCcc-ceeeeEEEeCCeeEEEEeccc
Q 046595           75 LIGEGSYGRVFYAKLTD-----GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF-VELLGYCMESNNRILVYQFAT  148 (363)
Q Consensus        75 ~lg~G~~g~V~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~  148 (363)
                      .|-.|-...+|++...+     ++.|++|......  +..-....|..+++.+..-++ .++++.+..+    .|.+|++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--CeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            34457788899987532     3678888876532  222234778888888854333 3455544322    5788887


Q ss_pred             CCChhhh-----------------hcCCCCCCCCCCCCCcCHHHHHHHHHHH-----------------HHHHHH----h
Q 046595          149 MGSLHDV-----------------LHGRKGVQGAEPGPVLTWNQRVKVAYGA-----------------AKGLEF----L  190 (363)
Q Consensus       149 ~g~L~~~-----------------l~~~~~~~~~~~~~~~~~~~~~~i~~~i-----------------~~~l~~----l  190 (363)
                      +.+|...                 ++....   ........+.++..+..++                 ...+..    +
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~---~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~  193 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDM---PGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL  193 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCC---CCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence            7665321                 111110   0000011222232322111                 111111    1


Q ss_pred             hc-cCCCCeEEecccCCceeecC-CCceEEeeeccCCC
Q 046595          191 HE-KVQPPIVHRDVRSSNVLLFD-DFKSKIADFNLTNQ  226 (363)
Q Consensus       191 H~-~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~a~~  226 (363)
                      .. .....++|+|+++.||++++ ++.+.|+||..+..
T Consensus       194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            11 11226899999999999986 47899999987643

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.16  E-value=0.0058  Score=54.94  Aligned_cols=30  Identities=17%  Similarity=0.182  Sum_probs=27.6

Q ss_pred             CeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          197 PIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       197 ~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +++|+|+.+.||+++.++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            799999999999999999999999998754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.12  E-value=0.0044  Score=56.23  Aligned_cols=72  Identities=15%  Similarity=0.267  Sum_probs=44.3

Q ss_pred             eeeccCCceEEEEEeCC----CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCcc-ceeeeEEEeCCeeEEEEecccC
Q 046595           75 LIGEGSYGRVFYAKLTD----GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF-VELLGYCMESNNRILVYQFATM  149 (363)
Q Consensus        75 ~lg~G~~g~V~~~~~~~----~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~  149 (363)
                      .|..|=...+|++...+    +..|++|+.....  +..-...+|..+++.+..-++ .++++++. ..   +|.+|+++
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t--~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT--DYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCc--CeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            35557778889886543    2378888775532  222344678888888865444 34555442 22   58888877


Q ss_pred             CCh
Q 046595          150 GSL  152 (363)
Q Consensus       150 g~L  152 (363)
                      .+|
T Consensus        95 ~~l   97 (330)
T PLN02421         95 RTL   97 (330)
T ss_pred             CCC
Confidence            655

>PRK11768 serine/threonine protein kinase; Provisional

Probab=97.10  E-value=0.058  Score=48.84  Aligned_cols=71  Identities=14%  Similarity=0.111  Sum_probs=43.8

Q ss_pred             cCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCc--cceee---e--EEEeCCeeEEEEecccCCC
Q 046595           79 GSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEH--FVELL---G--YCMESNNRILVYQFATMGS  151 (363)
Q Consensus        79 G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~---~--~~~~~~~~~lv~e~~~~g~  151 (363)
                      +.-..||+....++..+++|+.....  .....+..|...+..|....  ++...   +  +...++..+.+++++.|..
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~--~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPER--WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCccc--CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            45577999988788889999875322  23456677777777663211  22211   1  1223456778899988754

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=97.07  E-value=0.0033  Score=52.40  Aligned_cols=102  Identities=16%  Similarity=0.092  Sum_probs=64.1

Q ss_pred             EEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHH
Q 046595           95 AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWN  174 (363)
Q Consensus        95 ~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~  174 (363)
                      ..+|++....-.-...-+..+..++.++.  .|+++..-  ....+-+++|+|-.-..                  ....
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------------~~~N  145 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------------NFSN  145 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------------chhH
Confidence            34555543322212245677788888775  46776632  34455688888854111                  1111


Q ss_pred             HHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          175 QRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       175 ~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                         .|... +++|.-.|+..+ +.+|+|..|+||+-|..|.+||.|=+.
T Consensus       146 ---~i~ag-i~~L~~fH~~~~-~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  146 ---FITAG-IKDLMDFHSENQ-HCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             ---HHHHh-HHHHHHhhccCC-CeecCCCChhheeecCCCCEEecChhh
Confidence               11111 467788886533 899999999999999999999999764

The function of this family is unknown.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.98  E-value=0.0011  Score=61.70  Aligned_cols=187  Identities=20%  Similarity=0.249  Sum_probs=101.5

Q ss_pred             EEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeC-CeeEEEEecccCCChhhhhcCCCCC
Q 046595           84 VFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMES-NNRILVYQFATMGSLHDVLHGRKGV  162 (363)
Q Consensus        84 V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~  162 (363)
                      ++.|..+.|..+ ..-+..   ......+.-...+++.+.|+|....+++.... ....+|+|++.. +|.+.+..+...
T Consensus         5 ~~~a~~~~~~~c-~nglpl---t~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~l~   79 (725)
T KOG1093|consen    5 TFFAQEKPGDVC-SNGLPL---TPNSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGNLK   79 (725)
T ss_pred             EEehhcCCCccc-cCCCcC---CCcHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcccc
Confidence            455655555544 222222   22234667778899999999999999887654 345688998865 999998765411


Q ss_pred             CCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCcccccccccccccc
Q 046595          163 QGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT  242 (363)
Q Consensus       163 ~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt  242 (363)
                      .       .             +++  .|     ++.|-.            .++++| -++...               
T Consensus        80 ~-------~-------------s~~--~~-----~~~~~~------------~~~~td-~~~t~~---------------  104 (725)
T KOG1093|consen   80 D-------E-------------SLL--AH-----GVLHLN------------IIYITD-HFLTKY---------------  104 (725)
T ss_pred             h-------h-------------hhc--cc-----ccceeh------------hhhccc-cccccC---------------
Confidence            0       0             000  11     344332            233333 111000               


Q ss_pred             cCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCCCCCCHHHHHH
Q 046595          243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAK  322 (363)
Q Consensus       243 ~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (363)
                           |     ....+++||||+|.++.++.-|..-+................  ..+.........   ..+--+++..
T Consensus       105 -----~-----~~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~--~~d~~~~~~a~e---~~~~~~~d~~  169 (725)
T KOG1093|consen  105 -----P-----SPIGPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYY--TDDQELLSTAME---HLIQLLADKK  169 (725)
T ss_pred             -----C-----CCCCcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhc--cCchhHHHHHHH---HHHHHhhhHh
Confidence                 0     011149999999999999999886654322111111100000  000000000000   0112356777


Q ss_pred             HHHHHHhccCCCCCCCCCHHHHH
Q 046595          323 LAAVAALCVQYEADFRPNMTIVV  345 (363)
Q Consensus       323 l~~li~~cl~~~p~~RPs~~~vl  345 (363)
                      +.++..+|+-..|..||...++.
T Consensus       170 ~~~~~~~c~~~~~~ir~l~~~~~  192 (725)
T KOG1093|consen  170 RLPLLKKCLWLEPIIRPLPMELS  192 (725)
T ss_pred             HHHHhccCCccccccccchhHHh
Confidence            89999999999999888655543

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.94  E-value=0.022  Score=51.29  Aligned_cols=145  Identities=18%  Similarity=0.247  Sum_probs=79.4

Q ss_pred             eeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCc------cceeee----EEEeCCeeEEEEe
Q 046595           76 IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEH------FVELLG----YCMESNNRILVYQ  145 (363)
Q Consensus        76 lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~----~~~~~~~~~lv~e  145 (363)
                      |.+ .-..+|+....+|+. ++|+....   .....+..|...++.|.-.+      +...-|    ........+-+++
T Consensus        34 l~s-~eN~~f~~~~~~g~~-iLki~~~~---~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~  108 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRY-ILKIYRPG---WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE  108 (331)
T ss_pred             ccc-ccCceEEEEecCCCe-EEEEecCC---CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence            444 567799998877776 88887663   34456777777777773211      111111    1111136678899


Q ss_pred             cccCCChhh-hh--------------cCC-CCCC--CCCCCCCcCHHH-------------HHHHHHHHHHHHHHhhccC
Q 046595          146 FATMGSLHD-VL--------------HGR-KGVQ--GAEPGPVLTWNQ-------------RVKVAYGAAKGLEFLHEKV  194 (363)
Q Consensus       146 ~~~~g~L~~-~l--------------~~~-~~~~--~~~~~~~~~~~~-------------~~~i~~~i~~~l~~lH~~~  194 (363)
                      |++|..+.. ..              +.. ....  .........|..             -.....++...+..+.+..
T Consensus       109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~  188 (331)
T COG2334         109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL  188 (331)
T ss_pred             ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence            999877762 10              000 0000  000011122220             0011223333333333321


Q ss_pred             ----CCC---eEEecccCCceeecCCCc-eEEeeeccCC
Q 046595          195 ----QPP---IVHRDVRSSNVLLFDDFK-SKIADFNLTN  225 (363)
Q Consensus       195 ----~~~---ivH~Dlkp~Nill~~~~~-vkl~Dfg~a~  225 (363)
                          ..+   +||+|+.|.||+++.+.. +.++||+-+.
T Consensus       189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence                123   999999999999998874 8999999764

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.73  E-value=0.011  Score=54.28  Aligned_cols=75  Identities=12%  Similarity=0.060  Sum_probs=51.4

Q ss_pred             CCeeeccCCceEEEEEeCC-CCeEEEEEcc----C-CCCCCchHHHHHHHHHHhcCC--CC-ccceeeeEEEeCCeeEEE
Q 046595           73 KALIGEGSYGRVFYAKLTD-GTPAAIKKLD----T-SSAPEPESDFAAQLSVVSRLK--HE-HFVELLGYCMESNNRILV  143 (363)
Q Consensus        73 ~~~lg~G~~g~V~~~~~~~-~~~~avK~~~----~-~~~~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~lv  143 (363)
                      .+.||.|....||++...+ ++.++||.-.    . ...+-...+...|.+.|+...  .| ++.++|.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            3468999999999998743 5679998643    1 123445577788888888763  23 56667654  44556789


Q ss_pred             EecccC
Q 046595          144 YQFATM  149 (363)
Q Consensus       144 ~e~~~~  149 (363)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998853

>PRK06148 hypothetical protein; Provisional

Probab=96.63  E-value=0.095  Score=54.86  Aligned_cols=165  Identities=16%  Similarity=0.238  Sum_probs=84.9

Q ss_pred             cCHHHHH-HHhcCCCCC---CeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-------CCc
Q 046595           58 IKLDELN-RLTSNFGTK---ALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-------HEH  126 (363)
Q Consensus        58 ~~~~~~~-~~~~~y~~~---~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-------h~~  126 (363)
                      +...+.. .+.+.|.+.   +.|+ |..-.+|+....++..+++|+.....   ....+..|..++..|.       -|.
T Consensus        11 ~s~~~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~---~~~~~~~q~~~L~hL~~~~~glpvP~   86 (1013)
T PRK06148         11 FTTKDAEALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSE---PRVESDFQTAALDHLAAVAPDLPVPR   86 (1013)
T ss_pred             CCHHHHHHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCcc---chhHHHHHHHHHHHHHhhCCCCCcCe
Confidence            3444433 334556553   3453 45688899988788899999987632   2233444555555442       223


Q ss_pred             cceee-----eEEEe-CC--eeEEEEecccCCChhhhhcC-----------------C-CCCCCCCCCCCcCHH------
Q 046595          127 FVELL-----GYCME-SN--NRILVYQFATMGSLHDVLHG-----------------R-KGVQGAEPGPVLTWN------  174 (363)
Q Consensus       127 i~~~~-----~~~~~-~~--~~~lv~e~~~~g~L~~~l~~-----------------~-~~~~~~~~~~~~~~~------  174 (363)
                      ++.-.     ..... ..  ..+-+++|++|..|.+....                 . ....-......+.|.      
T Consensus        87 ~i~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~  166 (1013)
T PRK06148         87 LIPSLSGASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGR  166 (1013)
T ss_pred             eeecCCCCeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchh
Confidence            33221     11111 11  45678999999777551110                 0 000000000011111      


Q ss_pred             -----------HHHHHHHHHHHHHH-----HhhccCCCCeEEecccCCceeecCCC--ceE-EeeeccCCCC
Q 046595          175 -----------QRVKVAYGAAKGLE-----FLHEKVQPPIVHRDVRSSNVLLFDDF--KSK-IADFNLTNQS  227 (363)
Q Consensus       175 -----------~~~~i~~~i~~~l~-----~lH~~~~~~ivH~Dlkp~Nill~~~~--~vk-l~Dfg~a~~~  227 (363)
                                 ....++.+++..+.     .+.+ ...++||+|+.+.||+++.++  ++. |+|||.+...
T Consensus       167 l~~~l~~i~d~~~r~~l~~~~~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~~  237 (1013)
T PRK06148        167 ARDRLHFIDDPEDRALVERFLARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVHA  237 (1013)
T ss_pred             hhhhhhhcCCHHHHHHHHHHHHHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECcccccc
Confidence                       11122223322221     1221 122799999999999999775  555 9999987543

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.56  E-value=0.0094  Score=53.48  Aligned_cols=55  Identities=22%  Similarity=0.346  Sum_probs=48.1

Q ss_pred             cCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCC
Q 046595          171 LTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS  228 (363)
Q Consensus       171 ~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~  228 (363)
                      ..+.+++.++.+.+..+.-+..+.  ..-||++.-.||||+ .|+|-|+||-+++...
T Consensus       318 ~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl~~  372 (488)
T COG5072         318 DRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRLSY  372 (488)
T ss_pred             ccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeeccc
Confidence            568899999999998888888775  789999999999999 9999999999987433

>PTZ00384 choline kinase; Provisional

Probab=96.06  E-value=0.078  Score=49.03  Aligned_cols=73  Identities=21%  Similarity=0.284  Sum_probs=43.1

Q ss_pred             eeeccCCceEEEEEeCCC--Ce-----EEEEEccCCCCCCchHHHHHHHHHHhcCCCCcc-ceeeeEEEeCCeeEEEEec
Q 046595           75 LIGEGSYGRVFYAKLTDG--TP-----AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF-VELLGYCMESNNRILVYQF  146 (363)
Q Consensus        75 ~lg~G~~g~V~~~~~~~~--~~-----~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~  146 (363)
                      .|..|-...+|++...++  ..     |.++....  .....-.-.+|+.+++.+...++ .++++.+.    -+++.||
T Consensus        57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~--~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ef  130 (383)
T PTZ00384         57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST--YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEW  130 (383)
T ss_pred             EeCCcccceEEEEEecCCCCCccccceEEEEeccC--CCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEE
Confidence            455577889999965432  22     34333211  11122234678899998865444 45555443    2589999


Q ss_pred             ccCCChh
Q 046595          147 ATMGSLH  153 (363)
Q Consensus       147 ~~~g~L~  153 (363)
                      ++|.+|.
T Consensus       131 IeGr~l~  137 (383)
T PTZ00384        131 VEGNTMG  137 (383)
T ss_pred             eccccCC
Confidence            9887663

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.84  E-value=0.089  Score=44.37  Aligned_cols=73  Identities=16%  Similarity=0.223  Sum_probs=49.8

Q ss_pred             eeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcC---CCCccceeeeEEEeCCeeEEEEecccCCCh
Q 046595           76 IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL---KHEHFVELLGYCMESNNRILVYQFATMGSL  152 (363)
Q Consensus        76 lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~g~L  152 (363)
                      +.-|..-..|...+ +...+.+|+-..    +....|..|+.-|+.|   +--.+.+++.+..+..+.|+||+|++.+.+
T Consensus        24 v~gG~inea~~v~d-g~~~~FvK~n~~----~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~   98 (286)
T COG3001          24 VSGGDINEAWRLRD-GTDPFFVKCNQR----EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL   98 (286)
T ss_pred             cCCccccceeEeec-CCcceEEEecch----hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence            44444444444443 356788887432    3345677777655555   457788999999999999999999987665


Q ss_pred             h
Q 046595          153 H  153 (363)
Q Consensus       153 ~  153 (363)
                      .
T Consensus        99 d   99 (286)
T COG3001          99 D   99 (286)
T ss_pred             C
Confidence            4

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=95.50  E-value=0.087  Score=45.60  Aligned_cols=78  Identities=22%  Similarity=0.155  Sum_probs=53.7

Q ss_pred             CeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEeccc-CCCh
Q 046595           74 ALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFAT-MGSL  152 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~g~L  152 (363)
                      ..+..|..+.|+.++..+|...++|+........   .-......|+..+-...+++++.-  .....|++|.+. +.+|
T Consensus         8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~---~E~~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~~L   82 (253)
T PF04655_consen    8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAE---HEARGEAALRWWNGRGAVRLLAAD--PERGALLLERLDPGRSL   82 (253)
T ss_pred             CCCCCCcceEEEEEEcCCCCeEEEEecCCcccch---hhhhHHhHhheeCCCCceeeeccc--cccchhhhhhccCCCch
Confidence            3466788999999998899999999976422111   111122558878888889998764  335568899984 4477


Q ss_pred             hhhh
Q 046595          153 HDVL  156 (363)
Q Consensus       153 ~~~l  156 (363)
                      .+..
T Consensus        83 ~~~~   86 (253)
T PF04655_consen   83 ASLP   86 (253)
T ss_pred             hhcc
Confidence            6655

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>PTZ00296 choline kinase; Provisional

Probab=95.21  E-value=0.26  Score=46.52  Aligned_cols=73  Identities=11%  Similarity=0.095  Sum_probs=43.7

Q ss_pred             CeeeccCCceEEEEEeCC---------CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccc-eeeeEEEeCCeeEEE
Q 046595           74 ALIGEGSYGRVFYAKLTD---------GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV-ELLGYCMESNNRILV  143 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~---------~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv  143 (363)
                      +.|..|-.-.+|++...+         ++.|++++.....  +..-....|..+++.+..-+|. ++++.+.    -+.|
T Consensus       111 ~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t--e~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I  184 (442)
T PTZ00296        111 NQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV--DELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRI  184 (442)
T ss_pred             EEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc--cceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence            345567778888886542         3578888775422  2222446677777777544443 4444332    3467


Q ss_pred             EecccCCCh
Q 046595          144 YQFATMGSL  152 (363)
Q Consensus       144 ~e~~~~g~L  152 (363)
                      .+|++|.+|
T Consensus       185 ~efi~g~~l  193 (442)
T PTZ00296        185 EEWLYGDPL  193 (442)
T ss_pred             EEeeCCccC
Confidence            899987644

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	363
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-47
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-47
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-45
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-44
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		9e-40
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-39
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-39
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-38
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-26
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-26
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-23
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-22
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-22
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-22
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-20
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		8e-20
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		8e-20
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		9e-20
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-19
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-19
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-19
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-19
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-19
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-19
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-19
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-19
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-19
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-19
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-19
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-19
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-19
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-19
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-19
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-19
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-19
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-19
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-19
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-19
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-19
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		7e-19
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-19
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		8e-19
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-19
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		8e-19
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		8e-19
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-18
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-18
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-18
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-18
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-18
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-18
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-18
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-18
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-18
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-18
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-18
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-18
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-18
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-18
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-18
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-18
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-18
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-18
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-18
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		6e-18
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		6e-18
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-18
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-18
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		8e-18
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-18
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		9e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		9e-18
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-17
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-17
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-17
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-17
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-17
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-17
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-17
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-17
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-17
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-17
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-17
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-17
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-17
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-17
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-17
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-17
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-17
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-17
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-17
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		8e-17
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		8e-17
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		8e-17
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-16
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-16
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-16
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-16
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-16
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-16
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-16
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		6e-16
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		6e-16
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-16
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		7e-16
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		7e-16
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		7e-16
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		7e-16
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		7e-16
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		7e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		7e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		8e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		8e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		8e-16
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		9e-16
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-15
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-15
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-15
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-15
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-15
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-15
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-15
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-15
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-15
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-15
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-15
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-15
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-15
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-15
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-15
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-15
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-15
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-15
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-15
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-15
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-15
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-15
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-15
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-15
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-15
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-15
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-15
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-15
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-15
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		6e-15
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-15
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		7e-15
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		7e-15
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		7e-15
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-15
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-15
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		8e-15
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		9e-15
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-14
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-14
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-14
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-14
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-14
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-14
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-14
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-14
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-14
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-14
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-14
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-14
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-14
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-14
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-14
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-14
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-14
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-14
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-14
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-14
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		6e-14
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-14
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-14
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		7e-14
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-14
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-14
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		7e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		7e-14
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-14
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		8e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		9e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		9e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		9e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-13
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-13
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-13
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-13
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-13
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-13
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-13
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-13
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-13
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-13
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-13
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-13
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-13
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-13
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-13
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-13
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-13
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		8e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		8e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		8e-13
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		9e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		9e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		9e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		9e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		9e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		9e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-12
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-12
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-12
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-12
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-12
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-12
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-12
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-12
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-12
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		7e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		8e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		8e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		8e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		9e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		9e-12
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-11
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-11
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-11
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-11
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-11
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-11
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-11
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-11
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-11
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-11
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-11
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-11
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-11
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-11
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-11
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-11
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-11
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-11
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-11
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-11
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-11
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-11
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-11
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-11
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-11
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-11
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-11
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-11
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-11
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-11
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-11
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-11
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-11
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-11
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-11
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		6e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		6e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-11
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		7e-11
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		8e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		8e-11
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-11
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		8e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		8e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-11
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-11
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		8e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		8e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		8e-11
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		8e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		9e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		9e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		9e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		9e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		9e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-10
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-10
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-10
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-10
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-10
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-10
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-10
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-10
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-10
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-10
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-10
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-10
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-10
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-10
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-10
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		7e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		7e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		9e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		9e-10
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		9e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		9e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-09
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-09
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		5e-09
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		5e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-08
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-08
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		6e-08
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		6e-08
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		8e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		8e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		8e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		9e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		9e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		9e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		9e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		9e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		9e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		9e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		9e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		9e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		9e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-07
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-07
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		8e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		8e-07
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		8e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		8e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		9e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		9e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-06
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-06
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-06
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-06
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-06
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-06
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		6e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		6e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		6e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		6e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		7e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-05
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-05
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-05
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-05
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-05
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-05
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-05
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-05
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-05
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-05
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-05
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-05
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-05
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-05
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-05
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-05
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-05
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-05
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-05
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-05
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-05
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-05
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-05
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-05
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-05
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-05
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-05
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-05
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-05
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-05
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-05
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-05
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-05
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		6e-05
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-05
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		7e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		8e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		9e-05
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		9e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		9e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		9e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-04
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-04
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-04
3soa_A	444	Full-Length Human Camkii Length = 444		1e-04
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-04
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		1e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-04
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-04
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-04
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-04
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		3e-04
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-04
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-04
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-04
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		3e-04
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-04
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-04
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-04
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		4e-04
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		4e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-04
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-04
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-04
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-04
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-04
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-04
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		5e-04
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		5e-04
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-04
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-04
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		5e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-04
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-04
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		5e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-04
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-04
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-04
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		6e-04
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		6e-04
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-04
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-04
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		7e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		7e-04
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		7e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-04
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		7e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		7e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		7e-04
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		7e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		7e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		7e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		7e-04
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		7e-04
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		7e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-04
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		8e-04
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		8e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-04
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-04
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		8e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		8e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		8e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		8e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-04
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		8e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		8e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		8e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		9e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		9e-04
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		9e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		9e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		9e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		9e-04
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-04

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  186 bits (471), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 105/322 (32%), Positives = 172/322 (53%), Gaps = 9/322 (2%)
Query: 31  GSARGEPRTNVVKTGTPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLT 90
           GS   +   ++    +    +P E  ++ L +L   T+NF  K LIG G +G+V+   L 
Sbjct: 2   GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 91  DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMG 150
           DG   A+K+  T  + +   +F  ++  +S  +H H V L+G+C E N  IL+Y++   G
Sbjct: 62  DGAKVALKR-RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120
Query: 151 SLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL 210
           +L   L+G        P   ++W QR+++  GAA+GL +LH +    I+HRDV+S N+LL
Sbjct: 121 NLKRHLYGSD-----LPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILL 172
Query: 211 FDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLL 270
            ++F  KI DF ++ + ++         V GT GY  PEY + G++T+KSDVYSFGVVL 
Sbjct: 173 DENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLF 232
Query: 271 ELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXC 330
           E+L  R  +  ++P+   +L  WA    +  +++Q VDP L +   P            C
Sbjct: 233 EVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKC 292
Query: 331 VQYEADFRPNMTIVVKALQPLL 352
           +   ++ RP+M  V+  L+  L
Sbjct: 293 LALSSEDRPSMGDVLWKLEYAL 314

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  185 bits (469), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 105/322 (32%), Positives = 172/322 (53%), Gaps = 9/322 (2%)
Query: 31  GSARGEPRTNVVKTGTPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLT 90
           GS   +   ++    +    +P E  ++ L +L   T+NF  K LIG G +G+V+   L 
Sbjct: 2   GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 91  DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMG 150
           DG   A+K+  T  + +   +F  ++  +S  +H H V L+G+C E N  IL+Y++   G
Sbjct: 62  DGAKVALKR-RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120
Query: 151 SLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL 210
           +L   L+G        P   ++W QR+++  GAA+GL +LH +    I+HRDV+S N+LL
Sbjct: 121 NLKRHLYG-----SDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILL 172
Query: 211 FDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLL 270
            ++F  KI DF ++ + ++         V GT GY  PEY + G++T+KSDVYSFGVVL 
Sbjct: 173 DENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLF 232
Query: 271 ELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXC 330
           E+L  R  +  ++P+   +L  WA    +  +++Q VDP L +   P            C
Sbjct: 233 EVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKC 292
Query: 331 VQYEADFRPNMTIVVKALQPLL 352
           +   ++ RP+M  V+  L+  L
Sbjct: 293 LALSSEDRPSMGDVLWKLEYAL 314

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 98/298 (32%), Positives = 156/298 (52%), Gaps = 8/298 (2%)
Query: 54  EIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFA 113
           ++ +  L EL   + NF  K ++G G +G+V+  +L DGT  A+K+L        E  F 
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQ 83
Query: 114 AQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTW 173
            ++ ++S   H + + L G+CM    R+LVY +   GS+   L  R      E  P L W
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER-----PESQPPLDW 138
Query: 174 NQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAAR 233
            +R ++A G+A+GL +LH+   P I+HRDV+++N+LL ++F++ + DF L  +  D    
Sbjct: 139 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDX 197
Query: 234 LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQS--LV 291
                V GT G+ APEY  TG+ ++K+DV+ +GV+LLEL+TG++  D           L+
Sbjct: 198 HVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 257
Query: 292 TWATPRLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQ 349
            W    L E K++  VD  L  +Y              C Q     RP M+ VV+ L+
Sbjct: 258 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 96/298 (32%), Positives = 154/298 (51%), Gaps = 8/298 (2%)
Query: 54  EIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFA 113
           ++ +  L EL   + NF  K ++G G +G+V+  +L DG   A+K+L        E  F 
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQ 75
Query: 114 AQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTW 173
            ++ ++S   H + + L G+CM    R+LVY +   GS+   L  R      E  P L W
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER-----PESQPPLDW 130
Query: 174 NQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAAR 233
            +R ++A G+A+GL +LH+   P I+HRDV+++N+LL ++F++ + DF L  +  D    
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDX 189
Query: 234 LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQS--LV 291
                V G  G+ APEY  TG+ ++K+DV+ +GV+LLEL+TG++  D           L+
Sbjct: 190 HVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249
Query: 292 TWATPRLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQ 349
            W    L E K++  VD  L  +Y              C Q     RP M+ VV+ L+
Sbjct: 250 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  160 bits (406), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 107/303 (35%), Positives = 161/303 (53%), Gaps = 24/303 (7%)
Query: 62  ELNRLTSNFGTKAL------IGEGSYGRVFYAKLTDGTPAAIKKLDTS---SAPEPESDF 112
           EL  +T+NF  + +      +GEG +G V Y    + T  A+KKL      +  E +  F
Sbjct: 19  ELKNVTNNFDERPISVGGNKMGEGGFG-VVYKGYVNNTTVAVKKLAAMVDITTEELKQQF 77
Query: 113 AAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLT 172
             ++ V+++ +HE+ VELLG+  + ++  LVY +   GSL D L    G       P L+
Sbjct: 78  DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT------PPLS 131
Query: 173 WNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA 232
           W+ R K+A GAA G+ FLHE      +HRD++S+N+LL + F +KI+DF L   S   A 
Sbjct: 132 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 233 RLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD-HTMPKGQQSLV 291
            +  +R++GT  Y APE A+ G+IT KSD+YSFGVVLLE++TG   VD H  P  Q  L 
Sbjct: 189 TVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP--QLLLD 245
Query: 292 TWATPRLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPL 351
                   E  ++  +D K+ ND               C+  + + RP++  V + LQ +
Sbjct: 246 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
Query: 352 LNS 354
             S
Sbjct: 305 TAS 307

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 107/303 (35%), Positives = 160/303 (52%), Gaps = 24/303 (7%)
Query: 62  ELNRLTSNFGTKAL------IGEGSYGRVFYAKLTDGTPAAIKKLDTS---SAPEPESDF 112
           EL  +T+NF  + +      +GEG +G V Y    + T  A+KKL      +  E +  F
Sbjct: 19  ELKNVTNNFDERPISVGGNKMGEGGFG-VVYKGYVNNTTVAVKKLAAMVDITTEELKQQF 77
Query: 113 AAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLT 172
             ++ V+++ +HE+ VELLG+  + ++  LVY +   GSL D L    G       P L+
Sbjct: 78  DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT------PPLS 131
Query: 173 WNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA 232
           W+ R K+A GAA G+ FLHE      +HRD++S+N+LL + F +KI+DF L   S   A 
Sbjct: 132 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 233 RLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD-HTMPKGQQSLV 291
            +   R++GT  Y APE A+ G+IT KSD+YSFGVVLLE++TG   VD H  P  Q  L 
Sbjct: 189 TVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP--QLLLD 245
Query: 292 TWATPRLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPL 351
                   E  ++  +D K+ ND               C+  + + RP++  V + LQ +
Sbjct: 246 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
Query: 352 LNS 354
             S
Sbjct: 305 TAS 307

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 107/303 (35%), Positives = 160/303 (52%), Gaps = 24/303 (7%)
Query: 62  ELNRLTSNFGTKAL------IGEGSYGRVFYAKLTDGTPAAIKKLDTS---SAPEPESDF 112
           EL  +T+NF  + +      +GEG +G V Y    + T  A+KKL      +  E +  F
Sbjct: 13  ELKNVTNNFDERPISVGGNKMGEGGFG-VVYKGYVNNTTVAVKKLAAMVDITTEELKQQF 71
Query: 113 AAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLT 172
             ++ V+++ +HE+ VELLG+  + ++  LVY +   GSL D L    G       P L+
Sbjct: 72  DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT------PPLS 125
Query: 173 WNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA 232
           W+ R K+A GAA G+ FLHE      +HRD++S+N+LL + F +KI+DF L   S   A 
Sbjct: 126 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 182
Query: 233 RLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD-HTMPKGQQSLV 291
            +   R++GT  Y APE A+ G+IT KSD+YSFGVVLLE++TG   VD H  P  Q  L 
Sbjct: 183 XVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP--QLLLD 239
Query: 292 TWATPRLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPL 351
                   E  ++  +D K+ ND               C+  + + RP++  V + LQ +
Sbjct: 240 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 298
Query: 352 LNS 354
             S
Sbjct: 299 TAS 301

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 107/298 (35%), Positives = 157/298 (52%), Gaps = 24/298 (8%)
Query: 62  ELNRLTSNFGTKAL------IGEGSYGRVFYAKLTDGTPAAIKKLDTS---SAPEPESDF 112
           EL  +T+NF  + +       GEG +G V Y    + T  A+KKL      +  E +  F
Sbjct: 10  ELKNVTNNFDERPISVGGNKXGEGGFG-VVYKGYVNNTTVAVKKLAAMVDITTEELKQQF 68
Query: 113 AAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLT 172
             ++ V ++ +HE+ VELLG+  + ++  LVY +   GSL D L    G       P L+
Sbjct: 69  DQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGT------PPLS 122
Query: 173 WNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA 232
           W+ R K+A GAA G+ FLHE      +HRD++S+N+LL + F +KI+DF L   S   A 
Sbjct: 123 WHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 179
Query: 233 RLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD-HTMPKGQQSLV 291
            +  +R++GT  Y APE A+ G+IT KSD+YSFGVVLLE++TG   VD H  P  Q  L 
Sbjct: 180 XVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP--QLLLD 236
Query: 292 TWATPRLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQ 349
                   E  ++  +D K  ND               C+  + + RP++  V + LQ
Sbjct: 237 IKEEIEDEEKTIEDYIDKK-XNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQ 293

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 85/295 (28%), Positives = 148/295 (50%), Gaps = 26/295 (8%)
Query: 61  DELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKL-DTSSAPEPESDFAAQLSVV 119
           D+++    +   K  IG GS+G V  A+   G+  A+K L +     E  ++F  +++++
Sbjct: 30  DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIM 88
Query: 120 SRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKV 179
            RL+H + V  +G   +  N  +V ++ + GSL+ +LH + G +       L   +R+ +
Sbjct: 89  KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQ-----LDERRRLSM 142
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
           AY  AKG+ +LH +  PPIVHR+++S N+L+   +  K+ DF L+   + T   L S   
Sbjct: 143 AYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF--LSSKSA 199
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS 299
            GT  + APE        +KSDVYSFGV+L EL T ++P  +  P    + V +   RL 
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL- 258
Query: 300 EDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNS 354
             ++ + ++P++                  C   E   RP+   ++  L+PL+ S
Sbjct: 259 --EIPRNLNPQV------------AAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 85/295 (28%), Positives = 148/295 (50%), Gaps = 26/295 (8%)
Query: 61  DELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKL-DTSSAPEPESDFAAQLSVV 119
           D+++    +   K  IG GS+G V  A+   G+  A+K L +     E  ++F  +++++
Sbjct: 30  DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIM 88
Query: 120 SRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKV 179
            RL+H + V  +G   +  N  +V ++ + GSL+ +LH + G +       L   +R+ +
Sbjct: 89  KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQ-----LDERRRLSM 142
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
           AY  AKG+ +LH +  PPIVHRD++S N+L+   +  K+ DF L+   +  +  L S   
Sbjct: 143 AYDVAKGMNYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--SXFLXSKXA 199
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS 299
            GT  + APE        +KSDVYSFGV+L EL T ++P  +  P    + V +   RL 
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL- 258
Query: 300 EDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNS 354
             ++ + ++P++                  C   E   RP+   ++  L+PL+ S
Sbjct: 259 --EIPRNLNPQV------------AAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 31/300 (10%)
Query: 69  NFGTKALIGEGSYGRVFYAKLTDGTP------AAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           N   K  +GEG++G+VF A+  +  P       A+K L  +S      DF  +  +++ L
Sbjct: 14  NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNL 72
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVL--HGRKGVQGAEPGP--VLTWNQRVK 178
           +HEH V+  G C+E +  I+V+++   G L+  L  HG   V  AE  P   LT +Q + 
Sbjct: 73  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH 132
Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
           +A   A G+ +L  +     VHRD+ + N L+ ++   KI DF ++     T        
Sbjct: 133 IAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 189
Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPR 297
            +    +  PE  M  + T +SDV+S GVVL E+ T G++P              W   +
Sbjct: 190 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP--------------WY--Q 233
Query: 298 LSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKPA 357
           LS ++V +C+        P             C Q E   R N+  +   LQ L  + P 
Sbjct: 234 LSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPV 293

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 34/219 (15%)
Query: 75  LIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVV-------SRLKHEHF 127
           +IG G +G+V+ A    G   A+K    ++  +P+ D +  +  V       + LKH + 
Sbjct: 14  IIGIGGFGKVYRA-FWIGDEVAVK----AARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68
Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
           + L G C++  N  LV +FA  G L+ VL G++      P  ++ W  ++      A+G+
Sbjct: 69  IALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQI------ARGM 118
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKS--------KIADFNLTNQSSDTAARLHSTRV 239
            +LH++   PI+HRD++SSN+L+    ++        KI DF L  +   T         
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSA 174
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            G + + APE       ++ SDV+S+GV+L ELLTG  P
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 130/290 (44%), Gaps = 32/290 (11%)
Query: 72  TKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
            + ++G G++G V  AK       AIK++++ S       F  +L  +SR+ H + V+L 
Sbjct: 13  VEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESE---RKAFIVELRQLSRVNHPNIVKLY 68
Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G C+  N   LV ++A  GSL++VLHG      AEP P  T    +      ++G+ +LH
Sbjct: 69  GACL--NPVCLVMEYAEGGSLYNVLHG------AEPLPYYTAAHAMSWCLQCSQGVAYLH 120
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEY 250
                 ++HRD++  N+LL       KI DF      +    + H T   G+  + APE 
Sbjct: 121 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFG-----TACDIQTHMTNNKGSAAWMAPEV 175
Query: 251 AMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPK 310
                 ++K DV+S+G++L E++T RKP D     G    + WA        V     P 
Sbjct: 176 FEGSNYSEKCDVFSWGIILWEVITRRKPFDEI--GGPAFRIMWA--------VHNGTRPP 225
Query: 311 LNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKPAGPE 360
           L  + P             C   +   RP+M  +VK +  L+   P   E
Sbjct: 226 LIKNLP----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 271

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 130/290 (44%), Gaps = 32/290 (11%)
Query: 72  TKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
            + ++G G++G V  AK       AIK++++ S       F  +L  +SR+ H + V+L 
Sbjct: 12  VEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESE---RKAFIVELRQLSRVNHPNIVKLY 67
Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G C+  N   LV ++A  GSL++VLHG      AEP P  T    +      ++G+ +LH
Sbjct: 68  GACL--NPVCLVMEYAEGGSLYNVLHG------AEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEY 250
                 ++HRD++  N+LL       KI DF      +    + H T   G+  + APE 
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFG-----TACDIQTHMTNNKGSAAWMAPEV 174
Query: 251 AMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPK 310
                 ++K DV+S+G++L E++T RKP D     G    + WA        V     P 
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDEI--GGPAFRIMWA--------VHNGTRPP 224
Query: 311 LNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKPAGPE 360
           L  + P             C   +   RP+M  +VK +  L+   P   E
Sbjct: 225 LIKNLP----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 112/231 (48%), Gaps = 19/231 (8%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           IG GS+G V+  K        I K+     PE    F  +++V+ + +H + +  +GY M
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKV-VDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY-M 101
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
             +N  +V Q+    SL+  LH    VQ  +        Q + +A   A+G+++LH K  
Sbjct: 102 TKDNLAIVTQWCEGSSLYKHLH----VQETK----FQMFQLIDIARQTAQGMDYLHAK-- 151
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQ 255
             I+HRD++S+N+ L +    KI DF L    S  +      +  G+  + APE      
Sbjct: 152 -NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQD 210
Query: 256 ---ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT---WATPRLSE 300
               + +SDVYS+G+VL EL+TG  P  H   + Q   +    +A+P LS+
Sbjct: 211 NNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSK 261

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 108/206 (52%), Gaps = 19/206 (9%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G+G +G V+       T  AIK L   +   PE+ F  +  V+ +L+HE  V+L     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           E    I++ ++ + GSL D L G       E G  L   Q V +A   A G+ ++ E++ 
Sbjct: 84  EEPIYIVI-EYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYV-ERMN 134
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAMT 253
              VHRD+R++N+L+ ++   K+ADF L     D     ++ R    F   + APE A+ 
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALY 189
Query: 254 GQITQKSDVYSFGVVLLELLT-GRKP 278
           G+ T KSDV+SFG++L EL T GR P
Sbjct: 190 GRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 110/207 (53%), Gaps = 21/207 (10%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G+G +G V+       T  AIK L   +   PE+ F  +  V+ +L+HE  V+L  Y +
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEA-FLQEAQVMKKLRHEKLVQL--YAV 74
Query: 136 ESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            S   I +V ++ + GSL D L G       E G  L   Q V +A   A G+ ++ E++
Sbjct: 75  VSEEPIYIVTEYMSKGSLLDFLKG-------ETGKYLRLPQLVDMAAQIASGMAYV-ERM 126
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAM 252
               VHRD+R++N+L+ ++   K+ADF L     D     ++ R    F   + APE A+
Sbjct: 127 N--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 181
Query: 253 TGQITQKSDVYSFGVVLLELLT-GRKP 278
            G+ T KSDV+SFG++L EL T GR P
Sbjct: 182 YGRFTIKSDVWSFGILLTELTTKGRVP 208

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 110/207 (53%), Gaps = 21/207 (10%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G+G +G V+       T  AIK L   +   PE+ F  +  V+ +L+HE  V+L  Y +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEA-FLQEAQVMKKLRHEKLVQL--YAV 81
Query: 136 ESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            S   I +V ++ + GSL D L G       E G  L   Q V +A   A G+ ++ E++
Sbjct: 82  VSEEPIYIVCEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYV-ERM 133
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAM 252
               VHRD+R++N+L+ ++   K+ADF L     D     ++ R    F   + APE A+
Sbjct: 134 N--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 188
Query: 253 TGQITQKSDVYSFGVVLLELLT-GRKP 278
            G+ T KSDV+SFG++L EL T GR P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 110/207 (53%), Gaps = 21/207 (10%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G+G +G V+       T  AIK L   +   PE+ F  +  V+ +L+HE  V+L  Y +
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEA-FLQEAQVMKKLRHEKLVQL--YAV 70
Query: 136 ESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            S   I +V ++ + GSL D L G       E G  L   Q V +A   A G+ ++ E++
Sbjct: 71  VSEEPIYIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYV-ERM 122
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAM 252
               VHRD+R++N+L+ ++   K+ADF L     D     ++ R    F   + APE A+
Sbjct: 123 N--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 177
Query: 253 TGQITQKSDVYSFGVVLLELLT-GRKP 278
            G+ T KSDV+SFG++L EL T GR P
Sbjct: 178 YGRFTIKSDVWSFGILLTELTTKGRVP 204

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 110/207 (53%), Gaps = 21/207 (10%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G+G +G V+       T  AIK L   +   PE+ F  +  V+ +L+HE  V+L  Y +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEA-FLQEAQVMKKLRHEKLVQL--YAV 81
Query: 136 ESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            S   I +V ++ + GSL D L G       E G  L   Q V +A   A G+ ++ E++
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYV-ERM 133
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAM 252
               VHRD+R++N+L+ ++   K+ADF L     D     ++ R    F   + APE A+
Sbjct: 134 N--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 188
Query: 253 TGQITQKSDVYSFGVVLLELLT-GRKP 278
            G+ T KSDV+SFG++L EL T GR P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 110/207 (53%), Gaps = 21/207 (10%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G+G +G V+       T  AIK L   +   PE+ F  +  V+ +L+HE  V+L  Y +
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEA-FLQEAQVMKKLRHEKLVQL--YAV 72
Query: 136 ESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            S   I +V ++ + GSL D L G       E G  L   Q V +A   A G+ ++ E++
Sbjct: 73  VSEEPIYIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYV-ERM 124
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAM 252
               VHRD+R++N+L+ ++   K+ADF L     D     ++ R    F   + APE A+
Sbjct: 125 N--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 179
Query: 253 TGQITQKSDVYSFGVVLLELLT-GRKP 278
            G+ T KSDV+SFG++L EL T GR P
Sbjct: 180 YGRFTIKSDVWSFGILLTELTTKGRVP 206

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 110/207 (53%), Gaps = 21/207 (10%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G+G +G V+       T  AIK L   +   PE+ F  +  V+ +L+HE  V+L  Y +
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEA-FLQEAQVMKKLRHEKLVQL--YAV 330
Query: 136 ESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            S   I +V ++ + GSL D L G       E G  L   Q V +A   A G+ ++ E++
Sbjct: 331 VSEEPIYIVTEYMSKGSLLDFLKG-------ETGKYLRLPQLVDMAAQIASGMAYV-ERM 382
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAM 252
               VHRD+R++N+L+ ++   K+ADF L     D     ++ R    F   + APE A+
Sbjct: 383 N--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 437
Query: 253 TGQITQKSDVYSFGVVLLELLT-GRKP 278
            G+ T KSDV+SFG++L EL T GR P
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVP 464

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 109/207 (52%), Gaps = 21/207 (10%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G+G +G V+       T  AIK L   +   PE+ F  +  V+ +L+HE  V+L  Y +
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEA-FLQEAQVMKKLRHEKLVQL--YAV 71
Query: 136 ESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            S   I +V ++ + GSL D L G       E G  L   Q V +A   A G+ ++ E++
Sbjct: 72  VSEEPIXIVTEYMSKGSLLDFLKG-------ETGKYLRLPQLVDMAAQIASGMAYV-ERM 123
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAM 252
               VHRD+R++N+L+ ++   K+ADF L     D      + R    F   + APE A+
Sbjct: 124 N--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEX---TARQGAKFPIKWTAPEAAL 178
Query: 253 TGQITQKSDVYSFGVVLLELLT-GRKP 278
            G+ T KSDV+SFG++L EL T GR P
Sbjct: 179 YGRFTIKSDVWSFGILLTELTTKGRVP 205

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 107/206 (51%), Gaps = 19/206 (9%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G+G +G V+       T  AIK L   +   PE+ F  +  V+ +L+HE  V+L     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           E    I++ ++ + GSL D L G       E G  L   Q V +A   A G+ ++ E++ 
Sbjct: 84  EEPIYIVI-EYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYV-ERMN 134
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAMT 253
              VHRD+R++N+L+ ++   K+ADF L     D      + R    F   + APE A+ 
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEX---TARQGAKFPIKWTAPEAALY 189
Query: 254 GQITQKSDVYSFGVVLLELLT-GRKP 278
           G+ T KSDV+SFG++L EL T GR P
Sbjct: 190 GRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 134/290 (46%), Gaps = 43/290 (14%)
Query: 76  IGEGSYGRVFYAKLT-DGTPAAIKKL------DTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           IG+G +G V   +L  D +  AIK L        +   E   +F  ++ ++S L H + V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 129 ELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
           +L G  +  N   +V +F   G L+  L     +  A P   + W+ ++++    A G+E
Sbjct: 87  KLYG--LMHNPPRMVMEFVPCGDLYHRL-----LDKAHP---IKWSVKLRLMLDIALGIE 136
Query: 189 FLHEKVQPPIVHRDVRSSNVLL--FDD---FKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
           ++  +  PPIVHRD+RS N+ L   D+     +K+ADF+L+ QS  + + L     LG F
Sbjct: 137 YMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGL-----LGNF 190
Query: 244 GYHAPEY--AMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED 301
            + APE   A     T+K+D YSF ++L  +LTG  P D           ++   +    
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE---------YSYGKIKFINM 241
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPL 351
             ++ + P +  D PP            C   +   RP+ + +VK L  L
Sbjct: 242 IREEGLRPTIPEDCPP----RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/245 (33%), Positives = 126/245 (51%), Gaps = 29/245 (11%)
Query: 39  TNVVKTGTPQ-KALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAI 97
           TNV  T  PQ + L  +  +I  + L RL      +  +G+G +G V+       T  AI
Sbjct: 162 TNVCPTSKPQTQGLAKDAWEIPRESL-RL------EVKLGQGCFGEVWMGTWNGTTRVAI 214
Query: 98  KKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVL 156
           K L   +   PE+ F  +  V+ +L+HE  V+L  Y + S   I +V ++ + GSL D L
Sbjct: 215 KTLKPGNM-SPEA-FLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFL 270
Query: 157 HGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS 216
            G       E G  L   Q V +A   A G+ ++ E++    VHRD+R++N+L+ ++   
Sbjct: 271 KG-------EMGKYLRLPQLVDMAAQIASGMAYV-ERMN--YVHRDLRAANILVGENLVC 320
Query: 217 KIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
           K+ADF L     D     ++ R    F   + APE A+ G+ T KSDV+SFG++L EL T
Sbjct: 321 KVADFGLGRLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 377
Query: 275 -GRKP 278
            GR P
Sbjct: 378 KGRVP 382

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 110/207 (53%), Gaps = 21/207 (10%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G+G +G V+       T  AIK L   +   PE+ F  +  V+ +L+HE  V+L  Y +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEA-FLQEAQVMKKLRHEKLVQL--YAV 247
Query: 136 ESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            S   I +V ++ + GSL D L G       E G  L   Q V +A   A G+ ++ E++
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKG-------ETGKYLRLPQLVDMAAQIASGMAYV-ERM 299
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAM 252
               VHRD+R++N+L+ ++   K+ADF L     D     ++ R    F   + APE A+
Sbjct: 300 N--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 354
Query: 253 TGQITQKSDVYSFGVVLLELLT-GRKP 278
            G+ T KSDV+SFG++L EL T GR P
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 110/207 (53%), Gaps = 21/207 (10%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G+G +G V+       T  AIK L   +   PE+ F  +  V+ +L+HE  V+L  Y +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEA-FLQEAQVMKKLRHEKLVQL--YAV 247
Query: 136 ESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            S   I +V ++ + GSL D L G       E G  L   Q V +A   A G+ ++ E++
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKG-------ETGKYLRLPQLVDMAAQIASGMAYV-ERM 299
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAM 252
               VHRD+R++N+L+ ++   K+ADF L     D     ++ R    F   + APE A+
Sbjct: 300 N--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 354
Query: 253 TGQITQKSDVYSFGVVLLELLT-GRKP 278
            G+ T KSDV+SFG++L EL T GR P
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/207 (34%), Positives = 110/207 (53%), Gaps = 21/207 (10%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G+G +G V+       T  AIK L   +   PE+ F  +  V+ +++HE  V+L  Y +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEA-FLQEAQVMKKIRHEKLVQL--YAV 81
Query: 136 ESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            S   I +V ++ + GSL D L G       E G  L   Q V +A   A G+ ++ E++
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYV-ERM 133
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAM 252
               VHRD+R++N+L+ ++   K+ADF L     D     ++ R    F   + APE A+
Sbjct: 134 N--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 188
Query: 253 TGQITQKSDVYSFGVVLLELLT-GRKP 278
            G+ T KSDV+SFG++L EL T GR P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/207 (34%), Positives = 109/207 (52%), Gaps = 21/207 (10%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G+G +G V+       T  AIK L   +   PE+ F  +  V+ +L+HE  V+L  Y +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEA-FLQEAQVMKKLRHEKLVQL--YAV 81
Query: 136 ESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            S   I +V ++ + G L D L G       E G  L   Q V +A   A G+ ++ E++
Sbjct: 82  VSEEPIYIVMEYMSKGCLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYV-ERM 133
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAM 252
               VHRD+R++N+L+ ++   K+ADF L     D     ++ R    F   + APE A+
Sbjct: 134 N--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 188
Query: 253 TGQITQKSDVYSFGVVLLELLT-GRKP 278
            G+ T KSDV+SFG++L EL T GR P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/207 (34%), Positives = 109/207 (52%), Gaps = 21/207 (10%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G+G +G V+       T  AIK L   +   PE+ F  +  V+ +L+HE  V+L  Y +
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEA-FLQEAQVMKKLRHEKLVQL--YAV 78
Query: 136 ESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            S   I +V ++   GSL D L G       E G  L   Q V ++   A G+ ++ E++
Sbjct: 79  VSEEPIYIVTEYMNKGSLLDFLKG-------ETGKYLRLPQLVDMSAQIASGMAYV-ERM 130
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAM 252
               VHRD+R++N+L+ ++   K+ADF L     D     ++ R    F   + APE A+
Sbjct: 131 N--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 185
Query: 253 TGQITQKSDVYSFGVVLLELLT-GRKP 278
            G+ T KSDV+SFG++L EL T GR P
Sbjct: 186 YGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 133/290 (45%), Gaps = 43/290 (14%)
Query: 76  IGEGSYGRVFYAKLT-DGTPAAIKKL------DTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           IG+G +G V   +L  D +  AIK L        +   E   +F  ++ ++S L H + V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 129 ELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
           +L G  +  N   +V +F   G L+  L     +  A P   + W+ ++++    A G+E
Sbjct: 87  KLYG--LMHNPPRMVMEFVPCGDLYHRL-----LDKAHP---IKWSVKLRLMLDIALGIE 136
Query: 189 FLHEKVQPPIVHRDVRSSNVLL--FDD---FKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
           ++  +  PPIVHRD+RS N+ L   D+     +K+ADF L+ QS  + + L     LG F
Sbjct: 137 YMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGL-----LGNF 190
Query: 244 GYHAPEY--AMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED 301
            + APE   A     T+K+D YSF ++L  +LTG  P D           ++   +    
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE---------YSYGKIKFINM 241
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPL 351
             ++ + P +  D PP            C   +   RP+ + +VK L  L
Sbjct: 242 IREEGLRPTIPEDCPP----RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 128/298 (42%), Gaps = 35/298 (11%)
Query: 73  KALIGEGSYGRVFYAKLTDGTP------AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEH 126
           K  +GEG++G+VF A+  +  P       A+K L  +S      DF  +  +++ L+H+H
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE-SARQDFQREAELLTMLQHQH 104
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVL--HG--RKGVQGAE---PGPVLTWNQRVKV 179
            V   G C E    ++V+++   G L+  L  HG   K + G E   PGP L   Q + V
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP-LGLGQLLAV 163
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
           A   A G+ +L        VHRD+ + N L+      KI DF ++     T       R 
Sbjct: 164 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRL 298
           +    +  PE  +  + T +SDV+SFGVVL E+ T G++P              W   +L
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--------------WY--QL 264
Query: 299 SEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKP 356
           S  +   C+      + P             C Q E   R ++  V   LQ L  + P
Sbjct: 265 SNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP 322

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 110/207 (53%), Gaps = 21/207 (10%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G+G +G V+       T  AIK L   +   PE+ F  +  V+ +L+HE  V+L  Y +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEA-FLQEAQVMKKLRHEKLVQL--YAV 247
Query: 136 ESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            S   I +V ++ + GSL D L G       E G  L   Q V +A   A G+ ++ E++
Sbjct: 248 VSEEPIYIVGEYMSKGSLLDFLKG-------ETGKYLRLPQLVDMAAQIASGMAYV-ERM 299
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAM 252
               VHRD+R++N+L+ ++   K+ADF L     D     ++ R    F   + APE A+
Sbjct: 300 N--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 354
Query: 253 TGQITQKSDVYSFGVVLLELLT-GRKP 278
            G+ T KSDV+SFG++L EL T GR P
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/207 (34%), Positives = 109/207 (52%), Gaps = 21/207 (10%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G+G +G V+       T  AIK L   +   PE+ F  +  V+ +L+HE  V+L  Y +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEA-FLQEAQVMKKLRHEKLVQL--YAV 81
Query: 136 ESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            S   I +V ++ + G L D L G       E G  L   Q V +A   A G+ ++ E++
Sbjct: 82  VSEEPIYIVTEYMSKGCLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYV-ERM 133
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAM 252
               VHRD+R++N+L+ ++   K+ADF L     D     ++ R    F   + APE A+
Sbjct: 134 N--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 188
Query: 253 TGQITQKSDVYSFGVVLLELLT-GRKP 278
            G+ T KSDV+SFG++L EL T GR P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 128/299 (42%), Gaps = 35/299 (11%)
Query: 73  KALIGEGSYGRVFYAKLTDGTP------AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEH 126
           K  +GEG++G+VF A+  +  P       A+K L  +S      DF  +  +++ L+H+H
Sbjct: 17  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE-SARQDFQREAELLTMLQHQH 75
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVL--HG--RKGVQGAE---PGPVLTWNQRVKV 179
            V   G C E    ++V+++   G L+  L  HG   K + G E   PGP L   Q + V
Sbjct: 76  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP-LGLGQLLAV 134
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
           A   A G+ +L        VHRD+ + N L+      KI DF ++     T       R 
Sbjct: 135 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 191
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRL 298
           +    +  PE  +  + T +SDV+SFGVVL E+ T G++P              W   +L
Sbjct: 192 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--------------WY--QL 235
Query: 299 SEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKPA 357
           S  +   C+      + P             C Q E   R ++  V   LQ L  + P 
Sbjct: 236 SNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 294

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 107/220 (48%), Gaps = 19/220 (8%)
Query: 73  KALIGEGSYGRVFYAKLTDGTP------AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEH 126
           K  +GEG++G+VF A+  +  P       A+K L  +S      DF  +  +++ L+H+H
Sbjct: 23  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE-SARQDFQREAELLTMLQHQH 81
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVL--HG--RKGVQGAE---PGPVLTWNQRVKV 179
            V   G C E    ++V+++   G L+  L  HG   K + G E   PGP L   Q + V
Sbjct: 82  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP-LGLGQLLAV 140
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
           A   A G+ +L        VHRD+ + N L+      KI DF ++     T       R 
Sbjct: 141 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 197
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
           +    +  PE  +  + T +SDV+SFGVVL E+ T G++P
Sbjct: 198 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 76  IGEGSYGRVFYA--------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEH 126
           +GEG++G+V  A        K    T  A+K L + +  +  SD  +++ ++  + KH++
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRK--GVQGA-----EPGPVLTWNQRVKV 179
            + LLG C +     ++ ++A+ G+L + L  R+  G++ +      P   L+    V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
           AY  A+G+E+L  K     +HRD+ + NVL+ +D   KIADF L            +T  
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                + APE       T +SDV+SFGV+L E+ T
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 128/294 (43%), Gaps = 32/294 (10%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPE-----PESDFAAQLSVVSRLKHEHFVEL 130
           +GEG++G+VF A+  + +P   K L    A +        DF  +  +++ L+HEH V+ 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 131 LGYCMESNNRILVYQFATMGSLHDVL--HGRKGVQGAEPGPV-----LTWNQRVKVAYGA 183
            G C + +  I+V+++   G L+  L  HG   +   +  P      L  +Q + +A   
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
           A G+ +L  +     VHRD+ + N L+  +   KI DF ++     T         +   
Sbjct: 143 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDK 302
            +  PE  M  + T +SDV+SFGV+L E+ T G++P              W   +LS  +
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--------------WF--QLSNTE 243
Query: 303 VKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKP 356
           V +C+      + P             C Q E   R N+  + K L  L  + P
Sbjct: 244 VIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKATP 297

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 71/207 (34%), Positives = 108/207 (52%), Gaps = 21/207 (10%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G+G +G V+       T  AIK L   +   PE+ F  +  V+ +L+HE  V+L  Y +
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEA-FLQEAQVMKKLRHEKLVQL--YAV 78
Query: 136 ESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            S   I +V ++   GSL D L G       E G  L   Q V ++   A G+ ++ E++
Sbjct: 79  VSEEPIYIVTEYMNKGSLLDFLKG-------ETGKYLRLPQLVDMSAQIASGMAYV-ERM 130
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAM 252
               VHRD+R++N+L+ ++   K+ADF L     D      + R    F   + APE A+
Sbjct: 131 N--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE---WTARQGAKFPIKWTAPEAAL 185
Query: 253 TGQITQKSDVYSFGVVLLELLT-GRKP 278
            G+ T KSDV+SFG++L EL T GR P
Sbjct: 186 YGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 76  IGEGSYGRVFYA--------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEH 126
           +GEG++G+V  A        K    T  A+K L + +  +  SD  +++ ++  + KH++
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRK--GVQ-----GAEPGPVLTWNQRVKV 179
            + LLG C +     ++ ++A+ G+L + L  R+  G++        P   L+    V  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
           AY  A+G+E+L  K     +HRD+ + NVL+ +D   KIADF L            +T  
Sbjct: 141 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                + APE       T +SDV+SFGV+L E+ T
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 76  IGEGSYGRVFYA--------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEH 126
           +GEG++G+V  A        K    T  A+K L + +  +  SD  +++ ++  + KH++
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRK--GVQGA-----EPGPVLTWNQRVKV 179
            + LLG C +     ++ ++A+ G+L + L  R+  G++ +      P   L+    V  
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
           AY  A+G+E+L  K     +HRD+ + NVL+ +D   KIADF L            +T  
Sbjct: 148 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                + APE       T +SDV+SFGV+L E+ T
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 76  IGEGSYGRVFYA--------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEH 126
           +GEG++G+V  A        K    T  A+K L + +  +  SD  +++ ++  + KH++
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRK--GVQ-----GAEPGPVLTWNQRVKV 179
            + LLG C +     ++ ++A+ G+L + L  R+  G++        P   L+    V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
           AY  A+G+E+L  K     +HRD+ + NVL+ +D   KIADF L            +T  
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                + APE       T +SDV+SFGV+L E+ T
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 76  IGEGSYGRVFYA--------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEH 126
           +GEG++G+V  A        K    T  A+K L + +  +  SD  +++ ++  + KH++
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRK--GVQGA-----EPGPVLTWNQRVKV 179
            + LLG C +     ++ ++A+ G+L + L  R+  G++ +      P   L+    V  
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
           AY  A+G+E+L  K     +HRD+ + NVL+ +D   KIADF L            +T  
Sbjct: 145 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                + APE       T +SDV+SFGV+L E+ T
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 76  IGEGSYGRVFYA--------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEH 126
           +GEG++G+V  A        K    T  A+K L + +  +  SD  +++ ++  + KH++
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRK--GVQGA-----EPGPVLTWNQRVKV 179
            + LLG C +     ++ ++A+ G+L + L  R+  G++ +      P   L+    V  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
           AY  A+G+E+L  K     +HRD+ + NVL+ +D   KIADF L            +T  
Sbjct: 149 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                + APE       T +SDV+SFGV+L E+ T
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 76  IGEGSYGRVFYA--------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEH 126
           +GEG++G+V  A        K    T  A+K L + +  +  SD  +++ ++  + KH++
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRK--GVQGA-----EPGPVLTWNQRVKV 179
            + LLG C +     ++ ++A+ G+L + L  R+  G++ +      P   L+    V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
           AY  A+G+E+L  K     +HRD+ + NVL+ +D   KIADF L            +T  
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                + APE       T +SDV+SFGV+L E+ T
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 71/207 (34%), Positives = 109/207 (52%), Gaps = 21/207 (10%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G+G +G V+       T  AIK L   +   PE+ F  +  V+ +L+HE  V+L  Y +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEA-FLQEAQVMKKLRHEKLVQL--YAV 81
Query: 136 ESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            S   I +V ++ + GSL D L G       E G  L   Q V +A   A G+ ++ E++
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYV-ERM 133
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAM 252
               VHRD+ ++N+L+ ++   K+ADF L     D     ++ R    F   + APE A+
Sbjct: 134 N--YVHRDLAAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 188
Query: 253 TGQITQKSDVYSFGVVLLELLT-GRKP 278
            G+ T KSDV+SFG++L EL T GR P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 76  IGEGSYGRVFYA--------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEH 126
           +GEG++G+V  A        K    T  A+K L + +  +  SD  +++ ++  + KH++
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRK--GVQGA-----EPGPVLTWNQRVKV 179
            + LLG C +     ++ ++A+ G+L + L  R+  G++ +      P   L+    V  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
           AY  A+G+E+L  K     +HRD+ + NVL+ +D   KIADF L            +T  
Sbjct: 197 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                + APE       T +SDV+SFGV+L E+ T
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/243 (30%), Positives = 118/243 (48%), Gaps = 32/243 (13%)
Query: 42  VKTGTPQKAL---PIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIK 98
           ++T  PQK       E+P+  L  + RL          G G +G V+       T  A+K
Sbjct: 4   MQTQKPQKPWWEDEWEVPRETLKLVERL----------GAGQFGEVWMGYYNGHTKVAVK 53
Query: 99  KLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHG 158
            L   S   P++ F A+ +++ +L+H+  V L     +    I+  ++   GSL D L  
Sbjct: 54  SLKQGSM-SPDA-FLAEANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKT 110
Query: 159 RKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI 218
             G++       LT N+ + +A   A+G+ F+ E+     +HRD+R++N+L+ D    KI
Sbjct: 111 PSGIK-------LTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKI 160
Query: 219 ADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAMTGQITQKSDVYSFGVVLLELLT-G 275
           ADF L     D     ++ R    F   + APE    G  T KSDV+SFG++L E++T G
Sbjct: 161 ADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 217
Query: 276 RKP 278
           R P
Sbjct: 218 RIP 220

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 76  IGEGSYGRVFYA--------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEH 126
           +GEG++G+V  A        K    T  A+K L + +  +  SD  +++ ++  + KH++
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRK--GVQGA-----EPGPVLTWNQRVKV 179
            + LLG C +     ++ ++A+ G+L + L  R+  G++ +      P   L+    V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
           AY  A+G+E+L  K     +HRD+ + NVL+ +D   KIADF L            +T  
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                + APE       T +SDV+SFGV+L E+ T
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 132/290 (45%), Gaps = 43/290 (14%)
Query: 76  IGEGSYGRVFYAKLT-DGTPAAIKKL------DTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           IG+G +G V   +L  D +  AIK L        +   E   +F  ++ ++S L H + V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 129 ELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
           +L G  +  N   +V +F   G L+  L     +  A P   + W+ ++++    A G+E
Sbjct: 87  KLYG--LMHNPPRMVMEFVPCGDLYHRL-----LDKAHP---IKWSVKLRLMLDIALGIE 136
Query: 189 FLHEKVQPPIVHRDVRSSNVLL--FDD---FKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
           ++  +  PPIVHRD+RS N+ L   D+     +K+ADF  + QS  + + L     LG F
Sbjct: 137 YMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGL-----LGNF 190
Query: 244 GYHAPEY--AMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED 301
            + APE   A     T+K+D YSF ++L  +LTG  P D           ++   +    
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE---------YSYGKIKFINM 241
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPL 351
             ++ + P +  D PP            C   +   RP+ + +VK L  L
Sbjct: 242 IREEGLRPTIPEDCPP----RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 108/215 (50%), Gaps = 19/215 (8%)
Query: 76  IGEGSYGRVFYA--------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEH 126
           +GEG++G+V  A        K  +    A+K L   +  E  SD  +++ ++  + KH++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRK--GVQGAE-----PGPVLTWNQRVKV 179
            + LLG C +     ++ ++A+ G+L + L  R+  G++ +      P   +T+   V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
            Y  A+G+E+L  +     +HRD+ + NVL+ ++   KIADF L    ++      +T  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                + APE       T +SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 19/215 (8%)
Query: 76  IGEGSYGRVFYA--------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEH 126
           +GEG++G+V  A        K  +    A+K L   +  +  SD  +++ ++  + KH++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRK--GVQGAE-----PGPVLTWNQRVKV 179
            + LLG C +     ++ ++A+ G+L + L  R+  G++ +      P   +T+   V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
            Y  A+G+E+L  +     +HRD+ + NVL+ ++   KIADF L    ++      +T  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                + APE       T +SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/242 (30%), Positives = 117/242 (48%), Gaps = 32/242 (13%)
Query: 43  KTGTPQKAL---PIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKK 99
           +T  PQK       E+P+  L  + RL          G G +G V+       T  A+K 
Sbjct: 1   QTQKPQKPWWEDEWEVPRETLKLVERL----------GAGQFGEVWMGYYNGHTKVAVKS 50
Query: 100 LDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGR 159
           L   S   P++ F A+ +++ +L+H+  V L     +    I+  ++   GSL D L   
Sbjct: 51  LKQGSM-SPDA-FLAEANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTP 107
Query: 160 KGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA 219
            G++       LT N+ + +A   A+G+ F+ E+     +HRD+R++N+L+ D    KIA
Sbjct: 108 SGIK-------LTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIA 157
Query: 220 DFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GR 276
           DF L     D     ++ R    F   + APE    G  T KSDV+SFG++L E++T GR
Sbjct: 158 DFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 214
Query: 277 KP 278
            P
Sbjct: 215 IP 216

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 105/206 (50%), Gaps = 19/206 (9%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V+       T  A+K L   S   P++ F A+ +++ +L+H+  V L     
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDA-FLAEANLMKQLQHQRLVRLYAVVT 83
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           +    I+  ++   GSL D L    G++       LT N+ + +A   A+G+ F+ E+  
Sbjct: 84  QEPIYIIT-EYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEER-- 133
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAMT 253
              +HRD+R++N+L+ D    KIADF L     D     ++ R    F   + APE    
Sbjct: 134 -NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINY 189
Query: 254 GQITQKSDVYSFGVVLLELLT-GRKP 278
           G  T KSDV+SFG++L E++T GR P
Sbjct: 190 GTFTIKSDVWSFGILLTEIVTHGRIP 215

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 19/215 (8%)
Query: 76  IGEGSYGRVFYA--------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEH 126
           +GEG++G+V  A        K  +    A+K L   +  +  SD  +++ ++  + KH++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRK--GVQGAE-----PGPVLTWNQRVKV 179
            + LLG C +     ++ ++A+ G+L + L  R+  G++ +      P   +T+   V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
            Y  A+G+E+L  +     +HRD+ + NVL+ ++   KIADF L    ++      +T  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                + APE       T +SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 109/215 (50%), Gaps = 19/215 (8%)
Query: 76  IGEGSYGRVFYA--------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEH 126
           +GEG++G+V  A        K  +    A+K L   +  +  SD  +++ ++  + KH++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRK--GVQGAE-----PGPVLTWNQRVKV 179
            + LLG C +     ++ ++A+ G+L + L  R+  G++ +      P   +T+   V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
            Y  A+G+E+L  +     +HRD+ + NVL+ ++   KIADF L    ++     ++T  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                + APE       T +SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 105/206 (50%), Gaps = 19/206 (9%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V+       T  A+K L   S   P++ F A+ +++ +L+H+  V L     
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDA-FLAEANLMKQLQHQRLVRLYAVVT 78
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           +    I+  ++   GSL D L    G++       LT N+ + +A   A+G+ F+ E+  
Sbjct: 79  QEPIYIIT-EYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEER-- 128
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAMT 253
              +HRD+R++N+L+ D    KIADF L     D     ++ R    F   + APE    
Sbjct: 129 -NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINY 184
Query: 254 GQITQKSDVYSFGVVLLELLT-GRKP 278
           G  T KSDV+SFG++L E++T GR P
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 108/216 (50%), Gaps = 18/216 (8%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLD-TSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG GS+G V+  K       A+K L+ T+  P+    F  ++ V+ + +H + +  +GY 
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            +    I V Q+    SL+  LH  +              + + +A   A+G+++LH K 
Sbjct: 90  TKPQLAI-VTQWCEGSSLYHHLHASE--------TKFEMKKLIDIARQTARGMDYLHAK- 139
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM-- 252
              I+HRD++S+N+ L +D   KI DF L  + S  +      ++ G+  + APE     
Sbjct: 140 --SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 253 -TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQ 287
            +   + +SDVY+FG+VL EL+TG+ P  +   + Q
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 105/206 (50%), Gaps = 19/206 (9%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V+       T  A+K L   S   P++ F A+ +++ +L+H+  V L     
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDA-FLAEANLMKQLQHQRLVRLYAVVT 73
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           +    I+  ++   GSL D L    G++       LT N+ + +A   A+G+ F+ E+  
Sbjct: 74  QEPIYIIT-EYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEER-- 123
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAMT 253
              +HRD+R++N+L+ D    KIADF L     D     ++ R    F   + APE    
Sbjct: 124 -NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINY 179
Query: 254 GQITQKSDVYSFGVVLLELLT-GRKP 278
           G  T KSDV+SFG++L E++T GR P
Sbjct: 180 GTFTIKSDVWSFGILLTEIVTHGRIP 205

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/242 (30%), Positives = 116/242 (47%), Gaps = 32/242 (13%)
Query: 43  KTGTPQKAL---PIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKK 99
           +T  PQK       E+P+  L  + RL          G G +G V+       T  A+K 
Sbjct: 3   QTQKPQKPWWEDEWEVPRETLKLVERL----------GAGQFGEVWMGYYNGHTKVAVKS 52
Query: 100 LDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGR 159
           L   S   P++ F A+ +++ +L+H+  V L     +    I+  ++   GSL D L   
Sbjct: 53  LKQGSM-SPDA-FLAEANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTP 109
Query: 160 KGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA 219
            G++       LT N+ + +A   A+G+ F+ E+     +HRD+R++N+L+ D    KIA
Sbjct: 110 SGIK-------LTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIA 159
Query: 220 DFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GR 276
           DF L     D      + R    F   + APE    G  T KSDV+SFG++L E++T GR
Sbjct: 160 DFGLARLIEDNEX---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 216
Query: 277 KP 278
            P
Sbjct: 217 IP 218

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/242 (30%), Positives = 116/242 (47%), Gaps = 32/242 (13%)
Query: 43  KTGTPQKAL---PIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKK 99
           +T  PQK       E+P+  L  + RL          G G +G V+       T  A+K 
Sbjct: 1   QTQKPQKPWWEDEWEVPRETLKLVERL----------GAGQFGEVWMGYYNGHTKVAVKS 50
Query: 100 LDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGR 159
           L   S   P++ F A+ +++ +L+H+  V L     +    I+  ++   GSL D L   
Sbjct: 51  LKQGSM-SPDA-FLAEANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTP 107
Query: 160 KGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA 219
            G++       LT N+ + +A   A+G+ F+ E+     +HRD+R++N+L+ D    KIA
Sbjct: 108 SGIK-------LTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIA 157
Query: 220 DFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GR 276
           DF L     D      + R    F   + APE    G  T KSDV+SFG++L E++T GR
Sbjct: 158 DFGLARLIEDNEX---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 214
Query: 277 KP 278
            P
Sbjct: 215 IP 216

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/229 (33%), Positives = 112/229 (48%), Gaps = 31/229 (13%)
Query: 54  EIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFA 113
           EIP+  L  + RL          G G +G V+       T  AIK L   +   PES F 
Sbjct: 5   EIPRESLQLIKRL----------GNGQFGEVWMGTWNGNTKVAIKTLKPGTM-SPES-FL 52
Query: 114 AQLSVVSRLKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLT 172
            +  ++ +LKH+  V+L  Y + S   I +V ++   GSL D L   +G     P     
Sbjct: 53  EEAQIMKKLKHDKLVQL--YAVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLP----- 105
Query: 173 WNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA 232
               V +A   A G+ ++ E++    +HRD+RS+N+L+ +    KIADF L     D   
Sbjct: 106 --NLVDMAAQVAAGMAYI-ERMN--YIHRDLRSANILVGNGLICKIADFGLARLIEDNEX 160
Query: 233 RLHSTRVLGTF--GYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
              + R    F   + APE A+ G+ T KSDV+SFG++L EL+T GR P
Sbjct: 161 ---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 206

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 19/206 (9%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V+       T  A+K L   S   P++ F A+ +++ +L+H+  V L     
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDA-FLAEANLMKQLQHQRLVRLYAVVT 87
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           +    I+  ++   GSL D L    G++       LT N+ + +A   A+G+ F+ E+  
Sbjct: 88  QEPIYIIT-EYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEER-- 137
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAMT 253
              +HRD+R++N+L+ D    KIADF L     D      + R    F   + APE    
Sbjct: 138 -NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPEAINY 193
Query: 254 GQITQKSDVYSFGVVLLELLT-GRKP 278
           G  T KSDV+SFG++L E++T GR P
Sbjct: 194 GTFTIKSDVWSFGILLTEIVTHGRIP 219

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 21/207 (10%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V+       T  A+K L   S   P++ F A+ +++ +L+H+  V L  Y +
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDA-FLAEANLMKQLQHQRLVRL--YAV 78
Query: 136 ESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            +   I ++ ++   GSL D L    G++       LT N+ + +A   A+G+ F+ E+ 
Sbjct: 79  VTQEPIYIITEYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEER- 130
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAM 252
               +HRD+R++N+L+ D    KIADF L     D      + R    F   + APE   
Sbjct: 131 --NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPEAIN 185
Query: 253 TGQITQKSDVYSFGVVLLELLT-GRKP 278
            G  T KSDV+SFG++L E++T GR P
Sbjct: 186 YGTFTIKSDVWSFGILLTEIVTHGRIP 212

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 19/206 (9%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V+       T  A+K L   S   P++ F A+ +++ +L+H+  V L     
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDA-FLAEANLMKQLQHQRLVRLYAVVT 78
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           +    I+  ++   GSL D L    G++       LT N+ + +A   A+G+ F+ E+  
Sbjct: 79  QEPIYIIT-EYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEER-- 128
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAMT 253
              +HRD+R++N+L+ D    KIADF L     D      + R    F   + APE    
Sbjct: 129 -NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPEAINY 184
Query: 254 GQITQKSDVYSFGVVLLELLT-GRKP 278
           G  T KSDV+SFG++L E++T GR P
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 107/216 (49%), Gaps = 18/216 (8%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLD-TSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG GS+G V+  K       A+K L+ T+  P+    F  ++ V+ + +H + +  +GY 
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
                 I V Q+    SL+  LH  +              + + +A   A+G+++LH K 
Sbjct: 90  TAPQLAI-VTQWCEGSSLYHHLHASE--------TKFEMKKLIDIARQTARGMDYLHAK- 139
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM-- 252
              I+HRD++S+N+ L +D   KI DF L  + S  +      ++ G+  + APE     
Sbjct: 140 --SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 253 -TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQ 287
            +   + +SDVY+FG+VL EL+TG+ P  +   + Q
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 76  IGEGSYGRVFYA--------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEH 126
           +GEG +G+V  A        K  +    A+K L   +  +  SD  +++ ++  + KH++
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRK--GVQGAE-----PGPVLTWNQRVKV 179
            + LLG C +     ++ ++A+ G+L + L  R+  G++ +      P   +T+   V  
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
            Y  A+G+E+L  +     +HRD+ + NVL+ ++   KIADF L    ++      +T  
Sbjct: 209 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                + APE       T +SDV+SFGV++ E+ T
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 19/215 (8%)
Query: 76  IGEGSYGRVFYA--------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEH 126
           +GEG++G+V  A        K  +    A+K L   +  +  SD  +++ ++  + KH++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRK--GVQGAE-----PGPVLTWNQRVKV 179
            + LLG C +     ++ ++A+ G+L + L  R+  G++ +      P   +T+   V  
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
            Y  A+G+E+L  +     +HRD+ + NVL+ ++   KIADF L    ++      +T  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                + APE       T +SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 19/215 (8%)
Query: 76  IGEGSYGRVFYA--------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEH 126
           +GEG++G+V  A        K  +    A+K L   +  +  SD  +++ ++  + KH++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRK--GVQGAE-----PGPVLTWNQRVKV 179
            + LLG C +     ++ ++A+ G+L + L  R+  G++ +      P   +T+   V  
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
            Y  A+G+E+L  +     +HRD+ + NVL+ ++   KIADF L    ++      +T  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                + APE       T +SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 76  IGEGSYGRVFYA--------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEH 126
           +GEG +G+V  A        K  +    A+K L   +  +  SD  +++ ++  + KH++
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRK--GVQGAE-----PGPVLTWNQRVKV 179
            + LLG C +     ++ ++A+ G+L + L  R+  G++ +      P   +T+   V  
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
            Y  A+G+E+L  +     +HRD+ + NVL+ ++   KIADF L    ++      +T  
Sbjct: 150 TYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                + APE       T +SDV+SFGV++ E+ T
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 76  IGEGSYGRVFYA--------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEH 126
           +GEG +G+V  A        K  +    A+K L   +  +  SD  +++ ++  + KH++
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRK--GVQGAE-----PGPVLTWNQRVKV 179
            + LLG C +     ++ ++A+ G+L + L  R+  G++ +      P   +T+   V  
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
            Y  A+G+E+L  +     +HRD+ + NVL+ ++   KIADF L    ++      +T  
Sbjct: 155 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                + APE       T +SDV+SFGV++ E+ T
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 76  IGEGSYGRVFYA--------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEH 126
           +GEG +G+V  A        K  +    A+K L   +  +  SD  +++ ++  + KH++
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRK--GVQGAE-----PGPVLTWNQRVKV 179
            + LLG C +     ++ ++A+ G+L + L  R+  G++ +      P   +T+   V  
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
            Y  A+G+E+L  +     +HRD+ + NVL+ ++   KIADF L    ++      +T  
Sbjct: 152 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                + APE       T +SDV+SFGV++ E+ T
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 21/207 (10%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V+       T  A+K L   S   P++ F A+ +++ +L+H+  V L  Y +
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDA-FLAEANLMKQLQHQRLVRL--YAV 77
Query: 136 ESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            +   I ++ ++   GSL D L    G++       LT N+ + +A   A+G+ F+ E+ 
Sbjct: 78  VTQEPIYIITEYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEER- 129
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAM 252
               +HRD+R++N+L+ D    KIADF L     D      + R    F   + APE   
Sbjct: 130 --NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPEAIN 184
Query: 253 TGQITQKSDVYSFGVVLLELLT-GRKP 278
            G  T KSDV+SFG++L E++T GR P
Sbjct: 185 YGTFTIKSDVWSFGILLTEIVTHGRIP 211

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 19/206 (9%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V+       T  A+K L   S   P++ F A+ +++ +L+H+  V L     
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDA-FLAEANLMKQLQHQRLVRLYAVVT 78
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           +    I+  ++   GSL D L    G++       LT N+ + +A   A+G+ F+ E+  
Sbjct: 79  QEPIYIIT-EYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEER-- 128
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAMT 253
              +HRD+R++N+L+ D    KIADF L     D      + R    F   + APE    
Sbjct: 129 -NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPEAINY 184
Query: 254 GQITQKSDVYSFGVVLLELLT-GRKP 278
           G  T KSDV+SFG++L E++T GR P
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 108/215 (50%), Gaps = 19/215 (8%)
Query: 76  IGEGSYGRVFYA--------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEH 126
           +GEG++G+V  A        K  +    A+K L   +  +  SD  +++ ++  + KH++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRK--GVQGAE-----PGPVLTWNQRVKV 179
            + LLG C +     ++ ++A+ G+L + L  R+  G++ +      P   +T+   V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
            Y  A+G+E+L  +     +HRD+ + NVL+ ++   +IADF L    ++      +T  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                + APE       T +SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 27/293 (9%)
Query: 76  IGEGSYGRVFYAKLTD------GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G+GS+G V+     D       T  A+K ++ S++     +F  + SV+      H V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPG-PVLTWNQRVKVAYGAAKGLE 188
           LLG   +    ++V +    G L   L   +      PG P  T  + +++A   A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +L+ K     VHRD+ + N ++  DF  KI DF +T    +TA      + L    + AP
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 249 EYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD 308
           E    G  T  SD++SFGVVL E+                SL       LS ++V + V 
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFVM 246
Query: 309 PKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKPAGPEA 361
                D P             C Q+    RP    +V  L+  L+  P+ PE 
Sbjct: 247 DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH--PSFPEV 297

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 76  IGEGSYGRVFYA--------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEH 126
           +GEG++G+V  A        K  +    A+K L   +  +  SD  +++ ++  + KH++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRK--GVQGAE-----PGPVLTWNQRVKV 179
            + LLG C +     ++  +A+ G+L + L  R+  G++ +      P   +T+   V  
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
            Y  A+G+E+L  +     +HRD+ + NVL+ ++   KIADF L    ++      +T  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                + APE       T +SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 121/293 (41%), Gaps = 27/293 (9%)
Query: 76  IGEGSYGRVFYAKLTD------GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G+GS+G V+     D       T  A+K ++ S++     +F  + SV+      H V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPG-PVLTWNQRVKVAYGAAKGLE 188
           LLG   +    ++V +    G L   L   +      PG P  T  + +++A   A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +L+ K     VHRD+ + N ++  DF  KI DF +T    +T       + L    + AP
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 249 EYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD 308
           E    G  T  SD++SFGVVL E+                SL       LS ++V + V 
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFVM 246
Query: 309 PKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKPAGPEA 361
                D P             C Q+  + RP    +V  L+  L+  P+ PE 
Sbjct: 247 DGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLH--PSFPEV 297

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 107/216 (49%), Gaps = 18/216 (8%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLD-TSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG GS+G V+  K       A+K L+ T+  P+    F  ++ V+ + +H + +  +GY 
Sbjct: 20  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            +    I V Q+    SL+  LH  +              + + +A   A+G+++LH K 
Sbjct: 78  TKPQLAI-VTQWCEGSSLYHHLHASE--------TKFEMKKLIDIARQTARGMDYLHAK- 127
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM-- 252
              I+HRD++S+N+ L +D   KI DF L    S  +      ++ G+  + APE     
Sbjct: 128 --SIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 185
Query: 253 -TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQ 287
            +   + +SDVY+FG+VL EL+TG+ P  +   + Q
Sbjct: 186 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 221

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 21/213 (9%)
Query: 75  LIGEGSYGRVFYAKLT-DG--TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE-HFVEL 130
           +IGEG++G+V  A++  DG    AAIK++   ++ +   DFA +L V+ +L H  + + L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQ-------GAEPGPVLTWNQRVKVAYGA 183
           LG C       L  ++A  G+L D L   + ++              L+  Q +  A   
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
           A+G+++L +K     +HRD+ + N+L+ +++ +KIADF L+         ++  + +G  
Sbjct: 152 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRL 203
Query: 244 --GYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
              + A E       T  SDV+S+GV+L E+++
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 19/206 (9%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V+       T  A+K L   S   P++ F A+ +++ +L+H+  V L     
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDA-FLAEANLMKQLQHQRLVRLYAVVT 74
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           +    I+  ++   GSL D L    G++       LT N+ + +A   A+G+ F+ E+  
Sbjct: 75  QEPIYIIT-EYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEER-- 124
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAMT 253
              +HR++R++N+L+ D    KIADF L     D     ++ R    F   + APE    
Sbjct: 125 -NYIHRNLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINY 180
Query: 254 GQITQKSDVYSFGVVLLELLT-GRKP 278
           G  T KSDV+SFG++L E++T GR P
Sbjct: 181 GTFTIKSDVWSFGILLTEIVTHGRIP 206

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 21/213 (9%)
Query: 75  LIGEGSYGRVFYAKLT-DG--TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE-HFVEL 130
           +IGEG++G+V  A++  DG    AAIK++   ++ +   DFA +L V+ +L H  + + L
Sbjct: 22  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 81
Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQ-------GAEPGPVLTWNQRVKVAYGA 183
           LG C       L  ++A  G+L D L   + ++              L+  Q +  A   
Sbjct: 82  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 141
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
           A+G+++L +K     +HRD+ + N+L+ +++ +KIADF L+         ++  + +G  
Sbjct: 142 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRL 193
Query: 244 --GYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
              + A E       T  SDV+S+GV+L E+++
Sbjct: 194 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 76  IGEGSYGRVFYA--------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEH 126
           +GEG++G+V  A        K  +    A+K L   +  +  SD  +++ ++  + KH++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRK--GVQGAE-----PGPVLTWNQRVKV 179
            + LLG C +     ++  +A+ G+L + L  R+  G++ +      P   +T+   V  
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
            Y  A+G+E+L  +     +HRD+ + NVL+ ++   KIADF L    ++      +T  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                + APE       T +SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 120/293 (40%), Gaps = 27/293 (9%)
Query: 76  IGEGSYGRVFYAKLTD------GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G+GS+G V+     D       T  A+K ++ S++     +F  + SV+      H V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPG-PVLTWNQRVKVAYGAAKGLE 188
           LLG   +    ++V +    G L   L   +      PG P  T  + +++A   A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +L+ K     VHRD+ + N ++  DF  KI DF +T    +T       + L    + AP
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 249 EYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD 308
           E    G  T  SD++SFGVVL E+                SL       LS ++V + V 
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFVM 246
Query: 309 PKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKPAGPEA 361
                D P             C Q+    RP    +V  L+  L+  P+ PE 
Sbjct: 247 DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH--PSFPEV 297

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 133/288 (46%), Gaps = 35/288 (12%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLD-TSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG GS+G V+  K       A+K L+ T+  P+    F  ++ V+ + +H + +  +GY 
Sbjct: 16  IGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            +    I V Q+    SL+  LH  +              + + +A   A+G+++LH K 
Sbjct: 74  TKPQLAI-VTQWCEGSSLYHHLHIIE--------TKFEMIKLIDIARQTAQGMDYLHAK- 123
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              I+HRD++S+N+ L +D   KI DF L  + S  +      ++ G+  + APE     
Sbjct: 124 --SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 255 Q---ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT---WATPRLSEDKVKQCVD 308
                + +SDVY+FG+VL EL+TG+ P  +   + Q   +    + +P LS         
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS--------- 232
Query: 309 PKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKP 356
            K+ ++ P             C++ + D RP    ++ +++ L  S P
Sbjct: 233 -KVRSNCP----KAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G  G V+       T  A+K L   S   P++ F A+ +++ +L+H+  V L     
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSM-SPDA-FLAEANLMKQLQHQRLVRLYAVVT 78
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           +    I+  ++   GSL D L    G++       LT N+ + +A   A+G+ F+ E+  
Sbjct: 79  QEPIYIIT-EYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEER-- 128
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAMT 253
              +HRD+R++N+L+ D    KIADF L     D      + R    F   + APE    
Sbjct: 129 -NYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEX---TAREGAKFPIKWTAPEAINY 184
Query: 254 GQITQKSDVYSFGVVLLELLT-GRKP 278
           G  T KSDV+SFG++L E++T GR P
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 123/264 (46%), Gaps = 32/264 (12%)
Query: 59  KLDELNRLTSN----FGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFA 113
           KLDE + LT      F     +GEGSYG V+ A   + G   AIK++   S  +   +  
Sbjct: 17  KLDE-DSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ---EII 72
Query: 114 AQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTW 173
            ++S++ +    H V+  G   ++ +  +V ++   GS+ D++  R           LT 
Sbjct: 73  KEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR--------NKTLTE 124
Query: 174 NQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAAR 233
           ++   +     KGLE+LH   +   +HRD+++ N+LL  +  +K+ADF +  Q +D  A+
Sbjct: 125 DEIATILQSTLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAK 181
Query: 234 LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLV-- 291
                V+GT  + APE          +D++S G+  +E+  G+ P     P     ++  
Sbjct: 182 --RNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT 239
Query: 292 ----TWATPRLSEDK----VKQCV 307
               T+  P L  D     VKQC+
Sbjct: 240 NPPPTFRKPELWSDNFTDFVKQCL 263

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 135/291 (46%), Gaps = 41/291 (14%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLD-TSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG GS+G V+  K       A+K L+ T+  P+    F  ++ V+ + +H + +  +GY 
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK---VAYGAAKGLEFLH 191
            +    I V Q+    SL+  LH            + T  + +K   +A   A+G+++LH
Sbjct: 102 TKPQLAI-VTQWCEGSSLYHHLH-----------IIETKFEMIKLIDIARQTAQGMDYLH 149
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA 251
            K    I+HRD++S+N+ L +D   KI DF L  + S  +      ++ G+  + APE  
Sbjct: 150 AK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 206
Query: 252 MTGQ---ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT---WATPRLSEDKVKQ 305
                   + +SDVY+FG+VL EL+TG+ P  +   + Q   +    + +P LS      
Sbjct: 207 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS------ 260
Query: 306 CVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKP 356
               K+ ++ P             C++ + D RP    ++ +++ L  S P
Sbjct: 261 ----KVRSNCPK----AMKRLMAECLKKKRDERPLFPQILASIELLARSLP 303

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 120/293 (40%), Gaps = 27/293 (9%)
Query: 76  IGEGSYGRVFYAKLTD------GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G+GS+G V+     D       T  A+K ++ S++     +F  + SV+      H V 
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPG-PVLTWNQRVKVAYGAAKGLE 188
           LLG   +    ++V +    G L   L   +      PG P  T  + +++A   A G+ 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +L+ K     VHRD+ + N ++  DF  KI DF +T    +T       + L    + AP
Sbjct: 142 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 249 EYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD 308
           E    G  T  SD++SFGVVL E+                SL       LS ++V + V 
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFVM 243
Query: 309 PKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKPAGPEA 361
                D P             C Q+    RP    +V  L+  L+  P+ PE 
Sbjct: 244 DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH--PSFPEV 294

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 135/291 (46%), Gaps = 41/291 (14%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLD-TSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG GS+G V+  K       A+K L+ T+  P+    F  ++ V+ + +H + +  +GY 
Sbjct: 36  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK---VAYGAAKGLEFLH 191
            +    I V Q+    SL+  LH            + T  + +K   +A   A+G+++LH
Sbjct: 94  TKPQLAI-VTQWCEGSSLYHHLH-----------IIETKFEMIKLIDIARQTAQGMDYLH 141
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA 251
            K    I+HRD++S+N+ L +D   KI DF L  + S  +      ++ G+  + APE  
Sbjct: 142 AK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 198
Query: 252 MTGQ---ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT---WATPRLSEDKVKQ 305
                   + +SDVY+FG+VL EL+TG+ P  +   + Q   +    + +P LS      
Sbjct: 199 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS------ 252
Query: 306 CVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKP 356
               K+ ++ P             C++ + D RP    ++ +++ L  S P
Sbjct: 253 ----KVRSNCPK----AMKRLMAECLKKKRDERPLFPQILASIELLARSLP 295

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 120/293 (40%), Gaps = 27/293 (9%)
Query: 76  IGEGSYGRVFYAKLTD------GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G+GS+G V+     D       T  A+K ++ S++     +F  + SV+      H V 
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPG-PVLTWNQRVKVAYGAAKGLE 188
           LLG   +    ++V +    G L   L   +      PG P  T  + +++A   A G+ 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +L+ K     VHRD+ + N ++  DF  KI DF +T    +T       + L    + AP
Sbjct: 144 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 249 EYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD 308
           E    G  T  SD++SFGVVL E+                SL       LS ++V + V 
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFVM 245
Query: 309 PKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKPAGPEA 361
                D P             C Q+    RP    +V  L+  L+  P+ PE 
Sbjct: 246 DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH--PSFPEV 296

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 110/213 (51%), Gaps = 21/213 (9%)
Query: 75  LIGEGSYGRVFYAKLT-DG--TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE-HFVEL 130
           +IGEG++G+V  A++  DG    AAIK++   ++ +   DFA +L V+ +L H  + + L
Sbjct: 29  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 88
Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQ-------GAEPGPVLTWNQRVKVAYGA 183
           LG C       L  ++A  G+L D L   + ++              L+  Q +  A   
Sbjct: 89  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 148
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
           A+G+++L +K     +HR++ + N+L+ +++ +KIADF L+         ++  + +G  
Sbjct: 149 ARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRL 200
Query: 244 --GYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
              + A E       T  SDV+S+GV+L E+++
Sbjct: 201 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 120/293 (40%), Gaps = 27/293 (9%)
Query: 76  IGEGSYGRVFYAKLTD------GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G+GS+G V+     D       T  A+K ++ S++     +F  + SV+      H V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPG-PVLTWNQRVKVAYGAAKGLE 188
           LLG   +    ++V +    G L   L   +      PG P  T  + +++A   A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +L+ K     VHRD+ + N ++  DF  KI DF +T    +T       + L    + AP
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 249 EYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD 308
           E    G  T  SD++SFGVVL E+                SL       LS ++V + V 
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFVM 246
Query: 309 PKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKPAGPEA 361
                D P             C Q+    RP    +V  L+  L+  P+ PE 
Sbjct: 247 DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH--PSFPEV 297

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 132/288 (45%), Gaps = 35/288 (12%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLD-TSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG GS+G V+  K       A+K L+ T+  P+    F  ++ V+ + +H + +  +GY 
Sbjct: 21  IGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            +    I V Q+    SL+  LH  +              + + +A   A+G+++LH K 
Sbjct: 79  TKPQLAI-VTQWCEGSSLYHHLHIIE--------TKFEMIKLIDIARQTAQGMDYLHAK- 128
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              I+HRD++S+N+ L +D   KI DF L    S  +      ++ G+  + APE     
Sbjct: 129 --SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 255 Q---ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT---WATPRLSEDKVKQCVD 308
                + +SDVY+FG+VL EL+TG+ P  +   + Q   +    + +P LS         
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS--------- 237
Query: 309 PKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKP 356
            K+ ++ P             C++ + D RP    ++ +++ L  S P
Sbjct: 238 -KVRSNCP----KAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 280

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 132/288 (45%), Gaps = 35/288 (12%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLD-TSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG GS+G V+  K       A+K L+ T+  P+    F  ++ V+ + +H + +  +GY 
Sbjct: 16  IGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            +    I V Q+    SL+  LH  +              + + +A   A+G+++LH K 
Sbjct: 74  TKPQLAI-VTQWCEGSSLYHHLHIIE--------TKFEMIKLIDIARQTAQGMDYLHAK- 123
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              I+HRD++S+N+ L +D   KI DF L    S  +      ++ G+  + APE     
Sbjct: 124 --SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 255 Q---ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT---WATPRLSEDKVKQCVD 308
                + +SDVY+FG+VL EL+TG+ P  +   + Q   +    + +P LS         
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS--------- 232
Query: 309 PKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKP 356
            K+ ++ P             C++ + D RP    ++ +++ L  S P
Sbjct: 233 -KVRSNCP----KAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 132/288 (45%), Gaps = 35/288 (12%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLD-TSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG GS+G V+  K       A+K L+ T+  P+    F  ++ V+ + +H + +  +GY 
Sbjct: 21  IGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            +    I V Q+    SL+  LH  +              + + +A   A+G+++LH K 
Sbjct: 79  TKPQLAI-VTQWCEGSSLYHHLHIIE--------TKFEMIKLIDIARQTAQGMDYLHAK- 128
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              I+HRD++S+N+ L +D   KI DF L    S  +      ++ G+  + APE     
Sbjct: 129 --SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 255 Q---ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT---WATPRLSEDKVKQCVD 308
                + +SDVY+FG+VL EL+TG+ P  +   + Q   +    + +P LS         
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS--------- 237
Query: 309 PKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKP 356
            K+ ++ P             C++ + D RP    ++ +++ L  S P
Sbjct: 238 -KVRSNCPK----AMKRLMAECLKKKRDERPLFPQILASIELLARSLP 280

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 30/223 (13%)
Query: 76  IGEGSYGRV-----FYAKLTDG-TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +GEG +G+V     F+ K   G T  A+K L  +++P    D  ++ +V+ ++ H H ++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPV------------------L 171
           L G C +    +L+ ++A  GSL   L   + V    PG +                  L
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVG---PGYLGSGGSRNSSSLDHPDERAL 147
Query: 172 TWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTA 231
           T    +  A+  ++G+++L E     +VHRD+ + N+L+ +  K KI+DF L+    +  
Sbjct: 148 TMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 232 ARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
           + +  ++      + A E       T +SDV+SFGV+L E++T
Sbjct: 205 SXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 134/291 (46%), Gaps = 41/291 (14%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLD-TSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG GS+G V+  K       A+K L+ T+  P+    F  ++ V+ + +H + +  +GY 
Sbjct: 43  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK---VAYGAAKGLEFLH 191
            +    I V Q+    SL+  LH            + T  + +K   +A   A+G+++LH
Sbjct: 101 TKPQLAI-VTQWCEGSSLYHHLH-----------IIETKFEMIKLIDIARQTAQGMDYLH 148
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA 251
            K    I+HRD++S+N+ L +D   KI DF L    S  +      ++ G+  + APE  
Sbjct: 149 AK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 205
Query: 252 MTGQ---ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT---WATPRLSEDKVKQ 305
                   + +SDVY+FG+VL EL+TG+ P  +   + Q   +    + +P LS      
Sbjct: 206 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS------ 259
Query: 306 CVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKP 356
               K+ ++ P             C++ + D RP    ++ +++ L  S P
Sbjct: 260 ----KVRSNCPK----AMKRLMAECLKKKRDERPLFPQILASIELLARSLP 302

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 134/291 (46%), Gaps = 41/291 (14%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLD-TSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG GS+G V+  K       A+K L+ T+  P+    F  ++ V+ + +H + +  +GY 
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK---VAYGAAKGLEFLH 191
            +    I V Q+    SL+  LH            + T  + +K   +A   A+G+++LH
Sbjct: 102 TKPQLAI-VTQWCEGSSLYHHLH-----------IIETKFEMIKLIDIARQTAQGMDYLH 149
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA 251
            K    I+HRD++S+N+ L +D   KI DF L    S  +      ++ G+  + APE  
Sbjct: 150 AK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 206
Query: 252 MTGQ---ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT---WATPRLSEDKVKQ 305
                   + +SDVY+FG+VL EL+TG+ P  +   + Q   +    + +P LS      
Sbjct: 207 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS------ 260
Query: 306 CVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKP 356
               K+ ++ P             C++ + D RP    ++ +++ L  S P
Sbjct: 261 ----KVRSNCPK----AMKRLMAECLKKKRDERPLFPQILASIELLARSLP 303

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 30/223 (13%)
Query: 76  IGEGSYGRV-----FYAKLTDG-TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +GEG +G+V     F+ K   G T  A+K L  +++P    D  ++ +V+ ++ H H ++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPV------------------L 171
           L G C +    +L+ ++A  GSL   L   + V    PG +                  L
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVG---PGYLGSGGSRNSSSLDHPDERAL 147
Query: 172 TWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTA 231
           T    +  A+  ++G+++L E     +VHRD+ + N+L+ +  K KI+DF L+    +  
Sbjct: 148 TMGDLISFAWQISQGMQYLAEM---SLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 232 ARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
           + +  ++      + A E       T +SDV+SFGV+L E++T
Sbjct: 205 SXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 30/223 (13%)
Query: 76  IGEGSYGRV-----FYAKLTDG-TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +GEG +G+V     F+ K   G T  A+K L  +++P    D  ++ +V+ ++ H H ++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPV------------------L 171
           L G C +    +L+ ++A  GSL   L   + V    PG +                  L
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVG---PGYLGSGGSRNSSSLDHPDERAL 147
Query: 172 TWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTA 231
           T    +  A+  ++G+++L E     +VHRD+ + N+L+ +  K KI+DF L+    +  
Sbjct: 148 TMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 232 ARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
           + +  ++      + A E       T +SDV+SFGV+L E++T
Sbjct: 205 SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 132/288 (45%), Gaps = 35/288 (12%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLD-TSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG GS+G V+  K       A+K L+ T+  P+    F  ++ V+ + +H + +  +GY 
Sbjct: 18  IGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            +    I V Q+    SL+  LH  +              + + +A   A+G+++LH K 
Sbjct: 76  TKPQLAI-VTQWCEGSSLYHHLHIIE--------TKFEMIKLIDIARQTAQGMDYLHAK- 125
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              I+HRD++S+N+ L +D   KI DF L    S  +      ++ G+  + APE     
Sbjct: 126 --SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 183
Query: 255 Q---ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT---WATPRLSEDKVKQCVD 308
                + +SDVY+FG+VL EL+TG+ P  +   + Q   +    + +P LS         
Sbjct: 184 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS--------- 234
Query: 309 PKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKP 356
            K+ ++ P             C++ + D RP    ++ +++ L  S P
Sbjct: 235 -KVRSNCP----KAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 277

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 117/250 (46%), Gaps = 27/250 (10%)
Query: 39  TNVVKTGTPQKALP--IEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKL-----TD 91
           T +V+  TP    P   ++  +K  EL R+        ++G G++G V+         T 
Sbjct: 14  TELVEPLTPSGTAPNQAQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETV 66
Query: 92  GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGS 151
             P AIK L+ ++ P+   +F  +  +++ + H H V LLG C+    + LV Q    G 
Sbjct: 67  KIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGC 125
Query: 152 LHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF 211
           L + +H  K   G++   +L W  ++      AKG+ +L E+    +VHRD+ + NVL+ 
Sbjct: 126 LLEYVHEHKDNIGSQ--LLLNWCVQI------AKGMMYLEER---RLVHRDLAARNVLVK 174
Query: 212 DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLE 271
                KI DF L           ++        + A E     + T +SDV+S+GV + E
Sbjct: 175 SPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWE 234
Query: 272 LLT-GRKPVD 280
           L+T G KP D
Sbjct: 235 LMTFGGKPYD 244

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 121/293 (41%), Gaps = 27/293 (9%)
Query: 76  IGEGSYGRVFYAKLTD------GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G+GS+G V+     D       T  A+K ++ S++     +F  + SV+      H V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPG-PVLTWNQRVKVAYGAAKGLE 188
           LLG   +    ++V +    G L   L   +      PG P  T  + +++A   A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +L+ K     VHR++ + N ++  DF  KI DF +T    +T       + L    + AP
Sbjct: 145 YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 249 EYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD 308
           E    G  T  SD++SFGVVL E+                SL       LS ++V + V 
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFVM 246
Query: 309 PKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKPAGPEA 361
                D P             C Q+  + RP    +V  L+  L+  P+ PE 
Sbjct: 247 DGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLH--PSFPEV 297

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 131/288 (45%), Gaps = 35/288 (12%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLD-TSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG GS+G V+  K       A+K L+ T+  P+    F  ++ V+ + +H + +  +GY 
Sbjct: 16  IGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
                 I V Q+    SL+  LH  +              + + +A   A+G+++LH K 
Sbjct: 74  TAPQLAI-VTQWCEGSSLYHHLHIIE--------TKFEMIKLIDIARQTAQGMDYLHAK- 123
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              I+HRD++S+N+ L +D   KI DF L    S  +      ++ G+  + APE     
Sbjct: 124 --SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 255 Q---ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT---WATPRLSEDKVKQCVD 308
                + +SDVY+FG+VL EL+TG+ P  +   + Q   +    + +P LS         
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS--------- 232
Query: 309 PKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKP 356
            K+ ++ P             C++ + D RP    ++ +++ L  S P
Sbjct: 233 -KVRSNCP----KAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 121/293 (41%), Gaps = 27/293 (9%)
Query: 76  IGEGSYGRVFYAKLTD------GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G+GS+G V+     D       T  A+K ++ S++     +F  + SV+      H V 
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPG-PVLTWNQRVKVAYGAAKGLE 188
           LLG   +    ++V +    G L   L   +      PG P  T  + +++A   A G+ 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +L+ K     VHR++ + N ++  DF  KI DF +T    +T       + L    + AP
Sbjct: 146 YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 249 EYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD 308
           E    G  T  SD++SFGVVL E+                SL       LS ++V + V 
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFVM 247
Query: 309 PKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKPAGPEA 361
                D P             C Q+  + RP    +V  L+  L+  P+ PE 
Sbjct: 248 DGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLH--PSFPEV 298

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 76  IGEGSYGRVFYAKL-----TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +GEG +G+V   +        G   A+K L   S     +D   ++ ++  L HE+ V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 131 LGYCMES--NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C E   N   L+ +F   GSL + L   K          +   Q++K A    KG++
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK--------INLKQQLKYAVQICKGMD 140
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN--QSSDTAARLHSTRVLGTFGYH 246
           +L  +     VHRD+ + NVL+  + + KI DF LT   ++      +   R    F Y 
Sbjct: 141 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY- 196
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT 274
           APE  M  +    SDV+SFGV L ELLT
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 18/212 (8%)
Query: 75  LIGEGSYGRVFYAKL-----TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           ++G G++G V+         T   P AIK L+ ++ P+   +F  +  +++ + H H V 
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           LLG C+    + LV Q    G L + +H  K   G++   +L W  ++      AKG+ +
Sbjct: 82  LLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQ--LLLNWCVQI------AKGMMY 132
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE 249
           L E+    +VHRD+ + NVL+      KI DF L           ++        + A E
Sbjct: 133 LEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 189
Query: 250 YAMTGQITQKSDVYSFGVVLLELLT-GRKPVD 280
                + T +SDV+S+GV + EL+T G KP D
Sbjct: 190 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 221

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 19/206 (9%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V+ A     T  A+K +   S       F A+ +V+  L+H+  V+L     
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV--EAFLAEANVMKTLQHDKLVKLHAVVT 80
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           +    I+  +F   GSL D L   +G +  +P P L     +  +   A+G+ F+ ++  
Sbjct: 81  KEPIYIIT-EFMAKGSLLDFLKSDEGSK--QPLPKL-----IDFSAQIAEGMAFIEQR-- 130
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAMT 253
              +HRD+R++N+L+      KIADF L     D     ++ R    F   + APE    
Sbjct: 131 -NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINF 186
Query: 254 GQITQKSDVYSFGVVLLELLT-GRKP 278
           G  T KSDV+SFG++L+E++T GR P
Sbjct: 187 GSFTIKSDVWSFGILLMEIVTYGRIP 212

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 76  IGEGSYGRVF------YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G+GS+G V+        K    T  AIK ++ +++     +F  + SV+      H V 
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVL---TWNQRVKVAYGAAKG 186
           LLG   +    +++ +  T G L   L   +     E  PVL   + ++ +++A   A G
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLR--PEMENNPVLAPPSLSKMIQMAGEIADG 135
Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           + +L+       VHRD+ + N ++ +DF  KI DF +T    +T       + L    + 
Sbjct: 136 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 192
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT 274
           +PE    G  T  SDV+SFGVVL E+ T
Sbjct: 193 SPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 76  IGEGSYGRVFYAKL-----TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +GEG +G+V   +        G   A+K L   S     +D   ++ ++  L HE+ V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 131 LGYCMES--NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C E   N   L+ +F   GSL + L   K          +   Q++K A    KG++
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK--------INLKQQLKYAVQICKGMD 128
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN--QSSDTAARLHSTRVLGTFGYH 246
           +L  +     VHRD+ + NVL+  + + KI DF LT   ++      +   R    F Y 
Sbjct: 129 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY- 184
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT 274
           APE  M  +    SDV+SFGV L ELLT
Sbjct: 185 APECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 76  IGEGSYGRVFYAKLTDG-------TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           +G+GS+G V Y  +  G       T  AIK ++ +++     +F  + SV+      H V
Sbjct: 27  LGQGSFGMV-YEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 129 ELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVL---TWNQRVKVAYGAAK 185
            LLG   +    +++ +  T G L   L   +     E  PVL   + ++ +++A   A 
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR--PEMENNPVLAPPSLSKMIQMAGEIAD 143
Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           G+ +L+       VHRD+ + N ++ +DF  KI DF +T    +T       + L    +
Sbjct: 144 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 200
Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLT 274
            +PE    G  T  SDV+SFGVVL E+ T
Sbjct: 201 MSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 15/207 (7%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           IG G +G V      +    AIK +   S  E   DF  +  V+ +L H   V+L G C+
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSE--DDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           E     LV++F   G L D L  ++G+  AE          + +     +G+ +L E   
Sbjct: 93  EQAPICLVFEFMEHGCLSDYLRTQRGLFAAET--------LLGMCLDVCEGMAYLEEAC- 143
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQ 255
             ++HRD+ + N L+ ++   K++DF +T    D      ST       + +PE     +
Sbjct: 144 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSR 200
Query: 256 ITQKSDVYSFGVVLLELLT-GRKPVDH 281
            + KSDV+SFGV++ E+ + G+ P ++
Sbjct: 201 YSSKSDVWSFGVLMWEVFSEGKIPYEN 227

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 19/206 (9%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V+ A     T  A+K +   S       F A+ +V+  L+H+  V+L     
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV--EAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           +    I+  +F   GSL D L   +G +  +P P L     +  +   A+G+ F+ ++  
Sbjct: 254 KEPIYIIT-EFMAKGSLLDFLKSDEGSK--QPLPKL-----IDFSAQIAEGMAFIEQR-- 303
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAMT 253
              +HRD+R++N+L+      KIADF L     D     ++ R    F   + APE    
Sbjct: 304 -NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINF 359
Query: 254 GQITQKSDVYSFGVVLLELLT-GRKP 278
           G  T KSDV+SFG++L+E++T GR P
Sbjct: 360 GSFTIKSDVWSFGILLMEIVTYGRIP 385

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 124/283 (43%), Gaps = 24/283 (8%)
Query: 76  IGEGSYGRV---FYAKLTDGT--PAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +GEG +G+V    Y    DGT    A+K L   + P+  S +  ++ ++  L HEH ++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 131 LGYCMESN--NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C ++   +  LV ++  +GSL D L          P   +   Q +  A    +G+ 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL----------PRHSIGLAQLLLFAQQICEGMA 148
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT--FGYH 246
           +LH +     +HRD+ + NVLL +D   KI DF L  ++       +  R  G     ++
Sbjct: 149 YLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA-KAVPEGHEXYRVREDGDSPVFWY 204
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC 306
           APE     +    SDV+SFGV L ELLT       + P     L+  A  +++  ++ + 
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263
Query: 307 VDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQ 349
           ++       P             C + EA FRP    ++  L+
Sbjct: 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 76  IGEGSYGRVFYAKLTDG-------TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           +G+GS+G V Y  +  G       T  AIK ++ +++     +F  + SV+      H V
Sbjct: 20  LGQGSFGMV-YEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 129 ELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVL---TWNQRVKVAYGAAK 185
            LLG   +    +++ +  T G L   L   +     E  PVL   + ++ +++A   A 
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR--PEMENNPVLAPPSLSKMIQMAGEIAD 136
Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           G+ +L+       VHRD+ + N ++ +DF  KI DF +T    +T       + L    +
Sbjct: 137 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 193
Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLT 274
            +PE    G  T  SDV+SFGVVL E+ T
Sbjct: 194 MSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 15/207 (7%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           IG G +G V      +    AIK +   +  E   DF  +  V+ +L H   V+L G C+
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           E     LV++F   G L D L  ++G+  AE          + +     +G+ +L E   
Sbjct: 76  EQAPICLVFEFMEHGCLSDYLRTQRGLFAAET--------LLGMCLDVCEGMAYLEEAC- 126
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQ 255
             ++HRD+ + N L+ ++   K++DF +T    D      ST       + +PE     +
Sbjct: 127 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSR 183
Query: 256 ITQKSDVYSFGVVLLELLT-GRKPVDH 281
            + KSDV+SFGV++ E+ + G+ P ++
Sbjct: 184 YSSKSDVWSFGVLMWEVFSEGKIPYEN 210

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 76  IGEGSYGRVFYAKLTDG-------TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           +G+GS+G V Y  +  G       T  AIK ++ +++     +F  + SV+      H V
Sbjct: 26  LGQGSFGMV-YEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 129 ELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVL---TWNQRVKVAYGAAK 185
            LLG   +    +++ +  T G L   L   +     E  PVL   + ++ +++A   A 
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR--PEMENNPVLAPPSLSKMIQMAGEIAD 142
Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           G+ +L+       VHRD+ + N ++ +DF  KI DF +T    +T       + L    +
Sbjct: 143 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 199
Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLT 274
            +PE    G  T  SDV+SFGVVL E+ T
Sbjct: 200 MSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 76  IGEGSYGRVF------YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G+GS+G V+        K    T  AIK ++ +++     +F  + SV+      H V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVL---TWNQRVKVAYGAAKG 186
           LLG   +    +++ +  T G L   L   +     E  PVL   + ++ +++A   A G
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLR--PEMENNPVLAPPSLSKMIQMAGEIADG 150
Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           + +L+       VHRD+ + N ++ +DF  KI DF +T    +T       + L    + 
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT 274
           +PE    G  T  SDV+SFGVVL E+ T
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 76  IGEGSYGRVFYAKLTDGTP------AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           IGEG++GRVF A+     P       A+K L   ++ + ++DF  + ++++   + + V+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 130 LLGYCMESNNRILVYQFATMGSL----------------HDVLHGRKGVQGAEPGPVLTW 173
           LLG C       L++++   G L                H  L  R  V    P P L+ 
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP-LSC 173
Query: 174 NQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAAR 233
            +++ +A   A G+ +L E+     VHRD+ + N L+ ++   KIADF L+         
Sbjct: 174 AEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 234 LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
                      +  PE     + T +SDV+++GVVL E+ + G +P
Sbjct: 231 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 15/207 (7%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           IG G +G V      +    AIK +   +  E   DF  +  V+ +L H   V+L G C+
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           E     LV++F   G L D L  ++G+  AE          + +     +G+ +L E   
Sbjct: 73  EQAPICLVFEFMEHGCLSDYLRTQRGLFAAET--------LLGMCLDVCEGMAYLEEAC- 123
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQ 255
             ++HRD+ + N L+ ++   K++DF +T    D      ST       + +PE     +
Sbjct: 124 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSR 180
Query: 256 ITQKSDVYSFGVVLLELLT-GRKPVDH 281
            + KSDV+SFGV++ E+ + G+ P ++
Sbjct: 181 YSSKSDVWSFGVLMWEVFSEGKIPYEN 207

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 15/207 (7%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           IG G +G V      +    AIK +   +  E   DF  +  V+ +L H   V+L G C+
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           E     LV++F   G L D L  ++G+  AE          + +     +G+ +L E   
Sbjct: 71  EQAPICLVFEFMEHGCLSDYLRTQRGLFAAET--------LLGMCLDVCEGMAYLEEAC- 121
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQ 255
             ++HRD+ + N L+ ++   K++DF +T    D      ST       + +PE     +
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSR 178
Query: 256 ITQKSDVYSFGVVLLELLT-GRKPVDH 281
            + KSDV+SFGV++ E+ + G+ P ++
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYEN 205

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 116/278 (41%), Gaps = 29/278 (10%)
Query: 76  IGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG G++G VF  +L  D T  A+K    +  P+ ++ F  +  ++ +  H + V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            +     +V +    G     L      +GA     L     +++   AA G+E+L  K 
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLR----TEGAR----LRVKTLLQMVGDAAAGMEYLESKC 233
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
               +HRD+ + N L+ +    KI+DF ++ + +D               + APE    G
Sbjct: 234 ---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYG 290
Query: 255 QITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNN 313
           + + +SDV+SFG++L E  + G  P                 P LS  + ++ V+     
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASPY----------------PNLSNQQTREFVEKGGRL 334
Query: 314 DYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPL 351
             P             C  YE   RP+ + + + LQ +
Sbjct: 335 PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 76  IGEGSYGRVFYAKLTDG-------TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           +G+GS+G V Y  +  G       T  AIK ++ +++     +F  + SV+      H V
Sbjct: 24  LGQGSFGMV-YEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 82
Query: 129 ELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVL---TWNQRVKVAYGAAK 185
            LLG   +    +++ +  T G L   L   +     E  PVL   + ++ +++A   A 
Sbjct: 83  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR--PEMENNPVLAPPSLSKMIQMAGEIAD 140
Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           G+ +L+       VHRD+ + N ++ +DF  KI DF +T    +T       + L    +
Sbjct: 141 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 197
Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLT 274
            +PE    G  T  SDV+SFGVVL E+ T
Sbjct: 198 MSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 76  IGEGSYGRVFYAKLTDG-------TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           +G+GS+G V Y  +  G       T  AIK ++ +++     +F  + SV+      H V
Sbjct: 26  LGQGSFGMV-YEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 129 ELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVL---TWNQRVKVAYGAAK 185
            LLG   +    +++ +  T G L   L   +     E  PVL   + ++ +++A   A 
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR--PEMENNPVLAPPSLSKMIQMAGEIAD 142
Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           G+ +L+       VHRD+ + N ++ +DF  KI DF +T    +T       + L    +
Sbjct: 143 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 199
Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLT 274
            +PE    G  T  SDV+SFGVVL E+ T
Sbjct: 200 MSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 76  IGEGSYGRVFYAKLTDG-------TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           +G+GS+G V Y  +  G       T  AIK ++ +++     +F  + SV+      H V
Sbjct: 27  LGQGSFGMV-YEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 129 ELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVL---TWNQRVKVAYGAAK 185
            LLG   +    +++ +  T G L   L   +     E  PVL   + ++ +++A   A 
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR--PEMENNPVLAPPSLSKMIQMAGEIAD 143
Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           G+ +L+       VHRD+ + N ++ +DF  KI DF +T    +T       + L    +
Sbjct: 144 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 200
Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLT 274
            +PE    G  T  SDV+SFGVVL E+ T
Sbjct: 201 MSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 110/227 (48%), Gaps = 30/227 (13%)
Query: 61  DELNRLTSNFGTKAL-----IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQ 115
           DE  R       K L     IG+G +G V       G   A+K +   +  +    F A+
Sbjct: 181 DEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAE 236
Query: 116 LSVVSRLKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWN 174
            SV+++L+H + V+LLG  +E    + +V ++   GSL D L  R          VL  +
Sbjct: 237 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGD 289
Query: 175 QRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARL 234
             +K +    + +E+L        VHRD+ + NVL+ +D  +K++DF LT ++S      
Sbjct: 290 CLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS------ 340
Query: 235 HSTRVLGTF--GYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
            ST+  G     + APE     + + KSDV+SFG++L E+ + GR P
Sbjct: 341 -STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           IG+G +G V       G   A+K +   +  +    F A+ SV+++L+H + V+LLG  +
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69
Query: 136 ESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
           E    + +V ++   GSL D L  R          VL  +  +K +    + +E+L    
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSR-------GRSVLGGDCLLKFSLDVCEAMEYLEGN- 121
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAM 252
               VHRD+ + NVL+ +D  +K++DF LT ++S       ST+  G     + APE   
Sbjct: 122 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEALR 172
Query: 253 TGQITQKSDVYSFGVVLLELLT-GRKP 278
             + + KSDV+SFG++L E+ + GR P
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVP 199

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 25/207 (12%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           IG+G +G V       G   A+K +   +  +    F A+ SV+++L+H + V+LLG  +
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 75
Query: 136 ESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
           E    + +V ++   GSL D L  R          VL  +  +K +    + +E+L    
Sbjct: 76  EEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEGN- 127
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAM 252
               VHRD+ + NVL+ +D  +K++DF LT ++S       ST+  G     + APE   
Sbjct: 128 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEALR 178
Query: 253 TGQITQKSDVYSFGVVLLELLT-GRKP 278
               + KSDV+SFG++L E+ + GR P
Sbjct: 179 EAAFSTKSDVWSFGILLWEIYSFGRVP 205

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 110/227 (48%), Gaps = 30/227 (13%)
Query: 61  DELNRLTSNFGTKAL-----IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQ 115
           DE  R       K L     IG+G +G V       G   A+K +   +  +    F A+
Sbjct: 9   DEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAE 64
Query: 116 LSVVSRLKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWN 174
            SV+++L+H + V+LLG  +E    + +V ++   GSL D L  R          VL  +
Sbjct: 65  ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-------GRSVLGGD 117
Query: 175 QRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARL 234
             +K +    + +E+L        VHRD+ + NVL+ +D  +K++DF LT ++S      
Sbjct: 118 CLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS------ 168
Query: 235 HSTRVLGTF--GYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
            ST+  G     + APE     + + KSDV+SFG++L E+ + GR P
Sbjct: 169 -STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           IG G +G V      +    AIK +   +  E   DF  +  V+ +L H   V+L G C+
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           E     LV++F   G L D L  ++G+  AE          + +     +G+ +L E   
Sbjct: 73  EQAPICLVFEFMEHGCLSDYLRTQRGLFAAET--------LLGMCLDVCEGMAYLEE--- 121
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT---FGYHAPEYAM 252
             ++HRD+ + N L+ ++   K++DF +T    D       T   GT     + +PE   
Sbjct: 122 ASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD----QYTSSTGTKFPVKWASPEVFS 177
Query: 253 TGQITQKSDVYSFGVVLLELLT-GRKPVDH 281
             + + KSDV+SFGV++ E+ + G+ P ++
Sbjct: 178 FSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 207

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/278 (23%), Positives = 114/278 (41%), Gaps = 29/278 (10%)
Query: 76  IGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG G++G VF  +L  D T  A+K    +  P+ ++ F  +  ++ +  H + V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            +     +V +    G     L           G  L     +++   AA G+E+L  K 
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTE--------GARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
               +HRD+ + N L+ +    KI+DF ++ + +D               + APE    G
Sbjct: 234 ---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG 290
Query: 255 QITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNN 313
           + + +SDV+SFG++L E  + G  P                 P LS  + ++ V+     
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASPY----------------PNLSNQQTREFVEKGGRL 334
Query: 314 DYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPL 351
             P             C  YE   RP+ + + + LQ +
Sbjct: 335 PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 121/280 (43%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++G G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 79  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI----- 130
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L ++    +VHRD+ + NVL+      KI DF L           H+      
Sbjct: 131 -AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 186
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 244
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 245 --------------PPICTIDVYMIMVKCWMIDADSRPKF 270

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 76  IGEGSYGRVFYAKLTDG-------TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           +G+GS+G V Y  +  G       T  AIK ++ +++     +F  + SV+      H V
Sbjct: 55  LGQGSFGMV-YEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 113
Query: 129 ELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVL---TWNQRVKVAYGAAK 185
            LLG   +    +++ +  T G L   L   +     E  PVL   + ++ +++A   A 
Sbjct: 114 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR--PEMENNPVLAPPSLSKMIQMAGEIAD 171
Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           G+ +L+       VHRD+ + N ++ +DF  KI DF +T    +T       + L    +
Sbjct: 172 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 228
Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLT 274
            +PE    G  T  SDV+SFGVVL E+ T
Sbjct: 229 MSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 123/283 (43%), Gaps = 36/283 (12%)
Query: 76  IGEGSYGRVFYAKLTDGTP---AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           IG+GS+G VF  K  D       AIK +D   A +   D   +++V+S+    +  +  G
Sbjct: 30  IGKGSFGEVF--KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
             ++     ++ ++   GS  D+L         EPGP L   Q   +     KGL++LH 
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLL---------EPGP-LDETQIATILREILKGLDYLHS 137
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           + +   +HRD++++NVLL +  + K+ADF +  Q +DT  ++     +GT  + APE   
Sbjct: 138 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QIKRNXFVGTPFWMAPEVIK 192
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLN 312
                 K+D++S G+  +EL  G  P     P     L+    P            P L 
Sbjct: 193 QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP------------PTLE 240
Query: 313 NDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSK 355
            +Y              C+  E  FRP    ++K    L N+K
Sbjct: 241 GNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK 279

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 121/280 (43%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++G G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI----- 128
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L ++    +VHRD+ + NVL+      KI DF L           H+      
Sbjct: 129 -AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 184
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 242
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 243 --------------PPICTIDVYMIMVKCWMIDADSRPKF 268

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 121/280 (43%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++G G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 76  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI----- 127
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L ++    +VHRD+ + NVL+      KI DF L           H+      
Sbjct: 128 -AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 183
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 241
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 242 --------------PPICTIDVYMIMVKCWMIDADSRPKF 267

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 121/280 (43%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++G G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI----- 126
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L ++    +VHRD+ + NVL+      KI DF L           H+      
Sbjct: 127 -AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 240
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 241 --------------PPICTIDVYMIMVKCWMIDADSRPKF 266

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 122/283 (43%), Gaps = 24/283 (8%)
Query: 76  IGEGSYGRV---FYAKLTDGT--PAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +GEG +G+V    Y    DGT    A+K L     P+  S +  ++ ++  L HEH ++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 131 LGYCMESNNRI--LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C +   +   LV ++  +GSL D L          P   +   Q +  A    +G+ 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL----------PRHSIGLAQLLLFAQQICEGMA 131
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT--FGYH 246
           +LH +     +HR++ + NVLL +D   KI DF L  ++       +  R  G     ++
Sbjct: 132 YLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLA-KAVPEGHEYYRVREDGDSPVFWY 187
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC 306
           APE     +    SDV+SFGV L ELLT       + P     L+  A  +++  ++ + 
Sbjct: 188 APECLKEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 246
Query: 307 VDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQ 349
           ++       P             C + EA FRP    ++  L+
Sbjct: 247 LERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILK 289

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 121/280 (43%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++G G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI----- 129
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L ++    +VHRD+ + NVL+      KI DF L           H+      
Sbjct: 130 -AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 243
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 244 --------------PPICTIDVYMIMVKCWMIDADSRPKF 269

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 76  IGEGSYGRVF------YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G+GS+G V+        K    T  AIK ++ +++     +F  + SV+      H V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVL---TWNQRVKVAYGAAKG 186
           LLG   +    +++ +  T G L   L   +        PVL   + ++ +++A   A G
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN--NPVLAPPSLSKMIQMAGEIADG 150
Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           + +L+       VHRD+ + N ++ +DF  KI DF +T    +T       + L    + 
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT 274
           +PE    G  T  SDV+SFGVVL E+ T
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 16/209 (7%)
Query: 76  IGEGSYGRVFYAKLTDG-------TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           +G+GS+G V Y  +  G       T  AIK ++ +++     +F  + SV+      H V
Sbjct: 23  LGQGSFGMV-YEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 81
Query: 129 ELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVL---TWNQRVKVAYGAAK 185
            LLG   +    +++ +  T G L   L   +        PVL   + ++ +++A   A 
Sbjct: 82  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN--NPVLAPPSLSKMIQMAGEIAD 139
Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           G+ +L+       VHRD+ + N ++ +DF  KI DF +T    +T       + L    +
Sbjct: 140 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 196
Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLT 274
            +PE    G  T  SDV+SFGVVL E+ T
Sbjct: 197 MSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 123/283 (43%), Gaps = 36/283 (12%)
Query: 76  IGEGSYGRVFYAKLTDGTP---AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           IG+GS+G VF  K  D       AIK +D   A +   D   +++V+S+    +  +  G
Sbjct: 15  IGKGSFGEVF--KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
             ++     ++ ++   GS  D+L         EPGP L   Q   +     KGL++LH 
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLL---------EPGP-LDETQIATILREILKGLDYLHS 122
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           + +   +HRD++++NVLL +  + K+ADF +  Q +DT  ++     +GT  + APE   
Sbjct: 123 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QIKRNXFVGTPFWMAPEVIK 177
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLN 312
                 K+D++S G+  +EL  G  P     P     L+    P            P L 
Sbjct: 178 QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP------------PTLE 225
Query: 313 NDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSK 355
            +Y              C+  E  FRP    ++K    L N+K
Sbjct: 226 GNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK 264

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 121/280 (43%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++G G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI----- 128
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L ++    +VHRD+ + NVL+      KI DF L           H+      
Sbjct: 129 -AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 184
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 242
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 243 --------------PPICTIDVYMIMVKCWMIDADSRPKF 268

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 121/280 (43%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++G G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 76  DNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQ--YLLNWCVQI----- 127
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L ++    +VHRD+ + NVL+      KI DF L           H+      
Sbjct: 128 -AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 183
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 241
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 242 --------------PPICTIDVYMIMVKCWMIDADSRPKF 267

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 121/280 (43%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++G G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI----- 129
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L ++    +VHRD+ + NVL+      KI DF L           H+      
Sbjct: 130 -AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 243
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 244 --------------PPICTIDVYMIMVKCWMIDADSRPKF 269

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 16/209 (7%)
Query: 76  IGEGSYGRVFYAKLTDG-------TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           +G+GS+G V Y  +  G       T  AIK ++ +++     +F  + SV+      H V
Sbjct: 20  LGQGSFGMV-YEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 129 ELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVL---TWNQRVKVAYGAAK 185
            LLG   +    +++ +  T G L   L   +     E  PVL   + ++ +++A   A 
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR--PEMENNPVLAPPSLSKMIQMAGEIAD 136
Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           G+ +L+       VHRD+ + N  + +DF  KI DF +T    +T       + L    +
Sbjct: 137 GMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 193
Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLT 274
            +PE    G  T  SDV+SFGVVL E+ T
Sbjct: 194 MSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 124/283 (43%), Gaps = 36/283 (12%)
Query: 76  IGEGSYGRVFYAKLTDGTP---AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           IG+GS+G VF  K  D       AIK +D   A +   D   +++V+S+    +  +  G
Sbjct: 15  IGKGSFGEVF--KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
             ++     ++ ++   GS  D+L         EPGP L   Q   +     KGL++LH 
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLL---------EPGP-LDETQIATILREILKGLDYLHS 122
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           + +   +HRD++++NVLL +  + K+ADF +  Q +DT  + ++   +GT  + APE   
Sbjct: 123 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIK 177
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLN 312
                 K+D++S G+  +EL  G  P     P     L+    P            P L 
Sbjct: 178 QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP------------PTLE 225
Query: 313 NDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSK 355
            +Y              C+  E  FRP    ++K    L N+K
Sbjct: 226 GNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK 264

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 121/280 (43%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++G G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI----- 129
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L ++    +VHRD+ + NVL+      KI DF L           H+      
Sbjct: 130 -AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 243
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 244 --------------PPICTIDVYMIMVKCWMIDADSRPKF 269

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 121/280 (43%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++G G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI----- 126
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L ++    +VHRD+ + NVL+      KI DF L           H+      
Sbjct: 127 -AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 240
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 241 --------------PPICTIDVYMIMRKCWMIDADSRPKF 266

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 121/280 (43%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++G G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI----- 129
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L ++    +VHRD+ + NVL+      KI DF L           H+      
Sbjct: 130 -AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 243
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 244 --------------PPICTIDVYMIMRKCWMIDADSRPKF 269

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 121/280 (43%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++G G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI----- 126
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L ++    +VHRD+ + NVL+      KI DF L           H+      
Sbjct: 127 -AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 240
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 241 --------------PPICTIDVYMIMVKCWMIDADSRPKF 266

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 122/283 (43%), Gaps = 24/283 (8%)
Query: 76  IGEGSYGRV---FYAKLTDGT--PAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +GEG +G+V    Y    DGT    A+K L     P+  S +  ++ ++  L HEH ++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 131 LGYCMESNNRI--LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C +   +   LV ++  +GSL D L          P   +   Q +  A    +G+ 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL----------PRHSIGLAQLLLFAQQICEGMA 131
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT--FGYH 246
           +LH +     +HR++ + NVLL +D   KI DF L  ++       +  R  G     ++
Sbjct: 132 YLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLA-KAVPEGHEYYRVREDGDSPVFWY 187
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC 306
           APE     +    SDV+SFGV L ELLT       + P     L+  A  +++  ++ + 
Sbjct: 188 APECLKEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 246
Query: 307 VDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQ 349
           ++       P             C + EA FRP    ++  L+
Sbjct: 247 LERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILK 289

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 124/283 (43%), Gaps = 36/283 (12%)
Query: 76  IGEGSYGRVFYAKLTDGTP---AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           IG+GS+G VF  K  D       AIK +D   A +   D   +++V+S+    +  +  G
Sbjct: 35  IGKGSFGEVF--KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 92
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
             ++     ++ ++   GS  D+L         EPGP L   Q   +     KGL++LH 
Sbjct: 93  SYLKDTKLWIIMEYLGGGSALDLL---------EPGP-LDETQIATILREILKGLDYLHS 142
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           + +   +HRD++++NVLL +  + K+ADF +  Q +DT  + ++   +GT  + APE   
Sbjct: 143 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIK 197
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLN 312
                 K+D++S G+  +EL  G  P     P     L+    P            P L 
Sbjct: 198 QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP------------PTLE 245
Query: 313 NDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSK 355
            +Y              C+  E  FRP    ++K    L N+K
Sbjct: 246 GNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK 284

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 121/280 (43%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++G G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 85  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI----- 136
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L ++    +VHRD+ + NVL+      KI DF L           H+      
Sbjct: 137 -AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 192
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 193 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 250
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 251 --------------PPICTIDVYMIMRKCWMIDADSRPKF 276

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 121/280 (43%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++G G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI----- 133
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L ++    +VHRD+ + NVL+      KI DF L           H+      
Sbjct: 134 -AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 247
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 248 --------------PPICTIDVYMIMVKCWMIDADSRPKF 273

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 121/280 (43%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++G G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 100 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI----- 151
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L ++    +VHRD+ + NVL+      KI DF L           H+      
Sbjct: 152 -AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 207
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 208 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 265
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 266 --------------PPICTIDVYMIMVKCWMIDADSRPKF 291

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 121/280 (43%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++G G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 81  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI----- 132
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L ++    +VHRD+ + NVL+      KI DF L           H+      
Sbjct: 133 -AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 188
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 189 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 246
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 247 --------------PPICTIDVYMIMVKCWMIDADSRPKF 272

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 121/280 (43%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++G G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQ--YLLNWCVQI----- 126
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L ++    +VHRD+ + NVL+      KI DF L           H+      
Sbjct: 127 -AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 240
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 241 --------------PPICTIDVYMIMVKCWMIDADSRPKF 266

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 29/206 (14%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V+ A     T  A+K +   S       F A+ +V+  L+H+  V+L     
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV--EAFLAEANVMKTLQHDKLVKLHAVVT 247
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           +    I+  +F   GSL D L   +G +  +P P L     +  +   A+G+ F+ ++  
Sbjct: 248 KEPIYIIT-EFMAKGSLLDFLKSDEGSK--QPLPKL-----IDFSAQIAEGMAFIEQR-- 297
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAMT 253
              +HRD+R++N+L+      KIADF L              RV   F   + APE    
Sbjct: 298 -NYIHRDLRAANILVSASLVCKIADFGLA-------------RVGAKFPIKWTAPEAINF 343
Query: 254 GQITQKSDVYSFGVVLLELLT-GRKP 278
           G  T KSDV+SFG++L+E++T GR P
Sbjct: 344 GSFTIKSDVWSFGILLMEIVTYGRIP 369

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 106/235 (45%), Gaps = 28/235 (11%)
Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYA------KLTDGTPAAIKKLDTSSAPEPESDFAAQ 115
           E  R    FG   ++G G++G+V  A      K       A+K L   +         ++
Sbjct: 41  EFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSE 98
Query: 116 LSVVSRL-KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGR--------------K 160
           L ++++L  HE+ V LLG C  S    L++++   G L + L  +              K
Sbjct: 99  LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 158
Query: 161 GVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD 220
            ++  E   VLT+   +  AY  AKG+EFL  K     VHRD+ + NVL+      KI D
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICD 215
Query: 221 FNLTNQ-SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
           F L     SD+   +     L    + APE    G  T KSDV+S+G++L E+ +
Sbjct: 216 FGLARDIMSDSNYVVRGNARLPV-KWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 121/280 (43%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++G G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 69  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI----- 120
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L ++    +VHRD+ + NVL+      KI DF L           H+      
Sbjct: 121 -AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 234
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 235 --------------PPICTIDVYMIMVKCWMIDADSRPKF 260

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 15/207 (7%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           IG G +G V      +    AIK +   +  E   DF  +  V+ +L H   V+L G C+
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           E     LV +F   G L D L  ++G+  AE          + +     +G+ +L E   
Sbjct: 74  EQAPICLVTEFMEHGCLSDYLRTQRGLFAAET--------LLGMCLDVCEGMAYLEEAC- 124
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQ 255
             ++HRD+ + N L+ ++   K++DF +T    D      ST       + +PE     +
Sbjct: 125 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSR 181
Query: 256 ITQKSDVYSFGVVLLELLT-GRKPVDH 281
            + KSDV+SFGV++ E+ + G+ P ++
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIPYEN 208

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 126/294 (42%), Gaps = 46/294 (15%)
Query: 76  IGEGSYGRV---FYAKLTDGT--PAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +GEG +G+V    Y    DGT    A+K L     P+  S +  ++ ++  L HEH V+ 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 131 LGYCMESNNRI--LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C +   +   LV ++  +GSL D L          P   +   Q +  A    +G+ 
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL----------PRHCVGLAQLLLFAQQICEGMA 125
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT--FGYH 246
           +LH +     +HR + + NVLL +D   KI DF L  ++       +  R  G     ++
Sbjct: 126 YLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLA-KAVPEGHEYYRVREDGDSPVFWY 181
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT----GRKP-------VDHTMPKGQQSLVTWAT 295
           APE     +    SDV+SFGV L ELLT     + P       + HT  +GQ +++    
Sbjct: 182 APECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHT--QGQMTVL---- 235
Query: 296 PRLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQ 349
            RL+E   +    P+     P             C + EA FRP    +V  LQ
Sbjct: 236 -RLTELLERGERLPR-----PDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQ 283

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 126/294 (42%), Gaps = 46/294 (15%)
Query: 76  IGEGSYGRV---FYAKLTDGT--PAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +GEG +G+V    Y    DGT    A+K L     P+  S +  ++ ++  L HEH V+ 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 131 LGYCMESNNRI--LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C +   +   LV ++  +GSL D L          P   +   Q +  A    +G+ 
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL----------PRHCVGLAQLLLFAQQICEGMA 126
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT--FGYH 246
           +LH +     +HR + + NVLL +D   KI DF L  ++       +  R  G     ++
Sbjct: 127 YLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLA-KAVPEGHEYYRVREDGDSPVFWY 182
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT----GRKP-------VDHTMPKGQQSLVTWAT 295
           APE     +    SDV+SFGV L ELLT     + P       + HT  +GQ +++    
Sbjct: 183 APECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHT--QGQMTVL---- 236
Query: 296 PRLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQ 349
            RL+E   +    P+     P             C + EA FRP    +V  LQ
Sbjct: 237 -RLTELLERGERLPR-----PDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQ 284

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 122/284 (42%), Gaps = 31/284 (10%)
Query: 76  IGEGSYGRVFYAKLT----DGTP--AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G G++G V+  +++    D +P   A+K L    + + E DF  +  ++S+L H++ V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
            +G  ++S  R ++ +    G L   L   +  + ++P   L     + VA   A G ++
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPS-SLAMLDLLHVARDIACGCQY 170
Query: 190 LHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           L E      +HRD+ + N LL        +KI DF +       +        +    + 
Sbjct: 171 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ 305
            PE  M G  T K+D +SFGV+L E+ + G  P      K  Q ++ + T     D  K 
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFVTSGGRMDPPKN 284
Query: 306 CVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQ 349
           C  P                    C Q++ + RPN  I+++ ++
Sbjct: 285 CPGP-------------VYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 122/284 (42%), Gaps = 31/284 (10%)
Query: 76  IGEGSYGRVFYAKLT----DGTP--AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G G++G V+  +++    D +P   A+K L    + + E DF  +  ++S+L H++ V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
            +G  ++S  R ++ +    G L   L   +  + ++P   L     + VA   A G ++
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPS-SLAMLDLLHVARDIACGCQY 156
Query: 190 LHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           L E      +HRD+ + N LL        +KI DF +       +        +    + 
Sbjct: 157 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 213
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ 305
            PE  M G  T K+D +SFGV+L E+ + G  P      K  Q ++ + T     D  K 
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFVTSGGRMDPPKN 270
Query: 306 CVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQ 349
           C  P                    C Q++ + RPN  I+++ ++
Sbjct: 271 CPGP-------------VYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 121/280 (43%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++G G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 72  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI----- 123
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            A+G+ +L ++    +VHRD+ + NVL+      KI DF L           H+      
Sbjct: 124 -AEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 179
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 180 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 237
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 238 --------------PPICTIDVYMIMVKCWMIDADSRPKF 263

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 120/280 (42%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++  G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI----- 133
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L ++    +VHRD+ + NVL+      KI DF L           H+      
Sbjct: 134 -AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 247
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 248 --------------PPICTIDVYMIMVKCWMIDADSRPKF 273

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 120/280 (42%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++G G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI----- 128
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L ++    +VHRD+ + NVL+      KI DF             H+      
Sbjct: 129 -AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 242
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 243 --------------PPICTIDVYMIMRKCWMIDADSRPKF 268

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 120/280 (42%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++G G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 79  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI----- 130
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L ++    +VHRD+ + NVL+      KI DF             H+      
Sbjct: 131 -AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 186
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 244
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 245 --------------PPICTIDVYMIMVKCWMIDADSRPKF 270

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 120/280 (42%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++G G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI----- 128
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L ++    +VHRD+ + NVL+      KI DF             H+      
Sbjct: 129 -AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 242
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 243 --------------PPICTIDVYMIMVKCWMIDADSRPKF 268

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 120/280 (42%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++  G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI----- 133
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L ++    +VHRD+ + NVL+      KI DF L           H+      
Sbjct: 134 -AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 247
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 248 --------------PPICTIDVYMIMVKCWMIDADSRPKF 273

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 120/280 (42%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++  G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI----- 126
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L ++    +VHRD+ + NVL+      KI DF L           H+      
Sbjct: 127 -AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 240
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 241 --------------PPICTIDVYMIMVKCWMIDADSRPKF 266

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 120/280 (42%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++G G++G V+    + +G     P AI +L  +++P+   +   +  V++ +
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 109 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI----- 160
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L ++    +VHRD+ + NVL+      KI DF L           H+      
Sbjct: 161 -AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 216
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 217 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 274
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 275 --------------PPICTIDVYMIMVKCWMIDADSRPKF 300

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 20/203 (9%)
Query: 76  IGEGSYGRVFYAKLTDGTP-AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           +G+G++G+V+ A+  + +  AA K +DT S  E E D+  ++ +++   H + V+LL   
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASCDHPNIVKLLDAF 103
Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
              NN  ++ +F   G++  V+     ++   P   LT +Q   V       L +LH+  
Sbjct: 104 YYENNLWILIEFCAGGAVDAVM-----LELERP---LTESQIQVVCKQTLDALNYLHDN- 154
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              I+HRD+++ N+L   D   K+ADF ++ +++ T  R  S   +GT  + APE  M  
Sbjct: 155 --KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCE 210
Query: 255 Q-----ITQKSDVYSFGVVLLEL 272
                    K+DV+S G+ L+E+
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEM 233

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 120/280 (42%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++G G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI----- 128
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L ++    +VHRD+ + NVL+      KI DF             H+      
Sbjct: 129 -AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 242
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 243 --------------PPICTIDVYMIMRKCWMIDADSRPKF 268

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 120/280 (42%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++G G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI----- 126
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L ++    +VHRD+ + NVL+      KI DF             H+      
Sbjct: 127 -AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 182
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 240
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 241 --------------PPICTIDVYMIMVKCWMIDADSRPKF 266

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 121/284 (42%), Gaps = 31/284 (10%)
Query: 76  IGEGSYGRVFYAKLT----DGTP--AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G G++G V+  +++    D +P   A+K L    + + E DF  +  ++S+  H++ V 
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
            +G  ++S  R ++ +    G L   L   +  + ++P   L     + VA   A G ++
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPS-SLAMLDLLHVARDIACGCQY 147
Query: 190 LHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           L E      +HRD+ + N LL        +KI DF +       +        +    + 
Sbjct: 148 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 204
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ 305
            PE  M G  T K+D +SFGV+L E+ + G  P      K  Q ++ + T     D  K 
Sbjct: 205 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFVTSGGRMDPPKN 261
Query: 306 CVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQ 349
           C  P                    C Q++ + RPN  I+++ ++
Sbjct: 262 CPGPVYR-------------IMTQCWQHQPEDRPNFAIILERIE 292

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 120/280 (42%), Gaps = 34/280 (12%)
Query: 68  SNFGTKALIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + F    ++G G++G V+    + +G     P AIK+L  +++P+   +   +  V++ +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + H   LLG C+ S  + L+ Q    G L D +   K   G++   +L W  ++     
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI----- 133
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+ +L ++    +VHRD+ + NVL+      KI DF             H+      
Sbjct: 134 -AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 189
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + A E  +    T +SDV+S+GV + EL+T G KP D  +P  + S +     RL + 
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ- 247
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNM 341
                         PP            C   +AD RP  
Sbjct: 248 --------------PPICTIDVYMIMVKCWMIDADSRPKF 273

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 121/284 (42%), Gaps = 31/284 (10%)
Query: 76  IGEGSYGRVFYAKLT----DGTP--AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G G++G V+  +++    D +P   A+K L    + + E DF  +  ++S+  H++ V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
            +G  ++S  R ++ +    G L   L   +  + ++P   L     + VA   A G ++
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRP-RPSQPS-SLAMLDLLHVARDIACGCQY 170
Query: 190 LHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           L E      +HRD+ + N LL        +KI DF +       +        +    + 
Sbjct: 171 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ 305
            PE  M G  T K+D +SFGV+L E+ + G  P      K  Q ++ + T     D  K 
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFVTSGGRMDPPKN 284
Query: 306 CVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQ 349
           C  P                    C Q++ + RPN  I+++ ++
Sbjct: 285 CPGP-------------VYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 121/284 (42%), Gaps = 31/284 (10%)
Query: 76  IGEGSYGRVFYAKLT----DGTP--AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G G++G V+  +++    D +P   A+K L    + + E DF  +  ++S+  H++ V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
            +G  ++S  R ++ +    G L   L   +  + ++P   L     + VA   A G ++
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRP-RPSQPS-SLAMLDLLHVARDIACGCQY 155
Query: 190 LHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           L E      +HRD+ + N LL        +KI DF +       +        +    + 
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ 305
            PE  M G  T K+D +SFGV+L E+ + G  P      K  Q ++ + T     D  K 
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFVTSGGRMDPPKN 269
Query: 306 CVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQ 349
           C  P                    C Q++ + RPN  I+++ ++
Sbjct: 270 CPGP-------------VYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 121/284 (42%), Gaps = 31/284 (10%)
Query: 76  IGEGSYGRVFYAKLT----DGTP--AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G G++G V+  +++    D +P   A+K L    + + E DF  +  ++S+  H++ V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
            +G  ++S  R ++ +    G L   L   +  + ++P   L     + VA   A G ++
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPS-SLAMLDLLHVARDIACGCQY 155
Query: 190 LHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           L E      +HRD+ + N LL        +KI DF +       +        +    + 
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ 305
            PE  M G  T K+D +SFGV+L E+ + G  P      K  Q ++ + T     D  K 
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFVTSGGRMDPPKN 269
Query: 306 CVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQ 349
           C  P                    C Q++ + RPN  I+++ ++
Sbjct: 270 CPGP-------------VYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 121/284 (42%), Gaps = 31/284 (10%)
Query: 76  IGEGSYGRVFYAKLT----DGTP--AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G G++G V+  +++    D +P   A+K L    + + E DF  +  ++S+  H++ V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
            +G  ++S  R ++ +    G L   L   +  + ++P   L     + VA   A G ++
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPS-SLAMLDLLHVARDIACGCQY 156
Query: 190 LHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           L E      +HRD+ + N LL        +KI DF +       +        +    + 
Sbjct: 157 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWM 213
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ 305
            PE  M G  T K+D +SFGV+L E+ + G  P      K  Q ++ + T     D  K 
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFVTSGGRMDPPKN 270
Query: 306 CVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQ 349
           C  P                    C Q++ + RPN  I+++ ++
Sbjct: 271 CPGP-------------VYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 121/284 (42%), Gaps = 31/284 (10%)
Query: 76  IGEGSYGRVFYAKLT----DGTP--AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G G++G V+  +++    D +P   A+K L    + + E DF  +  ++S+  H++ V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
            +G  ++S  R ++ +    G L   L   +  + ++P   L     + VA   A G ++
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPS-SLAMLDLLHVARDIACGCQY 156
Query: 190 LHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           L E      +HRD+ + N LL        +KI DF +       +        +    + 
Sbjct: 157 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 213
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ 305
            PE  M G  T K+D +SFGV+L E+ + G  P      K  Q ++ + T     D  K 
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFVTSGGRMDPPKN 270
Query: 306 CVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQ 349
           C  P                    C Q++ + RPN  I+++ ++
Sbjct: 271 CPGP-------------VYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 121/284 (42%), Gaps = 31/284 (10%)
Query: 76  IGEGSYGRVFYAKLT----DGTP--AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G G++G V+  +++    D +P   A+K L    + + E DF  +  ++S+  H++ V 
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
            +G  ++S  R ++ +    G L   L   +  + ++P   L     + VA   A G ++
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPSS-LAMLDLLHVARDIACGCQY 162
Query: 190 LHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           L E      +HRD+ + N LL        +KI DF +       +        +    + 
Sbjct: 163 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 219
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ 305
            PE  M G  T K+D +SFGV+L E+ + G  P      K  Q ++ + T     D  K 
Sbjct: 220 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFVTSGGRMDPPKN 276
Query: 306 CVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQ 349
           C  P                    C Q++ + RPN  I+++ ++
Sbjct: 277 CPGP-------------VYRIMTQCWQHQPEDRPNFAIILERIE 307

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 121/284 (42%), Gaps = 31/284 (10%)
Query: 76  IGEGSYGRVFYAKLT----DGTP--AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G G++G V+  +++    D +P   A+K L    + + E DF  +  ++S+  H++ V 
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
            +G  ++S  R ++ +    G L   L   +  + ++P   L     + VA   A G ++
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPS-SLAMLDLLHVARDIACGCQY 172
Query: 190 LHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           L E      +HRD+ + N LL        +KI DF +       +        +    + 
Sbjct: 173 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 229
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ 305
            PE  M G  T K+D +SFGV+L E+ + G  P      K  Q ++ + T     D  K 
Sbjct: 230 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFVTSGGRMDPPKN 286
Query: 306 CVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQ 349
           C  P                    C Q++ + RPN  I+++ ++
Sbjct: 287 CPGP-------------VYRIMTQCWQHQPEDRPNFAIILERIE 317

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 76  IGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAA-QLSVVSRLKHEHFVELLGY 133
           IGEGS+G+    K T DG    IK+++ S     E + +  +++V++ +KH + V+    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             E+ +  +V  +   G L   ++ +KGV   E   +L W  ++ +A      L+ +H++
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE-DQILDWFVQICLA------LKHVHDR 144
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               I+HRD++S N+ L  D   ++ DF +    + T     +   +GT  Y +PE    
Sbjct: 145 ---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC--IGTPYYLSPEICEN 199
Query: 254 GQITQKSDVYSFGVVLLELLT 274
                KSD+++ G VL EL T
Sbjct: 200 KPYNNKSDIWALGCVLYELCT 220

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 120/284 (42%), Gaps = 31/284 (10%)
Query: 76  IGEGSYGRVFYAKLT----DGTP--AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G G++G V+  +++    D +P   A+K L    + + E DF  +  ++S+  H++ V 
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
            +G  ++S  R ++ +    G L   L   +  + ++P   L     + VA   A G ++
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPS-SLAMLDLLHVARDIACGCQY 173
Query: 190 LHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           L E      +HRD+ + N LL        +KI DF +                +    + 
Sbjct: 174 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 230
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ 305
            PE  M G  T K+D +SFGV+L E+ + G  P      K  Q ++ + T     D  K 
Sbjct: 231 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFVTSGGRMDPPKN 287
Query: 306 CVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQ 349
           C  P                    C Q++ + RPN  I+++ ++
Sbjct: 288 CPGP-------------VYRIMTQCWQHQPEDRPNFAIILERIE 318

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 107/235 (45%), Gaps = 17/235 (7%)
Query: 52  PIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYA------KLTDGTPAAIKKLDTSSA 105
           P ++P  +  E  R    FG    +G G++G+V  A      K       A+K L +++ 
Sbjct: 32  PTQLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 89
Query: 106 PEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQG 164
            + +    ++L ++S L +HE+ V LLG C      +++ ++   G L + L  +  V  
Sbjct: 90  ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLE 149
Query: 165 AEPG-----PVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA 219
            +P        L+    +  +   A+G+ FL  K     +HRDV + NVLL +   +KI 
Sbjct: 150 TDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIG 206
Query: 220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
           DF L     + +  +          + APE       T +SDV+S+G++L E+ +
Sbjct: 207 DFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 104/212 (49%), Gaps = 18/212 (8%)
Query: 75  LIGEGSYGRVFYA-KLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           ++G G++G V+    + DG     P AIK L  +++P+   +   +  V++ +   +   
Sbjct: 24  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSR 83
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           LLG C+ S  + LV Q    G L D +   +G  G++   +L W  ++      AKG+ +
Sbjct: 84  LLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQD--LLNWCMQI------AKGMSY 134
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE 249
           L E V+  +VHRD+ + NVL+      KI DF L           H+        + A E
Sbjct: 135 L-EDVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 191
Query: 250 YAMTGQITQKSDVYSFGVVLLELLT-GRKPVD 280
             +  + T +SDV+S+GV + EL+T G KP D
Sbjct: 192 SILRRRFTHQSDVWSYGVTVWELMTFGAKPYD 223

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 120/284 (42%), Gaps = 31/284 (10%)
Query: 76  IGEGSYGRVFYAKLT----DGTP--AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G G++G V+  +++    D +P   A+K L    + + E DF  +  ++S+  H++ V 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
            +G  ++S  R ++ +    G L   L   +  + ++P   L     + VA   A G ++
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPS-SLAMLDLLHVARDIACGCQY 196
Query: 190 LHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           L E      +HRD+ + N LL        +KI DF +                +    + 
Sbjct: 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 253
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ 305
            PE  M G  T K+D +SFGV+L E+ + G  P      K  Q ++ + T     D  K 
Sbjct: 254 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFVTSGGRMDPPKN 310
Query: 306 CVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQ 349
           C  P                    C Q++ + RPN  I+++ ++
Sbjct: 311 CPGP-------------VYRIMTQCWQHQPEDRPNFAIILERIE 341

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V+     + T  A+K L   +       F  + +++  L+H+  V L     
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV--QAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
                 ++ ++   GSL D L   +G      G VL   + +  +   A+G+ ++  K  
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEG------GKVLL-PKLIDFSAQIAEGMAYIERK-- 129
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAMT 253
              +HRD+R++NVL+ +    KIADF L     D     ++ R    F   + APE    
Sbjct: 130 -NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINF 185
Query: 254 GQITQKSDVYSFGVVLLELLT-GRKP 278
           G  T KSDV+SFG++L E++T G+ P
Sbjct: 186 GCFTIKSDVWSFGILLYEIVTYGKIP 211

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 121/284 (42%), Gaps = 31/284 (10%)
Query: 76  IGEGSYGRVFYAKLT----DGTP--AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G G++G V+  +++    D +P   A+K L    + + E DF  +  ++S+  H++ V 
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
            +G  ++S  R ++ +    G L   L   +  + ++P   L     + VA   A G ++
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPSS-LAMLDLLHVARDIACGCQY 182
Query: 190 LHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           L E      +HRD+ + N LL        +KI DF +       +        +    + 
Sbjct: 183 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 239
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ 305
            PE  M G  T K+D +SFGV+L E+ + G  P      K  Q ++ + T     D  K 
Sbjct: 240 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFVTSGGRMDPPKN 296
Query: 306 CVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQ 349
           C  P                    C Q++ + RPN  I+++ ++
Sbjct: 297 CPGP-------------VYRIMTQCWQHQPEDRPNFAIILERIE 327

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 121/284 (42%), Gaps = 31/284 (10%)
Query: 76  IGEGSYGRVFYAKLT----DGTP--AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G G++G V+  +++    D +P   A+K L    + + E DF  +  ++S+  H++ V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
            +G  ++S  R ++ +    G L   L   +  + ++P   L     + VA   A G ++
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPS-SLAMLDLLHVARDIACGCQY 170
Query: 190 LHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           L E      +HRD+ + N LL        +KI DF +       +        +    + 
Sbjct: 171 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ 305
            PE  M G  T K+D +SFGV+L E+ + G  P      K  Q ++ + T     D  K 
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFVTSGGRMDPPKN 284
Query: 306 CVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQ 349
           C  P                    C Q++ + RPN  I+++ ++
Sbjct: 285 CPGP-------------VYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V+     + T  A+K L   +       F  + +++  L+H+  V L     
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV--QAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           +     ++ +F   GSL D L   +G      G VL   + +  +   A+G+ ++  K  
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEG------GKVLL-PKLIDFSAQIAEGMAYIERK-- 128
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAMT 253
              +HRD+R++NVL+ +    KIADF L     D     ++ R    F   + APE    
Sbjct: 129 -NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINF 184
Query: 254 GQITQKSDVYSFGVVLLELLT-GRKP 278
           G  T KS+V+SFG++L E++T G+ P
Sbjct: 185 GCFTIKSNVWSFGILLYEIVTYGKIP 210

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 75  LIGEGSYGRVFY-AKLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           ++G G +G V     + +G     P  IK ++  S  +        +  +  L H H V 
Sbjct: 38  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 97
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           LLG C  S+ + LV Q+  +GSL D +   +G  G  P  +L W  ++      AKG+ +
Sbjct: 98  LLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALG--PQLLLNWGVQI------AKGMYY 148
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE 249
           L E     +VHR++ + NVLL    + ++ADF + +       +L  +       + A E
Sbjct: 149 LEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 205
Query: 250 YAMTGQITQKSDVYSFGVVLLELLT 274
               G+ T +SDV+S+GV + EL+T
Sbjct: 206 SIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 17/210 (8%)
Query: 75  LIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +IG G +G V   +L        P AIK L      +   DF  + S++ +  H + + L
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
            G   +S   ++V ++   GSL   L    G          T  Q V +  G + G+++L
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFLKKNDG--------QFTVIQLVGMLRGISAGMKYL 140
Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT-FGYHAPE 249
            +      VHRD+ + N+L+  +   K++DF L+    D     ++TR       + APE
Sbjct: 141 SDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 197
Query: 250 YAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
                + T  SDV+S+G+V+ E+++ G +P
Sbjct: 198 AIAFRKFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 110/235 (46%), Gaps = 17/235 (7%)
Query: 52  PIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYA------KLTDGTPAAIKKLDTSSA 105
           P ++P  +  E  R    FG    +G G++G+V  A      K       A+K L +++ 
Sbjct: 32  PTQLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 89
Query: 106 PEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQG 164
            + +    ++L ++S L +HE+ V LLG C      +++ ++   G L + L  +  V  
Sbjct: 90  ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLE 149
Query: 165 AEPGPVL---TWNQRVKVAYGA--AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA 219
            +P   +   T + R  + + +  A+G+ FL  K     +HRDV + NVLL +   +KI 
Sbjct: 150 TDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIG 206
Query: 220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
           DF L     + +  +          + APE       T +SDV+S+G++L E+ +
Sbjct: 207 DFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 76  IGEGSYGRV---FYAKLTD--GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +G+G++G V    Y  L D  G   A+KKL  S+  E   DF  ++ ++  L+H++ V+ 
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKY 75
Query: 131 LGYCMESNNR--ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C  +  R   L+ ++   GSL D L   K  +  +   +L +  ++       KG+E
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI------CKGME 127
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ--SSDTAARLHSTRVLGTFGYH 246
           +L  K     +HRD+ + N+L+ ++ + KI DF LT          ++        F Y 
Sbjct: 128 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY- 183
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT 274
           APE     + +  SDV+SFGVVL EL T
Sbjct: 184 APESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 105/231 (45%), Gaps = 13/231 (5%)
Query: 52  PIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYA------KLTDGTPAAIKKLDTSSA 105
           P ++P  +  E  R    FG    +G G++G+V  A      K       A+K L +++ 
Sbjct: 32  PTQLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 89
Query: 106 PEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQ- 163
            + +    ++L ++S L +HE+ V LLG C      +++ ++   G L + L  +     
Sbjct: 90  ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADL 149
Query: 164 GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL 223
             E G  L     +  +   A+G+ FL  K     +HRDV + NVLL +   +KI DF L
Sbjct: 150 DKEDGRPLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGL 206
Query: 224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                + +  +          + APE       T +SDV+S+G++L E+ +
Sbjct: 207 ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 104/203 (51%), Gaps = 20/203 (9%)
Query: 76  IGEGSYGRVFYAKLTDGTP-AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           +G+G++G+V+ A+  + +  AA K +DT S  E E D+  ++ +++   H + V+LL   
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASCDHPNIVKLLDAF 103
Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
              NN  ++ +F   G++  V+     ++   P   LT +Q   V       L +LH+  
Sbjct: 104 YYENNLWILIEFCAGGAVDAVM-----LELERP---LTESQIQVVCKQTLDALNYLHDN- 154
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              I+HRD+++ N+L   D   K+ADF ++ +++    R  S   +GT  + APE  M  
Sbjct: 155 --KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDS--FIGTPYWMAPEVVMCE 210
Query: 255 Q-----ITQKSDVYSFGVVLLEL 272
                    K+DV+S G+ L+E+
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEM 233

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 76  IGEGSYGRV---FYAKLTD--GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +G+G++G V    Y  L D  G   A+KKL  S+  E   DF  ++ ++  L+H++ V+ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKY 76
Query: 131 LGYCMESNNR--ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C  +  R   L+ ++   GSL D L   K  +  +   +L +  ++       KG+E
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI------CKGME 128
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ--SSDTAARLHSTRVLGTFGYH 246
           +L  K     +HRD+ + N+L+ ++ + KI DF LT          ++        F Y 
Sbjct: 129 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY- 184
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT 274
           APE     + +  SDV+SFGVVL EL T
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 105/231 (45%), Gaps = 13/231 (5%)
Query: 52  PIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYA------KLTDGTPAAIKKLDTSSA 105
           P ++P  +  E  R    FG    +G G++G+V  A      K       A+K L +++ 
Sbjct: 24  PTQLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 81
Query: 106 PEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQ- 163
            + +    ++L ++S L +HE+ V LLG C      +++ ++   G L + L  +     
Sbjct: 82  ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADL 141
Query: 164 GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL 223
             E G  L     +  +   A+G+ FL  K     +HRDV + NVLL +   +KI DF L
Sbjct: 142 DKEDGRPLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGL 198
Query: 224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                + +  +          + APE       T +SDV+S+G++L E+ +
Sbjct: 199 ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 76  IGEGSYGRV---FYAKLTD--GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +G+G++G V    Y  L D  G   A+KKL  S+  E   DF  ++ ++  L+H++ V+ 
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKY 80
Query: 131 LGYCMESNNR--ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C  +  R   L+ ++   GSL D L   K  +  +   +L +  ++       KG+E
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI------CKGME 132
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ--SSDTAARLHSTRVLGTFGYH 246
           +L  K     +HRD+ + N+L+ ++ + KI DF LT          ++        F Y 
Sbjct: 133 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY- 188
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT 274
           APE     + +  SDV+SFGVVL EL T
Sbjct: 189 APESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 76  IGEGSYGRV---FYAKLTD--GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +G+G++G V    Y  L D  G   A+KKL  S+  E   DF  ++ ++  L+H++ V+ 
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKY 74
Query: 131 LGYCMESNNR--ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C  +  R   L+ ++   GSL D L   K  +  +   +L +  ++       KG+E
Sbjct: 75  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI------CKGME 126
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ--SSDTAARLHSTRVLGTFGYH 246
           +L  K     +HRD+ + N+L+ ++ + KI DF LT          ++        F Y 
Sbjct: 127 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY- 182
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT 274
           APE     + +  SDV+SFGVVL EL T
Sbjct: 183 APESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 76  IGEGSYGRV---FYAKLTD--GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +G+G++G V    Y  L D  G   A+KKL  S+  E   DF  ++ ++  L+H++ V+ 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKY 94
Query: 131 LGYCMESNNR--ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C  +  R   L+ ++   GSL D L   K  +  +   +L +  ++       KG+E
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI------CKGME 146
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ--SSDTAARLHSTRVLGTFGYH 246
           +L  K     +HRD+ + N+L+ ++ + KI DF LT          ++        F Y 
Sbjct: 147 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY- 202
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT 274
           APE     + +  SDV+SFGVVL EL T
Sbjct: 203 APESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 76  IGEGSYGRV---FYAKLTD--GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +G+G++G V    Y  L D  G   A+KKL  S+  E   DF  ++ ++  L+H++ V+ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKY 79
Query: 131 LGYCMESNNR--ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C  +  R   L+ ++   GSL D L   K  +  +   +L +  ++       KG+E
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI------CKGME 131
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ--SSDTAARLHSTRVLGTFGYH 246
           +L  K     +HRD+ + N+L+ ++ + KI DF LT          ++        F Y 
Sbjct: 132 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY- 187
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT 274
           APE     + +  SDV+SFGVVL EL T
Sbjct: 188 APESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 75  LIGEGSYGRVFY-AKLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           ++G G +G V     + +G     P  IK ++  S  +        +  +  L H H V 
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           LLG C  S+ + LV Q+  +GSL D +   +G  G  P  +L W  ++      AKG+ +
Sbjct: 80  LLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALG--PQLLLNWGVQI------AKGMYY 130
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE 249
           L E     +VHR++ + NVLL    + ++ADF + +       +L  +       + A E
Sbjct: 131 LEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 187
Query: 250 YAMTGQITQKSDVYSFGVVLLELLT 274
               G+ T +SDV+S+GV + EL+T
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 76  IGEGSYGRV---FYAKLTD--GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +G+G++G V    Y  L D  G   A+KKL  S+  E   DF  ++ ++  L+H++ V+ 
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKY 107
Query: 131 LGYCMESNNR--ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C  +  R   L+ ++   GSL D L   K  +  +   +L +  ++       KG+E
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI------CKGME 159
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ--SSDTAARLHSTRVLGTFGYH 246
           +L  K     +HRD+ + N+L+ ++ + KI DF LT          ++        F Y 
Sbjct: 160 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY- 215
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT 274
           APE     + +  SDV+SFGVVL EL T
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 76  IGEGSYGRV---FYAKLTD--GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +G+G++G V    Y  L D  G   A+KKL  S+  E   DF  ++ ++  L+H++ V+ 
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKY 83
Query: 131 LGYCMESNNR--ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C  +  R   L+ ++   GSL D L   K  +  +   +L +  ++       KG+E
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI------CKGME 135
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ--SSDTAARLHSTRVLGTFGYH 246
           +L  K     +HRD+ + N+L+ ++ + KI DF LT          ++        F Y 
Sbjct: 136 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY- 191
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT 274
           APE     + +  SDV+SFGVVL EL T
Sbjct: 192 APESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 76  IGEGSYGRV---FYAKLTD--GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +G+G++G V    Y  L D  G   A+KKL  S+  E   DF  ++ ++  L+H++ V+ 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKY 94
Query: 131 LGYCMESNNR--ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C  +  R   L+ ++   GSL D L   K  +  +   +L +  ++       KG+E
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI------CKGME 146
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ--SSDTAARLHSTRVLGTFGYH 246
           +L  K     +HRD+ + N+L+ ++ + KI DF LT          ++        F Y 
Sbjct: 147 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY- 202
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT 274
           APE     + +  SDV+SFGVVL EL T
Sbjct: 203 APESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 115/245 (46%), Gaps = 22/245 (8%)
Query: 76  IGEGSYGRVFYAKLTDGTP--AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           IG+GS+G V Y  + + T    AIK +D   A +   D   +++V+S+    +     G 
Sbjct: 27  IGKGSFGEV-YKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGS 85
Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
            ++S    ++ ++   GS  D+L         +PGP L       +     KGL++LH +
Sbjct: 86  YLKSTKLWIIMEYLGGGSALDLL---------KPGP-LEETYIATILREILKGLDYLHSE 135
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
            +   +HRD++++NVLL +    K+ADF +  Q +DT  ++     +GT  + APE    
Sbjct: 136 RK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKRNXFVGTPFWMAPEVIKQ 190
Query: 254 GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK----VKQCVDP 309
                K+D++S G+  +EL  G  P     P     L+   +P   E +     K+ V+ 
Sbjct: 191 SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEA 250
Query: 310 KLNND 314
            LN D
Sbjct: 251 CLNKD 255

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 76  IGEGSYGRV---FYAKLTD--GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +G+G++G V    Y  L D  G   A+KKL  S+  E   DF  ++ ++  L+H++ V+ 
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKY 81
Query: 131 LGYCMESNNR--ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C  +  R   L+ ++   GSL D L   K  +  +   +L +  ++       KG+E
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI------CKGME 133
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ--SSDTAARLHSTRVLGTFGYH 246
           +L  K     +HRD+ + N+L+ ++ + KI DF LT          ++        F Y 
Sbjct: 134 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY- 189
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT 274
           APE     + +  SDV+SFGVVL EL T
Sbjct: 190 APESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 76  IGEGSYGRV---FYAKLTD--GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +G+G++G V    Y  L D  G   A+KKL  S+  E   DF  ++ ++  L+H++ V+ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKY 76
Query: 131 LGYCMESNNR--ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C  +  R   L+ ++   GSL D L   K  +  +   +L +  ++       KG+E
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI------CKGME 128
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ--SSDTAARLHSTRVLGTFGYH 246
           +L  K     +HRD+ + N+L+ ++ + KI DF LT          ++        F Y 
Sbjct: 129 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY- 184
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT 274
           APE     + +  SDV+SFGVVL EL T
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 76  IGEGSYGRV---FYAKLTD--GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +G+G++G V    Y  L D  G   A+KKL  S+  E   DF  ++ ++  L+H++ V+ 
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKY 82
Query: 131 LGYCMESNNR--ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C  +  R   L+ ++   GSL D L   K  +  +   +L +  ++       KG+E
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI------CKGME 134
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ--SSDTAARLHSTRVLGTFGYH 246
           +L  K     +HRD+ + N+L+ ++ + KI DF LT          ++        F Y 
Sbjct: 135 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY- 190
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT 274
           APE     + +  SDV+SFGVVL EL T
Sbjct: 191 APESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/322 (23%), Positives = 130/322 (40%), Gaps = 55/322 (17%)
Query: 45  GTPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKL 100
           G+ + A  I++  +K++E+            IG G +G V   +L       +  AIK L
Sbjct: 3   GSMEFAKEIDVSYVKIEEV------------IGAGEFGEVCRGRLKAPGKKESCVAIKTL 50
Query: 101 DTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRK 160
                     +F ++ S++ + +H + + L G    S   +++ +F   G+L   L    
Sbjct: 51  KGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLND 110
Query: 161 GVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD 220
           G          T  Q V +  G A G+ +L E      VHRD+ + N+L+  +   K++D
Sbjct: 111 GQ--------FTVIQLVGMLRGIASGMRYLAEM---SYVHRDLAARNILVNSNLVCKVSD 159
Query: 221 FNLTNQSSDTAARLHSTRVLGT---FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GR 276
           F L+    + ++    T  LG      + APE     + T  SD +S+G+V+ E+++ G 
Sbjct: 160 FGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGE 219
Query: 277 KPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDY----PPXXXXXXXXXXXXCVQ 332
           +P              W       D   Q V   +  DY    PP            C Q
Sbjct: 220 RPY-------------W-------DMSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQ 259
Query: 333 YEADFRPNMTIVVKALQPLLNS 354
            + + RP    VV AL  ++ +
Sbjct: 260 KDRNARPRFPQVVSALDKMIRN 281

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/289 (23%), Positives = 117/289 (40%), Gaps = 34/289 (11%)
Query: 73  KALIGEGSYGRVFYAKLTDGT-----PAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           + +IG G +G V+   L   +     P AIK L      +   DF  +  ++ +  H + 
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
           + L G   +    +++ ++   G+L   L  + G        VL   Q V +  G A G+
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDG-----EFSVL---QLVGMLRGIAAGM 160
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT-FGYH 246
           ++L        VHRD+ + N+L+  +   K++DF L+    D     ++T        + 
Sbjct: 161 KYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 217
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ 305
           APE     + T  SDV+SFG+V+ E++T G +P              W    LS  +V +
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPY-------------W---ELSNHEVMK 261
Query: 306 CVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNS 354
            ++       P             C Q E   RP    +V  L  L+ +
Sbjct: 262 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 22/208 (10%)
Query: 76  IGEGSYGRV---FYAKLTD--GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +G+G++G V    Y  L D  G   A+KKL  S+  E   DF  ++ ++  L+H++ V+ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKY 76
Query: 131 LGYCMESNNR--ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C  +  R   L+ ++   GSL D L   K  +  +   +L +  ++       KG+E
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI------CKGME 128
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT--FGYH 246
           +L  K     +HRD+ + N+L+ ++ + KI DF LT +           +  G     ++
Sbjct: 129 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLT-KVLPQDKEFFKVKEPGESPIFWY 184
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT 274
           APE     + +  SDV+SFGVVL EL T
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 76  IGEGSYGRV---FYAKLTD--GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +G+G++G V    Y  L D  G   A+KKL  S+  E   DF  ++ ++  L+H++ V+ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKY 79
Query: 131 LGYCMESNNR--ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C  +  R   L+ +F   GSL + L   K  +  +   +L +  ++       KG+E
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYLQKHK--ERIDHIKLLQYTSQI------CKGME 131
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ--SSDTAARLHSTRVLGTFGYH 246
           +L  K     +HRD+ + N+L+ ++ + KI DF LT          ++        F Y 
Sbjct: 132 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY- 187
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT 274
           APE     + +  SDV+SFGVVL EL T
Sbjct: 188 APESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 98/222 (44%), Gaps = 40/222 (18%)
Query: 75  LIGEGSYGRVFYAKLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +IG G +G V++  L D        A+K L+  +     S F  +  ++    H + + L
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 131 LGYCMESNNR-ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK--VAYG--AAK 185
           LG C+ S    ++V  +   G L + +               T N  VK  + +G   AK
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNE------------THNPTVKDLIGFGLQVAK 203
Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD---------TAARLHS 236
           G++FL  K     VHRD+ + N +L + F  K+ADF L     D         T A+L  
Sbjct: 204 GMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL-- 258
Query: 237 TRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
                   + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 259 -----PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 118/292 (40%), Gaps = 43/292 (14%)
Query: 75  LIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +IG G +G V   +L       +  AIK L          +F ++ S++ + +H + + L
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
            G    S   +++ +F   G+L   L    G          T  Q V +  G A G+ +L
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQ--------FTVIQLVGMLRGIASGMRYL 134
Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT---FGYHA 247
            E      VHRD+ + N+L+  +   K++DF L+    + ++    T  LG      + A
Sbjct: 135 AEM---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTA 191
Query: 248 PEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC 306
           PE     + T  SD +S+G+V+ E+++ G +P              W       D   Q 
Sbjct: 192 PEAIAFRKFTSASDAWSYGIVMWEVMSFGERPY-------------W-------DMSNQD 231
Query: 307 VDPKLNNDY----PPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNS 354
           V   +  DY    PP            C Q + + RP    VV AL  ++ +
Sbjct: 232 VINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRN 283

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 117/293 (39%), Gaps = 33/293 (11%)
Query: 68  SNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK 123
           +N     ++G G +G V   +L          AIK L      +   DF  + S++ +  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           H + + L G   +S   ++V ++   GSL   L               T  Q V +  G 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--------FTVIQLVGMLRGI 156
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT- 242
           A G+++L +      VHRD+ + N+L+  +   K++DF L+    D     ++TR     
Sbjct: 157 ASGMKYLSDM---GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + +PE     + T  SDV+S+G+VL E+++ G +P              W    +S  
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W---EMSNQ 257
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNS 354
            V + VD       P             C Q + + RP    +V  L  L+ +
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 75  LIGEGSYGRVFYAKLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +IG G +G V++  L D        A+K L+  +     S F  +  ++    H + + L
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 131 LGYCMESNNR-ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           LG C+ S    ++V  +   G L      R  ++     P  T    +      AKG++F
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNP--TVKDLIGFGLQVAKGMKF 153
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD---------TAARLHSTRVL 240
           L  K     VHRD+ + N +L + F  K+ADF L     D         T A+L      
Sbjct: 154 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL------ 204
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
               + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 205 -PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 103/203 (50%), Gaps = 20/203 (9%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           +G+G++G+V+ AK  + G  AA K ++T S  E E D+  ++ +++   H + V+LLG  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYIVEIEILATCDHPYIVKLLGAY 77
Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
                  ++ +F   G++  ++         E    LT  Q   V     + L FLH K 
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIM--------LELDRGLTEPQIQVVCRQMLEALNFLHSK- 128
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              I+HRD+++ NVL+  +   ++ADF ++ ++  T  +  S   +GT  + APE  M  
Sbjct: 129 --RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCE 184
Query: 255 QITQ-----KSDVYSFGVVLLEL 272
            +       K+D++S G+ L+E+
Sbjct: 185 TMKDTPYDYKADIWSLGITLIEM 207

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 75  LIGEGSYGRVFYAKLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +IG G +G V++  L D        A+K L+  +     S F  +  ++    H + + L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 131 LGYCMESNNR-ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           LG C+ S    ++V  +   G L      R  ++     P  T    +      AKG++F
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNP--TVKDLIGFGLQVAKGMKF 149
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD---------TAARLHSTRVL 240
           L  K     VHRD+ + N +L + F  K+ADF L     D         T A+L      
Sbjct: 150 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL------ 200
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
               + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 201 -PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 19/212 (8%)
Query: 75  LIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +IG G +G V    L          AIK L +    +   DF ++ S++ +  H + + L
Sbjct: 40  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 99
Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
            G   +S   +++ +F   GSL   L    G          T  Q V +  G A G+++L
Sbjct: 100 EGVVTKSTPVMIITEFMENGSLDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYL 151
Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT---FGYHA 247
            +      VHRD+ + N+L+  +   K++DF L+    D  +    T  LG      + A
Sbjct: 152 ADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 208
Query: 248 PEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
           PE     + T  SDV+S+G+V+ E+++ G +P
Sbjct: 209 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 240

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 108/238 (45%), Gaps = 21/238 (8%)
Query: 52  PIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYA------KLTDGTPAAIKKLDTSSA 105
           P ++P  +  E  R    FG    +G G++G+V  A      K       A+K L +++ 
Sbjct: 32  PTQLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 89
Query: 106 PEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQG 164
            + +    ++L ++S L +HE+ V LLG C      +++ ++   G L + L  RK   G
Sbjct: 90  ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR-RKRPPG 148
Query: 165 AE--------PGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS 216
            E        P   L+    +  +   A+G+ FL  K     +HRDV + NVLL +   +
Sbjct: 149 LEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVA 205
Query: 217 KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
           KI DF L     + +  +          + APE       T +SDV+S+G++L E+ +
Sbjct: 206 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 75  LIGEGSYGRVFYAKLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +IG G +G V++  L D        A+K L+  +     S F  +  ++    H + + L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 131 LGYCMESNNR-ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           LG C+ S    ++V  +   G L      R  ++     P  T    +      AKG++F
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNP--TVKDLIGFGLQVAKGMKF 146
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD---------TAARLHSTRVL 240
           L  K     VHRD+ + N +L + F  K+ADF L     D         T A+L      
Sbjct: 147 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL------ 197
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
               + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 198 -PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 75  LIGEGSYGRVFYAKLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +IG G +G V++  L D        A+K L+  +     S F  +  ++    H + + L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 131 LGYCMESNNR-ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           LG C+ S    ++V  +   G L      R  ++     P  T    +      AKG++F
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNP--TVKDLIGFGLQVAKGMKF 148
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD---------TAARLHSTRVL 240
           L  K     VHRD+ + N +L + F  K+ADF L     D         T A+L      
Sbjct: 149 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL------ 199
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
               + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 200 -PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 75  LIGEGSYGRVFYAKLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +IG G +G V++  L D        A+K L+  +     S F  +  ++    H + + L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 131 LGYCMESNNR-ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           LG C+ S    ++V  +   G L      R  ++     P  T    +      AKG++F
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNP--TVKDLIGFGLQVAKGMKF 148
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD---------TAARLHSTRVL 240
           L  K     VHRD+ + N +L + F  K+ADF L     D         T A+L      
Sbjct: 149 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL------ 199
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
               + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 200 -PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 103/203 (50%), Gaps = 20/203 (9%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           +G+G++G+V+ AK  + G  AA K ++T S  E E D+  ++ +++   H + V+LLG  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYIVEIEILATCDHPYIVKLLGAY 85
Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
                  ++ +F   G++  ++         E    LT  Q   V     + L FLH K 
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIM--------LELDRGLTEPQIQVVCRQMLEALNFLHSK- 136
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              I+HRD+++ NVL+  +   ++ADF ++ ++  T  +  S   +GT  + APE  M  
Sbjct: 137 --RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCE 192
Query: 255 QITQ-----KSDVYSFGVVLLEL 272
            +       K+D++S G+ L+E+
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEM 215

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 75  LIGEGSYGRVFYAKLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +IG G +G V++  L D        A+K L+  +     S F  +  ++    H + + L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 131 LGYCMESNNR-ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           LG C+ S    ++V  +   G L      R  ++     P  T    +      AKG++F
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNP--TVKDLIGFGLQVAKGMKF 149
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD---------TAARLHSTRVL 240
           L  K     VHRD+ + N +L + F  K+ADF L     D         T A+L      
Sbjct: 150 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKL------ 200
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
               + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 201 -PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 25/221 (11%)
Query: 68  SNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK 123
           S    + +IG G  G V Y +L        P AIK L          DF ++ S++ +  
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           H + + L G        ++V ++   GSL   L    G          T  Q V +  G 
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG--------QFTIMQLVGMLRGV 160
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
             G+ +L +      VHRD+ + NVL+  +   K++DF L+    D     ++T    T 
Sbjct: 161 GAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT----TG 213
Query: 244 G-----YHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
           G     + APE       +  SDV+SFGVV+ E+L  G +P
Sbjct: 214 GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 103/203 (50%), Gaps = 20/203 (9%)
Query: 76  IGEGSYGRVFYAKLTDGTP-AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           +G+G++G+V+ A+  + +  AA K +DT S  E E D+  ++ +++   H + V+LL   
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASCDHPNIVKLLDAF 103
Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
              NN  ++ +F   G++  V+     ++   P   LT +Q   V       L +LH+  
Sbjct: 104 YYENNLWILIEFCAGGAVDAVM-----LELERP---LTESQIQVVCKQTLDALNYLHDN- 154
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              I+HRD+++ N+L   D   K+ADF ++ +++    R      +GT  + APE  M  
Sbjct: 155 --KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQR--RDXFIGTPYWMAPEVVMCE 210
Query: 255 Q-----ITQKSDVYSFGVVLLEL 272
                    K+DV+S G+ L+E+
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEM 233

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 70/309 (22%), Positives = 126/309 (40%), Gaps = 35/309 (11%)
Query: 58  IKLDELNRLTSNFGTKALIGEGSYGRVF---YAKLTDGTPAAIKKLDTSSAPEPESDFAA 114
           + LD+     ++   K  +G G YG V+   + K +        K DT    E    F  
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLK 56
Query: 115 QLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWN 174
           + +V+  +KH + V+LLG C       ++ +F T G+L D L  R+  +      VL + 
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLY- 113
Query: 175 QRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARL 234
               +A   +  +E+L +K     +HRD+ + N L+ ++   K+ADF L+   +      
Sbjct: 114 ----MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTA 166
Query: 235 HSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTW 293
           H+        + APE     + + KSDV++FGV+L E+ T G  P               
Sbjct: 167 HAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-------------- 211
Query: 294 ATPRLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLN 353
             P +   +V + ++     + P             C Q+    RP+   + +A + +  
Sbjct: 212 --PGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 269
Query: 354 SKPAGPEAQ 362
                 E +
Sbjct: 270 ESSISDEVE 278

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 17/217 (7%)
Query: 68  SNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK 123
           +N     ++G G +G V   +L          AIK L      +   DF  + S++ +  
Sbjct: 16  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 75
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           H + + L G   +S   ++V ++   GSL   L               T  Q V +  G 
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--------FTVIQLVGMLRGI 127
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT- 242
           A G+++L +      VHRD+ + N+L+  +   K++DF L+    D     ++TR     
Sbjct: 128 ASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 184
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
             + +PE     + T  SDV+S+G+VL E+++ G +P
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 17/217 (7%)
Query: 68  SNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK 123
           +N     ++G G +G V   +L          AIK L      +   DF  + S++ +  
Sbjct: 33  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 92
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           H + + L G   +S   ++V ++   GSL   L               T  Q V +  G 
Sbjct: 93  HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--------FTVIQLVGMLRGI 144
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT- 242
           A G+++L +      VHRD+ + N+L+  +   K++DF L+    D     ++TR     
Sbjct: 145 ASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 201
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
             + +PE     + T  SDV+S+G+VL E+++ G +P
Sbjct: 202 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 238

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 76  IGEGSYGRV---FYAKLTD--GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +G+G++G V    Y  L D  G   A+KKL  S+  E   DF  ++ ++  L+H++ V+ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKY 79
Query: 131 LGYCMESNNR--ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C  +  R   L+ ++   GSL D L      +  +   +L +  ++       KG+E
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQAH--AERIDHIKLLQYTSQI------CKGME 131
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ--SSDTAARLHSTRVLGTFGYH 246
           +L  K     +HRD+ + N+L+ ++ + KI DF LT          ++        F Y 
Sbjct: 132 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY- 187
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT 274
           APE     + +  SDV+SFGVVL EL T
Sbjct: 188 APESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 117/293 (39%), Gaps = 33/293 (11%)
Query: 68  SNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK 123
           +N     ++G G +G V   +L          AIK L      +   DF  + S++ +  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           H + + L G   +S   ++V ++   GSL   L               T  Q V +  G 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--------FTVIQLVGMLRGI 156
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT- 242
           A G+++L +      VHRD+ + N+L+  +   K++DF L+    D     ++TR     
Sbjct: 157 ASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + +PE     + T  SDV+S+G+VL E+++ G +P              W    +S  
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W---EMSNQ 257
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNS 354
            V + VD       P             C Q + + RP    +V  L  L+ +
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 103/229 (44%), Gaps = 16/229 (6%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHE 125
           +F    L+G+GS+  V+ A+ +  G   AIK +D  +  +         ++ +  +LKH 
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
             +EL  Y  +SN   LV +    G ++  L  R      +P    + N+     +    
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR-----VKP---FSENEARHFMHQIIT 123
Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           G+ +LH      I+HRD+  SN+LL  +   KIADF L  Q      + H T + GT  Y
Sbjct: 124 GMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK-HYT-LCGTPNY 178
Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWA 294
            +PE A       +SDV+S G +   LL GR P D    K   + V  A
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA 227

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 117/293 (39%), Gaps = 33/293 (11%)
Query: 68  SNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK 123
           +N     ++G G +G V   +L          AIK L      +   DF  + S++ +  
Sbjct: 43  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 102
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           H + + L G   +S   ++V ++   GSL   L               T  Q V +  G 
Sbjct: 103 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--------FTVIQLVGMLRGI 154
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT- 242
           A G+++L +      VHRD+ + N+L+  +   K++DF L+    D     ++TR     
Sbjct: 155 ASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 211
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + +PE     + T  SDV+S+G+VL E+++ G +P              W    +S  
Sbjct: 212 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W---EMSNQ 255
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNS 354
            V + VD       P             C Q + + RP    +V  L  L+ +
Sbjct: 256 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 308

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 117/293 (39%), Gaps = 33/293 (11%)
Query: 68  SNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK 123
           +N     ++G G +G V   +L          AIK L      +   DF  + S++ +  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           H + + L G   +S   ++V ++   GSL   L               T  Q V +  G 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--------FTVIQLVGMLRGI 156
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT- 242
           A G+++L +      VHRD+ + N+L+  +   K++DF L+    D     ++TR     
Sbjct: 157 ASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + +PE     + T  SDV+S+G+VL E+++ G +P              W    +S  
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W---EMSNQ 257
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNS 354
            V + VD       P             C Q + + RP    +V  L  L+ +
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 112/243 (46%), Gaps = 33/243 (13%)
Query: 57  QIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTP------AAIKKLDTSSAPEPES 110
           Q KL E++     F  +  +GE  +G+V+   L    P       AIK L   +      
Sbjct: 17  QAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLRE 74
Query: 111 DFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGR----------- 159
           +F  +  + +RL+H + V LLG   +     +++ + + G LH+ L  R           
Sbjct: 75  EFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDD 134
Query: 160 -KGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI 218
            + V+ A   P       V +    A G+E+L       +VH+D+ + NVL++D    KI
Sbjct: 135 DRTVKSALEPPDF-----VHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKI 186
Query: 219 ADFNLTNQ--SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-G 275
           +D  L  +  ++D    L ++  L    + APE  M G+ +  SD++S+GVVL E+ + G
Sbjct: 187 SDLGLFREVYAADYYKLLGNS--LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYG 244
Query: 276 RKP 278
            +P
Sbjct: 245 LQP 247

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 124/305 (40%), Gaps = 35/305 (11%)
Query: 60  LDELNRLTSNFGTKALIGEGSYGRVF---YAKLTDGTPAAIKKLDTSSAPEPESDFAAQL 116
           LD+     ++   K  +G G YG V+   + K +        K DT    E    F  + 
Sbjct: 3   LDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEA 58
Query: 117 SVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
           +V+  +KH + V+LLG C       ++ +F T G+L D L  R+  +      VL     
Sbjct: 59  AVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVL----- 111
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS 236
           + +A   +  +E+L +K     +HRD+ + N L+ ++   K+ADF L+   +      H+
Sbjct: 112 LYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHA 168
Query: 237 TRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWAT 295
                   + APE     + + KSDV++FGV+L E+ T G  P                 
Sbjct: 169 GAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY---------------- 211
Query: 296 PRLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSK 355
           P +   +V + ++     + P             C Q+    RP+   + +A + +    
Sbjct: 212 PGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 271
Query: 356 PAGPE 360
               E
Sbjct: 272 SISDE 276

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 117/293 (39%), Gaps = 33/293 (11%)
Query: 68  SNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK 123
           +N     ++G G +G V   +L          AIK L      +   DF  + S++ +  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           H + + L G   +S   ++V ++   GSL   L               T  Q V +  G 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--------FTVIQLVGMLRGI 156
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT- 242
           A G+++L +      VHRD+ + N+L+  +   K++DF L+    D     ++TR     
Sbjct: 157 ASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + +PE     + T  SDV+S+G+VL E+++ G +P              W    +S  
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W---EMSNQ 257
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNS 354
            V + VD       P             C Q + + RP    +V  L  L+ +
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 117/293 (39%), Gaps = 33/293 (11%)
Query: 68  SNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK 123
           +N     ++G G +G V   +L          AIK L      +   DF  + S++ +  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           H + + L G   +S   ++V ++   GSL   L               T  Q V +  G 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--------FTVIQLVGMLRGI 156
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT- 242
           A G+++L +      VHRD+ + N+L+  +   K++DF L+    D     ++TR     
Sbjct: 157 ASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + +PE     + T  SDV+S+G+VL E+++ G +P              W    +S  
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W---EMSNQ 257
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNS 354
            V + VD       P             C Q + + RP    +V  L  L+ +
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 76  IGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IGEGS G V  A + + G   A+KK+D       E  F  ++ ++   +HE+ VE+    
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHENVVEMYNSY 217
Query: 135 MESNNRILVYQFATMGSLHDVL-HGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
           +  +   +V +F   G+L D++ H R           +   Q   V     + L  LH +
Sbjct: 218 LVGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIAAVCLAVLQALSVLHAQ 266
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               ++HRD++S ++LL  D + K++DF    Q S    R     ++GT  + APE    
Sbjct: 267 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISR 321
Query: 254 GQITQKSDVYSFGVVLLELLTGRKP 278
                + D++S G++++E++ G  P
Sbjct: 322 LPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 92/217 (42%), Gaps = 17/217 (7%)
Query: 68  SNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK 123
           S    + +IG G  G V Y +L        P AIK L          DF ++ S++ +  
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           H + + L G        ++V ++   GSL   L    G          T  Q V +  G 
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG--------QFTIMQLVGMLRGV 160
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN-QSSDTAARLHSTRVLGT 242
             G+ +L +      VHRD+ + NVL+  +   K++DF L+     D  A   +T     
Sbjct: 161 GAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIP 217
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
             + APE       +  SDV+SFGVV+ E+L  G +P
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 22/208 (10%)
Query: 76  IGEGSYGRV---FYAKLTD--GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +G+G++G V    Y  L D  G   A+KKL  S+  E   DF  ++ ++  L+H++ V+ 
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKY 77
Query: 131 LGYCMESNNR--ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C  +  R   L+ ++   GSL D L   K  +  +   +L +  ++       KG+E
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI------CKGME 129
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT--FGYH 246
           +L  K     +HR++ + N+L+ ++ + KI DF LT +        +  +  G     ++
Sbjct: 130 YLGTK---RYIHRNLATRNILVENENRVKIGDFGLT-KVLPQDKEYYKVKEPGESPIFWY 185
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT 274
           APE     + +  SDV+SFGVVL EL T
Sbjct: 186 APESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 76  IGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IGEGS G V  A + + G   A+KK+D       E  F  ++ ++   +HE+ VE+    
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHENVVEMYNSY 140
Query: 135 MESNNRILVYQFATMGSLHDVL-HGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
           +  +   +V +F   G+L D++ H R           +   Q   V     + L  LH +
Sbjct: 141 LVGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIAAVCLAVLQALSVLHAQ 189
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               ++HRD++S ++LL  D + K++DF    Q S    R     ++GT  + APE    
Sbjct: 190 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISR 244
Query: 254 GQITQKSDVYSFGVVLLELLTGRKP 278
                + D++S G++++E++ G  P
Sbjct: 245 LPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 75  LIGEGSYGRVFYAKLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +IG G +G V++  L D        A+K L+  +     S F  +  ++    H + + L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 131 LGYCMESNNR-ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           LG C+ S    ++V  +   G L      R  ++     P  T    +      AKG+++
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNP--TVKDLIGFGLQVAKGMKY 147
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT-AARLHS-TRVLGTFGYHA 247
           L  K     VHRD+ + N +L + F  K+ADF L     D     +H+ T       + A
Sbjct: 148 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMA 204
Query: 248 PEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 116/293 (39%), Gaps = 33/293 (11%)
Query: 68  SNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK 123
           +N     ++G G +G V   +L          AIK L      +   DF  + S++ +  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           H + + L G   +S   ++V ++   GSL   L               T  Q V +  G 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVIQLVGMLRGI 156
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT- 242
           A G+++L +      VHRD+ + N+L+  +   K++DF L     D     ++TR     
Sbjct: 157 ASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIP 213
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + +PE     + T  SDV+S+G+VL E+++ G +P              W    +S  
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W---EMSNQ 257
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNS 354
            V + VD       P             C Q + + RP    +V  L  L+ +
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 101/228 (44%), Gaps = 38/228 (16%)
Query: 79  GSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMES 137
           G +G V+ A+L  D     I  L    + + E +  +       +KHE+ ++ +      
Sbjct: 26  GRFGCVWKAQLMNDFVAVKIFPLQDKQSWQSEREIFS----TPGMKHENLLQFIAAEKRG 81
Query: 138 NNR----ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
           +N      L+  F   GSL D L G           ++TWN+   VA   ++GL +LHE 
Sbjct: 82  SNLEVELWLITAFHDKGSLTDYLKGN----------IITWNELCHVAETMSRGLSYLHED 131
Query: 194 V--------QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           V        +P I HRD +S NVLL  D  + +ADF L  +         +   +GT  Y
Sbjct: 132 VPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRY 191
Query: 246 HAPEYAMTGQIT------QKSDVYSFGVVLLELLTGRK----PVDHTM 283
            APE  + G I        + D+Y+ G+VL EL++  K    PVD  M
Sbjct: 192 MAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYM 238

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/309 (22%), Positives = 126/309 (40%), Gaps = 35/309 (11%)
Query: 58  IKLDELNRLTSNFGTKALIGEGSYGRVF---YAKLTDGTPAAIKKLDTSSAPEPESDFAA 114
           + LD+     ++   K  +G G +G V+   + K +        K DT    E    F  
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLK 56
Query: 115 QLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWN 174
           + +V+  +KH + V+LLG C       ++ +F T G+L D L  R+  +      VL + 
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLY- 113
Query: 175 QRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARL 234
               +A   +  +E+L +K     +HRD+ + N L+ ++   K+ADF L+   +      
Sbjct: 114 ----MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTA 166
Query: 235 HSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTW 293
           H+        + APE     + + KSDV++FGV+L E+ T G  P               
Sbjct: 167 HAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-------------- 211
Query: 294 ATPRLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLN 353
             P +   +V + ++     + P             C Q+    RP+   + +A + +  
Sbjct: 212 --PGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 269
Query: 354 SKPAGPEAQ 362
                 E +
Sbjct: 270 ESSISDEVE 278

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 76  IGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IGEGS G V  A + + G   A+KK+D       E  F  ++ ++   +HE+ VE+    
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHENVVEMYNSY 95
Query: 135 MESNNRILVYQFATMGSLHDVL-HGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
           +  +   +V +F   G+L D++ H R           +   Q   V     + L  LH +
Sbjct: 96  LVGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIAAVCLAVLQALSVLHAQ 144
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               ++HRD++S ++LL  D + K++DF    Q S    R     ++GT  + APE    
Sbjct: 145 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISR 199
Query: 254 GQITQKSDVYSFGVVLLELLTGRKP 278
                + D++S G++++E++ G  P
Sbjct: 200 LPYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 76  IGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IGEGS G V  A + + G   A+KK+D       E  F  ++ ++   +HE+ VE+    
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHENVVEMYNSY 97
Query: 135 MESNNRILVYQFATMGSLHDVL-HGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
           +  +   +V +F   G+L D++ H R           +   Q   V     + L  LH +
Sbjct: 98  LVGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIAAVCLAVLQALSVLHAQ 146
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               ++HRD++S ++LL  D + K++DF    Q S    R     ++GT  + APE    
Sbjct: 147 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISR 201
Query: 254 GQITQKSDVYSFGVVLLELLTGRKP 278
                + D++S G++++E++ G  P
Sbjct: 202 LPYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 75  LIGEGSYGRVFYAKLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +IG G +G V++  L D        A+K L+  +     S F  +  ++    H + + L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 131 LGYCMESNNR-ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           LG C+ S    ++V  +   G L      R  ++     P  T    +      AKG+++
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNP--TVKDLIGFGLQVAKGMKY 148
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD---------TAARLHSTRVL 240
           L  K     VHRD+ + N +L + F  K+ADF L     D         T A+L      
Sbjct: 149 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL------ 199
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
               + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 200 -PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/313 (22%), Positives = 125/313 (39%), Gaps = 39/313 (12%)
Query: 56  PQIKLDELNRLTSNFGTKALIGEGSYGRVF---YAKLTDGTPAAIKKLDTSSAPEPESDF 112
           P    D+     ++   K  +G G YG V+   + K +        K DT    E    F
Sbjct: 2   PSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----F 57
Query: 113 AAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPV 170
             + +V+  +KH + V+LLG C       ++ +F T G+L D L    R+ V       V
Sbjct: 58  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAV----V 113
Query: 171 LTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT 230
           L +     +A   +  +E+L +K     +HRD+ + N L+ ++   K+ADF L+   +  
Sbjct: 114 LLY-----MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 165
Query: 231 AARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQS 289
               H+        + APE     + + KSDV++FGV+L E+ T G  P           
Sbjct: 166 TXTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY---------- 214
Query: 290 LVTWATPRLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQ 349
                 P +   +V + ++     + P             C Q+    RP+   + +A +
Sbjct: 215 ------PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 268
Query: 350 PLLNSKPAGPEAQ 362
            +        E +
Sbjct: 269 TMFQESSISDEVE 281

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 98/222 (44%), Gaps = 40/222 (18%)
Query: 75  LIGEGSYGRVFYAKLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +IG G +G V++  L D        A+K L+  +     S F  +  ++    H + + L
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 131 LGYCMESNNR-ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK--VAYG--AAK 185
           LG C+ S    ++V  +   G L + +               T N  VK  + +G   AK
Sbjct: 89  LGICLRSEGSPLVVLPYMKHGDLRNFIRNE------------THNPTVKDLIGFGLQVAK 136
Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD---------TAARLHS 236
           G+++L  K     VHRD+ + N +L + F  K+ADF L     D         T A+L  
Sbjct: 137 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL-- 191
Query: 237 TRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
                   + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 192 -----PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 75  LIGEGSYGRVFYAKLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +IG G +G V++  L D        A+K L+  +     S F  +  ++    H + + L
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 131 LGYCMESNNR-ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           LG C+ S    ++V  +   G L      R  ++     P  T    +      AKG+++
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNP--TVKDLIGFGLQVAKGMKY 166
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD---------TAARLHSTRVL 240
           L  K     VHRD+ + N +L + F  K+ADF L     D         T A+L      
Sbjct: 167 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL------ 217
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
               + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 218 -PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 105/209 (50%), Gaps = 19/209 (9%)
Query: 76  IGEGSYGRV---FYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           +G G++G V    Y         AIK L   +      +   +  ++ +L + + V L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
            C ++   +LV + A  G LH  L G++     E  PV   +   ++ +  + G+++L E
Sbjct: 78  VC-QAEALMLVMEMAGGGPLHKFLVGKR-----EEIPV---SNVAELLHQVSMGMKYLEE 128
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEY 250
           K     VHRD+ + NVLL +   +KI+DF L+ ++       ++ R  G +   ++APE 
Sbjct: 129 K---NFVHRDLAARNVLLVNRHYAKISDFGLS-KALGADDSYYTARSAGKWPLKWYAPEC 184
Query: 251 AMTGQITQKSDVYSFGVVLLELLT-GRKP 278
               + + +SDV+S+GV + E L+ G+KP
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 75  LIGEGSYGRVFYAKLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +IG G +G V++  L D        A+K L+  +     S F  +  ++    H + + L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 131 LGYCMESNNR-ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           LG C+ S    ++V  +   G L      R  ++     P  T    +      AKG+++
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNP--TVKDLIGFGLQVAKGMKY 146
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD---------TAARLHSTRVL 240
           L  K     VHRD+ + N +L + F  K+ADF L     D         T A+L      
Sbjct: 147 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL------ 197
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
               + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 198 -PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 116/293 (39%), Gaps = 33/293 (11%)
Query: 68  SNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK 123
           +N     ++G G +G V   +L          AIK L      +   DF  + S++ +  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           H + + L G   +S   ++V ++   GSL   L               T  Q V +  G 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVIQLVGMLRGI 156
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT- 242
           A G+++L +      VHRD+ + N+L+  +   K++DF L     D     ++TR     
Sbjct: 157 ASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + +PE     + T  SDV+S+G+VL E+++ G +P              W    +S  
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W---EMSNQ 257
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNS 354
            V + VD       P             C Q + + RP    +V  L  L+ +
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 75  LIGEGSYGRVFYAKLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +IG G +G V++  L D        A+K L+  +     S F  +  ++    H + + L
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 131 LGYCMESNNR-ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           LG C+ S    ++V  +   G L      R  ++     P  T    +      AKG+++
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNP--TVKDLIGFGLQVAKGMKY 167
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD---------TAARLHSTRVL 240
           L  K     VHRD+ + N +L + F  K+ADF L     D         T A+L      
Sbjct: 168 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL------ 218
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
               + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 219 -PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 76  IGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IGEGS G V  A + + G   A+KK+D       E  F  ++ ++   +HE+ VE+    
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHENVVEMYNSY 86
Query: 135 MESNNRILVYQFATMGSLHDVL-HGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
           +  +   +V +F   G+L D++ H R           +   Q   V     + L  LH +
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIAAVCLAVLQALSVLHAQ 135
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               ++HRD++S ++LL  D + K++DF    Q S    R     ++GT  + APE    
Sbjct: 136 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISR 190
Query: 254 GQITQKSDVYSFGVVLLELLTGRKP 278
                + D++S G++++E++ G  P
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 75  LIGEGSYGRVFYAKLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +IG G +G V++  L D        A+K L+  +     S F  +  ++    H + + L
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 131 LGYCMESNNR-ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           LG C+ S    ++V  +   G L      R  ++     P  T    +      AKG+++
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNP--TVKDLIGFGLQVAKGMKY 145
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD---------TAARLHSTRVL 240
           L  K     VHRD+ + N +L + F  K+ADF L     D         T A+L      
Sbjct: 146 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL------ 196
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
               + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 197 -PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 75  LIGEGSYGRVFYAKLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +IG G +G V++  L D        A+K L+  +     S F  +  ++    H + + L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 131 LGYCMESNNR-ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           LG C+ S    ++V  +   G L      R  ++     P  T    +      AKG+++
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNP--TVKDLIGFGLQVAKGMKY 147
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD---------TAARLHSTRVL 240
           L  K     VHRD+ + N +L + F  K+ADF L     D         T A+L      
Sbjct: 148 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL------ 198
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
               + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 199 -PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 75  LIGEGSYGRVFYAKLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +IG G +G V++  L D        A+K L+  +     S F  +  ++    H + + L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 131 LGYCMESNNR-ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           LG C+ S    ++V  +   G L      R  ++     P  T    +      AKG+++
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNP--TVKDLIGFGLQVAKGMKY 148
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD---------TAARLHSTRVL 240
           L  K     VHRD+ + N +L + F  K+ADF L     D         T A+L      
Sbjct: 149 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL------ 199
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
               + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 200 -PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 76  IGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IGEGS G V  A + + G   A+KK+D       E  F  ++ ++   +HE+ VE+    
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHENVVEMYNSY 90
Query: 135 MESNNRILVYQFATMGSLHDVL-HGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
           +  +   +V +F   G+L D++ H R           +   Q   V     + L  LH +
Sbjct: 91  LVGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIAAVCLAVLQALSVLHAQ 139
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               ++HRD++S ++LL  D + K++DF    Q S    R     ++GT  + APE    
Sbjct: 140 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISR 194
Query: 254 GQITQKSDVYSFGVVLLELLTGRKP 278
                + D++S G++++E++ G  P
Sbjct: 195 LPYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 75  LIGEGSYGRVFYAKLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +IG G +G V++  L D        A+K L+  +     S F  +  ++    H + + L
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 131 LGYCMESNNR-ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           LG C+ S    ++V  +   G L      R  ++     P  T    +      AKG+++
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNP--TVKDLIGFGLQVAKGMKY 143
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD---------TAARLHSTRVL 240
           L  K     VHRD+ + N +L + F  K+ADF L     D         T A+L      
Sbjct: 144 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL------ 194
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
               + A E   T + T KSDV+SFGV+L EL+T   P
Sbjct: 195 -PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 113/246 (45%), Gaps = 24/246 (9%)
Query: 76  IGEGSYGRVFYAKLTDGTP---AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           IG+GS+G VF  K  D       AIK +D   A +   D   +++V+S+    +  +  G
Sbjct: 31  IGKGSFGEVF--KGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYG 88
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
             ++ +   ++ ++   GS  D+L           GP   + Q   +     KGL++LH 
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALDLLRA---------GPFDEF-QIATMLKEILKGLDYLHS 138
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           + +   +HRD++++NVLL +    K+ADF +  Q +DT  ++     +GT  + APE   
Sbjct: 139 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKRNTFVGTPFWMAPEVIQ 193
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT-PRLSED---KVKQCVD 308
                 K+D++S G+  +EL  G  P     P     L+     P L  D     K+ +D
Sbjct: 194 QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFID 253
Query: 309 PKLNND 314
             LN D
Sbjct: 254 ACLNKD 259

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 17/217 (7%)
Query: 68  SNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK 123
           +N     ++G G +G V   +L          AIK L      +   DF  + S++ +  
Sbjct: 16  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 75
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           H + + L G   +S   ++V +    GSL   L               T  Q V +  G 
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ--------FTVIQLVGMLRGI 127
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT- 242
           A G+++L +      VHRD+ + N+L+  +   K++DF L+    D     ++TR     
Sbjct: 128 ASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 184
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
             + +PE     + T  SDV+S+G+VL E+++ G +P
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/306 (22%), Positives = 124/306 (40%), Gaps = 35/306 (11%)
Query: 61  DELNRLTSNFGTKALIGEGSYGRVF---YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLS 117
           D+     ++   K  +G G YG V+   + K +        K DT    E    F  + +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAA 61
Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV 177
           V+  +KH + V+LLG C       ++ +F T G+L D L  R+  +      VL +    
Sbjct: 62  VMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLY---- 115
Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
            +A   +  +E+L +K     +HRD+ + N L+ ++   K+ADF L+   +      H+ 
Sbjct: 116 -MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171
Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATP 296
                  + APE     + + KSDV++FGV+L E+ T G  P                 P
Sbjct: 172 AKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY----------------P 214
Query: 297 RLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKP 356
            +   +V + ++     + P             C Q+    RP+   + +A + +     
Sbjct: 215 GIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274
Query: 357 AGPEAQ 362
              E +
Sbjct: 275 ISDEVE 280

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 108/236 (45%), Gaps = 32/236 (13%)
Query: 59  KLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTP------AAIKKLDTSSAPEPESDF 112
           KL E++     F  +  +GE  +G+V+   L    P       AIK L   +      +F
Sbjct: 2   KLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEF 59
Query: 113 AAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGR------------K 160
             +  + +RL+H + V LLG   +     +++ + + G LH+ L  R            +
Sbjct: 60  RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119
Query: 161 GVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD 220
            V+ A   P       V +    A G+E+L       +VH+D+ + NVL++D    KI+D
Sbjct: 120 TVKSALEPPDF-----VHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISD 171
Query: 221 FNLTNQ--SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
             L  +  ++D    L ++  L    + APE  M G+ +  SD++S+GVVL E+ +
Sbjct: 172 LGLFREVYAADYYKLLGNS--LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/306 (22%), Positives = 124/306 (40%), Gaps = 35/306 (11%)
Query: 61  DELNRLTSNFGTKALIGEGSYGRVF---YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLS 117
           D+     ++   K  +G G YG V+   + K +        K DT    E    F  + +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAA 61
Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV 177
           V+  +KH + V+LLG C       ++ +F T G+L D L  R+  +      VL +    
Sbjct: 62  VMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLY---- 115
Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
            +A   +  +E+L +K     +HRD+ + N L+ ++   K+ADF L+   +      H+ 
Sbjct: 116 -MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171
Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATP 296
                  + APE     + + KSDV++FGV+L E+ T G  P                 P
Sbjct: 172 AKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY----------------P 214
Query: 297 RLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKP 356
            +   +V + ++     + P             C Q+    RP+   + +A + +     
Sbjct: 215 GIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274
Query: 357 AGPEAQ 362
              E +
Sbjct: 275 ISDEVE 280

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 39/228 (17%)
Query: 79  GSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESN 138
           G +G V+ A+L +    A+K          ++++  ++  +  +KHE+ ++ +G      
Sbjct: 35  GRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIGAEKRGT 91
Query: 139 ----NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
               +  L+  F   GSL D L             V++WN+   +A   A+GL +LHE +
Sbjct: 92  SVDVDLWLITAFHEKGSLSDFLKAN----------VVSWNELCHIAETMARGLAYLHEDI 141
Query: 195 -------QPPIVHRDVRSSNVLLFDDFKSKIADFNLT--NQSSDTAARLHSTRVLGTFGY 245
                  +P I HRD++S NVLL ++  + IADF L    ++  +A   H    +GT  Y
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ--VGTRRY 199
Query: 246 HAPEYAMTGQIT------QKSDVYSFGVVLLELLT----GRKPVDHTM 283
            APE  + G I        + D+Y+ G+VL EL +       PVD  M
Sbjct: 200 MAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/306 (22%), Positives = 124/306 (40%), Gaps = 35/306 (11%)
Query: 61  DELNRLTSNFGTKALIGEGSYGRVF---YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLS 117
           D+     ++   K  +G G YG V+   + K +        K DT    E    F  + +
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAA 66
Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV 177
           V+  +KH + V+LLG C       ++ +F T G+L D L  R+  +      VL +    
Sbjct: 67  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLY---- 120
Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
            +A   +  +E+L +K     +HRD+ + N L+ ++   K+ADF L+   +      H+ 
Sbjct: 121 -MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 176
Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATP 296
                  + APE     + + KSDV++FGV+L E+ T G  P                 P
Sbjct: 177 AKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY----------------P 219
Query: 297 RLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKP 356
            +   +V + ++     + P             C Q+    RP+   + +A + +     
Sbjct: 220 GIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 279
Query: 357 AGPEAQ 362
              E +
Sbjct: 280 ISDEVE 285

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 116/293 (39%), Gaps = 33/293 (11%)
Query: 68  SNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK 123
           +N     ++G G +G V   +L          AIK L      +   DF  + S++ +  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           H + + L G   +S   ++V +    GSL   L               T  Q V +  G 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ--------FTVIQLVGMLRGI 156
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT- 242
           A G+++L +      VHRD+ + N+L+  +   K++DF L+    D     ++TR     
Sbjct: 157 ASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + +PE     + T  SDV+S+G+VL E+++ G +P              W    +S  
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W---EMSNQ 257
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNS 354
            V + VD       P             C Q + + RP    +V  L  L+ +
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 75  LIGEGSYGRVFYAKLT--DGTP--AAIK--KLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           ++GEG +G V    L   DGT    A+K  KLD SS  E E +F ++ + +    H + +
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIE-EFLSEAACMKDFSHPNVI 99
Query: 129 ELLGYCMESNNR-----ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
            LLG C+E +++     +++  F   G LH  L   +   G +  P+ T    +K     
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT---LLKFMVDI 156
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
           A G+E+L  +     +HRD+ + N +L DD    +ADF L+ +                 
Sbjct: 157 ALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 213
Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
            + A E       T KSDV++FGV + E+ T
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 116/293 (39%), Gaps = 33/293 (11%)
Query: 68  SNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK 123
           +N     ++G G +G V   +L          AIK L      +   DF  + S++ +  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           H + + L G   +S   ++V +    GSL   L               T  Q V +  G 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ--------FTVIQLVGMLRGI 156
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT- 242
           A G+++L +      VHRD+ + N+L+  +   K++DF L+    D     ++TR     
Sbjct: 157 ASGMKYLSDM---GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
             + +PE     + T  SDV+S+G+VL E+++ G +P              W    +S  
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W---EMSNQ 257
Query: 302 KVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNS 354
            V + VD       P             C Q + + RP    +V  L  L+ +
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/306 (22%), Positives = 124/306 (40%), Gaps = 35/306 (11%)
Query: 61  DELNRLTSNFGTKALIGEGSYGRVF---YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLS 117
           D+     ++   K  +G G YG V+   + K +        K DT    E    F  + +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAA 61
Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV 177
           V+  +KH + V+LLG C       ++ +F T G+L D L  R+  +      VL +    
Sbjct: 62  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLY---- 115
Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
            +A   +  +E+L +K     +HRD+ + N L+ ++   K+ADF L+   +      H+ 
Sbjct: 116 -MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171
Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATP 296
                  + APE     + + KSDV++FGV+L E+ T G  P                 P
Sbjct: 172 AKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY----------------P 214
Query: 297 RLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKP 356
            +   +V + ++     + P             C Q+    RP+   + +A + +     
Sbjct: 215 GIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274
Query: 357 AGPEAQ 362
              E +
Sbjct: 275 ISDEVE 280

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 130/301 (43%), Gaps = 33/301 (10%)
Query: 47  PQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSA 105
           PQKAL    P +  + L    +NF  +  IG G +  V+ A  L DG P A+KK+     
Sbjct: 18  PQKALR---PDMGYNTL----ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL 70
Query: 106 PEPES--DFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQ 163
            + ++  D   ++ ++ +L H + ++     +E N   +V + A  G L  ++   K  +
Sbjct: 71  MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK 130
Query: 164 GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL 223
              P   + W   V++       LE +H +    ++HRD++ +NV +      K+ D  L
Sbjct: 131 RLIPERTV-WKYFVQLC----SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGL 182
Query: 224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTM 283
               S      HS  ++GT  Y +PE         KSD++S G +L E+   + P     
Sbjct: 183 GRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----F 236
Query: 284 PKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTI 343
              + +L +         K++QC  P L +D+              C+  + + RP++T 
Sbjct: 237 YGDKMNLYSLCK------KIEQCDYPPLPSDH---YSEELRQLVNMCINPDPEKRPDVTY 287
Query: 344 V 344
           V
Sbjct: 288 V 288

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 112/246 (45%), Gaps = 33/246 (13%)
Query: 55  IPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFA 113
           + +I L  L      F    L+G G+YG+V+  + +  G  AAIK +D +   + E +  
Sbjct: 11  LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIK 68
Query: 114 AQLSVVSRLKH-EHFVELLGYCMESN------NRILVYQFATMGSLHDVLHGRKGVQGAE 166
            +++++ +  H  +     G  ++ N         LV +F   GS+ D++   KG    E
Sbjct: 69  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 128
Query: 167 PGPVLTWNQRVKVAY---GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL 223
                 W     +AY      +GL  LH   Q  ++HRD++  NVLL ++ + K+ DF +
Sbjct: 129 -----EW-----IAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGV 175
Query: 224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQ-----ITQKSDVYSFGVVLLELLTGRKP 278
           + Q   T  R ++   +GT  + APE     +        KSD++S G+  +E+  G  P
Sbjct: 176 SAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
Query: 279 VDHTMP 284
           +    P
Sbjct: 234 LCDMHP 239

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 25/222 (11%)
Query: 67  TSNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
            S    + +IG G +G V   +L          AIK L      +   DF  + S++ + 
Sbjct: 42  ASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQF 101
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            H + V L G        ++V +F   G+L   L    G          T  Q V +  G
Sbjct: 102 DHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDG--------QFTVIQLVGMLRG 153
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            A G+ +L +      VHRD+ + N+L+  +   K++DF L+    D    +++T    T
Sbjct: 154 IAAGMRYLADM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTT----T 206
Query: 243 FG-----YHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
            G     + APE     + T  SDV+S+G+V+ E+++ G +P
Sbjct: 207 GGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/308 (22%), Positives = 124/308 (40%), Gaps = 39/308 (12%)
Query: 61  DELNRLTSNFGTKALIGEGSYGRVF---YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLS 117
           D+     ++   K  +G G YG V+   + K +        K DT    E    F  + +
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAA 66
Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQ 175
           V+  +KH + V+LLG C       ++ +F T G+L D L    R+ V       VL +  
Sbjct: 67  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLY-- 120
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
              +A   +  +E+L +K     +HRD+ + N L+ ++   K+ADF L+   +      H
Sbjct: 121 ---MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 174
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWA 294
           +        + APE     + + KSDV++FGV+L E+ T G  P                
Sbjct: 175 AGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY--------------- 218
Query: 295 TPRLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNS 354
            P +   +V + ++     + P             C Q+    RP+   + +A + +   
Sbjct: 219 -PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 277
Query: 355 KPAGPEAQ 362
                E +
Sbjct: 278 SSISDEVE 285

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/308 (22%), Positives = 124/308 (40%), Gaps = 39/308 (12%)
Query: 61  DELNRLTSNFGTKALIGEGSYGRVF---YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLS 117
           D+     ++   K  +G G YG V+   + K +        K DT    E    F  + +
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAA 63
Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQ 175
           V+  +KH + V+LLG C       ++ +F T G+L D L    R+ V       VL +  
Sbjct: 64  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLY-- 117
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
              +A   +  +E+L +K     +HRD+ + N L+ ++   K+ADF L+   +      H
Sbjct: 118 ---MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 171
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWA 294
           +        + APE     + + KSDV++FGV+L E+ T G  P                
Sbjct: 172 AGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY--------------- 215
Query: 295 TPRLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNS 354
            P +   +V + ++     + P             C Q+    RP+   + +A + +   
Sbjct: 216 -PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 274
Query: 355 KPAGPEAQ 362
                E +
Sbjct: 275 SSISDEVE 282

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 27/210 (12%)
Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTS--SAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           IG GS+G V++A+ + +    AIKK+  S   + E   D   ++  + +L+H + ++  G
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 133 YCMESNNRILVYQFATMGSLHDVLH-GRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
             +  +   LV ++  +GS  D+L   +K +Q  E   V          +GA +GL +LH
Sbjct: 122 CYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAV---------THGALQGLAYLH 171
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA 251
                 ++HRDV++ N+LL +    K+ DF     S+   A   +   +GT  + APE  
Sbjct: 172 SH---NMIHRDVKAGNILLSEPGLVKLGDFG----SASIMAP--ANXFVGTPYWMAPEVI 222
Query: 252 MT---GQITQKSDVYSFGVVLLELLTGRKP 278
           +    GQ   K DV+S G+  +E L  RKP
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIE-LAERKP 251

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/308 (22%), Positives = 124/308 (40%), Gaps = 39/308 (12%)
Query: 61  DELNRLTSNFGTKALIGEGSYGRVF---YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLS 117
           D+     ++   K  +G G YG V+   + K +        K DT    E    F  + +
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAA 63
Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQ 175
           V+  +KH + V+LLG C       ++ +F T G+L D L    R+ V       VL +  
Sbjct: 64  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLY-- 117
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
              +A   +  +E+L +K     +HRD+ + N L+ ++   K+ADF L+   +      H
Sbjct: 118 ---MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 171
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWA 294
           +        + APE     + + KSDV++FGV+L E+ T G  P                
Sbjct: 172 AGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY--------------- 215
Query: 295 TPRLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNS 354
            P +   +V + ++     + P             C Q+    RP+   + +A + +   
Sbjct: 216 -PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 274
Query: 355 KPAGPEAQ 362
                E +
Sbjct: 275 SSISDEVE 282

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/286 (22%), Positives = 115/286 (40%), Gaps = 35/286 (12%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V Y K       AIK +   S  E E  F  +  V+  L HE  V+L G C 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE--FIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           +     ++ ++   G L + L         E        Q +++     + +E+L  K  
Sbjct: 75  KQRPIFIITEYMANGCLLNYLR--------EMRHRFQTQQLLEMCKDVCEAMEYLESK-- 124
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAMT 253
              +HRD+ + N L+ D    K++DF L+    D     +++ V   F   +  PE  M 
Sbjct: 125 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMY 180
Query: 254 GQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLN 312
            + + KSD+++FGV++ E+ + G+ P +                R +  +  + +   L 
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPYE----------------RFTNSETAEHIAQGLR 224
Query: 313 NDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKPAG 358
              P             C   +AD RP   I++  +  +++    G
Sbjct: 225 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDENLYG 270

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/306 (22%), Positives = 124/306 (40%), Gaps = 35/306 (11%)
Query: 61  DELNRLTSNFGTKALIGEGSYGRVF---YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLS 117
           D+     ++   K  +G G YG V+   + K +        K DT    E    F  + +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAA 61
Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV 177
           V+  +KH + V+LLG C       ++ +F T G+L D L  R+  +      VL     +
Sbjct: 62  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVL-----L 114
Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
            +A   +  +E+L +K     +HRD+ + N L+ ++   K+ADF L+   +      H+ 
Sbjct: 115 YMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171
Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATP 296
                  + APE     + + KSDV++FGV+L E+ T G  P                 P
Sbjct: 172 AKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY----------------P 214
Query: 297 RLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKP 356
            +   +V + ++     + P             C Q+    RP+   + +A + +     
Sbjct: 215 GIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274
Query: 357 AGPEAQ 362
              E +
Sbjct: 275 ISDEVE 280

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/283 (22%), Positives = 115/283 (40%), Gaps = 35/283 (12%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V Y K       AIK +   S  E E  F  +  V+  L HE  V+L G C 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE--FIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           +     ++ ++   G L + L         E        Q +++     + +E+L  K  
Sbjct: 90  KQRPIFIITEYMANGCLLNYLR--------EMRHRFQTQQLLEMCKDVCEAMEYLESK-- 139
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAMT 253
              +HRD+ + N L+ D    K++DF L+    D     +++ V   F   +  PE  M 
Sbjct: 140 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMY 195
Query: 254 GQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLN 312
            + + KSD+++FGV++ E+ + G+ P +                R +  +  + +   L 
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYE----------------RFTNSETAEHIAQGLR 239
Query: 313 NDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSK 355
              P             C   +AD RP   I++  +  +++ +
Sbjct: 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 27/210 (12%)
Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTS--SAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           IG GS+G V++A+ + +    AIKK+  S   + E   D   ++  + +L+H + ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 133 YCMESNNRILVYQFATMGSLHDVLH-GRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
             +  +   LV ++  +GS  D+L   +K +Q  E   V          +GA +GL +LH
Sbjct: 83  CYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAV---------THGALQGLAYLH 132
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA 251
                 ++HRDV++ N+LL +    K+ DF     S+   A   +   +GT  + APE  
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFG----SASIMAP--ANXFVGTPYWMAPEVI 183
Query: 252 MT---GQITQKSDVYSFGVVLLELLTGRKP 278
           +    GQ   K DV+S G+  +E L  RKP
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIE-LAERKP 212

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 27/244 (11%)
Query: 76  IGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG+G+ G V+ A  +  G   AI++++    P+ E     ++ V+   K+ + V  L   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIVNYLDSY 86
Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
           +  +   +V ++   GSL DV+      +G          Q   V     + LEFLH   
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEG----------QIAAVCRECLQALEFLHSN- 135
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              ++HRD++S N+LL  D   K+ DF    Q +   ++   + ++GT  + APE     
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSEMVGTPYWMAPEVVTRK 191
Query: 255 QITQKSDVYSFGVVLLELLTGRKPVDHTMP-KGQQSLVTWATPRLS---------EDKVK 304
               K D++S G++ +E++ G  P  +  P +    + T  TP L           D + 
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251
Query: 305 QCVD 308
           +C+D
Sbjct: 252 RCLD 255

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 22/224 (9%)
Query: 56  PQIKLDELNRLTSNFGTKALIGEGSYGRVF---YAKLTDGTPAAIKKLDTSSAPEPESDF 112
           P    D+     ++   K  +G G YG V+   + K +        K DT    E    F
Sbjct: 5   PSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----F 60
Query: 113 AAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPV 170
             + +V+  +KH + V+LLG C       ++ +F T G+L D L    R+ V       V
Sbjct: 61  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV----V 116
Query: 171 LTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT 230
           L     + +A   +  +E+L +K     +HRD+ + N L+ ++   K+ADF L+   +  
Sbjct: 117 L-----LYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168
Query: 231 AARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
               H+        + APE     + + KSDV++FGV+L E+ T
Sbjct: 169 TYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 22/219 (10%)
Query: 61  DELNRLTSNFGTKALIGEGSYGRVF---YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLS 117
           D+     ++   K  +G G YG V+   + K +        K DT    E    F  + +
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAA 66
Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQ 175
           V+  +KH + V+LLG C       ++ +F T G+L D L    R+ V       VL    
Sbjct: 67  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV----VL---- 118
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
            + +A   +  +E+L +K     +HRD+ + N L+ ++   K+ADF L+   +      H
Sbjct: 119 -LYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAH 174
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
           +        + APE     + + KSDV++FGV+L E+ T
Sbjct: 175 AGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 107/244 (43%), Gaps = 26/244 (10%)
Query: 52  PIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYA------KLTDGTPAAIKKLDTSSA 105
           P ++P  +  E  R    FG    +G G++G+V  A      K       A+K L +++ 
Sbjct: 17  PTQLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 74
Query: 106 PEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLH------- 157
            + +    ++L ++S L +HE+ V LLG C      +++ ++   G L + L        
Sbjct: 75  ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAML 134
Query: 158 GRKGVQGAEP-------GPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL 210
           G     G +P       G  L     +  +   A+G+ FL  K     +HRDV + NVLL
Sbjct: 135 GPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLL 191
Query: 211 FDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLL 270
            +   +KI DF L     + +  +          + APE       T +SDV+S+G++L 
Sbjct: 192 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW 251
Query: 271 ELLT 274
           E+ +
Sbjct: 252 EIFS 255

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/283 (22%), Positives = 115/283 (40%), Gaps = 35/283 (12%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V Y K       AIK +   S  E E  F  +  V+  L HE  V+L G C 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE--FIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           +     ++ ++   G L + L         E        Q +++     + +E+L  K  
Sbjct: 81  KQRPIFIITEYMANGCLLNYLR--------EMRHRFQTQQLLEMCKDVCEAMEYLESK-- 130
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAMT 253
              +HRD+ + N L+ D    K++DF L+    D     +++ V   F   +  PE  M 
Sbjct: 131 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMY 186
Query: 254 GQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLN 312
            + + KSD+++FGV++ E+ + G+ P +                R +  +  + +   L 
Sbjct: 187 SKFSSKSDIWAFGVLMWEIYSLGKMPYE----------------RFTNSETAEHIAQGLR 230
Query: 313 NDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSK 355
              P             C   +AD RP   I++  +  +++ +
Sbjct: 231 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 273

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 70/308 (22%), Positives = 124/308 (40%), Gaps = 39/308 (12%)
Query: 61  DELNRLTSNFGTKALIGEGSYGRVF---YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLS 117
           D+     ++   K  +G G YG V+   + K +        K DT    E    F  + +
Sbjct: 19  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAA 74
Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQ 175
           V+  +KH + V+LLG C       ++ +F T G+L D L    R+ V       VL +  
Sbjct: 75  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLY-- 128
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
              +A   +  +E+L +K     +HRD+ + N L+ ++   K+ADF L+   +      H
Sbjct: 129 ---MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 182
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWA 294
           +        + APE     + + KSDV++FGV+L E+ T G  P                
Sbjct: 183 AGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY--------------- 226
Query: 295 TPRLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNS 354
            P +   +V + ++     + P             C Q+    RP+   + +A + +   
Sbjct: 227 -PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 285
Query: 355 KPAGPEAQ 362
                E +
Sbjct: 286 SSISDEVE 293

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 106/221 (47%), Gaps = 29/221 (13%)
Query: 68  SNFGTKALIGEGSYGRVFYAKLTDGTPA----AIKKLDTSSAPEPESDFAAQLSVVSRLK 123
           S F    ++G+GS+G+VF  K   G+ A    A+K L             A L V  R++
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK-----------KATLKVRDRVR 72
Query: 124 HEHFVELLGYCMESNNRILV---YQFATMGSLHDVLHGRKG--VQGAEPGPVLTWNQRVK 178
            +   ++L   +E N+  +V   Y F T G L+ +L   +G  +       V+   + VK
Sbjct: 73  TKMERDIL---VEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK 129
Query: 179 VAYGA-AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
                 A  L+ LH      I++RD++  N+LL ++   K+ DF L+ +S D   + +S 
Sbjct: 130 FYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS- 185
Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
              GT  Y APE       TQ +D +SFGV++ E+LTG  P
Sbjct: 186 -FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 75  LIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +IG G +G V    L          AIK L +    +   DF ++ S++ +  H + + L
Sbjct: 14  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 73
Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
            G   +S   +++ +F   GSL   L    G          T  Q V +  G A G+++L
Sbjct: 74  EGVVTKSTPVMIITEFMENGSLDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYL 125
Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT---FGYHA 247
            +      VHR + + N+L+  +   K++DF L+    D  +    T  LG      + A
Sbjct: 126 ADM---NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 182
Query: 248 PEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
           PE     + T  SDV+S+G+V+ E+++ G +P
Sbjct: 183 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 214

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 22/219 (10%)
Query: 61  DELNRLTSNFGTKALIGEGSYGRVF---YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLS 117
           D+     ++   K  +G G YG V+   + K +        K DT    E    F  + +
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAA 66
Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQ 175
           V+  +KH + V+LLG C       ++ +F T G+L D L    R+ V       VL    
Sbjct: 67  VMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAV----VL---- 118
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
            + +A   +  +E+L +K     +HRD+ + N L+ ++   K+ADF L+   +      H
Sbjct: 119 -LYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 174
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
           +        + APE     + + KSDV++FGV+L E+ T
Sbjct: 175 AGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 117/252 (46%), Gaps = 27/252 (10%)
Query: 76  IGEGSYGRVF--YAKLTDGTPAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELL 131
           +G G++G V   Y ++         K+  + A +P  + +  A+ +V+ +L + + V ++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G C E+ + +LV + A +G L+  L   + V+             +++ +  + G+++L 
Sbjct: 79  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI---------IELVHQVSMGMKYLE 128
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ-SSDTAARLHSTRVLGTFGYHAPEY 250
           E      VHRD+ + NVLL     +KI+DF L+    +D       T       ++APE 
Sbjct: 129 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPEC 185
Query: 251 AMTGQITQKSDVYSFGVVLLELLT-GRKP--------VDHTMPKGQQSLVTWATPRLSED 301
               + + KSDV+SFGV++ E  + G+KP        V   + KG++       PR   D
Sbjct: 186 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 245
Query: 302 KVKQCVDPKLNN 313
            +  C    + N
Sbjct: 246 LMNLCWTYDVEN 257

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 109/244 (44%), Gaps = 27/244 (11%)
Query: 76  IGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG+G+ G V+ A  +  G   AI++++    P+ E     ++ V+   K+ + V  L   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIVNYLDSY 86
Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
           +  +   +V ++   GSL DV+      +G          Q   V     + LEFLH   
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEG----------QIAAVCRECLQALEFLHSN- 135
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              ++HRD++S N+LL  D   K+ DF    Q +   ++  ST V GT  + APE     
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMV-GTPYWMAPEVVTRK 191
Query: 255 QITQKSDVYSFGVVLLELLTGRKPVDHTMP-KGQQSLVTWATPRLS---------EDKVK 304
               K D++S G++ +E++ G  P  +  P +    + T  TP L           D + 
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251
Query: 305 QCVD 308
           +C+D
Sbjct: 252 RCLD 255

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/284 (22%), Positives = 114/284 (40%), Gaps = 37/284 (13%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V Y K       AIK +   S  E E  F  +  V+  L HE  V+L G C 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE--FIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           +     ++ ++   G L + L         E        Q +++     + +E+L  K  
Sbjct: 90  KQRPIFIITEYMANGCLLNYLR--------EMRHRFQTQQLLEMCKDVCEAMEYLESK-- 139
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT---FGYHAPEYAM 252
              +HRD+ + N L+ D    K++DF L+    D       T  +G+     +  PE  M
Sbjct: 140 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD----EETSSVGSKFPVRWSPPEVLM 194
Query: 253 TGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKL 311
             + + KSD+++FGV++ E+ + G+ P +                R +  +  + +   L
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMPYE----------------RFTNSETAEHIAQGL 238
Query: 312 NNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSK 355
               P             C   +AD RP   I++  +  +++ +
Sbjct: 239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 22/219 (10%)
Query: 61  DELNRLTSNFGTKALIGEGSYGRVF---YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLS 117
           D+     ++   K  +G G YG V+   + K +        K DT    E    F  + +
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAA 66
Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQ 175
           V+  +KH + V+LLG C       ++ +F T G+L D L    R+ V       VL    
Sbjct: 67  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV----VL---- 118
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
            + +A   +  +E+L +K     +HRD+ + N L+ ++   K+ADF L+   +      H
Sbjct: 119 -LYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 174
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
           +        + APE     + + KSDV++FGV+L E+ T
Sbjct: 175 AGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 106/221 (47%), Gaps = 29/221 (13%)
Query: 68  SNFGTKALIGEGSYGRVFYAKLTDGTPA----AIKKLDTSSAPEPESDFAAQLSVVSRLK 123
           S F    ++G+GS+G+VF  K   G+ A    A+K L             A L V  R++
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK-----------ATLKVRDRVR 73
Query: 124 HEHFVELLGYCMESNNRILV---YQFATMGSLHDVLHGRKG--VQGAEPGPVLTWNQRVK 178
            +   ++L   +E N+  +V   Y F T G L+ +L   +G  +       V+   + VK
Sbjct: 74  TKMERDIL---VEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK 130
Query: 179 VAYGA-AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
                 A  L+ LH      I++RD++  N+LL ++   K+ DF L+ +S D   + +S 
Sbjct: 131 FYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS- 186
Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
              GT  Y APE       TQ +D +SFGV++ E+LTG  P
Sbjct: 187 -FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 106/221 (47%), Gaps = 29/221 (13%)
Query: 68  SNFGTKALIGEGSYGRVFYAKLTDGTPA----AIKKLDTSSAPEPESDFAAQLSVVSRLK 123
           S F    ++G+GS+G+VF  K   G+ A    A+K L             A L V  R++
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK-----------KATLKVRDRVR 72
Query: 124 HEHFVELLGYCMESNNRILV---YQFATMGSLHDVLHGRKG--VQGAEPGPVLTWNQRVK 178
            +   ++L   +E N+  +V   Y F T G L+ +L   +G  +       V+   + VK
Sbjct: 73  TKMERDIL---VEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK 129
Query: 179 VAYGA-AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
                 A  L+ LH      I++RD++  N+LL ++   K+ DF L+ +S D   + +S 
Sbjct: 130 FYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS- 185
Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
              GT  Y APE       TQ +D +SFGV++ E+LTG  P
Sbjct: 186 -FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/283 (22%), Positives = 115/283 (40%), Gaps = 35/283 (12%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V Y K       AIK +   S  E E  F  +  V+  L HE  V+L G C 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE--FIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           +     ++ ++   G L + L         E        Q +++     + +E+L  K  
Sbjct: 74  KQRPIFIITEYMANGCLLNYLR--------EMRHRFQTQQLLEMCKDVCEAMEYLESK-- 123
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAMT 253
              +HRD+ + N L+ D    K++DF L+    D     +++ V   F   +  PE  M 
Sbjct: 124 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMY 179
Query: 254 GQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLN 312
            + + KSD+++FGV++ E+ + G+ P +                R +  +  + +   L 
Sbjct: 180 SKFSSKSDIWAFGVLMWEIYSLGKMPYE----------------RFTNSETAEHIAQGLR 223
Query: 313 NDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSK 355
              P             C   +AD RP   I++  +  +++ +
Sbjct: 224 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 266

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 117/252 (46%), Gaps = 27/252 (10%)
Query: 76  IGEGSYGRVF--YAKLTDGTPAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELL 131
           +G G++G V   Y ++         K+  + A +P  + +  A+ +V+ +L + + V ++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G C E+ + +LV + A +G L+  L   + V+             +++ +  + G+++L 
Sbjct: 95  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---------KNIIELVHQVSMGMKYLE 144
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ-SSDTAARLHSTRVLGTFGYHAPEY 250
           E      VHRD+ + NVLL     +KI+DF L+    +D       T       ++APE 
Sbjct: 145 ES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 201
Query: 251 AMTGQITQKSDVYSFGVVLLELLT-GRKP--------VDHTMPKGQQSLVTWATPRLSED 301
               + + KSDV+SFGV++ E  + G+KP        V   + KG++       PR   D
Sbjct: 202 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 261
Query: 302 KVKQCVDPKLNN 313
            +  C    + N
Sbjct: 262 LMNLCWTYDVEN 273

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 117/252 (46%), Gaps = 27/252 (10%)
Query: 76  IGEGSYGRVF--YAKLTDGTPAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELL 131
           +G G++G V   Y ++         K+  + A +P  + +  A+ +V+ +L + + V ++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G C E+ + +LV + A +G L+  L   + V+             +++ +  + G+++L 
Sbjct: 95  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---------KNIIELVHQVSMGMKYLE 144
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ-SSDTAARLHSTRVLGTFGYHAPEY 250
           E      VHRD+ + NVLL     +KI+DF L+    +D       T       ++APE 
Sbjct: 145 ES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 201
Query: 251 AMTGQITQKSDVYSFGVVLLELLT-GRKP--------VDHTMPKGQQSLVTWATPRLSED 301
               + + KSDV+SFGV++ E  + G+KP        V   + KG++       PR   D
Sbjct: 202 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 261
Query: 302 KVKQCVDPKLNN 313
            +  C    + N
Sbjct: 262 LMNLCWTYDVEN 273

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 18/225 (8%)
Query: 76  IGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG+G+ G V+ A  +  G   AI++++    P+ E     ++ V+   K+ + V  L   
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIVNYLDSY 87
Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
           +  +   +V ++   GSL DV+      +G          Q   V     + LEFLH   
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVVTETCMDEG----------QIAAVCRECLQALEFLHSN- 136
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              ++HRD++S N+LL  D   K+ DF    Q +   ++   + ++GT  + APE     
Sbjct: 137 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPEVVTRK 192
Query: 255 QITQKSDVYSFGVVLLELLTGRKPVDHTMP-KGQQSLVTWATPRL 298
               K D++S G++ +E++ G  P  +  P +    + T  TP L
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL 237

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 117/252 (46%), Gaps = 27/252 (10%)
Query: 76  IGEGSYGRVF--YAKLTDGTPAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELL 131
           +G G++G V   Y ++         K+  + A +P  + +  A+ +V+ +L + + V ++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G C E+ + +LV + A +G L+  L   + V+             +++ +  + G+++L 
Sbjct: 79  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI---------IELVHQVSMGMKYLE 128
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ-SSDTAARLHSTRVLGTFGYHAPEY 250
           E      VHRD+ + NVLL     +KI+DF L+    +D       T       ++APE 
Sbjct: 129 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 185
Query: 251 AMTGQITQKSDVYSFGVVLLELLT-GRKP--------VDHTMPKGQQSLVTWATPRLSED 301
               + + KSDV+SFGV++ E  + G+KP        V   + KG++       PR   D
Sbjct: 186 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 245
Query: 302 KVKQCVDPKLNN 313
            +  C    + N
Sbjct: 246 LMNLCWTYDVEN 257

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 18/225 (8%)
Query: 76  IGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG+G+ G V+ A  +  G   AI++++    P+ E     ++ V+   K+ + V  L   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIVNYLDSY 86
Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
           +  +   +V ++   GSL DV+      +G          Q   V     + LEFLH   
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEG----------QIAAVCRECLQALEFLHSN- 135
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              ++HRD++S N+LL  D   K+ DF    Q +   ++   + ++GT  + APE     
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPEVVTRK 191
Query: 255 QITQKSDVYSFGVVLLELLTGRKPVDHTMP-KGQQSLVTWATPRL 298
               K D++S G++ +E++ G  P  +  P +    + T  TP L
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL 236

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 117/252 (46%), Gaps = 27/252 (10%)
Query: 76  IGEGSYGRVF--YAKLTDGTPAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELL 131
           +G G++G V   Y ++         K+  + A +P  + +  A+ +V+ +L + + V ++
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G C E+ + +LV + A +G L+  L   + V+             +++ +  + G+++L 
Sbjct: 437 GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---------KNIIELVHQVSMGMKYLE 486
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ-SSDTAARLHSTRVLGTFGYHAPEY 250
           E      VHRD+ + NVLL     +KI+DF L+    +D       T       ++APE 
Sbjct: 487 ES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 543
Query: 251 AMTGQITQKSDVYSFGVVLLELLT-GRKP--------VDHTMPKGQQSLVTWATPRLSED 301
               + + KSDV+SFGV++ E  + G+KP        V   + KG++       PR   D
Sbjct: 544 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 603
Query: 302 KVKQCVDPKLNN 313
            +  C    + N
Sbjct: 604 LMNLCWTYDVEN 615

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 13/138 (9%)
Query: 142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHR 201
           +V ++    +L D++H          GP +T  + ++V   A + L F H   Q  I+HR
Sbjct: 93  IVMEYVDGVTLRDIVHTE--------GP-MTPKRAIEVIADACQALNFSH---QNGIIHR 140
Query: 202 DVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR-VLGTFGYHAPEYAMTGQITQKS 260
           DV+ +N+L+      K+ DF +    +D+   +  T  V+GT  Y +PE A    +  +S
Sbjct: 141 DVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARS 200
Query: 261 DVYSFGVVLLELLTGRKP 278
           DVYS G VL E+LTG  P
Sbjct: 201 DVYSLGCVLYEVLTGEPP 218

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 117/252 (46%), Gaps = 27/252 (10%)
Query: 76  IGEGSYGRVF--YAKLTDGTPAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELL 131
           +G G++G V   Y ++         K+  + A +P  + +  A+ +V+ +L + + V ++
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G C E+ + +LV + A +G L+  L   + V+             +++ +  + G+++L 
Sbjct: 93  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---------KNIIELVHQVSMGMKYLE 142
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ-SSDTAARLHSTRVLGTFGYHAPEY 250
           E      VHRD+ + NVLL     +KI+DF L+    +D       T       ++APE 
Sbjct: 143 ES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 199
Query: 251 AMTGQITQKSDVYSFGVVLLELLT-GRKP--------VDHTMPKGQQSLVTWATPRLSED 301
               + + KSDV+SFGV++ E  + G+KP        V   + KG++       PR   D
Sbjct: 200 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 259
Query: 302 KVKQCVDPKLNN 313
            +  C    + N
Sbjct: 260 LMNLCWTYDVEN 271

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 22/219 (10%)
Query: 61  DELNRLTSNFGTKALIGEGSYGRVF---YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLS 117
           D+     ++   K  +G G YG V+   + K +        K DT    E    F  + +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAA 61
Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQ 175
           V+  +KH + V+LLG C       ++ +F T G+L D L    R+ V       VL    
Sbjct: 62  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV----VL---- 113
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
            + +A   +  +E+L +K     +HRD+ + N L+ ++   K+ADF L+   +      H
Sbjct: 114 -LYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 169
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
           +        + APE     + + KSDV++FGV+L E+ T
Sbjct: 170 AGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 117/252 (46%), Gaps = 27/252 (10%)
Query: 76  IGEGSYGRVF--YAKLTDGTPAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELL 131
           +G G++G V   Y ++         K+  + A +P  + +  A+ +V+ +L + + V ++
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G C E+ + +LV + A +G L+  L   + V+             +++ +  + G+++L 
Sbjct: 438 GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---------KNIIELVHQVSMGMKYLE 487
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ-SSDTAARLHSTRVLGTFGYHAPEY 250
           E      VHRD+ + NVLL     +KI+DF L+    +D       T       ++APE 
Sbjct: 488 ES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 544
Query: 251 AMTGQITQKSDVYSFGVVLLELLT-GRKP--------VDHTMPKGQQSLVTWATPRLSED 301
               + + KSDV+SFGV++ E  + G+KP        V   + KG++       PR   D
Sbjct: 545 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 604
Query: 302 KVKQCVDPKLNN 313
            +  C    + N
Sbjct: 605 LMNLCWTYDVEN 616

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 117/252 (46%), Gaps = 27/252 (10%)
Query: 76  IGEGSYGRVF--YAKLTDGTPAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELL 131
           +G G++G V   Y ++         K+  + A +P  + +  A+ +V+ +L + + V ++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G C E+ + +LV + A +G L+  L   + V+             +++ +  + G+++L 
Sbjct: 85  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI---------IELVHQVSMGMKYLE 134
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ-SSDTAARLHSTRVLGTFGYHAPEY 250
           E      VHRD+ + NVLL     +KI+DF L+    +D       T       ++APE 
Sbjct: 135 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 191
Query: 251 AMTGQITQKSDVYSFGVVLLELLT-GRKP--------VDHTMPKGQQSLVTWATPRLSED 301
               + + KSDV+SFGV++ E  + G+KP        V   + KG++       PR   D
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 251
Query: 302 KVKQCVDPKLNN 313
            +  C    + N
Sbjct: 252 LMNLCWTYDVEN 263

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 15/206 (7%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V   K       A+K +   S  E E  F  +   + +L H   V+  G C 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE--FFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           +     +V ++ + G L + L  R   +G EP      +Q +++ Y   +G+ FL     
Sbjct: 74  KEYPIYIVTEYISNGCLLNYL--RSHGKGLEP------SQLLEMCYDVCEGMAFLESH-- 123
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQ 255
              +HRD+ + N L+  D   K++DF +T    D    + S        + APE     +
Sbjct: 124 -QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VSSVGTKFPVKWSAPEVFHYFK 181
Query: 256 ITQKSDVYSFGVVLLELLT-GRKPVD 280
            + KSDV++FG+++ E+ + G+ P D
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMPYD 207

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 117/252 (46%), Gaps = 27/252 (10%)
Query: 76  IGEGSYGRVF--YAKLTDGTPAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELL 131
           +G G++G V   Y ++         K+  + A +P  + +  A+ +V+ +L + + V ++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G C E+ + +LV + A +G L+  L   + V+             +++ +  + G+++L 
Sbjct: 75  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI---------IELVHQVSMGMKYLE 124
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ-SSDTAARLHSTRVLGTFGYHAPEY 250
           E      VHRD+ + NVLL     +KI+DF L+    +D       T       ++APE 
Sbjct: 125 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 251 AMTGQITQKSDVYSFGVVLLELLT-GRKP--------VDHTMPKGQQSLVTWATPRLSED 301
               + + KSDV+SFGV++ E  + G+KP        V   + KG++       PR   D
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 241
Query: 302 KVKQCVDPKLNN 313
            +  C    + N
Sbjct: 242 LMNLCWTYDVEN 253

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/283 (22%), Positives = 115/283 (40%), Gaps = 35/283 (12%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V Y K       AIK +   S  E E  F  +  V+  L HE  V+L G C 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE--FIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           +     ++ ++   G L + L         E        Q +++     + +E+L  K  
Sbjct: 70  KQRPIFIITEYMANGCLLNYLR--------EMRHRFQTQQLLEMCKDVCEAMEYLESK-- 119
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEYAMT 253
              +HRD+ + N L+ D    K++DF L+    D     +++ V   F   +  PE  M 
Sbjct: 120 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMY 175
Query: 254 GQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLN 312
            + + KSD+++FGV++ E+ + G+ P +                R +  +  + +   L 
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYE----------------RFTNSETAEHIAQGLR 219
Query: 313 NDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSK 355
              P             C   +AD RP   I++  +  +++ +
Sbjct: 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 262

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 117/252 (46%), Gaps = 27/252 (10%)
Query: 76  IGEGSYGRVF--YAKLTDGTPAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELL 131
           +G G++G V   Y ++         K+  + A +P  + +  A+ +V+ +L + + V ++
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G C E+ + +LV + A +G L+  L   + V+             +++ +  + G+++L 
Sbjct: 73  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI---------IELVHQVSMGMKYLE 122
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ-SSDTAARLHSTRVLGTFGYHAPEY 250
           E      VHRD+ + NVLL     +KI+DF L+    +D       T       ++APE 
Sbjct: 123 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 179
Query: 251 AMTGQITQKSDVYSFGVVLLELLT-GRKP--------VDHTMPKGQQSLVTWATPRLSED 301
               + + KSDV+SFGV++ E  + G+KP        V   + KG++       PR   D
Sbjct: 180 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 239
Query: 302 KVKQCVDPKLNN 313
            +  C    + N
Sbjct: 240 LMNLCWTYDVEN 251

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/309 (22%), Positives = 125/309 (40%), Gaps = 41/309 (13%)
Query: 61  DELNRLTSNFGTKALIGEGSYGRVF---YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLS 117
           D+     ++   K  +G G YG V+   + K +        K DT    E    F  + +
Sbjct: 7   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAA 62
Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQ 175
           V+  +KH + V+LLG C       ++ +F T G+L D L    R+ V       VL +  
Sbjct: 63  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLY-- 116
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN-QSSDTAARL 234
              +A   +  +E+L +K     +HRD+ + N L+ ++   K+ADF L+   + DT    
Sbjct: 117 ---MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAP 170
Query: 235 HSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTW 293
              +      + APE     + + KSDV++FGV+L E+ T G  P               
Sbjct: 171 AGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-------------- 214
Query: 294 ATPRLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLN 353
             P +   +V + ++     + P             C Q+    RP+   + +A + +  
Sbjct: 215 --PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 272
Query: 354 SKPAGPEAQ 362
                 E +
Sbjct: 273 ESSISDEVE 281

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 22/219 (10%)
Query: 61  DELNRLTSNFGTKALIGEGSYGRVF---YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLS 117
           D+     ++   K  +G G YG V+   + K +        K DT    E    F  + +
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAA 61
Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQ 175
           V+  +KH + V+LLG C       ++ +F T G+L D L    R+ V       VL    
Sbjct: 62  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV----VL---- 113
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
            + +A   +  +E+L +K     +HRD+ + N L+ ++   K+ADF L+   +      H
Sbjct: 114 -LYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 169
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
           +        + APE     + + KSDV++FGV+L E+ T
Sbjct: 170 AGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 17/218 (7%)
Query: 67  TSNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
            S    + +IG G +G V   +L          AIK L      +   DF ++ S++ + 
Sbjct: 13  ASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQF 72
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            H + + L G   +    +++ ++   GSL   L    G          T  Q V +  G
Sbjct: 73  DHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR--------FTVIQLVGMLRG 124
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
              G+++L +      VHRD+ + N+L+  +   K++DF ++    D     ++TR    
Sbjct: 125 IGSGMKYLSDM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI 181
Query: 243 -FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
              + APE     + T  SDV+S+G+V+ E+++ G +P
Sbjct: 182 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/309 (22%), Positives = 125/309 (40%), Gaps = 41/309 (13%)
Query: 61  DELNRLTSNFGTKALIGEGSYGRVF---YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLS 117
           D+     ++   K  +G G YG V+   + K +        K DT    E    F  + +
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAA 63
Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQ 175
           V+  +KH + V+LLG C       ++ +F T G+L D L    R+ V       VL +  
Sbjct: 64  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLY-- 117
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN-QSSDTAARL 234
              +A   +  +E+L +K     +HRD+ + N L+ ++   K+ADF L+   + DT    
Sbjct: 118 ---MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAP 171
Query: 235 HSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTW 293
              +      + APE     + + KSDV++FGV+L E+ T G  P               
Sbjct: 172 AGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-------------- 215
Query: 294 ATPRLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLN 353
             P +   +V + ++     + P             C Q+    RP+   + +A + +  
Sbjct: 216 --PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 273
Query: 354 SKPAGPEAQ 362
                 E +
Sbjct: 274 ESSISDEVE 282

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 105/209 (50%), Gaps = 19/209 (9%)
Query: 76  IGEGSYGRV---FYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           +G G++G V    Y         AIK L   +      +   +  ++ +L + + V L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
            C ++   +LV + A  G LH  L G++     E  PV   +   ++ +  + G+++L E
Sbjct: 404 VC-QAEALMLVMEMAGGGPLHKFLVGKR-----EEIPV---SNVAELLHQVSMGMKYLEE 454
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF--GYHAPEY 250
           K     VHR++ + NVLL +   +KI+DF L+ ++       ++ R  G +   ++APE 
Sbjct: 455 K---NFVHRNLAARNVLLVNRHYAKISDFGLS-KALGADDSYYTARSAGKWPLKWYAPEC 510
Query: 251 AMTGQITQKSDVYSFGVVLLELLT-GRKP 278
               + + +SDV+S+GV + E L+ G+KP
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 17/218 (7%)
Query: 67  TSNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
            S    + +IG G +G V   +L          AIK L      +   DF ++ S++ + 
Sbjct: 7   ASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQF 66
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            H + + L G   +    +++ ++   GSL   L    G          T  Q V +  G
Sbjct: 67  DHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR--------FTVIQLVGMLRG 118
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
              G+++L +      VHRD+ + N+L+  +   K++DF ++    D     ++TR    
Sbjct: 119 IGSGMKYLSDM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI 175
Query: 243 -FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
              + APE     + T  SDV+S+G+V+ E+++ G +P
Sbjct: 176 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 97/217 (44%), Gaps = 17/217 (7%)
Query: 68  SNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK 123
           S    + +IG G +G V   +L          AIK L      +   DF ++ S++ +  
Sbjct: 29  SCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFD 88
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           H + + L G   +    +++ ++   GSL   L    G          T  Q V +  G 
Sbjct: 89  HPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR--------FTVIQLVGMLRGI 140
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT- 242
             G+++L +      VHRD+ + N+L+  +   K++DF ++    D     ++TR     
Sbjct: 141 GSGMKYLSDM---SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP 197
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
             + APE     + T  SDV+S+G+V+ E+++ G +P
Sbjct: 198 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 234

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 16/216 (7%)
Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +GEG+YG V  A  ++T+    A+K +D   A +   +   ++ + + L HE+ V+  G+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGH 73
Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             E N + L  ++ + G L D +    G+   EP     ++Q +        G+ +LH  
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGM--PEPDAQRFFHQLM-------AGVVYLH-- 122
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               I HRD++  N+LL +    KI+DF L              ++ GT  Y APE    
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 254 GQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ 288
            +   +  DV+S G+VL  +L G  P D      Q+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 16/209 (7%)
Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +GEG+YG V  A  ++T+    A+K +D   A +   +   ++ +   L HE+ V+  G+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             E N + L  ++ + G L D +    G+   EP     ++Q +        G+ +LH  
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGM--PEPDAQRFFHQLM-------AGVVYLH-- 122
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               I HRD++  N+LL +    KI+DF L              ++ GT  Y APE    
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 254 GQI-TQKSDVYSFGVVLLELLTGRKPVDH 281
            +   +  DV+S G+VL  +L G  P D 
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 16/209 (7%)
Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +GEG+YG V  A  ++T+    A+K +D   A +   +   ++ +   L HE+ V+  G+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             E N + L  ++ + G L D +    G+   EP     ++Q +        G+ +LH  
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGM--PEPDAQRFFHQLM-------AGVVYLH-- 122
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               I HRD++  N+LL +    KI+DF L              ++ GT  Y APE    
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 254 GQI-TQKSDVYSFGVVLLELLTGRKPVDH 281
            +   +  DV+S G+VL  +L G  P D 
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 16/209 (7%)
Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +GEG+YG V  A  ++T+    A+K +D   A +   +   ++ +   L HE+ V+  G+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             E N + L  ++ + G L D +    G+   EP     ++Q +        G+ +LH  
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGM--PEPDAQRFFHQLM-------AGVVYLH-- 122
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               I HRD++  N+LL +    KI+DF L              ++ GT  Y APE    
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 254 GQI-TQKSDVYSFGVVLLELLTGRKPVDH 281
            +   +  DV+S G+VL  +L G  P D 
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/308 (22%), Positives = 124/308 (40%), Gaps = 39/308 (12%)
Query: 61  DELNRLTSNFGTKALIGEGSYGRVF---YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLS 117
           D+     ++   K  +G G YG V+   + K +        K DT    E    F  + +
Sbjct: 252 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAA 307
Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQ 175
           V+  +KH + V+LLG C       ++ +F T G+L D L    R+ V       VL +  
Sbjct: 308 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV----VLLY-- 361
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
              +A   +  +E+L +K     +HR++ + N L+ ++   K+ADF L+   +      H
Sbjct: 362 ---MATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 415
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWA 294
           +        + APE     + + KSDV++FGV+L E+ T G  P                
Sbjct: 416 AGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY--------------- 459
Query: 295 TPRLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNS 354
            P +   +V + ++     + P             C Q+    RP+   + +A + +   
Sbjct: 460 -PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 518
Query: 355 KPAGPEAQ 362
                E +
Sbjct: 519 SSISDEVE 526

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 16/216 (7%)
Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +GEG+YG V  A  ++T+    A+K +D   A +   +   ++ +   L HE+ V+  G+
Sbjct: 13  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             E N + L  ++ + G L D +    G+   EP     ++Q +        G+ +LH  
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRIEPDIGM--PEPDAQRFFHQLM-------AGVVYLH-- 120
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               I HRD++  N+LL +    KI+DF L              ++ GT  Y APE    
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 254 GQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ 288
            +   +  DV+S G+VL  +L G  P D      Q+
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 215

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/306 (22%), Positives = 124/306 (40%), Gaps = 35/306 (11%)
Query: 61  DELNRLTSNFGTKALIGEGSYGRVF---YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLS 117
           D+     ++   K  +G G YG V+   + K +        K DT    E    F  + +
Sbjct: 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAA 268
Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV 177
           V+  +KH + V+LLG C       ++ +F T G+L D L  R+  +      VL +    
Sbjct: 269 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLY---- 322
Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
            +A   +  +E+L +K     +HR++ + N L+ ++   K+ADF L+   +      H+ 
Sbjct: 323 -MATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 378
Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATP 296
                  + APE     + + KSDV++FGV+L E+ T G  P                 P
Sbjct: 379 AKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY----------------P 421
Query: 297 RLSEDKVKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLNSKP 356
            +   +V + ++     + P             C Q+    RP+   + +A + +     
Sbjct: 422 GIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 481
Query: 357 AGPEAQ 362
              E +
Sbjct: 482 ISDEVE 487

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 66  LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKH 124
           ++S+F  K+L+GEG+YG V  A     G   AIKK++    P        ++ ++   KH
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKH 68
Query: 125 EHFVELLGY----CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
           E+ + +         E+ N + + Q      LH V+  +          +L+ +      
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ----------MLSDDHIQYFI 118
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL--------TNQSSDTAA 232
           Y   + ++ LH      ++HRD++ SN+L+  +   K+ DF L         + S  T  
Sbjct: 119 YQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 233 RLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPV 279
           +   T  + T  Y APE  +T  + ++  DV+S G +L EL   R+P+
Sbjct: 176 QSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 16/216 (7%)
Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +GEG+YG V  A  ++T+    A+K +D   A +   +   ++ +   L HE+ V+  G+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             E N + L  ++ + G L D +    G+   EP     ++Q +        G+ +LH  
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGM--PEPDAQRFFHQLM-------AGVVYLH-- 122
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               I HRD++  N+LL +    KI+DF L              ++ GT  Y APE    
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 254 GQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ 288
            +   +  DV+S G+VL  +L G  P D      Q+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 16/216 (7%)
Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +GEG+YG V  A  ++T+    A+K +D   A +   +   ++ +   L HE+ V+  G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             E N + L  ++ + G L D +    G+   EP     ++Q +        G+ +LH  
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGM--PEPDAQRFFHQLM-------AGVVYLH-- 121
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               I HRD++  N+LL +    KI+DF L              ++ GT  Y APE    
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 254 GQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ 288
            +   +  DV+S G+VL  +L G  P D      Q+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 66  LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKH 124
           ++S+F  K+L+GEG+YG V  A     G   AIKK++    P        ++ ++   KH
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKH 68
Query: 125 EHFVELLGY----CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
           E+ + +         E+ N + + Q      LH V+  +          +L+ +      
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ----------MLSDDHIQYFI 118
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL--------TNQSSDTAA 232
           Y   + ++ LH      ++HRD++ SN+L+  +   K+ DF L         + S  T  
Sbjct: 119 YQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 233 RLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPV 279
           +   T  + T  Y APE  +T  + ++  DV+S G +L EL   R+P+
Sbjct: 176 QSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 16/216 (7%)
Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +GEG+YG V  A  ++T+    A+K +D   A +   +   ++ +   L HE+ V+  G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             E N + L  ++ + G L D +    G+   EP     ++Q +        G+ +LH  
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGM--PEPDAQRFFHQLM-------AGVVYLH-- 121
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               I HRD++  N+LL +    KI+DF L              ++ GT  Y APE    
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 254 GQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ 288
            +   +  DV+S G+VL  +L G  P D      Q+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 16/216 (7%)
Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +GEG+YG V  A  ++T+    A+K +D   A +   +   ++ +   L HE+ V+  G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             E N + L  ++ + G L D +    G+   EP     ++Q +        G+ +LH  
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGM--PEPDAQRFFHQLM-------AGVVYLH-- 121
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               I HRD++  N+LL +    KI+DF L              ++ GT  Y APE    
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 254 GQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ 288
            +   +  DV+S G+VL  +L G  P D      Q+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 16/216 (7%)
Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +GEG+YG V  A  ++T+    A+K +D   A +   +   ++ +   L HE+ V+  G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             E N + L  ++ + G L D +    G+   EP     ++Q +        G+ +LH  
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGM--PEPDAQRFFHQLM-------AGVVYLH-- 121
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               I HRD++  N+LL +    KI+DF L              ++ GT  Y APE    
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 254 GQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ 288
            +   +  DV+S G+VL  +L G  P D      Q+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 16/216 (7%)
Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +GEG+YG V  A  ++T+    A+K +D   A +   +   ++ +   L HE+ V+  G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             E N + L  ++ + G L D +    G+   EP     ++Q +        G+ +LH  
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGM--PEPDAQRFFHQLM-------AGVVYLH-- 121
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               I HRD++  N+LL +    KI+DF L              ++ GT  Y APE    
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 254 GQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ 288
            +   +  DV+S G+VL  +L G  P D      Q+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 71/138 (51%), Gaps = 13/138 (9%)
Query: 142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHR 201
           +V ++    +L D++H          GP +T  + ++V   A + L F H   Q  I+HR
Sbjct: 93  IVMEYVDGVTLRDIVHTE--------GP-MTPKRAIEVIADACQALNFSH---QNGIIHR 140
Query: 202 DVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR-VLGTFGYHAPEYAMTGQITQKS 260
           DV+ +N+++      K+ DF +    +D+   +  T  V+GT  Y +PE A    +  +S
Sbjct: 141 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARS 200
Query: 261 DVYSFGVVLLELLTGRKP 278
           DVYS G VL E+LTG  P
Sbjct: 201 DVYSLGCVLYEVLTGEPP 218

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 16/216 (7%)
Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +GEG+YG V  A  ++T+    A+K +D   A +   +   ++ +   L HE+ V+  G+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             E N + L  ++ + G L D +    G+   EP     ++Q +        G+ +LH  
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGM--PEPDAQRFFHQLM-------AGVVYLH-- 122
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               I HRD++  N+LL +    KI+DF L              ++ GT  Y APE    
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 254 GQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ 288
            +   +  DV+S G+VL  +L G  P D      Q+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/282 (22%), Positives = 114/282 (40%), Gaps = 37/282 (13%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G +G V Y K       AIK +   S  E E  F  +  V+  L HE  V+L G C 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE--FIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           +     ++ ++   G L + L         E        Q +++     + +E+L  K  
Sbjct: 75  KQRPIFIITEYMANGCLLNYLR--------EMRHRFQTQQLLEMCKDVCEAMEYLESK-- 124
Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD---TAARLHSTRVLGTFGYHAPEYAM 252
              +HRD+ + N L+ D    K++DF L+    D   T++R     V     +  PE  M
Sbjct: 125 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPV----RWSPPEVLM 179
Query: 253 TGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKL 311
             + + KSD+++FGV++ E+ + G+ P +                R +  +  + +   L
Sbjct: 180 YSKFSSKSDIWAFGVLMWEIYSLGKMPYE----------------RFTNSETAEHIAQGL 223
Query: 312 NNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLLN 353
               P             C   +AD RP   I++  +  +++
Sbjct: 224 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 265

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 16/216 (7%)
Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +GEG+YG V  A  ++T+    A+K +D   A +   +   ++ +   L HE+ V+  G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             E N + L  ++ + G L D +    G+   EP     ++Q +        G+ +LH  
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGM--PEPDAQRFFHQLM-------AGVVYLH-- 121
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               I HRD++  N+LL +    KI+DF L              ++ GT  Y APE    
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 254 GQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ 288
            +   +  DV+S G+VL  +L G  P D      Q+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 71/138 (51%), Gaps = 13/138 (9%)
Query: 142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHR 201
           +V ++    +L D++H          GP +T  + ++V   A + L F H   Q  I+HR
Sbjct: 93  IVMEYVDGVTLRDIVHTE--------GP-MTPKRAIEVIADACQALNFSH---QNGIIHR 140
Query: 202 DVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR-VLGTFGYHAPEYAMTGQITQKS 260
           DV+ +N+++      K+ DF +    +D+   +  T  V+GT  Y +PE A    +  +S
Sbjct: 141 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARS 200
Query: 261 DVYSFGVVLLELLTGRKP 278
           DVYS G VL E+LTG  P
Sbjct: 201 DVYSLGCVLYEVLTGEPP 218

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 16/209 (7%)
Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +GEG+YG V  A  ++T+    A+K +D   A +   +   ++ +   L HE+ V+  G+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             E N + L  ++ + G L D +    G+   EP     ++Q +        G+ +LH  
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGM--PEPDAQRFFHQLM-------AGVVYLH-- 122
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               I HRD++  N+LL +    KI+DF L              ++ GT  Y APE    
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 254 GQI-TQKSDVYSFGVVLLELLTGRKPVDH 281
            +   +  DV+S G+VL  +L G  P D 
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 71/138 (51%), Gaps = 13/138 (9%)
Query: 142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHR 201
           +V ++    +L D++H          GP +T  + ++V   A + L F H   Q  I+HR
Sbjct: 93  IVMEYVDGVTLRDIVHTE--------GP-MTPKRAIEVIADACQALNFSH---QNGIIHR 140
Query: 202 DVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR-VLGTFGYHAPEYAMTGQITQKS 260
           DV+ +N+++      K+ DF +    +D+   +  T  V+GT  Y +PE A    +  +S
Sbjct: 141 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARS 200
Query: 261 DVYSFGVVLLELLTGRKP 278
           DVYS G VL E+LTG  P
Sbjct: 201 DVYSLGCVLYEVLTGEPP 218

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 71/138 (51%), Gaps = 13/138 (9%)
Query: 142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHR 201
           +V ++    +L D++H          GP +T  + ++V   A + L F H   Q  I+HR
Sbjct: 93  IVMEYVDGVTLRDIVHTE--------GP-MTPKRAIEVIADACQALNFSH---QNGIIHR 140
Query: 202 DVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR-VLGTFGYHAPEYAMTGQITQKS 260
           DV+ +N+++      K+ DF +    +D+   +  T  V+GT  Y +PE A    +  +S
Sbjct: 141 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARS 200
Query: 261 DVYSFGVVLLELLTGRKP 278
           DVYS G VL E+LTG  P
Sbjct: 201 DVYSLGCVLYEVLTGEPP 218

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 16/216 (7%)
Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +GEG+YG V  A  ++T+    A+K +D   A +   +   ++ +   L HE+ V+  G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             E N + L  ++ + G L D +    G+   EP     ++Q +        G+ +LH  
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGM--PEPDAQRFFHQLM-------AGVVYLH-- 121
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               I HRD++  N+LL +    KI+DF L              ++ GT  Y APE    
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 254 GQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ 288
            +   +  DV+S G+VL  +L G  P D      Q+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 16/216 (7%)
Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +GEG+YG V  A  ++T+    A+K +D   A +   +   ++ +   L HE+ V+  G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             E N + L  ++ + G L D +    G+   EP     ++Q +        G+ +LH  
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGM--PEPDAQRFFHQLM-------AGVVYLH-- 121
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               I HRD++  N+LL +    KI+DF L              ++ GT  Y APE    
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 254 GQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ 288
            +   +  DV+S G+VL  +L G  P D      Q+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 16/216 (7%)
Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +GEG+YG V  A  ++T+    A+K +D   A +   +   ++ +   L HE+ V+  G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             E N + L  ++ + G L D +    G+   EP     ++Q +        G+ +LH  
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGM--PEPDAQRFFHQLM-------AGVVYLH-- 121
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               I HRD++  N+LL +    KI+DF L              ++ GT  Y APE    
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 254 GQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ 288
            +   +  DV+S G+VL  +L G  P D      Q+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 16/216 (7%)
Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +GEG+YG V  A  ++T+    A+K +D   A +   +   ++ +   L HE+ V+  G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             E N + L  ++ + G L D +    G+   EP     ++Q +        G+ +LH  
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGM--PEPDAQRFFHQLM-------AGVVYLH-- 121
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               I HRD++  N+LL +    KI+DF L              ++ GT  Y APE    
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 254 GQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ 288
            +   +  DV+S G+VL  +L G  P D      Q+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQE 216

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 16/209 (7%)
Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +GEG+YG V  A  ++T+    A+K +D   A +   +   ++ +   L HE+ V+  G+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 73
Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             E N + L  ++ + G L D +    G+   EP     ++Q +        G+ +LH  
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGM--PEPDAQRFFHQLM-------AGVVYLH-- 122
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               I HRD++  N+LL +    KI+DF L              ++ GT  Y APE    
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 181
Query: 254 GQI-TQKSDVYSFGVVLLELLTGRKPVDH 281
            +   +  DV+S G+VL  +L G  P D 
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 18/225 (8%)
Query: 76  IGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG+G+ G V+ A  +  G   AI++++    P+ E     ++ V+   K+ + V  L   
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIVNYLDSY 87
Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
           +  +   +V ++   GSL DV+      +G          Q   V     + LEFLH   
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVVTETCMDEG----------QIAAVCRECLQALEFLHSN- 136
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              ++HR+++S N+LL  D   K+ DF    Q +   ++  ST V GT  + APE     
Sbjct: 137 --QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMV-GTPYWMAPEVVTRK 192
Query: 255 QITQKSDVYSFGVVLLELLTGRKPVDHTMP-KGQQSLVTWATPRL 298
               K D++S G++ +E++ G  P  +  P +    + T  TP L
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL 237

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 16/209 (7%)
Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +GEG+YG V  A  ++T+    A+K +D   A +   +   ++ +   L HE+ V+  G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             E N + L  ++ + G L D +    G+   EP     ++Q +        G+ +LH  
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGM--PEPDAQRFFHQLM-------AGVVYLH-- 121
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               I HRD++  N+LL +    KI+DF L              ++ GT  Y APE    
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 254 GQI-TQKSDVYSFGVVLLELLTGRKPVDH 281
            +   +  DV+S G+VL  +L G  P D 
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 20/213 (9%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 63
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            + V+LL      N   LV++F +M  L D +     + G  P P++         +   
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDA-SALTGI-PLPLIK-----SYLFQLL 115
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
           +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R +   V+ T  
Sbjct: 116 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-TLW 170
Query: 245 YHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
           Y APE  +  +    + D++S G +  E++T R
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 63  LNRLTSNFGTKAL-----IGEGSYGRV----FYAKLTDGTPAAIKKL--DTSSAPEPESD 111
           L  LT   G K L     +G+GS+G V    + A        A+K L  D  S PE   D
Sbjct: 8   LQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD 67
Query: 112 FAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVL 171
           F  +++ +  L H + + L G  +    + +V + A +GSL D L   +G          
Sbjct: 68  FIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH--------F 118
Query: 172 TWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN---QSS 228
                 + A   A+G+ +L  K     +HRD+ + N+LL      KI DF L     Q+ 
Sbjct: 119 LLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175
Query: 229 DTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
           D        +V   F + APE   T   +  SD + FGV L E+ T G++P
Sbjct: 176 DHXVMQEHRKV--PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 94/218 (43%), Gaps = 24/218 (11%)
Query: 75  LIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           ++G+G +G+       +     + K       E +  F  ++ V+  L+H + ++ +G  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            +      + ++   G+L  ++   K +    P     W+QRV  A   A G+ +LH   
Sbjct: 77  YKDKRLNFITEYIKGGTLRGII---KSMDSQYP-----WSQRVSFAKDIASGMAYLHSM- 127
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR------------VLGT 242
              I+HRD+ S N L+ ++    +ADF L     D   +    R            V+G 
Sbjct: 128 --NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
             + APE        +K DV+SFG+VL E++ GR   D
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNAD 222

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 71/138 (51%), Gaps = 13/138 (9%)
Query: 142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHR 201
           +V ++    +L D++H          GP +T  + ++V   A + L F H   Q  I+HR
Sbjct: 110 IVMEYVDGVTLRDIVHTE--------GP-MTPKRAIEVIADACQALNFSH---QNGIIHR 157
Query: 202 DVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR-VLGTFGYHAPEYAMTGQITQKS 260
           DV+ +N+++      K+ DF +    +D+   +  T  V+GT  Y +PE A    +  +S
Sbjct: 158 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARS 217
Query: 261 DVYSFGVVLLELLTGRKP 278
           DVYS G VL E+LTG  P
Sbjct: 218 DVYSLGCVLYEVLTGEPP 235

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 20/213 (9%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P +    ++S++  L H
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 64
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            + V+LL      N   LV++F +M  L D +     + G  P P++         +   
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDA-SALTGI-PLPLIK-----SYLFQLL 116
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
           +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R +   V+ T  
Sbjct: 117 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-TLW 171
Query: 245 YHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
           Y APE  +  +    + D++S G +  E++T R
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 103/233 (44%), Gaps = 26/233 (11%)
Query: 48  QKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP 106
           QKA   ++ ++K D+  R++        +G G+ G V   +    G   A K +     P
Sbjct: 6   QKA---KVGELKDDDFERISE-------LGAGNGGVVTKVQHRPSGLIMARKLIHLEIKP 55
Query: 107 EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE 166
              +    +L V+      + V   G         +  +    GSL  VL   K +    
Sbjct: 56  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRI---- 111
Query: 167 PGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ 226
           P  +L      KV+    +GL +L EK Q  I+HRDV+ SN+L+    + K+ DF ++ Q
Sbjct: 112 PEEILG-----KVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 164
Query: 227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPV 279
             D+ A       +GT  Y APE       + +SD++S G+ L+EL  GR P+
Sbjct: 165 LIDSMA----NSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLGYC 134
           +GEG+YG V+ AK + G   A+K++   +  E   S    ++S++  L H + V L+   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 135 MESNNRILVYQFATMGSLHDVLHGRK-GVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
                  LV++F     L  VL   K G+Q ++    L         Y   +G+   H  
Sbjct: 89  HSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYL---------YQLLRGVAHCH-- 136
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM- 252
            Q  I+HRD++  N+L+  D   K+ADF L  ++     R ++  V+ T  Y AP+  M 
Sbjct: 137 -QHRILHRDLKPQNLLINSDGALKLADFGLA-RAFGIPVRSYTHEVV-TLWYRAPDVLMG 193
Query: 253 TGQITQKSDVYSFGVVLLELLTGR 276
           + + +   D++S G +  E++TG+
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 25/221 (11%)
Query: 65  RLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLD-TSSAPEPESDFAAQLSVVSRL 122
           R   +F    LIG G +G+VF AK   DG    IK++   +   E E    A+L  V+ +
Sbjct: 8   RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIV 67
Query: 123 KHEHFVELLGYCMESNNR----------ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLT 172
            +    +   Y  E++++           +  +F   G+L   +  R+G +  +   +  
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 173 WNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA 232
           + Q         KG++++H K    +++RD++ SN+ L D  + KI DF L     +   
Sbjct: 128 FEQ-------ITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 177
Query: 233 RLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELL 273
           R  S    GT  Y +PE   +    ++ D+Y+ G++L ELL
Sbjct: 178 RXRSK---GTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLGYC 134
           +GEG+YG V+ AK + G   A+K++   +  E   S    ++S++  L H + V L+   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 135 MESNNRILVYQFATMGSLHDVLHGRK-GVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
                  LV++F     L  VL   K G+Q ++    L         Y   +G+   H  
Sbjct: 89  HSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYL---------YQLLRGVAHCH-- 136
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM- 252
            Q  I+HRD++  N+L+  D   K+ADF L  ++     R ++  V+ T  Y AP+  M 
Sbjct: 137 -QHRILHRDLKPQNLLINSDGALKLADFGLA-RAFGIPVRSYTHEVV-TLWYRAPDVLMG 193
Query: 253 TGQITQKSDVYSFGVVLLELLTGR 276
           + + +   D++S G +  E++TG+
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLD-TSSAPEPESDFAAQLSVVSRLKHEH 126
           N+  +  IG+G++ +V  A+ +  G   A+K +D T   P        ++ ++  L H +
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVL--HGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            V+L           LV ++A+ G + D L  HGR   + A       + Q V       
Sbjct: 76  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA----KFRQIVS------ 125
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
             +++ H+K    IVHRD+++ N+LL  D   KIADF  +N+ +    +L +    G+  
Sbjct: 126 -AVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFT-VGNKLDT--FCGSPP 178
Query: 245 YHAPEYAMTGQITQ-KSDVYSFGVVLLELLTGRKPVD 280
           Y APE     +    + DV+S GV+L  L++G  P D
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 66  LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKH 124
           ++S+F  K+L+GEG+YG V  A     G   AIKK++    P        ++ ++   KH
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKH 68
Query: 125 EHFVELLGY----CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
           E+ + +         E+ N + + Q      LH V+  +          +L+ +      
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ----------MLSDDHIQYFI 118
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA-------- 232
           Y   + ++ LH      ++HRD++ SN+L+  +   K+ DF L     ++AA        
Sbjct: 119 YQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 233 RLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPV 279
           +      + T  Y APE  +T  + ++  DV+S G +L EL   R+P+
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 63  LNRLTSNFGTKAL-----IGEGSYGRV----FYAKLTDGTPAAIKKL--DTSSAPEPESD 111
           L  LT   G K L     +G+GS+G V    + A        A+K L  D  S PE   D
Sbjct: 8   LQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD 67
Query: 112 FAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVL 171
           F  +++ +  L H + + L G  +    + +V + A +GSL D L   +G          
Sbjct: 68  FIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH--------F 118
Query: 172 TWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN---QSS 228
                 + A   A+G+ +L  K     +HRD+ + N+LL      KI DF L     Q+ 
Sbjct: 119 LLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175
Query: 229 DTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
           D        +V   F + APE   T   +  SD + FGV L E+ T G++P
Sbjct: 176 DHYVMQEHRKV--PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 87/208 (41%), Gaps = 18/208 (8%)
Query: 76  IGEGSYGRV----FYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
           IGEG +G V    + +        AIK     ++      F  +   + +  H H V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G   E N   ++ +  T+G L   L  RK          L     +  AY  +  L +L 
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFLQVRKFS--------LDLASLILYAYQLSTALAYLE 128
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA 251
            K     VHRD+ + NVL+  +   K+ DF L+    D+     S   L    + APE  
Sbjct: 129 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKL-PIKWMAPESI 184
Query: 252 MTGQITQKSDVYSFGVVLLELLT-GRKP 278
              + T  SDV+ FGV + E+L  G KP
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 138
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D  A   +TR      Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WYRA 190
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 138
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D  A   +TR      Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WYRA 190
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 76  IGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IGEGS G V  A +   G   A+KK+D       E  F  ++ ++    H++ V++    
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN-EVVIMRDYHHDNVVDMYSSY 111
Query: 135 MESNNRILVYQFATMGSLHDVL-HGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
           +  +   +V +F   G+L D++ H R           +   Q   V     + L +LH +
Sbjct: 112 LVGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIATVCLSVLRALSYLHNQ 160
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               ++HRD++S ++LL  D + K++DF    Q S    +     ++GT  + APE    
Sbjct: 161 ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKXLVGTPYWMAPEVISR 215
Query: 254 GQITQKSDVYSFGVVLLELLTGRKP 278
                + D++S G++++E++ G  P
Sbjct: 216 LPYGTEVDIWSLGIMVIEMIDGEPP 240

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 134
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D  A   +TR      Y A
Sbjct: 135 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WYRA 186
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 16/212 (7%)
Query: 69  NFGTKALIGEGSYGRVF-YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           +F   + +G G+ G VF  +    G   A K +     P   +    +L V+      + 
Sbjct: 69  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 128
Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
           V   G         +  +    GSL  VL       G  P  +L      KV+    KGL
Sbjct: 129 VGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILG-----KVSIAVIKGL 179
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
            +L EK +  I+HRDV+ SN+L+    + K+ DF ++ Q  D+ A       +GT  Y +
Sbjct: 180 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMS 233
Query: 248 PEYAMTGQITQKSDVYSFGVVLLELLTGRKPV 279
           PE       + +SD++S G+ L+E+  GR P+
Sbjct: 234 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 99/228 (43%), Gaps = 29/228 (12%)
Query: 66  LTSNFGTKAL-----IGEGSYGRV----FYAKLTDGTPAAIKKL--DTSSAPEPESDFAA 114
           LT   G K L     +G+GS+G V    + A        A+K L  D  S PE   DF  
Sbjct: 1   LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 60
Query: 115 QLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWN 174
           +++ +  L H + + L G  +    + +V + A +GSL D L   +G             
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH--------FLLG 111
Query: 175 QRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN---QSSDTA 231
              + A   A+G+ +L  K     +HRD+ + N+LL      KI DF L     Q+ D  
Sbjct: 112 TLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHX 168
Query: 232 ARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
                 +V   F + APE   T   +  SD + FGV L E+ T G++P
Sbjct: 169 VMQEHRKV--PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLD-TSSAPEPESDFAAQLSVVSRLKHEH 126
           N+     IG+G++ +V  A+ +  G   AIK +D T   P        ++ ++  L H +
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVL--HGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            V+L           L+ ++A+ G + D L  HGR   + A       + Q V       
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS----KFRQIVS------ 122
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
             +++ H+K    IVHRD+++ N+LL  D   KIADF  +N+ +    +L +    G+  
Sbjct: 123 -AVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT-VGGKLDT--FCGSPP 175
Query: 245 YHAPEYAMTGQITQ-KSDVYSFGVVLLELLTGRKPVD 280
           Y APE     +    + DV+S GV+L  L++G  P D
Sbjct: 176 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 99/228 (43%), Gaps = 29/228 (12%)
Query: 66  LTSNFGTKAL-----IGEGSYGRV----FYAKLTDGTPAAIKKL--DTSSAPEPESDFAA 114
           LT   G K L     +G+GS+G V    + A        A+K L  D  S PE   DF  
Sbjct: 5   LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 64
Query: 115 QLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWN 174
           +++ +  L H + + L G  +    + +V + A +GSL D L   +G             
Sbjct: 65  EVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH--------FLLG 115
Query: 175 QRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN---QSSDTA 231
              + A   A+G+ +L  K     +HRD+ + N+LL      KI DF L     Q+ D  
Sbjct: 116 TLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 172
Query: 232 ARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
                 +V   F + APE   T   +  SD + FGV L E+ T G++P
Sbjct: 173 VMQEHRKV--PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 101/239 (42%), Gaps = 21/239 (8%)
Query: 52  PIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYA------KLTDGTPAAIKKLDTSSA 105
           P ++P     E  R   +FG    +G G++G+V  A      K       A+K L  S+ 
Sbjct: 25  PTQLPYDHKWEFPRNRLSFGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 82
Query: 106 PEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLH-GRKGVQ 163
                   ++L V+S L  H + V LLG C      +++ ++   G L + L   R    
Sbjct: 83  LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 142
Query: 164 GAEPGPVLTWNQRV--------KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK 215
            ++  P +  +  +          +Y  AKG+ FL  K     +HRD+ + N+LL     
Sbjct: 143 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRI 199
Query: 216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
           +KI DF L     + +  +          + APE       T +SDV+S+G+ L EL +
Sbjct: 200 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 87/208 (41%), Gaps = 18/208 (8%)
Query: 76  IGEGSYGRV----FYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
           IGEG +G V    + +        AIK     ++      F  +   + +  H H V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G   E N   ++ +  T+G L   L  RK          L     +  AY  +  L +L 
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFLQVRKYS--------LDLASLILYAYQLSTALAYLE 128
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA 251
            K     VHRD+ + NVL+  +   K+ DF L+    D+     S   L    + APE  
Sbjct: 129 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESI 184
Query: 252 MTGQITQKSDVYSFGVVLLELLT-GRKP 278
              + T  SDV+ FGV + E+L  G KP
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 87/208 (41%), Gaps = 18/208 (8%)
Query: 76  IGEGSYGRV----FYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
           IGEG +G V    + +        AIK     ++      F  +   + +  H H V+L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G   E N   ++ +  T+G L   L  RK          L     +  AY  +  L +L 
Sbjct: 106 GVITE-NPVWIIMELCTLGELRSFLQVRKYS--------LDLASLILYAYQLSTALAYLE 156
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA 251
            K     VHRD+ + NVL+  +   K+ DF L+    D+     S   L    + APE  
Sbjct: 157 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESI 212
Query: 252 MTGQITQKSDVYSFGVVLLELLT-GRKP 278
              + T  SDV+ FGV + E+L  G KP
Sbjct: 213 NFRRFTSASDVWMFGVCMWEILMHGVKP 240

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 87/208 (41%), Gaps = 18/208 (8%)
Query: 76  IGEGSYGRV----FYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
           IGEG +G V    + +        AIK     ++      F  +   + +  H H V+L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G   E N   ++ +  T+G L   L  RK          L     +  AY  +  L +L 
Sbjct: 75  GVITE-NPVWIIMELCTLGELRSFLQVRKYS--------LDLASLILYAYQLSTALAYLE 125
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA 251
            K     VHRD+ + NVL+  +   K+ DF L+    D+     S   L    + APE  
Sbjct: 126 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESI 181
Query: 252 MTGQITQKSDVYSFGVVLLELLT-GRKP 278
              + T  SDV+ FGV + E+L  G KP
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKP 209

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 87/208 (41%), Gaps = 18/208 (8%)
Query: 76  IGEGSYGRV----FYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
           IGEG +G V    + +        AIK     ++      F  +   + +  H H V+L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G   E N   ++ +  T+G L   L  RK          L     +  AY  +  L +L 
Sbjct: 83  GVITE-NPVWIIMELCTLGELRSFLQVRKYS--------LDLASLILYAYQLSTALAYLE 133
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA 251
            K     VHRD+ + NVL+  +   K+ DF L+    D+     S   L    + APE  
Sbjct: 134 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESI 189
Query: 252 MTGQITQKSDVYSFGVVLLELLT-GRKP 278
              + T  SDV+ FGV + E+L  G KP
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILMHGVKP 217

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLD-TSSAPEPESDFAAQLSVVSRLKHEH 126
           N+     IG+G++ +V  A+ +  G   AIK +D T   P        ++ ++  L H +
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVL--HGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            V+L           L+ ++A+ G + D L  HGR   + A       + Q V       
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS----KFRQIVS------ 125
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
             +++ H+K    IVHRD+++ N+LL  D   KIADF  +N+ +    +L +    G   
Sbjct: 126 -AVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT-VGGKLDA--FCGAPP 178
Query: 245 YHAPEYAMTGQITQ-KSDVYSFGVVLLELLTGRKPVD 280
           Y APE     +    + DV+S GV+L  L++G  P D
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 87/208 (41%), Gaps = 18/208 (8%)
Query: 76  IGEGSYGRV----FYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
           IGEG +G V    + +        AIK     ++      F  +   + +  H H V+L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G   E N   ++ +  T+G L   L  RK          L     +  AY  +  L +L 
Sbjct: 81  GVITE-NPVWIIMELCTLGELRSFLQVRKYS--------LDLASLILYAYQLSTALAYLE 131
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA 251
            K     VHRD+ + NVL+  +   K+ DF L+    D+     S   L    + APE  
Sbjct: 132 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESI 187
Query: 252 MTGQITQKSDVYSFGVVLLELLT-GRKP 278
              + T  SDV+ FGV + E+L  G KP
Sbjct: 188 NFRRFTSASDVWMFGVCMWEILMHGVKP 215

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 101/239 (42%), Gaps = 21/239 (8%)
Query: 52  PIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYA------KLTDGTPAAIKKLDTSSA 105
           P ++P     E  R   +FG    +G G++G+V  A      K       A+K L  S+ 
Sbjct: 32  PTQLPYDHKWEFPRNRLSFGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 89
Query: 106 PEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLH-GRKGVQ 163
                   ++L V+S L  H + V LLG C      +++ ++   G L + L   R    
Sbjct: 90  LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 149
Query: 164 GAEPGPVLTWNQRV--------KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK 215
            ++  P +  +  +          +Y  AKG+ FL  K     +HRD+ + N+LL     
Sbjct: 150 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRI 206
Query: 216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
           +KI DF L     + +  +          + APE       T +SDV+S+G+ L EL +
Sbjct: 207 TKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 87/208 (41%), Gaps = 18/208 (8%)
Query: 76  IGEGSYGRV----FYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
           IGEG +G V    + +        AIK     ++      F  +   + +  H H V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G   E N   ++ +  T+G L   L  RK          L     +  AY  +  L +L 
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFLQVRKYS--------LDLASLILYAYQLSTALAYLE 128
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA 251
            K     VHRD+ + NVL+  +   K+ DF L+    D+     S   L    + APE  
Sbjct: 129 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESI 184
Query: 252 MTGQITQKSDVYSFGVVLLELLT-GRKP 278
              + T  SDV+ FGV + E+L  G KP
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 87/208 (41%), Gaps = 18/208 (8%)
Query: 76  IGEGSYGRV----FYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
           IGEG +G V    + +        AIK     ++      F  +   + +  H H V+L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G   E N   ++ +  T+G L   L  RK          L     +  AY  +  L +L 
Sbjct: 80  GVITE-NPVWIIMELCTLGELRSFLQVRKYS--------LDLASLILYAYQLSTALAYLE 130
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA 251
            K     VHRD+ + NVL+  +   K+ DF L+    D+     S   L    + APE  
Sbjct: 131 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESI 186
Query: 252 MTGQITQKSDVYSFGVVLLELLT-GRKP 278
              + T  SDV+ FGV + E+L  G KP
Sbjct: 187 NFRRFTSASDVWMFGVCMWEILMHGVKP 214

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 16/212 (7%)
Query: 69  NFGTKALIGEGSYGRVF-YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           +F   + +G G+ G VF  +    G   A K +     P   +    +L V+      + 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
           V   G         +  +    GSL  VL       G  P  +L      KV+    KGL
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILG-----KVSIAVIKGL 117
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
            +L EK +  I+HRDV+ SN+L+    + K+ DF ++ Q  D+ A       +GT  Y +
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMS 171
Query: 248 PEYAMTGQITQKSDVYSFGVVLLELLTGRKPV 279
           PE       + +SD++S G+ L+E+  GR P+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 17/213 (7%)
Query: 76  IGEGSYGRVFYA------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE-HFV 128
           +G G++G+V  A      K       A+K L   +         ++L ++  + H  + V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 129 ELLGYCMESNNRILVY-QFATMGSLHDVLHGRKGVQGAEPGP------VLTWNQRVKVAY 181
            LLG C +    ++V  +F   G+L   L  ++        P       LT    +  ++
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG 241
             AKG+EFL  +     +HRD+ + N+LL +    KI DF L          +       
Sbjct: 156 QVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
              + APE       T +SDV+SFGV+L E+ +
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 99/228 (43%), Gaps = 29/228 (12%)
Query: 66  LTSNFGTKAL-----IGEGSYGRV----FYAKLTDGTPAAIKKL--DTSSAPEPESDFAA 114
           LT   G K L     +G+GS+G V    + A        A+K L  D  S PE   DF  
Sbjct: 1   LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 60
Query: 115 QLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWN 174
           +++ +  L H + + L G  +    + +V + A +GSL D L   +G             
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH--------FLLG 111
Query: 175 QRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN---QSSDTA 231
              + A   A+G+ +L  K     +HRD+ + N+LL      KI DF L     Q+ D  
Sbjct: 112 TLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 168
Query: 232 ARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
                 +V   F + APE   T   +  SD + FGV L E+ T G++P
Sbjct: 169 VMQEHRKV--PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 16/212 (7%)
Query: 69  NFGTKALIGEGSYGRVF-YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           +F   + +G G+ G VF  +    G   A K +     P   +    +L V+      + 
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 93
Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
           V   G         +  +    GSL  VL       G  P  +L      KV+    KGL
Sbjct: 94  VGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILG-----KVSIAVIKGL 144
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
            +L EK +  I+HRDV+ SN+L+    + K+ DF ++ Q  D+ A       +GT  Y +
Sbjct: 145 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMS 198
Query: 248 PEYAMTGQITQKSDVYSFGVVLLELLTGRKPV 279
           PE       + +SD++S G+ L+E+  GR P+
Sbjct: 199 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 99/228 (43%), Gaps = 29/228 (12%)
Query: 66  LTSNFGTKAL-----IGEGSYGRV----FYAKLTDGTPAAIKKL--DTSSAPEPESDFAA 114
           LT   G K L     +G+GS+G V    + A        A+K L  D  S PE   DF  
Sbjct: 5   LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 64
Query: 115 QLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWN 174
           +++ +  L H + + L G  +    + +V + A +GSL D L   +G             
Sbjct: 65  EVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH--------FLLG 115
Query: 175 QRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN---QSSDTA 231
              + A   A+G+ +L  K     +HRD+ + N+LL      KI DF L     Q+ D  
Sbjct: 116 TLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 172
Query: 232 ARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
                 +V   F + APE   T   +  SD + FGV L E+ T G++P
Sbjct: 173 VMQEHRKV--PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 34/233 (14%)
Query: 65  RLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK 123
           R  ++F     +G G +G VF AK   D    AIK++   +          ++  +++L+
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 124 HEHFVELLGYCMESNN---------RILVY---QFATMGSLHDVLHGRKGVQGAEPGPVL 171
           H   V      +E N          ++ +Y   Q     +L D ++GR  ++  E    L
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 172 TWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT---NQSS 228
                  +    A+ +EFLH K    ++HRD++ SN+    D   K+ DF L    +Q  
Sbjct: 122 ------HIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 229 DTAARL--------HSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELL 273
           +    L        H+ +V GT  Y +PE       + K D++S G++L ELL
Sbjct: 173 EEQTVLTPMPAYARHTGQV-GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 101/239 (42%), Gaps = 21/239 (8%)
Query: 52  PIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYA------KLTDGTPAAIKKLDTSSA 105
           P ++P     E  R   +FG    +G G++G+V  A      K       A+K L  S+ 
Sbjct: 32  PTQLPYDHKWEFPRNRLSFGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 89
Query: 106 PEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLH-GRKGVQ 163
                   ++L V+S L  H + V LLG C      +++ ++   G L + L   R    
Sbjct: 90  LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 149
Query: 164 GAEPGPVLTWNQRV--------KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK 215
            ++  P +  +  +          +Y  AKG+ FL  K     +HRD+ + N+LL     
Sbjct: 150 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRI 206
Query: 216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
           +KI DF L     + +  +          + APE       T +SDV+S+G+ L EL +
Sbjct: 207 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 16/212 (7%)
Query: 69  NFGTKALIGEGSYGRVF-YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           +F   + +G G+ G VF  +    G   A K +     P   +    +L V+      + 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
           V   G         +  +    GSL  VL       G  P  +L      KV+    KGL
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILG-----KVSIAVIKGL 117
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
            +L EK +  I+HRDV+ SN+L+    + K+ DF ++ Q  D+ A       +GT  Y +
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMS 171
Query: 248 PEYAMTGQITQKSDVYSFGVVLLELLTGRKPV 279
           PE       + +SD++S G+ L+E+  GR P+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 16/212 (7%)
Query: 69  NFGTKALIGEGSYGRVF-YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           +F   + +G G+ G VF  +    G   A K +     P   +    +L V+      + 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
           V   G         +  +    GSL  VL       G  P  +L      KV+    KGL
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILG-----KVSIAVIKGL 117
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
            +L EK +  I+HRDV+ SN+L+    + K+ DF ++ Q  D+ A       +GT  Y +
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMS 171
Query: 248 PEYAMTGQITQKSDVYSFGVVLLELLTGRKPV 279
           PE       + +SD++S G+ L+E+  GR P+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 99/228 (43%), Gaps = 29/228 (12%)
Query: 66  LTSNFGTKAL-----IGEGSYGRV----FYAKLTDGTPAAIKKL--DTSSAPEPESDFAA 114
           LT   G K L     +G+GS+G V    + A        A+K L  D  S PE   DF  
Sbjct: 1   LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 60
Query: 115 QLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWN 174
           +++ +  L H + + L G  +    + +V + A +GSL D L   +G             
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH--------FLLG 111
Query: 175 QRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN---QSSDTA 231
              + A   A+G+ +L  K     +HRD+ + N+LL      KI DF L     Q+ D  
Sbjct: 112 TLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 168
Query: 232 ARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
                 +V   F + APE   T   +  SD + FGV L E+ T G++P
Sbjct: 169 VMQEHRKV--PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           IG G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 143
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 144 KYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRA 195
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G+G YG V+   L  G   A+K    SS  E       ++     L+H++ +  +   M
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIF--SSRDEQSWFRETEIYNTVLLRHDNILGFIASDM 72
Query: 136 ESNNR----ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
            S N      L+  +   GSL+D L      Q  EP   L      ++A  AA GL  LH
Sbjct: 73  TSRNSSTQLWLITHYHEHGSLYDFLQR----QTLEPHLAL------RLAVSAACGLAHLH 122
Query: 192 EKV-----QPPIVHRDVRSSNVLLFDDFKSKIADFNLT---NQSSDTAARLHSTRVLGTF 243
            ++     +P I HRD +S NVL+  + +  IAD  L    +Q SD     ++ RV GT 
Sbjct: 123 VEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV-GTK 181
Query: 244 GYHAPEYAMTGQIT-------QKSDVYSFGVVLLEL 272
            Y APE  +  QI        + +D+++FG+VL E+
Sbjct: 182 RYMAPE-VLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 114/283 (40%), Gaps = 31/283 (10%)
Query: 52  PIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYA------KLTDGTPAAIKKLDTSSA 105
           P ++P     E  R   +FG    +G G++G+V  A      K       A+K L  S+ 
Sbjct: 9   PTQLPYDHKWEFPRNRLSFGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 66
Query: 106 PEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLH-GRKGVQ 163
                   ++L V+S L  H + V LLG C      +++ ++   G L + L   R    
Sbjct: 67  LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 126
Query: 164 GAEPGPVLTWNQRV--------KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK 215
            ++  P +  +  +          +Y  AKG+ FL  K     +HRD+ + N+LL     
Sbjct: 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRI 183
Query: 216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTG 275
           +KI DF L     + +  +          + APE       T +SDV+S+G+ L EL + 
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243
Query: 276 RK------PVDHTMPK----GQQSLVTWATPRLSEDKVKQCVD 308
                   PVD    K    G + L     P    D +K C D
Sbjct: 244 GSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWD 286

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 145
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   ++D       T  + T  Y A
Sbjct: 146 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-----TGYVATRWYRA 197
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 101/239 (42%), Gaps = 21/239 (8%)
Query: 52  PIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYA------KLTDGTPAAIKKLDTSSA 105
           P ++P     E  R   +FG    +G G++G+V  A      K       A+K L  S+ 
Sbjct: 27  PTQLPYDHKWEFPRNRLSFGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 84
Query: 106 PEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLH-GRKGVQ 163
                   ++L V+S L  H + V LLG C      +++ ++   G L + L   R    
Sbjct: 85  LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 144
Query: 164 GAEPGPVLTWNQRV--------KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK 215
            ++  P +  +  +          +Y  AKG+ FL  K     +HRD+ + N+LL     
Sbjct: 145 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRI 201
Query: 216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
           +KI DF L     + +  +          + APE       T +SDV+S+G+ L EL +
Sbjct: 202 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 111/249 (44%), Gaps = 32/249 (12%)
Query: 41  VVKTGTPQKALPIEIPQIKLDELNR----LTSNFGTKALIGEGSYGRVFYAKLTD-GTPA 95
           +V  G+    +  E P     ELN+    +   +   + +G G+YG V  A  T  G   
Sbjct: 14  LVPRGSHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRV 73
Query: 96  AIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL-----GYCMESNNRILVYQFAT 148
           A+KKL     S    +  +  +L ++  +KHE+ + LL        +E  N + +     
Sbjct: 74  AVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM 132
Query: 149 MGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNV 208
              L++++  +K          LT +    + Y   +GL+++H      I+HRD++ SN+
Sbjct: 133 GADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNL 179
Query: 209 LLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGV 267
            + +D + KI DF L   + D      +TR      Y APE  +      Q  D++S G 
Sbjct: 180 AVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGC 234
Query: 268 VLLELLTGR 276
           ++ ELLTGR
Sbjct: 235 IMAELLTGR 243

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 145
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   ++D       T  + T  Y A
Sbjct: 146 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-----TGYVATRWYRA 197
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 102/234 (43%), Gaps = 38/234 (16%)
Query: 65  RLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLD-TSSAPEPESDFAAQLSVVSRL 122
           R   +F    LIG G +G+VF AK   DG    I+++   +   E E    A+L  V+ +
Sbjct: 9   RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIV 68
Query: 123 KHEHFVELLGY-------CMESNNR----------------ILVYQFATMGSLHDVLHGR 159
            +    +   Y        +ES++                  +  +F   G+L   +  R
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 160 KGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA 219
           +G +  +   +  + Q         KG++++H K    ++HRD++ SN+ L D  + KI 
Sbjct: 129 RGEKLDKVLALELFEQ-------ITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIG 178
Query: 220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELL 273
           DF L     +   R   TR  GT  Y +PE   +    ++ D+Y+ G++L ELL
Sbjct: 179 DFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 106/236 (44%), Gaps = 32/236 (13%)
Query: 54  EIPQIKLDELNR----LTSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAP 106
           E P     ELN+    +   +   A +G G+YG V  A  T  G   A+KKL     S  
Sbjct: 14  ERPTFYRQELNKTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 73
Query: 107 EPESDFAAQLSVVSRLKHEHFVELL-----GYCMESNNRILVYQFATMGSLHDVLHGRKG 161
             +  +  +L ++  +KHE+ + LL        +E  N + +        L++++  +K 
Sbjct: 74  HAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK- 131
Query: 162 VQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADF 221
                    LT +    + Y   +GL+++H      I+HRD++ SN+ + +D + KI DF
Sbjct: 132 ---------LTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDF 179
Query: 222 NLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
            L   + D       T  + T  Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 180 GLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 16/212 (7%)
Query: 69  NFGTKALIGEGSYGRVF-YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           +F   + +G G+ G VF  +    G   A K +     P   +    +L V+      + 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
           V   G         +  +    GSL  VL       G  P  +L      KV+    KGL
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILG-----KVSIAVIKGL 117
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
            +L EK +  I+HRDV+ SN+L+    + K+ DF ++ Q  D+ A       +GT  Y +
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMS 171
Query: 248 PEYAMTGQITQKSDVYSFGVVLLELLTGRKPV 279
           PE       + +SD++S G+ L+E+  GR P+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 16/212 (7%)
Query: 69  NFGTKALIGEGSYGRVF-YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           +F   + +G G+ G VF  +    G   A K +     P   +    +L V+      + 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
           V   G         +  +    GSL  VL       G  P  +L      KV+    KGL
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILG-----KVSIAVIKGL 117
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
            +L EK +  I+HRDV+ SN+L+    + K+ DF ++ Q  D+ A       +GT  Y +
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMS 171
Query: 248 PEYAMTGQITQKSDVYSFGVVLLELLTGRKPV 279
           PE       + +SD++S G+ L+E+  GR P+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 87/208 (41%), Gaps = 18/208 (8%)
Query: 76  IGEGSYGRV----FYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
           IGEG +G V    + +        AIK     ++      F  +   + +  H H V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G   E N   ++ +  T+G L   L  RK          L     +  AY  +  L +L 
Sbjct: 458 GVITE-NPVWIIMELCTLGELRSFLQVRKFS--------LDLASLILYAYQLSTALAYLE 508
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA 251
            K     VHRD+ + NVL+  +   K+ DF L+    D+     S   L    + APE  
Sbjct: 509 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESI 564
Query: 252 MTGQITQKSDVYSFGVVLLELLT-GRKP 278
              + T  SDV+ FGV + E+L  G KP
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKP 592

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 145
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   ++D      +TR      Y A
Sbjct: 146 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WYRA 197
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 138
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 190
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 191 PEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 20/213 (9%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 64
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            + V+LL      N   LV++F +M  L   +     + G  P P++         +   
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDA-SALTGI-PLPLIK-----SYLFQLL 116
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
           +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R +   V+ T  
Sbjct: 117 QGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-TLW 171
Query: 245 YHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
           Y APE  +  +    + D++S G +  E++T R
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 99
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 149
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 150 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 201
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 20/213 (9%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 62
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            + V+LL      N   LV++F +M  L   +     + G  P P++         +   
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDA-SALTGI-PLPLIK-----SYLFQLL 114
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
           +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R +   V+ T  
Sbjct: 115 QGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-TLW 169
Query: 245 YHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
           Y APE  +  +    + D++S G +  E++T R
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 143
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 144 KYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRA 195
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 16/216 (7%)
Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +GEG+ G V  A  ++T+    A+K +D   A +   +   ++ +   L HE+ V+  G+
Sbjct: 14  LGEGAAGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             E N + L  ++ + G L D +    G+   EP     ++Q +        G+ +LH  
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGM--PEPDAQRFFHQLM-------AGVVYLH-- 121
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               I HRD++  N+LL +    KI+DF L              ++ GT  Y APE    
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 254 GQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ 288
            +   +  DV+S G+VL  +L G  P D      Q+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 32/212 (15%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAA----QLSVVSRLKHEHFVEL 130
           +G G+YG V  A  T  G   A+KKL   S P      A     +L ++  +KHE+ + L
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKL---SKPFQSIIHAKRTYRELRLLKHMKHENVIGL 98
Query: 131 L-----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
           L        +E  N + +        L++++  +K          LT +    + Y   +
Sbjct: 99  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILR 148
Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           GL+++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y
Sbjct: 149 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 200
Query: 246 HAPEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
            APE  +      Q  D++S G ++ ELLTGR
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 99
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 149
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 150 KYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRA 201
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKSQK----------LTDDHVQFLIYQILRGL 138
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D       T  + T  Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEM-----TGYVATRWYRA 190
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 150
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 151 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 202
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 150
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 151 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 202
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 158
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 159 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 210
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 104/222 (46%), Gaps = 34/222 (15%)
Query: 70  FGTKALIGEGSYGRVFYAK---------LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVS 120
           +  +  +GEGS+G+V  A          L   +   +KK D     E E      +S + 
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVERE------ISYLK 64
Query: 121 RLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
            L+H H ++L        + ++V ++A  G L D +  +K +   E      + Q++  A
Sbjct: 65  LLRHPHIIKLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGR---RFFQQIICA 120
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
                 +E+ H   +  IVHRD++  N+LL D+   KIADF L+N  +D      S    
Sbjct: 121 ------IEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC--- 168
Query: 241 GTFGYHAPEYAMTGQITQ--KSDVYSFGVVLLELLTGRKPVD 280
           G+  Y APE  + G++    + DV+S G+VL  +L GR P D
Sbjct: 169 GSPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 140
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 141 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 192
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 145
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 146 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 197
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 138
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 190
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 107
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 157
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 158 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 209
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 138
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 190
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 138
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 190
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 140
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D       T  + T  Y A
Sbjct: 141 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRA 192
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 138
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 190
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQK----------LTDDHVQFLIYQILRGL 138
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRA 190
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 138
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 190
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 140
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 141 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 192
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYAKLTDGT-PAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+        A+K L  +   +   E     ++ + S L+H + + L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELANALSYCHS 152
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL    + KIADF  +  +  +      T + GT  Y  PE   
Sbjct: 153 KR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIE 205
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD 280
                +K D++S GV+  E L G+ P +
Sbjct: 206 GRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 143
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 144 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 195
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 138
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D       T  + T  Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGXVATRWYRA 190
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 87
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 88  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 137
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 138 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 189
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 190 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 138
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 190
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 86/208 (41%), Gaps = 18/208 (8%)
Query: 76  IGEGSYGRV----FYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
           IGEG +G V    + +        AIK     ++      F  +   + +  H H V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G   E N   ++ +  T+G L   L  RK          L     +  AY  +  L +L 
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFLQVRKFS--------LDLASLILYAYQLSTALAYLE 128
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA 251
            K     VHRD+ + NVL+      K+ DF L+    D+     S   L    + APE  
Sbjct: 129 SK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESI 184
Query: 252 MTGQITQKSDVYSFGVVLLELLT-GRKP 278
              + T  SDV+ FGV + E+L  G KP
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 144
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D       T  + T  Y A
Sbjct: 145 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRA 196
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 100/227 (44%), Gaps = 23/227 (10%)
Query: 54  EIPQIKLDELNRLTSNFGTKALIGEGSYGRVF-YAKLTDGTPAAIKKLDTSSAPEPESDF 112
           ++ ++K D+  +++        +G G+ G VF  +    G   A K +     P   +  
Sbjct: 18  KVGELKDDDFEKISE-------LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI 70
Query: 113 AAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLT 172
             +L V+      + V   G         +  +    GSL  VL       G  P  +L 
Sbjct: 71  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILG 126
Query: 173 WNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA 232
                KV+    KGL +L EK +  I+HRDV+ SN+L+    + K+ DF ++ Q  D+ A
Sbjct: 127 -----KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 179
Query: 233 RLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPV 279
                  +GT  Y +PE       + +SD++S G+ L+E+  GR P+
Sbjct: 180 ----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 86
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 136
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 137 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 188
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQK----------LTDDHVQFLIYQILRGL 138
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 190
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 107
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 157
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D       T  + T  Y A
Sbjct: 158 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRA 209
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 138
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 190
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 143
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 144 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 195
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 135
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 136 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 187
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 158
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D       T  + T  Y A
Sbjct: 159 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRA 210
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 134
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 135 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 186
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 69  NFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTS--SAPEPESDFAAQLSVVSRLKHE 125
           N+     +GEGS+G+V  A   T G   A+K ++    +  + +     ++S +  L+H 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
           H ++L       +  I+V ++A    L D +  R  +   E      + Q++  A     
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAG-NELFDYIVQRDKMSEQEAR---RFFQQIISA----- 115
Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
            +E+ H   +  IVHRD++  N+LL +    KIADF L+N  +D      S    G+  Y
Sbjct: 116 -VEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNY 168
Query: 246 HAPEYAMTGQITQ--KSDVYSFGVVLLELLTGRKPVD 280
            APE  ++G++    + DV+S GV+L  +L  R P D
Sbjct: 169 AAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 16/212 (7%)
Query: 76  IGEGSYGRVFYA------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE-HFV 128
           +G G++G+V  A      K       A+K L   +         ++L ++  + H  + V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 129 ELLGYCMESNNRILVY-QFATMGSLHDVLHGRKG-VQGAEPGPV----LTWNQRVKVAYG 182
            LLG C +    ++V  +F   G+L   L  ++      +P  +    LT    +  ++ 
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            AKG+EFL  +     +HRD+ + N+LL +    KI DF L          +        
Sbjct: 157 VAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
             + APE       T +SDV+SFGV+L E+ +
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 135
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 136 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 187
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 138
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D       T  + T  Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRA 190
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 23/210 (10%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEP---ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+  +       K+   +  E    E     ++ + S L+H + + L G
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  +S    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELANALSYCHS 126
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ--SSDTAARLHSTRVLGTFGYHAPEY 250
           K    ++HRD++  N+LL    + KIADF  +    SS  AA      + GT  Y  PE 
Sbjct: 127 K---KVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA------LCGTLDYLPPEM 177
Query: 251 AMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
                  +K D++S GV+  E L G+ P +
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 158
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 159 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVATR-----WYRA 210
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 69  NFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTS--SAPEPESDFAAQLSVVSRLKHE 125
           N+     +GEGS+G+V  A   T G   A+K ++    +  + +     ++S +  L+H 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
           H ++L       +  I+V ++A    L D +  R  +   E      + Q++  A     
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAG-NELFDYIVQRDKMSEQEAR---RFFQQIISA----- 119
Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
            +E+ H   +  IVHRD++  N+LL +    KIADF L+N  +D      S    G+  Y
Sbjct: 120 -VEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNY 172
Query: 246 HAPEYAMTGQITQ--KSDVYSFGVVLLELLTGRKPVD 280
            APE  ++G++    + DV+S GV+L  +L  R P D
Sbjct: 173 AAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 140
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 141 KYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR-----WYRA 192
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 69  NFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTS--SAPEPESDFAAQLSVVSRLKHE 125
           N+     +GEGS+G+V  A   T G   A+K ++    +  + +     ++S +  L+H 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
           H ++L       +  I+V ++A    L D +  R  +   E      + Q++  A     
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAG-NELFDYIVQRDKMSEQEAR---RFFQQIISA----- 125
Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
            +E+ H   +  IVHRD++  N+LL +    KIADF L+N  +D      S    G+  Y
Sbjct: 126 -VEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNY 178
Query: 246 HAPEYAMTGQITQ--KSDVYSFGVVLLELLTGRKPVD 280
            APE  ++G++    + DV+S GV+L  +L  R P D
Sbjct: 179 AAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 18/218 (8%)
Query: 60  LDELNRLTSNFGTKALIGEGSYGRVF---YAKLTDGTPAAIKKLDTSSAPEPESDFAAQL 116
           +D+     ++   K  +G G YG V+   + K +        K DT    E    F  + 
Sbjct: 24  MDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEE----FLKEA 79
Query: 117 SVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
           +V+  +KH + V+LLG C       +V ++   G+L D L  R+  +      VL     
Sbjct: 80  AVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYL--RECNREEVTAVVL----- 132
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS 236
           + +A   +  +E+L +K     +HRD+ + N L+ ++   K+ADF L+   +      H+
Sbjct: 133 LYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHA 189
Query: 237 TRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
                   + APE       + KSDV++FGV+L E+ T
Sbjct: 190 GAKF-PIKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 111
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 161
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 162 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATR-----WYRA 213
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYAKLTDGT-PAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+        A+K L  +   +   E     ++ + S L+H + + L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELANALSYCHS 126
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL    + KIADF  +  +  +      T + GT  Y  PE   
Sbjct: 127 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTELCGTLDYLPPEMIE 179
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD 280
                +K D++S GV+  E L G+ P +
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 69  NFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTS--SAPEPESDFAAQLSVVSRLKHE 125
           N+     +GEGS+G+V  A   T G   A+K ++    +  + +     ++S +  L+H 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
           H ++L       +  I+V ++A    L D +  R  +   E      + Q++  A     
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAG-NELFDYIVQRDKMSEQEAR---RFFQQIISA----- 124
Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
            +E+ H   +  IVHRD++  N+LL +    KIADF L+N  +D      S    G+  Y
Sbjct: 125 -VEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNY 177
Query: 246 HAPEYAMTGQITQ--KSDVYSFGVVLLELLTGRKPVD 280
            APE  ++G++    + DV+S GV+L  +L  R P D
Sbjct: 178 AAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 144
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D       T  + T  Y A
Sbjct: 145 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRA 196
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 134
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D       T  + T  Y A
Sbjct: 135 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRA 186
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 61
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE--PGPVLTWNQRVKVAYG 182
            + V+LL      N   LV++F     LH  L            P P++         + 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQ 111
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
             +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R ++  V+ T
Sbjct: 112 LLQGLSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV-T 166
Query: 243 FGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
             Y APE  +  +    + D++S G +  E++T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYAKLTDGT-PAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+        A+K L  +   +   E     ++ + S L+H + + L G
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 93  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELANALSYCHS 143
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL    + KIADF  +  +  +      T + GT  Y  PE   
Sbjct: 144 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIE 196
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD 280
                +K D++S GV+  E L G+ P +
Sbjct: 197 GRMHDEKVDLWSLGVLCYEFLVGKPPFE 224

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 144
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D       T  + T  Y A
Sbjct: 145 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRA 196
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 11/212 (5%)
Query: 67  TSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE 125
           +S F     +G G+Y  V+     T G   A+K++   S     S    ++S++  LKHE
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHE 63
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
           + V L       N   LV++F     L   +  R    G  P   L  N      +   +
Sbjct: 64  NIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSR--TVGNTPRG-LELNLVKYFQWQLLQ 119
Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           GL F HE     I+HRD++  N+L+    + K+ DF L  ++        S+ V+ T  Y
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA-RAFGIPVNTFSSEVV-TLWY 174
Query: 246 HAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
            AP+  M  +    S D++S G +L E++TG+
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 102/240 (42%), Gaps = 20/240 (8%)
Query: 45  GTPQKALPI-EIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTS 103
           G+  K+ P+ EIP + +D   R    +     +G+G + + +     D       K+   
Sbjct: 4   GSDPKSAPLKEIPDVLVDP--RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPK 61
Query: 104 SA---PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRK 160
           S    P  +   + ++++   L + H V   G+  + +   +V +     SL ++   RK
Sbjct: 62  SMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRK 121
Query: 161 GVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD 220
            V   EP       Q ++       G+++LH      ++HRD++  N+ L DD   KI D
Sbjct: 122 AV--TEPEARYFMRQTIQ-------GVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGD 169
Query: 221 FNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
           F L  +      R     + GT  Y APE       + + D++S G +L  LL G+ P +
Sbjct: 170 FGLATKIEFDGER--KKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 227

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 138
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D       T  + T  Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEM-----TGYVATRWYRA 190
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSR 121
              NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  
Sbjct: 8   FMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKE 65
Query: 122 LKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE--PGPVLTWNQRVKV 179
           L H + V+LL      N   LV++F     LH  L            P P++        
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SY 115
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
            +   +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R ++  V
Sbjct: 116 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEV 171
Query: 240 LGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
           + T  Y APE  +  +    + D++S G +  E++T R
Sbjct: 172 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 76  IGEGSYGRVFYA------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE-HFV 128
           +G G++G+V  A      K       A+K L   +         ++L ++  + H  + V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 129 ELLGYCMESNNRILVY-QFATMGSLHDVLHGRKG-VQGAEPGP------VLTWNQRVKVA 180
            LLG C +    ++V  +F   G+L   L  ++      +  P       LT    +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           +  AKG+EFL  +     +HRD+ + N+LL +    KI DF L          +      
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
               + APE       T +SDV+SFGV+L E+ +
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 144
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 145 KYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR-----WYRA 196
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEP---ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+          K+   +  E    E     ++ + S L+H + + L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELANALSYCHS 126
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL    + KIADF  +  +  +      T + GT  Y  PE   
Sbjct: 127 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIE 179
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD 280
                +K D++S GV+  E L G+ P +
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYAKLTDGT-PAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+        A+K L  +   +   E     ++ + S L+H + + L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELANALSYCHS 131
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL    + KIADF  +  +  +      T + GT  Y  PE   
Sbjct: 132 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIE 184
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD 280
                +K D++S GV+  E L G+ P +
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYAKLTDGT-PAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+        A+K L  +   +   E     ++ + S L+H + + L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELANALSYCHS 126
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL    + KIADF  +  +  +      T + GT  Y  PE   
Sbjct: 127 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYLPPEMIE 179
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD 280
                +K D++S GV+  E L G+ P +
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 61
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE--PGPVLTWNQRVKVAYG 182
            + V+LL      N   LV++F     LH  L            P P++         + 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQ 111
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
             +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R ++  V+ T
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV-T 166
Query: 243 FGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
             Y APE  +  +    + D++S G +  E++T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSR 121
              NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  
Sbjct: 8   FMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKE 65
Query: 122 LKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE--PGPVLTWNQRVKV 179
           L H + V+LL      N   LV++F     LH  L            P P++        
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SY 115
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
            +   +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R ++  V
Sbjct: 116 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEV 171
Query: 240 LGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
           + T  Y APE  +  +    + D++S G +  E++T R
Sbjct: 172 V-TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 60
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE--PGPVLTWNQRVKVAYG 182
            + V+LL      N   LV++F     LH  L            P P++         + 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQ 110
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
             +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R ++  V+ T
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV-T 165
Query: 243 FGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
             Y APE  +  +    + D++S G +  E++T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 61
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            + V+LL      N   LV++F     L D +     + G  P P++         +   
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDA-SALTGI-PLPLIK-----SYLFQLL 113
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
           +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R +   V+ T  
Sbjct: 114 QGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-TLW 168
Query: 245 YHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
           Y APE  +  +    + D++S G +  E++T R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 98/230 (42%), Gaps = 29/230 (12%)
Query: 57  QIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTP----AAIKKLDTSSAPEPESDF 112
           QIKL        +F    ++G+GS+G+VF A+           A+KK       + E   
Sbjct: 12  QIKLK-----IEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTM 66
Query: 113 AAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLT 172
             +  +    +H     +        N   V ++   G L  + H    +Q      +  
Sbjct: 67  VEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYH----IQSCHKFDL-- 118
Query: 173 WNQRVKVAYGAAK---GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD 229
                +  + AA+   GL+FLH K    IV+RD++  N+LL  D   KIADF +  ++  
Sbjct: 119 ----SRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 171
Query: 230 TAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPV 279
             A+  +    GT  Y APE  +  +     D +SFGV+L E+L G+ P 
Sbjct: 172 GDAK--TNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 106/236 (44%), Gaps = 32/236 (13%)
Query: 54  EIPQIKLDELNR----LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDT--SSAP 106
           E P     ELN+    +   + T + +G G+YG V  +  +  G   A+KKL     S  
Sbjct: 33  ERPTFYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSII 92
Query: 107 EPESDFAAQLSVVSRLKHEHFVELL-----GYCMESNNRILVYQFATMGSLHDVLHGRKG 161
             +  +  +L ++  +KHE+ + LL        +E  N + +        L++++  +K 
Sbjct: 93  HAKRTYR-ELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQK- 150
Query: 162 VQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADF 221
                    LT +    + Y   +GL+++H      I+HRD++ SN+ + +D + KI DF
Sbjct: 151 ---------LTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDF 198
Query: 222 NLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
            L   + D       T  + T  Y APE  +         D++S G ++ ELLTGR
Sbjct: 199 GLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 107/225 (47%), Gaps = 27/225 (12%)
Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVS 120
           E+N L  N G    +G G+ G+V+  +    G   A+K++  S   E        L VV 
Sbjct: 23  EINDL-ENLGE---MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVL 78
Query: 121 RLKHE--HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK 178
           +  H+  + V+  G  + + +  +  +   MG+  + L  +K +QG  P  +L      K
Sbjct: 79  K-SHDCPYIVQCFGTFITNTDVFIAMEL--MGTCAEKL--KKRMQGPIPERILG-----K 128
Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
           +     K L +L EK    ++HRDV+ SN+LL +  + K+ DF ++ +  D  A+    R
Sbjct: 129 MTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DR 183
Query: 239 VLGTFGYHAPEYAMTGQITQ-----KSDVYSFGVVLLELLTGRKP 278
             G   Y APE       T+     ++DV+S G+ L+EL TG+ P
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 61
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE--PGPVLTWNQRVKVAYG 182
            + V+LL      N   LV++F     LH  L            P P++         + 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQ 111
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
             +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R ++  V+ T
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV-T 166
Query: 243 FGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
             Y APE  +  +    + D++S G +  E++T R
Sbjct: 167 LWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYAKLTDGT-PAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+        A+K L  +   +   E     ++ + S L+H + + L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELANALSYCHS 129
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL    + KIADF  +  +  +      T + GT  Y  PE   
Sbjct: 130 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIE 182
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD 280
                +K D++S GV+  E L G+ P +
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEP---ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+          K+   +  E    E     ++ + S L+H + + L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELANALSYCHS 126
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL    + KIADF  +  +  +      T + GT  Y  PE   
Sbjct: 127 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTXLCGTLDYLPPEMIE 179
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD 280
                +K D++S GV+  E L G+ P +
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 60
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE--PGPVLTWNQRVKVAYG 182
            + V+LL      N   LV++F     LH  L            P P++         + 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQ 110
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
             +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R ++  V+ T
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV-T 165
Query: 243 FGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
             Y APE  +  +    + D++S G +  E++T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 16/211 (7%)
Query: 69  NFGTKALIGEGSYGRVF-YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           +F   + +G G+ G VF  +    G   A K +     P   +    +L V+      + 
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 69
Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
           V   G         +  +    GSL  VL       G  P  +L      KV+    KGL
Sbjct: 70  VGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILG-----KVSIAVIKGL 120
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
            +L EK +  I+HRDV+ SN+L+    + K+ DF ++ Q  D  A       +GT  Y +
Sbjct: 121 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMA----NEFVGTRSYMS 174
Query: 248 PEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           PE       + +SD++S G+ L+E+  GR P
Sbjct: 175 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 65
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE--PGPVLTWNQRVKVAYG 182
            + V+LL      N   LV++F     LH  L            P P++         + 
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQ 115
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
             +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R ++  V+ T
Sbjct: 116 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV-T 170
Query: 243 FGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
             Y APE  +  +    + D++S G +  E++T R
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYAKLTDGT-PAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+        A+K L  +   +   E     ++ + S L+H + + L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELANALSYCHS 126
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL    + KIADF  +  +  +      T + GT  Y  PE   
Sbjct: 127 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYLPPEMIE 179
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD 280
                +K D++S GV+  E L G+ P +
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 61
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE--PGPVLTWNQRVKVAYG 182
            + V+LL      N   LV++F     LH  L            P P++         + 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQ 111
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
             +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R ++  V+ T
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV-T 166
Query: 243 FGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
             Y APE  +  +    + D++S G +  E++T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 62
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE--PGPVLTWNQRVKVAYG 182
            + V+LL      N   LV++F     LH  L            P P++         + 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQ 112
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
             +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R ++  V+ T
Sbjct: 113 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV-T 167
Query: 243 FGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
             Y APE  +  +    + D++S G +  E++T R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 86/208 (41%), Gaps = 18/208 (8%)
Query: 76  IGEGSYGRV----FYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
           IGEG +G V    + +        AIK     ++      F  +   + +  H H V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G   E N   ++ +  T+G L   L  RK          L     +  AY  +  L +L 
Sbjct: 458 GVITE-NPVWIIMELCTLGELRSFLQVRKFS--------LDLASLILYAYQLSTALAYLE 508
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA 251
            K     VHRD+ + NVL+      K+ DF L+    D+     S   L    + APE  
Sbjct: 509 SK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESI 564
Query: 252 MTGQITQKSDVYSFGVVLLELLT-GRKP 278
              + T  SDV+ FGV + E+L  G KP
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKP 592

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYAKLTDGT-PAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+        A+K L  +   +   E     ++ + S L+H + + L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELANALSYCHS 127
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL    + KIADF  +  +  +      T + GT  Y  PE   
Sbjct: 128 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYLPPEMIE 180
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD 280
                +K D++S GV+  E L G+ P +
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 99/237 (41%), Gaps = 19/237 (8%)
Query: 47  PQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSA- 105
           P+ A   EIP + +D   R    +     +G+G + + +     D       K+   S  
Sbjct: 23  PKSAPLKEIPDVLVDP--RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSML 80
Query: 106 --PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQ 163
             P  +   + ++++   L + H V   G+  + +   +V +     SL ++   RK V 
Sbjct: 81  LKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAV- 139
Query: 164 GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL 223
             EP       Q ++       G+++LH      ++HRD++  N+ L DD   KI DF L
Sbjct: 140 -TEPEARYFMRQTIQ-------GVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGL 188
Query: 224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
             +      R     + GT  Y APE       + + D++S G +L  LL G+ P +
Sbjct: 189 ATKIEFDGER--KKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 105/239 (43%), Gaps = 25/239 (10%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES--DFAAQLSVVSRLKHE 125
           +F    ++GEGS+  V  A+ L      AIK L+     +         +  V+SRL H 
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 97
Query: 126 HFVELLGYCMESNNRILV-YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA- 183
            FV+L  +C + + ++     +A  G L   +  RK         + ++++     Y A 
Sbjct: 98  FFVKLY-FCFQDDEKLYFGLSYAKNGELLKYI--RK---------IGSFDETCTRFYTAE 145
Query: 184 -AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
               LE+LH K    I+HRD++  N+LL +D   +I DF      S  + +  +   +GT
Sbjct: 146 IVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED 301
             Y +PE        + SD+++ G ++ +L+ G  P       G + L+     +L  D
Sbjct: 203 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKLEYD 257

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYAKLTDGT-PAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+        A+K L  +   +   E     ++ + S L+H + + L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELANALSYCHS 131
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL    + KIADF  +  +  +      T + GT  Y  PE   
Sbjct: 132 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYLPPEMIE 184
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD 280
                +K D++S GV+  E L G+ P +
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 76  IGEGSYGRVFYA------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE-HFV 128
           +G G++G+V  A      K       A+K L   +         ++L ++  + H  + V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 129 ELLGYCMESNNRILVY-QFATMGSLHDVLHGRKG-VQGAEPGP------VLTWNQRVKVA 180
            LLG C +    ++V  +F   G+L   L  ++      +  P       LT    +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           +  AKG+EFL  +     +HRD+ + N+LL +    KI DF L          +      
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
               + APE       T +SDV+SFGV+L E+ +
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 66  LTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPE-SDFAAQLSVVSRLK 123
               +    ++G+GS+G V   K        A+K ++ +SA   + S    ++ ++ +L 
Sbjct: 20  FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           H + ++L     +S++  +V +  T G L D +  RK     +   ++            
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK---------QV 130
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFD---DFKSKIADFNLTN---QSSDTAARLHST 237
             G+ ++H   +  IVHRD++  N+LL     D   KI DF L+    Q++    R+   
Sbjct: 131 FSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--- 184
Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
              GT  Y APE  + G   +K DV+S GV+L  LL+G  P
Sbjct: 185 ---GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYAKLTDGT-PAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+        A+K L  +   +   E     ++ + S L+H + + L G
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 75  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELANALSYCHS 125
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL    + KIADF  +  +  +      T + GT  Y  PE   
Sbjct: 126 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIE 178
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD 280
                +K D++S GV+  E L G+ P +
Sbjct: 179 GRMHDEKVDLWSLGVLCYEFLVGKPPFE 206

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 100/237 (42%), Gaps = 19/237 (8%)
Query: 47  PQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSA- 105
           P+ A   EIP + +D   R    +     +G+G + + +     D       K+   S  
Sbjct: 23  PKSAPLKEIPDVLVDP--RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSML 80
Query: 106 --PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQ 163
             P  +   + ++++   L + H V   G+  + +   +V +     SL ++   RK V 
Sbjct: 81  LKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAV- 139
Query: 164 GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL 223
             EP       Q ++       G+++LH      ++HRD++  N+ L DD   KI DF L
Sbjct: 140 -TEPEARYFMRQTIQ-------GVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGL 188
Query: 224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
             +      R  +  + GT  Y APE       + + D++S G +L  LL G+ P +
Sbjct: 189 ATKIEFDGERKKT--LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 76  IGEGSYGRVFYA------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE-HFV 128
           +G G++G+V  A      K       A+K L   +         ++L ++  + H  + V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 129 ELLGYCMESNNRILVY-QFATMGSLHDVLHGRKG-VQGAEPGP------VLTWNQRVKVA 180
            LLG C +    ++V  +F   G+L   L  ++      +  P       LT    +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           +  AKG+EFL  +     +HRD+ + N+LL +    KI DF L          +      
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
               + APE       T +SDV+SFGV+L E+ +
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 76  IGEGSYGRVFYA------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE-HFV 128
           +G G++G+V  A      K       A+K L   +         ++L ++  + H  + V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 129 ELLGYCMESNNRILVY-QFATMGSLHDVLHGRKG-VQGAEPGP------VLTWNQRVKVA 180
            LLG C +    ++V  +F   G+L   L  ++      +  P       LT    +  +
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           +  AKG+EFL  +     +HRD+ + N+LL +    KI DF L          +      
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
               + APE       T +SDV+SFGV+L E+ +
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYAKLTDGT-PAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+        A+K L  +   +   E     ++ + S L+H + + L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELANALSYCHS 131
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL    + KIADF  +  +  +      T + GT  Y  PE   
Sbjct: 132 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEXIE 184
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD 280
                +K D++S GV+  E L G+ P +
Sbjct: 185 GRXHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 66  LTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPE-SDFAAQLSVVSRLK 123
               +    ++G+GS+G V   K        A+K ++ +SA   + S    ++ ++ +L 
Sbjct: 20  FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           H + ++L     +S++  +V +  T G L D +  RK     +   ++            
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK---------QV 130
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFD---DFKSKIADFNLTN---QSSDTAARLHST 237
             G+ ++H   +  IVHRD++  N+LL     D   KI DF L+    Q++    R+   
Sbjct: 131 FSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--- 184
Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
              GT  Y APE  + G   +K DV+S GV+L  LL+G  P
Sbjct: 185 ---GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 76  IGEGSYGRVFYA------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE-HFV 128
           +G G++G+V  A      K       A+K L   +         ++L ++  + H  + V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 129 ELLGYCMESNNRILVY-QFATMGSLHDVLHGRKG-VQGAEPGP------VLTWNQRVKVA 180
            LLG C +    ++V  +F   G+L   L  ++      +  P       LT    +  +
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           +  AKG+EFL  +     +HRD+ + N+LL +    KI DF L          +      
Sbjct: 157 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
               + APE       T +SDV+SFGV+L E+ +
Sbjct: 214 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYAKLTDGT-PAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+        A+K L  +   +   E     ++ + S L+H + + L G
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELANALSYCHS 130
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL    + KIADF  +  +  +      T + GT  Y  PE   
Sbjct: 131 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIE 183
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD 280
                +K D++S GV+  E L G+ P +
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGKPPFE 211

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 22/214 (10%)
Query: 76  IGEGSYGRVFYA------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE-HFV 128
           +G G++G+V  A      K       A+K L   +         ++L ++  + H  + V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 129 ELLGYCMESNNRILVY-QFATMGSLHDVLHGRKGVQGAEPGP-------VLTWNQRVKVA 180
            LLG C +    ++V  +F   G+L   L  ++     E  P        LT    +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN----EFVPYKDLYKDFLTLEHLICYS 150
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           +  AKG+EFL  +     +HRD+ + N+LL +    KI DF L          +      
Sbjct: 151 FQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 207
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
               + APE       T +SDV+SFGV+L E+ +
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 99/237 (41%), Gaps = 19/237 (8%)
Query: 47  PQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSA- 105
           P+ A   EIP + +D   R    +     +G+G + + +     D       K+   S  
Sbjct: 23  PKSAPLKEIPDVLVDP--RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSML 80
Query: 106 --PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQ 163
             P  +   + ++++   L + H V   G+  + +   +V +     SL ++   RK V 
Sbjct: 81  LKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAV- 139
Query: 164 GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL 223
             EP       Q ++       G+++LH      ++HRD++  N+ L DD   KI DF L
Sbjct: 140 -TEPEARYFMRQTIQ-------GVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGL 188
Query: 224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
             +      R     + GT  Y APE       + + D++S G +L  LL G+ P +
Sbjct: 189 ATKIEFDGER--KKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 138
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI D+ L   + D      +TR      Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATR-----WYRA 190
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++   K          LT +    + Y   +GL
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCAK----------LTDDHVQFLIYQILRGL 134
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI DF L   + D      +TR      Y A
Sbjct: 135 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 186
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 76  IGEGSYGRVFYA------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE-HFV 128
           +G G++G+V  A      K       A+K L   +         ++L ++  + H  + V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 129 ELLGYCMESNNRILVY-QFATMGSLHDVLHGRKG-VQGAEPGP------VLTWNQRVKVA 180
            LLG C +    ++V  +F   G+L   L  ++      +  P       LT    +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           +  AKG+EFL  +     +HRD+ + N+LL +    KI DF L          +      
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
               + APE       T +SDV+SFGV+L E+ +
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYAKLTDGT-PAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+        A+K L  +   +   E     ++ + S L+H + + L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELANALSYCHS 129
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL    + KIADF  +  +  +      T + GT  Y  PE   
Sbjct: 130 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIE 182
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD 280
                +K D++S GV+  E L G+ P +
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 19/230 (8%)
Query: 54  EIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSS---APEPES 110
           EIP++ +D  +R          +G+G + + F     D       K+   S    P    
Sbjct: 9   EIPEVLVDPRSRRRYV--RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 66
Query: 111 DFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPV 170
             + ++S+   L H+H V   G+  +++   +V +     SL ++   RK +   EP   
Sbjct: 67  KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKAL--TEPEAR 124
Query: 171 LTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT 230
               Q V        G ++LH      ++HRD++  N+ L +D + KI DF L  +    
Sbjct: 125 YYLRQIVL-------GCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 174
Query: 231 AARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
             R     + GT  Y APE       + + DV+S G ++  LL G+ P +
Sbjct: 175 GER--KKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 222

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 22/214 (10%)
Query: 76  IGEGSYGRVFYA------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE-HFV 128
           +G G++G+V  A      K       A+K L   +         ++L ++  + H  + V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 129 ELLGYCMESNNRILVY-QFATMGSLHDVLHGRKGVQGAEPGP-------VLTWNQRVKVA 180
            LLG C +    ++V  +F   G+L   L  ++     E  P        LT    +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN----EFVPYKDLYKDFLTLEHLIXYS 150
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           +  AKG+EFL  +     +HRD+ + N+LL +    KI DF L          +      
Sbjct: 151 FQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDAR 207
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
               + APE       T +SDV+SFGV+L E+ +
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 76  IGEGSYGRV---FYAKLTDGTPA--AIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +G+G++G V    Y  L D T A  A+K+L   S P+ + DF  ++ ++  L  +  V+ 
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQL-QHSGPDQQRDFQREIQILKALHSDFIVKY 77
Query: 131 LG--YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G  Y     +  LV ++   G L D L   +    A    +L ++ ++       KG+E
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA--SRLLLYSSQI------CKGME 129
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT--FGYH 246
           +L  +     VHRD+ + N+L+  +   KIADF L           +  R  G     ++
Sbjct: 130 YLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLP-LDKDYYVVREPGQSPIFWY 185
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT 274
           APE       +++SDV+SFGVVL EL T
Sbjct: 186 APESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 61
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE--PGPVLTWNQRVKVAYG 182
            + V+LL      N   LV++F     LH  L            P P++         + 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQ 111
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
             +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R +   V+ T
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-T 166
Query: 243 FGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
             Y APE  +  +    + D++S G +  E++T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 65
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE--PGPVLTWNQRVKVAYG 182
            + V+LL      N   LV++F     LH  L            P P++         + 
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQ 115
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
             +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R +   V+ T
Sbjct: 116 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-T 170
Query: 243 FGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
             Y APE  +  +    + D++S G +  E++T R
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 63
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE--PGPVLTWNQRVKVAYG 182
            + V+LL      N   LV++F     LH  L            P P++         + 
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQ 113
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
             +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R +   V+ T
Sbjct: 114 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-T 168
Query: 243 FGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
             Y APE  +  +    + D++S G +  E++T R
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 61
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE--PGPVLTWNQRVKVAYG 182
            + V+LL      N   LV++F     LH  L            P P++         + 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQ 111
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
             +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R +   V+ T
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-T 166
Query: 243 FGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
             Y APE  +  +    + D++S G +  E++T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 63
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE--PGPVLTWNQRVKVAYG 182
            + V+LL      N   LV++F     LH  L            P P++         + 
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQ 113
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
             +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R +   V+ T
Sbjct: 114 LLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-T 168
Query: 243 FGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
             Y APE  +  +    + D++S G +  E++T R
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 98/230 (42%), Gaps = 29/230 (12%)
Query: 57  QIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTP----AAIKKLDTSSAPEPESDF 112
           QIKL        +F    ++G+GS+G+VF A+           A+KK       + E   
Sbjct: 11  QIKLK-----IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTM 65
Query: 113 AAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLT 172
             +  +    +H     +        N   V ++   G L  + H    +Q      +  
Sbjct: 66  VEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYH----IQSCHKFDL-- 117
Query: 173 WNQRVKVAYGAAK---GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD 229
                +  + AA+   GL+FLH K    IV+RD++  N+LL  D   KIADF +  ++  
Sbjct: 118 ----SRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170
Query: 230 TAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPV 279
             A+  +    GT  Y APE  +  +     D +SFGV+L E+L G+ P 
Sbjct: 171 GDAK--TNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 61
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE--PGPVLTWNQRVKVAYG 182
            + V+LL      N   LV++F     LH  L            P P++         + 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQ 111
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
             +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R +   V+ T
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-T 166
Query: 243 FGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
             Y APE  +  +    + D++S G +  E++T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIK-KLDTSSAPEPESDFAAQLSVVSRLKHE 125
           NF     IGEG+YG V+ A  KLT    A  K +LDT +   P S    ++S++  L H 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVP-STAIREISLLKELNHP 62
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE--PGPVLTWNQRVKVAYGA 183
           + V+LL      N   LV++F     LH  L            P P++         +  
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQL 112
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
            +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R ++  V+ T 
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV-TL 167
Query: 244 GYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
            Y APE  +  +    + D++S G +  E++T R
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 76  IGEGSYGRV---FYAKLTDGTPA--AIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +G+G++G V    Y  L D T A  A+K+L   S P+ + DF  ++ ++  L  +  V+ 
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQL-QHSGPDQQRDFQREIQILKALHSDFIVKY 73
Query: 131 LG--YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G  Y        LV ++   G L D L   +    A    +L ++ ++       KG+E
Sbjct: 74  RGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDA--SRLLLYSSQI------CKGME 125
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGTFGYHA 247
           +L  +     VHRD+ + N+L+  +   KIADF L      D    +          ++A
Sbjct: 126 YLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYA 182
Query: 248 PEYAMTGQITQKSDVYSFGVVLLELLT 274
           PE       +++SDV+SFGVVL EL T
Sbjct: 183 PESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIK-KLDTSSAPEPESDFAAQLSVVSRLKHE 125
           NF     IGEG+YG V+ A  KLT    A  K +LDT +   P S    ++S++  L H 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVP-STAIREISLLKELNHP 61
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE--PGPVLTWNQRVKVAYGA 183
           + V+LL      N   LV++F     LH  L            P P++         +  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQL 111
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
            +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R ++  V+ T 
Sbjct: 112 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV-TL 166
Query: 244 GYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
            Y APE  +  +    + D++S G +  E++T R
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 76  IGEGSYGRVFYA------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE-HFV 128
           +G G++G+V  A      K       A+K L   +         ++L ++  + H  + V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 129 ELLGYCMESNNRILVY-QFATMGSLHDVLHGRKG-VQGAEPGP------VLTWNQRVKVA 180
            LLG C +    ++V  +F   G+L   L  ++      +  P       LT    +  +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           +  AKG+EFL  +     +HRD+ + N+LL +    KI DF L          +      
Sbjct: 192 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
               + APE       T +SDV+SFGV+L E+ +
Sbjct: 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 19/230 (8%)
Query: 54  EIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSS---APEPES 110
           EIP++ +D  +R          +G+G + + F     D       K+   S    P    
Sbjct: 5   EIPEVLVDPRSRRRYV--RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 62
Query: 111 DFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPV 170
             + ++S+   L H+H V   G+  +++   +V +     SL ++   RK +   EP   
Sbjct: 63  KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKAL--TEPEAR 120
Query: 171 LTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT 230
               Q V        G ++LH      ++HRD++  N+ L +D + KI DF L  +    
Sbjct: 121 YYLRQIVL-------GCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 170
Query: 231 AARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
             R     + GT  Y APE       + + DV+S G ++  LL G+ P +
Sbjct: 171 GER--KKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 64
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE--PGPVLTWNQRVKVAYG 182
            + V+LL      N   LV++F     LH  L            P P++         + 
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQ 114
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
             +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R +   V+ T
Sbjct: 115 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-T 169
Query: 243 FGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
             Y APE  +  +    + D++S G +  E++T R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 63
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE--PGPVLTWNQRVKVAYG 182
            + V+LL      N   LV++F     LH  L            P P++         + 
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQ 113
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
             +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R +   V+ T
Sbjct: 114 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-T 168
Query: 243 FGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
             Y APE  +  +    + D++S G +  E++T R
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 60
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE--PGPVLTWNQRVKVAYG 182
            + V+LL      N   LV++F     LH  L            P P++         + 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQ 110
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
             +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R +   V+ T
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-T 165
Query: 243 FGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
             Y APE  +  +    + D++S G +  E++T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 19/205 (9%)
Query: 76  IGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IGEGS G V  A+    G   A+K +D       E  F  ++ ++   +H + VE+    
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFN-EVVIMRDYQHFNVVEMYKSY 111
Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
           +      ++ +F   G+L D++   +          L   Q   V     + L +LH + 
Sbjct: 112 LVGEELWVLMEFLQGGALTDIVSQVR----------LNEEQIATVCEAVLQALAYLHAQ- 160
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ-SSDTAARLHSTRVLGTFGYHAPEYAMT 253
              ++HRD++S ++LL  D + K++DF    Q S D   R     ++GT  + APE    
Sbjct: 161 --GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KXLVGTPYWMAPEVISR 215
Query: 254 GQITQKSDVYSFGVVLLELLTGRKP 278
                + D++S G++++E++ G  P
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 60
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE--PGPVLTWNQRVKVAYG 182
            + V+LL      N   LV++F     LH  L            P P++         + 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQ 110
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
             +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R +   V+ T
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-T 165
Query: 243 FGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
             Y APE  +  +    + D++S G +  E++T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYAKLTDGT-PAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+        A+K L  +   +   E     ++ + S L+H + + L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELANALSYCHS 127
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL    + KIADF  +  +  +      T + GT  Y  PE   
Sbjct: 128 K---RVIHRDIKPENLLLGSAGELKIADFGWSCHAPSS----RRTTLSGTLDYLPPEMIE 180
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD 280
                +K D++S GV+  E L G+ P +
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 64
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE--PGPVLTWNQRVKVAYG 182
            + V+LL      N   LV++F     LH  L            P P++         + 
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEF-----LHQDLKTFMDASALTGIPLPLIK-----SYLFQ 114
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
             +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R +   V+ T
Sbjct: 115 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-T 169
Query: 243 FGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
             Y APE  +  +    + D++S G +  E++T R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 62
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE--PGPVLTWNQRVKVAYG 182
            + V+LL      N   LV++F     LH  L            P P++         + 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQ 112
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
             +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R +   V+ T
Sbjct: 113 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-T 167
Query: 243 FGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
             Y APE  +  +    + D++S G +  E++T R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 62
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE--PGPVLTWNQRVKVAYG 182
            + V+LL      N   LV++F     LH  L            P P++         + 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQ 112
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
             +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R +   V+ T
Sbjct: 113 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-T 167
Query: 243 FGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
             Y APE  +  +    + D++S G +  E++T R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 62
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE--PGPVLTWNQRVKVAYG 182
            + V+LL      N   LV++F     LH  L            P P++         + 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQ 112
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
             +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R +   V+ T
Sbjct: 113 LLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-T 167
Query: 243 FGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
             Y APE  +  +    + D++S G +  E++T R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 64
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE--PGPVLTWNQRVKVAYG 182
            + V+LL      N   LV++F     LH  L            P P++         + 
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQ 114
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
             +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R +   V+ T
Sbjct: 115 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-T 169
Query: 243 FGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
             Y APE  +  +    + D++S G +  E++T R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 61
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE--PGPVLTWNQRVKVAYG 182
            + V+LL      N   LV++F     LH  L            P P++         + 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK-----SYLFQ 111
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
             +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R +   V+ T
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-T 166
Query: 243 FGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
             Y APE  +  +    + D++S G +  E++T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 19/230 (8%)
Query: 54  EIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSS---APEPES 110
           EIP++ +D  +R          +G+G + + F     D       K+   S    P    
Sbjct: 27  EIPEVLVDPRSRRRYV--RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 84
Query: 111 DFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPV 170
             + ++S+   L H+H V   G+  +++   +V +     SL ++   RK +   EP   
Sbjct: 85  KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKAL--TEPEAR 142
Query: 171 LTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT 230
               Q V        G ++LH      ++HRD++  N+ L +D + KI DF L  +    
Sbjct: 143 YYLRQIVL-------GCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 192
Query: 231 AARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
             R     + GT  Y APE       + + DV+S G ++  LL G+ P +
Sbjct: 193 GER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 240

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 19/230 (8%)
Query: 54  EIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSS---APEPES 110
           EIP++ +D  +R          +G+G + + F     D       K+   S    P    
Sbjct: 5   EIPEVLVDPRSRRRYV--RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 62
Query: 111 DFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPV 170
             + ++S+   L H+H V   G+  +++   +V +     SL ++   RK +   EP   
Sbjct: 63  KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKAL--TEPEAR 120
Query: 171 LTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT 230
               Q V        G ++LH      ++HRD++  N+ L +D + KI DF L  +    
Sbjct: 121 YYLRQIVL-------GCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 170
Query: 231 AARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
             R     + GT  Y APE       + + DV+S G ++  LL G+ P +
Sbjct: 171 GER--KKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 19/230 (8%)
Query: 54  EIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSS---APEPES 110
           EIP++ +D  +R          +G+G + + F     D       K+   S    P    
Sbjct: 29  EIPEVLVDPRSRRRYV--RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 86
Query: 111 DFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPV 170
             + ++S+   L H+H V   G+  +++   +V +     SL ++   RK +   EP   
Sbjct: 87  KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKAL--TEPEAR 144
Query: 171 LTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT 230
               Q V        G ++LH      ++HRD++  N+ L +D + KI DF L  +    
Sbjct: 145 YYLRQIVL-------GCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194
Query: 231 AARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
             R     + GT  Y APE       + + DV+S G ++  LL G+ P +
Sbjct: 195 GER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 76  IGEGSYGRVFYA------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE-HFV 128
           +G G++G+V  A      K       A+K L   +         ++L ++  + H  + V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 129 ELLGYCMESNNRILVY-QFATMGSLHDVLHGRKG-VQGAEPGP------VLTWNQRVKVA 180
            LLG C +    ++V  +F   G+L   L  ++      +  P       LT    +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           +  AKG+EFL  +     +HRD+ + N+LL +    KI DF L          +      
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
               + APE       T +SDV+SFGV+L E+ +
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 76  IGEGSYGRV---FYAKLTDGTPA--AIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +G+G++G V    Y  L D T A  A+K+L   S P+ + DF  ++ ++  L  +  V+ 
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 131 LG--YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G  Y     +  LV ++   G L D L   +    A    +L ++ ++       KG+E
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA--SRLLLYSSQI------CKGME 141
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT--FGYH 246
           +L  +     VHRD+ + N+L+  +   KIADF L           +  R  G     ++
Sbjct: 142 YLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLP-LDKDYYVVREPGQSPIFWY 197
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT 274
           APE       +++SDV+SFGVVL EL T
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 76  IGEGSYGRV---FYAKLTDGTPA--AIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +G+G++G V    Y  L D T A  A+K+L   S P+ + DF  ++ ++  L  +  V+ 
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILKALHSDFIVKY 76
Query: 131 LG--YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G  Y     +  LV ++   G L D L   +    A    +L ++ ++       KG+E
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA--SRLLLYSSQI------CKGME 128
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT--FGYH 246
           +L  +     VHRD+ + N+L+  +   KIADF L           +  R  G     ++
Sbjct: 129 YLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLP-LDKDYYVVREPGQSPIFWY 184
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT 274
           APE       +++SDV+SFGVVL EL T
Sbjct: 185 APESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 70  FGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPE-SDFAAQLSVVSRLKHEHF 127
           +    ++G+GS+G V   K        A+K ++ +SA   + S    ++ ++ +L H + 
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
           ++L     +S++  +V +  T G L D +  RK     +   +      +K  +    G+
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI------IKQVFS---GI 134
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFD---DFKSKIADFNLTN---QSSDTAARLHSTRVLG 241
            ++H   +  IVHRD++  N+LL     D   KI DF L+    Q++    R+      G
Sbjct: 135 TYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI------G 185
Query: 242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           T  Y APE  + G   +K DV+S GV+L  LL+G  P
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 76  IGEGSYGRVFYA------KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE-HFV 128
           +G G++G+V  A      K       A+K L   +         ++L ++  + H  + V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 129 ELLGYCMESNNRILVY-QFATMGSLHDVLHGRKG-VQGAEPGP------VLTWNQRVKVA 180
            LLG C +    ++V  +F   G+L   L  ++      +  P       LT    +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           +  AKG+EFL  +     +HRD+ + N+LL +    KI DF L          +      
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
               + APE       T +SDV+SFGV+L E+ +
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYAKLTDGT-PAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+        A+K L  +   +   E     ++ + S L+H + + L G
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 73  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELANALSYCHS 123
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL    + KIADF  +  +  +      T + GT  Y  PE   
Sbjct: 124 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIE 176
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD 280
                +K D++S GV+  E L G+ P +
Sbjct: 177 GRMHDEKVDLWSLGVLCYEFLVGKPPFE 204

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 76  IGEGSYGRVFYAKLTDGT-PAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+        A+K L  +   +   E     ++ + S L+H + + L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELANALSYCHS 129
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ--SSDTAARLHSTRVLGTFGYHAPEY 250
           K    ++HRD++  N+LL    + KIADF  +    SS  AA      + GT  Y  PE 
Sbjct: 130 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA------LCGTLDYLPPEM 180
Query: 251 AMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
                  +K D++S GV+  E L G+ P +
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLD-TSSAPEPESDFAAQLSVVSRLKHEH 126
           N+     IG+G++ +V  A+ +  G   A+K +D T            ++ ++  L H +
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVL--HGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            V+L           LV ++A+ G + D L  HGR   + A       + Q V       
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA----KFRQIVS------ 124
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
             +++ H+K    IVHRD+++ N+LL  D   KIADF  +N+ +    +L +    G+  
Sbjct: 125 -AVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGNKLDT--FCGSPP 177
Query: 245 YHAPEYAMTGQITQ-KSDVYSFGVVLLELLTGRKPVD 280
           Y APE     +    + DV+S GV+L  L++G  P D
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 105/259 (40%), Gaps = 27/259 (10%)
Query: 67  TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPE---SDFAAQLSVVSRLK 123
             +F     +G+G +G V+ A+          K+   S  E E        ++ + S L+
Sbjct: 14  IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 73
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVL--HGRKGVQGAEPGPVLTWNQRVKVAY 181
           H + + +  Y  +     L+ +FA  G L+  L  HGR   Q +      T+ + +    
Sbjct: 74  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-----TFMEEL---- 124
Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG 241
             A  L + HE+    ++HRD++  N+L+    + KIADF      S  A  L    + G
Sbjct: 125 --ADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGW----SVHAPSLRRRXMCG 175
Query: 242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD---HTMPKGQQSLVTWATPRL 298
           T  Y  PE        +K D++  GV+  E L G  P D   HT    +   V    P  
Sbjct: 176 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPF 235
Query: 299 SEDKVKQCVDPKLNNDYPP 317
             D  K  +  KL   +PP
Sbjct: 236 LSDGSKDLIS-KLLRYHPP 253

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 18/232 (7%)
Query: 70  FGTKALIGEGSYGRV-FYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           F  K  +G G++G V    + + G    IK ++   +  P     A++ V+  L H + +
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 129 ELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
           ++     + +N  +V +    G L +     + V     G  L+     ++       L 
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLE-----RIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKS---KIADFNLTNQ-SSDTAARLHSTRVLGTFG 244
           + H +    +VH+D++  N+L  D       KI DF L     SD     HST   GT  
Sbjct: 139 YFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE----HSTNAAGTAL 191
Query: 245 YHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATP 296
           Y APE      +T K D++S GVV+  LLTG  P   T  +  Q   T+  P
Sbjct: 192 YMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP 242

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 20/211 (9%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEP---ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+          K+   +  E    E     ++ + S L+H + + L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT---------ELANALSYCHS 130
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL  + + KIADF  +  +  +      T + GT  Y  PE   
Sbjct: 131 K---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIE 183
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD-HT 282
                +K D++S GV+  E L G  P + HT
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPPFEAHT 214

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLD-TSSAPEPESDFAAQLSVVSRLKHEH 126
           N+     IG+G++ +V  A+ +  G   A+K +D T            ++ ++  L H +
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVL--HGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            V+L           LV ++A+ G + D L  HGR   + A       + Q V       
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA----KFRQIVS------ 124
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
             +++ H+K    IVHRD+++ N+LL  D   KIADF  +N+ +    +L +    G+  
Sbjct: 125 -AVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGNKLDT--FCGSPP 177
Query: 245 YHAPEYAMTGQITQ-KSDVYSFGVVLLELLTGRKPVD 280
           Y APE     +    + DV+S GV+L  L++G  P D
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 105/230 (45%), Gaps = 18/230 (7%)
Query: 63  LNRLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSR 121
           +NR   ++  + +IG G+   V  A         AIK+++         +   ++  +S+
Sbjct: 7   INR--DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQ 64
Query: 122 LKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY 181
             H + V      +  +   LV +  + GS+ D++      +G     VL  +    +  
Sbjct: 65  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIK-HIVAKGEHKSGVLDESTIATILR 123
Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN----LTNQSSDTAARLHST 237
              +GLE+LH+  Q   +HRDV++ N+LL +D   +IADF     L      T  ++  T
Sbjct: 124 EVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 180
Query: 238 RVLGTFGYHAPEYAMTGQITQ---KSDVYSFGVVLLELLTGRKPVDHTMP 284
            V GT  + APE  +  Q+     K+D++SFG+  +EL TG  P  H  P
Sbjct: 181 FV-GTPCWMAPE--VMEQVRGYDFKADIWSFGITAIELATGAAPY-HKYP 226

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 105/259 (40%), Gaps = 27/259 (10%)
Query: 67  TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPE---SDFAAQLSVVSRLK 123
             +F     +G+G +G V+ A+          K+   S  E E        ++ + S L+
Sbjct: 13  IDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVL--HGRKGVQGAEPGPVLTWNQRVKVAY 181
           H + + +  Y  +     L+ +FA  G L+  L  HGR   Q +      T+ + +    
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-----TFMEEL---- 123
Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG 241
             A  L + HE+    ++HRD++  N+L+    + KIADF      S  A  L    + G
Sbjct: 124 --ADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGW----SVHAPSLRRRXMCG 174
Query: 242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD---HTMPKGQQSLVTWATPRL 298
           T  Y  PE        +K D++  GV+  E L G  P D   HT    +   V    P  
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPF 234
Query: 299 SEDKVKQCVDPKLNNDYPP 317
             D  K  +  KL   +PP
Sbjct: 235 LSDGSKDLIS-KLLRYHPP 252

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYAKLTDGT-PAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+        A+K L  +   +   E     ++ + S L+H + + L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELANALSYCHS 152
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL    + KIADF  +  +  +        + GT  Y  PE   
Sbjct: 153 KR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRDDLCGTLDYLPPEMIE 205
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD 280
                +K D++S GV+  E L G+ P +
Sbjct: 206 GRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 23/210 (10%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEP---ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+          K+   +  E    E     ++ + S L+H + + L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELANALSYCHS 126
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ--SSDTAARLHSTRVLGTFGYHAPEY 250
           K    ++HRD++  N+LL    + KIADF  +    SS  AA      + GT  Y  PE 
Sbjct: 127 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA------LCGTLDYLPPEM 177
Query: 251 AMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
                  +K D++S GV+  E L G+ P +
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYAKLTDGT-PAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+        A+K L  +   +   E     ++ + S L+H + + L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A  G ++  L              +T           A  L + H 
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYIT---------ELANALSYCHS 131
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL    + KIADF  +  +  +      T + GT  Y  PE   
Sbjct: 132 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIE 184
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD 280
                +K D++S GV+  E L G+ P +
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 105/230 (45%), Gaps = 18/230 (7%)
Query: 63  LNRLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSR 121
           +NR   ++  + +IG G+   V  A         AIK+++         +   ++  +S+
Sbjct: 12  INR--DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQ 69
Query: 122 LKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY 181
             H + V      +  +   LV +  + GS+ D++      +G     VL  +    +  
Sbjct: 70  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIK-HIVAKGEHKSGVLDESTIATILR 128
Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN----LTNQSSDTAARLHST 237
              +GLE+LH+  Q   +HRDV++ N+LL +D   +IADF     L      T  ++  T
Sbjct: 129 EVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 238 RVLGTFGYHAPEYAMTGQITQ---KSDVYSFGVVLLELLTGRKPVDHTMP 284
            V GT  + APE  +  Q+     K+D++SFG+  +EL TG  P  H  P
Sbjct: 186 FV-GTPCWMAPE--VMEQVRGYDFKADIWSFGITAIELATGAAPY-HKYP 231

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 19/230 (8%)
Query: 54  EIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSS---APEPES 110
           EIP++ +D  +R          +G+G + + F     D       K+   S    P    
Sbjct: 3   EIPEVLVDPRSRRRYV--RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 60
Query: 111 DFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPV 170
             + ++S+   L H+H V   G+  +++   +V +     SL ++   RK +   EP   
Sbjct: 61  KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKAL--TEPEAR 118
Query: 171 LTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT 230
               Q V        G ++LH      ++HRD++  N+ L +D + KI DF L  +    
Sbjct: 119 YYLRQIVL-------GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168
Query: 231 AARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
             R     + GT  Y APE       + + DV+S G ++  LL G+ P +
Sbjct: 169 GER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 26/227 (11%)
Query: 76  IGEGSYGRV-FYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGY 133
           +GEG +  V     L DG   A+K++      + E   A + + + RL  H + + L+ Y
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREE--AQREADMHRLFNHPNILRLVAY 94
Query: 134 CMES----NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           C+      +   L+  F   G+L + +   K     + G  LT +Q + +  G  +GLE 
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLK-----DKGNFLTEDQILWLLLGICRGLEA 149
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS------SDTAARLHSTRV-LGT 242
           +H K      HRD++ +N+LL D+ +  + D    NQ+      S  A  L        T
Sbjct: 150 IHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 243 FGYHAPE-YAMTGQ--ITQKSDVYSFGVVLLELLTGRKPVDHTMPKG 286
             Y APE +++     I +++DV+S G VL  ++ G  P D    KG
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 97/224 (43%), Gaps = 46/224 (20%)
Query: 76  IGEGSYGRVFYAKLT---DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKH-EHFVELL 131
           IG G+YG V   K+     G   A+K++ ++   + +      L VV R     + V+  
Sbjct: 30  IGRGAYGSV--NKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 132 G---------YCME----SNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK 178
           G          CME    S ++   Y ++    L DV+          P  +L      K
Sbjct: 88  GALFREGDCWICMELMSTSFDKFYKYVYSV---LDDVI----------PEEILG-----K 129
Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
           +     K L  L E ++  I+HRD++ SN+LL      K+ DF ++ Q  D+ A+   TR
Sbjct: 130 ITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK---TR 184
Query: 239 VLGTFGYHAPEYAMTGQITQ----KSDVYSFGVVLLELLTGRKP 278
             G   Y APE        Q    +SDV+S G+ L EL TGR P
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYAKLTDGT-PAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+        A+K L  +   +   E     ++ + S L+H + + L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELANALSYCHS 128
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL    + KIADF  +  +  +        + GT  Y  PE   
Sbjct: 129 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRXXLCGTLDYLPPEMIE 181
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD 280
                +K D++S GV+  E L G+ P +
Sbjct: 182 GRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYAKLTDGT-PAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+        A+K L  +   +   E     ++ + S L+H + + L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELANALSYCHS 128
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL    + KIA+F  +  +  +      T + GT  Y  PE   
Sbjct: 129 K---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSS----RRTTLCGTLDYLPPEMIE 181
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD 280
                +K D++S GV+  E L G+ P +
Sbjct: 182 GRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 109/222 (49%), Gaps = 36/222 (16%)
Query: 71  GTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFA----AQLSVVSRLKHE 125
           G + ++G+G+YG V+  + L++    AIK++     PE +S ++     ++++   LKH+
Sbjct: 25  GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI-----PERDSRYSQPLHEEIALHKHLKHK 79
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
           + V+ LG   E+    +  +    GSL  +L  + G        +  + +++       +
Sbjct: 80  NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI------LE 133
Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS--KIADFNLTNQSSDTAARLH-----STR 238
           GL++LH+     IVHRD++  NVL+ + +    KI+DF        T+ RL      +  
Sbjct: 134 GLKYLHDN---QIVHRDIKGDNVLI-NTYSGVLKISDFG-------TSKRLAGINPCTET 182
Query: 239 VLGTFGYHAPEYAMTG--QITQKSDVYSFGVVLLELLTGRKP 278
             GT  Y APE    G     + +D++S G  ++E+ TG+ P
Sbjct: 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLD-TSSAPEPESDFAAQLSVVSRLKHEH 126
           N+     IG+G++ +V  A+ +  G   A+K +D T            ++ ++  L H +
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVL--HGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            V+L           LV ++A+ G + D L  HGR   + A       + Q V       
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA----KFRQIVS------ 124
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
             +++ H+K    IVHRD+++ N+LL  D   KIADF  +N+ +    +L +    G   
Sbjct: 125 -AVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGNKLDA--FCGAPP 177
Query: 245 YHAPEYAMTGQITQ-KSDVYSFGVVLLELLTGRKPVD 280
           Y APE     +    + DV+S GV+L  L++G  P D
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 74  ALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAA-QLSVVSRLKHEHFVELL 131
            L+GEGSYG V   +  D G   AIKK   S   +     A  ++ ++ +L+HE+ V LL
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
             C +     LV++F     L D+     G         L +    K  +    G+ F H
Sbjct: 91  EVCKKKKRWYLVFEFVDHTILDDLELFPNG---------LDYQVVQKYLFQIINGIGFCH 141
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA 251
                 I+HRD++  N+L+      K+ DF    ++      ++   V  T  Y APE  
Sbjct: 142 SH---NIIHRDIKPENILVSQSGVVKLCDFGFA-RTLAAPGEVYDDEV-ATRWYRAPE-L 195
Query: 252 MTGQIT--QKSDVYSFGVVLLELLTG 275
           + G +   +  DV++ G ++ E+  G
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 89/208 (42%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEP---ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+          K+   +  E    E     ++ + S L+H + + L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELANALSYCHS 129
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL    + KIA+F  +  +  +      T + GT  Y  PE   
Sbjct: 130 K---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSS----RRTTLCGTLDYLPPEMIE 182
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD 280
                +K D++S GV+  E L G+ P +
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 23/220 (10%)
Query: 75  LIGEGSYGRVFYAKLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +IG+G +G V++ +  D        AIK L   +  +    F  +  ++  L H + + L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 131 LGYCM--ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
           +G  +  E    +L+  +   G L       + ++  +  P  T    +      A+G+E
Sbjct: 88  IGIMLPPEGLPHVLL-PYMCHGDL------LQFIRSPQRNP--TVKDLISFGLQVARGME 138
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT---AARLHSTRVLGTFGY 245
           +L E+     VHRD+ + N +L + F  K+ADF L     D    + + H    L    +
Sbjct: 139 YLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV-KW 194
Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMP 284
            A E   T + T KSDV+SFGV+L ELLT G  P  H  P
Sbjct: 195 TALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP 234

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 79/167 (47%), Gaps = 13/167 (7%)
Query: 112 FAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVL 171
           F  ++   S+L H++ V ++    E +   LV ++    +L + +           GP L
Sbjct: 58  FEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--------GP-L 108
Query: 172 TWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTA 231
           + +  +        G++  H+     IVHRD++  N+L+  +   KI DF +    S+T+
Sbjct: 109 SVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165
Query: 232 ARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
               +  VLGT  Y +PE A      + +D+YS G+VL E+L G  P
Sbjct: 166 LT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 138
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI  F L   + D      +TR      Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATR-----WYRA 190
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 108/222 (48%), Gaps = 36/222 (16%)
Query: 71  GTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFA----AQLSVVSRLKHE 125
           G + ++G+G+YG V+  + L++    AIK++     PE +S ++     ++++   LKH+
Sbjct: 11  GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI-----PERDSRYSQPLHEEIALHKHLKHK 65
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
           + V+ LG   E+    +  +    GSL  +L  + G        +  + +++       +
Sbjct: 66  NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI------LE 119
Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS--KIADFNLTNQSSDTAARLHSTR----- 238
           GL++LH+     IVHRD++  NVL+ + +    KI+DF        T+ RL         
Sbjct: 120 GLKYLHDN---QIVHRDIKGDNVLI-NTYSGVLKISDFG-------TSKRLAGINPCTET 168
Query: 239 VLGTFGYHAPEYAMTG--QITQKSDVYSFGVVLLELLTGRKP 278
             GT  Y APE    G     + +D++S G  ++E+ TG+ P
Sbjct: 169 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 210

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 88/208 (42%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEP---ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+          K+   +  E    E     ++ + S L+H + + L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELANALSYCHS 126
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL    + KIADF  +  +  +        + GT  Y  PE   
Sbjct: 127 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRXXLCGTLDYLPPEMIE 179
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD 280
                +K D++S GV+  E L G+ P +
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLD-TSSAPEPESDFAAQLSVVSRLKHEH 126
           N+     IG+G++ +V  A+ +  G   A++ +D T            ++ ++  L H +
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVL--HGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            V+L           LV ++A+ G + D L  HGR   + A       + Q V       
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA----KFRQIVS------ 124
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
             +++ H+K    IVHRD+++ N+LL  D   KIADF  +N+ +    +L +    G+  
Sbjct: 125 -AVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGNKLDT--FCGSPP 177
Query: 245 YHAPEYAMTGQITQ-KSDVYSFGVVLLELLTGRKPVD 280
           Y APE     +    + DV+S GV+L  L++G  P D
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 88/208 (42%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEP---ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+          K+   +  E    E     ++ + S L+H + + L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELANALSYCHS 129
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL    + KIADF  +  +  +        + GT  Y  PE   
Sbjct: 130 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRXXLCGTLDYLPPEMIE 182
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD 280
                +K D++S GV+  E L G+ P +
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYAKLTDGT-PAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+        A+K L  +   +   E     ++ + S L+H + + L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELANALSYCHS 127
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL    + KIADF  +  +  +        + GT  Y  PE   
Sbjct: 128 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRDTLCGTLDYLPPEMIE 180
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD 280
                +K D++S GV+  E L G+ P +
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 138
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI D  L   + D       T  + T  Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEM-----TGYVATRWYRA 190
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 99/231 (42%), Gaps = 28/231 (12%)
Query: 61  DELNRLTSNFGTKALIGEGSYGRVFYAK--LTDGTPAAIKKLDTSSAPE--PESDF--AA 114
           D L R    +   A IGEG+YG+VF A+     G   A+K++   +  E  P S     A
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 115 QLSVVSRLKHEHFVELLGYCMESNNR-----ILVYQFATMGSLHDVLHGRKGVQGAEPG- 168
            L  +   +H + V L   C  S         LV++        D+      V   EPG 
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKV--PEPGV 117
Query: 169 PVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS 228
           P  T      + +   +GL+FLH      +VHRD++  N+L+    + K+ADF L    S
Sbjct: 118 PTETIKD---MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
Query: 229 DTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPV 279
              A    T V+ T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 172 FQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 15/230 (6%)
Query: 68  SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           S+F    ++G+GS+G+VF  +        + + D+      +    A L V  R++ +  
Sbjct: 28  SHFELLKVLGQGSFGKVFLVR-------KVTRPDSGHLYAMKVLKKATLKVRDRVRTKME 80
Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKG--VQGAEPGPVLTWNQRVKVAYGA-A 184
            ++L          L Y F T G L+ +L   +G  +       V+   + VK      A
Sbjct: 81  RDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELA 140
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
            GL+ LH      I++RD++  N+LL ++   K+ DF L+ ++ D   + +S    GT  
Sbjct: 141 LGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGTVE 195
Query: 245 YHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWA 294
           Y APE       +  +D +S+GV++ E+LTG  P      K   +L+  A
Sbjct: 196 YMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKA 245

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES--DFAAQLSVVSRLKHE 125
           +F    ++GEGS+  V  A+ L      AIK L+     +         +  V+SRL H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA-- 183
            FV+L     +         +A  G L   +  RK         + ++++     Y A  
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGCLLKYI--RK---------IGSFDETCTRFYTAEI 141
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
              LE+LH K    I+HRD++  N+LL +D   +I DF      S  + +  +   +GT 
Sbjct: 142 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 198
Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            Y +PE       ++ SD+++ G ++ +L+ G  P
Sbjct: 199 QYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 99/231 (42%), Gaps = 28/231 (12%)
Query: 61  DELNRLTSNFGTKALIGEGSYGRVFYAK--LTDGTPAAIKKLDTSSAPE--PESDF--AA 114
           D L R    +   A IGEG+YG+VF A+     G   A+K++   +  E  P S     A
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 115 QLSVVSRLKHEHFVELLGYCMESNNR-----ILVYQFATMGSLHDVLHGRKGVQGAEPG- 168
            L  +   +H + V L   C  S         LV++        D+      V   EPG 
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKV--PEPGV 117
Query: 169 PVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS 228
           P  T      + +   +GL+FLH      +VHRD++  N+L+    + K+ADF L    S
Sbjct: 118 PTETIKD---MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
Query: 229 DTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPV 279
              A    T V+ T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 172 FQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 88/208 (42%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEP---ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+          K+   +  E    E     ++ + S L+H + + L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELANALSYCHS 129
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL    + KIADF  +  +  +        + GT  Y  PE   
Sbjct: 130 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRDDLCGTLDYLPPEMIE 182
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD 280
                +K D++S GV+  E L G+ P +
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLD-TSSAPEPESDFAAQLSVVSRLKHEH 126
           N+     IG+G++ +V  A+ +  G   A++ +D T            ++ ++  L H +
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVL--HGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            V+L           LV ++A+ G + D L  HGR   + A       + Q V       
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA----KFRQIVS------ 124
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
             +++ H+K    IVHRD+++ N+LL  D   KIADF  +N+ +    +L      G+  
Sbjct: 125 -AVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGNKLDE--FCGSPP 177
Query: 245 YHAPEYAMTGQITQ-KSDVYSFGVVLLELLTGRKPVD 280
           Y APE     +    + DV+S GV+L  L++G  P D
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 99/231 (42%), Gaps = 28/231 (12%)
Query: 61  DELNRLTSNFGTKALIGEGSYGRVFYAK--LTDGTPAAIKKLDTSSAPE--PESDF--AA 114
           D L R    +   A IGEG+YG+VF A+     G   A+K++   +  E  P S     A
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 115 QLSVVSRLKHEHFVELLGYCMESNNR-----ILVYQFATMGSLHDVLHGRKGVQGAEPG- 168
            L  +   +H + V L   C  S         LV++        D+      V   EPG 
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKV--PEPGV 117
Query: 169 PVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS 228
           P  T      + +   +GL+FLH      +VHRD++  N+L+    + K+ADF L    S
Sbjct: 118 PTETIKD---MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
Query: 229 DTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPV 279
              A    T V+ T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 172 FQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 138
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI D  L   + D       T  + T  Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEM-----TGYVATRWYRA 190
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 100/238 (42%), Gaps = 23/238 (9%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES--DFAAQLSVVSRLKHE 125
           +F    ++GEGS+  V  A+ L      AIK L+     +         +  V+SRL H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA-- 183
            FV+L     +         +A  G L   +  RK         + ++++     Y A  
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RK---------IGSFDETCTRFYTAEI 141
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
              LE+LH K    I+HRD++  N+LL +D   +I DF      S  + +  +   +GT 
Sbjct: 142 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED 301
            Y +PE        + SD+++ G ++ +L+ G  P       G + L+     +L  D
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEGLIFAKIIKLEYD 252

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 28/210 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVELL- 131
           +G G+YG V  A  T  G   A+KKL     S    +  +  +L ++  +KHE+ + LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 132 ----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E  N + +        L++++  +K          LT +    + Y   +GL
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGL 138
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           +++H      I+HRD++ SN+ + +D + KI D  L   + D      +TR      Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATR-----WYRA 190
Query: 248 PEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           PE  +      Q  D++S G ++ ELLTGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 19/215 (8%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES--DFAAQLSVVSRLKHE 125
           +F    ++GEGS+  V  A+ L      AIK L+     +         +  V+SRL H 
Sbjct: 11  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 70
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA-- 183
            FV+L     +         +A  G L   +  RK         + ++++     Y A  
Sbjct: 71  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RK---------IGSFDETCTRFYTAEI 119
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
              LE+LH K    I+HRD++  N+LL +D   +I DF      S  + +  +   +GT 
Sbjct: 120 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 176
Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            Y +PE        + SD+++ G ++ +L+ G  P
Sbjct: 177 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 100/236 (42%), Gaps = 33/236 (13%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKK-LDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           IGEGSYG VF  +  D G   AIKK L++   P  +     ++ ++ +LKH + V LL  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
                   LV+++     LH++   ++GV    P  ++       + +   + + F H+ 
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHELDRYQRGV----PEHLVK-----SITWQTLQAVNFCHKH 121
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM- 252
                +HRDV+  N+L+      K+ DF        T    +    + T  Y +PE  + 
Sbjct: 122 ---NCIHRDVKPENILITKHSVIKLCDFGFARLL--TGPSDYYDDEVATRWYRSPELLVG 176
Query: 253 TGQITQKSDVYSFGVVLLELLTG----------------RKPVDHTMPKGQQSLVT 292
             Q     DV++ G V  ELL+G                RK +   +P+ QQ   T
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLGYC 134
           IGEG+YG V+ A+   G   A+KK+      E   S    ++S++  LKH + V+L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 135 MESNNRILVYQFAT--MGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
                 +LV++     +  L DV  G  G++       L              G+ + H+
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLL---------QLLNGIAYCHD 118
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           +    ++HRD++  N+L+  + + KIADF L  ++     R ++  V+ T  Y AP+  M
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLA-RAFGIPVRKYTHEVV-TLWYRAPDVLM 173
Query: 253 -TGQITQKSDVYSFGVVLLELLTG 275
            + + +   D++S G +  E++ G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLGYC 134
           IGEG+YG V+ A+   G   A+KK+      E   S    ++S++  LKH + V+L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 135 MESNNRILVYQFAT--MGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
                 +LV++     +  L DV  G  G++       L              G+ + H+
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLL---------QLLNGIAYCHD 118
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           +    ++HRD++  N+L+  + + KIADF L  ++     R ++  V+ T  Y AP+  M
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLA-RAFGIPVRKYTHEVV-TLWYRAPDVLM 173
Query: 253 -TGQITQKSDVYSFGVVLLELLTG 275
            + + +   D++S G +  E++ G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 100/238 (42%), Gaps = 23/238 (9%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES--DFAAQLSVVSRLKHE 125
           +F    ++GEGS+  V  A+ L      AIK L+     +         +  V+SRL H 
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA-- 183
            FV+L     +         +A  G L   +  RK         + ++++     Y A  
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RK---------IGSFDETCTRFYTAEI 142
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
              LE+LH K    I+HRD++  N+LL +D   +I DF      S  + +  +   +GT 
Sbjct: 143 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 199
Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED 301
            Y +PE        + SD+++ G ++ +L+ G  P       G + L+     +L  D
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKLEYD 253

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 19/215 (8%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES--DFAAQLSVVSRLKHE 125
           +F    ++GEGS+  V  A+ L      AIK L+     +         +  V+SRL H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA-- 183
            FV+L     +         +A  G L   +  RK         + ++++     Y A  
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RK---------IGSFDETCTRFYTAEI 141
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
              LE+LH K    I+HRD++  N+LL +D   +I DF      S  + +  +   +GT 
Sbjct: 142 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            Y +PE        + SD+++ G ++ +L+ G  P
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 19/215 (8%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES--DFAAQLSVVSRLKHE 125
           +F    ++GEGS+  V  A+ L      AIK L+     +         +  V+SRL H 
Sbjct: 10  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 69
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA-- 183
            FV+L     +         +A  G L   +  RK         + ++++     Y A  
Sbjct: 70  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RK---------IGSFDETCTRFYTAEI 118
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
              LE+LH K    I+HRD++  N+LL +D   +I DF      S  + +  +   +GT 
Sbjct: 119 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 175
Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            Y +PE        + SD+++ G ++ +L+ G  P
Sbjct: 176 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 19/215 (8%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES--DFAAQLSVVSRLKHE 125
           +F    ++GEGS+  V  A+ L      AIK L+     +         +  V+SRL H 
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA-- 183
            FV+L     +         +A  G L   +  RK         + ++++     Y A  
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RK---------IGSFDETCTRFYTAEI 142
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
              LE+LH K    I+HRD++  N+LL +D   +I DF      S  + +  +   +GT 
Sbjct: 143 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 199
Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            Y +PE        + SD+++ G ++ +L+ G  P
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 19/215 (8%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES--DFAAQLSVVSRLKHE 125
           +F    ++GEGS+  V  A+ L      AIK L+     +         +  V+SRL H 
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 95
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA-- 183
            FV+L     +         +A  G L   +  RK         + ++++     Y A  
Sbjct: 96  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RK---------IGSFDETCTRFYTAEI 144
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
              LE+LH K    I+HRD++  N+LL +D   +I DF      S  + +  +   +GT 
Sbjct: 145 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 201
Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            Y +PE        + SD+++ G ++ +L+ G  P
Sbjct: 202 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 90/211 (42%), Gaps = 20/211 (9%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEP---ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+          K+   +  E    E     ++ + S L+H + + L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A +G+++  L              +T           A  L + H 
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT---------ELANALSYCHS 130
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL  + + KIADF  +  +  +        + GT  Y  PE   
Sbjct: 131 K---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSS----RRDTLCGTLDYLPPEMIE 183
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD-HT 282
                +K D++S GV+  E L G  P + HT
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPPFEAHT 214

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 100/238 (42%), Gaps = 23/238 (9%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES--DFAAQLSVVSRLKHE 125
           +F    ++GEGS+  V  A+ L      AIK L+     +         +  V+SRL H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA-- 183
            FV+L     +         +A  G L   +  RK         + ++++     Y A  
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RK---------IGSFDETCTRFYTAEI 141
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
              LE+LH K    I+HRD++  N+LL +D   +I DF      S  + +  +   +GT 
Sbjct: 142 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED 301
            Y +PE        + SD+++ G ++ +L+ G  P       G + L+     +L  D
Sbjct: 199 QYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPP----FRAGNEGLIFAKIIKLEYD 252

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 100/238 (42%), Gaps = 23/238 (9%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES--DFAAQLSVVSRLKHE 125
           +F    ++GEGS+  V  A+ L      AIK L+     +         +  V+SRL H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA-- 183
            FV+L     +         +A  G L   +  RK         + ++++     Y A  
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RK---------IGSFDETCTRFYTAEI 141
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
              LE+LH K    I+HRD++  N+LL +D   +I DF      S  + +  +   +GT 
Sbjct: 142 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED 301
            Y +PE        + SD+++ G ++ +L+ G  P       G + L+     +L  D
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKLEYD 252

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLGYC 134
           IGEG+YG V+ A+   G   A+KK+      E   S    ++S++  LKH + V+L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 135 MESNNRILVYQFAT--MGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
                 +LV++     +  L DV  G  G++       L              G+ + H+
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLL---------QLLNGIAYCHD 118
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           +    ++HRD++  N+L+  + + KIADF L  ++     R ++  ++ T  Y AP+  M
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLA-RAFGIPVRKYTHEIV-TLWYRAPDVLM 173
Query: 253 -TGQITQKSDVYSFGVVLLELLTG 275
            + + +   D++S G +  E++ G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 100/238 (42%), Gaps = 23/238 (9%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES--DFAAQLSVVSRLKHE 125
           +F    ++GEGS+  V  A+ L      AIK L+     +         +  V+SRL H 
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA-- 183
            FV+L     +         +A  G L   +  RK         + ++++     Y A  
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RK---------IGSFDETCTRFYTAEI 139
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
              LE+LH K    I+HRD++  N+LL +D   +I DF      S  + +  +   +GT 
Sbjct: 140 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED 301
            Y +PE        + SD+++ G ++ +L+ G  P       G + L+     +L  D
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKLEYD 250

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 22/217 (10%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLD-TSSAPEPESDFAAQLSVVSRLKHEH 126
           N+     IG+G++ +V  A+ +  G   A+K +D T            ++ +   L H +
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVL--HGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            V+L           LV ++A+ G + D L  HGR   + A       + Q V       
Sbjct: 75  IVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARA----KFRQIVS------ 124
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
             +++ H+K    IVHRD+++ N+LL  D   KIADF  +N+ +    +L +    G   
Sbjct: 125 -AVQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFT-FGNKLDA--FCGAPP 177
Query: 245 YHAPEYAMTGQITQ-KSDVYSFGVVLLELLTGRKPVD 280
           Y APE     +    + DV+S GV+L  L++G  P D
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 100/238 (42%), Gaps = 23/238 (9%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES--DFAAQLSVVSRLKHE 125
           +F    ++GEGS+  V  A+ L      AIK L+     +         +  V+SRL H 
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA-- 183
            FV+L     +         +A  G L   +  RK         + ++++     Y A  
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RK---------IGSFDETCTRFYTAEI 139
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
              LE+LH K    I+HRD++  N+LL +D   +I DF      S  + +  +   +GT 
Sbjct: 140 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED 301
            Y +PE        + SD+++ G ++ +L+ G  P       G + L+     +L  D
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKLEYD 250

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYAKLTDGT-PAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+        A+K L  +   +   E     ++ + S L+H + + L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  ++    L+ ++A  G ++  L              +T           A  L + H 
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYIT---------ELANALSYCHS 131
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL    + KIADF  +  +  +        + GT  Y  PE   
Sbjct: 132 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRXXLXGTLDYLPPEMIE 184
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD 280
                +K D++S GV+  E L G+ P +
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 24/215 (11%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 60
Query: 125 EHFVELLGYCMESNNRILVYQFA--TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + V+LL      N   LV++     + +  D       + G  P P++         + 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDA----SALTGI-PLPLIK-----SYLFQ 110
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
             +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R ++  V+ T
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV-T 165
Query: 243 FGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
             Y APE  +  +    + D++S G +  E++T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 108/232 (46%), Gaps = 27/232 (11%)
Query: 58  IKLDELNRL-TSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQ 115
           I ++  NRL   NF    ++G+GS+G+V  A++ + G   A+K L      + + D    
Sbjct: 12  IGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ-DDDVECT 70
Query: 116 LS---VVSRLKHEHFVELLGYCMESNNRIL-VYQFATMGSLHDVLHGRKGVQGAEPGPVL 171
           ++   ++S  ++  F+  L  C ++ +R+  V +F   G L  + H +K  +  E     
Sbjct: 71  MTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDE----- 123
Query: 172 TWNQRVKVAYGAAK---GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS 228
                 +  + AA+    L FLH+K    I++RD++  NVLL  +   K+ADF +  +  
Sbjct: 124 -----ARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG- 174
Query: 229 DTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
                + +    GT  Y APE           D ++ GV+L E+L G  P +
Sbjct: 175 -ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 100/238 (42%), Gaps = 23/238 (9%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES--DFAAQLSVVSRLKHE 125
           +F    ++GEGS+  V  A+ L      AIK L+     +         +  V+SRL H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA-- 183
            FV+L     +         +A  G L   +  RK         + ++++     Y A  
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RK---------IGSFDETCTRFYTAEI 117
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
              LE+LH K    I+HRD++  N+LL +D   +I DF      S  + +  +   +GT 
Sbjct: 118 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 174
Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED 301
            Y +PE        + SD+++ G ++ +L+ G  P       G + L+     +L  D
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKLEYD 228

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLD-TSSAPEPESDFAAQLSVVSRLKHEH 126
           N+     IG+G++ +V  A+ +  G   A+K +D T            ++ ++  L H +
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKG 186
            V+L           LV ++A+ G + D L     ++  E         R K        
Sbjct: 68  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEA--------RAKFR-QIVSA 118
Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           +++ H+K    IVHRD+++ N+LL  D   KIADF  +N+ +    +L +    G+  Y 
Sbjct: 119 VQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGNKLDT--FCGSPPYA 172
Query: 247 APEYAMTGQITQ-KSDVYSFGVVLLELLTGRKPVD 280
           APE     +    + DV+S GV+L  L++G  P D
Sbjct: 173 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 107/225 (47%), Gaps = 19/225 (8%)
Query: 61  DELNRLT-SNFGTKALIGEGSYGRVFYA--KLTDGTPA-AIKKLDTSSAPEPESDFAAQL 116
           + L+R+  ++F    ++G+GS+G+V  A  K T+   A  I K D     +       + 
Sbjct: 11  NNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEK 70
Query: 117 SVVSRLKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQ 175
            V++ L    F+  L  C ++ +R+  V ++   G L  + H ++  +  EP       Q
Sbjct: 71  RVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEP-------Q 121
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
            V  A   + GL FLH++    I++RD++  NV+L  +   KIADF +  +       + 
Sbjct: 122 AVFYAAEISIGLFFLHKR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEH--MMDGVT 176
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
           +    GT  Y APE        +  D +++GV+L E+L G+ P D
Sbjct: 177 TREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 100/238 (42%), Gaps = 23/238 (9%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES--DFAAQLSVVSRLKHE 125
           +F    ++GEGS+  V  A+ L      AIK L+     +         +  V+SRL H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA-- 183
            FV+L     +         +A  G L   +  RK         + ++++     Y A  
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RK---------IGSFDETCTRFYTAEI 141
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
              LE+LH K    I+HRD++  N+LL +D   +I DF      S  + +  +   +GT 
Sbjct: 142 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED 301
            Y +PE        + SD+++ G ++ +L+ G  P       G + L+     +L  D
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKLEYD 252

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 89/219 (40%), Gaps = 22/219 (10%)
Query: 70  FGTKALIGEGSYGRVF-YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           +  K  +G G +G V  +     G   AIK+     +P+    +  ++ ++ +L H + V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 129 EL------LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
                   L     ++  +L  ++   G L   L+  +   G + GP+ T      +   
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT------LLSD 130
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRV 239
            +  L +LHE     I+HRD++  N++L         KI D     +          T  
Sbjct: 131 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEF 184
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           +GT  Y APE     + T   D +SFG +  E +TG +P
Sbjct: 185 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 100/238 (42%), Gaps = 23/238 (9%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES--DFAAQLSVVSRLKHE 125
           +F    ++GEGS+  V  A+ L      AIK L+     +         +  V+SRL H 
Sbjct: 8   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 67
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA-- 183
            FV+L     +         +A  G L   +  RK         + ++++     Y A  
Sbjct: 68  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RK---------IGSFDETCTRFYTAEI 116
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
              LE+LH K    I+HRD++  N+LL +D   +I DF      S  + +  +   +GT 
Sbjct: 117 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 173
Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED 301
            Y +PE        + SD+++ G ++ +L+ G  P       G + L+     +L  D
Sbjct: 174 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKLEYD 227

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 89/219 (40%), Gaps = 22/219 (10%)
Query: 70  FGTKALIGEGSYGRVF-YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           +  K  +G G +G V  +     G   AIK+     +P+    +  ++ ++ +L H + V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 129 EL------LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
                   L     ++  +L  ++   G L   L+  +   G + GP+ T      +   
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT------LLSD 129
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRV 239
            +  L +LHE     I+HRD++  N++L         KI D     +          T  
Sbjct: 130 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEF 183
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           +GT  Y APE     + T   D +SFG +  E +TG +P
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 119/271 (43%), Gaps = 46/271 (16%)
Query: 65  RLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK 123
           R  S+F   A++G+G++G+V  A+   D    AIKK+      E  S   +++ +++ L 
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI--RHTEEKLSTILSEVMLLASLN 60
Query: 124 HEHFVELLGYCMESNNRI-------------LVYQFATMGSLHDVLHGRKGVQGAEPGPV 170
           H++ V      +E  N +             +  ++   G+L+D++H     Q  +    
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE--- 117
Query: 171 LTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN--QSS 228
             W    ++     + L ++H +    I+HRD++  N+ + +    KI DF L      S
Sbjct: 118 -YW----RLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 229 DTAARLHS----------TRVLGTFGYHAPEYAM-TGQITQKSDVYSFGVVLLELL---- 273
               +L S          T  +GT  Y A E    TG   +K D+YS G++  E++    
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFS 229
Query: 274 TGRKPVDHTMPKGQQSLVTWATPRLSEDKVK 304
           TG + V+  + K  +S+     P   ++K+K
Sbjct: 230 TGMERVN--ILKKLRSVSIEFPPDFDDNKMK 258

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 32/223 (14%)
Query: 76  IGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAA----QLSVVSRLKHEHFVEL 130
           +G G+YG V  A     G   AIKKL   S P     FA     +L ++  ++HE+ + L
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKL---SRPFQSEIFAKRAYRELLLLKHMQHENVIGL 106
Query: 131 LGYCMESNNRILVYQF-ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK-VAYGAAKGLE 188
           L     +++    Y F   M  +   L    G++ +E        ++++ + Y   KGL+
Sbjct: 107 LDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSE--------EKIQYLVYQMLKGLK 158
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           ++H      +VHRD++  N+ + +D + KI DF L        A    T  + T  Y AP
Sbjct: 159 YIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH-----ADAEMTGYVVTRWYRAP 210
Query: 249 EYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSL 290
           E  ++     Q  D++S G ++ E+LTG+     T+ KG+  L
Sbjct: 211 EVILSWMHYNQTVDIWSVGCIMAEMLTGK-----TLFKGKDYL 248

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 100/238 (42%), Gaps = 23/238 (9%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES--DFAAQLSVVSRLKHE 125
           +F    ++GEGS+  V  A+ L      AIK L+     +         +  V+SRL H 
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA-- 183
            FV+L     +         +A  G L   +  RK         + ++++     Y A  
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RK---------IGSFDETCTRFYTAEI 139
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
              LE+LH K    I+HRD++  N+LL +D   +I DF      S  + +  +   +GT 
Sbjct: 140 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTA 196
Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED 301
            Y +PE        + SD+++ G ++ +L+ G  P       G + L+     +L  D
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKLEYD 250

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 32/223 (14%)
Query: 76  IGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAA----QLSVVSRLKHEHFVEL 130
           +G G+YG V  A     G   AIKKL   S P     FA     +L ++  ++HE+ + L
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKL---SRPFQSEIFAKRAYRELLLLKHMQHENVIGL 88
Query: 131 LGYCMESNNRILVYQF-ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK-VAYGAAKGLE 188
           L     +++    Y F   M  +   L    G++ +E        ++++ + Y   KGL+
Sbjct: 89  LDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSE--------EKIQYLVYQMLKGLK 140
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           ++H      +VHRD++  N+ + +D + KI DF L        A    T  + T  Y AP
Sbjct: 141 YIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH-----ADAEMTGYVVTRWYRAP 192
Query: 249 EYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSL 290
           E  ++     Q  D++S G ++ E+LTG+     T+ KG+  L
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGK-----TLFKGKDYL 230

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 100/238 (42%), Gaps = 23/238 (9%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES--DFAAQLSVVSRLKHE 125
           +F    ++GEGS+  V  A+ L      AIK L+     +         +  V+SRL H 
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 74
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA-- 183
            FV+L     +         +A  G L   +  RK         + ++++     Y A  
Sbjct: 75  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RK---------IGSFDETCTRFYTAEI 123
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
              LE+LH K    I+HRD++  N+LL +D   +I DF      S  + +  +   +GT 
Sbjct: 124 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 180
Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED 301
            Y +PE        + SD+++ G ++ +L+ G  P       G + L+     +L  D
Sbjct: 181 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKLEYD 234

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 76  IGEGSYGRVFYAK--LTDGTPAAIKKLDTSSAPEPESDFAA--QLSVVSRLKHEHFVELL 131
           +G G+YG V   K  LT G   AIK +  SS     +  A   +++V+ +L H + ++L 
Sbjct: 29  LGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 87
Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
            +  +  N  LV +    G L D +  R+     +   ++              G  +LH
Sbjct: 88  EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK---------QVLSGTTYLH 138
Query: 192 EKVQPPIVHRDVRSSNVLLFD---DFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
              +  IVHRD++  N+LL     D   KI DF L+    +   ++     LGT  Y AP
Sbjct: 139 ---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF-EVGGKMKER--LGTAYYIAP 192
Query: 249 EYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           E  +  +  +K DV+S GV+L  LL G  P
Sbjct: 193 E-VLRKKYDEKCDVWSCGVILYILLCGYPP 221

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 23/212 (10%)
Query: 75  LIGEGSYGRVFYAKLTDGTPA----AIKKLDTSSAPEPESDFA---AQLSVVSRLKHEHF 127
           ++G+G YG+VF  +   G       A+K L  +       D A   A+ +++  +KH   
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 128 VELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKG 186
           V+L+ Y  ++  ++ L+ ++ + G L   L  R+G+   +      +   + +A G    
Sbjct: 84  VDLI-YAFQTGGKLYLILEYLSGGELFMQLE-REGIFMEDTACF--YLAEISMALG---- 135
Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
              LH+K    I++RD++  N++L      K+ DF L  +S       H+    GT  Y 
Sbjct: 136 --HLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYM 188
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           APE  M     +  D +S G ++ ++LTG  P
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 70/290 (24%), Positives = 119/290 (41%), Gaps = 44/290 (15%)
Query: 76  IGEGSYGRVF---------YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEH 126
           +G+G++ ++F         Y +L + T   +K LD +     ES F A  S++S+L H+H
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHE-TEVLLKVLDKAHRNYSESFFEAA-SMMSKLSHKH 73
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKG 186
            V   G C+  +  ILV +F   GSL   L   K          + W  +++VA   A  
Sbjct: 74  LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCIN------ILW--KLEVAKQLAAA 125
Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLF--DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
           + FL E     ++H +V + N+LL   +D K+    F   +    +   L    +     
Sbjct: 126 MHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP 182
Query: 245 YHAPEYAMT-GQITQKSDVYSFGVVLLELLTG-RKPVDHTMPKGQQSLVTWATPRLSEDK 302
           +  PE       +   +D +SFG  L E+ +G  KP+  +    Q+ L      +  ED+
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL--SALDSQRKL------QFYEDR 234
Query: 303 VKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLL 352
                     +  P             C+ YE D RP+   +++ L  L 
Sbjct: 235 ----------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 100/238 (42%), Gaps = 23/238 (9%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES--DFAAQLSVVSRLKHE 125
           +F    ++GEGS+  V  A+ L      AIK L+     +         +  V+SRL H 
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA-- 183
            FV+L     +         +A  G L   +  RK         + ++++     Y A  
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RK---------IGSFDETCTRFYTAEI 138
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
              LE+LH K    I+HRD++  N+LL +D   +I DF      S  + +  +   +GT 
Sbjct: 139 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 195
Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED 301
            Y +PE        + SD+++ G ++ +L+ G  P       G + L+     +L  D
Sbjct: 196 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKLEYD 249

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 100/238 (42%), Gaps = 23/238 (9%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES--DFAAQLSVVSRLKHE 125
           +F    ++GEGS+  V  A+ L      AIK L+     +         +  V+SRL H 
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA-- 183
            FV+L     +         +A  G L   +  RK         + ++++     Y A  
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RK---------IGSFDETCTRFYTAEI 138
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
              LE+LH K    I+HRD++  N+LL +D   +I DF      S  + +  +   +GT 
Sbjct: 139 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 195
Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED 301
            Y +PE        + SD+++ G ++ +L+ G  P       G + L+     +L  D
Sbjct: 196 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKLEYD 249

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 89/216 (41%), Gaps = 26/216 (12%)
Query: 69  NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTS-----SAPEPESDFAAQLSVVSRL 122
           +F     +G GS+GRV   +   +G   A+K L           E  +D    LS+V+  
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-- 64
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            H   + + G   ++    ++  +   G L  +L   +      P PV  +      A  
Sbjct: 65  -HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF----PNPVAKF-----YAAE 114
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
               LE+LH K    I++RD++  N+LL  +   KI DF       D    L      GT
Sbjct: 115 VCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXL-----CGT 166
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
             Y APE   T    +  D +SFG+++ E+L G  P
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 23/218 (10%)
Query: 66  LTSNFGTKALIGEGSYGRVFYAK--LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK 123
           +   F    ++G G++  VF  K  LT G   A+K +  S A   +S    +++V+ ++K
Sbjct: 7   IRKTFIFMEVLGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFR-DSSLENEIAVLKKIK 64
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           HE+ V L      + +  LV Q  + G L D +  R GV   +   ++   Q+V  A   
Sbjct: 65  HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER-GVYTEKDASLVI--QQVLSA--- 118
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVL 240
              +++LHE     IVHRD++  N+L     ++ K  I DF L+    +       +   
Sbjct: 119 ---VKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STAC 168
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           GT GY APE       ++  D +S GV+   LL G  P
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 27/213 (12%)
Query: 76  IGEGSYGRVFYAK--LTDGTPAAIKKLDTSSAPEPE--SDFAAQLSVVSRLKHEHFVELL 131
           +G G++G+V   K  LT G   A+K L+       +       ++  +   +H H ++L 
Sbjct: 24  LGVGTFGKVKVGKHELT-GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 132 GYCMESNNRILVYQFATMGSLHDVL--HGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
                 ++  +V ++ + G L D +  +GR           L   +  ++      G+++
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYICKNGR-----------LDEKESRRLFQQILSGVDY 131
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE 249
            H  +   +VHRD++  NVLL     +KIADF L+N  SD      S    G+  Y APE
Sbjct: 132 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC---GSPNYAAPE 185
Query: 250 YAMTGQITQ--KSDVYSFGVVLLELLTGRKPVD 280
             ++G++    + D++S GV+L  LL G  P D
Sbjct: 186 -VISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/290 (24%), Positives = 118/290 (40%), Gaps = 44/290 (15%)
Query: 76  IGEGSYGRVF---------YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEH 126
           +G+G++ ++F         Y +L + T   +K LD +     ES F A  S++S+L H+H
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHE-TEVLLKVLDKAHRNYSESFFEAA-SMMSKLSHKH 73
Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKG 186
            V   G C   +  ILV +F   GSL   L   K          + W  +++VA   A  
Sbjct: 74  LVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCIN------ILW--KLEVAKQLAWA 125
Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLF--DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
           + FL E     ++H +V + N+LL   +D K+    F   +    +   L    +     
Sbjct: 126 MHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP 182
Query: 245 YHAPEYAMT-GQITQKSDVYSFGVVLLELLTG-RKPVDHTMPKGQQSLVTWATPRLSEDK 302
           +  PE       +   +D +SFG  L E+ +G  KP+  +    Q+ L      +  ED+
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL--SALDSQRKL------QFYEDR 234
Query: 303 VKQCVDPKLNNDYPPXXXXXXXXXXXXCVQYEADFRPNMTIVVKALQPLL 352
                     +  P             C+ YE D RP+   +++ L  L 
Sbjct: 235 ----------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 23/212 (10%)
Query: 75  LIGEGSYGRVFYAKLTDGTPA----AIKKLDTSSAPEPESDFA---AQLSVVSRLKHEHF 127
           ++G+G YG+VF  +   G       A+K L  +       D A   A+ +++  +KH   
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 128 VELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKG 186
           V+L+ Y  ++  ++ L+ ++ + G L   L  R+G+   +      +   + +A G    
Sbjct: 84  VDLI-YAFQTGGKLYLILEYLSGGELFMQLE-REGIFMEDTACF--YLAEISMALG---- 135
Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
              LH+K    I++RD++  N++L      K+ DF L  +S       H     GT  Y 
Sbjct: 136 --HLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHX--FCGTIEYM 188
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           APE  M     +  D +S G ++ ++LTG  P
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 76  IGEGSYGRVFYAK--LTDGTPAAIKKLDTSSAPEPESDFAA--QLSVVSRLKHEHFVELL 131
           +G G+YG V   K  LT G   AIK +  SS     +  A   +++V+ +L H + ++L 
Sbjct: 12  LGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 70
Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
            +  +  N  LV +    G L D +  R+     +   ++              G  +LH
Sbjct: 71  EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK---------QVLSGTTYLH 121
Query: 192 EKVQPPIVHRDVRSSNVLLFD---DFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
              +  IVHRD++  N+LL     D   KI DF L+    +   ++     LGT  Y AP
Sbjct: 122 ---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF-EVGGKMKER--LGTAYYIAP 175
Query: 249 EYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           E  +  +  +K DV+S GV+L  LL G  P
Sbjct: 176 E-VLRKKYDEKCDVWSCGVILYILLCGYPP 204

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 20/213 (9%)
Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKK--LDTSSAPEPESDFAAQLSVVSRLKH 124
           NF     IGEG+YG V+ A  KLT G   A+KK  LDT +   P S    ++S++  L H
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVP-STAIREISLLKELNH 64
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            + V+LL      N   LV++      L   +     + G  P P++         +   
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDA-SALTGI-PLPLIK-----SYLFQLL 116
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
           +GL F H      ++HRD++  N+L+  +   K+ADF L  ++     R +   V+ T  
Sbjct: 117 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVV-TLW 171
Query: 245 YHAPEYAMTGQITQKS-DVYSFGVVLLELLTGR 276
           Y APE  +  +    + D++S G +  E++T R
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 99/238 (41%), Gaps = 23/238 (9%)
Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES--DFAAQLSVVSRLKHE 125
           +F    ++GEGS+     A+ L      AIK L+     +         +  V+SRL H 
Sbjct: 31  DFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA-- 183
            FV+L     +         +A  G L   +  RK         + ++++     Y A  
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RK---------IGSFDETCTRFYTAEI 139
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
              LE+LH K    I+HRD++  N+LL +D   +I DF      S  + +  +   +GT 
Sbjct: 140 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED 301
            Y +PE        + SD+++ G ++ +L+ G  P       G + L+     +L  D
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKLEYD 250

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 23/217 (10%)
Query: 68  SNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKL--DTSSAPEPESDFAAQLSVVSRLKH 124
           ++F    L+G+G++G+V   +    G   A+K L  +   A +  +    +  V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 125 EHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
             F+  L Y  ++++R+  V ++A  G L   L   +         V T  +R +  YGA
Sbjct: 65  P-FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---------VFT-EERARF-YGA 112
Query: 184 --AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG 241
                LE+LH +    +V+RD++  N++L  D   KI DF L  +     A + +    G
Sbjct: 113 EIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCG 167
Query: 242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           T  Y APE        +  D +  GVV+ E++ GR P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 19/206 (9%)
Query: 76  IGEGSYGRV-FYAKLTDGTPAAIKKLDTSSAPEPESD-FAAQLSVVSRLKHEHFVELLGY 133
           IG GSYGR     + +DG     K+LD  S  E E     ++++++  LKH + V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 134 CMESNNRIL--VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
            ++  N  L  V ++   G L  V+      +G +    L     ++V       L+  H
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVI-----TKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 192 EKVQ--PPIVHRDVRSSNVLLFDDFKSKIADFNLT---NQSSDTAARLHSTRVLGTFGYH 246
            +      ++HRD++ +NV L      K+ DF L    N   D A        +GT  Y 
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEF-----VGTPYYM 183
Query: 247 APEYAMTGQITQKSDVYSFGVVLLEL 272
           +PE        +KSD++S G +L EL
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 68/132 (51%), Gaps = 13/132 (9%)
Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
           K+A    K LE LH K+   ++HRDV+ SNVL+    + K+ DF ++    D+ A+   T
Sbjct: 157 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAK---T 211
Query: 238 RVLGTFGYHAPEYAMTGQITQ-----KSDVYSFGVVLLELLTGRKPVDHTMPKGQQ--SL 290
              G   Y APE  +  ++ Q     KSD++S G+ ++EL   R P D      QQ   +
Sbjct: 212 IDAGCKPYMAPE-RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 270
Query: 291 VTWATPRLSEDK 302
           V   +P+L  DK
Sbjct: 271 VEEPSPQLPADK 282

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 19/213 (8%)
Query: 70  FGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           F  K  +G G++  V  A+    G   A+K +   +    ES    +++V+ ++KHE+ V
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 129 ELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            L       N+  LV Q  + G L D +   KG    +    L   Q +   Y       
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRI-VEKGFYTEKDASTLI-RQVLDAVY------- 134
Query: 189 FLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           +LH   +  IVHRD++  N+L +   ++ K  I+DF L+    +    + ST   GT GY
Sbjct: 135 YLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM--EGKGDVMST-ACGTPGY 188
Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            APE       ++  D +S GV+   LL G  P
Sbjct: 189 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 23/217 (10%)
Query: 68  SNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKL--DTSSAPEPESDFAAQLSVVSRLKH 124
           ++F    L+G+G++G+V   +    G   A+K L  +   A +  +    +  V+   +H
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 125 EHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
             F+  L Y  ++++R+  V ++A  G L   L   +         V T  +R +  YGA
Sbjct: 68  P-FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---------VFT-EERARF-YGA 115
Query: 184 --AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG 241
                LE+LH +    +V+RD++  N++L  D   KI DF L  +     A + +    G
Sbjct: 116 EIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCG 170
Query: 242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           T  Y APE        +  D +  GVV+ E++ GR P
Sbjct: 171 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 32/215 (14%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G+G YG V+      G   A+K    SS  E       +L     L+HE+ +  +   M
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIF--SSRDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 136 ESNNR----ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
            S +      L+  +  MGSL+D L     +   +    L      ++    A GL  LH
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCL------RIVLSIASGLAHLH 122
Query: 192 EKV-----QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARL---HSTRVLGTF 243
            ++     +P I HRD++S N+L+  + +  IAD  L    S +  +L   ++ RV GT 
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTK 181
Query: 244 GYHAPEYA-MTGQIT-----QKSDVYSFGVVLLEL 272
            Y APE    T Q+      ++ D+++FG+VL E+
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 23/217 (10%)
Query: 68  SNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKL--DTSSAPEPESDFAAQLSVVSRLKH 124
           ++F    L+G+G++G+V   +    G   A+K L  +   A +  +    +  V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 125 EHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
             F+  L Y  ++++R+  V ++A  G L   L   +         V T  +R +  YGA
Sbjct: 65  P-FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---------VFT-EERARF-YGA 112
Query: 184 --AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG 241
                LE+LH +    +V+RD++  N++L  D   KI DF L  +     A + +    G
Sbjct: 113 EIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCG 167
Query: 242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           T  Y APE        +  D +  GVV+ E++ GR P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 32/215 (14%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G+G YG V+      G   A+K    SS  E       +L     L+HE+ +  +   M
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIF--SSRDEKSWFRETELYNTVMLRHENILGFIASDM 101
Query: 136 ESNNR----ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
            S +      L+  +  MGSL+D L              L     +++    A GL  LH
Sbjct: 102 TSRHSSTQLWLITHYHEMGSLYDYLQL----------TTLDTVSCLRIVLSIASGLAHLH 151
Query: 192 EKV-----QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARL---HSTRVLGTF 243
            ++     +P I HRD++S N+L+  + +  IAD  L    S +  +L   ++ RV GT 
Sbjct: 152 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTK 210
Query: 244 GYHAPEYA-MTGQIT-----QKSDVYSFGVVLLEL 272
            Y APE    T Q+      ++ D+++FG+VL E+
Sbjct: 211 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/264 (23%), Positives = 112/264 (42%), Gaps = 27/264 (10%)
Query: 25  GNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRV 84
           G+ +P G  + EP            AL   +     D    +   +     IG G+YG V
Sbjct: 15  GSAEPPGPVKAEPAHTAASVAAKNLAL---LKARSFDVTFDVGDEYEIIETIGNGAYGVV 71
Query: 85  FYAK--LTDGTPAAIKKL-DTSSAPEPESDFAAQLSVVSRLKHEHFV---ELLGYCMESN 138
             A+  LT G   AIKK+ +             +L ++   KH++ +   ++L   +   
Sbjct: 72  SSARRRLT-GQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG 130
Query: 139 NRILVYQFATM--GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQP 196
               VY    +    LH ++H       ++P   LT        Y   +GL+++H     
Sbjct: 131 EFKSVYVVLDLMESDLHQIIHS------SQP---LTLEHVRYFLYQLLRGLKYMHSA--- 178
Query: 197 PIVHRDVRSSNVLLFDDFKSKIADFNLTNQ--SSDTAARLHSTRVLGTFGYHAPEYAMT- 253
            ++HRD++ SN+L+ ++ + KI DF +     +S    +   T  + T  Y APE  ++ 
Sbjct: 179 QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSL 238
Query: 254 GQITQKSDVYSFGVVLLELLTGRK 277
            + TQ  D++S G +  E+L  R+
Sbjct: 239 HEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 32/215 (14%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G+G YG V+      G   A+K    SS  E       +L     L+HE+ +  +   M
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIF--SSRDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 136 ESNNR----ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
            S +      L+  +  MGSL+D L     +   +    L      ++    A GL  LH
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCL------RIVLSIASGLAHLH 122
Query: 192 EKV-----QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARL---HSTRVLGTF 243
            ++     +P I HRD++S N+L+  + +  IAD  L    S +  +L   ++ RV GT 
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTK 181
Query: 244 GYHAPEYA-MTGQIT-----QKSDVYSFGVVLLEL 272
            Y APE    T Q+      ++ D+++FG+VL E+
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 68  SNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKL--DTSSAPEPESDFAAQLSVVSRLKH 124
           ++F    L+G+G++G+V   +    G   A+K L  +   A +  +    +  V+   +H
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 125 EHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
             F+  L Y  ++++R+  V ++A  G L   L   +         V T  +R +  YGA
Sbjct: 70  P-FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---------VFT-EERARF-YGA 117
Query: 184 --AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG 241
                LE+LH +    +V+RD++  N++L  D   KI DF L  +     A +      G
Sbjct: 118 EIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX--FCG 172
Query: 242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           T  Y APE        +  D +  GVV+ E++ GR P
Sbjct: 173 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 22/221 (9%)
Query: 66  LTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEP--ESDFAAQLSVVSRL 122
            +  +  + ++G+GS+G V   K    G   A+K +      +   +     ++ ++ +L
Sbjct: 30  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 89
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            H + ++L  +  +     LV +  T G L D +  RK     +   ++           
Sbjct: 90  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR---------Q 140
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLL---FDDFKSKIADFNLTNQSSDTAARLHSTRV 239
              G+ ++H   +  IVHRD++  N+LL     D   +I DF L   S+   A       
Sbjct: 141 VLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGL---STHFEASKKMKDK 194
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
           +GT  Y APE  + G   +K DV+S GV+L  LL+G  P +
Sbjct: 195 IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFN 234

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 42/220 (19%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDF-AAQLSVVSRLKHEHFVELLGYC 134
           IG+G +G V+  K   G   A+K     S+ E  S F  A++     L+HE+   +LG+ 
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHEN---ILGFI 102
Query: 135 MESNNR-------ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
              N          LV  +   GSL D L+             +T    +K+A   A GL
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----------TVTVEGMIKLALSTASGL 152
Query: 188 EFLHEKV-----QPPIVHRDVRSSNVLLFDDFKSKIADFNLT---NQSSDTAARLHSTRV 239
             LH ++     +P I HRD++S N+L+  +    IAD  L    + ++DT     + RV
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 240 LGTFGYHAPEYAMTGQITQK-------SDVYSFGVVLLEL 272
            GT  Y APE  +   I  K       +D+Y+ G+V  E+
Sbjct: 213 -GTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 23/209 (11%)
Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKL-DTSSAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           +G G+YG V     K+T     AIK +  TS +    S    +++V+  L H + ++L  
Sbjct: 45  LGSGAYGEVLLCRDKVT-HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           +  +  N  LV +    G L D +  R      +   ++              G+ +LH 
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK---------QVLSGVTYLH- 153
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKS---KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE 249
             +  IVHRD++  N+LL    K    KI DF L   S+    +      LGT  Y APE
Sbjct: 154 --KHNIVHRDLKPENLLLESKEKDALIKIVDFGL---SAVFENQKKMKERLGTAYYIAPE 208
Query: 250 YAMTGQITQKSDVYSFGVVLLELLTGRKP 278
             +  +  +K DV+S GV+L  LL G  P
Sbjct: 209 -VLRKKYDEKCDVWSIGVILFILLAGYPP 236

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 68  SNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKL--DTSSAPEPESDFAAQLSVVSRLKH 124
           ++F    L+G+G++G+V   +    G   A+K L  +   A +  +    +  V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 125 EHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
             F+  L Y  ++++R+  V ++A  G L   L   +         V T  +R +  YGA
Sbjct: 65  P-FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---------VFT-EERARF-YGA 112
Query: 184 --AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG 241
                LE+LH +    +V+RD++  N++L  D   KI DF L  +     A +      G
Sbjct: 113 EIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX--FCG 167
Query: 242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           T  Y APE        +  D +  GVV+ E++ GR P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 101/242 (41%), Gaps = 40/242 (16%)
Query: 65  RLTSNFGTKALIGEGSYGRVFYAKLTDGTP-AAIKKLDTSSAPEPESD-FAAQLSVVSRL 122
           ++  N+  K LIG GSYG V+ A   +     AIKK++       +      ++++++RL
Sbjct: 25  KVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRL 84
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLH-GRKGVQGAEPGPVLTWNQRVK-VA 180
           K ++ + L       ++ I+         L+ VL      ++     P+    Q VK + 
Sbjct: 85  KSDYIIRL-------HDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTIL 137
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           Y    G +F+HE     I+HRD++ +N LL  D   KI DF L  ++ ++   +H    L
Sbjct: 138 YNLLLGEKFIHE---SGIIHRDLKPANCLLNQDCSVKICDFGLA-RTINSDKDIHIVNDL 193
Query: 241 G------------------------TFGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTG 275
                                    T  Y APE  +  +  T   D++S G +  ELL  
Sbjct: 194 EEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNM 253
Query: 276 RK 277
            K
Sbjct: 254 MK 255

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 109/260 (41%), Gaps = 27/260 (10%)
Query: 31  GSARGEPRTNVVKTGT---PQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYA 87
           G A GEPR+     GT   P   L               +  +  + ++G+GS+G V   
Sbjct: 9   GGAAGEPRSRGHAAGTSGGPGDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILC 68
Query: 88  K-LTDGTPAAIK---KLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV 143
           K    G   A+K   K       + ES    ++ ++ +L H + ++L  +  +     LV
Sbjct: 69  KDKITGQECAVKVISKRQVKQKTDKES-LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 127
Query: 144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDV 203
            +  T G L D +  RK     +   ++              G+ ++H   +  IVHRD+
Sbjct: 128 GEVYTGGELFDEIISRKRFSEVDAARIIR---------QVLSGITYMH---KNKIVHRDL 175
Query: 204 RSSNVLL---FDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKS 260
           +  N+LL     D   +I DF L   S+   A       +GT  Y APE  + G   +K 
Sbjct: 176 KPENLLLESKSKDANIRIIDFGL---STHFEASKKMKDKIGTAYYIAPE-VLHGTYDEKC 231
Query: 261 DVYSFGVVLLELLTGRKPVD 280
           DV+S GV+L  LL+G  P +
Sbjct: 232 DVWSTGVILYILLSGCPPFN 251

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 109/260 (41%), Gaps = 27/260 (10%)
Query: 31  GSARGEPRTNVVKTGT---PQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYA 87
           G A GEPR+     GT   P   L               +  +  + ++G+GS+G V   
Sbjct: 10  GGAAGEPRSRGHAAGTSGGPGDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILC 69
Query: 88  K-LTDGTPAAIK---KLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV 143
           K    G   A+K   K       + ES    ++ ++ +L H + ++L  +  +     LV
Sbjct: 70  KDKITGQECAVKVISKRQVKQKTDKES-LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 128
Query: 144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDV 203
            +  T G L D +  RK     +   ++              G+ ++H   +  IVHRD+
Sbjct: 129 GEVYTGGELFDEIISRKRFSEVDAARIIRQ---------VLSGITYMH---KNKIVHRDL 176
Query: 204 RSSNVLL---FDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKS 260
           +  N+LL     D   +I DF L   S+   A       +GT  Y APE  + G   +K 
Sbjct: 177 KPENLLLESKSKDANIRIIDFGL---STHFEASKKMKDKIGTAYYIAPE-VLHGTYDEKC 232
Query: 261 DVYSFGVVLLELLTGRKPVD 280
           DV+S GV+L  LL+G  P +
Sbjct: 233 DVWSTGVILYILLSGCPPFN 252

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 42/220 (19%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDF-AAQLSVVSRLKHEHFVELLGYC 134
           IG+G +G V+  K   G   A+K     S+ E  S F  A++     L+HE+   +LG+ 
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHEN---ILGFI 69
Query: 135 MESNNR-------ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
              N          LV  +   GSL D L+             +T    +K+A   A GL
Sbjct: 70  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----------YTVTVEGMIKLALSTASGL 119
Query: 188 EFLHEKV-----QPPIVHRDVRSSNVLLFDDFKSKIADFNLT---NQSSDTAARLHSTRV 239
             LH ++     +P I HRD++S N+L+  +    IAD  L    + ++DT     + RV
Sbjct: 120 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 179
Query: 240 LGTFGYHAPEYAMTGQITQK-------SDVYSFGVVLLEL 272
            GT  Y APE  +   I  K       +D+Y+ G+V  E+
Sbjct: 180 -GTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 27/213 (12%)
Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPE--SDFAAQLSVVSRLKHEHFVELL 131
           +G G++G+V     +LT G   A+K L+       +       ++  +   +H H ++L 
Sbjct: 19  LGVGTFGKVKIGEHQLT-GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 132 GYCMESNNRILVYQFATMGSLHDVL--HGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
                  +  +V ++ + G L D +  HGR  V+  E   +    Q++  A      +++
Sbjct: 78  QVISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLF---QQILSA------VDY 126
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE 249
            H  +   +VHRD++  NVLL     +KIADF L+N  SD      S    G+  Y APE
Sbjct: 127 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC---GSPNYAAPE 180
Query: 250 YAMTGQITQ--KSDVYSFGVVLLELLTGRKPVD 280
             ++G++    + D++S GV+L  LL G  P D
Sbjct: 181 -VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 42/220 (19%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDF-AAQLSVVSRLKHEHFVELLGYC 134
           IG+G +G V+  K   G   A+K     S+ E  S F  A++     L+HE+   +LG+ 
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHEN---ILGFI 64
Query: 135 MESNNR-------ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
              N          LV  +   GSL D L+             +T    +K+A   A GL
Sbjct: 65  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----------YTVTVEGMIKLALSTASGL 114
Query: 188 EFLHEKV-----QPPIVHRDVRSSNVLLFDDFKSKIADFNLT---NQSSDTAARLHSTRV 239
             LH ++     +P I HRD++S N+L+  +    IAD  L    + ++DT     + RV
Sbjct: 115 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 174
Query: 240 LGTFGYHAPEYAMTGQITQK-------SDVYSFGVVLLEL 272
            GT  Y APE  +   I  K       +D+Y+ G+V  E+
Sbjct: 175 -GTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 42/220 (19%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDF-AAQLSVVSRLKHEHFVELLGYC 134
           IG+G +G V+  K   G   A+K     S+ E  S F  A++     L+HE+   +LG+ 
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHEN---ILGFI 89
Query: 135 MESNNR-------ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
              N          LV  +   GSL D L+             +T    +K+A   A GL
Sbjct: 90  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----------YTVTVEGMIKLALSTASGL 139
Query: 188 EFLHEKV-----QPPIVHRDVRSSNVLLFDDFKSKIADFNLT---NQSSDTAARLHSTRV 239
             LH ++     +P I HRD++S N+L+  +    IAD  L    + ++DT     + RV
Sbjct: 140 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 199
Query: 240 LGTFGYHAPEYAMTGQITQK-------SDVYSFGVVLLEL 272
            GT  Y APE  +   I  K       +D+Y+ G+V  E+
Sbjct: 200 -GTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 42/220 (19%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDF-AAQLSVVSRLKHEHFVELLGYC 134
           IG+G +G V+  K   G   A+K     S+ E  S F  A++     L+HE+   +LG+ 
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHEN---ILGFI 66
Query: 135 MESNNR-------ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
              N          LV  +   GSL D L+             +T    +K+A   A GL
Sbjct: 67  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----------YTVTVEGMIKLALSTASGL 116
Query: 188 EFLHEKV-----QPPIVHRDVRSSNVLLFDDFKSKIADFNLT---NQSSDTAARLHSTRV 239
             LH ++     +P I HRD++S N+L+  +    IAD  L    + ++DT     + RV
Sbjct: 117 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 176
Query: 240 LGTFGYHAPEYAMTGQITQK-------SDVYSFGVVLLEL 272
            GT  Y APE  +   I  K       +D+Y+ G+V  E+
Sbjct: 177 -GTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 68  SNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKL--DTSSAPEPESDFAAQLSVVSRLKH 124
           ++F    L+G+G++G+V   +    G   A+K L  +   A +  +    +  V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 125 EHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
             F+  L Y  ++++R+  V ++A  G L   L   +         V T  +R +  YGA
Sbjct: 65  P-FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---------VFT-EERARF-YGA 112
Query: 184 --AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG 241
                LE+LH +    +V+RD++  N++L  D   KI DF L  +     A +      G
Sbjct: 113 EIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX--FCG 167
Query: 242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           T  Y APE        +  D +  GVV+ E++ GR P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 97/233 (41%), Gaps = 37/233 (15%)
Query: 68  SNFGTKALIGEGSYGRVF--YAKLTDGTPAAIKKLDTSSAPEPESD-FAAQLSVVSRLKH 124
            N+  K LIG GSYG V+  Y K T+    AIKK++       +      ++++++RLK 
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKN-VAIKKVNRMFEDLIDCKRILREITILNRLKS 84
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLH-GRKGVQGAEPGPVLTWNQRVK-VAYG 182
           ++ + L    +  +             L+ VL      ++     P+    + +K + Y 
Sbjct: 85  DYIIRLYDLIIPDD-------LLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYN 137
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL---TNQSSDTAA------- 232
              G  F+HE     I+HRD++ +N LL  D   K+ DF L    N   DT         
Sbjct: 138 LLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 233 ----------RLHSTRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLT 274
                     +   T  + T  Y APE  +  +   KS D++S G +  ELL 
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 68  SNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKL--DTSSAPEPESDFAAQLSVVSRLKH 124
           ++F    L+G+G++G+V   +    G   A+K L  +   A +  +    +  V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 125 EHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
             F+  L Y  ++++R+  V ++A  G L   L   +         V T  +R +  YGA
Sbjct: 65  P-FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---------VFT-EERARF-YGA 112
Query: 184 --AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG 241
                LE+LH +    +V+RD++  N++L  D   KI DF L  +     A +      G
Sbjct: 113 EIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX--FCG 167
Query: 242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           T  Y APE        +  D +  GVV+ E++ GR P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 42/220 (19%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDF-AAQLSVVSRLKHEHFVELLGYC 134
           IG+G +G V+  K   G   A+K     S+ E  S F  A++     L+HE+   +LG+ 
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHEN---ILGFI 63
Query: 135 MESNNR-------ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
              N          LV  +   GSL D L+             +T    +K+A   A GL
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----------YTVTVEGMIKLALSTASGL 113
Query: 188 EFLHEKV-----QPPIVHRDVRSSNVLLFDDFKSKIADFNLT---NQSSDTAARLHSTRV 239
             LH ++     +P I HRD++S N+L+  +    IAD  L    + ++DT     + RV
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173
Query: 240 LGTFGYHAPEYAMTGQITQK-------SDVYSFGVVLLEL 272
            GT  Y APE  +   I  K       +D+Y+ G+V  E+
Sbjct: 174 -GTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 27/213 (12%)
Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPE--SDFAAQLSVVSRLKHEHFVELL 131
           +G G++G+V     +LT G   A+K L+       +       ++  +   +H H ++L 
Sbjct: 19  LGVGTFGKVKIGEHQLT-GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 132 GYCMESNNRILVYQFATMGSLHDVL--HGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
                  +  +V ++ + G L D +  HGR  V+  E   +    Q++  A      +++
Sbjct: 78  QVISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLF---QQILSA------VDY 126
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE 249
            H  +   +VHRD++  NVLL     +KIADF L+N  SD      S    G+  Y APE
Sbjct: 127 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE 180
Query: 250 YAMTGQITQ--KSDVYSFGVVLLELLTGRKPVD 280
             ++G++    + D++S GV+L  LL G  P D
Sbjct: 181 -VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 27/211 (12%)
Query: 75  LIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPE-SDFAAQLSVVSRLKHEHFVELLGY 133
           LIG+G +G+V++ +       AI+ +D     E +   F  ++    + +HE+ V  +G 
Sbjct: 40  LIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
           CM   +  ++       +L+ V+   K         VL  N+  ++A    KG+ +LH K
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVVRDAK--------IVLDVNKTRQIAQEIVKGMGYLHAK 149
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA--RLHSTRVLGTFGYH-APEY 250
               I+H+D++S NV  +D+ K  I DF L + S    A  R    R+   +  H APE 
Sbjct: 150 ---GILHKDLKSKNV-FYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 251 AMTGQ---------ITQKSDVYSFGVVLLEL 272
                          ++ SDV++ G +  EL
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 15/204 (7%)
Query: 76  IGEGSYGRV-FYAKLTDGTPAAIKKLDTSSAPEPESD-FAAQLSVVSRLKHEHFVELLGY 133
           IG GSYGR     + +DG     K+LD  S  E E     ++++++  LKH + V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 134 CMESNNRIL--VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
            ++  N  L  V ++   G L  V+      +G +    L     ++V       L+  H
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVI-----TKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 192 EKVQ--PPIVHRDVRSSNVLLFDDFKSKIADFNLTN-QSSDTAARLHSTRVLGTFGYHAP 248
            +      ++HRD++ +NV L      K+ DF L    + DT+    +   +GT  Y +P
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS---FAKTFVGTPYYMSP 185
Query: 249 EYAMTGQITQKSDVYSFGVVLLEL 272
           E        +KSD++S G +L EL
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 23/210 (10%)
Query: 76  IGEGSYGRVFYAKLTDGTP-AAIKK--LDTSSAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           IGEG+YG VF AK  +     A+K+  LD      P S    ++ ++  LKH++ V L  
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHD 68
Query: 133 YCMESNNRILVYQFAT--MGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
                    LV++F    +    D  +G       +P  V ++       +   KGL F 
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNG-----DLDPEIVKSF------LFQLLKGLGFC 117
Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEY 250
           H +    ++HRD++  N+L+  + + K+ADF L  ++     R +S  V+ T  Y  P+ 
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLADFGLA-RAFGIPVRCYSAEVV-TLWYRPPDV 172
Query: 251 AMTGQITQKS-DVYSFGVVLLELLTGRKPV 279
               ++   S D++S G +  EL    +P+
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/264 (23%), Positives = 112/264 (42%), Gaps = 27/264 (10%)
Query: 25  GNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRV 84
           G+ +P G  + EP            AL   +     D    +   +     IG G+YG V
Sbjct: 14  GSAEPPGPVKAEPAHTAASVAAKNLAL---LKARSFDVTFDVGDEYEIIETIGNGAYGVV 70
Query: 85  FYAK--LTDGTPAAIKKL-DTSSAPEPESDFAAQLSVVSRLKHEHFV---ELLGYCMESN 138
             A+  LT G   AIKK+ +             +L ++   KH++ +   ++L   +   
Sbjct: 71  SSARRRLT-GQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG 129
Query: 139 NRILVYQFATM--GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQP 196
               VY    +    LH ++H       ++P   LT        Y   +GL+++H     
Sbjct: 130 EFKSVYVVLDLMESDLHQIIHS------SQP---LTLEHVRYFLYQLLRGLKYMHSA--- 177
Query: 197 PIVHRDVRSSNVLLFDDFKSKIADFNLTNQ--SSDTAARLHSTRVLGTFGYHAPEYAMT- 253
            ++HRD++ SN+L+ ++ + KI DF +     +S    +   T  + T  Y APE  ++ 
Sbjct: 178 QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSL 237
Query: 254 GQITQKSDVYSFGVVLLELLTGRK 277
            + TQ  D++S G +  E+L  R+
Sbjct: 238 HEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 15/204 (7%)
Query: 76  IGEGSYGRV-FYAKLTDGTPAAIKKLDTSSAPEPESD-FAAQLSVVSRLKHEHFVELLGY 133
           IG GSYGR     + +DG     K+LD  S  E E     ++++++  LKH + V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 134 CMESNNRIL--VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
            ++  N  L  V ++   G L  V+      +G +    L     ++V       L+  H
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVI-----TKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 192 EKVQ--PPIVHRDVRSSNVLLFDDFKSKIADFNLTN-QSSDTAARLHSTRVLGTFGYHAP 248
            +      ++HRD++ +NV L      K+ DF L    + DT+    +   +GT  Y +P
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS---FAKAFVGTPYYMSP 185
Query: 249 EYAMTGQITQKSDVYSFGVVLLEL 272
           E        +KSD++S G +L EL
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 34/220 (15%)
Query: 76  IGEGSYGRVFYAKLTDG-TPAAIKKL------------DTSSAPEPESDFAAQLSVVSRL 122
           +G G+YG V   K  +G +  AIK +            D  +  +   +   ++S++  L
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            H + ++L     +     LV +F   G L + +  R      +   ++           
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK---------Q 154
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD---FKSKIADFNLTNQ-SSDTAARLHSTR 238
              G+ +LH   +  IVHRD++  N+LL +       KI DF L++  S D   R     
Sbjct: 155 ILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR--- 208
Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            LGT  Y APE  +  +  +K DV+S GV++  LL G  P
Sbjct: 209 -LGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 110/235 (46%), Gaps = 24/235 (10%)
Query: 59  KLDELNRLTSNFGTKALIGEGSYGRVFYAKLT--DGT--PAAIKKL--DTSSAPEPESDF 112
           KL+++      F    ++G+G +G V  A+L   DG+    A+K L  D  ++ + E +F
Sbjct: 14  KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE-EF 72
Query: 113 AAQLSVVSRLKHEHFVELLGYCMESNNR------ILVYQFATMGSLHDVLHGRKGVQGAE 166
             + + +    H H  +L+G  + S  +      +++  F   G LH  L   +  +   
Sbjct: 73  LREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132
Query: 167 PGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ 226
             P+ T    V+     A G+E+L  +     +HRD+ + N +L +D    +ADF L+ +
Sbjct: 133 NLPLQTL---VRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRK 186
Query: 227 --SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
             S D   +  ++++     + A E       T  SDV++FGV + E++T G+ P
Sbjct: 187 IYSGDYYRQGCASKL--PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 102/234 (43%), Gaps = 31/234 (13%)
Query: 59  KLDELNRLTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLS 117
           K +++ +LTS      L+GEG+Y +V  A  L +G   A+K ++  +       F    +
Sbjct: 9   KFEDMYKLTSE-----LLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVET 63
Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV 177
           +     +++ +EL+ +  +     LV++    GS+   +  +K     E           
Sbjct: 64  LYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREAS--------- 114
Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS---KIADFNL-----TNQSSD 229
           +V    A  L+FLH K    I HRD++  N+L     K    KI DF+L      N S  
Sbjct: 115 RVVRDVAAALDFLHTK---GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCT 171
Query: 230 TAARLHSTRVLGTFGYHAPEYA--MTGQIT---QKSDVYSFGVVLLELLTGRKP 278
                  T   G+  Y APE     T Q T   ++ D++S GVVL  +L+G  P
Sbjct: 172 PITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/271 (23%), Positives = 118/271 (43%), Gaps = 46/271 (16%)
Query: 65  RLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK 123
           R  S+F   A++G+G++G+V  A+   D    AIKK+      E  S   +++ +++ L 
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI--RHTEEKLSTILSEVMLLASLN 60
Query: 124 HEHFVELLGYCMESNNRI-------------LVYQFATMGSLHDVLHGRKGVQGAEPGPV 170
           H++ V      +E  N +             +  ++    +L+D++H     Q  +    
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE--- 117
Query: 171 LTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN--QSS 228
             W    ++     + L ++H +    I+HRD++  N+ + +    KI DF L      S
Sbjct: 118 -YW----RLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 229 DTAARLHS----------TRVLGTFGYHAPEYAM-TGQITQKSDVYSFGVVLLELL---- 273
               +L S          T  +GT  Y A E    TG   +K D+YS G++  E++    
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFS 229
Query: 274 TGRKPVDHTMPKGQQSLVTWATPRLSEDKVK 304
           TG + V+  + K  +S+     P   ++K+K
Sbjct: 230 TGMERVN--ILKKLRSVSIEFPPDFDDNKMK 258

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 117/267 (43%), Gaps = 27/267 (10%)
Query: 26  NTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLDE-LNRLTSN-FGTKALIGEGSYGR 83
            T   G  + E      ++G+P      E  ++ L +  +R+T N F    L+G+G++G+
Sbjct: 107 QTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGK 166
Query: 84  VFYAK-LTDGTPAAIK--KLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNR 140
           V   K    G   A+K  K +   A +  +    +  V+   +H  F+  L Y  ++++R
Sbjct: 167 VILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP-FLTALKYSFQTHDR 225
Query: 141 I-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA--AKGLEFLHEKVQPP 197
           +  V ++A  G L   L   +            +++     YGA     L++LH   +  
Sbjct: 226 LCFVMEYANGGELFFHLSRER-----------VFSEDRARFYGAEIVSALDYLHS--EKN 272
Query: 198 IVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQIT 257
           +V+RD++  N++L  D   KI DF L  +     A + +    GT  Y APE        
Sbjct: 273 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDNDYG 330
Query: 258 QKSDVYSFGVVLLELLTGRKPV---DH 281
           +  D +  GVV+ E++ GR P    DH
Sbjct: 331 RAVDWWGLGVVMYEMMCGRLPFYNQDH 357

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 24/222 (10%)
Query: 66  LTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIK---KLDTSSAPEPESDFAAQLSVVSR 121
            +  +  + ++G+GS+G V   K    G   A+K   K       + ES    ++ ++ +
Sbjct: 24  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES-LLREVQLLKQ 82
Query: 122 LKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY 181
           L H + ++L  +  +     LV +  T G L D +  RK     +   ++          
Sbjct: 83  LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR--------- 133
Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLL---FDDFKSKIADFNLTNQSSDTAARLHSTR 238
               G+ ++H   +  IVHRD++  N+LL     D   +I DF L   S+   A      
Sbjct: 134 QVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGL---STHFEASKKMKD 187
Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
            +GT  Y APE  + G   +K DV+S GV+L  LL+G  P +
Sbjct: 188 KIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 26/228 (11%)
Query: 64  NRLTSN-FGTKALIGEGSYGRVFYAK-LTDGTPAAIK--KLDTSSAPEPESDFAAQLSVV 119
           +R+T N F    L+G+G++G+V   K    G   A+K  K +   A +  +    +  V+
Sbjct: 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL 202
Query: 120 SRLKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK 178
              +H  F+  L Y  ++++R+  V ++A  G L   L   +            +++   
Sbjct: 203 QNSRHP-FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-----------VFSEDRA 250
Query: 179 VAYGA--AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS 236
             YGA     L++LH   +  +V+RD++  N++L  D   KI DF L  +     A + +
Sbjct: 251 RFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 308
Query: 237 TRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPV---DH 281
               GT  Y APE        +  D +  GVV+ E++ GR P    DH
Sbjct: 309 --FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 354

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 24/210 (11%)
Query: 76  IGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE----L 130
           IGEG+YG V  A      T  AIKK+              ++ ++ R +HE+ +     L
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
               +E+   + + Q      L+ +L  ++          L+ +      Y   +GL+++
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKLLKSQQ----------LSNDHICYFLYQILRGLKYI 160
Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL---TNQSSDTAARLHSTRVLGTFGYHA 247
           H      ++HRD++ SN+L+      KI DF L    +   D    L  T  + T  Y A
Sbjct: 161 HSA---NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFL--TEXVATRWYRA 215
Query: 248 PEYAMTGQ-ITQKSDVYSFGVVLLELLTGR 276
           PE  +  +  T+  D++S G +L E+L+ R
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 96/226 (42%), Gaps = 21/226 (9%)
Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKL-----DTSSAPEPESDFAAQ- 115
           EL+ + S +  +  I  GSYG V     ++G P AIK++     D  +       F  + 
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 116 -LSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDV--LHGRKGVQGAEPGPVLT 172
            L  +  L H H   +LG      +  + ++   M  L+ V  L      Q      ++ 
Sbjct: 76  VLREIRLLNHFHHPNILGL----RDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVI 131
Query: 173 WNQRVK-VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTA 231
             Q ++   Y    GL  LHE     +VHRD+   N+LL D+    I DFNL  + +  A
Sbjct: 132 SPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 232 ARLHSTRVLGTFGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGR 276
            + H    +    Y APE  M  +  T+  D++S G V+ E+   +
Sbjct: 189 NKTH---YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 96/226 (42%), Gaps = 21/226 (9%)
Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKL-----DTSSAPEPESDFAAQ- 115
           EL+ + S +  +  I  GSYG V     ++G P AIK++     D  +       F  + 
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 116 -LSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDV--LHGRKGVQGAEPGPVLT 172
            L  +  L H H   +LG      +  + ++   M  L+ V  L      Q      ++ 
Sbjct: 76  VLREIRLLNHFHHPNILGL----RDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVI 131
Query: 173 WNQRVK-VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTA 231
             Q ++   Y    GL  LHE     +VHRD+   N+LL D+    I DFNL  + +  A
Sbjct: 132 SPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 232 ARLHSTRVLGTFGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGR 276
            + H    +    Y APE  M  +  T+  D++S G V+ E+   +
Sbjct: 189 NKTH---YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 70  FGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           +   + IGEG+YG V  A    +    AIKK+              ++ ++ R +HE+ +
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 129 ELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVL-----TWNQRVKVAYGA 183
            +       N+ I       M  ++ V H    + GA+   +L     + +      Y  
Sbjct: 105 GI-------NDIIRAPTIEQMKDVYLVTH----LMGADLYKLLKTQHLSNDHICYFLYQI 153
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGT 242
            +GL+++H      ++HRD++ SN+LL      KI DF L   +  D       T  + T
Sbjct: 154 LRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 210
Query: 243 FGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGR 276
             Y APE  +  +  T+  D++S G +L E+L+ R
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/132 (33%), Positives = 66/132 (50%), Gaps = 13/132 (9%)
Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
           K+A    K LE LH K+   ++HRDV+ SNVL+    + K+ DF ++    D  A+    
Sbjct: 113 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA 170
Query: 238 RVLGTFGYHAPEYAMTGQITQ-----KSDVYSFGVVLLELLTGRKPVDHTMPKGQQ--SL 290
              G   Y APE  +  ++ Q     KSD++S G+ ++EL   R P D      QQ   +
Sbjct: 171 ---GCKPYMAPE-RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 226
Query: 291 VTWATPRLSEDK 302
           V   +P+L  DK
Sbjct: 227 VEEPSPQLPADK 238

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 18/217 (8%)
Query: 68  SNFGTKALIGEGSYGRVFYA--KLTDGTPAA-IKKLDTSSAPEPESDFAAQLSVVSRLKH 124
           ++F    ++G+GS+G+V  +  K TD   A  I K D     +       +  V++    
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 125 EHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
             F+  L  C ++ +R+  V ++   G L  + H ++  +  EP  V         A   
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVF-------YAAEI 451
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
           A GL FL  K    I++RD++  NV+L  +   KIADF +  +  +    + +    GT 
Sbjct: 452 AIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKXFCGTP 506
Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
            Y APE        +  D ++FGV+L E+L G+ P +
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 24/221 (10%)
Query: 65  RLTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPE-SDFAAQLSVVSRL 122
           + + N+  K  +G+G++  V      T G   A K ++T      +      +  +  +L
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV--KVA 180
           +H + V L     E +   LV+   T G L + +  R+    A+    +   Q++   +A
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI---QQILESIA 119
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS---KIADFNLTNQSSDTAARLHST 237
           Y  + G           IVHR+++  N+LL    K    K+ADF L  + +D+ A  H  
Sbjct: 120 YCHSNG-----------IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHG- 166
Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
              GT GY +PE       ++  D+++ GV+L  LL G  P
Sbjct: 167 -FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 24/221 (10%)
Query: 65  RLTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPE-SDFAAQLSVVSRL 122
           + + N+  K  +G+G++  V      T G   A K ++T      +      +  +  +L
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV--KVA 180
           +H + V L     E +   LV+   T G L + +  R+    A+    +   Q++   +A
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI---QQILESIA 119
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS---KIADFNLTNQSSDTAARLHST 237
           Y  + G           IVHR+++  N+LL    K    K+ADF L  + +D+ A  H  
Sbjct: 120 YCHSNG-----------IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHG- 166
Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
              GT GY +PE       ++  D+++ GV+L  LL G  P
Sbjct: 167 -FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 24/221 (10%)
Query: 65  RLTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPE-SDFAAQLSVVSRL 122
           + + N+  K  +G+G++  V      T G   A K ++T      +      +  +  +L
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 61
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV--KVA 180
           +H + V L     E +   LV+   T G L + +  R+    A+    +   Q++   +A
Sbjct: 62  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI---QQILESIA 118
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS---KIADFNLTNQSSDTAARLHST 237
           Y  + G           IVHR+++  N+LL    K    K+ADF L  + +D+ A  H  
Sbjct: 119 YCHSNG-----------IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHG- 165
Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
              GT GY +PE       ++  D+++ GV+L  LL G  P
Sbjct: 166 -FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 100/229 (43%), Gaps = 24/229 (10%)
Query: 57  QIKLDELNRLTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPE-SDFAA 114
           +  ++   + + N+  K  +G+G++  V      T G   A K ++T      +      
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77
Query: 115 QLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWN 174
           +  +  +L+H + V L     E +   LV+   T G L + +  R+    A+    +   
Sbjct: 78  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI--- 134
Query: 175 QRV--KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS---KIADFNLTNQSSD 229
           Q++   +AY  + G           IVHR+++  N+LL    K    K+ADF L  + +D
Sbjct: 135 QQILESIAYCHSNG-----------IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183
Query: 230 TAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           + A  H     GT GY +PE       ++  D+++ GV+L  LL G  P
Sbjct: 184 SEA-WHG--FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 23/210 (10%)
Query: 76  IGEGSYGRVFYAKLTDGTP-AAIKK--LDTSSAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           IGEG+YG VF AK  +     A+K+  LD      P S    ++ ++  LKH++ V L  
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHD 68
Query: 133 YCMESNNRILVYQFAT--MGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
                    LV++F    +    D  +G       +P  V ++       +   KGL F 
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNG-----DLDPEIVKSF------LFQLLKGLGFC 117
Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEY 250
           H +    ++HRD++  N+L+  + + K+A+F L  ++     R +S  V+ T  Y  P+ 
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLA-RAFGIPVRCYSAEVV-TLWYRPPDV 172
Query: 251 AMTGQITQKS-DVYSFGVVLLELLTGRKPV 279
               ++   S D++S G +  EL    +P+
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 87/225 (38%), Gaps = 29/225 (12%)
Query: 67  TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDF-------AAQLSVV 119
           TS +   A IG G+YG V+ A+  D        L +   P  E           A L  +
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKAR--DPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 120 SRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKV 179
              +H + V L+  C  S       +         V    +      P P L       +
Sbjct: 61  EAFEHPNVVRLMDVCATSRTD---REIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 117
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR- 238
                +GL+FLH      IVHRD++  N+L+      K+ADF L        AR++S + 
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGL--------ARIYSYQM 166
Query: 239 ----VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPV 279
               V+ T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 167 ALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 100/223 (44%), Gaps = 23/223 (10%)
Query: 63  LNRLTSN-FGTKALIGEGSYGRVFYAK-LTDGTPAAIK--KLDTSSAPEPESDFAAQLSV 118
           + R+T N F    L+G+G++G+V   K    G   A+K  K +   A +  +    +  V
Sbjct: 3   MARVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV 62
Query: 119 VSRLKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV 177
           +   +H  F+  L Y  ++++R+  V ++A  G L   L   +            +++  
Sbjct: 63  LQNSRHP-FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-----------VFSEDR 110
Query: 178 KVAYGA--AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
              YGA     L++LH   +  +V+RD++  N++L  D   KI DF L  +     A + 
Sbjct: 111 ARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 168
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
                GT  Y APE        +  D +  GVV+ E++ GR P
Sbjct: 169 X--FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 24/222 (10%)
Query: 66  LTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIK---KLDTSSAPEPESDFAAQLSVVSR 121
            +  +  + ++G+GS+G V   K    G   A+K   K       + ES    ++ ++ +
Sbjct: 24  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES-LLREVQLLKQ 82
Query: 122 LKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY 181
           L H +  +L  +  +     LV +  T G L D +  RK     +   ++          
Sbjct: 83  LDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR--------- 133
Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLL---FDDFKSKIADFNLTNQSSDTAARLHSTR 238
               G+ + H   +  IVHRD++  N+LL     D   +I DF L   S+   A      
Sbjct: 134 QVLSGITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGL---STHFEASKKXKD 187
Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
            +GT  Y APE  + G   +K DV+S GV+L  LL+G  P +
Sbjct: 188 KIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 23/222 (10%)
Query: 64  NRLTSN-FGTKALIGEGSYGRVFYAK-LTDGTPAAIK--KLDTSSAPEPESDFAAQLSVV 119
           +R+T N F    L+G+G++G+V   K    G   A+K  K +   A +  +    +  V+
Sbjct: 3   SRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL 62
Query: 120 SRLKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK 178
              +H  F+  L Y  ++++R+  V ++A  G L   L   +            +++   
Sbjct: 63  QNSRHP-FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-----------VFSEDRA 110
Query: 179 VAYGA--AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS 236
             YGA     L++LH   +  +V+RD++  N++L  D   KI DF L  +     A +  
Sbjct: 111 RFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX 168
Query: 237 TRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
               GT  Y APE        +  D +  GVV+ E++ GR P
Sbjct: 169 --FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 87/218 (39%), Gaps = 15/218 (6%)
Query: 67  TSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPE--PESDF--AAQLSVVSR 121
           TS +   A IG G+YG V+ A+    G   A+K +   +  E  P S     A L  +  
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEA 62
Query: 122 LKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY 181
            +H + V L+  C  S       +         V    +      P P L       +  
Sbjct: 63  FEHPNVVRLMDVCATSRTD---REIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR 119
Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG 241
              +GL+FLH      IVHRD++  N+L+      K+ADF L    S   A      V+ 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFP---VVV 173
Query: 242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPV 279
           T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 91/223 (40%), Gaps = 25/223 (11%)
Query: 67  TSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPE--PESDF--AAQLSVVSR 121
           TS +   A IG G+YG V+ A+    G   A+K +   +  E  P S     A L  +  
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEA 62
Query: 122 LKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY 181
            +H + V L+  C  S       +         V    +      P P L       +  
Sbjct: 63  FEHPNVVRLMDVCATSRTD---REIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR 119
Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR--- 238
              +GL+FLH      IVHRD++  N+L+      K+ADF L        AR++S +   
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGL--------ARIYSYQMAL 168
Query: 239 --VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPV 279
             V+ T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 169 APVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 18/217 (8%)
Query: 68  SNFGTKALIGEGSYGRVFYA--KLTDGTPAA-IKKLDTSSAPEPESDFAAQLSVVSRLKH 124
           ++F    ++G+GS+G+V  +  K TD   A  I K D     +       +  V++    
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 125 EHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
             F+  L  C ++ +R+  V ++   G L  + H ++  +  EP  V         A   
Sbjct: 80  PPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVF-------YAAEI 130
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
           A GL FL  K    I++RD++  NV+L  +   KIADF +  +  +    + +    GT 
Sbjct: 131 AIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKXFCGTP 185
Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
            Y APE        +  D ++FGV+L E+L G+ P +
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 39/227 (17%)
Query: 76  IGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFA-AQLSVVSRLKHEHFVELLGY 133
           +G G+YG V  A     G   AIKKL      E  +  A  +L ++  ++HE+ + LL  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 134 CM------ESNNRILVYQF--ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK-VAYGAA 184
                   +  +  LV  F    +G L  + H + G              R++ + Y   
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKL--MKHEKLG------------EDRIQFLVYQML 138
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
           KGL ++H      I+HRD++  N+ + +D + KI DF L  Q+         TR      
Sbjct: 139 KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTR-----W 190
Query: 245 YHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSL 290
           Y APE  +   + TQ  D++S G ++ E++TG+     T+ KG   L
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK-----TLFKGSDHL 232

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 23/221 (10%)
Query: 65  RLTSN-FGTKALIGEGSYGRVFYAK-LTDGTPAAIK--KLDTSSAPEPESDFAAQLSVVS 120
           R+T N F    L+G+G++G+V   K    G   A+K  K +   A +  +    +  V+ 
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 65
Query: 121 RLKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKV 179
             +H  F+  L Y  ++++R+  V ++A  G L   L   +            +++    
Sbjct: 66  NSRHP-FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-----------VFSEDRAR 113
Query: 180 AYGA--AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
            YGA     L++LH   +  +V+RD++  N++L  D   KI DF L  +     A +   
Sbjct: 114 FYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX- 170
Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
              GT  Y APE        +  D +  GVV+ E++ GR P
Sbjct: 171 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 102/230 (44%), Gaps = 21/230 (9%)
Query: 53  IEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTP-AAIKKLDTSSAPEPESD 111
           +E P+ K  E  R   +F  + ++G G++  V  A+        AIK +   +    E  
Sbjct: 5   VEGPRWKQAEDIRDIYDF--RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS 62
Query: 112 FAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVL 171
              +++V+ ++KH + V L        +  L+ Q  + G L D +         E G   
Sbjct: 63  MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--------VEKG-FY 113
Query: 172 TWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSS 228
           T     ++ +     +++LH+     IVHRD++  N+L +   +D K  I+DF L+ +  
Sbjct: 114 TERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KME 169
Query: 229 DTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           D  + L +    GT GY APE       ++  D +S GV+   LL G  P
Sbjct: 170 DPGSVLSTA--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 105/244 (43%), Gaps = 27/244 (11%)
Query: 57  QIKLDELN-RLTSN-FGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFA 113
           Q K  ELN  LT N F    +IG G +G V+  +  D G   A+K LD       + +  
Sbjct: 176 QWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL 235
Query: 114 A-----QLSVVSRLKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEP 167
           A      LS+VS      F+  + Y   + +++  +      G LH  L        ++ 
Sbjct: 236 ALNERIMLSLVS-TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--------SQH 286
Query: 168 GPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS 227
           G     + R   A     GLE +H +    +V+RD++ +N+LL +    +I+D  L    
Sbjct: 287 GVFSEADMRFYAA-EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342
Query: 228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDHTMPKG 286
           S    + H++  +GT GY APE    G     S D +S G +L +LL G  P      K 
Sbjct: 343 S--KKKPHAS--VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 398
Query: 287 QQSL 290
           +  +
Sbjct: 399 KHEI 402

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 105/244 (43%), Gaps = 27/244 (11%)
Query: 57  QIKLDELN-RLTSN-FGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFA 113
           Q K  ELN  LT N F    +IG G +G V+  +  D G   A+K LD       + +  
Sbjct: 176 QWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL 235
Query: 114 A-----QLSVVSRLKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEP 167
           A      LS+VS      F+  + Y   + +++  +      G LH  L        ++ 
Sbjct: 236 ALNERIMLSLVSTGDCP-FIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--------SQH 286
Query: 168 GPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS 227
           G     + R   A     GLE +H +    +V+RD++ +N+LL +    +I+D  L    
Sbjct: 287 GVFSEADMRFYAA-EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342
Query: 228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDHTMPKG 286
           S    + H++  +GT GY APE    G     S D +S G +L +LL G  P      K 
Sbjct: 343 S--KKKPHAS--VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 398
Query: 287 QQSL 290
           +  +
Sbjct: 399 KHEI 402

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 105/244 (43%), Gaps = 27/244 (11%)
Query: 57  QIKLDELN-RLTSN-FGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFA 113
           Q K  ELN  LT N F    +IG G +G V+  +  D G   A+K LD       + +  
Sbjct: 176 QWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL 235
Query: 114 A-----QLSVVSRLKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEP 167
           A      LS+VS      F+  + Y   + +++  +      G LH  L        ++ 
Sbjct: 236 ALNERIMLSLVSTGDCP-FIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--------SQH 286
Query: 168 GPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS 227
           G     + R   A     GLE +H +    +V+RD++ +N+LL +    +I+D  L    
Sbjct: 287 GVFSEADMRFYAA-EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342
Query: 228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDHTMPKG 286
           S    + H++  +GT GY APE    G     S D +S G +L +LL G  P      K 
Sbjct: 343 S--KKKPHAS--VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 398
Query: 287 QQSL 290
           +  +
Sbjct: 399 KHEI 402

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 105/244 (43%), Gaps = 27/244 (11%)
Query: 57  QIKLDELN-RLTSN-FGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFA 113
           Q K  ELN  LT N F    +IG G +G V+  +  D G   A+K LD       + +  
Sbjct: 175 QWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL 234
Query: 114 A-----QLSVVSRLKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEP 167
           A      LS+VS      F+  + Y   + +++  +      G LH  L        ++ 
Sbjct: 235 ALNERIMLSLVS-TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--------SQH 285
Query: 168 GPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS 227
           G     + R   A     GLE +H +    +V+RD++ +N+LL +    +I+D  L    
Sbjct: 286 GVFSEADMRFYAA-EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 341
Query: 228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDHTMPKG 286
           S    + H++  +GT GY APE    G     S D +S G +L +LL G  P      K 
Sbjct: 342 S--KKKPHAS--VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 397
Query: 287 QQSL 290
           +  +
Sbjct: 398 KHEI 401

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 102/230 (44%), Gaps = 21/230 (9%)
Query: 53  IEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTP-AAIKKLDTSSAPEPESD 111
           +E P+ K  E  R   +F  + ++G G++  V  A+        AIK +   +    E  
Sbjct: 5   VEGPRWKQAEDIRDIYDF--RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS 62
Query: 112 FAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVL 171
              +++V+ ++KH + V L        +  L+ Q  + G L D +         E G   
Sbjct: 63  MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--------VEKG-FY 113
Query: 172 TWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSS 228
           T     ++ +     +++LH+     IVHRD++  N+L +   +D K  I+DF L+ +  
Sbjct: 114 TERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KME 169
Query: 229 DTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           D  + L +    GT GY APE       ++  D +S GV+   LL G  P
Sbjct: 170 DPGSVLSTA--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 36/214 (16%)
Query: 76  IGEGSYGRV---FYAKLTDGTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +G G+YG V   + A+L      A+KKL     S       +  +L ++  LKHE+ + L
Sbjct: 28  VGSGAYGSVCSAYDARLRQKV--AVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 84
Query: 131 LGYCMESNNRILVYQFATMGSLHDV--LHGRKGVQGAEPGPVLTW----NQRVK-VAYGA 183
           L              F    S+ D   ++    + GA+   ++      ++ V+ + Y  
Sbjct: 85  LDV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQL 132
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
            +GL+++H      I+HRD++ SNV + +D + +I DF L  Q+ +       T  + T 
Sbjct: 133 LRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEM-----TGYVATR 184
Query: 244 GYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
            Y APE  +      Q  D++S G ++ ELL G+
Sbjct: 185 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 105/249 (42%), Gaps = 58/249 (23%)
Query: 56  PQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQ 115
           P + LD L  L        LIG G YG V+   L D  P A+K    ++      +F  +
Sbjct: 8   PSLDLDNLKLLE-------LIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINE 55
Query: 116 LSV--VSRLKHEHFVELL--GYCMESNNR---ILVYQFATMGSLHDVLHGRKGVQGAEPG 168
            ++  V  ++H++    +     + ++ R   +LV ++   GSL   L            
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS------- 108
Query: 169 PVLTWNQRVKVAYGAAKGLEFLHEKV------QPPIVHRDVRSSNVLLFDDFKSKIADFN 222
               W    ++A+   +GL +LH ++      +P I HRD+ S NVL+ +D    I+DF 
Sbjct: 109 ---DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165
Query: 223 LTNQ----------SSDTAARLHSTRVLGTFGYHAPEYAMTGQIT--------QKSDVYS 264
           L+ +            D AA       +GT  Y APE  + G +         ++ D+Y+
Sbjct: 166 LSMRLTGNRLVRPGEEDNAA----ISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYA 220
Query: 265 FGVVLLELL 273
            G++  E+ 
Sbjct: 221 LGLIYWEIF 229

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 86/221 (38%), Gaps = 18/221 (8%)
Query: 67  TSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSA-------PEPESDFAAQLSV 118
           TS +   A IG G+YG V+ A+    G   A+K +   +        P       A L  
Sbjct: 8   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67
Query: 119 VSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK 178
           +   +H + V L+  C  S       +         V    +      P P L       
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTD---REIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKD 124
Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
           +     +GL+FLH      IVHRD++  N+L+      K+ADF L    S   A    T 
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LTP 178
Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPV 279
           V+ T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 91/220 (41%), Gaps = 24/220 (10%)
Query: 76  IGEGSYGRVFYAKLTDGTP--AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           IG GS+  V+    T+ T   A  +  D          F  +   +  L+H + V     
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD- 92
Query: 134 CMESNNR-----ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
             ES  +     +LV +  T G+L   L   K  +  +   + +W +++       KGL+
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYL---KRFKVXKIKVLRSWCRQI------LKGLQ 143
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           FLH +  PPI+HRD++  N+ +     S KI D  L      + A+     V+GT  + A
Sbjct: 144 FLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFXA 198
Query: 248 PEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQ 287
           PE     +  +  DVY+FG   LE  T   P        Q
Sbjct: 199 PE-XYEEKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQ 237

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 102/230 (44%), Gaps = 21/230 (9%)
Query: 53  IEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTP-AAIKKLDTSSAPEPESD 111
           +E P+ K  E  R   +F  + ++G G++  V  A+        AIK +   +    E  
Sbjct: 5   VEGPRWKQAEDIRDIYDF--RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS 62
Query: 112 FAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVL 171
              +++V+ ++KH + V L        +  L+ Q  + G L D +         E G   
Sbjct: 63  MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--------VEKG-FY 113
Query: 172 TWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSS 228
           T     ++ +     +++LH+     IVHRD++  N+L +   +D K  I+DF L+ +  
Sbjct: 114 TERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KME 169
Query: 229 DTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           D  + L +    GT GY APE       ++  D +S GV+   LL G  P
Sbjct: 170 DPGSVLSTA--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 22/215 (10%)
Query: 70  FGTKALIGEGSYGRVF--YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           +   + IGEG+YG V   Y  L +    AIKK+              ++ ++ R +HE+ 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENI 87
Query: 128 VELLGYC----MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           + +        +E    + + Q      L+ +L  +           L+ +      Y  
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----------LSNDHICYFLYQI 137
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGT 242
            +GL+++H      ++HRD++ SN+LL      KI DF L   +  D       T  + T
Sbjct: 138 LRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 243 FGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGR 276
             Y APE  +  +  T+  D++S G +L E+L+ R
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 70/161 (43%), Gaps = 19/161 (11%)
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGS-----LHDVLHGRKGVQGAEPGPVLTWNQRVK 178
           H  F+  L Y  E+   + +      G      +++V     G Q  EP  +    Q V 
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ--EPRAIFYTAQIVS 300
Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
                  GLE LH++    I++RD++  NVLL DD   +I+D  L  +    A +  +  
Sbjct: 301 -------GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKG 348
Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPV 279
             GT G+ APE  +  +     D ++ GV L E++  R P 
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 70/161 (43%), Gaps = 19/161 (11%)
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGS-----LHDVLHGRKGVQGAEPGPVLTWNQRVK 178
           H  F+  L Y  E+   + +      G      +++V     G Q  EP  +    Q V 
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ--EPRAIFYTAQIVS 300
Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
                  GLE LH++    I++RD++  NVLL DD   +I+D  L  +    A +  +  
Sbjct: 301 -------GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKG 348
Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPV 279
             GT G+ APE  +  +     D ++ GV L E++  R P 
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/253 (22%), Positives = 106/253 (41%), Gaps = 24/253 (9%)
Query: 70  FGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           +   + IGEG+YG V  A    +    AIKK+              ++ ++ R +HE+ +
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 129 ELLGYC----MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            +        +E    + + Q      L+ +L  +           L+ +      Y   
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----------LSNDHICYFLYQIL 134
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGTF 243
           +GL+++H      ++HRD++ SN+LL      KI DF L   +  D       T  + T 
Sbjct: 135 RGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 244 GYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGRK--PVDHTMPKGQQSLVTWATPRLSE 300
            Y APE  +  +  T+  D++S G +L E+L+ R   P  H + +    L    +P  S+
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP--SQ 249
Query: 301 DKVKQCVDPKLNN 313
           + +   ++ K  N
Sbjct: 250 EDLNXIINLKARN 262

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 89/169 (52%), Gaps = 20/169 (11%)
Query: 115 QLSVVSRLKHEHFVELLGYCMESN--NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLT 172
           +++++ +L H + V+L+    + N  +  +V++    G + +V          +P   L+
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV-------PTLKP---LS 135
Query: 173 WNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA 232
            +Q         KG+E+LH +    I+HRD++ SN+L+ +D   KIADF ++N+   + A
Sbjct: 136 EDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 233 RLHSTRVLGTFGYHAPE-YAMTGQIT--QKSDVYSFGVVLLELLTGRKP 278
            L +T  +GT  + APE  + T +I   +  DV++ GV L   + G+ P
Sbjct: 193 LLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 102/230 (44%), Gaps = 21/230 (9%)
Query: 53  IEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTP-AAIKKLDTSSAPEPESD 111
           +E P+ K  E  R   +F  + ++G G++  V  A+        AIK +   +    E  
Sbjct: 5   VEGPRWKQAEDIRDIYDF--RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS 62
Query: 112 FAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVL 171
              +++V+ ++KH + V L        +  L+ Q  + G L D +         E G   
Sbjct: 63  MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--------VEKG-FY 113
Query: 172 TWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSS 228
           T     ++ +     +++LH+     IVHRD++  N+L +   +D K  I+DF L+ +  
Sbjct: 114 TERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KME 169
Query: 229 DTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           D  + L +    GT GY APE       ++  D +S GV+   LL G  P
Sbjct: 170 DPGSVLSTA--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 70/161 (43%), Gaps = 19/161 (11%)
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGS-----LHDVLHGRKGVQGAEPGPVLTWNQRVK 178
           H  F+  L Y  E+   + +      G      +++V     G Q  EP  +    Q V 
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ--EPRAIFYTAQIVS 300
Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
                  GLE LH++    I++RD++  NVLL DD   +I+D  L  +    A +  +  
Sbjct: 301 -------GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKG 348
Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPV 279
             GT G+ APE  +  +     D ++ GV L E++  R P 
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 20/214 (9%)
Query: 70  FGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           +   + IGEG+YG V  A    +    AIKK+              ++ ++ R +HE+ +
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 129 ELLGYC----MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            +        +E    + + Q      L+ +L  +           L+ +      Y   
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----------LSNDHICYFLYQIL 136
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGTF 243
           +GL+++H      ++HRD++ SN+LL      KI DF L   +  D       T  + T 
Sbjct: 137 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 244 GYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGR 276
            Y APE  +  +  T+  D++S G +L E+L+ R
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 20/214 (9%)
Query: 70  FGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           +   + IGEG+YG V  A    +    AIKK+              ++ ++ R +HE+ +
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 129 ELLGYC----MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            +        +E    + + Q      L+ +L  +           L+ +      Y   
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----------LSNDHICYFLYQIL 134
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGTF 243
           +GL+++H      ++HRD++ SN+LL      KI DF L   +  D       T  + T 
Sbjct: 135 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 244 GYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGR 276
            Y APE  +  +  T+  D++S G +L E+L+ R
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 70/161 (43%), Gaps = 19/161 (11%)
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGS-----LHDVLHGRKGVQGAEPGPVLTWNQRVK 178
           H  F+  L Y  E+   + +      G      +++V     G Q  EP  +    Q V 
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ--EPRAIFYTAQIVS 300
Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
                  GLE LH++    I++RD++  NVLL DD   +I+D  L  +    A +  +  
Sbjct: 301 -------GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKG 348
Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPV 279
             GT G+ APE  +  +     D ++ GV L E++  R P 
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 20/214 (9%)
Query: 70  FGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           +   + IGEG+YG V  A    +    AIKK+              ++ ++ R +HE+ +
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 129 ELLGYC----MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            +        +E    + + Q      L+ +L  +           L+ +      Y   
Sbjct: 105 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----------LSNDHICYFLYQIL 154
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGTF 243
           +GL+++H      ++HRD++ SN+LL      KI DF L   +  D       T  + T 
Sbjct: 155 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 244 GYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGR 276
            Y APE  +  +  T+  D++S G +L E+L+ R
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 32/212 (15%)
Query: 76  IGEGSYGRV---FYAKLTDGTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +G G+YG V   + A+L      A+KKL     S       +  +L ++  LKHE+ + L
Sbjct: 36  VGSGAYGSVCSAYDARLRQKV--AVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 131 L-----GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
           L        +E  + + +        L++++  +           L+      + Y   +
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQ----------ALSDEHVQFLVYQLLR 142
Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           GL+++H      I+HRD++ SNV + +D + +I DF L  Q+ +       T  + T  Y
Sbjct: 143 GLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEM-----TGYVATRWY 194
Query: 246 HAPEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
            APE  +      Q  D++S G ++ ELL G+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 20/214 (9%)
Query: 70  FGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           +   + IGEG+YG V  A    +    AIKK+              ++ ++ R +HE+ +
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 129 ELLGYC----MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            +        +E    + + Q      L+ +L  +           L+ +      Y   
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----------LSNDHICYFLYQIL 134
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGTF 243
           +GL+++H      ++HRD++ SN+LL      KI DF L   +  D       T  + T 
Sbjct: 135 RGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 244 GYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGR 276
            Y APE  +  +  T+  D++S G +L E+L+ R
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 36/214 (16%)
Query: 76  IGEGSYGRV---FYAKLTDGTPAAIKKLDT--SSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +G G+YG V   + A+L      A+KKL     S       +  +L ++  LKHE+ + L
Sbjct: 36  VGSGAYGSVCSAYDARLRQKV--AVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 131 LGYCMESNNRILVYQFATMGSLHDV--LHGRKGVQGAEPGPVLTW----NQRVK-VAYGA 183
           L              F    S+ D   ++    + GA+   ++      ++ V+ + Y  
Sbjct: 93  LDV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQL 140
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
            +GL+++H      I+HRD++ SNV + +D + +I DF L  Q+ +       T  + T 
Sbjct: 141 LRGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEM-----TGYVATR 192
Query: 244 GYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGR 276
            Y APE  +      Q  D++S G ++ ELL G+
Sbjct: 193 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 20/214 (9%)
Query: 70  FGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           +   + IGEG+YG V  A    +    AIKK+              ++ ++ R +HE+ +
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 129 ELLGYC----MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            +        +E    + + Q      L+ +L  +           L+ +      Y   
Sbjct: 93  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----------LSNDHICYFLYQIL 142
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGTF 243
           +GL+++H      ++HRD++ SN+LL      KI DF L   +  D       T  + T 
Sbjct: 143 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 199
Query: 244 GYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGR 276
            Y APE  +  +  T+  D++S G +L E+L+ R
Sbjct: 200 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 20/214 (9%)
Query: 70  FGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           +   + IGEG+YG V  A    +    AIKK+              ++ ++ R +HE+ +
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 129 ELLGYC----MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            +        +E    + + Q      L+ +L  +           L+ +      Y   
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----------LSNDHICYFLYQIL 134
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGTF 243
           +GL+++H      ++HRD++ SN+LL      KI DF L   +  D       T  + T 
Sbjct: 135 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 244 GYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGR 276
            Y APE  +  +  T+  D++S G +L E+L+ R
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 20/214 (9%)
Query: 70  FGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           +   + IGEG+YG V  A    +    AIKK+              ++ ++ R +HE+ +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 129 ELLGYC----MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            +        +E    + + Q      L+ +L  +           L+ +      Y   
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQH----------LSNDHICYFLYQIL 138
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGTF 243
           +GL+++H      ++HRD++ SN+LL      KI DF L   +  D       T  + T 
Sbjct: 139 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 244 GYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGR 276
            Y APE  +  +  T+  D++S G +L E+L+ R
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 34/230 (14%)
Query: 67  TSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAA-QLSVVSRLKH 124
            S +   A IG+G++G VF A+    G   A+KK+   +  E     A  ++ ++  LKH
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 125 EHFVELLGYCMESN---NRI-----LVYQFA---TMGSLHDVLHGRKGVQGAEPGPVLTW 173
           E+ V L+  C       NR      LV+ F      G L +VL               T 
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK------------FTL 124
Query: 174 NQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS---DT 230
           ++  +V      GL ++H      I+HRD++++NVL+  D   K+ADF L    S   ++
Sbjct: 125 SEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 181
Query: 231 AARLHSTRVLGTFGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGRKPV 279
               +  RV+ T  Y  PE  +  +      D++  G ++ E+ T R P+
Sbjct: 182 QPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 96/236 (40%), Gaps = 27/236 (11%)
Query: 69  NFGTKALIGEGSYGRVFYAKLTDGTPA-------AIKKLDTSSAPEPESDFAAQLSVVSR 121
           NF    ++G G+YG+VF  +   G           +KK       +       +  V+  
Sbjct: 55  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 122 LKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
           ++   F+  L Y  ++  ++ L+  +   G L   L  R+     E          V++ 
Sbjct: 115 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE----------VQIY 164
Query: 181 YG-AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ-SSDTAARLHSTR 238
            G     LE LH   +  I++RD++  N+LL  +    + DF L+ +  +D   R +   
Sbjct: 165 VGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-- 219
Query: 239 VLGTFGYHAPEYAMTGQITQKS--DVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT 292
             GT  Y AP+    G        D +S GV++ ELLTG  P      K  Q+ ++
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 275

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 22/215 (10%)
Query: 70  FGTKALIGEGSYGRVF--YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           +   + IGEG+YG V   Y  L +    AIKK+              ++ ++ R +HE+ 
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 128 VELLGYC----MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           + +        +E    + + Q      L+ +L  +           L+ +      Y  
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----------LSNDHICYFLYQI 138
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGT 242
            +GL+++H      ++HRD++ SN+LL      KI DF L   +  D       T  + T
Sbjct: 139 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 195
Query: 243 FGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGR 276
             Y APE  +  +  T+  D++S G +L E+L+ R
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 20/214 (9%)
Query: 70  FGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           +   + IGEG+YG V  A    +    AIKK+              ++ ++ R +HE+ +
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 129 ELLGYC----MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            +        +E    + + Q      L+ +L  +           L+ +      Y   
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----------LSNDHICYFLYQIL 132
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGTF 243
           +GL+++H      ++HRD++ SN+LL      KI DF L   +  D       T  + T 
Sbjct: 133 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 189
Query: 244 GYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGR 276
            Y APE  +  +  T+  D++S G +L E+L+ R
Sbjct: 190 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/132 (33%), Positives = 64/132 (48%), Gaps = 13/132 (9%)
Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
           K+A    K LE LH K+   ++HRDV+ SNVL+    + K  DF ++    D  A+    
Sbjct: 140 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA 197
Query: 238 RVLGTFGYHAPEYAMTGQITQ-----KSDVYSFGVVLLELLTGRKPVDHTMPKGQQ--SL 290
              G   Y APE  +  ++ Q     KSD++S G+  +EL   R P D      QQ   +
Sbjct: 198 ---GCKPYXAPE-RINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQV 253
Query: 291 VTWATPRLSEDK 302
           V   +P+L  DK
Sbjct: 254 VEEPSPQLPADK 265

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 22/215 (10%)
Query: 70  FGTKALIGEGSYGRVF--YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           +   + IGEG+YG V   Y  L +    AIKK+              ++ ++ R +HE+ 
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 89
Query: 128 VELLGYC----MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           + +        +E    + + Q      L+ +L  +           L+ +      Y  
Sbjct: 90  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----------LSNDHICYFLYQI 139
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGT 242
            +GL+++H      ++HRD++ SN+LL      KI DF L   +  D       T  + T
Sbjct: 140 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 196
Query: 243 FGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGR 276
             Y APE  +  +  T+  D++S G +L E+L+ R
Sbjct: 197 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 22/215 (10%)
Query: 70  FGTKALIGEGSYGRVF--YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           +   + IGEG+YG V   Y  L +    AIKK+              ++ ++ R +HE+ 
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 80
Query: 128 VELLGYC----MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           + +        +E    + + Q      L+ +L  +           L+ +      Y  
Sbjct: 81  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----------LSNDHICYFLYQI 130
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGT 242
            +GL+++H      ++HRD++ SN+LL      KI DF L   +  D       T  + T
Sbjct: 131 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 187
Query: 243 FGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGR 276
             Y APE  +  +  T+  D++S G +L E+L+ R
Sbjct: 188 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 22/215 (10%)
Query: 70  FGTKALIGEGSYGRVF--YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           +   + IGEG+YG V   Y  L +    AIKK+              ++ ++ R +HE+ 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 128 VELLGYC----MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           + +        +E    + + Q      L+ +L  +           L+ +      Y  
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----------LSNDHICYFLYQI 137
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGT 242
            +GL+++H      ++HRD++ SN+LL      KI DF L   +  D       T  + T
Sbjct: 138 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 243 FGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGR 276
             Y APE  +  +  T+  D++S G +L E+L+ R
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 115/271 (42%), Gaps = 46/271 (16%)
Query: 65  RLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK 123
           R  S+F   A++G+G++G+V  A+   D    AIKK+      E  S   +++ +++ L 
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI--RHTEEKLSTILSEVXLLASLN 60
Query: 124 HEHFVELLGYCMESNNRI-------------LVYQFATMGSLHDVLHGRKGVQGAEPGPV 170
           H++ V      +E  N +             +  ++    +L+D++H     Q  +    
Sbjct: 61  HQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE--- 117
Query: 171 LTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN--QSS 228
             W    ++     + L ++H +    I+HR+++  N+ + +    KI DF L      S
Sbjct: 118 -YW----RLFRQILEALSYIHSQ---GIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 229 DTAARLHS----------TRVLGTFGYHAPEYAM-TGQITQKSDVYSFGVVLLELL---- 273
               +L S          T  +GT  Y A E    TG   +K D YS G++  E +    
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFS 229
Query: 274 TGRKPVDHTMPKGQQSLVTWATPRLSEDKVK 304
           TG + V+  + K  +S+     P   ++K K
Sbjct: 230 TGXERVN--ILKKLRSVSIEFPPDFDDNKXK 258

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/253 (22%), Positives = 106/253 (41%), Gaps = 24/253 (9%)
Query: 70  FGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           +   + IGEG+YG V  A    +    AIKK+              ++ ++ R +HE+ +
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 129 ELLGYC----MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            +        +E    + + Q      L+ +L  +           L+ +      Y   
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----------LSNDHICYFLYQIL 134
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGTF 243
           +GL+++H      ++HRD++ SN+LL      KI DF L   +  D       T  + T 
Sbjct: 135 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATR 191
Query: 244 GYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGRK--PVDHTMPKGQQSLVTWATPRLSE 300
            Y APE  +  +  T+  D++S G +L E+L+ R   P  H + +    L    +P  S+
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP--SQ 249
Query: 301 DKVKQCVDPKLNN 313
           + +   ++ K  N
Sbjct: 250 EDLNXIINLKARN 262

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 34/230 (14%)
Query: 67  TSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAA-QLSVVSRLKH 124
            S +   A IG+G++G VF A+    G   A+KK+   +  E     A  ++ ++  LKH
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 125 EHFVELLGYCMESN---NRI-----LVYQFA---TMGSLHDVLHGRKGVQGAEPGPVLTW 173
           E+ V L+  C       NR      LV+ F      G L +VL               T 
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK------------FTL 124
Query: 174 NQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS---DT 230
           ++  +V      GL ++H      I+HRD++++NVL+  D   K+ADF L    S   ++
Sbjct: 125 SEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 181
Query: 231 AARLHSTRVLGTFGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGRKPV 279
               +  RV+ T  Y  PE  +  +      D++  G ++ E+ T R P+
Sbjct: 182 QPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 20/214 (9%)
Query: 70  FGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           +   + IGEG+YG V  A    +    AIKK+              ++ ++ R +HE+ +
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 129 ELLGYC----MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            +        +E    + + Q      L+ +L  +           L+ +      Y   
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----------LSNDHICYFLYQIL 132
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGTF 243
           +GL+++H      ++HRD++ SN+LL      KI DF L   +  D       T  + T 
Sbjct: 133 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 189
Query: 244 GYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGR 276
            Y APE  +  +  T+  D++S G +L E+L+ R
Sbjct: 190 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 22/215 (10%)
Query: 70  FGTKALIGEGSYGRVF--YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           +   + IGEG+YG V   Y  L +    AIKK+              ++ ++ R +HE+ 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 128 VELLGYC----MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           + +        +E    + + Q      L+ +L  +           L+ +      Y  
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----------LSNDHICYFLYQI 137
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGT 242
            +GL+++H      ++HRD++ SN+LL      KI DF L   +  D       T  + T
Sbjct: 138 LRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 243 FGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGR 276
             Y APE  +  +  T+  D++S G +L E+L+ R
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 34/230 (14%)
Query: 67  TSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAA-QLSVVSRLKH 124
            S +   A IG+G++G VF A+    G   A+KK+   +  E     A  ++ ++  LKH
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 125 EHFVELLGYCMESN---NRI-----LVYQFA---TMGSLHDVLHGRKGVQGAEPGPVLTW 173
           E+ V L+  C       NR      LV+ F      G L +VL               T 
Sbjct: 77  ENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK------------FTL 124
Query: 174 NQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS---DT 230
           ++  +V      GL ++H      I+HRD++++NVL+  D   K+ADF L    S   ++
Sbjct: 125 SEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 181
Query: 231 AARLHSTRVLGTFGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGRKPV 279
               +  RV+ T  Y  PE  +  +      D++  G ++ E+ T R P+
Sbjct: 182 QPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 34/216 (15%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDF-AAQLSVVSRLKHEHFVELLGYC 134
           IG+G YG V+  K   G   A+K   T+   E  S F   ++     ++HE+ +  +   
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 135 MESNNR----ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
           ++         L+  +   GSL+D L              L     +K+AY +  GL  L
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYL----------KSTTLDAKSMLKLAYSSVSGLCHL 150
Query: 191 HEKV-----QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH---STRVLGT 242
           H ++     +P I HRD++S N+L+  +    IAD  L  +       +    +TRV GT
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GT 209
Query: 243 FGYHAPEYAMTG------QITQKSDVYSFGVVLLEL 272
             Y  PE           Q    +D+YSFG++L E+
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 34/230 (14%)
Query: 67  TSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAA-QLSVVSRLKH 124
            S +   A IG+G++G VF A+    G   A+KK+   +  E     A  ++ ++  LKH
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 125 EHFVELLGYCMESN---NRI-----LVYQFA---TMGSLHDVLHGRKGVQGAEPGPVLTW 173
           E+ V L+  C       NR      LV+ F      G L +VL               T 
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK------------FTL 123
Query: 174 NQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS---DT 230
           ++  +V      GL ++H      I+HRD++++NVL+  D   K+ADF L    S   ++
Sbjct: 124 SEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 231 AARLHSTRVLGTFGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGRKPV 279
               +  RV+ T  Y  PE  +  +      D++  G ++ E+ T R P+
Sbjct: 181 QPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 228

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 101/228 (44%), Gaps = 38/228 (16%)
Query: 76  IGEGSYGRVFYA-KLTDGTPAAIKKLDTS--SAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           +G+G+YG V+ +     G   A+KK+  +  ++ + +  F   + +     HE+ V LL 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 133 YCMESNNRILVYQFATMGS-LHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
                N+R +   F  M + LH V+             +L    +  V Y   K +++LH
Sbjct: 77  VLRADNDRDVYLVFDYMETDLHAVIRAN----------ILEPVHKQYVVYQLIKVIKYLH 126
Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS--------------- 236
                 ++HRD++ SN+LL  +   K+ADF L+    +     ++               
Sbjct: 127 ---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 237 ----TRVLGTFGYHAPEYAM-TGQITQKSDVYSFGVVLLELLTGRKPV 279
               T  + T  Y APE  + + + T+  D++S G +L E+L G KP+
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPI 230

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 92/215 (42%), Gaps = 22/215 (10%)
Query: 70  FGTKALIGEGSYGRVF--YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           +   + IGEG+YG V   Y  L +    AI+K+              ++ ++ R +HE+ 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL-NKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 128 VELLGYC----MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           + +        +E    + + Q      L+ +L  +           L+ +      Y  
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----------LSNDHICYFLYQI 137
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGT 242
            +GL+++H      ++HRD++ SN+LL      KI DF L   +  D       T  + T
Sbjct: 138 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 243 FGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGR 276
             Y APE  +  +  T+  D++S G +L E+L+ R
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 75  LIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           ++GEG +G V+    T    +    A+K        + +  F ++  ++  L H H V+L
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 131 LGYCMESNNRIL--VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
           +G   E    I+  +Y +  +G  H +   +  ++      VLT    V  +    K + 
Sbjct: 91  IGIIEEEPTWIIMELYPYGELG--HYLERNKNSLK------VLT---LVLYSLQICKAMA 139
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +L E +    VHRD+   N+L+      K+ DF L+    D      S   L    + +P
Sbjct: 140 YL-ESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL-PIKWMSP 195
Query: 249 EYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
           E     + T  SDV+ F V + E+L+ G++P
Sbjct: 196 ESINFRRFTTASDVWMFAVCMWEILSFGKQP 226

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 75  LIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           ++GEG +G V+    T    +    A+K        + +  F ++  ++  L H H V+L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 131 LGYCMESNNRIL--VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
           +G   E    I+  +Y +  +G  H +   +  ++      VLT    V  +    K + 
Sbjct: 79  IGIIEEEPTWIIMELYPYGELG--HYLERNKNSLK------VLT---LVLYSLQICKAMA 127
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +L E +    VHRD+   N+L+      K+ DF L+    D      S   L    + +P
Sbjct: 128 YL-ESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL-PIKWMSP 183
Query: 249 EYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
           E     + T  SDV+ F V + E+L+ G++P
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 75  LIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           ++GEG +G V+    T    +    A+K        + +  F ++  ++  L H H V+L
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 131 LGYCMESNNRIL--VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
           +G   E    I+  +Y +  +G  H +   +  ++      VLT    V  +    K + 
Sbjct: 75  IGIIEEEPTWIIMELYPYGELG--HYLERNKNSLK------VLT---LVLYSLQICKAMA 123
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +L E +    VHRD+   N+L+      K+ DF L+    D      S   L    + +P
Sbjct: 124 YL-ESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL-PIKWMSP 179
Query: 249 EYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
           E     + T  SDV+ F V + E+L+ G++P
Sbjct: 180 ESINFRRFTTASDVWMFAVCMWEILSFGKQP 210

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/241 (22%), Positives = 111/241 (46%), Gaps = 15/241 (6%)
Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           +G G  G VF A   D     AIKK+   + P+       ++ ++ RL H++ V++    
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKI-VLTDPQSVKHALREIKIIRRLDHDNIVKVFEIL 77
Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQG-----AEPGPVLTWNQRVKVAYGAAKGLEF 189
             S ++ L     ++  L+ V   ++ ++       E GP+L  + R+   Y   +GL++
Sbjct: 78  GPSGSQ-LTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL-FMYQLLRGLKY 135
Query: 190 LHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTN-QSSDTAARLHSTRVLGTFGYHA 247
           +H      ++HRD++ +N+ +  +D   KI DF L        + + H +  L T  Y +
Sbjct: 136 IH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRS 192
Query: 248 PEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC 306
           P   ++    T+  D+++ G +  E+LTG+          Q  L+  + P + E+  ++ 
Sbjct: 193 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQEL 252
Query: 307 V 307
           +
Sbjct: 253 L 253

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 49/104 (47%), Gaps = 3/104 (2%)
Query: 171 LTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT 230
           LT    +  ++  AKG+EFL  +     +HRD+ + N+LL +    KI DF L       
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 251
Query: 231 AARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
              +          + APE       T +SDV+SFGV+L E+ +
Sbjct: 252 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 90/212 (42%), Gaps = 18/212 (8%)
Query: 75  LIGEGSYGRVFYA-KLTDGTPAAIKKLD----TSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +IG+G++  V        G   A+K +D    TSS      D   + S+   LKH H VE
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           LL          +V++F     L       + V+ A+ G V +            + L +
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADL-----CFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKS---KIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
            H+     I+HRDV+  NVLL     S   K+ DF +  Q  ++   L +   +GT  + 
Sbjct: 146 CHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESG--LVAGGRVGTPHFM 200
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           APE        +  DV+  GV+L  LL+G  P
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 49/104 (47%), Gaps = 3/104 (2%)
Query: 171 LTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT 230
           LT    +  ++  AKG+EFL  +     +HRD+ + N+LL +    KI DF L       
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 253
Query: 231 AARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
              +          + APE       T +SDV+SFGV+L E+ +
Sbjct: 254 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 49/104 (47%), Gaps = 3/104 (2%)
Query: 171 LTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT 230
           LT    +  ++  AKG+EFL  +     +HRD+ + N+LL +    KI DF L       
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 231 AARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
              +          + APE       T +SDV+SFGV+L E+ +
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 50/104 (48%), Gaps = 3/104 (2%)
Query: 171 LTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT 230
           +T    +  ++  A+G+EFL  +     +HRD+ + N+LL ++   KI DF L       
Sbjct: 196 ITMEDLISYSFQVARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKN 252
Query: 231 AARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
              +          + APE       + KSDV+S+GV+L E+ +
Sbjct: 253 PDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 83/208 (39%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPE---SDFAAQLSVVSRLKHEHFVELLG 132
           +G+G +G V+ A+          K+   S  E E        ++ + + L H + + L  
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y  +     L+ ++A  G L+  L         +        +   +    A  L + H 
Sbjct: 91  YFYDRRRIYLILEYAPRGELYKEL---------QKSCTFDEQRTATIMEELADALMYCHG 141
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           K    ++HRD++  N+LL    + KIADF      S  A  L    + GT  Y  PE   
Sbjct: 142 K---KVIHRDIKPENLLLGLKGELKIADFGW----SVHAPSLRRKTMCGTLDYLPPEMIE 194
Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVD 280
                +K D++  GV+  ELL G  P +
Sbjct: 195 GRMHNEKVDLWCIGVLCYELLVGNPPFE 222

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 49/104 (47%), Gaps = 3/104 (2%)
Query: 171 LTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT 230
           LT    +  ++  AKG+EFL  +     +HRD+ + N+LL +    KI DF L       
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 244
Query: 231 AARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
              +          + APE       T +SDV+SFGV+L E+ +
Sbjct: 245 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 70/164 (42%), Gaps = 21/164 (12%)
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           H H + L+     S+   LV+     G L D L  +  +   E   ++            
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMR---------SL 209
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
            + + FLH      IVHRD++  N+LL D+ + +++DF  +    +   +L    + GT 
Sbjct: 210 LEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCH-LEPGEKLRE--LCGTP 263
Query: 244 GYHAPEYAMTGQ------ITQKSDVYSFGVVLLELLTGRKPVDH 281
           GY APE              ++ D+++ GV+L  LL G  P  H
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH 307

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 20/214 (9%)
Query: 70  FGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           +   + IGEG+YG V  A    +    AIKK+              ++ ++ R +HE+ +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 129 ELLGYC----MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            +        +E    + + Q      L+ +L  +           L+ +      Y   
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----------LSNDHICYFLYQIL 138
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGTF 243
           +GL+++H      ++HRD++ SN+LL      KI DF L   +  D          + T 
Sbjct: 139 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATR 195
Query: 244 GYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGR 276
            Y APE  +  +  T+  D++S G +L E+L+ R
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 20/214 (9%)
Query: 70  FGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           +   + IGEG+YG V  A    +    AIKK+              ++ ++ R +HE+ +
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 129 ELLGYC----MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            +        +E    + + Q      L+ +L  +           L+ +      Y   
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----------LSNDHICYFLYQIL 139
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGTF 243
           +GL+++H      ++HRD++ SN+LL      KI DF L   +  D          + T 
Sbjct: 140 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATR 196
Query: 244 GYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGR 276
            Y APE  +  +  T+  D++S G +L E+L+ R
Sbjct: 197 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 20/214 (9%)
Query: 70  FGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           +   + IGEG+YG V  A    +    AIKK+              ++ ++   +HE+ +
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 129 ELLGYC----MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            +        +E    + + Q      L+ +L  +           L+ +      Y   
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----------LSNDHICYFLYQIL 136
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGTF 243
           +GL+++H      ++HRD++ SN+LL      KI DF L   +  D       T  + T 
Sbjct: 137 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 244 GYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGR 276
            Y APE  +  +  T+  D++S G +L E+L+ R
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 71/156 (45%), Gaps = 22/156 (14%)
Query: 131 LGYCMESNNRILVY---QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
           +G    S+ ++ +Y   Q     +L D ++ R  ++  E G  L       +    A+ +
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL------HIFIQIAEAV 177
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN--------QSSDTAARLHSTRV 239
           EFLH K    ++HRD++ SN+    D   K+ DF L          Q+  T    ++T  
Sbjct: 178 EFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHX 234
Query: 240 --LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELL 273
             +GT  Y +PE       + K D++S G++L ELL
Sbjct: 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 28/218 (12%)
Query: 69  NFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPES-DFAAQLSVVSRLKHEHF 127
           NF TK  + E   G ++  +   G    +K L        +S DF  +   +    H + 
Sbjct: 13  NFLTK--LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 128 VELLGYCME--SNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
           + +LG C    + +  L+  +   GSL++VLH            V+  +Q VK A   A+
Sbjct: 70  LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-------VVDQSQAVKFALDMAR 122
Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI--ADFNLTNQSSDTAARLHSTRVLGTF 243
           G+ FLH  ++P I    + S +V++ +D  ++I  AD   + QS     R+++       
Sbjct: 123 GMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS---PGRMYAP------ 172
Query: 244 GYHAPEYAMT---GQITQKSDVYSFGVVLLELLTGRKP 278
            + APE           + +D++SF V+L EL+T   P
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 20/214 (9%)
Query: 70  FGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
           +   + IGEG+YG V  A    +    AIKK+              ++ ++   +HE+ +
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 129 ELLGYC----MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            +        +E    + + Q      L+ +L  +           L+ +      Y   
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----------LSNDHICYFLYQIL 136
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGTF 243
           +GL+++H      ++HRD++ SN+LL      KI DF L   +  D       T  + T 
Sbjct: 137 RGLKYIHSA---NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 244 GYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGR 276
            Y APE  +  +  T+  D++S G +L E+L+ R
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 69  NFGTKALIGEGSYGRVFYAKL--TDGTPAA-IKKLDTSSAPEPESDFAAQLSVVSRLKHE 125
           +F    +IG GSY +V   +L  TD   A  + K +  +  E       +  V  +  + 
Sbjct: 21  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 80
Query: 126 HFVELLGYCMESNNRIL-VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            F+  L  C ++ +R+  V ++   G L  + H ++  +  E      ++  + +A    
Sbjct: 81  PFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARF-YSAEISLA---- 133
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS---SDTAARLHSTRVLG 241
             L +LHE+    I++RD++  NVLL  +   K+ D+ +  +     DT     ++   G
Sbjct: 134 --LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-----TSXFCG 183
Query: 242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
           T  Y APE           D ++ GV++ E++ GR P D
Sbjct: 184 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 75  LIGEGSYGRVFYAKLTDGTP-AAIKKLDTSSAPEPESDF----AAQLSVVSRLKHEHFVE 129
            +GEG +  V+ A+  +     AIKK+      E +         ++ ++  L H + + 
Sbjct: 17  FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           LL      +N  LV+ F  M +  +V+     +       VLT +          +GLE+
Sbjct: 77  LLDAFGHKSNISLVFDF--METDLEVIIKDNSL-------VLTPSHIKAYMLMTLQGLEY 127
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE 249
           LH   Q  I+HRD++ +N+LL ++   K+ADF L  +S  +  R +  +V+ T  Y APE
Sbjct: 128 LH---QHWILHRDLKPNNLLLDENGVLKLADFGLA-KSFGSPNRAYXHQVV-TRWYRAPE 182
Query: 250 YAMTGQITQKS-DVYSFGVVLLELL 273
                ++     D+++ G +L ELL
Sbjct: 183 LLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 69  NFGTKALIGEGSYGRVFYAKL--TDGTPAA-IKKLDTSSAPEPESDFAAQLSVVSRLKHE 125
           +F    +IG GSY +V   +L  TD   A  + K +  +  E       +  V  +  + 
Sbjct: 10  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 126 HFVELLGYCMESNNRIL-VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            F+  L  C ++ +R+  V ++   G L  + H ++  +  E      ++  + +A    
Sbjct: 70  PFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARF-YSAEISLA---- 122
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS---SDTAARLHSTRVLG 241
             L +LHE+    I++RD++  NVLL  +   K+ D+ +  +     DT     ++   G
Sbjct: 123 --LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-----TSXFCG 172
Query: 242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
           T  Y APE           D ++ GV++ E++ GR P D
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 69  NFGTKALIGEGSYGRVFYAKL--TDGTPAA-IKKLDTSSAPEPESDFAAQLSVVSRLKHE 125
           +F    +IG GSY +V   +L  TD   A  + K +  +  E       +  V  +  + 
Sbjct: 53  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 126 HFVELLGYCMESNNRIL-VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            F+  L  C ++ +R+  V ++   G L  + H ++  +  E      ++  + +A    
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARF-YSAEISLA---- 165
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS---SDTAARLHSTRVLG 241
             L +LHE+    I++RD++  NVLL  +   K+ D+ +  +     DT     ++   G
Sbjct: 166 --LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-----TSTFCG 215
Query: 242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
           T  Y APE           D ++ GV++ E++ GR P D
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 69  NFGTKALIGEGSYGRVFYAKL--TDGTPAA-IKKLDTSSAPEPESDFAAQLSVVSRLKHE 125
           +F    +IG GSY +V   +L  TD   A  + K +  +  E       +  V  +  + 
Sbjct: 6   DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 65
Query: 126 HFVELLGYCMESNNRIL-VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            F+  L  C ++ +R+  V ++   G L  + H ++  +  E      ++  + +A    
Sbjct: 66  PFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARF-YSAEISLA---- 118
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS---SDTAARLHSTRVLG 241
             L +LHE+    I++RD++  NVLL  +   K+ D+ +  +     DT     ++   G
Sbjct: 119 --LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-----TSXFCG 168
Query: 242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
           T  Y APE           D ++ GV++ E++ GR P D
Sbjct: 169 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 89/219 (40%), Gaps = 21/219 (9%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSS-APEPESDFAAQLSVVSRLK 123
           +T  +     IG+G++  V    KL  G   A K ++T   +         +  +   LK
Sbjct: 2   MTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLK 61
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           H + V L     E     LV+   T G L + +  R+    A+    +   Q++      
Sbjct: 62  HSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCI---QQI------ 112
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS---KIADFNLTNQ-SSDTAARLHSTRV 239
              LE +    Q  +VHRD++  N+LL    K    K+ADF L  +   D  A       
Sbjct: 113 ---LEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFA-- 167
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            GT GY +PE        +  D+++ GV+L  LL G  P
Sbjct: 168 -GTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           +G G+YG V+ AK  DG       L              +++++  LKH + + L    +
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 136 ESNNR--ILVYQFATMGSLHDVLHGRKGVQG--AEPGPVLTWNQRVK-VAYGAAKGLEFL 190
              +R   L++ +A     HD+ H  K  +   A   PV      VK + Y    G+ +L
Sbjct: 89  SHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 191 HEKVQPPIVHRDVRSSNVLLF----DDFKSKIADF---NLTNQSSDTAARLHSTRVLGTF 243
           H      ++HRD++ +N+L+     +  + KIAD     L N      A L    V+ TF
Sbjct: 145 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP--VVVTF 199
Query: 244 GYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGRKPVDH 281
            Y APE  +  +  T+  D+++ G +  ELLT  +P+ H
Sbjct: 200 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 237

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 90/217 (41%), Gaps = 21/217 (9%)
Query: 68  SNFGTKALIGEGSYGRVFYAKLTDGTPA-AIKKLDTSSAPEPES--DFAAQLSVVSRLKH 124
            +F     IG+GS+G+V   +  D     A+K ++     E     +   +L ++  L+H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
              V L     +  +  +V      G L    H ++ V   E    L   + V       
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLR--YHLQQNVHFKEETVKLFICELVM------ 126
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
             L++L  +    I+HRD++  N+LL +     I DFN+   ++        T + GT  
Sbjct: 127 -ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNI---AAMLPRETQITTMAGTKP 179
Query: 245 YHAPEYAMTGQITQKS---DVYSFGVVLLELLTGRKP 278
           Y APE   + +    S   D +S GV   ELL GR+P
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 3/101 (2%)
Query: 200 HRDVRSSNVLLFDDFKSKIADFNLTNQSSDTA-ARLHSTRVLGTFGYHAPEYAMTGQITQ 258
           HRDV+  N+L+  D  + + DF + + ++D    +L +T  +GT  Y APE       T 
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNT--VGTLYYXAPERFSESHATY 214
Query: 259 KSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS 299
           ++D+Y+   VL E LTG  P          + +  A PR S
Sbjct: 215 RADIYALTCVLYECLTGSPPYQGDQLSVXGAHINQAIPRPS 255

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 75  LIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           ++G G +G+V   + T  G   A K + T    + E +   ++SV+++L H + ++L   
Sbjct: 96  ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE-EVKNEISVMNQLDHANLIQLYDA 154
Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
               N+ +LV ++   G L D +   +     E   +L   Q         +G+  +H  
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRIID-ESYNLTELDTILFMKQ-------ICEGIRHMH-- 204
Query: 194 VQPPIVHRDVRSSNVLLF--DDFKSKIADFNLTNQSSDTAARLHSTRV-----LGTFGYH 246
            Q  I+H D++  N+L    D  + KI DF L        AR +  R       GT  + 
Sbjct: 205 -QMYILHLDLKPENILCVNRDAKQIKIIDFGL--------ARRYKPREKLKVNFGTPEFL 255
Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           APE      ++  +D++S GV+   LL+G  P
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/247 (24%), Positives = 106/247 (42%), Gaps = 37/247 (14%)
Query: 40  NVVKTGTPQKALPIEIPQIKL----DELNRLTSN-FGTKALIGEGSYGRVFYAKLTDGTP 94
           ++ K   PQ   P+E+ Q  +    D L  L S  FG      E + GRVF AK  + TP
Sbjct: 32  DIWKKYVPQ---PVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN-TP 87
Query: 95  AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHD 154
             + K    +          ++S++++L H   + L     +    +L+ +F + G L D
Sbjct: 88  YPLDKYTVKN----------EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFD 137
Query: 155 VLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF 214
            +        A     ++  + +     A +GL+ +HE     IVH D++  N++     
Sbjct: 138 RI--------AAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKK 186
Query: 215 KS--KIADFNL-TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLE 271
            S  KI DF L T  + D   ++ +     T  + APE      +   +D+++ GV+   
Sbjct: 187 ASSVKIIDFGLATKLNPDEIVKVTT----ATAEFAAPEIVDREPVGFYTDMWAIGVLGYV 242
Query: 272 LLTGRKP 278
           LL+G  P
Sbjct: 243 LLSGLSP 249

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 92/214 (42%), Gaps = 32/214 (14%)
Query: 75  LIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +IG GS+G V+ AKL D G   AIKK+    A +       +L ++ +L H + V L  +
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-----ELQIMRKLDHCNIVRLRYF 81
Query: 134 CMESN--------NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKV-AYGAA 184
              S         N +L Y  AT+  +      R   +  +  PV+     VK+  Y   
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPATVYRV-----ARHYSRAKQTLPVIY----VKLYMYQLF 132
Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLHSTRVLGTF 243
           + L ++H      I HRD++  N+LL  D    K+ DF    Q       +     + + 
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX---ICSR 186
Query: 244 GYHAPEYAM-TGQITQKSDVYSFGVVLLELLTGR 276
            Y APE        T   DV+S G VL ELL G+
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 6/100 (6%)
Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           GLE LH +    IV+RD++  N+LL D    +I+D  L     +   +    RV GT GY
Sbjct: 298 GLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRV-GTVGY 351
Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPK 285
            APE     + T   D ++ G +L E++ G+ P      K
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 103/248 (41%), Gaps = 53/248 (21%)
Query: 65  RLTSNFGTKALIGEGSYGRVFYA--KLTDG--TPAAIKKLDTSSAPEPESDFAAQLSVVS 120
           +L++ F  +  IGEG++  V+ A  +L  G     A+K L  +S P      AA+L  ++
Sbjct: 18  QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHP---IRIAAELQCLT 74
Query: 121 RLKHEHFVELLGYCMESNNRILVYQ-FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKV 179
               +  V  + YC   N+ +++   +    S  D+L+             L++ +  + 
Sbjct: 75  VAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS------------LSFQEVREY 122
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARL---- 234
                K L+ +H   Q  IVHRDV+ SN L     K   + DF L   + DT   L    
Sbjct: 123 MLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFV 179
Query: 235 ----HSTRV------------------LGTFGYHAPEYAMTGQITQKS--DVYSFGVVLL 270
                  R                    GT G+ APE  +T    Q +  D++S GV+ L
Sbjct: 180 QSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPE-VLTKCPNQTTAIDMWSAGVIFL 238
Query: 271 ELLTGRKP 278
            LL+GR P
Sbjct: 239 SLLSGRYP 246

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 76  IGEGSYGRV---FYAKLTDGTPAAI---KKLDTSSAPE--PESDFAAQLSVVSRLKHEHF 127
           +G G+ G V   F  K        I   +K    SA E  P  +   ++ ++ +L H   
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 76
Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
           +++  +  ++ +  +V +    G L D + G K ++ A               Y     +
Sbjct: 77  IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF---------YQMLLAV 126
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
           ++LHE     I+HRD++  NVLL    +D   KI DF  +    +T+  L  T + GT  
Sbjct: 127 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRT-LCGTPT 180
Query: 245 YHAPEYAM---TGQITQKSDVYSFGVVLLELLTGRKP 278
           Y APE  +   T    +  D +S GV+L   L+G  P
Sbjct: 181 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 217

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 76  IGEGSYGRV---FYAKLTDGTPAAI---KKLDTSSAPE--PESDFAAQLSVVSRLKHEHF 127
           +G G+ G V   F  K        I   +K    SA E  P  +   ++ ++ +L H   
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
           +++  +  ++ +  +V +    G L D + G K ++ A               Y     +
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF---------YQMLLAV 127
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
           ++LHE     I+HRD++  NVLL    +D   KI DF  +    +T+  L  T + GT  
Sbjct: 128 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRT-LCGTPT 181
Query: 245 YHAPEYAM---TGQITQKSDVYSFGVVLLELLTGRKP 278
           Y APE  +   T    +  D +S GV+L   L+G  P
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 76  IGEGSYGRV---FYAKLTDGTPAAI---KKLDTSSAPE--PESDFAAQLSVVSRLKHEHF 127
           +G G+ G V   F  K        I   +K    SA E  P  +   ++ ++ +L H   
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
           +++  +  ++ +  +V +    G L D + G K ++ A               Y     +
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF---------YQMLLAV 127
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
           ++LHE     I+HRD++  NVLL    +D   KI DF  +    +T+  L  T + GT  
Sbjct: 128 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRT-LCGTPT 181
Query: 245 YHAPEYAM---TGQITQKSDVYSFGVVLLELLTGRKP 278
           Y APE  +   T    +  D +S GV+L   L+G  P
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 6/100 (6%)
Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           GLE LH +    IV+RD++  N+LL D    +I+D  L     +   +    RV GT GY
Sbjct: 298 GLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRV-GTVGY 351
Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPK 285
            APE     + T   D ++ G +L E++ G+ P      K
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 76  IGEGSYGRV---FYAKLTDGTPAAI---KKLDTSSAPE--PESDFAAQLSVVSRLKHEHF 127
           +G G+ G V   F  K        I   +K    SA E  P  +   ++ ++ +L H   
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
           +++  +  ++ +  +V +    G L D + G K ++ A               Y     +
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF---------YQMLLAV 127
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
           ++LHE     I+HRD++  NVLL    +D   KI DF  +    +T+  L  T + GT  
Sbjct: 128 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRT-LCGTPT 181
Query: 245 YHAPEYAM---TGQITQKSDVYSFGVVLLELLTGRKP 278
           Y APE  +   T    +  D +S GV+L   L+G  P
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 83/201 (41%), Gaps = 30/201 (14%)
Query: 96  AIKKLDTS-----SAPEPESDFAAQLSVVSRLK----HEHFVELLGYCMESNNRILVYQF 146
           A+K +D +     SA E +    A L  V  L+    H + ++L      +    LV+  
Sbjct: 46  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDL 105
Query: 147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSS 206
              G L D L  +  +   E   ++     V  A         LH   +  IVHRD++  
Sbjct: 106 MKKGELFDYLTEKVTLSEKETRKIMRALLEVICA---------LH---KLNIVHRDLKPE 153
Query: 207 NVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQ------ITQKS 260
           N+LL DD   K+ DF  + Q  D   +L S  V GT  Y APE              ++ 
Sbjct: 154 NILLDDDMNIKLTDFGFSCQ-LDPGEKLRS--VCGTPSYLAPEIIECSMNDNHPGYGKEV 210
Query: 261 DVYSFGVVLLELLTGRKPVDH 281
           D++S GV++  LL G  P  H
Sbjct: 211 DMWSTGVIMYTLLAGSPPFWH 231

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 76  IGEGSYGRV---FYAKLTDGTPAAI---KKLDTSSAPE--PESDFAAQLSVVSRLKHEHF 127
           +G G+ G V   F  K        I   +K    SA E  P  +   ++ ++ +L H   
Sbjct: 24  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 83
Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
           +++  +  ++ +  +V +    G L D + G K ++ A               Y     +
Sbjct: 84  IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF---------YQMLLAV 133
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
           ++LHE     I+HRD++  NVLL    +D   KI DF  +    +T+  L  T + GT  
Sbjct: 134 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRT-LCGTPT 187
Query: 245 YHAPEYAM---TGQITQKSDVYSFGVVLLELLTGRKP 278
           Y APE  +   T    +  D +S GV+L   L+G  P
Sbjct: 188 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 224

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/226 (23%), Positives = 94/226 (41%), Gaps = 23/226 (10%)
Query: 65  RLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSA------PEPESDFAAQLSV 118
           +L   +    L+GEGSYG+V   ++ D      + +           P  E++   ++ +
Sbjct: 2   KLIGKYLMGDLLGEGSYGKV--KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQL 59
Query: 119 VSRLKHEHFVELLG--YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
           + RL+H++ ++L+   Y  E     +V ++   G + ++L        + P       Q 
Sbjct: 60  LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLD-------SVPEKRFPVCQA 111
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS 236
                    GLE+LH +    IVH+D++  N+LL      KI+   +       AA    
Sbjct: 112 HGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC 168
Query: 237 TRVLGTFGYHAPEYA--MTGQITQKSDVYSFGVVLLELLTGRKPVD 280
               G+  +  PE A  +      K D++S GV L  + TG  P +
Sbjct: 169 RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 104/242 (42%), Gaps = 27/242 (11%)
Query: 40  NVVKTGTPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVF-YAKLTDGTPAAIK 98
           ++ K   PQ   P+EI        + +  ++     +G G++G V    +   G   A K
Sbjct: 138 DIWKQYYPQ---PVEIKH------DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAK 188
Query: 99  KLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHG 158
            + T    + E+    ++  +S L+H   V L     + N  +++Y+F + G L + +  
Sbjct: 189 FVMTPHESDKET-VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV-- 245
Query: 159 RKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS-- 216
                 A+    ++ ++ V+      KGL  +HE      VH D++  N++      +  
Sbjct: 246 ------ADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNEL 296
Query: 217 KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGR 276
           K+ DF LT       +   +T   GT  + APE A    +   +D++S GV+   LL+G 
Sbjct: 297 KLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 353
Query: 277 KP 278
            P
Sbjct: 354 SP 355

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 69  NFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           ++    +IG GS+G V+ AKL D G   AIKK+    A +       +L ++ +L H + 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-----NRELQIMRKLDHCNI 75
Query: 128 VELLGYCMES-NNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQRVKV-AYGA 183
           V L  +   S   +  VY    +  + + ++   R   +  +  PV+     VK+  Y  
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY----VKLYMYQL 131
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLHSTRVLGT 242
            + L ++H      I HRD++  N+LL  D    K+ DF    Q         +   + +
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICS 185
Query: 243 FGYHAPEYAM-TGQITQKSDVYSFGVVLLELLTGR 276
             Y APE        T   DV+S G VL ELL G+
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 104/242 (42%), Gaps = 27/242 (11%)
Query: 40  NVVKTGTPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVF-YAKLTDGTPAAIK 98
           ++ K   PQ   P+EI        + +  ++     +G G++G V    +   G   A K
Sbjct: 32  DIWKQYYPQ---PVEIKH------DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAK 82
Query: 99  KLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHG 158
            + T    + E+    ++  +S L+H   V L     + N  +++Y+F + G L + +  
Sbjct: 83  FVMTPHESDKET-VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV-- 139
Query: 159 RKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS-- 216
                 A+    ++ ++ V+      KGL  +HE      VH D++  N++      +  
Sbjct: 140 ------ADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNEL 190
Query: 217 KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGR 276
           K+ DF LT       +   +T   GT  + APE A    +   +D++S GV+   LL+G 
Sbjct: 191 KLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 247
Query: 277 KP 278
            P
Sbjct: 248 SP 249

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 69  NFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           ++    +IG GS+G V+ AKL D G   AIKK+      +       +L ++ +L H + 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNI 75
Query: 128 VELLGYCMES-NNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQRVKV-AYGA 183
           V L  +   S   + +VY    +  + + ++   R   +  +  PV+     VK+  Y  
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY----VKLYMYQL 131
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLHSTRVLGT 242
            + L ++H      I HRD++  N+LL  D    K+ DF    Q       +     + +
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX---ICS 185
Query: 243 FGYHAPEYAM-TGQITQKSDVYSFGVVLLELLTGR 276
             Y APE        T   DV+S G VL ELL G+
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 101/234 (43%), Gaps = 32/234 (13%)
Query: 55  IPQIKLDELNR--LTSNFGTKALIGEGSYGRVFYAKLTDGT--PAAIKKLDTSSAPEPES 110
           +P   +D  NR  L+  F  ++ +G G+   V+  K   GT  P A+K L  +     + 
Sbjct: 38  VPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCK-QKGTQKPYALKVLKKTV---DKK 93
Query: 111 DFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPV 170
               ++ V+ RL H + ++L           LV +  T G L D +         E G  
Sbjct: 94  IVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRI--------VEKG-- 143
Query: 171 LTWNQRVKVAYGAAKGLE---FLHEKVQPPIVHRDVRSSNVLLFD---DFKSKIADFNLT 224
             +++R   A    + LE   +LHE     IVHRD++  N+L      D   KIADF L 
Sbjct: 144 -YYSER-DAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGL- 197
Query: 225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
             S     ++    V GT GY APE         + D++S G++   LL G +P
Sbjct: 198 --SKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 76  IGEGSYGRV---FYAKLTDGTPAAI---KKLDTSSAPE--PESDFAAQLSVVSRLKHEHF 127
           +G G+ G V   F  K        I   +K    SA E  P  +   ++ ++ +L H   
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
           +++  +  ++ +  +V +    G L D + G K ++ A               Y     +
Sbjct: 203 IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF---------YQMLLAV 252
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
           ++LHE     I+HRD++  NVLL    +D   KI DF  +    +T+  L  T + GT  
Sbjct: 253 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRT-LCGTPT 306
Query: 245 YHAPEYAM---TGQITQKSDVYSFGVVLLELLTGRKP 278
           Y APE  +   T    +  D +S GV+L   L+G  P
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 69  NFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           ++    +IG GS+G V+ AKL D G   AIKK+    A +       +L ++ +L H + 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-----ELQIMRKLDHCNI 75
Query: 128 VELLGYCMES-NNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQRVKV-AYGA 183
           V L  +   S   +  VY    +  + + ++   R   +  +  PV+     VK+  Y  
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY----VKLYMYQL 131
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLHSTRVLGT 242
            + L ++H      I HRD++  N+LL  D    K+ DF    Q         +   + +
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICS 185
Query: 243 FGYHAPEYAM-TGQITQKSDVYSFGVVLLELLTGR 276
             Y APE        T   DV+S G VL ELL G+
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 76  IGEGSYGRV---FYAKLTDGTPAAI---KKLDTSSAPE--PESDFAAQLSVVSRLKHEHF 127
           +G G+ G V   F  K        I   +K    SA E  P  +   ++ ++ +L H   
Sbjct: 157 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 216
Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
           +++  +  ++ +  +V +    G L D + G K ++ A               Y     +
Sbjct: 217 IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF---------YQMLLAV 266
Query: 188 EFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
           ++LHE     I+HRD++  NVLL    +D   KI DF  +    +T+  L  T + GT  
Sbjct: 267 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRT-LCGTPT 320
Query: 245 YHAPEYAM---TGQITQKSDVYSFGVVLLELLTGRKP 278
           Y APE  +   T    +  D +S GV+L   L+G  P
Sbjct: 321 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 357

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 82/201 (40%), Gaps = 30/201 (14%)
Query: 96  AIKKLDTS-----SAPEPESDFAAQLSVVSRLK----HEHFVELLGYCMESNNRILVYQF 146
           A+K +D +     SA E +    A L  V  L+    H + ++L      +    LV+  
Sbjct: 33  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDL 92
Query: 147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSS 206
              G L D L  +  +   E   ++     V  A         LH   +  IVHRD++  
Sbjct: 93  MKKGELFDYLTEKVTLSEKETRKIMRALLEVICA---------LH---KLNIVHRDLKPE 140
Query: 207 NVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQ------ITQKS 260
           N+LL DD   K+ DF  + Q  D   +L    V GT  Y APE              ++ 
Sbjct: 141 NILLDDDMNIKLTDFGFSCQ-LDPGEKLRE--VCGTPSYLAPEIIECSMNDNHPGYGKEV 197
Query: 261 DVYSFGVVLLELLTGRKPVDH 281
           D++S GV++  LL G  P  H
Sbjct: 198 DMWSTGVIMYTLLAGSPPFWH 218

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/239 (22%), Positives = 94/239 (39%), Gaps = 38/239 (15%)
Query: 65  RLTSNFGTKALIGEGSYGRVF--YAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           ++   +  + LIG GSYG V   Y KL     A  K L              ++++++RL
Sbjct: 50  QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL 109
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK-VAY 181
            H+H V++L   +  +    V +F  +  + ++       +     PV      +K + Y
Sbjct: 110 NHDHVVKVLDIVIPKD----VEKFDELYVVLEI--ADSDFKKLFRTPVYLTELHIKTLLY 163
Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADF-------------------- 221
               G++++H      I+HRD++ +N L+  D   K+ DF                    
Sbjct: 164 NLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 222 -----NLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLT 274
                NL         +   T  + T  Y APE  +  +  T+  DV+S G +  ELL 
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 91/204 (44%), Gaps = 18/204 (8%)
Query: 76  IGEGSYGRVFY--AKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +GEG+Y  V+   +KLTD    A+K++              ++S++  LKH + V L   
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
                +  LV+++     L   L         + G ++  +      +   +GL + H +
Sbjct: 69  IHTEKSLTLVFEYLD-KDLKQYLD--------DCGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM- 252
               ++HRD++  N+L+ +  + K+ADF L    S    + +   V+ T  Y  P+  + 
Sbjct: 120 ---KVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYDNEVV-TLWYRPPDILLG 174
Query: 253 TGQITQKSDVYSFGVVLLELLTGR 276
           +   + + D++  G +  E+ TGR
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGR 198

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 88/222 (39%), Gaps = 23/222 (10%)
Query: 64  NRLTSNFGTKALIGEGSYGRVFYAKLTDGTPA---AIKKLDTSS-APEPESDFAAQLSVV 119
            R T ++     +G+G++  V   +    TP    A K ++T   +         +  + 
Sbjct: 27  TRFTDDYQLFEELGKGAFSVV--RRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARIC 84
Query: 120 SRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKV 179
             LKH + V L     E     LV+   T G L + +  R+    A+             
Sbjct: 85  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEAD------------A 132
Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS---KIADFNLTNQSSDTAARLHS 236
           ++   + LE ++   Q  IVHRD++  N+LL    K    K+ADF L  +          
Sbjct: 133 SHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFG 192
Query: 237 TRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
               GT GY +PE        +  D+++ GV+L  LL G  P
Sbjct: 193 --FAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 82/201 (40%), Gaps = 30/201 (14%)
Query: 96  AIKKLDTS-----SAPEPESDFAAQLSVVSRLK----HEHFVELLGYCMESNNRILVYQF 146
           A+K +D +     SA E +    A L  V  L+    H + ++L      +    LV+  
Sbjct: 46  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDL 105
Query: 147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSS 206
              G L D L  +  +   E   ++     V  A         LH   +  IVHRD++  
Sbjct: 106 MKKGELFDYLTEKVTLSEKETRKIMRALLEVICA---------LH---KLNIVHRDLKPE 153
Query: 207 NVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQ------ITQKS 260
           N+LL DD   K+ DF  + Q  D   +L    V GT  Y APE              ++ 
Sbjct: 154 NILLDDDMNIKLTDFGFSCQ-LDPGEKLRE--VCGTPSYLAPEIIECSMNDNHPGYGKEV 210
Query: 261 DVYSFGVVLLELLTGRKPVDH 281
           D++S GV++  LL G  P  H
Sbjct: 211 DMWSTGVIMYTLLAGSPPFWH 231

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 69  NFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           ++    +IG GS+G V+ AKL D G   AIKK+      +       +L ++ +L H + 
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNI 83
Query: 128 VELLGYCMES-NNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQRVKV-AYGA 183
           V L  +   S   +  VY    +  + + ++   R   +  +  PV+     VK+  Y  
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY----VKLYMYQL 139
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLHSTRVLGT 242
            + L ++H      I HRD++  N+LL  D    K+ DF    Q       +     + +
Sbjct: 140 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX---ICS 193
Query: 243 FGYHAPEYAM-TGQITQKSDVYSFGVVLLELLTGR 276
             Y APE        T   DV+S G VL ELL G+
Sbjct: 194 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 69  NFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           ++    +IG GS+G V+ AKL D G   AIKK+      +       +L ++ +L H + 
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNI 94
Query: 128 VELLGYCMES-NNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQRVKV-AYGA 183
           V L  +   S   +  VY    +  + + ++   R   +  +  PV+     VK+  Y  
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY----VKLYMYQL 150
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLHSTRVLGT 242
            + L ++H      I HRD++  N+LL  D    K+ DF    Q       +     + +
Sbjct: 151 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX---ICS 204
Query: 243 FGYHAPEYAM-TGQITQKSDVYSFGVVLLELLTGR 276
             Y APE        T   DV+S G VL ELL G+
Sbjct: 205 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 69  NFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           ++    +IG GS+G V+ AKL D G   AIKK+      +       +L ++ +L H + 
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNI 76
Query: 128 VELLGYCMES-NNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQRVKV-AYGA 183
           V L  +   S   +  VY    +  + + ++   R   +  +  PV+     VK+  Y  
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY----VKLYMYQL 132
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLHSTRVLGT 242
            + L ++H      I HRD++  N+LL  D    K+ DF    Q       +     + +
Sbjct: 133 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX---ICS 186
Query: 243 FGYHAPEYAM-TGQITQKSDVYSFGVVLLELLTGR 276
             Y APE        T   DV+S G VL ELL G+
Sbjct: 187 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 69  NFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           ++    +IG GS+G V+ AKL D G   AIKK+      +       +L ++ +L H + 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNI 75
Query: 128 VELLGYCMES-NNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQRVKV-AYGA 183
           V L  +   S   +  VY    +  + + ++   R   +  +  PV+     VK+  Y  
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY----VKLYMYQL 131
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLHSTRVLGT 242
            + L ++H      I HRD++  N+LL  D    K+ DF    Q       +     + +
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX---ICS 185
Query: 243 FGYHAPEYAM-TGQITQKSDVYSFGVVLLELLTGR 276
             Y APE        T   DV+S G VL ELL G+
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 69  NFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           ++    +IG GS+G V+ AKL D G   AIKK+      +       +L ++ +L H + 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNI 75
Query: 128 VELLGYCMES-NNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQRVKV-AYGA 183
           V L  +   S   +  VY    +  + + ++   R   +  +  PV+     VK+  Y  
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY----VKLYMYQL 131
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLHSTRVLGT 242
            + L ++H      I HRD++  N+LL  D    K+ DF    Q       +     + +
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX---ICS 185
Query: 243 FGYHAPEYAM-TGQITQKSDVYSFGVVLLELLTGR 276
             Y APE        T   DV+S G VL ELL G+
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 69  NFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           ++    +IG GS+G V+ AKL D G   AIKK+      +       +L ++ +L H + 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNI 75
Query: 128 VELLGYCMES-NNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQRVKV-AYGA 183
           V L  +   S   +  VY    +  + + ++   R   +  +  PV+     VK+  Y  
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY----VKLYMYQL 131
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLHSTRVLGT 242
            + L ++H      I HRD++  N+LL  D    K+ DF    Q         +   + +
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICS 185
Query: 243 FGYHAPEYAM-TGQITQKSDVYSFGVVLLELLTGR 276
             Y APE        T   DV+S G VL ELL G+
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 75  LIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +IG GS+G V+ AKL D G   AIKK+      +       +L ++ +L H + V L  +
Sbjct: 39  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYF 93
Query: 134 CMES-NNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQRVKV-AYGAAKGLEF 189
              S   +  VY    +  + + ++   R   +  +  PV+     VK+  Y   + L +
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY----VKLYMYQLFRSLAY 149
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +H      I HRD++  N+LL  D    K+ DF    Q       +     + +  Y AP
Sbjct: 150 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX---ICSRYYRAP 203
Query: 249 EYAM-TGQITQKSDVYSFGVVLLELLTGR 276
           E        T   DV+S G VL ELL G+
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 75  LIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +IG GS+G V+ AKL D G   AIKK+      +       +L ++ +L H + V L  +
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYF 115
Query: 134 CMES-NNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQRVKV-AYGAAKGLEF 189
              S   +  VY    +  + + ++   R   +  +  PV+     VK+  Y   + L +
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY----VKLYMYQLFRSLAY 171
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +H      I HRD++  N+LL  D    K+ DF    Q       +     + +  Y AP
Sbjct: 172 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX---ICSRYYRAP 225
Query: 249 EYAM-TGQITQKSDVYSFGVVLLELLTGR 276
           E        T   DV+S G VL ELL G+
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 69  NFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           ++    +IG GS+G V+ AKL D G   AIKK+      +       +L ++ +L H + 
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNI 88
Query: 128 VELLGYCMES-NNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQRVKV-AYGA 183
           V L  +   S   +  VY    +  + + ++   R   +  +  PV+     VK+  Y  
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY----VKLYMYQL 144
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLHSTRVLGT 242
            + L ++H      I HRD++  N+LL  D    K+ DF    Q         +   + +
Sbjct: 145 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICS 198
Query: 243 FGYHAPEYAM-TGQITQKSDVYSFGVVLLELLTGR 276
             Y APE        T   DV+S G VL ELL G+
Sbjct: 199 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 75  LIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +IG GS+G V+ AKL D G   AIKK+      +       +L ++ +L H + V L  +
Sbjct: 39  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYF 93
Query: 134 CMES-NNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQRVKV-AYGAAKGLEF 189
              S   +  VY    +  + + ++   R   +  +  PV+     VK+  Y   + L +
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY----VKLYMYQLFRSLAY 149
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +H      I HRD++  N+LL  D    K+ DF    Q       +     + +  Y AP
Sbjct: 150 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX---ICSRYYRAP 203
Query: 249 EYAM-TGQITQKSDVYSFGVVLLELLTGR 276
           E        T   DV+S G VL ELL G+
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 69  NFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           ++    +IG GS+G V+ AKL D G   AIKK+      +       +L ++ +L H + 
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNI 79
Query: 128 VELLGYCMES-NNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQRVKV-AYGA 183
           V L  +   S   +  VY    +  + + ++   R   +  +  PV+     VK+  Y  
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY----VKLYMYQL 135
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLHSTRVLGT 242
            + L ++H      I HRD++  N+LL  D    K+ DF    Q       +     + +
Sbjct: 136 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX---ICS 189
Query: 243 FGYHAPEYAM-TGQITQKSDVYSFGVVLLELLTGR 276
             Y APE        T   DV+S G VL ELL G+
Sbjct: 190 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 80/194 (41%), Gaps = 17/194 (8%)
Query: 92  GTPAAIKKLD----TSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA 147
           G   A+K +D    TSS      D   + S+   LKH H VELL          +V++F 
Sbjct: 51  GQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFM 110
Query: 148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSN 207
               L   +     V+ A+ G V +            + L + H+     I+HRDV+   
Sbjct: 111 DGADLCFEI-----VKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHC 162
Query: 208 VLLFDDFKS---KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYS 264
           VLL     S   K+  F +  Q  ++   L +   +GT  + APE        +  DV+ 
Sbjct: 163 VLLASKENSAPVKLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWG 220
Query: 265 FGVVLLELLTGRKP 278
            GV+L  LL+G  P
Sbjct: 221 CGVILFILLSGCLP 234

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 75  LIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +IG GS+G V+ AKL D G   AIKK+      +       +L ++ +L H + V L  +
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYF 115
Query: 134 CMES-NNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQRVKV-AYGAAKGLEF 189
              S   +  VY    +  + + ++   R   +  +  PV+     VK+  Y   + L +
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY----VKLYMYQLFRSLAY 171
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +H      I HRD++  N+LL  D    K+ DF    Q       +     + +  Y AP
Sbjct: 172 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAP 225
Query: 249 EYAM-TGQITQKSDVYSFGVVLLELLTGR 276
           E        T   DV+S G VL ELL G+
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 75  LIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +IG GS+G V+ AKL D G   AIKK+      +       +L ++ +L H + V L  +
Sbjct: 63  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYF 117
Query: 134 CMES-NNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQRVKV-AYGAAKGLEF 189
              S   +  VY    +  + + ++   R   +  +  PV+     VK+  Y   + L +
Sbjct: 118 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY----VKLYMYQLFRSLAY 173
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +H      I HRD++  N+LL  D    K+ DF    Q       +     + +  Y AP
Sbjct: 174 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAP 227
Query: 249 EYAM-TGQITQKSDVYSFGVVLLELLTGR 276
           E        T   DV+S G VL ELL G+
Sbjct: 228 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 38/223 (17%)
Query: 69  NFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPES-DFAAQLSVVSRLKHEHF 127
           NF TK  + E   G ++  +   G    +K L        +S DF  +   +    H + 
Sbjct: 13  NFLTK--LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 128 VELLGYCME--SNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
           + +LG C    + +  L+  +   GSL++VLH            V+  +Q VK A   A+
Sbjct: 70  LPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNF-------VVDQSQAVKFALDXAR 122
Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI--ADFNLTNQSSDTAARLHSTRVLGTF 243
           G  FLH  ++P I    + S +V + +D  ++I  AD   + QS                
Sbjct: 123 GXAFLH-TLEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRX------------ 169
Query: 244 GYHAPEYAMTGQITQK--------SDVYSFGVVLLELLTGRKP 278
             +AP +     + +K        +D +SF V+L EL+T   P
Sbjct: 170 --YAPAWVAPEALQKKPEDTNRRSADXWSFAVLLWELVTREVP 210

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 75  LIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +IG GS+G V+ AKL D G   AIKK+      +       +L ++ +L H + V L  +
Sbjct: 55  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYF 109
Query: 134 CMES-NNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQRVKV-AYGAAKGLEF 189
              S   +  VY    +  + + ++   R   +  +  PV+     VK+  Y   + L +
Sbjct: 110 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI----YVKLYMYQLFRSLAY 165
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +H      I HRD++  N+LL  D    K+ DF    Q       +     + +  Y AP
Sbjct: 166 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAP 219
Query: 249 EYAM-TGQITQKSDVYSFGVVLLELLTGR 276
           E        T   DV+S G VL ELL G+
Sbjct: 220 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 75  LIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +IG GS+G V+ AKL D G   AIKK+      +       +L ++ +L H + V L  +
Sbjct: 65  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYF 119
Query: 134 CMES-NNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQRVKV-AYGAAKGLEF 189
              S   +  VY    +  + + ++   R   +  +  PV+     VK+  Y   + L +
Sbjct: 120 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY----VKLYMYQLFRSLAY 175
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +H      I HRD++  N+LL  D    K+ DF    Q       +     + +  Y AP
Sbjct: 176 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAP 229
Query: 249 EYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           E        T   DV+S G VL ELL G+
Sbjct: 230 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 80/194 (41%), Gaps = 17/194 (8%)
Query: 92  GTPAAIKKLD----TSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA 147
           G   A+K +D    TSS      D   + S+   LKH H VELL          +V++F 
Sbjct: 49  GQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFM 108
Query: 148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSN 207
               L       + V+ A+ G V +            + L + H+     I+HRDV+   
Sbjct: 109 DGADL-----CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHC 160
Query: 208 VLLFDDFKS---KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYS 264
           VLL     S   K+  F +  Q  ++   L +   +GT  + APE        +  DV+ 
Sbjct: 161 VLLASKENSAPVKLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWG 218
Query: 265 FGVVLLELLTGRKP 278
            GV+L  LL+G  P
Sbjct: 219 CGVILFILLSGCLP 232

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 79/188 (42%), Gaps = 21/188 (11%)
Query: 97  IKKLDTSSAPE--PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHD 154
           IKK  T S+       D   ++S++  ++H + + L        + IL+ +    G L D
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 155 VLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF 214
            L  ++ +   E    L              G+ +LH      I H D++  N++L D  
Sbjct: 104 FLAEKESLTEEEATEFLK---------QILNGVYYLH---SLQIAHFDLKPENIMLLDRN 151
Query: 215 ----KSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLL 270
               + KI DF L ++  D      +  + GT  + APE      +  ++D++S GV+  
Sbjct: 152 VPKPRIKIIDFGLAHKI-DFGNEFKN--IFGTPAFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 271 ELLTGRKP 278
            LL+G  P
Sbjct: 209 ILLSGASP 216

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 85/208 (40%), Gaps = 19/208 (9%)
Query: 76  IGEGSYGRVFYA-KLTDGTPAAIKKLDTSS-APEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +G+G++  V    K+  G   A K ++T   +         +  +   LKH + V L   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             E  +  L++   T G L + +  R+    A+    +   Q++         LE +   
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI---QQI---------LEAVLHC 137
Query: 194 VQPPIVHRDVRSSNVLLFDDFKS---KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEY 250
            Q  +VHRD++  N+LL    K    K+ADF L  +              GT GY +PE 
Sbjct: 138 HQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEV 195
Query: 251 AMTGQITQKSDVYSFGVVLLELLTGRKP 278
                  +  D+++ GV+L  LL G  P
Sbjct: 196 LRKDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 75  LIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +IG GS+G V+ AKL D G   AIKK+      +       +L ++ +L H + V L  +
Sbjct: 32  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYF 86
Query: 134 CMES-NNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQRVKV-AYGAAKGLEF 189
              S   +  VY    +  + + ++   R   +  +  PV+     VK+  Y   + L +
Sbjct: 87  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY----VKLYMYQLFRSLAY 142
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +H      I HRD++  N+LL  D    K+ DF    Q       +     + +  Y AP
Sbjct: 143 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAP 196
Query: 249 EYAM-TGQITQKSDVYSFGVVLLELLTGR 276
           E        T   DV+S G VL ELL G+
Sbjct: 197 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 89/219 (40%), Gaps = 27/219 (12%)
Query: 75  LIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           ++G+G+   VF  +    G   AIK  +  S   P      +  V+ +L H++ V+L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 134 CMESNNR--ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
             E+  R  +L+ +F   GSL+ VL       G      L       V      G+  L 
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI------VLRDVVGGMNHLR 129
Query: 192 EKVQPPIVHRDVRSSNVL--LFDDFKS--KIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           E     IVHR+++  N++  + +D +S  K+ DF    +  D         + GT  Y  
Sbjct: 130 EN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVXLYGTEEYLH 183
Query: 248 P---EYAMTGQITQKS-----DVYSFGVVLLELLTGRKP 278
           P   E A+  +  QK      D++S GV      TG  P
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 42/85 (49%), Gaps = 5/85 (5%)
Query: 198 IVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT---- 253
           ++HRDV+  N+LL      K+ADF  T    D    +H    +GT  Y +PE   +    
Sbjct: 195 LIHRDVKPDNMLLDKHGHLKLADFG-TCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGD 253
Query: 254 GQITQKSDVYSFGVVLLELLTGRKP 278
           G   ++ D +S GV L E+L G  P
Sbjct: 254 GYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 75  LIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +IG GS+G V+ AKL D G   AIKK+      +       +L ++ +L H + V L  +
Sbjct: 106 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYF 160
Query: 134 CMES-NNRILVYQFATMGSLHDVLH--GRKGVQGAEPGPVLTWNQRVKV-AYGAAKGLEF 189
              S   +  VY    +  + + ++   R   +  +  PV+     VK+  Y   + L +
Sbjct: 161 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY----VKLYMYQLFRSLAY 216
Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +H      I HRD++  N+LL  D    K+ DF    Q       +     + +  Y AP
Sbjct: 217 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAP 270
Query: 249 EYAMTG-QITQKSDVYSFGVVLLELLTGR 276
           E        T   DV+S G VL ELL G+
Sbjct: 271 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/185 (20%), Positives = 82/185 (44%), Gaps = 19/185 (10%)
Query: 98  KKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLH 157
           ++L +S       +   +++++  ++H + + L        + +L+ +  + G L D L 
Sbjct: 48  RRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA 107
Query: 158 GRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD----D 213
            ++          LT ++  +       G+ +LH K    I H D++  N++L D    +
Sbjct: 108 EKES---------LTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPN 155
Query: 214 FKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELL 273
            + K+ DF + ++     A      + GT  + APE      +  ++D++S GV+   LL
Sbjct: 156 PRIKLIDFGIAHK---IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 212
Query: 274 TGRKP 278
           +G  P
Sbjct: 213 SGASP 217

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/185 (20%), Positives = 82/185 (44%), Gaps = 19/185 (10%)
Query: 98  KKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLH 157
           ++L +S       +   +++++  ++H + + L        + +L+ +  + G L D L 
Sbjct: 41  RRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA 100
Query: 158 GRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD----D 213
            ++          LT ++  +       G+ +LH K    I H D++  N++L D    +
Sbjct: 101 EKES---------LTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPN 148
Query: 214 FKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELL 273
            + K+ DF + ++     A      + GT  + APE      +  ++D++S GV+   LL
Sbjct: 149 PRIKLIDFGIAHK---IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 205
Query: 274 TGRKP 278
           +G  P
Sbjct: 206 SGASP 210

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/185 (20%), Positives = 82/185 (44%), Gaps = 19/185 (10%)
Query: 98  KKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLH 157
           ++L +S       +   +++++  ++H + + L        + +L+ +  + G L D L 
Sbjct: 62  RRLXSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA 121
Query: 158 GRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD----D 213
            ++          LT ++  +       G+ +LH K    I H D++  N++L D    +
Sbjct: 122 EKES---------LTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPN 169
Query: 214 FKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELL 273
            + K+ DF + ++     A      + GT  + APE      +  ++D++S GV+   LL
Sbjct: 170 PRIKLIDFGIAHK---IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 226
Query: 274 TGRKP 278
           +G  P
Sbjct: 227 SGASP 231

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 96/229 (41%), Gaps = 29/229 (12%)
Query: 60  LDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSA---PEPESDFAAQ 115
           LD+  R+ +       +G GS+GRV   K +  G   A+K LD        E E     +
Sbjct: 40  LDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEK 92
Query: 116 LSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQ 175
             ++  +     V+L     +++N  +V ++A  G +    H R+  + +EP       Q
Sbjct: 93  -RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFSEPHARFYAAQ 149
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
            V          E+LH      +++RD++  N+++      K+ DF L  +      +  
Sbjct: 150 IVLT-------FEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKR-----VKGR 194
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
           +  + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/228 (22%), Positives = 95/228 (41%), Gaps = 27/228 (11%)
Query: 60  LDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPE--SDFAAQL 116
           LD+  R+ +       IG GS+GRV   K +  G   A+K LD     + +       + 
Sbjct: 40  LDQFERIKT-------IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 117 SVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            ++  +     V+L     +++N  +V ++   G +    H R+  + +EP       Q 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFYAAQI 150
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS 236
           V          E+LH      +++RD++  N+L+      K+ADF    +      +  +
Sbjct: 151 VLT-------FEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKR-----VKGRT 195
Query: 237 TRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
             + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 80/188 (42%), Gaps = 21/188 (11%)
Query: 97  IKKLDTSSAPEPES--DFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHD 154
           IKK  T S+    S  D   ++S++  ++H + + L        + IL+ +    G L D
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 155 VLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF 214
            L  ++ +   E    L              G+ +LH      I H D++  N++L D  
Sbjct: 104 FLAEKESLTEEEATEFLK---------QILNGVYYLH---SLQIAHFDLKPENIMLLDRN 151
Query: 215 ----KSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLL 270
               + KI DF L ++  D      +  + GT  + APE      +  ++D++S GV+  
Sbjct: 152 VPKPRIKIIDFGLAHKI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 271 ELLTGRKP 278
            LL+G  P
Sbjct: 209 ILLSGASP 216

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 89/219 (40%), Gaps = 27/219 (12%)
Query: 75  LIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           ++G+G+   VF  +    G   AIK  +  S   P      +  V+ +L H++ V+L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 134 CMESNNR--ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
             E+  R  +L+ +F   GSL+ VL       G      L       V      G+  L 
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI------VLRDVVGGMNHLR 129
Query: 192 EKVQPPIVHRDVRSSNVL--LFDDFKS--KIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           E     IVHR+++  N++  + +D +S  K+ DF    +  D         + GT  Y  
Sbjct: 130 EN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLH 183
Query: 248 P---EYAMTGQITQKS-----DVYSFGVVLLELLTGRKP 278
           P   E A+  +  QK      D++S GV      TG  P
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 80/188 (42%), Gaps = 21/188 (11%)
Query: 97  IKKLDTSSAPEPES--DFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHD 154
           IKK  T S+    S  D   ++S++  ++H + + L        + IL+ +    G L D
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 155 VLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF 214
            L  ++ +   E    L              G+ +LH      I H D++  N++L D  
Sbjct: 104 FLAEKESLTEEEATEFLK---------QILNGVYYLH---SLQIAHFDLKPENIMLLDRN 151
Query: 215 ----KSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLL 270
               + KI DF L ++  D      +  + GT  + APE      +  ++D++S GV+  
Sbjct: 152 VPKPRIKIIDFGLAHKI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 271 ELLTGRKP 278
            LL+G  P
Sbjct: 209 ILLSGASP 216

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 80/188 (42%), Gaps = 21/188 (11%)
Query: 97  IKKLDTSSAPEPES--DFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHD 154
           IKK  T S+    S  D   ++S++  ++H + + L        + IL+ +    G L D
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 155 VLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF 214
            L  ++ +   E    L              G+ +LH      I H D++  N++L D  
Sbjct: 104 FLAEKESLTEEEATEFLK---------QILNGVYYLH---SLQIAHFDLKPENIMLLDRN 151
Query: 215 ----KSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLL 270
               + KI DF L ++  D      +  + GT  + APE      +  ++D++S GV+  
Sbjct: 152 VPKPRIKIIDFGLAHKI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 271 ELLTGRKP 278
            LL+G  P
Sbjct: 209 ILLSGASP 216

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 80/188 (42%), Gaps = 21/188 (11%)
Query: 97  IKKLDTSSAPEPES--DFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHD 154
           IKK  T S+    S  D   ++S++  ++H + + L        + IL+ +    G L D
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 155 VLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF 214
            L  ++ +   E    L              G+ +LH      I H D++  N++L D  
Sbjct: 104 FLAEKESLTEEEATEFLK---------QILNGVYYLH---SLQIAHFDLKPENIMLLDRN 151
Query: 215 ----KSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLL 270
               + KI DF L ++  D      +  + GT  + APE      +  ++D++S GV+  
Sbjct: 152 VPKPRIKIIDFGLAHKI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 271 ELLTGRKP 278
            LL+G  P
Sbjct: 209 ILLSGASP 216

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 80/188 (42%), Gaps = 21/188 (11%)
Query: 97  IKKLDTSSAPEPES--DFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHD 154
           IKK  T S+    S  D   ++S++  ++H + + L        + IL+ +    G L D
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 155 VLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF 214
            L  ++ +   E    L              G+ +LH      I H D++  N++L D  
Sbjct: 104 FLAEKESLTEEEATEFLK---------QILNGVYYLH---SLQIAHFDLKPENIMLLDRN 151
Query: 215 ----KSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLL 270
               + KI DF L ++  D      +  + GT  + APE      +  ++D++S GV+  
Sbjct: 152 VPKPRIKIIDFGLAHKI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 271 ELLTGRKP 278
            LL+G  P
Sbjct: 209 ILLSGASP 216

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 80/188 (42%), Gaps = 21/188 (11%)
Query: 97  IKKLDTSSAPEPES--DFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHD 154
           IKK  T S+    S  D   ++S++  ++H + + L        + IL+ +    G L D
Sbjct: 43  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 102
Query: 155 VLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF 214
            L  ++ +   E    L              G+ +LH      I H D++  N++L D  
Sbjct: 103 FLAEKESLTEEEATEFLK---------QILNGVYYLH---SLQIAHFDLKPENIMLLDRN 150
Query: 215 ----KSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLL 270
               + KI DF L ++  D      +  + GT  + APE      +  ++D++S GV+  
Sbjct: 151 VPKPRIKIIDFGLAHKI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 207
Query: 271 ELLTGRKP 278
            LL+G  P
Sbjct: 208 ILLSGASP 215

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 80/188 (42%), Gaps = 21/188 (11%)
Query: 97  IKKLDTSSAPEPES--DFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHD 154
           IKK  T S+    S  D   ++S++  ++H + + L        + IL+ +    G L D
Sbjct: 43  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 102
Query: 155 VLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF 214
            L  ++ +   E    L              G+ +LH      I H D++  N++L D  
Sbjct: 103 FLAEKESLTEEEATEFLK---------QILNGVYYLH---SLQIAHFDLKPENIMLLDRN 150
Query: 215 ----KSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLL 270
               + KI DF L ++  D      +  + GT  + APE      +  ++D++S GV+  
Sbjct: 151 VPKPRIKIIDFGLAHKI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 207
Query: 271 ELLTGRKP 278
            LL+G  P
Sbjct: 208 ILLSGASP 215

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 79/188 (42%), Gaps = 21/188 (11%)
Query: 97  IKKLDTSSAPE--PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHD 154
           IKK  T S+       D   ++S++  ++H + + L        + IL+ +    G L D
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 155 VLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF 214
            L  ++ +   E    L              G+ +LH      I H D++  N++L D  
Sbjct: 104 FLAEKESLTEEEATEFLK---------QILNGVYYLH---SLQIAHFDLKPENIMLLDRN 151
Query: 215 ----KSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLL 270
               + KI DF L ++  D      +  + GT  + APE      +  ++D++S GV+  
Sbjct: 152 VPKPRIKIIDFGLAHKI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 271 ELLTGRKP 278
            LL+G  P
Sbjct: 209 ILLSGASP 216

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 80/188 (42%), Gaps = 21/188 (11%)
Query: 97  IKKLDTSSAPEPES--DFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHD 154
           IKK  T S+    S  D   ++S++  ++H + + L        + IL+ +    G L D
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 155 VLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF 214
            L  ++ +   E    L              G+ +LH      I H D++  N++L D  
Sbjct: 104 FLAEKESLTEEEATEFLK---------QILNGVYYLH---SLQIAHFDLKPENIMLLDRN 151
Query: 215 ----KSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLL 270
               + KI DF L ++  D      +  + GT  + APE      +  ++D++S GV+  
Sbjct: 152 VPKPRIKIIDFGLAHKI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 271 ELLTGRKP 278
            LL+G  P
Sbjct: 209 ILLSGASP 216

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 7/100 (7%)
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD-FKSKIADFN--LTNQSSDTAARLHSTRV 239
           A +GLE+LH +    I+H DV++ NVLL  D  ++ + DF   L  Q       L +   
Sbjct: 159 ALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215
Query: 240 L-GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           + GT  + APE  M      K D++S   ++L +L G  P
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 7/100 (7%)
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD-FKSKIADFN--LTNQSSDTAARLHSTRV 239
           A +GLE+LH +    I+H DV++ NVLL  D  ++ + DF   L  Q       L +   
Sbjct: 175 ALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 231
Query: 240 L-GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           + GT  + APE  M      K D++S   ++L +L G  P
Sbjct: 232 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 80/188 (42%), Gaps = 21/188 (11%)
Query: 97  IKKLDTSSAPEPES--DFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHD 154
           IKK  T S+    S  D   ++S++  ++H + + L        + IL+ +    G L D
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 155 VLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF 214
            L  ++ +   E    L              G+ +LH      I H D++  N++L D  
Sbjct: 104 FLAEKESLTEEEATEFLK---------QILNGVYYLH---SLQIAHFDLKPENIMLLDRN 151
Query: 215 ----KSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLL 270
               + KI DF L ++  D      +  + GT  + APE      +  ++D++S GV+  
Sbjct: 152 VPKPRIKIIDFGLAHKI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 271 ELLTGRKP 278
            LL+G  P
Sbjct: 209 ILLSGASP 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 80/188 (42%), Gaps = 21/188 (11%)
Query: 97  IKKLDTSSAPEPES--DFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHD 154
           IKK  T S+    S  D   ++S++  ++H + + L        + IL+ +    G L D
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 155 VLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF 214
            L  ++ +   E    L              G+ +LH      I H D++  N++L D  
Sbjct: 104 FLAEKESLTEEEATEFLK---------QILNGVYYLH---SLQIAHFDLKPENIMLLDRN 151
Query: 215 ----KSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLL 270
               + KI DF L ++  D      +  + GT  + APE      +  ++D++S GV+  
Sbjct: 152 VPKPRIKIIDFGLAHKI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 271 ELLTGRKP 278
            LL+G  P
Sbjct: 209 ILLSGASP 216

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/228 (22%), Positives = 95/228 (41%), Gaps = 27/228 (11%)
Query: 60  LDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPE--SDFAAQL 116
           LD+  R+ +       IG GS+GRV   K +  G   A+K LD     + +       + 
Sbjct: 40  LDQFERIKT-------IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 117 SVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            ++  +     V+L     +++N  +V ++   G +    H R+  + +EP       Q 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFS--HLRRIGRFSEPHARFYAAQI 150
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS 236
           V          E+LH      +++RD++  N+L+      K+ADF    +      +  +
Sbjct: 151 VLT-------FEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKR-----VKGRT 195
Query: 237 TRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
             + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 46/95 (48%), Gaps = 6/95 (6%)
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           Y    G++ LH      I+HRD++ SN+++  D   KI DF L   +S        T  +
Sbjct: 131 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAS---TNFMMTPYV 184
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTG 275
            T  Y APE  +     +  D++S G ++ EL+ G
Sbjct: 185 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 90/221 (40%), Gaps = 27/221 (12%)
Query: 65  RLTSNFGTKALIGEGSYG--RVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + T  +  K  IG GSY   +    K T+    A+K +D S     + D   ++ ++ R 
Sbjct: 19  QFTDGYEVKEDIGVGSYSVCKRCIHKATN-MEFAVKIIDKS-----KRDPTEEIEILLRY 72
Query: 123 -KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY 181
            +H + + L     +     +V +    G L D +  +K     E   VL         +
Sbjct: 73  GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL---------F 123
Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS----KIADFNLTNQSSDTAARLHST 237
              K +E+LH +    +VHRD++ SN+L  D+  +    +I DF    Q       L + 
Sbjct: 124 TITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP 180
Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
                F   APE           D++S GV+L  +LTG  P
Sbjct: 181 CYTANFV--APEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/228 (22%), Positives = 95/228 (41%), Gaps = 27/228 (11%)
Query: 60  LDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPE--SDFAAQL 116
           LD+  R+ +       IG GS+GRV   K +  G   A+K LD     + +       + 
Sbjct: 40  LDQFERIKT-------IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 117 SVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            ++  +     V+L     +++N  +V ++   G +    H R+  + +EP       Q 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFS--HLRRIGRFSEPHARFYAAQI 150
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS 236
           V          E+LH      +++RD++  N+L+      K+ADF    +      +  +
Sbjct: 151 VLT-------FEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKR-----VKGRT 195
Query: 237 TRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
             + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 7/100 (7%)
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD-FKSKIADFN--LTNQSSDTAARLHSTRV 239
           A +GLE+LH +    I+H DV++ NVLL  D  ++ + DF   L  Q       L +   
Sbjct: 173 ALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 229
Query: 240 L-GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           + GT  + APE  M      K D++S   ++L +L G  P
Sbjct: 230 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/168 (22%), Positives = 73/168 (43%), Gaps = 19/168 (11%)
Query: 115 QLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWN 174
           ++S++ ++ H + + L        + +L+ +  + G L D L  ++ +   E    +   
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-- 122
Query: 175 QRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF----KSKIADFNLTNQSSDT 230
                      G+ +LH K    I H D++  N++L D        K+ DF L ++  D 
Sbjct: 123 -------QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 231 AARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
              +    + GT  + APE      +  ++D++S GV+   LL+G  P
Sbjct: 173 ---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/168 (22%), Positives = 73/168 (43%), Gaps = 19/168 (11%)
Query: 115 QLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWN 174
           ++S++ ++ H + + L        + +L+ +  + G L D L  ++ +   E    +   
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-- 122
Query: 175 QRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF----KSKIADFNLTNQSSDT 230
                      G+ +LH K    I H D++  N++L D        K+ DF L ++  D 
Sbjct: 123 -------QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 231 AARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
              +    + GT  + APE      +  ++D++S GV+   LL+G  P
Sbjct: 173 ---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 79/188 (42%), Gaps = 21/188 (11%)
Query: 97  IKKLDTSSAPE--PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHD 154
           IKK  T S+       D   ++S++  ++H + + L        + IL+ +    G L D
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 155 VLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF 214
            L  ++ +   E    L              G+ +LH      I H D++  N++L D  
Sbjct: 104 FLAEKESLTEEEATEFLK---------QILNGVYYLH---SLQIAHFDLKPENIMLLDRN 151
Query: 215 ----KSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLL 270
               + KI DF L ++  D      +  + GT  + APE      +  ++D++S GV+  
Sbjct: 152 VPKPRIKIIDFGLAHKI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 271 ELLTGRKP 278
            LL+G  P
Sbjct: 209 ILLSGASP 216

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 91/220 (41%), Gaps = 27/220 (12%)
Query: 66  LTSNFGTKALIGEGSYG--RVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL- 122
            +  +  K  IG GSY   +    K T+    A+K +D S     + D + ++ ++ R  
Sbjct: 25  FSDGYVVKETIGVGSYSECKRCVHKATN-MEYAVKVIDKS-----KRDPSEEIEILLRYG 78
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
           +H + + L     +  +  LV +    G L D +  +K     E   VL         + 
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVL---------HT 129
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS----KIADFNLTNQSSDTAARLHSTR 238
             K +E+LH +    +VHRD++ SN+L  D+  +    +I DF    Q       L +  
Sbjct: 130 IGKTVEYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPC 186
Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
               F   APE        +  D++S G++L  +L G  P
Sbjct: 187 YTANFV--APEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 85/211 (40%), Gaps = 29/211 (13%)
Query: 76  IGEGSYGRVFYAKLTD---GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           +G GS+G V   ++ D   G   A+KK+        E   A +L   + L     V L G
Sbjct: 101 LGRGSFGEVH--RMEDKQTGFQCAVKKVRL------EVFRAEELMACAGLTSPRIVPLYG 152
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA-KGLEFLH 191
              E     +  +    GSL  ++      QG  P        R     G A +GLE+LH
Sbjct: 153 AVREGPWVNIFMELLEGGSLGQLVK----EQGCLP------EDRALYYLGQALEGLEYLH 202
Query: 192 EKVQPPIVHRDVRSSNVLLFDD-FKSKIADFN---LTNQSSDTAARLHSTRVLGTFGYHA 247
            +    I+H DV++ NVLL  D   + + DF             + L    + GT  + A
Sbjct: 203 SRR---ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMA 259
Query: 248 PEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           PE  +      K DV+S   ++L +L G  P
Sbjct: 260 PEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 6/95 (6%)
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           Y    G++ LH      I+HRD++ SN+++  D   KI DF L   +  +      T  +
Sbjct: 133 YQMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS---FMMTPYV 186
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTG 275
            T  Y APE  +     +  D++S GV++ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/168 (22%), Positives = 73/168 (43%), Gaps = 19/168 (11%)
Query: 115 QLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWN 174
           ++S++ ++ H + + L        + +L+ +  + G L D L  ++ +   E    +   
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-- 122
Query: 175 QRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF----KSKIADFNLTNQSSDT 230
                      G+ +LH K    I H D++  N++L D        K+ DF L ++  D 
Sbjct: 123 -------QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 231 AARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
              +    + GT  + APE      +  ++D++S GV+   LL+G  P
Sbjct: 173 ---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/168 (22%), Positives = 73/168 (43%), Gaps = 19/168 (11%)
Query: 115 QLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWN 174
           ++S++ ++ H + + L        + +L+ +  + G L D L  ++ +   E    +   
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-- 122
Query: 175 QRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF----KSKIADFNLTNQSSDT 230
                      G+ +LH K    I H D++  N++L D        K+ DF L ++  D 
Sbjct: 123 -------QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 231 AARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
              +    + GT  + APE      +  ++D++S GV+   LL+G  P
Sbjct: 173 ---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 6/95 (6%)
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           Y    G++ LH      I+HRD++ SN+++  D   KI DF L   +  +      T  +
Sbjct: 133 YQMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS---FMMTPYV 186
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTG 275
            T  Y APE  +     +  D++S GV++ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 27/220 (12%)
Query: 66  LTSNFGTKALIGEGSYGRV--FYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL- 122
            +  +  K  IG GSY        K T+    A+K +D S     + D + ++ ++ R  
Sbjct: 25  FSDGYVVKETIGVGSYSECKRCVHKATN-MEYAVKVIDKS-----KRDPSEEIEILLRYG 78
Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
           +H + + L     +  +  LV +    G L D +  +K     E   VL         + 
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVL---------HT 129
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS----KIADFNLTNQSSDTAARLHSTR 238
             K +E+LH +    +VHRD++ SN+L  D+  +    +I DF    Q       L +  
Sbjct: 130 IGKTVEYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPC 186
Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
               F   APE        +  D++S G++L  +L G  P
Sbjct: 187 YTANFV--APEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 57/116 (49%), Gaps = 9/116 (7%)
Query: 166 EPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF---KSKIADFN 222
           E   +++ N  +++     +G+ +LH   Q  IVH D++  N+LL   +     KI DF 
Sbjct: 123 ELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179
Query: 223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           ++ +    A  L    ++GT  Y APE      IT  +D+++ G++   LLT   P
Sbjct: 180 MSRKIGH-ACELR--EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 37/168 (22%), Positives = 73/168 (43%), Gaps = 19/168 (11%)
Query: 115 QLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWN 174
           ++S++ ++ H + + L        + +L+ +  + G L D L  ++ +   E    +   
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-- 122
Query: 175 QRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF----KSKIADFNLTNQSSDT 230
                      G+ +LH K    I H D++  N++L D        K+ DF L ++  D 
Sbjct: 123 -------QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 231 AARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
              +    + GT  + APE      +  ++D++S GV+   LL+G  P
Sbjct: 173 ---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 87/211 (41%), Gaps = 29/211 (13%)
Query: 76  IGEGSYGRVFYAKLTD---GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           +G GS+G V   ++ D   G   A+KK+        E   A +L   + L     V L G
Sbjct: 82  LGRGSFGEVH--RMEDKQTGFQCAVKKVRL------EVFRAEELMACAGLTSPRIVPLYG 133
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA-KGLEFLH 191
              E     +  +    GSL  ++      QG  P        R     G A +GLE+LH
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLVK----EQGCLP------EDRALYYLGQALEGLEYLH 183
Query: 192 EKVQPPIVHRDVRSSNVLLFDD-FKSKIADF-NLTNQSSDTAAR--LHSTRVLGTFGYHA 247
            +    I+H DV++ NVLL  D   + + DF +      D   +  L    + GT  + A
Sbjct: 184 SRR---ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMA 240
Query: 248 PEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           PE  +      K DV+S   ++L +L G  P
Sbjct: 241 PEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 52/228 (22%), Positives = 96/228 (42%), Gaps = 27/228 (11%)
Query: 60  LDELNRLTSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPE-PESDFAAQLS 117
           LD+  R+ +       +G GS+GRV   K  + G   A+K LD     +  + +      
Sbjct: 41  LDQFERIRT-------LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 118 VVSRLKHEHFVELLGYCMESN-NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            + +  +  F+  L +  + N N  +V ++A  G +    H R+  + +EP       Q 
Sbjct: 94  RIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFS--HLRRIGRFSEPHARFYAAQI 151
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS 236
           V          E+LH      +++RD++  N+L+      K+ADF    +      +  +
Sbjct: 152 VLT-------FEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKR-----VKGRT 196
Query: 237 TRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
             + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 89/219 (40%), Gaps = 21/219 (9%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSS-APEPESDFAAQLSVVSRLK 123
           +T  +     +G+G++  V    K+  G   A K ++T   +         +  +   LK
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLK 61
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           H + V L     E     LV+   T G L + +  R+    A+    +   Q++      
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCI---QQI------ 112
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS---KIADFNLTNQ-SSDTAARLHSTRV 239
              LE ++      IVHRD++  N+LL    K    K+ADF L  +   D  A       
Sbjct: 113 ---LESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG---F 166
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            GT GY +PE        +  D+++ GV+L  LL G  P
Sbjct: 167 AGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 89/219 (40%), Gaps = 21/219 (9%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSS-APEPESDFAAQLSVVSRLK 123
           +T  +     +G+G++  V    K+  G   A K ++T   +         +  +   LK
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLK 61
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           H + V L     E     LV+   T G L + +  R+    A+    +   Q++      
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCI---QQI------ 112
Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS---KIADFNLTNQ-SSDTAARLHSTRV 239
              LE ++      IVHRD++  N+LL    K    K+ADF L  +   D  A       
Sbjct: 113 ---LESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA-- 167
Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            GT GY +PE        +  D+++ GV+L  LL G  P
Sbjct: 168 -GTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 29/229 (12%)
Query: 60  LDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSA---PEPESDFAAQ 115
           LD+  R+ +       +G GS+GRV   K +  G   A+K LD        E E     +
Sbjct: 40  LDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEK 92
Query: 116 LSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQ 175
             ++  +     V+L     +++N  +V ++A  G +    H R+  + +EP       Q
Sbjct: 93  -RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFSEPHARFYAAQ 149
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
            V          E+LH      +++RD++  N+++      ++ DF L  +      +  
Sbjct: 150 IVLT-------FEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKR-----VKGR 194
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
           +  + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 80/188 (42%), Gaps = 21/188 (11%)
Query: 97  IKKLDTSSAPEPES--DFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHD 154
           IKK  T S+    S  D   ++S++  ++H + + L        + IL+ +    G L D
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFD 103
Query: 155 VLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF 214
            L  ++ +   E    L              G+ +LH      I H D++  N++L D  
Sbjct: 104 FLAEKESLTEEEATEFLK---------QILNGVYYLH---SLQIAHFDLKPENIMLLDRN 151
Query: 215 ----KSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLL 270
               + KI DF L ++  D      +  + GT  + APE      +  ++D++S GV+  
Sbjct: 152 VPKPRIKIIDFGLAHKI-DFGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 271 ELLTGRKP 278
            LL+G  P
Sbjct: 209 ILLSGASP 216

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/168 (22%), Positives = 73/168 (43%), Gaps = 19/168 (11%)
Query: 115 QLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWN 174
           ++S++ ++ H + + L        + +L+ +  + G L D L  ++ +   E    +   
Sbjct: 65  EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-- 122
Query: 175 QRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF----KSKIADFNLTNQSSDT 230
                      G+ +LH K    I H D++  N++L D        K+ DF L ++  D 
Sbjct: 123 -------QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 231 AARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
              +    + GT  + APE      +  ++D++S GV+   LL+G  P
Sbjct: 173 ---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 89/221 (40%), Gaps = 27/221 (12%)
Query: 65  RLTSNFGTKALIGEGSYG--RVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           + T  +  K  IG GSY   +    K T+    A+K +D S     + D   ++ ++ R 
Sbjct: 19  QFTDGYEVKEDIGVGSYSVCKRCIHKATN-XEFAVKIIDKS-----KRDPTEEIEILLRY 72
Query: 123 -KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY 181
            +H + + L     +     +V +    G L D +  +K     E   VL         +
Sbjct: 73  GQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVL---------F 123
Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS----KIADFNLTNQSSDTAARLHST 237
              K +E+LH +    +VHRD++ SN+L  D+  +    +I DF    Q       L + 
Sbjct: 124 TITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTP 180
Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
                F   APE           D++S GV+L   LTG  P
Sbjct: 181 CYTANFV--APEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 87/220 (39%), Gaps = 19/220 (8%)
Query: 64  NRLTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSS-APEPESDFAAQLSVVSR 121
            R T  +     +G+G++  V    K+  G   A   ++T   +         +  +   
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66
Query: 122 LKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY 181
           LKH + V L     E  +  L++   T G L + +  R+    A+    +   Q++    
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI---QQI---- 119
Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS---KIADFNLTNQSSDTAARLHSTR 238
                LE +    Q  +VHR+++  N+LL    K    K+ADF L  +            
Sbjct: 120 -----LEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-- 172
Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
             GT GY +PE        +  D+++ GV+L  LL G  P
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 37/226 (16%)
Query: 65  RLTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL- 122
           +    +   +LIG+GS+G+V  A    +    AIK +    A      F  Q  +  RL 
Sbjct: 32  KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA------FLNQAQIEVRLL 85
Query: 123 ----KHE-----HFVELLGYCMESNNRILVYQFATMGSLHDVLHGR--KGVQGAEPGPVL 171
               KH+     + V L  + M  N+  LV++  +  +L+D+L     +GV         
Sbjct: 86  ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGV--------- 135
Query: 172 TWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS--KIADFNLTNQSSD 229
           + N   K A      L FL    +  I+H D++  N+LL +  +S  KI DF  + Q   
Sbjct: 136 SLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 194
Query: 230 TAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTG 275
              +   +R      Y +PE  +        D++S G +L+E+ TG
Sbjct: 195 RIYQXIQSRF-----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 235

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 37/226 (16%)
Query: 65  RLTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL- 122
           +    +   +LIG+GS+G+V  A    +    AIK +    A      F  Q  +  RL 
Sbjct: 51  KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA------FLNQAQIEVRLL 104
Query: 123 ----KHE-----HFVELLGYCMESNNRILVYQFATMGSLHDVLHGR--KGVQGAEPGPVL 171
               KH+     + V L  + M  N+  LV++  +  +L+D+L     +GV         
Sbjct: 105 ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGV--------- 154
Query: 172 TWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS--KIADFNLTNQSSD 229
           + N   K A      L FL    +  I+H D++  N+LL +  +S  KI DF  + Q   
Sbjct: 155 SLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 213
Query: 230 TAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTG 275
              +   +R      Y +PE  +        D++S G +L+E+ TG
Sbjct: 214 RIYQXIQSRF-----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 6/95 (6%)
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           Y    G++ LH      I+HRD++ SN+++  D   KI DF L   +  +      T  +
Sbjct: 134 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYV 187
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTG 275
            T  Y APE  +     +  D++S G ++ E++ G
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 47/97 (48%), Gaps = 6/97 (6%)
Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
           + Y    G++ LH      I+HRD++ SN+++  D   KI DF L   +  +      T 
Sbjct: 131 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTP 184
Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTG 275
            + T  Y APE  +     +  D++S G ++ E++ G
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/228 (21%), Positives = 95/228 (41%), Gaps = 27/228 (11%)
Query: 60  LDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPE--SDFAAQL 116
           LD+  R+ +       +G GS+GRV   K +  G   A+K LD     + +       + 
Sbjct: 40  LDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 117 SVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            ++  +     V+L     +++N  +V ++A  G +    H R+  + +EP       Q 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFSEPHARFYAAQI 150
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS 236
           V          E+LH      +++RD++  N+++      K+ DF    +      +  +
Sbjct: 151 VLT-------FEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR-----VKGRT 195
Query: 237 TRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
             + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 6/95 (6%)
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           Y    G++ LH      I+HRD++ SN+++  D   KI DF L   +  +      T  +
Sbjct: 133 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYV 186
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTG 275
            T  Y APE  +     +  D++S G ++ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 44/95 (46%), Gaps = 6/95 (6%)
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           Y    G++ LH      I+HRD++ SN+++  D   KI DF L   +         T  +
Sbjct: 133 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYV 186
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTG 275
            T  Y APE  +        D++S G ++ EL+ G
Sbjct: 187 VTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 6/95 (6%)
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           Y    G++ LH      I+HRD++ SN+++  D   KI DF L   +  +      T  +
Sbjct: 133 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYV 186
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTG 275
            T  Y APE  +     +  D++S G ++ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/229 (21%), Positives = 96/229 (41%), Gaps = 27/229 (11%)
Query: 59  KLDELNRLTSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPE--SDFAAQ 115
           +LD+ +R+ +       +G GS+GRV   K  + G   A+K LD     + +       +
Sbjct: 39  QLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 116 LSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQ 175
             ++  +     V+L     +++N  +V ++   G +    H R+  + AEP       Q
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFAEPHARFYAAQ 149
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
            V          E+LH      +++RD++  N+L+      ++ DF    +      +  
Sbjct: 150 IVLT-------FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGR 194
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
           +  + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 47/97 (48%), Gaps = 6/97 (6%)
Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
           + Y    G++ LH      I+HRD++ SN+++  D   KI DF L   +  +      T 
Sbjct: 131 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTP 184
Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTG 275
            + T  Y APE  +     +  D++S G ++ E++ G
Sbjct: 185 EVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 6/95 (6%)
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           Y    G++ LH      I+HRD++ SN+++  D   KI DF L   +  +      T  +
Sbjct: 133 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS---FMMTPYV 186
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTG 275
            T  Y APE  +     +  D++S G ++ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 6/95 (6%)
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           Y    G++ LH      I+HRD++ SN+++  D   KI DF L   +  +      T  +
Sbjct: 133 YQMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS---FMMTPYV 186
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTG 275
            T  Y APE  +     +  D++S G ++ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/228 (21%), Positives = 94/228 (41%), Gaps = 27/228 (11%)
Query: 60  LDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPE--SDFAAQL 116
           LD+  R+ +       +G GS+GRV   K +  G   A+K LD     + +       + 
Sbjct: 40  LDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 117 SVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            ++  +     V+L     +++N  +V ++A  G +    H R+  +  EP       Q 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFXEPHARFYAAQI 150
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS 236
           V          E+LH      +++RD++  N+++      K+ DF    +      +  +
Sbjct: 151 VLT-------FEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR-----VKGRT 195
Query: 237 TRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
             + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 6/95 (6%)
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           Y    G++ LH      I+HRD++ SN+++  D   KI DF L   +  +      T  +
Sbjct: 133 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS---FMMTPYV 186
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTG 275
            T  Y APE  +     +  D++S G ++ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 48/116 (41%), Gaps = 27/116 (23%)
Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVL--------LFDDFKS-----------KIA 219
           +AY     L FLHE     + H D++  N+L        L+++ KS           ++A
Sbjct: 128 MAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTG 275
           DF      S T    H T ++ T  Y  PE  +     Q  DV+S G +L E   G
Sbjct: 185 DF-----GSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/228 (21%), Positives = 95/228 (41%), Gaps = 27/228 (11%)
Query: 60  LDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPE-PESDFAAQLS 117
           LD+  R+ +       +G GS+GRV   K +  G   A+K LD     +  + +      
Sbjct: 41  LDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 118 VVSRLKHEHFVELLGYCMESN-NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            + +  +  F+  L +  + N N  +V ++A  G +    H R+  + +EP       Q 
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFSEPHARFYAAQI 151
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS 236
           V          E+LH      +++RD++  N+++      K+ DF    +      +  +
Sbjct: 152 VLT-------FEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR-----VKGRT 196
Query: 237 TRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
             + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/228 (21%), Positives = 95/228 (41%), Gaps = 27/228 (11%)
Query: 60  LDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPE-PESDFAAQLS 117
           LD+  R+ +       +G GS+GRV   K +  G   A+K LD     +  + +      
Sbjct: 41  LDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 118 VVSRLKHEHFVELLGYCMESN-NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            + +  +  F+  L +  + N N  +V ++A  G +    H R+  + +EP       Q 
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFSEPHARFYAAQI 151
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS 236
           V          E+LH      +++RD++  N+++      K+ DF    +      +  +
Sbjct: 152 VLT-------FEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR-----VKGRT 196
Query: 237 TRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
             + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/254 (21%), Positives = 104/254 (40%), Gaps = 29/254 (11%)
Query: 43  KTGTPQKALPIEIPQIKLDELNRLTS---------NFGTKALIGEGSYGRVFYAKLTD-G 92
           K G+ Q+++   + + K D L +  S          F     +G GS+GRV   K  + G
Sbjct: 8   KKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETG 67
Query: 93  TPAAIKKLDTSSAPEPE--SDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMG 150
              A+K LD     + +       +  ++  +     V+L     +++N  +V ++A  G
Sbjct: 68  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGG 127
Query: 151 SLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL 210
            +    H R+  + +EP       Q V          E+LH      +++RD++  N+++
Sbjct: 128 EMFS--HLRRIGRFSEPHARFYAAQIVLT-------FEYLH---SLDLIYRDLKPENLMI 175
Query: 211 FDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLL 270
                 K+ DF    +      +  +  + GT  Y APE  ++    +  D ++ GV++ 
Sbjct: 176 DQQGYIKVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 271 ELLTGRKPVDHTMP 284
           E+  G  P     P
Sbjct: 231 EMAAGYPPFFADQP 244

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 48/116 (41%), Gaps = 27/116 (23%)
Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVL--------LFDDFKS-----------KIA 219
           +AY     L FLHE     + H D++  N+L        L+++ KS           ++A
Sbjct: 137 MAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 193
Query: 220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTG 275
           DF      S T    H T ++ T  Y  PE  +     Q  DV+S G +L E   G
Sbjct: 194 DF-----GSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 244

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/95 (27%), Positives = 45/95 (47%), Gaps = 6/95 (6%)
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           Y    G++ LH      I+HRD++ SN+++  D   KI DF L   +  +         +
Sbjct: 135 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMVPFV 188
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTG 275
            T  Y APE  +     +  D++S G ++ E++ G
Sbjct: 189 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/229 (20%), Positives = 97/229 (42%), Gaps = 27/229 (11%)
Query: 59  KLDELNRLTSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPE--SDFAAQ 115
           +LD+ +R+ +       +G GS+GRV   K  + G   A+K LD     + +       +
Sbjct: 26  QLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 78
Query: 116 LSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQ 175
             ++  +     V+L     +++N  +V ++   G +    H R+  + +EP       Q
Sbjct: 79  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFYAAQ 136
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
            V          E+LH      +++RD++  N+L+ +    ++ DF    +      +  
Sbjct: 137 IVLT-------FEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKR-----VKGR 181
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
           +  + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 182 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 230

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/229 (20%), Positives = 96/229 (41%), Gaps = 27/229 (11%)
Query: 59  KLDELNRLTSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPE--SDFAAQ 115
           +LD+ +R+ +       +G GS+GRV   K  + G   A+K LD     + +       +
Sbjct: 39  QLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 116 LSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQ 175
             ++  +     V+L     +++N  +V ++   G +    H R+  + +EP       Q
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFYAAQ 149
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
            V          E+LH      +++RD++  N+L+      ++ DF    +      +  
Sbjct: 150 IVLT-------FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGR 194
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
           +  + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 48/116 (41%), Gaps = 27/116 (23%)
Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVL--------LFDDFKS-----------KIA 219
           +AY     L FLHE     + H D++  N+L        L+++ KS           ++A
Sbjct: 160 MAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 216
Query: 220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTG 275
           DF      S T    H T ++ T  Y  PE  +     Q  DV+S G +L E   G
Sbjct: 217 DF-----GSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 267

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLD---TSSAPEPESDFAAQLSVVSR 121
           L S +    L+G G +G V+   +++D  P AIK ++    S   E  +     + VV  
Sbjct: 6   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 65
Query: 122 LK----HEHFVELLGYCMESNNRILVYQ-FATMGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            K        + LL +    ++ +L+ +    +  L D +  R  +Q  E      W   
Sbjct: 66  KKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQ-EELARSFFWQVL 124
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTNQSSDTAARLH 235
             V +    G           ++HRD++  N+L+  +  + K+ DF       DT     
Sbjct: 125 EAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 170
Query: 236 STRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDH 281
            T   GT  Y  PE+    +   +S  V+S G++L +++ G  P +H
Sbjct: 171 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 216

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 87/209 (41%), Gaps = 23/209 (11%)
Query: 75  LIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           +IG GS+G VF AKL +    AIKK+      +       +L ++  +KH + V+L  + 
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK-----NRELQIMRIVKHPNVVDLKAFF 101
Query: 135 MESNNRI------LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
             + ++       LV ++          H  K  Q     P+L     +   Y   + L 
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTM---PMLLIKLYM---YQLLRSLA 155
Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           ++H      I HRD++  N+LL D     +   +  +     A   + + +   + Y AP
Sbjct: 156 YIHSI---GICHRDIKPQNLLL-DPPSGVLKLIDFGSAKILIAGEPNVSXICSRY-YRAP 210
Query: 249 EYAM-TGQITQKSDVYSFGVVLLELLTGR 276
           E        T   D++S G V+ EL+ G+
Sbjct: 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 30/227 (13%)
Query: 72  TKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
           ++ ++G GS G V +     G P A+K++          D A     +     +H   + 
Sbjct: 37  SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC-----DIALMEIKLLTESDDHPNVIR 91
Query: 132 GYCMESNNRILVYQFATMG-SLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
            YC E+ +R L         +L D++   K V          +N  + +    A G+  L
Sbjct: 92  YYCSETTDRFLYIALELCNLNLQDLVES-KNVSDENLKLQKEYNP-ISLLRQIASGVAHL 149
Query: 191 HEKVQPPIVHRDVRSSNVLL-------------FDDFKSKIADFNLTNQ--SSDTAARLH 235
           H      I+HRD++  N+L+              ++ +  I+DF L  +  S     R +
Sbjct: 150 H---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXN 206
Query: 236 STRVLGTFGYHAPEY---AMTGQITQKSDVYSFGVVLLELLT-GRKP 278
                GT G+ APE    +   ++T+  D++S G V   +L+ G+ P
Sbjct: 207 LNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHP 253

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 93/218 (42%), Gaps = 30/218 (13%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESD-FAAQLSVVSRLKH--EHFVELLG 132
           IG G   +VF          AIK ++   A     D +  +++ +++L+   +  + L  
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 79
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y +       +Y     G++ D+    K  +  +P     W ++   +Y     LE +H 
Sbjct: 80  YEITDQ---YIYMVMECGNI-DLNSWLKKKKSIDP-----WERK---SYWK-NMLEAVHT 126
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGTFGYHAPEYA 251
             Q  IVH D++ +N L+ D    K+ DF + NQ   DT + +  ++V GT  Y  PE  
Sbjct: 127 IHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAI 184
Query: 252 MTGQITQKS-----------DVYSFGVVLLELLTGRKP 278
                ++++           DV+S G +L  +  G+ P
Sbjct: 185 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 222

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 20/216 (9%)
Query: 68  SNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSS---APEPESDFAAQLSVVSRLK 123
           S+F    +IG+GS+G+V  A+   +    A+K L   +     E +   + +  ++  +K
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKV-AYG 182
           H   V L      ++    V  +   G L    H ++     EP        R +  A  
Sbjct: 98  HPFLVGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEP--------RARFYAAE 147
Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            A  L +LH      IV+RD++  N+LL       + DF L  ++ +  +   ++   GT
Sbjct: 148 IASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGT 202
Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
             Y APE        +  D +  G VL E+L G  P
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/229 (21%), Positives = 94/229 (41%), Gaps = 27/229 (11%)
Query: 59  KLDELNRLTSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPE--SDFAAQ 115
           +LD+ +R+ +       +G GS+GRV   K  + G   A+K LD     + +       +
Sbjct: 60  QLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 112
Query: 116 LSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQ 175
             ++  +     V+L     +++N  +V ++   G +    H R+  + +EP       Q
Sbjct: 113 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFYAAQ 170
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
            V          E+LH      +++RD++  N+L+      ++ DF    +       L 
Sbjct: 171 IVLT-------FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTL- 219
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
                GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 220 ----CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/229 (20%), Positives = 96/229 (41%), Gaps = 27/229 (11%)
Query: 59  KLDELNRLTSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPE--SDFAAQ 115
           +LD+ +R+ +       +G GS+GRV   K  + G   A+K LD     + +       +
Sbjct: 39  QLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 116 LSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQ 175
             ++  +     V+L     +++N  +V ++   G +    H R+  + +EP       Q
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFYAAQ 149
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
            V          E+LH      +++RD++  N+L+      ++ DF    +      +  
Sbjct: 150 IVLT-------FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGR 194
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
           +  + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/229 (20%), Positives = 96/229 (41%), Gaps = 27/229 (11%)
Query: 59  KLDELNRLTSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPE--SDFAAQ 115
           +LD+ +R+ +       +G GS+GRV   K  + G   A+K LD     + +       +
Sbjct: 39  QLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 116 LSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQ 175
             ++  +     V+L     +++N  +V ++   G +    H R+  + +EP       Q
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFYAAQ 149
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
            V          E+LH      +++RD++  N+L+      ++ DF    +      +  
Sbjct: 150 IVLT-------FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGR 194
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
           +  + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/229 (20%), Positives = 96/229 (41%), Gaps = 27/229 (11%)
Query: 59  KLDELNRLTSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPE--SDFAAQ 115
           +LD+ +R+ +       +G GS+GRV   K  + G   A+K LD     + +       +
Sbjct: 39  QLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 116 LSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQ 175
             ++  +     V+L     +++N  +V ++   G +    H R+  + +EP       Q
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFYAAQ 149
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
            V          E+LH      +++RD++  N+L+      ++ DF    +      +  
Sbjct: 150 IVLT-------FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGR 194
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
           +  + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 95/226 (42%), Gaps = 37/226 (16%)
Query: 65  RLTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL- 122
           +    +   +LIG+GS+G+V  A    +    AIK +    A      F  Q  +  RL 
Sbjct: 51  KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA------FLNQAQIEVRLL 104
Query: 123 ----KHE-----HFVELLGYCMESNNRILVYQFATMGSLHDVLHGR--KGVQGAEPGPVL 171
               KH+     + V L  + M  N+  LV++  +  +L+D+L     +GV         
Sbjct: 105 ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGV--------- 154
Query: 172 TWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS--KIADFNLTNQSSD 229
           + N   K A      L FL    +  I+H D++  N+LL +  +   KI DF  + Q   
Sbjct: 155 SLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQ 213
Query: 230 TAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTG 275
              +   +R      Y +PE  +        D++S G +L+E+ TG
Sbjct: 214 RIYQXIQSRF-----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 50/228 (21%), Positives = 94/228 (41%), Gaps = 27/228 (11%)
Query: 60  LDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPE-PESDFAAQLS 117
           LD+  R+ +       +G GS+GRV   K +  G   A+K LD     +  + +      
Sbjct: 41  LDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 118 VVSRLKHEHFVELLGYCMESN-NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            + +  +  F+  L +  + N N  +V ++A  G +    H R+  +  EP       Q 
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFXEPHARFYAAQI 151
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS 236
           V          E+LH      +++RD++  N+++      K+ DF    +      +  +
Sbjct: 152 VLT-------FEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKR-----VKGRT 196
Query: 237 TRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
             + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 30/227 (13%)
Query: 72  TKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
           ++ ++G GS G V +     G P A+K++          D A     +     +H   + 
Sbjct: 37  SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC-----DIALMEIKLLTESDDHPNVIR 91
Query: 132 GYCMESNNRILVYQFATMG-SLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
            YC E+ +R L         +L D++   K V          +N  + +    A G+  L
Sbjct: 92  YYCSETTDRFLYIALELCNLNLQDLVES-KNVSDENLKLQKEYNP-ISLLRQIASGVAHL 149
Query: 191 HEKVQPPIVHRDVRSSNVLL-------------FDDFKSKIADFNLTNQ--SSDTAARLH 235
           H      I+HRD++  N+L+              ++ +  I+DF L  +  S     R +
Sbjct: 150 H---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXN 206
Query: 236 STRVLGTFGYHAPEY---AMTGQITQKSDVYSFGVVLLELLT-GRKP 278
                GT G+ APE    +   ++T+  D++S G V   +L+ G+ P
Sbjct: 207 LNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHP 253

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/229 (20%), Positives = 96/229 (41%), Gaps = 27/229 (11%)
Query: 59  KLDELNRLTSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPE--SDFAAQ 115
           +LD+ +R+ +       +G GS+GRV   K  + G   A+K LD     + +       +
Sbjct: 40  QLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 116 LSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQ 175
             ++  +     V+L     +++N  +V ++   G +    H R+  + +EP       Q
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFYAAQ 150
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
            V          E+LH      +++RD++  N+L+      ++ DF    +      +  
Sbjct: 151 IVLT-------FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGR 195
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
           +  + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 196 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 93/218 (42%), Gaps = 30/218 (13%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESD-FAAQLSVVSRLKH--EHFVELLG 132
           IG G   +VF          AIK ++   A     D +  +++ +++L+   +  + L  
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 75
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y +       +Y     G++ D+    K  +  +P     W ++   +Y     LE +H 
Sbjct: 76  YEITDQ---YIYMVMECGNI-DLNSWLKKKKSIDP-----WERK---SYWK-NMLEAVHT 122
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGTFGYHAPEYA 251
             Q  IVH D++ +N L+ D    K+ DF + NQ   DT + +  ++V GT  Y  PE  
Sbjct: 123 IHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAI 180
Query: 252 MTGQITQKS-----------DVYSFGVVLLELLTGRKP 278
                ++++           DV+S G +L  +  G+ P
Sbjct: 181 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 218

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/228 (21%), Positives = 95/228 (41%), Gaps = 27/228 (11%)
Query: 60  LDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPE--SDFAAQL 116
           LD+  R+ +       +G GS+GRV   K +  G   A+K LD     + +       + 
Sbjct: 40  LDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 117 SVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            ++  +     V+L     +++N  +V ++A  G +    H R+  + +EP       Q 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFSEPHARFYAAQI 150
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS 236
           V          E+LH      +++RD++  N+++      ++ DF    +      +  +
Sbjct: 151 VLT-------FEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKR-----VKGRT 195
Query: 237 TRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
             + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLD---TSSAPEPESDFAAQLSVVSR 121
           L S +    L+G G +G V+   +++D  P AIK ++    S   E  +     + VV  
Sbjct: 22  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 81
Query: 122 LK----HEHFVELLGYCMESNNRILVYQFAT-MGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            K        + LL +    ++ +L+ +    +  L D +  R  +Q  E      W   
Sbjct: 82  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ-EELARSFFWQVL 140
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTNQSSDTAARLH 235
             V +    G           ++HRD++  N+L+  +  + K+ DF       DT     
Sbjct: 141 EAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 186
Query: 236 STRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDH 281
            T   GT  Y  PE+    +   +S  V+S G++L +++ G  P +H
Sbjct: 187 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 232

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLD---TSSAPEPESDFAAQLSVVSR 121
           L S +    L+G G +G V+   +++D  P AIK ++    S   E  +     + VV  
Sbjct: 41  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 100
Query: 122 LK----HEHFVELLGYCMESNNRILVYQFAT-MGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            K        + LL +    ++ +L+ +    +  L D +  R  +Q  E      W   
Sbjct: 101 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ-EELARSFFWQVL 159
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTNQSSDTAARLH 235
             V +    G           ++HRD++  N+L+  +  + K+ DF       DT     
Sbjct: 160 EAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 205
Query: 236 STRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDH 281
            T   GT  Y  PE+    +   +S  V+S G++L +++ G  P +H
Sbjct: 206 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLD---TSSAPEPESDFAAQLSVVSR 121
           L S +    L+G G +G V+   +++D  P AIK ++    S   E  +     + VV  
Sbjct: 21  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 80
Query: 122 LK----HEHFVELLGYCMESNNRILVYQFAT-MGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            K        + LL +    ++ +L+ +    +  L D +  R  +Q  E      W   
Sbjct: 81  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ-EELARSFFWQVL 139
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTNQSSDTAARLH 235
             V +    G           ++HRD++  N+L+  +  + K+ DF       DT     
Sbjct: 140 EAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 185
Query: 236 STRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDH 281
            T   GT  Y  PE+    +   +S  V+S G++L +++ G  P +H
Sbjct: 186 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 231

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/223 (21%), Positives = 95/223 (42%), Gaps = 27/223 (12%)
Query: 59  KLDELNRLTSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPE--SDFAAQ 115
           +LD+ +R+ +       +G GS+GRV   K  + G   A+K LD     + +       +
Sbjct: 39  QLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 116 LSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQ 175
             ++  +     V+L     +++N  +V ++   G +    H R+  + +EP       Q
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFYAAQ 149
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
            V          E+LH      +++RD++  N+L+      ++ DF    +      +  
Sbjct: 150 IVLT-------FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGR 194
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           +  + GT  Y APE  ++    +  D ++ GV++ E+  G  P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLD---TSSAPEPESDFAAQLSVVSR 121
           L S +    L+G G +G V+   +++D  P AIK ++    S   E  +     + VV  
Sbjct: 22  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 81
Query: 122 LK----HEHFVELLGYCMESNNRILVYQFAT-MGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            K        + LL +    ++ +L+ +    +  L D +  R  +Q  E      W   
Sbjct: 82  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ-EELARSFFWQVL 140
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTNQSSDTAARLH 235
             V +    G           ++HRD++  N+L+  +  + K+ DF       DT     
Sbjct: 141 EAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 186
Query: 236 STRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDH 281
            T   GT  Y  PE+    +   +S  V+S G++L +++ G  P +H
Sbjct: 187 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 232

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 48/107 (44%), Gaps = 12/107 (11%)
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           Y    G++ LH      I+HRD++ SN+++  D   KI DF L   +  +      T  +
Sbjct: 133 YQMLXGIKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS---FMMTPYV 186
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLE------LLTGRKPVDH 281
            T  Y APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/228 (21%), Positives = 94/228 (41%), Gaps = 27/228 (11%)
Query: 60  LDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPE--SDFAAQL 116
           LD+  R+ +       +G GS+GRV   K +  G   A+K LD     + +       + 
Sbjct: 40  LDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 117 SVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            ++  +     V+L     +++N  +V ++   G +    H R+  + +EP       Q 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFYAAQI 150
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS 236
           V          E+LH      +++RD++  N+L+      ++ DF    +      +  +
Sbjct: 151 VLT-------FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRT 195
Query: 237 TRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
             + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/229 (20%), Positives = 96/229 (41%), Gaps = 27/229 (11%)
Query: 59  KLDELNRLTSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPE--SDFAAQ 115
           +LD+ +R+ +       +G GS+GRV   K  + G   A+K LD     + +       +
Sbjct: 39  QLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 116 LSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQ 175
             ++  +     V+L     +++N  +V ++   G +    H R+  + +EP       Q
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFYAAQ 149
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
            V          E+LH      +++RD++  N+L+      ++ DF    +      +  
Sbjct: 150 IVLT-------FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGR 194
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
           +  + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 195 TWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 40/188 (21%), Positives = 79/188 (42%), Gaps = 25/188 (13%)
Query: 101 DTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRK 160
           D  S      DF  +L +++ +K+E+ +   G     +   ++Y++    S+        
Sbjct: 79  DKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSI-------- 130
Query: 161 GVQGAEPGPVLTWN-------QRVK-VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD 212
            ++  E   VL  N       Q +K +         ++H   +  I HRDV+ SN+L+  
Sbjct: 131 -LKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDK 187
Query: 213 DFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQ--KSDVYSFGVVLL 270
           + + K++DF  +    D   ++  +R  GT+ +  PE+          K D++S G+ L 
Sbjct: 188 NGRVKLSDFGESEYMVD--KKIKGSR--GTYEFMPPEFFSNESSYNGAKVDIWSLGICLY 243
Query: 271 ELLTGRKP 278
            +     P
Sbjct: 244 VMFYNVVP 251

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLD---TSSAPEPESDFAAQLSVVSR 121
           L S +    L+G G +G V+   +++D  P AIK ++    S   E  +     + VV  
Sbjct: 22  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 81
Query: 122 LK----HEHFVELLGYCMESNNRILVYQFAT-MGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            K        + LL +    ++ +L+ +    +  L D +  R  +Q  E      W   
Sbjct: 82  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ-EELARSFFWQVL 140
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTNQSSDTAARLH 235
             V +    G           ++HRD++  N+L+  +  + K+ DF       DT     
Sbjct: 141 EAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 186
Query: 236 STRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDH 281
            T   GT  Y  PE+    +   +S  V+S G++L +++ G  P +H
Sbjct: 187 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 232

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLD---TSSAPEPESDFAAQLSVVSR 121
           L S +    L+G G +G V+   +++D  P AIK ++    S   E  +     + VV  
Sbjct: 21  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 80
Query: 122 LK----HEHFVELLGYCMESNNRILVYQFAT-MGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            K        + LL +    ++ +L+ +    +  L D +  R  +Q  E      W   
Sbjct: 81  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ-EELARSFFWQVL 139
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTNQSSDTAARLH 235
             V +    G           ++HRD++  N+L+  +  + K+ DF       DT     
Sbjct: 140 EAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 185
Query: 236 STRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDH 281
            T   GT  Y  PE+    +   +S  V+S G++L +++ G  P +H
Sbjct: 186 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 231

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 93/218 (42%), Gaps = 30/218 (13%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESD-FAAQLSVVSRLKH--EHFVELLG 132
           IG G   +VF          AIK ++   A     D +  +++ +++L+   +  + L  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y +       +Y     G++ D+    K  +  +P     W ++   +Y     LE +H 
Sbjct: 124 YEITDQ---YIYMVMECGNI-DLNSWLKKKKSIDP-----WERK---SYWK-NMLEAVHT 170
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGTFGYHAPEYA 251
             Q  IVH D++ +N L+ D    K+ DF + NQ   DT + +  ++V GT  Y  PE  
Sbjct: 171 IHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAI 228
Query: 252 MTGQITQKS-----------DVYSFGVVLLELLTGRKP 278
                ++++           DV+S G +L  +  G+ P
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 49/108 (45%), Gaps = 12/108 (11%)
Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
           + Y    G++ LH      I+HRD++ SN+++  D   KI DF L   +  +      T 
Sbjct: 124 LLYQMLXGIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS---FMMTP 177
Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLE------LLTGRKPVD 280
            + T  Y APE  +     +  D++S G ++ E      L  GR  +D
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLD---TSSAPEPESDFAAQLSVVSR 121
           L S +    L+G G +G V+   +++D  P AIK ++    S   E  +     + VV  
Sbjct: 29  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 88
Query: 122 LK----HEHFVELLGYCMESNNRILVYQFAT-MGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            K        + LL +    ++ +L+ +    +  L D +  R  +Q  E      W   
Sbjct: 89  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ-EELARSFFWQVL 147
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTNQSSDTAARLH 235
             V +    G           ++HRD++  N+L+  +  + K+ DF       DT     
Sbjct: 148 EAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 193
Query: 236 STRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDH 281
            T   GT  Y  PE+    +   +S  V+S G++L +++ G  P +H
Sbjct: 194 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 239

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/229 (20%), Positives = 95/229 (41%), Gaps = 27/229 (11%)
Query: 59  KLDELNRLTSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPE--SDFAAQ 115
           +LD+ +R+ +       +G GS+GRV   K  + G   A+K LD     + +       +
Sbjct: 39  QLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 116 LSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQ 175
             ++  +     V+L     +++N  +V ++   G +    H R+  +  EP       Q
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFXEPHARFYAAQ 149
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
            V          E+LH      +++RD++  N+L+      ++ DF    +      +  
Sbjct: 150 IVLT-------FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGR 194
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
           +  + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/229 (20%), Positives = 95/229 (41%), Gaps = 27/229 (11%)
Query: 59  KLDELNRLTSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPE--SDFAAQ 115
           +LD+ +R+ +       +G GS+GRV   K  + G   A+K LD     + +       +
Sbjct: 60  QLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 112
Query: 116 LSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQ 175
             ++  +     V+L     +++N  +V ++   G +    H R+  +  EP       Q
Sbjct: 113 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFXEPHARFYAAQ 170
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
            V          E+LH      +++RD++  N+L+      ++ DF    +      +  
Sbjct: 171 IVLT-------FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGR 215
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
           +  + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 216 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 48/107 (44%), Gaps = 12/107 (11%)
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           Y    G++ LH      I+HRD++ SN+++  D   KI DF L   +  +      T  +
Sbjct: 133 YQMLXGIKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS---FMMTPYV 186
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLE------LLTGRKPVDH 281
            T  Y APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 48/229 (20%), Positives = 96/229 (41%), Gaps = 27/229 (11%)
Query: 59  KLDELNRLTSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPE--SDFAAQ 115
           +LD+ +R+ +       +G GS+GRV   K  + G   A+K LD     + +       +
Sbjct: 39  QLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 116 LSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQ 175
             ++  +     V+L     +++N  +V ++   G +    H R+  + +EP       Q
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFYAAQ 149
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
            V          E+LH      +++RD++  N+L+      ++ DF    +      +  
Sbjct: 150 IVLT-------FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGR 194
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
           +  + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 195 TWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLD---TSSAPEPESDFAAQLSVVSR 121
           L S +    L+G G +G V+   +++D  P AIK ++    S   E  +     + VV  
Sbjct: 54  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 113
Query: 122 LK----HEHFVELLGYCMESNNRILVYQFAT-MGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            K        + LL +    ++ +L+ +    +  L D +  R  +Q  E      W   
Sbjct: 114 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ-EELARSFFWQVL 172
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTNQSSDTAARLH 235
             V +    G           ++HRD++  N+L+  +  + K+ DF       DT     
Sbjct: 173 EAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 218
Query: 236 STRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDH 281
            T   GT  Y  PE+    +   +S  V+S G++L +++ G  P +H
Sbjct: 219 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 264

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLD---TSSAPEPESDFAAQLSVVSR 121
           L S +    L+G G +G V+   +++D  P AIK ++    S   E  +     + VV  
Sbjct: 34  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 122 LK----HEHFVELLGYCMESNNRILVYQFAT-MGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            K        + LL +    ++ +L+ +    +  L D +  R  +Q  E      W   
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ-EELARSFFWQVL 152
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTNQSSDTAARLH 235
             V +    G           ++HRD++  N+L+  +  + K+ DF       DT     
Sbjct: 153 EAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 198
Query: 236 STRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDH 281
            T   GT  Y  PE+    +   +S  V+S G++L +++ G  P +H
Sbjct: 199 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 244

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLD---TSSAPEPESDFAAQLSVVSR 121
           L S +    L+G G +G V+   +++D  P AIK ++    S   E  +     + VV  
Sbjct: 49  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 108
Query: 122 LK----HEHFVELLGYCMESNNRILVYQFAT-MGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            K        + LL +    ++ +L+ +    +  L D +  R  +Q  E      W   
Sbjct: 109 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ-EELARSFFWQVL 167
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTNQSSDTAARLH 235
             V +    G           ++HRD++  N+L+  +  + K+ DF       DT     
Sbjct: 168 EAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 213
Query: 236 STRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDH 281
            T   GT  Y  PE+    +   +S  V+S G++L +++ G  P +H
Sbjct: 214 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 259

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLD---TSSAPEPESDFAAQLSVVSR 121
           L S +    L+G G +G V+   +++D  P AIK ++    S   E  +     + VV  
Sbjct: 35  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 122 LK----HEHFVELLGYCMESNNRILVYQFAT-MGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            K        + LL +    ++ +L+ +    +  L D +  R  +Q  E      W   
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ-EELARSFFWQVL 153
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTNQSSDTAARLH 235
             V +    G           ++HRD++  N+L+  +  + K+ DF       DT     
Sbjct: 154 EAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 199
Query: 236 STRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDH 281
            T   GT  Y  PE+    +   +S  V+S G++L +++ G  P +H
Sbjct: 200 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 245

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 93/218 (42%), Gaps = 30/218 (13%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESD-FAAQLSVVSRLKH--EHFVELLG 132
           IG G   +VF          AIK ++   A     D +  +++ +++L+   +  + L  
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y +       +Y     G++ D+    K  +  +P     W ++   +Y     LE +H 
Sbjct: 96  YEITDQ---YIYMVMECGNI-DLNSWLKKKKSIDP-----WERK---SYWK-NMLEAVHT 142
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGTFGYHAPEYA 251
             Q  IVH D++ +N L+ D    K+ DF + NQ   DT + +  ++V GT  Y  PE  
Sbjct: 143 IHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAI 200
Query: 252 MTGQITQKS-----------DVYSFGVVLLELLTGRKP 278
                ++++           DV+S G +L  +  G+ P
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 57/268 (21%), Positives = 107/268 (39%), Gaps = 31/268 (11%)
Query: 29  PGGSARGEPRTNVVKTGTPQKALPIEIPQIKLDELNRLTS---------NFGTKALIGEG 79
           P GS  G       K G+ Q+++   + + K D L +  S          F     +G G
Sbjct: 16  PRGSHMGN--AAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTG 73
Query: 80  SYGRVFYAKLTD-GTPAAIKKLDTSSAPEPE--SDFAAQLSVVSRLKHEHFVELLGYCME 136
           S+GRV   K  + G   A+K LD     + +       +  ++  +     V+L     +
Sbjct: 74  SFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 133
Query: 137 SNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQP 196
           ++N  +V ++   G +    H R+  + +EP       Q V          E+LH     
Sbjct: 134 NSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFYAAQIVLT-------FEYLH---SL 181
Query: 197 PIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQI 256
            +++RD++  N+L+      ++ DF    +      +  +  + GT  Y APE  ++   
Sbjct: 182 DLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGY 236
Query: 257 TQKSDVYSFGVVLLELLTGRKPVDHTMP 284
            +  D ++ GV++ E+  G  P     P
Sbjct: 237 NKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLD---TSSAPEPESDFAAQLSVVSR 121
           L S +    L+G G +G V+   +++D  P AIK ++    S   E  +     + VV  
Sbjct: 34  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 122 LK----HEHFVELLGYCMESNNRILVYQFAT-MGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            K        + LL +    ++ +L+ +    +  L D +  R  +Q  E      W   
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ-EELARSFFWQVL 152
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTNQSSDTAARLH 235
             V +    G           ++HRD++  N+L+  +  + K+ DF       DT     
Sbjct: 153 EAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 198
Query: 236 STRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDH 281
            T   GT  Y  PE+    +   +S  V+S G++L +++ G  P +H
Sbjct: 199 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 244

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLD---TSSAPEPESDFAAQLSVVSR 121
           L S +    L+G G +G V+   +++D  P AIK ++    S   E  +     + VV  
Sbjct: 34  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 122 LK----HEHFVELLGYCMESNNRILVYQFAT-MGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            K        + LL +    ++ +L+ +    +  L D +  R  +Q  E      W   
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ-EELARSFFWQVL 152
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTNQSSDTAARLH 235
             V +    G           ++HRD++  N+L+  +  + K+ DF       DT     
Sbjct: 153 EAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 198
Query: 236 STRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDH 281
            T   GT  Y  PE+    +   +S  V+S G++L +++ G  P +H
Sbjct: 199 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 244

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 48/229 (20%), Positives = 95/229 (41%), Gaps = 27/229 (11%)
Query: 59  KLDELNRLTSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPE--SDFAAQ 115
           +LD+ +R+ +       +G GS+GRV   K  + G   A+K LD     + +       +
Sbjct: 39  QLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 116 LSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQ 175
             ++  +     V+L     +++N  +V ++   G +    H R+  +  EP       Q
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFXEPHARFYAAQ 149
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
            V          E+LH      +++RD++  N+L+      ++ DF    +      +  
Sbjct: 150 IVLT-------FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGR 194
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
           +  + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 48/107 (44%), Gaps = 12/107 (11%)
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           Y    G++ LH      I+HRD++ SN+++  D   KI DF L   +  +      T  +
Sbjct: 171 YQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYV 224
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLE------LLTGRKPVDH 281
            T  Y APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 271

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 46/89 (51%), Gaps = 6/89 (6%)
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEY--AM 252
           Q   VHRD++  NVLL  +   ++ADF    + +D    + S+  +GT  Y +PE   AM
Sbjct: 193 QLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGT-VQSSVAVGTPDYISPEILQAM 251
Query: 253 ---TGQITQKSDVYSFGVVLLELLTGRKP 278
               G+   + D +S GV + E+L G  P
Sbjct: 252 EDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLD---TSSAPEPESDFAAQLSVVSR 121
           L S +    L+G G +G V+   +++D  P AIK ++    S   E  +     + VV  
Sbjct: 35  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 122 LK----HEHFVELLGYCMESNNRILVYQFAT-MGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            K        + LL +    ++ +L+ +    +  L D +  R  +Q  E      W   
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ-EELARSFFWQVL 153
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTNQSSDTAARLH 235
             V +    G           ++HRD++  N+L+  +  + K+ DF       DT     
Sbjct: 154 EAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 199
Query: 236 STRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDH 281
            T   GT  Y  PE+    +   +S  V+S G++L +++ G  P +H
Sbjct: 200 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 245

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLD---TSSAPEPESDFAAQLSVVSR 121
           L S +    L+G G +G V+   +++D  P AIK ++    S   E  +     + VV  
Sbjct: 34  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 122 LK----HEHFVELLGYCMESNNRILVYQFAT-MGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            K        + LL +    ++ +L+ +    +  L D +  R  +Q  E      W   
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ-EELARSFFWQVL 152
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTNQSSDTAARLH 235
             V +    G           ++HRD++  N+L+  +  + K+ DF       DT     
Sbjct: 153 EAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 198
Query: 236 STRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDH 281
            T   GT  Y  PE+    +   +S  V+S G++L +++ G  P +H
Sbjct: 199 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 244

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLD---TSSAPEPESDFAAQLSVVSR 121
           L S +    L+G G +G V+   +++D  P AIK ++    S   E  +     + VV  
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 66
Query: 122 LK----HEHFVELLGYCMESNNRILVYQFAT-MGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            K        + LL +    ++ +L+ +    +  L D +  R  +Q  E      W   
Sbjct: 67  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ-EELARSFFWQVL 125
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTNQSSDTAARLH 235
             V +    G           ++HRD++  N+L+  +  + K+ DF       DT     
Sbjct: 126 EAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 171
Query: 236 STRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDH 281
            T   GT  Y  PE+    +   +S  V+S G++L +++ G  P +H
Sbjct: 172 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 217

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 93/218 (42%), Gaps = 30/218 (13%)
Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESD-FAAQLSVVSRLKH--EHFVELLG 132
           IG G   +VF          AIK ++   A     D +  +++ +++L+   +  + L  
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y +       +Y     G++ D+    K  +  +P     W ++   +Y     LE +H 
Sbjct: 77  YEITDQ---YIYMVMECGNI-DLNSWLKKKKSIDP-----WERK---SYWK-NMLEAVHT 123
Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGTFGYHAPEYA 251
             Q  IVH D++ +N L+ D    K+ DF + NQ   DT + +  ++V GT  Y  PE  
Sbjct: 124 IHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAI 181
Query: 252 MTGQITQKS-----------DVYSFGVVLLELLTGRKP 278
                ++++           DV+S G +L  +  G+ P
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLD---TSSAPEPESDFAAQLSVVSR 121
           L S +    L+G G +G V+   +++D  P AIK ++    S   E  +     + VV  
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 122 LK----HEHFVELLGYCMESNNRILVYQFAT-MGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            K        + LL +    ++ +L+ +    +  L D +  R  +Q  E      W   
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ-EELARSFFWQVL 120
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTNQSSDTAARLH 235
             V +    G           ++HRD++  N+L+  +  + K+ DF       DT     
Sbjct: 121 EAVRHCHNXG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 166
Query: 236 STRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDH 281
            T   GT  Y  PE+    +   +S  V+S G++L +++ G  P +H
Sbjct: 167 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLD---TSSAPEPESDFAAQLSVVSR 121
           L S +    L+G G +G V+   +++D  P AIK ++    S   E  +     + VV  
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 66
Query: 122 LK----HEHFVELLGYCMESNNRILVYQFAT-MGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            K        + LL +    ++ +L+ +    +  L D +  R  +Q  E      W   
Sbjct: 67  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ-EELARSFFWQVL 125
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTNQSSDTAARLH 235
             V +    G           ++HRD++  N+L+  +  + K+ DF       DT     
Sbjct: 126 EAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 171
Query: 236 STRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDH 281
            T   GT  Y  PE+    +   +S  V+S G++L +++ G  P +H
Sbjct: 172 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 217

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLD---TSSAPEPESDFAAQLSVVSR 121
           L S +    L+G G +G V+   +++D  P AIK ++    S   E  +     + VV  
Sbjct: 35  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 122 LK----HEHFVELLGYCMESNNRILVYQFAT-MGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            K        + LL +    ++ +L+ +    +  L D +  R  +Q  E      W   
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ-EELARSFFWQVL 153
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTNQSSDTAARLH 235
             V +    G           ++HRD++  N+L+  +  + K+ DF       DT     
Sbjct: 154 EAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 199
Query: 236 STRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDH 281
            T   GT  Y  PE+    +   +S  V+S G++L +++ G  P +H
Sbjct: 200 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 245

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLD---TSSAPEPESDFAAQLSVVSR 121
           L S +    L+G G +G V+   +++D  P AIK ++    S   E  +     + VV  
Sbjct: 6   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 65
Query: 122 LK----HEHFVELLGYCMESNNRILVYQFAT-MGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            K        + LL +    ++ +L+ +    +  L D +  R  +Q  E      W   
Sbjct: 66  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ-EELARSFFWQVL 124
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTNQSSDTAARLH 235
             V +    G           ++HRD++  N+L+  +  + K+ DF       DT     
Sbjct: 125 EAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 170
Query: 236 STRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDH 281
            T   GT  Y  PE+    +   +S  V+S G++L +++ G  P +H
Sbjct: 171 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 216

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLD---TSSAPEPESDFAAQLSVVSR 121
           L S +    L+G G +G V+   +++D  P AIK ++    S   E  +     + VV  
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 66
Query: 122 LK----HEHFVELLGYCMESNNRILVYQFAT-MGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            K        + LL +    ++ +L+ +    +  L D +  R  +Q  E      W   
Sbjct: 67  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ-EELARSFFWQVL 125
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTNQSSDTAARLH 235
             V +    G           ++HRD++  N+L+  +  + K+ DF       DT     
Sbjct: 126 EAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 171
Query: 236 STRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDH 281
            T   GT  Y  PE+    +   +S  V+S G++L +++ G  P +H
Sbjct: 172 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 217

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLD---TSSAPEPESDFAAQLSVVSR 121
           L S +    L+G G +G V+   +++D  P AIK ++    S   E  +     + VV  
Sbjct: 35  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 122 LK----HEHFVELLGYCMESNNRILVYQFAT-MGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            K        + LL +    ++ +L+ +    +  L D +  R  +Q  E      W   
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ-EELARSFFWQVL 153
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTNQSSDTAARLH 235
             V +    G           ++HRD++  N+L+  +  + K+ DF       DT     
Sbjct: 154 EAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 199
Query: 236 STRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDH 281
            T   GT  Y  PE+    +   +S  V+S G++L +++ G  P +H
Sbjct: 200 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 245

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 48/229 (20%), Positives = 95/229 (41%), Gaps = 27/229 (11%)
Query: 59  KLDELNRLTSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPE--SDFAAQ 115
           +LD+ +R+ +       +G GS+GRV   K  + G   A+K LD     + +       +
Sbjct: 34  QLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 86
Query: 116 LSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQ 175
             ++  +     V+L     +++N  +V ++   G +    H R+  +  EP       Q
Sbjct: 87  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFXEPHARFYAAQ 144
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
            V          E+LH      +++RD++  N+L+      ++ DF    +      +  
Sbjct: 145 IVLT-------FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGR 189
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
           +  + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 190 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 238

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/112 (26%), Positives = 48/112 (42%), Gaps = 17/112 (15%)
Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF-----DDFKSKIA---------DFNL 223
           K+AY   K + FLH      + H D++  N+L       + +  KI          D  +
Sbjct: 122 KMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTG 275
            +  S T    H + ++ T  Y APE  +    +Q  DV+S G +L+E   G
Sbjct: 179 VDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 46/89 (51%), Gaps = 6/89 (6%)
Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEY--AM 252
           Q   VHRD++  NVLL  +   ++ADF    + +D    + S+  +GT  Y +PE   AM
Sbjct: 209 QLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGT-VQSSVAVGTPDYISPEILQAM 267
Query: 253 ---TGQITQKSDVYSFGVVLLELLTGRKP 278
               G+   + D +S GV + E+L G  P
Sbjct: 268 EDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 50/104 (48%), Gaps = 14/104 (13%)
Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS-DTAARLHSTRVLGTFGY 245
           LE +H   Q  IVH D++ +N L+ D    K+ DF + NQ   DT + +  ++V GT  Y
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV-GTVNY 222
Query: 246 HAPEYAMTGQITQKS-----------DVYSFGVVLLELLTGRKP 278
             PE       ++++           DV+S G +L  +  G+ P
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 48/107 (44%), Gaps = 12/107 (11%)
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           Y    G++ LH      I+HRD++ SN+++  D   KI DF L   +  +      T  +
Sbjct: 134 YQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYV 187
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLE------LLTGRKPVDH 281
            T  Y APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 234

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 66  LTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLD---TSSAPEPESDFAAQLSVVSR 121
           L S +    L+G G +G V+   +++D  P AIK ++    S   E  +     + VV  
Sbjct: 49  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 108
Query: 122 LK----HEHFVELLGYCMESNNRILVYQFAT-MGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            K        + LL +    ++ +L+ +    +  L D +  R  +Q  E      W   
Sbjct: 109 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ-EELARSFFWQVL 167
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTNQSSDTAARLH 235
             V +    G           ++HRD++  N+L+  +  + K+ DF       DT     
Sbjct: 168 EAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--- 213
Query: 236 STRVLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKPVDH 281
            T   GT  Y  PE+    +   +S  V+S G++L +++ G  P +H
Sbjct: 214 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 259

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 48/229 (20%), Positives = 95/229 (41%), Gaps = 27/229 (11%)
Query: 59  KLDELNRLTSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPE--SDFAAQ 115
           +LD+ +R+ +       +G GS+GRV   K  + G   A+K LD     + +       +
Sbjct: 39  QLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 116 LSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQ 175
             ++  +     V+L     +++N  +V ++   G +    H R+  +  EP       Q
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFXEPHARFYAAQ 149
Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH 235
            V          E+LH      +++RD++  N+L+      ++ DF    +      +  
Sbjct: 150 IVLT-------FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGR 194
Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
           +  + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 26/86 (30%), Positives = 42/86 (48%), Gaps = 12/86 (13%)
Query: 198 IVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL----GTFGYHAPEYAMT 253
           I+HRD++  N+++ +DF  K+ DF        +AA L   ++     GT  Y APE  M 
Sbjct: 151 IIHRDIKDENIVIAEDFTIKLIDFG-------SAAYLERGKLFYTFCGTIEYCAPEVLMG 203
Query: 254 GQITQ-KSDVYSFGVVLLELLTGRKP 278
                 + +++S GV L  L+    P
Sbjct: 204 NPYRGPELEMWSLGVTLYTLVFEENP 229

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 49/108 (45%), Gaps = 12/108 (11%)
Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
           + Y    G++ LH      I+HRD++ SN+++  D   KI DF L   +  +      T 
Sbjct: 124 LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTP 177
Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLE------LLTGRKPVD 280
            + T  Y APE  +     +  D++S G ++ E      L  GR  +D
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 48/107 (44%), Gaps = 12/107 (11%)
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           Y    G++ LH      I+HRD++ SN+++  D   KI DF L   +  +      T  +
Sbjct: 134 YQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYV 187
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLE------LLTGRKPVDH 281
            T  Y APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 234

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 48/107 (44%), Gaps = 12/107 (11%)
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           Y    G++ LH      I+HRD++ SN+++  D   KI DF L   +  +      T  +
Sbjct: 133 YQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYV 186
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLE------LLTGRKPVDH 281
            T  Y APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 48/106 (45%), Gaps = 12/106 (11%)
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           Y    G++ LH      I+HRD++ SN+++  D   KI DF L   +  +      T  +
Sbjct: 171 YQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYV 224
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLE------LLTGRKPVD 280
            T  Y APE  +     +  D++S G ++ E      L  GR  +D
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 270

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 48/106 (45%), Gaps = 12/106 (11%)
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           Y    G++ LH      I+HRD++ SN+++  D   KI DF L   +  +      T  +
Sbjct: 127 YQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYV 180
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLE------LLTGRKPVD 280
            T  Y APE  +     +  D++S G ++ E      L  GR  +D
Sbjct: 181 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 226

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 48/228 (21%), Positives = 94/228 (41%), Gaps = 27/228 (11%)
Query: 60  LDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPE--SDFAAQL 116
           LD+  R+ +       +G GS+GRV   K +  G   A+K LD     + +       + 
Sbjct: 40  LDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 117 SVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            ++  +     V+L     +++N  +V ++   G +    H R+  + +EP       Q 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFYAAQI 150
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS 236
           V          E+LH      +++RD++  N+L+      ++ DF    +      +  +
Sbjct: 151 VLT-------FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRT 195
Query: 237 TRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
             + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 48/107 (44%), Gaps = 12/107 (11%)
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           Y    G++ LH      I+HRD++ SN+++  D   KI DF L   +  +      T  +
Sbjct: 133 YQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYV 186
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLE------LLTGRKPVDH 281
            T  Y APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 48/107 (44%), Gaps = 12/107 (11%)
Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           Y    G++ LH      I+HRD++ SN+++  D   KI DF L   +  +      T  +
Sbjct: 132 YQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYV 185
Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLE------LLTGRKPVDH 281
            T  Y APE  +     +  D++S G ++ E      L  GR  +D 
Sbjct: 186 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 232

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 49/108 (45%), Gaps = 12/108 (11%)
Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
           + Y    G++ LH      I+HRD++ SN+++  D   KI DF L   +  +      T 
Sbjct: 125 LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTP 178
Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLE------LLTGRKPVD 280
            + T  Y APE  +     +  D++S G ++ E      L  GR  +D
Sbjct: 179 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 226

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 48/228 (21%), Positives = 94/228 (41%), Gaps = 27/228 (11%)
Query: 60  LDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPE--SDFAAQL 116
           LD+  R+ +       +G GS+GRV   K +  G   A+K LD     + +       + 
Sbjct: 41  LDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 117 SVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            ++  +     V+L     +++N  +V ++   G +    H R+  + +EP       Q 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFYAAQI 151
Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS 236
           V          E+LH      +++RD++  N+L+      ++ DF    +      +  +
Sbjct: 152 VLT-------FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRT 196
Query: 237 TRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
             + GT  Y APE  ++    +  D ++ GV++ E+  G  P     P
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	363
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-129
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-129
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-118
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-80
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-63
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-61
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-60
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-59
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-57
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-56
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-55
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-55
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-55
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-54
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-52
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-52
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-52
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-51
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-39
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-35
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-34
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-34
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-34
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-34
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-34
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-34
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-34
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-34
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	8e-34
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-33
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-33
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-33
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-33
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-33
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-33
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-33
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-33
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-33
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-32
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-32
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-32
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-32
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-32
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-32
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-32
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-32
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-32
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-32
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-32
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-32
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-32
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-32
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	8e-32
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-31
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-31
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-31
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-31
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-31
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	8e-31
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-30
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-30
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-30
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-30
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-30
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-30
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-30
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-30
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-30
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-30
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-30
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-30
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-29
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-29
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-29
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-29
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-29
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-28
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-27
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-27
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-27
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-27
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-27
3aln_A	327	Dual specificity mitogen-activated protein kinase;	7e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-26
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-26
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-26
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-26
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-26
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-26
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-26
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-25
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-25
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-25
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-25
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-25
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-25
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-25
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-25
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	8e-25
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-23
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-23
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-23
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-23
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-23
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-23
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-23
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-22
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-22
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-22
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-22
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-22
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-22
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-22
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-22
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-22
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-21
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-21
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-19
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-19
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-19
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-19
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-06
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-18
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-18
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	7e-18
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-17
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-17
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	7e-17
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-17
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	9e-17
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-16
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-16
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-16
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-16
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-16
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	7e-16
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-16
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-15
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-15
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-15
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-15
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-15
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-15
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-15
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-15
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	6e-15
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	7e-15
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-14
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-14
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-14
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-14
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-14
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-14
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-13
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-13
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-13
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-13
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-13
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-13
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-13
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	9e-13
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-12
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-12
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-12
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-12
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-12
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-12
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-12
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-12
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-12
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-12
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-12
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-12
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-12
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-11
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-11
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-11
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-11
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-11
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-11
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-11
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-11
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-11
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-11
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-11
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-11
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-11
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-11
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-11
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-10
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-10
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-10
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-10
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-10
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-10
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-10
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-10
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-10
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-10
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-10
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-09
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-09
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-09
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-09
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	6e-09
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-08
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-08
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-08
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-08
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-07
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-07
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	8e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-05
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  373 bits (960), Expect = e-129
 Identities = 111/325 (34%), Positives = 177/325 (54%), Gaps = 13/325 (4%)

Query: 31  GSARGEPRTNVVKTGTPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLT 90
           GS   +   ++    +    +P E  ++ L +L   T+NF  K LIG G +G+V+   L 
Sbjct: 2   GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61

Query: 91  DGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATM 149
           DG   A+K+    S+    E  F  ++  +S  +H H V L+G+C E N  IL+Y++   
Sbjct: 62  DGAKVALKRRTPESSQGIEE--FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMEN 119

Query: 150 GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVL 209
           G+L   L+G        P   ++W QR+++  GAA+GL +LH      I+HRDV+S N+L
Sbjct: 120 GNLKRHLYGSDL-----PTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINIL 171

Query: 210 LFDDFKSKIADFNLTNQSSDTAARLH-STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVV 268
           L ++F  KI DF ++ +      + H ST V GT GY  PEY + G++T+KSDVYSFGVV
Sbjct: 172 LDENFVPKITDFGIS-KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVV 230

Query: 269 LLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAA 328
           L E+L  R  +  ++P+   +L  WA    +  +++Q VDP L +   P+++ K    A 
Sbjct: 231 LFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAV 290

Query: 329 LCVQYEADFRPNMTIVVKALQPLLN 353
            C+   ++ RP+M  V+  L+  L 
Sbjct: 291 KCLALSSEDRPSMGDVLWKLEYALR 315

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  373 bits (960), Expect = e-129
 Identities = 105/298 (35%), Positives = 163/298 (54%), Gaps = 22/298 (7%)

Query: 60  LDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVV 119
           L EL   + NF  K ++G G +G+V+  +L DGT  A+K+L        E  F  ++ ++
Sbjct: 22  LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMI 81

Query: 120 SRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKV 179
           S   H + + L G+CM    R+LVY +   GS+   L  R   Q     P L W +R ++
Sbjct: 82  SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-----PPLDWPKRQRI 136

Query: 180 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARL----- 234
           A G+A+GL +LH+   P I+HRDV+++N+LL ++F++ + DF L        A+L     
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL--------AKLMDYKD 188

Query: 235 -H-STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQS--L 290
            H +T V GT G+ APEY  TG+ ++K+DV+ +GV+LLEL+TG++  D           L
Sbjct: 189 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248

Query: 291 VTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKAL 348
           + W    L E K++  VD  L  +Y  + + +L  VA LC Q     RP M+ VV+ L
Sbjct: 249 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  343 bits (883), Expect = e-118
 Identities = 106/328 (32%), Positives = 171/328 (52%), Gaps = 43/328 (13%)

Query: 48  QKALPIEIPQIK---LDELNRLTSNFGTKA------LIGEGSYGRVFYAKLTDGTPAAIK 98
            K+L +   +       EL  +T+NF  +        +GEG +G V+   + + T  A+K
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60

Query: 99  KLDTSSAPEP---ESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDV 155
           KL           +  F  ++ V+++ +HE+ VELLG+  + ++  LVY +   GSL D 
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120

Query: 156 LHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK 215
           L    G       P L+W+ R K+A GAA G+ FLHE      +HRD++S+N+LL + F 
Sbjct: 121 LSCLDG------TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFT 171

Query: 216 SKIADFNLTNQSSDTAARL-------H-STRVLGTFGYHAPEYAMTGQITQKSDVYSFGV 267
           +KI+DF L        AR          ++R++GT  Y APE  + G+IT KSD+YSFGV
Sbjct: 172 AKISDFGL--------ARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGV 222

Query: 268 VLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK-VKQCVDPKLNNDYPPKAIAKLAAV 326
           VLLE++TG   VD       Q L+        E+K ++  +D K+N+     ++  + +V
Sbjct: 223 VLLEIITGLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSV 279

Query: 327 AALCVQYEADFRPNMTIVVKALQPLLNS 354
           A+ C+  + + RP++  V + LQ +  S
Sbjct: 280 ASQCLHEKKNKRPDIKKVQQLLQEMTAS 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  247 bits (633), Expect = 2e-80
 Identities = 68/314 (21%), Positives = 123/314 (39%), Gaps = 35/314 (11%)

Query: 60  LDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVV 119
            + L   +       +   G +G V+ A+L      A+K        +       ++  +
Sbjct: 16  TENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD--KQSWQNEYEVYSL 72

Query: 120 SRLKHEHFVELLGYCMESNN----RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQ 175
             +KHE+ ++ +G      +      L+  F   GSL D L             V++WN+
Sbjct: 73  PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----------VVSWNE 122

Query: 176 RVKVAYGAAKGLEFLHEKVQ-------PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS 228
              +A   A+GL +LHE +        P I HRD++S NVLL ++  + IADF L  +  
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182

Query: 229 DTAARLHSTRVLGTFGYHAPEYAMTG-----QITQKSDVYSFGVVLLELLTGRKPVDHTM 283
              +   +   +GT  Y APE              + D+Y+ G+VL EL +     D  +
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242

Query: 284 PKGQQSLVTWATPRLSEDKVKQCV-----DPKLNNDYPP-KAIAKLAAVAALCVQYEADF 337
            +             S + +++ V      P L + +     +A L      C  ++A+ 
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302

Query: 338 RPNMTIVVKALQPL 351
           R +   V + +  +
Sbjct: 303 RLSAGCVGERITQM 316

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  202 bits (515), Expect = 6e-63
 Identities = 80/304 (26%), Positives = 131/304 (43%), Gaps = 39/304 (12%)

Query: 58  IKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLS 117
           I   E+            +G G++G V  AK       AIK++++ S  +    F  +L 
Sbjct: 5   IDYKEIE-----VEEV--VGRGAFGVVCKAKW-RAKDVAIKQIESESERK---AFIVELR 53

Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV 177
            +SR+ H + V+L G C+  N   LV ++A  GSL++VLHG +      P P  T    +
Sbjct: 54  QLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAE------PLPYYTAAHAM 105

Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLHS 236
                 ++G+ +LH      ++HRD++  N+LL       KI DF               
Sbjct: 106 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----M 160

Query: 237 TRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATP 296
           T   G+  + APE       ++K DV+S+G++L E++T RKP D       +  + WA  
Sbjct: 161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWA-- 216

Query: 297 RLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP 356
                 V     P L  + P      + ++   C   +   RP+M  +VK +  L+   P
Sbjct: 217 ------VHNGTRPPLIKNLPK----PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266

Query: 357 AGPE 360
              E
Sbjct: 267 GADE 270

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  197 bits (503), Expect = 4e-61
 Identities = 89/314 (28%), Positives = 148/314 (47%), Gaps = 33/314 (10%)

Query: 42  VKTGTPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLD 101
            +    Q A+  +   I   +LN        K  IG GS+G V  A+   G+  A+K L 
Sbjct: 18  TENLYFQGAMDGDDMDIPWCDLN-----IKEK--IGAGSFGTVHRAEW-HGSDVAVKILM 69

Query: 102 TSS-APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRK 160
                 E  ++F  +++++ RL+H + V  +G   +  N  +V ++ + GSL+ +LH   
Sbjct: 70  EQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS- 128

Query: 161 GVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD 220
                     L   +R+ +AY  AKG+ +LH +  PPIVHR+++S N+L+   +  K+ D
Sbjct: 129 -----GAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCD 182

Query: 221 FNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
           F L+   + T     S    GT  + APE        +KSDVYSFGV+L EL T ++P  
Sbjct: 183 FGLSRLKASTFLSSKSAA--GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240

Query: 281 HTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPN 340
           + +   Q   V  A          +C   ++  +  P    ++AA+   C   E   RP+
Sbjct: 241 N-LNPAQ---VVAAV-------GFKCKRLEIPRNLNP----QVAAIIEGCWTNEPWKRPS 285

Query: 341 MTIVVKALQPLLNS 354
              ++  L+PL+ S
Sbjct: 286 FATIMDLLRPLIKS 299

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  197 bits (502), Expect = 1e-60
 Identities = 65/339 (19%), Positives = 120/339 (35%), Gaps = 50/339 (14%)

Query: 57  QIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQL 116
           +    E +    N     LIG G YG V+   L D  P A+K    ++      +F  + 
Sbjct: 2   EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEK 56

Query: 117 SV--VSRLKHEHFVELLGYCME-----SNNRILVYQFATMGSLHDVLHGRKGVQGAEPGP 169
           ++  V  ++H++    +              +LV ++   GSL   L             
Sbjct: 57  NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--------- 107

Query: 170 VLTWNQRVKVAYGAAKGLEFLHEKV------QPPIVHRDVRSSNVLLFDDFKSKIADFNL 223
              W    ++A+   +GL +LH ++      +P I HRD+ S NVL+ +D    I+DF L
Sbjct: 108 -SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166

Query: 224 ------TNQSSDTAARLHSTRVLGTFGYHAPEYAM-------TGQITQKSDVYSFGVVLL 270
                             +   +GT  Y APE               ++ D+Y+ G++  
Sbjct: 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW 226

Query: 271 ELLTGRKPVDH--TMPKGQQSLVTWATPRLSEDKVKQCVD-----PKLNNDYP--PKAIA 321
           E+      +    ++P+ Q +  T      + + ++  V      PK    +     A+ 
Sbjct: 227 EIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVR 286

Query: 322 KLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGPE 360
            L      C   +A+ R       + +  L+        
Sbjct: 287 SLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKS 325

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  192 bits (489), Expect = 3e-59
 Identities = 80/313 (25%), Positives = 140/313 (44%), Gaps = 52/313 (16%)

Query: 54  EIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKL------DTSSAP 106
            +P +  +E+      +  +  IG+G +G V   + + D +  AIK L        +   
Sbjct: 12  RLPTLADNEIE-----YEKQ--IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64

Query: 107 EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE 166
           E   +F  ++ ++S L H + V+L G         +V +F   G L+  L  +       
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP---- 118

Query: 167 PGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-----FDDFKSKIADF 221
               + W+ ++++    A G+E++  +  PPIVHRD+RS N+ L          +K+ADF
Sbjct: 119 ----IKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173

Query: 222 NLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQI---TQKSDVYSFGVVLLELLTGRKP 278
            L+ QS  +      + +LG F + APE  +  +    T+K+D YSF ++L  +LTG  P
Sbjct: 174 GLSQQSVHS-----VSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGP 227

Query: 279 VDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFR 338
            D     G+   +            ++ + P +  D PP    +L  V  LC   +   R
Sbjct: 228 FDE-YSYGKIKFINMI--------REEGLRPTIPEDCPP----RLRNVIELCWSGDPKKR 274

Query: 339 PNMTIVVKALQPL 351
           P+ + +VK L  L
Sbjct: 275 PHFSYIVKELSEL 287

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  186 bits (475), Expect = 3e-57
 Identities = 64/303 (21%), Positives = 117/303 (38%), Gaps = 46/303 (15%)

Query: 58  IKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSS-APEPESDFAAQL 116
           I   +LN     F TK  + E   G ++  +   G    +K L     +     DF  + 
Sbjct: 7   IDFKQLN-----FLTK--LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEEC 58

Query: 117 SVVSRLKHEHFVELLGYCME--SNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWN 174
             +    H + + +LG C    + +  L+  +   GSL++VLH            V+  +
Sbjct: 59  PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-------FVVDQS 111

Query: 175 QRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARL 234
           Q VK A   A+G+ FLH   +P I    + S +V++ +D  ++I+         D     
Sbjct: 112 QAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMA-------DVKFSF 163

Query: 235 HSTRVLGTFGYHAPEYAMTGQ----ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSL 290
            S   +    + APE A+  +      + +D++SF V+L EL+T   P            
Sbjct: 164 QSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK 222

Query: 291 VTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQP 350
           V     R           P +     P     ++ +  +C+  +   RP   ++V  L+ 
Sbjct: 223 VALEGLR-----------PTIPPGISP----HVSKLMKICMNEDPAKRPKFDMIVPILEK 267

Query: 351 LLN 353
           + +
Sbjct: 268 MQD 270

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  180 bits (459), Expect = 6e-55
 Identities = 74/306 (24%), Positives = 125/306 (40%), Gaps = 48/306 (15%)

Query: 57  QIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPES---DFA 113
           +I   EL            IG G +G+V+ A    G   A+K        +      +  
Sbjct: 3   EIDFAELT-----LEEI--IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVR 54

Query: 114 AQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTW 173
            +  + + LKH + + L G C++  N  LV +FA  G L+ VL G++          +  
Sbjct: 55  QEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----------IPP 104

Query: 174 NQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS--------KIADFNLTN 225
           +  V  A   A+G+ +LH++   PI+HRD++SSN+L+    ++        KI DF L  
Sbjct: 105 DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164

Query: 226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPK 285
           +   T          G + + APE       ++ SDV+S+GV+L ELLTG  P    +  
Sbjct: 165 EWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG-IDG 219

Query: 286 GQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVV 345
                V +             +   + +  P       A +   C   +   RP+ T ++
Sbjct: 220 LA---VAYG-------VAMNKLALPIPSTCPE----PFAKLMEDCWNPDPHSRPSFTNIL 265

Query: 346 KALQPL 351
             L  +
Sbjct: 266 DQLTTI 271

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  180 bits (460), Expect = 7e-55
 Identities = 75/303 (24%), Positives = 136/303 (44%), Gaps = 39/303 (12%)

Query: 54  EIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKL-DTSSAPEPESDF 112
           EIP  ++    R          IG GS+G V+  K       A+K L  T+  P+    F
Sbjct: 20  EIPDGQITVGQR----------IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAF 67

Query: 113 AAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLT 172
             ++ V+ + +H + +  +GY       I V Q+    SL+  LH  +            
Sbjct: 68  KNEVGVLRKTRHVNILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHASE--------TKFE 118

Query: 173 WNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA 232
             + + +A   A+G+++LH K    I+HRD++S+N+ L +D   KI DF L  + S  + 
Sbjct: 119 MKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175

Query: 233 RLHSTRVLGTFGYHAPE---YAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQS 289
                ++ G+  + APE      +   + +SDVY+FG+VL EL+TG+ P  +   + Q  
Sbjct: 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-- 233

Query: 290 LVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ 349
            +     R            K+ ++ P     ++  + A C++ + D RP+   ++  ++
Sbjct: 234 -IIEMVGR----GSLSPDLSKVRSNCPK----RMKRLMAECLKKKRDERPSFPRILAEIE 284

Query: 350 PLL 352
            L 
Sbjct: 285 ELA 287

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  181 bits (462), Expect = 7e-55
 Identities = 70/317 (22%), Positives = 123/317 (38%), Gaps = 51/317 (16%)

Query: 58  IKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSS-APEPESDFAAQL 116
           I  ++L       G    IG+G +G+V++ +   G   AI+ +D      +    F  ++
Sbjct: 30  IPFEQLE-----IGEL--IGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREV 80

Query: 117 SVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
               + +HE+ V  +G CM   +  ++       +L+ V+   K         VL  N+ 
Sbjct: 81  MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK--------IVLDVNKT 132

Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS 236
            ++A    KG+ +LH      I+H+D++S NV   D+ K  I DF L + S    A    
Sbjct: 133 RQIAQEIVKGMGYLH---AKGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRRE 188

Query: 237 ---TRVLGTFGYHAPEYAMTGQI---------TQKSDVYSFGVVLLELLTGRKPVDHTMP 284
                  G   + APE                ++ SDV++ G +  EL     P     P
Sbjct: 189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QP 247

Query: 285 KGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIV 344
                 + W         +   + P L+     K I+ +      C  +E + RP  T +
Sbjct: 248 AEA---IIWQ--------MGTGMKPNLSQIGMGKEISDI---LLFCWAFEQEERPTFTKL 293

Query: 345 VKALQPL--LNSKPAGP 359
           +  L+ L   N + + P
Sbjct: 294 MDMLEKLPKRNRRLSHP 310

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  180 bits (459), Expect = 3e-54
 Identities = 67/331 (20%), Positives = 121/331 (36%), Gaps = 48/331 (14%)

Query: 50  ALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPE 109
            LP+ + +    ++         +  IG+G YG V+  K   G   A+K          E
Sbjct: 26  GLPLLVQRTIAKQIQ-----MVKQ--IGKGRYGEVWMGKW-RGEKVAVKVFF----TTEE 73

Query: 110 SDFAAQLSV--VSRLKHEHFVELLGYCMESNNRI----LVYQFATMGSLHDVLHGRKGVQ 163
           + +  +  +     ++HE+ +  +   ++         L+  +   GSL+D L       
Sbjct: 74  ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--- 130

Query: 164 GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV-----QPPIVHRDVRSSNVLLFDDFKSKI 218
                  L     +K+AY +  GL  LH ++     +P I HRD++S N+L+  +    I
Sbjct: 131 -------LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183

Query: 219 ADFNL--TNQSSDTAARLHSTRVLGTFGYHAPE------YAMTGQITQKSDVYSFGVVLL 270
           AD  L     S      +     +GT  Y  PE           Q    +D+YSFG++L 
Sbjct: 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILW 243

Query: 271 ELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD-----PKLNNDYPPKAI-AKLA 324
           E+   R      + + Q           S + +++ V      P   N +       ++ 
Sbjct: 244 EVAR-RCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMG 302

Query: 325 AVAALCVQYEADFRPNMTIVVKALQPLLNSK 355
            +   C  +    R     V K L  +  S+
Sbjct: 303 KLMTECWAHNPASRLTALRVKKTLAKMSESQ 333

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  175 bits (446), Expect = 3e-52
 Identities = 73/342 (21%), Positives = 123/342 (35%), Gaps = 63/342 (18%)

Query: 44  TGTPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTS 103
           +G P          I L E             IG+G +G V+  K   G   A+K     
Sbjct: 30  SGLPLLVQRTIARTIVLQES------------IGKGRFGEVWRGKW-RGEEVAVKIFS-- 74

Query: 104 SAPEPESDFAAQLSV--VSRLKHEHFVELLGYCMESNNRI----LVYQFATMGSLHDVLH 157
                E  +  +  +     L+HE+ +  +    + N       LV  +   GSL D L+
Sbjct: 75  --SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN 132

Query: 158 GRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ-----PPIVHRDVRSSNVLLFD 212
                        +T    +K+A   A GL  LH ++      P I HRD++S N+L+  
Sbjct: 133 RYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 182

Query: 213 DFKSKIADFNLT---NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQI-------TQKSDV 262
           +    IAD  L    + ++DT     + RV GT  Y APE  +   I        +++D+
Sbjct: 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKRYMAPE-VLDDSINMKHFESFKRADI 240

Query: 263 YSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCV---------DPKLNN 313
           Y+ G+V  E+   R  +       Q           S +++++ V           +  +
Sbjct: 241 YAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQS 299

Query: 314 DYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK 355
               + +AK+      C       R     + K L  L   +
Sbjct: 300 CEALRVMAKI---MRECWYANGAARLTALRIKKTLSQLSQQE 338

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  174 bits (443), Expect = 4e-52
 Identities = 60/300 (20%), Positives = 111/300 (37%), Gaps = 39/300 (13%)

Query: 76  IGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           +G+G +G+         G    +K+L      E +  F  ++ V+  L+H + ++ +G  
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDE-ETQRTFLKEVKVMRCLEHPNVLKFIGVL 76

Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            +      + ++   G+L  ++                W+QRV  A   A G+ +LH   
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSMDS--------QYPWSQRVSFAKDIASGMAYLHSM- 127

Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNL------------TNQSSDTAARLHSTRVLGT 242
              I+HRD+ S N L+ ++    +ADF L              +S     R     V+G 
Sbjct: 128 --NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185

Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK 302
             + APE        +K DV+SFG+VL E++         +P+     +           
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL----------N 235

Query: 303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGPEAQ 362
           V+  +D     + PP        +   C   + + RP+   +   L+ L           
Sbjct: 236 VRGFLDRYCPPNCPP----SFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  172 bits (438), Expect = 2e-51
 Identities = 63/302 (20%), Positives = 114/302 (37%), Gaps = 41/302 (13%)

Query: 75  LIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSV--VSRLKHEHFVELLG 132
            +G+G YG V+      G   A+K          E  +  +  +     L+HE+ +  + 
Sbjct: 15  CVGKGRYGEVWRGSW-QGENVAVKIFS----SRDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 133 YCMESNNRI----LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
             M S +      L+  +  MGSL+D L              L     +++    A GL 
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----------LDTVSCLRIVLSIASGLA 119

Query: 189 FLHEKV-----QPPIVHRDVRSSNVLLFDDFKSKIADFNL--TNQSSDTAARLHSTRVLG 241
            LH ++     +P I HRD++S N+L+  + +  IAD  L   +  S     + +   +G
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179

Query: 242 TFGYHAPE------YAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT 295
           T  Y APE              ++ D+++FG+VL E+   R   +  +   +        
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYKPPFYDVVP 238

Query: 296 PRLSEDKVKQCVD-----PKL-NNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ 349
              S + +++ V      P + N  +    +  LA +   C       R     + K L 
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

Query: 350 PL 351
            +
Sbjct: 299 KI 300

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  141 bits (358), Expect = 5e-39
 Identities = 69/305 (22%), Positives = 120/305 (39%), Gaps = 55/305 (18%)

Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVS 120
            LN    +      IG G++G VF  +L  D T  A+K    +  P+ ++ F  +  ++ 
Sbjct: 110 VLNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILK 167

Query: 121 RLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
           +  H + V L+G C +     +V +    G     L           G  L     +++ 
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE--------GARLRVKTLLQMV 219

Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
             AA G+E+L  K     +HRD+ + N L+ +    KI+DF ++ + +D           
Sbjct: 220 GDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV----YAASG 272

Query: 241 G--------TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLV 291
           G        T    APE    G+ + +SDV+SFG++L E  + G  P             
Sbjct: 273 GLRQVPVKWT----APEALNYGRYSSESDVWSFGILLWETFSLGASPY------------ 316

Query: 292 TWATPRLSEDKVKQCVDPKLNNDY----PPKAIAKLAAVAALCVQYEADFRPNMTIVVKA 347
               P LS  + ++ V+           P      +  +   C  YE   RP+ + + + 
Sbjct: 317 ----PNLSNQQTREFVE----KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQE 368

Query: 348 LQPLL 352
           LQ + 
Sbjct: 369 LQSIR 373

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  132 bits (335), Expect = 3e-35
 Identities = 74/302 (24%), Positives = 123/302 (40%), Gaps = 53/302 (17%)

Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSR 121
            LN           IG+G +G V       G   A+K +   +  +    F A+ SV+++
Sbjct: 189 ALNM--KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ---AFLAEASVMTQ 242

Query: 122 LKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
           L+H + V+LLG  +E    + +V ++   GSL D L  R          VL  +  +K +
Sbjct: 243 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFS 295

Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAAR-LHSTRV 239
               + +E+L        VHRD+ + NVL+ +D  +K++DF L         +   ST+ 
Sbjct: 296 LDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL--------TKEASSTQD 344

Query: 240 LGTFGYH--APEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATP 296
            G       APE     + + KSDV+SFG++L E+ + GR P                 P
Sbjct: 345 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY----------------P 388

Query: 297 RLSEDKVKQCVDPKLNNDY----PPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL 352
           R+    V      ++   Y    P      +  V   C   +A  RP    + + L+ + 
Sbjct: 389 RIPLKDVVP----RVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444

Query: 353 NS 354
             
Sbjct: 445 TH 446

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  128 bits (325), Expect = 1e-34
 Identities = 59/253 (23%), Positives = 102/253 (40%), Gaps = 58/253 (22%)

Query: 47  PQKALPIEIP--QIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDG-----TPAAIKK 99
           P +AL   +   + K  ++            +G G++G V+             P AIK+
Sbjct: 4   PNQALLRILKETEFKKIKV------------LGSGAFGTVYKGLWIPEGEKVKIPVAIKE 51

Query: 100 LDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGR 159
           L  +++P+   +   +  V++ + + H   LLG C+ S  ++ + Q    G L D +   
Sbjct: 52  LREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREH 110

Query: 160 KGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA 219
           K          +     +      AKG+ +L ++    +VHRD+ + NVL+      KI 
Sbjct: 111 KDN--------IGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT 159

Query: 220 DFNLTNQSSDTAARLHSTRVLGTFGYH-------------APEYAMTGQITQKSDVYSFG 266
           DF L              ++LG                  A E  +    T +SDV+S+G
Sbjct: 160 DFGLA-------------KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 206

Query: 267 VVLLELLT-GRKP 278
           V + EL+T G KP
Sbjct: 207 VTVWELMTFGSKP 219

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  129 bits (325), Expect = 1e-34
 Identities = 65/329 (19%), Positives = 127/329 (38%), Gaps = 36/329 (10%)

Query: 41  VVKTGTPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLT-----DGTPA 95
             +    Q A+          +      +      +G+G++G V   +        G   
Sbjct: 16  TTENLYFQGAMGSAFEDRDPTQFEE--RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVV 73

Query: 96  AIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNR--ILVYQFATMGSLH 153
           A+KKL  S+  E   DF  ++ ++  L+H++ V+  G C  +  R   L+ ++   GSL 
Sbjct: 74  AVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 132

Query: 154 DVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD 213
           D L   K          +   + ++      KG+E+L  K     +HRD+ + N+L+ ++
Sbjct: 133 DYLQKHKER--------IDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENE 181

Query: 214 FKSKIADFNLT---NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLL 270
            + KI DF LT    Q  +               ++APE     + +  SDV+SFGVVL 
Sbjct: 182 NRVKIGDFGLTKVLPQDKEYYKVKEPGES--PIFWYAPESLTESKFSVASDVWSFGVVLY 239

Query: 271 ELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD-----PKLNNDYPPKAIAKLAA 325
           EL T  +       +  + +      ++    + + +      P+     P     ++  
Sbjct: 240 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR-----PDGCPDEIYM 294

Query: 326 VAALCVQYEADFRPNMTIVVKALQPLLNS 354
           +   C     + RP+   +   +  + + 
Sbjct: 295 IMTECWNNNVNQRPSFRDLALRVDQIRDQ 323

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  128 bits (323), Expect = 1e-34
 Identities = 73/304 (24%), Positives = 126/304 (41%), Gaps = 42/304 (13%)

Query: 76  IGEGSYGRVFYAKLTD-----GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +GEG +G+V            G   A+K L   + P+  S +  ++ ++  L HEH ++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 131 LGYCMESNNR--ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C ++      LV ++  +GSL D L              +   Q +  A    +G+ 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----------IGLAQLLLFAQQICEGMA 148

Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT---NQSSDTAARLHSTRVLGTFGY 245
           +LH +     +HRD+ + NVLL +D   KI DF L     +  +   R+        F Y
Sbjct: 149 YLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY-YRVREDGDSPVFWY 204

Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVK 304
            APE     +    SDV+SFGV L ELLT             +   +     +++  ++ 
Sbjct: 205 -APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ--GQMTVLRLT 261

Query: 305 QCVD-----PKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGP 359
           + ++     P+     P K  A++  +   C + EA FRP    ++  L+ +        
Sbjct: 262 ELLERGERLPR-----PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK----Y 312

Query: 360 EAQA 363
           + QA
Sbjct: 313 QGQA 316

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  127 bits (321), Expect = 3e-34
 Identities = 71/291 (24%), Positives = 118/291 (40%), Gaps = 32/291 (10%)

Query: 76  IGEGSYGRVFYAKLT-----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +GEG +G+V   +        G   A+K L   S     +D   ++ ++  L HE+ V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 131 LGYCMESNNR--ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C E       L+ +F   GSL + L   K          +   Q++K A    KG++
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN--------KINLKQQLKYAVQICKGMD 140

Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN--QSSDTAARLHSTRVLGTFGYH 246
           +L  +     VHRD+ + NVL+  + + KI DF LT   ++      +   R    F Y 
Sbjct: 141 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY- 196

Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ 305
           APE  M  +    SDV+SFGV L ELLT             +    T     ++      
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR----- 251

Query: 306 CVDPKLNNDY----PPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL 352
            +   L        PP    ++  +   C +++   R +   +++  + LL
Sbjct: 252 -LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  127 bits (320), Expect = 3e-34
 Identities = 64/293 (21%), Positives = 122/293 (41%), Gaps = 32/293 (10%)

Query: 76  IGEGSYGRVFYAKLT-----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +G+G++G V   +        G   A+KKL  S+  E   DF  ++ ++  L+H++ V+ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKY 76

Query: 131 LGYCMESNNR--ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G C  +  R   L+ ++   GSL D L   K          +   + ++      KG+E
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--------IDHIKLLQYTSQICKGME 128

Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN--QSSDTAARLHSTRVLGTFGYH 246
           +L  K     +HRD+ + N+L+ ++ + KI DF LT          ++        F Y 
Sbjct: 129 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY- 184

Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC 306
           APE     + +  SDV+SFGVVL EL T  +       +  + +      ++    + + 
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244

Query: 307 VD-----PKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS 354
           +      P+     P     ++  +   C     + RP+   +   +  + ++
Sbjct: 245 LKNNGRLPR-----PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  127 bits (321), Expect = 4e-34
 Identities = 66/294 (22%), Positives = 118/294 (40%), Gaps = 35/294 (11%)

Query: 76  IGEGSYGRVFYAKLT-----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVEL 130
           +G+G++G V   +        G   A+K+L   S P+ + DF  ++ ++  L  +  V+ 
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQL-QHSGPDQQRDFQREIQILKALHSDFIVKY 89

Query: 131 LGYCMESNNR--ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            G       +   LV ++   G L D L   +          L  ++ +  +    KG+E
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR--------ARLDASRLLLYSSQICKGME 141

Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN--QSSDTAARLHSTRVLGTFGYH 246
           +L  +     VHRD+ + N+L+  +   KIADF L            +        F Y 
Sbjct: 142 YLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY- 197

Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ 305
           APE       +++SDV+SFGVVL EL T   K    +       ++       +  ++ +
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLLE 255

Query: 306 CVD-----PKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS 354
            ++     P      PP   A++  +  LC       RP+ + +   L  L + 
Sbjct: 256 LLEEGQRLPA-----PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  125 bits (316), Expect = 6e-34
 Identities = 64/301 (21%), Positives = 121/301 (40%), Gaps = 47/301 (15%)

Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKL-DTSSAPEPESDFAAQLSVVS 120
            ++   S       IG G +G V      +    AIK + + + + E   DF  +  V+ 
Sbjct: 4   VIDP--SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMM 58

Query: 121 RLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
           +L H   V+L G C+E     LV +F   G L D L  ++G        +      + + 
Sbjct: 59  KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG--------LFAAETLLGMC 110

Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
               +G+ +L E     ++HRD+ + N L+ ++   K++DF +T    D     +++   
Sbjct: 111 LDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTG 164

Query: 241 GTFGYH--APEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPR 297
             F     +PE     + + KSDV+SFGV++ E+ + G+ P                   
Sbjct: 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY----------------EN 208

Query: 298 LSEDKVKQCVDPKLNNDY----PPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN 353
            S  +V + +       +    P  A   +  +   C +   + RP  + +++ L  +  
Sbjct: 209 RSNSEVVEDIS----TGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264

Query: 354 S 354
           S
Sbjct: 265 S 265

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  125 bits (317), Expect = 6e-34
 Identities = 74/302 (24%), Positives = 124/302 (41%), Gaps = 53/302 (17%)

Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSR 121
            LN           IG+G +G V       G   A+K +   +  +    F A+ SV+++
Sbjct: 17  ALNMKELKLLQT--IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ---AFLAEASVMTQ 70

Query: 122 LKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
           L+H + V+LLG  +E    + +V ++   GSL D L  R          VL  +  +K +
Sbjct: 71  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFS 123

Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAAR-LHSTRV 239
               + +E+L        VHRD+ + NVL+ +D  +K++DF L         +   ST+ 
Sbjct: 124 LDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL--------TKEASSTQD 172

Query: 240 LGTFGYH--APEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATP 296
            G       APE     + + KSDV+SFG++L E+ + GR P                 P
Sbjct: 173 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY----------------P 216

Query: 297 RLSEDKVKQCVDPKLNNDY----PPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL 352
           R+    V      ++   Y    P      +  V   C   +A  RP+   + + L+ + 
Sbjct: 217 RIPLKDVVP----RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272

Query: 353 NS 354
             
Sbjct: 273 TH 274

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  129 bits (325), Expect = 8e-34
 Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 43/299 (14%)

Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKL-DTSSAPEPESDFAAQLSVVS 120
           E+ R   +   +  +G+G +G V+       T  AIK L   + +PE    F  +  V+ 
Sbjct: 180 EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMK 234

Query: 121 RLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
           +L+HE  V+L     E    I V ++ + GSL D L G  G         L   Q V +A
Sbjct: 235 KLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETG-------KYLRLPQLVDMA 286

Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
              A G+ ++        VHRD+R++N+L+ ++   K+ADF L     D           
Sbjct: 287 AQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 343

Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLS 299
               + APE A+ G+ T KSDV+SFG++L EL T GR P                 P + 
Sbjct: 344 -PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY----------------PGMV 386

Query: 300 EDKVKQCVDPKLNNDY----PPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS 354
             +V   V+      Y    PP+    L  +   C + E + RP    +   L+    S
Sbjct: 387 NREVLDQVE----RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  126 bits (318), Expect = 1e-33
 Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 37/224 (16%)

Query: 76  IGEGSYGRVFYAKLTDG------TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G+GS+G V+             T  AIK ++ +++     +F  + SV+      H V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEP-GPVLTWNQRVKVAYGAAKGLE 188
           LLG   +    +++ +  T G L   L   +      P     + ++ +++A   A G+ 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152

Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH-- 246
           +L+       VHRD+ + N ++ +DF  KI DF +             TR +    Y+  
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM-------------TRDIYETDYYRK 196

Query: 247 -----------APEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
                      +PE    G  T  SDV+SFGVVL E+ T   +P
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  124 bits (314), Expect = 2e-33
 Identities = 64/255 (25%), Positives = 98/255 (38%), Gaps = 60/255 (23%)

Query: 47  PQKALPIEIP--QIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLT----DGTPAAIK-- 98
           P ++L   I    ++L E             +G+GS+G V   +           A+K  
Sbjct: 7   PLQSLTCLIGEKDLRLLEK------------LGDGSFGVVRRGEWDAPSGKTVSVAVKCL 54

Query: 99  KLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHG 158
           K D  S PE   DF  +++ +  L H + + L G  +    ++ V + A +GSL D L  
Sbjct: 55  KPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK 113

Query: 159 RKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI 218
            +G                + A   A+G+ +L  K     +HRD+ + N+LL      KI
Sbjct: 114 HQGH--------FLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKI 162

Query: 219 ADFNLTNQSSDTAARLHSTRVLGTFG--YH------------APEYAMTGQITQKSDVYS 264
            DF L              R L      Y             APE   T   +  SD + 
Sbjct: 163 GDFGL-------------MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWM 209

Query: 265 FGVVLLELLT-GRKP 278
           FGV L E+ T G++P
Sbjct: 210 FGVTLWEMFTYGQEP 224

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  124 bits (313), Expect = 2e-33
 Identities = 62/300 (20%), Positives = 116/300 (38%), Gaps = 47/300 (15%)

Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKL-DTSSAPEPESDFAAQLSVVS 120
           EL R          +G G +G V   K       A+K + + S + +   +F  +   + 
Sbjct: 4   ELKR--EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMM 58

Query: 121 RLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
           +L H   V+  G C +     +V ++ + G L + L           G  L  +Q +++ 
Sbjct: 59  KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH--------GKGLEPSQLLEMC 110

Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           Y   +G+ FL        +HRD+ + N L+  D   K++DF +T    D     + + V 
Sbjct: 111 YDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ---YVSSVG 164

Query: 241 GTFGYH--APEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPR 297
             F     APE     + + KSDV++FG+++ E+ + G+ P                   
Sbjct: 165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY----------------DL 208

Query: 298 LSEDKVKQCVDPKLNNDY----PPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN 353
            +  +V   V       +    P  A   +  +   C     + RP    ++ +++PL  
Sbjct: 209 YTNSEVVLKVS----QGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  125 bits (315), Expect = 3e-33
 Identities = 58/253 (22%), Positives = 96/253 (37%), Gaps = 58/253 (22%)

Query: 47  PQKALPIEIP--QIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDG-----TPAAIKK 99
             K L       +++  ++            +G G +G V              P  IK 
Sbjct: 2   AMKVLARIFKETELRKLKV------------LGSGVFGTVHKGVWIPEGESIKIPVCIKV 49

Query: 100 LDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGR 159
           ++  S  +        +  +  L H H V LLG C  S+ ++ V Q+  +GSL D +   
Sbjct: 50  IEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQH 108

Query: 160 KGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA 219
           +G         L     +      AKG+ +L E     +VHR++ + NVLL    + ++A
Sbjct: 109 RGA--------LGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVA 157

Query: 220 DFNLTNQSSDTAARLHSTRVLGTFGYH-------------APEYAMTGQITQKSDVYSFG 266
           DF +               +L                   A E    G+ T +SDV+S+G
Sbjct: 158 DFGVA-------------DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYG 204

Query: 267 VVLLELLT-GRKP 278
           V + EL+T G +P
Sbjct: 205 VTVWELMTFGAEP 217

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  128 bits (323), Expect = 3e-33
 Identities = 69/314 (21%), Positives = 125/314 (39%), Gaps = 43/314 (13%)

Query: 48  QKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKL-DTSSA 105
           +  +    P     E+ R       K  +G G YG V+           A+K L + +  
Sbjct: 202 KPTIYGVSPNYDKWEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 259

Query: 106 PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGA 165
            E   +F  + +V+  +KH + V+LLG C       ++ +F T G+L D L         
Sbjct: 260 VE---EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR---- 312

Query: 166 EPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN 225
                ++    + +A   +  +E+L +K     +HR++ + N L+ ++   K+ADF L+ 
Sbjct: 313 ---QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSR 366

Query: 226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMP 284
             +      H+        + APE     + + KSDV++FGV+L E+ T G  P      
Sbjct: 367 LMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY----- 420

Query: 285 KGQQSLVTWATPRLSEDKVKQCVDPKLNNDY----PPKAIAKLAAVAALCVQYEADFRPN 340
                      P +   +V +     L  DY    P     K+  +   C Q+    RP+
Sbjct: 421 -----------PGIDLSQVYE----LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPS 465

Query: 341 MTIVVKALQPLLNS 354
              + +A + +   
Sbjct: 466 FAEIHQAFETMFQE 479

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  123 bits (312), Expect = 3e-33
 Identities = 62/301 (20%), Positives = 121/301 (40%), Gaps = 47/301 (15%)

Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKL-DTSSAPEPESDFAAQLSVVS 120
           E++    +      +G G +G V Y K       AIK + + S + +   +F  +  V+ 
Sbjct: 20  EIDP--KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMM 74

Query: 121 RLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
            L HE  V+L G C +     ++ ++   G L + L   +              Q +++ 
Sbjct: 75  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--------FQTQQLLEMC 126

Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
               + +E+L  K     +HRD+ + N L+ D    K++DF L+    D     +++ V 
Sbjct: 127 KDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVG 180

Query: 241 GTFGYH--APEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPR 297
             F      PE  M  + + KSD+++FGV++ E+ + G+ P                  R
Sbjct: 181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY----------------ER 224

Query: 298 LSEDKVKQCVDPKLNNDY----PPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN 353
            +  +  + +            P  A  K+  +   C   +AD RP   I++  +  +++
Sbjct: 225 FTNSETAEHIA----QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280

Query: 354 S 354
            
Sbjct: 281 E 281

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  124 bits (313), Expect = 4e-33
 Identities = 63/245 (25%), Positives = 97/245 (39%), Gaps = 47/245 (19%)

Query: 50  ALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDG----TPAAIKKLDTSSA 105
            +      +  +E+            IG G +G V++  L D        A+K L+  + 
Sbjct: 19  VIGPSSLIVHFNEV------------IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 66

Query: 106 PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL-VYQFATMGSLHDVLHGRKGVQG 164
               S F  +  ++    H + + LLG C+ S    L V  +   G L + +        
Sbjct: 67  IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---- 122

Query: 165 AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT 224
                  T    +      AKG+++L  K     VHRD+ + N +L + F  K+ADF L 
Sbjct: 123 ----HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGL- 174

Query: 225 NQSSDTAAR-LHST---RVLGTFGYH------APEYAMTGQITQKSDVYSFGVVLLELLT 274
                  AR ++      V    G        A E   T + T KSDV+SFGV+L EL+T
Sbjct: 175 -------ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

Query: 275 -GRKP 278
            G  P
Sbjct: 228 RGAPP 232

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  123 bits (312), Expect = 4e-33
 Identities = 58/215 (26%), Positives = 90/215 (41%), Gaps = 27/215 (12%)

Query: 76  IGEGSYGRVFYAKLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
           IG+G +G V++ +  D        AIK L   +  +    F  +  ++  L H + + L+
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88

Query: 132 GYCMESNNRIL-VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
           G  +        +  +   G L   +          P    T    +      A+G+E+L
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIR--------SPQRNPTVKDLISFGLQVARGMEYL 140

Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT---NQSSDTAARLHSTRVL---GTFG 244
            E+     VHRD+ + N +L + F  K+ADF L          + + H    L    T  
Sbjct: 141 AEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT-- 195

Query: 245 YHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
             A E   T + T KSDV+SFGV+L ELLT G  P
Sbjct: 196 --ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  123 bits (310), Expect = 7e-33
 Identities = 50/234 (21%), Positives = 86/234 (36%), Gaps = 44/234 (18%)

Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKLTDG----TPAAIKKLDTSSAPEPESDFAAQLS 117
            + R   +     ++GEG +G V+    T+        A+K        + +  F ++  
Sbjct: 8   GIAR--EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 65

Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV 177
           ++  L H H V+L+G   E    I + +    G L   L   K          L     V
Sbjct: 66  IMKNLDHPHIVKLIGIIEEEPTWI-IMELYPYGELGHYLERNKNS--------LKVLTLV 116

Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
             +    K + +L        VHRD+   N+L+      K+ DF L+             
Sbjct: 117 LYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLS------------- 160

Query: 238 RVLGTFGYH------------APEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
           R +    Y+            +PE     + T  SDV+ F V + E+L+ G++P
Sbjct: 161 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  123 bits (311), Expect = 1e-32
 Identities = 73/307 (23%), Positives = 114/307 (37%), Gaps = 51/307 (16%)

Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKLTDG----TPAAIKKLDTSSAPEPESDFAAQLS 117
           E+    S    + +IG G  G V Y +L        P AIK L          DF ++ S
Sbjct: 45  EIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEAS 102

Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV 177
           ++ +  H + + L G        ++V ++   GSL   L    G          T  Q V
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG--------QFTIMQLV 154

Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT---NQSSDTAARL 234
            +  G   G+ +L +      VHRD+ + NVL+  +   K++DF L+       D A   
Sbjct: 155 GMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT 211

Query: 235 HSTR--VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLV 291
              +  +  T    APE       +  SDV+SFGVV+ E+L  G +P             
Sbjct: 212 TGGKIPIRWT----APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY------------ 255

Query: 292 TWATPRLSEDKVKQCVDPKLNNDY----PPKAIAKLAAVAALCVQYEADFRPNMTIVVKA 347
                 ++   V   V+      Y    P      L  +   C   +   RP  + +V  
Sbjct: 256 ----WNMTNRDVISSVE----EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV 307

Query: 348 LQPLLNS 354
           L  L+ S
Sbjct: 308 LDALIRS 314

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  127 bits (321), Expect = 1e-32
 Identities = 64/275 (23%), Positives = 98/275 (35%), Gaps = 20/275 (7%)

Query: 9   EEPQPPASQTTAPPRSGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLDELNRLTS 68
           ++    A  +     +   Q   S                +     +P  +  E+ R   
Sbjct: 333 QKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQR--E 390

Query: 69  NFGTKALIGEGSYGRVFYAKLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKH 124
                  IGEG +G V               AIK     ++      F  +   + +  H
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 450

Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            H V+L+G   E+   I + +  T+G L   L  RK          L     +  AY  +
Sbjct: 451 PHIVKLIGVITENPVWI-IMELCTLGELRSFLQVRK--------FSLDLASLILYAYQLS 501

Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
             L +L  K     VHRD+ + NVL+  +   K+ DF L+    D+     S   L    
Sbjct: 502 TALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 558

Query: 245 YHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
             APE     + T  SDV+ FGV + E+L  G KP
Sbjct: 559 M-APESINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  122 bits (309), Expect = 1e-32
 Identities = 75/313 (23%), Positives = 130/313 (41%), Gaps = 70/313 (22%)

Query: 76  IGEGSYGRVFYAKLTDGTPA------AIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +GEG++G+VF A+  + +P       A+K L   +      DF  +  +++ L+HEH V+
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA-RKDFQREAELLTNLQHEHIVK 81

Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGR-------KGVQGAEPGPVLTWNQRVKVAYG 182
             G C + +  I+V+++   G L+  L             Q  +    L  +Q + +A  
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141

Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
            A G+ +L  +     VHRD+ + N L+  +   KI DF +             +R + +
Sbjct: 142 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGM-------------SRDVYS 185

Query: 243 FGYH-------------APEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQ 288
             Y+              PE  M  + T +SDV+SFGV+L E+ T G++P          
Sbjct: 186 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW--------- 236

Query: 289 SLVTWATPRLSEDKVKQCVD-----PKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTI 343
                   +LS  +V +C+       +     P     ++  V   C Q E   R N+  
Sbjct: 237 -------FQLSNTEVIECITQGRVLER-----PRVCPKEVYDVMLGCWQREPQQRLNIKE 284

Query: 344 VVKALQPLLNSKP 356
           + K L  L  + P
Sbjct: 285 IYKILHALGKATP 297

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  123 bits (310), Expect = 2e-32
 Identities = 59/253 (23%), Positives = 102/253 (40%), Gaps = 58/253 (22%)

Query: 47  PQKALPIEIP--QIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDG-----TPAAIKK 99
           P +AL   +   + K  ++            +G G++G V+             P AIK+
Sbjct: 4   PNQALLRILKETEFKKIKV------------LGSGAFGTVYKGLWIPEGEKVKIPVAIKE 51

Query: 100 LDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGR 159
           L  +++P+   +   +  V++ + + H   LLG C+ S  ++ + Q    G L D +   
Sbjct: 52  LREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREH 110

Query: 160 KGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA 219
           K          +     +      AKG+ +L ++    +VHRD+ + NVL+      KI 
Sbjct: 111 KDN--------IGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT 159

Query: 220 DFNLTNQSSDTAARLHSTRVLGTFGYH-------------APEYAMTGQITQKSDVYSFG 266
           DF L              ++LG                  A E  +    T +SDV+S+G
Sbjct: 160 DFGLA-------------KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 206

Query: 267 VVLLELLT-GRKP 278
           V + EL+T G KP
Sbjct: 207 VTVWELMTFGSKP 219

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  125 bits (315), Expect = 2e-32
 Identities = 75/301 (24%), Positives = 124/301 (41%), Gaps = 47/301 (15%)

Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKL-DTSSAPEPESDFAAQLSVVS 120
           E+ R +     K  +G G +G V+ A     T  A+K +   S + E    F A+ +V+ 
Sbjct: 184 EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---AFLAEANVMK 238

Query: 121 RLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
            L+H+  V+L     +    I + +F   GSL D L   +G             + +  +
Sbjct: 239 TLQHDKLVKLHAVVTKEPIYI-ITEFMAKGSLLDFLKSDEG-------SKQPLPKLIDFS 290

Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
              A+G+ F+ ++     +HRD+R++N+L+      KIADF L     D     ++ R  
Sbjct: 291 AQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREG 344

Query: 241 GTFGYH--APEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPR 297
             F     APE    G  T KSDV+SFG++L+E++T GR P                 P 
Sbjct: 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY----------------PG 388

Query: 298 LSEDKVKQCVDPKLNNDY----PPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN 353
           +S  +V +     L   Y    P     +L  +   C +   + RP    +   L     
Sbjct: 389 MSNPEVIR----ALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444

Query: 354 S 354
           +
Sbjct: 445 A 445

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  121 bits (307), Expect = 2e-32
 Identities = 60/247 (24%), Positives = 101/247 (40%), Gaps = 45/247 (18%)

Query: 59  KLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDG------TPAAIKKLDTSSAPEPESDF 112
           KL E++     F  +  +GE  +G+V+   L            AIK L   +      +F
Sbjct: 2   KLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEF 59

Query: 113 AAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGR-------KGVQGA 165
             +  + +RL+H + V LLG   +     +++ + + G LH+ L  R             
Sbjct: 60  RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119

Query: 166 EPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN 225
                L     V +    A G+E+L       +VH+D+ + NVL++D    KI+D  L  
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGL-- 174

Query: 226 QSSDTAARLHSTRVLGTFGYH-------------APEYAMTGQITQKSDVYSFGVVLLEL 272
                       R +    Y+             APE  M G+ +  SD++S+GVVL E+
Sbjct: 175 -----------FREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 223

Query: 273 LT-GRKP 278
            + G +P
Sbjct: 224 FSYGLQP 230

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  121 bits (306), Expect = 2e-32
 Identities = 67/221 (30%), Positives = 107/221 (48%), Gaps = 23/221 (10%)

Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKL-DTSSAPEPESDFAAQLSVVS 120
           E+ R          +G G +G V+       T  A+K L   S +P+    F A+ +++ 
Sbjct: 9   EVPR--ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMK 63

Query: 121 RLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
           +L+H+  V L     +    I + ++   GSL D L    G++       LT N+ + +A
Sbjct: 64  QLQHQRLVRLYAVVTQEPIYI-ITEYMENGSLVDFLKTPSGIK-------LTINKLLDMA 115

Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
              A+G+ F+ E+     +HRD+R++N+L+ D    KIADF L     D     ++ R  
Sbjct: 116 AQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREG 169

Query: 241 GTFGYH--APEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
             F     APE    G  T KSDV+SFG++L E++T GR P
Sbjct: 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  121 bits (306), Expect = 3e-32
 Identities = 67/302 (22%), Positives = 111/302 (36%), Gaps = 52/302 (17%)

Query: 65  RLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK 123
           R  ++F     +G G +G VF AK   D    AIK++   +          ++  +++L+
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61

Query: 124 HEHFVELLGYCMESNN---------RILVY---QFATMGSLHDVLHGRKGVQGAEPGPVL 171
           H   V      +E N          ++ +Y   Q     +L D ++GR  ++  E    L
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 172 TWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL-------- 223
                       A+ +EFLH K    ++HRD++ SN+    D   K+ DF L        
Sbjct: 122 HI------FLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172

Query: 224 ---TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
              T  +   A   H+ +V GT  Y +PE       + K D++S G++L ELL    P  
Sbjct: 173 EEQTVLTPMPAYARHTGQV-GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS 228

Query: 281 HTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPN 340
             M + +               V+    P L     P        +    +      RP 
Sbjct: 229 TQMERVRTL-----------TDVRNLKFPPLFTQKYP----CEYVMVQDMLSPSPMERPE 273

Query: 341 MT 342
             
Sbjct: 274 AI 275

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  125 bits (315), Expect = 4e-32
 Identities = 81/295 (27%), Positives = 125/295 (42%), Gaps = 35/295 (11%)

Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKL-DTSSAPEPESDFAAQLSVVS 120
           E+ R   +   +  +G+G +G V+       T  AIK L   + +PE    F  +  V+ 
Sbjct: 263 EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMK 317

Query: 121 RLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
           +L+HE  V+L     E    I V ++ + GSL D L G  G         L   Q V +A
Sbjct: 318 KLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETG-------KYLRLPQLVDMA 369

Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
              A G+ ++        VHRD+R++N+L+ ++   K+ADF L     D           
Sbjct: 370 AQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 426

Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLS 299
               + APE A+ G+ T KSDV+SFG++L EL T GR P                 P + 
Sbjct: 427 -PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY----------------PGMV 469

Query: 300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS 354
             +V   V+       PP+    L  +   C + E + RP    +   L+    S
Sbjct: 470 NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  122 bits (307), Expect = 5e-32
 Identities = 63/244 (25%), Positives = 115/244 (47%), Gaps = 42/244 (17%)

Query: 54  EIP--QIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDG---TPAAIKKL-DTSSAPE 107
            +    IK  ++            IGEG++G+V  A++        AAIK++ + +S  +
Sbjct: 21  VLDWNDIKFQDV------------IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD 68

Query: 108 PESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQ--- 163
              DFA +L V+ +L  H + + LLG C       L  ++A  G+L D L   + ++   
Sbjct: 69  HR-DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDP 127

Query: 164 ----GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA 219
                      L+  Q +  A   A+G+++L +K     +HRD+ + N+L+ +++ +KIA
Sbjct: 128 AFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA 184

Query: 220 DFNLTNQSSDTAARLHSTRV----LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT- 274
           DF L+ +  +   +    R+    +      A E       T  SDV+S+GV+L E+++ 
Sbjct: 185 DFGLS-RGQEVYVKKTMGRLPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVSL 237

Query: 275 GRKP 278
           G  P
Sbjct: 238 GGTP 241

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  120 bits (303), Expect = 6e-32
 Identities = 59/234 (25%), Positives = 87/234 (37%), Gaps = 44/234 (18%)

Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKLTDG----TPAAIKKLDTSSAPEPESDFAAQLS 117
           E+ R          IGEG +G V               AIK     ++      F  +  
Sbjct: 11  EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 68

Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV 177
            + +  H H V+L+G   E+   I + +  T+G L   L  RK          L     +
Sbjct: 69  TMRQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFLQVRKYS--------LDLASLI 119

Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
             AY  +  L +L  K     VHRD+ + NVL+  +   K+ DF L             +
Sbjct: 120 LYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL-------------S 163

Query: 238 RVLGTFGYH------------APEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
           R +    Y+            APE     + T  SDV+ FGV + E+L  G KP
Sbjct: 164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  120 bits (303), Expect = 7e-32
 Identities = 65/319 (20%), Positives = 116/319 (36%), Gaps = 72/319 (22%)

Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKLTD--------GTPAAIKKLDTSSAPEPESDFA 113
           ++     +      +G+G++ ++F     +         T   +K LD +        F 
Sbjct: 4   KIRN--EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFF 60

Query: 114 AQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTW 173
              S++S+L H+H V   G C+  +  ILV +F   GSL   L   K          +  
Sbjct: 61  EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN--------CINI 112

Query: 174 NQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS--------KIADFNLTN 225
             +++VA   A  + FL E     ++H +V + N+LL  +           K++D  +  
Sbjct: 113 LWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI-- 167

Query: 226 QSSDTAARLHSTRVLGTFGYH------APEYAMTGQI-TQKSDVYSFGVVLLELLT-GRK 277
                 +      VL             PE     +     +D +SFG  L E+ + G K
Sbjct: 168 ------SIT----VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217

Query: 278 PVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDY--PPKAIAKLAAVAALCVQYEA 335
           P+                  L   +  Q  +    + +  P    A+LA +   C+ YE 
Sbjct: 218 PL----------------SALDSQRKLQFYE----DRHQLPAPKAAELANLINNCMDYEP 257

Query: 336 DFRPNMTIVVKALQPLLNS 354
           D RP+   +++ L  L   
Sbjct: 258 DHRPSFRAIIRDLNSLFTP 276

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  121 bits (305), Expect = 7e-32
 Identities = 52/227 (22%), Positives = 92/227 (40%), Gaps = 43/227 (18%)

Query: 76  IGEGSYGRVFYAKLTDG----TPAAIKKLDTSSAPEPE-SDFAAQLSVVSRLKHEHFVEL 130
           +GEG +G V    L          A+K +   ++ + E  +F ++ + +    H + + L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101

Query: 131 LGYCMESNNRI-----LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
           LG C+E +++      ++  F   G LH  L   +          +     +K     A 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRL---ETGPKHIPLQTLLKFMVDIAL 158

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           G+E+L  +     +HRD+ + N +L DD    +ADF L+             + + +  Y
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLS-------------KKIYSGDY 202

Query: 246 H-------------APEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
           +             A E       T KSDV++FGV + E+ T G  P
Sbjct: 203 YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  121 bits (305), Expect = 7e-32
 Identities = 54/229 (23%), Positives = 93/229 (40%), Gaps = 46/229 (20%)

Query: 76  IGEGSYGRVFYAKLTDG----TPAAIK--KLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G+G +G V  A+L          A+K  K D  ++ + E +F  + + +    H H  +
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE-EFLREAACMKEFDHPHVAK 89

Query: 130 LLGYCMESNNRI------LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           L+G  + S  +       ++  F   G LH  L   +     E    L     V+     
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRI---GENPFNLPLQTLVRFMVDI 146

Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
           A G+E+L  +     +HRD+ + N +L +D    +ADF L+             R + + 
Sbjct: 147 ACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLS-------------RKIYSG 190

Query: 244 GYH-------------APEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
            Y+             A E       T  SDV++FGV + E++T G+ P
Sbjct: 191 DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  121 bits (305), Expect = 8e-32
 Identities = 69/309 (22%), Positives = 124/309 (40%), Gaps = 54/309 (17%)

Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKLTDGT-----PAAIKKLDTSSAPEPESDFAAQL 116
           E++   S    + +IG G +G V+   L   +     P AIK L      +   DF  + 
Sbjct: 40  EIHP--SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 97

Query: 117 SVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            ++ +  H + + L G   +    +++ ++   G+L   L  + G          +  Q 
Sbjct: 98  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--------EFSVLQL 149

Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS 236
           V +  G A G+++L        VHRD+ + N+L+  +   K++DF L+    D     ++
Sbjct: 150 VGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 206

Query: 237 TR-----VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSL 290
           T      +  T    APE     + T  SDV+SFG+V+ E++T G +P            
Sbjct: 207 TSGGKIPIRWT----APEAISYRKFTSASDVWSFGIVMWEVMTYGERPY----------- 251

Query: 291 VTWATPRLSEDKVKQCVD-----PKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVV 345
                  LS  +V + ++     P      P    + +  +   C Q E   RP    +V
Sbjct: 252 -----WELSNHEVMKAINDGFRLPT-----PMDCPSAIYQLMMQCWQQERARRPKFADIV 301

Query: 346 KALQPLLNS 354
             L  L+ +
Sbjct: 302 SILDKLIRA 310

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  121 bits (306), Expect = 1e-31
 Identities = 73/308 (23%), Positives = 123/308 (39%), Gaps = 53/308 (17%)

Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLS 117
           EL+   +N     ++G G +G V   +L          AIK L      +   DF  + S
Sbjct: 41  ELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98

Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV 177
           ++ +  H + + L G   +S   ++V ++   GSL   L               T  Q V
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVIQLV 150

Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
            +  G A G+++L +      VHRD+ + N+L+  +   K++DF L     D     ++T
Sbjct: 151 GMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT 207

Query: 238 R-----VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLV 291
           R     +  T    +PE     + T  SDV+S+G+VL E+++ G +P             
Sbjct: 208 RGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------------ 251

Query: 292 TWATPRLSEDKVKQCVD-----PKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK 346
                 +S   V + VD     P      P    A L  +   C Q + + RP    +V 
Sbjct: 252 ----WEMSNQDVIKAVDEGYRLPP-----PMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

Query: 347 ALQPLLNS 354
            L  L+ +
Sbjct: 303 ILDKLIRN 310

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  119 bits (300), Expect = 2e-31
 Identities = 54/224 (24%), Positives = 94/224 (41%), Gaps = 43/224 (19%)

Query: 73  KALIGEGSYGRVFYAKLTDG---TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
              +G G++G V              AIK L   +      +   +  ++ +L + + V 
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           L+G C      + V + A  G LH  L G++          +  +   ++ +  + G+++
Sbjct: 75  LIGVCQAEALML-VMEMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVSMGMKY 125

Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT--FGYH- 246
           L EK     VHRD+ + NVLL +   +KI+DF L             ++ LG     Y  
Sbjct: 126 LEEK---NFVHRDLAARNVLLVNRHYAKISDFGL-------------SKALGADDSYYTA 169

Query: 247 -----------APEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
                      APE     + + +SDV+S+GV + E L+ G+KP
Sbjct: 170 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  120 bits (303), Expect = 2e-31
 Identities = 64/294 (21%), Positives = 122/294 (41%), Gaps = 36/294 (12%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQ-LSVVSRLKHEHFVELLG 132
            IGEGS+G+    K   DG    IK+++ S     E + + + ++V++ +KH + V+   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
              E+ +  +V  +   G L   ++ +KGV   E       +Q +         L+ +H+
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE-------DQILDWFVQICLALKHVHD 143

Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
           +    I+HRD++S N+ L  D   ++ DF +    + T     +   +GT  Y +PE   
Sbjct: 144 RK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEICE 198

Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLN 312
                 KSD+++ G VL EL T +   +       ++LV          K+     P ++
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAFEA---GSMKNLVL---------KIISGSFPPVS 246

Query: 313 NDYPPKAIAKLAAVAALCVQYEADFRP------NMTIVVKALQPLLNSKPAGPE 360
             Y       L ++ +   +     RP          + K ++  L+ +    E
Sbjct: 247 LHYSY----DLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEE 296

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  118 bits (299), Expect = 2e-31
 Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 45/233 (19%)

Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKLTDG-TPAAIK--KLDTSSAPEPESDFAAQLSV 118
           E+ R  ++   K  +G G YG V+           A+K  K DT        +F  + +V
Sbjct: 9   EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 62

Query: 119 VSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK 178
           +  +KH + V+LLG C       ++ +F T G+L D L              ++    + 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-------QEVSAVVLLY 115

Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
           +A   +  +E+L +K     +HRD+ + N L+ ++   K+ADF L+             R
Sbjct: 116 MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS-------------R 159

Query: 239 VLGTFGYH------------APEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
           ++    Y             APE     + + KSDV++FGV+L E+ T G  P
Sbjct: 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  120 bits (303), Expect = 3e-31
 Identities = 69/302 (22%), Positives = 107/302 (35%), Gaps = 64/302 (21%)

Query: 15  ASQTTAPPRSGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLD------------- 61
            +     PR      G  +  E  T++ K    +         + +D             
Sbjct: 21  VAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQ 80

Query: 62  ----ELNRLTSNFGTKALIGEGSYGRVFYAKLTDG----TPAAIKKLDTSSAPEPESDFA 113
                 + L  +F     IG G +G V++  L D        A+K L+  +     S F 
Sbjct: 81  HVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL 138

Query: 114 AQLSVVSRLKHEHFVELLGYCMESNNRIL-VYQFATMGSLHDVLHGRKGVQGAEPGPVLT 172
            +  ++    H + + LLG C+ S    L V  +   G L + +               T
Sbjct: 139 TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--------HNPT 190

Query: 173 WNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA 232
               +      AKG++FL  K     VHRD+ + N +L + F  K+ADF L         
Sbjct: 191 VKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGL--------- 238

Query: 233 RLHSTRVLGTFGYH---------------APEYAMTGQITQKSDVYSFGVVLLELLT-GR 276
                R +    +                A E   T + T KSDV+SFGV+L EL+T G 
Sbjct: 239 ----ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 294

Query: 277 KP 278
            P
Sbjct: 295 PP 296

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  119 bits (300), Expect = 8e-31
 Identities = 81/353 (22%), Positives = 138/353 (39%), Gaps = 64/353 (18%)

Query: 32  SARGEPRTNVVKTGTPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTD 91
                   N+   G        E+P+    EL R     G    +GEG++G+V  A+   
Sbjct: 35  DYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKP--LGEGAFGQVVLAEAIG 92

Query: 92  --------GTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRIL 142
                    T  A+K L + +  +  SD  +++ ++  + KH++ + LLG C +     +
Sbjct: 93  LDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV 152

Query: 143 VYQFATMGSLHDVLHGRKGVQGA-------EPGPVLTWNQRVKVAYGAAKGLEFLHEKVQ 195
           + ++A+ G+L + L  R+             P   L+    V  AY  A+G+E+L  K  
Sbjct: 153 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-- 210

Query: 196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH--------- 246
              +HRD+ + NVL+ +D   KIADF L              R +    Y+         
Sbjct: 211 -KCIHRDLAARNVLVTEDNVMKIADFGL-------------ARDIHHIDYYKKTTNGRLP 256

Query: 247 ----APEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED 301
               APE       T +SDV+SFGV+L E+ T G  P                 P +  +
Sbjct: 257 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP----------------YPGVPVE 300

Query: 302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS 354
           ++ + +      D P     +L  +   C       RP    +V+ L  ++  
Sbjct: 301 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  117 bits (295), Expect = 1e-30
 Identities = 58/281 (20%), Positives = 100/281 (35%), Gaps = 54/281 (19%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPE-SDFAAQLSVVSRLKHEHFVELLG 132
            IG GS+  V+           A  +L      + E   F  +  ++  L+H + V    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 133 YCM---ESNNRILVY-QFATMGSLHDVL--HGRKGVQGAEPGPVLTWNQRVKVAYGAAKG 186
                 +    I++  +  T G+L   L                +             KG
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-----------MKIKVLRSWCRQILKG 141

Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKS---KIADFNLTNQSSDTAARLHSTRVLGTF 243
           L+FLH +  PPI+HRD++  N+ +     +   KI D  L      + A+     V+GT 
Sbjct: 142 LQFLHTR-TPPIIHRDLKCDNIFI--TGPTGSVKIGDLGLATLKRASFAK----AVIGTP 194

Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV 303
            + APE     +  +  DVY+FG+ +LE+ T   P                    SE + 
Sbjct: 195 EFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP-------------------YSECQN 234

Query: 304 KQCVDPKLNNDYPPKAIAKLAAVAA-----LCVQYEADFRP 339
              +  ++ +   P +  K+A          C++   D R 
Sbjct: 235 AAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY 275

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  116 bits (294), Expect = 1e-30
 Identities = 60/274 (21%), Positives = 105/274 (38%), Gaps = 33/274 (12%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQ-LSVVSRLKHEHFVELLG 132
            IG GSYGR    +  +DG     K+LD  S  E E       ++++  LKH + V    
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 133 YCMESNNRIL--VYQFATMGSLHDVL--HGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
             ++  N  L  V ++   G L  V+    ++     E          ++V       L+
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE-------EFVLRVMTQLTLALK 125

Query: 189 FLHEKVQPP--IVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
             H +      ++HRD++ +NV L      K+ DF L    +   +   +   +GT  Y 
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183

Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC 306
           +PE        +KSD++S G +L EL     P        Q+ L           K+++ 
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA---FSQKELA---------GKIREG 231

Query: 307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPN 340
              ++   Y      +L  +    +  +   RP+
Sbjct: 232 KFRRIPYRYSD----ELNEIITRMLNLKDYHRPS 261

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  117 bits (296), Expect = 1e-30
 Identities = 52/217 (23%), Positives = 90/217 (41%), Gaps = 23/217 (10%)

Query: 76  IGEGSYGRVFYAKLTDG------TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G G++G V+  +++           A+K L    + + E DF  +  ++S+  H++ V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
            +G  ++S  R ++ +    G L   L   +          L     + VA   A G ++
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRP--RPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 190 LHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTN--QSSDTAARLHSTR--VLGT 242
           L E      +HRD+ + N LL        +KI DF +      +    +       V   
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212

Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
                PE  M G  T K+D +SFGV+L E+ + G  P
Sbjct: 213 ----PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  117 bits (296), Expect = 1e-30
 Identities = 64/258 (24%), Positives = 106/258 (41%), Gaps = 50/258 (19%)

Query: 47  PQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDG------TPAAIKKL 100
           PQ      +  IK  ++         +  +GEG++G+VF A+  +          A+K L
Sbjct: 27  PQYFSDACVHHIKRRDIV-----LKWE--LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL 79

Query: 101 DTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRK 160
             +S      DF  +  +++ L+H+H V   G C E    ++V+++   G L+  L    
Sbjct: 80  KEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHG 138

Query: 161 GVQGAEPGPV------LTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF 214
                  G        L   Q + VA   A G+ +L        VHRD+ + N L+    
Sbjct: 139 PDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGL 195

Query: 215 KSKIADFNLTNQSSDTAARLHSTRVLGTFGYH-------------APEYAMTGQITQKSD 261
             KI DF +             +R + +  Y+              PE  +  + T +SD
Sbjct: 196 VVKIGDFGM-------------SRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESD 242

Query: 262 VYSFGVVLLELLT-GRKP 278
           V+SFGVVL E+ T G++P
Sbjct: 243 VWSFGVVLWEIFTYGKQP 260

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  117 bits (296), Expect = 1e-30
 Identities = 65/248 (26%), Positives = 104/248 (41%), Gaps = 46/248 (18%)

Query: 54  EIP--QIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTD------GTPAAIKKL-DTSS 104
           E P   ++  +             +G G++G+V  A              A+K L  T+ 
Sbjct: 42  EFPRNNLQFGKT------------LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 89

Query: 105 APEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQ 163
           A E E    ++L ++S L +HE+ V LLG C      +++ ++   G L + L  +  V 
Sbjct: 90  ADEKE-ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVL 148

Query: 164 GAEP-----GPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI 218
             +P         +    +  +   A+G+ FL  K     +HRDV + NVLL +   +KI
Sbjct: 149 ETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKI 205

Query: 219 ADFNLT-------NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLE 271
            DF L        N      ARL    V       APE       T +SDV+S+G++L E
Sbjct: 206 GDFGLARDIMNDSNYIVKGNARL---PVKWM----APESIFDCVYTVQSDVWSYGILLWE 258

Query: 272 LLT-GRKP 278
           + + G  P
Sbjct: 259 IFSLGLNP 266

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  116 bits (293), Expect = 2e-30
 Identities = 52/218 (23%), Positives = 98/218 (44%), Gaps = 37/218 (16%)

Query: 76  IGEGSYGRVFYAKLTDG---TPAAIKKL-DTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
           +G G++G V              A+K L + ++ P  + +  A+ +V+ +L + + V ++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G C   +  + V + A +G L+  L   +          +     +++ +  + G+++L 
Sbjct: 85  GICEAESWML-VMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLE 134

Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT----NQSSDTAARLHS------TRVLG 241
           E      VHRD+ + NVLL     +KI+DF L+       +   A+ H            
Sbjct: 135 ES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---- 187

Query: 242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
                APE     + + KSDV+SFGV++ E  + G+KP
Sbjct: 188 -----APECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  117 bits (296), Expect = 2e-30
 Identities = 64/263 (24%), Positives = 111/263 (42%), Gaps = 48/263 (18%)

Query: 46  TPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTD--------GTPAAI 97
                   E+P+    E  R     G    +GEG++G+V  A+               A+
Sbjct: 15  MLAGVSEYELPEDPKWEFPRDKLTLGKP--LGEGAFGQVVMAEAVGIDKDKPKEAVTVAV 72

Query: 98  KKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATMGSLHDVL 156
           K L   +  +  SD  +++ ++  + KH++ + LLG C +     ++ ++A+ G+L + L
Sbjct: 73  KMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132

Query: 157 HGRKGVQ-------GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVL 209
             R+             P   +T+   V   Y  A+G+E+L  +     +HRD+ + NVL
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 189

Query: 210 LFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH-------------APEYAMTGQI 256
           + ++   KIADF L              R +    Y+             APE       
Sbjct: 190 VTENNVMKIADFGL-------------ARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY 236

Query: 257 TQKSDVYSFGVVLLELLT-GRKP 278
           T +SDV+SFGV++ E+ T G  P
Sbjct: 237 THQSDVWSFGVLMWEIFTLGGSP 259

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  118 bits (297), Expect = 2e-30
 Identities = 78/378 (20%), Positives = 140/378 (37%), Gaps = 76/378 (20%)

Query: 7   QEEEPQPPASQTTAPPRSGNTQPGGSARGEPRTNVVKTGTPQKALPIEIP--QIKLDELN 64
                +  +S  +  P    T    S    P    V      +    E P  ++ L +  
Sbjct: 30  VTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKP- 88

Query: 65  RLTSNFGTKALIGEGSYGRVFYAKLTD--------GTPAAIKKLDTSSAPEPESDFAAQL 116
                      +GEG +G+V  A+               A+K L   +  +  SD  +++
Sbjct: 89  -----------LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 137

Query: 117 SVVSRL-KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQ-------GAEPG 168
            ++  + KH++ + LLG C +     ++ ++A+ G+L + L  R+             P 
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197

Query: 169 PVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS 228
             +T+   V   Y  A+G+E+L  +     +HRD+ + NVL+ ++   KIADF L     
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGL----- 249

Query: 229 DTAARLHSTRVLGTFGYH-------------APEYAMTGQITQKSDVYSFGVVLLELLT- 274
                    R +    Y+             APE       T +SDV+SFGV++ E+ T 
Sbjct: 250 --------ARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 301

Query: 275 GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYE 334
           G  P                 P +  +++ + +      D P     +L  +   C    
Sbjct: 302 GGSP----------------YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAV 345

Query: 335 ADFRPNMTIVVKALQPLL 352
              RP    +V+ L  +L
Sbjct: 346 PSQRPTFKQLVEDLDRIL 363

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  116 bits (293), Expect = 3e-30
 Identities = 63/306 (20%), Positives = 117/306 (38%), Gaps = 44/306 (14%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
            +GEG +  V   + L DG   A+K++      +   +   +  +     H + + L+ Y
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAY 94

Query: 134 CMESNNR----ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           C+          L+  F   G+L + +   K     + G  LT +Q + +  G  +GLE 
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLK-----DKGNFLTEDQILWLLLGICRGLEA 149

Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL-------GT 242
           +H        HRD++ +N+LL D+ +  + D    NQ+            L        T
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 243 FGYHAPE------YAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATP 296
             Y APE      + +   I +++DV+S G VL  ++ G  P D    KG    +     
Sbjct: 207 ISYRAPELFSVQSHCV---IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL----- 258

Query: 297 RLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP 356
                 V+  +    +  +       L  +    +  +   RP++ +++  L+ L    P
Sbjct: 259 -----AVQNQLSIPQSPRHSS----ALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309

Query: 357 AGPEAQ 362
                Q
Sbjct: 310 GQHTTQ 315

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  116 bits (293), Expect = 4e-30
 Identities = 59/256 (23%), Positives = 98/256 (38%), Gaps = 59/256 (23%)

Query: 54  EIP--QIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTD------GTPAAIKKLDTSSA 105
           E P  ++KL +             +G G++G+V  A              A+K L   + 
Sbjct: 23  EFPRDRLKLGKP------------LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT 70

Query: 106 PEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILV-YQFATMGSLHDVLHGRKG-- 161
                   ++L ++  +  H + V LLG C +    ++V  +F   G+L   L  ++   
Sbjct: 71  HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 130

Query: 162 -----VQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS 216
                         LT    +  ++  AKG+EFL  +     +HRD+ + N+LL +    
Sbjct: 131 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVV 187

Query: 217 KIADFNLTNQSSDTAARLHSTRVLGTFGYH-------------APEYAMTGQITQKSDVY 263
           KI DF L              R +     +             APE       T +SDV+
Sbjct: 188 KICDFGL-------------ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 234

Query: 264 SFGVVLLELLT-GRKP 278
           SFGV+L E+ + G  P
Sbjct: 235 SFGVLLWEIFSLGASP 250

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  116 bits (293), Expect = 5e-30
 Identities = 58/238 (24%), Positives = 107/238 (44%), Gaps = 51/238 (21%)

Query: 76  IGEGSYGRVFYAKLTDG------TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           IGEG++GRVF A+          T  A+K L   ++ + ++DF  + ++++   + + V+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRK---------------GVQGAEPGPVLTWN 174
           LLG C       L++++   G L++ L                       +   P L+  
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174

Query: 175 QRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARL 234
           +++ +A   A G+ +L E+     VHRD+ + N L+ ++   KIADF L           
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGL----------- 220

Query: 235 HSTRVLGTFGYH-------------APEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
             +R + +  Y+              PE     + T +SDV+++GVVL E+ + G +P
Sbjct: 221 --SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  115 bits (291), Expect = 7e-30
 Identities = 62/262 (23%), Positives = 99/262 (37%), Gaps = 48/262 (18%)

Query: 47  PQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTD------GTPAAIKKL 100
                P ++P     E  R   +FG    +G G++G+V  A              A+K L
Sbjct: 4   YVYIDPTQLPYDHKWEFPRNRLSFGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61

Query: 101 DTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGR 159
             S+         ++L V+S L  H + V LLG C      +++ ++   G L + L  +
Sbjct: 62  KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121

Query: 160 KGVQ---------GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL 210
           +              +    L     +  +Y  AKG+ FL  K     +HRD+ + N+LL
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178

Query: 211 FDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH-------------APEYAMTGQIT 257
                +KI DF L              R +     +             APE       T
Sbjct: 179 THGRITKICDFGL-------------ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT 225

Query: 258 QKSDVYSFGVVLLELLT-GRKP 278
            +SDV+S+G+ L EL + G  P
Sbjct: 226 FESDVWSYGIFLWELFSLGSSP 247

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  118 bits (298), Expect = 1e-29
 Identities = 53/225 (23%), Positives = 94/225 (41%), Gaps = 43/225 (19%)

Query: 72  TKALIGEGSYGRVFYAKLTDG---TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFV 128
               +G G++G V              AIK L   +      +   +  ++ +L + + V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399

Query: 129 ELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            L+G C      + V + A  G LH  L G++          +  +   ++ +  + G++
Sbjct: 400 RLIGVCQAEALML-VMEMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVSMGMK 450

Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT--FGYH 246
           +L EK     VHR++ + NVLL +   +KI+DF L             ++ LG     Y 
Sbjct: 451 YLEEK---NFVHRNLAARNVLLVNRHYAKISDFGL-------------SKALGADDSYYT 494

Query: 247 ------------APEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
                       APE     + + +SDV+S+GV + E L+ G+KP
Sbjct: 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  115 bits (291), Expect = 1e-29
 Identities = 66/302 (21%), Positives = 116/302 (38%), Gaps = 57/302 (18%)

Query: 76  IGEGSYGRVFYAKLTDG------TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +G G++G V+  +++           A+K L    + + E DF  +  ++S+  H++ V 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
            +G  ++S  R ++ +    G L   L   +          L     + VA   A G ++
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRP--RPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 190 LHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           L E      +HRD+ + N LL        +KI DF +              R +   GY+
Sbjct: 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGM-------------ARDIYRAGYY 240

Query: 247 -------------APEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVT 292
                         PE  M G  T K+D +SFGV+L E+ + G  P              
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY------------- 287

Query: 293 WATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL 352
              P  S  +V + V      D P      +  +   C Q++ + RPN  I+++ ++   
Sbjct: 288 ---PSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344

Query: 353 NS 354
             
Sbjct: 345 QD 346

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  114 bits (287), Expect = 2e-29
 Identities = 61/262 (23%), Positives = 105/262 (40%), Gaps = 65/262 (24%)

Query: 54  EIP--QIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDG------TPAAIKKLDTSSA 105
           E P   + L +             +GEG +G+V  A           T  A+K L  +++
Sbjct: 19  EFPRKNLVLGKT------------LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS 66

Query: 106 PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVL--------- 156
           P    D  ++ +V+ ++ H H ++L G C +    +L+ ++A  GSL   L         
Sbjct: 67  PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPG 126

Query: 157 ------HGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL 210
                               LT    +  A+  ++G+++L E     +VHRD+ + N+L+
Sbjct: 127 YLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILV 183

Query: 211 FDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH-------------APEYAMTGQIT 257
            +  K KI+DF L             +R +     +             A E       T
Sbjct: 184 AEGRKMKISDFGL-------------SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT 230

Query: 258 QKSDVYSFGVVLLELLT-GRKP 278
            +SDV+SFGV+L E++T G  P
Sbjct: 231 TQSDVWSFGVLLWEIVTLGGNP 252

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  112 bits (283), Expect = 5e-29
 Identities = 67/283 (23%), Positives = 106/283 (37%), Gaps = 58/283 (20%)

Query: 57  QIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQ 115
           ++K D+L  +         +G G+YG V   +    G   A+K++  +   + +      
Sbjct: 3   EVKADDLEPI-------MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMD 55

Query: 116 LSVVSRL-KHEHFVELLG---------YCMESNNRILVYQFATM-GSLHDVLHGRKGVQG 164
           L +  R       V   G          CME            M  SL            
Sbjct: 56  LDISMRTVDCPFTVTFYGALFREGDVWICME-------L----MDTSLDKFYKQVIDKGQ 104

Query: 165 AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT 224
             P  +L      K+A    K LE LH K+   ++HRDV+ SNVL+    + K+ DF ++
Sbjct: 105 TIPEDILG-----KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGIS 157

Query: 225 NQSSDTAARLHSTRVLGTFGYHAPE----YAMTGQITQKSDVYSFGVVLLELLTGRKP-- 278
               D  A+       G   Y APE           + KSD++S G+ ++EL   R P  
Sbjct: 158 GYLVDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214

Query: 279 -VDHTMPKGQQSLVTWATPRLSEDK--------VKQCV--DPK 310
                  + +Q +V   +P+L  DK          QC+  + K
Sbjct: 215 SWGTPFQQLKQ-VVEEPSPQLPADKFSAEFVDFTSQCLKKNSK 256

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  113 bits (286), Expect = 6e-29
 Identities = 70/256 (27%), Positives = 107/256 (41%), Gaps = 53/256 (20%)

Query: 54  EIP--QIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDG------TPAAIKKLDTSSA 105
           E P   ++  ++            +G G++G+V  A              A+K L   + 
Sbjct: 41  EFPRENLEFGKV------------LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD 88

Query: 106 PEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATMGSLHDVL-------- 156
                   ++L ++++L  HE+ V LLG C  S    L++++   G L + L        
Sbjct: 89  SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFS 148

Query: 157 ------HGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL 210
                   +K ++  E   VLT+   +  AY  AKG+EFL  K     VHRD+ + NVL+
Sbjct: 149 EDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLV 205

Query: 211 FDDFKSKIADFNLT-------NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVY 263
                 KI DF L        N      ARL    V       APE    G  T KSDV+
Sbjct: 206 THGKVVKICDFGLARDIMSDSNYVVRGNARL---PVKWM----APESLFEGIYTIKSDVW 258

Query: 264 SFGVVLLELLT-GRKP 278
           S+G++L E+ + G  P
Sbjct: 259 SYGILLWEIFSLGVNP 274

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  111 bits (280), Expect = 4e-28
 Identities = 65/283 (22%), Positives = 111/283 (39%), Gaps = 41/283 (14%)

Query: 54  EIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDF 112
           ++ ++K D+  +++        +G G+ G VF       G   A K +     P   +  
Sbjct: 26  KVGELKDDDFEKISE-------LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI 78

Query: 113 AAQLSVVSRLKHEHFVELLG---------YCMESNNRILVYQFATMGSLHDVLHGRKGVQ 163
             +L V+      + V   G          CME             GSL  VL     + 
Sbjct: 79  IRELQVLHECNSPYIVGFYGAFYSDGEISICME---------HMDGGSLDQVLKKAGRI- 128

Query: 164 GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL 223
              P  +L      KV+    KGL +L EK +  I+HRDV+ SN+L+    + K+ DF +
Sbjct: 129 ---PEQIL-----GKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGV 178

Query: 224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTM 283
           + Q  D+ A    + V GT  Y +PE       + +SD++S G+ L+E+  GR P+    
Sbjct: 179 SGQLIDSMAN---SFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234

Query: 284 PKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAV 326
            K  + +        + +   +   P    +          A+
Sbjct: 235 AKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAI 277

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  110 bits (277), Expect = 5e-28
 Identities = 57/240 (23%), Positives = 101/240 (42%), Gaps = 24/240 (10%)

Query: 44  TGTPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDT 102
              PQKAL  ++    L        NF  +  IG G +  V+ A  L DG P A+KK+  
Sbjct: 15  QFQPQKALRPDMGYNTLA-------NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQI 67

Query: 103 SSAPEPESDFAAQ--LSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVL--HG 158
               + ++       + ++ +L H + ++     +E N   +V + A  G L  ++    
Sbjct: 68  FDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFK 127

Query: 159 RKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI 218
           ++     E   V  +  ++         LE +H +    ++HRD++ +NV +      K+
Sbjct: 128 KQKRLIPER-TVWKYFVQL------CSALEHMHSRR---VMHRDIKPANVFITATGVVKL 177

Query: 219 ADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            D  L    S      HS  ++GT  Y +PE         KSD++S G +L E+   + P
Sbjct: 178 GDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  109 bits (274), Expect = 1e-27
 Identities = 59/248 (23%), Positives = 109/248 (43%), Gaps = 29/248 (11%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG+G+ G V+ A  +  G   AI++++    P+ +     ++ V+   K+ + V  L   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSY 86

Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
           +  +   +V ++   GSL DV+              +   Q   V     + LEFLH   
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSN- 135

Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              ++HRD++S N+LL  D   K+ DF    Q +   ++  +  ++GT  + APE     
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRK 191

Query: 255 QITQKSDVYSFGVVLLELLTGRKPVDHTMP-KGQQSLVTWATPRLSE---------DKVK 304
               K D++S G++ +E++ G  P  +  P +    + T  TP L           D + 
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251

Query: 305 QC--VDPK 310
           +C  +D +
Sbjct: 252 RCLEMDVE 259

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  108 bits (273), Expect = 1e-27
 Identities = 55/232 (23%), Positives = 99/232 (42%), Gaps = 37/232 (15%)

Query: 65  RLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQ-LSVVSRL 122
           R   +F    LIG G +G+VF AK   DG    IK++         ++ A + +  +++L
Sbjct: 8   RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY------NNEKAEREVKALAKL 61

Query: 123 KHEHFVELLGYCMESNNRI----------------LVYQFATMGSLHDVLHGRKGVQGAE 166
            H + V   G     +                   +  +F   G+L   +  R+G +  +
Sbjct: 62  DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121

Query: 167 PGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ 226
                     +++     KG++++H K    +++RD++ SN+ L D  + KI DF L   
Sbjct: 122 V-------LALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171

Query: 227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
             +   R   TR  GT  Y +PE   +    ++ D+Y+ G++L ELL     
Sbjct: 172 LKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  109 bits (274), Expect = 2e-27
 Identities = 59/271 (21%), Positives = 97/271 (35%), Gaps = 27/271 (9%)

Query: 16  SQTTAPPRSGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLD--ELNRLTSNFGTK 73
           S ++    S  +     + G  +   +   T      +   ++K    E          +
Sbjct: 4   SVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQ 63

Query: 74  ALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLG 132
             +G GS+G V   K    G   A+KK+        E      L   + L     V L G
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE------LVACAGLSSPRIVPLYG 117

Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
              E     +  +    GSL  ++  ++   G  P               A +GLE+LH 
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLI--KQM--GCLPEDRAL-----YYLGQALEGLEYLHT 168

Query: 193 KVQPPIVHRDVRSSNVLLFDD-FKSKIADF----NLTNQSSDTAARLHSTRVLGTFGYHA 247
           +    I+H DV++ NVLL  D  ++ + DF     L       +       + GT  + A
Sbjct: 169 R---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY-IPGTETHMA 224

Query: 248 PEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           PE  M      K D++S   ++L +L G  P
Sbjct: 225 PEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  108 bits (271), Expect = 3e-27
 Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 20/209 (9%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           +G+G++G+V+ AK    G  AA K ++T S  E E D+  ++ +++   H + V+LLG  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYIVEIEILATCDHPYIVKLLGAY 85

Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
                  ++ +F   G++  ++              LT  Q   V     + L FLH K 
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRG--------LTEPQIQVVCRQMLEALNFLHSK- 136

Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              I+HRD+++ NVL+  +   ++ADF ++ ++  T  +  S   +GT  + APE  M  
Sbjct: 137 --RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCE 192

Query: 255 QITQ-----KSDVYSFGVVLLELLTGRKP 278
            +       K+D++S G+ L+E+     P
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  107 bits (270), Expect = 6e-27
 Identities = 68/274 (24%), Positives = 125/274 (45%), Gaps = 35/274 (12%)

Query: 56  PQIKLDELNRLTSN------FGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEP 108
           P+ +L +L+  +        F     +GEGSYG V+ A     G   AIK++   S  + 
Sbjct: 11  PRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ- 69

Query: 109 ESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPG 168
             +   ++S++ +    H V+  G   ++ +  +V ++   GS+ D++  R         
Sbjct: 70  --EIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT------ 121

Query: 169 PVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS 228
             LT ++   +     KGLE+LH       +HRD+++ N+LL  +  +K+ADF +  Q +
Sbjct: 122 --LTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176

Query: 229 DTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP-KGQ 287
           DT A+ ++  V+GT  + APE          +D++S G+  +E+  G+ P     P +  
Sbjct: 177 DTMAKRNT--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI 234

Query: 288 QSLVTWATPRLSEDK---------VKQC--VDPK 310
             + T   P   + +         VKQC    P+
Sbjct: 235 FMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPE 268

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  107 bits (270), Expect = 7e-27
 Identities = 71/286 (24%), Positives = 106/286 (37%), Gaps = 60/286 (20%)

Query: 57  QIKLDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQ 115
               ++L  L         IG G+YG V        G   A+K++ ++   + +      
Sbjct: 18  DFTAEDLKDL-------GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMD 70

Query: 116 LSVVSRL-KHEHFVELLG---------YCMESNNRILVYQFATM-GSLHDVLHGRKGVQG 164
           L VV R     + V+  G          CME            M  S          V  
Sbjct: 71  LDVVMRSSDCPYIVQFYGALFREGDCWICME-------L----MSTSFDKFYKYVYSVLD 119

Query: 165 AE-PGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL 223
              P  +L      K+     K L  L E ++  I+HRD++ SN+LL      K+ DF +
Sbjct: 120 DVIPEEILG-----KITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGI 172

Query: 224 TNQSSDTAARLHSTRVLGTFGYHAPE----YAMTGQITQKSDVYSFGVVLLELLTGRKPV 279
           + Q  D+ A+   TR  G   Y APE     A       +SDV+S G+ L EL TGR P 
Sbjct: 173 SGQLVDSIAK---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY 229

Query: 280 D--HTMPKGQQSLVTWATPRLSEDK-----------VKQCV--DPK 310
              +++      +V    P+LS  +           V  C+  D  
Sbjct: 230 PKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDES 275

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  106 bits (267), Expect = 1e-26
 Identities = 65/246 (26%), Positives = 111/246 (45%), Gaps = 26/246 (10%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG+GS+G VF           AIK +D   A +   D   +++V+S+    +  +  G  
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89

Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
           ++     ++ ++   GS  D+L         EPGP L   Q   +     KGL++LH + 
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLL---------EPGP-LDETQIATILREILKGLDYLHSE- 138

Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
               +HRD++++NVLL +  + K+ADF +  Q +DT  + ++   +GT  + APE     
Sbjct: 139 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 194

Query: 255 QITQKSDVYSFGVVLLELLTGRKPVDHTMP-KGQQSLVTWATPRLSE-------DKVKQC 306
               K+D++S G+  +EL  G  P     P K    +     P L         + V+ C
Sbjct: 195 AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC 254

Query: 307 --VDPK 310
              +P 
Sbjct: 255 LNKEPS 260

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  107 bits (268), Expect = 2e-26
 Identities = 58/329 (17%), Positives = 113/329 (34%), Gaps = 49/329 (14%)

Query: 52  PIEIPQIKLDELNRLTSN-FGTKALIGEGSYGRVFYAKLTDGTPA------AIKKLDTSS 104
             ++P IK     +L S       L+GEG++ +V+ A   D   A       +K      
Sbjct: 48  QCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK--- 104

Query: 105 APEPESDFAAQLSVVSRLK---HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKG 161
            P    +F     ++ RLK      F++     +  N  +LV +  + G+L + ++  K 
Sbjct: 105 -PANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKN 163

Query: 162 VQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS----- 216
                    +     +  A      +E +H+     I+H D++  N +L + F       
Sbjct: 164 TPEKV----MPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDED 216

Query: 217 ------KIADF----NLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQI-TQKSDVYSF 265
                  + D     ++      T      T    T G+   E  ++ +    + D +  
Sbjct: 217 DLSAGLALIDLGQSIDMKLFPKGTIF----TAKCETSGFQCVE-MLSNKPWNYQIDYFGV 271

Query: 266 GVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL-SEDKVKQCVDPKLNNDYPPKAIAKLA 324
              +  +L G         +G +        RL   D   +     LN   P      L 
Sbjct: 272 AATVYCMLFGTYM--KVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLN--IPDC--HHLP 325

Query: 325 AVAALCVQYEADFRPNMTIVVKALQPLLN 353
           ++  L  + +  F+ + T  ++AL+  L 
Sbjct: 326 SLDLLRQKLKKVFQQHYTNKIRALRNRLI 354

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  106 bits (266), Expect = 3e-26
 Identities = 33/223 (14%), Positives = 87/223 (39%), Gaps = 30/223 (13%)

Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLD------------TSSAPEPESDFAAQL----SVV 119
           + +G + ++   +       A+KK +            +++                 ++
Sbjct: 39  LNQGKFNKIILCEKD-NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 120 SRLKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK 178
           + +K+E+ +   G  + + + + ++Y++    S+         +       +     +  
Sbjct: 98  TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK-C 155

Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
           +         ++H +    I HRDV+ SN+L+  + + K++DF  +    D   ++  +R
Sbjct: 156 IIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVD--KKIKGSR 211

Query: 239 VLGTFGYHAPEYAMTGQIT---QKSDVYSFGVVLLELLTGRKP 278
             GT+ +  PE   + + +    K D++S G+ L  +     P
Sbjct: 212 --GTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  105 bits (265), Expect = 4e-26
 Identities = 54/281 (19%), Positives = 101/281 (35%), Gaps = 42/281 (14%)

Query: 75  LIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESD-FAAQLSVVSRLKH--EHFVELL 131
            IG G   +VF          AIK ++   A     D +  +++ +++L+   +  + L 
Sbjct: 16  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75

Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
            Y +      +V +      L+  L  +K          +   +R        + +  +H
Sbjct: 76  DYEITDQYIYMVMECGN-IDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIH 125

Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE-- 249
           +     IVH D++ +N  L  D   K+ DF + NQ       +     +GT  Y  PE  
Sbjct: 126 QH---GIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181

Query: 250 ---------YAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE 300
                         +I+ KSDV+S G +L  +  G+ P              +       
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--------------FQQIINQI 227

Query: 301 DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNM 341
            K+   +DP    ++P      L  V   C++ +   R ++
Sbjct: 228 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 268

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  106 bits (267), Expect = 4e-26
 Identities = 52/280 (18%), Positives = 94/280 (33%), Gaps = 31/280 (11%)

Query: 16  SQTTAPPRSGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLDELNRLTSNFGTKAL 75
           S    P  SG  +   +       +    GT             +    R    +     
Sbjct: 7   SSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGR---IYSILKQ 63

Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESD-FAAQLSVVSRLKH--EHFVELLG 132
           IG G   +VF          AIK ++   A     D +  +++ +++L+   +  + L  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123

Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
           Y +      +V +      L+  L  +K +          W   ++        +  +H+
Sbjct: 124 YEITDQYIYMVMECGN-IDLNSWLKKKKSID--PWERKSYWKNMLE-------AVHTIHQ 173

Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE--- 249
                IVH D++ +N  L  D   K+ DF + NQ       +     +G   Y  PE   
Sbjct: 174 H---GIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229

Query: 250 --------YAMTGQITQKSDVYSFGVVLLELLTGRKPVDH 281
                        +I+ KSDV+S G +L  +  G+ P   
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  105 bits (264), Expect = 4e-26
 Identities = 56/248 (22%), Positives = 106/248 (42%), Gaps = 29/248 (11%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IGEGS G V  A+    G   A+K +D             ++ ++   +H + VE+    
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR-RELLFNEVVIMRDYQHFNVVEMYKSY 111

Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
           +      ++ +F   G+L D++   +          L   Q   V     + L +LH + 
Sbjct: 112 LVGEELWVLMEFLQGGALTDIVSQVR----------LNEEQIATVCEAVLQALAYLHAQ- 160

Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              ++HRD++S ++LL  D + K++DF    Q S    +  S  ++GT  + APE     
Sbjct: 161 --GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRS 216

Query: 255 QITQKSDVYSFGVVLLELLTGRKPVDHTMP-KGQQSLVTWATPRLSE---------DKVK 304
               + D++S G++++E++ G  P     P +  + L     P+L           D ++
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLE 276

Query: 305 QC--VDPK 310
           +    DP+
Sbjct: 277 RMLVRDPQ 284

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  104 bits (262), Expect = 7e-26
 Identities = 46/221 (20%), Positives = 83/221 (37%), Gaps = 28/221 (12%)

Query: 75  LIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESD-FAAQLSVVSRLKH--EHFVELL 131
            IG G   +VF          AIK ++   A     D +  +++ +++L+   +  + L 
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94

Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
            Y +      +V +      L+  L  +K          +   +R        + +  +H
Sbjct: 95  DYEITDQYIYMVMECGN-IDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIH 144

Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE-- 249
           +     IVH D++ +N  L  D   K+ DF + NQ       +     +GT  Y  PE  
Sbjct: 145 QH---GIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200

Query: 250 ---------YAMTGQITQKSDVYSFGVVLLELLTGRKPVDH 281
                         +I+ KSDV+S G +L  +  G+ P   
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  103 bits (259), Expect = 2e-25
 Identities = 65/265 (24%), Positives = 105/265 (39%), Gaps = 54/265 (20%)

Query: 76  IGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLG- 132
           +G G+ G+V+  +    G   A+K++  S   E        L VV +     + V+  G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92

Query: 133 --------YCMESNNRILVYQFATMG-SLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
                     ME            MG     +    K +QG  P  +L      K+    
Sbjct: 93  FITNTDVFIAME-------L----MGTCAEKLK---KRMQGPIPERILG-----KMTVAI 133

Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
            K L +L EK    ++HRDV+ SN+LL +  + K+ DF ++ +  D  A+    R  G  
Sbjct: 134 VKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCA 188

Query: 244 GYHAPEYAMTGQITQ-----KSDVYSFGVVLLELLTGRKPVDHTMPKGQQ--SLVTWATP 296
            Y APE       T+     ++DV+S G+ L+EL TG+ P  +     +    ++    P
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP 248

Query: 297 RLSEDK---------VKQCV--DPK 310
            L             VK C+  D +
Sbjct: 249 LLPGHMGFSGDFQSFVKDCLTKDHR 273

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  102 bits (257), Expect = 3e-25
 Identities = 56/229 (24%), Positives = 105/229 (45%), Gaps = 27/229 (11%)

Query: 67  TSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE 125
               G + ++G+G+YG V+  + L++    AIK++    +   +     ++++   LKH+
Sbjct: 21  YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP-LHEEIALHKHLKHK 79

Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA- 184
           + V+ LG   E+    +  +    GSL  +L  + G         L  N++    Y    
Sbjct: 80  NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGP--------LKDNEQTIGFYTKQI 131

Query: 185 -KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS---KIADFNLTNQSSDTAARLHSTRVL 240
            +GL++LH+     IVHRD++  NVL+  +  S   KI+DF  + + +       +    
Sbjct: 132 LEGLKYLHDN---QIVHRDIKGDNVLI--NTYSGVLKISDFGTSKRLAGINPCTET--FT 184

Query: 241 GTFGYHAPEYAMTGQI--TQKSDVYSFGVVLLELLTGRKP---VDHTMP 284
           GT  Y APE    G     + +D++S G  ++E+ TG+ P   +     
Sbjct: 185 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA 233

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  104 bits (262), Expect = 3e-25
 Identities = 46/241 (19%), Positives = 91/241 (37%), Gaps = 35/241 (14%)

Query: 56  PQIKLDELNRLTS-------NFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTS--SAP 106
           P ++ D+ +  TS       +F  K ++G G+ G + Y  + D    A+K++     S  
Sbjct: 5   PSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA 64

Query: 107 EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE 166
           + E     +       +H + +       +   + +  +     +L + +  +K      
Sbjct: 65  DREVQLLRESD-----EHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVE-QKDFAHLG 117

Query: 167 PGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD-----DFKSKIADF 221
                   + + +      GL  LH      IVHRD++  N+L+         K+ I+DF
Sbjct: 118 L-------EPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDF 167

Query: 222 NLTNQ-SSDTAARLHSTRVLGTFGYHAPEY---AMTGQITQKSDVYSFGVVLLELLTGRK 277
            L  + +    +    + V GT G+ APE          T   D++S G V   +++   
Sbjct: 168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS 227

Query: 278 P 278
            
Sbjct: 228 H 228

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  102 bits (257), Expect = 3e-25
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 22/214 (10%)

Query: 74  ALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPE--SDFAAQLSVVSRLKHEHFVEL 130
            ++G G    V  A+ L D    A+K L    A +P     F  +    + L H   V +
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77

Query: 131 LGYCMESNNRILVYQFATM-----GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
                E+        +  M      +L D++H          GP +T  + ++V   A +
Sbjct: 78  YDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTE--------GP-MTPKRAIEVIADACQ 127

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST-RVLGTFG 244
            L F H+     I+HRDV+ +N+++      K+ DF +    +D+   +  T  V+GT  
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184

Query: 245 YHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           Y +PE A    +  +SDVYS G VL E+LTG  P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  102 bits (257), Expect = 4e-25
 Identities = 59/259 (22%), Positives = 113/259 (43%), Gaps = 38/259 (14%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLG- 132
           +G G+YG+V+  + +  G  AAIK +D +   + E +   +++++ +   H +     G 
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGA 89

Query: 133 ----YCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                    ++++ LV +F   GS+ D++   KG         L       +     +GL
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-------NTLKEEWIAYICREILRGL 142

Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
             LH+     ++HRD++  NVLL ++ + K+ DF ++ Q   T  R ++   +GT  + A
Sbjct: 143 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMA 197

Query: 248 PEYAMTGQITQ-----KSDVYSFGVVLLELLTGRKPVDHTMP-KGQQSLVTWATPRLSED 301
           PE     +        KSD++S G+  +E+  G  P+    P +    +     PRL   
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK 257

Query: 302 K--------VKQC--VDPK 310
           K        ++ C   +  
Sbjct: 258 KWSKKFQSFIESCLVKNHS 276

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  102 bits (256), Expect = 4e-25
 Identities = 53/211 (25%), Positives = 93/211 (44%), Gaps = 22/211 (10%)

Query: 74  ALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPE--SDFAAQLSVVSRLKHEHFVEL 130
             +G G    V+ A+        AIK +      + E    F  ++   S+L H++ V +
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
           +    E +   LV ++    +L + +           GP L+ +  +        G++  
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESH--------GP-LSVDTAINFTNQILDGIKHA 127

Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL---TNQSSDTAARLHSTRVLGTFGYHA 247
           H+     IVHRD++  N+L+  +   KI DF +    +++S T     +  VLGT  Y +
Sbjct: 128 HDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT----QTNHVLGTVQYFS 180

Query: 248 PEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           PE A      + +D+YS G+VL E+L G  P
Sbjct: 181 PEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  101 bits (255), Expect = 4e-25
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 22/210 (10%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQL----SVVSRLKHEHFVE 129
           L+G+GS+  V+ A+ +  G   AIK +D  +  +       ++     +  +LKH   +E
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKA--GMVQRVQNEVKIHCQLKHPSILE 75

Query: 130 LLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
           L  Y  E +N + LV +    G ++  L  R            + N+     +    G+ 
Sbjct: 76  LYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKP--------FSENEARHFMHQIITGML 126

Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           +LH      I+HRD+  SN+LL  +   KIADF L  Q      + ++    GT  Y +P
Sbjct: 127 YLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTPNYISP 181

Query: 249 EYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           E A       +SDV+S G +   LL GR P
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  102 bits (255), Expect = 7e-25
 Identities = 52/258 (20%), Positives = 88/258 (34%), Gaps = 21/258 (8%)

Query: 24  SGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGR 83
           + N       + +PR    +    +          + +       +F   + +G GSYG 
Sbjct: 15  TENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPES--FFQQSFQRLSRLGHGSYGE 72

Query: 84  VFYA-KLTDGTPAAIKKLDTSSAPEPESDFA-AQLSVVSRL-KHEHFVELLGYCMESNNR 140
           VF      DG   A+K+  +      +     A++    ++ +H   V L     E    
Sbjct: 73  VFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132

Query: 141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVH 200
            L  +     SL               G  L   Q           L  LH +    +VH
Sbjct: 133 YLQTELCG-PSLQQHCE--------AWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVH 180

Query: 201 RDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKS 260
            DV+ +N+ L    + K+ DF L  +     A     +  G   Y APE  + G     +
Sbjct: 181 LDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG--EVQE-GDPRYMAPE-LLQGSYGTAA 236

Query: 261 DVYSFGVVLLELLTGRKP 278
           DV+S G+ +LE+    + 
Sbjct: 237 DVFSLGLTILEVACNMEL 254

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  101 bits (254), Expect = 8e-25
 Identities = 53/239 (22%), Positives = 102/239 (42%), Gaps = 40/239 (16%)

Query: 64  NRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
            R  S+F   A++G+G++G+V  A+   D    AIKK+  +   E  S   +++ +++ L
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASL 59

Query: 123 KHEHFVELLGYCMESNNRI-------------LVYQFATMGSLHDVLHGRKGVQGAEPGP 169
            H++ V      +E  N +             +  ++   G+L+D++H     Q  +   
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQ--QRDE 117

Query: 170 VLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD 229
                +++       + L ++H +    I+HRD++  N+ + +    KI DF L      
Sbjct: 118 YWRLFRQI------LEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHR 168

Query: 230 TAARLHS------------TRVLGTFGYHAPE-YAMTGQITQKSDVYSFGVVLLELLTG 275
           +   L              T  +GT  Y A E    TG   +K D+YS G++  E++  
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 98.1 bits (245), Expect = 1e-23
 Identities = 51/212 (24%), Positives = 89/212 (41%), Gaps = 29/212 (13%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQL----SVVSRLKHEHFVE 129
            +G+G +G V+ A+        A+K L  +   +  +    QL     + S L+H + + 
Sbjct: 16  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK--AGVEHQLRREVEIQSHLRHPNILR 73

Query: 130 LLGYCMESNNRI-LVYQFATMGSLHDVL--HGRKGVQGAEPGPVLTWNQRVKVAYGAAKG 186
           L GY      R+ L+ ++A +G+++  L    +               +        A  
Sbjct: 74  LYGY-FHDATRVYLILEYAPLGTVYRELQKLSK-----------FDEQRTATYITELANA 121

Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           L + H K    ++HRD++  N+LL    + KIADF     S    +   +  + GT  Y 
Sbjct: 122 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGW---SVHAPSSRRTD-LCGTLDYL 174

Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            PE        +K D++S GV+  E L G+ P
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 98.2 bits (245), Expect = 1e-23
 Identities = 53/276 (19%), Positives = 97/276 (35%), Gaps = 48/276 (17%)

Query: 65  RLTSNFGTKALIGEGSYGRVFYA-KLTDGTPAAIKKLDTSSAPEPESDFAAQ-LSVVSRL 122
           R T+ F     IG G +G VF   K  DG   AIK+     A   +   A + +   + L
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67

Query: 123 -KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY 181
            +H H V       E ++ ++  ++   GSL D +     +        L  +    +  
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL-KD----LLL 122

Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLL--------------FDDFKS-----KIADFN 222
              +GL ++H      +VH D++ SN+ +               DD+ S     KI D  
Sbjct: 123 QVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179

Query: 223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGRKPVD- 280
              + S            G   + A E          K+D+++  + ++           
Sbjct: 180 HVTRISSP-----QVEE-GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233

Query: 281 ----HTMPKGQQSLVTWATPRLSE---DKVKQCVDP 309
               H + +G+   +      LS+   + +K  + P
Sbjct: 234 GDQWHEIRQGRLPRI---PQVLSQEFTELLKVMIHP 266

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 98.5 bits (246), Expect = 1e-23
 Identities = 49/215 (22%), Positives = 82/215 (38%), Gaps = 30/215 (13%)

Query: 74  ALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEP--------ESDFAAQLSVVSRLKH 124
            L+G G  G V+ A+        A+K +  + + +P        E+  A +L        
Sbjct: 40  RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ------E 93

Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            H V +  +        +  +      L  +L           GP L   + V +     
Sbjct: 94  PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLR--------RQGP-LAPPRAVAIVRQIG 144

Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST-RVLGTF 243
             L+  H        HRDV+  N+L+  D  + + DF + + ++D   +L      +GT 
Sbjct: 145 SALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDE--KLTQLGNTVGTL 199

Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            Y APE       T ++D+Y+   VL E LTG  P
Sbjct: 200 YYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 98.9 bits (247), Expect = 1e-23
 Identities = 64/273 (23%), Positives = 105/273 (38%), Gaps = 41/273 (15%)

Query: 13  PPASQTTAPPRSGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLDELNRLTSNFGT 72
           P  +        G   PG  A   P                EIP++ +D  +R    +  
Sbjct: 2   PAPADPGKAGVPGVAAPGAPAAAPPAK--------------EIPEVLVDPRSR--RRYVR 45

Query: 73  KALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVE 129
              +G+G + + F     D     A K +  S    P      + ++S+   L H+H V 
Sbjct: 46  GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 105

Query: 130 LLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY---GAAK 185
             G+  E N+ + +V +     SL ++   RK +   EP          +  Y       
Sbjct: 106 FHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALT--EP----------EARYYLRQIVL 152

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           G ++LH      ++HRD++  N+ L +D + KI DF L  +      R       GT  Y
Sbjct: 153 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNY 207

Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            APE       + + DV+S G ++  LL G+ P
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 97.9 bits (244), Expect = 2e-23
 Identities = 52/233 (22%), Positives = 90/233 (38%), Gaps = 30/233 (12%)

Query: 75  LIGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           ++G+G+   VF    K T G   AIK  +  S   P      +  V+ +L H++ V+L  
Sbjct: 16  ILGQGATANVFRGRHKKT-GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74

Query: 133 Y--CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
                 + +++L+ +F   GSL+ VL       G      L  ++ + V      G+  L
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG------LPESEFLIVLRDVVGGMNHL 128

Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKS----KIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
            E     IVHR+++  N++           K+ DF    +  D   +  S  + GT  Y 
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LYGTEEYL 182

Query: 247 APE--------YAMTGQITQKSDVYSFGVVLLELLTGRKP-VDHTMPKGQQSL 290
            P+             +     D++S GV      TG  P      P+  + +
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 97.9 bits (244), Expect = 3e-23
 Identities = 45/226 (19%), Positives = 87/226 (38%), Gaps = 30/226 (13%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVELLG 132
           ++ EG +  V+ A+ +  G   A+K+L ++   E       ++  + +L  H + V+   
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 133 YCMESNNR-------ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
                           L+      G L + L   +          L+ +  +K+ Y   +
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP------LSCDTVLKIFYQTCR 147

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL----- 240
            ++ +H + +PPI+HRD++  N+LL +    K+ DF      S       S +       
Sbjct: 148 AVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 241 -----GTFGYHAPE---YAMTGQITQKSDVYSFGVVLLELLTGRKP 278
                 T  Y  PE         I +K D+++ G +L  L   + P
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 96.9 bits (242), Expect = 4e-23
 Identities = 57/234 (24%), Positives = 96/234 (41%), Gaps = 27/234 (11%)

Query: 54  EIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSS--APEPES 110
           EIP++ +D   R    +     +G+G + + F     D     A K +  S    P    
Sbjct: 3   EIPEVLVD--PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 60

Query: 111 DFAAQLSVVSRLKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGP 169
             + ++S+   L H+H V   G+  E N+ + +V +     SL ++   RK +   E   
Sbjct: 61  KMSMEISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPE--- 116

Query: 170 VLTWNQRVKVAY---GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ 226
                      Y       G ++LH      ++HRD++  N+ L +D + KI DF L  +
Sbjct: 117 ---------ARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATK 164

Query: 227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
                 R       GT  Y APE       + + DV+S G ++  LL G+ P +
Sbjct: 165 VEYDGERKKVL--CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 98.6 bits (245), Expect = 1e-22
 Identities = 50/229 (21%), Positives = 88/229 (38%), Gaps = 24/229 (10%)

Query: 64  NRLTSNFGTKALIGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSR 121
            +    +  K  +G G +G V     + T G   AIK+     +P+    +  ++ ++ +
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDT-GEQVAIKQCRQELSPKNRERWCLEIQIMKK 68

Query: 122 LKHEHFVELL------GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQ 175
           L H + V              ++  +L  ++   G L   L+  +   G      L    
Sbjct: 69  LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG------LKEGP 122

Query: 176 RVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS---KIADFNLTNQSSDTAA 232
              +    +  L +LHE     I+HRD++  N++L    +    KI D     +      
Sbjct: 123 IRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-- 177

Query: 233 RLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDH 281
            L +  V GT  Y APE     + T   D +SFG +  E +TG +P   
Sbjct: 178 ELCTEFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 98.4 bits (245), Expect = 1e-22
 Identities = 41/223 (18%), Positives = 80/223 (35%), Gaps = 31/223 (13%)

Query: 74  ALIGEGSYGRVFYAK--LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELL 131
             I  G  G ++ A     +G P  +K L  S   E ++   A+   ++ + H   V++ 
Sbjct: 86  GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 132 GYCMESNNRILVYQFATM-----GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKG 186
            +   ++       +  M      SL      +           L   + +         
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----------LPVAEAIAYLLEILPA 194

Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST-RVLGTFGY 245
           L +LH      +V+ D++  N++L ++ + K+ D           +R++S   + GT G+
Sbjct: 195 LSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA-------VSRINSFGYLYGTPGF 243

Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ 288
            APE       T  +D+Y+ G  L  L       +     G  
Sbjct: 244 QAPEIV-RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP 285

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 95.5 bits (238), Expect = 1e-22
 Identities = 61/248 (24%), Positives = 102/248 (41%), Gaps = 22/248 (8%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG G+   V  A         AIK+++         +   ++  +S+  H + V      
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82

Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
           +  +   LV +  + GS+ D++         + G  L  +    +     +GLE+LH+  
Sbjct: 83  VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-LDESTIATILREVLEGLEYLHKNG 141

Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADF----NLTNQSSDTAARLHSTRVLGTFGYHAPEY 250
           Q   +HRDV++ N+LL +D   +IADF     L      T  ++  T V GT  + APE 
Sbjct: 142 Q---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTPCWMAPEV 197

Query: 251 AMTGQITQ------KSDVYSFGVVLLELLTGRKPVDHTMP-KGQQSLVTWATPRLSEDKV 303
                + Q      K+D++SFG+  +EL TG  P     P K     +    P L     
Sbjct: 198 -----MEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ 252

Query: 304 KQCVDPKL 311
            + +  K 
Sbjct: 253 DKEMLKKY 260

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 96.3 bits (239), Expect = 2e-22
 Identities = 31/290 (10%), Positives = 60/290 (20%), Gaps = 42/290 (14%)

Query: 31  GSARGEPRTNVVKTGTPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAK-L 89
                      +         P          L++          +  G    VF  + +
Sbjct: 25  CREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDV 84

Query: 90  TDGTPAAIKKLDTSSAPEPES--DFAAQLSVVSRLKHEHFVELLGYC------------- 134
                 A+K     +                 +RL  E   E                  
Sbjct: 85  ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQS 144

Query: 135 -------------MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY 181
                            N +L+   A+   L  +      V                +  
Sbjct: 145 QPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV--YVFRGDEGILALHILTA 201

Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG 241
              +    L  K    +VH      N+ +  D +  + D +   +               
Sbjct: 202 QLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSV 253

Query: 242 TFGYHAPEYAM--TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQS 289
              Y   E+    T   T   + +  G+ +  +     P     P  + S
Sbjct: 254 PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 96.2 bits (239), Expect = 2e-22
 Identities = 39/355 (10%), Positives = 87/355 (24%), Gaps = 64/355 (18%)

Query: 5   GGQEEEPQPPASQTTAPPRSGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLDELN 64
           G +    Q P         +   Q       E   +   +           P     EL 
Sbjct: 10  GRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELG 69

Query: 65  RLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES------------- 110
                     ++G+        A     G    +     +  P   +             
Sbjct: 70  ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 129

Query: 111 --------------DFAAQLSVVSRLKHEHFVELLGYC--MESNNRILVYQFA--TMGSL 152
                          F     +V   + +  + +      M   +R  +Y      + + 
Sbjct: 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 189

Query: 153 HDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD 212
            +VL        +     L  + R+++     + L  LH      +VH  +R  +++L  
Sbjct: 190 GEVLLSHSSTHKS-----LVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQ 241

Query: 213 DFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-----------GQITQKSD 261
                +  F    +               + G+  PE                 +T   D
Sbjct: 242 RGGVFLTGFEHLVRDG------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFD 295

Query: 262 VYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ------CVDPK 310
            ++ G+V+  +     P+      G    +  +   + +  V+           +
Sbjct: 296 AWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQP-VRALLEGFLRYPKE 349

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 96.5 bits (240), Expect = 2e-22
 Identities = 52/233 (22%), Positives = 90/233 (38%), Gaps = 30/233 (12%)

Query: 75  LIGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           ++G+G+   VF    K T G   AIK  +  S   P      +  V+ +L H++ V+L  
Sbjct: 16  ILGQGATANVFRGRHKKT-GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74

Query: 133 Y--CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
                 + +++L+ +F   GSL+ VL       G      L  ++ + V      G+  L
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG------LPESEFLIVLRDVVGGMNHL 128

Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKS----KIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
            E     IVHR+++  N++           K+ DF    +  D   +  S  + GT  Y 
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LYGTEEYL 182

Query: 247 APE--------YAMTGQITQKSDVYSFGVVLLELLTGRKP-VDHTMPKGQQSL 290
            P+             +     D++S GV      TG  P      P+  + +
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 95.7 bits (238), Expect = 3e-22
 Identities = 45/217 (20%), Positives = 73/217 (33%), Gaps = 27/217 (12%)

Query: 76  IGEG--SYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQ-LSVVSRLKHEHFVELL 131
           IG+G      V  A+    G    +++++  +       F    L V     H + V   
Sbjct: 33  IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92

Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY---GAAKGLE 188
              +  N   +V  F   GS  D++         E            +AY   G  K L+
Sbjct: 93  ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNEL----------AIAYILQGVLKALD 142

Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL-----GTF 243
           ++H       VHR V++S++L+  D K  ++             R               
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199

Query: 244 GYHAPEYAMTGQI--TQKSDVYSFGVVLLELLTGRKP 278
            + +PE           KSD+YS G+   EL  G  P
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 95.2 bits (237), Expect = 3e-22
 Identities = 68/319 (21%), Positives = 121/319 (37%), Gaps = 48/319 (15%)

Query: 12  QPPASQTTAPPRSGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLDELNR-LTSNF 70
                     P + N    G+    P           +A  ++ P +            F
Sbjct: 5   HHHHHHDYDIPTTENLYFQGAMDPMPA--------GGRAGSLKDPDVAELFFKDDPEKLF 56

Query: 71  GTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPE--SDFAAQLSVVSRLKHEHF 127
                IG GS+G V++A+ + +    AIKK+  S     E   D   ++  + +L+H + 
Sbjct: 57  SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 116

Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
           ++  G  +  +   LV ++   GS  D+L   K          L   +   V +GA +GL
Sbjct: 117 IQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKP--------LQEVEIAAVTHGALQGL 167

Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS--DTAARLHSTRVLGTFGY 245
            +LH      ++HRDV++ N+LL +    K+ DF   +  +  ++         +GT  +
Sbjct: 168 AYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS--------FVGTPYW 216

Query: 246 HAPEYAMTGQITQ---KSDVYSFGVVLLELLTGRKPVDHTMP-KGQQSLVTWATPRLSED 301
            APE  +     Q   K DV+S G+  +EL   + P+ +         +    +P L   
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG 276

Query: 302 K--------VKQC--VDPK 310
                    V  C    P+
Sbjct: 277 HWSEYFRNFVDSCLQKIPQ 295

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 93.8 bits (234), Expect = 4e-22
 Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 29/212 (13%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQL----SVVSRLKHEHFVE 129
            +G+G +G V+ A+   +    A+K L  S   +       QL     + S L+H + + 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK--EGVEHQLRREIEIQSHLRHPNILR 78

Query: 130 LLGYCMESNNRI-LVYQFATMGSLHDVL--HGRKGVQGAEPGPVLTWNQRVKVAYGAAKG 186
           +  Y      RI L+ +FA  G L+  L  HGR               +        A  
Sbjct: 79  MYNY-FHDRKRIYLMLEFAPRGELYKELQKHGR-----------FDEQRSATFMEELADA 126

Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           L + HE+    ++HRD++  N+L+    + KIADF  +  +     R  +    GT  Y 
Sbjct: 127 LHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--RRRTM--CGTLDYL 179

Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            PE        +K D++  GV+  E L G  P
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 94.5 bits (235), Expect = 1e-21
 Identities = 43/238 (18%), Positives = 91/238 (38%), Gaps = 33/238 (13%)

Query: 64  NRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK 123
             L +   ++ ++G GS G V +     G P A+K++      +       ++ +++   
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML----IDFCDIALMEIKLLTESD 66

Query: 124 -HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            H + +             +  +     +L D++  +      E   +      + +   
Sbjct: 67  DHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKN--VSDENLKLQKEYNPISLLRQ 123

Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLL-------------FDDFKSKIADFNLTNQ--S 227
            A G+  LH      I+HRD++  N+L+              ++ +  I+DF L  +  S
Sbjct: 124 IASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 228 SDTAARLHSTRVLGTFGYHAPE-------YAMTGQITQKSDVYSFGVVLLELLTGRKP 278
             ++ R +     GT G+ APE            ++T+  D++S G V   +L+  K 
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 92.0 bits (228), Expect = 8e-21
 Identities = 28/265 (10%), Positives = 67/265 (25%), Gaps = 46/265 (17%)

Query: 74  ALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES---------------------- 110
            ++G+        A     G    +     +  P   +                      
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 111 -----DFAAQLSVVSRLKHEHFVELL--GYCMESNNRILVYQFA--TMGSLHDVLHGRKG 161
                 F     +V   + +  + +      M   +R  +Y      + +  +VL     
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 162 VQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADF 221
              +        + R+++     + L  LH      +VH  +R  +++L       +  F
Sbjct: 204 THKSLV-----HHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGF 255

Query: 222 NLTNQSSDTAARLHSTRVLGTFGYHAPE-----YAMTGQITQKSDVYSFGVVLLELLTGR 276
                    +A     R        A             +T   D ++ G+ +  +    
Sbjct: 256 EHL-VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

Query: 277 KPVDHTMPKGQQSLVTWATPRLSED 301
            P       G    +  +   + + 
Sbjct: 315 LPNTDDAALGGSEWIFRSCKNIPQP 339

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 86.6 bits (215), Expect = 2e-19
 Identities = 59/245 (24%), Positives = 100/245 (40%), Gaps = 53/245 (21%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLD---------------------TSSAPEPESDF 112
            IG+GSYG V  A    D T  A+K L                                 
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 113 AAQL----SVVSRLKHEHFVELLGYC-MESNNR---ILVYQFATMGSLHDVL-HGRKGVQ 163
             Q+    +++ +L H + V+L     ++  N     +V++    G + +V         
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP---- 133

Query: 164 GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL 223
                  L+ +Q         KG+E+LH +    I+HRD++ SN+L+ +D   KIADF +
Sbjct: 134 -------LSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGV 183

Query: 224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQIT---QKSDVYSFGVVLLELLTGRKP-V 279
           +N+   + A L +T   GT  + APE     +     +  DV++ GV L   + G+ P +
Sbjct: 184 SNEFKGSDALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241

Query: 280 DHTMP 284
           D  + 
Sbjct: 242 DERIM 246

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 87.8 bits (218), Expect = 3e-19
 Identities = 59/238 (24%), Positives = 93/238 (39%), Gaps = 21/238 (8%)

Query: 46  TPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSS 104
             Q  L          +   L+  +     +G G+YG V   +        AIK +  +S
Sbjct: 15  YFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS 74

Query: 105 -APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQ 163
            +    S    +++V+  L H + ++L  +  +  N  LV +    G L D +  R    
Sbjct: 75  VSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM--- 131

Query: 164 GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIAD 220
                          +      G+ +LH+     IVHRD++  N+LL     D   KI D
Sbjct: 132 ------KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVD 182

Query: 221 FNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           F L+    +          LGT  Y APE  +  +  +K DV+S GV+L  LL G  P
Sbjct: 183 FGLSAVFENQKKM---KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 86.7 bits (215), Expect = 6e-19
 Identities = 55/240 (22%), Positives = 97/240 (40%), Gaps = 22/240 (9%)

Query: 45  GTPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTS 103
           G+    L               +  +  + ++G+GS+G V   K    G   A+K +   
Sbjct: 3   GSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 62

Query: 104 --SAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKG 161
                  +     ++ ++ +L H + ++L  +  +     LV +  T G L D +  RK 
Sbjct: 63  QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK- 121

Query: 162 VQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKI 218
                     +     ++      G+ ++H+     IVHRD++  N+LL     D   +I
Sbjct: 122 --------RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRI 170

Query: 219 ADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            DF L+     +         +GT  Y APE  + G   +K DV+S GV+L  LL+G  P
Sbjct: 171 IDFGLSTHFEASKKM---KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 85.3 bits (211), Expect = 7e-19
 Identities = 43/171 (25%), Positives = 71/171 (41%), Gaps = 24/171 (14%)

Query: 119 VSRLKHEHFVELLGYCMESNNRILVY---QFATMGSLHDVLHGRKGVQGAEPGPVLTW-N 174
           + R+        +G    S+ ++ +Y   Q     +L D ++ R  ++  E G  L    
Sbjct: 112 IRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI 171

Query: 175 QRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL----------T 224
           Q        A+ +EFLH K    ++HRD++ SN+    D   K+ DF L           
Sbjct: 172 Q-------IAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221

Query: 225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTG 275
              +   A    T  +GT  Y +PE       + K D++S G++L ELL  
Sbjct: 222 TVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 46.4 bits (110), Expect = 7e-06
 Identities = 17/86 (19%), Positives = 34/86 (39%), Gaps = 1/86 (1%)

Query: 65  RLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK 123
           R  ++F     +G G +G VF AK   D    AIK++   +          ++  +++L+
Sbjct: 3   RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62

Query: 124 HEHFVELLGYCMESNNRILVYQFATM 149
           H   V      +E+       +   +
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEI 88

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 85.9 bits (213), Expect = 1e-18
 Identities = 56/259 (21%), Positives = 99/259 (38%), Gaps = 32/259 (12%)

Query: 36  EPRTNVVKTGTPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTP 94
               +  +     + + I        +  ++  ++     +G G+YG V   K     + 
Sbjct: 4   HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63

Query: 95  AAIKKLDTS------------SAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL 142
            AIK +  S            +  +   +   ++S++  L H + ++L     +     L
Sbjct: 64  KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL 123

Query: 143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRD 202
           V +F   G L + +  R                   +      G+ +LH+     IVHRD
Sbjct: 124 VTEFYEGGELFEQIINRH---------KFDECDAANIMKQILSGICYLHKH---NIVHRD 171

Query: 203 VRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQK 259
           ++  N+LL         KI DF L++  S    +L     LGT  Y APE  +  +  +K
Sbjct: 172 IKPENILLENKNSLLNIKIVDFGLSSFFSKDY-KLRD--RLGTAYYIAPE-VLKKKYNEK 227

Query: 260 SDVYSFGVVLLELLTGRKP 278
            DV+S GV++  LL G  P
Sbjct: 228 CDVWSCGVIMYILLCGYPP 246

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 83.8 bits (208), Expect = 1e-18
 Identities = 56/222 (25%), Positives = 87/222 (39%), Gaps = 42/222 (18%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
            +GEG+YG V  A         A+K +D   A +   +   ++ +   L HE+ V+  G 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG- 72

Query: 134 CMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK------- 185
                N   L  ++ + G L D +    G+   +                A +       
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD----------------AQRFFHQLMA 116

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD-TAARLHSTRVLGTFG 244
           G+ +LH      I HRD++  N+LL +    KI+DF L          RL +    GT  
Sbjct: 117 GVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLP 172

Query: 245 YHAPE------YAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
           Y APE      +       +  DV+S G+VL  +L G  P D
Sbjct: 173 YVAPELLKRREFH--A---EPVDVWSCGIVLTAMLAGELPWD 209

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 82.4 bits (204), Expect = 7e-18
 Identities = 56/222 (25%), Positives = 87/222 (39%), Gaps = 42/222 (18%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
            +GEG+YG V  A         A+K +D   A +   +   ++ +   L HE+ V+  G 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG- 72

Query: 134 CMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK------- 185
                N   L  ++ + G L D +    G+   +                A +       
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD----------------AQRFFHQLMA 116

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD-TAARLHSTRVLGTFG 244
           G+ +LH      I HRD++  N+LL +    KI+DF L          RL +    GT  
Sbjct: 117 GVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLP 172

Query: 245 YHAPE------YAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
           Y APE      +       +  DV+S G+VL  +L G  P D
Sbjct: 173 YVAPELLKRREFH--A---EPVDVWSCGIVLTAMLAGELPWD 209

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 81.1 bits (201), Expect = 1e-17
 Identities = 47/207 (22%), Positives = 84/207 (40%), Gaps = 16/207 (7%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           +G G++G V   +  + G    IK ++   +  P     A++ V+  L H + +++    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
            + +N  +V +    G L + +   +          L+     ++       L + H + 
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGK-----ALSEGYVAELMKQMMNALAYFHSQ- 143

Query: 195 QPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA 251
              +VH+D++  N+L          KI DF L            +    GT  Y APE  
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAA-GTALYMAPE-V 197

Query: 252 MTGQITQKSDVYSFGVVLLELLTGRKP 278
               +T K D++S GVV+  LLTG  P
Sbjct: 198 FKRDVTFKCDIWSAGVVMYFLLTGCLP 224

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 82.8 bits (205), Expect = 1e-17
 Identities = 55/219 (25%), Positives = 99/219 (45%), Gaps = 21/219 (9%)

Query: 65  RLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSS-APEPESDFAAQLSVVSRL 122
                +    ++G+GS+G V   K        A+K ++ +S   +  S    ++ ++ +L
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78

Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            H + ++L     +S++  +V +  T G L D +  RK           + +   ++   
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK---------RFSEHDAARIIKQ 129

Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRV 239
              G+ ++H+     IVHRD++  N+LL     D   KI DF L+        ++     
Sbjct: 130 VFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKD--R 183

Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           +GT  Y APE  + G   +K DV+S GV+L  LL+G  P
Sbjct: 184 IGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 39/224 (17%)

Query: 76  IGEGSYGRVFYAK--LTDGTPAAIKKLDTSSAPEPESDFAAQ-LSVVSRLKHEHFVELLG 132
           IG+G++ +V  A+  LT G   AIK +D +           + + ++  L H + V+L  
Sbjct: 23  IGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL-- 79

Query: 133 Y-CMESNNRI-LVYQFATMGSLHD--VLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
           +  +E+   + L+ ++A+ G + D  V HGR           +   +           ++
Sbjct: 80  FEVIETEKTLYLIMEYASGGEVFDYLVAHGR-----------MKEKEARSKFRQIVSAVQ 128

Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           + H+K    IVHRD+++ N+LL  D   KIADF  +N+ +            G   Y AP
Sbjct: 129 YCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV--GGKLDAFC-GAPPYAAP 182

Query: 249 E------YAMTGQITQKSDVYSFGVVLLELLTGRKP-VDHTMPK 285
           E      Y   G    + DV+S GV+L  L++G  P     + +
Sbjct: 183 ELFQGKKYD--G---PEVDVWSLGVILYTLVSGSLPFDGQNLKE 221

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 80.0 bits (198), Expect = 7e-17
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 35/219 (15%)

Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKL-DTSSAPEPESDFAAQ---------LSVVSRLKHE 125
           I  GSYG V     ++G P AIK++ +T S     +  +           + +++   H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89

Query: 126 HFVELLG----YCMESNNRI-LVYQFATMGS-LHDVLHGRKGVQGAEPGPVLTWNQRVKV 179
           + + L      +   + +++ LV +   M + L  V+H ++         V++  Q ++ 
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTEL--MRTDLAQVIHDQR--------IVIS-PQHIQY 138

Query: 180 -AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
             Y    GL  LHE     +VHRD+   N+LL D+    I DFNL  + +  A   + T 
Sbjct: 139 FMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTH 192

Query: 239 VLGTFGYHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGR 276
            +    Y APE  M  +  T+  D++S G V+ E+   +
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 78.4 bits (194), Expect = 9e-17
 Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 41/221 (18%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQL----SVVSRLKHEHFVE 129
            +G G++G+V   +    G   A+K L+         D   ++      +   +H H ++
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRS--LDVVGKIKREIQNLKLFRHPHIIK 75

Query: 130 LLGY-CMESNNRI-LVYQFATMGSLHD--VLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
           L  Y  + +     +V ++ + G L D    HGR           +   +  ++      
Sbjct: 76  L--YQVISTPTDFFMVMEYVSGGELFDYICKHGR-----------VEEMEARRLFQQILS 122

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
            +++ H      +VHRD++  NVLL     +KIADF L+N  SD    L ++   G+  Y
Sbjct: 123 AVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTS--CGSPNY 176

Query: 246 HAPE------YAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
            APE      YA  G    + D++S GV+L  LL G  P D
Sbjct: 177 AAPEVISGRLYA--G---PEVDIWSCGVILYALLCGTLPFD 212

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 79.3 bits (196), Expect = 9e-17
 Identities = 62/264 (23%), Positives = 99/264 (37%), Gaps = 26/264 (9%)

Query: 21  PPRSGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGS 80
              SG      +   +  ++V  +  P  A  +    I     + L+  F  ++ +G G+
Sbjct: 6   HHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGA 65

Query: 81  YGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNN 139
              V+  K      P A+K L  +     +     ++ V+ RL H + ++L         
Sbjct: 66  TSIVYRCKQKGTQKPYALKVLKKTVD---KKIVRTEIGVLLRLSHPNIIKLKEIFETPTE 122

Query: 140 RILVYQFATMGSLHD--VLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPP 197
             LV +  T G L D  V  G             +            + + +LHE     
Sbjct: 123 ISLVLELVTGGELFDRIVEKGY-----------YSERDAADAVKQILEAVAYLHEN---G 168

Query: 198 IVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
           IVHRD++  N+L      D   KIADF L+         L  T   GT GY APE     
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VLMKTVC-GTPGYCAPEILRGC 225

Query: 255 QITQKSDVYSFGVVLLELLTGRKP 278
               + D++S G++   LL G +P
Sbjct: 226 AYGPEVDMWSVGIITYILLCGFEP 249

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 79.9 bits (197), Expect = 1e-16
 Identities = 56/278 (20%), Positives = 104/278 (37%), Gaps = 28/278 (10%)

Query: 9   EEPQPPASQTTAPPRSGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLDELNRLTS 68
                P  +          + G   RG+   +               PQ    + + +  
Sbjct: 98  APVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLD 157

Query: 69  NFGTKALIGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEH 126
           ++     +G G++G V     + T G   A K + T    + E     ++  +S L+H  
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERAT-GNNFAAKFVMTPHESDKE-TVRKEIQTMSVLRHPT 215

Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKG 186
            V L     + N  +++Y+F + G L + +              ++ ++ V+      KG
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--------MSEDEAVEYMRQVCKG 267

Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKS--KIADFNLTNQSSDTAARLHSTRVL---- 240
           L  +HE      VH D++  N++      +  K+ DF L        A L   + +    
Sbjct: 268 LCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGL-------TAHLDPKQSVKVTT 317

Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           GT  + APE A    +   +D++S GV+   LL+G  P
Sbjct: 318 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 78.7 bits (194), Expect = 1e-16
 Identities = 51/246 (20%), Positives = 79/246 (32%), Gaps = 47/246 (19%)

Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPES----DFAAQLSVVSRLKHEHFVE 129
           IG+GSYG V  A    T     AIK ++ +   +           ++ ++ +L H +   
Sbjct: 34  IGQGSYGVVRVAIENQT-RAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92

Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG------- 182
           L     +     LV +    G L D L+        +    +   Q              
Sbjct: 93  LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152

Query: 183 -----------------AAK-------GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS-- 216
                             +         L +LH +    I HRD++  N L   +     
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEI 209

Query: 217 KIADFNLTN--QSSDTAARLHSTRVLGTFGYHAPE--YAMTGQITQKSDVYSFGVVLLEL 272
           K+ DF L+      +       T   GT  + APE           K D +S GV+L  L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269

Query: 273 LTGRKP 278
           L G  P
Sbjct: 270 LMGAVP 275

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 77.4 bits (191), Expect = 3e-16
 Identities = 41/221 (18%), Positives = 83/221 (37%), Gaps = 33/221 (14%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIK-----KLDTSSAPEPESDFAAQLSVVSRLKHE--H 126
           L+G G +G V+    ++D  P AIK     ++         +    ++ ++ ++      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 127 FVELLGYCMESNNRI-LVYQFAT-MGSLHD--VLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            + LL +  E  +   L+ +    +  L D     G            L         + 
Sbjct: 110 VIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGA-----------LQEELARSFFWQ 157

Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLHSTRVLG 241
             + +   H      ++HRD++  N+L+  +    K+ DF       DT          G
Sbjct: 158 VLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDF--DG 210

Query: 242 TFGYHAPEYAMTGQIT-QKSDVYSFGVVLLELLTGRKPVDH 281
           T  Y  PE+    +   + + V+S G++L +++ G  P +H
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 77.1 bits (190), Expect = 6e-16
 Identities = 56/271 (20%), Positives = 107/271 (39%), Gaps = 37/271 (13%)

Query: 16  SQTTAPPRSGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLDELNRLTSNFGTKAL 75
               +  R     P  +   +   ++ K   PQ   P+E+ Q        +   +     
Sbjct: 8   HHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQ---PVEVKQ------GSVYDYYDILEE 58

Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +G G++G V     K T G     K ++T    +       ++S++++L H   + L   
Sbjct: 59  LGSGAFGVVHRCVEKAT-GRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPKLINLHDA 116

Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             +    +L+ +F + G L D +        A     ++  + +     A +GL+ +HE 
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRI--------AAEDYKMSEAEVINYMRQACEGLKHMHEH 168

Query: 194 VQPPIVHRDVRSSNVLLFDDFKS--KIADFNLTNQSSDTAARLHSTRVL----GTFGYHA 247
               IVH D++  N++      S  KI DF L       A +L+   ++     T  + A
Sbjct: 169 ---SIVHLDIKPENIMCETKKASSVKIIDFGL-------ATKLNPDEIVKVTTATAEFAA 218

Query: 248 PEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           PE      +   +D+++ GV+   LL+G  P
Sbjct: 219 PEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 76.5 bits (189), Expect = 7e-16
 Identities = 54/227 (23%), Positives = 92/227 (40%), Gaps = 43/227 (18%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTS---SAPEPESDFAAQLSVVSRLKHEHFVEL 130
           L+GEGSYG+V            A+K L        P  E++   ++ ++ RL+H++ ++L
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 131 LG-YCMESNNRI-LVYQFATMGS--LHD-VLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
           +     E   ++ +V ++   G   + D V   R               Q       A  
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-----------FPVCQ-------AHG 113

Query: 186 -------GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA--RLHS 236
                  GLE+LH +    IVH+D++  N+LL      KI+   +       AA     +
Sbjct: 114 YFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170

Query: 237 TRVLGTFGYHAPEYAMTGQI--TQKSDVYSFGVVLLELLTGRKPVDH 281
           ++  G+  +  PE A         K D++S GV L  + TG  P + 
Sbjct: 171 SQ--GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 77.1 bits (190), Expect = 7e-16
 Identities = 51/226 (22%), Positives = 92/226 (40%), Gaps = 46/226 (20%)

Query: 76  IGEGSYGRVFYAK---LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           +G G+YG V+ AK     D    A+K+++ +           +++++  LKH + + L  
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS---MSACREIALLRELKHPNVISLQK 85

Query: 133 YCMESNNRI--LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
             +   +R   L++ +A    L  ++   +  +  +    L       + Y    G+ +L
Sbjct: 86  VFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKS----KIADFNLTNQSSDTAARL---------HST 237
           H      ++HRD++ +N+L+  +       KIAD           ARL            
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF--------ARLFNSPLKPLADLD 193

Query: 238 RVLGTFGYHAPE-------YAMTGQITQKSDVYSFGVVLLELLTGR 276
            V+ TF Y APE       Y  T  I    D+++ G +  ELLT  
Sbjct: 194 PVVVTFWYRAPELLLGARHY--TKAI----DIWAIGCIFAELLTSE 233

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 77.4 bits (191), Expect = 7e-16
 Identities = 55/243 (22%), Positives = 90/243 (37%), Gaps = 40/243 (16%)

Query: 57  QIKLDELNRLTSNFGTK----ALIGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPES 110
            + +D+ +        +      +G G+ G V  A  + T     AI+ +         +
Sbjct: 120 DLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKT-CKKVAIRIISKRKFAIGSA 178

Query: 111 DFAAQLSVVSR-------LKHEHFVELLGYCMESNNRILVYQFATMGSLHD--VLHGRKG 161
             A     V         L H   +++  +  ++ +  +V +    G L D  V + R  
Sbjct: 179 READPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKR-- 235

Query: 162 VQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKI 218
                    L         Y     +++LHE     I+HRD++  NVLL    +D   KI
Sbjct: 236 ---------LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283

Query: 219 ADFNLTNQSSDTAARLHSTRVLGTFGYHAPE---YAMTGQITQKSDVYSFGVVLLELLTG 275
            DF  +    +T+  L  T   GT  Y APE      T    +  D +S GV+L   L+G
Sbjct: 284 TDFGHSKILGETS--LMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

Query: 276 RKP 278
             P
Sbjct: 341 YPP 343

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 57/280 (20%), Positives = 107/280 (38%), Gaps = 30/280 (10%)

Query: 8   EEEPQPPASQTTAPPRSGNTQPGGSARGE-PRTNVVKTGTPQKALPIEIPQIKLDELNRL 66
           +++ +   ++      + +       + +      V    P       I   K   +N  
Sbjct: 29  DQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSF 88

Query: 67  TSNFGTKALIGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKH 124
                   ++G G +G+V       T G   A K + T    + E +   ++SV+++L H
Sbjct: 89  Y-TVSKTEILGGGRFGQVHKCEETAT-GLKLAAKIIKTRGMKDKE-EVKNEISVMNQLDH 145

Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            + ++L       N+ +LV ++   G L D +         +    LT    +       
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRI--------IDESYNLTELDTILFMKQIC 197

Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLF--DDFKSKIADFNLTNQSSDTAARLHSTRVL-- 240
           +G+  +H+     I+H D++  N+L    D  + KI DF L       A R      L  
Sbjct: 198 EGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGL-------ARRYKPREKLKV 247

Query: 241 --GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
             GT  + APE      ++  +D++S GV+   LL+G  P
Sbjct: 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 53/292 (18%), Positives = 93/292 (31%), Gaps = 36/292 (12%)

Query: 5   GGQEEEPQPPASQTTAPPRSGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLDELN 64
               E+ +         P         + +              +++  E          
Sbjct: 31  NLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAK 90

Query: 65  RLTSNFGTKALIGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSR- 121
                +  K +IG G    V     + T G   A+K ++ ++                R 
Sbjct: 91  EFYQKYDPKDVIGRGVSSVVRRCVHRAT-GHEFAVKIMEVTAERLSPEQLEEVREATRRE 149

Query: 122 ---LK----HEHFVELLGYCMESNNRILVYQFATMGSLHD--VLHGRKGVQGAEPGPVLT 172
              L+    H H + L+     S+   LV+     G L D                  L+
Sbjct: 150 THILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA-----------LS 198

Query: 173 WNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA 232
             +   +     + + FLH      IVHRD++  N+LL D+ + +++DF  +        
Sbjct: 199 EKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-- 253

Query: 233 RLHSTRVLGTFGYHAPE------YAMTGQITQKSDVYSFGVVLLELLTGRKP 278
                   GT GY APE              ++ D+++ GV+L  LL G  P
Sbjct: 254 EKLRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 55/293 (18%), Positives = 90/293 (30%), Gaps = 83/293 (28%)

Query: 54  EIP--QIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTD------GTPAAIKKLDTSSA 105
           E P  ++KL +             +G G++G+V  A              A+K L   + 
Sbjct: 18  EFPRDRLKLGKP------------LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT 65

Query: 106 PEPESDFAA----------------QLSVVSRLKHEHFV--------ELLGYCMESNNRI 141
                   +                 L   ++      V         L  Y     N  
Sbjct: 66  HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 125

Query: 142 LVYQFAT---------MGSLHDVLHGR--------------------------KGVQGAE 166
           + Y+            +G++   L  R                          +      
Sbjct: 126 VPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDL 185

Query: 167 PGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ 226
               LT    +  ++  AKG+EFL  +     +HRD+ + N+LL +    KI DF L   
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD 242

Query: 227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKP 278
                  +          + APE       T +SDV+SFGV+L E+ + G  P
Sbjct: 243 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 74.4 bits (183), Expect = 2e-15
 Identities = 30/210 (14%), Positives = 53/210 (25%), Gaps = 50/210 (23%)

Query: 74  ALIGEGSYGRVFYAKLTD---GTPAAIKKLDTSSAPEPE--SDFAAQLSVVSRLKHEHFV 128
              G     + + A   D       A+  +D       +   +  ++   +SR+      
Sbjct: 37  IFHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94

Query: 129 ELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            +L         ++V ++   GSL +V           P PV      ++     A   +
Sbjct: 95  RVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-------PSPV----GAIRAMQSLAAAAD 143

Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
             H      +       S V +  D                         VL        
Sbjct: 144 AAHRA---GVALSIDHPSRVRVSID----------------------GDVVLAYPATMPD 178

Query: 249 EYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
                     + D+   G  L  LL  R P
Sbjct: 179 A-------NPQDDIRGIGASLYALLVNRWP 201

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 74.5 bits (184), Expect = 2e-15
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 25/220 (11%)

Query: 65  RLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK 123
            +   F    ++G G++  VF  K    G   A+K +  S A         +++V+ ++K
Sbjct: 6   NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDS-SLENEIAVLKKIK 64

Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHD--VLHGRKGVQGAEPGPVLTWNQRVKVAY 181
           HE+ V L      + +  LV Q  + G L D  +  G             T      V  
Sbjct: 65  HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGV-----------YTEKDASLVIQ 113

Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTR 238
                +++LHE     IVHRD++  N+L     ++ K  I DF L+    +       + 
Sbjct: 114 QVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----ST 166

Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
             GT GY APE       ++  D +S GV+   LL G  P
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 74.7 bits (184), Expect = 3e-15
 Identities = 46/244 (18%), Positives = 78/244 (31%), Gaps = 39/244 (15%)

Query: 56  PQIKLDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAA 114
           P     +     + +    L+G+G +G VF    LTD    AIK +  +          +
Sbjct: 19  PPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPL--S 76

Query: 115 QLSVVSR-----------LKHEHFVELLGYCMESNNRI-LVYQFATMGS-LHD--VLHGR 159
                               H   + LL +  E+     LV +       L D     G 
Sbjct: 77  DSVTCPLEVALLWKVGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGP 135

Query: 160 KGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKI 218
                      L               ++  H +    +VHRD++  N+L+      +K+
Sbjct: 136 -----------LGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKL 181

Query: 219 ADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQIT-QKSDVYSFGVVLLELLTGRK 277
            DF       D           GT  Y  PE+    Q     + V+S G++L +++ G  
Sbjct: 182 IDFGSGALLHDEP--YTDF--DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI 237

Query: 278 PVDH 281
           P + 
Sbjct: 238 PFER 241

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 74.6 bits (184), Expect = 3e-15
 Identities = 65/221 (29%), Positives = 101/221 (45%), Gaps = 42/221 (19%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQL----SVVSRLKHEHFVE 129
            +GEGS+G+V  A         A+K +      +  SD   ++    S +  L+H H ++
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK--SDMHMRVEREISYLKLLRHPHIIK 73

Query: 130 LLGY-CMESNNRI-LVYQFATMGSLHD--VLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
           L  Y  + +   I +V ++A  G L D  V   R           +T ++  +       
Sbjct: 74  L--YDVITTPTDIVMVIEYAG-GELFDYIVEKKR-----------MTEDEGRRFFQQIIC 119

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
            +E+ H      IVHRD++  N+LL D+   KIADF L+N  +D    L ++   G+  Y
Sbjct: 120 AIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-GNFLKTS--CGSPNY 173

Query: 246 HAPE------YAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
            APE      YA  G    + DV+S G+VL  +L GR P D
Sbjct: 174 AAPEVINGKLYA--G---PEVDVWSCGIVLYVMLVGRLPFD 209

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 74.4 bits (183), Expect = 4e-15
 Identities = 47/223 (21%), Positives = 83/223 (37%), Gaps = 41/223 (18%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLD---TSSAPEPESDFAAQL----SVVSRLKHEHF 127
           +G G++G V+ A          +K +           E     ++    +++SR++H + 
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 128 VELLGYCMESNNRI-LVYQFATMGS-LHD--VLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
           +++L    E+     LV +    G  L      H R           L       +    
Sbjct: 92  IKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPR-----------LDEPLASYIFRQL 139

Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTF 243
              + +L  K    I+HRD++  N+++ +DF  K+ DF           +L  T   GT 
Sbjct: 140 VSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER--GKLFYTFC-GTI 193

Query: 244 GYHAPE------YAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
            Y APE      Y   G    + +++S GV L  L+    P  
Sbjct: 194 EYCAPEVLMGNPYR--G---PELEMWSLGVTLYTLVFEENPFC 231

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 73.8 bits (182), Expect = 4e-15
 Identities = 46/209 (22%), Positives = 82/209 (39%), Gaps = 25/209 (11%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           IG GS+G V  A         A KK+      + +  F  ++ ++  L H + + L    
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD-RFKQEIEIMKSLDHPNIIRLYETF 75

Query: 135 MESNNRILVYQFATMGSLHD--VLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
            ++ +  LV +  T G L +  V                  +   ++       + + H+
Sbjct: 76  EDNTDIYLVMELCTGGELFERVVHKRV-----------FRESDAARIMKDVLSAVAYCHK 124

Query: 193 KVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE 249
                + HRD++  N L      D   K+ DF L  +      ++  T+V GT  Y +P+
Sbjct: 125 L---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKV-GTPYYVSPQ 178

Query: 250 YAMTGQITQKSDVYSFGVVLLELLTGRKP 278
             + G    + D +S GV++  LL G  P
Sbjct: 179 -VLEGLYGPECDEWSAGVMMYVLLCGYPP 206

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 74.8 bits (184), Expect = 6e-15
 Identities = 56/232 (24%), Positives = 94/232 (40%), Gaps = 26/232 (11%)

Query: 57  QIKLDELNRLT-SNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAA 114
           Q K  E   +    F    ++G G +G VF  ++   G   A KKL+     +    +  
Sbjct: 173 QWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK-RKGYQG 231

Query: 115 QLS---VVSRLKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQG--AEPG 168
            +    +++++    F+  L Y  E+   + LV      G +   ++          EP 
Sbjct: 232 AMVEKKILAKVHS-RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP- 289

Query: 169 PVLTWNQRVKVAYGA--AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ 226
                  R    Y A    GLE LH++    I++RD++  NVLL DD   +I+D  L  +
Sbjct: 290 -------RAIF-YTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVE 338

Query: 227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
                 +       GT G+ APE  +  +     D ++ GV L E++  R P
Sbjct: 339 LKAGQTKTK-GYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 72.6 bits (179), Expect = 1e-14
 Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 25/221 (11%)

Query: 65  RLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSS-APEPESDFAAQLSVVSRL 122
                +    ++G+GS+G V   K        A+K ++ +S   +  S    ++ ++ +L
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78

Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHD--VLHGRKGVQGAEPGPVLTWNQRVKVA 180
            H + ++L     +S++  +V +  T G L D  +   R            + +   ++ 
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-----------FSEHDAARII 127

Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHST 237
                G+ ++H+     IVHRD++  N+LL     D   KI DF L+             
Sbjct: 128 KQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKD 182

Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           R+ GT  Y APE  + G   +K DV+S GV+L  LL+G  P
Sbjct: 183 RI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 41/221 (18%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQL----SVVSRLKHEHFVE 129
            +G G++G+V   K    G   A+K L+         D   ++      +   +H H ++
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRS--LDVVGKIRREIQNLKLFRHPHIIK 80

Query: 130 LLGY-CMESNNRI-LVYQFATMGSLHD--VLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
           L  Y  + + + I +V ++ + G L D    +GR      E      + Q +        
Sbjct: 81  L--YQVISTPSDIFMVMEYVSGGELFDYICKNGRL----DEKESRRLFQQILS------- 127

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           G+++ H  +   +VHRD++  NVLL     +KIADF L+N  SD    L ++   G+  Y
Sbjct: 128 GVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTS--CGSPNY 181

Query: 246 HAPE------YAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
            APE      YA  G    + D++S GV+L  LL G  P D
Sbjct: 182 AAPEVISGRLYA--G---PEVDIWSSGVILYALLCGTLPFD 217

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 73.8 bits (181), Expect = 2e-14
 Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 29/221 (13%)

Query: 68  SNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQ-----LSVVSR 121
           ++F    +IG G +G V+  +  D G   A+K LD       + +  A      LS+VS 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 122 LKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
                F+  + Y   + +++  +      G LH   H  +    +E          ++  
Sbjct: 249 GDC-PFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEA--------DMRF- 296

Query: 181 YGA--AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
           Y A    GLE +H +    +V+RD++ +N+LL +    +I+D  L    S          
Sbjct: 297 YAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---AS 350

Query: 239 VLGTFGYHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKP 278
           V GT GY APE    G     S D +S G +L +LL G  P
Sbjct: 351 V-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 71.9 bits (177), Expect = 3e-14
 Identities = 55/220 (25%), Positives = 83/220 (37%), Gaps = 36/220 (16%)

Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSR-------LKHEH 126
           +G G+ G V  A  + T     AIK +         +  A     V         L H  
Sbjct: 18  LGSGACGEVKLAFERKT-CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 127 FVELLGYCMESNNRILVYQFATMGSLHD--VLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            +++  +  ++ +  +V +    G L D  V + R           L         Y   
Sbjct: 77  IIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR-----------LKEATCKLYFYQML 124

Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTRVLG 241
             +++LHE     I+HRD++  NVLL    +D   KI DF  +    +T   L  T   G
Sbjct: 125 LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLC-G 178

Query: 242 TFGYHAPE---YAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           T  Y APE      T    +  D +S GV+L   L+G  P
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 62/232 (26%), Positives = 96/232 (41%), Gaps = 29/232 (12%)

Query: 57  QIKLDELNRLT-SNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAA 114
           Q K  E   +T + F    ++G+G +G V   ++   G   A KKL+     +     A 
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAM 230

Query: 115 QLS---VVSRLKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPV 170
            L+   ++ ++    FV  L Y  E+ + + LV      G L   ++        E    
Sbjct: 231 ALNEKQILEKVNS-RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA--- 286

Query: 171 LTWNQRVKVAYGA--AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT--NQ 226
                R    Y A    GLE LH +    IV+RD++  N+LL D    +I+D  L     
Sbjct: 287 -----RAVF-YAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337

Query: 227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
              T       RV GT GY APE     + T   D ++ G +L E++ G+ P
Sbjct: 338 EGQTI----KGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 50/226 (22%), Positives = 86/226 (38%), Gaps = 53/226 (23%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
            IG G++G     +        A+K ++  +A +   +   ++     L+H + V     
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIERGAAID--ENVQREIINHRSLRHPNIVRF--K 82

Query: 134 -CMESNNRI-LVYQFATMGSLHD--VLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK---- 185
             + +   + ++ ++A+ G L++     GR      E                A      
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERICNAGR--FSEDE----------------ARFFFQQ 124

Query: 186 ---GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS--KIADFNLTNQSSDTAARLHSTRVL 240
              G+ + H      I HRD++  N LL        KI DF  +  S    ++  ST  +
Sbjct: 125 LLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKST--V 178

Query: 241 GTFGYHAPE------YAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
           GT  Y APE      Y   G+    +DV+S GV L  +L G  P +
Sbjct: 179 GTPAYIAPEVLLRQEYD--GK---IADVWSCGVTLYVMLVGAYPFE 219

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 46/220 (20%), Positives = 80/220 (36%), Gaps = 21/220 (9%)

Query: 65  RLTSNFGTKALIGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPE-SDFAAQLSVVSR 121
           R T  +     +G+G++  V      L  G   A   ++T      +      +  +   
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLA-GQEYAAMIINTKKLSARDHQKLEREARICRL 66

Query: 122 LKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY 181
           LKH + V L     E  +  L++   T G L + +  R+           +         
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE---------YYSEADASHCIQ 117

Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSDTAARLHSTR 238
              + +   H+     +VHR+++  N+LL         K+ADF L  +            
Sbjct: 118 QILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-- 172

Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
             GT GY +PE        +  D+++ GV+L  LL G  P
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 42/217 (19%)

Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEP-ESDFAAQ-----LSVVSRLKHEHFV 128
           +G G+YG V  A  T  G   A+KKL       P +S   A+     L ++  +KHE+ +
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL-----SRPFQSIIHAKRTYRELRLLKHMKHENVI 91

Query: 129 ELL-----GYCMESNNRI-LVYQFATMGS-LHDVLHGRKGVQGAEPGPVLTWNQRVK-VA 180
            LL        +E  N + LV     MG+ L++++  +K          LT +  V+ + 
Sbjct: 92  GLLDVFTPARSLEEFNDVYLVTHL--MGADLNNIVKCQK----------LT-DDHVQFLI 138

Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           Y   +GL+++H      I+HRD++ SN+ + +D + KI DF L   ++D      +TR  
Sbjct: 139 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW- 194

Query: 241 GTFGYHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGR 276
               Y APE  +      Q  D++S G ++ ELLTGR
Sbjct: 195 ----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 65/279 (23%), Positives = 111/279 (39%), Gaps = 31/279 (11%)

Query: 7   QEEEPQPPASQTTAPPRSGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLDELNRL 66
           +E E    A QT A             R    ++       + +L     ++ ++     
Sbjct: 94  EEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMN----- 148

Query: 67  TSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIK---KLDTSSAPEPESDFAAQLSVVSRL 122
              F    L+G+G++G+V   K    G   A+K   K    +  E          V+   
Sbjct: 149 --EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN-RVLQNS 205

Query: 123 KHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY 181
           +H  F+  L Y  ++++R+  V ++A  G L    H  +    +E         R +  Y
Sbjct: 206 RH-PFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSED--------RARF-Y 253

Query: 182 GA--AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRV 239
           GA     L++LH +    +V+RD++  N++L  D   KI DF L  +     A + +   
Sbjct: 254 GAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--F 309

Query: 240 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            GT  Y APE        +  D +  GVV+ E++ GR P
Sbjct: 310 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 60/248 (24%), Positives = 94/248 (37%), Gaps = 22/248 (8%)

Query: 45  GTPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYA--KLTDGTPAAIK---- 98
           G+P  +          D+       +    +IG+G +  V     + T G   A+K    
Sbjct: 1   GSPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRET-GQQFAVKIVDV 59

Query: 99  -KLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLH 157
            K  +S     E D   + S+   LKH H VELL          +V++F     L   + 
Sbjct: 60  AKFTSSPGLSTE-DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEI- 117

Query: 158 GRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS- 216
               V+ A+ G V +            + L + H+     I+HRDV+   VLL     S 
Sbjct: 118 ----VKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSA 170

Query: 217 --KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT 274
             K+  F +  Q  ++         +GT  + APE        +  DV+  GV+L  LL+
Sbjct: 171 PVKLGGFGVAIQLGESGLVAGG--RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS 228

Query: 275 GRKPVDHT 282
           G  P   T
Sbjct: 229 GCLPFYGT 236

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 68.9 bits (169), Expect = 3e-13
 Identities = 53/220 (24%), Positives = 91/220 (41%), Gaps = 48/220 (21%)

Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQ-----LSVVSRLKHEHFVE 129
           IG G+ G V  A         AIKKL  S   + ++   A+     L ++  + H++ + 
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTH--AKRAYRELVLMKCVNHKNIIG 88

Query: 130 LL-----GYCMESNNRI-LVYQFATMGS-LHDVLHGRKGVQGAEPGPVLTWNQRVK-VAY 181
           LL        +E    + +V +   M + L  V+              L  ++R+  + Y
Sbjct: 89  LLNVFTPQKSLEEFQDVYIVMEL--MDANLCQVIQME-----------LD-HERMSYLLY 134

Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG 241
               G++ LH      I+HRD++ SN+++  D   KI DF L        AR   T  + 
Sbjct: 135 QMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL--------ARTAGTSFMM 183

Query: 242 TFG-----YHAPEYAMTGQITQKSDVYSFGVVLLELLTGR 276
           T       Y APE  +     +  D++S G ++ E++ G 
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 68.1 bits (167), Expect = 6e-13
 Identities = 50/229 (21%), Positives = 92/229 (40%), Gaps = 22/229 (9%)

Query: 56  PQIKLDELNRLTSNFGTKALIGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPE-SDF 112
            +  ++   + + N+  K  +G+G++  V     K T G   A K ++T      +    
Sbjct: 17  SEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTT-GLEFAAKIINTKKLSARDFQKL 75

Query: 113 AAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLT 172
             +  +  +L+H + V L     E +   LV+   T G L + +  R+           +
Sbjct: 76  EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---------FYS 126

Query: 173 WNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNLTNQSSD 229
                       + + + H      IVHR+++  N+LL         K+ADF L  + +D
Sbjct: 127 EADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183

Query: 230 TAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           +          GT GY +PE       ++  D+++ GV+L  LL G  P
Sbjct: 184 S--EAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 68.1 bits (167), Expect = 6e-13
 Identities = 50/213 (23%), Positives = 87/213 (40%), Gaps = 33/213 (15%)

Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAA-QLSVVSRLKHEHFVELLGYC 134
           IG GS+G VF AKL +    AIKK+        +  F   +L ++  +KH + V+L  + 
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKV------LQDKRFKNRELQIMRIVKHPNVVDLKAFF 101

Query: 135 MESNNRI------LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKV-AYGAAKGL 187
             + ++       LV ++    +++        ++   P         +K+  Y   + L
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP------MLLIKLYMYQLLRSL 154

Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLH--STRVLGTFG 244
            ++H      I HRD++  N+LL       K+ DF            +    +R      
Sbjct: 155 AYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY----- 206

Query: 245 YHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGR 276
           Y APE        T   D++S G V+ EL+ G+
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 68.6 bits (168), Expect = 6e-13
 Identities = 69/286 (24%), Positives = 102/286 (35%), Gaps = 67/286 (23%)

Query: 14  PASQTTAPPRSGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLDELNRLTSNFGTK 73
                  P   G+ +      G   T VV T       P E+             ++   
Sbjct: 13  SCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEV-------------SYTDT 59

Query: 74  ALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAA-QLSVVSRLKHEHFVELL 131
            +IG GS+G V+ AKL D G   AIKK+        +  F   +L ++ +L H + V L 
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLR 113

Query: 132 GYCMESNNRI-------LVYQFATMGS-LHDVLHGRKGVQGAEPGPVLTWNQRVKV-AYG 182
            Y   S+          LV  +  +   ++ V       +   P         VK+  Y 
Sbjct: 114 -YFFYSSGEKKDEVYLNLVLDY--VPETVYRVARHYSRAKQTLP------VIYVKLYMYQ 164

Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS-KIADFNLTNQSSDTAARLHS----- 236
             + L ++H      I HRD++  N+LL  D    K+ DF          A+        
Sbjct: 165 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS--------AKQLVRGEPN 213

Query: 237 -----TRVLGTFGYHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGR 276
                +R      Y APE        T   DV+S G VL ELL G+
Sbjct: 214 VSYICSRY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 67.6 bits (166), Expect = 7e-13
 Identities = 38/222 (17%), Positives = 79/222 (35%), Gaps = 29/222 (13%)

Query: 65  RLTSNFGTKALIGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
            L   +     +G G +G V       +       K +        +     ++S+++  
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSS-KKTYMAKFVKVK--GTDQVLVKKEISILNIA 58

Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
           +H + + L          +++++F +   + + +              L   + V   + 
Sbjct: 59  RHRNILHLHESFESMEELVMIFEFISGLDIFERI--------NTSAFELNEREIVSYVHQ 110

Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS--KIADFNLTNQSSDTAARLHSTRVL 240
             + L+FLH      I H D+R  N++      S  KI +F         A +L      
Sbjct: 111 VCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQ-------ARQLKPGDNF 160

Query: 241 ----GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
                   Y+APE      ++  +D++S G ++  LL+G  P
Sbjct: 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 67.7 bits (166), Expect = 9e-13
 Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 43/217 (19%)

Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEP-ESDFAAQ-----LSVVSRLKHEHFV 128
           +G G+YG V  A     G   AIKKL       P +S+  A+     L ++  ++HE+ +
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKL-----SRPFQSEIFAKRAYRELLLLKHMQHENVI 86

Query: 129 ELL-----GYCMESNNRI-LVYQFATMGS-LHDVLHGRKGVQGAEPGPVLTWNQRVK-VA 180
            LL        + +     LV  F  M + L  ++  +            +  ++++ + 
Sbjct: 87  GLLDVFTPASSLRNFYDFYLVMPF--MQTDLQKIMGLK-----------FS-EEKIQYLV 132

Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           Y   KGL+++H      +VHRD++  N+ + +D + KI DF L   +         TR  
Sbjct: 133 YQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW- 188

Query: 241 GTFGYHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGR 276
               Y APE  ++     Q  D++S G ++ E+LTG+
Sbjct: 189 ----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 66.8 bits (164), Expect = 1e-12
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 26/208 (12%)

Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESD---FAA--QLSVVSRLKHEHFVEL 130
           +GEG+YG V+ AK + G   A+K++      + E +     A  ++S++  L H + V L
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRL----DAEDEGIPSTAIREISLLKELHHPNIVSL 84

Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
           +          LV++F       D+    K V        L  +Q     Y   +G+   
Sbjct: 85  IDVIHSERCLTLVFEFME----KDL----KKVLDENKTG-LQDSQIKIYLYQLLRGVAHC 135

Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEY 250
           H+     I+HRD++  N+L+  D   K+ADF L         R ++  V+ T  Y AP+ 
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TLWYRAPDV 190

Query: 251 AMTGQITQKS--DVYSFGVVLLELLTGR 276
            M G     +  D++S G +  E++TG+
Sbjct: 191 LM-GSKKYSTSVDIWSIGCIFAEMITGK 217

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 37/220 (16%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPE--PESDFAA--QLSVVSRLKHEHFVEL 130
           IG+G++G VF A+    G   A+KK+   +  E  P     A  ++ ++  LKHE+ V L
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP---ITALREIKILQLLKHENVVNL 81

Query: 131 LGYCMESNNRILVYQFATMGSLHDVL----HGRKGVQGAEPGPVLTWNQRVKVAYGAAKG 186
           +  C    +          GS++ V     H   G+  +      T ++  +V      G
Sbjct: 82  IEICRTKASP----YNRCKGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNG 136

Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT---NQSSDTAARLHSTRVLGTF 243
           L ++H      I+HRD++++NVL+  D   K+ADF L    + + ++    ++ RV+ T 
Sbjct: 137 LYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-TL 192

Query: 244 GYHAPE-------YAMTGQITQKSDVYSFGVVLLELLTGR 276
            Y  PE       Y     I    D++  G ++ E+ T  
Sbjct: 193 WYRPPELLLGERDY--GPPI----DLWGAGCIMAEMWTRS 226

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 44/229 (19%), Positives = 84/229 (36%), Gaps = 35/229 (15%)

Query: 65  RLTSNFGTKALIGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQ-----LS 117
           ++   +     +G G +  V     K T G   A K +    +         +     +S
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKST-GLEYAAKFIKKRQSRASRRGVCREEIEREVS 67

Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV 177
           ++ ++ H + + L        + +L+ +  + G L D L  ++          L+  +  
Sbjct: 68  ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE---------SLSEEEAT 118

Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL----FDDFKSKIADFNLTNQSSDTAAR 233
                   G+ +LH K    I H D++  N++L          K+ DF L       A  
Sbjct: 119 SFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL-------AHE 168

Query: 234 LHSTRVL----GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           +          GT  + APE      +  ++D++S GV+   LL+G  P
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 66.0 bits (162), Expect = 2e-12
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 25/210 (11%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPE--PESDFAA--QLSVVSRLKHEHFVEL 130
           IGEG+YG VF AK        A+K++      E  P S   A  ++ ++  LKH++ V L
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS---ALREICLLKELKHKNIVRL 66

Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
                      LV++F       D+    K    +  G  L         +   KGL F 
Sbjct: 67  HDVLHSDKKLTLVFEFCD----QDL----KKYFDSCNGD-LDPEIVKSFLFQLLKGLGFC 117

Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEY 250
           H +    ++HRD++  N+L+  + + K+A+F L         R +S  V+ T  Y  P+ 
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVV-TLWYRPPDV 172

Query: 251 AMTGQITQKS--DVYSFGVVLLELLTGRKP 278
              G     +  D++S G +  EL    +P
Sbjct: 173 LF-GAKLYSTSIDMWSAGCIFAELANAGRP 201

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 66.1 bits (162), Expect = 2e-12
 Identities = 54/219 (24%), Positives = 85/219 (38%), Gaps = 37/219 (16%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDF-------AAQLSVVSRLKHEHF 127
           IG G+YG V+ A+    G   A+K +   +                A L  +   +H + 
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 128 VELLGYCMESNNRI-----LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
           V L+  C  S         LV++        D+    +      P P L       +   
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVD----QDL----RTYLDKAPPPGLPAETIKDLMRQ 128

Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS-----T 237
             +GL+FLH      IVHRD++  N+L+      K+ADF L        AR++S     T
Sbjct: 129 FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL--------ARIYSYQMALT 177

Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGR 276
            V+ T  Y APE  +        D++S G +  E+   +
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 66.0 bits (162), Expect = 2e-12
 Identities = 52/226 (23%), Positives = 91/226 (40%), Gaps = 34/226 (15%)

Query: 65  RLTSNFGTKALIGEGSYGRVFYA--KLTDGTPAAIKKLDTSS-APEPESDFAAQLSVVSR 121
           + + N+  K  +G+G++  V     K T G   A K ++T   +         +  +  +
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTT-GLEFAAKIINTKKLSARDFQKLEREARICRK 61

Query: 122 LKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY 181
           L+H + V L     E +   LV+   T G L + +  R+           +         
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---------FYSEADASHCIQ 112

Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS---KIADFNLTNQSSDTAARLHSTR 238
              + + + H      IVHR+++  N+LL    K    K+ADF L  + +D+        
Sbjct: 113 QILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGF 167

Query: 239 VLGTFGYHAPE------YAMTGQITQKSDVYSFGVVLLELLTGRKP 278
             GT GY +PE      Y      ++  D+++ GV+L  LL G  P
Sbjct: 168 A-GTPGYLSPEVLKKDPY------SKPVDIWACGVILYILLVGYPP 206

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 51/224 (22%), Positives = 94/224 (41%), Gaps = 36/224 (16%)

Query: 66  LTSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQ-----LSVV 119
           +   +     IG G+ G V  A         AIKKL  S   + ++   A+     L ++
Sbjct: 60  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTH--AKRAYRELVLM 115

Query: 120 SRLKHEHFVELL-----GYCMESNNRI-LVYQFATMGS-LHDVLHGRKGVQGAEPGPVLT 172
             + H++ + LL        +E    + LV +   M + L  V+              L 
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL--MDANLCQVIQME-----------LD 162

Query: 173 WNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA 232
             +   + Y    G++ LH      I+HRD++ SN+++  D   KI DF L  +++ T+ 
Sbjct: 163 HERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTSF 218

Query: 233 RLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGR 276
            +  T  + T  Y APE  +     +  D++S G ++ E++  +
Sbjct: 219 MM--TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 65.7 bits (161), Expect = 2e-12
 Identities = 45/228 (19%), Positives = 93/228 (40%), Gaps = 35/228 (15%)

Query: 66  LTSNFGTKALIGEGSYGRVFYA--KLTDGTPAAIK-----KLDTSSAPEPESDFAAQLSV 118
           +  ++     +G G +  V     K T G   A K     +L +S       +   ++++
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGT-GKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 119 VSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK 178
           +  ++H + + L        + +L+ +  + G L D L  ++          LT ++  +
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---------SLTEDEATQ 112

Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL----FDDFKSKIADFNLTNQSSDTAARL 234
                  G+ +LH K    I H D++  N++L      + + K+ DF +       A ++
Sbjct: 113 FLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI-------AHKI 162

Query: 235 HSTRVL----GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
            +        GT  + APE      +  ++D++S GV+   LL+G  P
Sbjct: 163 EAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 51/223 (22%), Positives = 93/223 (41%), Gaps = 43/223 (19%)

Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQ-----LSVVSRLKHEHFVE 129
           +GEG+YG V  A     G   AIKK++     +      A      + ++   KHE+ + 
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLF--ALRTLREIKILKHFKHENIIT 73

Query: 130 LL----GYCMESNNRI-LVYQFATMGS-LHDVLHGRKGVQGAEPGPVLTWNQRVKV-AYG 182
           +         E+ N + ++ +   M + LH V+  +           L+ +  ++   Y 
Sbjct: 74  IFNIQRPDSFENFNEVYIIQEL--MQTDLHRVISTQM----------LS-DDHIQYFIYQ 120

Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
             + ++ LH      ++HRD++ SN+L+  +   K+ DF L     ++AA         +
Sbjct: 121 TLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177

Query: 243 FG--------YHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGR 276
                     Y APE  +T    ++  DV+S G +L EL   R
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 65.7 bits (161), Expect = 3e-12
 Identities = 51/235 (21%), Positives = 85/235 (36%), Gaps = 37/235 (15%)

Query: 66  LTSNFGTKALIGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAP--------EPESDFAAQ 115
              N+  K ++G G    V     K T     A+K +D +           E       +
Sbjct: 15  FYENYEPKEILGRGVSSVVRRCIHKPT-CKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73

Query: 116 LSVVSRLK-HEHFVELLGYCMESNNRILVYQFATMGSLHD--VLHGRKGVQGAEPGPVLT 172
           + ++ ++  H + ++L      +    LV+     G L D                  L+
Sbjct: 74  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-----------LS 122

Query: 173 WNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA 232
             +  K+     + +  LH+     IVHRD++  N+LL DD   K+ DF  + Q      
Sbjct: 123 EKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-- 177

Query: 233 RLHSTRVLGTFGYHAPE------YAMTGQITQKSDVYSFGVVLLELLTGRKPVDH 281
                   GT  Y APE              ++ D++S GV++  LL G  P  H
Sbjct: 178 EKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 65.8 bits (161), Expect = 3e-12
 Identities = 43/215 (20%), Positives = 80/215 (37%), Gaps = 40/215 (18%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVELLGY 133
           +G G Y  VF A  +T+     +K L     P  +     ++ ++  L+   + + L   
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILK----PVKKKKIKREIKILENLRGGPNIITLADI 99

Query: 134 CM--ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
                S    LV++         +               LT        Y   K L++ H
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFKQLY------------QTLTDYDIRFYMYEILKALDYCH 147

Query: 192 EKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTNQSSDTAARLHST------RVLGTFG 244
                 I+HRDV+  NV++  +  K ++ D+ L        A  +        RV  +  
Sbjct: 148 SM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL--------AEFYHPGQEYNVRV-ASRY 195

Query: 245 YHAPEYAMTGQITQKS-DVYSFGVVLLELLTGRKP 278
           +  PE  +  Q+   S D++S G +L  ++  ++P
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 65.2 bits (160), Expect = 4e-12
 Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 36/213 (16%)

Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPE--PESDFAA--QLSVVSRLKHEHFVELL 131
           IGEG+YG V+ A+   G   A+KK+      E  P +      ++S++  LKH + V+L 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPST---TIREISILKELKHSNIVKLY 66

Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK-VAYGAAKGLEFL 190
                    +LV++        D+    K +     G + +     K        G+ + 
Sbjct: 67  DVIHTKKRLVLVFEHLD----QDL----KKLLDVCEGGLESVT--AKSFLLQLLNGIAYC 116

Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE- 249
           H++    ++HRD++  N+L+  + + KIADF L         R ++  ++ T  Y AP+ 
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIV-TLWYRAPDV 171

Query: 250 ------YAMTGQITQKSDVYSFGVVLLELLTGR 276
                 Y  +  I    D++S G +  E++ G 
Sbjct: 172 LMGSKKY--STTI----DIWSVGCIFAEMVNGT 198

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 65.4 bits (160), Expect = 4e-12
 Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 40/216 (18%)

Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEP-ESDFAAQ-----LSVVSRLKHEHFV 128
           +G G+YG V  A     G   AIKKL       P +S+  A+     L ++  ++HE+ +
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKL-----YRPFQSELFAKRAYRELRLLKHMRHENVI 87

Query: 129 ELL-----GYCMESNNRI-LVYQFATMGS-LHDVLHGRKGVQGAEPGPVLTWNQRVKVAY 181
            LL        ++      LV  F  MG+ L  ++   K          L  ++   + Y
Sbjct: 88  GLLDVFTPDETLDDFTDFYLVMPF--MGTDLGKLMKHEK----------LGEDRIQFLVY 135

Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG 241
              KGL ++H      I+HRD++  N+ + +D + KI DF L  Q+         TR   
Sbjct: 136 QMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-- 190

Query: 242 TFGYHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGR 276
              Y APE  +     TQ  D++S G ++ E++TG+
Sbjct: 191 ---YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 65.0 bits (159), Expect = 5e-12
 Identities = 53/223 (23%), Positives = 89/223 (39%), Gaps = 30/223 (13%)

Query: 72  TKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVE 129
            + ++GEG++ RV     L      A+K ++        S    ++ ++ + + H + +E
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ-PGHIRSRVFREVEMLYQCQGHRNVLE 75

Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           L+ +  E +   LV++    GS+   +H R+              +   V    A  L+F
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSILSHIHKRR---------HFNELEASVVVQDVASALDF 126

Query: 190 LHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADFNL------TNQSSDTAARLHSTRVL 240
           LH K    I HRD++  N+L          KI DF+L          S  +     T   
Sbjct: 127 LHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC- 182

Query: 241 GTFGYHAPEYAMTGQITQKS-----DVYSFGVVLLELLTGRKP 278
           G+  Y APE                D++S GV+L  LL+G  P
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 65.0 bits (159), Expect = 5e-12
 Identities = 45/229 (19%), Positives = 85/229 (37%), Gaps = 35/229 (15%)

Query: 65  RLTSNFGTKALIGEGSYGRVFYA--KLTDGTPAAIK-----KLDTSSAPEPESDFAAQLS 117
           ++   +     +G G +  V     K T G   A K     +   S       +   ++S
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKST-GLEYAAKFIKKRQSRASRRGVSREEIEREVS 67

Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV 177
           ++ ++ H + + L        + +L+ +  + G L D L  ++          L+  +  
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---------SLSEEEAT 118

Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF----DDFKSKIADFNLTNQSSDTAAR 233
                   G+ +LH K    I H D++  N++L          K+ DF L       A  
Sbjct: 119 SFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL-------AHE 168

Query: 234 LHSTRVL----GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           +          GT  + APE      +  ++D++S GV+   LL+G  P
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 38/217 (17%)

Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEP-ESDFAAQ-----LSVVSRLKHEHFV 128
           IGEG+YG V  A         AIKK+       P E     Q     + ++ R +HE+ +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKIS------PFEHQTYCQRTLREIKILLRFRHENII 88

Query: 129 ELLG----YCMESNNRI-LVYQFATMGS-LHDVLHGRKGVQGAEPGPVLTWNQRVKV-AY 181
            +        +E    + +V     M + L+ +L  +           L+ N  +    Y
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQH----------LS-NDHICYFLY 135

Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT-NQSSDTAARLHSTRVL 240
              +GL+++H      ++HRD++ SN+LL      KI DF L      D       T  +
Sbjct: 136 QILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192

Query: 241 GTFGYHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGR 276
            T  Y APE  +  +  T+  D++S G +L E+L+ R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 48/230 (20%), Positives = 84/230 (36%), Gaps = 39/230 (16%)

Query: 66  LTSNFGTKALIGEGSYGRVFYA--KLTDGTPAAIK-----KLDTSSAPEPESDFAAQLSV 118
           +   + T   +G G +  V     K T G   A K     +  +S       D   ++S+
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKST-GLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67

Query: 119 VSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHD--VLHGRKGVQGAEPGPVLTWNQR 176
           +  ++H + + L        + IL+ +    G L D                  LT  + 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----------LTEEEA 116

Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL----FDDFKSKIADFNLTNQSSDTAA 232
            +       G+ +LH      I H D++  N++L        + KI DF L       A 
Sbjct: 117 TEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL-------AH 166

Query: 233 RLHSTRVL----GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           ++          GT  + APE      +  ++D++S GV+   LL+G  P
Sbjct: 167 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 63.8 bits (156), Expect = 1e-11
 Identities = 50/226 (22%), Positives = 93/226 (41%), Gaps = 47/226 (20%)

Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQ-----LSVVSRLKHEHFVE 129
           +G G  G VF A   D     AIKK+              +     + ++ RL H++ V+
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKI----VLTDPQS--VKHALREIKIIRRLDHDNIVK 72

Query: 130 LL--------------GYCMESNNRILVYQFATMGS-LHDVLHGRKGVQGAEPGPVLTWN 174
           +               G   E N+  +V ++  M + L +VL              L   
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEY--METDLANVLEQGP----------LL-E 119

Query: 175 QRVK-VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLT-NQSSDTA 231
           +  +   Y   +GL+++H      ++HRD++ +N+ +  +D   KI DF L        +
Sbjct: 120 EHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176

Query: 232 ARLHSTRVLGTFGYHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGR 276
            + H +  L T  Y +P   ++    T+  D+++ G +  E+LTG+
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 63.8 bits (156), Expect = 1e-11
 Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 31/213 (14%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAA----QLSVVSRLKHEHFVEL 130
           +G G+Y  V+     T G   A+K++      + E    +    ++S++  LKHE+ V L
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKL----DSEEGTPSTAIREISLMKELKHENIVRL 68

Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
                  N   LV++F     L   +  R           L  N      +   +GL F 
Sbjct: 69  YDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRG---LELNLVKYFQWQLLQGLAFC 124

Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE- 249
           HE     I+HRD++  N+L+    + K+ DF L            S+ V+ T  Y AP+ 
Sbjct: 125 HENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGI-PVNTFSSEVV-TLWYRAPDV 179

Query: 250 ------YAMTGQITQKSDVYSFGVVLLELLTGR 276
                 Y  +  I    D++S G +L E++TG+
Sbjct: 180 LMGSRTY--STSI----DIWSCGCILAEMITGK 206

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 63.4 bits (153), Expect = 2e-11
 Identities = 43/248 (17%), Positives = 70/248 (28%), Gaps = 52/248 (20%)

Query: 67  TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDF-------------- 112
           T        IGEG +G VF     D TP AIK +                          
Sbjct: 19  TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77

Query: 113 --AAQLSVVSRLKHEHFVELL------GYCMESNNRILVYQFATMGSLHDVLHGRKGVQ- 163
              + LS     + E F+ L       G       +   +  +T GS +D     K  Q 
Sbjct: 78  KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137

Query: 164 ---------GAE----PGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL 210
                    G +       + +      + +     L      ++    HRD+   NVLL
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLL 195

Query: 211 FDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP--EYAMTGQITQKSDVYSFGVV 268
                 K+        S+           + + G      +Y ++        V+    +
Sbjct: 196 KKTSLKKLHYTLNGKSST-----------IPSCGLQVSIIDYTLSRLERDGIVVFCDVSM 244

Query: 269 LLELLTGR 276
             +L TG 
Sbjct: 245 DEDLFTGD 252

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 63.0 bits (154), Expect = 2e-11
 Identities = 47/214 (21%), Positives = 85/214 (39%), Gaps = 29/214 (13%)

Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSS-APEPESDFAAQLSVVSRLKH-EHFVELL 131
           +G G +  V     K T G   A K L       +  ++   +++V+   K     + L 
Sbjct: 37  LGRGKFAVVRQCISKST-GQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
                ++  IL+ ++A  G +  +         +E   +    Q ++       G+ +LH
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE-------GVYYLH 148

Query: 192 EKVQPPIVHRDVRSSNVLL---FDDFKSKIADFNLTNQSSDTAARLHSTRVL----GTFG 244
           +     IVH D++  N+LL   +     KI DF +       + ++     L    GT  
Sbjct: 149 QN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGM-------SRKIGHACELREIMGTPE 198

Query: 245 YHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           Y APE      IT  +D+++ G++   LLT   P
Sbjct: 199 YLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 63.0 bits (154), Expect = 3e-11
 Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 32/213 (15%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQ----LSVVSRLKHEHFVEL 130
           +GEG +  V+ A+        AIKK+      E +          + ++  L H + + L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
           L      +N  LV+ F       D+    + +   +   VLT +          +GLE+L
Sbjct: 78  LDAFGHKSNISLVFDFME----TDL----EVII-KDNSLVLTPSHIKAYMLMTLQGLEYL 128

Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE- 249
           H+     I+HRD++ +N+LL ++   K+ADF L         R ++ +V+ T  Y APE 
Sbjct: 129 HQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAYTHQVV-TRWYRAPEL 183

Query: 250 ------YAMTGQITQKSDVYSFGVVLLELLTGR 276
                 Y     +    D+++ G +L ELL   
Sbjct: 184 LFGARMY--GVGV----DMWAVGCILAELLLRV 210

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 62.7 bits (153), Expect = 4e-11
 Identities = 43/209 (20%), Positives = 82/209 (39%), Gaps = 25/209 (11%)

Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVELLG 132
           +GEGS+        K +     A+K +        E++   +++ +   + H + V+L  
Sbjct: 19  LGEGSFSICRKCVHKKS-NQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKLHE 73

Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
              +  +  LV +    G L + +  +K           +  +   +       +  +H+
Sbjct: 74  VFHDQLHTFLVMELLNGGELFERIKKKK---------HFSETEASYIMRKLVSAVSHMHD 124

Query: 193 KVQPPIVHRDVRSSNVLLFDDFKS---KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE 249
                +VHRD++  N+L  D+  +   KI DF            L  T    T  Y APE
Sbjct: 125 V---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL-KTPC-FTLHYAAPE 179

Query: 250 YAMTGQITQKSDVYSFGVVLLELLTGRKP 278
                   +  D++S GV+L  +L+G+ P
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 62.7 bits (153), Expect = 4e-11
 Identities = 48/222 (21%), Positives = 81/222 (36%), Gaps = 44/222 (19%)

Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKK--LDTSSAPEPESDFA----AQLSVVSRLKHEHFV 128
            G+G++G V   K    G   AIKK   D          F       +  ++ L H + V
Sbjct: 31  AGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--------FRNRELQIMQDLAVLHHPNIV 82

Query: 129 ELLGYCMESNNR--------ILVYQFATMGS-LHDVLHGRKGVQGAEPGPVLTWNQRVKV 179
           +L      +            +V ++  +   LH     R   +     P +     +KV
Sbjct: 83  QLQ-SYFYTLGERDRRDIYLNVVMEY--VPDTLHRCC--RNYYRRQVAPPPIL----IKV 133

Query: 180 -AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTNQSSDTAARLH-- 235
             +   + +  LH      + HRD++  NVL+   D   K+ DF    + S +   +   
Sbjct: 134 FLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192

Query: 236 STRVLGTFGYHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGR 276
            +R      Y APE     Q  T   D++S G +  E++ G 
Sbjct: 193 CSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 62.2 bits (152), Expect = 4e-11
 Identities = 61/255 (23%), Positives = 103/255 (40%), Gaps = 30/255 (11%)

Query: 29  PGGSARGEPRTNVVKTGTPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAK 88
            G +A   P    ++   P    P +  + + +       +F    ++GEGS+  V  A+
Sbjct: 2   DGTAAEPRPGAGSLQHAQP----PPQPRKKRPE-------DFKFGKILGEGSFSTVVLAR 50

Query: 89  LTD-GTPAAIKKLDTSS-APEPESDFA-AQLSVVSRLKHEHFVELLGYCMESNNRILVYQ 145
                   AIK L+      E +  +   +  V+SRL H  FV+L     +         
Sbjct: 51  ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 110

Query: 146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA--AKGLEFLHEKVQPPIVHRDV 203
           +A  G L   +  RK     E           +  Y A     LE+LH K    I+HRD+
Sbjct: 111 YAKNGELLKYI--RKIGSFDET--------CTRF-YTAEIVSALEYLHGK---GIIHRDL 156

Query: 204 RSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVY 263
           +  N+LL +D   +I DF      S  + +  +   +GT  Y +PE        + SD++
Sbjct: 157 KPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLW 216

Query: 264 SFGVVLLELLTGRKP 278
           + G ++ +L+ G  P
Sbjct: 217 ALGCIIYQLVAGLPP 231

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 62.8 bits (153), Expect = 4e-11
 Identities = 58/291 (19%), Positives = 93/291 (31%), Gaps = 42/291 (14%)

Query: 1   MLCCGGQEEEPQPPASQTTAPPRSGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKL 60
           ML     +  P P  +    P       P   A+  P           K+      QIK 
Sbjct: 1   MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKS----GLQIKK 56

Query: 61  DELNRLTSNFGTKALIGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSV 118
           + +            +G G  G+V     K T     A+K L        E +   + S 
Sbjct: 57  NAIIDDYKVTSQV--LGLGINGKVLQIFNKRT-QEKFALKMLQDCPKARREVELHWRAS- 112

Query: 119 VSRLKHEHFVELLGYC----MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWN 174
               +  H V ++             ++V +    G L   +  R      E        
Sbjct: 113 ----QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE-------R 161

Query: 175 QRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS---KIADFNLTNQSSDTA 231
           +  ++     + +++LH      I HRDV+  N+L      +   K+ DF         A
Sbjct: 162 EASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF-------A 211

Query: 232 ARLHSTRVL----GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
               S   L     T  Y APE     +  +  D++S GV++  LL G  P
Sbjct: 212 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 62.2 bits (152), Expect = 4e-11
 Identities = 53/216 (24%), Positives = 83/216 (38%), Gaps = 41/216 (18%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAA-QLSVVSRLKHEHFVELLGY 133
           +GEGSYG V   +    G   AIKK   S   +     A  ++ ++ +L+HE+ V LL  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92

Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
           C +     LV++F      H +           P   L +    K  +    G+ F H  
Sbjct: 93  CKKKKRWYLVFEFVD----HTI----LDDLELFPNG-LDYQVVQKYLFQIINGIGFCHSH 143

Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS------TRVLGTFGYHA 247
               I+HRD++  N+L+      K+ DF          AR  +         + T  Y A
Sbjct: 144 ---NIIHRDIKPENILVSQSGVVKLCDFGF--------ARTLAAPGEVYDDEVATRWYRA 192

Query: 248 PE-------YAMTGQITQKSDVYSFGVVLLELLTGR 276
           PE       Y          DV++ G ++ E+  G 
Sbjct: 193 PELLVGDVKYGKA------VDVWAIGCLVTEMFMGE 222

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 62.3 bits (152), Expect = 5e-11
 Identities = 61/284 (21%), Positives = 108/284 (38%), Gaps = 43/284 (15%)

Query: 7   QEEEPQPPASQTTAPPRSGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLDELNRL 66
           +EE      +  T+       +   + + E RT  + TG  +K                 
Sbjct: 9   EEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANL-TGHAEKVGI-------------- 53

Query: 67  TSNFGTKALIGEGSYGRVFYAKLTDGTPA----AIKKLDTSSAPEPESDFA---AQLSVV 119
             NF    ++G G+YG+VF  +   G       A+K L  ++  +          +  V+
Sbjct: 54  -ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 112

Query: 120 SRLKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK 178
             ++   F+  L Y  ++  ++ L+  +   G L    H  +  +  E          V+
Sbjct: 113 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRERFTEH--------EVQ 162

Query: 179 VAYGA--AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS 236
           + Y       LE LH+     I++RD++  N+LL  +    + DF L+ +          
Sbjct: 163 I-YVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 218

Query: 237 TRVLGTFGYHAPEYAMTGQI--TQKSDVYSFGVVLLELLTGRKP 278
               GT  Y AP+    G     +  D +S GV++ ELLTG  P
Sbjct: 219 D-FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 62.4 bits (152), Expect = 5e-11
 Identities = 41/239 (17%), Positives = 78/239 (32%), Gaps = 52/239 (21%)

Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAA-QLSVVSRLKHEHFVELLGY 133
           +G GS+G V      + G   A+KK+        +  +   +L ++  L H + ++L+ Y
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKV------LQDPRYKNRELDIMKVLDHVNIIKLVDY 68

Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWN---------------QRVK 178
              + +                          +   V                    +V 
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128

Query: 179 VAYGAAK-----------------GLEFLHEKVQPPIVHRDVRSSNVLLF-DDFKSKIAD 220
            ++  +                   + F+H      I HRD++  N+L+   D   K+ D
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCD 185

Query: 221 FNLTNQSSDTAARLH--STRVLGTFGYHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGR 276
           F    +   +   +    +R      Y APE  +     T   D++S G V  EL+ G+
Sbjct: 186 FGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 61.8 bits (151), Expect = 6e-11
 Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 39/219 (17%)

Query: 76  IGEGSYGRVFYAK--LTDGTPAAIKKLDTSSAPE--PESDFA----AQLSVVSRLKHEHF 127
           IGEG+YG+VF A+     G   A+K++   +  E  P S       A L  +   +H + 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS--TIREVAVLRHLETFEHPNV 76

Query: 128 VELL----GYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
           V L         +   ++ LV++        D+           P P +       + + 
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVD----QDL----TTYLDKVPEPGVPTETIKDMMFQ 128

Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS-----T 237
             +GL+FLH      +VHRD++  N+L+    + K+ADF L        AR++S     T
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------ARIYSFQMALT 177

Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGR 276
            V+ T  Y APE  +        D++S G +  E+   +
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 61.7 bits (150), Expect = 9e-11
 Identities = 50/233 (21%), Positives = 91/233 (39%), Gaps = 48/233 (20%)

Query: 68  SNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEH 126
            +F    +IG G++G V   KL +     A+K L+                ++ R +   
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE-------------MLKRAETAC 120

Query: 127 FVE---LLGYCMESNNRILV---YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
           F E   +L   +  +++ +    Y F    +L+ V+    G      G +LT   + +  
Sbjct: 121 FREERDVL---VNGDSKWITTLHYAFQDDNNLYLVMDYYVG------GDLLTLLSKFEDR 171

Query: 181 --------YGA--AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT 230
                   Y A     ++ +H+      VHRD++  N+L+  +   ++ADF    +  + 
Sbjct: 172 LPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228

Query: 231 AARLHSTRVLGTFGYHAPEYAMTGQITQKS-----DVYSFGVVLLELLTGRKP 278
                S  V GT  Y +PE     +  +       D +S GV + E+L G  P
Sbjct: 229 GTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 61.1 bits (149), Expect = 1e-10
 Identities = 48/221 (21%), Positives = 84/221 (38%), Gaps = 47/221 (21%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPE--P-----ESDFAAQLSVVSRLKHEHF 127
           +GEG+YG V+ A         AIK++      E  P     E      +S++  L+H + 
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIRE------VSLLKELQHRNI 95

Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
           +EL      ++   L++++A    L   +         +  P ++        Y    G+
Sbjct: 96  IELKSVIHHNHRLHLIFEYAEN-DLKKYM---------DKNPDVSMRVIKSFLYQLINGV 145

Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKS-----KIADFNLTNQSSDTAARLHSTRVLGT 242
            F H +     +HRD++  N+LL     S     KI DF L         R  +  ++ T
Sbjct: 146 NFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHEII-T 200

Query: 243 FGYHAPE-------YAMTGQITQKSDVYSFGVVLLELLTGR 276
             Y  PE       Y  +  +    D++S   +  E+L   
Sbjct: 201 LWYRPPEILLGSRHY--STSV----DIWSIACIWAEMLMKT 235

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 61.4 bits (149), Expect = 1e-10
 Identities = 61/312 (19%), Positives = 111/312 (35%), Gaps = 60/312 (19%)

Query: 15  ASQTTAPPRSGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLDELNRLTSNFGTKA 74
           +S   A  +  N+    +  G  +    +           +P+   D   ++   +  + 
Sbjct: 2   SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDW--QIPDRYEIRH 59

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQ-----LSVVSRLKHEHFV 128
           LIG GSYG V  A    +    AIKK+      E   D   +     +++++RL H+H V
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKI--LRVFEDLID--CKRILREIAILNRLNHDHVV 115

Query: 129 ELL----GYCMESNNRI-LVYQFATMGS-LHDVLHGRKGVQGAEPGPVLTWNQRVKV-AY 181
           ++L       +E  + + +V +     S    +               LT    +K   Y
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEI--ADSDFKKLFRT---------PVYLT-ELHIKTLLY 163

Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL---TNQSSDTAARLHSTR 238
               G++++H      I+HRD++ +N L+  D   K+ DF L    +   +  ++L  + 
Sbjct: 164 NLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220

Query: 239 VLGTFG----------------------YHAPEYAMTGQI-TQKSDVYSFGVVLLELLTG 275
                                       Y APE  +  +  T+  DV+S G +  ELL  
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280

Query: 276 RKPVDHTMPKGQ 287
            K          
Sbjct: 281 IKENVAYHADRG 292

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 51/216 (23%), Positives = 80/216 (37%), Gaps = 29/216 (13%)

Query: 72  TKALIGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           +K ++G G  G+V     + T G   A+K L  S     E D   Q S        H V 
Sbjct: 33  SKQVLGLGVNGKVLECFHRRT-GQKCALKLLYDSPKARQEVDHHWQAS-----GGPHIVC 86

Query: 130 LLGYCMESNNRI----LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
           +L      ++      ++ +    G L   +  R      E        +  ++      
Sbjct: 87  ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE-------REAAEIMRDIGT 139

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS---KIADFNLTNQSSDTAARLHSTRVLGT 242
            ++FLH      I HRDV+  N+L     K    K+ DF     + +T      T    T
Sbjct: 140 AIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF---AKETTQNALQTPC-YT 192

Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
             Y APE     +  +  D++S GV++  LL G  P
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 57/246 (23%), Positives = 95/246 (38%), Gaps = 43/246 (17%)

Query: 62  ELNRLTSNFG----TKALIGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQ 115
           +L+R +  F      K  IG GSY        K T     A+K +D S       D   +
Sbjct: 12  QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKAT-NMEFAVKIIDKSK-----RDPTEE 65

Query: 116 LSVVSRL-KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWN 174
           + ++ R  +H + + L     +     +V +    G L D +  +K           +  
Sbjct: 66  IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK---------FFSER 116

Query: 175 QRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS----KIADFNLTNQSSDT 230
           +   V +   K +E+LH +    +VHRD++ SN+L  D+  +    +I DF    Q    
Sbjct: 117 EASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173

Query: 231 AARLHSTRVLGTFGYHAPE------YAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP 284
              L  T    T  + APE      Y          D++S GV+L  +LTG  P  +   
Sbjct: 174 NGLLM-TPC-YTANFVAPEVLERQGY------DAACDIWSLGVLLYTMLTGYTPFANGPD 225

Query: 285 KGQQSL 290
              + +
Sbjct: 226 DTPEEI 231

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 59.9 bits (146), Expect = 3e-10
 Identities = 47/213 (22%), Positives = 87/213 (40%), Gaps = 36/213 (16%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAA----QLSVVSRLKHEHFVEL 130
           +GEG+Y  V+  K        A+K++      E E         ++S++  LKH + V L
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRL----EHEEGAPCTAIREVSLLKDLKHANIVTL 65

Query: 131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
                   +  LV+++       D+    K          +  +      +   +GL + 
Sbjct: 66  HDIIHTEKSLTLVFEYLD----KDL----KQYLDDCGNI-INMHNVKLFLFQLLRGLAYC 116

Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE- 249
           H +    ++HRD++  N+L+ +  + K+ADF L    S    + +   V+ T  Y  P+ 
Sbjct: 117 HRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVV-TLWYRPPDI 171

Query: 250 ------YAMTGQITQKSDVYSFGVVLLELLTGR 276
                 Y  + QI    D++  G +  E+ TGR
Sbjct: 172 LLGSTDY--STQI----DMWGVGCIFYEMATGR 198

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 60/280 (21%), Positives = 107/280 (38%), Gaps = 25/280 (8%)

Query: 7   QEEEPQPPASQTTAPPRSGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLDELNRL 66
             +E     +    P  S   +         +         +K              +R+
Sbjct: 279 LSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRM 338

Query: 67  T-SNFGTKALIGEGSYGRVFYAKLTD-GTPAAIK---KLDTSSAPEPESDFAAQLSVVSR 121
             ++F    ++G+GS+G+V  ++        A+K   K       + E     +  +   
Sbjct: 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 398

Query: 122 LKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
            K   F+  L  C ++ +R+  V ++   G L  + H ++  +  EP             
Sbjct: 399 GKP-PFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEP--------HAVF- 446

Query: 181 YGA--AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
           Y A  A GL FL  K    I++RD++  NV+L  +   KIADF +  ++        +  
Sbjct: 447 YAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-- 501

Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
             GT  Y APE        +  D ++FGV+L E+L G+ P
Sbjct: 502 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 59.5 bits (145), Expect = 3e-10
 Identities = 53/216 (24%), Positives = 82/216 (37%), Gaps = 41/216 (18%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAA-QLSVVSRLKHEHFVELLGY 133
           IGEGSYG VF  +    G   AIKK   S         A  ++ ++ +LKH + V LL  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
                   LV+++      H V               +  +    + +   + + F H+ 
Sbjct: 71  FRRKRRLHLVFEYCD----HTV----LHELDRYQRG-VPEHLVKSITWQTLQAVNFCHKH 121

Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS------TRVLGTFGYHA 247
                +HRDV+  N+L+      K+ DF          ARL +         + T  Y +
Sbjct: 122 ---NCIHRDVKPENILITKHSVIKLCDFGF--------ARLLTGPSDYYDDEVATRWYRS 170

Query: 248 PE-------YAMTGQITQKSDVYSFGVVLLELLTGR 276
           PE       Y     +    DV++ G V  ELL+G 
Sbjct: 171 PELLVGDTQY--GPPV----DVWAIGCVFAELLSGV 200

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 59.5 bits (145), Expect = 3e-10
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 27/221 (12%)

Query: 68  SNFGTKALIGEGSYGRVFYAKLTDGTPA----AIKKLDTSSAPEPESDFA---AQLSVVS 120
             F    ++G+G YG+VF  +   G       A+K L  +       D A   A+ +++ 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 121 RLKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKV 179
            +KH  F+  L Y  ++  ++ L+ ++ + G L   +   +     E             
Sbjct: 77  EVKHP-FIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMED--------TACF 125

Query: 180 AYGA--AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
            Y A  +  L  LH+K    I++RD++  N++L      K+ DF L  +S       H+ 
Sbjct: 126 -YLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT- 180

Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
              GT  Y APE  M     +  D +S G ++ ++LTG  P
Sbjct: 181 -FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 55/237 (23%), Positives = 88/237 (37%), Gaps = 53/237 (22%)

Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQ-----LSVVSRLKHEHFVE 129
           IG GSYG V+ A   +     AIKK+  +   E   D   +     +++++RLK ++ + 
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLID--CKRILREITILNRLKSDYIIR 89

Query: 130 LLGYCMESNNRI-----LVYQFATMGS-LHDVLHGRKGVQGAEPGPVLTWNQRVKV-AYG 182
           L    +  +        +V +     S L  +               LT  + +K   Y 
Sbjct: 90  LYDLIIPDDLLKFDELYIVLEI--ADSDLKKLFKTPI---------FLT-EEHIKTILYN 137

Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL---TNQSSDTAARLHSTRV 239
              G  F+HE     I+HRD++ +N LL  D   K+ DF L    N   DT         
Sbjct: 138 LLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194

Query: 240 LGTFG-----------------YHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGRKP 278
                                 Y APE  +  +  T+  D++S G +  ELL   + 
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 59.2 bits (144), Expect = 4e-10
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 25/218 (11%)

Query: 68  SNFGTKALIGEGSYGRVFYAKLTD-GTPAAIK---KLDTSSAPEPESDFAAQLSVVSRLK 123
           ++F    L+G+G++G+V   +    G   A+K   K    +  E          V+   +
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES-RVLQNTR 63

Query: 124 HEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
           H     L  Y  ++++R+  V ++A  G L    H  +     E         R +  YG
Sbjct: 64  HPFLTALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEE--------RARF-YG 111

Query: 183 A--AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           A     LE+LH +    +V+RD++  N++L  D   KI DF L  +     A + +    
Sbjct: 112 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FC 166

Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           GT  Y APE        +  D +  GVV+ E++ GR P
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 59.7 bits (145), Expect = 5e-10
 Identities = 45/224 (20%), Positives = 81/224 (36%), Gaps = 28/224 (12%)

Query: 68  SNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPE--SDFAAQLSVVSRLKH 124
            +F    +IG G++  V   K+   G   A+K ++     +    S F  +  V+     
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 125 EHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
             ++  L +  +  N + LV ++   G L  +L  + G +              +  Y A
Sbjct: 121 R-WITQLHFAFQDENYLYLVMEYYVGGDLLTLLS-KFGERIPAE--------MARF-YLA 169

Query: 184 --AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG 241
                ++ +H       VHRD++  N+LL      ++ADF    +            V G
Sbjct: 170 EIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-G 225

Query: 242 TFGYHAPEYAMTGQITQKSDVY-------SFGVVLLELLTGRKP 278
           T  Y +PE          +  Y       + GV   E+  G+ P
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 59.1 bits (144), Expect = 5e-10
 Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 26/235 (11%)

Query: 53  IEIPQIKLDELNRLT-SNFGTKALIGEGSYGRVFYAKLTDGTPA----AIKKLDTSSAPE 107
           I I     +   +   S F    ++G+GS+G+VF  K   G+ A    A+K L  ++   
Sbjct: 8   IAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV 67

Query: 108 P-ESDFAAQLSVVSRLKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGA 165
                   +  ++  + H  F+  L Y  ++  ++ L+  F   G L       K V   
Sbjct: 68  RDRVRTKMERDILVEVNH-PFIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFT 124

Query: 166 EPGPVLTWNQRVKVAYGA--AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL 223
           E          VK  Y A  A  L+ LH      I++RD++  N+LL ++   K+ DF L
Sbjct: 125 EE--------DVKF-YLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGL 172

Query: 224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           + +S D   + +S    GT  Y APE       TQ +D +SFGV++ E+LTG  P
Sbjct: 173 SKESIDHEKKAYS--FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 59.3 bits (144), Expect = 5e-10
 Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 27/220 (12%)

Query: 68  SNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPES--DFAAQLSVVSRLKH 124
            +F     IG+GS+G+V   +  D     A+K ++     E     +   +L ++  L+H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 125 EHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
             F+  L Y  +    + +V      G L    H ++ V   E          VK+ +  
Sbjct: 75  P-FLVNLWYSFQDEEDMFMVVDLLLGGDLR--YHLQQNVHFKEE--------TVKL-FIC 122

Query: 184 --AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG 241
                L++L  +    I+HRD++  N+LL +     I DFN+   ++        T + G
Sbjct: 123 ELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNI---AAMLPRETQITTMAG 176

Query: 242 TFGYHAPE--YAMTGQITQKS-DVYSFGVVLLELLTGRKP 278
           T  Y APE   +  G     + D +S GV   ELL GR+P
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 55/232 (23%), Positives = 100/232 (43%), Gaps = 51/232 (21%)

Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQ-----LSVVSRLK-HEHFV 128
           +G+G+YG V+ +     G   A+KK+    A +  +D  AQ     + +++ L  HE+ V
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKI--FDAFQNSTD--AQRTFREIMILTELSGHENIV 72

Query: 129 ELLG-YCMESNNRI-LVYQFATMGS-LHDVLHGRKGVQGAEPGPVLTWNQRVK-VAYGAA 184
            LL     +++  + LV+ +  M + LH V+             +L      + V Y   
Sbjct: 73  NLLNVLRADNDRDVYLVFDY--METDLHAVIRAN----------ILE-PVHKQYVVYQLI 119

Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL---------TNQSSDTAARLH 235
           K +++LH      ++HRD++ SN+LL  +   K+ADF L            +   +   +
Sbjct: 120 KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176

Query: 236 STRVLGTFG----------YHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGR 276
           +                  Y APE  +     T+  D++S G +L E+L G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 52/230 (22%), Positives = 83/230 (36%), Gaps = 45/230 (19%)

Query: 68  SNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEH 126
            ++    +IG G++G V   +        A+K L                 ++ R     
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE-------------MIKRSDSAF 115

Query: 127 FVE---LLGYCMESNNRILV---YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
           F E   ++     +N+  +V   Y F     L+ V+    G      G ++       V 
Sbjct: 116 FWEERDIM---AFANSPWVVQLFYAFQDDRYLYMVMEYMPG------GDLVNLMSNYDVP 166

Query: 181 ------YGA--AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA 232
                 Y A     L+ +H       +HRDV+  N+LL      K+ADF    + +    
Sbjct: 167 EKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223

Query: 233 RLHSTRVLGTFGYHAPE----YAMTGQITQKSDVYSFGVVLLELLTGRKP 278
               T V GT  Y +PE        G   ++ D +S GV L E+L G  P
Sbjct: 224 VRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 56.2 bits (136), Expect = 5e-09
 Identities = 54/286 (18%), Positives = 102/286 (35%), Gaps = 52/286 (18%)

Query: 7   QEEEPQPPASQTTAPPRSGNTQPGGSARGEPRTNVVKTGTPQKALPIEIPQIKLDELNRL 66
                      TT           G    +   N  ++G    +L ++            
Sbjct: 5   HHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQ------------ 52

Query: 67  TSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE 125
             +F    +IG GSY +V   +L       A++ +        + +       +  ++ E
Sbjct: 53  --DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVV--------KKELVNDDEDIDWVQTE 102

Query: 126 ---------H-FVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWN 174
                    H F+  L  C ++ +R+  V ++   G L    H ++  +  E        
Sbjct: 103 KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLM--FHMQRQRKLPEE------- 153

Query: 175 QRVKVAYGA--AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAA 232
              +  Y A  +  L +LHE+    I++RD++  NVLL  +   K+ D+ +  +      
Sbjct: 154 -HARF-YSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 208

Query: 233 RLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
              +    GT  Y APE           D ++ GV++ E++ GR P
Sbjct: 209 TTST--FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 56.1 bits (136), Expect = 5e-09
 Identities = 49/225 (21%), Positives = 90/225 (40%), Gaps = 38/225 (16%)

Query: 68  SNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE- 125
            +F    +IG GSY +V   +L       A+K +        + +       +  ++ E 
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVV--------KKELVNDDEDIDWVQTEK 60

Query: 126 --------H-FVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQ 175
                   H F+  L  C ++ +R+  V ++   G L    H ++  +  E         
Sbjct: 61  HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLM--FHMQRQRKLPEE-------- 110

Query: 176 RVKVAYGA--AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAAR 233
             +  Y A  +  L +LHE+    I++RD++  NVLL  +   K+ D+ +  +       
Sbjct: 111 HARF-YSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 166

Query: 234 LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
             +    GT  Y APE           D ++ GV++ E++ GR P
Sbjct: 167 TST--FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 55.7 bits (135), Expect = 6e-09
 Identities = 62/240 (25%), Positives = 100/240 (41%), Gaps = 39/240 (16%)

Query: 54  EIPQIKLDELNRLT-SNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESD 111
           E+ + +     +L   +F    ++G+GS+G+VF A+        AIK L        + D
Sbjct: 2   ELNKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL--------KKD 53

Query: 112 FAAQLSVVSRLKHE---------H-FVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRK 160
                  V     E         H F+  +    ++   +  V ++   G L    H + 
Sbjct: 54  VVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLM--YHIQS 111

Query: 161 GVQGAEPGPVLTWNQRVKVAYGA--AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI 218
             +            R    Y A    GL+FLH K    IV+RD++  N+LL  D   KI
Sbjct: 112 CHKFDLS--------RAT-FYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKI 159

Query: 219 ADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           ADF +  ++    A+ ++    GT  Y APE  +  +     D +SFGV+L E+L G+ P
Sbjct: 160 ADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 24/218 (11%)

Query: 68  SNFGTKALIGEGSYGRVFYAKLTD-GTPAAIK---KLDTSSAPEPESDFAAQLSVVSRLK 123
           S+F    +IG+GS+G+V  A+        A+K   K       E +   + +  ++  +K
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97

Query: 124 HEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
           H  F+  L +  ++ +++  V  +   G L    H ++     EP        R +  Y 
Sbjct: 98  H-PFLVGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEP--------RARF-YA 145

Query: 183 A--AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           A  A  L +LH      IV+RD++  N+LL       + DF L  ++ +  +   +    
Sbjct: 146 AEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FC 200

Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           GT  Y APE        +  D +  G VL E+L G  P
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 54.2 bits (131), Expect = 3e-08
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 24/218 (11%)

Query: 68  SNFGTKALIGEGSYGRVFYAKLTD-GTPAAIK---KLDTSSAPEPESDFAAQLSVVSRLK 123
           ++F    ++G+GS+G+V  ++        A+K   K       + E     +  V++   
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEK-RVLALPG 78

Query: 124 HEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
              F+  L  C ++ +R+  V ++   G L  + H ++  +  EP             Y 
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEP--------HAVF-YA 127

Query: 183 A--AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
           A  A GL FL  K    I++RD++  NV+L  +   KIADF +  ++        +    
Sbjct: 128 AEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FC 182

Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           GT  Y APE        +  D ++FGV+L E+L G+ P
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 52.9 bits (128), Expect = 4e-08
 Identities = 59/254 (23%), Positives = 84/254 (33%), Gaps = 83/254 (32%)

Query: 56  PQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAA 114
           P+  L +   L         +G GS+GRV   +    G   A+K L              
Sbjct: 1   PKYSLQDFQIL-------RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKE----------- 42

Query: 115 QLSVVSRLKHEHFVELLGYCMESNNRILV-----------YQFATMGSLHDVL------- 156
              +V RLK    VE           +L              F     +  ++       
Sbjct: 43  ---IVVRLKQ---VE----HTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGE 92

Query: 157 ---HGRKGVQGAEPGPVLTWNQRVKVAYGA--AKGLEFLHEKVQPPIVHRDVRSSNVLLF 211
                RK  +   P          K  Y A     LE+LH K    I++RD++  N+LL 
Sbjct: 93  LFSLLRKSQRFPNP--------VAKF-YAAEVCLALEYLHSK---DIIYRDLKPENILLD 140

Query: 212 DDFKSKIADFNLTNQSSDTAARLHSTRVL-GTFGYHAPEYAMTGQITQKS------DVYS 264
            +   KI DF       D       T  L GT  Y APE      +          D +S
Sbjct: 141 KNGHIKITDFGFAKYVPDV------TYTLCGTPDYIAPE------VVSTKPYNKSIDWWS 188

Query: 265 FGVVLLELLTGRKP 278
           FG+++ E+L G  P
Sbjct: 189 FGILIYEMLAGYTP 202

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 53.4 bits (129), Expect = 4e-08
 Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 38/225 (16%)

Query: 68  SNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE- 125
            NF    ++G+GS+G+V  A++ + G   A+K L        + D   Q   V     E 
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVL--------KKDVILQDDDVECTMTEK 74

Query: 126 --------H-FVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQ 175
                   H F+  L  C ++ +R+  V +F   G L  + H +K  +  E         
Sbjct: 75  RILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEA-------- 124

Query: 176 RVKVAYGA--AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAAR 233
           R +  Y A     L FLH+K    I++RD++  NVLL  +   K+ADF +  +       
Sbjct: 125 RARF-YAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180

Query: 234 LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP 278
             +    GT  Y APE           D ++ GV+L E+L G  P
Sbjct: 181 TAT--FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 59/268 (22%), Positives = 100/268 (37%), Gaps = 69/268 (25%)

Query: 43  KTGTPQKALPIEIPQIKLDELNRLT---------SNFGTKALIGEGSYGRVFYAKLTD-G 92
           K G+ Q+++   + + K D L +             F     +G GS+GRV   K  + G
Sbjct: 7   KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66

Query: 93  TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKH-EHFVELLGYCMESNNRIL--------- 142
              A+K LD                 V +LK  EH          +  RIL         
Sbjct: 67  NHYAMKILDKQ--------------KVVKLKQIEH--------TLNEKRILQAVNFPFLV 104

Query: 143 --VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK-----VA--YGA--AKGLEFLH 191
              + F    +L+ V+   + V G E   + +  +R+       A  Y A      E+LH
Sbjct: 105 KLEFSFKDNSNLYMVM---EYVAGGE---MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158

Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL-GTFGYHAPEY 250
                 +++RD++  N+L+      ++ DF    +          T  L GT    APE 
Sbjct: 159 SL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPEALAPEI 209

Query: 251 AMTGQITQKSDVYSFGVVLLELLTGRKP 278
            ++    +  D ++ GV++ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 50.9 bits (122), Expect = 2e-07
 Identities = 53/220 (24%), Positives = 91/220 (41%), Gaps = 25/220 (11%)

Query: 66  LTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIK----KLDTSSAPEPESDFAAQLSVVS 120
               +   +LIG+GS+G+V  A    +    AIK    K    +  + E      ++   
Sbjct: 52  WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHD 111

Query: 121 RLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVL--HGRKGVQGAEPGPVLTWNQRVK 178
                + V L  + M  N+  LV++  +  +L+D+L     +G         ++ N   K
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRG---------VSLNLTRK 161

Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS--KIADFNLTNQSSDTAARLHS 236
            A      L FL    +  I+H D++  N+LL +  +S  KI DF     SS    +   
Sbjct: 162 FAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG----SSCQLGQRIY 216

Query: 237 TRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGR 276
             +   F Y +PE  +        D++S G +L+E+ TG 
Sbjct: 217 QYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 51/222 (22%), Positives = 80/222 (36%), Gaps = 43/222 (19%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQL----SVVSRLKH-EHFVE 129
           IG GS+G ++    +  G   AIK        E       QL     +   ++       
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKL-------ECVKTKHPQLHIESKIYKMMQGGVGIPT 69

Query: 130 LLGYCMESNNRILVYQFATMG-SLHDVL--HGRKGVQGAEPGPVLTWNQRVKVAYGAAKG 186
           +     E +  ++V +   +G SL D+     RK           +    + +A      
Sbjct: 70  IRWCGAEGDYNVMVMEL--LGPSLEDLFNFCSRK----------FSLKTVLLLADQMISR 117

Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKSK---IADFNLTNQSSDTAARLH-----STR 238
           +E++H K     +HRDV+  N L+    K     I DF L  +  D     H     +  
Sbjct: 118 IEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 174

Query: 239 VLGTFGYHAPEYAMTGQITQ--KSDVYSFGVVLLELLTGRKP 278
           + GT  Y A      G I Q  + D+ S G VL+    G  P
Sbjct: 175 LTGTARY-ASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLP 214

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 50.5 bits (121), Expect = 4e-07
 Identities = 24/98 (24%), Positives = 41/98 (41%), Gaps = 13/98 (13%)

Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS------KIADFNLTNQSSDTAARLHSTR 238
            GL+++H +    I+H D++  NVL+            KIAD        +       TR
Sbjct: 142 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199

Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGR 276
                 Y +PE  +       +D++S   ++ EL+TG 
Sbjct: 200 E-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 49.7 bits (119), Expect = 8e-07
 Identities = 52/216 (24%), Positives = 94/216 (43%), Gaps = 35/216 (16%)

Query: 74  ALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQ----LSVVSRLKHE--- 125
            +IG+GS+G+V  A         A+K +        E  F  Q    + ++  L+ +   
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMV------RNEKRFHRQAAEEIRILEHLRKQDKD 156

Query: 126 ---HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
              + + +L      N+  + ++  +M +L++++   K  QG       +     K A+ 
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKF-QG------FSLPLVRKFAHS 208

Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS--KIADFNLTNQSSDTAARLHSTRVL 240
             + L+ LH+     I+H D++  N+LL    +S  K+ DF     SS    +   T + 
Sbjct: 209 ILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG----SSCYEHQRVYTYIQ 261

Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGR 276
             F Y APE  +  +     D++S G +L ELLTG 
Sbjct: 262 SRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 47.0 bits (112), Expect = 4e-06
 Identities = 52/224 (23%), Positives = 78/224 (34%), Gaps = 45/224 (20%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKH-----EHFVE 129
           IGEGS+G +F    L +    AIK        EP    A QL    R             
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKF-------EPRRSDAPQLRDEYRTYKLLAGCTGIPN 70

Query: 130 LLGYCMESNNRILVYQFATMG-SLHDVL--HGRKGVQGAEPGPVLTWNQRVKVAYGAAKG 186
           +  +  E  + +LV     +G SL D+L   GRK           +       A      
Sbjct: 71  VYYFGQEGLHNVLVIDL--LGPSLEDLLDLCGRK----------FSVKTVAMAAKQMLAR 118

Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKSK-----IADFNLTNQSSDTAARLH-----S 236
           ++ +HEK    +V+RD++  N L+            + DF +     D   + H      
Sbjct: 119 VQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175

Query: 237 TRVLGTFGYHAPEYAMTGQITQ--KSDVYSFGVVLLELLTGRKP 278
             + GT  Y        G   Q  + D+ + G V +  L G  P
Sbjct: 176 KNLSGTARY-MSINTHLG-REQSRRDDLEALGHVFMYFLRGSLP 217

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 48/280 (17%), Positives = 90/280 (32%), Gaps = 63/280 (22%)

Query: 36  EPRTNVVKTGTPQKALPIEIPQIKLDELNRLTSNFGTK----ALIGEGSYGRVFYAK-LT 90
              + V           +  P+ K+     L    G +      IG G +G ++ A    
Sbjct: 6   HHSSGVDLGTENLYFQSMPFPEGKV-----LDDMEGNQWVLGKKIGSGGFGLIYLAFPTN 60

Query: 91  DGTPAAIK--KLDTSSAP--EPESDF---AAQLSVVSRLKHEHFVELLG-----YC---- 134
                A    K++         E  F    A+   + +      ++ LG           
Sbjct: 61  KPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTE 120

Query: 135 -MESNNRILVYQFATMG-SLHDVL--HGR---KGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
               + R +V +   +G  L  +   +G      V              +++       L
Sbjct: 121 FKGRSYRFMVMER--LGIDLQKISGQNGTFKKSTV--------------LQLGIRMLDVL 164

Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI--ADFNLTNQSSDTAARLH----STRVL- 240
           E++HE      VH D++++N+LL      ++  AD+ L+ +               +   
Sbjct: 165 EYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHN 221

Query: 241 GTFGYHAPEYAMTGQITQ--KSDVYSFGVVLLELLTGRKP 278
           GT  +     A  G +    +SDV   G  +L  L G+ P
Sbjct: 222 GTIEF-TSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLP 259

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 41/217 (18%), Positives = 66/217 (30%), Gaps = 59/217 (27%)

Query: 76  IGEGSYGRVFYA--KLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +G G  G+V     K T     A+K L        E +   + S     +  H V ++  
Sbjct: 26  LGLGINGKVLQIFNKRT-QEKFALKMLQDCPKARREVELHWRAS-----QCPHIVRIVDV 79

Query: 134 C----MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
                      ++V +    G L   +  R      E           +        +++
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA-------IQY 132

Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKS---KIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           LH      I HRDV+  N+L      +   K+ DF                         
Sbjct: 133 LHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF----------------------- 166

Query: 247 APE-----YAMTGQITQKSDVYSFGVVLLELLTGRKP 278
           A E     Y       +  D++S GV++  LL G  P
Sbjct: 167 AKETTGEKY------DKSCDMWSLGVIMYILLCGYPP 197

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 54/222 (24%), Positives = 85/222 (38%), Gaps = 43/222 (19%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-----KHEHFVE 129
           IG GS+G ++    +      AIK        E       QL   S++            
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKL-------ENVKTKHPQLLYESKIYRILQGGTGIPN 67

Query: 130 LLGYCMESNNRILVYQFATMG-SLHDVL--HGRKGVQGAEPGPVLTWNQRVKVAYGAAKG 186
           +  + +E +  +LV     +G SL D+     RK          L+    + +A      
Sbjct: 68  VRWFGVEGDYNVLVMDL--LGPSLEDLFNFCSRK----------LSLKTVLMLADQMINR 115

Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKSK---IADFNLTNQSSDTAARLH-----STR 238
           +EF+H K     +HRD++  N L+    ++    I DF L  +  DT+   H     +  
Sbjct: 116 VEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172

Query: 239 VLGTFGYHAPEYAMTGQITQ--KSDVYSFGVVLLELLTGRKP 278
           + GT  Y A      G I Q  + D+ S G VL+  L G  P
Sbjct: 173 LTGTARY-ASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLP 212

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 43.5 bits (103), Expect = 6e-05
 Identities = 47/224 (20%), Positives = 78/224 (34%), Gaps = 45/224 (20%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKH-----EHFVE 129
           IG G++G +   K L      AIK        EP    A QL +  R        +   +
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKL-------EPMKSRAPQLHLEYRFYKQLGSGDGIPQ 69

Query: 130 LLGYCMESNNRILVYQFATMG-SLHDV--LHGRKGVQGAEPGPVLTWNQRVKVAYGAAKG 186
           +  +        +V +   +G SL D+  L  R            +    + +A      
Sbjct: 70  VYYFGPCGKYNAMVLEL--LGPSLEDLFDLCDRT----------FSLKTVLMIAIQLISR 117

Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKSK-----IADFNLTNQSSDTAARLH-----S 236
           +E++H K    +++RDV+  N L+            I DF L  +  D   + H      
Sbjct: 118 MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREH 174

Query: 237 TRVLGTFGYHAPEYAMTGQITQ--KSDVYSFGVVLLELLTGRKP 278
             + GT  Y        G   Q  + D+ + G + +  L G  P
Sbjct: 175 KSLTGTARY-MSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLP 216

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 43/277 (15%), Positives = 91/277 (32%), Gaps = 54/277 (19%)

Query: 36  EPRTNVVKTGTPQKALPIEIPQIKLDELNRLTSNFGTK----ALIGEGSYGRVFYAKLTD 91
                  +  + ++ L  +    ++     +T            IG+G +G ++ A +  
Sbjct: 4   VKAAQAGRQSSAKRHLAEQFAVGEI-----ITDMAAAAWKVGLPIGQGGFGCIYLADMNS 58

Query: 92  GTPAAIK-----KLDTSSAP--EPESDF---AAQLSVVSRLKHEHFVELLG-----YCME 136
                       K++ S       E  F   AA+   + +      ++ LG         
Sbjct: 59  SESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGL 118

Query: 137 SNNRILVYQFATM---G-SLHDVL--HGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFL 190
            +     Y+F  M   G  L  +   + ++           +    ++++      LE++
Sbjct: 119 HDKNGKSYRFMIMDRFGSDLQKIYEANAKR----------FSRKTVLQLSLRILDILEYI 168

Query: 191 HEKVQPPIVHRDVRSSNVLLFDDFKSKI--ADFNLTNQSSDTAARLH-----STRVLGTF 243
           HE      VH D+++SN+LL      ++   D+ L  +                   GT 
Sbjct: 169 HEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTI 225

Query: 244 GYHAPEYAMTGQITQ--KSDVYSFGVVLLELLTGRKP 278
            +     A  G +    + D+   G  +++ LTG  P
Sbjct: 226 EF-TSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLP 260

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 40.8 bits (96), Expect = 5e-04
 Identities = 51/260 (19%), Positives = 90/260 (34%), Gaps = 71/260 (27%)

Query: 57  QIKLDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIK------KLDTSSAPEPE 109
             K   L  L + F     +G+G++GRV   + + +    A+K      K   S+  E  
Sbjct: 26  SWKKGML--LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE-- 81

Query: 110 SDFAAQLSVVSRLKHE-----HFVELLGYCMESNNRILVYQFATMG-SLHDVL--HGRKG 161
                   ++ +++++     + V+  G  M  ++  L+  F  +G SL++++  +   G
Sbjct: 82  ------ADILKKIQNDDINNNNIVKYHGKFMYYDHMCLI--FEPLGPSLYEIITRNNYNG 133

Query: 162 VQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADF 221
                                  K L +L +     + H D++  N+LL D +  K    
Sbjct: 134 ---------FHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLIT 181

Query: 222 NLTNQSSDTAARLHSTRV---LGTFG-----------------YHAPE------YAMTGQ 255
                         +      L  FG                 Y APE      +     
Sbjct: 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW----- 236

Query: 256 ITQKSDVYSFGVVLLELLTG 275
               SD++SFG VL EL TG
Sbjct: 237 -DVSSDMWSFGCVLAELYTG 255

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 40.7 bits (95), Expect = 5e-04
 Identities = 30/184 (16%), Positives = 51/184 (27%), Gaps = 64/184 (34%)

Query: 142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHR 201
           +V++      L   +          P P +       +     +GL++LH K +  I+H 
Sbjct: 122 MVFEVLGH-HLLKWIIKSNY--QGLPLPCVKK-----IIQQVLQGLDYLHTKCR--IIHT 171

Query: 202 DVRSSNVLL-------------------------------------------------FD 212
           D++  N+LL                                                  +
Sbjct: 172 DIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAE 231

Query: 213 DFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLEL 272
             K KIAD                TR      Y + E  +       +D++S   +  EL
Sbjct: 232 KLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFEL 286

Query: 273 LTGR 276
            TG 
Sbjct: 287 ATGD 290

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 40.6 bits (94), Expect = 7e-04
 Identities = 51/421 (12%), Positives = 107/421 (25%), Gaps = 142/421 (33%)

Query: 48  QKALPIEIPQIK--------LDELNRLTSNFGTKALIG-----EGSYGRVFYAKLTDGTP 94
           +  L +               D    + S      +I       G+  R+F+  L+    
Sbjct: 19  KDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTL-RLFWTLLSKQEE 77

Query: 95  AAIKKLDTSSAPEPESDF-AAQLSVVSR---LKHEHFVELLGYCMESNNRIL----VYQF 146
              K ++          F  + +    R   +    ++E     + ++N++     V + 
Sbjct: 78  MVQKFVEEVL--RINYKFLMSPIKTEQRQPSMMTRMYIEQRDR-LYNDNQVFAKYNVSRL 134

Query: 147 ATMGSLHD-----------VLHGRKG---------------VQGAEPGPVLTW------- 173
                L             ++ G  G               VQ      +  W       
Sbjct: 135 QPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIF-WLNLKNCN 193

Query: 174 ----------------------------NQRVKVAYGAAKGLEFLHEKVQPP--IVHRDV 203
                                       N ++++    A+    L  K      +V  +V
Sbjct: 194 SPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNV 253

Query: 204 RSSNVL-LFDDFKSKI----ADFNLTNQ-SSDTAARLHSTRVLGTFGYHAPEYAMTGQIT 257
           +++     F +   KI        +T+  S+ T   +       T     P+   +    
Sbjct: 254 QNAKAWNAF-NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLT---PDEVKS---- 305

Query: 258 QKSDVYSFGVVLLELLTGRKPVD--HTMPKG------------QQSLVTWAT-PRLSEDK 302
                      LL      +P D    +               +  L TW     ++ DK
Sbjct: 306 -----------LLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDK 354

Query: 303 VKQCVDPKLNNDYPP--KAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL-LNSKPAGP 359
           +   ++  LN   P   + +    +V          F P+  I    L  +  +   +  
Sbjct: 355 LTTIIESSLNVLEPAEYRKMFDRLSV----------FPPSAHIPTILLSLIWFDVIKSDV 404

Query: 360 E 360
            
Sbjct: 405 M 405

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	363
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.79
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.51
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.41
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.35
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.13
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.96
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.76
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.74
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.69
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.54
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.53
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.36
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.34
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.05
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.04
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.03
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	98.03
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.92
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.87
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.83
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.74
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.67
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.64
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.52
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.48
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.4
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.98
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.86
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.4
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	95.08
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	94.82
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	83.77

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.7e-62  Score=433.61  Aligned_cols=267  Identities=24%  Similarity=0.353  Sum_probs=219.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRI  141 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  141 (363)
                      .++++.+.||+|+||.||+|++.      +++.||||+++........+.|.+|+.++++++|||||++++++.+....+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            35667888999999999999863      467899999987655556688999999999999999999999999999999


Q ss_pred             EEEecccCCChhhhhcCCCCCCC-------CCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQG-------AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF  214 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~  214 (363)
                      |||||+++|+|.++|........       ......+++.+++.++.||+.||.|||++   +||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence            99999999999999975432111       11123489999999999999999999999   999999999999999999


Q ss_pred             ceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhh
Q 046595          215 KSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTW  293 (363)
Q Consensus       215 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~  293 (363)
                      .+||+|||+++...........+...||+.|||||++.++.|+.++|||||||+||||+| |..||......+       
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~-------  255 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-------  255 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH-------
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH-------
Confidence            999999999986655444333455689999999999999999999999999999999998 899997543221       


Q ss_pred             ccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccc
Q 046595          294 ATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN  353 (363)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~  353 (363)
                               +...+..+.....+..++..+.+|+.+||+.||++|||+.+|++.|+...+
T Consensus       256 ---------~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n  306 (308)
T 4gt4_A          256 ---------VVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN  306 (308)
T ss_dssp             ---------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred             ---------HHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence                     111122222334456777889999999999999999999999999987643

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.1e-62  Score=436.28  Aligned_cols=270  Identities=27%  Similarity=0.447  Sum_probs=219.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRI  141 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  141 (363)
                      ++|.+.+.||+|+||.||+|++.      ++..||||+++.. .....+.|.+|+.+|++++|||||++++++.+.+..+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            46888999999999999999764      4678999999753 2334568999999999999999999999999999999


Q ss_pred             EEEecccCCChhhhhcCCCCC----CCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceE
Q 046595          142 LVYQFATMGSLHDVLHGRKGV----QGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSK  217 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~----~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk  217 (363)
                      |||||+++|+|.++|......    ........+++.+++.++.|++.||.|||++   +|+||||||+||||+.++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence            999999999999999764310    0112223499999999999999999999999   999999999999999999999


Q ss_pred             EeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccc
Q 046595          218 IADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATP  296 (363)
Q Consensus       218 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~  296 (363)
                      |+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||........         
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~---------  239 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---------  239 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---------
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---------
Confidence            999999976544443333444679999999999999999999999999999999999 8999975433211         


Q ss_pred             cccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCC
Q 046595          297 RLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA  357 (363)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~  357 (363)
                             ...+..+.....|..++.++.+|+.+||+.||++|||+++|++.|+++.+..|.
T Consensus       240 -------~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p~  293 (299)
T 4asz_A          240 -------IECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPV  293 (299)
T ss_dssp             -------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCC
T ss_pred             -------HHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCCc
Confidence                   111111222334556778899999999999999999999999999999877664

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=8e-62  Score=436.61  Aligned_cols=270  Identities=27%  Similarity=0.416  Sum_probs=212.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRI  141 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  141 (363)
                      ++|.+.+.||+|+||.||+|++.      +++.||||+++.. .....+.|.+|+.+|++++|||||+++++|.+....+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            46778889999999999999864      4778999999753 2334568999999999999999999999999999999


Q ss_pred             EEEecccCCChhhhhcCCCCCCC------CCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCc
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQG------AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK  215 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~  215 (363)
                      |||||+++|+|.+++........      ......+++.+++.++.|++.||.|||++   +|+||||||+||||++++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence            99999999999999986542211      11223599999999999999999999999   9999999999999999999


Q ss_pred             eEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhc
Q 046595          216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWA  294 (363)
Q Consensus       216 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~  294 (363)
                      +||+|||+++...............||+.|||||++.+..|+.++|||||||+||||+| |+.||........       
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~-------  269 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA-------  269 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH-------
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH-------
Confidence            99999999987655444333455689999999999999999999999999999999999 8999975432211       


Q ss_pred             cccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCC
Q 046595          295 TPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA  357 (363)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~  357 (363)
                               ...+..+.....|..++.++.+|+.+||+.||++|||+.+|++.|+.+.+..+.
T Consensus       270 ---------~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp~  323 (329)
T 4aoj_A          270 ---------IDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV  323 (329)
T ss_dssp             ---------HHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC-
T ss_pred             ---------HHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCcc
Confidence                     111111222344556778899999999999999999999999999999887553

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.7e-61  Score=432.80  Aligned_cols=249  Identities=23%  Similarity=0.370  Sum_probs=210.1

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      +.|++.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.+|+.++|||||++++++.+.+.+||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            46999999999999999999865 69999999997643 33456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      ++||+|.+++....          +++.++..++.||+.||.|||++   +|+||||||+||||+.+|.+||+|||+|+.
T Consensus       153 ~~gg~L~~~l~~~~----------l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~  219 (346)
T 4fih_A          153 LEGGALTDIVTHTR----------MNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ  219 (346)
T ss_dssp             CTTEEHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             CCCCcHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCcee
Confidence            99999999997643          89999999999999999999999   999999999999999999999999999976


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      .......  ....+||+.|||||++.+..|+.++|||||||+||||++|+.||...........+.            ..
T Consensus       220 ~~~~~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~------------~~  285 (346)
T 4fih_A          220 VSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR------------DN  285 (346)
T ss_dssp             CCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------------HS
T ss_pred             cCCCCCc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH------------cC
Confidence            5443222  345789999999999999999999999999999999999999997543322111111            00


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ...  .......++.++.+||.+||+.||++|||+.|+++
T Consensus       286 ~~~--~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          286 LPP--RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             SCC--CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCC--CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            000  11122345677999999999999999999999987

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=6.3e-61  Score=425.19  Aligned_cols=265  Identities=27%  Similarity=0.439  Sum_probs=208.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      +++.+.+.||+|+||.||+|++.+  .||||+++..... ...+.|.+|+.++++++|||||++++++.+ +.++|||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            467888999999999999998753  5999998754322 234679999999999999999999998754 678999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +++|+|.++|.....        .+++.+++.|+.|++.||.|||++   +||||||||+||||++++.+||+|||+|+.
T Consensus       113 ~~gGsL~~~l~~~~~--------~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  181 (307)
T 3omv_A          113 CEGSSLYKHLHVQET--------KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATV  181 (307)
T ss_dssp             CSSCBHHHHHHTSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred             CCCCCHHHHHhhcCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCcee
Confidence            999999999975432        389999999999999999999999   999999999999999999999999999987


Q ss_pred             CCcccccccccccccccCCCCcccccc---CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMT---GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      .............+||+.|||||++.+   +.|+.++|||||||+||||+||+.||............  ...       
T Consensus       182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~--~~~-------  252 (307)
T 3omv_A          182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM--VGR-------  252 (307)
T ss_dssp             ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH--HHT-------
T ss_pred             cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH--Hhc-------
Confidence            654444333456789999999999864   46899999999999999999999999754332211111  000       


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCC
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA  357 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~  357 (363)
                       ....+. ....+..++..+.+|+.+||+.||++|||+.+|++.|+.|....+.
T Consensus       253 -~~~~p~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk  304 (307)
T 3omv_A          253 -GYASPD-LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK  304 (307)
T ss_dssp             -TCCCCC-STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred             -CCCCCC-cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence             000111 1223445677899999999999999999999999999988776654

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.8e-62  Score=430.83  Aligned_cols=248  Identities=23%  Similarity=0.329  Sum_probs=210.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|++++.||+|+||.||+|++. +++.||||++....  .....+.+.+|+++++.++||||+++++++.+.+.+||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            36999999999999999999764 69999999996532  2345678999999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||++||+|.+++....         .+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|
T Consensus       112 Ey~~gG~L~~~i~~~~---------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla  179 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG---------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTA  179 (311)
T ss_dssp             CCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCc
Confidence            9999999999997654         299999999999999999999999   9999999999999999999999999999


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      +..............+||+.|||||++.+..|+.++|||||||+||||++|+.||...+.......+             
T Consensus       180 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i-------------  246 (311)
T 4aw0_A          180 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKI-------------  246 (311)
T ss_dssp             EECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------------
T ss_pred             eecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------------
Confidence            8765443333455678999999999999999999999999999999999999999754322111111             


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIV  344 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~v  344 (363)
                        ....  ..++...+.++.+||.+||+.||++|||++|+
T Consensus       247 --~~~~--~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~  282 (311)
T 4aw0_A          247 --IKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEM  282 (311)
T ss_dssp             --HHTC--CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred             --HcCC--CCCCcccCHHHHHHHHHHccCCHhHCcChHHH
Confidence              1111  12344456679999999999999999999885

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.9e-61  Score=433.29  Aligned_cols=251  Identities=22%  Similarity=0.354  Sum_probs=204.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      ++|++++.||+|+||.||+|++. +|+.||||++...... ...+.+.+|+.++++++|||||++++++.+.+.+|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            48999999999999999999864 6999999999765432 234678999999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      ||+||+|.++|...+.       ..+++.+++.++.||+.||.|||++   +|+||||||+||||+.+|.+||+|||+|+
T Consensus       104 y~~gg~L~~~i~~~~~-------~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~  173 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKG-------VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIAR  173 (350)
T ss_dssp             CCTTCBHHHHHHHTTT-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEES
T ss_pred             CCCCCcHHHHHHHcCC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccce
Confidence            9999999999975432       1378999999999999999999999   99999999999999999999999999998


Q ss_pred             CCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      ........  ....+||+.|||||++.+..|+.++|||||||+||||++|+.||...........+              
T Consensus       174 ~~~~~~~~--~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i--------------  237 (350)
T 4b9d_A          174 VLNSTVEL--ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI--------------  237 (350)
T ss_dssp             CCCHHHHH--HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--------------
T ss_pred             eecCCccc--ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH--------------
Confidence            76543221  34568999999999999999999999999999999999999999754332111111              


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                       ..... ...+..++.++.+||.+||+.||++|||+.++++
T Consensus       238 -~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          238 -ISGSF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             -HHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HcCCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             11010 1223345677999999999999999999999986

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.6e-60  Score=436.54  Aligned_cols=249  Identities=23%  Similarity=0.373  Sum_probs=210.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      +.|++.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.+|+.++|||||++++++.+.+.+||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT-CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            46999999999999999999865 69999999997643 34456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      |+||+|.+++....          +++.++..++.||+.||.|||++   +|+||||||+||||+.+|.+||+|||+|+.
T Consensus       230 ~~gG~L~~~i~~~~----------l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~  296 (423)
T 4fie_A          230 LEGGALTDIVTHTR----------MNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ  296 (423)
T ss_dssp             CTTEEHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEE
T ss_pred             CCCCcHHHHHhccC----------CCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceE
Confidence            99999999997643          89999999999999999999999   999999999999999999999999999976


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      .......  ....+||+.|||||++.+..|+.++|||||||++|||++|+.||...........+.            ..
T Consensus       297 ~~~~~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~------------~~  362 (423)
T 4fie_A          297 VSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR------------DN  362 (423)
T ss_dssp             CCSSCCC--BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------------HS
T ss_pred             CCCCCcc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH------------cC
Confidence            5443222  345789999999999999999999999999999999999999997553322211111            00


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ....  ......++.++.+||.+||+.||++|||+.|+++
T Consensus       363 ~~~~--~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          363 LPPR--LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             CCCC--CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCC--CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0001  1112345567999999999999999999999987

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5e-60  Score=423.36  Aligned_cols=255  Identities=23%  Similarity=0.272  Sum_probs=209.1

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      ..|.+.+.||+|+||.||+|++. +|+.||||+++....      ..+|+.+++.++|||||++++++.+...+||||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            45788889999999999999865 699999999976322      24699999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC-ceEEeeeccCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF-KSKIADFNLTN  225 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Dfg~a~  225 (363)
                      ++||+|.++|....         .+++.++..++.|++.||.|||++   +|+||||||+||||+.+| .+||+|||+|+
T Consensus       132 ~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~  199 (336)
T 4g3f_A          132 LEGGSLGQLIKQMG---------CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHAL  199 (336)
T ss_dssp             CTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred             cCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence            99999999997654         399999999999999999999999   999999999999999887 69999999997


Q ss_pred             CCCccccc---ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          226 QSSDTAAR---LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       226 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      ........   ......+||+.|||||++.+..|+.++|||||||+||||++|+.||...........+....+      
T Consensus       200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~------  273 (336)
T 4g3f_A          200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP------  273 (336)
T ss_dssp             EC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCC------
T ss_pred             EccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCC------
Confidence            65432211   122346799999999999999999999999999999999999999976544332221111000      


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                              ....++..++..+.++|.+||+.||.+|||+.||++.|...+.+
T Consensus       274 --------~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          274 --------PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             --------GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence                    00123445667899999999999999999999999988776654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.6e-59  Score=408.39  Aligned_cols=246  Identities=24%  Similarity=0.336  Sum_probs=193.1

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|++.+.||+|+||.||+|++. +|+.||||++....  .......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            58999999999999999999864 69999999997643  2334567999999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+ +|+|.+++....         .+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|
T Consensus        93 Ey~-~g~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla  159 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD---------KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLS  159 (275)
T ss_dssp             ECC-CEEHHHHHHHSC---------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC
T ss_pred             eCC-CCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCC
Confidence            999 679999997654         399999999999999999999999   9999999999999999999999999999


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCC-CccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      +.......   ....+||+.|||||++.+..| +.++|||||||++|+|++|+.||...........+            
T Consensus       160 ~~~~~~~~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i------------  224 (275)
T 3hyh_A          160 NIMTDGNF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI------------  224 (275)
T ss_dssp             ------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------------
T ss_pred             eecCCCCc---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------------
Confidence            76544322   345689999999999998876 57999999999999999999999754221110000            


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                         ...  ...++..++.++.+||.+||+.||++|||++|+++
T Consensus       225 ---~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          225 ---SNG--VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ---HHT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---HcC--CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence               000  01223445677999999999999999999999987

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.1e-59  Score=423.04  Aligned_cols=273  Identities=23%  Similarity=0.358  Sum_probs=221.6

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeCC------CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCC-CccceeeeEEEeC
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLTD------GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKH-EHFVELLGYCMES  137 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~  137 (363)
                      .-.++|++.+.||+|+||.||+|.+..      ++.||||.+.........+.+.+|+.+|.+++| ||||+++++|.+.
T Consensus        61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            335689999999999999999997542      357999999875554455779999999999965 9999999998764


Q ss_pred             -CeeEEEEecccCCChhhhhcCCCCCC-------CCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCcee
Q 046595          138 -NNRILVYQFATMGSLHDVLHGRKGVQ-------GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVL  209 (363)
Q Consensus       138 -~~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil  209 (363)
                       ..+++|||||++|+|.++|+......       .......+++.+++.++.||+.||.|||++   +||||||||+|||
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NIL  217 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL  217 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCcccee
Confidence             56899999999999999997543211       011123589999999999999999999999   9999999999999


Q ss_pred             ecCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCcccc
Q 046595          210 LFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQ  288 (363)
Q Consensus       210 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~  288 (363)
                      +++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||........ 
T Consensus       218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~-  296 (353)
T 4ase_A          218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-  296 (353)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-
T ss_pred             eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH-
Confidence            99999999999999987655444333456789999999999999999999999999999999998 8999975432211 


Q ss_pred             chhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccC
Q 046595          289 SLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK  355 (363)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~  355 (363)
                                    +...+..+.....|..++.++.+++.+||+.||++|||+.+|++.|+.++++.
T Consensus       297 --------------~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          297 --------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             --------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             --------------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence                          11111222233445566778999999999999999999999999999998764

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.1e-58  Score=407.93  Aligned_cols=245  Identities=23%  Similarity=0.348  Sum_probs=197.0

Q ss_pred             CCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEe----CCeeEEEE
Q 046595           71 GTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCME----SNNRILVY  144 (363)
Q Consensus        71 ~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~  144 (363)
                      ++.+.||+|+||.||+|.+. ++..||+|++..... ....+.+.+|+.+++.++|||||++++++.+    ...++|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            66778999999999999765 688999999875432 2234678999999999999999999999875    34578999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCC--eEEecccCCceeecC-CCceEEeee
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPP--IVHRDVRSSNVLLFD-DFKSKIADF  221 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nill~~-~~~vkl~Df  221 (363)
                      ||++||+|.+++....         .+++..+..++.||+.||.|||++   +  |+||||||+||||+. +|.+||+||
T Consensus       109 Ey~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DF  176 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDL  176 (290)
T ss_dssp             ECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCT
T ss_pred             eCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeC
Confidence            9999999999997654         389999999999999999999998   7  999999999999984 799999999


Q ss_pred             ccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccc
Q 046595          222 NLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       222 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      |+|+.....    .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||........  +.....      
T Consensus       177 Gla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~~~i~------  243 (290)
T 3fpq_A          177 GLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVT------  243 (290)
T ss_dssp             TGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHHT------
T ss_pred             cCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HHHHHH------
Confidence            999754332    2345689999999998864 699999999999999999999999965432111  111000      


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                            .......++...+.++.+||.+||+.||++|||++++++
T Consensus       244 ------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          244 ------SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ------TTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------cCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  000001112223456899999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.7e-59  Score=415.01  Aligned_cols=248  Identities=23%  Similarity=0.329  Sum_probs=199.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC----CCCeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      ++|++.+.||+|+||.||+|+..    +++.||||++..... ......+.+|+.++++++||||+++++++.+.+..||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            47999999999999999999752    478899999875431 1223468889999999999999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ||||++||+|.+++....         .+++.++..++.|++.||.|||++   +|+||||||+|||++.+|.+||+|||
T Consensus       104 vmEy~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFG  171 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV---------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFG  171 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSE
T ss_pred             EEEcCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccc
Confidence            999999999999998654         289999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      +|+........  ....+||+.|||||++.+..|+.++|||||||+||||++|+.||...........+           
T Consensus       172 la~~~~~~~~~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i-----------  238 (304)
T 3ubd_A          172 LSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI-----------  238 (304)
T ss_dssp             EEEC-----CC--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----------
T ss_pred             cceeccCCCcc--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH-----------
Confidence            99765443222  34578999999999999999999999999999999999999999754332211111           


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPN-----MTIVVK  346 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~~vl~  346 (363)
                          ...  ...++..++.++.+||.+||+.||++|||     ++|+++
T Consensus       239 ----~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          239 ----LKA--KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             ----HHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             ----HcC--CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence                011  11234456677999999999999999998     467775

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.7e-58  Score=410.72  Aligned_cols=274  Identities=23%  Similarity=0.350  Sum_probs=205.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHH--HHHHHHHhcCCCCccceeeeEEEeCC----ee
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDF--AAQLSVVSRLKHEHFVELLGYCMESN----NR  140 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~--~~e~~~l~~l~h~~i~~~~~~~~~~~----~~  140 (363)
                      .++|.+.+.||+|+||.||+|++ +|+.||||++...    ....+  ..|+..+..++||||+++++++.+.+    .+
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~----~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc----chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            35688889999999999999988 4899999998642    22333  34556667889999999999998764    57


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccC-----CCCeEEecccCCceeecCCCc
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV-----QPPIVHRDVRSSNVLLFDDFK  215 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-----~~~ivH~Dlkp~Nill~~~~~  215 (363)
                      +|||||+++|+|.++++...          +++..++.++.|++.||.|||+++     .++|+||||||+||||+.++.
T Consensus        77 ~lV~Ey~~~gsL~~~l~~~~----------l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~  146 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  146 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred             EEEecCCCCCcHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC
Confidence            89999999999999998654          899999999999999999999752     338999999999999999999


Q ss_pred             eEEeeeccCCCCCccccc--ccccccccccCCCCccccccC------CCCccCceehhHHHHHHHHhCCCCCCCCCCccc
Q 046595          216 SKIADFNLTNQSSDTAAR--LHSTRVLGTFGYHAPEYAMTG------QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQ  287 (363)
Q Consensus       216 vkl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~  287 (363)
                      +||+|||+|+........  ......+||+.|||||++.+.      .++.++|||||||+||||+||..||....... 
T Consensus       147 ~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~-  225 (303)
T 3hmm_A          147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ-  225 (303)
T ss_dssp             EEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC-
T ss_pred             EEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccc-
Confidence            999999998754332221  122346799999999998754      46789999999999999999998876433221 


Q ss_pred             cchhhhccccccccccc-cccCCcCCCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCC
Q 046595          288 QSLVTWATPRLSEDKVK-QCVDPKLNNDYP-----PKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP  356 (363)
Q Consensus       288 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~  356 (363)
                      ..+..+.........+. ......+...++     .+++..+.+|+.+||+.||++|||+.+|++.|++|.++..
T Consensus       226 ~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~  300 (303)
T 3hmm_A          226 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             ccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence            11111111111111111 122233333333     3567789999999999999999999999999999887653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.6e-57  Score=402.51  Aligned_cols=250  Identities=23%  Similarity=0.369  Sum_probs=191.6

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCC-------
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESN-------  138 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------  138 (363)
                      .++|++.+.||+|+||.||+|++. +|+.||||++.........+.+.+|+.+|+.++||||+++++++.+.+       
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            456999999999999999999865 699999999976544444567899999999999999999999987654       


Q ss_pred             -----eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCC
Q 046595          139 -----NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD  213 (363)
Q Consensus       139 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~  213 (363)
                           .+|+||||+.+|+|.+++.......      ...+..++.++.|++.||+|||++   +|+||||||+|||++.+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~------~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~  154 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIE------ERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMD  154 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGG------GSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCC------hhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCC
Confidence                 3689999999999999998654321      245677899999999999999999   99999999999999999


Q ss_pred             CceEEeeeccCCCCCccccc----------ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCC
Q 046595          214 FKSKIADFNLTNQSSDTAAR----------LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTM  283 (363)
Q Consensus       214 ~~vkl~Dfg~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~  283 (363)
                      +.+||+|||+|+........          ...+..+||+.|||||++.+..|+.++|||||||+||||++   ||....
T Consensus       155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~  231 (299)
T 4g31_A          155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM  231 (299)
T ss_dssp             CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred             CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence            99999999999866543221          11234679999999999999999999999999999999996   775221


Q ss_pred             CccccchhhhccccccccccccccCCcCCCCCC---HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          284 PKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYP---PKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .  ...            .+....    ...++   ......+.+||.+||+.||.+|||+.++++
T Consensus       232 ~--~~~------------~~~~~~----~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          232 E--RVR------------TLTDVR----NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             H--HHH------------HHHHHH----TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H--HHH------------HHHHHh----cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0  000            000111    11223   233456788999999999999999999987

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-55  Score=404.29  Aligned_cols=271  Identities=22%  Similarity=0.332  Sum_probs=206.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC-chHHHHHHHHHHhcCCCCccceeeeEEEe------CC
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLGYCME------SN  138 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~  138 (363)
                      .++|++++.||+|+||.||+|++. +|+.||||++....... ....+.+|+.+|+.++||||+++++++..      ..
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            357999999999999999999864 79999999997643322 23578899999999999999999998764      35


Q ss_pred             eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEE
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI  218 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl  218 (363)
                      ..||||||+. |+|.+++....         .+++.++..++.||+.||.|||++   ||+||||||+|||++.+|.+||
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~---------~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki  199 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQ---------PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKI  199 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSS---------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEE
T ss_pred             EEEEEEeCCC-CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEE
Confidence            7899999996 58999997654         399999999999999999999999   9999999999999999999999


Q ss_pred             eeeccCCCCCcccc--cccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 046595          219 ADFNLTNQSSDTAA--RLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      +|||+|+.......  .......+||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+....++...+....
T Consensus       200 ~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~  279 (398)
T 4b99_A          200 GDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVL  279 (398)
T ss_dssp             CCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH
T ss_pred             eecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence            99999986543221  2223457899999999998875 56999999999999999999999998665443332221111


Q ss_pred             ccccccc--------cccccCCcC-CCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhcc
Q 046595          296 PRLSEDK--------VKQCVDPKL-NNDY-----PPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQP  350 (363)
Q Consensus       296 ~~~~~~~--------~~~~~~~~~-~~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~  350 (363)
                      .......        ....+.... ....     .+..+.++.+||.+||..||.+|||+.++++  +|++
T Consensus       280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~  350 (398)
T 4b99_A          280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK  350 (398)
T ss_dssp             CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred             CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence            1111000        000000000 0000     1123567899999999999999999999987  4544

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.4e-53  Score=388.42  Aligned_cols=202  Identities=26%  Similarity=0.390  Sum_probs=172.5

Q ss_pred             HHHhcCCCCCCeeeccCCceEEEEEeC----CCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCC
Q 046595           64 NRLTSNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESN  138 (363)
Q Consensus        64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~  138 (363)
                      ..+.++|++.+.||+|+||.||+|+.+    +++.||+|++...   ....++.+|+++++.+ +||||+++++++.+.+
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~---~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT---SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT---SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc---cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            346678999999999999999999753    4678999998653   3346788999999988 6999999999999999


Q ss_pred             eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCC-CceE
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD-FKSK  217 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-~~vk  217 (363)
                      ..++||||+++|+|.+++..            +++.++..++.|++.||+|||++   ||+||||||+|||++.+ +.+|
T Consensus        94 ~~~lvmE~~~g~~L~~~~~~------------l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~k  158 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDILNS------------LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYA  158 (361)
T ss_dssp             EEEEEEECCCCCCHHHHHTT------------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEE
T ss_pred             EEEEEEeCCCcccHHHHHcC------------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEE
Confidence            99999999999999999952            88999999999999999999999   99999999999999876 8999


Q ss_pred             EeeeccCCCCCccccc--------------------------ccccccccccCCCCccccccC-CCCccCceehhHHHHH
Q 046595          218 IADFNLTNQSSDTAAR--------------------------LHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLL  270 (363)
Q Consensus       218 l~Dfg~a~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~  270 (363)
                      |+|||+|+........                          ......+||+.|+|||++.+. .|+.++||||+||++|
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~  238 (361)
T 4f9c_A          159 LVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFL  238 (361)
T ss_dssp             ECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred             ECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHH
Confidence            9999999754332111                          112335799999999999875 5899999999999999


Q ss_pred             HHHhCCCCCCCCC
Q 046595          271 ELLTGRKPVDHTM  283 (363)
Q Consensus       271 ell~g~~p~~~~~  283 (363)
                      ||++|+.||....
T Consensus       239 ell~G~~Pf~~~~  251 (361)
T 4f9c_A          239 SLLSGRYPFYKAS  251 (361)
T ss_dssp             HHHHTCSSSSCCS
T ss_pred             HHHHCCCCCCCCC
Confidence            9999999996443

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5.9e-53  Score=380.91  Aligned_cols=281  Identities=36%  Similarity=0.677  Sum_probs=241.3

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ...++|++.+.||+|+||.||+|.+.+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  114 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY  114 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC-CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEE
T ss_pred             HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            456799999999999999999999888999999998764 3344578899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+|+|.+++.....     ....+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++
T Consensus       115 e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  186 (321)
T 2qkw_B          115 KYMENGNLKRHLYGSDL-----PTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGIS  186 (321)
T ss_dssp             ECCTTCBTGGGSSSSCC-----CSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred             EcCCCCcHHHHHhccCC-----CccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccc
Confidence            99999999999976432     122489999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      ................||+.|+|||++.+..++.++||||||+++|||++|+.||....+........|.........+.
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (321)
T 2qkw_B          187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE  266 (321)
T ss_dssp             EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred             cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence            75443332222344568999999999999999999999999999999999999998777666555555555444455566


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                      ..+++.+....+..++..+.+++.+||+.||++|||+.+|++.|+.+++.
T Consensus       267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            67777777788899999999999999999999999999999999988764

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=9.9e-53  Score=403.13  Aligned_cols=249  Identities=23%  Similarity=0.320  Sum_probs=202.2

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHH---HHHHHhcCCCCccceeeeEEEeCCeeE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAA---QLSVVSRLKHEHFVELLGYCMESNNRI  141 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~  141 (363)
                      ++|++.++||+|+||.||+|+.. +|+.||||++.+..  ..........   ++.+++.++||||+++++++.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            46999999999999999999765 69999999986432  1122233333   456777889999999999999999999


Q ss_pred             EEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeee
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADF  221 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df  221 (363)
                      |||||+.||+|.++|....         .+++..+..++.||+.||.|||++   |||||||||+||||+.+|.+||+||
T Consensus       269 lVmEy~~GGdL~~~l~~~~---------~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DF  336 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG---------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDL  336 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEeccc
Confidence            9999999999999997654         399999999999999999999999   9999999999999999999999999


Q ss_pred             ccCCCCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccc
Q 046595          222 NLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE  300 (363)
Q Consensus       222 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  300 (363)
                      |+|+......    ....+||+.|||||++.+ ..|+.++|||||||+||||++|..||......+.......       
T Consensus       337 GlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~-------  405 (689)
T 3v5w_A          337 GLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-------  405 (689)
T ss_dssp             TTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH-------
T ss_pred             ceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-------
Confidence            9997654332    345689999999999964 5799999999999999999999999975433221111110       


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 046595          301 DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPN-----MTIVVK  346 (363)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~~vl~  346 (363)
                           ...  ....++..++.++.+||.+||+.||.+|++     +++|++
T Consensus       406 -----i~~--~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          406 -----TLT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             -----HHH--CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             -----hcC--CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                 000  112334456677999999999999999998     678765

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.5e-52  Score=403.51  Aligned_cols=252  Identities=19%  Similarity=0.281  Sum_probs=208.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      .++|++.+.||+|+||.||+|.++ +|+.||+|++.... ....+.+.+|+.+|+.++||||+++++++.+...++||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E  234 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  234 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            468999999999999999999765 69999999987632 2234678899999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCC--CceEEeeecc
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD--FKSKIADFNL  223 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~--~~vkl~Dfg~  223 (363)
                      |+.||+|.++|.....        .+++.++..++.||+.||.|||++   +|+||||||+|||++.+  +.+||+|||+
T Consensus       235 ~~~gg~L~~~i~~~~~--------~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~  303 (573)
T 3uto_A          235 FMSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGL  303 (573)
T ss_dssp             CCCCCBHHHHHTCTTS--------CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred             ecCCCcHHHHHHHhCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccc
Confidence            9999999999965432        389999999999999999999999   99999999999999854  8999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      |+.......   ....+||+.|||||++.+..|+.++|||||||+||||++|..||...........+.....       
T Consensus       304 a~~~~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~-------  373 (573)
T 3uto_A          304 TAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW-------  373 (573)
T ss_dssp             CEECCTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC-------
T ss_pred             eeEccCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCC-------
Confidence            987654322   3446899999999999999999999999999999999999999976543222111111000       


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                            .+.......++.++.+||.+||+.||.+|||+.|+++
T Consensus       374 ------~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          374 ------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             ------CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  0111111234567899999999999999999999987

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.7e-51  Score=369.25  Aligned_cols=291  Identities=35%  Similarity=0.655  Sum_probs=243.9

Q ss_pred             CCccCHHHHHHHhcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEE
Q 046595           55 IPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC  134 (363)
Q Consensus        55 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~  134 (363)
                      ...+...++....++|.+.+.||+|+||.||+|+..+++.||||++...........+.+|+.+++.++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            34567788888999999999999999999999998889999999998765554555789999999999999999999999


Q ss_pred             EeCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC
Q 046595          135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF  214 (363)
Q Consensus       135 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~  214 (363)
                      ......++||||+.+|+|.+++......     ...+++..++.++.|++.||.|||+++..+|+||||||+|||++.++
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~  171 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPES-----QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF  171 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTT-----CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC
Confidence            9999999999999999999999865422     23489999999999999999999998666899999999999999999


Q ss_pred             ceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCC--CCccccchhh
Q 046595          215 KSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHT--MPKGQQSLVT  292 (363)
Q Consensus       215 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~--~~~~~~~~~~  292 (363)
                      .+||+|||++......... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...  ..........
T Consensus       172 ~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  250 (326)
T 3uim_A          172 EAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD  250 (326)
T ss_dssp             CEEECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHH
T ss_pred             CEEeccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHH
Confidence            9999999998765433222 233456999999999999899999999999999999999999999621  1122233444


Q ss_pred             hccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 046595          293 WATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL  351 (363)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l  351 (363)
                      |.........+....+..+...++...+..+.+++.+||+.||.+|||+.+|++.|+..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             HHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            55555555666777777777888899999999999999999999999999999999854

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.2e-51  Score=379.04  Aligned_cols=269  Identities=25%  Similarity=0.427  Sum_probs=217.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC--------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeC
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT--------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMES  137 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  137 (363)
                      .++|.+.+.||+|+||.||+|++.        ++..||||++...........+.+|+.+++.+ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            357999999999999999999752        34569999997654434456789999999999 899999999999999


Q ss_pred             CeeEEEEecccCCChhhhhcCCCCCC-------CCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceee
Q 046595          138 NNRILVYQFATMGSLHDVLHGRKGVQ-------GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL  210 (363)
Q Consensus       138 ~~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill  210 (363)
                      ...++||||+.+|+|.+++.......       .......+++.+++.++.|++.||.|||++   +|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence            99999999999999999997654210       011123489999999999999999999999   99999999999999


Q ss_pred             cCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccc
Q 046595          211 FDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQS  289 (363)
Q Consensus       211 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~  289 (363)
                      +.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|||++ |..||.......   
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---  313 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---  313 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence            9999999999999976544333222344567889999999999999999999999999999999 999997543211   


Q ss_pred             hhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          290 LVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                                   +...+........+..++..+.+++.+||+.||.+||++.+|++.|+.++..
T Consensus       314 -------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~  365 (370)
T 2psq_A          314 -------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  365 (370)
T ss_dssp             -------------HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence                         1111111222334455667899999999999999999999999999998754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2e-50  Score=362.19  Aligned_cols=268  Identities=30%  Similarity=0.458  Sum_probs=207.6

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ...+|++.+.||+|+||.||+|++ +++.||||++...... .....+.+|+.++++++||||+++++++......++||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            346899999999999999999987 5888999998764422 22357889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCC--eEEecccCCceeecCCCceEEeeec
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPP--IVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ||+.+|+|.+++......      ..+++..++.++.|++.||.|||++   +  |+||||||+||+++.++.+||+|||
T Consensus       114 e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg  184 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAR------EQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFG  184 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHH------HHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred             ecCCCCcHHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCC
Confidence            999999999999764311      1288999999999999999999999   8  9999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      ++........  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.............          
T Consensus       185 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~----------  252 (309)
T 3p86_A          185 LSRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG----------  252 (309)
T ss_dssp             -------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH----------
T ss_pred             CCcccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----------
Confidence            9875443322  1334679999999999999999999999999999999999999997543321111110          


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCCCCC
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGPE  360 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~~~~  360 (363)
                           ........+..++..+.+++.+||+.||.+|||+.+|++.|+.++++...++.
T Consensus       253 -----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~  305 (309)
T 3p86_A          253 -----FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN  305 (309)
T ss_dssp             -----HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-------
T ss_pred             -----hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCC
Confidence                 01111233445567799999999999999999999999999999987655544

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.3e-50  Score=364.38  Aligned_cols=264  Identities=26%  Similarity=0.415  Sum_probs=214.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC----CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      .++|++.+.||+|+||.||+|.+.    .+..||||++...........+.+|+.+++.++||||+++++++.+....++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            357999999999999999999864    2445999999865444455789999999999999999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ||||+.+++|.+++.....        .+++.+++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus       128 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg  196 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDG--------QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFG  196 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCS
T ss_pred             EeeCCCCCcHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCC
Confidence            9999999999999965432        389999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCccccc-ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccc
Q 046595          223 LTNQSSDTAAR-LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSE  300 (363)
Q Consensus       223 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~  300 (363)
                      ++......... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||........             
T Consensus       197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-------------  263 (325)
T 3kul_A          197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV-------------  263 (325)
T ss_dssp             SCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-------------
T ss_pred             cccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH-------------
Confidence            98765443221 11223456788999999999999999999999999999999 9999965432211             


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCC
Q 046595          301 DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA  357 (363)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~  357 (363)
                         ...+........+..++..+.+++..||+.||.+|||+.+|++.|+.+++....
T Consensus       264 ---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~  317 (325)
T 3kul_A          264 ---ISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES  317 (325)
T ss_dssp             ---HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred             ---HHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence               111111222333445667899999999999999999999999999999876543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.3e-49  Score=355.11  Aligned_cols=250  Identities=23%  Similarity=0.361  Sum_probs=209.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      .++|++.+.||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            46899999999999999999985 568999999987543 3345678999999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+|+|.+++....          +++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.
T Consensus        98 ~~~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~  164 (297)
T 3fxz_A           98 YLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (297)
T ss_dssp             CCTTCBHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CCCCCCHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCce
Confidence            999999999997653          89999999999999999999999   99999999999999999999999999986


Q ss_pred             CCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      ........  .....||+.|+|||++.+..++.++||||||+++|+|++|..||....+.........            
T Consensus       165 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~------------  230 (297)
T 3fxz_A          165 QITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT------------  230 (297)
T ss_dssp             ECCSTTCC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH------------
T ss_pred             ecCCcccc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------
Confidence            55433222  3446799999999999999999999999999999999999999975433221111100            


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                        ........+..++..+.+++.+||+.||++|||+.++++
T Consensus       231 --~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          231 --NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             --HCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence              000111223445677999999999999999999999987

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=6.6e-51  Score=375.31  Aligned_cols=261  Identities=23%  Similarity=0.403  Sum_probs=215.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      .++|.+.+.||+|+||.||+|++. +++.||||++...........+.+|+.+++.++||||+++++++......++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            357889999999999999999876 7899999998764333334568899999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+|+|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       193 ~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~  261 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGA--------RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSR  261 (377)
T ss_dssp             CCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             cCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCce
Confidence            9999999999975431        288999999999999999999999   99999999999999999999999999987


Q ss_pred             CCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      ...............++..|+|||++.+..++.++||||||+++|||++ |..||.......                +.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~----------------~~  325 (377)
T 3cbl_A          262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ----------------TR  325 (377)
T ss_dssp             ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH----------------HH
T ss_pred             ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HH
Confidence            6544332222222346778999999999999999999999999999998 999997543211                11


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                      ..+........+..++..+.+++.+||+.||++|||+.+|++.|+.+.++
T Consensus       326 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          326 EFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            11222222334455677899999999999999999999999999988754

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=8.7e-50  Score=360.22  Aligned_cols=255  Identities=24%  Similarity=0.316  Sum_probs=206.9

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      +.++|++.+.||+|+||.||+|.+. +++.||+|++.........+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            3568999999999999999999865 789999999976554444567889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+++|.+++....         .+++.+++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        85 e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a  152 (323)
T 3tki_A           85 EYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLA  152 (323)
T ss_dssp             ECCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EcCCCCcHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeecc
Confidence            9999999999997654         289999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCC-CccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      ................||+.|+|||++.+..+ +.++||||||+++|+|++|+.||......... ...+..        
T Consensus       153 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~--------  223 (323)
T 3tki_A          153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKE--------  223 (323)
T ss_dssp             EECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHHT--------
T ss_pred             ceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhc--------
Confidence            76543333333445689999999999987775 78999999999999999999999755432111 111111        


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                           ..........++..+.+|+.+||+.||.+|||+.++++
T Consensus       224 -----~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          224 -----KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             -----TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----ccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                 11111112344567899999999999999999999987

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.8e-50  Score=362.62  Aligned_cols=276  Identities=24%  Similarity=0.339  Sum_probs=214.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCe----eEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNN----RIL  142 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~l  142 (363)
                      .++|++.+.||+|+||.||+|++. ++.||||++...  .........|+.++++++||||+++++++.....    .++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ--DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC--chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            358999999999999999999876 789999998652  2223455678889999999999999999987543    699


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccC-------CCCeEEecccCCceeecCCCc
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV-------QPPIVHRDVRSSNVLLFDDFK  215 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-------~~~ivH~Dlkp~Nill~~~~~  215 (363)
                      ||||+.+|+|.+++....          +++..++.++.|++.||.|||+..       ..+|+||||||+|||++.++.
T Consensus       100 v~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~  169 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKANV----------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT  169 (322)
T ss_dssp             EEECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred             EEecCCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe
Confidence            999999999999997643          899999999999999999999751       227999999999999999999


Q ss_pred             eEEeeeccCCCCCcccccccccccccccCCCCccccccC-----CCCccCceehhHHHHHHHHhCCCCCCCCCCccccch
Q 046595          216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG-----QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSL  290 (363)
Q Consensus       216 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~  290 (363)
                      +||+|||++................||+.|+|||++.+.     .++.++|||||||++|||++|+.||..........+
T Consensus       170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~  249 (322)
T 3soc_A          170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF  249 (322)
T ss_dssp             EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred             EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence            999999999655443333233446799999999998863     466788999999999999999999986554433332


Q ss_pred             hhhccccccccccccc-cCCcCCCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccC
Q 046595          291 VTWATPRLSEDKVKQC-VDPKLNNDY-----PPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK  355 (363)
Q Consensus       291 ~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~  355 (363)
                      ............+... .........     ....+..+.+++.+||+.||++|||+.+|++.|+++.+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             HHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             hhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            2221111111111111 111111111     2256678999999999999999999999999999987654

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.9e-49  Score=353.51  Aligned_cols=270  Identities=22%  Similarity=0.344  Sum_probs=214.2

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCc--hHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      +.++|++.+.||+|+||.||+|++. +++.||+|++........  ...+.+|+.+++.++||||+++++++.+.+..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l   88 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL   88 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence            4568999999999999999999754 689999999865443332  3678899999999999999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ||||+++++|.+++....         .+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||
T Consensus        89 v~e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg  156 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIESHG---------PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFG  156 (294)
T ss_dssp             EEECCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCS
T ss_pred             EEeCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCC
Confidence            999999999999997654         289999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      ++......... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..........  ....       
T Consensus       157 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~--~~~~-------  226 (294)
T 4eqm_A          157 IAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI--KHIQ-------  226 (294)
T ss_dssp             SSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHH--HHHS-------
T ss_pred             Ccccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHhh-------
Confidence            99765443221 2334579999999999999999999999999999999999999997543211100  0000       


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhccccccCCCCCC
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP-NMTIVVKALQPLLNSKPAGPE  360 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~~vl~~l~~l~~~~~~~~~  360 (363)
                        .. .+.........++..+.+++.+||+.||.+|| +++++++.|+.++......+.
T Consensus       227 --~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~  282 (294)
T 4eqm_A          227 --DS-VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANED  282 (294)
T ss_dssp             --SC-CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCC
T ss_pred             --cc-CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcc
Confidence              00 00000112233456799999999999999998 999999999999887665543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.2e-49  Score=357.46  Aligned_cols=262  Identities=23%  Similarity=0.408  Sum_probs=212.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      ++|.+.+.||+|+||.||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++++.+....++||||
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            57999999999999999999865 6899999988542 333456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|.+++.....        .+++.+++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++..
T Consensus        89 ~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  157 (310)
T 3s95_A           89 IKGGTLRGIIKSMDS--------QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARL  157 (310)
T ss_dssp             CTTCBHHHHHHHCCT--------TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEE
T ss_pred             cCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeeccccee
Confidence            999999999976432        389999999999999999999999   999999999999999999999999999876


Q ss_pred             CCcccccc------------cccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhc
Q 046595          227 SSDTAARL------------HSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWA  294 (363)
Q Consensus       227 ~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~  294 (363)
                      ........            ......||+.|+|||++.+..++.++||||||+++|||++|..||............   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~---  234 (310)
T 3s95_A          158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL---  234 (310)
T ss_dssp             CC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB---
T ss_pred             cccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh---
Confidence            54332211            011457999999999999999999999999999999999999998754332211100   


Q ss_pred             cccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccC
Q 046595          295 TPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK  355 (363)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~  355 (363)
                             .......    ...+..++..+.+++.+||+.||++|||+.+|++.|+.+....
T Consensus       235 -------~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          235 -------NVRGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             -------CHHHHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -------hhhcccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence                   0011111    1112334456999999999999999999999999999887653

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=367.48  Aligned_cols=274  Identities=26%  Similarity=0.409  Sum_probs=222.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC--------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeC
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT--------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMES  137 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  137 (363)
                      .++|.+.+.||+|+||.||+|++.        ++..||+|++...........+.+|+.+++.+ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            458999999999999999999752        23569999997754444457789999999999 899999999999999


Q ss_pred             CeeEEEEecccCCChhhhhcCCCCCC-------CCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceee
Q 046595          138 NNRILVYQFATMGSLHDVLHGRKGVQ-------GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL  210 (363)
Q Consensus       138 ~~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill  210 (363)
                      +..++||||+.+|+|.+++.......       .......+++.+++.++.|++.||.|||++   +|+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence            99999999999999999997654211       111223599999999999999999999999   99999999999999


Q ss_pred             cCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccc
Q 046595          211 FDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQS  289 (363)
Q Consensus       211 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~  289 (363)
                      +.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.......   
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~---  301 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---  301 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence            9999999999999986654433333444567899999999999999999999999999999999 999997543211   


Q ss_pred             hhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCCCC
Q 046595          290 LVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGP  359 (363)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~~~  359 (363)
                                   +...+........+..++..+.+++.+||+.||++|||+.+|++.|+.++......+
T Consensus       302 -------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~  358 (382)
T 3tt0_A          302 -------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE  358 (382)
T ss_dssp             -------------HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred             -------------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence                         111111122223344556779999999999999999999999999999987665443

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.2e-49  Score=357.84  Aligned_cols=270  Identities=25%  Similarity=0.423  Sum_probs=219.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe------CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCee
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKL------TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNR  140 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  140 (363)
                      .++|.+.+.||+|+||.||+|.+      .++..||+|++...........+.+|+.+++.++||||+++++++.+....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            46899999999999999999975      245789999997654444457889999999999999999999999999999


Q ss_pred             EEEEecccCCChhhhhcCCCCCCC---------------CCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccC
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQG---------------AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRS  205 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~---------------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp  205 (363)
                      ++||||+.+++|.+++........               ......+++.+++.++.|++.||.|||++   +|+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence            999999999999999976542110               00123489999999999999999999999   999999999


Q ss_pred             CceeecCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCC
Q 046595          206 SNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMP  284 (363)
Q Consensus       206 ~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~  284 (363)
                      +||+++.++.+||+|||++................|++.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999876544333333344567889999999999999999999999999999999 9999975433


Q ss_pred             ccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccC
Q 046595          285 KGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK  355 (363)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~  355 (363)
                      ....                ..+........+..++..+.+++.+||+.||.+||++.+|++.|++++...
T Consensus       259 ~~~~----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  313 (314)
T 2ivs_A          259 ERLF----------------NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR  313 (314)
T ss_dssp             GGHH----------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             HHHH----------------HHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhhc
Confidence            2111                111111122334455677999999999999999999999999999988753

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.7e-49  Score=349.33  Aligned_cols=257  Identities=25%  Similarity=0.414  Sum_probs=214.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      ++|++.+.||+|+||.||+|.+.+++.||+|++....  ...+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc--cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            5789999999999999999998888999999997633  33567999999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      ++++|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++...
T Consensus        88 ~~~~L~~~l~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  156 (269)
T 4hcu_A           88 EHGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFV  156 (269)
T ss_dssp             TTCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             CCCcHHHHHHhcCc--------ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccc
Confidence            99999999975432        389999999999999999999999   9999999999999999999999999998755


Q ss_pred             CcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      ...... ......||+.|+|||++.+..++.++||||||+++|+|++ |..||..........                .
T Consensus       157 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~----------------~  219 (269)
T 4hcu_A          157 LDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----------------D  219 (269)
T ss_dssp             CCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----------------H
T ss_pred             cccccc-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHH----------------H
Confidence            433221 1234457888999999999999999999999999999999 999997543221111                0


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                      +........+...+..+.+++.+||+.||++|||+.++++.|+++.++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          220 ISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            111111222334456799999999999999999999999999998765

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.5e-49  Score=359.06  Aligned_cols=249  Identities=24%  Similarity=0.339  Sum_probs=207.4

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      ..++|++.+.||+|+||.||+|++ .+|+.||||++..... ......+.+|+.+++.++||||+++++++......++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            346899999999999999999986 5799999999876432 22346788999999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.+|+|.+++....         .+++.++..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        93 ~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~  160 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHG---------RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGF  160 (328)
T ss_dssp             ECCCTTCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTC
T ss_pred             EECCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccC
Confidence            99999999999997654         289999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCCC-ccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQIT-QKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      +.......   .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...........+.          
T Consensus       161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~----------  227 (328)
T 3fe3_A          161 SNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL----------  227 (328)
T ss_dssp             CGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----------
T ss_pred             ceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH----------
Confidence            86544322   23456899999999999988765 79999999999999999999997543221111110          


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                           ...  ...+...+..+.+++.+||+.||.+|||++++++
T Consensus       228 -----~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          228 -----RGK--YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             -----HCC--CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             -----hCC--CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                 000  1223345567899999999999999999999987

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.5e-49  Score=365.47  Aligned_cols=261  Identities=25%  Similarity=0.414  Sum_probs=203.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC----CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      ..+|.+.+.||+|+||.||+|+..    ++..||||++...........+.+|+.++++++||||+++++++.+....++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357999999999999999999764    5778999999775444445679999999999999999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ||||+.+|+|.+++.....        .+++.+++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus       124 v~e~~~~~sL~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg  192 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDA--------QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFG  192 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             EEeCCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCc
Confidence            9999999999999976431        389999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccc-cccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccc
Q 046595          223 LTNQSSDTAARL-HSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSE  300 (363)
Q Consensus       223 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~  300 (363)
                      ++.......... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.......              
T Consensus       193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--------------  258 (373)
T 2qol_A          193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--------------  258 (373)
T ss_dssp             ---------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--------------
T ss_pred             cccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--------------
Confidence            997654432211 1122345778999999999999999999999999999998 999996543211              


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          301 DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                        +...+........+..++..+.+++.+||+.||.+||++.+|++.|+.+++.
T Consensus       259 --~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          259 --VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             --HHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --HHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence              1111111222223345667799999999999999999999999999988764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-50  Score=369.42  Aligned_cols=268  Identities=23%  Similarity=0.361  Sum_probs=215.7

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCee
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNR  140 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  140 (363)
                      .++|++.+.||+|+||.||+|.+.      +++.||||++...........+.+|+.+++.++||||+++++++......
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            357999999999999999999843      46689999997654444456788999999999999999999999999999


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC---ceE
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF---KSK  217 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~---~vk  217 (363)
                      ++||||+.+|+|.+++........  ....+++.+++.++.|++.||.|||++   +|+||||||+|||++.++   .+|
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPS--QPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             EEEEEeCCCCCHHHHHHhhccccC--ccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEE
Confidence            999999999999999976543211  122489999999999999999999999   999999999999999554   599


Q ss_pred             EeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccc
Q 046595          218 IADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATP  296 (363)
Q Consensus       218 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~  296 (363)
                      |+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||........         
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~---------  295 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---------  295 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---------
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---------
Confidence            999999864333222222344568999999999999999999999999999999998 9999975432211         


Q ss_pred             cccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccC
Q 046595          297 RLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK  355 (363)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~  355 (363)
                             ...+........+..++..+.+|+.+||+.||.+|||+.+|++.|+.+.+..
T Consensus       296 -------~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          296 -------LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             -------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             -------HHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence                   1111111222334455667999999999999999999999999999887643

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.4e-49  Score=365.48  Aligned_cols=252  Identities=18%  Similarity=0.240  Sum_probs=192.3

Q ss_pred             hcCCCCC-CeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHh-cCCCCccceeeeEEEe----CCe
Q 046595           67 TSNFGTK-ALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVS-RLKHEHFVELLGYCME----SNN  139 (363)
Q Consensus        67 ~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~----~~~  139 (363)
                      .++|.+. ++||+|+||.||+|.+. +++.||||++..      ...+.+|+.++. ..+||||+++++++..    ...
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence            4567766 68999999999999765 689999999863      246778888874 4589999999998876    567


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC---CCce
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD---DFKS  216 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~~~v  216 (363)
                      .++||||+.+|+|.+++.....       ..+++.++..++.|++.||.|||++   +|+||||||+|||++.   ++.+
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~  203 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAIL  203 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC----------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCE
T ss_pred             EEEEEEeCCCCcHHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccE
Confidence            8999999999999999986432       1389999999999999999999999   9999999999999997   7899


Q ss_pred             EEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccc
Q 046595          217 KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATP  296 (363)
Q Consensus       217 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~  296 (363)
                      ||+|||+++......   .....+||+.|+|||++.+..++.++|||||||++|||++|..||.............   .
T Consensus       204 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~---~  277 (400)
T 1nxk_A          204 KLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---T  277 (400)
T ss_dssp             EECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH---H
T ss_pred             EEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH---H
Confidence            999999987544322   1245678999999999999999999999999999999999999997554322110000   0


Q ss_pred             cccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          297 RLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .+...      ...+.......++.++.+||.+||+.||++|||+.+|++
T Consensus       278 ~i~~~------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          278 RIRMG------QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             HHHHT------CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHcC------cccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00000      000001111235567999999999999999999999997

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-50  Score=365.15  Aligned_cols=273  Identities=24%  Similarity=0.367  Sum_probs=216.0

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCC
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESN  138 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  138 (363)
                      ...++|++.+.||+|+||.||+|++.      +++.||+|++...........+.+|+.+++.++||||+++++++.+..
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            34578999999999999999999764      347899999986544444577899999999999999999999999999


Q ss_pred             eeEEEEecccCCChhhhhcCCCCCCC---------------CCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecc
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQG---------------AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDV  203 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~~---------------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dl  203 (363)
                      ..++||||+.+++|.+++........               ......+++.+++.++.|++.||.|||++   +|+||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dl  200 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDL  200 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence            99999999999999999976431110               00113589999999999999999999999   9999999


Q ss_pred             cCCceeecCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCC
Q 046595          204 RSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHT  282 (363)
Q Consensus       204 kp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~  282 (363)
                      ||+||+++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            99999999999999999999865443322222344568999999999999999999999999999999999 99999754


Q ss_pred             CCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCC
Q 046595          283 MPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP  356 (363)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~  356 (363)
                      .......                .+........+..++..+.+++.+||+.||.+|||+.+|++.|+++..+..
T Consensus       281 ~~~~~~~----------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          281 AHEEVIY----------------YVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             CHHHHHH----------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             ChHHHHH----------------HHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence            3211110                000111122344556779999999999999999999999999999987653

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.3e-49  Score=346.49  Aligned_cols=259  Identities=22%  Similarity=0.351  Sum_probs=213.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      .++|++.+.||+|+||.||+|++.++..||+|++....  .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT--BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC--CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            45799999999999999999998888899999997633  3356789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +++++|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++..
T Consensus        85 ~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  153 (268)
T 3sxs_A           85 ISNGCLLNYLRSHGK--------GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRY  153 (268)
T ss_dssp             CTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred             cCCCcHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCcccee
Confidence            999999999976431        389999999999999999999999   999999999999999999999999999875


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      ....... ......||+.|+|||++.+..++.++||||||+++|+|++ |..||............              
T Consensus       154 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~--------------  218 (268)
T 3sxs_A          154 VLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV--------------  218 (268)
T ss_dssp             CCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH--------------
T ss_pred             cchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH--------------
Confidence            5443222 1233456778999999999899999999999999999999 99999754332111110              


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccC
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK  355 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~  355 (363)
                        ........+...+..+.+++.+||+.||.+|||+.++++.|+.+.++.
T Consensus       219 --~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          219 --SQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             --HTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             --HcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence              011111222334567999999999999999999999999999997653

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.2e-49  Score=358.37  Aligned_cols=259  Identities=25%  Similarity=0.425  Sum_probs=204.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCe----EEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTP----AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~----~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      ++|++.+.||+|+||.||+|++. +++.    |++|.+...........+.+|+.++++++||||+++++++.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            57999999999999999999854 3443    58888876555556678999999999999999999999998754 789


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      |++|+.+|+|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        94 v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg  162 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFG  162 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTT--------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTT
T ss_pred             EEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCc
Confidence            9999999999999976432        389999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      +++...............||+.|+|||++.+..++.++||||||+++|||++ |..||.......               
T Consensus       163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---------------  227 (327)
T 3poz_A          163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------------  227 (327)
T ss_dssp             HHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---------------
T ss_pred             ceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---------------
Confidence            9865443333323334567889999999999999999999999999999999 999997543322               


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                       +...+........+..++..+.+++.+||+.||.+||++.+|++.|+.+.+.
T Consensus       228 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          228 -ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             -HHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             -HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence             1112222222333445667799999999999999999999999999887653

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=6.5e-49  Score=355.88  Aligned_cols=248  Identities=23%  Similarity=0.321  Sum_probs=207.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....  .......+.+|+.+++.++||||+++++++.+....++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            57999999999999999999865 69999999986532  2334567889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+|+|..++....         .+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||++
T Consensus        85 E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a  152 (337)
T 1o6l_A           85 EYANGGELFFHLSRER---------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLC  152 (337)
T ss_dssp             ECCTTCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             eCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccch
Confidence            9999999999997654         289999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      +.......  .....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+             
T Consensus       153 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i-------------  217 (337)
T 1o6l_A          153 KEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI-------------  217 (337)
T ss_dssp             BCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------------
T ss_pred             hhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH-------------
Confidence            75432221  134568999999999999999999999999999999999999999754321111100             


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP-----NMTIVVK  346 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  346 (363)
                        ...  ...++...+.++.++|.+||+.||.+||     ++.+|++
T Consensus       218 --~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          218 --LME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             --HHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --HcC--CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence              000  1123345567799999999999999999     8999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.4e-49  Score=349.86  Aligned_cols=258  Identities=24%  Similarity=0.401  Sum_probs=212.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      ++|++.+.||+|+||.||++++.++..||+|++....  .....+.+|+.+++.++||||+++++++.+....++||||+
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC--CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            5799999999999999999999888899999997633  23567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      .+++|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++...
T Consensus       102 ~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  170 (283)
T 3gen_A          102 ANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV  170 (283)
T ss_dssp             TTCBHHHHHHCGGG--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred             CCCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccc
Confidence            99999999976332        289999999999999999999999   9999999999999999999999999998755


Q ss_pred             CcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      ...... ......||+.|+|||++.+..++.++||||||+++|+|++ |+.||..........                .
T Consensus       171 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~----------------~  233 (283)
T 3gen_A          171 LDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE----------------H  233 (283)
T ss_dssp             CCHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH----------------H
T ss_pred             cccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH----------------H
Confidence            433221 1233457788999999999999999999999999999998 999997543221111                1


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccC
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK  355 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~  355 (363)
                      +........+...+..+.+++.+||+.||.+|||+.++++.|++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e  282 (283)
T 3gen_A          234 IAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE  282 (283)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence            1111122223344567999999999999999999999999999998764

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.3e-47  Score=343.72  Aligned_cols=286  Identities=35%  Similarity=0.596  Sum_probs=228.1

Q ss_pred             CCccCHHHHHHHhcCCCCC------CeeeccCCceEEEEEeCCCCeEEEEEccCCC---CCCchHHHHHHHHHHhcCCCC
Q 046595           55 IPQIKLDELNRLTSNFGTK------ALIGEGSYGRVFYAKLTDGTPAAIKKLDTSS---APEPESDFAAQLSVVSRLKHE  125 (363)
Q Consensus        55 ~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~e~~~l~~l~h~  125 (363)
                      ...+...++..+..+|...      +.||+|+||.||+|.. +++.||+|++....   .....+.+.+|+.+++.++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            3457788888888887766      8999999999999987 58899999987543   223356789999999999999


Q ss_pred             ccceeeeEEEeCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccC
Q 046595          126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRS  205 (363)
Q Consensus       126 ~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp  205 (363)
                      ||+++++++.+....++||||+.+++|.+++.....      ...+++..++.++.|++.||.|||++   +|+|+||||
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp  161 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG------TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKS  161 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG------CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC------CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCH
Confidence            999999999999999999999999999999975332      12389999999999999999999999   999999999


Q ss_pred             CceeecCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCc
Q 046595          206 SNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPK  285 (363)
Q Consensus       206 ~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~  285 (363)
                      +||+++.++.+||+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|..||......
T Consensus       162 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~  240 (307)
T 2nru_A          162 ANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP  240 (307)
T ss_dssp             GGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred             HHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence            999999999999999999876544333222344679999999998764 5889999999999999999999999765432


Q ss_pred             cccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccc
Q 046595          286 GQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN  353 (363)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~  353 (363)
                      .....+.... ......+...++..+ ...+...+..+.+++.+||+.||.+|||+.+|++.|+++..
T Consensus       241 ~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          241 QLLLDIKEEI-EDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             SBTTHHHHHH-HTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHHHHHHh-hhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            2111110000 001112233333333 34577888999999999999999999999999999998764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=9.3e-50  Score=365.46  Aligned_cols=278  Identities=22%  Similarity=0.356  Sum_probs=220.3

Q ss_pred             HHHHHHHhcCCCCCCeeeccCCceEEEEEe------CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeee
Q 046595           60 LDELNRLTSNFGTKALIGEGSYGRVFYAKL------TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLG  132 (363)
Q Consensus        60 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~  132 (363)
                      ........++|++.+.||+|+||.||+|++      .+++.||||++...........+.+|+.++.++ +||||+++++
T Consensus        14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~   93 (359)
T 3vhe_A           14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   93 (359)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence            344455567899999999999999999973      246789999997654444456789999999999 7999999999


Q ss_pred             EEEeCCe-eEEEEecccCCChhhhhcCCCCCCC-----------------------------------------------
Q 046595          133 YCMESNN-RILVYQFATMGSLHDVLHGRKGVQG-----------------------------------------------  164 (363)
Q Consensus       133 ~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~-----------------------------------------------  164 (363)
                      ++.+.+. .++||||+.+|+|.+++........                                               
T Consensus        94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (359)
T 3vhe_A           94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL  173 (359)
T ss_dssp             EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred             eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence            9887654 8999999999999999986542100                                               


Q ss_pred             ----------CCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCcccccc
Q 046595          165 ----------AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARL  234 (363)
Q Consensus       165 ----------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~  234 (363)
                                ......+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++..........
T Consensus       174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  250 (359)
T 3vhe_A          174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV  250 (359)
T ss_dssp             ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred             chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence                      00022389999999999999999999999   99999999999999999999999999998664443333


Q ss_pred             cccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccccccCCcCCC
Q 046595          235 HSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNN  313 (363)
Q Consensus       235 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (363)
                      ......||+.|+|||++.+..++.++||||||+++|||++ |..||..........               ..+......
T Consensus       251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~---------------~~~~~~~~~  315 (359)
T 3vhe_A          251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC---------------RRLKEGTRM  315 (359)
T ss_dssp             EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH---------------HHHHHTCCC
T ss_pred             hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH---------------HHHHcCCCC
Confidence            3445678999999999999999999999999999999998 999997543321110               111111112


Q ss_pred             CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccC
Q 046595          314 DYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK  355 (363)
Q Consensus       314 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~  355 (363)
                      ..+..++..+.+++..||+.||.+|||+.+|++.|+.++++.
T Consensus       316 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          316 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence            223345567999999999999999999999999999988653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=9.2e-49  Score=358.00  Aligned_cols=249  Identities=18%  Similarity=0.309  Sum_probs=207.3

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC-----chHHHHHHHHHHhcCCCCccceeeeEEEeCCe
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE-----PESDFAAQLSVVSRLKHEHFVELLGYCMESNN  139 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  139 (363)
                      +.++|.+.+.||+|+||.||+|... +|+.||+|++.......     ..+.+.+|+.+++.++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            4568999999999999999999865 68999999997654322     24678999999999999999999999999999


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC----c
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF----K  215 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~----~  215 (363)
                      .++||||+.+|+|.+++....         .+++..+..++.|++.||.|||++   ||+||||||+|||++.++    .
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~  157 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPH  157 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTCS---------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCC
T ss_pred             EEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccC
Confidence            999999999999999997643         389999999999999999999999   999999999999998776    7


Q ss_pred             eEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 046595          216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       216 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      +||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+    
T Consensus       158 vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i----  230 (361)
T 2yab_A          158 IKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI----  230 (361)
T ss_dssp             EEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH----
T ss_pred             EEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----
Confidence            99999999876544321   34467999999999999999999999999999999999999999754322111110    


Q ss_pred             ccccccccccccCCcCCCCCCH----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          296 PRLSEDKVKQCVDPKLNNDYPP----KAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                                 ...  ...++.    ..+..+.++|.+||..||.+|||+.++++
T Consensus       231 -----------~~~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          231 -----------TAV--SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             -----------HTT--CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -----------Hhc--CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                       000  011121    23567999999999999999999999986

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=7.6e-50  Score=356.23  Aligned_cols=278  Identities=22%  Similarity=0.326  Sum_probs=210.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe-----CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeC--Ce
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKL-----TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMES--NN  139 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~  139 (363)
                      .++|++.+.||+|+||.||+|++     .+++.||||++... .....+.+.+|+.+++.++||||+++++++...  ..
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            46899999999999999999973     35889999998753 223346788999999999999999999998653  56


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEe
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA  219 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~  219 (363)
                      .++||||+.+++|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~  156 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIG  156 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHCGG--------GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEEC
T ss_pred             eEEEEEeCCCCCHHHHHHhccc--------ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEc
Confidence            8999999999999999976532        289999999999999999999999   99999999999999999999999


Q ss_pred             eeccCCCCCccccc-ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 046595          220 DFNLTNQSSDTAAR-LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL  298 (363)
Q Consensus       220 Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  298 (363)
                      |||++......... .......|+..|+|||++.+..++.++||||||+++|+|++|..||...................
T Consensus       157 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T 3ugc_A          157 DFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM  236 (295)
T ss_dssp             CCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHH
T ss_pred             cCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccch
Confidence            99999765433221 11223457788999999999999999999999999999999999986431110000000000000


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCC
Q 046595          299 SEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP  356 (363)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~  356 (363)
                      ....+...+........+..++..+.+++.+||+.||++|||+.+|++.|+.+.++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~  294 (295)
T 3ugc_A          237 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA  294 (295)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             hHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence            0001112222223334455667889999999999999999999999999999987653

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-49  Score=358.60  Aligned_cols=272  Identities=26%  Similarity=0.411  Sum_probs=214.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe------CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKL------TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNN  139 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~  139 (363)
                      .++|.+.+.||+|+||.||+|.+      .++..||+|++...........+.+|+.+++++ +||||+++++++...+.
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  123 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  123 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence            46899999999999999999975      245679999998655555567899999999999 89999999999999999


Q ss_pred             eEEEEecccCCChhhhhcCCCCCC--------------CCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccC
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQ--------------GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRS  205 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~--------------~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp  205 (363)
                      .++||||+++|+|.+++.......              .......+++..++.++.|++.||.|||++   +|+||||||
T Consensus       124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp  200 (344)
T 1rjb_A          124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA  200 (344)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred             cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCh
Confidence            999999999999999997654210              001123489999999999999999999999   999999999


Q ss_pred             CceeecCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCC
Q 046595          206 SNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMP  284 (363)
Q Consensus       206 ~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~  284 (363)
                      +||+++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus       201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  280 (344)
T 1rjb_A          201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  280 (344)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence            999999999999999999976544333323344567889999999999999999999999999999998 9999975432


Q ss_pred             ccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCC
Q 046595          285 KGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP  356 (363)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~  356 (363)
                      ...               +...+........+..++..+.+++.+||+.||.+|||+.+|++.|+.++....
T Consensus       281 ~~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  337 (344)
T 1rjb_A          281 DAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE  337 (344)
T ss_dssp             SHH---------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             HHH---------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence            211               111111122223344556779999999999999999999999999999887643

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.8e-49  Score=357.46  Aligned_cols=259  Identities=24%  Similarity=0.391  Sum_probs=209.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCe----EEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTP----AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~----~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      ++|++.+.||+|+||.||+|.+. +++.    |++|.+...........+.+|+.+++.++||||+++++++. ....++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            57999999999999999999864 4554    78888765544444567788999999999999999999886 567889


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ||||+.+|+|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        92 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg  160 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRG--------ALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFG  160 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGG--------GSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCS
T ss_pred             EEEeCCCCCHHHHHHHccc--------cCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCC
Confidence            9999999999999976532        388999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      +++...............|+..|+|||++.+..++.++||||||+++|+|++ |..||...........+          
T Consensus       161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~----------  230 (325)
T 3kex_A          161 VADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL----------  230 (325)
T ss_dssp             GGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH----------
T ss_pred             cccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH----------
Confidence            9987654443333455678889999999999999999999999999999999 99999765432221111          


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                            ........+..++..+.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus       231 ------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          231 ------EKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             ------HTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             ------HcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                  11111222333445689999999999999999999999999988653

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=6.2e-49  Score=354.84  Aligned_cols=271  Identities=21%  Similarity=0.338  Sum_probs=199.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCC-C---CeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEeCCee-
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTD-G---TPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNR-  140 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~-~---~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-  140 (363)
                      .++|++.+.||+|+||.||+|.+.. +   ..||||++..... ....+.+.+|+.+++.++||||+++++++...... 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            4589999999999999999998654 3   2799999976432 23357889999999999999999999999877665 


Q ss_pred             -----EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCc
Q 046595          141 -----ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK  215 (363)
Q Consensus       141 -----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~  215 (363)
                           ++||||+.+|+|.+++.......   ....+++..++.++.|++.||.|||++   +|+||||||+||+++.++.
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGE---NPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSC
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccc---cccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCC
Confidence                 89999999999999996543211   111389999999999999999999999   9999999999999999999


Q ss_pred             eEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhc
Q 046595          216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWA  294 (363)
Q Consensus       216 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~  294 (363)
                      +||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........    
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~----  251 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY----  251 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH----
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH----
Confidence            99999999976654433333344567889999999999999999999999999999999 8999975433221111    


Q ss_pred             cccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCCCC
Q 046595          295 TPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGP  359 (363)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~~~  359 (363)
                                  +........+..++..+.+++.+||+.||.+|||+.++++.|+++++.....+
T Consensus       252 ------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~  304 (323)
T 3qup_A          252 ------------LIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS  304 (323)
T ss_dssp             ------------HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred             ------------HhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence                        11111122334556779999999999999999999999999999988765544

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.9e-49  Score=372.01  Aligned_cols=263  Identities=24%  Similarity=0.399  Sum_probs=217.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      .++|.+.+.||+|+||.||+|.+.++..||||++....  ...+.+.+|+.+++.++||||+++++++. ....++||||
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~  263 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF  263 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence            46789999999999999999998888899999997632  34678999999999999999999999886 6678999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+|+|.+++......       .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       264 ~~~g~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  333 (454)
T 1qcf_A          264 MAKGSLLDFLKSDEGS-------KQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV  333 (454)
T ss_dssp             CTTCBHHHHHHSHHHH-------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred             cCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence            9999999999754311       278899999999999999999999   999999999999999999999999999976


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      ....... ......++..|+|||++.+..++.++||||||++||||++ |+.||........                ..
T Consensus       334 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~----------------~~  396 (454)
T 1qcf_A          334 IEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV----------------IR  396 (454)
T ss_dssp             BCCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH----------------HH
T ss_pred             cCCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH----------------HH
Confidence            5433221 1223456789999999999999999999999999999999 9999975432111                11


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCCCC
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGP  359 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~~~  359 (363)
                      .+........+..++..+.+|+.+||+.||++|||+.+|++.|+.+......+.
T Consensus       397 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~~  450 (454)
T 1qcf_A          397 ALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQY  450 (454)
T ss_dssp             HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCSS
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccccc
Confidence            111122223345567789999999999999999999999999999987765543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.3e-48  Score=350.84  Aligned_cols=272  Identities=22%  Similarity=0.295  Sum_probs=207.7

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCC-chHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      +.++|++.+.||+|+||.||+|++.+++.||+|++....... ....+.+|+.+++.++||||+++++++.+....++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            456899999999999999999998889999999997654333 2467889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+ +|.+++.....        .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        99 e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a  166 (311)
T 3niz_A           99 EFMEK-DLKKVLDENKT--------GLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLA  166 (311)
T ss_dssp             ECCSE-EHHHHHHTCTT--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             cCCCC-CHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCc
Confidence            99986 88888875432        389999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      .........  .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+............
T Consensus       167 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  244 (311)
T 3niz_A          167 RAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW  244 (311)
T ss_dssp             EETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTS
T ss_pred             eecCCCccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHh
Confidence            765432221  334578999999999876 56899999999999999999999999866554432222111000000000


Q ss_pred             c------cccCCcC--CC-----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhccc
Q 046595          304 K------QCVDPKL--NN-----DYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPL  351 (363)
Q Consensus       304 ~------~~~~~~~--~~-----~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l  351 (363)
                      .      .+.....  ..     .....++.++.+|+.+||+.||.+|||+.++++  .++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  307 (311)
T 3niz_A          245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL  307 (311)
T ss_dssp             GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred             hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence            0      0000000  00     011223467899999999999999999999998  44443

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-48  Score=353.05  Aligned_cols=259  Identities=25%  Similarity=0.418  Sum_probs=206.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCe----EEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTP----AAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~----~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      ++|++.+.||+|+||.||+|.+. +++.    |++|.+...........+.+|+.+++.++||||+++++++.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            57999999999999999999854 4554    57777766555666788999999999999999999999998754 789


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      |++|+.+|+|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        94 v~~~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG  162 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFG  162 (327)
T ss_dssp             EECCCSSCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTT
T ss_pred             EEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCc
Confidence            9999999999999976432        389999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      ++................||+.|+|||++.+..++.++||||||+++|||++ |..||........              
T Consensus       163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--------------  228 (327)
T 3lzb_A          163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--------------  228 (327)
T ss_dssp             C----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--------------
T ss_pred             ceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--------------
Confidence            9987654443333444567889999999999999999999999999999999 9999975433221              


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                        ...+........+..++..+.+++.+||+.||.+||++.+|++.|+.+.+.
T Consensus       229 --~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          229 --SSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             --HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             --HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence              111122222333445666799999999999999999999999999988754

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-48  Score=380.55  Aligned_cols=257  Identities=24%  Similarity=0.397  Sum_probs=207.8

Q ss_pred             eeeccCCceEEEEEeC---CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccCCC
Q 046595           75 LIGEGSYGRVFYAKLT---DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGS  151 (363)
Q Consensus        75 ~lg~G~~g~V~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~g~  151 (363)
                      .||+|+||.||+|.+.   ++..||||+++........+.+.+|+.+++.++||||+++++++.. +..++||||+.+|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999753   4567999999876555567889999999999999999999999876 56899999999999


Q ss_pred             hhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCccc
Q 046595          152 LHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTA  231 (363)
Q Consensus       152 L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~  231 (363)
                      |.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus       422 L~~~l~~~~~--------~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~  490 (613)
T 2ozo_A          422 LHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD  490 (613)
T ss_dssp             HHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred             HHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence            9999975432        389999999999999999999999   99999999999999999999999999998664332


Q ss_pred             ccc-cccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccccccCC
Q 046595          232 ARL-HSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDP  309 (363)
Q Consensus       232 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (363)
                      ... ......+++.|+|||++.+..++.++|||||||+||||++ |+.||.......                +...+..
T Consensus       491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----------------~~~~i~~  554 (613)
T 2ozo_A          491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----------------VMAFIEQ  554 (613)
T ss_dssp             -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH----------------HHHHHHT
T ss_pred             ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----------------HHHHHHc
Confidence            211 1122345789999999999999999999999999999998 999997543321                1112222


Q ss_pred             cCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCCCC
Q 046595          310 KLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGP  359 (363)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~~~  359 (363)
                      ......+..++..+.+||..||+.||++||++.+|++.|+.+..+.....
T Consensus       555 ~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~  604 (613)
T 2ozo_A          555 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV  604 (613)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSC
T ss_pred             CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcccc
Confidence            23334455677889999999999999999999999999998766544433

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=9.5e-49  Score=346.74  Aligned_cols=260  Identities=25%  Similarity=0.390  Sum_probs=202.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCC----CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTD----GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      .++|++.+.||+|+||.||+|.+..    +..||+|++.........+.+.+|+.+++.++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4689999999999999999997643    44699999876544444567899999999999999999999874 567899


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ||||+.+++|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||
T Consensus        93 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  161 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKY--------SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG  161 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTT--------TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--
T ss_pred             EEecCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccc
Confidence            9999999999999975431        389999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      ++......... ......+++.|+|||++.+..++.++||||||+++|||++ |..||...........           
T Consensus       162 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~-----------  229 (281)
T 1mp8_A          162 LSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-----------  229 (281)
T ss_dssp             ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-----------
T ss_pred             cccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHH-----------
Confidence            98765443221 1233457789999999999999999999999999999997 9999975433221111           


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccC
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK  355 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~  355 (363)
                           +........+..++..+.+++.+||+.||++|||+.+|++.|+.++++.
T Consensus       230 -----i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          230 -----IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             -----HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -----HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                 0111112234456677999999999999999999999999999987653

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=6e-49  Score=353.23  Aligned_cols=272  Identities=23%  Similarity=0.375  Sum_probs=219.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe------CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKL------TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNN  139 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~  139 (363)
                      .++|.+.+.||+|+||.||+|++      .+++.||+|++.........+.+.+|+.+++++ +||||+++++++...+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            46899999999999999999974      246789999997654434457889999999999 89999999999999999


Q ss_pred             eEEEEecccCCChhhhhcCCCCCC---------CCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceee
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQ---------GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL  210 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~---------~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill  210 (363)
                      .++||||+.+|+|.+++.......         .......+++..++.++.|++.||.|||++   +|+||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence            999999999999999997654210         001122489999999999999999999999   99999999999999


Q ss_pred             cCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccc
Q 046595          211 FDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQS  289 (363)
Q Consensus       211 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~  289 (363)
                      +.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||..........
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  258 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY  258 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence            9999999999999977655443333344567889999999999999999999999999999999 999997543221110


Q ss_pred             hhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCC
Q 046595          290 LVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP  356 (363)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~  356 (363)
                                     ..+........+..++..+.+++.+||+.||.+|||+.+|++.|++++.+..
T Consensus       259 ---------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  310 (313)
T 1t46_A          259 ---------------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (313)
T ss_dssp             ---------------HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             ---------------HHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence                           0111111122233456679999999999999999999999999999887654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.1e-47  Score=346.27  Aligned_cols=248  Identities=22%  Similarity=0.345  Sum_probs=205.2

Q ss_pred             CCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEeccc
Q 046595           70 FGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFAT  148 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  148 (363)
                      |...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++......++||||+.
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  125 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ  125 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence            666778999999999999876 79999999987643 3446778999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCC
Q 046595          149 MGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSS  228 (363)
Q Consensus       149 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~  228 (363)
                      +++|.+++....          +++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++....
T Consensus       126 ~~~L~~~l~~~~----------l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  192 (321)
T 2c30_A          126 GGALTDIVSQVR----------LNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS  192 (321)
T ss_dssp             SCBHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecc
Confidence            999999987543          89999999999999999999999   99999999999999999999999999986554


Q ss_pred             cccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccC
Q 046595          229 DTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD  308 (363)
Q Consensus       229 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (363)
                      .....  .....||+.|+|||++.+..++.++||||||+++|+|++|+.||............            .....
T Consensus       193 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~------------~~~~~  258 (321)
T 2c30_A          193 KDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL------------RDSPP  258 (321)
T ss_dssp             SSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------------HHSSC
T ss_pred             cCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------------hcCCC
Confidence            33221  24467999999999999999999999999999999999999999754322111100            00000


Q ss_pred             CcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          309 PKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                      +.  .......+..+.+++.+||+.||++|||+.++++.
T Consensus       259 ~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          259 PK--LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             CC--CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CC--cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00  01122345679999999999999999999999873

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.2e-48  Score=372.06  Aligned_cols=261  Identities=23%  Similarity=0.384  Sum_probs=218.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCC-CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      ..+|.+.+.||+|+||.||+|.+.. +..||||++...  ....+.+.+|+.++++++||||+++++++......++|||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc--ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            3568889999999999999998764 888999999763  3346789999999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+|+|.+++.....       ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       297 ~~~~g~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~  366 (495)
T 1opk_A          297 FMTYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSR  366 (495)
T ss_dssp             CCTTCBHHHHHHHSCT-------TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred             ccCCCCHHHHHHhcCc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccce
Confidence            9999999999976432       1388999999999999999999999   99999999999999999999999999997


Q ss_pred             CCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      ........ ......++..|+|||++.+..++.++||||||++||||++ |..||.......                +.
T Consensus       367 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~----------------~~  429 (495)
T 1opk_A          367 LMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VY  429 (495)
T ss_dssp             CCTTCCEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----------------HH
T ss_pred             eccCCcee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH----------------HH
Confidence            65433221 1233456789999999999999999999999999999999 999997543211                11


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCC
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP  356 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~  356 (363)
                      ..+........+..++..+.+||.+||+.||.+|||+.+|++.|+.++....
T Consensus       430 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~~  481 (495)
T 1opk_A          430 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS  481 (495)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSSC
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhccc
Confidence            2222233334455667789999999999999999999999999999886544

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.3e-48  Score=368.10  Aligned_cols=264  Identities=28%  Similarity=0.451  Sum_probs=212.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      .++|++.+.||+|+||.||+|.+.++..||||++....  ...+.+.+|+.+++.++||||+++++++.+ ...++||||
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            45788999999999999999998887889999997643  345689999999999999999999999876 678999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+|+|.+++.....       ..+++.+++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       260 ~~~gsL~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  329 (452)
T 1fmk_A          260 MSKGSLLDFLKGETG-------KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL  329 (452)
T ss_dssp             CTTCBHHHHHSHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred             hcCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCcccee
Confidence            999999999975321       1288999999999999999999999   999999999999999999999999999976


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      ....... ......++..|+|||++.+..++.++||||||+++|||++ |..||.......                +..
T Consensus       330 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~----------------~~~  392 (452)
T 1fmk_A          330 IEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLD  392 (452)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----------------HHH
T ss_pred             cCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH----------------HHH
Confidence            5433221 1223457889999999999999999999999999999999 999997543211                111


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCCCCC
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGPE  360 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~~~~  360 (363)
                      .+........+..++..+.+++.+||+.||++|||+.+|++.|+.+........+
T Consensus       393 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~  447 (452)
T 1fmk_A          393 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ  447 (452)
T ss_dssp             HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCC
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcccc
Confidence            1112223334556677899999999999999999999999999999877655443

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.3e-48  Score=365.18  Aligned_cols=253  Identities=28%  Similarity=0.439  Sum_probs=211.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCC-eeEEEEe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESN-NRILVYQ  145 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e  145 (363)
                      .++|++.+.||+|+||.||+|.+. ++.||||+++...   ..+.+.+|+.+++.++||||+++++++.... ..++|||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            357888999999999999999885 7799999997632   4568999999999999999999999987765 7899999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+|+|.+++.....       ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       268 ~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~  337 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK  337 (450)
T ss_dssp             CCTTCBHHHHHHHHCT-------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecCCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcc
Confidence            9999999999986532       1278999999999999999999999   99999999999999999999999999987


Q ss_pred             CCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      .....     .....++..|+|||++.+..++.++||||||+++|||++ |..||........                .
T Consensus       338 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~----------------~  396 (450)
T 1k9a_A          338 EASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV----------------V  396 (450)
T ss_dssp             ECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH----------------H
T ss_pred             ccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------H
Confidence            43322     122357889999999999999999999999999999998 9999975433221                1


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                      ..+..+.....+..++..+.++|.+||+.||.+|||+.+|++.|+.+...
T Consensus       397 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          397 PRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            11122233344556778899999999999999999999999999988754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=345.74  Aligned_cols=277  Identities=21%  Similarity=0.259  Sum_probs=217.3

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCC--eeEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESN--NRIL  142 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l  142 (363)
                      +.++|.+.+.||+|+||.||+|.+. +++.||||++...........+.+|+.++++++||||+++++++....  ..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            3468999999999999999999865 589999999976554555678889999999999999999999988765  7799


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceee----cCCCceEE
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL----FDDFKSKI  218 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill----~~~~~vkl  218 (363)
                      ||||+.+++|.+++......      ..+++..++.++.|++.||.|||++   +|+||||||+||++    +.++.+||
T Consensus        87 v~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL  157 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKL  157 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGGT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEE
T ss_pred             EEeCCCCCCHHHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEE
Confidence            99999999999999865421      1289999999999999999999999   99999999999999    78888999


Q ss_pred             eeeccCCCCCcccccccccccccccCCCCccccc--------cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccch
Q 046595          219 ADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM--------TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSL  290 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~  290 (363)
                      +|||++........   .....||+.|+|||++.        +..++.++|||||||++|||++|..||...........
T Consensus       158 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  234 (319)
T 4euu_A          158 TDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE  234 (319)
T ss_dssp             CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHH
T ss_pred             ccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHH
Confidence            99999876544322   23457999999999886        57889999999999999999999999975433221111


Q ss_pred             h--hhcccccc--ccccc-------cc-cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          291 V--TWATPRLS--EDKVK-------QC-VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       291 ~--~~~~~~~~--~~~~~-------~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                      .  ........  ...+.       .+ ........+....+..+.+++.+||+.||++|||++++++...+....
T Consensus       235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~  310 (319)
T 4euu_A          235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (319)
T ss_dssp             HHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred             HHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence            1  00000000  00000       00 011122355678899999999999999999999999999988765543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.9e-49  Score=356.26  Aligned_cols=276  Identities=25%  Similarity=0.378  Sum_probs=218.2

Q ss_pred             cCC-CCCCeeeccCCceEEEEEeC-----CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeC--Ce
Q 046595           68 SNF-GTKALIGEGSYGRVFYAKLT-----DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMES--NN  139 (363)
Q Consensus        68 ~~y-~~~~~lg~G~~g~V~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~  139 (363)
                      ++| ++.+.||+|+||.||++.+.     +++.||||++...........+.+|+.+++.++||||+++++++.+.  ..
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            455 89999999999999988642     58889999998754444456789999999999999999999999884  67


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEe
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA  219 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~  219 (363)
                      .++||||+.+++|.+++....          +++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~  176 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRHS----------IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIG  176 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGSC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEEecccCCcHHHHHhhCC----------CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEEC
Confidence            899999999999999997654          89999999999999999999999   99999999999999999999999


Q ss_pred             eeccCCCCCccccc-ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 046595          220 DFNLTNQSSDTAAR-LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL  298 (363)
Q Consensus       220 Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  298 (363)
                      |||++......... .......||..|+|||++.+..++.++||||||+++|+|++|..||....... .....+.....
T Consensus       177 Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~  255 (318)
T 3lxp_A          177 DFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQM  255 (318)
T ss_dssp             CGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHH
T ss_pred             CccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccch
Confidence            99998765443221 12234568889999999999999999999999999999999999986431110 00000111111


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCC
Q 046595          299 SEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA  357 (363)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~  357 (363)
                      ....+...+........+..++..+.+++.+||+.||.+|||+.+|++.|+.+.++...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~  314 (318)
T 3lxp_A          256 TVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG  314 (318)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred             hHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence            11122333333444445566778899999999999999999999999999998876543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-48  Score=348.70  Aligned_cols=248  Identities=16%  Similarity=0.220  Sum_probs=206.0

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      +.++|.+.+.||+|+||.||+|.+. +++.||+|.+...  ......+.+|+.+++.++||||+++++++.+....++||
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   80 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence            4578999999999999999999765 5888999998653  233467889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC--CCceEEeeec
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD--DFKSKIADFN  222 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~--~~~vkl~Dfg  222 (363)
                      ||+.+++|.+++.....        .+++.+++.++.|++.||.|||++   +|+||||||+|||++.  ++.+||+|||
T Consensus        81 e~~~g~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg  149 (321)
T 1tki_A           81 EFISGLDIFERINTSAF--------ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             CCCCCCBHHHHHTSSSC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             EeCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECC
Confidence            99999999999975431        389999999999999999999999   9999999999999987  7899999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      ++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+           
T Consensus       150 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-----------  215 (321)
T 1tki_A          150 QARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI-----------  215 (321)
T ss_dssp             TCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-----------
T ss_pred             CCeECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH-----------
Confidence            9876543322   23457999999999999888999999999999999999999999754322111111           


Q ss_pred             cccccCCcCCCCCC----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          303 VKQCVDPKLNNDYP----PKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       303 ~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                          .....  .++    ...+.++.+++.+||+.||.+|||+.++++
T Consensus       216 ----~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          216 ----MNAEY--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ----HHTCC--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----HcCCC--CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                00000  111    133567999999999999999999999998

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2e-48  Score=352.66  Aligned_cols=267  Identities=16%  Similarity=0.204  Sum_probs=213.0

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      +.++|++.+.||+|+||.||+|+. .+++.||||++.....   ...+.+|+.+++.+ +||||+++++++......++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv   83 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV   83 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence            346899999999999999999985 5789999999876432   34588999999999 999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCc-----eEE
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK-----SKI  218 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~-----vkl  218 (363)
                      |||+ +++|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.     +||
T Consensus        84 ~e~~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl  151 (330)
T 2izr_A           84 LELL-GPSLEDLFDLCDR--------TFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHI  151 (330)
T ss_dssp             EECC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEE
T ss_pred             EEeC-CCCHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEE
Confidence            9999 8899999985421        389999999999999999999999   9999999999999998887     999


Q ss_pred             eeeccCCCCCcccccc-----cccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhh
Q 046595          219 ADFNLTNQSSDTAARL-----HSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTW  293 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~  293 (363)
                      +|||++..........     ......||+.|+|||++.+..++.++||||||+++|||++|+.||..............
T Consensus       152 ~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~  231 (330)
T 2izr_A          152 IDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK  231 (330)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHH
T ss_pred             EEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHH
Confidence            9999997654332211     12356799999999999999999999999999999999999999986543322221111


Q ss_pred             ccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCC
Q 046595          294 ATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA  357 (363)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~  357 (363)
                      ..........     ..+    ....+ ++.+++..||+.||.+||++.+|++.|+++.++...
T Consensus       232 i~~~~~~~~~-----~~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~  285 (330)
T 2izr_A          232 IGDTKRATPI-----EVL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY  285 (330)
T ss_dssp             HHHHHHHSCH-----HHH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             HHhhhccCCH-----HHH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence            1000000000     000    01133 799999999999999999999999999998877644

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.2e-48  Score=356.38  Aligned_cols=252  Identities=21%  Similarity=0.276  Sum_probs=191.9

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      .+.++|++.+.||+|+||.||+|++. +++.||||++....   ..+.+.+|+.++++++||||+++++++......++|
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            35578999999999999999999876 58889999997632   235678899999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC---CCceEEee
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD---DFKSKIAD  220 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~~~vkl~D  220 (363)
                      |||+.+++|.+++....         .+++.+++.++.|++.||.|||++   +|+||||||+|||++.   ++.+||+|
T Consensus       127 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~D  194 (349)
T 2w4o_A          127 LELVTGGELFDRIVEKG---------YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIAD  194 (349)
T ss_dssp             ECCCCSCBHHHHHTTCS---------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECC
T ss_pred             EEeCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEcc
Confidence            99999999999997643         389999999999999999999999   9999999999999975   88999999


Q ss_pred             eccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccc
Q 046595          221 FNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE  300 (363)
Q Consensus       221 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  300 (363)
                      ||++........   .....||+.|+|||++.+..++.++|||||||++|||++|..||......... ......     
T Consensus       195 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~i~~-----  265 (349)
T 2w4o_A          195 FGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM-FRRILN-----  265 (349)
T ss_dssp             CC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH-HHHHHT-----
T ss_pred             CccccccCcccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH-HHHHHh-----
Confidence            999876543221   23467999999999999999999999999999999999999999654322100 000000     


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          301 DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ..      ...........+..+.++|.+||+.||++|||+.++++
T Consensus       266 ~~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          266 CE------YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             TC------CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CC------CccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00      00111112345667999999999999999999999987

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=6.7e-49  Score=351.22  Aligned_cols=271  Identities=25%  Similarity=0.400  Sum_probs=213.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-----CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeC--Cee
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-----TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMES--NNR  140 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~  140 (363)
                      ++|++.+.||+|+||.||+|++     .+++.||+|++...........+.+|+.+++.++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4689999999999999999983     368899999998766556678899999999999999999999999876  668


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEee
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD  220 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D  220 (363)
                      ++||||+.+++|.+++.....        .+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+|
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D  169 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKN--------KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGD  169 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTT--------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECC
T ss_pred             EEEEEeCCCCcHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECc
Confidence            999999999999999965432        289999999999999999999999   999999999999999999999999


Q ss_pred             eccCCCCCccccc-ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc---c
Q 046595          221 FNLTNQSSDTAAR-LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT---P  296 (363)
Q Consensus       221 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~---~  296 (363)
                      ||++......... .......||..|+|||++.+..++.++||||||+++|+|++|..|+......    ......   .
T Consensus       170 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~  245 (302)
T 4e5w_A          170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL----FLKMIGPTHG  245 (302)
T ss_dssp             CTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHHCSCCG
T ss_pred             ccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH----HhhccCCccc
Confidence            9998765433221 2233456888999999999999999999999999999999999986422100    000000   0


Q ss_pred             cccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccc
Q 046595          297 RLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN  353 (363)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~  353 (363)
                      ......+...+........+..++..+.+++.+||+.||.+|||+.++++.|+++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~  302 (302)
T 4e5w_A          246 QMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK  302 (302)
T ss_dssp             GGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             ccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence            011112222222333344455667789999999999999999999999999998864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=6.4e-49  Score=358.15  Aligned_cols=249  Identities=21%  Similarity=0.313  Sum_probs=202.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l  142 (363)
                      .++|++.+.||+|+||.||+|++. +++.||||++....  .......+..|..+++.+ +||||+++++++.+....++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            368999999999999999999865 68999999986531  223456788899999988 79999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ||||+.+|+|.+++....         .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus       102 v~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG  169 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSR---------RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFG  169 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccc
Confidence            999999999999997654         289999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      +++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+           
T Consensus       170 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i-----------  236 (353)
T 3txo_A          170 MCKEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI-----------  236 (353)
T ss_dssp             TCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----------
T ss_pred             ceeecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH-----------
Confidence            9875332222  234568999999999999889999999999999999999999999754332111111           


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH------HHHHH
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNM------TIVVK  346 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~------~~vl~  346 (363)
                          ...  ...++...+..+.+++.+||+.||.+||++      .+|++
T Consensus       237 ----~~~--~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          237 ----LND--EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             ----HHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             ----HcC--CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                011  112334456679999999999999999998      77765

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.3e-48  Score=351.99  Aligned_cols=247  Identities=24%  Similarity=0.337  Sum_probs=204.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      .++|.+.+.||+|+||.||+|.+ .+++.||+|++....  .......+.+|+.+++.++||||+++++++......++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            46899999999999999999986 578999999986421  223346789999999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+ +|+|.+++....         .+++.+++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        88 ~E~~-~g~l~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~  154 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK---------RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGL  154 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSC
T ss_pred             EECC-CCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEecc
Confidence            9999 679999887554         289999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCC-CccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      +........   ....+||+.|+|||++.+..+ +.++||||||+++|+|++|..||..........             
T Consensus       155 s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-------------  218 (336)
T 3h4j_B          155 SNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-------------  218 (336)
T ss_dssp             TBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-------------
T ss_pred             ceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-------------
Confidence            876544322   244579999999999988776 689999999999999999999997543221110             


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                         .+... ....+...+..+.+++.+||+.||.+|||+.++++
T Consensus       219 ---~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          219 ---KVNSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             ---CCCSS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             ---HHHcC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence               00000 11233445677999999999999999999999987

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=9.7e-49  Score=353.38  Aligned_cols=271  Identities=24%  Similarity=0.370  Sum_probs=216.1

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCC
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESN  138 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  138 (363)
                      ...++|++.+.||+|+||.||+|.+.      +++.||+|.+...........+.+|+.+++.++||||+++++++.+..
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~  101 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ  101 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence            34568999999999999999999654      367899999976444344567889999999999999999999999999


Q ss_pred             eeEEEEecccCCChhhhhcCCCCCC-CCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceE
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQ-GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSK  217 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk  217 (363)
                      ..++||||+.+|+|.+++....... .......+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+|
T Consensus       102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~k  178 (322)
T 1p4o_A          102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK  178 (322)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEE
T ss_pred             ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEE
Confidence            9999999999999999997532100 000011378999999999999999999999   999999999999999999999


Q ss_pred             EeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccc
Q 046595          218 IADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATP  296 (363)
Q Consensus       218 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~  296 (363)
                      |+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||...........      
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~------  252 (322)
T 1p4o_A          179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------  252 (322)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH------
T ss_pred             ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH------
Confidence            999999876544333223344567899999999999999999999999999999999 8899975432111110      


Q ss_pred             cccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          297 RLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                                +........+..++..+.+++.+||+.||.+|||+.++++.|++++..
T Consensus       253 ----------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          253 ----------VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             ----------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             ----------HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence                      000111122345567799999999999999999999999999988653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.5e-48  Score=363.11  Aligned_cols=255  Identities=18%  Similarity=0.234  Sum_probs=206.5

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      .+.++|++.+.||+|+||.||+|.. .+++.+|+|++...... ...+.+.+|+.+++.++||||+++++++.+....++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            4567899999999999999999975 46899999998764322 224578899999999999999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec---CCCceEEe
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIA  219 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~---~~~~vkl~  219 (363)
                      ||||+.+|+|.+++....         .+++..+..++.|++.||.|||++   +|+||||||+|||++   .++.+||+
T Consensus        88 v~E~~~gg~L~~~i~~~~---------~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~  155 (444)
T 3soa_A           88 IFDLVTGGELFEDIVARE---------YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLA  155 (444)
T ss_dssp             EECCCBCCBHHHHHHHCS---------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEEC
T ss_pred             EEEeCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEc
Confidence            999999999999997654         289999999999999999999999   999999999999998   46889999


Q ss_pred             eeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc
Q 046595          220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       220 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      |||++.........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.....   
T Consensus       156 DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---  230 (444)
T 3soa_A          156 DFGLAIEVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAY---  230 (444)
T ss_dssp             CCSSCBCCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC---
T ss_pred             cCceeEEecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC---
Confidence            99999765543222  2346799999999999999999999999999999999999999975432211111100000   


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                                .........++..+.++|.+||+.||.+|||+.++++
T Consensus       231 ----------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          231 ----------DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             ----------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ----------CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                      0001111234567999999999999999999999987

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.4e-48  Score=354.12  Aligned_cols=271  Identities=25%  Similarity=0.417  Sum_probs=216.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC--------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeC
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT--------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMES  137 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  137 (363)
                      .++|++.+.||+|+||.||+|++.        ++..||+|++...........+.+|+.+++.+ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            468999999999999999999763        46789999997654444456789999999999 899999999999999


Q ss_pred             CeeEEEEecccCCChhhhhcCCCCCCC-------CCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceee
Q 046595          138 NNRILVYQFATMGSLHDVLHGRKGVQG-------AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL  210 (363)
Q Consensus       138 ~~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill  210 (363)
                      ...++||||+.+|+|.+++........       ......+++.+++.++.|++.||.|||++   +|+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence            999999999999999999986542110       01122489999999999999999999999   99999999999999


Q ss_pred             cCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccc
Q 046595          211 FDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQS  289 (363)
Q Consensus       211 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~  289 (363)
                      +.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||......... 
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-  269 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF-  269 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH-
Confidence            9999999999999876554333222334567889999999998899999999999999999999 99999754321111 


Q ss_pred             hhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCC
Q 046595          290 LVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP  356 (363)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~  356 (363)
                                     ..+........+..++..+.+++.+||+.||.+|||+.+|++.|+.++....
T Consensus       270 ---------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          270 ---------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             ---------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             ---------------HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence                           0111111122334556779999999999999999999999999999876543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.9e-48  Score=355.30  Aligned_cols=251  Identities=22%  Similarity=0.304  Sum_probs=207.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      .++|++.+.||+|+||.||+|... +++.||+|++....  .......+.+|+.+++.++||||+++++++.+....++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            357999999999999999999765 58899999986432  233456788999999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.+|+|..++....         .+++..+..++.|++.||.|||++   ||+||||||+|||++.+|.+||+|||+
T Consensus        94 ~e~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~  161 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNV---------HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNI  161 (384)
T ss_dssp             ECCCTTEEHHHHHHTTC---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccce
Confidence            99999999999998654         289999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCcccccc---CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMT---GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE  300 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  300 (363)
                      +.......   ......||+.|+|||++.+   ..++.++|||||||++|||++|..||................     
T Consensus       162 a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-----  233 (384)
T 4fr4_A          162 AAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE-----  233 (384)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH-----
T ss_pred             eeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-----
Confidence            97654322   2345689999999999864   468999999999999999999999997544332222111110     


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 046595          301 DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPN-MTIVVK  346 (363)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~~vl~  346 (363)
                               .....++..++..+.+||.+||+.||.+||+ +++|++
T Consensus       234 ---------~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          234 ---------TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ---------HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ---------hcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                     0112234455677999999999999999998 777765

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.9e-48  Score=345.52  Aligned_cols=271  Identities=16%  Similarity=0.197  Sum_probs=216.7

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      +.++|++.+.||+|+||.||+|.. .+++.||+|++.....   ...+.+|+.+++.+ +|+|++.+++++......++|
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   84 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   84 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence            456899999999999999999985 5789999999865332   34578899999999 799999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCc-----eEE
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK-----SKI  218 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~-----vkl  218 (363)
                      |||+ +++|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+||+++.++.     +||
T Consensus        85 ~e~~-~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl  152 (298)
T 1csn_A           85 IDLL-GPSLEDLLDLCGR--------KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYV  152 (298)
T ss_dssp             EECC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred             EEec-CCCHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEE
Confidence            9999 8899999975431        389999999999999999999999   9999999999999987766     999


Q ss_pred             eeeccCCCCCccccc-----ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhh
Q 046595          219 ADFNLTNQSSDTAAR-----LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTW  293 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~  293 (363)
                      +|||++.........     .......||+.|+|||++.+..++.++||||||+++|||++|+.||..............
T Consensus       153 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  232 (298)
T 1csn_A          153 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER  232 (298)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred             EECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH
Confidence            999998765443221     112446799999999999999999999999999999999999999986543322221111


Q ss_pred             ccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCCCCC
Q 046595          294 ATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGPE  360 (363)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~~~~  360 (363)
                      ...........         .....++..+.+++.+||+.||++||++.+|++.|++++++.....+
T Consensus       233 ~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~  290 (298)
T 1csn_A          233 IGEKKQSTPLR---------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED  290 (298)
T ss_dssp             HHHHHHHSCHH---------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSC
T ss_pred             HHhhccCccHH---------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCC
Confidence            10000000000         00113456799999999999999999999999999999988766544

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.1e-48  Score=349.80  Aligned_cols=253  Identities=20%  Similarity=0.306  Sum_probs=206.4

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC-----chHHHHHHHHHHhcCCCCccceeeeEEEeCCe
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE-----PESDFAAQLSVVSRLKHEHFVELLGYCMESNN  139 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  139 (363)
                      +.++|.+.+.||+|+||.||+|... +++.||+|++.......     ..+.+.+|+.+++.++||||+++++++.+...
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            3457999999999999999999865 68999999987644322     35678999999999999999999999999999


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC----c
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF----K  215 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~----~  215 (363)
                      .++||||+.+++|.+++....         .+++..++.++.|++.||.|||++   +|+||||||+||+++.++    .
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~  156 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAEKE---------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPR  156 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTTSS---------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCC
T ss_pred             EEEEEEcCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCC
Confidence            999999999999999997543         389999999999999999999999   999999999999999877    8


Q ss_pred             eEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 046595          216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       216 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      +||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+....
T Consensus       157 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~  233 (326)
T 2y0a_A          157 IKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN  233 (326)
T ss_dssp             EEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTC
T ss_pred             EEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcC
Confidence            99999999876543221   234579999999999998999999999999999999999999997543221111100000


Q ss_pred             ccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          296 PRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                                   ...........+..+.+++.+||+.||.+|||+.++++
T Consensus       234 -------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          234 -------------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             -------------CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -------------CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                         00000001123567899999999999999999999987

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.3e-47  Score=340.48  Aligned_cols=253  Identities=29%  Similarity=0.490  Sum_probs=206.5

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCch------HHHHHHHHHHhcCCCCccceeeeEEEeCCee
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPE------SDFAAQLSVVSRLKHEHFVELLGYCMESNNR  140 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  140 (363)
                      ++|++.+.||+|+||.||+|++ .+++.||+|++.........      +.+.+|+.+++.++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            5899999999999999999986 47899999999765443322      57889999999999999999999986554  


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCC--eEEecccCCceeecCCCc---
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPP--IVHRDVRSSNVLLFDDFK---  215 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nill~~~~~---  215 (363)
                      ++||||+.+++|.+++.....        .+++..++.++.|++.||.|||++   +  |+||||||+||+++.++.   
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~  165 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKAH--------PIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAP  165 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCS
T ss_pred             eEEEEecCCCCHHHHHhcccC--------CccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCc
Confidence            799999999999998865432        389999999999999999999999   8  999999999999988776   


Q ss_pred             --eEEeeeccCCCCCcccccccccccccccCCCCccccc--cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchh
Q 046595          216 --SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM--TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLV  291 (363)
Q Consensus       216 --vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~  291 (363)
                        +||+|||++......     .....||+.|+|||++.  ...++.++||||||+++|+|++|+.||........... 
T Consensus       166 ~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-  239 (287)
T 4f0f_A          166 VCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI-  239 (287)
T ss_dssp             CCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH-
T ss_pred             eeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH-
Confidence              999999998754432     33467999999999984  45678999999999999999999999975433221111 


Q ss_pred             hhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 046595          292 TWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL  351 (363)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l  351 (363)
                                  ............+..++..+.+++.+||+.||.+|||+.+|++.|++|
T Consensus       240 ------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          240 ------------NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             ------------HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ------------HHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                        111112222334455667899999999999999999999999999875

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.9e-48  Score=353.42  Aligned_cols=254  Identities=20%  Similarity=0.286  Sum_probs=206.7

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      .+.++|.+.+.||+|+||.||+|.+. +++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+....++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            45678999999999999999999765 6899999999764432 234678899999999999999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCC---CceEEe
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD---FKSKIA  219 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~---~~vkl~  219 (363)
                      ||||+.+|+|.+++....         .+++..++.++.|++.||.|||++   +|+||||||+|||++.+   +.+||+
T Consensus       106 v~e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~  173 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVARE---------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLA  173 (362)
T ss_dssp             EECCCCSCBHHHHHTTCS---------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEEC
T ss_pred             EEecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEe
Confidence            999999999999997653         389999999999999999999999   99999999999999864   459999


Q ss_pred             eeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc
Q 046595          220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       220 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      |||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.....   
T Consensus       174 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~---  247 (362)
T 2bdw_A          174 DFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY---  247 (362)
T ss_dssp             CCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---
T ss_pred             ecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC---
Confidence            9999976653322   2346799999999999998999999999999999999999999975432111111000000   


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                                .........++..+.++|.+||+.||++||++.++++
T Consensus       248 ----------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          248 ----------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             ----------CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ----------CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                      0000111234567999999999999999999999886

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.8e-48  Score=343.61  Aligned_cols=262  Identities=25%  Similarity=0.453  Sum_probs=198.6

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCC-chHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      .++|++.+.||+|+||.||+|++.+  .+|+|++....... ..+.+.+|+.+++.++||||++++++. .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            4689999999999999999998653  59999987654322 246789999999999999999999965 5567899999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+++|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++.
T Consensus       100 ~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~  168 (289)
T 3og7_A          100 WCEGSSLYHHLHASET--------KFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLAT  168 (289)
T ss_dssp             CCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred             ecCCCcHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecc
Confidence            9999999999965432        389999999999999999999999   99999999999999999999999999987


Q ss_pred             CCCcccccccccccccccCCCCccccc---cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAM---TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      ...............||+.|+|||++.   +..++.++||||||+++|+|++|+.||.........  ........    
T Consensus       169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~~~~----  242 (289)
T 3og7_A          169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IEMVGRGS----  242 (289)
T ss_dssp             ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH--HHHHHHTS----
T ss_pred             ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH--HHHhcccc----
Confidence            654433333334567999999999986   567889999999999999999999999754332111  11100000    


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccc
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN  353 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~  353 (363)
                          ... ........++..+.+++.+||+.||.+|||+.+|++.|+++.+
T Consensus       243 ----~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          243 ----LSP-DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             ----CCC-CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ----cCc-chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence                000 0112233456779999999999999999999999999998875

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.6e-48  Score=340.39  Aligned_cols=251  Identities=28%  Similarity=0.476  Sum_probs=198.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCC---CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAP---EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|++.+.||+|+||.||+|.+. ++.||+|++......   ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            57999999999999999999875 888999998764322   23467889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCC---eEEecccCCceeecC--------C
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPP---IVHRDVRSSNVLLFD--------D  213 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nill~~--------~  213 (363)
                      ||+.+++|.+++....          +++..++.++.|++.||.|||++   +   |+||||||+||+++.        +
T Consensus        86 e~~~~~~L~~~~~~~~----------~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~  152 (271)
T 3dtc_A           86 EFARGGPLNRVLSGKR----------IPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSN  152 (271)
T ss_dssp             ECCTTEEHHHHHTSSC----------CCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred             EcCCCCCHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccC
Confidence            9999999999996543          89999999999999999999999   7   999999999999986        7


Q ss_pred             CceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhh
Q 046595          214 FKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTW  293 (363)
Q Consensus       214 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~  293 (363)
                      +.+||+|||++.......    .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||..........    
T Consensus       153 ~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----  224 (271)
T 3dtc_A          153 KILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY----  224 (271)
T ss_dssp             CCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH----
T ss_pred             cceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----
Confidence            789999999987554332    224578999999999999999999999999999999999999997543221111    


Q ss_pred             ccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 046595          294 ATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL  351 (363)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l  351 (363)
                                 ...........+..++..+.+++.+||+.||.+|||+.++++.|+.|
T Consensus       225 -----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          225 -----------GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             -----------HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             -----------hhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                       11111222233445567799999999999999999999999999864

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3e-48  Score=343.08  Aligned_cols=266  Identities=26%  Similarity=0.408  Sum_probs=213.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      .++|++.+.||+|+||.||+|...++..||+|++....  ...+.+.+|+.+++.++||||+++++++. .+..++||||
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   88 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY   88 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence            46799999999999999999998888899999987532  34578999999999999999999999876 4568999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+++|.+++.....       ..+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||++..
T Consensus        89 ~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  158 (279)
T 1qpc_A           89 MENGSLVDFLKTPSG-------IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL  158 (279)
T ss_dssp             CTTCBHHHHTTSHHH-------HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCCCCHHHHHhcCCC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence            999999999975421       1289999999999999999999999   999999999999999999999999999876


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      ....... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.........                .
T Consensus       159 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~----------------~  221 (279)
T 1qpc_A          159 IEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI----------------Q  221 (279)
T ss_dssp             CSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH----------------H
T ss_pred             ccCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH----------------H
Confidence            5443221 1233457889999999998899999999999999999999 89999754321110                1


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCCCCCCC
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGPEAQ  362 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~~~~~~  362 (363)
                      .+........+..++..+.+++.+||+.||++|||+.+|++.|+++......+..++
T Consensus       222 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~  278 (279)
T 1qpc_A          222 NLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQ  278 (279)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-------
T ss_pred             HHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCCCCC
Confidence            111111122234456779999999999999999999999999999988766555443

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-48  Score=344.43  Aligned_cols=266  Identities=24%  Similarity=0.390  Sum_probs=215.7

Q ss_pred             cCCCCCC-eeeccCCceEEEEEeC---CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           68 SNFGTKA-LIGEGSYGRVFYAKLT---DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        68 ~~y~~~~-~lg~G~~g~V~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      ++|.+.+ .||+|+||.||+|.+.   ++..||+|++.........+.+.+|+.+++.++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4566666 8999999999999753   57789999998754444457789999999999999999999998 55678999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.+++|.+++.....        .+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||+
T Consensus        88 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~  156 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGL  156 (287)
T ss_dssp             EECCTTEEHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred             EEeCCCCCHHHHHHhCCc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccc
Confidence            999999999999965321        389999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCccccc-ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccc
Q 046595          224 TNQSSDTAAR-LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       224 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      +......... .......||+.|+|||++.+..++.++||||||+++|+|++ |+.||.........             
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-------------  223 (287)
T 1u59_A          157 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-------------  223 (287)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-------------
T ss_pred             eeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH-------------
Confidence            8765432221 11223457889999999998899999999999999999998 99999754332111             


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCCCCCC
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGPEA  361 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~~~~~  361 (363)
                         ..+........+..++..+.+++..||+.||.+||++.+|++.|+.+..+...+.+.
T Consensus       224 ---~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~  280 (287)
T 1u59_A          224 ---AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG  280 (287)
T ss_dssp             ---HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred             ---HHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccC
Confidence               111111122334556678999999999999999999999999999998876655443

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-48  Score=346.99  Aligned_cols=245  Identities=22%  Similarity=0.330  Sum_probs=206.1

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....  .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            57999999999999999999865 69999999986532  2234567889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+|+|.+++....         .+++..+..++.|++.||.|||++   +|+||||||+|||++.+|.+||+|||++
T Consensus        86 e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a  153 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQ---------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFA  153 (318)
T ss_dssp             CCCCSCBHHHHHHHTS---------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             eCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcc
Confidence            9999999999997644         289999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      ......     ....+||+.|+|||++.+..++.++|||||||++|||++|..||..........               
T Consensus       154 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---------------  213 (318)
T 1fot_A          154 KYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE---------------  213 (318)
T ss_dssp             EECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---------------
T ss_pred             eecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH---------------
Confidence            754432     234679999999999999999999999999999999999999997543211111               


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP-----NMTIVVK  346 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  346 (363)
                      .+....  ..++...+.++.+++.+||+.||.+||     ++++|++
T Consensus       214 ~i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          214 KILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             HHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHhCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            111111  123344566799999999999999999     8999885

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6.2e-48  Score=349.34  Aligned_cols=255  Identities=21%  Similarity=0.307  Sum_probs=202.8

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCC-----
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESN-----  138 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----  138 (363)
                      ++.++|++.+.||+|+||.||+|++. +++.||||++.........+.+.+|+.++++++||||+++++++.+..     
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred             hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence            35568999999999999999999876 799999999987655556678999999999999999999999986654     


Q ss_pred             ----------------------------------------------------eeEEEEecccCCChhhhhcCCCCCCCCC
Q 046595          139 ----------------------------------------------------NRILVYQFATMGSLHDVLHGRKGVQGAE  166 (363)
Q Consensus       139 ----------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~  166 (363)
                                                                          ..++||||+.+++|.+++.......   
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~---  159 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE---  159 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG---
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc---
Confidence                                                                2789999999999999998754321   


Q ss_pred             CCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCccccc----------ccc
Q 046595          167 PGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAAR----------LHS  236 (363)
Q Consensus       167 ~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~----------~~~  236 (363)
                         ...+..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++.........          ...
T Consensus       160 ---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T 3qd2_B          160 ---DREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH  233 (332)
T ss_dssp             ---GSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CC
T ss_pred             ---chhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccc
Confidence               256778999999999999999999   9999999999999999999999999998765543211          112


Q ss_pred             cccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCCCCCC
Q 046595          237 TRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYP  316 (363)
Q Consensus       237 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (363)
                      ....||+.|+|||++.+..++.++||||||+++|||++|..|+...     ...            ...... .......
T Consensus       234 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~------------~~~~~~-~~~~~~~  295 (332)
T 3qd2_B          234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VRI------------ITDVRN-LKFPLLF  295 (332)
T ss_dssp             CSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHH------------HHHHHT-TCCCHHH
T ss_pred             cccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHH------------HHHhhc-cCCCccc
Confidence            3457999999999999999999999999999999999987765211     000            000000 0001112


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          317 PKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       317 ~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ...+..+.+++.+||+.||.+|||+.++++
T Consensus       296 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          296 TQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             ccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            345567899999999999999999999987

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.2e-48  Score=356.26  Aligned_cols=257  Identities=20%  Similarity=0.290  Sum_probs=204.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC--CCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA--PEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l  142 (363)
                      .++|++.++||+|+||.||+|+.. +++.||+|++.....  ......+..|..++.++ +||||+++++++.+....++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            357999999999999999999865 578899999875432  22345688899999887 89999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ||||+.+|+|..++....         .+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||
T Consensus       131 V~E~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG  198 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR---------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYG  198 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEcCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecc
Confidence            999999999999997654         289999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      +++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........       .....
T Consensus       199 la~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~-------~~~~~  269 (396)
T 4dc2_A          199 MCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDY  269 (396)
T ss_dssp             TCBCCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------------CCHHH
T ss_pred             eeeecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch-------hhHHH
Confidence            9975332222  23457899999999999999999999999999999999999999964322111000       00000


Q ss_pred             c-ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH------HHHHH
Q 046595          303 V-KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNM------TIVVK  346 (363)
Q Consensus       303 ~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~------~~vl~  346 (363)
                      + ..+...  ...++..++..+.+||.+||+.||.+||++      .+|++
T Consensus       270 ~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          270 LFQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             HHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             HHHHHhcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence            0 001111  123344566779999999999999999985      56665

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1e-47  Score=345.89  Aligned_cols=274  Identities=23%  Similarity=0.315  Sum_probs=197.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      .++|++.+.||+|+||.||+|... +++.||+|++...........+.+|+.+++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            358999999999999999999865 6899999999876555556788999999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+ +|.+++.......   ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.
T Consensus        84 ~~~~-~L~~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~  156 (317)
T 2pmi_A           84 FMDN-DLKKYMDSRTVGN---TPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLAR  156 (317)
T ss_dssp             CCCC-BHHHHHHHHHSSS---CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred             ecCC-CHHHHHHhccccc---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccce
Confidence            9985 9999986543211   112388999999999999999999999   99999999999999999999999999987


Q ss_pred             CCCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccc----
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE----  300 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~----  300 (363)
                      ........  .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+.........    
T Consensus       157 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  234 (317)
T 2pmi_A          157 AFGIPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP  234 (317)
T ss_dssp             ETTSCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCG
T ss_pred             ecCCCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhh
Confidence            55432211  2345789999999998764 6899999999999999999999999765433221111100000000    


Q ss_pred             -----------------cccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhccccc
Q 046595          301 -----------------DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPLLN  353 (363)
Q Consensus       301 -----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l~~  353 (363)
                                       ..+...+....    ....+..+.+++.+||+.||++|||+.++++  .+.+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  302 (317)
T 2pmi_A          235 SVTKLPKYNPNIQQRPPRDLRQVLQPHT----KEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH  302 (317)
T ss_dssp             GGGGCTTCCTTCCCCCCCCSHHHHGGGC----SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred             hhhhhhhcccccccccchhHHHhhcccc----cccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence                             00000001111    1123457999999999999999999999987  4555443

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.6e-48  Score=356.39  Aligned_cols=244  Identities=22%  Similarity=0.290  Sum_probs=192.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC--CCchHHHHHHHHH-HhcCCCCccceeeeEEEeCCeeEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA--PEPESDFAAQLSV-VSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++.....  ......+..|..+ ++.++||||+++++++.+.+..++|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            57999999999999999999865 588899999876432  2233456667766 5678999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.+|+|.+++....         .+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+
T Consensus       118 ~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~  185 (373)
T 2r5t_A          118 LDYINGGELFYHLQRER---------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGL  185 (373)
T ss_dssp             EECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCB
T ss_pred             EeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcc
Confidence            99999999999997654         288999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      ++.......  .....+||+.|+|||++.+..++.++|+|||||++|||++|..||..........              
T Consensus       186 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~--------------  249 (373)
T 2r5t_A          186 CKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD--------------  249 (373)
T ss_dssp             CGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHH--------------
T ss_pred             ccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH--------------
Confidence            865322211  2345689999999999999999999999999999999999999997543211111              


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMT  342 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~  342 (363)
                       .+....  ..++...+..+.++|.+||+.||.+||++.
T Consensus       250 -~i~~~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~  285 (373)
T 2r5t_A          250 -NILNKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAK  285 (373)
T ss_dssp             -HHHHSC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred             -HHHhcc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence             011111  122334556799999999999999999974

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.8e-48  Score=344.14  Aligned_cols=250  Identities=24%  Similarity=0.328  Sum_probs=196.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC-------------------------CchHHHHHHHHHHh
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP-------------------------EPESDFAAQLSVVS  120 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-------------------------~~~~~~~~e~~~l~  120 (363)
                      .++|++.+.||+|+||.||+|... +++.||||++......                         ...+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            358999999999999999999764 6889999998654311                         12356889999999


Q ss_pred             cCCCCccceeeeEEEe--CCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCe
Q 046595          121 RLKHEHFVELLGYCME--SNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPI  198 (363)
Q Consensus       121 ~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i  198 (363)
                      .++||||+++++++.+  ....++||||+.+++|.+++...          .+++.+++.++.|++.||.|||++   +|
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~i  158 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----------PLSEDQARFYFQDLIKGIEYLHYQ---KI  158 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----------CCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence            9999999999999986  56789999999999998876543          289999999999999999999999   99


Q ss_pred             EEecccCCceeecCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCC---CCccCceehhHHHHHHHHhC
Q 046595          199 VHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQ---ITQKSDVYSFGVVLLELLTG  275 (363)
Q Consensus       199 vH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~ell~g  275 (363)
                      +||||||+||+++.++.+||+|||++.........  .....||+.|+|||++.+..   ++.++||||||+++|+|++|
T Consensus       159 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g  236 (298)
T 2zv2_A          159 IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG  236 (298)
T ss_dssp             ECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred             eccCCCHHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence            99999999999999999999999998765433221  23457999999999988665   47889999999999999999


Q ss_pred             CCCCCCCCCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          276 RKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       276 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      +.||...........+               ............++..+.+++.+||+.||++|||+.+|++
T Consensus       237 ~~pf~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          237 QCPFMDERIMCLHSKI---------------KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SCSSCCSSHHHHHHHH---------------HHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCCCCccHHHHHHHH---------------hcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            9999754221100000               0000001111234567999999999999999999999875

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4e-48  Score=339.99  Aligned_cols=257  Identities=25%  Similarity=0.405  Sum_probs=213.5

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      ++|++.+.||+|+||.||+|.+.+++.||+|++....  ...+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            5789999999999999999998888899999997643  23468899999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      .+++|.+++.....        .+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++...
T Consensus        86 ~~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  154 (267)
T 3t9t_A           86 EHGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFV  154 (267)
T ss_dssp             TTCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             CCCcHHHHHhhCcc--------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccc
Confidence            99999999976432        388999999999999999999999   9999999999999999999999999998755


Q ss_pred             CcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      ...... ......|+..|+|||++.+..++.++||||||+++|+|++ |..||..........                .
T Consensus       155 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~----------------~  217 (267)
T 3t9t_A          155 LDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----------------D  217 (267)
T ss_dssp             CCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----------------H
T ss_pred             cccccc-ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHH----------------H
Confidence            432211 1233467889999999999999999999999999999999 899997543211110                0


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                      +........+...+..+.+++.+||+.||.+|||+.++++.|+++.++
T Consensus       218 i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          218 ISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            011111222334456799999999999999999999999999998764

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.2e-47  Score=338.70  Aligned_cols=255  Identities=24%  Similarity=0.316  Sum_probs=209.4

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      +.++|++.+.||+|+||.||+|... +++.||+|++...........+.+|+.+++.++||||+++++++.+....++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            4568999999999999999999865 689999999876555555678999999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+++|.+++....         .+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||++
T Consensus        85 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~  152 (276)
T 2yex_A           85 EYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLA  152 (276)
T ss_dssp             ECCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EecCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCc
Confidence            9999999999997543         389999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCC-CccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      ................|++.|+|||++.+..+ +.++||||||+++|+|++|..||......... ...+..        
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~--------  223 (276)
T 2yex_A          153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKE--------  223 (276)
T ss_dssp             EECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHHHT--------
T ss_pred             cccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHhhh--------
Confidence            75543322222345679999999999987765 78999999999999999999999765432111 111111        


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                           ...........+..+.+++.+||+.||.+|||+.+|++
T Consensus       224 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          224 -----KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             -----TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----cccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                 00001112234567899999999999999999999987

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=8.9e-48  Score=343.70  Aligned_cols=262  Identities=23%  Similarity=0.367  Sum_probs=201.7

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhc--CCCCccceeeeEEEeC----Ce
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSR--LKHEHFVELLGYCMES----NN  139 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~----~~  139 (363)
                      +.++|++.+.||+|+||.||+|++ +++.||||++..    .....+..|.+++..  ++||||+++++++...    ..
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~   80 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ   80 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc----ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence            457899999999999999999988 588999999864    234556667766666  7999999999986553    45


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh--------ccCCCCeEEecccCCceeec
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH--------EKVQPPIVHRDVRSSNVLLF  211 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--------~~~~~~ivH~Dlkp~Nill~  211 (363)
                      .++||||+.+|+|.+++....          +++..++.++.|++.||.|||        ++   +|+||||||+|||++
T Consensus        81 ~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~  147 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQLTT----------LDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVK  147 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTTCC----------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEEC
T ss_pred             eEEehhhccCCCHHHHHhhcc----------cCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEc
Confidence            789999999999999996543          899999999999999999999        88   999999999999999


Q ss_pred             CCCceEEeeeccCCCCCccccc--ccccccccccCCCCccccccC------CCCccCceehhHHHHHHHHhC--------
Q 046595          212 DDFKSKIADFNLTNQSSDTAAR--LHSTRVLGTFGYHAPEYAMTG------QITQKSDVYSFGVVLLELLTG--------  275 (363)
Q Consensus       212 ~~~~vkl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~ell~g--------  275 (363)
                      .++.+||+|||++.........  .......||+.|+|||++.+.      .++.++||||||+++|||++|        
T Consensus       148 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~  227 (301)
T 3q4u_A          148 KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE  227 (301)
T ss_dssp             TTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccc
Confidence            9999999999998643332221  112335799999999999876      455799999999999999999        


Q ss_pred             --CCCCCCCCCccccchhhhccccccccccccccCCcCC-CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 046595          276 --RKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLN-NDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL  351 (363)
Q Consensus       276 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l  351 (363)
                        ..||................  .    ........+. ..+...++..+.+++.+||+.||.+|||+.+|++.|+++
T Consensus       228 ~~~~pf~~~~~~~~~~~~~~~~--~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          228 DYKPPFYDVVPNDPSFEDMRKV--V----CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCCCTTTTTSCSSCCHHHHHHH--H----TTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccccccCCCCcchhhhhHH--H----hccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence              77775443322111000000  0    0000000110 112235788899999999999999999999999999875

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.7e-48  Score=354.16  Aligned_cols=249  Identities=24%  Similarity=0.313  Sum_probs=205.4

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRI  141 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~  141 (363)
                      ..++|.+.+.||+|+||.||+|++. +++.||+|++....  .......+..|..++..+ +||||+++++++.+....+
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            3468999999999999999999865 68899999987532  133456788899998877 8999999999999999999


Q ss_pred             EEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeee
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADF  221 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df  221 (363)
                      +||||+.+|+|.+++....         .+++..+..++.|++.||.|||++   +|+||||||+|||++.+|.+||+||
T Consensus        95 lv~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DF  162 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQSCH---------KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADF  162 (345)
T ss_dssp             EEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEC
Confidence            9999999999999997643         289999999999999999999999   9999999999999999999999999


Q ss_pred             ccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccc
Q 046595          222 NLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       222 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      |+++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+.         
T Consensus       163 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~---------  231 (345)
T 1xjd_A          163 GMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR---------  231 (345)
T ss_dssp             TTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---------
T ss_pred             hhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH---------
Confidence            99875432222  1345689999999999999999999999999999999999999997543221111110         


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMT-IVV  345 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~-~vl  345 (363)
                            ..  ...++...+..+.++|.+||+.||.+||++. +|+
T Consensus       232 ------~~--~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          232 ------MD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             ------HC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ------hC--CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                  00  0122334566799999999999999999997 665

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.2e-47  Score=339.89  Aligned_cols=265  Identities=20%  Similarity=0.272  Sum_probs=202.5

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCc-hHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEP-ESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++........ ...+.+|+.++++++||||+++++++.+....++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            47999999999999999999865 689999999976543333 4678899999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+ +|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++.
T Consensus        82 ~~~~-~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  149 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNG--------DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLAR  149 (292)
T ss_dssp             CCSE-EHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCC-CHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccce
Confidence            9987 66666654321        389999999999999999999999   99999999999999999999999999987


Q ss_pred             CCCcccccccccccccccCCCCccccccCC-CCccCceehhHHHHHHHHhCCCCCCCCCCccc-cchhhhccccccccc-
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQ-QSLVTWATPRLSEDK-  302 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~-  302 (363)
                      .......  ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||........ ...+........... 
T Consensus       150 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~  227 (292)
T 3o0g_A          150 AFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW  227 (292)
T ss_dssp             ECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred             ecCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhh
Confidence            5543222  134457899999999998765 89999999999999999999888643322111 000000000000000 


Q ss_pred             --cccc---------cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          303 --VKQC---------VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       303 --~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                        ....         .............+..+.+++.+||+.||++|||++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence              0000         0001111223345677999999999999999999999987

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=9.6e-48  Score=343.11  Aligned_cols=264  Identities=25%  Similarity=0.372  Sum_probs=209.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCC----CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEE-eCCeeE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTD----GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM-ESNNRI  141 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~  141 (363)
                      ..+|++.+.||+|+||.||+|.+.+    ...+++|.+...........+.+|+.++++++||||+++++++. .....+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3468899999999999999997543    22589998876544445578899999999999999999999864 456789


Q ss_pred             EEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeee
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADF  221 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df  221 (363)
                      +||||+.+++|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+||
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Df  172 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADF  172 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTC--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSC
T ss_pred             EEEeCCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcc
Confidence            99999999999999975432        388999999999999999999999   9999999999999999999999999


Q ss_pred             ccCCCCCccccc--ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccc
Q 046595          222 NLTNQSSDTAAR--LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRL  298 (363)
Q Consensus       222 g~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~  298 (363)
                      |++.........  .......||+.|+|||.+.+..++.++||||||+++|+|++ |..||............       
T Consensus       173 g~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~-------  245 (298)
T 3f66_A          173 GLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-------  245 (298)
T ss_dssp             GGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH-------
T ss_pred             cccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-------
Confidence            999766543321  12234567889999999999999999999999999999999 55666543322211111       


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCC
Q 046595          299 SEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA  357 (363)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~  357 (363)
                               ........+..++..+.+++.+||+.||++|||+.++++.|++++++...
T Consensus       246 ---------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~  295 (298)
T 3f66_A          246 ---------LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  295 (298)
T ss_dssp             ---------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred             ---------hcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence                     01111122333456799999999999999999999999999999886654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.3e-48  Score=351.61  Aligned_cols=253  Identities=21%  Similarity=0.347  Sum_probs=200.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCC-chHHHHHHHHHHhcCCC--CccceeeeEEEeCCeeEEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKH--EHFVELLGYCMESNNRILV  143 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv  143 (363)
                      .++|++.+.||+|+||.||++...+++.||||++....... ....+.+|+.+++.++|  +||+++++++......++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            45799999999999999999998889999999987643322 23678899999999976  9999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      ||+ .+++|.+++....         .+++.++..++.|++.||.|||++   +|+||||||+|||++ ++.+||+|||+
T Consensus        88 ~e~-~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~  153 (343)
T 3dbq_A           88 MEC-GNIDLNSWLKKKK---------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGI  153 (343)
T ss_dssp             ECC-CSEEHHHHHHHSC---------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSS
T ss_pred             EeC-CCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccc
Confidence            994 5779999998654         289999999999999999999999   999999999999997 67899999999


Q ss_pred             CCCCCcccccccccccccccCCCCcccccc-----------CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhh
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMT-----------GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT  292 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~  292 (363)
                      +................||+.|+|||++.+           ..++.++|||||||++|+|++|+.||.......      
T Consensus       154 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------  227 (343)
T 3dbq_A          154 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------  227 (343)
T ss_dssp             SCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH------
T ss_pred             ccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH------
Confidence            987655443333445679999999999865           678999999999999999999999996432210      


Q ss_pred             hccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          293 WATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                              ..+....+......++...+..+.+++.+||+.||.+|||+.++++.
T Consensus       228 --------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          228 --------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             --------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --------HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence                    11112222222333344445679999999999999999999999873

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.2e-48  Score=372.46  Aligned_cols=263  Identities=29%  Similarity=0.453  Sum_probs=216.5

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      ++|++.+.||+|+||.||+|.+.++..||||++....  ...+.+.+|+.+++.++|+||+++++++.+ ...++||||+
T Consensus       267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~  343 (535)
T 2h8h_A          267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  343 (535)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence            4577788999999999999999888889999997643  345689999999999999999999999866 6789999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      .+|+|.+++.....       ..+++.+++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       344 ~~gsL~~~l~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          344 SKGSLLDFLKGETG-------KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI  413 (535)
T ss_dssp             TTEEHHHHHSHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred             cCCcHHHHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence            99999999975321       1288999999999999999999999   9999999999999999999999999999876


Q ss_pred             CcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      ...... ......++..|+|||++.+..++.++||||||++||||++ |+.||.......                +...
T Consensus       414 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~----------------~~~~  476 (535)
T 2h8h_A          414 EDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLDQ  476 (535)
T ss_dssp             CCHHHH-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH----------------HHHH
T ss_pred             CCCcee-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHH
Confidence            543221 1223457789999999999999999999999999999999 999997543211                1111


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCCCCC
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGPE  360 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~~~~  360 (363)
                      +........+..++..+.+||.+||+.||++|||+.+|++.|+.++.......+
T Consensus       477 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~  530 (535)
T 2h8h_A          477 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ  530 (535)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSSC
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcccC
Confidence            112222334456677899999999999999999999999999999877655433

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1e-47  Score=351.83  Aligned_cols=252  Identities=17%  Similarity=0.256  Sum_probs=194.6

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      .++|++.+.||+|+||.||+++.. +++.||+|++....  .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA--AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST--TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc--cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            358999999999999999999865 78999999997643  234678899999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCc--eEEeeecc
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK--SKIADFNL  223 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~--vkl~Dfg~  223 (363)
                      |+.+|+|.+++....         .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.  +||+|||+
T Consensus        97 ~~~~~~L~~~l~~~~---------~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~  164 (361)
T 3uc3_A           97 YASGGELYERICNAG---------RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGY  164 (361)
T ss_dssp             CCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCC
T ss_pred             eCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCc
Confidence            999999999997644         289999999999999999999999   9999999999999987765  99999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCCCcc-CceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQK-SDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      ++......   ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||............           
T Consensus       165 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~-----------  230 (361)
T 3uc3_A          165 SKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT-----------  230 (361)
T ss_dssp             C------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH-----------
T ss_pred             cccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH-----------
Confidence            86433221   1234579999999999988877655 89999999999999999999754332211110           


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      +................+..+.+||.+||+.||.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          231 IQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             HHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            01111111111111134567899999999999999999999987

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=7.6e-48  Score=350.80  Aligned_cols=245  Identities=19%  Similarity=0.258  Sum_probs=206.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....  .......+.+|+.+++.++||||+++++++.+....++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57999999999999999999865 68999999986532  2234567889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+|+|.+++....         .+++..++.++.|++.||.|||++   +|+||||||+|||++.+|.+||+|||++
T Consensus       121 e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a  188 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG---------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFA  188 (350)
T ss_dssp             ECCTTCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             cCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccc
Confidence            9999999999997643         289999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      ......     ....+||+.|+|||++.+..++.++|||||||++|||++|..||...........              
T Consensus       189 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~--------------  249 (350)
T 1rdq_E          189 KRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK--------------  249 (350)
T ss_dssp             EECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------------
T ss_pred             eeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHH--------------
Confidence            755432     2346799999999999999999999999999999999999999975432111110              


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPN-----MTIVVK  346 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~~vl~  346 (363)
                       +...  ...++..++..+.++|.+||+.||.+||+     +++|++
T Consensus       250 -i~~~--~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          250 -IVSG--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -HHHC--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -HHcC--CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence             0000  01233445677999999999999999998     888876

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-48  Score=354.43  Aligned_cols=262  Identities=26%  Similarity=0.390  Sum_probs=201.5

Q ss_pred             CCCCCCeeeccCCceEEEEEeC--CC--CeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEe-CCeeEEE
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT--DG--TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCME-SNNRILV  143 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~--~~--~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv  143 (363)
                      .|.+.+.||+|+||.||+|.+.  ++  ..||+|.+...........+.+|+.++++++||||+++++++.. ....++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4677889999999999999753  22  35899998765444556789999999999999999999998754 4678999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.+|+|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       170 ~e~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~  238 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGL  238 (373)
T ss_dssp             EECCTTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred             EECCCCCCHHHHHhhccc--------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccc
Confidence            999999999999976432        378999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCccccc--ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccc
Q 046595          224 TNQSSDTAAR--LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSE  300 (363)
Q Consensus       224 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~  300 (363)
                      ++........  .......||+.|+|||++.+..++.++||||||+++|||++ |..||............         
T Consensus       239 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~---------  309 (373)
T 3c1x_A          239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---------  309 (373)
T ss_dssp             -------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH---------
T ss_pred             cccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH---------
Confidence            9765433211  11233467889999999999999999999999999999999 67777654332211111         


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCC
Q 046595          301 DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA  357 (363)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~  357 (363)
                             ........+..++..+.+++.+||+.||++|||+.+|++.|+.++.+...
T Consensus       310 -------~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~  359 (373)
T 3c1x_A          310 -------LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  359 (373)
T ss_dssp             -------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             -------HcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence                   01111122334566799999999999999999999999999999877654

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-47  Score=343.26  Aligned_cols=262  Identities=27%  Similarity=0.466  Sum_probs=204.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      ++|++.+.||+|+||.||++++. ++.||+|++..   ......+.+|+.++++++||||+++++++.  +..++||||+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~   81 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES---ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA   81 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS---TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC---hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence            57899999999999999999885 78899999864   334578899999999999999999999876  4578999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCc-eEEeeeccCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK-SKIADFNLTNQ  226 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~-vkl~Dfg~a~~  226 (363)
                      .+++|.+++......      ..++...++.++.|++.||.|||+....+|+||||||+||+++.++. +||+|||++..
T Consensus        82 ~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           82 EGGSLYNVLHGAEPL------PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             TTCBHHHHHHCSSSE------ECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             CCCCHHHHHhccCCC------CccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            999999999865321      13788999999999999999999921118999999999999998886 79999999865


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      ....     .....||+.|+|||++.+..++.++||||||+++|||++|+.||..........  .+..           
T Consensus       156 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~~-----------  217 (307)
T 2eva_A          156 IQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI--MWAV-----------  217 (307)
T ss_dssp             --------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH--HHHH-----------
T ss_pred             cccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH--HHHH-----------
Confidence            4332     233468999999999999999999999999999999999999997543221110  0000           


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCCCCC
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGPE  360 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~~~~  360 (363)
                       ........+..++..+.+++.+||+.||.+|||+.+|++.|+.+.+..+...+
T Consensus       218 -~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~  270 (307)
T 2eva_A          218 -HNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE  270 (307)
T ss_dssp             -HTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred             -hcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence             00111122334556799999999999999999999999999999877665443

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=5.4e-48  Score=343.01  Aligned_cols=260  Identities=23%  Similarity=0.376  Sum_probs=216.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      ..+|++.+.||+|+||.||+|.+. ++..||+|++..  .....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS--CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            467999999999999999999865 488899999875  33445789999999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+++|.+++.....       ..+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||++.
T Consensus        90 ~~~~~~L~~~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~  159 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR  159 (288)
T ss_dssp             CCTTEEHHHHHHHCCT-------TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred             cCCCCcHHHHHHhccc-------CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccce
Confidence            9999999999976432       1389999999999999999999999   99999999999999999999999999987


Q ss_pred             CCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      ........ ......||+.|+|||++.+..++.++||||||+++|+|++ |..||........                .
T Consensus       160 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~----------------~  222 (288)
T 3kfa_A          160 LMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----------------Y  222 (288)
T ss_dssp             TSCSSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH----------------H
T ss_pred             eccCCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------H
Confidence            65533221 2334567889999999999999999999999999999999 9999975432211                1


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccC
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK  355 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~  355 (363)
                      ..+........+..++..+.+++.+||+.||.+|||+.+|++.|+.++.+.
T Consensus       223 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          223 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence            111122223334455677999999999999999999999999999887653

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.2e-47  Score=346.91  Aligned_cols=249  Identities=22%  Similarity=0.321  Sum_probs=197.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe----CCCCeEEEEEccCCCC---CCchHHHHHHHHHHhcCCCCccceeeeEEEeCCe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKL----TDGTPAAIKKLDTSSA---PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNN  139 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~----~~~~~~avK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  139 (363)
                      .++|++.+.||+|+||.||+|+.    .+++.||+|++.....   ......+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            35799999999999999999976    4789999999976432   2234567889999999999999999999999999


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEe
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA  219 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~  219 (363)
                      .++||||+.+++|.+++....         .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~  163 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG---------IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLT  163 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEEC
T ss_pred             EEEEEeCCCCCcHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEE
Confidence            999999999999999997654         288999999999999999999999   99999999999999999999999


Q ss_pred             eeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc
Q 046595          220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       220 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      |||++........  ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........         
T Consensus       164 Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---------  232 (327)
T 3a62_A          164 DFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK---------  232 (327)
T ss_dssp             CCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---------
T ss_pred             eCCcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHH---------
Confidence            9999875432221  13346799999999999999999999999999999999999999975432111110         


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP-----NMTIVVK  346 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  346 (363)
                            +...  ...++...+..+.+++.+||+.||.+||     ++.++++
T Consensus       233 ------i~~~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          233 ------ILKC--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ------HHHT--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ------HHhC--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                  0000  1123344567799999999999999999     7888876

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2e-48  Score=350.25  Aligned_cols=278  Identities=22%  Similarity=0.356  Sum_probs=219.6

Q ss_pred             HHHHHHhcCCCCCCeeeccCCceEEEEEe------CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeE
Q 046595           61 DELNRLTSNFGTKALIGEGSYGRVFYAKL------TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGY  133 (363)
Q Consensus        61 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~  133 (363)
                      .......++|++.+.||+|+||.||+|++      .+++.||+|++...........+.+|+.++..+ +||||++++++
T Consensus        20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   99 (316)
T 2xir_A           20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   99 (316)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence            34444567899999999999999999973      346789999997654444456788999999999 79999999999


Q ss_pred             EEeCC-eeEEEEecccCCChhhhhcCCCCCCC-------CCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccC
Q 046595          134 CMESN-NRILVYQFATMGSLHDVLHGRKGVQG-------AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRS  205 (363)
Q Consensus       134 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp  205 (363)
                      +...+ ..++||||+.+++|.+++........       ......+++..++.++.|++.||.|||++   +|+||||||
T Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp  176 (316)
T 2xir_A          100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA  176 (316)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCcc
Confidence            87754 48999999999999999986542110       00112388999999999999999999999   999999999


Q ss_pred             CceeecCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCC
Q 046595          206 SNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMP  284 (363)
Q Consensus       206 ~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~  284 (363)
                      +||+++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus       177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~  256 (316)
T 2xir_A          177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  256 (316)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence            999999999999999999976654433333445678899999999999999999999999999999998 9999975432


Q ss_pred             ccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCC
Q 046595          285 KGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP  356 (363)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~  356 (363)
                      .....               ..+........+...+..+.+++.+||+.||.+|||+.+|++.|+.+++...
T Consensus       257 ~~~~~---------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  313 (316)
T 2xir_A          257 DEEFC---------------RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  313 (316)
T ss_dssp             SHHHH---------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             hHHHH---------------HHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            21110               0000111112233455679999999999999999999999999999987644

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=7.8e-48  Score=338.72  Aligned_cols=253  Identities=21%  Similarity=0.346  Sum_probs=208.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeC--CeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMES--NNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~  144 (363)
                      ++|.+.+.||+|+||.||+|++. ++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.  ...++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            57999999999999999999985 888999999865422 2346789999999999999999999999877  7789999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCC--eEEecccCCceeecCCCceEEeeec
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPP--IVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ||+++|+|.+++.....       ..+++..++.++.|++.||.|||++   +  |+||||||+||+++.++.++|+|||
T Consensus        89 e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~  158 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTN-------FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMAD  158 (271)
T ss_dssp             ECCTTCBHHHHHHSCSS-------CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGG
T ss_pred             cccCCCcHHHHHhhccc-------CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEecc
Confidence            99999999999986542       1389999999999999999999999   8  9999999999999999999999998


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCc---cCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQ---KSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      ++....       .....||+.|+|||++.+..++.   ++||||||+++|||++|+.||.........           
T Consensus       159 ~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-----------  220 (271)
T 3kmu_A          159 VKFSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG-----------  220 (271)
T ss_dssp             SCCTTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH-----------
T ss_pred             ceeeec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH-----------
Confidence            865422       23357899999999998765544   799999999999999999999754322111           


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccc
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN  353 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~  353 (363)
                          ............+..++..+.+++..||+.||++|||+.++++.|+.+.+
T Consensus       221 ----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          221 ----MKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             ----HHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             ----HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                11111122233344566779999999999999999999999999998865

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-47  Score=341.59  Aligned_cols=263  Identities=24%  Similarity=0.364  Sum_probs=210.2

Q ss_pred             CCCCCCeeeccCCceEEEEEeCC-CC---eEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCee-EEE
Q 046595           69 NFGTKALIGEGSYGRVFYAKLTD-GT---PAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNR-ILV  143 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~~-~~---~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~lv  143 (363)
                      .|.+.+.||+|+||.||+|.+.+ +.   .+|+|.+.........+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            46667899999999999997532 22   69999987644444457889999999999999999999999876665 899


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.+++|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       102 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~  170 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQR--------NPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGL  170 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTS
T ss_pred             EecccCCCHHHHHhcccc--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCC
Confidence            999999999999976332        388999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccc--cccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCC-CCCCCccccchhhhccccccc
Q 046595          224 TNQSSDTAA--RLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPV-DHTMPKGQQSLVTWATPRLSE  300 (363)
Q Consensus       224 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~-~~~~~~~~~~~~~~~~~~~~~  300 (363)
                      +........  ........|++.|+|||.+.+..++.++||||||+++|+|++|..|+ ........             
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~-------------  237 (298)
T 3pls_A          171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL-------------  237 (298)
T ss_dssp             SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH-------------
T ss_pred             cccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH-------------
Confidence            976544322  11223456889999999999999999999999999999999966554 33222111             


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCCC
Q 046595          301 DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAG  358 (363)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~~  358 (363)
                         ...+........+..++..+.+++.+||+.||.+|||+.++++.|++++++....
T Consensus       238 ---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~  292 (298)
T 3pls_A          238 ---THFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD  292 (298)
T ss_dssp             ---HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred             ---HHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence               1111111112223345567999999999999999999999999999998876544

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=7.9e-48  Score=342.05  Aligned_cols=265  Identities=20%  Similarity=0.296  Sum_probs=201.5

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      ++|++.+.||+|+||.||+|+..+++.||+|++...... .....+.+|+.+++.++||||+++++++......++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            478999999999999999999888999999998764322 2346788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+ +|.+++.....        .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++..
T Consensus        82 ~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  149 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEG--------GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARA  149 (288)
T ss_dssp             CSE-EHHHHHHTSTT--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred             cCC-CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccc
Confidence            987 99999876432        388999999999999999999999   999999999999999999999999999864


Q ss_pred             CCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccc---c
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED---K  302 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~  302 (363)
                      ......  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||......................   .
T Consensus       150 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (288)
T 1ob3_A          150 FGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN  227 (288)
T ss_dssp             HCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             cCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchh
Confidence            332211  12345789999999998764 58999999999999999999999997653322111110000000000   0


Q ss_pred             cc--cccCCcC-------CCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          303 VK--QCVDPKL-------NNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       303 ~~--~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ..  ...+...       ...+....+..+.+++.+||+.||++|||+.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00  0000000       01112234567899999999999999999999986

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.3e-48  Score=347.22  Aligned_cols=269  Identities=22%  Similarity=0.346  Sum_probs=202.3

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC----CCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeCCe-
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESNN-  139 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-  139 (363)
                      ..++|.+.+.||+|+||.||+|...    ++..||+|.+...... .....+.+|+.+++.++||||+++++++.+... 
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            3468999999999999999999653    3447999998764322 223678899999999999999999999887653 


Q ss_pred             ----eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCc
Q 046595          140 ----RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK  215 (363)
Q Consensus       140 ----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~  215 (363)
                          .++||||+.+++|.+++.......   ....+++..++.++.|++.||.|||++   +|+||||||+||+++.++.
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLET---GPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTT---SCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSC
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhc---CCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCc
Confidence                489999999999999985432111   112489999999999999999999999   9999999999999999999


Q ss_pred             eEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhc
Q 046595          216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWA  294 (363)
Q Consensus       216 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~  294 (363)
                      +||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........    
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----  261 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY----  261 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH----
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH----
Confidence            99999999876554332222334567889999999999999999999999999999999 8899975433211110    


Q ss_pred             cccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCC
Q 046595          295 TPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP  356 (363)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~  356 (363)
                                  .........+..++..+.+++.+||+.||.+|||+.+|++.|+.++++.+
T Consensus       262 ------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          262 ------------LLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             ------------HHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             ------------HHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence                        11111122234455679999999999999999999999999999987765

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.7e-48  Score=348.44  Aligned_cols=261  Identities=24%  Similarity=0.410  Sum_probs=206.1

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCC-----CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTD-----GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      ++|.+.+.||+|+||.||+|....     +..||+|.+...........+.+|+.+++.++||||+++++++......++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            578888999999999999997542     235999999765444445678899999999999999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ||||+.+++|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||
T Consensus       124 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  192 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDG--------EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFG  192 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTT--------CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             EEeCCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCC
Confidence            9999999999999975421        389999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCccccc-ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccc
Q 046595          223 LTNQSSDTAAR-LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSE  300 (363)
Q Consensus       223 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~  300 (363)
                      ++......... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||........             
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~-------------  259 (333)
T 1mqb_A          193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-------------  259 (333)
T ss_dssp             C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------------
T ss_pred             cchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH-------------
Confidence            98765433221 11223356789999999999999999999999999999999 9999964432111             


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccC
Q 046595          301 DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK  355 (363)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~  355 (363)
                         ...+........+..++..+.+++.+||+.||.+||++.+|++.|+++++..
T Consensus       260 ---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          260 ---MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             ---HHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             ---HHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence               1111111112223455677999999999999999999999999999887653

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1e-47  Score=350.10  Aligned_cols=249  Identities=22%  Similarity=0.269  Sum_probs=206.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l  142 (363)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....  .......+..|..++..+ +||||+++++++.+.+..++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            468999999999999999999876 48899999987532  233456788999999988 79999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ||||+.||+|.+++....         .+++..++.++.|++.||.|||++   ||+||||||+|||++.+|.+||+|||
T Consensus        99 v~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG  166 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVG---------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFG  166 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCC
Confidence            999999999999997643         289999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      +++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........            
T Consensus       167 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~------------  232 (353)
T 2i0e_A          167 MCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS------------  232 (353)
T ss_dssp             TCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------------
T ss_pred             cccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHH------------
Confidence            9875432221  23456899999999999999999999999999999999999999975432211110            


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPN-----MTIVVK  346 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~~vl~  346 (363)
                         +...  ...++...+.++.++|.+||+.||.+||+     +.+|++
T Consensus       233 ---i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          233 ---IMEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             ---HHHC--CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             ---HHhC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence               1111  11234455677999999999999999995     577765

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-47  Score=351.33  Aligned_cols=253  Identities=19%  Similarity=0.269  Sum_probs=206.1

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      +.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  127 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  127 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence            4568999999999999999999765 68899999987532 223457889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec--CCCceEEeeec
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF--DDFKSKIADFN  222 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~--~~~~vkl~Dfg  222 (363)
                      ||+.+|+|.+++.....        .+++.+++.++.|++.||.|||++   +|+||||||+|||++  .++.+||+|||
T Consensus       128 E~~~gg~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG  196 (387)
T 1kob_A          128 EFLSGGELFDRIAAEDY--------KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG  196 (387)
T ss_dssp             ECCCCCBHHHHTTCTTC--------CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred             EcCCCCcHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecc
Confidence            99999999999975431        389999999999999999999999   999999999999997  45789999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      ++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...        
T Consensus       197 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~--------  265 (387)
T 1kob_A          197 LATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC--------  265 (387)
T ss_dssp             TCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC--------
T ss_pred             cceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------
Confidence            9876543321   23457999999999999999999999999999999999999999754322111111000        


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                           ...........++.++.++|.+||+.||.+|||+.++++
T Consensus       266 -----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          266 -----DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             -----CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             -----CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                 000111122345567999999999999999999999987

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.2e-47  Score=350.28  Aligned_cols=253  Identities=22%  Similarity=0.277  Sum_probs=204.1

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC----CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCee
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS----APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNR  140 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  140 (363)
                      +.++|++.+.||+|+||.||+|.+. +++.||||++....    .....+.+.+|+.+++.++||||+++++++.+....
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            4568999999999999999999764 68999999985421    222457899999999999999999999999999999


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCc---eE
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK---SK  217 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~---vk  217 (363)
                      ++||||+.+++|.+++......     +..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.   +|
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vk  173 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADA-----GFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVK  173 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEE
T ss_pred             EEEEeCCCCCCHHHHHHHhccc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEE
Confidence            9999999999999888643211     12389999999999999999999999   9999999999999986554   99


Q ss_pred             EeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccc
Q 046595          218 IADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR  297 (363)
Q Consensus       218 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~  297 (363)
                      |+|||++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....    ....     
T Consensus       174 l~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~-----  242 (351)
T 3c0i_A          174 LGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFE-----  242 (351)
T ss_dssp             ECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHH-----
T ss_pred             EecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHH-----
Confidence            999999876544322  13446799999999999999999999999999999999999999975311    0000     


Q ss_pred             ccccccccccCCcCCCCCC----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          298 LSEDKVKQCVDPKLNNDYP----PKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                             .+.....  ..+    ..++..+.++|.+||+.||++|||+.++++
T Consensus       243 -------~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          243 -------GIIKGKY--KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             -------HHHHTCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -------HHHcCCC--CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                   0000000  011    123567999999999999999999999986

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.2e-47  Score=354.87  Aligned_cols=251  Identities=21%  Similarity=0.351  Sum_probs=199.5

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCC--CCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLK--HEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      .+|.+.+.||+|+||.||+|...+++.||||++...... .....+.+|+.+++.++  ||||+++++++......++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            469999999999999999999888999999998764332 23467899999999996  599999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      | +.+++|.+++....         .+++.+++.++.||+.||.|||++   +|+||||||+|||++ ++.+||+|||++
T Consensus       136 E-~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a  201 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK---------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIA  201 (390)
T ss_dssp             E-CCSEEHHHHHHHCS---------SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSS
T ss_pred             e-cCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcc
Confidence            9 56779999997654         288999999999999999999999   999999999999995 589999999999


Q ss_pred             CCCCcccccccccccccccCCCCcccccc-----------CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhh
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMT-----------GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTW  293 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~  293 (363)
                      ................||+.|+|||++.+           ..++.++|||||||+||||++|..||.......       
T Consensus       202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-------  274 (390)
T 2zmd_A          202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-------  274 (390)
T ss_dssp             CCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-------
T ss_pred             ccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-------
Confidence            87654433323345679999999999865           368899999999999999999999996432210       


Q ss_pred             ccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          294 ATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                             ..+...++......++...+..+.+||.+||+.||.+|||+.+|++
T Consensus       275 -------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          275 -------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             -------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -------HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence                   0111122222222333333567999999999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.7e-48  Score=351.28  Aligned_cols=270  Identities=24%  Similarity=0.402  Sum_probs=214.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCC-C-----CeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTD-G-----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNN  139 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~-~-----~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~  139 (363)
                      .++|.+.+.||+|+||.||+|.+.. +     ..||+|.+...........+.+|+.+++.+ +||||+++++++.....
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  124 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP  124 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence            4689999999999999999998642 2     479999997654444457789999999999 89999999999999999


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCC-----CCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQG-----AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF  214 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~-----~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~  214 (363)
                      .++||||+.+|+|.+++........     ......+++..++.++.|++.||.|||++   +|+||||||+||+++.++
T Consensus       125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~  201 (333)
T 2i1m_A          125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGH  201 (333)
T ss_dssp             CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGG
T ss_pred             eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCC
Confidence            9999999999999999975421000     00112379999999999999999999999   999999999999999999


Q ss_pred             ceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhh
Q 046595          215 KSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTW  293 (363)
Q Consensus       215 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~  293 (363)
                      .+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||.........     
T Consensus       202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-----  276 (333)
T 2i1m_A          202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF-----  276 (333)
T ss_dssp             EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH-----
T ss_pred             eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH-----
Confidence            999999999976544333222344567889999999999999999999999999999999 99999754322111     


Q ss_pred             ccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          294 ATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                                ............+..++..+.+++..||+.||.+|||+.+|++.|+++..+
T Consensus       277 ----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          277 ----------YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             ----------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence                      011111111222334456799999999999999999999999999987654

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.6e-47  Score=346.29  Aligned_cols=268  Identities=25%  Similarity=0.425  Sum_probs=210.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCe--EEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTP--AAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~--~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      ++|++.+.||+|+||.||+|++. ++..  +++|.+...........+.+|+.+++++ +||||+++++++.+....++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57999999999999999999764 4554  4999887655555567899999999999 899999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCC-------CCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCce
Q 046595          144 YQFATMGSLHDVLHGRKGVQG-------AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS  216 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v  216 (363)
                      |||+++++|.+++........       ......+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence            999999999999976531000       00112389999999999999999999999   99999999999999999999


Q ss_pred             EEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcc
Q 046595          217 KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       217 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      ||+|||++........   .....+++.|+|||++.+..++.++||||||+++|+|++ |..||........   .    
T Consensus       182 kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~---~----  251 (327)
T 1fvr_A          182 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---Y----  251 (327)
T ss_dssp             EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H----
T ss_pred             EEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH---H----
Confidence            9999999864332211   233457889999999998899999999999999999998 9999975432111   0    


Q ss_pred             ccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCC
Q 046595          296 PRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA  357 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~  357 (363)
                               ..+........+..++..+.+++.+||+.||.+|||+.++++.|+.++++...
T Consensus       252 ---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  304 (327)
T 1fvr_A          252 ---------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  304 (327)
T ss_dssp             ---------HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred             ---------HHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence                     11111112223345567799999999999999999999999999999887654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.6e-47  Score=353.62  Aligned_cols=278  Identities=20%  Similarity=0.263  Sum_probs=218.9

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCC--eeEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESN--NRIL  142 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l  142 (363)
                      +.++|.+.+.||+|+||.||+|++. +++.||||++...........+.+|+.+++.++||||+++++++....  ..++
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            3468999999999999999999865 589999999976554555678889999999999999999999998765  6799


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceee----cCCCceEE
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL----FDDFKSKI  218 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill----~~~~~vkl  218 (363)
                      ||||+.+|+|.+++......      ..+++..++.++.|++.||.|||++   +|+||||||+|||+    +.++.+||
T Consensus        87 v~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL  157 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKL  157 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGGT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEE
T ss_pred             EEecCCCCCHHHHHHhhhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEE
Confidence            99999999999999765421      1289999999999999999999999   99999999999999    77888999


Q ss_pred             eeeccCCCCCcccccccccccccccCCCCcccccc--------CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccc-
Q 046595          219 ADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT--------GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQS-  289 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~-  289 (363)
                      +|||++........   .....||+.|+|||++.+        ..++.++|||||||++|||++|+.||.......... 
T Consensus       158 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~  234 (396)
T 4eut_A          158 TDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE  234 (396)
T ss_dssp             CCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHH
T ss_pred             ecCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHH
Confidence            99999876544322   234579999999999875        567889999999999999999999997543221111 


Q ss_pred             hh-hhcccccc--ccccc-------ccc-CCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccC
Q 046595          290 LV-TWATPRLS--EDKVK-------QCV-DPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK  355 (363)
Q Consensus       290 ~~-~~~~~~~~--~~~~~-------~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~  355 (363)
                      .. ........  ...+.       .+. .......+....+..+.+++.+||+.||++||++.++++.++.+++.+
T Consensus       235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~  311 (396)
T 4eut_A          235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM  311 (396)
T ss_dssp             HHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred             HHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence            11 11000000  00000       000 111123455788999999999999999999999999999999988764

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-46  Score=340.67  Aligned_cols=270  Identities=23%  Similarity=0.396  Sum_probs=208.6

Q ss_pred             HHHHHhcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcC--CCCccceeeeEEEeC--
Q 046595           62 ELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL--KHEHFVELLGYCMES--  137 (363)
Q Consensus        62 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~--  137 (363)
                      ....+.++|++.+.||+|+||.||+|++. ++.||||++...    ....+..|.+++..+  +||||+++++++...  
T Consensus        31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            34456678999999999999999999886 899999998542    234556666666655  899999999999887  


Q ss_pred             --CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccC-----CCCeEEecccCCceee
Q 046595          138 --NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV-----QPPIVHRDVRSSNVLL  210 (363)
Q Consensus       138 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-----~~~ivH~Dlkp~Nill  210 (363)
                        ...++||||+.+|+|.+++....          +++..++.++.|++.||.|||++.     ..+|+||||||+|||+
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill  175 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKSTT----------LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV  175 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE
T ss_pred             CCCceEEEEeccCCCcHHHHhhccC----------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE
Confidence              78899999999999999997643          899999999999999999999751     2279999999999999


Q ss_pred             cCCCceEEeeeccCCCCCcccccc--cccccccccCCCCccccccCCCCcc------CceehhHHHHHHHHhC-------
Q 046595          211 FDDFKSKIADFNLTNQSSDTAARL--HSTRVLGTFGYHAPEYAMTGQITQK------SDVYSFGVVLLELLTG-------  275 (363)
Q Consensus       211 ~~~~~vkl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~~l~ell~g-------  275 (363)
                      +.++.+||+|||++..........  ......||+.|+|||++.+..++..      +|||||||++|||++|       
T Consensus       176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~  255 (337)
T 3mdy_A          176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV  255 (337)
T ss_dssp             CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence            999999999999986544332211  1224579999999999987766655      9999999999999999       


Q ss_pred             ---CCCCCCCCCccccchhhhcccccccccccc-ccCCcCCCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          276 ---RKPVDHTMPKGQQSLVTWATPRLSEDKVKQ-CVDPKLNNDYP-----PKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       276 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                         ..||..........           ..+.. .........++     ..++..+.+++.+||+.||.+|||+.+|++
T Consensus       256 ~~~~~p~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  324 (337)
T 3mdy_A          256 EEYQLPYHDLVPSDPSY-----------EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK  324 (337)
T ss_dssp             CCCCCTTTTTSCSSCCH-----------HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccccccHhhhcCCCCch-----------hhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence               55554332221110           00000 11111222222     378889999999999999999999999999


Q ss_pred             HhccccccCCC
Q 046595          347 ALQPLLNSKPA  357 (363)
Q Consensus       347 ~l~~l~~~~~~  357 (363)
                      .|+.+.++...
T Consensus       325 ~L~~l~~~~~~  335 (337)
T 3mdy_A          325 TLAKMSESQDI  335 (337)
T ss_dssp             HHHHHHHTTTC
T ss_pred             HHHHHHhhccc
Confidence            99999887653

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=7.9e-48  Score=353.29  Aligned_cols=275  Identities=15%  Similarity=0.230  Sum_probs=207.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCC------CCeEEEEEccCCCCCC----------chHHHHHHHHHHhcCCCCcccee
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTD------GTPAAIKKLDTSSAPE----------PESDFAAQLSVVSRLKHEHFVEL  130 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~avK~~~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~  130 (363)
                      .++|++.+.||+|+||.||+|.+.+      ++.||||++.......          ....+..|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4589999999999999999998654      4789999986532110          00123345566778889999999


Q ss_pred             eeEEEeC----CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCC
Q 046595          131 LGYCMES----NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSS  206 (363)
Q Consensus       131 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~  206 (363)
                      ++++...    ...++||||+ +++|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~  181 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK--------RFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKAS  181 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGG
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHH
Confidence            9998775    4579999999 8899999976421        389999999999999999999999   9999999999


Q ss_pred             ceeec--CCCceEEeeeccCCCCCcccccc-----cccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCC
Q 046595          207 NVLLF--DDFKSKIADFNLTNQSSDTAARL-----HSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPV  279 (363)
Q Consensus       207 Nill~--~~~~vkl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~  279 (363)
                      |||++  .++.+||+|||+++.........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       182 Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf  261 (364)
T 3op5_A          182 NLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW  261 (364)
T ss_dssp             GEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             HEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99999  88999999999997654432211     113345999999999999999999999999999999999999999


Q ss_pred             CCCCCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCCCC
Q 046595          280 DHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGP  359 (363)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~~~  359 (363)
                      ..........  ....... ...+..+++..+.   ...++.++.+++..||+.||.+||++.+|++.|+.++++.....
T Consensus       262 ~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~  335 (364)
T 3op5_A          262 EDNLKDPKYV--RDSKIRY-RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKD  335 (364)
T ss_dssp             GGGTTCHHHH--HHHHHHH-HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred             cccccCHHHH--HHHHHHh-hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCc
Confidence            7533221111  0000000 0111122211111   11235679999999999999999999999999999988765543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2e-47  Score=347.52  Aligned_cols=256  Identities=20%  Similarity=0.292  Sum_probs=204.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC--chHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE--PESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++.......  ....+.+|..++..+ +||||+++++++.+....++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            57999999999999999999865 58899999997643322  235678899999887 899999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.+|+|.+++....         .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        89 ~e~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~  156 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR---------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGM  156 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGG
T ss_pred             EeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccc
Confidence            99999999999997643         289999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      ++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........       .....+
T Consensus       157 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-------~~~~~~  227 (345)
T 3a8x_A          157 CKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL  227 (345)
T ss_dssp             CBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--------------CHHHH
T ss_pred             cccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc-------ccHHHH
Confidence            875332221  13456899999999999999999999999999999999999999964322110000       000000


Q ss_pred             -ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH------HHHHH
Q 046595          304 -KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNM------TIVVK  346 (363)
Q Consensus       304 -~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~------~~vl~  346 (363)
                       ..+...  ...++...+..+.++|.+||+.||.+||++      .++++
T Consensus       228 ~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          228 FQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             HHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             HHHHHcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence             001111  122344566779999999999999999995      66664

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.6e-47  Score=338.90  Aligned_cols=259  Identities=22%  Similarity=0.328  Sum_probs=207.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCC----CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTD----GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      .++|.+.+.||+|+||.||+|.+.+    +..||+|.+.........+.+.+|+.+++.++||||+++++++.+ ...++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            4579999999999999999997542    335999998775444455788999999999999999999998764 56789


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ||||+.+++|.+++.....        .+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||
T Consensus        90 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  158 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKN--------SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFG  158 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTT--------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCC
T ss_pred             EEecCCCCCHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccC
Confidence            9999999999999975432        388999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      ++......... ......|++.|+|||++.+..++.++||||||+++|+|++ |+.||.............         
T Consensus       159 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~---------  228 (281)
T 3cc6_A          159 LSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE---------  228 (281)
T ss_dssp             GGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH---------
T ss_pred             CCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh---------
Confidence            98765443221 1233457889999999999999999999999999999998 999997543322111110         


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                             .......+..++..+.+++.+||+.||.+|||+.+|++.|+.+.+.
T Consensus       229 -------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          229 -------KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             -------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------cCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence                   0111122334556799999999999999999999999999988653

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=9.4e-48  Score=342.07  Aligned_cols=259  Identities=23%  Similarity=0.377  Sum_probs=207.8

Q ss_pred             hcCCCCCC-eeeccCCceEEEEEe---CCCCeEEEEEccCCCCCCc-hHHHHHHHHHHhcCCCCccceeeeEEEeCCeeE
Q 046595           67 TSNFGTKA-LIGEGSYGRVFYAKL---TDGTPAAIKKLDTSSAPEP-ESDFAAQLSVVSRLKHEHFVELLGYCMESNNRI  141 (363)
Q Consensus        67 ~~~y~~~~-~lg~G~~g~V~~~~~---~~~~~~avK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  141 (363)
                      .++|.+.+ .||+|+||.||+|.+   .+++.||||++........ .+.+.+|+.+++.++||||+++++++ .....+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45788888 999999999999953   2467899999976543332 46789999999999999999999998 567789


Q ss_pred             EEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeee
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADF  221 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df  221 (363)
                      +||||+.+++|.+++....         .+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+||
T Consensus        94 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Df  161 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR---------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDF  161 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCC
T ss_pred             EEEEeCCCCCHHHHHHhCc---------CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccC
Confidence            9999999999999997643         289999999999999999999999   9999999999999999999999999


Q ss_pred             ccCCCCCccccc-ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccc
Q 046595          222 NLTNQSSDTAAR-LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       222 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      |++......... .......|++.|+|||++.+..++.++||||||+++|+|++ |..||........            
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------------  229 (291)
T 1xbb_A          162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV------------  229 (291)
T ss_dssp             TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------------
T ss_pred             CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH------------
Confidence            998765433221 11222346789999999998899999999999999999999 9999975432211            


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                          ...+........+..++..+.+++.+||+.||.+||++.+|++.|++++..
T Consensus       230 ----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          230 ----TAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             ----HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ----HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence                111111112233445667899999999999999999999999999998765

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.1e-47  Score=361.52  Aligned_cols=249  Identities=22%  Similarity=0.303  Sum_probs=197.6

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCC--CCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTS--SAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      .++|++.+.||+|+||.||+|+.. +++.||||++...  ........+.+|+.+++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            357999999999999999999754 6899999998653  1233345678899999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-cCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE-KVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      |||+.+|+|.+++....         .+++..+..++.|++.||.|||+ +   +|+||||||+|||++.++.+||+|||
T Consensus       227 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG  294 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER---------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFG  294 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCC
T ss_pred             EeeCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCC
Confidence            99999999999997654         28999999999999999999998 8   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      +++........  .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.          
T Consensus       295 ~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~----------  362 (446)
T 4ejn_A          295 LCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL----------  362 (446)
T ss_dssp             CCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----------
T ss_pred             CceeccCCCcc--cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH----------
Confidence            98754332222  345689999999999999999999999999999999999999997543221111110          


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP-----NMTIVVK  346 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  346 (363)
                           ..  ...++...+..+.+||.+||+.||.+||     ++.++++
T Consensus       363 -----~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          363 -----ME--EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             -----HC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -----hC--CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                 00  0122344567799999999999999999     9999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=7.4e-48  Score=348.42  Aligned_cols=268  Identities=23%  Similarity=0.364  Sum_probs=210.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe------CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCee
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKL------TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNR  140 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  140 (363)
                      .++|++.+.||+|+||.||+|++      .++..||||.+...........+.+|+.+++.++||||+++++++......
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46899999999999999999973      257789999997644444456788999999999999999999999999999


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC---CCceE
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD---DFKSK  217 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~~~vk  217 (363)
                      ++||||+.+++|.+++.......  .....+++..++.++.|++.||.|||++   +|+||||||+||+++.   +..+|
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRP--SQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCS--SSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             EEEEecCCCCcHHHHHHhhcccc--cccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEE
Confidence            99999999999999998654221  1112489999999999999999999999   9999999999999984   45699


Q ss_pred             EeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccc
Q 046595          218 IADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATP  296 (363)
Q Consensus       218 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~  296 (363)
                      |+|||++................|++.|+|||++.+..++.++||||||+++|+|++ |..||.........        
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--------  255 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL--------  255 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH--------
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH--------
Confidence            999998754332222222334568899999999999999999999999999999998 99999754321111        


Q ss_pred             cccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccC
Q 046595          297 RLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK  355 (363)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~  355 (363)
                              ..+........+..++..+.+++.+||+.||.+||++.+|++.|+.+.+..
T Consensus       256 --------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          256 --------EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             --------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             --------HHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence                    111111112223445667999999999999999999999999999876644

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=8e-48  Score=345.76  Aligned_cols=266  Identities=24%  Similarity=0.350  Sum_probs=200.7

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCc--hHHHHHHHHHHhcCCCCccceeeeEEEeCCee--
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKHEHFVELLGYCMESNNR--  140 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~--  140 (363)
                      +.++|++.+.||+|+||.||+|++ .+++.||||++........  ...+.+|+.+++.++||||+++++++......  
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            456899999999999999999986 5789999999976543322  35788999999999999999999998766543  


Q ss_pred             --EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEE
Q 046595          141 --ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI  218 (363)
Q Consensus       141 --~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl  218 (363)
                        ++||||+++++|.+++....         .+++.+++.++.|++.||.|||++   +|+||||||+||+++.++.+||
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl  157 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKV  157 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEE
T ss_pred             ccEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEE
Confidence              89999999999999997543         289999999999999999999999   9999999999999999999999


Q ss_pred             eeeccCCCCCccccc-ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccc
Q 046595          219 ADFNLTNQSSDTAAR-LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR  297 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~  297 (363)
                      +|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||............  ....
T Consensus       158 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~--~~~~  235 (311)
T 3ork_A          158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH--VRED  235 (311)
T ss_dssp             CCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHCC
T ss_pred             eeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--hcCC
Confidence            999998765443221 1233457999999999999999999999999999999999999999754332111100  0000


Q ss_pred             ccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHH-HHHHhccccccCC
Q 046595          298 LSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTI-VVKALQPLLNSKP  356 (363)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~-vl~~l~~l~~~~~  356 (363)
                      .           .........++..+.+++.+||+.||++||+..+ +...+..+.+..+
T Consensus       236 ~-----------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~  284 (311)
T 3ork_A          236 P-----------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEP  284 (311)
T ss_dssp             C-----------CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCC
T ss_pred             C-----------CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCC
Confidence            0           0000001124567999999999999999996555 4456666555443

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.9e-47  Score=340.43  Aligned_cols=270  Identities=21%  Similarity=0.333  Sum_probs=202.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCC--chHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPE--PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|++.+.||+|+||.||+|.. .+++.||+|++.......  ....+.+|+.+++.++||||+++++++......++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            5799999999999999999975 478999999997643222  3467889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+++|.+++......     ...+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++
T Consensus       112 e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~  183 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQ-----KRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLG  183 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC---
T ss_pred             ecCCCCCHHHHHHHhccc-----ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccce
Confidence            999999999998642210     11389999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      .........  .....|++.|+|||++.+..++.++||||||+++|+|++|..||........ .....         +.
T Consensus       184 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~---------~~  251 (310)
T 2wqm_A          184 RFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCKK---------IE  251 (310)
T ss_dssp             -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-HHHHH---------HH
T ss_pred             eeecCCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-HHHHH---------hh
Confidence            765433221  2345789999999999999999999999999999999999999964322110 00000         00


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCCCCC
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGPE  360 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~~~~  360 (363)
                         ...........++..+.+++.+||+.||.+|||+.+|++.|+++......++|
T Consensus       252 ---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~  304 (310)
T 2wqm_A          252 ---QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE  304 (310)
T ss_dssp             ---TTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred             ---cccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence               00111111134456799999999999999999999999999999988777665

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.4e-47  Score=357.34  Aligned_cols=252  Identities=22%  Similarity=0.315  Sum_probs=208.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      .++|.+.+.||+|+||.||+|++. +|+.||||++....  .......+.+|+.+++.++||||+++++++......++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            358999999999999999999865 79999999986532  223456789999999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.+|+|.+++....         .+++.+++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        95 ~E~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~  162 (476)
T 2y94_A           95 MEYVSGGELFDYICKNG---------RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGL  162 (476)
T ss_dssp             EECCSSEEHHHHTTSSS---------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred             EeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccc
Confidence            99999999999997643         289999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCC-CccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      +........   ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........            
T Consensus       163 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~------------  227 (476)
T 2y94_A          163 SNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK------------  227 (476)
T ss_dssp             CEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHH------------
T ss_pred             hhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHH------------
Confidence            876543321   234579999999999988765 6899999999999999999999975432111110            


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhcc
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQP  350 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~  350 (363)
                         +.+..  ...+...+..+.+++.+||+.||.+|||+.+|++  .++.
T Consensus       228 ---i~~~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          228 ---ICDGI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             ---HHTTC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             ---HhcCC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence               00100  1122334567999999999999999999999997  4443

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.6e-47  Score=340.73  Aligned_cols=266  Identities=21%  Similarity=0.281  Sum_probs=200.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCc-hHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEP-ESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++........ ...+.+|+.+++.++||||+++++++......++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            468999999999999999999865 589999999876443222 356788999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+++|.+++....         .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        82 e~~~~~~l~~~~~~~~---------~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  149 (311)
T 4agu_A           82 EYCDHTVLHELDRYQR---------GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFA  149 (311)
T ss_dssp             ECCSEEHHHHHHHTSS---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EeCCCchHHHHHhhhc---------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCc
Confidence            9999999999887554         289999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccc---
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE---  300 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~---  300 (363)
                      .........  .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.....................   
T Consensus       150 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  227 (311)
T 4agu_A          150 RLLTGPSDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQ  227 (311)
T ss_dssp             EECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             hhccCcccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccc
Confidence            765433221  234578999999999876 57899999999999999999999999765443322211110000000   


Q ss_pred             ------cccccccCCcCCCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          301 ------DKVKQCVDPKLNNDY-----PPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       301 ------~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                            ........+......     ....+..+.+++.+||+.||.+|||++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                  000000000000000     0134566899999999999999999999986

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.9e-47  Score=348.53  Aligned_cols=250  Identities=21%  Similarity=0.298  Sum_probs=196.4

Q ss_pred             CCCC--CCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           69 NFGT--KALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        69 ~y~~--~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      .|.+  .+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E  166 (373)
T 2x4f_A           88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME  166 (373)
T ss_dssp             TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            4444  56799999999999976 468999999987632 2334678999999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceee--cCCCceEEeeecc
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL--FDDFKSKIADFNL  223 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill--~~~~~vkl~Dfg~  223 (363)
                      |+++++|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+|||+  +.++.+||+|||+
T Consensus       167 ~~~~~~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~  235 (373)
T 2x4f_A          167 YVDGGELFDRIIDESY--------NLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGL  235 (373)
T ss_dssp             CCTTCEEHHHHHHTGG--------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSS
T ss_pred             CCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCC
Confidence            9999999998865321        288999999999999999999999   99999999999999  5678999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      +........   .....||+.|+|||++.+..++.++|||||||++|||++|..||...........+  .....     
T Consensus       236 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i--~~~~~-----  305 (373)
T 2x4f_A          236 ARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI--LACRW-----  305 (373)
T ss_dssp             CEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--HHTCC-----
T ss_pred             ceecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhccC-----
Confidence            876543322   23456999999999999889999999999999999999999999755332111111  00000     


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                            .+.......++.++.+||.+||+.||.+|||+.++++
T Consensus       306 ------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          306 ------DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             ------CSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ------CCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                  0000111234567999999999999999999999987

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1e-47  Score=341.42  Aligned_cols=260  Identities=23%  Similarity=0.411  Sum_probs=203.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCC-C-------CeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCC
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTD-G-------TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESN  138 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~-~-------~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  138 (363)
                      .++|.+.+.||+|+||.||+|.+.. +       ..|++|++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            3579999999999999999997543 3       469999986532 334578899999999999999999999999999


Q ss_pred             eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCc---
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK---  215 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~---  215 (363)
                      ..++||||+.+++|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.   
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~  154 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKNKN--------CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKT  154 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGG--------GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGG
T ss_pred             CCEEEEECCCCCCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccc
Confidence            99999999999999999976532        288999999999999999999999   9999999999999998887   


Q ss_pred             -----eEEeeeccCCCCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccc
Q 046595          216 -----SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQS  289 (363)
Q Consensus       216 -----vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~  289 (363)
                           +||+|||++......      ....||+.|+|||++.+ ..++.++||||||+++|+|++|..|+..........
T Consensus       155 ~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~  228 (289)
T 4fvq_A          155 GNPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL  228 (289)
T ss_dssp             TBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred             cccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH
Confidence                 999999998655432      23458899999999987 679999999999999999999655443221111100


Q ss_pred             hhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCCCCCC
Q 046595          290 LVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGPEA  361 (363)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~~~~~  361 (363)
                        .....               ....+...+..+.+++.+||+.||.+|||+.++++.|+.++.....++++
T Consensus       229 --~~~~~---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~~~  283 (289)
T 4fvq_A          229 --QFYED---------------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGS  283 (289)
T ss_dssp             --HHHHT---------------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---------
T ss_pred             --HHhhc---------------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCCCc
Confidence              00000               01111122345899999999999999999999999999999977666543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=9e-47  Score=337.65  Aligned_cols=250  Identities=26%  Similarity=0.388  Sum_probs=209.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      .+.|.+.+.||+|+||.||+|.. .+++.||+|++...........+.+|+.+++.++||||+++++++......++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            35799999999999999999975 46899999999876655667889999999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+++|.+++....          +++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||++.
T Consensus       101 ~~~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~  167 (303)
T 3a7i_A          101 YLGGGSALDLLEPGP----------LDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG  167 (303)
T ss_dssp             CCTTEEHHHHHTTSC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             eCCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccce
Confidence            999999999997543          89999999999999999999999   99999999999999999999999999986


Q ss_pred             CCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      .......  ......|++.|+|||++.+..++.++||||||+++|+|++|..||............            ..
T Consensus       168 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------------~~  233 (303)
T 3a7i_A          168 QLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI------------PK  233 (303)
T ss_dssp             ECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------------HH
T ss_pred             ecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh------------hc
Confidence            5543322  123457899999999999999999999999999999999999999754322111100            00


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                          ......+..++..+.+++.+||+.||.+|||+.+|++.
T Consensus       234 ----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          234 ----NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             ----SCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             ----CCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                01112223345669999999999999999999999874

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=7.8e-48  Score=348.30  Aligned_cols=279  Identities=22%  Similarity=0.328  Sum_probs=213.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-----CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEE--eCCee
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-----TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM--ESNNR  140 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~  140 (363)
                      ++|++.+.||+|+||.||+|++     .+++.||+|++... .....+.+.+|+.++++++||||+++++++.  .....
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            5799999999999999999983     35888999998763 2233467899999999999999999999887  45668


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEee
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD  220 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D  220 (363)
                      ++||||+.+++|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~D  170 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRA--------RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIAD  170 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECC
T ss_pred             EEEEeecCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcc
Confidence            899999999999999976431        289999999999999999999999   999999999999999999999999


Q ss_pred             eccCCCCCccccc-ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc
Q 046595          221 FNLTNQSSDTAAR-LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       221 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      ||++......... .......||..|+|||++.+..++.++||||||+++|+|++|..||.......... .........
T Consensus       171 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~  249 (327)
T 3lxl_A          171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM-MGCERDVPA  249 (327)
T ss_dssp             GGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-CC----CCH
T ss_pred             cccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh-ccccccccc
Confidence            9998765433221 12233568889999999999999999999999999999999999986432110000 000000001


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCCCC
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGP  359 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~~~  359 (363)
                      ...+...+........+..++..+.+++.+||+.||.+|||+.+|++.|+.+........
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~  309 (327)
T 3lxl_A          250 LSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE  309 (327)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------
T ss_pred             HHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcc
Confidence            112222333333444456677889999999999999999999999999999987665443

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=8.4e-47  Score=349.58  Aligned_cols=276  Identities=18%  Similarity=0.257  Sum_probs=206.8

Q ss_pred             hcCCCCCCeeecc--CCceEEEEEeC-CCCeEEEEEccCCCCCC-chHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           67 TSNFGTKALIGEG--SYGRVFYAKLT-DGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        67 ~~~y~~~~~lg~G--~~g~V~~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      .++|++.+.||+|  +||.||+|+.. +++.||||++....... ....+.+|+.+++.++||||+++++++.+....++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            3589999999999  99999999865 69999999997643322 23677889999999999999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ||||+.+|+|.+++......       .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus       104 v~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg  173 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMD-------GMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLR  173 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTT-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGG
T ss_pred             EEEccCCCCHHHHHhhhccc-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccc
Confidence            99999999999999764321       289999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCccccc-----ccccccccccCCCCcccccc--CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhc-
Q 046595          223 LTNQSSDTAAR-----LHSTRVLGTFGYHAPEYAMT--GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWA-  294 (363)
Q Consensus       223 ~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~-  294 (363)
                      ++.........     .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||............... 
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  253 (389)
T 3gni_B          174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT  253 (389)
T ss_dssp             GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----
T ss_pred             cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence            87543221111     11223478999999999987  57999999999999999999999999764433221110000 


Q ss_pred             cccc------cccc-------------ccccc---------CCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          295 TPRL------SEDK-------------VKQCV---------DPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       295 ~~~~------~~~~-------------~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .+..      ....             .....         .......++..++..+.+||.+||+.||.+|||+.++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            0000      0000             00000         000001123345677999999999999999999999986


Q ss_pred             --Hhcccc
Q 046595          347 --ALQPLL  352 (363)
Q Consensus       347 --~l~~l~  352 (363)
                        .++.+.
T Consensus       334 hp~f~~~~  341 (389)
T 3gni_B          334 HSFFKQIK  341 (389)
T ss_dssp             SGGGGGC-
T ss_pred             CHHHHHHh
Confidence              354443

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=9.5e-48  Score=356.37  Aligned_cols=253  Identities=18%  Similarity=0.223  Sum_probs=204.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....  .......+.+|+.+++.++||||+++++++.+....++|
T Consensus        68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV  147 (410)
T 3v8s_A           68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV  147 (410)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            468999999999999999999865 58899999986421  122234578999999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.||+|.+++....          +++..+..++.|++.||.|||++   +|+||||||+|||++.+|.+||+|||+
T Consensus       148 ~E~~~gg~L~~~l~~~~----------~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          148 MEYMPGGDLVNLMSNYD----------VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             ECCCTTEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EeCCCCCcHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccce
Confidence            99999999999997643          89999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCC----CCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQ----ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      ++....... ......+||+.|+|||++.+..    ++.++|||||||++|||++|+.||...........+.....   
T Consensus       215 a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---  290 (410)
T 3v8s_A          215 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN---  290 (410)
T ss_dssp             CEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH---
T ss_pred             eEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc---
Confidence            876543321 1234568999999999998665    88999999999999999999999975433221111100000   


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADF--RPNMTIVVK  346 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~~vl~  346 (363)
                                .+.......++.++.+||.+||+.+|.+  ||++++|++
T Consensus       291 ----------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          291 ----------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             ----------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             ----------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence                      0000001134567999999999999988  999999997

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.2e-47  Score=352.21  Aligned_cols=269  Identities=22%  Similarity=0.318  Sum_probs=194.9

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCC-CCccceeeeEEEeCC--e
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLK-HEHFVELLGYCMESN--N  139 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~  139 (363)
                      .+.++|++.+.||+|+||.||+|.+ .+++.||||++...... .....+.+|+.+++.+. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            4567999999999999999999975 46999999998654322 23467889999999997 999999999997544  6


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEe
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA  219 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~  219 (363)
                      .++||||+.+ +|.+++....          +++..+..++.|++.||.|||++   ||+||||||+|||++.++.+||+
T Consensus        86 ~~lv~e~~~~-~L~~~~~~~~----------~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~  151 (388)
T 3oz6_A           86 VYLVFDYMET-DLHAVIRANI----------LEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVA  151 (388)
T ss_dssp             EEEEEECCSE-EHHHHHHHTC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred             EEEEecccCc-CHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEec
Confidence            8999999985 9999997643          89999999999999999999999   99999999999999999999999


Q ss_pred             eeccCCCCCccc-------------------ccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCC
Q 046595          220 DFNLTNQSSDTA-------------------ARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPV  279 (363)
Q Consensus       220 Dfg~a~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~  279 (363)
                      |||+++......                   ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus       152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf  231 (388)
T 3oz6_A          152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF  231 (388)
T ss_dssp             CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence            999986543210                   1111234679999999999886 67999999999999999999999999


Q ss_pred             CCCCCccccchhhhcccccccccccccc------------------CCcCCCCC------------CHHHHHHHHHHHHh
Q 046595          280 DHTMPKGQQSLVTWATPRLSEDKVKQCV------------------DPKLNNDY------------PPKAIAKLAAVAAL  329 (363)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~------------~~~~~~~l~~li~~  329 (363)
                      .......+...+...........+....                  .......+            ...++..+.+|+.+
T Consensus       232 ~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~  311 (388)
T 3oz6_A          232 PGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDK  311 (388)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHH
Confidence            7654433222211100000000000000                  00000000            01234578999999


Q ss_pred             ccCCCCCCCCCHHHHHHH
Q 046595          330 CVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       330 cl~~~p~~RPs~~~vl~~  347 (363)
                      ||+.||++|||+.++++.
T Consensus       312 ~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          312 LLQFNPNKRISANDALKH  329 (388)
T ss_dssp             HCCSSGGGSCCHHHHTTS
T ss_pred             hhccCcccCCCHHHHhCC
Confidence            999999999999999874

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=6.1e-47  Score=337.38  Aligned_cols=271  Identities=17%  Similarity=0.273  Sum_probs=207.5

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEE-EeCCeeEE
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC-MESNNRIL  142 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~l  142 (363)
                      .+.++|++.+.||+|+||.||+|.+ .+++.||+|++.....   ...+.+|+.+++.++|++++..+..+ ......++
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence            3567899999999999999999986 5688999998765332   23578899999999988777666655 66778899


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceee---cCCCceEEe
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL---FDDFKSKIA  219 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~  219 (363)
                      ||||+ +++|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+||++   +.++.+||+
T Consensus        83 v~e~~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~  150 (296)
T 4hgt_A           83 VMELL-GPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYII  150 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEEC
T ss_pred             EEEcc-CCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEe
Confidence            99999 8899999974321        289999999999999999999999   99999999999999   789999999


Q ss_pred             eeccCCCCCccccc-----ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhc
Q 046595          220 DFNLTNQSSDTAAR-----LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWA  294 (363)
Q Consensus       220 Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~  294 (363)
                      |||++.........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...............
T Consensus       151 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  230 (296)
T 4hgt_A          151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI  230 (296)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred             cCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhh
Confidence            99998765433221     1123467999999999999999999999999999999999999999765443322221111


Q ss_pred             cccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCCCC
Q 046595          295 TPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGP  359 (363)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~~~  359 (363)
                      ..........     ..    ...++..+.+++..||+.||++|||+.+|++.|++++++.....
T Consensus       231 ~~~~~~~~~~-----~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~  286 (296)
T 4hgt_A          231 SEKKMSTPIE-----VL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY  286 (296)
T ss_dssp             HHHHHHSCHH-----HH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred             hcccccchhh-----hh----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence            0000000000     00    11235679999999999999999999999999999998766544

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=346.50  Aligned_cols=275  Identities=19%  Similarity=0.290  Sum_probs=202.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+|+.+++.++||||+++++++......++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            47899999999999999999865 78999999997654333333456799999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.+ +|.+++.....        .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++..
T Consensus        82 ~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  149 (324)
T 3mtl_A           82 LDK-DLKQYLDDCGN--------IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARA  149 (324)
T ss_dssp             CSE-EHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEEC
T ss_pred             ccc-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCccccc
Confidence            985 99998876432        389999999999999999999999   999999999999999999999999999865


Q ss_pred             CCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      .......  .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..............
T Consensus       150 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  227 (324)
T 3mtl_A          150 KSIPTKT--YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPG  227 (324)
T ss_dssp             C--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             ccCCccc--cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchh
Confidence            4433221  334578999999999876 5689999999999999999999999976543332221111100000000000


Q ss_pred             cc---------CCcCCC----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HhccccccCC
Q 046595          306 CV---------DPKLNN----DYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPLLNSKP  356 (363)
Q Consensus       306 ~~---------~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l~~~~~  356 (363)
                      ..         .+....    .....++..+.+|+.+||+.||.+|||+.++++  .+..+.+...
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  293 (324)
T 3mtl_A          228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIH  293 (324)
T ss_dssp             GGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTS
T ss_pred             hhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccc
Confidence            00         000000    001234567899999999999999999999988  5666554433

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.5e-47  Score=341.37  Aligned_cols=249  Identities=19%  Similarity=0.318  Sum_probs=206.6

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC-----chHHHHHHHHHHhcCCCCccceeeeEEEeCCe
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE-----PESDFAAQLSVVSRLKHEHFVELLGYCMESNN  139 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  139 (363)
                      +.++|++.+.||+|+||.||+|... +++.||+|++.......     ....+.+|+.+++.++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            4567999999999999999999865 68999999987654322     35678999999999999999999999999999


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC----c
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF----K  215 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~----~  215 (363)
                      .++||||+.+++|.+++....         .+++..++.++.|++.||.|||++   +|+||||||+||+++.++    .
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~  157 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPH  157 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHTCS---------CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCC
T ss_pred             EEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCC
Confidence            999999999999999997643         389999999999999999999999   999999999999999887    7


Q ss_pred             eEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 046595          216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       216 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      +||+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.   
T Consensus       158 ~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~---  231 (321)
T 2a2a_A          158 IKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT---  231 (321)
T ss_dssp             EEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH---
T ss_pred             EEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH---
Confidence            99999999876544321   234579999999999999999999999999999999999999997543211111000   


Q ss_pred             ccccccccccccCCcCCCCCC----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          296 PRLSEDKVKQCVDPKLNNDYP----PKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                                  ..  ...++    ...+..+.+++.+||+.||++|||+.++++
T Consensus       232 ------------~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          232 ------------SV--SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             ------------TT--CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             ------------hc--ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                        00  00111    123467999999999999999999999987

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.8e-47  Score=337.54  Aligned_cols=258  Identities=24%  Similarity=0.389  Sum_probs=206.9

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEe-------
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCME-------  136 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------  136 (363)
                      .+..+|++.+.||+|+||.||+|.+. +++.||+|.+....     ..+.+|+.+++.++||||+++++++..       
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence            45678999999999999999999875 79999999987532     356789999999999999999998864       


Q ss_pred             ---------CCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCc
Q 046595          137 ---------SNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSN  207 (363)
Q Consensus       137 ---------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~N  207 (363)
                               ....++||||+.+++|.+++.....       ..+++..++.++.|++.||.|||++   +|+|+||||+|
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~N  152 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-------EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSN  152 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHGGG-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhccC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHH
Confidence                     4457899999999999999975432       1389999999999999999999999   99999999999


Q ss_pred             eeecCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccc
Q 046595          208 VLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQ  287 (363)
Q Consensus       208 ill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~  287 (363)
                      |+++.++.+||+|||++........   .....|++.|+|||++.+..++.++||||||+++|+|++|..||....    
T Consensus       153 il~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----  225 (284)
T 2a19_B          153 IFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----  225 (284)
T ss_dssp             EEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----
T ss_pred             EEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----
Confidence            9999999999999999866543322   234569999999999999999999999999999999999998874210    


Q ss_pred             cchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCCCCCC
Q 046595          288 QSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGPEA  361 (363)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~~~~~  361 (363)
                       ...            .......+    +...+..+.+++.+||+.||.+|||+.++++.|+.+.+.....++.
T Consensus       226 -~~~------------~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~~~  282 (284)
T 2a19_B          226 -KFF------------TDLRDGII----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERH  282 (284)
T ss_dssp             -HHH------------HHHHTTCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--------
T ss_pred             -HHH------------HHhhcccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCccccc
Confidence             000            00111111    2234456899999999999999999999999999998776665554

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.3e-47  Score=344.54  Aligned_cols=249  Identities=22%  Similarity=0.342  Sum_probs=206.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC--CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP--EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      .++|.+.+.||+|+||.||++.+. +++.|++|++......  ...+.+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            468999999999999999999865 5888999998754322  2346788999999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.+++|.+++....         .+++.+++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       120 ~e~~~~~~L~~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~  187 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK---------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGL  187 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             EecCCCCCHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccC
Confidence            99999999999987643         289999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      +.........  .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.           
T Consensus       188 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-----------  254 (335)
T 2owb_A          188 ATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK-----------  254 (335)
T ss_dssp             CEECCSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-----------
T ss_pred             ceecccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh-----------
Confidence            8755432211  234579999999999999999999999999999999999999997543211110000           


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                          ..  ...++..++..+.+++.+||+.||++|||+.++++
T Consensus       255 ----~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          255 ----KN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             ----HT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ----cC--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                00  01123344567899999999999999999999987

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.6e-47  Score=350.84  Aligned_cols=270  Identities=19%  Similarity=0.267  Sum_probs=206.8

Q ss_pred             CHHHHHHHhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-----CCccceeee
Q 046595           59 KLDELNRLTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-----HEHFVELLG  132 (363)
Q Consensus        59 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~  132 (363)
                      .+.+...+.++|.+.+.||+|+||.||+|++ .+++.||||++...  ......+..|+.+++.+.     ||||+++++
T Consensus        26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~  103 (360)
T 3llt_A           26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVKYHG  103 (360)
T ss_dssp             CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred             eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence            3334445678999999999999999999986 46899999998642  223456778999999886     999999999


Q ss_pred             EEEeCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC
Q 046595          133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD  212 (363)
Q Consensus       133 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~  212 (363)
                      ++...+..++||||+ +++|.+++......       .+++..+..++.|++.||.|||++   +|+||||||+|||++.
T Consensus       104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~  172 (360)
T 3llt_A          104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYN-------GFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDD  172 (360)
T ss_dssp             EEEETTEEEEEECCC-CCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESC
T ss_pred             eeeECCeeEEEEcCC-CCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcc
Confidence            999999999999999 88999999765421       288999999999999999999999   9999999999999975


Q ss_pred             -------------------------CCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHH
Q 046595          213 -------------------------DFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGV  267 (363)
Q Consensus       213 -------------------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~  267 (363)
                                               ++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~  247 (360)
T 3llt_A          173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGC  247 (360)
T ss_dssp             TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHH
T ss_pred             ccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHH
Confidence                                     789999999998654332     23467899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCccccchhhhcccccccccccc--------cc-CCcCCCCCC--------------------HH
Q 046595          268 VLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ--------CV-DPKLNNDYP--------------------PK  318 (363)
Q Consensus       268 ~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~-~~~~~~~~~--------------------~~  318 (363)
                      ++|+|++|+.||...........+..............        .. ...+...++                    ..
T Consensus       248 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  327 (360)
T 3llt_A          248 VLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKII  327 (360)
T ss_dssp             HHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHC
T ss_pred             HHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccc
Confidence            99999999999976543322221111111110000000        00 000000000                    01


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          319 AIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       319 ~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ....+.+|+.+||+.||.+|||+.++++
T Consensus       328 ~~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          328 KHELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             CCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             hHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            1256889999999999999999999975

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6.6e-47  Score=357.60  Aligned_cols=196  Identities=26%  Similarity=0.393  Sum_probs=154.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeC-----Ce
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMES-----NN  139 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~  139 (363)
                      .++|++.+.||+|+||.||+|.+. +++.||||++...... .....+.+|+.+++.++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            468999999999999999999755 6899999998654322 2246788999999999999999999998543     56


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEe
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA  219 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~  219 (363)
                      .++||||+. ++|.+++....         .+++..+..++.||+.||.|||++   +|+||||||+||||+.++.+||+
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~  198 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTPV---------YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVC  198 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSSC---------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEEC
T ss_pred             EEEEEeccc-cchhhhcccCC---------CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeec
Confidence            899999985 59999997653         389999999999999999999999   99999999999999999999999


Q ss_pred             eeccCCCCCccccc-------------------------ccccccccccCCCCcccc-ccCCCCccCceehhHHHHHHHH
Q 046595          220 DFNLTNQSSDTAAR-------------------------LHSTRVLGTFGYHAPEYA-MTGQITQKSDVYSFGVVLLELL  273 (363)
Q Consensus       220 Dfg~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~~l~ell  273 (363)
                      |||+++........                         ......+||+.|+|||++ .+..|+.++|||||||+||||+
T Consensus       199 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ell  278 (458)
T 3rp9_A          199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL  278 (458)
T ss_dssp             CCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             ccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHH
Confidence            99999765422110                         123446789999999976 4667999999999999999999


Q ss_pred             hC
Q 046595          274 TG  275 (363)
Q Consensus       274 ~g  275 (363)
                      +|
T Consensus       279 tg  280 (458)
T 3rp9_A          279 NM  280 (458)
T ss_dssp             TT
T ss_pred             Hh
Confidence            93

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=7.3e-47  Score=335.33  Aligned_cols=255  Identities=23%  Similarity=0.348  Sum_probs=201.7

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      +.++|.+.+.||+|+||.||+|... ++..+|+|++...........+.+|+.+++.++||||+++++++.+....++||
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            3458999999999999999999764 689999999987665666788999999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceee---cCCCceEEeee
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL---FDDFKSKIADF  221 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~Df  221 (363)
                      ||+.+++|.+++......     ...+++..++.++.|++.||.|||++   +|+||||||+||++   +.++.+||+||
T Consensus       100 e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Df  171 (285)
T 3is5_A          100 ETCEGGELLERIVSAQAR-----GKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDF  171 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             EeCCCCcHHHHHHhhhhc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEee
Confidence            999999999998543210     11389999999999999999999999   99999999999999   45688999999


Q ss_pred             ccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccc
Q 046595          222 NLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       222 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      |++........   .....||+.|+|||++. ..++.++||||||+++|+|++|..||.............+..+.    
T Consensus       172 g~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~----  243 (285)
T 3is5_A          172 GLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN----  243 (285)
T ss_dssp             CCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----
T ss_pred             ecceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcc----
Confidence            99976543322   34467999999999876 57899999999999999999999999754332211111111100    


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                               .... ....+..+.+++.+||+.||++|||+.+|++
T Consensus       244 ---------~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          244 ---------YAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ---------CCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ---------cccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                     0000 0113456889999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.2e-46  Score=335.50  Aligned_cols=271  Identities=17%  Similarity=0.264  Sum_probs=212.0

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEE-EeCCeeEEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC-MESNNRILV  143 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv  143 (363)
                      +.++|++.+.||+|+||.||+|++ .+++.||+|++....   ....+.+|+.+++.++|++++..+.++ ......++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS---SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc---chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence            457899999999999999999986 578999999986643   234688999999999988766665554 567778999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceee---cCCCceEEee
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL---FDDFKSKIAD  220 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~D  220 (363)
                      |||+ +++|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+||++   +.++.+||+|
T Consensus        84 ~e~~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D  151 (296)
T 3uzp_A           84 MELL-GPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIID  151 (296)
T ss_dssp             EECC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECC
T ss_pred             EEec-CCCHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEee
Confidence            9999 8899999974321        389999999999999999999999   99999999999999   4889999999


Q ss_pred             eccCCCCCcccccc-----cccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 046595          221 FNLTNQSSDTAARL-----HSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       221 fg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      ||++..........     ......||+.|+|||++.+..++.++||||||+++|+|++|+.||................
T Consensus       152 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  231 (296)
T 3uzp_A          152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS  231 (296)
T ss_dssp             CTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred             CCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhc
Confidence            99987654432211     1234579999999999999999999999999999999999999998654332222111110


Q ss_pred             ccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCCCCC
Q 046595          296 PRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGPE  360 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~~~~  360 (363)
                      ........     ..    ....++..+.+++.+||+.||.+|||+.+|++.|+++.++.....+
T Consensus       232 ~~~~~~~~-----~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~  287 (296)
T 3uzp_A          232 EKKMSTPI-----EV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD  287 (296)
T ss_dssp             HHHHHSCH-----HH----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSS
T ss_pred             ccccCCch-----HH----HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccc
Confidence            00000000     00    0122356799999999999999999999999999999888766543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5.7e-47  Score=339.73  Aligned_cols=268  Identities=23%  Similarity=0.279  Sum_probs=202.3

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCC----CCchHHHHHHHHHHhcCC---CCccceeeeEEEe
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSA----PEPESDFAAQLSVVSRLK---HEHFVELLGYCME  136 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~----~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~  136 (363)
                      .+.++|++.+.||+|+||.||+|++ .+++.||+|++.....    ......+.+|+.++++++   ||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            3467999999999999999999986 4689999999874331    122356778888777764   9999999999987


Q ss_pred             CC-----eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec
Q 046595          137 SN-----NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF  211 (363)
Q Consensus       137 ~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~  211 (363)
                      ..     ..++||||+.+ +|.+++......       .+++..++.++.|++.||.|||++   +|+||||||+||+++
T Consensus        86 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~  154 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVDQ-DLRTYLDKAPPP-------GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVT  154 (308)
T ss_dssp             CCSSSEEEEEEEEECCCC-BHHHHHHTCCTT-------CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEEC
T ss_pred             cCCCCceeEEEEehhhhc-CHHHHHhhccCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEc
Confidence            65     47899999975 999999865421       289999999999999999999999   999999999999999


Q ss_pred             CCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchh
Q 046595          212 DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLV  291 (363)
Q Consensus       212 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~  291 (363)
                      .++.+||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+
T Consensus       155 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i  231 (308)
T 3g33_A          155 SGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI  231 (308)
T ss_dssp             TTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHH
T ss_pred             CCCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999976543322   34567999999999999999999999999999999999999999765443222211


Q ss_pred             hhccccccccccccc---cCCcCCC-------CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          292 TWATPRLSEDKVKQC---VDPKLNN-------DYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       292 ~~~~~~~~~~~~~~~---~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ...............   ....+..       ......+..+.++|.+||+.||++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            110000000000000   0000000       011234567899999999999999999999987

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.4e-46  Score=340.52  Aligned_cols=268  Identities=24%  Similarity=0.382  Sum_probs=213.0

Q ss_pred             HHHHHHHhcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhc--CCCCccceeeeEEEeC
Q 046595           60 LDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSR--LKHEHFVELLGYCMES  137 (363)
Q Consensus        60 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~  137 (363)
                      ......+.++|.+.+.||+|+||.||+|++ +++.||||++..    .....+.+|.+++..  ++||||+++++++...
T Consensus        34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            334456678999999999999999999988 489999999854    234567888888887  7899999999999887


Q ss_pred             C----eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh--------ccCCCCeEEecccC
Q 046595          138 N----NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH--------EKVQPPIVHRDVRS  205 (363)
Q Consensus       138 ~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--------~~~~~~ivH~Dlkp  205 (363)
                      .    ..++||||+.+|+|.+++....          +++..++.++.|++.||.|||        +.   +|+||||||
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp  175 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKS  175 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSG
T ss_pred             CCccceeEEEEeecCCCcHHHHHhccC----------ccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCH
Confidence            6    7899999999999999997643          899999999999999999999        77   999999999


Q ss_pred             CceeecCCCceEEeeeccCCCCCccccc--ccccccccccCCCCccccccC------CCCccCceehhHHHHHHHHhC--
Q 046595          206 SNVLLFDDFKSKIADFNLTNQSSDTAAR--LHSTRVLGTFGYHAPEYAMTG------QITQKSDVYSFGVVLLELLTG--  275 (363)
Q Consensus       206 ~Nill~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~ell~g--  275 (363)
                      +||+++.++.+||+|||++.........  .......||+.|+|||++.+.      .++.++||||||+++|||++|  
T Consensus       176 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~  255 (342)
T 1b6c_B          176 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS  255 (342)
T ss_dssp             GGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred             HHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccC
Confidence            9999999999999999998654332211  112345799999999998865      234789999999999999999  


Q ss_pred             --------CCCCCCCCCccccchhhhccccccccccc-cccCCcCCCCCC-----HHHHHHHHHHHHhccCCCCCCCCCH
Q 046595          276 --------RKPVDHTMPKGQQSLVTWATPRLSEDKVK-QCVDPKLNNDYP-----PKAIAKLAAVAALCVQYEADFRPNM  341 (363)
Q Consensus       276 --------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~  341 (363)
                              ..||..........           ..+. ......+....+     ..++..+.+|+.+||+.||.+|||+
T Consensus       256 ~~~~~~~~~~p~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~  324 (342)
T 1b6c_B          256 IGGIHEDYQLPYYDLVPSDPSV-----------EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA  324 (342)
T ss_dssp             BTTBCCCCCCTTTTTSCSSCCH-----------HHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCH
T ss_pred             cCCcccccccCccccCcCcccH-----------HHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCH
Confidence                    67776443221110           0000 111112222222     3677889999999999999999999


Q ss_pred             HHHHHHhccccccCC
Q 046595          342 TIVVKALQPLLNSKP  356 (363)
Q Consensus       342 ~~vl~~l~~l~~~~~  356 (363)
                      .+|++.|+.+.++..
T Consensus       325 ~~i~~~L~~i~~~~~  339 (342)
T 1b6c_B          325 LRIKKTLSQLSQQEG  339 (342)
T ss_dssp             HHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhc
Confidence            999999999988764

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.1e-47  Score=374.83  Aligned_cols=252  Identities=24%  Similarity=0.388  Sum_probs=203.2

Q ss_pred             CeeeccCCceEEEEEeC---CCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccC
Q 046595           74 ALIGEGSYGRVFYAKLT---DGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATM  149 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~---~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  149 (363)
                      +.||+|+||.||+|.+.   +++.||||+++..... ...+.+.+|+.++++++||||+++++++.. +..++||||+.+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999542   4678999999764322 235789999999999999999999999864 568899999999


Q ss_pred             CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCc
Q 046595          150 GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       150 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      |+|.+++....         .+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|||+++....
T Consensus       454 g~L~~~l~~~~---------~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~  521 (635)
T 4fl3_A          454 GPLNKYLQQNR---------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  521 (635)
T ss_dssp             EEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred             CCHHHHHhhCC---------CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence            99999997543         289999999999999999999999   999999999999999999999999999875543


Q ss_pred             cccc-ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccccccccc
Q 046595          230 TAAR-LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCV  307 (363)
Q Consensus       230 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (363)
                      .... .......||+.|+|||++.+..++.++|||||||+||||++ |+.||......                .+...+
T Consensus       522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~----------------~~~~~i  585 (635)
T 4fl3_A          522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----------------EVTAML  585 (635)
T ss_dssp             -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----------------HHHHHH
T ss_pred             CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHH
Confidence            2221 11233457889999999999999999999999999999998 99999754322                122222


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          308 DPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                      ........+..++.++.+||..||+.||++||++.+|++.|+++..+
T Consensus       586 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          586 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            22333444556778899999999999999999999999999987654

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.1e-47  Score=336.44  Aligned_cols=253  Identities=28%  Similarity=0.443  Sum_probs=202.6

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeC-CeeEEEEe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMES-NNRILVYQ  145 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e  145 (363)
                      .++|++.+.||+|+||.||++++. ++.||+|++...   ...+.+.+|+.+++.++||||+++++++.+. ...++|||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch---hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            357999999999999999999875 889999998653   3456889999999999999999999987554 47899999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+++|.+++.....       ..+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||++.
T Consensus        96 ~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~  165 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK  165 (278)
T ss_dssp             CCTTEEHHHHHHHHHH-------HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             cCCCCCHHHHHHhccc-------ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccc
Confidence            9999999999975431       1278899999999999999999999   99999999999999999999999999986


Q ss_pred             CCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      .....     .....+++.|+|||++.+..++.++||||||+++|+|++ |..||........                .
T Consensus       166 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~----------------~  224 (278)
T 1byg_A          166 EASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV----------------V  224 (278)
T ss_dssp             ---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH----------------H
T ss_pred             ccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------H
Confidence            54432     123457889999999999999999999999999999998 9999975432111                1


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                      ..+........+..++..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       225 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          225 PRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             HHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            11111222233445567799999999999999999999999999988653

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.8e-47  Score=339.86  Aligned_cols=264  Identities=20%  Similarity=0.255  Sum_probs=202.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC--chHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE--PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      .++|++.+.||+|+||.||+|... +++.||+|++.......  ....+.+|+.+++.++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            468999999999999999999865 68899999987643222  236788999999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.+++|.+++....         .+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||+
T Consensus       113 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~  180 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG---------PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGI  180 (309)
T ss_dssp             EECCCCEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC
T ss_pred             EEecCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCcc
Confidence            99999999999997643         289999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      +......... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||......   ..........     
T Consensus       181 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~-----  251 (309)
T 2h34_A          181 ASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VMGAHINQAI-----  251 (309)
T ss_dssp             -----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHHHHHHSCC-----
T ss_pred             Cccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHHHHhccCC-----
Confidence            8765443221 123457899999999999999999999999999999999999999754221   0000000000     


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhccccccCCC
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP-NMTIVVKALQPLLNSKPA  357 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~~vl~~l~~l~~~~~~  357 (363)
                            ......+..++..+.+++.+||+.||++|| +++++++.|++++.....
T Consensus       252 ------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~  300 (309)
T 2h34_A          252 ------PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ  300 (309)
T ss_dssp             ------CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred             ------CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence                  000112234456799999999999999999 999999999988876643

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.3e-47  Score=343.68  Aligned_cols=245  Identities=20%  Similarity=0.289  Sum_probs=204.4

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCC-------chHHHHHHHHHHhcCCCCccceeeeEEEe
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPE-------PESDFAAQLSVVSRLKHEHFVELLGYCME  136 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  136 (363)
                      .+.++|++.+.||+|+||.||+|.+ .+++.||||++.......       ....+.+|+.+++.++||||+++++++.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            4567899999999999999999975 468899999997654221       23457789999999999999999999999


Q ss_pred             CCeeEEEEecccCC-ChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCc
Q 046595          137 SNNRILVYQFATMG-SLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK  215 (363)
Q Consensus       137 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~  215 (363)
                      ....++||||+.+| +|.+++....         .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~  168 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDRHP---------RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFT  168 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHTCC---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSC
T ss_pred             CCEEEEEEEeCCCCccHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCc
Confidence            99999999999776 9999998654         289999999999999999999999   9999999999999999999


Q ss_pred             eEEeeeccCCCCCcccccccccccccccCCCCccccccCCC-CccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhc
Q 046595          216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWA  294 (363)
Q Consensus       216 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~  294 (363)
                      +||+|||++........   .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||......         
T Consensus       169 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------  236 (335)
T 3dls_A          169 IKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------  236 (335)
T ss_dssp             EEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------
T ss_pred             EEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------
Confidence            99999999876543322   234679999999999988876 88999999999999999999999642110         


Q ss_pred             cccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          295 TPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                                  ....  ...+..++..+.+++.+||+.||++|||+.++++.
T Consensus       237 ------------~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 ------------VEAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ------------TTTC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ------------Hhhc--cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                        0000  01112245679999999999999999999999984

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5.5e-47  Score=344.17  Aligned_cols=253  Identities=22%  Similarity=0.322  Sum_probs=202.2

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEE
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l  142 (363)
                      .+.++|++.+.||+|+||.||+|.+. +++.||+|++.....     ...+|++++.++ +||||+++++++.+....++
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l   93 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV   93 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence            45668999999999999999999865 688999999976432     234688888887 79999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCC----CceEE
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD----FKSKI  218 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~----~~vkl  218 (363)
                      ||||+.+|+|.+++....         .+++.++..++.|++.||.|||++   ||+||||||+|||+.++    +.+||
T Consensus        94 v~E~~~gg~L~~~i~~~~---------~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl  161 (342)
T 2qr7_A           94 VTELMKGGELLDKILRQK---------FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRI  161 (342)
T ss_dssp             EECCCCSCBHHHHHHTCT---------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEE
T ss_pred             EEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEE
Confidence            999999999999997654         389999999999999999999999   99999999999998533    35999


Q ss_pred             eeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 046595          219 ADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL  298 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  298 (363)
                      +|||++.........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||................   
T Consensus       162 ~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~---  236 (342)
T 2qr7_A          162 CDFGFAKQLRAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG---  236 (342)
T ss_dssp             CCCTTCEECBCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH---
T ss_pred             EECCCcccCcCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc---
Confidence            999998765433221  234678999999999998889999999999999999999999997543222111111100   


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          299 SEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                       ...      ..+...+....+..+.+||.+||+.||++||++.++++
T Consensus       237 -~~~------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          237 -SGK------FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             -HCC------CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -cCC------cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             000      01111222345677999999999999999999999987

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.4e-47  Score=343.58  Aligned_cols=253  Identities=17%  Similarity=0.249  Sum_probs=181.9

Q ss_pred             cCCCC---CCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-CCccceeeeEEEeCCeeEE
Q 046595           68 SNFGT---KALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        68 ~~y~~---~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l  142 (363)
                      ++|.+   .+.||+|+||.||+|.+. +++.||||++..    .....+.+|+.+++.+. ||||+++++++.+....++
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l   83 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL   83 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEG----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEECh----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence            34554   478999999999999865 689999999864    23467889999999997 9999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC---ceEEe
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF---KSKIA  219 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~---~vkl~  219 (363)
                      ||||+.+|+|.+++....         .+++.++..++.|++.||.|||++   +|+||||||+|||++.++   .+||+
T Consensus        84 v~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~  151 (325)
T 3kn6_A           84 VMELLNGGELFERIKKKK---------HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKII  151 (325)
T ss_dssp             EECCCCSCBHHHHHHHCS---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEEC
T ss_pred             EEEccCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEe
Confidence            999999999999997654         389999999999999999999999   999999999999998765   89999


Q ss_pred             eeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc
Q 046595          220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       220 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      |||++.........  .....||+.|+|||++.+..++.++||||||+++|+|++|..||.............       
T Consensus       152 Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~-------  222 (325)
T 3kn6_A          152 DFGFARLKPPDNQP--LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV-------  222 (325)
T ss_dssp             CCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHH-------
T ss_pred             ccccceecCCCCCc--ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHH-------
Confidence            99998754433221  334578999999999999999999999999999999999999997543321110000       


Q ss_pred             ccccccccCCcCCCC--CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          300 EDKVKQCVDPKLNND--YPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                       ..+..+........  ....++.++.+|+.+||+.||.+|||+.++++
T Consensus       223 -~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          223 -EIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             -HHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             -HHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence             00011111111000  01234678999999999999999999999885

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=7.1e-47  Score=339.56  Aligned_cols=247  Identities=21%  Similarity=0.252  Sum_probs=193.4

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC-chHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l  142 (363)
                      +.++|++.+.||+|+||.||+|++. +++.||||++....... .......|+..+..+ +|+||+++++++.+....++
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            4468999999999999999999876 79999999986543222 223455555555555 89999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ||||+ +++|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus       135 v~e~~-~~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG  202 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWGA--------SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFG  202 (311)
T ss_dssp             EEECC-CCBHHHHHHHHCS--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCT
T ss_pred             EEecc-CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccce
Confidence            99999 5699998876432        389999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      ++........   .....||+.|+|||++.+ .++.++|||||||++|||++|..|+.....     .            
T Consensus       203 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-----~------------  261 (311)
T 3p1a_A          203 LLVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-----W------------  261 (311)
T ss_dssp             TCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----H------------
T ss_pred             eeeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----H------------
Confidence            9865543322   234569999999998875 799999999999999999999766642210     0            


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                       ..+........++..++..+.+++.+||+.||++|||+.++++
T Consensus       262 -~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          262 -QQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             -HHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -HHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence             0000111111111234567999999999999999999999987

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.5e-46  Score=333.04  Aligned_cols=254  Identities=20%  Similarity=0.290  Sum_probs=206.2

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      .+.++|++.+.||+|+||.||+|.+. +++.||+|++...... .....+.+|+.++++++||||+++++++......++
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (284)
T 3kk8_A            3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   82 (284)
T ss_dssp             TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence            35678999999999999999999765 6899999998764322 234678899999999999999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCc---eEEe
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK---SKIA  219 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~---vkl~  219 (363)
                      ||||+.+++|.+++....         .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.   +||+
T Consensus        83 v~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~  150 (284)
T 3kk8_A           83 VFDLVTGGELFEDIVARE---------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLA  150 (284)
T ss_dssp             EECCCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred             EEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEe
Confidence            999999999999887654         289999999999999999999999   9999999999999986655   9999


Q ss_pred             eeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc
Q 046595          220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       220 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      |||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||................    
T Consensus       151 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----  223 (284)
T 3kk8_A          151 DFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA----  223 (284)
T ss_dssp             CCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC----
T ss_pred             eceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcc----
Confidence            9999865543322   234679999999999999999999999999999999999999997543221111110000    


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                               ..........++..+.+++.+||+.||++|||+.++++
T Consensus       224 ---------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          224 ---------YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             ---------CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---------ccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                     00001111234567999999999999999999999987

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.9e-47  Score=344.15  Aligned_cols=273  Identities=22%  Similarity=0.235  Sum_probs=207.4

Q ss_pred             HHHHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC----CCCchHHHHHHHHHHhcCCCCccceeeeEEEeC
Q 046595           63 LNRLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS----APEPESDFAAQLSVVSRLKHEHFVELLGYCMES  137 (363)
Q Consensus        63 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  137 (363)
                      +..+.++|++.+.||+|+||.||+|... +++.||+|++....    .......+.+|+.+++.++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            4466789999999999999999999764 68899999986431    334557899999999999999999999999999


Q ss_pred             CeeEEEEecccCCChhhhhcCCCCCCC-------------------------------CCCCCCcCHHHHHHHHHHHHHH
Q 046595          138 NNRILVYQFATMGSLHDVLHGRKGVQG-------------------------------AEPGPVLTWNQRVKVAYGAAKG  186 (363)
Q Consensus       138 ~~~~lv~e~~~~g~L~~~l~~~~~~~~-------------------------------~~~~~~~~~~~~~~i~~~i~~~  186 (363)
                      ...++||||+.+|+|.+++........                               ......+++..++.++.|++.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            999999999999999999963211100                               0001125678889999999999


Q ss_pred             HHHhhccCCCCeEEecccCCceeecCCC--ceEEeeeccCCCCCccccc--ccccccccccCCCCcccccc--CCCCccC
Q 046595          187 LEFLHEKVQPPIVHRDVRSSNVLLFDDF--KSKIADFNLTNQSSDTAAR--LHSTRVLGTFGYHAPEYAMT--GQITQKS  260 (363)
Q Consensus       187 l~~lH~~~~~~ivH~Dlkp~Nill~~~~--~vkl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~  260 (363)
                      |.|||++   +|+||||||+||+++.++  .+||+|||++.........  .......||+.|+|||++.+  ..++.++
T Consensus       181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            9999999   999999999999998766  8999999998654322111  11334679999999999875  6789999


Q ss_pred             ceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCCC--CCCHHHHHHHHHHHHhccCCCCCCC
Q 046595          261 DVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNN--DYPPKAIAKLAAVAALCVQYEADFR  338 (363)
Q Consensus       261 DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~R  338 (363)
                      ||||||+++|||++|+.||............               .......  ......+..+.++|.+||+.||.+|
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  322 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQV---------------LNKKLCFENPNYNVLSPLARDLLSNLLNRNVDER  322 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---------------HHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHHHHHHH---------------HhcccccCCcccccCCHHHHHHHHHHcCCChhHC
Confidence            9999999999999999999754332211111               0111100  1111245679999999999999999


Q ss_pred             CCHHHHHH--Hhccccc
Q 046595          339 PNMTIVVK--ALQPLLN  353 (363)
Q Consensus       339 Ps~~~vl~--~l~~l~~  353 (363)
                      |++.++++  .++++..
T Consensus       323 ps~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          323 FDAMRALQHPWISQFSD  339 (345)
T ss_dssp             CCHHHHHHSHHHHTTSS
T ss_pred             CCHHHHhcChhhccChH
Confidence            99999988  5555443

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.7e-47  Score=355.89  Aligned_cols=258  Identities=19%  Similarity=0.214  Sum_probs=204.8

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeE
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRI  141 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  141 (363)
                      ...++|++.++||+|+||.||+|++. +++.||+|++....  .......+..|..++..++||||+++++++.+....+
T Consensus        71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  150 (437)
T 4aw2_A           71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY  150 (437)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence            34578999999999999999999876 47889999986421  1122345788999999999999999999999999999


Q ss_pred             EEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeee
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADF  221 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df  221 (363)
                      +||||+.+|+|.+++.....        .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus       151 lV~Ey~~gg~L~~~l~~~~~--------~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          151 LVMDYYVGGDLLTLLSKFED--------RLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             EEECCCTTCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEecCCCCcHHHHHHHccC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence            99999999999999976321        389999999999999999999999   9999999999999999999999999


Q ss_pred             ccCCCCCcccccccccccccccCCCCccccc-----cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccc
Q 046595          222 NLTNQSSDTAARLHSTRVLGTFGYHAPEYAM-----TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATP  296 (363)
Q Consensus       222 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~  296 (363)
                      |+++........ .....+||+.|+|||++.     +..++.++|||||||++|||++|+.||...........+.....
T Consensus       220 Gla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~  298 (437)
T 4aw2_A          220 GSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE  298 (437)
T ss_dssp             TTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred             hhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc
Confidence            998655432221 233468999999999987     45789999999999999999999999975533222111100000


Q ss_pred             cccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 046595          297 RLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADF--RPNMTIVVK  346 (363)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~~vl~  346 (363)
                      .        .   .+ ......++..+.+||.+||..+|++  ||++++|++
T Consensus       299 ~--------~---~~-p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          299 R--------F---QF-PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             H--------C---CC-CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             c--------c---cC-CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            0        0   00 0111224567999999999888888  999999987

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.1e-46  Score=332.98  Aligned_cols=247  Identities=22%  Similarity=0.384  Sum_probs=202.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++....  .......+.+|+.++++++||||+++++++.+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            457999999999999999999765 57789999985422  122346788999999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.+++|.+++....         .+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||+
T Consensus        88 ~e~~~~~~l~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~  155 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS---------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGW  155 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCE
T ss_pred             EecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccc
Confidence            99999999999997654         289999999999999999999999   999999999999999999999999998


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      +.......    .....|++.|+|||++.+..++.++||||||+++|+|++|..||...........+.           
T Consensus       156 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----------  220 (279)
T 3fdn_A          156 SVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-----------  220 (279)
T ss_dssp             ESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-----------
T ss_pred             cccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH-----------
Confidence            85543322    234578999999999999999999999999999999999999997543221111100           


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                            .....++...+..+.+++.+||+.||.+|||+.+|++
T Consensus       221 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          221 ------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             ------HTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ------hCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                  0111223345567999999999999999999999997

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.1e-46  Score=339.03  Aligned_cols=266  Identities=21%  Similarity=0.279  Sum_probs=200.0

Q ss_pred             HhcCCCCC-CeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEE
Q 046595           66 LTSNFGTK-ALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        66 ~~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l  142 (363)
                      +.++|.+. +.||+|+||.||+|... +++.||||++.... ......+.+|+.++.++ +||||+++++++.+.+..++
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l   88 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL   88 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            34578884 78999999999999854 69999999997643 34467889999999885 79999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCc---eEEe
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK---SKIA  219 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~---vkl~  219 (363)
                      ||||+.+++|.+++....         .+++..++.++.|++.||.|||++   +|+||||||+||+++.++.   +||+
T Consensus        89 v~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~  156 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHKRR---------HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKIC  156 (316)
T ss_dssp             EEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEEC
T ss_pred             EEEcCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEE
Confidence            999999999999997653         289999999999999999999999   9999999999999988766   9999


Q ss_pred             eeccCCCCCcccc-----cccccccccccCCCCcccccc-----CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccc
Q 046595          220 DFNLTNQSSDTAA-----RLHSTRVLGTFGYHAPEYAMT-----GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQS  289 (363)
Q Consensus       220 Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~  289 (363)
                      |||++........     ........||+.|+|||++.+     ..++.++|||||||++|+|++|+.||......+...
T Consensus       157 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  236 (316)
T 2ac3_A          157 DFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW  236 (316)
T ss_dssp             CTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC
T ss_pred             EccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccc
Confidence            9999875432211     111223469999999999875     468899999999999999999999997654432111


Q ss_pred             hhhhccccccccccccccCCcCCCCCCH----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          290 LVTWATPRLSEDKVKQCVDPKLNNDYPP----KAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ......+.........+....  ..++.    ..+..+.+++.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          237 DRGEACPACQNMLFESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             ----CCHHHHHHHHHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cccccchhHHHHHHHHHhccC--cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            000000000000000011111  11222    24567999999999999999999999998

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=331.58  Aligned_cols=250  Identities=26%  Similarity=0.388  Sum_probs=185.6

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++....  .......+.+|+.+++.++||||+++++++.+....++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            45799999999999999999986 479999999986432  223346789999999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.+++|.+++.....        .+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||+
T Consensus        90 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~  158 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVK--------PFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGL  158 (278)
T ss_dssp             EECCTTEEHHHHHHTCSS--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTT
T ss_pred             EecCCCCcHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecc
Confidence            999999999999976431        389999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      +.........  .....||+.|+|||++.+..++.++||||||+++|+|++|+.||..........              
T Consensus       159 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--------------  222 (278)
T 3cok_A          159 ATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN--------------  222 (278)
T ss_dssp             CEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------------
T ss_pred             eeeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH--------------
Confidence            8655432221  234578999999999998899999999999999999999999997543221110              


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                       ......  ...+...+..+.+++.+||+.||++|||+.++++
T Consensus       223 -~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          223 -KVVLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             --CCSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -HHhhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence             000000  1123345567999999999999999999999987

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.1e-46  Score=360.08  Aligned_cols=254  Identities=22%  Similarity=0.296  Sum_probs=208.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++....  .......+.+|+.+++.++||||+++++++.+....++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            356899999999999999999865 69999999986532  223456788999999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.||+|.+++......       .+++..++.++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+
T Consensus       263 mEy~~gg~L~~~l~~~~~~-------~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGl  332 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQA-------GFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGL  332 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEcCCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEeccc
Confidence            9999999999999765421       289999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      +........   ....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+            
T Consensus       333 a~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i------------  397 (576)
T 2acx_A          333 AVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV------------  397 (576)
T ss_dssp             CEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHH------------
T ss_pred             ceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHH------------
Confidence            976543322   23458999999999999989999999999999999999999999765332111110            


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP-----NMTIVVK  346 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  346 (363)
                      ...+. .....++...+..+.+||.+||+.||.+||     ++.+|++
T Consensus       398 ~~~i~-~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          398 ERLVK-EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             HHHHH-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             HHHhh-cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            00000 011223445567799999999999999999     7888876

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.3e-47  Score=345.04  Aligned_cols=272  Identities=22%  Similarity=0.349  Sum_probs=211.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe-----CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCC--e
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKL-----TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESN--N  139 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~  139 (363)
                      .++|++.+.||+|+||.||+|++     .+++.||+|++... .....+.+.+|+.+++.++||||+++++++....  .
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            45799999999999999999973     36889999998763 2334567899999999999999999999886644  7


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEe
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA  219 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~  219 (363)
                      .++||||+.+++|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+
T Consensus       119 ~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~  187 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIG  187 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHHSTT--------SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEEC
T ss_pred             eEEEEECCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEe
Confidence            8999999999999999976532        389999999999999999999999   99999999999999999999999


Q ss_pred             eeccCCCCCccccc-ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccc-
Q 046595          220 DFNLTNQSSDTAAR-LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR-  297 (363)
Q Consensus       220 Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~-  297 (363)
                      |||++......... .......++..|+|||++.+..++.++||||||+++|+|++|..||......    ........ 
T Consensus       188 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~----~~~~~~~~~  263 (326)
T 2w1i_A          188 DFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDK  263 (326)
T ss_dssp             CCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH----HHHHHCTTC
T ss_pred             cCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH----HHHhhcccc
Confidence            99998765433221 1122345778899999999989999999999999999999999988532100    00000000 


Q ss_pred             ---ccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          298 ---LSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       298 ---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                         .....+...+........+..++..+.+++.+||+.||.+|||+.+|++.|+.+..+
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          264 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             CTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             chhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence               000011122222222333455677899999999999999999999999999988754

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.5e-46  Score=353.40  Aligned_cols=268  Identities=18%  Similarity=0.270  Sum_probs=211.8

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCC-CccceeeeEEEeCCeeEEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKH-EHFVELLGYCMESNNRILV  143 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv  143 (363)
                      +.++|++.+.||+|+||.||+|.+ .+++.||||++.....   ...+..|+.+++.++| ++|..+..++......++|
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv   81 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV   81 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence            457899999999999999999986 5699999998876433   2357889999999976 5666777777888889999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceee---cCCCceEEee
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL---FDDFKSKIAD  220 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~D  220 (363)
                      |||+ +++|.+++.....        .+++..++.++.||+.||.|||++   +|+||||||+||||   +.++.+||+|
T Consensus        82 me~~-g~sL~~ll~~~~~--------~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~D  149 (483)
T 3sv0_A           82 MDLL-GPSLEDLFNFCSR--------KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIID  149 (483)
T ss_dssp             EECC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECC
T ss_pred             EECC-CCCHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEe
Confidence            9999 8899999974322        389999999999999999999999   99999999999999   6889999999


Q ss_pred             eccCCCCCcccccc-----cccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 046595          221 FNLTNQSSDTAARL-----HSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       221 fg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      ||+++.........     ......||+.|+|||++.+..++.++|||||||+||||++|+.||...........+....
T Consensus       150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~  229 (483)
T 3sv0_A          150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS  229 (483)
T ss_dssp             CTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHH
T ss_pred             CCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHh
Confidence            99997655432211     1225679999999999999999999999999999999999999998654433222221111


Q ss_pred             ccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCC
Q 046595          296 PRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA  357 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~  357 (363)
                      .......+..+         ...++.++.+|+..||+.+|++||++.+|++.|++++.....
T Consensus       230 ~~~~~~~~~~l---------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~  282 (483)
T 3sv0_A          230 EKKVATSIEAL---------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGF  282 (483)
T ss_dssp             HHHHHSCHHHH---------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             hccccccHHHH---------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCC
Confidence            11000000000         112356799999999999999999999999999999776543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.7e-46  Score=332.45  Aligned_cols=262  Identities=16%  Similarity=0.313  Sum_probs=208.1

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC-----chHHHHHHHHHHhcCCCCccceeeeEEEeCCe
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE-----PESDFAAQLSVVSRLKHEHFVELLGYCMESNN  139 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  139 (363)
                      +.++|++.+.||+|+||.||+|... +++.||+|++.......     ..+.+.+|+.+++.++||||+++++++.+...
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD   82 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence            3457999999999999999999875 68999999987643221     35789999999999999999999999999999


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC----c
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF----K  215 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~----~  215 (363)
                      .++||||+.+++|.+++....         .+++..++.++.|++.||.|||++   +|+|+||||+||+++.++    .
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~  150 (283)
T 3bhy_A           83 VVLILELVSGGELFDFLAEKE---------SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPR  150 (283)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCC
T ss_pred             EEEEEeecCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCc
Confidence            999999999999999997543         289999999999999999999999   999999999999998877    8


Q ss_pred             eEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 046595          216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       216 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      +||+|||++........   .....|++.|+|||++.+..++.++||||||+++|+|++|..||............... 
T Consensus       151 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-  226 (283)
T 3bhy_A          151 IKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV-  226 (283)
T ss_dssp             EEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-
T ss_pred             eEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhc-
Confidence            99999999865543221   23456899999999999899999999999999999999999999754322111100000 


Q ss_pred             ccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HhccccccC
Q 046595          296 PRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPLLNSK  355 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l~~~~  355 (363)
                                  ............+..+.+++.+||+.||.+|||+.++++  .++.+..+.
T Consensus       227 ------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  276 (283)
T 3bhy_A          227 ------------NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN  276 (283)
T ss_dssp             ------------CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred             ------------ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence                        000000001123567999999999999999999999998  566665544

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.3e-47  Score=345.78  Aligned_cols=271  Identities=18%  Similarity=0.233  Sum_probs=210.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCC---------CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccce--------
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTD---------GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE--------  129 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~--------  129 (363)
                      .++|++.+.||+|+||.||+|+...         ++.||+|++...      ..+.+|+.++++++||||++        
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST  114 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence            3589999999999999999998653         789999998753      35789999999999999987        


Q ss_pred             -------eeeEEEe-CCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEe
Q 046595          130 -------LLGYCME-SNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHR  201 (363)
Q Consensus       130 -------~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~  201 (363)
                             +++++.. ....++||||+ +++|.+++.....       ..+++.+++.++.|++.||.|||++   +|+||
T Consensus       115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~  183 (352)
T 2jii_A          115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK-------HVLSERSVLQVACRLLDALEFLHEN---EYVHG  183 (352)
T ss_dssp             TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG-------GCCCHHHHHHHHHHHHHHHHHHHHT---TCBCS
T ss_pred             CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCC
Confidence                   5677766 67889999999 8899999986521       1389999999999999999999999   99999


Q ss_pred             cccCCceeecCCC--ceEEeeeccCCCCCcccccc-----cccccccccCCCCccccccCCCCccCceehhHHHHHHHHh
Q 046595          202 DVRSSNVLLFDDF--KSKIADFNLTNQSSDTAARL-----HSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT  274 (363)
Q Consensus       202 Dlkp~Nill~~~~--~vkl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~  274 (363)
                      ||||+|||++.++  .+||+|||++..........     ......||+.|+|||++.+..++.++||||||+++|||++
T Consensus       184 Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  263 (352)
T 2jii_A          184 NVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLY  263 (352)
T ss_dssp             CCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHh
Confidence            9999999999998  99999999997665432211     1233579999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          275 GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       275 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                      |+.||...............  .. ............   ....++..+.+++.+||+.||.+|||+.+|++.|++++++
T Consensus       264 g~~pf~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  337 (352)
T 2jii_A          264 GFLPWTNCLPNTEDIMKQKQ--KF-VDKPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD  337 (352)
T ss_dssp             SCCTTGGGTTCHHHHHHHHH--HH-HHSCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CCCCcccCCcCHHHHHHHHH--hc-cCChhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence            99999755322111110000  00 000000100000   0012346799999999999999999999999999999988


Q ss_pred             CCCCCC
Q 046595          355 KPAGPE  360 (363)
Q Consensus       355 ~~~~~~  360 (363)
                      ....+.
T Consensus       338 ~~~~~~  343 (352)
T 2jii_A          338 LRVSPY  343 (352)
T ss_dssp             TTCCTT
T ss_pred             cCCCcC
Confidence            776543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.2e-47  Score=345.94  Aligned_cols=268  Identities=18%  Similarity=0.218  Sum_probs=200.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC----CCCeEEEEEccCCCCCC----------chHHHHHHHHHHhcCCCCccceeee
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPE----------PESDFAAQLSVVSRLKHEHFVELLG  132 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~  132 (363)
                      .++|.+.+.||+|+||.||+|.+.    ++..+|+|++.......          ....+.+|+.+++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            357999999999999999999865    57889999987643210          1123567888899999999999999


Q ss_pred             EEEe----CCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCce
Q 046595          133 YCME----SNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNV  208 (363)
Q Consensus       133 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Ni  208 (363)
                      ++..    ....++||||+ +++|.+++....         .+++.+++.++.|++.||.|||++   +|+||||||+||
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI  182 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---------TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANL  182 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHE
Confidence            9988    67889999999 889999998654         289999999999999999999999   999999999999


Q ss_pred             eecCCC--ceEEeeeccCCCCCccccc-----ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCC
Q 046595          209 LLFDDF--KSKIADFNLTNQSSDTAAR-----LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDH  281 (363)
Q Consensus       209 ll~~~~--~vkl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~  281 (363)
                      |++.++  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       183 ll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          183 LLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             EEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             EEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999877  9999999999765432211     112345799999999999999999999999999999999999999964


Q ss_pred             CCCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccc
Q 046595          282 TMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN  353 (363)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~  353 (363)
                      ...........  ..... ..+...+.....   ...++..+.+++..||+.||++||++.+|++.|+.+.-
T Consensus       263 ~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          263 NLKDPVAVQTA--KTNLL-DELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             GTTCHHHHHHH--HHHHH-HTTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             cccccHHHHHH--HHhhc-ccccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            32211111000  00000 000000000000   01345579999999999999999999999999998654

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=6.4e-46  Score=340.76  Aligned_cols=257  Identities=15%  Similarity=0.197  Sum_probs=207.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEE------eCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC---CCccceeeeEEEeC
Q 046595           67 TSNFGTKALIGEGSYGRVFYAK------LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK---HEHFVELLGYCMES  137 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~------~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~  137 (363)
                      .++|.+.+.||+|+||.||+|.      ..+++.||+|++...    ....+..|+.++++++   |+||+.+++++...
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            4679999999999999999993      446899999998652    3557788888888886   99999999999999


Q ss_pred             CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC-----
Q 046595          138 NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD-----  212 (363)
Q Consensus       138 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-----  212 (363)
                      +..++||||+.+|+|.+++......    ....+++..++.++.|++.||.|||++   +|+||||||+|||++.     
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNT----PEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTS----TTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcc----cccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCc
Confidence            9999999999999999999753211    112399999999999999999999999   9999999999999998     


Q ss_pred             ------CCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCcc
Q 046595          213 ------DFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKG  286 (363)
Q Consensus       213 ------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~  286 (363)
                            ++.+||+|||++................||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  292 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE  292 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred             cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence                  89999999999965432222223455679999999999999999999999999999999999999995322110


Q ss_pred             ccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHhccccccC
Q 046595          287 QQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFR-PNMTIVVKALQPLLNSK  355 (363)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-Ps~~~vl~~l~~l~~~~  355 (363)
                                    ..+...    +. .+  .....+.+++..|++.+|.+| |+++++.+.|++++...
T Consensus       293 --------------~~~~~~----~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          293 --------------CKPEGL----FR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             --------------EEECSC----CT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             --------------eeechh----cc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence                          001111    11 11  125568899999999999999 68999999998887663

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2e-46  Score=353.78  Aligned_cols=263  Identities=20%  Similarity=0.229  Sum_probs=197.3

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC-CCCchHHHHHHHHHHhcCCCCccceeeeEEEeC------
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS-APEPESDFAAQLSVVSRLKHEHFVELLGYCMES------  137 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------  137 (363)
                      +.++|++.+.||+|+||.||+|.+. +++.||||++.... .......+.+|+.+++.++||||+++++++...      
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            3568999999999999999999754 68899999997542 222346788999999999999999999998655      


Q ss_pred             CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceE
Q 046595          138 NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSK  217 (363)
Q Consensus       138 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk  217 (363)
                      ...++||||+.+ +|.+.+...           +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+|
T Consensus       140 ~~~~lv~E~~~~-~l~~~~~~~-----------l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~k  204 (464)
T 3ttj_A          140 QDVYLVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK  204 (464)
T ss_dssp             CEEEEEEECCSE-EHHHHHTSC-----------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred             CeEEEEEeCCCC-CHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEE
Confidence            356999999987 577777532           88999999999999999999999   999999999999999999999


Q ss_pred             EeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccc
Q 046595          218 IADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR  297 (363)
Q Consensus       218 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~  297 (363)
                      |+|||+++......   .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||......++...+......
T Consensus       205 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~  281 (464)
T 3ttj_A          205 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT  281 (464)
T ss_dssp             ECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred             EEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999997654322   234568999999999999999999999999999999999999999765433222111100000


Q ss_pred             ccc-------cccccccC---------------CcCCC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          298 LSE-------DKVKQCVD---------------PKLNN---DYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       298 ~~~-------~~~~~~~~---------------~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ...       ......+.               ..+..   ......+..+.+||.+||+.||++|||++++++
T Consensus       282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             CCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000       00000000               00000   001123677999999999999999999999987

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=6.9e-47  Score=340.54  Aligned_cols=270  Identities=24%  Similarity=0.381  Sum_probs=208.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEe----CCeeE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCME----SNNRI  141 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~  141 (363)
                      .++|++.+.||+|+||.||+++. .+++.||+|++... .......+.+|+.+++.++||||+++++++..    ....+
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            35899999999999999999986 57999999988652 22345678899999999999999999999873    34778


Q ss_pred             EEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeee
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADF  221 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df  221 (363)
                      +||||+.+++|.+++......     ...+++.+++.++.|++.||.|||++   +|+||||||+||+++.++.+||+||
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~df  178 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDK-----GNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDL  178 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEeCCCCcHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEec
Confidence            999999999999999753211     12389999999999999999999999   9999999999999999999999999


Q ss_pred             ccCCCCCcccccc-------cccccccccCCCCccccccCC---CCccCceehhHHHHHHHHhCCCCCCCCCCccccchh
Q 046595          222 NLTNQSSDTAARL-------HSTRVLGTFGYHAPEYAMTGQ---ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLV  291 (363)
Q Consensus       222 g~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~  291 (363)
                      |++..........       ......||+.|+|||++.+..   ++.++||||||+++|+|++|+.||.........   
T Consensus       179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---  255 (317)
T 2buj_A          179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS---  255 (317)
T ss_dssp             SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC---
T ss_pred             CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch---
Confidence            9886543221110       112345799999999987554   689999999999999999999999532111000   


Q ss_pred             hhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCCCC
Q 046595          292 TWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGP  359 (363)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~~~  359 (363)
                                 +...............++..+.+++.+||+.||.+|||+.+|++.|+.+....+.+.
T Consensus       256 -----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~  312 (317)
T 2buj_A          256 -----------VALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQH  312 (317)
T ss_dssp             -----------HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC--
T ss_pred             -----------hhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCCC
Confidence                       000000111112223455679999999999999999999999999999887666554

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.5e-46  Score=328.79  Aligned_cols=256  Identities=19%  Similarity=0.273  Sum_probs=208.6

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      .+.++|++.+.||+|+||.||+|... ++..+++|++.... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF-VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV   84 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence            45678999999999999999999865 57789999987643 23467899999999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceee---cCCCceEEee
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL---FDDFKSKIAD  220 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~D  220 (363)
                      |||+.+++|.+++....         .+++..++.++.|++.||.|||++   +|+|+||||+||++   +.++.+||+|
T Consensus        85 ~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~D  152 (277)
T 3f3z_A           85 MELCTGGELFERVVHKR---------VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLID  152 (277)
T ss_dssp             EECCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             EeccCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEe
Confidence            99999999999987654         289999999999999999999999   99999999999999   7889999999


Q ss_pred             eccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccc
Q 046595          221 FNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE  300 (363)
Q Consensus       221 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  300 (363)
                      ||++........   .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+.        
T Consensus       153 fg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--------  220 (277)
T 3f3z_A          153 FGLAARFKPGKM---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIR--------  220 (277)
T ss_dssp             CTTCEECCTTSC---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------
T ss_pred             cccceeccCccc---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHH--------
Confidence            999865543322   234579999999998875 49999999999999999999999997543221111100        


Q ss_pred             cccccccCCcCCCCCCH----HHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhcccccc
Q 046595          301 DKVKQCVDPKLNNDYPP----KAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPLLNS  354 (363)
Q Consensus       301 ~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l~~~  354 (363)
                             ...  ...+.    .++..+.+++.+||+.||.+|||+.++++  .+++.+..
T Consensus       221 -------~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~  271 (277)
T 3f3z_A          221 -------EGT--FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS  271 (277)
T ss_dssp             -------HCC--CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCC
T ss_pred             -------hCC--CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccccc
Confidence                   000  11122    24567999999999999999999999986  55554443

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-46  Score=345.21  Aligned_cols=265  Identities=24%  Similarity=0.315  Sum_probs=200.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCC-chHHHHHHHHHHhcCCCCccceeeeEEEeCC------
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLGYCMESN------  138 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------  138 (363)
                      .++|++.+.||+|+||.||+|.+ .+|+.||||++....... ....+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46899999999999999999976 469999999986543222 2367889999999999999999999987653      


Q ss_pred             eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEE
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI  218 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl  218 (363)
                      ..++||||+ +++|.+++....          +++..+..++.|++.||.|||++   ||+||||||+||+++.++.+||
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~~----------l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl  169 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHEK----------LGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKI  169 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEE
T ss_pred             eEEEEEecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEE
Confidence            459999999 779999997643          89999999999999999999999   9999999999999999999999


Q ss_pred             eeeccCCCCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccc
Q 046595          219 ADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR  297 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~  297 (363)
                      +|||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......++...+......
T Consensus       170 ~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~  244 (367)
T 1cm8_A          170 LDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT  244 (367)
T ss_dssp             CCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             Eeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            999998764332     344678999999999887 68999999999999999999999999865433222111110000


Q ss_pred             cccccc--------c-------cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhccc
Q 046595          298 LSEDKV--------K-------QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPL  351 (363)
Q Consensus       298 ~~~~~~--------~-------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l  351 (363)
                      .....+        .       ......+ .......+..+.+|+.+||+.||.+|||+.++++  .++.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~  314 (367)
T 1cm8_A          245 PPAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  314 (367)
T ss_dssp             CCHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             CCHHHHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence            000000        0       0000000 1112344667999999999999999999999998  45544

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.5e-47  Score=352.08  Aligned_cols=257  Identities=18%  Similarity=0.180  Sum_probs=203.1

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeE
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRI  141 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  141 (363)
                      ...++|++.+.||+|+||.||+|+.. +++.||+|++....  .......+..|..++..++||||+++++++.+....+
T Consensus        58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  137 (412)
T 2vd5_A           58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY  137 (412)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            34578999999999999999999865 69999999986421  1122345788999999999999999999999999999


Q ss_pred             EEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeee
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADF  221 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df  221 (363)
                      +||||+.+|+|.+++.....        .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus       138 lVmE~~~gg~L~~~l~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DF  206 (412)
T 2vd5_A          138 LVMEYYVGGDLLTLLSKFGE--------RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADF  206 (412)
T ss_dssp             EEECCCCSCBHHHHHHHHSS--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEcCCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeec
Confidence            99999999999999976431        289999999999999999999999   9999999999999999999999999


Q ss_pred             ccCCCCCcccccccccccccccCCCCccccc-------cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhc
Q 046595          222 NLTNQSSDTAARLHSTRVLGTFGYHAPEYAM-------TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWA  294 (363)
Q Consensus       222 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~  294 (363)
                      |+++....... ......+||+.|+|||++.       +..|+.++|||||||++|||++|+.||...........+...
T Consensus       207 Gla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  285 (412)
T 2vd5_A          207 GSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY  285 (412)
T ss_dssp             TTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred             hhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence            99876543221 1123468999999999987       356899999999999999999999999754332211111000


Q ss_pred             cccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCC---CCHHHHHH
Q 046595          295 TPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFR---PNMTIVVK  346 (363)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Ps~~~vl~  346 (363)
                      ....           . ....+..++.++.+||.+||. +|.+|   |++++|++
T Consensus       286 ~~~~-----------~-~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          286 KEHL-----------S-LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HHHC-----------C-CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             ccCc-----------C-CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            0000           0 011123456679999999999 99998   58999876

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.6e-46  Score=355.75  Aligned_cols=256  Identities=21%  Similarity=0.299  Sum_probs=207.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|.+.++||+|+||.||+|+.. +|+.||+|++....  .......+..|+.+++.++||||+++++++.+....++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            56888999999999999999875 69999999986532  2234567889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.||+|.+++......     ...+++..++.++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||++
T Consensus       265 E~~~gg~L~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla  336 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDED-----NPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLA  336 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTT-----SCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EeccCCCHHHHHHHhhcc-----cccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeeccee
Confidence            999999999999764321     12389999999999999999999999   9999999999999999999999999999


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      .........  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.............           .
T Consensus       337 ~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~-----------~  403 (543)
T 3c4z_A          337 VELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK-----------Q  403 (543)
T ss_dssp             EECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHH-----------H
T ss_pred             eeccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHH-----------H
Confidence            765433221  234589999999999999999999999999999999999999997543221111000           0


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNM-----TIVVK  346 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~~vl~  346 (363)
                      .+...  ...++..++..+.++|.+||+.||.+||++     .+|++
T Consensus       404 ~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          404 RVLEQ--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             HHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             HHhhc--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            00010  122344566789999999999999999975     66664

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.2e-46  Score=340.81  Aligned_cols=265  Identities=18%  Similarity=0.240  Sum_probs=194.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC-chHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      .++|++.+.||+|+||.||+|.+. +++.||||++....... ....+.+|+.+++.++||||+++++++.+....++||
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            458999999999999999999754 68999999997654322 2356789999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec-----CCCceEEe
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF-----DDFKSKIA  219 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~-----~~~~vkl~  219 (363)
                      ||+.+ +|.+++.....         +++..++.++.|++.||.|||++   +|+||||||+|||++     .++.+||+
T Consensus       113 e~~~~-~L~~~~~~~~~---------~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~  179 (329)
T 3gbz_A          113 EYAEN-DLKKYMDKNPD---------VSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIG  179 (329)
T ss_dssp             ECCSE-EHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred             ecCCC-CHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEEC
Confidence            99986 99999976542         89999999999999999999999   999999999999994     55669999


Q ss_pred             eeccCCCCCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 046595          220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL  298 (363)
Q Consensus       220 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  298 (363)
                      |||++........  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+.......
T Consensus       180 Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  257 (329)
T 3gbz_A          180 DFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP  257 (329)
T ss_dssp             CTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             cCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCC
Confidence            9999865432211  13345789999999999874 58999999999999999999999997654322211111000000


Q ss_pred             cccc------cccc-------cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          299 SEDK------VKQC-------VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       299 ~~~~------~~~~-------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ....      ...+       ....+.......++.++.+||.+||+.||.+|||+.++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            0000      0000       0000000001114567899999999999999999999987

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2e-46  Score=341.45  Aligned_cols=247  Identities=25%  Similarity=0.362  Sum_probs=200.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCC--chHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPE--PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      +.|.+.+.||+|+||.||+|+. .+++.||||++.......  ....+.+|+.+++.++||||+++++++......++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588999999999999999985 578999999987643222  2357889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.| +|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       134 e~~~g-~l~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a  201 (348)
T 1u5q_A          134 EYCLG-SASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA  201 (348)
T ss_dssp             ECCSE-EHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred             ecCCC-CHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCc
Confidence            99985 88888854321        389999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCccccc---cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAM---TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      ......      ....||+.|+|||++.   +..++.++|||||||++|||++|+.||..........  ..        
T Consensus       202 ~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~--~~--------  265 (348)
T 1u5q_A          202 SIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HI--------  265 (348)
T ss_dssp             BSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HH--------
T ss_pred             eecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH--HH--------
Confidence            765432      3457999999999885   5678999999999999999999999996543211110  00        


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                           .........+...+..+.+++.+||+.||++|||+.++++.
T Consensus       266 -----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          266 -----AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             -----HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             -----HhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                 00000111122345679999999999999999999999863

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-46  Score=338.37  Aligned_cols=269  Identities=23%  Similarity=0.267  Sum_probs=199.8

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC----chHHHHHHHHHHhcCCCCccceeeeEEEeCCe
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE----PESDFAAQLSVVSRLKHEHFVELLGYCMESNN  139 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  139 (363)
                      ...++|++.+.||+|+||.||+|.+. +++.||+|++.......    ....+.+|+.+++.++||||+++++++.....
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34568999999999999999999865 58999999997543222    12468899999999999999999999999999


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEe
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA  219 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~  219 (363)
                      .++||||+.+ +|.+++.....        .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~  154 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSL--------VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLA  154 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCS--------SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             eEEEEEcCCC-CHHHHHHhcCc--------CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEE
Confidence            9999999987 89888875432        388899999999999999999999   99999999999999999999999


Q ss_pred             eeccCCCCCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 046595          220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL  298 (363)
Q Consensus       220 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  298 (363)
                      |||++.........  .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+.......
T Consensus       155 Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~  232 (346)
T 1ua2_A          155 DFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP  232 (346)
T ss_dssp             CCGGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             ecccceeccCCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            99999765433222  3345789999999998764 58999999999999999999999997654322211110000000


Q ss_pred             cccc------cccccCCcCCCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          299 SEDK------VKQCVDPKLNNDYP-----PKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       299 ~~~~------~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                      ....      .............+     ...+..+.++|.+||+.||.+|||+.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0000      00000000001111     2345679999999999999999999999973

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.1e-46  Score=341.22  Aligned_cols=266  Identities=23%  Similarity=0.363  Sum_probs=201.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCc-hHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEP-ESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++........ ...+.+|+.+++.++||||+++++++.+....++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            358999999999999999999865 589999999876443222 355778999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+++|.+++....         .+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++
T Consensus       104 e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  171 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN---------GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFA  171 (331)
T ss_dssp             ECCSEEHHHHHHHSTT---------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ecCCcchHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCc
Confidence            9999998888876543         289999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc-----
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL-----  298 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~-----  298 (363)
                      .........  .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||...................     
T Consensus       172 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (331)
T 4aaa_A          172 RTLAAPGEV--YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ  249 (331)
T ss_dssp             --------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eeecCCccc--cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Confidence            765433221  2345789999999998875 78999999999999999999999997654322111110000000     


Q ss_pred             ----cccccccccCCcCCCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          299 ----SEDKVKQCVDPKLNNDYP-----PKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       299 ----~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                          ..........+......+     ..++..+.+|+.+||+.||++|||+.++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                000000011111111111     234677999999999999999999999886

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=8.4e-47  Score=333.78  Aligned_cols=258  Identities=21%  Similarity=0.302  Sum_probs=205.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEe--CCeeEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCME--SNNRIL  142 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l  142 (363)
                      .++|++.+.||+|+||.||++... +++.|++|.+...... ...+.+.+|+.+++.++||||+++++++..  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            357999999999999999999865 6899999999764432 234678899999999999999999998754  568899


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCC-----eEEecccCCceeecCCCceE
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPP-----IVHRDVRSSNVLLFDDFKSK  217 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-----ivH~Dlkp~Nill~~~~~vk  217 (363)
                      ||||+.+++|.+++......     ...+++..++.++.|++.||.|||++   +     |+|+||||+||+++.++.+|
T Consensus        85 v~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~k  156 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKE-----RQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVK  156 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEE
T ss_pred             EEeCCCCCCHHHHHHhhccc-----CCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEE
Confidence            99999999999999754311     12389999999999999999999999   8     99999999999999999999


Q ss_pred             EeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccc
Q 046595          218 IADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR  297 (363)
Q Consensus       218 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~  297 (363)
                      |+|||++.........  .....|++.|+|||++.+..++.++||||||+++|+|++|..||...........       
T Consensus       157 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------  227 (279)
T 2w5a_A          157 LGDFGLARILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK-------  227 (279)
T ss_dssp             ECCCCHHHHC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------
T ss_pred             EecCchheeecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHH-------
Confidence            9999998654432211  2335789999999999998999999999999999999999999975432111000       


Q ss_pred             ccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 046595          298 LSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQP  350 (363)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~  350 (363)
                           +.    .......+..++..+.+++.+||+.||.+|||+.+|++.+..
T Consensus       228 -----i~----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          228 -----IR----EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             -----HH----HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             -----Hh----hcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence                 00    011112233456779999999999999999999999986653

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.5e-46  Score=331.68  Aligned_cols=249  Identities=22%  Similarity=0.334  Sum_probs=206.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC--CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP--EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      .++|.+.+.||+|+||.||++.+. +++.+|+|++......  ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            468999999999999999999865 5888999998654322  2346788999999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.+++|.+++....         .+++.+++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||+
T Consensus        94 ~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~  161 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK---------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGL  161 (294)
T ss_dssp             EECCTTCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccC
Confidence            99999999999987643         289999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      +.........  .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........             
T Consensus       162 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-------------  226 (294)
T 2rku_A          162 ATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR-------------  226 (294)
T ss_dssp             CEECCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-------------
T ss_pred             ceecccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------------
Confidence            8654422211  2345789999999999988999999999999999999999999975432111100             


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                        ....  ....+...+..+.+++.+||+.||++|||+.++++
T Consensus       227 --~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          227 --IKKN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             --HHTT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             --Hhhc--cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence              0000  01223344567999999999999999999999987

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.2e-46  Score=338.93  Aligned_cols=276  Identities=21%  Similarity=0.334  Sum_probs=201.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHH--HhcCCCCccceeeeEEEe-----CCe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSV--VSRLKHEHFVELLGYCME-----SNN  139 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~--l~~l~h~~i~~~~~~~~~-----~~~  139 (363)
                      .++|++.+.||+|+||.||+|+. +++.||||++...    ....+..|.++  +..++|+||+++++.+..     ...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            35899999999999999999977 5899999998642    23445555555  445899999999985543     235


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccC------CCCeEEecccCCceeecCC
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV------QPPIVHRDVRSSNVLLFDD  213 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~------~~~ivH~Dlkp~Nill~~~  213 (363)
                      .++||||+++|+|.+++....          .++..++.++.|++.||.|||++.      ..+|+||||||+|||++.+
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~  156 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLHT----------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND  156 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred             EEEEEecCCCCcHHHHHhhcc----------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC
Confidence            689999999999999997654          689999999999999999999762      2279999999999999999


Q ss_pred             CceEEeeeccCCCCCcccc------cccccccccccCCCCcccccc-------CCCCccCceehhHHHHHHHHhCCCCCC
Q 046595          214 FKSKIADFNLTNQSSDTAA------RLHSTRVLGTFGYHAPEYAMT-------GQITQKSDVYSFGVVLLELLTGRKPVD  280 (363)
Q Consensus       214 ~~vkl~Dfg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~ell~g~~p~~  280 (363)
                      +.+||+|||++........      ........||+.|+|||++.+       ..++.++|||||||++|||++|..||.
T Consensus       157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~  236 (336)
T 3g2f_A          157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF  236 (336)
T ss_dssp             SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred             CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence            9999999999975543211      111234579999999999886       356788999999999999999987764


Q ss_pred             CCCCccccchhhh--cccccccccccc-ccCCcCCCCC------CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 046595          281 HTMPKGQQSLVTW--ATPRLSEDKVKQ-CVDPKLNNDY------PPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL  351 (363)
Q Consensus       281 ~~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l  351 (363)
                      .............  .........+.. .........+      ...++..+.+||.+||+.||.+|||+.++++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             TTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             CccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            4332221111000  000000000000 0011111111      235777899999999999999999999999999999


Q ss_pred             cccCCC
Q 046595          352 LNSKPA  357 (363)
Q Consensus       352 ~~~~~~  357 (363)
                      +.....
T Consensus       317 l~~~~~  322 (336)
T 3g2f_A          317 MMIWER  322 (336)
T ss_dssp             HHCCCC
T ss_pred             HHHHHh
Confidence            876654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.5e-46  Score=367.55  Aligned_cols=249  Identities=22%  Similarity=0.273  Sum_probs=207.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l  142 (363)
                      .++|++.++||+|+||.||+|+.. +++.||||++....  .......+..|..++..+ +||+|+.+++++.+.+.++|
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            467999999999999999999865 58889999987532  233456788899999988 79999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ||||+.+|+|.+++....         .+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|||
T Consensus       420 V~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFG  487 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVG---------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFG  487 (674)
T ss_dssp             EEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCT
T ss_pred             EEeCcCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecc
Confidence            999999999999998654         289999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      +++.......  .....+||+.|+|||++.+..|+.++||||||++||||++|..||..........             
T Consensus       488 la~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~-------------  552 (674)
T 3pfq_A          488 MCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ-------------  552 (674)
T ss_dssp             TCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------------
T ss_pred             eeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHH-------------
Confidence            9875332222  2345789999999999999999999999999999999999999997543321111             


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNM-----TIVVK  346 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~~vl~  346 (363)
                        .+...  ...++...+.++.+||.+||+.||.+||++     ++|++
T Consensus       553 --~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          553 --SIMEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             --HHHSS--CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             --HHHhC--CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence              11111  123344566789999999999999999997     77765

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.8e-45  Score=337.49  Aligned_cols=256  Identities=20%  Similarity=0.335  Sum_probs=206.2

Q ss_pred             HHHHHHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCc-------hHHHHHHHHHHhcC-CCCccceee
Q 046595           61 DELNRLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEP-------ESDFAAQLSVVSRL-KHEHFVELL  131 (363)
Q Consensus        61 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~-------~~~~~~e~~~l~~l-~h~~i~~~~  131 (363)
                      .....+.++|.+.+.||+|+||.||+|.+. +|+.||||++........       ...+.+|+.+++++ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            344566778999999999999999999875 799999999876432211       34677899999999 799999999


Q ss_pred             eEEEeCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec
Q 046595          132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF  211 (363)
Q Consensus       132 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~  211 (363)
                      +++......++||||+.+++|.+++....         .+++..+..++.|++.||.|||+.   ||+|+||||+||+++
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~  234 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTEKV---------ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLD  234 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence            99999999999999999999999997543         289999999999999999999999   999999999999999


Q ss_pred             CCCceEEeeeccCCCCCcccccccccccccccCCCCcccccc------CCCCccCceehhHHHHHHHHhCCCCCCCCCCc
Q 046595          212 DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT------GQITQKSDVYSFGVVLLELLTGRKPVDHTMPK  285 (363)
Q Consensus       212 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~  285 (363)
                      .++.+||+|||++........   .....||+.|+|||++.+      ..++.++|||||||++|+|++|..||......
T Consensus       235 ~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~  311 (365)
T 2y7j_A          235 DNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI  311 (365)
T ss_dssp             TTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             CCCCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH
Confidence            999999999999865543322   244679999999999864      35889999999999999999999999754321


Q ss_pred             cccchhhhccccccccccccccCCcCCCCCC--HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          286 GQQSLVTWATPRLSEDKVKQCVDPKLNNDYP--PKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .....+.               ........+  ...+..+.+++.+||+.||++|||+.++++
T Consensus       312 ~~~~~i~---------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          312 LMLRMIM---------------EGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHHHHH---------------HTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHH---------------hCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1111000               000000000  123456999999999999999999999987

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.3e-46  Score=344.83  Aligned_cols=265  Identities=22%  Similarity=0.298  Sum_probs=205.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++...........+.+|+.+++.++||||+++++++......++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            357999999999999999999865 6899999999875444445778999999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+++|.+++....         .+++..+..++.|++.||.|||+.+  +|+||||||+||+++.++.+||+|||++.
T Consensus       112 ~~~~~~L~~~l~~~~---------~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  180 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG---------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSG  180 (360)
T ss_dssp             CCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred             CCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCc
Confidence            999999999997654         2889999999999999999999832  79999999999999999999999999875


Q ss_pred             CCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc----------
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT----------  295 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~----------  295 (363)
                      .....    ......||+.|+|||++.+..++.++||||||+++|+|++|+.||................          
T Consensus       181 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (360)
T 3eqc_A          181 QLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR  256 (360)
T ss_dssp             HHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------
T ss_pred             ccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCC
Confidence            43221    1334679999999999999999999999999999999999999997543221111000000          


Q ss_pred             -------------ccccc----cccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          296 -------------PRLSE----DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       296 -------------~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                                   .....    ..+...............++..+.+|+.+||+.||.+|||+.++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             -----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                         00000    0000000001111111234567999999999999999999999987

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-46  Score=342.80  Aligned_cols=254  Identities=22%  Similarity=0.323  Sum_probs=204.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEe----CCCCeEEEEEccCCC---CCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCe
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL----TDGTPAAIKKLDTSS---APEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNN  139 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~avK~~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~  139 (363)
                      ++|++.+.||+|+||.||+|+.    .+++.||||++....   .......+.+|+.+++.+ +||||+++++++.....
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5799999999999999999986    368999999986532   122345677899999999 69999999999999999


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEe
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA  219 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~  219 (363)
                      .++||||+.+++|.+++....         .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~  201 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRE---------RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLT  201 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEES
T ss_pred             EEEEeecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEe
Confidence            999999999999999997643         289999999999999999999999   99999999999999999999999


Q ss_pred             eeccCCCCCcccccccccccccccCCCCccccccC--CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccc
Q 046595          220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG--QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR  297 (363)
Q Consensus       220 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~  297 (363)
                      |||+++........ ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||...........+.     
T Consensus       202 DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~-----  275 (355)
T 1vzo_A          202 DFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS-----  275 (355)
T ss_dssp             CSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH-----
T ss_pred             eCCCCeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHH-----
Confidence            99998765433221 23346799999999999863  57899999999999999999999997543322111100     


Q ss_pred             ccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 046595          298 LSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP-----NMTIVVKA  347 (363)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~~  347 (363)
                            .....  ....++..++..+.+||.+||+.||.+||     ++.++++.
T Consensus       276 ------~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          276 ------RRILK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             ------HHHHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             ------HHHhc--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence                  00000  01223445567799999999999999999     99999874

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=7.4e-46  Score=331.87  Aligned_cols=252  Identities=23%  Similarity=0.333  Sum_probs=204.6

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      .+.++|.+.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV   84 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence            35568999999999999999999865 799999999976432 2345788999999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceee---cCCCceEEee
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL---FDDFKSKIAD  220 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~D  220 (363)
                      |||+.+++|.+++....         .+++..++.++.|++.||.|||++   +|+|+||||+||++   +.++.+||+|
T Consensus        85 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~D  152 (304)
T 2jam_A           85 MQLVSGGELFDRILERG---------VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITD  152 (304)
T ss_dssp             ECCCCSCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCS
T ss_pred             EEcCCCccHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEcc
Confidence            99999999999987543         289999999999999999999999   99999999999999   7889999999


Q ss_pred             eccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccc
Q 046595          221 FNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE  300 (363)
Q Consensus       221 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  300 (363)
                      ||++.......    .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.  .     
T Consensus       153 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~--~-----  221 (304)
T 2jam_A          153 FGLSKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIK--E-----  221 (304)
T ss_dssp             CSTTCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--H-----
T ss_pred             CCcceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--c-----
Confidence            99986543321    234568999999999999999999999999999999999999997543211111000  0     


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          301 DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ..      ...........+..+.+++.+||+.||.+|||+.++++
T Consensus       222 ~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          222 GY------YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             CC------CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CC------CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            00      00111222345567999999999999999999999987

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.6e-46  Score=337.28  Aligned_cols=261  Identities=18%  Similarity=0.264  Sum_probs=207.4

Q ss_pred             HHHHHHHhcCCCCC-CeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC-CchHHHHHHHHHHhcC-CCCccceeeeEEE
Q 046595           60 LDELNRLTSNFGTK-ALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRL-KHEHFVELLGYCM  135 (363)
Q Consensus        60 ~~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~  135 (363)
                      +.....+.++|.+. +.||+|+||.||+|... +++.||+|++...... .....+.+|+.+++.+ +||||+++++++.
T Consensus        20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~   99 (327)
T 3lm5_A           20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE   99 (327)
T ss_dssp             SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            33445677788887 89999999999999765 6999999998764332 2356789999999999 5699999999999


Q ss_pred             eCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC---
Q 046595          136 ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD---  212 (363)
Q Consensus       136 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---  212 (363)
                      .....++||||+.+|+|.+++.....       ..+++..++.++.|++.||.|||++   +|+||||||+||+++.   
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~  169 (327)
T 3lm5_A          100 NTSEIILILEYAAGGEIFSLCLPELA-------EMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYP  169 (327)
T ss_dssp             CSSEEEEEEECCTTEEGGGGGSSCC--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTT
T ss_pred             eCCeEEEEEEecCCCcHHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCC
Confidence            99999999999999999999865321       2389999999999999999999999   9999999999999987   


Q ss_pred             CCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhh
Q 046595          213 DFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT  292 (363)
Q Consensus       213 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~  292 (363)
                      ++.+||+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.
T Consensus       170 ~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  246 (327)
T 3lm5_A          170 LGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS  246 (327)
T ss_dssp             BCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Confidence            78999999999876543322   234579999999999999999999999999999999999999997543221111110


Q ss_pred             hccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          293 WATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .             ............++..+.+++.+||+.||.+|||+.++++
T Consensus       247 ~-------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          247 Q-------------VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             H-------------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             h-------------cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            0             0011112222345667999999999999999999999987

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.1e-45  Score=344.82  Aligned_cols=250  Identities=21%  Similarity=0.328  Sum_probs=192.7

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC-------CCCchHHHHHHHHHHhcCCCCccceeeeEEEe
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS-------APEPESDFAAQLSVVSRLKHEHFVELLGYCME  136 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  136 (363)
                      .+.++|.+.+.||+|+||.||+|... +++.||+|++....       .......+.+|+.++++++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            45679999999999999999999764 68999999986532       1112235789999999999999999999875 


Q ss_pred             CCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCC---
Q 046595          137 SNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD---  213 (363)
Q Consensus       137 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~---  213 (363)
                      ....++||||+.+|+|.+++....         .+++..++.++.|++.||.|||++   +|+||||||+|||++.+   
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~  278 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVGNK---------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEED  278 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSSSC---------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSS
T ss_pred             cCceEEEEEcCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCc
Confidence            556899999999999999987654         389999999999999999999999   99999999999999754   


Q ss_pred             CceEEeeeccCCCCCcccccccccccccccCCCCcccccc---CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccch
Q 046595          214 FKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT---GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSL  290 (363)
Q Consensus       214 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~  290 (363)
                      +.+||+|||+++.......   .....||+.|+|||++.+   ..++.++|||||||++|+|++|..||.........  
T Consensus       279 ~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~--  353 (419)
T 3i6u_A          279 CLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--  353 (419)
T ss_dssp             CCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH--
T ss_pred             ceEEEeecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH--
Confidence            4599999999987654322   344679999999999863   57889999999999999999999999754322111  


Q ss_pred             hhhccccccccccccccCCcCCCCCCH----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          291 VTWATPRLSEDKVKQCVDPKLNNDYPP----KAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ..             .+.... ..+.+    .++..+.+++.+||+.||++|||+.++++
T Consensus       354 ~~-------------~i~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          354 KD-------------QITSGK-YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HH-------------HHHTTC-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HH-------------HHhcCC-CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            00             000000 01111    23567999999999999999999999987

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.2e-45  Score=337.21  Aligned_cols=267  Identities=21%  Similarity=0.297  Sum_probs=202.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCC-chHHHHHHHHHHhcCCCCccceeeeEEEe--------C
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLGYCME--------S  137 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~  137 (363)
                      ++|++.+.||+|+||.||+|+. .+++.||+|++....... ....+.+|+.+++.++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            5799999999999999999986 478999999986654332 34678899999999999999999999887        3


Q ss_pred             CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceE
Q 046595          138 NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSK  217 (363)
Q Consensus       138 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk  217 (363)
                      ...++||||+.+ +|.+.+.....        .+++.+++.++.|++.||.|||++   ||+||||||+|||++.++.+|
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~k  164 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVLV--------KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLK  164 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred             ceEEEEEeccCC-CHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEE
Confidence            468999999986 88887765432        289999999999999999999999   999999999999999999999


Q ss_pred             EeeeccCCCCCcccc--cccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhc
Q 046595          218 IADFNLTNQSSDTAA--RLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWA  294 (363)
Q Consensus       218 l~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~  294 (363)
                      |+|||++........  ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+...
T Consensus       165 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~  244 (351)
T 3mi9_A          165 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL  244 (351)
T ss_dssp             ECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             EccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence            999999865442211  112344578999999999876 46899999999999999999999999865433222211111


Q ss_pred             ccccccc--------ccccccCCcCC--CCCCHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          295 TPRLSED--------KVKQCVDPKLN--NDYPPK-----AIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       295 ~~~~~~~--------~~~~~~~~~~~--~~~~~~-----~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .......        ...........  ......     .+..+.+||.+||+.||.+|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            1011000        00000000000  000011     1356889999999999999999999997

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.1e-45  Score=351.74  Aligned_cols=253  Identities=23%  Similarity=0.333  Sum_probs=204.3

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC-CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS-APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      .+.++|++.+.||+|+||.||+|... +++.||||++.... .......+.+|+.++++++||||+++++++.+....++
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   98 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence            35568999999999999999999865 78999999986432 23345788999999999999999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec---CCCceEEe
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIA  219 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~---~~~~vkl~  219 (363)
                      ||||+.+++|.+++....         .+++..+..++.|++.||.|||++   +|+||||||+|||++   .++.+||+
T Consensus        99 v~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~  166 (486)
T 3mwu_A           99 VGELYTGGELFDEIIKRK---------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKII  166 (486)
T ss_dssp             EECCCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEEC
T ss_pred             EEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEE
Confidence            999999999999987654         289999999999999999999999   999999999999995   56689999


Q ss_pred             eeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc
Q 046595          220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       220 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      |||++........   .....||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+....  . 
T Consensus       167 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--~-  239 (486)
T 3mwu_A          167 DFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK--Y-  239 (486)
T ss_dssp             SCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--C-
T ss_pred             ECCcCeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C-
Confidence            9999876543322   234579999999998875 59999999999999999999999997543321111110000  0 


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                                .........++..+.++|.+||+.||.+|||+.++++
T Consensus       240 ----------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          240 ----------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             ----------CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----------CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                      0000111234567999999999999999999999998

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.2e-46  Score=355.27  Aligned_cols=252  Identities=22%  Similarity=0.341  Sum_probs=205.9

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC--CCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA--PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      +.++|++.+.||+|+||.||+|... +++.||||++.....  ......+.+|+.++++++||||+++++++.+....++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            4568999999999999999999865 799999999865432  3446789999999999999999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceee---cCCCceEEe
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL---FDDFKSKIA  219 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~  219 (363)
                      ||||+.+|+|.+++....         .+++..++.++.|++.||.|||++   +|+||||||+|||+   +.++.+||+
T Consensus       104 v~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~  171 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISRK---------RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRII  171 (484)
T ss_dssp             EECCCCSCBHHHHHHTCS---------CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred             EEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEE
Confidence            999999999999997654         289999999999999999999999   99999999999999   567899999


Q ss_pred             eeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc
Q 046595          220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       220 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      |||++........   .....||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+.....   
T Consensus       172 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~---  244 (484)
T 3nyv_A          172 DFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKY---  244 (484)
T ss_dssp             CTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---
T ss_pred             eeeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC---
Confidence            9999865433221   234579999999998875 799999999999999999999999975533221111110000   


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                                .........++..+.++|.+||+.||.+|||+.++++
T Consensus       245 ----------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          245 ----------TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             ----------CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----------CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence                      0000111234567999999999999999999999987

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=5.4e-46  Score=329.51  Aligned_cols=247  Identities=22%  Similarity=0.361  Sum_probs=205.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      .++|.+.+.||+|+||.||+|... +++.||+|++....  .......+.+|+.+++.++||||+++++++.+....++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            357999999999999999999865 57789999986432  223346789999999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.+++|.+++....         .+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||+
T Consensus        93 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~  160 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG---------RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGW  160 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEeCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccc
Confidence            99999999999997653         289999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      +.......    .....|++.|+|||++.+..++.++||||||+++|+|++|..||...........             
T Consensus       161 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-------------  223 (284)
T 2vgo_A          161 SVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR-------------  223 (284)
T ss_dssp             CEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-------------
T ss_pred             cccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH-------------
Confidence            85443321    2345789999999999999999999999999999999999999975432111110             


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                        ....  ...++...+..+.+++.+||+.||.+||++.++++
T Consensus       224 --~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          224 --IVNV--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             --HHTT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --Hhcc--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence              0000  11223345567999999999999999999999987

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.5e-46  Score=344.88  Aligned_cols=267  Identities=21%  Similarity=0.295  Sum_probs=205.4

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeC-----Ce
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMES-----NN  139 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~  139 (363)
                      +..+|++.+.||+|+||.||+|.+. +++.||||++...........+.+|+.+++.++||||+++++++...     ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            3468999999999999999999765 68889999997644333447788999999999999999999998765     36


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEe
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA  219 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~  219 (363)
                      .++||||+.+ +|.+++....          +++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+
T Consensus       105 ~~iv~e~~~~-~L~~~l~~~~----------~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~  170 (364)
T 3qyz_A          105 VYIVQDLMET-DLYKLLKTQH----------LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKIC  170 (364)
T ss_dssp             EEEEEECCSE-EHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred             EEEEEcccCc-CHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEE
Confidence            8999999986 9999997643          89999999999999999999999   99999999999999999999999


Q ss_pred             eeccCCCCCcccccc-cccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccc
Q 046595          220 DFNLTNQSSDTAARL-HSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR  297 (363)
Q Consensus       220 Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~  297 (363)
                      |||++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+......
T Consensus       171 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  250 (364)
T 3qyz_A          171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS  250 (364)
T ss_dssp             CCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCS
T ss_pred             eCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCC
Confidence            999997655432221 1244579999999998764 45899999999999999999999999766543322221111001


Q ss_pred             ccccccccc--------cCC-cCCCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          298 LSEDKVKQC--------VDP-KLNNDY-----PPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       298 ~~~~~~~~~--------~~~-~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .....+...        ... ......     ....+..+.+|+.+||+.||.+|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            100000000        000 000000     1233567999999999999999999999997

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.1e-46  Score=333.20  Aligned_cols=264  Identities=23%  Similarity=0.346  Sum_probs=199.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC--CCC--eEEEEEccCCCC--CCchHHHHHHHHHHhcCCCCccceeeeEEEeCCee
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT--DGT--PAAIKKLDTSSA--PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNR  140 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~--~~avK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  140 (363)
                      .++|++.+.||+|+||.||+|++.  +++  .||+|++.....  ....+.+.+|+.+++.++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            357999999999999999999753  333  589998876432  233467899999999999999999999988754 8


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEee
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD  220 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D  220 (363)
                      ++||||+.+++|.+++.....        .+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+|
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~D  164 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGD  164 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG--------GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECC
T ss_pred             eeeEecccCCCHHHHHHhccC--------CcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcc
Confidence            899999999999999975421        288999999999999999999999   999999999999999999999999


Q ss_pred             eccCCCCCccccc-ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccc
Q 046595          221 FNLTNQSSDTAAR-LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRL  298 (363)
Q Consensus       221 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~  298 (363)
                      ||++......... .......+|..|+|||++.+..++.++||||||+++|+|++ |..||..........         
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~---------  235 (291)
T 1u46_A          165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH---------  235 (291)
T ss_dssp             CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---------
T ss_pred             ccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHH---------
Confidence            9998765433221 11233467889999999998899999999999999999999 999997543221111         


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCC
Q 046595          299 SEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA  357 (363)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~  357 (363)
                            ...........+..++..+.+++.+||+.||.+|||+.+|++.|+++......
T Consensus       236 ------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  288 (291)
T 1u46_A          236 ------KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR  288 (291)
T ss_dssp             ------HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred             ------HHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccchh
Confidence                  01111111122334567799999999999999999999999999988765543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.9e-45  Score=350.51  Aligned_cols=252  Identities=24%  Similarity=0.336  Sum_probs=199.9

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      +.++|++.+.||+|+||.||+|+.. ++..||+|++..... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4557999999999999999999865 688999999876442 33457889999999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC---CCceEEee
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD---DFKSKIAD  220 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~~~vkl~D  220 (363)
                      |||+.+|+|.+++....         .+++..++.++.|++.||.|||++   +|+||||||+|||++.   ++.+||+|
T Consensus       115 ~e~~~~g~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~D  182 (494)
T 3lij_A          115 MECYKGGELFDEIIHRM---------KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVD  182 (494)
T ss_dssp             EECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             EecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEE
Confidence            99999999999887654         289999999999999999999999   9999999999999975   45599999


Q ss_pred             eccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccc
Q 046595          221 FNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE  300 (363)
Q Consensus       221 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  300 (363)
                      ||++........   .....||+.|+|||++. ..++.++|||||||++|+|++|..||...........+.......  
T Consensus       183 fG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--  256 (494)
T 3lij_A          183 FGLSAVFENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTF--  256 (494)
T ss_dssp             CTTCEECBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--
T ss_pred             CCCCeECCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--
Confidence            999876543322   34467999999999876 579999999999999999999999997553322111111000000  


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          301 DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                                 .......++..+.++|.+||+.||.+|||+.++++
T Consensus       257 -----------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          257 -----------DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             -----------CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -----------CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence                       00001134567999999999999999999999986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1e-45  Score=327.98  Aligned_cols=249  Identities=19%  Similarity=0.287  Sum_probs=200.4

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC-chHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeE
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRI  141 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~  141 (363)
                      .+.++|++.+.||+|+||.||+|.+. +++.||+|++....... ....+.+|+..+..+ +||||+++++++.+.+..+
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~   87 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML   87 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence            35568999999999999999999865 79999999987653332 346788899999998 8999999999999999999


Q ss_pred             EEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCC--------
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD--------  213 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~--------  213 (363)
                      +||||+++++|.+++......     ...+++..++.++.|++.||.|||++   +|+||||||+||+++.+        
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~  159 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRI-----MSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASE  159 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------
T ss_pred             EEEEecCCCcHHHHHHhhccc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccc
Confidence            999999999999999754210     01389999999999999999999999   99999999999999844        


Q ss_pred             -----------CceEEeeeccCCCCCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCC
Q 046595          214 -----------FKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDH  281 (363)
Q Consensus       214 -----------~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~  281 (363)
                                 ..+||+|||++......      ....||+.|+|||++.+. .++.++||||||+++|+|++|..++..
T Consensus       160 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~  233 (289)
T 1x8b_A          160 EGDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN  233 (289)
T ss_dssp             ----------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred             ccccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence                       47999999998655432      234589999999999866 677899999999999999999887642


Q ss_pred             CCCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          282 TMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ...     ...          +..    ......+..++..+.+++.+||+.||.+|||+.++++
T Consensus       234 ~~~-----~~~----------~~~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          234 GDQ-----WHE----------IRQ----GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             SHH-----HHH----------HHT----TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhH-----HHH----------HHc----CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            210     000          000    1112223345567999999999999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.2e-45  Score=351.01  Aligned_cols=249  Identities=24%  Similarity=0.344  Sum_probs=201.9

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC------------CchHHHHHHHHHHhcCCCCccceee
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP------------EPESDFAAQLSVVSRLKHEHFVELL  131 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~~  131 (363)
                      .+.++|.+.+.||+|+||.||+|... +++.||+|++......            .....+.+|+.+++.++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            35678999999999999999999865 5889999998764322            2346789999999999999999999


Q ss_pred             eEEEeCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec
Q 046595          132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF  211 (363)
Q Consensus       132 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~  211 (363)
                      +++.+....++||||+.+|+|.+++....         .+++..++.++.|++.||.|||++   +|+||||||+|||++
T Consensus       113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~  180 (504)
T 3q5i_A          113 DVFEDKKYFYLVTEFYEGGELFEQIINRH---------KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLE  180 (504)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEES
T ss_pred             EEEEcCCEEEEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEe
Confidence            99999999999999999999999987654         289999999999999999999999   999999999999998


Q ss_pred             CCC---ceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCcccc
Q 046595          212 DDF---KSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ  288 (363)
Q Consensus       212 ~~~---~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~  288 (363)
                      .++   .+||+|||++........   .....||+.|+|||++. ..++.++|||||||++|+|++|..||.........
T Consensus       181 ~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  256 (504)
T 3q5i_A          181 NKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII  256 (504)
T ss_dssp             STTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             cCCCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            776   699999999876543322   34467999999999887 56999999999999999999999999754332211


Q ss_pred             chhhhccccccccccccccCCcCCCCCC----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          289 SLVTWATPRLSEDKVKQCVDPKLNNDYP----PKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ..+.               ...+  .++    ..++..+.++|.+||+.||.+|||+.++++
T Consensus       257 ~~i~---------------~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          257 KKVE---------------KGKY--YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHHH---------------HCCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHH---------------cCCC--CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            1111               0000  011    123567999999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3e-46  Score=338.96  Aligned_cols=265  Identities=19%  Similarity=0.304  Sum_probs=193.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-CCccceeeeEEE--------e
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVELLGYCM--------E  136 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--------~  136 (363)
                      ..+|++.+.||+|+||.||+|++. +++.||+|++... .......+.+|+.+++++. ||||+++++++.        .
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            357999999999999999999864 6899999998553 2233467889999999995 999999999984        3


Q ss_pred             CCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCC--eEEecccCCceeecCCC
Q 046595          137 SNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPP--IVHRDVRSSNVLLFDDF  214 (363)
Q Consensus       137 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nill~~~~  214 (363)
                      ....+++|||+. |+|.+++......      ..+++.+++.++.|++.||.|||++   +  |+||||||+|||++.++
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~  175 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESR------GPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQG  175 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTT------CSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTS
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCC
Confidence            345789999997 5999988652211      1389999999999999999999999   8  99999999999999999


Q ss_pred             ceEEeeeccCCCCCcccccc----------cccccccccCCCCcccc---ccCCCCccCceehhHHHHHHHHhCCCCCCC
Q 046595          215 KSKIADFNLTNQSSDTAARL----------HSTRVLGTFGYHAPEYA---MTGQITQKSDVYSFGVVLLELLTGRKPVDH  281 (363)
Q Consensus       215 ~vkl~Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~~l~ell~g~~p~~~  281 (363)
                      .+||+|||++..........          ......||+.|+|||++   .+..++.++||||||+++|+|++|..||..
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  255 (337)
T 3ll6_A          176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED  255 (337)
T ss_dssp             CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            99999999997654322210          11134689999999998   566789999999999999999999999964


Q ss_pred             CCCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCCCCCC
Q 046595          282 TMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGPEA  361 (363)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~~~~~  361 (363)
                      ......                   .............+..+.+++.+||+.||.+|||+.++++.|+.+....+..++.
T Consensus       256 ~~~~~~-------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~  316 (337)
T 3ll6_A          256 GAKLRI-------------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS  316 (337)
T ss_dssp             -----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred             hhHHHh-------------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCc
Confidence            322110                   0001111111222345889999999999999999999999999999887776654

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5.2e-46  Score=341.04  Aligned_cols=272  Identities=23%  Similarity=0.332  Sum_probs=201.7

Q ss_pred             HHHHHHHhcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCc----------hHHHHHHHHHHhcCCCCccce
Q 046595           60 LDELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEP----------ESDFAAQLSVVSRLKHEHFVE  129 (363)
Q Consensus        60 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~  129 (363)
                      ..++..+.++|.+.+.||+|+||.||+|...+++.||||++........          .+.+.+|+.+++.++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            4577788899999999999999999999988899999999865433221          267899999999999999999


Q ss_pred             eeeEEEeC-----CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEeccc
Q 046595          130 LLGYCMES-----NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVR  204 (363)
Q Consensus       130 ~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlk  204 (363)
                      +++++...     ...++||||+.+ +|.+++.....        .+++..++.++.|++.||.|||++   +|+|||||
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk  161 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRI--------VISPQHIQYFMYHILLGLHVLHEA---GVVHRDLH  161 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCSE-EHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCC
T ss_pred             eeeeEEeccCCCcceEEEEEccCCC-CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCC
Confidence            99998543     357999999985 88888875432        389999999999999999999999   99999999


Q ss_pred             CCceeecCCCceEEeeeccCCCCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCC
Q 046595          205 SSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTM  283 (363)
Q Consensus       205 p~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~  283 (363)
                      |+||+++.++.+||+|||++........   .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus       162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  238 (362)
T 3pg1_A          162 PGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST  238 (362)
T ss_dssp             GGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             hHHEEEcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999864433222   334578999999999887 679999999999999999999999997654


Q ss_pred             Cccccchhhhccccc--------cccccccccCCcCCC-------CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          284 PKGQQSLVTWATPRL--------SEDKVKQCVDPKLNN-------DYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       284 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .......+.......        ............+..       ......+..+.+|+.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            322111110000000        000000111111100       111233567999999999999999999999997

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1e-45  Score=326.31  Aligned_cols=248  Identities=21%  Similarity=0.311  Sum_probs=197.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|++....  .......+.+|+.+++.++||||+++++++......++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            468999999999999999999865 79999999986432  233456789999999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.+++|.+++....         .+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||+
T Consensus        90 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~  157 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG---------RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGL  157 (276)
T ss_dssp             EECCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCG
T ss_pred             EeccCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccc
Confidence            99999999999997653         288999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCC-CccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      +........   .....|++.|+|||.+.+..+ +.++||||||+++|+|++|..||........   ...         
T Consensus       158 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~---------  222 (276)
T 2h6d_A          158 SNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL---FKK---------  222 (276)
T ss_dssp             GGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH---------
T ss_pred             ccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---HHH---------
Confidence            876544322   234568999999999987765 6899999999999999999999975322111   000         


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      +..    . ....+..++..+.+++.+||+.||.+|||+.+|++
T Consensus       223 ~~~----~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          223 IRG----G-VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             HHH----C-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhc----C-cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            000    0 01123334567999999999999999999999998

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.8e-45  Score=328.18  Aligned_cols=254  Identities=22%  Similarity=0.319  Sum_probs=199.4

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC---CCCchHHHHHHHHHHhcCCCCccceeeeEEE--eCC
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS---APEPESDFAAQLSVVSRLKHEHFVELLGYCM--ESN  138 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~  138 (363)
                      ++.++|++.+.||+|+||.||++... +++.||+|++....   .......+.+|+.+++.++||||+++++++.  +..
T Consensus         2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (305)
T 2wtk_C            2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ   81 (305)
T ss_dssp             ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred             ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence            35679999999999999999999864 68899999986532   2344578899999999999999999999984  456


Q ss_pred             eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEE
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI  218 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl  218 (363)
                      ..++||||+.++ |.+++.....       ..+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||
T Consensus        82 ~~~lv~e~~~~~-l~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl  150 (305)
T 2wtk_C           82 KMYMVMEYCVCG-MQEMLDSVPE-------KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKI  150 (305)
T ss_dssp             CEEEEEECCSEE-HHHHHHHSTT-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred             eEEEEehhccCC-HHHHHHhCcc-------cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEe
Confidence            789999999986 7777765332       1389999999999999999999999   9999999999999999999999


Q ss_pred             eeeccCCCCCcccccccccccccccCCCCccccccCC--CCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccc
Q 046595          219 ADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQ--ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATP  296 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~  296 (363)
                      +|||++................||+.|+|||++.+..  ++.++||||||+++|+|++|..||...........+     
T Consensus       151 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i-----  225 (305)
T 2wtk_C          151 SALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI-----  225 (305)
T ss_dssp             CCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-----
T ss_pred             eccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHH-----
Confidence            9999987654332222234457999999999987644  478999999999999999999999754221110000     


Q ss_pred             cccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          297 RLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                        ..        .  ...++..++..+.+++.+||+.||.+|||+.++++
T Consensus       226 --~~--------~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          226 --GK--------G--SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             --HH--------C--CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --hc--------C--CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              00        0  01123345567999999999999999999999997

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.3e-46  Score=365.69  Aligned_cols=259  Identities=25%  Similarity=0.389  Sum_probs=208.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCC----CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTD----GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      .++|++.+.||+|+||.||+|.+..    +..||+|.+.........+.+.+|+.+++.++||||+++++++. .+..++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence            4679999999999999999997642    45689999876444444477899999999999999999999884 567899


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ||||+.+|+|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus       468 v~E~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG  536 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVRKF--------SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG  536 (656)
T ss_dssp             EEECCTTCBHHHHHHHTTT--------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             EEEcCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecC
Confidence            9999999999999975431        288999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      ++......... ......||+.|+|||++.+..++.++||||||+++|||++ |..||...........           
T Consensus       537 ~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~-----------  604 (656)
T 2j0j_A          537 LSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-----------  604 (656)
T ss_dssp             CCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-----------
T ss_pred             CCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-----------
Confidence            99876443221 1233457889999999999999999999999999999997 9999975432211110           


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                           +........+..++..+.+++.+||+.||.+|||+.+|++.|+.++++
T Consensus       605 -----i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          605 -----IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             -----HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----HHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                 001111223445667899999999999999999999999999998764

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.3e-45  Score=327.96  Aligned_cols=248  Identities=23%  Similarity=0.330  Sum_probs=197.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEe----CCeeE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCME----SNNRI  141 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~  141 (363)
                      ..|.+.+.||+|+||.||+|.+. ++..|++|.+..... ......+.+|+.+++.++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            35788889999999999999764 688899999875432 2234678899999999999999999998875    35578


Q ss_pred             EEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCC--eEEecccCCceeec-CCCceEE
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPP--IVHRDVRSSNVLLF-DDFKSKI  218 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nill~-~~~~vkl  218 (363)
                      +||||+.+++|.+++....         .+++..++.++.|++.||.|||++   +  |+|+||||+||+++ .++.+||
T Consensus       106 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl  173 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKI  173 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEE
T ss_pred             EEEEecCCCCHHHHHHHcc---------CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEE
Confidence            9999999999999997643         288999999999999999999999   8  99999999999998 7899999


Q ss_pred             eeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 046595          219 ADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL  298 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  298 (363)
                      +|||++.......    .....||+.|+|||++. +.++.++||||||+++|+|++|+.||..........  ....   
T Consensus       174 ~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~---  243 (290)
T 1t4h_A          174 GDLGLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY--RRVT---  243 (290)
T ss_dssp             CCTTGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH--HHHT---
T ss_pred             eeCCCcccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH--HHHh---
Confidence            9999986443322    23457999999999876 469999999999999999999999997543221111  0000   


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          299 SEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                               .......++...+..+.+++.+||+.||.+|||+.++++
T Consensus       244 ---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          244 ---------SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ---------TTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---------ccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                     000001111223356999999999999999999999987

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-46  Score=336.88  Aligned_cols=252  Identities=25%  Similarity=0.438  Sum_probs=196.7

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEe------C
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCME------S  137 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~  137 (363)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++....  .....+.+|+.+++++ +||||+++++++..      .
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   99 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   99 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence            4568999999999999999999864 68999999987532  3456789999999999 79999999999987      4


Q ss_pred             CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceE
Q 046595          138 NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSK  217 (363)
Q Consensus       138 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk  217 (363)
                      ...++||||+.+++|.+++.....       ..+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+|
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~k  169 (326)
T 2x7f_A          100 DQLWLVMEFCGAGSVTDLIKNTKG-------NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVK  169 (326)
T ss_dssp             CEEEEEEECCTTEEHHHHHHHSGG-------GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred             ceEEEEEEcCCCCcHHHHHHhccc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEE
Confidence            678999999999999999976432       1388999999999999999999999   999999999999999999999


Q ss_pred             EeeeccCCCCCcccccccccccccccCCCCccccc-----cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhh
Q 046595          218 IADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM-----TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT  292 (363)
Q Consensus       218 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~  292 (363)
                      |+|||++.........  .....||+.|+|||++.     +..++.++||||||+++|+|++|..||.............
T Consensus       170 l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  247 (326)
T 2x7f_A          170 LVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP  247 (326)
T ss_dssp             ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             EeeCcCceecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh
Confidence            9999998765432221  23457999999999987     5678999999999999999999999996543221111000


Q ss_pred             hccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          293 WATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                          .           ..........++..+.++|.+||+.||.+||++.++++
T Consensus       248 ----~-----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          248 ----R-----------NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             ----H-----------SCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ----c-----------CccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                0           00001112233567999999999999999999999987

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.8e-46  Score=344.54  Aligned_cols=251  Identities=12%  Similarity=0.161  Sum_probs=192.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCC--CCCchHHHHHHH---HHHhcCCCCccceee-------eEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSS--APEPESDFAAQL---SVVSRLKHEHFVELL-------GYC  134 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~--~~~~~~~~~~e~---~~l~~l~h~~i~~~~-------~~~  134 (363)
                      ++|.+.+.||+|+||.||+|++ .+++.||||++....  .....+.+.+|+   .+++.++||||++++       +++
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~  152 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  152 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred             ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence            5688899999999999999986 469999999997542  233457888999   455556899999998       665


Q ss_pred             EeCC-----------------eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCC
Q 046595          135 MESN-----------------NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPP  197 (363)
Q Consensus       135 ~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~  197 (363)
                      ...+                 ..++||||+ +|+|.+++.......  .....+++..++.++.|++.||.|||++   +
T Consensus       153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~  226 (377)
T 3byv_A          153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS--STHKSLVHHARLQLTLQVIRLLASLHHY---G  226 (377)
T ss_dssp             ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTT--TTTHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccc--cccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            5543                 278999999 579999997643211  0011245688889999999999999999   9


Q ss_pred             eEEecccCCceeecCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccC-----------CCCccCceehhH
Q 046595          198 IVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG-----------QITQKSDVYSFG  266 (363)
Q Consensus       198 ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG  266 (363)
                      |+||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++.+.           .++.++||||||
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG  300 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG  300 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence            999999999999999999999999998753321     234567 999999999887           899999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          267 VVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       267 ~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      |++|||++|+.||............               .. .     ...++..+.+++.+||+.||.+|||+.++++
T Consensus       301 ~il~elltg~~Pf~~~~~~~~~~~~---------------~~-~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          301 LVIYWIWCADLPITKDAALGGSEWI---------------FR-S-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHHSSCCC------CCSGGG---------------GS-S-----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHHCCCCCcccccccchhhh---------------hh-h-----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            9999999999999754332211110               00 0     0123456999999999999999999999986


Q ss_pred             --Hhccc
Q 046595          347 --ALQPL  351 (363)
Q Consensus       347 --~l~~l  351 (363)
                        .++.+
T Consensus       360 hp~f~~~  366 (377)
T 3byv_A          360 TPEYEQL  366 (377)
T ss_dssp             SHHHHHH
T ss_pred             ChHHHHH
Confidence              44443

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3e-45  Score=329.34  Aligned_cols=251  Identities=25%  Similarity=0.400  Sum_probs=200.6

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|.+...   .....+.+|+.+++.++||||+++++++......++||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE---SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT---SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch---HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            3468999999999999999999865 5899999998763   23567899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+++|.+++....        ..+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++
T Consensus       104 e~~~~~~L~~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~  172 (314)
T 3com_A          104 EYCGAGSVSDIIRLRN--------KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA  172 (314)
T ss_dssp             ECCTTEEHHHHHHHHT--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             ecCCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccc
Confidence            9999999999996322        1389999999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      ........  ......|++.|+|||++.+..++.++||||||+++|+|++|..||.............            
T Consensus       173 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------------  238 (314)
T 3com_A          173 GQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP------------  238 (314)
T ss_dssp             EECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------------
T ss_pred             hhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh------------
Confidence            65543322  1234578999999999999899999999999999999999999997543221111000            


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ..  .......+...+..+.+++.+||+.||.+|||+.++++
T Consensus       239 ~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          239 TN--PPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HS--CCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cC--CCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            00  00001112334567999999999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.1e-45  Score=345.01  Aligned_cols=268  Identities=23%  Similarity=0.286  Sum_probs=197.5

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeC------Cee
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMES------NNR  140 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~  140 (363)
                      .+|++.+.||+|+||.||+|++. +++.||||++.....     ...+|+.+++.++||||+++++++...      ...
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            47999999999999999999875 689999999865322     234799999999999999999988542      236


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCC-CceEEe
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD-FKSKIA  219 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~  219 (363)
                      ++||||+.+ +|.+++......     ...+++..++.++.|++.||.|||++   +|+||||||+|||++.+ +.+||+
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~  199 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRA-----KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLC  199 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEEC
T ss_pred             Eeehhcccc-cHHHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEec
Confidence            799999987 677666432110     12389999999999999999999999   99999999999999954 678999


Q ss_pred             eeccCCCCCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 046595          220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL  298 (363)
Q Consensus       220 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  298 (363)
                      |||+++.......   .....||+.|+|||++.+. .++.++|||||||+||||++|+.||......++...+.......
T Consensus       200 DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p  276 (420)
T 1j1b_A          200 DFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP  276 (420)
T ss_dssp             CCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred             cchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999976543222   2346789999999998765 79999999999999999999999998654322221111100000


Q ss_pred             cccccc-------cccCCcCCC-----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhcccc
Q 046595          299 SEDKVK-------QCVDPKLNN-----DYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPLL  352 (363)
Q Consensus       299 ~~~~~~-------~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l~  352 (363)
                      ..+.+.       ....+.+..     .++...+.++.+||.+||+.||.+|||+.++++  .++.+.
T Consensus       277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~  344 (420)
T 1j1b_A          277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  344 (420)
T ss_dssp             CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence            001110       000000000     112334577999999999999999999999986  555543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4e-46  Score=333.21  Aligned_cols=270  Identities=22%  Similarity=0.306  Sum_probs=187.9

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ..++|++.+.||+|+||.||+|... +++.||||++...........+.+|+.+++.++||||+++++++...+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            3468999999999999999999754 689999999876544455567889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+++|.+++....... ......+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||++
T Consensus        93 e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKG-EHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTT-TTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             hhccCCchHHHHHHHhhcc-ccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            9999999999987421110 01112489999999999999999999999   9999999999999999999999999987


Q ss_pred             CCCCcccc---cccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccc
Q 046595          225 NQSSDTAA---RLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE  300 (363)
Q Consensus       225 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  300 (363)
                      ........   ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||..............   ....
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~~~  245 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ---NDPP  245 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT---SSCC
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc---cCCC
Confidence            65432211   111234579999999999876 5789999999999999999999999976543221111000   0000


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          301 DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .......+..    ....++..+.+++.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          246 SLETGVQDKE----MLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CTTC-----C----CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccccccccch----hhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            0000001111    12234456999999999999999999999987

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.2e-45  Score=332.00  Aligned_cols=254  Identities=21%  Similarity=0.344  Sum_probs=198.9

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCC--CCccceeeeEEEeCCeeEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLK--HEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~l  142 (363)
                      ..++|++.+.||+|+||.||++...+++.||+|++...... .....+.+|+.+++.++  |+||+++++++......++
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            34679999999999999999999888999999999764322 23467889999999997  5999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ||| +.+++|.+++....         .+++..++.++.|++.||.|||++   +|+||||||+||++++ +.+||+|||
T Consensus       106 v~e-~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg  171 (313)
T 3cek_A          106 VME-CGNIDLNSWLKKKK---------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFG  171 (313)
T ss_dssp             EEC-CCSEEHHHHHHHCS---------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred             EEe-cCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecc
Confidence            999 55779999997654         288999999999999999999999   9999999999999964 899999999


Q ss_pred             cCCCCCcccccccccccccccCCCCcccccc-----------CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchh
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-----------GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLV  291 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~  291 (363)
                      ++................||+.|+|||++.+           ..++.++||||||+++|+|++|..||........    
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~----  247 (313)
T 3cek_A          172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----  247 (313)
T ss_dssp             SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH----
T ss_pred             ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH----
Confidence            9976654433322345579999999999875           4788899999999999999999999965422110    


Q ss_pred             hhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          292 TWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                                .+....+......++...+..+.+++.+||+.||.+||++.++++.
T Consensus       248 ----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          248 ----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             ----------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ----------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence                      1111122222223333345679999999999999999999999873

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.2e-46  Score=337.50  Aligned_cols=264  Identities=23%  Similarity=0.338  Sum_probs=200.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      .++|++.+.||+|+||.||+|.+.+  .+++|++..... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  109 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS  109 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence            4689999999999999999998753  599999876433 2334567889999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+++|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+||+++ ++.+||+|||++.
T Consensus       110 ~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~  177 (319)
T 2y4i_B          110 LCKGRTLYSVVRDAKI--------VLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFS  177 (319)
T ss_dssp             CCCSEEHHHHTTSSCC--------CCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred             cccCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcc
Confidence            9999999999976431        388999999999999999999999   999999999999998 6799999999986


Q ss_pred             CCCcccc---cccccccccccCCCCcccccc---------CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhh
Q 046595          226 QSSDTAA---RLHSTRVLGTFGYHAPEYAMT---------GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTW  293 (363)
Q Consensus       226 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~  293 (363)
                      .......   ........|++.|+|||++.+         ..++.++||||||+++|+|++|+.||............  
T Consensus       178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--  255 (319)
T 2y4i_B          178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM--  255 (319)
T ss_dssp             ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH--
T ss_pred             ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh--
Confidence            5432211   111233468999999999874         35789999999999999999999999754322111000  


Q ss_pred             ccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCCCC
Q 046595          294 ATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGP  359 (363)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~~~  359 (363)
                                ........   ....++..+.+++.+||+.||.+|||+.+|++.|+.+.++....+
T Consensus       256 ----------~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~  308 (319)
T 2y4i_B          256 ----------GTGMKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLS  308 (319)
T ss_dssp             ----------HTTCCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--------
T ss_pred             ----------ccCCCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCC
Confidence                      00000000   011234459999999999999999999999999999988765543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.6e-45  Score=335.09  Aligned_cols=262  Identities=20%  Similarity=0.241  Sum_probs=194.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeCC------
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESN------  138 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------  138 (363)
                      .++|++.+.||+|+||.||+|... +++.||||++...... .....+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            468999999999999999999754 6889999998764322 22357889999999999999999999987665      


Q ss_pred             eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEE
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI  218 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl  218 (363)
                      ..++||||+.+ +|.+++...           +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl  168 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKI  168 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHSC-----------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred             ceEEEEEcCCC-CHHHHHhhc-----------cCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEE
Confidence            67999999986 788888632           88999999999999999999999   9999999999999999999999


Q ss_pred             eeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc---
Q 046595          219 ADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT---  295 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~---  295 (363)
                      +|||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+....   
T Consensus       169 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~  245 (371)
T 2xrw_A          169 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP  245 (371)
T ss_dssp             CCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCC
T ss_pred             EEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999987654322   1234679999999999999999999999999999999999999997654322111110000   


Q ss_pred             -------------------ccccccccccccCCcCCC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          296 -------------------PRLSEDKVKQCVDPKLNN---DYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       296 -------------------~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                                         +.................   ......+..+.+|+.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                               000000000000000000   011234678999999999999999999999987

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.7e-44  Score=325.44  Aligned_cols=263  Identities=16%  Similarity=0.260  Sum_probs=203.2

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-CCccceeeeEEEe--CCeeEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVELLGYCME--SNNRILV  143 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv  143 (363)
                      ++|++.+.||+|+||.||+|.. .+++.||+|++..    .....+.+|+.+++.++ ||||+++++++..  ....++|
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            5799999999999999999975 5789999999864    33568899999999997 9999999999988  6678999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC-ceEEeeec
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF-KSKIADFN  222 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Dfg  222 (363)
                      |||+.+++|.+++..            +++..+..++.|++.||.|||++   +|+||||||+|||++.++ .+||+|||
T Consensus       112 ~e~~~~~~l~~~~~~------------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg  176 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT------------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWG  176 (330)
T ss_dssp             EECCCCCCHHHHGGG------------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             EeccCchhHHHHHHh------------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCC
Confidence            999999999999853            88999999999999999999999   999999999999999776 89999999


Q ss_pred             cCCCCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchh----------
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLV----------  291 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~----------  291 (363)
                      ++........   .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||............          
T Consensus       177 ~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~  253 (330)
T 3nsz_A          177 LAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL  253 (330)
T ss_dssp             TCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred             CceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchh
Confidence            9875543322   234578999999999887 67999999999999999999999999543322110000          


Q ss_pred             -hhcccc-c-ccccc--------ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhcccc
Q 046595          292 -TWATPR-L-SEDKV--------KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPLL  352 (363)
Q Consensus       292 -~~~~~~-~-~~~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l~  352 (363)
                       .+.... . .....        ...............++..+.+||.+||+.||.+|||++++++  .++.+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          254 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             HHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             hhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence             000000 0 00000        0000001111112235677999999999999999999999998  455444

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.5e-46  Score=342.12  Aligned_cols=262  Identities=24%  Similarity=0.349  Sum_probs=185.4

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeC------
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMES------  137 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------  137 (363)
                      +.++|++.+.||+|+||.||+|.+ .+|+.||||++...... .....+.+|+.+++.++||||+++++++...      
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            346899999999999999999975 46899999998764322 2346788999999999999999999998654      


Q ss_pred             CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceE
Q 046595          138 NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSK  217 (363)
Q Consensus       138 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk  217 (363)
                      ...++|++++ +++|.+++....          +++..+..++.|++.||.|||++   ||+||||||+|||++.++.+|
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~k  172 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK  172 (367)
T ss_dssp             CCCEEEEECC-CEECC-----CC----------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred             CeEEEEeccc-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEE
Confidence            5679999998 679999887532          89999999999999999999999   999999999999999999999


Q ss_pred             EeeeccCCCCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccc
Q 046595          218 IADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATP  296 (363)
Q Consensus       218 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~  296 (363)
                      |+|||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.....
T Consensus       173 L~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g  247 (367)
T 2fst_X          173 ILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG  247 (367)
T ss_dssp             ECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             Eeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            9999998764432     234679999999999887 6799999999999999999999999976543322221111100


Q ss_pred             cc--------cccccccccCC---cCCCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          297 RL--------SEDKVKQCVDP---KLNNDY---PPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       297 ~~--------~~~~~~~~~~~---~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ..        ........+..   .....+   ....+..+.+|+.+||+.||.+|||+.++++
T Consensus       248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            00        00000000000   000000   0123567899999999999999999999987

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-45  Score=339.26  Aligned_cols=272  Identities=20%  Similarity=0.275  Sum_probs=200.3

Q ss_pred             HHHhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeC-----
Q 046595           64 NRLTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMES-----  137 (363)
Q Consensus        64 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----  137 (363)
                      ....++|++.+.||+|+||.||+|.+ .+++.||||++......     ..+|+.+++.++||||+++++++...     
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            34567899999999999999999975 57999999998654322     23799999999999999999998543     


Q ss_pred             ---------------------------------CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHH
Q 046595          138 ---------------------------------NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA  184 (363)
Q Consensus       138 ---------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~  184 (363)
                                                       ...++||||+.+ +|.+.+......     ...+++..+..++.|++
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~  151 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRS-----GRSIPMNLISIYIYQLF  151 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHT-----TCCCCHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhc-----CCCCCHHHHHHHHHHHH
Confidence                                             347899999985 887777542110     11389999999999999


Q ss_pred             HHHHHhhccCCCCeEEecccCCceeec-CCCceEEeeeccCCCCCcccccccccccccccCCCCccccccC-CCCccCce
Q 046595          185 KGLEFLHEKVQPPIVHRDVRSSNVLLF-DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDV  262 (363)
Q Consensus       185 ~~l~~lH~~~~~~ivH~Dlkp~Nill~-~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv  262 (363)
                      .||.|||++   ||+||||||+||+++ .++.+||+|||++........   .....||+.|+|||++.+. .++.++||
T Consensus       152 ~aL~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di  225 (383)
T 3eb0_A          152 RAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDL  225 (383)
T ss_dssp             HHHHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHH
T ss_pred             HHHHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhh
Confidence            999999999   999999999999998 689999999999875543322   2345789999999998875 58999999


Q ss_pred             ehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccc------------ccccccCCcCCCCCCHHHHHHHHHHHHhc
Q 046595          263 YSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED------------KVKQCVDPKLNNDYPPKAIAKLAAVAALC  330 (363)
Q Consensus       263 wslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~l~~li~~c  330 (363)
                      |||||++|||++|+.||......+....+..........            .............++...+..+.+|+.+|
T Consensus       226 wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  305 (383)
T 3eb0_A          226 WSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQI  305 (383)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHH
T ss_pred             hhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHH
Confidence            999999999999999998654332221111100000000            00000011111112334566799999999


Q ss_pred             cCCCCCCCCCHHHHHH--Hhcccc
Q 046595          331 VQYEADFRPNMTIVVK--ALQPLL  352 (363)
Q Consensus       331 l~~~p~~RPs~~~vl~--~l~~l~  352 (363)
                      |+.||.+|||+.++++  .++.+.
T Consensus       306 L~~dP~~R~t~~e~l~hp~f~~~~  329 (383)
T 3eb0_A          306 LRYEPDLRINPYEAMAHPFFDHLR  329 (383)
T ss_dssp             CCSSGGGSCCHHHHHTSGGGHHHH
T ss_pred             ccCChhhCCCHHHHhcCHHHHHHH
Confidence            9999999999999985  444443

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=5.9e-45  Score=324.45  Aligned_cols=252  Identities=23%  Similarity=0.346  Sum_probs=198.9

Q ss_pred             CCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           69 NFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      +|....+||+|+||.||+|.+ .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++......++||||+
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            345556899999999999986 468899999987643 344567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC-CCceEEeeeccCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD-DFKSKIADFNLTNQ  226 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~a~~  226 (363)
                      .+++|.+++......      ..+++..+..++.|++.||.|||++   +|+|+||||+||+++. ++.+||+|||++..
T Consensus       102 ~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~  172 (295)
T 2clq_A          102 PGGSLSALLRSKWGP------LKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKR  172 (295)
T ss_dssp             SEEEHHHHHHHTTCC------CTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred             CCCCHHHHHHhhccC------CCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccc
Confidence            999999999764311      1367899999999999999999999   9999999999999987 89999999999865


Q ss_pred             CCcccccccccccccccCCCCccccccCC--CCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQ--ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      ......  ......|++.|+|||++.+..  ++.++||||||+++|+|++|+.||.......... ..            
T Consensus       173 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~------------  237 (295)
T 2clq_A          173 LAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM-FK------------  237 (295)
T ss_dssp             SCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH-HH------------
T ss_pred             cCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH-Hh------------
Confidence            543221  123457899999999987653  8899999999999999999999996432211100 00            


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                       ..........+..++..+.+++.+||+.||++||++.++++
T Consensus       238 -~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          238 -VGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             -HHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             -hccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             00001112334455677999999999999999999999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.6e-45  Score=342.87  Aligned_cols=202  Identities=27%  Similarity=0.391  Sum_probs=167.9

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeC-----C
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMES-----N  138 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~  138 (363)
                      +.++|.+.+.||+|+||.||+|.+. +++.||||++...... .....+.+|+.+++.++||||+++++++...     .
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            3468999999999999999999765 5888999999764322 2236788999999999999999999998776     5


Q ss_pred             eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEE
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI  218 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl  218 (363)
                      ..++||||+.+ +|.+++....         .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||
T Consensus       104 ~~~lv~e~~~~-~L~~~~~~~~---------~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL  170 (432)
T 3n9x_A          104 ELYIVLEIADS-DLKKLFKTPI---------FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKV  170 (432)
T ss_dssp             CEEEEEECCSE-EHHHHHHSSC---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEE
T ss_pred             eEEEEEecCCc-CHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEE
Confidence            68999999875 9999997653         389999999999999999999999   9999999999999999999999


Q ss_pred             eeeccCCCCCccccc--------------------ccccccccccCCCCcccc-ccCCCCccCceehhHHHHHHHHhCCC
Q 046595          219 ADFNLTNQSSDTAAR--------------------LHSTRVLGTFGYHAPEYA-MTGQITQKSDVYSFGVVLLELLTGRK  277 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~~l~ell~g~~  277 (363)
                      +|||+++........                    ......+||+.|+|||++ .+..++.++|||||||++|||++|..
T Consensus       171 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~  250 (432)
T 3n9x_A          171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ  250 (432)
T ss_dssp             CCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred             ccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence            999999765433211                    113456899999999986 55679999999999999999998666


Q ss_pred             CCC
Q 046595          278 PVD  280 (363)
Q Consensus       278 p~~  280 (363)
                      ||.
T Consensus       251 p~~  253 (432)
T 3n9x_A          251 SHI  253 (432)
T ss_dssp             TTC
T ss_pred             ccc
Confidence            554

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.7e-45  Score=332.25  Aligned_cols=254  Identities=22%  Similarity=0.305  Sum_probs=196.7

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC-------CCchHHHHHHHHHHhcCCCCccceeeeEEEe
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA-------PEPESDFAAQLSVVSRLKHEHFVELLGYCME  136 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  136 (363)
                      .+.++|.+.+.||+|+||.||+|.+. +++.||||++.....       ......+.+|+.+++.++||||+++++++..
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   86 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA   86 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence            35568999999999999999999765 588999999875321       1223457899999999999999999999876


Q ss_pred             CCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCc-
Q 046595          137 SNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK-  215 (363)
Q Consensus       137 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~-  215 (363)
                      .. .++||||+.+++|.+++....         .+++..++.++.|++.||.|||++   +|+||||||+||+++.++. 
T Consensus        87 ~~-~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~  153 (322)
T 2ycf_A           87 ED-YYIVLELMEGGELFDKVVGNK---------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEED  153 (322)
T ss_dssp             SS-EEEEEECCTTEETHHHHSTTC---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSS
T ss_pred             Cc-eEEEEecCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCC
Confidence            54 899999999999999987543         389999999999999999999999   9999999999999987654 


Q ss_pred             --eEEeeeccCCCCCcccccccccccccccCCCCccccc---cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccch
Q 046595          216 --SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM---TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSL  290 (363)
Q Consensus       216 --vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~  290 (363)
                        +||+|||++........   .....||+.|+|||++.   +..++.++||||||+++|+|++|..||.........  
T Consensus       154 ~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--  228 (322)
T 2ycf_A          154 CLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--  228 (322)
T ss_dssp             CCEEECCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--
T ss_pred             CeEEEccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--
Confidence              99999999876543221   23457999999999874   467899999999999999999999999754332111  


Q ss_pred             hhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          291 VTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .....    ....      .........++..+.+++.+||+.||.+||++.++++
T Consensus       229 ~~~~~----~~~~------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          229 KDQIT----SGKY------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHHH----HTCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHH----hCcc------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            00000    0000      0000001123567999999999999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.2e-45  Score=345.60  Aligned_cols=274  Identities=19%  Similarity=0.247  Sum_probs=202.5

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcC------CCCccceeeeEEEeCC
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL------KHEHFVELLGYCMESN  138 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~  138 (363)
                      +..+|++.+.||+|+||.||+|... +++.||||++...  ......+.+|+.+++.+      +|+||+++++++....
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            4568999999999999999999765 5889999998652  22235677788877776      5789999999999999


Q ss_pred             eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCc--e
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK--S  216 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~--v  216 (363)
                      ..++||||+. ++|.+++......       .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.  +
T Consensus       173 ~~~lv~e~~~-~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~v  241 (429)
T 3kvw_A          173 HICMTFELLS-MNLYELIKKNKFQ-------GFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGI  241 (429)
T ss_dssp             EEEEEECCCC-CBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCE
T ss_pred             eEEEEEeccC-CCHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcce
Confidence            9999999997 4999999765422       289999999999999999999999   9999999999999999887  9


Q ss_pred             EEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccc
Q 046595          217 KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATP  296 (363)
Q Consensus       217 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~  296 (363)
                      ||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|..||......+....+.....
T Consensus       242 kL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~  316 (429)
T 3kvw_A          242 KVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG  316 (429)
T ss_dssp             EECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             EEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence            99999998644322     2345789999999999999999999999999999999999999976543322111100000


Q ss_pred             ccccc------cccccc--------------------------------CCcCCCC----CCHHHHHHHHHHHHhccCCC
Q 046595          297 RLSED------KVKQCV--------------------------------DPKLNND----YPPKAIAKLAAVAALCVQYE  334 (363)
Q Consensus       297 ~~~~~------~~~~~~--------------------------------~~~~~~~----~~~~~~~~l~~li~~cl~~~  334 (363)
                      .....      .....+                                .......    +....+..+.+||.+||+.|
T Consensus       317 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~d  396 (429)
T 3kvw_A          317 MPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWD  396 (429)
T ss_dssp             CCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSS
T ss_pred             CCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCC
Confidence            00000      000000                                0000000    01112467899999999999


Q ss_pred             CCCCCCHHHHHH--HhccccccCCC
Q 046595          335 ADFRPNMTIVVK--ALQPLLNSKPA  357 (363)
Q Consensus       335 p~~RPs~~~vl~--~l~~l~~~~~~  357 (363)
                      |++|||+.++++  .|+......+.
T Consensus       397 P~~Rpta~e~L~Hpw~~~~~~~~~~  421 (429)
T 3kvw_A          397 PAVRMTPGQALRHPWLRRRLPKPPT  421 (429)
T ss_dssp             TTTSCCHHHHHTSTTTC--------
T ss_pred             hhhCCCHHHHhCChhhccCCCCCCc
Confidence            999999999998  55555444433

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4e-45  Score=338.51  Aligned_cols=270  Identities=20%  Similarity=0.254  Sum_probs=198.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCe------e
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNN------R  140 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~  140 (363)
                      ..+|++.+.||+|+||.||+|++.++..+|+|++......     ..+|+.+++.++||||+++++++.....      .
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            4579999999999999999999877777999988653322     2369999999999999999999865443      7


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec-CCCceEEe
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF-DDFKSKIA  219 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~-~~~~vkl~  219 (363)
                      ++||||+.+ +|...+......     ...+++..+..++.|++.||.|||++   +|+||||||+|||++ .++.+||+
T Consensus       114 ~lv~e~~~~-~l~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~  184 (394)
T 4e7w_A          114 NLVLEYVPE-TVYRASRHYAKL-----KQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLI  184 (394)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEEC
T ss_pred             EEEeeccCc-cHHHHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEe
Confidence            899999987 444443321100     01389999999999999999999999   999999999999999 79999999


Q ss_pred             eeccCCCCCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 046595          220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL  298 (363)
Q Consensus       220 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  298 (363)
                      |||+++.......   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+.......
T Consensus       185 DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p  261 (394)
T 4e7w_A          185 DFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP  261 (394)
T ss_dssp             CCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             eCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999876543322   2345789999999998765 58999999999999999999999998654332221111000000


Q ss_pred             cc------------cccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhccccc
Q 046595          299 SE------------DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPLLN  353 (363)
Q Consensus       299 ~~------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l~~  353 (363)
                      ..            ..............++...+.++.+|+.+||+.||.+|||+.++++  .++.+..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence            00            0000000000001112235567999999999999999999999997  3555543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.1e-45  Score=334.00  Aligned_cols=271  Identities=16%  Similarity=0.211  Sum_probs=204.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCc----------------hHHHHHHHHHHhcCCCCcccee
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEP----------------ESDFAAQLSVVSRLKHEHFVEL  130 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~----------------~~~~~~e~~~l~~l~h~~i~~~  130 (363)
                      .++|++.+.||+|+||.||+|.. +++.||+|++........                ...+.+|+.+++.++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999988 899999999865322111                1789999999999999999999


Q ss_pred             eeEEEeCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-cCCCCeEEecccCCcee
Q 046595          131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE-KVQPPIVHRDVRSSNVL  209 (363)
Q Consensus       131 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nil  209 (363)
                      ++++.+.+..++||||+.+++|.+++........ .....+++..++.++.|++.||.|||+ +   ||+|+||||+||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence            9999999999999999999999999332110000 001249999999999999999999999 8   9999999999999


Q ss_pred             ecCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccC-CCCc-cCceehhHHHHHHHHhCCCCCCCCCCcc-
Q 046595          210 LFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQ-KSDVYSFGVVLLELLTGRKPVDHTMPKG-  286 (363)
Q Consensus       210 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~~l~ell~g~~p~~~~~~~~-  286 (363)
                      ++.++.+||+|||++......    ......|++.|+|||++.+. .++. ++||||||+++|+|++|..||....... 
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            999999999999998755333    23446799999999999877 6766 9999999999999999999997654311 


Q ss_pred             ccchhhhcccccccc--ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          287 QQSLVTWATPRLSED--KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       287 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ....+..........  .................++..+.+++.+||+.||.+|||+.++++
T Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111000000000000  000000000001111345677999999999999999999999987

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.9e-45  Score=328.79  Aligned_cols=253  Identities=23%  Similarity=0.355  Sum_probs=199.2

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ..++|++.+.||+|+||.||+|.+. +++.|++|++... .......+.+|+.+++.++||||+++++++......++||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC-CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            3568999999999999999999875 5889999998764 3345678999999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+++|.+++.....        .+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++
T Consensus        96 e~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  164 (302)
T 2j7t_A           96 EFCPGGAVDAIMLELDR--------GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS  164 (302)
T ss_dssp             ECCTTEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred             EeCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCC
Confidence            99999999999865321        289999999999999999999999   9999999999999999999999999986


Q ss_pred             CCCCcccccccccccccccCCCCccccc-----cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAM-----TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      .......  .......||+.|+|||++.     +..++.++||||||+++|+|++|..||..........  .....   
T Consensus       165 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~---  237 (302)
T 2j7t_A          165 AKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL--KIAKS---  237 (302)
T ss_dssp             HHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HHHHS---
T ss_pred             ccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH--HHhcc---
Confidence            4321111  1123457899999999883     5678999999999999999999999997543221110  00000   


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                               .......+..++..+.+++.+||+.||.+|||+.++++
T Consensus       238 ---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          238 ---------DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             ---------CCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ---------CCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                     00001112344567999999999999999999999986

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.7e-45  Score=339.56  Aligned_cols=275  Identities=19%  Similarity=0.283  Sum_probs=186.0

Q ss_pred             HHhcCCCC-CCeeeccCCceEEEEEeC---CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEe--CC
Q 046595           65 RLTSNFGT-KALIGEGSYGRVFYAKLT---DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCME--SN  138 (363)
Q Consensus        65 ~~~~~y~~-~~~lg~G~~g~V~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~  138 (363)
                      .+.+.|.+ +++||+|+||.||+|++.   +++.||+|++...   .....+.+|+.+++.++||||+++++++..  ..
T Consensus        17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (405)
T 3rgf_A           17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVISLQKVFLSHADR   93 (405)
T ss_dssp             CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS---SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred             hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC---CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence            34456776 558999999999999865   5789999999753   223578899999999999999999999965  67


Q ss_pred             eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceee----cCCC
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL----FDDF  214 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill----~~~~  214 (363)
                      ..++||||+.+ +|.+++..............+++..++.++.||+.||.|||++   +|+||||||+|||+    +.++
T Consensus        94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~  169 (405)
T 3rgf_A           94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERG  169 (405)
T ss_dssp             EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTT
T ss_pred             eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCC
Confidence            88999999976 8888886432111111122389999999999999999999999   99999999999999    6789


Q ss_pred             ceEEeeeccCCCCCccccc-ccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccc-----
Q 046595          215 KSKIADFNLTNQSSDTAAR-LHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQ-----  287 (363)
Q Consensus       215 ~vkl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~-----  287 (363)
                      .+||+|||++......... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||........     
T Consensus       170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  249 (405)
T 3rgf_A          170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY  249 (405)
T ss_dssp             CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred             cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence            9999999999765433221 223446799999999999874 589999999999999999999999975433210     


Q ss_pred             --cchhhhc--ccccccc---cc---------ccccCCcCCCCCC---------HHHHHHHHHHHHhccCCCCCCCCCHH
Q 046595          288 --QSLVTWA--TPRLSED---KV---------KQCVDPKLNNDYP---------PKAIAKLAAVAALCVQYEADFRPNMT  342 (363)
Q Consensus       288 --~~~~~~~--~~~~~~~---~~---------~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~RPs~~  342 (363)
                        ..+....  .......   .+         ...+.........         ...+..+.+||.+||+.||.+|||+.
T Consensus       250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~  329 (405)
T 3rgf_A          250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE  329 (405)
T ss_dssp             CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred             hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence              0000000  0000000   00         0000000000000         01145688999999999999999999


Q ss_pred             HHHH
Q 046595          343 IVVK  346 (363)
Q Consensus       343 ~vl~  346 (363)
                      ++++
T Consensus       330 e~L~  333 (405)
T 3rgf_A          330 QAMQ  333 (405)
T ss_dssp             HHHT
T ss_pred             HHhc
Confidence            9998

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.1e-45  Score=328.61  Aligned_cols=273  Identities=21%  Similarity=0.305  Sum_probs=205.6

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEe--CCCCeEEEEEccCCCCC-CchHHHHHHHHHHhcC---CCCccceeeeEEE---
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKL--TDGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRL---KHEHFVELLGYCM---  135 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~---  135 (363)
                      ...++|++.+.||+|+||.||+|++  .+++.||+|++...... .....+.+|+.+++.+   +||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            3457899999999999999999987  36788999998654322 2234566787777766   8999999999987   


Q ss_pred             --eCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCC
Q 046595          136 --ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD  213 (363)
Q Consensus       136 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~  213 (363)
                        .....++||||+. |+|.+++......       .+++..++.++.|++.||.|||++   ||+|+||||+||+++.+
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~  156 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEP-------GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSS  156 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTT-------CSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCC
Confidence              5567899999998 4999999765321       289999999999999999999999   99999999999999999


Q ss_pred             CceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhh
Q 046595          214 FKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTW  293 (363)
Q Consensus       214 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~  293 (363)
                      +.+||+|||++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+..
T Consensus       157 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~  233 (326)
T 1blx_A          157 GQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD  233 (326)
T ss_dssp             CCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             CCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            999999999987654332   13446789999999999999999999999999999999999999976543221111100


Q ss_pred             cccccccccc----------ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhccc
Q 046595          294 ATPRLSEDKV----------KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPL  351 (363)
Q Consensus       294 ~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l  351 (363)
                      ..........          ...........+...++..+.+++.+||+.||.+|||+.++++  .++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  303 (326)
T 1blx_A          234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  303 (326)
T ss_dssp             HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence            0000000000          0000000011122345667999999999999999999999995  44443

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=9.8e-45  Score=332.24  Aligned_cols=277  Identities=18%  Similarity=0.237  Sum_probs=193.8

Q ss_pred             HHHHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCe--
Q 046595           63 LNRLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNN--  139 (363)
Q Consensus        63 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--  139 (363)
                      .....++|++.+.||+|+||.||+|++. +++.||||++....  ........++..+..++||||+++++++.....  
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT--TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc--cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            4455678999999999999999999864 68999999986532  233466778888888999999999999876443  


Q ss_pred             -----eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh--ccCCCCeEEecccCCceeecC
Q 046595          140 -----RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH--EKVQPPIVHRDVRSSNVLLFD  212 (363)
Q Consensus       140 -----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~~~~ivH~Dlkp~Nill~~  212 (363)
                           .++||||+.+ +|...+.....     ....+++..+..++.|++.||.|||  ++   +|+||||||+|||++.
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~  166 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPD-TLHRCCRNYYR-----RQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNE  166 (360)
T ss_dssp             TTCEEEEEEEECCSC-BHHHHHHHHHT-----TTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEET
T ss_pred             ccceeEEEEeecccc-cHHHHHHHHhh-----cccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeC
Confidence                 7899999987 55554432110     0113889999999999999999999  88   9999999999999996


Q ss_pred             -CCceEEeeeccCCCCCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccch
Q 046595          213 -DFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSL  290 (363)
Q Consensus       213 -~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~  290 (363)
                       ++.+||+|||++........   .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........
T Consensus       167 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~  243 (360)
T 3e3p_A          167 ADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHE  243 (360)
T ss_dssp             TTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHH
Confidence             89999999999976554322   2345789999999998765 489999999999999999999999976543322111


Q ss_pred             hhhccccccccccc---------cccC------CcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhccccc
Q 046595          291 VTWATPRLSEDKVK---------QCVD------PKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPLLN  353 (363)
Q Consensus       291 ~~~~~~~~~~~~~~---------~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l~~  353 (363)
                      +...........+.         ....      ...........+..+.+|+.+||+.||.+|||+.++++  .++.+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD  323 (360)
T ss_dssp             HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred             HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence            11000000000000         0000      00011122235678999999999999999999999997  4555544

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.4e-45  Score=339.28  Aligned_cols=253  Identities=10%  Similarity=0.046  Sum_probs=182.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC--chHHHHHHH---HHHhcCCCCccceee-------eEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE--PESDFAAQL---SVVSRLKHEHFVELL-------GYC  134 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~--~~~~~~~e~---~~l~~l~h~~i~~~~-------~~~  134 (363)
                      .+|.+.+.||+|+||.||+|.+. +++.||||++.......  ....+.+|+   .+++. +||||++++       +++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence            35889999999999999999865 78999999998754322  235667775   45555 799988755       444


Q ss_pred             EeC-----------------CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHH------HHHHHHHHHHHHHhh
Q 046595          135 MES-----------------NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQR------VKVAYGAAKGLEFLH  191 (363)
Q Consensus       135 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~------~~i~~~i~~~l~~lH  191 (363)
                      ...                 ...++||||+. |+|.+++.....        .+.+..+      +.++.|++.||.|||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--------~~~~~~~~~~~vk~~i~~qi~~aL~~LH  211 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--------VYVFRGDEGILALHILTAQLIRLAANLQ  211 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--------SCCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--------ccchhhhhhhhhHHHHHHHHHHHHHHHH
Confidence            433                 33799999999 799999986421        1444445      677899999999999


Q ss_pred             ccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCcccccccccccccccCCCCcccccc--CCCCccCceehhHHHH
Q 046595          192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT--GQITQKSDVYSFGVVL  269 (363)
Q Consensus       192 ~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l  269 (363)
                      ++   +|+||||||+|||++.++.+||+|||++.......     ....||+.|+|||++.+  ..++.++|||||||++
T Consensus       212 ~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il  283 (371)
T 3q60_A          212 SK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSI  283 (371)
T ss_dssp             HT---TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHH
T ss_pred             HC---CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHH
Confidence            99   99999999999999999999999999987554321     13467799999999987  6799999999999999


Q ss_pred             HHHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          270 LELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       270 ~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      |||++|+.||....+.......        ...................++..+.+|+.+||+.||++|||+.++++
T Consensus       284 ~elltg~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          284 YRVWCLFLPFGLVTPGIKGSWK--------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             HHHHHSSCSTTBCCTTCTTCCC--------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             HHHHhCCCCCCCcCcccccchh--------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            9999999999765432211110        00000111111111112345677999999999999999999999975

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=6e-45  Score=330.54  Aligned_cols=268  Identities=19%  Similarity=0.300  Sum_probs=206.1

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEe--CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCC------ccceeeeEEEeC
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKL--TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE------HFVELLGYCMES  137 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~  137 (363)
                      +.++|++.+.||+|+||.||+|..  .+++.||+|++...  ......+.+|+.+++.++|+      +|+++++++...
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~   89 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH   89 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence            456899999999999999999975  36889999998642  22346788899999888655      499999999999


Q ss_pred             CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC-----
Q 046595          138 NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD-----  212 (363)
Q Consensus       138 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-----  212 (363)
                      ...++||||+ +++|.+++.....       ..+++..++.++.|++.||.|||++   +|+||||||+|||++.     
T Consensus        90 ~~~~lv~e~~-~~~l~~~l~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~  158 (339)
T 1z57_A           90 GHICIVFELL-GLSTYDFIKENGF-------LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTE  158 (339)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTT-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEE
T ss_pred             CcEEEEEcCC-CCCHHHHHHhcCC-------CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEecccccc
Confidence            9999999999 7899999976542       1388999999999999999999999   9999999999999987     


Q ss_pred             --------------CCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCC
Q 046595          213 --------------DFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP  278 (363)
Q Consensus       213 --------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p  278 (363)
                                    ++.+||+|||++......     .....||+.|+|||++.+..++.++||||||+++|||++|..|
T Consensus       159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  233 (339)
T 1z57_A          159 AYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTV  233 (339)
T ss_dssp             EEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence                          678999999998654322     2345789999999999999999999999999999999999999


Q ss_pred             CCCCCCccccchhhhccccccccccc--------------------------cccCC-cCCCCCCHHHHHHHHHHHHhcc
Q 046595          279 VDHTMPKGQQSLVTWATPRLSEDKVK--------------------------QCVDP-KLNNDYPPKAIAKLAAVAALCV  331 (363)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~-~~~~~~~~~~~~~l~~li~~cl  331 (363)
                      |.........................                          ..... ..........+..+.+++.+||
T Consensus       234 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  313 (339)
T 1z57_A          234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML  313 (339)
T ss_dssp             CCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHh
Confidence            97654332211111100000000000                          00000 0001223466788999999999


Q ss_pred             CCCCCCCCCHHHHHH--Hhccc
Q 046595          332 QYEADFRPNMTIVVK--ALQPL  351 (363)
Q Consensus       332 ~~~p~~RPs~~~vl~--~l~~l  351 (363)
                      +.||.+|||+.++++  .++.+
T Consensus       314 ~~dP~~Rpt~~ell~hp~f~~~  335 (339)
T 1z57_A          314 EYDPAKRITLREALKHPFFDLL  335 (339)
T ss_dssp             CSSTTTSCCHHHHTTSGGGGGG
T ss_pred             CcCcccccCHHHHhcCHHHHHH
Confidence            999999999999986  35444

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.3e-45  Score=326.34  Aligned_cols=259  Identities=23%  Similarity=0.296  Sum_probs=189.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHH-HHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESD-FAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~-~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++........... +..+...++.++||||+++++++.+....++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            46899999999999999999986 4789999999976433333333 344455688889999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+ +|.+++......     ...+++..++.++.|++.||.|||++.  +|+||||||+||+++.++.+||+|||++
T Consensus        86 e~~~~-~l~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDK-----GQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGIS  157 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred             ehhcc-chHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCc
Confidence            99986 888877542110     123899999999999999999999853  7999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCcccc----ccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYA----MTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE  300 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  300 (363)
                      ........   .....||+.|+|||++    .+..++.++||||||+++|+|++|+.||.........            
T Consensus       158 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------------  222 (290)
T 3fme_A          158 GYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ------------  222 (290)
T ss_dssp             ---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH------------
T ss_pred             cccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH------------
Confidence            76544322   2334799999999996    4567899999999999999999999999743221110            


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhcc
Q 046595          301 DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQP  350 (363)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~  350 (363)
                        +...............++..+.+++.+||+.||++|||+.++++  .++.
T Consensus       223 --~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          223 --LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             --HHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             --HHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence              01111111111112234567999999999999999999999987  4443

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.1e-45  Score=335.82  Aligned_cols=272  Identities=22%  Similarity=0.335  Sum_probs=203.7

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeC-----Ce
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMES-----NN  139 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~  139 (363)
                      +.++|.+.+.||+|+||.||+|.+. +++.||||++...........+.+|+.+++.++||||+++++++...     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            4568999999999999999999865 68899999997543333446788999999999999999999987654     67


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEe
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA  219 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~  219 (363)
                      .++||||+.+ +|.+++....          +++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+
T Consensus        89 ~~lv~e~~~~-~L~~~~~~~~----------~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~  154 (353)
T 2b9h_A           89 VYIIQELMQT-DLHRVISTQM----------LSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVC  154 (353)
T ss_dssp             EEEEECCCSE-EHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEEC
T ss_pred             EEEEEeccCc-cHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEE
Confidence            8999999985 9999987643          89999999999999999999999   99999999999999999999999


Q ss_pred             eeccCCCCCcccccc--------cccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccch
Q 046595          220 DFNLTNQSSDTAARL--------HSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSL  290 (363)
Q Consensus       220 Dfg~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~  290 (363)
                      |||++..........        ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........
T Consensus       155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  234 (353)
T 2b9h_A          155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL  234 (353)
T ss_dssp             CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence            999987654322111        1223578999999998765 6789999999999999999999999976542211111


Q ss_pred             hhhcccccc---------ccccccccCCc--CC----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhccc
Q 046595          291 VTWATPRLS---------EDKVKQCVDPK--LN----NDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPL  351 (363)
Q Consensus       291 ~~~~~~~~~---------~~~~~~~~~~~--~~----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l  351 (363)
                      +........         .....+.....  ..    ......++..+.+++.+||+.||.+|||+.++++  .++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (353)
T 2b9h_A          235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY  312 (353)
T ss_dssp             HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence            100000000         00000000000  00    0001234567899999999999999999999998  45443

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.5e-44  Score=322.30  Aligned_cols=254  Identities=20%  Similarity=0.264  Sum_probs=204.0

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC--------chHHHHHHHHHHhcCC-CCccceeeeEE
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE--------PESDFAAQLSVVSRLK-HEHFVELLGYC  134 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~--------~~~~~~~e~~~l~~l~-h~~i~~~~~~~  134 (363)
                      .+.++|++.+.||+|+||.||+|.+. +++.||||++.......        ....+.+|+.+++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            45678999999999999999999865 68899999997643211        1346778999999995 99999999999


Q ss_pred             EeCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC
Q 046595          135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF  214 (363)
Q Consensus       135 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~  214 (363)
                      ......++||||+.+++|.+++....         .+++..++.++.|++.||.|||++   +++|+||||+||+++.++
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~  161 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEKV---------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDM  161 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCC
Confidence            99999999999999999999997643         289999999999999999999999   999999999999999999


Q ss_pred             ceEEeeeccCCCCCcccccccccccccccCCCCccccc------cCCCCccCceehhHHHHHHHHhCCCCCCCCCCcccc
Q 046595          215 KSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM------TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ  288 (363)
Q Consensus       215 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~  288 (363)
                      .+||+|||++........   .....|++.|+|||++.      ...++.++||||||+++|+|++|..||.........
T Consensus       162 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~  238 (298)
T 1phk_A          162 NIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML  238 (298)
T ss_dssp             CEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             cEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH
Confidence            999999999865543221   23457899999999885      456889999999999999999999999654321111


Q ss_pred             chhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          289 SLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ..+....             ..........++..+.+++.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          239 RMIMSGN-------------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHHTC-------------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHhcCC-------------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            1000000             00001111345667999999999999999999999986

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.5e-44  Score=319.36  Aligned_cols=258  Identities=23%  Similarity=0.330  Sum_probs=206.8

Q ss_pred             HHHHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC-CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCee
Q 046595           63 LNRLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS-APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNR  140 (363)
Q Consensus        63 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  140 (363)
                      ...+.++|++.+.||+|+||.||+|+.. +++.||+|++.... .......+.+|+.++++++||||+++++++......
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence            3456779999999999999999999865 68999999986543 234467899999999999999999999999999999


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCC---CceE
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD---FKSK  217 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~---~~vk  217 (363)
                      ++||||+.+++|.+++....         .+++..++.++.|++.||.|||++   +++|+||||+||+++.+   +.+|
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~k  164 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIKRK---------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIK  164 (287)
T ss_dssp             EEEECCCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             EEEEEccCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEE
Confidence            99999999999999887543         289999999999999999999999   99999999999999754   4799


Q ss_pred             EeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccc
Q 046595          218 IADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR  297 (363)
Q Consensus       218 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~  297 (363)
                      |+|||++........   .....|++.|+|||++.+ .++.++||||||+++|+|++|..||...........+.     
T Consensus       165 L~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-----  235 (287)
T 2wei_A          165 IIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE-----  235 (287)
T ss_dssp             ECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----
T ss_pred             EeccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----
Confidence            999999865443221   233468999999998875 58999999999999999999999997543221111000     


Q ss_pred             ccccccccccCCcCCCCC--CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhccc
Q 046595          298 LSEDKVKQCVDPKLNNDY--PPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPL  351 (363)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l  351 (363)
                                ........  ...++..+.+++.+||+.||++|||+.++++  .+++.
T Consensus       236 ----------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          236 ----------TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             ----------HCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             ----------cCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence                      00000000  1234567999999999999999999999998  44443

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.3e-45  Score=335.25  Aligned_cols=261  Identities=24%  Similarity=0.338  Sum_probs=198.4

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC-chHHHHHHHHHHhcCCCCccceeeeEEEeCCee---
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLGYCMESNNR---  140 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~---  140 (363)
                      +.++|.+.+.||+|+||.||+|.+. +++.||||++....... ....+.+|+.+++.++||||+++++++......   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            4568999999999999999999764 68999999997643322 236788999999999999999999999877655   


Q ss_pred             ---EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceE
Q 046595          141 ---ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSK  217 (363)
Q Consensus       141 ---~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk  217 (363)
                         ++||||+.+ +|.+++...           +++..+..++.|++.||.|||++   +|+||||||+||+++.++.+|
T Consensus       120 ~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~k  184 (371)
T 4exu_A          120 YDFYLVMPFMQT-DLQKIMGME-----------FSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELK  184 (371)
T ss_dssp             CCCEEEEECCCE-EHHHHTTSC-----------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEE
T ss_pred             eeEEEEEccccc-cHHHHhhcC-----------CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEE
Confidence               999999985 898887432           89999999999999999999999   999999999999999999999


Q ss_pred             EeeeccCCCCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccc
Q 046595          218 IADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATP  296 (363)
Q Consensus       218 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~  296 (363)
                      |+|||++......     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.....
T Consensus       185 L~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~  259 (371)
T 4exu_A          185 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG  259 (371)
T ss_dssp             ECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             EEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            9999998754332     234678999999999887 6899999999999999999999999976543221111100000


Q ss_pred             cccccc-----------cccccCCcCCCC---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          297 RLSEDK-----------VKQCVDPKLNND---YPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       297 ~~~~~~-----------~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ......           ............   ....++..+.+||.+||+.||++|||+.++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            000000           000000000000   01234567999999999999999999999987

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-45  Score=328.40  Aligned_cols=254  Identities=20%  Similarity=0.329  Sum_probs=194.1

Q ss_pred             HHHhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCC-----chHHHHHHHHHHhcC----CCCccceeeeE
Q 046595           64 NRLTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPE-----PESDFAAQLSVVSRL----KHEHFVELLGY  133 (363)
Q Consensus        64 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~-----~~~~~~~e~~~l~~l----~h~~i~~~~~~  133 (363)
                      ..+.++|++.+.||+|+||.||+|+. .+++.||+|++.......     ....+.+|+.++.++    +|+||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            34567899999999999999999976 468899999997643221     223456788888888    89999999999


Q ss_pred             EEeCCeeEEEEec-ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec-
Q 046595          134 CMESNNRILVYQF-ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF-  211 (363)
Q Consensus       134 ~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~-  211 (363)
                      +...+..++|||+ +.+++|.+++....         .+++..++.++.|++.||.|||++   +|+||||||+||+++ 
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~  174 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKG---------PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDL  174 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEET
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeC
Confidence            9999999999999 78899999997643         289999999999999999999999   999999999999999 


Q ss_pred             CCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCC-ccCceehhHHHHHHHHhCCCCCCCCCCccccch
Q 046595          212 DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQIT-QKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSL  290 (363)
Q Consensus       212 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~  290 (363)
                      .++.+||+|||++.......    .....|+..|+|||++.+..+. .++||||||+++|+|++|+.||.....     .
T Consensus       175 ~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~  245 (312)
T 2iwi_A          175 RRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----I  245 (312)
T ss_dssp             TTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H
T ss_pred             CCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----H
Confidence            89999999999987654322    2345689999999999877664 589999999999999999999963210     0


Q ss_pred             hhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HhccccccCC
Q 046595          291 VTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPLLNSKP  356 (363)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l~~~~~  356 (363)
                      .   .             .  ...++..++..+.+++.+||+.||++|||+.++++  .++...+..+
T Consensus       246 ~---~-------------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~~~  295 (312)
T 2iwi_A          246 L---E-------------A--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVP  295 (312)
T ss_dssp             H---H-------------T--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC------
T ss_pred             h---h-------------h--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhccc
Confidence            0   0             0  01123345567999999999999999999999998  4444444333

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.3e-45  Score=328.94  Aligned_cols=266  Identities=21%  Similarity=0.319  Sum_probs=194.8

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEE---------
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM---------  135 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---------  135 (363)
                      +.++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+.+++.++||||+++++++.         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence            4578999999999999999999876 5899999998753 2233467889999999999999999998873         


Q ss_pred             -----eCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceee
Q 046595          136 -----ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL  210 (363)
Q Consensus       136 -----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill  210 (363)
                           +....++||||+.+ +|.+++....          +++..++.++.|++.||.|||++   +|+||||||+||++
T Consensus        88 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~  153 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYMET-DLANVLEQGP----------LLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFI  153 (320)
T ss_dssp             ---CCSCSEEEEEEECCSE-EHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEE
T ss_pred             cccccccCceeEEeeccCC-CHHHHhhcCC----------ccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEE
Confidence                 34678999999985 9999997543          88999999999999999999999   99999999999999


Q ss_pred             c-CCCceEEeeeccCCCCCccccc-ccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccc
Q 046595          211 F-DDFKSKIADFNLTNQSSDTAAR-LHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQ  287 (363)
Q Consensus       211 ~-~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~  287 (363)
                      + +++.+||+|||++......... .......||..|+|||.+.+ ..++.++||||||+++|||++|+.||........
T Consensus       154 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  233 (320)
T 2i6l_A          154 NTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ  233 (320)
T ss_dssp             ETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             cCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence            7 5779999999998765432211 11234567999999998875 6789999999999999999999999976543221


Q ss_pred             cchhhhccccccccccccc-------cCCcCC-C-----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          288 QSLVTWATPRLSEDKVKQC-------VDPKLN-N-----DYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~-------~~~~~~-~-----~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ...+....+........+.       ...... .     .....++..+.+++.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          234 MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            1111110000000000000       000000 0     011234567999999999999999999999987

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.8e-44  Score=334.56  Aligned_cols=264  Identities=17%  Similarity=0.200  Sum_probs=202.0

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC--------CCccceeeeEEE-
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK--------HEHFVELLGYCM-  135 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~-  135 (363)
                      +.++|++.+.||+|+||.||+|+.. +++.||||++...  ......+.+|+.+++.++        |+||+++++++. 
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            4578999999999999999999754 6889999998642  223467889999999885        788999999987 


Q ss_pred             ---eCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC
Q 046595          136 ---ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD  212 (363)
Q Consensus       136 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~  212 (363)
                         .....++||||+ +++|.+.+.....       ..+++..++.++.||+.||.|||+++  +|+||||||+|||++.
T Consensus       113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~  182 (397)
T 1wak_A          113 SGVNGTHICMVFEVL-GHHLLKWIIKSNY-------QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSV  182 (397)
T ss_dssp             EETTEEEEEEEECCC-CCBHHHHHHHTTT-------SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECC
T ss_pred             cCCCCceEEEEEecc-CccHHHHHHhccc-------CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEec
Confidence               556789999999 5577777654321       13899999999999999999999863  7999999999999987


Q ss_pred             CC-------------------------------------------------ceEEeeeccCCCCCccccccccccccccc
Q 046595          213 DF-------------------------------------------------KSKIADFNLTNQSSDTAARLHSTRVLGTF  243 (363)
Q Consensus       213 ~~-------------------------------------------------~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~  243 (363)
                      ++                                                 .+||+|||++......     .....||+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~  257 (397)
T 1wak_A          183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTR  257 (397)
T ss_dssp             CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCG
T ss_pred             cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCC
Confidence            75                                                 7999999998765432     23457999


Q ss_pred             CCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchh-------hhccc---------ccc------cc
Q 046595          244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLV-------TWATP---------RLS------ED  301 (363)
Q Consensus       244 ~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~-------~~~~~---------~~~------~~  301 (363)
                      .|+|||++.+..++.++|||||||+||||++|+.||............       .....         ...      ..
T Consensus       258 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  337 (397)
T 1wak_A          258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG  337 (397)
T ss_dssp             GGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTS
T ss_pred             cccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcc
Confidence            999999999999999999999999999999999999765433211000       00000         000      00


Q ss_pred             ccccccCCc---------CCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          302 KVKQCVDPK---------LNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       302 ~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ......+..         -...++...+..+.+||.+||+.||++|||+.++++
T Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             SBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            000000000         012346778889999999999999999999999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=329.48  Aligned_cols=259  Identities=24%  Similarity=0.345  Sum_probs=198.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC-chHHHHHHHHHHhcCCCCccceeeeEEEeCCe-----
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLGYCMESNN-----  139 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----  139 (363)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++....... ....+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            468999999999999999999764 68999999997643222 23578899999999999999999999987654     


Q ss_pred             -eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEE
Q 046595          140 -RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI  218 (363)
Q Consensus       140 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl  218 (363)
                       .++||||+.+ +|.+++..           .+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~-----------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl  167 (353)
T 3coi_A          103 DFYLVMPFMQT-DLQKIMGL-----------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKI  167 (353)
T ss_dssp             CCEEEEECCSE-EGGGTTTS-----------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEE
T ss_pred             eEEEEeccccC-CHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEE
Confidence             4999999985 88888753           289999999999999999999999   9999999999999999999999


Q ss_pred             eeeccCCCCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccc
Q 046595          219 ADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR  297 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~  297 (363)
                      +|||++......     .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...........+......
T Consensus       168 ~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~  242 (353)
T 3coi_A          168 LDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV  242 (353)
T ss_dssp             CSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCB
T ss_pred             eecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            999998764332     234578999999999887 67899999999999999999999999765432211111000000


Q ss_pred             --------cccc-------ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          298 --------LSED-------KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       298 --------~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                              ....       .+.......+ .......+..+.+++.+||+.||++|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             CCHHHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCHHHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                    0000       0000000011 1222355678999999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.7e-44  Score=325.04  Aligned_cols=258  Identities=25%  Similarity=0.352  Sum_probs=179.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHH-HHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLS-VVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      ++|++.+.||+|+||.||+|... +++.||||++...........+..|+. +++.++||||+++++++...+..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            58999999999999999999865 689999999976543333445666665 7777899999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+ +|.+++......    ....+++..+..++.|++.||.|||+..  +|+||||||+||+++.++.+||+|||++.
T Consensus       102 ~~~~-~l~~~~~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  174 (327)
T 3aln_A          102 LMST-SFDKFYKYVYSV----LDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISG  174 (327)
T ss_dssp             CCSE-EHHHHHHHHHHT----TCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred             ecCC-ChHHHHHHHHhh----hcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence            9986 888877631100    0113899999999999999999999853  79999999999999999999999999987


Q ss_pred             CCCcccccccccccccccCCCCcccc----ccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYA----MTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      .......   .....||+.|+|||++    .+..++.++||||||+++|+|++|+.||......... .          .
T Consensus       175 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~----------~  240 (327)
T 3aln_A          175 QLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-L----------T  240 (327)
T ss_dssp             C---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------C
T ss_pred             ecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-H----------H
Confidence            6544322   2334799999999998    4567899999999999999999999999753221100 0          0


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .+.......+.......++..+.+++.+||+.||.+|||+.+|++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          241 QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            000000111111112234567999999999999999999999876

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.5e-44  Score=322.90  Aligned_cols=253  Identities=22%  Similarity=0.397  Sum_probs=194.4

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEe--------
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCME--------  136 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------  136 (363)
                      +.++|++.+.||+|+||.||+|+.. +++.||+|++...  ......+.+|+.+++.++||||+++++++.+        
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM   81 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence            4568999999999999999999864 7999999998642  2334678899999999999999999998865        


Q ss_pred             -----CCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec
Q 046595          137 -----SNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF  211 (363)
Q Consensus       137 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~  211 (363)
                           ....++||||+.+++|.+++.....        .+++..++.++.|++.||.|||++   +|+|+||||+||+++
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~  150 (303)
T 1zy4_A           82 TAVKKKSTLFIQMEYCENGTLYDLIHSENL--------NQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFID  150 (303)
T ss_dssp             ----CEEEEEEEEECCCSCBHHHHHHHSCG--------GGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred             cccccCCceEEEEecCCCCCHHHhhhcccc--------ccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEc
Confidence                 3567899999999999999975431        378899999999999999999999   999999999999999


Q ss_pred             CCCceEEeeeccCCCCCcccc------------cccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCC
Q 046595          212 DDFKSKIADFNLTNQSSDTAA------------RLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKP  278 (363)
Q Consensus       212 ~~~~vkl~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p  278 (363)
                      .++.+||+|||++........            ........||+.|+|||++.+. .++.++||||||+++|+|++   |
T Consensus       151 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p  227 (303)
T 1zy4_A          151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---P  227 (303)
T ss_dssp             TTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---C
T ss_pred             CCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---c
Confidence            999999999999876543211            1112345689999999998864 78999999999999999998   5


Q ss_pred             CCCCCCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          279 VDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      |.....  ......         .+. .....+...++...+..+.+++.+||+.||.+|||+.++++
T Consensus       228 ~~~~~~--~~~~~~---------~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          228 FSTGME--RVNILK---------KLR-SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             CSSHHH--HHHHHH---------HHH-STTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCchh--HHHHHH---------hcc-ccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            532110  000000         000 01112223344556677999999999999999999999987

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.7e-45  Score=328.47  Aligned_cols=245  Identities=19%  Similarity=0.363  Sum_probs=200.7

Q ss_pred             HHHHhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCC-----chHHHHHHHHHHhcCC--CCccceeeeEE
Q 046595           63 LNRLTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPE-----PESDFAAQLSVVSRLK--HEHFVELLGYC  134 (363)
Q Consensus        63 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~-----~~~~~~~e~~~l~~l~--h~~i~~~~~~~  134 (363)
                      ...+.++|++.+.||+|+||.||+|.. .+++.||||++.......     ....+.+|+.++++++  |+||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            345667899999999999999999975 468899999987643222     2245678999999996  59999999999


Q ss_pred             EeCCeeEEEEecccC-CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec-C
Q 046595          135 MESNNRILVYQFATM-GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF-D  212 (363)
Q Consensus       135 ~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~-~  212 (363)
                      ......++|||++.+ ++|.+++....         .+++..++.++.|++.||.|||++   +|+||||||+|||++ +
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~  185 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITERG---------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLN  185 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETT
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCC
Confidence            999999999999986 79999997643         289999999999999999999999   999999999999999 7


Q ss_pred             CCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCC-CccCceehhHHHHHHHHhCCCCCCCCCCccccchh
Q 046595          213 DFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLV  291 (363)
Q Consensus       213 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~  291 (363)
                      ++.+||+|||++.......    .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....     ..
T Consensus       186 ~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~  256 (320)
T 3a99_A          186 RGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----II  256 (320)
T ss_dssp             TTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HH
T ss_pred             CCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----hh
Confidence            8999999999987654322    234579999999999987766 7889999999999999999999963210     00


Q ss_pred             hhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          292 TWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                         .     ..          ..++..++..+.+++.+||+.||.+|||+.+|++
T Consensus       257 ---~-----~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          257 ---R-----GQ----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ---H-----CC----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---c-----cc----------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               0     00          0112234467999999999999999999999987

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.3e-43  Score=327.30  Aligned_cols=204  Identities=24%  Similarity=0.310  Sum_probs=170.8

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-CC-----ccceeeeEEEeC
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HE-----HFVELLGYCMES  137 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~  137 (363)
                      .+.++|++.+.||+|+||.||+|... +++.||||++...  ......+..|+.+++.++ |+     +|+.+++++...
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            45678999999999999999999765 6888999998642  222356777888888774 44     599999999999


Q ss_pred             CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec--CCCc
Q 046595          138 NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF--DDFK  215 (363)
Q Consensus       138 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~--~~~~  215 (363)
                      ...++||||+.+ +|.+++......       .+++..+..++.|++.||.|||.+ ..+|+||||||+|||++  .++.
T Consensus       129 ~~~~lv~e~~~~-~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~  199 (382)
T 2vx3_A          129 NHLCLVFEMLSY-NLYDLLRNTNFR-------GVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSA  199 (382)
T ss_dssp             TEEEEEEECCCC-BHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCC
T ss_pred             CceEEEEecCCC-CHHHHHhhcCcC-------CCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCc
Confidence            999999999975 999999765321       289999999999999999999952 11899999999999995  4788


Q ss_pred             eEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCC
Q 046595          216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP  284 (363)
Q Consensus       216 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~  284 (363)
                      +||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       200 ~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          200 IKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             EEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999998765432     2346789999999999999999999999999999999999999986543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=8.9e-44  Score=322.74  Aligned_cols=257  Identities=19%  Similarity=0.246  Sum_probs=176.2

Q ss_pred             HhcCCCCCC-eeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEe----CCe
Q 046595           66 LTSNFGTKA-LIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCME----SNN  139 (363)
Q Consensus        66 ~~~~y~~~~-~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~  139 (363)
                      +.++|.+.+ +||+|+||.||+|.+. +++.||||++...     ..........++.+.||||+++++++..    ...
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  100 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC  100 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence            456899854 6999999999999865 6999999998642     1222223344666799999999999876    445


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC---CCce
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD---DFKS  216 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~~~v  216 (363)
                      .++||||+.+|+|.+++.....       ..+++.+++.++.|++.||.|||++   +|+||||||+||+++.   ++.+
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~~-------~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~  170 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERGD-------QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVL  170 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC-C-------CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCE
T ss_pred             EEEEEeccCCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceE
Confidence            8899999999999999986542       2389999999999999999999999   9999999999999975   4569


Q ss_pred             EEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccc
Q 046595          217 KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATP  296 (363)
Q Consensus       217 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~  296 (363)
                      ||+|||++.......    .....||+.|+|||++.+..++.++||||||+++|+|++|..||.............    
T Consensus       171 kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----  242 (336)
T 3fhr_A          171 KLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK----  242 (336)
T ss_dssp             EECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------
T ss_pred             EEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH----
Confidence            999999986544321    234578999999999988899999999999999999999999996543321110000    


Q ss_pred             cccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhcc
Q 046595          297 RLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQP  350 (363)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~  350 (363)
                          ..+ ..............++..+.+++.+||+.||.+|||+.++++  .+++
T Consensus       243 ----~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          243 ----RRI-RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             -------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             ----Hhh-hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence                000 000001111111345667999999999999999999999998  4444

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.2e-43  Score=332.62  Aligned_cols=257  Identities=18%  Similarity=0.283  Sum_probs=190.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      +.|.+.+.||+|+||+||.+...+|+.||||++...    ....+.+|+.+++.+ +||||+++++++.+....++||||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~   90 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL   90 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence            456677899999999998877778999999998652    245678899999876 899999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCC-------------
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD-------------  213 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~-------------  213 (363)
                      +. |+|.+++.........  .....+..++.++.|++.||.|||++   +|+||||||+|||++.+             
T Consensus        91 ~~-gsL~~~l~~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~  164 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDEN--LKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAEN  164 (434)
T ss_dssp             CS-EEHHHHHHTC--------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred             CC-CCHHHHHhccCCCchh--hhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCc
Confidence            96 5999999865422110  00123445678999999999999999   99999999999999754             


Q ss_pred             CceEEeeeccCCCCCccccc--ccccccccccCCCCcccccc-------CCCCccCceehhHHHHHHHHh-CCCCCCCCC
Q 046595          214 FKSKIADFNLTNQSSDTAAR--LHSTRVLGTFGYHAPEYAMT-------GQITQKSDVYSFGVVLLELLT-GRKPVDHTM  283 (363)
Q Consensus       214 ~~vkl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~ell~-g~~p~~~~~  283 (363)
                      +.+||+|||++.........  .......||+.|+|||++.+       ..++.++|||||||++|||++ |..||....
T Consensus       165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~  244 (434)
T 2rio_A          165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY  244 (434)
T ss_dssp             CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred             eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence            48999999999765543221  11234579999999999875       578999999999999999999 999996543


Q ss_pred             CccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          284 PKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      .... .   .......        ...........++.++.+++.+||+.||.+|||+.+|++
T Consensus       245 ~~~~-~---i~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          245 SRES-N---IIRGIFS--------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             THHH-H---HHHTCCC--------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhHH-H---HhcCCCC--------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            2110 0   0000000        011112224577889999999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.2e-43  Score=324.18  Aligned_cols=268  Identities=17%  Similarity=0.271  Sum_probs=202.7

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CC-CeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCc------cceeeeEEEeC
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DG-TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEH------FVELLGYCMES  137 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~-~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~  137 (363)
                      +.++|++.+.||+|+||.||+|... ++ +.||+|++...  ......+.+|+.+++.++|++      ++.+++++...
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~   94 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH   94 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence            4578999999999999999999764 34 68999998642  223467788999999887655      89999999999


Q ss_pred             CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceee-------
Q 046595          138 NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-------  210 (363)
Q Consensus       138 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill-------  210 (363)
                      ...++||||+ +++|.+++.....       ..+++..++.++.|++.||.|||++   +|+||||||+|||+       
T Consensus        95 ~~~~lv~e~~-~~~l~~~l~~~~~-------~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~  163 (355)
T 2eu9_A           95 GHMCIAFELL-GKNTFEFLKENNF-------QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFET  163 (355)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTT-------CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEE
T ss_pred             CeEEEEEecc-CCChHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccc
Confidence            9999999999 5578777765431       1389999999999999999999999   99999999999999       


Q ss_pred             ------------cCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCC
Q 046595          211 ------------FDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP  278 (363)
Q Consensus       211 ------------~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p  278 (363)
                                  +.++.+||+|||++......     .....||+.|+|||++.+..++.++||||||+++|||++|..|
T Consensus       164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  238 (355)
T 2eu9_A          164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTL  238 (355)
T ss_dssp             EECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCC
Confidence                        56889999999998653332     2345799999999999999999999999999999999999999


Q ss_pred             CCCCCCccccchhhhccccccccccc--------------------------cccCC-cCCCCCCHHHHHHHHHHHHhcc
Q 046595          279 VDHTMPKGQQSLVTWATPRLSEDKVK--------------------------QCVDP-KLNNDYPPKAIAKLAAVAALCV  331 (363)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~-~~~~~~~~~~~~~l~~li~~cl  331 (363)
                      |.........................                          ..... ..........+..+.+|+.+||
T Consensus       239 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  318 (355)
T 2eu9_A          239 FQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRML  318 (355)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred             CCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHh
Confidence            97654322111111110000000000                          00000 0001112345678999999999


Q ss_pred             CCCCCCCCCHHHHHH--Hhccc
Q 046595          332 QYEADFRPNMTIVVK--ALQPL  351 (363)
Q Consensus       332 ~~~p~~RPs~~~vl~--~l~~l  351 (363)
                      +.||.+|||+.++++  .++.+
T Consensus       319 ~~dP~~Rpt~~e~l~hp~f~~~  340 (355)
T 2eu9_A          319 EFDPAQRITLAEALLHPFFAGL  340 (355)
T ss_dssp             CSSTTTSCCHHHHTTSGGGGGC
T ss_pred             cCChhhCcCHHHHhcChhhcCC
Confidence            999999999999985  44443

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=6.3e-43  Score=309.80  Aligned_cols=235  Identities=15%  Similarity=0.099  Sum_probs=187.4

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC--chHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE--PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      +.++|++.+.||+|+||.||+|.+. +++.||||++.......  ....+.+|+.++..++||||+++++++...+..++
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            3468999999999999999999865 58999999998754332  23678999999999999999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ||||+.|++|.+++...           ....++..++.|++.||.|||++   ||+||||||+|||++.+|.+||+++|
T Consensus       109 v~e~~~g~~L~~~l~~~-----------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADTS-----------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA  174 (286)
T ss_dssp             EEECCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC
T ss_pred             EEEecCCCCHHHHHhcC-----------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc
Confidence            99999999999999542           35567889999999999999999   99999999999999999999998544


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                                            |++       .++.++|||||||++|||++|+.||............           
T Consensus       175 ----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-----------  214 (286)
T 3uqc_A          175 ----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-----------  214 (286)
T ss_dssp             ----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-----------
T ss_pred             ----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-----------
Confidence                                  233       3788999999999999999999999865432211000           


Q ss_pred             cccccCCcCC--CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCC
Q 046595          303 VKQCVDPKLN--NDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP  356 (363)
Q Consensus       303 ~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~  356 (363)
                       .........  ......++..+.+++.+||+.||++| |+.++++.|+++.....
T Consensus       215 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          215 -ERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             -CBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             -HHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence             000000000  01112345679999999999999999 99999999998776543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.5e-43  Score=342.04  Aligned_cols=272  Identities=22%  Similarity=0.297  Sum_probs=207.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEe------CCe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCME------SNN  139 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~  139 (363)
                      .++|++.+.||+|+||.||+|.+ .+++.||||++...........+.+|+.++++++||||+++++++..      ...
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            36899999999999999999976 46899999998765444445778999999999999999999998755      667


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCc---e
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK---S  216 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~---v  216 (363)
                      .++||||+.+|+|.+++......      ..+++..++.++.|++.||.|||++   ||+||||||+||+++.++.   +
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~------~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~v  163 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENC------CGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIH  163 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCT------TCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEE
T ss_pred             EEEEEEeCCCCCHHHHHHhcccC------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeE
Confidence            79999999999999999865421      1388899999999999999999999   9999999999999997664   9


Q ss_pred             EEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccc
Q 046595          217 KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATP  296 (363)
Q Consensus       217 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~  296 (363)
                      ||+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||......     ..|...
T Consensus       164 KL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~  235 (676)
T 3qa8_A          164 KIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGK  235 (676)
T ss_dssp             EECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTT
T ss_pred             EEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhh
Confidence            9999999976544322   24467999999999999999999999999999999999999999643111     011000


Q ss_pred             c------------ccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHH-----HHHHhccccccC
Q 046595          297 R------------LSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTI-----VVKALQPLLNSK  355 (363)
Q Consensus       297 ~------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~-----vl~~l~~l~~~~  355 (363)
                      .            .....+.-.........+....+..+.+++.+||+.||++|||+.+     +.+.+..+++..
T Consensus       236 i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k  311 (676)
T 3qa8_A          236 VREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK  311 (676)
T ss_dssp             CC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred             hhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence            0            0000000000011122345567889999999999999999999987     556666666544

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.4e-43  Score=326.08  Aligned_cols=269  Identities=16%  Similarity=0.241  Sum_probs=201.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-----------CCccceeeeEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-----------HEHFVELLGYC  134 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~  134 (363)
                      .++|++.+.||+|+||.||+|++ .+++.||||++...  ......+.+|+.++++++           |+||+++++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            35899999999999999999986 46899999998642  223456788999988886           89999999998


Q ss_pred             EeCC----eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceee
Q 046595          135 MESN----NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL  210 (363)
Q Consensus       135 ~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill  210 (363)
                      ....    ..++||||+ +++|.+++......       .+++..++.++.|++.||.|||+++  +|+||||||+|||+
T Consensus        96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll  165 (373)
T 1q8y_A           96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHR-------GIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLM  165 (373)
T ss_dssp             EEEETTEEEEEEEECCC-CEEHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEE
T ss_pred             hccCCCCceEEEEEecC-CCCHHHHHHHhhcc-------CCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEE
Confidence            8654    788999999 78999999764321       2889999999999999999999953  79999999999999


Q ss_pred             c------CCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCC
Q 046595          211 F------DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMP  284 (363)
Q Consensus       211 ~------~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~  284 (363)
                      +      ..+.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus       166 ~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  240 (373)
T 1q8y_A          166 EIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG  240 (373)
T ss_dssp             EEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             eccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcc
Confidence            5      3448999999998655432     2345789999999999999999999999999999999999999975432


Q ss_pred             ccccc----h---hhhcccc--------------cccc-ccccccCC---------cCCCCCCHHHHHHHHHHHHhccCC
Q 046595          285 KGQQS----L---VTWATPR--------------LSED-KVKQCVDP---------KLNNDYPPKAIAKLAAVAALCVQY  333 (363)
Q Consensus       285 ~~~~~----~---~~~~~~~--------------~~~~-~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~  333 (363)
                      .....    .   .......              .... ........         .....++...+..+.+||.+||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  320 (373)
T 1q8y_A          241 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL  320 (373)
T ss_dssp             ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred             cccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhcc
Confidence            21100    0   0000000              0000 00000000         001245678899999999999999


Q ss_pred             CCCCCCCHHHHHH--Hhcccc
Q 046595          334 EADFRPNMTIVVK--ALQPLL  352 (363)
Q Consensus       334 ~p~~RPs~~~vl~--~l~~l~  352 (363)
                      ||.+|||+.++++  .+++..
T Consensus       321 dP~~Rpt~~ell~hp~f~~~~  341 (373)
T 1q8y_A          321 DPRKRADAGGLVNHPWLKDTL  341 (373)
T ss_dssp             STTTCBCHHHHHTCGGGTTCT
T ss_pred             CccccCCHHHHhhChhhhccc
Confidence            9999999999998  555543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4e-43  Score=328.27  Aligned_cols=249  Identities=19%  Similarity=0.276  Sum_probs=187.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      .+|.+.+.||+|+||+|+.....+++.||||++....    ...+.+|+.+++.+ +||||+++++++.+....++||||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC----FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT----EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            3688999999999999877666789999999986532    23456899999999 799999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC---C--CceEEeee
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD---D--FKSKIADF  221 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~--~~vkl~Df  221 (363)
                      +.+ +|.+++......        +....++.++.|++.||.|||++   +|+||||||+|||++.   +  ..+||+||
T Consensus       100 ~~g-~L~~~l~~~~~~--------~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DF  167 (432)
T 3p23_A          100 CAA-TLQEYVEQKDFA--------HLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDF  167 (432)
T ss_dssp             CSE-EHHHHHHSSSCC--------CCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred             CCC-CHHHHHHhcCCC--------ccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence            975 999999865421        44455678999999999999999   9999999999999953   2  35789999


Q ss_pred             ccCCCCCccccc-ccccccccccCCCCccccc---cCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccc
Q 046595          222 NLTNQSSDTAAR-LHSTRVLGTFGYHAPEYAM---TGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATP  296 (363)
Q Consensus       222 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~  296 (363)
                      |++......... .......||+.|+|||++.   +..++.++|||||||++|||++ |..||...........    ..
T Consensus       168 G~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~----~~  243 (432)
T 3p23_A          168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL----LG  243 (432)
T ss_dssp             TEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH----TT
T ss_pred             cceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH----hc
Confidence            998765433211 1234467999999999987   4567889999999999999999 8999954322111000    00


Q ss_pred             cccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          297 RLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ..         .. .........+..+.+||.+||+.||.+|||+.+|++
T Consensus       244 ~~---------~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          244 AC---------SL-DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CC---------CC-TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cC---------Cc-cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            00         00 001112345667899999999999999999999984

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.7e-43  Score=315.52  Aligned_cols=252  Identities=21%  Similarity=0.299  Sum_probs=179.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHH-HHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESD-FAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~-~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      .++|++.+.||+|+||.||+|.+. +++.||||++........... +..+..+++.++||||+++++++.+....++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            357899999999999999999875 689999999976543333333 334455788889999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-cCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE-KVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      ||+ ++.+..+.....        ..+++..++.++.|++.||.|||+ +   +|+|+||||+||+++.++.+||+|||+
T Consensus       104 e~~-~~~~~~l~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~  171 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQ--------GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGI  171 (318)
T ss_dssp             CCC-SEEHHHHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             ecc-CCcHHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCC
Confidence            999 445555554321        138999999999999999999998 6   899999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccc-----cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAM-----TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL  298 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  298 (363)
                      +........   .....||+.|+|||++.     +..++.++||||||+++|+|++|+.||......... ......   
T Consensus       172 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~---  244 (318)
T 2dyl_A          172 SGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV-LTKVLQ---  244 (318)
T ss_dssp             C-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-HHHHHH---
T ss_pred             chhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH-HHHHhc---
Confidence            865543322   23457899999999984     457889999999999999999999999753221100 000000   


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          299 SEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                             .....+  .....++..+.+++.+||+.||.+||++.+|++
T Consensus       245 -------~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          245 -------EEPPLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             -------SCCCCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -------cCCCCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                   000000  001124566999999999999999999999886

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.2e-43  Score=346.53  Aligned_cols=243  Identities=20%  Similarity=0.304  Sum_probs=196.5

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEeC--CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCe---
Q 046595           65 RLTSNFGTKALIGEGSYGRVFYAKLT--DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNN---  139 (363)
Q Consensus        65 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---  139 (363)
                      .+.++|++.+.||+|+||.||+|.+.  +++.||||++...........+.+|+.++++++||||+++++++.....   
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence            34578999999999999999999865  5899999998764443445678899999999999999999999988765   


Q ss_pred             --eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceE
Q 046595          140 --RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSK  217 (363)
Q Consensus       140 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk  217 (363)
                        .++||||+.+++|.+++..           .+++.+++.++.|++.||.|||++   +|+||||||+|||++.+ .+|
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~-----------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~k  221 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQ-----------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLK  221 (681)
T ss_dssp             EEEEEEEECCCCEECC----C-----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEE
T ss_pred             ceeEEEEEeCCCCcHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEE
Confidence              6999999999999887754           289999999999999999999999   99999999999999885 899


Q ss_pred             EeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccc
Q 046595          218 IADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR  297 (363)
Q Consensus       218 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~  297 (363)
                      |+|||++......      ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.......           
T Consensus       222 l~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------  283 (681)
T 2pzi_A          222 LIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------  283 (681)
T ss_dssp             ECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------
T ss_pred             EEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc-----------
Confidence            9999998655432      345799999999998765 4899999999999999999988876321100           


Q ss_pred             ccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhcccc
Q 046595          298 LSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP-NMTIVVKALQPLL  352 (363)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~~vl~~l~~l~  352 (363)
                      .            .........+..+.++|.+||+.||.+|| +++++...|..++
T Consensus       284 ~------------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          284 L------------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             C------------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             c------------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence            0            00011123456799999999999999999 5666776766554

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=9.6e-41  Score=297.98  Aligned_cols=228  Identities=17%  Similarity=0.292  Sum_probs=179.8

Q ss_pred             HhcCCCCC-CeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHH-hcCCCCccceeeeEEEe----CC
Q 046595           66 LTSNFGTK-ALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVV-SRLKHEHFVELLGYCME----SN  138 (363)
Q Consensus        66 ~~~~y~~~-~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~~  138 (363)
                      +.++|.+. +.||+|+||.||+|.. .+++.||+|++..      ...+.+|+.++ +.++||||+++++++..    ..
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   88 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK   88 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence            34577776 7899999999999976 4689999999854      34677888887 55689999999999887    67


Q ss_pred             eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC---CCc
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD---DFK  215 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~~~  215 (363)
                      ..++||||+.+++|.+++.....       ..+++..++.++.|++.||.|||++   +|+||||||+||+++.   ++.
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~  158 (299)
T 3m2w_A           89 CLLIVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAI  158 (299)
T ss_dssp             EEEEEECCCCSCBHHHHHHHCTT-------CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCC
T ss_pred             eEEEEEeecCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCc
Confidence            78999999999999999986532       1389999999999999999999999   9999999999999997   789


Q ss_pred             eEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 046595          216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       216 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      +||+|||++...                        .+..++.++|||||||++|+|++|..||..........      
T Consensus       159 ~kl~Dfg~a~~~------------------------~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~------  208 (299)
T 3m2w_A          159 LKLTDFGFAKET------------------------TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------  208 (299)
T ss_dssp             EEECCCTTCEEC------------------------TTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C------
T ss_pred             EEEecccccccc------------------------ccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH------
Confidence            999999987432                        13457889999999999999999999996543221100      


Q ss_pred             ccccccccccccCCcCCCCCC----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          296 PRLSEDKVKQCVDPKLNNDYP----PKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                            .+....... ...++    ..++..+.+++.+||+.||.+|||+.++++
T Consensus       209 ------~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          209 ------GMKTRIRMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             ------CSCCSSCTT-CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ------HHHHHHhhc-cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                  000000000 01112    234677999999999999999999999997

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.4e-41  Score=313.97  Aligned_cols=244  Identities=12%  Similarity=0.135  Sum_probs=178.1

Q ss_pred             CCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCC--chHHHHHHHHHHhcCCC-Ccccee---------e----
Q 046595           69 NFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPE--PESDFAAQLSVVSRLKH-EHFVEL---------L----  131 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~--~~~~~~~e~~~l~~l~h-~~i~~~---------~----  131 (363)
                      .|...+.||+|+||.||+|.+ .+|+.||||++.......  ..+.+.+|+.+++.+.| .|+..+         +    
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            477788999999999999985 479999999987543322  35789999999999977 322111         1    


Q ss_pred             --------eEEEe-----CCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCe
Q 046595          132 --------GYCME-----SNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPI  198 (363)
Q Consensus       132 --------~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i  198 (363)
                              .++..     ....+++|+++ +++|.+++.......  .....+++..++.++.|++.||.|||++   +|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  232 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS--STHKSLVHHARLQLTLQVIRLLASLHHY---GL  232 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHT--TTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhccc--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence                    11111     22356667665 569999885221000  0012378889999999999999999999   99


Q ss_pred             EEecccCCceeecCCCceEEeeeccCCCCCcccccccccccccccCCCCcccc----------ccCCCCccCceehhHHH
Q 046595          199 VHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA----------MTGQITQKSDVYSFGVV  268 (363)
Q Consensus       199 vH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwslG~~  268 (363)
                      +||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          .+..++.++|||||||+
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            99999999999999999999999998754433     334577 999999999          55568889999999999


Q ss_pred             HHHHHhCCCCCCCCCCccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 046595          269 LLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVV  345 (363)
Q Consensus       269 l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl  345 (363)
                      +|||++|+.||..........               ..+...  .    .++..+.+||.+||+.||++||++.+++
T Consensus       307 l~elltg~~Pf~~~~~~~~~~---------------~~~~~~--~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGGSE---------------WIFRSC--K----NIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSCSG---------------GGGSSC--C----CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHHCCCCCCCcchhhhHH---------------HHHhhc--c----cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            999999999997543221111               111100  1    2346699999999999999999966654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.9e-42  Score=311.43  Aligned_cols=241  Identities=19%  Similarity=0.222  Sum_probs=183.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCC-------CCchHHHHHHHHHHhcCC---------CCcccee
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSA-------PEPESDFAAQLSVVSRLK---------HEHFVEL  130 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~e~~~l~~l~---------h~~i~~~  130 (363)
                      .++|++.+.||+|+||.||+|++ +++.||||++.....       ......+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            45799999999999999999988 689999999976532       223377889999988886         6666655


Q ss_pred             eeE-----------------EEe-------------CCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHH
Q 046595          131 LGY-----------------CME-------------SNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA  180 (363)
Q Consensus       131 ~~~-----------------~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~  180 (363)
                      .++                 +.+             ....++||||+.+|++.+.+...          .+++..++.++
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~----------~~~~~~~~~i~  167 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK----------LSSLATAKSIL  167 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT----------CCCHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc----------CCCHHHHHHHH
Confidence            554                 333             67899999999999877777542          28999999999


Q ss_pred             HHHHHHHHHhh-ccCCCCeEEecccCCceeecCCC--------------------ceEEeeeccCCCCCccccccccccc
Q 046595          181 YGAAKGLEFLH-EKVQPPIVHRDVRSSNVLLFDDF--------------------KSKIADFNLTNQSSDTAARLHSTRV  239 (363)
Q Consensus       181 ~~i~~~l~~lH-~~~~~~ivH~Dlkp~Nill~~~~--------------------~vkl~Dfg~a~~~~~~~~~~~~~~~  239 (363)
                      .|++.||.||| ++   +|+||||||+|||++.++                    .+||+|||+++....       ...
T Consensus       168 ~qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~  237 (336)
T 2vuw_A          168 HQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIV  237 (336)
T ss_dssp             HHHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEE
T ss_pred             HHHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcE
Confidence            99999999999 89   999999999999999887                    999999999875432       234


Q ss_pred             ccccCCCCccccccCCCCccCceehhHHH-HHHHHhCCCCCCCCCCccccchhhhccccccccccc-c-ccCCcCCCCCC
Q 046595          240 LGTFGYHAPEYAMTGQITQKSDVYSFGVV-LLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK-Q-CVDPKLNNDYP  316 (363)
Q Consensus       240 ~gt~~y~aPE~~~~~~~~~~~DvwslG~~-l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~  316 (363)
                      .||+.|+|||++.+.. +.++|||||+++ .+++++|..||...         .|... . ...+. . ...........
T Consensus       238 ~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~-~-~~~~~~~~~~~~~~~~~~~  305 (336)
T 2vuw_A          238 VFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHY-L-TDKMLKQMTFKTKCNTPAM  305 (336)
T ss_dssp             ECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHH-H-HHHHHHTCCCSSCCCSHHH
T ss_pred             EEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhH-H-HHhhhhhhccCcccchhhh
Confidence            7999999999998666 899999998777 77888899998421         00000 0 00000 0 00111111223


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 046595          317 PKAIAKLAAVAALCVQYEADFRPNMTIVV  345 (363)
Q Consensus       317 ~~~~~~l~~li~~cl~~~p~~RPs~~~vl  345 (363)
                      ..++.++.+||.+||+.|     |+.+++
T Consensus       306 ~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          306 KQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             hhcCHHHHHHHHHHhccC-----CHHHHH
Confidence            568889999999999976     899888

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=6.2e-35  Score=281.00  Aligned_cols=185  Identities=14%  Similarity=0.061  Sum_probs=129.6

Q ss_pred             eeccCCceEEEEE-eCCCCeEEEEEccCCCCCC---------chHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEEEE
Q 046595           76 IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPE---------PESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        76 lg~G~~g~V~~~~-~~~~~~~avK~~~~~~~~~---------~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      .+.|++|.+..++ ...|+.+++|++.......         ..+.+.+|+++|+++ .|+||++++++++++...||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4566666666553 3458899999997643211         124688999999999 7999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||++|++|.++|.....         ++..   +|+.||+.||.|||++   |||||||||+||||+.+|.+||+|||+|
T Consensus       322 Eyv~G~~L~d~i~~~~~---------l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlA  386 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGEE---------IDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSI  386 (569)
T ss_dssp             ECCCSEEHHHHHHTTCC---------CCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTE
T ss_pred             ecCCCCcHHHHHHhCCC---------CCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccC
Confidence            99999999999986542         5544   4789999999999999   9999999999999999999999999999


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCC
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP  278 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p  278 (363)
                      +........  ....+||+.|+|||++.+ .+...+|+||+|++++++.++..+
T Consensus       387 r~~~~~~~~--~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          387 VTTPQDCSW--PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ESCC---CC--SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             eeCCCCCcc--ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            766543322  345689999999998875 567789999999998877665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=2.5e-30  Score=247.56  Aligned_cols=186  Identities=17%  Similarity=0.172  Sum_probs=146.5

Q ss_pred             CCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCc-------hHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           71 GTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEP-------ESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        71 ~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      ...+.||+|+||.||++.. .++.+++|+.........       .+++.+|+.++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4456899999999999955 478889988655332211       23578999999999999999666666678888999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+++++|.+++..                 ++.++.|++.||.|||++   +|+||||||+|||++.  .+||+|||+
T Consensus       418 mE~~~ggsL~~~l~~-----------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGl  475 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGL  475 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTT
T ss_pred             EECCCCCCHHHHHHH-----------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECcc
Confidence            999999999999875                 347999999999999999   9999999999999998  999999999


Q ss_pred             CCCCCcccccc-----cccccccccCCCCcccccc--CCCCccCceehhHHHHHHHHhCCCCC
Q 046595          224 TNQSSDTAARL-----HSTRVLGTFGYHAPEYAMT--GQITQKSDVYSFGVVLLELLTGRKPV  279 (363)
Q Consensus       224 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~p~  279 (363)
                      ++.........     ......||+.|+|||++..  ..|+..+|+||..+-..+-+.++.+|
T Consensus       476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            98765543221     1235689999999999987  57888999999999888888877666

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=3.3e-26  Score=201.57  Aligned_cols=147  Identities=14%  Similarity=0.061  Sum_probs=116.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCC-----------------chHHHHHHHHHHhcCCCCcccee
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPE-----------------PESDFAAQLSVVSRLKHEHFVEL  130 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~-----------------~~~~~~~e~~~l~~l~h~~i~~~  130 (363)
                      ..|.+.+.||+|+||.||+|.+.+|+.||+|++.......                 ....+.+|+.++++++  | +++
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            3566779999999999999988779999999996532111                 2356889999999998  4 555


Q ss_pred             eeEEEeCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceee
Q 046595          131 LGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL  210 (363)
Q Consensus       131 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill  210 (363)
                      .+++.. +..++||||++|++|.+ +..               .....++.|++.||.|||++   ||+||||||+|||+
T Consensus       167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl  226 (282)
T 1zar_A          167 PKVYAW-EGNAVLMELIDAKELYR-VRV---------------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV  226 (282)
T ss_dssp             CCEEEE-ETTEEEEECCCCEEGGG-CCC---------------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred             CeEEec-cceEEEEEecCCCcHHH-cch---------------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEE
Confidence            554433 55699999999999988 421               12346999999999999999   99999999999999


Q ss_pred             cCCCceEEeeeccCCCCCcccccccccccccccCCCCcccccc
Q 046595          211 FDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT  253 (363)
Q Consensus       211 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  253 (363)
                      + ++.+||+|||++.               .+..++|||.+..
T Consensus       227 ~-~~~vkl~DFG~a~---------------~~~~~~a~e~l~r  253 (282)
T 1zar_A          227 S-EEGIWIIDFPQSV---------------EVGEEGWREILER  253 (282)
T ss_dssp             E-TTEEEECCCTTCE---------------ETTSTTHHHHHHH
T ss_pred             E-CCcEEEEECCCCe---------------ECCCCCHHHHHHH
Confidence            9 9999999999874               2445788998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=2.2e-22  Score=175.03  Aligned_cols=137  Identities=20%  Similarity=0.220  Sum_probs=105.3

Q ss_pred             CCCCCeeeccCCceEEEEEe-CCCCe--EEEEEccCCCCCC-----------------------chHHHHHHHHHHhcCC
Q 046595           70 FGTKALIGEGSYGRVFYAKL-TDGTP--AAIKKLDTSSAPE-----------------------PESDFAAQLSVVSRLK  123 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~-~~~~~--~avK~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~  123 (363)
                      |.+.+.||+|+||.||+|.+ .+|+.  ||||+++......                       ....+.+|+.++.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56788999999999999987 67888  9999875432110                       0135788999999998


Q ss_pred             CCcc--ceeeeEEEeCCeeEEEEecccC-C----ChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhh-ccCC
Q 046595          124 HEHF--VELLGYCMESNNRILVYQFATM-G----SLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH-EKVQ  195 (363)
Q Consensus       124 h~~i--~~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~~  195 (363)
                      |++|  ..++++    ...++||||+.+ |    +|.++...            .++..+..++.|++.+|.||| +.  
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------------~~~~~~~~i~~qi~~~l~~lH~~~--  190 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------------LKELDVEGIFNDVVENVKRLYQEA--  190 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------------GGGSCHHHHHHHHHHHHHHHHHTS--
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------------cChHHHHHHHHHHHHHHHHHHHHC--
Confidence            8754  344432    356899999942 3    56655432            234467789999999999999 88  


Q ss_pred             CCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          196 PPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       196 ~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                       ||+||||||+|||++.  .++|+|||+|...
T Consensus       191 -givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          191 -ELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             -CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             -CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence             9999999999999988  9999999998543

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.79  E-value=2.7e-20  Score=168.29  Aligned_cols=137  Identities=12%  Similarity=0.147  Sum_probs=98.8

Q ss_pred             CCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCC-------------CchHHH--------HHHHHHHhcCCCCccc
Q 046595           70 FGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAP-------------EPESDF--------AAQLSVVSRLKHEHFV  128 (363)
Q Consensus        70 y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~-------------~~~~~~--------~~e~~~l~~l~h~~i~  128 (363)
                      |.+.+.||+|+||.||+|...+|+.||||+++.....             ......        .+|...|.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            8899999999999999999989999999987642110             001111        2455566666443332


Q ss_pred             eeeeEEEeCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCce
Q 046595          129 ELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNV  208 (363)
Q Consensus       129 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Ni  208 (363)
                      ...-+..  ...+|||||+.|++|..+...               .....++.|++.+|.|||+.   |||||||||.||
T Consensus       177 vp~p~~~--~~~~LVME~i~G~~L~~l~~~---------------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NI  236 (397)
T 4gyi_A          177 VPEPIAQ--SRHTIVMSLVDALPMRQVSSV---------------PDPASLYADLIALILRLAKH---GLIHGDFNEFNI  236 (397)
T ss_dssp             CCCEEEE--ETTEEEEECCSCEEGGGCCCC---------------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSE
T ss_pred             CCeeeec--cCceEEEEecCCccHhhhccc---------------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHE
Confidence            2111111  223799999999888665431               12356789999999999999   999999999999


Q ss_pred             eecCCC----------ceEEeeeccCCC
Q 046595          209 LLFDDF----------KSKIADFNLTNQ  226 (363)
Q Consensus       209 ll~~~~----------~vkl~Dfg~a~~  226 (363)
                      |+++++          .+.|+||+.+..
T Consensus       237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          237 LIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             EEeCCCCcccccccccceEEEEeCCccc
Confidence            998876          389999997643

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.51  E-value=6e-14  Score=121.94  Aligned_cols=145  Identities=14%  Similarity=0.064  Sum_probs=112.1

Q ss_pred             HHHhcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-CCccceeeeEEEeCCeeEE
Q 046595           64 NRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l  142 (363)
                      ......|++...++.|+.+.||++... +..+++|....... .....+.+|+.+++.+. +..+.++++++...+..++
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            344467888888898999999999864 68899999865221 22345889999999884 6778899999998889999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccC----------------------------
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV----------------------------  194 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~----------------------------  194 (363)
                      ||||++|.+|.+.+..              ......++.++..+|..||+..                            
T Consensus        88 v~e~i~G~~l~~~~~~--------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (263)
T 3tm0_A           88 LMSEADGVLCSEEYED--------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV  153 (263)
T ss_dssp             EEECCSSEEHHHHCCT--------------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred             EEEecCCeehhhccCC--------------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccc
Confidence            9999999999876421              1122367788899999999810                            


Q ss_pred             ----------------------------CCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          195 ----------------------------QPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       195 ----------------------------~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                                                  ...++|+|++|.||++++++.+.|+||+.+
T Consensus       154 ~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a  211 (263)
T 3tm0_A          154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS  211 (263)
T ss_dssp             SGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred             ccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence                                        025899999999999987666679999975

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.41  E-value=6.2e-13  Score=115.22  Aligned_cols=135  Identities=14%  Similarity=0.033  Sum_probs=97.8

Q ss_pred             CCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCc--cceeeeEEEeCCeeEEEEec
Q 046595           69 NFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEH--FVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~  146 (363)
                      .|.+..+.+.|..+.||++...+|..+++|.....    ....+..|+.+++.+.+.+  +.+++++....+..++||||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            44444333456669999998777888999997653    2245788999998885434  56688888877788999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccC--------------------------------
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV--------------------------------  194 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--------------------------------  194 (363)
                      ++|.+|.  ...            ...   ..++.+++..|..||+..                                
T Consensus        97 i~G~~l~--~~~------------~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (264)
T 1nd4_A           97 VPGQDLL--SSH------------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD  159 (264)
T ss_dssp             CSSEETT--TSC------------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred             cCCcccC--cCc------------CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence            9998884  211            111   245666777777777641                                


Q ss_pred             -----------------------CCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          195 -----------------------QPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       195 -----------------------~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                                             ...++|+|++|.||++++++.+.|+||+.+
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a  212 (264)
T 1nd4_A          160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL  212 (264)
T ss_dssp             GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred             hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhc
Confidence                                   012999999999999987766779999975

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.35  E-value=3.6e-12  Score=115.88  Aligned_cols=143  Identities=14%  Similarity=0.188  Sum_probs=104.8

Q ss_pred             CCCeeeccCCceEEEEEeCCCCeEEEEEcc--CCCCCCchHHHHHHHHHHhcCC--CCccceeeeEEEeC---CeeEEEE
Q 046595           72 TKALIGEGSYGRVFYAKLTDGTPAAIKKLD--TSSAPEPESDFAAQLSVVSRLK--HEHFVELLGYCMES---NNRILVY  144 (363)
Q Consensus        72 ~~~~lg~G~~g~V~~~~~~~~~~~avK~~~--~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~---~~~~lv~  144 (363)
                      ..+.|+.|.++.||++... +..+++|+..  ..........+.+|+.+++.+.  +..+.+++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            3456899999999999875 4678888876  3322223456788999999886  45678888888766   3478999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccC------------------------------
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV------------------------------  194 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~------------------------------  194 (363)
                      ||++|..+.+....           .++..+...++.+++..|..||+..                              
T Consensus       121 e~v~G~~l~~~~~~-----------~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (359)
T 3dxp_A          121 EFVSGRVLWDQSLP-----------GMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS  189 (359)
T ss_dssp             ECCCCBCCCCTTCT-----------TCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred             EecCCeecCCCccc-----------cCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence            99999877542211           1677888889999999999999731                              


Q ss_pred             -------------------------CCCeEEecccCCceeecCCCc--eEEeeeccCCC
Q 046595          195 -------------------------QPPIVHRDVRSSNVLLFDDFK--SKIADFNLTNQ  226 (363)
Q Consensus       195 -------------------------~~~ivH~Dlkp~Nill~~~~~--vkl~Dfg~a~~  226 (363)
                                               ...++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                     136999999999999987653  68999998753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.13  E-value=8.9e-12  Score=110.63  Aligned_cols=183  Identities=17%  Similarity=0.143  Sum_probs=118.4

Q ss_pred             CCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-CCc--cceeeeEEEeCC---eeEEEEec
Q 046595           73 KALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEH--FVELLGYCMESN---NRILVYQF  146 (363)
Q Consensus        73 ~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~~---~~~lv~e~  146 (363)
                      .+.++.|....||++.    ..+++|.....   .....+.+|..+++.+. +..  +.+++.......   ..|+||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            4568999999999864    56888885431   23467889999998873 332  445554443332   34789999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccC--------------------------------
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV--------------------------------  194 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--------------------------------  194 (363)
                      ++|.+|.+....           .++..+...++.+++..|..||+..                                
T Consensus        98 i~G~~l~~~~~~-----------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (304)
T 3sg8_A           98 IKGVPLTPLLLN-----------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELK  166 (304)
T ss_dssp             CCCEECCHHHHH-----------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSC
T ss_pred             cCCeECCccccc-----------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCC
Confidence            999888754321           1566777777778877777777510                                


Q ss_pred             -----------------------CCCeEEecccCCceeecC--CCceEEeeeccCCCCCcccccccccccccccCC---C
Q 046595          195 -----------------------QPPIVHRDVRSSNVLLFD--DFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY---H  246 (363)
Q Consensus       195 -----------------------~~~ivH~Dlkp~Nill~~--~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y---~  246 (363)
                                             ...++|+|++|.||++++  ++.+.|+||+.+.........      .....+   .
T Consensus       167 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl------~~~~~~~~~~  240 (304)
T 3sg8_A          167 GPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF------ISLMEDDEEY  240 (304)
T ss_dssp             HHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH------HTTCCTTTSC
T ss_pred             cccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH------HHHHhhcccc
Confidence                                   125899999999999998  556789999987532211100      001111   2


Q ss_pred             Ccccccc-----CC---------CCccCceehhHHHHHHHHhCCCCC
Q 046595          247 APEYAMT-----GQ---------ITQKSDVYSFGVVLLELLTGRKPV  279 (363)
Q Consensus       247 aPE~~~~-----~~---------~~~~~DvwslG~~l~ell~g~~p~  279 (363)
                      .|+....     +.         .....+.|+++.++|.+.+|..+|
T Consensus       241 ~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          241 GMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            2222110     01         112258999999999999998776

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.76  E-value=5.6e-08  Score=84.40  Aligned_cols=133  Identities=12%  Similarity=0.078  Sum_probs=95.4

Q ss_pred             eeccCCc-eEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-CCccceeeeEEEeCCeeEEEEecccCCCh
Q 046595           76 IGEGSYG-RVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVELLGYCMESNNRILVYQFATMGSL  152 (363)
Q Consensus        76 lg~G~~g-~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~g~L  152 (363)
                      +..|..| .||+.... ++..+++|+-..    .....+.+|..+|+.+. +--+.++++++.+.+..++||++++|.++
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            4556555 68988754 467789998643    23567888999988874 33477889999999999999999999888


Q ss_pred             hhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccC--------------------------------------
Q 046595          153 HDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV--------------------------------------  194 (363)
Q Consensus       153 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--------------------------------------  194 (363)
                      .+.....             ......+..++...|.-||...                                      
T Consensus       108 ~~~~~~~-------------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (272)
T 4gkh_A          108 FQVLEEY-------------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW  174 (272)
T ss_dssp             HHHHHHC-------------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred             cccccCC-------------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence            7765421             1222345555666666666431                                      


Q ss_pred             -----------------CCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          195 -----------------QPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       195 -----------------~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                                       ...++|+|+.+.||++++++.+-|+||+.+.
T Consensus       175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                             0138999999999999988777899999763

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.74  E-value=6.8e-08  Score=85.52  Aligned_cols=134  Identities=13%  Similarity=0.116  Sum_probs=88.9

Q ss_pred             CeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCC---ccceeeeEEE-eCCeeEEEEecccC
Q 046595           74 ALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE---HFVELLGYCM-ESNNRILVYQFATM  149 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e~~~~  149 (363)
                      ..++.|....||+.    +..+++|+...   ......+..|..+++.+.+.   .+.+++.++. ..+..++||++++|
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            45788888899988    56788888422   22346788999999998642   3566666664 34557899999999


Q ss_pred             CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcc------------------------------------
Q 046595          150 GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK------------------------------------  193 (363)
Q Consensus       150 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~------------------------------------  193 (363)
                      .+|.+..-..           ++..+...++.++...|..||+.                                    
T Consensus        98 ~~l~~~~~~~-----------l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~  166 (306)
T 3tdw_A           98 QILGEDGMAV-----------LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDE  166 (306)
T ss_dssp             EECHHHHHTT-----------SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCH
T ss_pred             eECchhhhhh-----------CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccch
Confidence            8886632110           23333334444444444444432                                    


Q ss_pred             ---------------------CCCCeEEecccCCceeecC---CCc-eEEeeeccCC
Q 046595          194 ---------------------VQPPIVHRDVRSSNVLLFD---DFK-SKIADFNLTN  225 (363)
Q Consensus       194 ---------------------~~~~ivH~Dlkp~Nill~~---~~~-vkl~Dfg~a~  225 (363)
                                           ....++|+|+++.||+++.   ++. +.|+||+.+.
T Consensus       167 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~  223 (306)
T 3tdw_A          167 SLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA  223 (306)
T ss_dssp             HHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence                                 1225799999999999987   455 5899999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.53  E-value=1.6e-07  Score=84.88  Aligned_cols=81  Identities=6%  Similarity=-0.018  Sum_probs=54.5

Q ss_pred             Cee-eccCCceEEEEEeC-------CCCeEEEEEccCCCC--CCchHHHHHHHHHHhcCC-C--CccceeeeEEEeC---
Q 046595           74 ALI-GEGSYGRVFYAKLT-------DGTPAAIKKLDTSSA--PEPESDFAAQLSVVSRLK-H--EHFVELLGYCMES---  137 (363)
Q Consensus        74 ~~l-g~G~~g~V~~~~~~-------~~~~~avK~~~~~~~--~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~---  137 (363)
                      +.| +.|....+|+....       ++..+++|.......  ......+..|+.+++.+. +  -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            456 77888999988654       266788887654220  101245778888888874 2  3567788776554   


Q ss_pred             CeeEEEEecccCCChhh
Q 046595          138 NNRILVYQFATMGSLHD  154 (363)
Q Consensus       138 ~~~~lv~e~~~~g~L~~  154 (363)
                      ...++|||+++|..+.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            34689999999877654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.36  E-value=1.8e-06  Score=79.26  Aligned_cols=76  Identities=14%  Similarity=0.061  Sum_probs=50.1

Q ss_pred             CCeeeccCCceEEEEEeC-CCCeEEEEEccCCCC------CCchHHHHHHHHHHhcCCC--C-ccceeeeEEEeCCeeEE
Q 046595           73 KALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSA------PEPESDFAAQLSVVSRLKH--E-HFVELLGYCMESNNRIL  142 (363)
Q Consensus        73 ~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~------~~~~~~~~~e~~~l~~l~h--~-~i~~~~~~~~~~~~~~l  142 (363)
                      .+.||.|.++.||++... +++.+++|.......      .....++..|..+++.+..  + .+.+++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            446899999999999754 468899997653211      1234567789888887732  3 34456643  3456689


Q ss_pred             EEecccCC
Q 046595          143 VYQFATMG  150 (363)
Q Consensus       143 v~e~~~~g  150 (363)
                      |||++.+.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.34  E-value=5.7e-06  Score=74.05  Aligned_cols=145  Identities=16%  Similarity=0.210  Sum_probs=78.1

Q ss_pred             eeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC--CCccceeee------EEEeCCeeEEEEec
Q 046595           75 LIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK--HEHFVELLG------YCMESNNRILVYQF  146 (363)
Q Consensus        75 ~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~------~~~~~~~~~lv~e~  146 (363)
                      .|+.|..+.||++...++ .+++|+...     ....+..|..+++.|.  .-.+.+++.      +....+..+++|+|
T Consensus        39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~-----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           39 VIQGNQMALVWKVHTDSG-AVCLKRIHR-----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             ECC----CEEEEEEETTE-EEEEEEECS-----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eccccccCcEEEEEeCCC-CEEEEecCC-----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            355567899999987654 488998864     1234445566555553  112333332      12346678899999


Q ss_pred             ccCCChh--------------hhhcCCCC-C--C-CCC-CCCCcCHHH-------------------------------H
Q 046595          147 ATMGSLH--------------DVLHGRKG-V--Q-GAE-PGPVLTWNQ-------------------------------R  176 (363)
Q Consensus       147 ~~~g~L~--------------~~l~~~~~-~--~-~~~-~~~~~~~~~-------------------------------~  176 (363)
                      ++|.++.              ..++.... .  . ... ......|..                               +
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542              11111100 0  0 000 000112211                               0


Q ss_pred             HHHHHHHHHHHHHhhc----------cCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          177 VKVAYGAAKGLEFLHE----------KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       177 ~~i~~~i~~~l~~lH~----------~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      ..+..++..++.+|+.          .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            1111223345666652          012279999999999999888899999999763

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.05  E-value=3.4e-05  Score=68.07  Aligned_cols=75  Identities=13%  Similarity=0.105  Sum_probs=59.7

Q ss_pred             CCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC---CCccceeeeEEEeCCeeEEEEecccC
Q 046595           73 KALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK---HEHFVELLGYCMESNNRILVYQFATM  149 (363)
Q Consensus        73 ~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~  149 (363)
                      .+.|+.|.+..+|+... ++..+++|+....    ....+..|...|+.|.   ...+.+++.++...+..++||||+++
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            34688999999999986 4678889986542    3567888998888883   36688899888888889999999998


Q ss_pred             CCh
Q 046595          150 GSL  152 (363)
Q Consensus       150 g~L  152 (363)
                      ..+
T Consensus       116 ~~~  118 (312)
T 3jr1_A          116 SKN  118 (312)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            765

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.04  E-value=4.4e-05  Score=66.64  Aligned_cols=80  Identities=20%  Similarity=0.291  Sum_probs=57.2

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCC---CccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKH---EHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ....-...+|.|..+.||+.+..||+.+++|+..... ......+..|+..|+.|..   --+.+++++.    ..++||
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~   89 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM   89 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence            3445566789999999999999999999999875432 2334467889998888742   2345555542    347899


Q ss_pred             ecccCCCh
Q 046595          145 QFATMGSL  152 (363)
Q Consensus       145 e~~~~g~L  152 (363)
                      ||+.++..
T Consensus        90 e~l~~~~~   97 (288)
T 3f7w_A           90 EWVDERPP   97 (288)
T ss_dssp             ECCCCCCC
T ss_pred             EeecccCC
Confidence            99987654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.03  E-value=2.1e-05  Score=72.62  Aligned_cols=76  Identities=16%  Similarity=0.179  Sum_probs=45.6

Q ss_pred             CeEEecccCCceeecCCCceEEeeeccCCCCCccccccccccccc--ccCCCCccccccC---CCCccCceehhHHHHHH
Q 046595          197 PIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG--TFGYHAPEYAMTG---QITQKSDVYSFGVVLLE  271 (363)
Q Consensus       197 ~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~DvwslG~~l~e  271 (363)
                      .++|+|+++.||+++.++ ++|+||+.+.........   ....+  ...|++|+.....   ......++.++...+|+
T Consensus       233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl---a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI---GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             EEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH---HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             eEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH---HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            799999999999998876 999999987543221111   00111  1245555543211   11223445577777887


Q ss_pred             HHhCC
Q 046595          272 LLTGR  276 (363)
Q Consensus       272 ll~g~  276 (363)
                      .+++.
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=98.03  E-value=7.6e-05  Score=66.14  Aligned_cols=165  Identities=18%  Similarity=0.224  Sum_probs=87.8

Q ss_pred             ccCHHHHHHHhcCCCCCC-----eeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCc--cce
Q 046595           57 QIKLDELNRLTSNFGTKA-----LIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEH--FVE  129 (363)
Q Consensus        57 ~~~~~~~~~~~~~y~~~~-----~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~  129 (363)
                      .+..+++..+..+|.+..     .|+.|....+|++...++ .+++|......   ....+..|..+++.+...+  +.+
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~   81 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPL   81 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCc
Confidence            455667777777787632     355677889999987655 68888876521   2234566777777663211  233


Q ss_pred             eeeE------EEeCCeeEEEEecccCCChhh--------------hhcCCC-CCCCCC--CCCCcCHHHHHH--------
Q 046595          130 LLGY------CMESNNRILVYQFATMGSLHD--------------VLHGRK-GVQGAE--PGPVLTWNQRVK--------  178 (363)
Q Consensus       130 ~~~~------~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~-~~~~~~--~~~~~~~~~~~~--------  178 (363)
                      ++..      ....+..+++++|++|..+..              .++... ......  ......|...+.        
T Consensus        82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~  161 (322)
T 2ppq_A           82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE  161 (322)
T ss_dssp             BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred             ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence            3321      223456789999999865421              111110 000000  000011211100        


Q ss_pred             ----HHHHHHHHHHHhhcc----CCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          179 ----VAYGAAKGLEFLHEK----VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       179 ----i~~~i~~~l~~lH~~----~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                          +...+...+..++..    ...+++|+|+.+.||++++++.+.|+||+.+.
T Consensus       162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                001123334444421    12279999999999999887666899998763

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.92  E-value=0.00022  Score=63.31  Aligned_cols=93  Identities=9%  Similarity=0.037  Sum_probs=57.2

Q ss_pred             ccCHHHHHHHhcCCCC-----CCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCC--Cccce
Q 046595           57 QIKLDELNRLTSNFGT-----KALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKH--EHFVE  129 (363)
Q Consensus        57 ~~~~~~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~  129 (363)
                      .+..+.+..+...|.+     ...|+ |....||++...+|+.+++|......  .....+..|..+++.+..  -.+++
T Consensus        10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~~~g~~vp~   86 (328)
T 1zyl_A           10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAA   86 (328)
T ss_dssp             CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred             CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHHHcCCeecc
Confidence            3444555554454543     23466 88889999887778789999986321  234567778888777732  12344


Q ss_pred             eeeE-----EEeCCeeEEEEecccCCCh
Q 046595          130 LLGY-----CMESNNRILVYQFATMGSL  152 (363)
Q Consensus       130 ~~~~-----~~~~~~~~lv~e~~~~g~L  152 (363)
                      ++..     ....+..+++|++++|..+
T Consensus        87 ~~~~~g~~~~~~~g~~~~l~~~i~G~~~  114 (328)
T 1zyl_A           87 PVAFNGQTLLNHQGFYFAVFPSVGGRQF  114 (328)
T ss_dssp             CCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             eeecCCcEEEEECCEEEEEEEecCCCCC
Confidence            4432     2234566789999987543

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.87  E-value=5.6e-05  Score=66.43  Aligned_cols=71  Identities=11%  Similarity=0.078  Sum_probs=44.6

Q ss_pred             CCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCcc-ceeeeEEEeCCeeEEEEecc-cCC
Q 046595           73 KALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF-VELLGYCMESNNRILVYQFA-TMG  150 (363)
Q Consensus        73 ~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~-~~g  150 (363)
                      .+.|+.|....+|++     ..+++|+......  .......|+.+++.+...++ .+++.+  +.+.-+++++|+ .|.
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~--~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE--EYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCcc--ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence            567888999999999     5688888765311  11233567777777642222 455543  344457899999 664


Q ss_pred             Ch
Q 046595          151 SL  152 (363)
Q Consensus       151 ~L  152 (363)
                      +|
T Consensus        94 ~l   95 (301)
T 3dxq_A           94 TM   95 (301)
T ss_dssp             EC
T ss_pred             cC
Confidence            44

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.83  E-value=7.6e-05  Score=66.56  Aligned_cols=76  Identities=11%  Similarity=0.096  Sum_probs=39.4

Q ss_pred             eeeccCCce-EEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC--CCccceeeeEEEeCCeeEEEEecccCCC
Q 046595           75 LIGEGSYGR-VFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK--HEHFVELLGYCMESNNRILVYQFATMGS  151 (363)
Q Consensus        75 ~lg~G~~g~-V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~g~  151 (363)
                      .|+.|.... +|+....++..+++|.......    ..+..|+.+++.+.  .-.+.+++.+...  .-+++||++.+..
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~--~g~ll~e~l~~~~   98 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEHA--RGLLLIEDLGDAL   98 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEETT--TTEEEECCCCSCB
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecCC--CCEEEEeeCCCcc
Confidence            455554444 6677654467787776543211    23445666666663  2235566665332  2378999997766


Q ss_pred             hhhhh
Q 046595          152 LHDVL  156 (363)
Q Consensus       152 L~~~l  156 (363)
                      +.+.+
T Consensus        99 l~~~l  103 (333)
T 3csv_A           99 FTEVI  103 (333)
T ss_dssp             HHHHH
T ss_pred             hHHHh
Confidence            65544

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.74  E-value=4.6e-05  Score=62.40  Aligned_cols=103  Identities=17%  Similarity=0.141  Sum_probs=67.0

Q ss_pred             CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCc
Q 046595          150 GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       150 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      .+|.++|.....        ++++.++|.++.|.+.+|.-+-...  .-..+=+.|..|++..+|.|.+.+ +.+.    
T Consensus        33 vSL~eIL~~~~~--------PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----   97 (229)
T 2yle_A           33 LSLEEILRLYNQ--------PINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD----   97 (229)
T ss_dssp             EEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C-------
T ss_pred             ccHHHHHHHcCC--------CcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc----
Confidence            379999987653        5999999999999999987762210  111333557999999999998864 1110    


Q ss_pred             ccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCC
Q 046595          230 TAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKP  278 (363)
Q Consensus       230 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p  278 (363)
                                .....+.|||... ...+.+.=|||||++||..+--..|
T Consensus        98 ----------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ----------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ----------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                      1123567888653 3456777899999999999875443

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.67  E-value=0.00016  Score=66.92  Aligned_cols=72  Identities=18%  Similarity=0.232  Sum_probs=48.1

Q ss_pred             CeeeccCCceEEEEEeCC--------CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCc-cceeeeEEEeCCeeEEEE
Q 046595           74 ALIGEGSYGRVFYAKLTD--------GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEH-FVELLGYCMESNNRILVY  144 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~--------~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~  144 (363)
                      +.|+.|....+|++...+        +..+++|+....   .....+..|..+++.+...+ ..++++.+.  +  .+|+
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~  151 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE  151 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence            457778889999998653        478899887431   22245668998888884333 356666543  2  3899


Q ss_pred             ecccCCCh
Q 046595          145 QFATMGSL  152 (363)
Q Consensus       145 e~~~~g~L  152 (363)
                      +|++|.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986444

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.64  E-value=0.00013  Score=66.21  Aligned_cols=145  Identities=12%  Similarity=0.125  Sum_probs=81.5

Q ss_pred             CeeeccCCceEEEEEeC--------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-CCccceeeeEEEeCCeeEEEE
Q 046595           74 ALIGEGSYGRVFYAKLT--------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~--------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      +.|..|-...+|++...        +++.+++|+...  .......+.+|..+++.|. +.-..++++.+.+    .+||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~--~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA--ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC--ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            45777888999999864        247889988633  2234566778999998884 3333566665543    2899


Q ss_pred             ecccCCChhhh--------------hcCCCCCCCCCCCCCc--CHHHHHHHHHHHHH-------------------HHHH
Q 046595          145 QFATMGSLHDV--------------LHGRKGVQGAEPGPVL--TWNQRVKVAYGAAK-------------------GLEF  189 (363)
Q Consensus       145 e~~~~g~L~~~--------------l~~~~~~~~~~~~~~~--~~~~~~~i~~~i~~-------------------~l~~  189 (363)
                      ||++|.+|..-              +..-..... ..+...  -+.++.++..++-.                   .+..
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~-~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  208 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEM-PFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN  208 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCC-SSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCC-CCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence            99998655311              000000000 001111  24455555544321                   1222


Q ss_pred             h----hcc-CCCCeEEecccCCceeecCC----CceEEeeeccCC
Q 046595          190 L----HEK-VQPPIVHRDVRSSNVLLFDD----FKSKIADFNLTN  225 (363)
Q Consensus       190 l----H~~-~~~~ivH~Dlkp~Nill~~~----~~vkl~Dfg~a~  225 (363)
                      |    ... ....++|+|+.+.||+++.+    +.+.|+||..+.
T Consensus       209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            2    211 12268999999999999876    789999999764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.52  E-value=0.00029  Score=65.49  Aligned_cols=73  Identities=11%  Similarity=0.079  Sum_probs=46.3

Q ss_pred             CeeeccCCceEEEEEeCC-CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCcc-ceeeeEEEeCCeeEEEEecccCCC
Q 046595           74 ALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF-VELLGYCMESNNRILVYQFATMGS  151 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~-~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~g~  151 (363)
                      +.|+.|-...+|++...+ +..+++|+.....  ........|..+++.|...++ .++++.+.  +  .+|++|++|.+
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-C--CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            356778889999998764 4778888874421  112223688888888864444 56666652  2  35999998755


Q ss_pred             h
Q 046595          152 L  152 (363)
Q Consensus       152 L  152 (363)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.48  E-value=0.00015  Score=65.61  Aligned_cols=73  Identities=12%  Similarity=0.092  Sum_probs=43.2

Q ss_pred             CeeeccCCceEEEEEeCC---------CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCc-cceeeeEEEeCCeeEEE
Q 046595           74 ALIGEGSYGRVFYAKLTD---------GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEH-FVELLGYCMESNNRILV  143 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~---------~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv  143 (363)
                      +.|+.|....+|++...+         +..+++|+.....  ........|..+++.+...+ +.++++..  .  -++|
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV--DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG--GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc--cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            356778889999997653         2678888865421  11123467888888774323 44666543  2  3689


Q ss_pred             EecccCCCh
Q 046595          144 YQFATMGSL  152 (363)
Q Consensus       144 ~e~~~~g~L  152 (363)
                      |+|++|.++
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.40  E-value=0.00071  Score=60.41  Aligned_cols=29  Identities=24%  Similarity=0.352  Sum_probs=26.3

Q ss_pred             CeEEecccCCceeecCCCceEEeeeccCC
Q 046595          197 PIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       197 ~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      .++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~  235 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPM  235 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence            69999999999999988889999998654

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.86  E-value=0.0022  Score=58.84  Aligned_cols=73  Identities=12%  Similarity=0.072  Sum_probs=47.3

Q ss_pred             CeeeccCCceEEEEEeCC--------CCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-CCccceeeeEEEeCCeeEEEE
Q 046595           74 ALIGEGSYGRVFYAKLTD--------GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~--------~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      +.|..|-...+|++...+        +..+++++.....  .......+|..+++.+. +.-..++++.+  .  -++|+
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~  149 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE  149 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence            456668888999997653        5788998865421  22223467888888774 32345555432  2  37899


Q ss_pred             ecccCCCh
Q 046595          145 QFATMGSL  152 (363)
Q Consensus       145 e~~~~g~L  152 (363)
                      +|++|.+|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.40  E-value=0.0041  Score=56.82  Aligned_cols=28  Identities=29%  Similarity=0.519  Sum_probs=24.1

Q ss_pred             eEEecccCCceee------cCCCceEEeeeccCC
Q 046595          198 IVHRDVRSSNVLL------FDDFKSKIADFNLTN  225 (363)
Q Consensus       198 ivH~Dlkp~Nill------~~~~~vkl~Dfg~a~  225 (363)
                      ++|+|+.+.||++      +++..++++||.+|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            5799999999999      456789999999874

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=95.08  E-value=0.078  Score=43.31  Aligned_cols=116  Identities=9%  Similarity=0.114  Sum_probs=78.2

Q ss_pred             CCCccceeeeEEEeCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEec
Q 046595          123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRD  202 (363)
Q Consensus       123 ~h~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~D  202 (363)
                      .||+++.. .+-.+.+.+.+.++.-..+.=+..+..            ++..+.++++.+|+....+++..     +|--
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~------------~~~~eKlr~l~ni~~l~~~~~~r-----~tf~  104 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS------------FTKNEKLRYLLNIKNLEEVNRTR-----YTFV  104 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG------------SCHHHHHHHHHHGGGGGGGGGSS-----EECC
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh------------cCHHHHHHHHHHHHHHHHHhcCc-----eEEE
Confidence            68888877 456666666666665443222222332            78899999999999988666654     7889


Q ss_pred             ccCCceeecCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCC
Q 046595          203 VRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD  280 (363)
Q Consensus       203 lkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~  280 (363)
                      |.|+||+++.++.+++.-.|+-..                   ++|.     ..+...=+-.+=+++..+++++..|+
T Consensus       105 L~P~NL~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          105 LAPDELFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             CSGGGEEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EecceEEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999999999987775221                   1221     11111122345678888999988885

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=94.82  E-value=0.1  Score=42.84  Aligned_cols=82  Identities=7%  Similarity=-0.001  Sum_probs=61.3

Q ss_pred             CCCccceeeeEEEeCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHH-HhhccCCCCeEEe
Q 046595          123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE-FLHEKVQPPIVHR  201 (363)
Q Consensus       123 ~h~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~-~lH~~~~~~ivH~  201 (363)
                      .||++  --.+-.+.+.+.+.++.-.++.=+..+..            ++..+.++++.+++.... ++++     -+|-
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~------------~~~~eKlrll~nl~~L~~~~~~~-----r~tf  108 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK------------TTLLSRIRAAIHLVSKVKHHSAR-----RLIF  108 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT------------SCHHHHHHHHHHHHHHHSSCCSS-----SEEC
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh------------cCHHHHHHHHHHHHHHHHHhhhC-----ceeE
Confidence            57888  33344667777777776644433444432            788999999999988777 5654     4888


Q ss_pred             cccCCceeecCCCceEEeeecc
Q 046595          202 DVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       202 Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      -|.|+||+++.++.++|.-.|+
T Consensus       109 ~l~P~NL~f~~~~~p~i~hRGi  130 (219)
T 4ano_A          109 IVCPENLMFNRALEPFFLHVGV  130 (219)
T ss_dssp             CCCGGGEEECTTCCEEESCCEE
T ss_pred             EEeCceEEEeCCCcEEEEEcCC
Confidence            8999999999999999987775

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=83.77  E-value=0.17  Score=46.90  Aligned_cols=62  Identities=5%  Similarity=0.102  Sum_probs=18.0

Q ss_pred             CCCeeeccCCceEEEEEeCC-CCeEEE------EEccCCC-CCCchHHHHHHHHHHhcCCCCccceeeeEEEe
Q 046595           72 TKALIGEGSYGRVFYAKLTD-GTPAAI------KKLDTSS-APEPESDFAAQLSVVSRLKHEHFVELLGYCME  136 (363)
Q Consensus        72 ~~~~lg~G~~g~V~~~~~~~-~~~~av------K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  136 (363)
                      +.+.||   ||.||++.+.. ..+||+      |..+... ..+....+.+|..+++.++|||+++.+++...
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            455666   99999997753 457888      6554422 22233567888889999999999999887653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	363
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-66
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-63
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-62
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-61
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-60
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-60
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-60
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-59
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-58
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-58
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-58
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	9e-58
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-57
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-57
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-57
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-56
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-56
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-55
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-53
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-53
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-53
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-52
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-52
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-52
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-51
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-51
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	8e-51
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-50
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-50
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-48
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-47
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-44
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-43
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-43
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-42
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-42
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-41
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-41
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	7e-41
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-40
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-40
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-39
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-39
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	9e-38
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-37
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-37
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-36
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-36
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-35
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-34
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-34
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-33
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-33
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-32
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-31
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-31
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-31
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-28
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-27
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-26
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-25
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-24
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-14

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 4e-66
 Identities = 70/299 (23%), Positives = 129/299 (43%), Gaps = 31/299 (10%)

Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSA-PEPESDFAAQLSVVS 120
           E+            IG GS+G V+  K       A+K L+ ++  P+    F  ++ V+ 
Sbjct: 4   EIPD--GQITVGQRIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLR 59

Query: 121 RLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
           + +H + +  +GY   +    +V Q+    SL+  LH  +              + + +A
Sbjct: 60  KTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--------FEMIKLIDIA 110

Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
              A+G+++LH K    I+HRD++S+N+ L +D   KI DF L    S  +      ++ 
Sbjct: 111 RQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 167

Query: 241 GTFGYHAPEYAMT---GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR 297
           G+  + APE          + +SDVY+FG+VL EL+TG+ P  +   + Q          
Sbjct: 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--------- 218

Query: 298 LSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP 356
                V +       +         +  + A C++ + D RP    ++ +++ L  S P
Sbjct: 219 --IFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 3e-63
 Identities = 68/293 (23%), Positives = 120/293 (40%), Gaps = 31/293 (10%)

Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSR 121
           E+ R          +G G +G V+       T  A+K L   S       F A+ +++ +
Sbjct: 9   EVPR--ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQ 64

Query: 122 LKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY 181
           L+H+  V L     +     ++ ++   GSL D L    G++       LT N+ + +A 
Sbjct: 65  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-------LTINKLLDMAA 116

Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG 241
             A+G+ F+ E+     +HRD+R++N+L+ D    KIADF L     D            
Sbjct: 117 QIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKF 172

Query: 242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED 301
              + APE    G  T KSDV+SFG++L E++T  +     M   +              
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV-----------IQ 221

Query: 302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS 354
            +++       ++ P     +L  +  LC +   + RP    +   L+    +
Sbjct: 222 NLERGYRMVRPDNCPE----ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (508), Expect = 2e-62
 Identities = 67/318 (21%), Positives = 119/318 (37%), Gaps = 35/318 (11%)

Query: 52  PIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSA 105
           P ++P     E  R  +       +G G++G+V  A              A+K L  S+ 
Sbjct: 9   PTQLPYDHKWEFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 66

Query: 106 PEPESDFAAQLSVVSRLK-HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKG--- 161
                   ++L V+S L  H + V LLG C      +++ ++   G L + L  ++    
Sbjct: 67  LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 126

Query: 162 ------VQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK 215
                     +    L     +  +Y  AKG+ FL  K     +HRD+ + N+LL     
Sbjct: 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRI 183

Query: 216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTG 275
           +KI DF L     + +  +          + APE       T +SDV+S+G+ L EL + 
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243

Query: 276 RKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEA 335
                  MP               + K  + +        P  A A++  +   C   + 
Sbjct: 244 GSSPYPGMP--------------VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289

Query: 336 DFRPNMTIVVKALQPLLN 353
             RP    +V+ ++  ++
Sbjct: 290 LKRPTFKQIVQLIEKQIS 307

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 3e-61
 Identities = 66/302 (21%), Positives = 118/302 (39%), Gaps = 35/302 (11%)

Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCM 135
           IG+G +G V+  K   G   A+K   +    E      A++     L+HE+ +  +    
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADN 67

Query: 136 ESNNRI----LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           + N       LV  +   GSL D L+             +T    +K+A   A GL  LH
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLH 117

Query: 192 EKV-----QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ--SSDTAARLHSTRVLGTFG 244
            ++     +P I HRD++S N+L+  +    IAD  L  +  S+     +     +GT  
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177

Query: 245 YHAPEYAMT------GQITQKSDVYSFGVVLLELLTGRKP----VDHTMPKGQQSLVTWA 294
           Y APE           +  +++D+Y+ G+V  E+           D+ +P         +
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237

Query: 295 TPRLSEDKVKQCVDPKLNNDY-PPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN 353
              + +   +Q + P + N +   +A+  +A +   C       R     + K L  L  
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297

Query: 354 SK 355
            +
Sbjct: 298 QE 299

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  195 bits (496), Expect = 1e-60
 Identities = 68/315 (21%), Positives = 124/315 (39%), Gaps = 39/315 (12%)

Query: 59  KLDELNRLTSNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDF 112
           KL  L    +N      IGEG++GRVF A+          T  A+K L   ++ + ++DF
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 113 AAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKG----------- 161
             + ++++   + + V+LLG C       L++++   G L++ L                
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 162 ----VQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSK 217
                  +   P L+  +++ +A   A G+ +L E      VHRD+ + N L+ ++   K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180

Query: 218 IADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRK 277
           IADF L+                    +  PE     + T +SDV+++GVVL E+ +   
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240

Query: 278 PVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADF 337
              + M   +               V+         + P     +L  +  LC       
Sbjct: 241 QPYYGMAHEEVI-----------YYVRDGNILACPENCPL----ELYNLMRLCWSKLPAD 285

Query: 338 RPNMTIVVKALQPLL 352
           RP+   + + LQ + 
Sbjct: 286 RPSFCSIHRILQRMC 300

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 1e-60
 Identities = 71/295 (24%), Positives = 126/295 (42%), Gaps = 37/295 (12%)

Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSR 121
            LN           IG+G +G V       G   A+K +   +  +    F A+ SV+++
Sbjct: 3   ALNM--KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ---AFLAEASVMTQ 56

Query: 122 LKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
           L+H + V+LLG  +E    + +V ++   GSL D L  R          VL  +  +K +
Sbjct: 57  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFS 109

Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
               + +E+L        VHRD+ + NVL+ +D  +K++DF LT ++S T          
Sbjct: 110 LDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGK 161

Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE 300
               + APE     + + KSDV+SFG++L E+ +  +      P  +  L          
Sbjct: 162 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVV------ 210

Query: 301 DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK 355
            +V++       +  PP     +  V   C   +A  RP+   + + L+ +   +
Sbjct: 211 PRVEKGYKMDAPDGCPP----AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 8e-60
 Identities = 64/287 (22%), Positives = 114/287 (39%), Gaps = 29/287 (10%)

Query: 68  SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           S       IG G +G V      +    AIK +   +    E DF  +  V+ +L H   
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKL 62

Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
           V+L G C+E     LV++F   G L D L  ++G+              + +     +G+
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF--------AAETLLGMCLDVCEGM 114

Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
            +L E     ++HRD+ + N L+ ++   K++DF +T    D      ST       + +
Sbjct: 115 AYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWAS 170

Query: 248 PEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCV 307
           PE     + + KSDV+SFGV++ E+ +  K                     S  +V + +
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---------------SNSEVVEDI 215

Query: 308 DPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS 354
                   P  A   +  +   C +   + RP  + +++ L  +  S
Sbjct: 216 STGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 2e-59
 Identities = 70/311 (22%), Positives = 119/311 (38%), Gaps = 36/311 (11%)

Query: 51  LPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTD----GTPAAIKKLDTSSAP 106
           L   +  + +   + L  +F    +IG G +G V++  L D        A+K L+  +  
Sbjct: 13  LVQAVQHVVIGP-SSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI 69

Query: 107 EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGA 165
              S F  +  ++    H + + LLG C+ S     +V  +   G L + +         
Sbjct: 70  GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE------ 123

Query: 166 EPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN 225
                 T    +      AKG++FL        VHRD+ + N +L + F  K+ADF L  
Sbjct: 124 --THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178

Query: 226 Q--SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTM 283
                +  +  + T       + A E   T + T KSDV+SFGV+L EL+T   P     
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----- 233

Query: 284 PKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTI 343
           P    +             + Q          P      L  V   C   +A+ RP+ + 
Sbjct: 234 PYPDVNTFDIT------VYLLQGRRLLQPEYCPD----PLYEVMLKCWHPKAEMRPSFSE 283

Query: 344 VVKALQPLLNS 354
           +V  +  + ++
Sbjct: 284 LVSRISAIFST 294

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 1e-58
 Identities = 59/282 (20%), Positives = 107/282 (37%), Gaps = 29/282 (10%)

Query: 68  SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
            +      +G G +G V Y K       AIK +   S  E E  F  +  V+  L HE  
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE--FIEEAKVMMNLSHEKL 61

Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
           V+L G C +     ++ ++   G L + L   +              Q +++     + +
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--------FQTQQLLEMCKDVCEAM 113

Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           E+L  K     +HRD+ + N L+ D    K++DF L+    D      S        +  
Sbjct: 114 EYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSP 169

Query: 248 PEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCV 307
           PE  M  + + KSD+++FGV++ E+ +  K         +             + + Q +
Sbjct: 170 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-----------AEHIAQGL 218

Query: 308 DPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ 349
                +        K+  +   C   +AD RP   I++  + 
Sbjct: 219 RLYRPHLASE----KVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 2e-58
 Identities = 73/326 (22%), Positives = 126/326 (38%), Gaps = 43/326 (13%)

Query: 51  LPIEIPQIKLD---ELNRLTSNFGTKALIGEGSYGRVFYAKLTD------GTPAAIKKLD 101
             ++  + + D   E  R   N     ++G G++G+V  A              A+K L 
Sbjct: 19  FYVDFREYEYDLKWEFPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK 76

Query: 102 TSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRK 160
             +         ++L ++++L  HE+ V LLG C  S    L++++   G L + L  ++
Sbjct: 77  EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKR 136

Query: 161 G--------------VQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSS 206
                          ++  E   VLT+   +  AY  AKG+EFL  K     VHRD+ + 
Sbjct: 137 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193

Query: 207 NVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFG 266
           NVL+      KI DF L       +  +          + APE    G  T KSDV+S+G
Sbjct: 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYG 253

Query: 267 VVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAV 326
           ++L E+ +        +P                    + +      D P  A  ++  +
Sbjct: 254 ILLWEIFSLGVNPYPGIPVDAN--------------FYKLIQNGFKMDQPFYATEEIYII 299

Query: 327 AALCVQYEADFRPNMTIVVKALQPLL 352
              C  +++  RP+   +   L   L
Sbjct: 300 MQSCWAFDSRKRPSFPNLTSFLGCQL 325

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 3e-58
 Identities = 63/293 (21%), Positives = 117/293 (39%), Gaps = 32/293 (10%)

Query: 68  SNFGTKALIGEGSYGRVFYAKLTDGT-----PAAIKKLDTSSAPEPESDFAAQLSVVSRL 122
           S    + +IG G +G V+   L   +     P AIK L      +   DF  +  ++ + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
            H + + L G   +    +++ ++   G+L   L  + G          +  Q V +  G
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--------FSVLQLVGMLRG 118

Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST-RVLG 241
            A G+++L        VHRD+ + N+L+  +   K++DF L+    D     ++T     
Sbjct: 119 IAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175

Query: 242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED 301
              + APE     + T  SDV+SFG+V+ E++T  +     +               S  
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL---------------SNH 220

Query: 302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS 354
           +V + ++       P    + +  +   C Q E   RP    +V  L  L+ +
Sbjct: 221 EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 9e-58
 Identities = 55/225 (24%), Positives = 91/225 (40%), Gaps = 16/225 (7%)

Query: 67  TSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHE 125
             +F   + +G G+ G VF       G   A K +     P   +    +L V+      
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64

Query: 126 HFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAK 185
           + V   G         +  +    GSL  VL              +      KV+    K
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---------IPEQILGKVSIAVIK 115

Query: 186 GLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGY 245
           GL +L EK    I+HRDV+ SN+L+    + K+ DF ++ Q  D+     +   +GT  Y
Sbjct: 116 GLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSY 169

Query: 246 HAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSL 290
            +PE       + +SD++S G+ L+E+  GR P+     K  + +
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  186 bits (474), Expect = 2e-57
 Identities = 67/311 (21%), Positives = 120/311 (38%), Gaps = 42/311 (13%)

Query: 60  LDELNRLTSNFGTKA---------LIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAP 106
            ++ N     F  +          +IG G +G V    L          AIK L +    
Sbjct: 9   FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68

Query: 107 EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAE 166
           +   DF ++ S++ +  H + + L G   +S   +++ +F   GSL   L    G     
Sbjct: 69  KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF--- 125

Query: 167 PGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ 226
                T  Q V +  G A G+++L        VHRD+ + N+L+  +   K++DF L+  
Sbjct: 126 -----TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177

Query: 227 SSDTAARLHSTRVLG---TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTM 283
             D  +    T  LG      + APE     + T  SDV+S+G+V+ E+++  +     M
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237

Query: 284 PKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTI 343
                          +   V   ++       P    + L  +   C Q + + RP    
Sbjct: 238 ---------------TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282

Query: 344 VVKALQPLLNS 354
           +V  L  ++ +
Sbjct: 283 IVNTLDKMIRN 293

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 2e-57
 Identities = 70/316 (22%), Positives = 134/316 (42%), Gaps = 39/316 (12%)

Query: 52  PIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLTDG---TPAAIKKLDTSSAPEP 108
           P   P +  +++      F     IGEG++G+V  A++        AAIK++   ++ + 
Sbjct: 1   PTIYPVLDWNDIK-----FQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD 53

Query: 109 ESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQ---- 163
             DFA +L V+ +L  H + + LLG C       L  ++A  G+L D L   + ++    
Sbjct: 54  HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 113

Query: 164 ---GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD 220
                     L+  Q +  A   A+G+++L +K     +HRD+ + N+L+ +++ +KIAD
Sbjct: 114 FAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 170

Query: 221 FNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
           F L   S      +  T       + A E       T  SDV+S+GV+L E+++      
Sbjct: 171 FGL---SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-- 225

Query: 281 HTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPN 340
              P    +           +K+ Q    +   +   +       +   C + +   RP+
Sbjct: 226 ---PYCGMTCAELY------EKLPQGYRLEKPLNCDDEVY----DLMRQCWREKPYERPS 272

Query: 341 MTIVVKALQPLLNSKP 356
              ++ +L  +L  + 
Sbjct: 273 FAQILVSLNRMLEERK 288

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 9e-57
 Identities = 62/291 (21%), Positives = 125/291 (42%), Gaps = 31/291 (10%)

Query: 76  IGEGSYGRVFYAKL---TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLG 132
           +G G++G V              AIK L   +      +   +  ++ +L + + V L+G
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
            C ++   +LV + A  G LH  L G++          +  +   ++ +  + G+++L E
Sbjct: 77  VC-QAEALMLVMEMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVSMGMKYLEE 127

Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ-SSDTAARLHSTRVLGTFGYHAPEYA 251
           K     VHRD+ + NVLL +   +KI+DF L+    +D +     +       ++APE  
Sbjct: 128 K---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184

Query: 252 MTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKL 311
              + + +SDV+S+GV + E L+  +                   ++   +V   ++   
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQK---------------PYKKMKGPEVMAFIEQGK 229

Query: 312 NNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGPEAQ 362
             + PP+   +L A+ + C  Y+ + RP+   V + ++    S  +  E  
Sbjct: 230 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 280

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  184 bits (467), Expect = 2e-56
 Identities = 64/302 (21%), Positives = 121/302 (40%), Gaps = 31/302 (10%)

Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVS 120
           E+ R  ++   K  +G G YG V+           A+K L   +      +F  + +V+ 
Sbjct: 13  EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMK 68

Query: 121 RLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
            +KH + V+LLG C       ++ +F T G+L D L              ++    + +A
Sbjct: 69  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-------QEVSAVVLLYMA 121

Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
              +  +E+L +K     +HRD+ + N L+ ++   K+ADF L+   +      H     
Sbjct: 122 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGAK 177

Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE 300
               + APE     + + KSDV++FGV+L E+ T                     P +  
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY---------------PGIDL 222

Query: 301 DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGPE 360
            +V + ++     + P     K+  +   C Q+    RP+   + +A + +        E
Sbjct: 223 SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 282

Query: 361 AQ 362
            +
Sbjct: 283 VE 284

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 7e-56
 Identities = 76/301 (25%), Positives = 123/301 (40%), Gaps = 33/301 (10%)

Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSR 121
           E+ R   +   +  +G+G +G V+       T  AIK L   +       F  +  V+ +
Sbjct: 13  EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKK 68

Query: 122 LKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY 181
           L+HE  V+L           +V ++ + GSL D L G  G         L   Q V +A 
Sbjct: 69  LRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETG-------KYLRLPQLVDMAA 120

Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG 241
             A G+ ++    +   VHRD+R++N+L+ ++   K+ADF L     D            
Sbjct: 121 QIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKF 176

Query: 242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED 301
              + APE A+ G+ T KSDV+SFG++L EL T  +                  P +   
Sbjct: 177 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY---------------PGMVNR 221

Query: 302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGPEA 361
           +V   V+       PP+    L  +   C + E + RP    +   L+    S    P+ 
Sbjct: 222 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE--PQY 279

Query: 362 Q 362
           Q
Sbjct: 280 Q 280

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 4e-55
 Identities = 75/315 (23%), Positives = 131/315 (41%), Gaps = 36/315 (11%)

Query: 54  EIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAKLT--------DGTPAAIKKLDTSSA 105
           E+P+    EL R          +GEG++G+V  A+            T  A+K L + + 
Sbjct: 1   ELPEDPRWELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 58

Query: 106 PEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKG--- 161
            +  SD  +++ ++  + KH++ + LLG C +     ++ ++A+ G+L + L  R+    
Sbjct: 59  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118

Query: 162 ----VQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSK 217
                    P   L+    V  AY  A+G+E+L  K     +HRD+ + NVL+ +D   K
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMK 175

Query: 218 IADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRK 277
           IADF L            +T       + APE       T +SDV+SFGV+L E+ T   
Sbjct: 176 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235

Query: 278 PVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADF 337
                +P                +++ + +      D P     +L  +   C       
Sbjct: 236 SPYPGVP---------------VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQ 280

Query: 338 RPNMTIVVKALQPLL 352
           RP    +V+ L  ++
Sbjct: 281 RPTFKQLVEDLDRIV 295

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 2e-53
 Identities = 68/298 (22%), Positives = 122/298 (40%), Gaps = 27/298 (9%)

Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQ 115
           E+ R          +G+GS+G V+             T  AIK ++ +++     +F  +
Sbjct: 16  EVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73

Query: 116 LSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEP-GPVLTWN 174
            SV+      H V LLG   +    +++ +  T G L   L   +      P     + +
Sbjct: 74  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133

Query: 175 QRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARL 234
           + +++A   A G+ +L+       VHRD+ + N ++ +DF  KI DF +T    +T    
Sbjct: 134 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190

Query: 235 HSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWA 294
              + L    + +PE    G  T  SDV+SFGVVL E+ T  +     +           
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL----------- 239

Query: 295 TPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL 352
               S ++V + V      D P      L  +  +C QY    RP+   ++ +++  +
Sbjct: 240 ----SNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 2e-53
 Identities = 63/281 (22%), Positives = 119/281 (42%), Gaps = 35/281 (12%)

Query: 76  IGEGSYGRVFYAKLTD---GTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELL 131
           +G G++G V              A+K L   +  P  + +  A+ +V+ +L + + V ++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74

Query: 132 GYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLH 191
           G C E+ + +LV + A +G L+  L   +          +     +++ +  + G+++L 
Sbjct: 75  GIC-EAESWMLVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLE 124

Query: 192 EKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ-SSDTAARLHSTRVLGTFGYHAPEY 250
           E      VHRD+ + NVLL     +KI+DF L+    +D       T       ++APE 
Sbjct: 125 ES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181

Query: 251 AMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDP 309
               + + KSDV+SFGV++ E  + G+KP                   +   +V   ++ 
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG----------------MKGSEVTAMLEK 225

Query: 310 KLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQP 350
                 P     ++  +  LC  Y+ + RP    V   L+ 
Sbjct: 226 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 3e-53
 Identities = 59/284 (20%), Positives = 111/284 (39%), Gaps = 29/284 (10%)

Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPE-SDFAAQLSVVSRLKHEH 126
           ++     IG GSYGR    +  +DG     K+LD  S  E E     ++++++  LKH +
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 127 FVELLGYCMESNNRIL--VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            V      ++  N  L  V ++   G L  V+      +G +    L     ++V     
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT-----KGTKERQYLDEEFVLRVMTQLT 119

Query: 185 KGLEFLHEK--VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
             L+  H +      ++HRD++ +NV L      K+ DF L    +   +   +   +GT
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGT 177

Query: 243 FGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK 302
             Y +PE        +KSD++S G +L EL     P      K                K
Sbjct: 178 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA------------GK 225

Query: 303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK 346
           +++    ++   Y  +       +    +  +   RP++  +++
Sbjct: 226 IREGKFRRIPYRYSDELN----EIITRMLNLKDYHRPSVEEILE 265

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 1e-52
 Identities = 60/284 (21%), Positives = 108/284 (38%), Gaps = 32/284 (11%)

Query: 75  LIGEGSYGRVFYAKLTD-----GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVE 129
           ++G G++G V+             P AIK+L  +++P+   +   +  V++ + + H   
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75

Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           LLG C+ S  + L+ Q    G L D +   K                +      AKG+ +
Sbjct: 76  LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNI--------GSQYLLNWCVQIAKGMNY 126

Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE 249
           L ++    +VHRD+ + NVL+      KI DF L           H+        + A E
Sbjct: 127 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 250 YAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDP 309
             +    T +SDV+S+GV + EL+T        +P                 ++   ++ 
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---------------ASEISSILEK 228

Query: 310 KLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN 353
                 PP     +  +   C   +AD RP    ++     +  
Sbjct: 229 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 4e-52
 Identities = 66/272 (24%), Positives = 117/272 (43%), Gaps = 34/272 (12%)

Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYC 134
           +G+G++G+V+ A+  +    AA K +DT S  E E D+  ++ +++   H + V+LL   
Sbjct: 20  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASCDHPNIVKLLDAF 78

Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
              NN  ++ +F   G++  V+   +          LT +Q   V       L +LH+  
Sbjct: 79  YYENNLWILIEFCAGGAVDAVMLELER--------PLTESQIQVVCKQTLDALNYLHDN- 129

Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              I+HRD+++ N+L   D   K+ADF ++ +++ T  R  S   +GT  + APE  M  
Sbjct: 130 --KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCE 185

Query: 255 Q-----ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDP 309
                    K+DV+S G+ L+E+     P     P                 K+ +   P
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL------------LKIAKSEPP 233

Query: 310 KLNNDYPPKAIAKLAAVAALCVQYEADFRPNM 341
            L    P +  +        C++   D R   
Sbjct: 234 TL--AQPSRWSSNFKDFLKKCLEKNVDARWTT 263

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 6e-52
 Identities = 54/282 (19%), Positives = 109/282 (38%), Gaps = 36/282 (12%)

Query: 68  SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEP--ESDFAAQLSVVSRLKH 124
            +F     +G+G +G V+ A+        A+K L  +   +   E     ++ + S L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
            + + L GY  ++    L+ ++A +G+++  L                  +        A
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---------FDEQRTATYITELA 116

Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
             L + H K    ++HRD++  N+LL    + KIADF  +  +  +      T + GT  
Sbjct: 117 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLD 169

Query: 245 YHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK 304
           Y  PE        +K D++S GV+  E L G+ P +    +     ++       +   +
Sbjct: 170 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 229

Query: 305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK 346
              D                 + +  +++    RP +  V++
Sbjct: 230 GARD-----------------LISRLLKHNPSQRPMLREVLE 254

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 3e-51
 Identities = 59/278 (21%), Positives = 103/278 (37%), Gaps = 36/278 (12%)

Query: 76  IGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPE-SDFAAQLSVVSRLKHEHFVELLGY 133
           IG GS+  V+    T+     A  +L      + E   F  +  ++  L+H + V     
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 134 CMES----NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
              +       +LV +  T G+L   L   K         V+             KGL+F
Sbjct: 77  WESTVKGKKCIVLVTELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQF 127

Query: 190 LHEKVQPPIVHRDVRSSNVLLFD-DFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAP 248
           LH +  PPI+HRD++  N+ +       KI D  L      +     +  V+GT  + AP
Sbjct: 128 LHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAP 182

Query: 249 EYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD 308
           E     +  +  DVY+FG+ +LE+ T   P        Q                ++   
Sbjct: 183 EM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--------------YRRVTS 227

Query: 309 PKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK 346
                 +   AI ++  +   C++   D R ++  ++ 
Sbjct: 228 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  170 bits (433), Expect = 4e-51
 Identities = 61/277 (22%), Positives = 113/277 (40%), Gaps = 39/277 (14%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES--DFAAQLSVVSRLKHEHFVELLG 132
           IG GS+G V++A+ + +    AIKK+  S     E   D   ++  + +L+H + ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
             +  +   LV ++    +   +   +K          L   +   V +GA +GL +LH 
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEVHKKP---------LQEVEIAAVTHGALQGLAYLHS 133

Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
                ++HRDV++ N+LL +    K+ DF   +  +           +GT  + APE  +
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVIL 184

Query: 253 T---GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDP 309
               GQ   K DV+S G+  +EL   + P+ +                     + Q   P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------------YHIAQNESP 232

Query: 310 KLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK 346
            L + +  +           C+Q     RP   +++K
Sbjct: 233 ALQSGHWSEYFRNF---VDSCLQKIPQDRPTSEVLLK 266

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 8e-51
 Identities = 64/308 (20%), Positives = 113/308 (36%), Gaps = 34/308 (11%)

Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYA------KLTDGTPAAIKKLDTSSAPEPESDFAAQ 115
           E  R          +G G++G+V  A      K       A+K L   +         ++
Sbjct: 9   EFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 66

Query: 116 LSVVSRLKHEH-FVELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKG-------VQGAE 166
           L ++  + H    V LLG C +    + ++ +F   G+L   L  ++             
Sbjct: 67  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126

Query: 167 PGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ 226
               LT    +  ++  AKG+EFL  +     +HRD+ + N+LL +    KI DF L   
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD 183

Query: 227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKG 286
                  +          + APE       T +SDV+SFGV+L E+ +        +   
Sbjct: 184 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243

Query: 287 QQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK 346
           ++             ++K+    +  +   P+           C   E   RP  + +V+
Sbjct: 244 EEFC----------RRLKEGTRMRAPDYTTPEMY----QTMLDCWHGEPSQRPTFSELVE 289

Query: 347 ALQPLLNS 354
            L  LL +
Sbjct: 290 HLGNLLQA 297

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 1e-50
 Identities = 60/280 (21%), Positives = 104/280 (37%), Gaps = 28/280 (10%)

Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF 127
           ++     +GEG+YG V  A         A+K +D   A +   +   ++ +   L HE+ 
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65

Query: 128 VELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
           V+  G+  E N + L  ++ + G L D +    G         +      +  +    G+
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---------MPEPDAQRFFHQLMAGV 116

Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
            +LH      I HRD++  N+LL +    KI+DF L              ++ GT  Y A
Sbjct: 117 VYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 173

Query: 248 PEYAMTGQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC 306
           PE     +   +  DV+S G+VL  +L G  P D      Q+                  
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--------------YSDW 219

Query: 307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK 346
            + K   +   K  +   A+    +      R  +  + K
Sbjct: 220 KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 1e-50
 Identities = 66/300 (22%), Positives = 109/300 (36%), Gaps = 34/300 (11%)

Query: 62  ELNRLTSNFGTKALIGEGSYGRVFYAKLTD----GTPAAIKKLDTSSAPEPESDFAAQLS 117
           E+ R          IGEG +G V               AIK     ++      F  +  
Sbjct: 3   EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60

Query: 118 VVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV 177
            + +  H H V+L+G   E N   ++ +  T+G L   L  RK          L     +
Sbjct: 61  TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--------LDLASLI 111

Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHST 237
             AY  +  L +L  K     VHRD+ + NVL+  +   K+ DF L+    D+     ++
Sbjct: 112 LYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KAS 167

Query: 238 RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR 297
           +      + APE     + T  SDV+ FGV + E+L         +              
Sbjct: 168 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-------- 219

Query: 298 LSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA 357
               +++      +  + PP     L ++   C  Y+   RP  T +   L  +L  + A
Sbjct: 220 ---GRIENGERLPMPPNCPP----TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 272

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 5e-48
 Identities = 65/294 (22%), Positives = 117/294 (39%), Gaps = 36/294 (12%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
            IG+G+ G V+ A  +  G   AI++++    P+ E     ++ V+   K+ + V  L  
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNPNIVNYLDS 85

Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
            +  +   +V ++   GSL DV+                  Q   V     + LEFLH  
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCM----------DEGQIAAVCRECLQALEFLHSN 135

Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               ++HRD++S N+LL  D   K+ DF    Q +    +   + ++GT  + APE    
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVTR 190

Query: 254 GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNN 313
                K D++S G++ +E++ G  P  +  P                  +     P+L  
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------------YLIATNGTPEL-- 236

Query: 314 DYPPKAIAKLAAVAALCVQYEADFRPNMTIV-----VKALQPLLNSKPAGPEAQ 362
             P K  A        C+  + + R +   +     +K  +PL +  P    A+
Sbjct: 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAK 290

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 3e-47
 Identities = 61/281 (21%), Positives = 102/281 (36%), Gaps = 33/281 (11%)

Query: 76  IGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPES--DFAAQLSVVSRLKHEHFVE 129
           +G+GS+G V   +           A+K L      +PE+  DF  +++ +  L H + + 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           L G  +    ++ V + A +GSL D L   +G                + A   A+G+ +
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH--------FLLGTLSRYAVQVAEGMGY 126

Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLH-STRVLGTFGYHAP 248
           L  K     +HRD+ + N+LL      KI DF L                    F + AP
Sbjct: 127 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 249 EYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVD 308
           E   T   +  SD + FGV L E+ T  +     +             ++     K+   
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN----------GSQILHKIDKEGER 233

Query: 309 PKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ 349
                D P      +  V   C  ++ + RP    +   L 
Sbjct: 234 LPRPEDCPQ----DIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 4e-44
 Identities = 52/247 (21%), Positives = 88/247 (35%), Gaps = 15/247 (6%)

Query: 65  RLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPE--SDFAAQLSVVSR 121
           +   +F    ++GEGS+  V  A+ L      AIK L+     +         +  V+SR
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 122 LKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY 181
           L H  FV+L     +         +A  G L   +                         
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---------FDETCTRFYTA 115

Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLG 241
                LE+LH      I+HRD++  N+LL +D   +I DF      S  + +  +   +G
Sbjct: 116 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172

Query: 242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED 301
           T  Y +PE        + SD+++ G ++ +L+ G  P            +        E 
Sbjct: 173 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 232

Query: 302 KVKQCVD 308
              +  D
Sbjct: 233 FFPKARD 239

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  151 bits (382), Expect = 3e-43
 Identities = 51/270 (18%), Positives = 99/270 (36%), Gaps = 31/270 (11%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
            +G G++G V        G     K ++T    +  +    ++S++++L H   + L   
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT-VKNEISIMNQLHHPKLINLHDA 94

Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             +    +L+ +F + G L D +              ++  + +     A +GL+ +HE 
Sbjct: 95  FEDKYEMVLILEFLSGGELFDRIAAEDY--------KMSEAEVINYMRQACEGLKHMHEH 146

Query: 194 VQPPIVHRDVRSSNVLL--FDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA 251
               IVH D++  N++         KI DF L  + +       +T    T  + APE  
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIV 200

Query: 252 MTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKL 311
               +   +D+++ GV+   LL+G  P                        VK+C D + 
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL------------QNVKRC-DWEF 247

Query: 312 NNDYPPKAIAKLAAVAALCVQYEADFRPNM 341
           + D       +        +Q E   R  +
Sbjct: 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTV 277

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  149 bits (378), Expect = 9e-43
 Identities = 60/305 (19%), Positives = 112/305 (36%), Gaps = 40/305 (13%)

Query: 40  NVVKTGTPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIK 98
           ++ K   PQ   P+EI        + +  ++     +G G++G V        G   A K
Sbjct: 7   DIWKQYYPQ---PVEIKH------DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAK 57

Query: 99  KLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHG 158
            + T    + E     ++  +S L+H   V L     + N  +++Y+F + G L + +  
Sbjct: 58  FVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD 116

Query: 159 RKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS-- 216
                       ++ ++ V+      KGL  +HE      VH D++  N++      +  
Sbjct: 117 EHNK--------MSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNEL 165

Query: 217 KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGR 276
           K+ DF LT       +   +T   GT  + APE A    +   +D++S GV+   LL+G 
Sbjct: 166 KLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 222

Query: 277 KPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEAD 336
            P                        VK C D  +++                 +  + +
Sbjct: 223 SPFGGENDDETL------------RNVKSC-DWNMDDSAFSGISEDGKDFIRKLLLADPN 269

Query: 337 FRPNM 341
            R  +
Sbjct: 270 TRMTI 274

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  147 bits (373), Expect = 1e-42
 Identities = 53/289 (18%), Positives = 98/289 (33%), Gaps = 44/289 (15%)

Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESD--------FAAQLSVV 119
           N+  K ++G G    V            A+K +D +      ++           ++ ++
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 120 SRLK-HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK 178
            ++  H + ++L      +    LV+     G L D L  +           L+  +  K
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---------LSEKETRK 114

Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
           +     + +  LH+     IVHRD++  N+LL DD   K+ DF  + Q            
Sbjct: 115 IMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLRE 168

Query: 239 VLGTFGYHAPEYAMTGQ------ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT 292
           V GT  Y APE              ++ D++S GV++  LL G  P  H        ++ 
Sbjct: 169 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 228

Query: 293 WATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNM 341
               +               +DY       ++      +  +   R   
Sbjct: 229 SGNYQF---------GSPEWDDYSDTVKDLVSR----FLVVQPQKRYTA 264

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  146 bits (369), Expect = 7e-42
 Identities = 48/269 (17%), Positives = 91/269 (33%), Gaps = 26/269 (9%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           ++G G++  V  A+        AIK +   +    E     +++V+ ++KH + V L   
Sbjct: 16  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75

Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
                +  L+ Q  + G L D +  +            T     ++ +     +++LH+ 
Sbjct: 76  YESGGHLYLIMQLVSGGELFDRIVEKG---------FYTERDASRLIFQVLDAVKYLHDL 126

Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
                  +        L +D K  I+DF L+      +     +   GT GY APE    
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STACGTPGYVAPEVLAQ 183

Query: 254 GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNN 313
              ++  D +S GV+   LL G  P            +  A             D    +
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF---------DSPYWD 234

Query: 314 DYPPKAIAKLAAVAALCVQYEADFRPNMT 342
           D    A   +       ++ + + R    
Sbjct: 235 DISDSAKDFIRH----LMEKDPEKRFTCE 259

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  145 bits (367), Expect = 1e-41
 Identities = 49/300 (16%), Positives = 102/300 (34%), Gaps = 32/300 (10%)

Query: 65  RLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK 123
           R+ + +     IG GS+G ++    +  G   AIK     +          +  +   ++
Sbjct: 4   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQ 60

Query: 124 HEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGA 183
               +  + +C    +  ++       SL D+ +              +    + +A   
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--------FSLKTVLLLADQM 112

Query: 184 AKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA---DFNLTNQSSDTAARLH----- 235
              +E++H K     +HRDV+  N L+    K  +    DF L  +  D     H     
Sbjct: 113 ISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 169

Query: 236 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT 295
           +  + GT  Y +    +  + +++ D+ S G VL+    G  P        ++       
Sbjct: 170 NKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY---- 225

Query: 296 PRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK 355
                +K        L   YP     + A     C     D +P+ + + +  + L + +
Sbjct: 226 -ERISEKKMSTPIEVLCKGYPS----EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  145 bits (367), Expect = 4e-41
 Identities = 60/280 (21%), Positives = 101/280 (36%), Gaps = 37/280 (13%)

Query: 69  NFGTKALIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQ-----LSVVSRL 122
           +F    +IG G +G V+  +  D G   A+K LD       + +  A      LS+VS  
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 123 KHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
                V +       +    +      G LH  L                       A  
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---------EADMRFYAAE 115

Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGT 242
              GLE +H +    +V+RD++ +N+LL +    +I+D  L    S           +GT
Sbjct: 116 IILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGT 168

Query: 243 FGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED 301
            GY APE    G      +D +S G +L +LL G  P      K +  +          D
Sbjct: 169 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----------D 218

Query: 302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNM 341
           ++   +  +L + + P+  + L       +Q + + R   
Sbjct: 219 RMTLTMAVELPDSFSPELRSLLEG----LLQRDVNRRLGC 254

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  142 bits (360), Expect = 7e-41
 Identities = 64/299 (21%), Positives = 108/299 (36%), Gaps = 34/299 (11%)

Query: 64  NRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES--DFAAQLSVVS 120
           + L+  +    ++G G    V  A+ L      A+K L    A +P     F  +    +
Sbjct: 3   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62

Query: 121 RLKHEHFVELLGYCMESNNRI----LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQR 176
            L H   V +               +V ++    +L D++H             +T  + 
Sbjct: 63  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---------MTPKRA 113

Query: 177 VKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHS 236
           ++V   A + L F H+     I+HRDV+ +N+++      K+ DF +    +D+   +  
Sbjct: 114 IEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 170

Query: 237 T-RVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT 295
           T  V+GT  Y +PE A    +  +SDVYS G VL E+LTG  P     P           
Sbjct: 171 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED 230

Query: 296 PRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP-NMTIVVKALQPLLN 353
           P               +          L AV    +    + R      +   L  + N
Sbjct: 231 PIP---------PSARHEGLSA----DLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 3e-40
 Identities = 56/294 (19%), Positives = 96/294 (32%), Gaps = 25/294 (8%)

Query: 65  RLTSNFGTKALIGEGSYGRVFYAK--LTDGTPAAIKKLDTSSAPEPESD----FAAQLSV 118
           R    +   A IGEG+YG+VF A+     G   A+K++   +  E          A L  
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 119 VSRLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVK 178
           +   +H + V L   C  S              +              P P +       
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD---QDLTTYLDKVPEPGVPTETIKD 120

Query: 179 VAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTR 238
           + +   +GL+FLH      +VHRD++  N+L+    + K+ADF L    S        T 
Sbjct: 121 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTS 174

Query: 239 VLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLV------- 291
           V+ T  Y APE  +        D++S G +  E+   +     +    Q   +       
Sbjct: 175 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234

Query: 292 ---TWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMT 342
               W        +       +    +          +   C+ +    R +  
Sbjct: 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 6e-40
 Identities = 40/271 (14%), Positives = 91/271 (33%), Gaps = 32/271 (11%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
            +G G +G V      +       K +        +     ++S+++  +H + + L   
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHES 69

Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
                  +++++F +   + + ++             L   + V   +   + L+FLH  
Sbjct: 70  FESMEELVMIFEFISGLDIFERINTS--------AFELNEREIVSYVHQVCEALQFLHSH 121

Query: 194 VQPPIVHRDVRSSNVLL--FDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYA 251
               I H D+R  N++         KI +F    Q        +   +     Y+APE  
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVH 175

Query: 252 MTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKL 311
               ++  +D++S G ++  LL+G  P      +     +  A             D + 
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF---------DEEA 226

Query: 312 NNDYPPKAIAKLAAVAALCVQYEADFRPNMT 342
             +   +A+  +       +  E   R   +
Sbjct: 227 FKEISIEAMDFVDR----LLVKERKSRMTAS 253

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  140 bits (353), Expect = 1e-39
 Identities = 44/292 (15%), Positives = 86/292 (29%), Gaps = 34/292 (11%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
            IGEGS+G +F    L +    AIK     S          +      L     +  + Y
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP---QLRDEYRTYKLLAGCTGIPNVYY 68

Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
             +     ++       SL D+L           G   +       A      ++ +HEK
Sbjct: 69  FGQEGLHNVLVIDLLGPSLEDLLD--------LCGRKFSVKTVAMAAKQMLARVQSIHEK 120

Query: 194 VQPPIVHRDVRSSNVLLFDDFKS-----KIADFNLTNQSSDTAARLH-----STRVLGTF 243
               +V+RD++  N L+            + DF +     D   + H        + GT 
Sbjct: 121 ---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 244 GYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV 303
            Y +    +  + +++ D+ + G V +  L G  P         +            +++
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY---------ERI 228

Query: 304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK 355
            +        +       +             D  P+   +      +L   
Sbjct: 229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 2e-39
 Identities = 59/244 (24%), Positives = 95/244 (38%), Gaps = 18/244 (7%)

Query: 69  NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPES--DFAAQLSVVSR-LKH 124
           +F    ++G+GS+G+VF A+        AIK L        +       +  V+S   +H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
                +        N   V ++   G L   +                 ++    A    
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEII 113

Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
            GL+FLH K    IV+RD++  N+LL  D   KIADF +  ++    A+  +    GT  
Sbjct: 114 LGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPD 168

Query: 245 YHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK 304
           Y APE  +  +     D +SFGV+L E+L G+ P      +     +    P       K
Sbjct: 169 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEK 228

Query: 305 QCVD 308
           +  D
Sbjct: 229 EAKD 232

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 9e-38
 Identities = 57/297 (19%), Positives = 108/297 (36%), Gaps = 34/297 (11%)

Query: 66  LTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKH 124
           +   +   + IGEG+YG V  A    +    AIKK+              ++ ++ R +H
Sbjct: 6   VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65

Query: 125 EHFVELLGYCMESNNRILVYQFATM----GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
           E+ + +           +   +         L+ +L  +           L+ +      
Sbjct: 66  ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----------LSNDHICYFL 115

Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ-SSDTAARLHSTRV 239
           Y   +GL+++H      ++HRD++ SN+LL      KI DF L      D       T  
Sbjct: 116 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 172

Query: 240 LGTFGYHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL 298
           + T  Y APE  +  +  T+  D++S G +L E+L+ R          Q + +       
Sbjct: 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232

Query: 299 SEDKVKQCVDPKLNN--------------DYPPKAIAKLAAVAALCVQYEADFRPNM 341
           S++ +   ++ K  N                 P A +K   +    + +    R  +
Sbjct: 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 289

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  135 bits (339), Expect = 1e-37
 Identities = 46/279 (16%), Positives = 95/279 (34%), Gaps = 26/279 (9%)

Query: 76  IGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEP-ESDFAAQLSVVSRLKHEHFVELLGYC 134
           IGEG+YG V+ A+   G   A+KK+      E   S    ++S++  LKH + V+L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69

Query: 135 MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV 194
                 +LV++         +     G         L              G+ + H++ 
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEGG---------LESVTAKSFLLQLLNGIAYCHDR- 119

Query: 195 QPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG 254
              ++HRD++  N+L+  + + KIADF L         +     ++  +         + 
Sbjct: 120 --RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLMGSK 176

Query: 255 QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE------------DK 302
           + +   D++S G +  E++ G           Q   +       +             D 
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236

Query: 303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNM 341
                +P     +          + +  ++ + + R   
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  134 bits (339), Expect = 2e-37
 Identities = 52/244 (21%), Positives = 90/244 (36%), Gaps = 20/244 (8%)

Query: 68  SNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPE--SDFAAQLSVVSRLKH 124
            +F     +G GS+GRV   +   +G   A+K L        +       +  ++S + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 125 EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAA 184
              + + G   ++    ++  +   G L  +L   +                   A    
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---------PNPVAKFYAAEVC 114

Query: 185 KGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
             LE+LH K    I++RD++  N+LL  +   KI DF       D      +  + GT  
Sbjct: 115 LALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPD 166

Query: 245 YHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK 304
           Y APE   T    +  D +SFG+++ E+L G  P   +        +  A  R      +
Sbjct: 167 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNE 226

Query: 305 QCVD 308
              D
Sbjct: 227 DVKD 230

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 1e-36
 Identities = 50/277 (18%), Positives = 98/277 (35%), Gaps = 38/277 (13%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES-----DFAAQLSVVSRLKHEHFV 128
            +G G +  V   +  + G   A K +               D   ++S++  ++H + +
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 129 ELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLE 188
            L        + IL+ +    G L D L  ++          LT  +  +       G+ 
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAEKES---------LTEEEATEFLKQILNGVY 127

Query: 189 FLHEKVQPPIVHRDVRSSNVLLFDD----FKSKIADFNLTNQSSDTAARLHSTRVLGTFG 244
           +LH      I H D++  N++L D      + KI DF L ++            + GT  
Sbjct: 128 YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPE 181

Query: 245 YHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK 304
           + APE      +  ++D++S GV+   LL+G  P      +   + V+            
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA----------- 230

Query: 305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNM 341
             V+ +  ++Y     A         +  +   R  +
Sbjct: 231 --VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 265

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 2e-36
 Identities = 45/259 (17%), Positives = 98/259 (37%), Gaps = 30/259 (11%)

Query: 66  LTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES-----DFAAQLSVV 119
           L S +    L+G G +G V+    ++D  P AIK ++     +            ++ ++
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61

Query: 120 SRLKHEH--FVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRV 177
            ++       + LL +    ++ +L+ +              +G         L      
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--------LQEELAR 113

Query: 178 KVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTNQSSDTAARLHS 236
              +   + +   H      ++HRD++  N+L+  +  + K+ DF       DT      
Sbjct: 114 SFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VY 166

Query: 237 TRVLGTFGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGRKPVDHT--MPKGQQSLVTW 293
           T   GT  Y  PE+    +   + + V+S G++L +++ G  P +H   + +GQ      
Sbjct: 167 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 226

Query: 294 ATPRLSEDKVKQC--VDPK 310
            +    +  ++ C  + P 
Sbjct: 227 VSSEC-QHLIRWCLALRPS 244

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 2e-35
 Identities = 62/301 (20%), Positives = 106/301 (35%), Gaps = 35/301 (11%)

Query: 75  LIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQ----LSVVSRLKHEHFVE 129
            +GEG +  V+ A+        AIKK+      E +          + ++  L H + + 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 130 LLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
           LL      +N  LV+ F        +               LT +          +GLE+
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEVIIKDNSLV---------LTPSHIKAYMLMTLQGLEY 115

Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE 249
           LH+     I+HRD++ +N+LL ++   K+ADF L             T  + T  Y APE
Sbjct: 116 LHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPE 170

Query: 250 YAMTGQ-ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED------K 302
                +      D+++ G +L ELL     +       Q + +       +E+       
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230

Query: 303 VKQCVDPKLNNDYPPKAIAKLAAVAAL-----CVQYEADFRPNMTIVVKALQ-PLLNSKP 356
           +   V  K     P   I   A    L        +    R   T   +AL+    +++P
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT---QALKMKYFSNRP 287

Query: 357 A 357
            
Sbjct: 288 G 288

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 1e-34
 Identities = 56/288 (19%), Positives = 99/288 (34%), Gaps = 26/288 (9%)

Query: 69  NFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEP-ESDFAAQLSVVSRLKHEH 126
           NF     IGEG+YG V+ A+    G   A+KK+   +  E   S    ++S++  L H +
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 127 FVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKG 186
            V+LL      N   LV++F        +               +         +   +G
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--------IPLPLIKSYLFQLLQG 114

Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           L F H      ++HRD++  N+L+  +   K+ADF L         R ++  V+  +   
Sbjct: 115 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRA 170

Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC 306
                     +   D++S G +  E++T R          Q   +        E      
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230

Query: 307 VD--------PKLNNDYPPKAIAKLAAVA----ALCVQYEADFRPNMT 342
                     PK       K +  L        +  + Y+ + R +  
Sbjct: 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK 278

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 1e-34
 Identities = 61/287 (21%), Positives = 97/287 (33%), Gaps = 36/287 (12%)

Query: 75  LIGEGSYGRVFYAKLTD-GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           +IG GS+G V+ AKL D G   AIKK+        +     +L ++ +L H + V L  +
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYF 81

Query: 134 CMESNNR------ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
              S  +       LV  +          H  +  Q       L         Y   + L
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT------LPVIYVKLYMYQLFRSL 135

Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDD-FKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
            ++H      I HRD++  N+LL  D    K+ DF    Q        + + +   +   
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRA 190

Query: 247 APEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWA------------ 294
                     T   DV+S G VL ELL G+          Q   +               
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

Query: 295 TPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNM 341
            P  +E K  Q         + P+   +  A+ +  ++Y    R   
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 297

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 3e-33
 Identities = 52/248 (20%), Positives = 92/248 (37%), Gaps = 18/248 (7%)

Query: 65  RLT-SNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPE--SDFAAQLSVVS 120
           ++T ++F    L+G+G++G+V   +    G   A+K L        +  +    +  V+ 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60

Query: 121 RLKHEHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVA 180
             +H     L       +    V ++A  G L   L   +           T  +     
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---------FTEERARFYG 111

Query: 181 YGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVL 240
                 LE+LH +    +V+RD++  N++L  D   KI DF L  +     A +      
Sbjct: 112 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFC 166

Query: 241 GTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE 300
           GT  Y APE        +  D +  GVV+ E++ GR P  +   +    L+     R   
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR 226

Query: 301 DKVKQCVD 308
               +   
Sbjct: 227 TLSPEAKS 234

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 3e-33
 Identities = 44/273 (16%), Positives = 89/273 (32%), Gaps = 29/273 (10%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGY 133
           ++G G  G+V            A+K L        E +   +       +  H V ++  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRA-----SQCPHIVRIVDV 73

Query: 134 C----MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEF 189
                      ++V +    G L   +  R            T  +  ++     + +++
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQY 126

Query: 190 LHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPE 249
           LH      I HRDV+  N+L      + I        + +T +    T    T  Y APE
Sbjct: 127 LHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 183

Query: 250 YAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDP 309
                +  +  D++S GV++  LL G  P            +        + +++     
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--------KTRIRMG-QY 234

Query: 310 KLNNDYPPKAIAKLAAVAALCVQYEADFRPNMT 342
           +  N    +   ++  +    ++ E   R  +T
Sbjct: 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTIT 267

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 2e-32
 Identities = 57/277 (20%), Positives = 111/277 (40%), Gaps = 31/277 (11%)

Query: 53  IEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPES- 110
           +E P    DE+++    +   A IG+G++G VF A+    G   A+KK+   +  E    
Sbjct: 1   VECPFC--DEVSK----YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI 54

Query: 111 DFAAQLSVVSRLKHEHFVELLGYCMESNNRI--------LVYQFATMGSLHDVLHGRKGV 162
               ++ ++  LKHE+ V L+  C    +          LV+ F        + +     
Sbjct: 55  TALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK- 113

Query: 163 QGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN 222
                    T ++  +V      GL ++H      I+HRD++++NVL+  D   K+ADF 
Sbjct: 114 --------FTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFG 162

Query: 223 LTNQ--SSDTAARLHSTRVLGTFGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGRKPV 279
           L      +  +     T  + T  Y  PE  +  +      D++  G ++ E+ T    +
Sbjct: 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 222

Query: 280 DHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLNNDYP 316
                + Q +L++     ++ +      + +L     
Sbjct: 223 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLE 259

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  120 bits (301), Expect = 1e-31
 Identities = 43/251 (17%), Positives = 87/251 (34%), Gaps = 27/251 (10%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPE--SDFAAQLSVVSRLKHEHFVELLG 132
           +G GS+GRV   K    G   A+K LD     + +       +  ++  +     V+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
              +++N  +V ++   G +   L               +       A       E+LH 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGR---------FSEPHARFYAAQIVLTFEYLHS 159

Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
                +++RD++  N+L+      ++ DF    +         +  + GT    APE  +
Sbjct: 160 L---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIIL 211

Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE-------DKVKQ 305
           +    +  D ++ GV++ E+  G  P     P      +     R          D ++ 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

Query: 306 CVDPKLNNDYP 316
            +   L   + 
Sbjct: 272 LLQVDLTKRFG 282

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 2e-31
 Identities = 51/241 (21%), Positives = 93/241 (38%), Gaps = 14/241 (5%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESD-FAAQLSVVSRLKHEHFVELLG 132
            +G G+YG V  A     G   AIKKL      E  +     +L ++  ++HE+ + LL 
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 133 YCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE 192
                        F  +        G+           L  ++   + Y   KGL ++H 
Sbjct: 85  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-----LGEDRIQFLVYQMLKGLRYIHA 139

Query: 193 KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAM 252
                I+HRD++  N+ + +D + KI DF L  Q+        +  V+  +         
Sbjct: 140 A---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILN 192

Query: 253 TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCVDPKLN 312
             + TQ  D++S G ++ E++TG+     +    Q   +   T     + V++    +  
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252

Query: 313 N 313
           N
Sbjct: 253 N 253

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 3e-31
 Identities = 45/205 (21%), Positives = 78/205 (38%), Gaps = 15/205 (7%)

Query: 76  IGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEP-ESDFAAQLSVVSRLKHEHFVELLGY 133
           IGEG+YG VF AK        A+K++      E   S    ++ ++  LKH++ V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEK 193
                   LV++F               +                  +   KGL F H +
Sbjct: 70  LHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---------PEIVKSFLFQLLKGLGFCHSR 120

Query: 194 VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT 253
               ++HRD++  N+L+  + + K+A+F L         R +S  V+  +          
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGA 176

Query: 254 GQITQKSDVYSFGVVLLELLTGRKP 278
              +   D++S G +  EL    +P
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRP 201

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 5e-28
 Identities = 54/275 (19%), Positives = 102/275 (37%), Gaps = 36/275 (13%)

Query: 75  LIGEGSYGRVFYAKLT----DGTPAAIKKLDTSSAPEPESD---FAAQLSVVSRLKHEHF 127
           ++G G+YG+VF  +       G   A+K L  ++  +          +  V+  ++   F
Sbjct: 31  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90

Query: 128 VELLGYCMESNNRI-LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKG 186
           +  L Y  ++  ++ L+  +   G L   L  R+           T ++           
Sbjct: 91  LVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---------FTEHEVQIYVGEIVLA 141

Query: 187 LEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYH 246
           LE LH+     I++RD++  N+LL  +    + DF L+ +         +    GT  Y 
Sbjct: 142 LEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYM 197

Query: 247 APEYAMTGQ--ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK 304
           AP+    G     +  D +S GV++ ELLTG  P      K  Q+ ++    +       
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS------ 251

Query: 305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP 339
              +P    +    A   +       +  +   R 
Sbjct: 252 ---EPPYPQEMSALAKDLIQR----LLMKDPKKRL 279

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  106 bits (266), Expect = 6e-27
 Identities = 44/253 (17%), Positives = 89/253 (35%), Gaps = 32/253 (12%)

Query: 42  VKTGTPQKALPIEIPQIKLDELNRLTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKL 100
           V T  P++    E   ++    +     +     +G G Y  VF A  +T+     +K L
Sbjct: 13  VNTHRPREYWDYESHVVEWGNQDD----YQLVRKLGRGKYSEVFEAINITNNEKVVVKIL 68

Query: 101 DTSSAPEPESDFAAQLSVVSRLK-HEHFVELLGYCMESNNR--ILVYQFATMGSLHDVLH 157
                P  +     ++ ++  L+   + + L     +  +R   LV++         +  
Sbjct: 69  K----PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ 124

Query: 158 GRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS- 216
                        LT        Y   K L++ H      I+HRDV+  NV++  + +  
Sbjct: 125 T------------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKL 169

Query: 217 KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTG 275
           ++ D+ L                + +  +  PE  +  Q      D++S G +L  ++  
Sbjct: 170 RLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 226

Query: 276 RKPVDHTMPKGQQ 288
           ++P  H      Q
Sbjct: 227 KEPFFHGHDNYDQ 239

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 6e-26
 Identities = 57/263 (21%), Positives = 102/263 (38%), Gaps = 28/263 (10%)

Query: 62  ELNR----LTSNFGTKALIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESD-FAAQ 115
           ELN+    +   +   + +G G+YG V  A     G   A+KKL         +     +
Sbjct: 8   ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE 67

Query: 116 LSVVSRLKHEHFVELLGYCMESN-----NRILVYQFATMGSLHDVLHGRKGVQGAEPGPV 170
           L ++  +KHE+ + LL     +      N + +        L++++  +K          
Sbjct: 68  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---------- 117

Query: 171 LTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDT 230
           LT +    + Y   +GL+++H        HRD++ SN+ + +D + KI DF L   + D 
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 174

Query: 231 AARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSL 290
                +  V   +              Q  D++S G ++ ELLTGR     T    Q  L
Sbjct: 175 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230

Query: 291 VTWATPRLSEDKVKQCVDPKLNN 313
           +         + +K+       N
Sbjct: 231 ILRLVGTPGAELLKKISSESARN 253

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 2e-25
 Identities = 46/224 (20%), Positives = 84/224 (37%), Gaps = 24/224 (10%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESD-FAAQLSVVSRLKHEHFVELLG 132
            IG G+ G V  A         AIKKL      +  +     +L ++  + H++ + LL 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 133 YC-----MESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGL 187
                  +E    + +       +L  V+                  +   + Y    G+
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----------DHERMSYLLYQMLCGI 132

Query: 188 EFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHA 247
           + LH      I+HRD++ SN+++  D   KI DF L   +  +      T  + T  Y A
Sbjct: 133 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRA 186

Query: 248 PEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLV 291
           PE  +     +  D++S G ++ E++  +          Q + V
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 99.3 bits (246), Expect = 5e-24
 Identities = 36/219 (16%), Positives = 80/219 (36%), Gaps = 21/219 (9%)

Query: 75  LIGEGSYGRVFYAK-LTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKH--------- 124
            +G G +  V+ AK + + T  A+K +              ++ ++ R+           
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 125 --EHFVELLGYCMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYG 182
              H ++LL +        +           ++L   K  +              +++  
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI----PLIYVKQISKQ 133

Query: 183 AAKGLEFLHEKVQPPIVHRDVRSSNVLL-FDDFKSKIADFNLTNQSSDTAARLHSTRVLG 241
              GL+++H +    I+H D++  NVL+   D    +    + +  +      H T  + 
Sbjct: 134 LLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191

Query: 242 TFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVD 280
           T  Y +PE  +       +D++S   ++ EL+TG    +
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 69.0 bits (168), Expect = 2e-14
 Identities = 24/160 (15%), Positives = 43/160 (26%), Gaps = 33/160 (20%)

Query: 75  LIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEP---------ESDFAAQLSVVSRLKHE 125
           L+GEG    VF           +K                   +  F+      +R +  
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 126 HFVELLGYCM----ESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAY 181
              +L G  +          ++ +      L+ V                      +V  
Sbjct: 67  ALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV----------------RVENPDEVLD 110

Query: 182 GAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADF 221
              + +   +      IVH D+   NVL+  +    I DF
Sbjct: 111 MILEEVAKFY---HRGIVHGDLSQYNVLV-SEEGIWIIDF 146

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	363
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.87
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.52
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.19
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.73
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.55
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.51

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-60  Score=412.69  Aligned_cols=254  Identities=24%  Similarity=0.313  Sum_probs=207.7

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      .++|++.+.||+|+||.||+|++. +|+.||||++......+..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            357999999999999999999865 6899999999775544455678999999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+++|+|.+++....         .+++.++..++.|++.||.|||++   +|+||||||+|||+++++.+||+|||+|+
T Consensus        84 y~~gg~L~~~l~~~~---------~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~  151 (271)
T d1nvra_          84 YCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLAT  151 (271)
T ss_dssp             CCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ccCCCcHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhhe
Confidence            999999999997644         389999999999999999999999   99999999999999999999999999998


Q ss_pred             CCCcccccccccccccccCCCCccccccCCC-CccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      ..............+||+.|+|||++.+..+ +.++|||||||+||||++|+.||........... .+           
T Consensus       152 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~-~~-----------  219 (271)
T d1nvra_         152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-DW-----------  219 (271)
T ss_dssp             ECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH-HH-----------
T ss_pred             eeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH-HH-----------
Confidence            7654443333456789999999999988876 5789999999999999999999975433221111 11           


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                        .............+.++.+|+.+||+.||++|||++++++
T Consensus       220 --~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         220 --KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             --HTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --hcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              0111111112344567899999999999999999999987

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-59  Score=408.11  Aligned_cols=265  Identities=26%  Similarity=0.452  Sum_probs=209.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCC-CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSS-APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      .++|.+.+.||+|+||.||+|++.  ..||||+++... .....+.+.+|+.++++++||||+++++++. ....++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence            358999999999999999999865  359999997654 3344578999999999999999999999875 456899999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+++|+|.+++.....        .+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+
T Consensus        84 y~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~  152 (276)
T d1uwha_          84 WCEGSSLYHHLHIIET--------KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLAT  152 (276)
T ss_dssp             CCCEEEHHHHHHTSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred             cCCCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEcccccee
Confidence            9999999999975432        389999999999999999999999   99999999999999999999999999998


Q ss_pred             CCCcccccccccccccccCCCCcccccc---CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMT---GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      ...............||+.|||||++.+   ..|+.++|||||||+||||+||+.||....+........  ....    
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~--~~~~----  226 (276)
T d1uwha_         153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV--GRGY----  226 (276)
T ss_dssp             C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH--HHTS----
T ss_pred             eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHH--hcCC----
Confidence            7665444434456789999999999864   358999999999999999999999997654322111110  0000    


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCC
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP  356 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~  356 (363)
                          ..+. ....+..++..+.+|+.+||+.||++|||+++|++.|+.+.++.|
T Consensus       227 ----~~p~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         227 ----LSPD-LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             ----CCCC-GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             ----CCCc-chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence                0000 012234456779999999999999999999999999999987655

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-59  Score=404.64  Aligned_cols=257  Identities=25%  Similarity=0.412  Sum_probs=205.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      ++|++.+.||+|+||.||+|++.+++.||||++...  ....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC--cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            478889999999999999999988889999998753  344578999999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      ++|+|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+|||+++++.+||+|||+++..
T Consensus        83 ~~g~L~~~l~~~~~--------~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  151 (263)
T d1sm2a_          83 EHGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFV  151 (263)
T ss_dssp             TTCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred             CCCcHHHHhhcccc--------CCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheec
Confidence            99999999876432        388999999999999999999999   9999999999999999999999999999766


Q ss_pred             CcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhC-CCCCCCCCCccccchhhhccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTG-RKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      ...... ......||+.|+|||++.+..|+.++|||||||++|||+|+ .+||.......                +...
T Consensus       152 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~----------------~~~~  214 (263)
T d1sm2a_         152 LDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE----------------VVED  214 (263)
T ss_dssp             --------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH----------------HHHH
T ss_pred             cCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH----------------HHHH
Confidence            543322 22345789999999999999999999999999999999995 45554322111                1111


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                      +........+..++.++.+|+.+||+.||++|||+++|++.|+++.++
T Consensus       215 i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         215 ISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            111222333445567899999999999999999999999999998764

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-58  Score=404.92  Aligned_cols=249  Identities=23%  Similarity=0.366  Sum_probs=209.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      ++|++.+.||+|+||.||+|.+ .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc-ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            4799999999999999999986 469999999987643 33457899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +++|+|.+++.+..          +++.++..++.|++.||.|||++   ||+||||||+|||++.++.+||+|||+|+.
T Consensus        99 ~~gg~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~  165 (293)
T d1yhwa1          99 LAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ  165 (293)
T ss_dssp             CTTCBHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             cCCCcHHHHhhccC----------CCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhhee
Confidence            99999999987643          89999999999999999999999   999999999999999999999999999976


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      ......  ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.............  .           
T Consensus       166 ~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~--~-----------  230 (293)
T d1yhwa1         166 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA--T-----------  230 (293)
T ss_dssp             CCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--H-----------
T ss_pred             eccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHH--h-----------
Confidence            543322  2345679999999999999999999999999999999999999997543322111110  0           


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                       ........+..++..+.+||.+||+.||++|||+.|+++
T Consensus       231 -~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         231 -NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             -HCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -CCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             001111223455677999999999999999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1e-58  Score=410.49  Aligned_cols=260  Identities=25%  Similarity=0.421  Sum_probs=205.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCC---eEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGT---PAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~---~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      ++|++.++||+|+||.||+|++. +++   .||||.+.........+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            46788899999999999999865 333   58888887655544557899999999999999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+++|+|.+++.....        .+++.+++.++.|++.||.|||++   +|+||||||+||||+.++.+||+|||+
T Consensus       106 ~Ey~~~g~L~~~~~~~~~--------~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGl  174 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGL  174 (299)
T ss_dssp             EECCTTEEHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred             EEecCCCcceeeeccccC--------CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCccc
Confidence            999999999998876432        389999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCccccccc---ccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccc
Q 046595          224 TNQSSDTAARLH---STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       224 a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      ++..........   .....||+.|+|||.+.++.++.++|||||||+||||+| |+.||.......             
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~-------------  241 (299)
T d1jpaa_         175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-------------  241 (299)
T ss_dssp             ---------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------------
T ss_pred             ceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH-------------
Confidence            986654322211   223457999999999999999999999999999999998 899997543221             


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                         +...+........+..++..+.+|+.+||+.||++|||+.+|++.|+++++.
T Consensus       242 ---~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         242 ---VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             ---HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ---HHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence               1111222233344556778899999999999999999999999999998875

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-58  Score=400.25  Aligned_cols=246  Identities=22%  Similarity=0.375  Sum_probs=208.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|++.+.||+|+||.||+|++. +++.||+|++....  .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46999999999999999999875 68999999986432  2334567899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+++|+|.+++....         .+++.++..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|
T Consensus        86 Ey~~~g~L~~~l~~~~---------~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a  153 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS---------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS  153 (263)
T ss_dssp             ECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSC
T ss_pred             eecCCCcHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeeccccee
Confidence            9999999999997654         289999999999999999999999   9999999999999999999999999999


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      .......    .....||+.|+|||++.+..|+.++|||||||+||||++|+.||...........+             
T Consensus       154 ~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i-------------  216 (263)
T d2j4za1         154 VHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-------------  216 (263)
T ss_dssp             SCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-------------
T ss_pred             eecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH-------------
Confidence            7654432    24467999999999999999999999999999999999999999754322111110             


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                        ...  ...++..++.++.+|+.+||+.||++|||++++++
T Consensus       217 --~~~--~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         217 --SRV--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             --HTT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --HcC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence              010  11234445677999999999999999999999986

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.3e-58  Score=405.86  Aligned_cols=262  Identities=23%  Similarity=0.363  Sum_probs=219.1

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      ++|++.+.||+|+||.||+|.+. +++.||||+++..  ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT--CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc--cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            57888999999999999999875 5889999998753  34467899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +++|+|.+++.....       ..+++..++.++.|++.||+|||++   +|+||||||+||||+.++.+||+|||+|+.
T Consensus        95 ~~~g~l~~~l~~~~~-------~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~  164 (287)
T d1opja_          95 MTYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL  164 (287)
T ss_dssp             CTTCBHHHHHHHSCT-------TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred             ccCcchHHHhhhccc-------cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceee
Confidence            999999999975432       1389999999999999999999999   999999999999999999999999999987


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      ....... ......|++.|+|||++.+..|+.++|||||||++|||++|..||......               ..+...
T Consensus       165 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~---------------~~~~~~  228 (287)
T d1opja_         165 MTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---------------SQVYEL  228 (287)
T ss_dssp             CCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH---------------HHHHHH
T ss_pred             cCCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH---------------HHHHHH
Confidence            6543322 233456899999999999999999999999999999999987776433221               111222


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCC
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA  357 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~  357 (363)
                      +........+..++.++.+|+.+||+.||++|||+.+|++.|+.+.++...
T Consensus       229 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~~~  279 (287)
T d1opja_         229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI  279 (287)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSSCH
T ss_pred             HhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhCCC
Confidence            223333445556777899999999999999999999999999998776543

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-57  Score=393.57  Aligned_cols=254  Identities=24%  Similarity=0.399  Sum_probs=215.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      ++|++.+.||+|+||.||+|++++++.||||+++..  ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~--~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS--SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC--cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            479999999999999999999988889999999764  334578999999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      .+|+|..++.....        .+++..++.++.|+++||.|||++   +|+||||||+||++++++.+||+|||+++..
T Consensus        82 ~~g~l~~~~~~~~~--------~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~  150 (258)
T d1k2pa_          82 ANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV  150 (258)
T ss_dssp             TTEEHHHHHHSGGG--------CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBC
T ss_pred             CCCcHHHhhhcccc--------CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheec
Confidence            99999999765542        388999999999999999999999   9999999999999999999999999999765


Q ss_pred             CcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQC  306 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (363)
                      ...... ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||.........                ..
T Consensus       151 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~----------------~~  213 (258)
T d1k2pa_         151 LDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA----------------EH  213 (258)
T ss_dssp             SSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH----------------HH
T ss_pred             cCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH----------------HH
Confidence            544332 2334679999999999999999999999999999999998 89999755332111                11


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 046595          307 VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL  351 (363)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l  351 (363)
                      +........+..++.++.+|+.+||+.||++|||+++|++.|.+|
T Consensus       214 i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         214 IAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             HHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            112222334455667899999999999999999999999998764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-58  Score=401.40  Aligned_cols=257  Identities=26%  Similarity=0.414  Sum_probs=211.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      ++|++.+.||+|+||.||+|.+++++.||||++...  ....+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~   89 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG--SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM   89 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC--cCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeC
Confidence            578899999999999999999988889999999753  334578999999999999999999999875 45679999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      ++|+|.+++......       .+++.+++.++.||+.||.|||++   +|+||||||+||||++++.+||+|||+|+..
T Consensus        90 ~~g~L~~~~~~~~~~-------~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~  159 (272)
T d1qpca_          90 ENGSLVDFLKTPSGI-------KLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (272)
T ss_dssp             TTCBHHHHTTSHHHH-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCCcHHHHHhhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEc
Confidence            999999988654321       289999999999999999999999   9999999999999999999999999999866


Q ss_pred             CcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCV  307 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (363)
                      ...... ......||+.|+|||++.++.++.++|||||||++|||+||..|+......               ..+...+
T Consensus       160 ~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~---------------~~~~~~i  223 (272)
T d1qpca_         160 EDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---------------PEVIQNL  223 (272)
T ss_dssp             SSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------------HHHHHHH
T ss_pred             cCCccc-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH---------------HHHHHHH
Confidence            543222 233457899999999999999999999999999999999976555322111               0111111


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccc
Q 046595          308 DPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN  353 (363)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~  353 (363)
                      ........+..++.++.+|+.+||+.||++|||+++|++.|+++..
T Consensus       224 ~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         224 ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            2222333345566789999999999999999999999999998764

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-57  Score=408.94  Aligned_cols=264  Identities=27%  Similarity=0.428  Sum_probs=213.2

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCC-C-----CeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCee
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTD-G-----TPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNR  140 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~-~-----~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  140 (363)
                      ++|++.+.||+|+||.||+|++.. +     ..||+|.+...........+.+|+.++.++ +||||+++++++.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            478899999999999999997643 2     258999987765555667899999999998 899999999999999999


Q ss_pred             EEEEecccCCChhhhhcCCCCCC--------------CCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCC
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQ--------------GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSS  206 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~--------------~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~  206 (363)
                      ++||||+++|+|.++|.......              .......+++..++.++.|++.||.|||++   +|+||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence            99999999999999997654211              011223589999999999999999999999   9999999999


Q ss_pred             ceeecCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCc
Q 046595          207 NVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPK  285 (363)
Q Consensus       207 Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~  285 (363)
                      |||++.++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||+||||+| |..||......
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987655544434455678999999999999999999999999999999998 89999754332


Q ss_pred             cccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 046595          286 GQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQ  349 (363)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~  349 (363)
                      ..               +...+........+..++.++.+||.+||+.||++|||+++|++.|.
T Consensus       274 ~~---------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         274 AN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             HH---------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HH---------------HHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            11               11222223334455667788999999999999999999999999986

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-58  Score=401.82  Aligned_cols=256  Identities=21%  Similarity=0.305  Sum_probs=194.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEe--CCeeEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCME--SNNRILV  143 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv  143 (363)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++...... ...+.+.+|+.++++++||||+++++++.+  ...+++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            47999999999999999999764 6899999999775432 234678899999999999999999999865  4568999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccC--CCCeEEecccCCceeecCCCceEEeee
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV--QPPIVHRDVRSSNVLLFDDFKSKIADF  221 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~ivH~Dlkp~Nill~~~~~vkl~Df  221 (363)
                      |||+++|+|.+++......     ...+++..++.++.|++.||.|||++.  ..+|+||||||+||||+.++.+||+||
T Consensus        84 mEy~~~g~L~~~i~~~~~~-----~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF  158 (269)
T d2java1          84 MEYCEGGDLASVITKGTKE-----RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  158 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred             EecCCCCcHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence            9999999999998643211     123899999999999999999999971  013999999999999999999999999


Q ss_pred             ccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccc
Q 046595          222 NLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       222 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      |+++........  .....||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+          
T Consensus       159 G~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i----------  226 (269)
T d2java1         159 GLARILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI----------  226 (269)
T ss_dssp             HHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH----------
T ss_pred             cceeecccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHH----------
Confidence            998765443222  34568999999999999999999999999999999999999999754322111110          


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                           .. ......+..++.++.+|+.+||+.||.+|||+.||++
T Consensus       227 -----~~-~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         227 -----RE-GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             -----HH-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----Hc-CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                 00 0111223445667999999999999999999999975

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-58  Score=401.15  Aligned_cols=259  Identities=25%  Similarity=0.408  Sum_probs=212.1

Q ss_pred             cCCCCCCe-eeccCCceEEEEEeC---CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           68 SNFGTKAL-IGEGSYGRVFYAKLT---DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        68 ~~y~~~~~-lg~G~~g~V~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      ++|.+.+. ||+|+||.||+|.++   ++..||||+++........+.+.+|+.++++++||||+++++++.. +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            35666664 999999999999754   3457999999765544455789999999999999999999999865 568999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+++|+|.+++.....        .+++.+++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        87 mE~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGl  155 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGL  155 (285)
T ss_dssp             EECCTTEEHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred             EEeCCCCcHHHHhhcccc--------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchh
Confidence            999999999999865432        389999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCccccc-ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccc
Q 046595          224 TNQSSDTAAR-LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       224 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      ++........ .......||+.|+|||++.++.++.++|||||||++|||+| |+.||.......               
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---------------  220 (285)
T d1u59a_         156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---------------  220 (285)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---------------
T ss_pred             hhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---------------
Confidence            9765443222 22334568999999999999999999999999999999998 899997543321               


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                       +...+..+.....+..++.++.+|+.+||+.||++|||+.+|++.|+.+..+
T Consensus       221 -~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         221 -VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             -HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -HHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence             1111222233344566778899999999999999999999999999876553

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-57  Score=402.96  Aligned_cols=253  Identities=21%  Similarity=0.327  Sum_probs=194.0

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      +.+.|++.+.||+|+||.||+|++. +++.||||++...........+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            4567999999999999999999865 689999999987655455567889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec---CCCceEEeee
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIADF  221 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~---~~~~vkl~Df  221 (363)
                      ||++||+|.+++....         .+++.++..++.|++.||.|||++   +|+||||||+|||+.   +++.+||+||
T Consensus        87 E~~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DF  154 (307)
T d1a06a_          87 QLVSGGELFDRIVEKG---------FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDF  154 (307)
T ss_dssp             CCCCSCBHHHHHHTCS---------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred             eccCCCcHHHhhhccc---------CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEecc
Confidence            9999999999997654         399999999999999999999999   999999999999995   5789999999


Q ss_pred             ccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccc
Q 046595          222 NLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       222 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      |+++.......   ....+||+.|+|||++.+..|+.++|||||||+||||++|+.||...........+...       
T Consensus       155 G~a~~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-------  224 (307)
T d1a06a_         155 GLSKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA-------  224 (307)
T ss_dssp             ---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTT-------
T ss_pred             ceeEEccCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhcc-------
Confidence            99976543322   23467999999999999999999999999999999999999999754322111111000       


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                            ...........++.++.+|+.+||+.||++|||++|+++
T Consensus       225 ------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         225 ------EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             ------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ------CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                  011112223455677999999999999999999999998

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-58  Score=403.44  Aligned_cols=249  Identities=22%  Similarity=0.317  Sum_probs=205.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|++.+.||+|+||.||+|++. +++.||||++....  .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            46999999999999999999864 69999999986432  2344578999999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+++|+|.+++....         .+++..+..++.|++.||.|||++   +|+||||||+|||+++++.+||+|||+|
T Consensus        88 Ey~~gg~L~~~~~~~~---------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a  155 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG---------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTA  155 (288)
T ss_dssp             CCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EccCCCCHHHhhhccC---------CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccc
Confidence            9999999999987654         289999999999999999999999   9999999999999999999999999999


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      +..............+||+.|+|||++.+..|+.++|||||||+||||++|+.||...........              
T Consensus       156 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~--------------  221 (288)
T d1uu3a_         156 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK--------------  221 (288)
T ss_dssp             EECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------------
T ss_pred             eecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHH--------------
Confidence            876544433334556899999999999999999999999999999999999999975432211110              


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVV  345 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl  345 (363)
                       +...  ...++..++.++.+||.+||+.||.+|||++|++
T Consensus       222 -i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         222 -IIKL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             -HHTT--CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             -HHcC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence             0111  1123344567799999999999999999999863

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-57  Score=399.75  Aligned_cols=261  Identities=23%  Similarity=0.403  Sum_probs=208.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCC-----CeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDG-----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      +.|++.++||+|+||.||+|.++++     ..||||++...........+.+|+.++++++||||+++++++.+....++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            3688889999999999999976532     36999999765554455678999999999999999999999999999999


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      ||||+.+++|.+++.....        .+++.+++.++.|++.||.|||++   +|+||||||+||||+.++.+||+|||
T Consensus        87 v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG  155 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDG--------EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFG  155 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTT--------CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             EEEecccCcchhhhhcccc--------cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccc
Confidence            9999999999998865432        389999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCccccc-ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccc
Q 046595          223 LTNQSSDTAAR-LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       223 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      +++........ .......||+.|+|||++.++.++.++|||||||++|||++|..|+......               .
T Consensus       156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~---------------~  220 (283)
T d1mqba_         156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---------------H  220 (283)
T ss_dssp             C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---------------H
T ss_pred             hhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH---------------H
Confidence            99875443222 1233456899999999999999999999999999999999976665432211               1


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                      .+...+..+.....+..++..+.+|+.+||+.||++|||+.+|++.|+.+++.
T Consensus       221 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         221 EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             HHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            12222223334445556778899999999999999999999999999988764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-57  Score=398.87  Aligned_cols=251  Identities=24%  Similarity=0.367  Sum_probs=207.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      +.|++.+.||+|+||.||+|++. +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            36899999999999999999865 6899999998764 334457889999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +++|+|.+++.....        .+++.++..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|..
T Consensus        91 ~~~g~L~~~~~~~~~--------~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~  159 (288)
T d2jfla1          91 CAGGAVDAVMLELER--------PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK  159 (288)
T ss_dssp             CTTEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhc
Confidence            999999999865331        389999999999999999999999   999999999999999999999999999865


Q ss_pred             CCcccccccccccccccCCCCccccc-----cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAM-----TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      ......  ......||+.|+|||++.     +..|+.++|||||||++|||++|+.||....+......+.  ..     
T Consensus       160 ~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~--~~-----  230 (288)
T d2jfla1         160 NTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA--KS-----  230 (288)
T ss_dssp             CHHHHH--HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH--HS-----
T ss_pred             cCCCcc--cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH--cC-----
Confidence            543322  234568999999999984     4568999999999999999999999997654322111110  00     


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                             .......+..++.++.+||.+||+.||++|||+.|+++
T Consensus       231 -------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         231 -------EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             -------CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -------CCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   00111223456678999999999999999999999987

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-57  Score=406.18  Aligned_cols=268  Identities=22%  Similarity=0.308  Sum_probs=209.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      .++|++.+.||+|+||+||+|++. +|+.||+|+++..........+.+|+.+|+.++||||+++++++.+....++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            457999999999999999999864 6899999999876555556789999999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-cCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE-KVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      |+.+|+|.+++.+..         .+++..+..++.|++.||.|||+ +   +|+||||||+||||+.++.+||+|||+|
T Consensus        85 y~~gg~L~~~l~~~~---------~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla  152 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG---------RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVS  152 (322)
T ss_dssp             CCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred             cCCCCcHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCc
Confidence            999999999997654         28999999999999999999996 6   8999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhc-cccccc---
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWA-TPRLSE---  300 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~---  300 (363)
                      +.....    .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||............... ......   
T Consensus       153 ~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  228 (322)
T d1s9ja_         153 GQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP  228 (322)
T ss_dssp             HHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------
T ss_pred             cccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCc
Confidence            754322    234568999999999999999999999999999999999999999764332111100000 000000   


Q ss_pred             ----------------------cccccccCCcCCCCCC-HHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhcc
Q 046595          301 ----------------------DKVKQCVDPKLNNDYP-PKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQP  350 (363)
Q Consensus       301 ----------------------~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~  350 (363)
                                            ...............+ ...+.++.+|+.+||+.||.+|||++|+++  .+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             -----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             ccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence                                  0000000000000001 123467899999999999999999999987  4543

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-57  Score=393.77  Aligned_cols=250  Identities=24%  Similarity=0.389  Sum_probs=202.2

Q ss_pred             CeeeccCCceEEEEEeC---CCCeEEEEEccCCCCCC-chHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecccC
Q 046595           74 ALIGEGSYGRVFYAKLT---DGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFATM  149 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~---~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  149 (363)
                      +.||+|+||.||+|.+.   +++.||||+++...... ..+.+.+|+.++++++||||+++++++.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999754   35679999997643332 34679999999999999999999999865 567899999999


Q ss_pred             CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCCCc
Q 046595          150 GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQSSD  229 (363)
Q Consensus       150 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~  229 (363)
                      |+|.+++....         .+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        92 g~L~~~l~~~~---------~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~  159 (277)
T d1xbba_          92 GPLNKYLQQNR---------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  159 (277)
T ss_dssp             EEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             CcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccc
Confidence            99999997654         389999999999999999999999   999999999999999999999999999976543


Q ss_pred             cccc-ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccccccccc
Q 046595          230 TAAR-LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCV  307 (363)
Q Consensus       230 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (363)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.......                +...+
T Consensus       160 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~----------------~~~~i  223 (277)
T d1xbba_         160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----------------VTAML  223 (277)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----------------HHHHH
T ss_pred             cccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH----------------HHHHH
Confidence            3222 22334578999999999999999999999999999999998 899997543211                11122


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccc
Q 046595          308 DPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLL  352 (363)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~  352 (363)
                      ..+.....+..++.++.+|+.+||+.||++|||+++|++.|+...
T Consensus       224 ~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         224 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence            222334445567788999999999999999999999999887654

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-56  Score=392.06  Aligned_cols=261  Identities=28%  Similarity=0.428  Sum_probs=209.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      ++|++.+.||+|+||.||+|++++++.||||++...  ....+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~   93 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   93 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc--cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence            479999999999999999999988888999998753  334578999999999999999999999985 46689999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      .+|+|..++.....       ..+++.+++.++.|++.||.|||++   +|+||||||+||||++++.+||+|||+++..
T Consensus        94 ~~g~l~~~~~~~~~-------~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~  163 (285)
T d1fmka3          94 SKGSLLDFLKGETG-------KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI  163 (285)
T ss_dssp             TTCBHHHHHSHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             CCCchhhhhhhccc-------ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhc
Confidence            99999999875421       1289999999999999999999999   9999999999999999999999999999765


Q ss_pred             CcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccccc
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQCV  307 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (363)
                      ...... ......||+.|+|||++.++.++.++||||||+++|||++|..||......               ..+...+
T Consensus       164 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~---------------~~~~~~i  227 (285)
T d1fmka3         164 EDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------------REVLDQV  227 (285)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------------HHHHHHH
T ss_pred             cCCCce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH---------------HHHHHHH
Confidence            443322 233457899999999999999999999999999999999976665432211               1111112


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCC
Q 046595          308 DPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA  357 (363)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~  357 (363)
                      ........+..+++++.+++.+||+.||++|||+++|++.|++.+.....
T Consensus       228 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p  277 (285)
T d1fmka3         228 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  277 (285)
T ss_dssp             HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred             HhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence            22233345566778899999999999999999999999999988766543

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-56  Score=388.80  Aligned_cols=247  Identities=23%  Similarity=0.352  Sum_probs=197.3

Q ss_pred             CC-CCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEe----CCeeE
Q 046595           69 NF-GTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCME----SNNRI  141 (363)
Q Consensus        69 ~y-~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~  141 (363)
                      +| ++.+.||+|+||+||+|.+. +++.||+|++...... ...+.+.+|++++++++||||+++++++..    ....+
T Consensus         9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~   88 (270)
T d1t4ha_           9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV   88 (270)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence            44 56778999999999999865 6889999998764322 234678999999999999999999999875    34578


Q ss_pred             EEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCC--eEEecccCCceeec-CCCceEE
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPP--IVHRDVRSSNVLLF-DDFKSKI  218 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nill~-~~~~vkl  218 (363)
                      +||||+++|+|.+++....         .+++.++..++.|++.||.|||++   +  |+||||||+|||++ +++.+||
T Consensus        89 ivmE~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl  156 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKI  156 (270)
T ss_dssp             EEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEE
T ss_pred             EEEeCCCCCcHHHHHhccc---------cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEE
Confidence            9999999999999997654         289999999999999999999998   7  99999999999996 5789999


Q ss_pred             eeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 046595          219 ADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL  298 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  298 (363)
                      +|||+++......    .....||+.|+|||++.+ .|+.++|||||||++|||++|+.||........  ......   
T Consensus       157 ~DFGla~~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~~i~---  226 (270)
T d1t4ha_         157 GDLGLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVT---  226 (270)
T ss_dssp             CCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHHT---
T ss_pred             eecCcceeccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHHHHH---
Confidence            9999997543322    345689999999998875 699999999999999999999999964432211  110000   


Q ss_pred             cccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          299 SEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                               .......++...++++.+||.+||+.||++|||++|+++
T Consensus       227 ---------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         227 ---------SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             ---------TTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---------cCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                     000001112223456899999999999999999999986

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.1e-56  Score=394.21  Aligned_cols=245  Identities=24%  Similarity=0.352  Sum_probs=202.0

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC--chHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE--PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      .|+..+.||+|+||.||+|++. +++.||||++.......  ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            5899999999999999999764 68899999987644322  23568899999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+|+|..++....         .+++.+++.++.||+.||.|||++   ||+||||||+|||++.++.+||+|||+|.
T Consensus        96 ~~~~g~l~~~~~~~~---------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~  163 (309)
T d1u5ra_          96 YCLGSASDLLEVHKK---------PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSAS  163 (309)
T ss_dssp             CCSEEHHHHHHHHTS---------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred             ecCCCchHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeeccccc
Confidence            999999977765443         389999999999999999999999   99999999999999999999999999997


Q ss_pred             CCCcccccccccccccccCCCCcccccc---CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMT---GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      .....      ....||+.|+|||++.+   ..|+.++|||||||++|||++|..||..........             
T Consensus       164 ~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~-------------  224 (309)
T d1u5ra_         164 IMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------------  224 (309)
T ss_dssp             SSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------------
T ss_pred             ccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH-------------
Confidence            65432      34679999999999864   468999999999999999999999997543221111             


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                        ...........+..+++.+.+||.+||+.||.+|||++++++
T Consensus       225 --~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         225 --HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             --HHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --HHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence              001111111112334567999999999999999999999976

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-56  Score=388.87  Aligned_cols=258  Identities=25%  Similarity=0.391  Sum_probs=202.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCC----CCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTD----GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      ++|++.+.||+|+||.||+|.+..    +..||||.+...........+.+|+.++++++||||+++++++. .+..++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            579999999999999999997643    34588888876544444577999999999999999999999985 5678999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+.+|+|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        86 ~E~~~~g~l~~~~~~~~~--------~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~  154 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRKY--------SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL  154 (273)
T ss_dssp             EECCTTEEHHHHHHHTTT--------TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---
T ss_pred             EEeccCCcHHhhhhccCC--------CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchh
Confidence            999999999998765432        389999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      ++........ ......||+.|+|||++.+..++.++|||||||++|||++ |..||..........             
T Consensus       155 a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~-------------  220 (273)
T d1mp8a_         155 SRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG-------------  220 (273)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-------------
T ss_pred             heeccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHH-------------
Confidence            9765443222 2344578999999999999999999999999999999998 889997554322111             


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          303 VKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                         .+........+..++..+.+||.+||+.||++|||+.+|++.|+.++++
T Consensus       221 ---~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         221 ---RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             ---HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---HHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence               1111122334556678899999999999999999999999999988765

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.2e-55  Score=398.33  Aligned_cols=252  Identities=19%  Similarity=0.281  Sum_probs=207.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      .++|++.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE  103 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  103 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            458999999999999999999864 68999999997532 2234678899999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec--CCCceEEeeecc
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF--DDFKSKIADFNL  223 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~--~~~~vkl~Dfg~  223 (363)
                      |++||+|.+++.....        .+++.++..++.||+.||.|||++   ||+||||||+|||++  .++.+||+|||+
T Consensus       104 ~~~gg~L~~~l~~~~~--------~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~  172 (350)
T d1koaa2         104 FMSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGL  172 (350)
T ss_dssp             CCCSCBHHHHHTCTTS--------CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred             cCCCCCHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecch
Confidence            9999999999964431        399999999999999999999999   999999999999996  468899999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      ++.......   .....||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+....        
T Consensus       173 a~~~~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--------  241 (350)
T d1koaa2         173 TAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD--------  241 (350)
T ss_dssp             CEECCTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--------
T ss_pred             heecccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------
Confidence            876544322   344689999999999999999999999999999999999999997543322111111000        


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                           ..........++.++.+||.+||+.||++|||++++++
T Consensus       242 -----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         242 -----WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             -----CCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             -----CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 00111112344567999999999999999999999998

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=390.38  Aligned_cols=253  Identities=20%  Similarity=0.303  Sum_probs=207.5

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC-----CchHHHHHHHHHHhcCCCCccceeeeEEEeCCe
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP-----EPESDFAAQLSVVSRLKHEHFVELLGYCMESNN  139 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  139 (363)
                      +.++|++++.||+|+||.||+|++. +|+.||||++......     ...+.+.+|+.++++++||||+++++++.+...
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            4468999999999999999999864 6999999998654322     235789999999999999999999999999999


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC----c
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF----K  215 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~----~  215 (363)
                      .++||||+++|+|.+++....         .+++..+..++.|++.||.|||++   +|+||||||+|||++.++    .
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~---------~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~  155 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKE---------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPR  155 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCC
T ss_pred             EEEEEEcCCCccccchhcccc---------ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccc
Confidence            999999999999999997654         299999999999999999999999   999999999999998776    5


Q ss_pred             eEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 046595          216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       216 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      +||+|||++........   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+....
T Consensus       156 vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~  232 (293)
T d1jksa_         156 IKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN  232 (293)
T ss_dssp             EEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC
T ss_pred             eEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcC
Confidence            99999999876543322   344679999999999999999999999999999999999999997543221111110000


Q ss_pred             ccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          296 PRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                                   .......+..++..+.+||.+||+.||.+|||++++++
T Consensus       233 -------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         233 -------------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             -------------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -------------CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                         00000111234567899999999999999999999987

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-56  Score=396.19  Aligned_cols=258  Identities=25%  Similarity=0.437  Sum_probs=207.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCC----eEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGT----PAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRIL  142 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  142 (363)
                      .+|+++++||+|+||.||+|.+. +|+    .||+|++.........+.+.+|+.++++++||||+++++++.+. ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            36999999999999999999764 444    58999887666666678899999999999999999999999864 5678


Q ss_pred             EEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeec
Q 046595          143 VYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFN  222 (363)
Q Consensus       143 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg  222 (363)
                      +++|+.+|+|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        88 v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFG  156 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFG  156 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSS--------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCS
T ss_pred             EEEeccCCccccccccccc--------CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccc
Confidence            8999999999998876432        389999999999999999999999   99999999999999999999999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSED  301 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (363)
                      +++...............||+.|+|||++.++.|+.++|||||||+||||+| |..||.......               
T Consensus       157 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---------------  221 (317)
T d1xkka_         157 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------------  221 (317)
T ss_dssp             HHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---------------
T ss_pred             cceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---------------
Confidence            9976655444433445678999999999999999999999999999999998 788887543221               


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccc
Q 046595          302 KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN  353 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~  353 (363)
                       +...+..+.....+..++..+.+|+.+||+.||.+|||+.+|++.|..+.+
T Consensus       222 -~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         222 -ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             -HHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence             112222223334455677889999999999999999999999999887654

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.7e-55  Score=397.54  Aligned_cols=252  Identities=19%  Similarity=0.268  Sum_probs=208.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      .++|++.+.||+|+||.||+|++ .+|+.||||++.... ......+.+|+.++++++||||+++++++.+....++|||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE  106 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  106 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            45799999999999999999986 479999999987633 2234578899999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec--CCCceEEeeecc
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF--DDFKSKIADFNL  223 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~--~~~~vkl~Dfg~  223 (363)
                      |++||+|.+++.....        .+++.+++.++.||+.||.|||++   ||+||||||+||||+  .++.+||+|||+
T Consensus       107 ~~~gg~L~~~~~~~~~--------~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGl  175 (352)
T d1koba_         107 FLSGGELFDRIAAEDY--------KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGL  175 (352)
T ss_dssp             CCCCCBHHHHTTCTTC--------CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred             cCCCChHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeeccc
Confidence            9999999998765431        399999999999999999999999   999999999999997  678999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      |........   .....||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+...         
T Consensus       176 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~---------  243 (352)
T d1koba_         176 ATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC---------  243 (352)
T ss_dssp             CEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC---------
T ss_pred             ceecCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------
Confidence            976654322   34467999999999999999999999999999999999999999754332211111100         


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                          ...........++.++.+||.+||+.||.+|||+.++++
T Consensus       244 ----~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         244 ----DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             ----CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ----CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                011112223345667999999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.9e-56  Score=393.90  Aligned_cols=268  Identities=24%  Similarity=0.373  Sum_probs=215.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCee
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNR  140 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  140 (363)
                      .++|++.+.||+|+||.||+|++.      +++.||||++...........+.+|+.++++++||||+++++++......
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~   91 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM   91 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence            457999999999999999999754      35789999997655444457799999999999999999999999999999


Q ss_pred             EEEEecccCCChhhhhcCCCCCC---------------CCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccC
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQ---------------GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRS  205 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~---------------~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp  205 (363)
                      +++|||+.+|+|.+++.......               .......+++..++.++.|++.||+|||++   +|+||||||
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp  168 (301)
T d1lufa_          92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLAT  168 (301)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcc
Confidence            99999999999999996543211               011223489999999999999999999999   999999999


Q ss_pred             CceeecCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCC-CCCCCCCC
Q 046595          206 SNVLLFDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGR-KPVDHTMP  284 (363)
Q Consensus       206 ~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~-~p~~~~~~  284 (363)
                      +|||++.++.+||+|||+++...............||+.|+|||.+.+..|+.++|||||||++|||++|. .||.....
T Consensus       169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~  248 (301)
T d1lufa_         169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  248 (301)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence            99999999999999999987554443333344567899999999999999999999999999999999986 56764432


Q ss_pred             ccccchhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccc
Q 046595          285 KGQQSLVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN  353 (363)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~  353 (363)
                      ....                ..+........+..++.++.+|+.+||+.||++|||+.+|++.|+++.+
T Consensus       249 ~e~~----------------~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         249 EEVI----------------YYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             HHHH----------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             HHHH----------------HHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            2111                1111122233455566789999999999999999999999999998763

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-55  Score=394.05  Aligned_cols=248  Identities=22%  Similarity=0.311  Sum_probs=209.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|++++.||+|+||.||+|+. .+|+.||||++....  .......+.+|+.+|+.++||||+++++++.+.+.+++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5799999999999999999986 479999999987532  2344677899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.||+|.+++.....         +++..+..++.|++.||+|||++   +|+||||||+|||++.+|.+||+|||+|
T Consensus        85 ey~~gg~L~~~~~~~~~---------~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a  152 (337)
T d1o6la_          85 EYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLC  152 (337)
T ss_dssp             ECCTTCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             eccCCCchhhhhhcccC---------CcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccc
Confidence            99999999999987653         89999999999999999999999   9999999999999999999999999999


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      +.......  .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||............             
T Consensus       153 ~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i-------------  217 (337)
T d1o6la_         153 KEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI-------------  217 (337)
T ss_dssp             BCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------------
T ss_pred             cccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHH-------------
Confidence            76543322  234578999999999999999999999999999999999999999765332111110             


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPN-----MTIVVK  346 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~~vl~  346 (363)
                        ...  ...++..++.++.+||.+||+.||.+|++     ++++++
T Consensus       218 --~~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         218 --LME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             --HHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --hcC--CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence              000  12334456677999999999999999995     888876

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-55  Score=381.87  Aligned_cols=251  Identities=29%  Similarity=0.451  Sum_probs=202.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEe-CCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCME-SNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~  146 (363)
                      ++|++.+.||+|+||.||+|+++ |+.||||+++.   ....+.+.+|++++++++||||+++++++.+ .+..++||||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCC---CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECc---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            46888999999999999999985 77899999965   3345789999999999999999999999865 4568999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +++|+|.+++......       .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        83 ~~~g~L~~~l~~~~~~-------~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~  152 (262)
T d1byga_          83 MAKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE  152 (262)
T ss_dssp             CTTEEHHHHHHHHHHH-------HCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred             cCCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeeccccccee
Confidence            9999999999754311       289999999999999999999999   999999999999999999999999999876


Q ss_pred             CCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccccccccc
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      ....     .....+|..|+|||++.+..++.++||||||+++|||+| |+.||......+                +..
T Consensus       153 ~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~----------------~~~  211 (262)
T d1byga_         153 ASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----------------VVP  211 (262)
T ss_dssp             --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG----------------HHH
T ss_pred             cCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH----------------HHH
Confidence            4432     233468899999999999999999999999999999998 678876443221                112


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccc
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN  353 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~  353 (363)
                      .+.......++..++.++.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       212 ~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         212 RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             HHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            222233445556667789999999999999999999999999998764

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.3e-55  Score=388.20  Aligned_cols=245  Identities=22%  Similarity=0.326  Sum_probs=207.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|++++.||+|+||.||+|+++ +|+.||||++....  .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            47999999999999999999864 69999999986432  2344678899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.||+|..++.....         +++..+..++.||+.||.|||++   +|+||||||+||||+.+|.+||+|||+|
T Consensus        84 E~~~gg~l~~~~~~~~~---------~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a  151 (316)
T d1fota_          84 DYIEGGELFSLLRKSQR---------FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFA  151 (316)
T ss_dssp             CCCCSCBHHHHHHHTSS---------CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             eecCCcccccccccccc---------ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccc
Confidence            99999999999986653         78999999999999999999999   9999999999999999999999999999


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      +.....     ....+||+.|+|||++.+..|+.++|||||||+||||++|+.||...........              
T Consensus       152 ~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~--------------  212 (316)
T d1fota_         152 KYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK--------------  212 (316)
T ss_dssp             EECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--------------
T ss_pred             eEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHH--------------
Confidence            765443     2346899999999999999999999999999999999999999975432211111              


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP-----NMTIVVK  346 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  346 (363)
                       +...  ...++...+.++.+++.+||+.||.+|+     |++++++
T Consensus       213 -i~~~--~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         213 -ILNA--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             -HHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -HHcC--CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence             1111  1123445567799999999999999996     8999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.1e-55  Score=383.55  Aligned_cols=263  Identities=24%  Similarity=0.323  Sum_probs=205.2

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCC--chHHHHHHHHHHhcCCCCccceeeeEEEeCCe---
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPE--PESDFAAQLSVVSRLKHEHFVELLGYCMESNN---  139 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---  139 (363)
                      +.++|++.+.||+|+||.||+|++ .+|+.||||++.......  ....+.+|+.+++.++||||+++++++.....   
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence            456899999999999999999976 479999999997654333  23578999999999999999999999887543   


Q ss_pred             -eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEE
Q 046595          140 -RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI  218 (363)
Q Consensus       140 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl  218 (363)
                       .|+||||++|++|.+++....         .+++.+++.++.|++.||.|||++   ||+||||||+|||++.++.++|
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~---------~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l  152 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKV  152 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEE
T ss_pred             eEEEEEECCCCCEehhhhcccC---------CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCcccccee
Confidence             789999999999999987654         289999999999999999999999   9999999999999999999999


Q ss_pred             eeeccCCCCCcccc-cccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccc
Q 046595          219 ADFNLTNQSSDTAA-RLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR  297 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~  297 (363)
                      +|||.+........ ........||+.|+|||++.+..++.++|||||||++|||++|+.||....+...........+ 
T Consensus       153 ~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~-  231 (277)
T d1o6ya_         153 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP-  231 (277)
T ss_dssp             CCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-
T ss_pred             ehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCC-
Confidence            99998765433222 2223456799999999999999999999999999999999999999975433221111100000 


Q ss_pred             ccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhccccc
Q 046595          298 LSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP-NMTIVVKALQPLLN  353 (363)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~~vl~~l~~l~~  353 (363)
                                  .........++.++.++|.+||+.||.+|| |++++++.|.++.+
T Consensus       232 ------------~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         232 ------------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             ------------CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             ------------CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence                        000111223456799999999999999999 89999999987754

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-55  Score=388.29  Aligned_cols=268  Identities=26%  Similarity=0.423  Sum_probs=214.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCC--------CCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeC
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTD--------GTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMES  137 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  137 (363)
                      .++|++++.||+|+||.||+|+...        +..||||++...........+.+|...+.++ +||||+++++++.+.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            3579999999999999999997532        2369999998755544557788899888888 799999999999999


Q ss_pred             CeeEEEEecccCCChhhhhcCCCCCC-------CCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceee
Q 046595          138 NNRILVYQFATMGSLHDVLHGRKGVQ-------GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLL  210 (363)
Q Consensus       138 ~~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill  210 (363)
                      ...++||||+++|+|.+++.......       .......+++.+++.++.|++.||+|||++   +|+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence            99999999999999999997654211       112234589999999999999999999999   99999999999999


Q ss_pred             cCCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccc
Q 046595          211 FDDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQS  289 (363)
Q Consensus       211 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~  289 (363)
                      +.++.+||+|||++................||+.|+|||.+.++.|+.++||||||+++|||++ |..||.......   
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~---  245 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---  245 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---
Confidence            9999999999999987665554444555679999999999999999999999999999999998 688886443211   


Q ss_pred             hhhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccc
Q 046595          290 LVTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLN  353 (363)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~  353 (363)
                                   +...+..+.....+..++.++.+||.+||+.||.+|||+.+|++.|+++++
T Consensus       246 -------------~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         246 -------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             -------------HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------------HHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence                         111222233344455566789999999999999999999999999998875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-55  Score=389.51  Aligned_cols=270  Identities=23%  Similarity=0.352  Sum_probs=206.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeC-C
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMES-N  138 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~  138 (363)
                      .++|++.+.||+|+||.||+|++.      +++.||||++...........+..|..++.++ +|+||+.+++++... .
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            367999999999999999999753      24679999997655444456778888877777 689999999988765 4


Q ss_pred             eeEEEEecccCCChhhhhcCCCCCCC-------CCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQG-------AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF  211 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~  211 (363)
                      ..++||||+++|+|.+++........       ......+++.+++.++.|++.||.|||++   +|+||||||+||||+
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeEC
Confidence            68899999999999999975432110       01123489999999999999999999999   999999999999999


Q ss_pred             CCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCC-CCCCCCCCccccch
Q 046595          212 DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGR-KPVDHTMPKGQQSL  290 (363)
Q Consensus       212 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~-~p~~~~~~~~~~~~  290 (363)
                      +++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|. .||........   
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~---  245 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---  245 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH---
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH---
Confidence            99999999999998765544444445678999999999999999999999999999999999975 57754332111   


Q ss_pred             hhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          291 VTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                                  +...+........+..++.++.+++.+||+.||++|||+.+|++.|+.++++
T Consensus       246 ------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         246 ------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             ------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------------HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                        1111111222334445667799999999999999999999999999998865

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-54  Score=386.04  Aligned_cols=268  Identities=25%  Similarity=0.411  Sum_probs=211.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCC-CC--eEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCeeEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTD-GT--PAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~-~~--~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      ++|++.++||+|+||.||+|.+.+ +.  .||||.+......+..+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            478889999999999999998653 44  47788876655555567899999999999 799999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCC-------CCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCce
Q 046595          144 YQFATMGSLHDVLHGRKGVQ-------GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS  216 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v  216 (363)
                      |||+++|+|.++|.......       .......+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence            99999999999997642100       001123499999999999999999999999   99999999999999999999


Q ss_pred             EEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCC-CCCCCCCCccccchhhhcc
Q 046595          217 KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGR-KPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       217 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~-~p~~~~~~~~~~~~~~~~~  295 (363)
                      ||+|||+++.......   .....||..|+|||.+.+..++.++|||||||++|||++|. .||.......         
T Consensus       167 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---------  234 (309)
T d1fvra_         167 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------  234 (309)
T ss_dssp             EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---------
T ss_pred             EEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---------
Confidence            9999999875543322   23456899999999999999999999999999999999976 4665432211         


Q ss_pred             ccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCC
Q 046595          296 PRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA  357 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~  357 (363)
                             +...+........+..++.++.+||.+||+.||++|||+++|++.|+.++++...
T Consensus       235 -------~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~  289 (309)
T d1fvra_         235 -------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  289 (309)
T ss_dssp             -------HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred             -------HHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcC
Confidence                   1111111222344556677899999999999999999999999999999876653

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=379.65  Aligned_cols=257  Identities=24%  Similarity=0.348  Sum_probs=199.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC--CC--CeEEEEEccCCCCC--CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT--DG--TPAAIKKLDTSSAP--EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRI  141 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~--~~--~~~avK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  141 (363)
                      ++|++.+.||+|+||.||+|+..  ++  ..||||++......  ...+.+.+|+.+++.++||||+++++++.+ ...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            57999999999999999999753  23  36899998764332  234689999999999999999999999965 5678


Q ss_pred             EEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeee
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADF  221 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df  221 (363)
                      +||||+++|+|.+++.....        .+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+||
T Consensus        87 lv~e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~Df  155 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDF  155 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGG--------GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCC
T ss_pred             eeeeeecCcchhhhhhcccC--------CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccc
Confidence            99999999999998865432        389999999999999999999999   9999999999999999999999999


Q ss_pred             ccCCCCCcccccc-cccccccccCCCCccccccCCCCccCceehhHHHHHHHHh-CCCCCCCCCCccccchhhhcccccc
Q 046595          222 NLTNQSSDTAARL-HSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLT-GRKPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       222 g~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      |+++......... ......|+..|+|||.+.+..++.++||||||+++|||+| |..||.........           
T Consensus       156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~-----------  224 (273)
T d1u46a_         156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL-----------  224 (273)
T ss_dssp             TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-----------
T ss_pred             hhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH-----------
Confidence            9998765443322 2334568889999999999999999999999999999998 89999754322111           


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPL  351 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l  351 (363)
                          ..+.........+..++..+.+|+.+||+.||++|||+.+|++.|++.
T Consensus       225 ----~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         225 ----HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ----HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----HHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                111122223334455667899999999999999999999999999864

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=386.25  Aligned_cols=270  Identities=23%  Similarity=0.367  Sum_probs=219.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEe------CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEeCCee
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL------TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCMESNNR  140 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  140 (363)
                      ++|++.+.||+|+||.||+|++      .+++.||||+++..........+.+|+.++..+ +||||+++++++.+....
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            5788899999999999999974      245689999998755544556789999999999 699999999999999999


Q ss_pred             EEEEecccCCChhhhhcCCCCCCC---------CCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQG---------AEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF  211 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~---------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~  211 (363)
                      ++||||+++|+|.+++........         ......+++..++.++.||+.||.|||++   +++||||||+||+++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT  179 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence            999999999999999976542111         11223589999999999999999999999   999999999999999


Q ss_pred             CCCceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCC-CCCCCCCCccccch
Q 046595          212 DDFKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGR-KPVDHTMPKGQQSL  290 (363)
Q Consensus       212 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~-~p~~~~~~~~~~~~  290 (363)
                      .++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+|+. +||.......    
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~----  255 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS----  255 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH----
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH----
Confidence            99999999999998776554444455678999999999999999999999999999999999954 5554332211    


Q ss_pred             hhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccC
Q 046595          291 VTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSK  355 (363)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~  355 (363)
                                 .+...++.......+...+..+.+||.+||+.||++|||+.+|++.|++++.+.
T Consensus       256 -----------~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~  309 (311)
T d1t46a_         256 -----------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (311)
T ss_dssp             -----------HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             -----------HHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence                       111222223333444556678999999999999999999999999999877653

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3e-54  Score=389.39  Aligned_cols=245  Identities=18%  Similarity=0.260  Sum_probs=207.2

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      ++|++++.||+|+||.||+|+++ +|+.||||++....  .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            47999999999999999999864 79999999986422  2344567899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccC
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLT  224 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a  224 (363)
                      ||+.+|+|..++....         .+++..++.++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+|
T Consensus       121 e~~~~g~l~~~l~~~~---------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a  188 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG---------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFA  188 (350)
T ss_dssp             ECCTTCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ccccccchhhhHhhcC---------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceee
Confidence            9999999999997654         289999999999999999999999   9999999999999999999999999999


Q ss_pred             CCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccccc
Q 046595          225 NQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVK  304 (363)
Q Consensus       225 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (363)
                      +.....     .....||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+.            
T Consensus       189 ~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~------------  251 (350)
T d1rdqe_         189 KRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV------------  251 (350)
T ss_dssp             EECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------------
T ss_pred             eecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHh------------
Confidence            765433     234679999999999999999999999999999999999999997543221111110            


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046595          305 QCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP-----NMTIVVK  346 (363)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  346 (363)
                         ..  ....+..++.++.++|.+||+.||.+|+     |+++|++
T Consensus       252 ---~~--~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         252 ---SG--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---HC--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---cC--CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence               00  0122334566799999999999999994     8999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=379.54  Aligned_cols=259  Identities=26%  Similarity=0.389  Sum_probs=208.7

Q ss_pred             CCeeeccCCceEEEEEeCCC----CeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeC-CeeEEEEecc
Q 046595           73 KALIGEGSYGRVFYAKLTDG----TPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMES-NNRILVYQFA  147 (363)
Q Consensus        73 ~~~lg~G~~g~V~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~  147 (363)
                      .++||+|+||+||+|++.++    ..||||+++.........++.+|++++++++||||+++++++... ...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            56799999999999986532    258999987654444557899999999999999999999998764 5789999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      ++|+|.+++.....        .+++..++.++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||+++..
T Consensus       112 ~~g~l~~~~~~~~~--------~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~  180 (311)
T d1r0pa_         112 KHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM  180 (311)
T ss_dssp             TTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred             ecCchhhhhccccc--------cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhc
Confidence            99999999876542        377889999999999999999999   9999999999999999999999999999876


Q ss_pred             Cccccc--ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccccc
Q 046595          228 SDTAAR--LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKVKQ  305 (363)
Q Consensus       228 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (363)
                      ......  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........               +..
T Consensus       181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~---------------~~~  245 (311)
T d1r0pa_         181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---------------ITV  245 (311)
T ss_dssp             TTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------------------CHH
T ss_pred             cccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH---------------HHH
Confidence            543322  123345789999999999999999999999999999999998888764322111               111


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCC
Q 046595          306 CVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPA  357 (363)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~  357 (363)
                      .+..+.....+..++.++.+|+.+||+.||++||++.||++.|+.++++...
T Consensus       246 ~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~  297 (311)
T d1r0pa_         246 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  297 (311)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             HHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence            1111112233445667899999999999999999999999999999877544

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6.5e-54  Score=374.98  Aligned_cols=252  Identities=20%  Similarity=0.265  Sum_probs=207.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCc--------hHHHHHHHHHHhcCC-CCccceeeeEEEe
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEP--------ESDFAAQLSVVSRLK-HEHFVELLGYCME  136 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~--------~~~~~~e~~~l~~l~-h~~i~~~~~~~~~  136 (363)
                      .++|++.+.||+|+||+||+|++. +++.||||++........        .+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            468999999999999999999864 689999999876543221        235788999999997 9999999999999


Q ss_pred             CCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCce
Q 046595          137 SNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKS  216 (363)
Q Consensus       137 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~v  216 (363)
                      .+..+|||||+++|+|.+++....         .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~  149 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKV---------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNI  149 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred             CcceEEEEEcCCCchHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCe
Confidence            999999999999999999997654         289999999999999999999999   99999999999999999999


Q ss_pred             EEeeeccCCCCCcccccccccccccccCCCCcccccc------CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccch
Q 046595          217 KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT------GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSL  290 (363)
Q Consensus       217 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~  290 (363)
                      ||+|||+++.......   .....||+.|+|||.+.+      ..++.++||||+||+||||++|+.||...........
T Consensus       150 kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~  226 (277)
T d1phka_         150 KLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM  226 (277)
T ss_dssp             EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHH
Confidence            9999999976554322   345679999999999863      3578899999999999999999999976543221111


Q ss_pred             hhhccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          291 VTWATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      +.-.             ...........+++++.+|+.+||+.||++|||+.+|++
T Consensus       227 i~~~-------------~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         227 IMSG-------------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHT-------------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHhC-------------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1000             001112223356678999999999999999999999976

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=380.91  Aligned_cols=248  Identities=16%  Similarity=0.221  Sum_probs=205.9

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      +.++|++++.||+|+||.||+|.+. +++.||||++....  .....+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm   80 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            4578999999999999999999865 68899999997632  23456889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC--CCceEEeeec
Q 046595          145 QFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD--DFKSKIADFN  222 (363)
Q Consensus       145 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~--~~~vkl~Dfg  222 (363)
                      ||++||+|.+++.....        .+++.+++.++.||+.||.|||++   ||+||||||+|||++.  .+.+||+|||
T Consensus        81 E~~~gg~L~~~i~~~~~--------~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG  149 (321)
T d1tkia_          81 EFISGLDIFERINTSAF--------ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             CCCCCCBHHHHHTSSSC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             ecCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccc
Confidence            99999999999976431        289999999999999999999999   9999999999999984  4589999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccccc
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDK  302 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (363)
                      ++........   .....||+.|+|||.+.+..|+.++|||||||++|+|++|..||...........+           
T Consensus       150 ~~~~~~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i-----------  215 (321)
T d1tkia_         150 QARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI-----------  215 (321)
T ss_dssp             TCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-----------
T ss_pred             hhhccccCCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH-----------
Confidence            9876543322   23457899999999999999999999999999999999999999754332111111           


Q ss_pred             cccccCCcCCCCCCH----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          303 VKQCVDPKLNNDYPP----KAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                          ....  ..++.    .++.++.+||.+||..||.+|||+.|+++
T Consensus       216 ----~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         216 ----MNAE--YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ----HHTC--CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----HhCC--CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                1101  11111    24567899999999999999999999987

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.2e-53  Score=387.52  Aligned_cols=249  Identities=23%  Similarity=0.318  Sum_probs=201.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHH---HHHHHhcCCCCccceeeeEEEeCCeeE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAA---QLSVVSRLKHEHFVELLGYCMESNNRI  141 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~  141 (363)
                      ++|++.+.||+|+||.||+|++. +|+.||||++....  .......+.+   ++.+++.++||||+++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            47999999999999999999865 69999999985421  1112223333   467788889999999999999999999


Q ss_pred             EEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeee
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADF  221 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df  221 (363)
                      +||||+.+|+|.+++....         .+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+||
T Consensus        84 ivmE~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DF  151 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG---------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDL  151 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCC
T ss_pred             EEEEecCCCcHHHHHHhcc---------cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeee
Confidence            9999999999999997654         288999999999999999999999   9999999999999999999999999


Q ss_pred             ccCCCCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccc
Q 046595          222 NLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE  300 (363)
Q Consensus       222 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  300 (363)
                      |+|+......    .....||+.|+|||++.+ ..|+.++|||||||+||||++|+.||................     
T Consensus       152 Gla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-----  222 (364)
T d1omwa3         152 GLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-----  222 (364)
T ss_dssp             TTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS-----
T ss_pred             ceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----
Confidence            9997654332    344679999999999874 568999999999999999999999997654332221111100     


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 046595          301 DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPN-----MTIVVK  346 (363)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~~vl~  346 (363)
                               .....++..++.++.+||.+||+.||.+|||     ++++++
T Consensus       223 ---------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         223 ---------TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ---------SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ---------cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                     1112223345667999999999999999999     688876

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-54  Score=380.21  Aligned_cols=274  Identities=23%  Similarity=0.328  Sum_probs=204.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHH--HHHHhcCCCCccceeeeEEEeCC----ee
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQ--LSVVSRLKHEHFVELLGYCMESN----NR  140 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e--~~~l~~l~h~~i~~~~~~~~~~~----~~  140 (363)
                      .++|.+.+.||+|+||.||+|++ +|+.||||++...    ....+.+|  +..+..++||||+++++++.+.+    ..
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence            35688889999999999999987 5889999998642    23344444  44556789999999999998754    57


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccC-----CCCeEEecccCCceeecCCCc
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV-----QPPIVHRDVRSSNVLLFDDFK  215 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-----~~~ivH~Dlkp~Nill~~~~~  215 (363)
                      ++||||+++|+|.++++...          +++..++.++.|++.||.|||+..     ..+|+||||||+||||+.++.
T Consensus        77 ~lv~Ey~~~g~L~~~l~~~~----------l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~  146 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  146 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred             EEEEecccCCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC
Confidence            89999999999999998653          899999999999999999999621     128999999999999999999


Q ss_pred             eEEeeeccCCCCCccccc--ccccccccccCCCCccccccCC------CCccCceehhHHHHHHHHhCCCCCCCCCCccc
Q 046595          216 SKIADFNLTNQSSDTAAR--LHSTRVLGTFGYHAPEYAMTGQ------ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQ  287 (363)
Q Consensus       216 vkl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~  287 (363)
                      +||+|||+++........  .......||+.|+|||++.+..      ++.++|||||||+||||+||..||........
T Consensus       147 ~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~  226 (303)
T d1vjya_         147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  226 (303)
T ss_dssp             EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred             eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence            999999998755332221  1234567999999999987642      67789999999999999999988864333221


Q ss_pred             cchhhhccccccccccc-cccCCcCCCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCC
Q 046595          288 QSLVTWATPRLSEDKVK-QCVDPKLNNDY-----PPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP  356 (363)
Q Consensus       288 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~  356 (363)
                      .. ............+. ...+..++...     ..+....+.+|+.+||+.||++|||+.+|++.|+++.++..
T Consensus       227 ~~-~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~  300 (303)
T d1vjya_         227 PY-YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             TT-TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             ch-hhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence            11 11111111111111 11222222222     23566789999999999999999999999999999887654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-54  Score=383.34  Aligned_cols=268  Identities=24%  Similarity=0.369  Sum_probs=217.5

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC------CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT------DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRI  141 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  141 (363)
                      ++|.+.+.||+|+||.||+|.+.      +++.||||+++..........+.+|+.++++++||||+++++++......+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            57889999999999999999753      357899999976544444467899999999999999999999999999999


Q ss_pred             EEEecccCCChhhhhcCCCCCC-CCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEee
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQ-GAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD  220 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D  220 (363)
                      +||||+.+|+|.+++....... .......+++..+..++.|++.||.|||++   +|+||||||+|||++.++++||+|
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEee
Confidence            9999999999999986432100 001112378999999999999999999999   999999999999999999999999


Q ss_pred             eccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCC-CCCCCCCCccccchhhhcccccc
Q 046595          221 FNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGR-KPVDHTMPKGQQSLVTWATPRLS  299 (363)
Q Consensus       221 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~-~p~~~~~~~~~~~~~~~~~~~~~  299 (363)
                      ||+++...............||+.|+|||.+.+..++.++||||||+++|||+||. .||........            
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~------------  244 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------------  244 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH------------
T ss_pred             cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH------------
Confidence            99998766555544455567999999999999999999999999999999999985 67754322111            


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcccccc
Q 046595          300 EDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNS  354 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~  354 (363)
                          ...+........+..++..+.+++.+||+.||++|||+++|++.|+..++.
T Consensus       245 ----~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~  295 (308)
T d1p4oa_         245 ----LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  295 (308)
T ss_dssp             ----HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             ----HHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence                111111122333455667899999999999999999999999999987663

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-53  Score=377.37  Aligned_cols=264  Identities=23%  Similarity=0.243  Sum_probs=198.6

Q ss_pred             CCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC----chHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEecc
Q 046595           73 KALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE----PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQFA  147 (363)
Q Consensus        73 ~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  147 (363)
                      +++||+|+||+||+|++. +|+.||||++.......    ....+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            468999999999999864 68999999997643222    1356889999999999999999999999999999999999


Q ss_pred             cCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCCC
Q 046595          148 TMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQS  227 (363)
Q Consensus       148 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~  227 (363)
                      .++++..++....         .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        83 ~~~~~~~~~~~~~---------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~  150 (299)
T d1ua2a_          83 ETDLEVIIKDNSL---------VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF  150 (299)
T ss_dssp             SEEHHHHHTTCCS---------SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             cchHHhhhhhccc---------CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCcccccc
Confidence            9977776665433         388999999999999999999999   9999999999999999999999999999766


Q ss_pred             CcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc---
Q 046595          228 SDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV---  303 (363)
Q Consensus       228 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  303 (363)
                      ......  ....+||+.|+|||++.+. .|+.++|||||||++|||++|..||......+....+.-..........   
T Consensus       151 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~  228 (299)
T d1ua2a_         151 GSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM  228 (299)
T ss_dssp             TSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred             CCCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccch
Confidence            544322  3346799999999988754 6899999999999999999999999765443322111100000000000   


Q ss_pred             ---ccccCCcCCCCCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhcc
Q 046595          304 ---KQCVDPKLNNDYP-----PKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQP  350 (363)
Q Consensus       304 ---~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~  350 (363)
                         ............+     ...+.++.+|+.+||+.||++|||++|+++  .|++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~  285 (299)
T d1ua2a_         229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN  285 (299)
T ss_dssp             TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred             hccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence               0000000000111     123567999999999999999999999987  4543

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-54  Score=384.06  Aligned_cols=248  Identities=25%  Similarity=0.330  Sum_probs=205.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCC--CCCchHHHHHHHHHHh-cCCCCccceeeeEEEeCCeeEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSS--APEPESDFAAQLSVVS-RLKHEHFVELLGYCMESNNRILV  143 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv  143 (363)
                      ++|++.+.||+|+||+||+|++. +++.||||++....  .......+..|..++. .++||||+++++++.+.+..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            47999999999999999999865 68999999996532  2344556777777665 68999999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeecc
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNL  223 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~  223 (363)
                      |||+++|+|.+++.....         +++.++..++.||+.||.|||++   +|+||||||+|||+++++.+||+|||+
T Consensus        82 mEy~~~g~L~~~i~~~~~---------~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~  149 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGM  149 (320)
T ss_dssp             EECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EeecCCCcHHHHhhccCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccch
Confidence            999999999999976543         89999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccccccccc
Q 046595          224 TNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSEDKV  303 (363)
Q Consensus       224 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (363)
                      ++........  .....||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+...         
T Consensus       150 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~---------  218 (320)
T d1xjda_         150 CKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD---------  218 (320)
T ss_dssp             CBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------
T ss_pred             hhhccccccc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC---------
Confidence            9765443322  34568999999999999999999999999999999999999999754332211111100         


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 046595          304 KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMT-IVVK  346 (363)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~-~vl~  346 (363)
                              ...++..++.++.+||.+||+.||.+||++. +|++
T Consensus       219 --------~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         219 --------NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             --------CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence                    1123344567799999999999999999995 6764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-53  Score=379.08  Aligned_cols=251  Identities=18%  Similarity=0.238  Sum_probs=199.7

Q ss_pred             HhcCCCCCC-eeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcC-CCCccceeeeEEEe----CC
Q 046595           66 LTSNFGTKA-LIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRL-KHEHFVELLGYCME----SN  138 (363)
Q Consensus        66 ~~~~y~~~~-~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~  138 (363)
                      +.++|.+.. +||+|+||.||+|++ .+++.||||++..      ...+.+|+.++.++ +||||+++++++.+    ..
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~   82 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK   82 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence            346898764 699999999999976 5789999999854      34678899886654 89999999999875    46


Q ss_pred             eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC---CCc
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD---DFK  215 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~---~~~  215 (363)
                      .+|+|||||+||+|.+++.....       ..+++.++..++.|++.||.|||++   +|+||||||+|||+++   ++.
T Consensus        83 ~~~ivmEy~~gg~L~~~i~~~~~-------~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~  152 (335)
T d2ozaa1          83 CLLIVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAI  152 (335)
T ss_dssp             EEEEEEECCCSEEHHHHHHSCSC-------CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCC
T ss_pred             EEEEEEECCCCCcHHHHHHhcCC-------CCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccc
Confidence            68999999999999999976432       2399999999999999999999999   9999999999999985   567


Q ss_pred             eEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 046595          216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       216 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      +||+|||+|+.......   .....||+.|+|||++.+..|+.++|||||||+||+|++|+.||............    
T Consensus       153 ~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~----  225 (335)
T d2ozaa1         153 LKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----  225 (335)
T ss_dssp             EEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------
T ss_pred             ccccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH----
Confidence            99999999976544322   34567999999999999999999999999999999999999999654332211100    


Q ss_pred             ccccccccccccCCcC--CCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          296 PRLSEDKVKQCVDPKL--NNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                             .........  .......++.++.+||.+||+.||++|||+.++++
T Consensus       226 -------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         226 -------KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             ---------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -------HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                   000111111  11112356778999999999999999999999987

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-53  Score=372.00  Aligned_cols=246  Identities=19%  Similarity=0.352  Sum_probs=200.6

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC-----chHHHHHHHHHHhcCC--CCccceeeeEEEeCC
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE-----PESDFAAQLSVVSRLK--HEHFVELLGYCMESN  138 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~-----~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~  138 (363)
                      .++|++.+.||+|+||.||+|++. +|+.||||++.......     ...++.+|+.++++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            468999999999999999999764 79999999987543221     1234678999999986  899999999999999


Q ss_pred             eeEEEEecccC-CChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC-CCce
Q 046595          139 NRILVYQFATM-GSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD-DFKS  216 (363)
Q Consensus       139 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-~~~v  216 (363)
                      ..++||||+.+ +++.+++....         .+++.++..++.|++.||.|||++   +|+||||||+|||++. ++.+
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~---------~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~v  150 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG---------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGEL  150 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEE
T ss_pred             eEEEEEEeccCcchHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeE
Confidence            99999999976 57888886544         289999999999999999999999   9999999999999985 5799


Q ss_pred             EEeeeccCCCCCcccccccccccccccCCCCccccccCCC-CccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 046595          217 KIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQI-TQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       217 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      ||+|||+|.......    .+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....     ..    
T Consensus       151 kl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----i~----  217 (273)
T d1xwsa_         151 KLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----II----  217 (273)
T ss_dssp             EECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HH----
T ss_pred             EECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----Hh----
Confidence            999999987544322    345689999999999987765 6779999999999999999999964210     00    


Q ss_pred             ccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhccc
Q 046595          296 PRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPL  351 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l  351 (363)
                          ..          ...++..++.++.+||.+||+.||++|||++|+++  .|+++
T Consensus       218 ----~~----------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         218 ----RG----------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             ----HC----------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             ----hc----------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence                00          01112234567999999999999999999999987  45544

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.9e-52  Score=369.05  Aligned_cols=265  Identities=19%  Similarity=0.247  Sum_probs=202.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCC-CCchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEec
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSA-PEPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQF  146 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  146 (363)
                      ++|++.+.||+|+||+||+|++++|+.||||++..... ......+.+|+.++++++||||+++++++...+..+++|++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            47999999999999999999998999999999976432 23357899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCCC
Q 046595          147 ATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTNQ  226 (363)
Q Consensus       147 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~  226 (363)
                      +.++.+..+.....         .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++..
T Consensus        82 ~~~~~~~~~~~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~  149 (286)
T d1ob3a_          82 LDQDLKKLLDVCEG---------GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARA  149 (286)
T ss_dssp             CSEEHHHHHHTSTT---------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred             ehhhhHHHHHhhcC---------CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEeccccccee
Confidence            98876666665443         399999999999999999999999   999999999999999999999999999865


Q ss_pred             CCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccc-----
Q 046595          227 SSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE-----  300 (363)
Q Consensus       227 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-----  300 (363)
                      .......  .....|++.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+.........     
T Consensus       150 ~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  227 (286)
T d1ob3a_         150 FGIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN  227 (286)
T ss_dssp             HCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             cccCccc--cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccc
Confidence            4332221  3345689999999998754 5689999999999999999999999765433221111100000000     


Q ss_pred             ----ccc---ccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          301 ----DKV---KQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       301 ----~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                          ...   ................+..+.+++.+||+.||++|||++|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                000   0000111111222344567999999999999999999999985

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-52  Score=367.63  Aligned_cols=271  Identities=23%  Similarity=0.322  Sum_probs=202.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      ++|++.+.||+|+||.||+|++ .+++.||||++...... .....+.+|+.++++++||||+++++++.+....++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            4799999999999999999986 57999999999764432 235788999999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      |+.+ ++.+++.....       ..+++.++..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+
T Consensus        82 ~~~~-~~~~~~~~~~~-------~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~  150 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASAL-------TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR  150 (298)
T ss_dssp             CCSE-EHHHHHHHTTT-------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHH
T ss_pred             ecCC-chhhhhhhhcc-------cCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcce
Confidence            9987 45444432221       1389999999999999999999999   99999999999999999999999999986


Q ss_pred             CCCcccccccccccccccCCCCccccccCC-CCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccccc---c
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRLSE---D  301 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~---~  301 (363)
                      .......  ......||+.|+|||++.... ++.++|||||||++|+|++|+.||......+..............   .
T Consensus       151 ~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  228 (298)
T d1gz8a_         151 AFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  228 (298)
T ss_dssp             HHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             eccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcc
Confidence            5443222  234457999999999887665 578999999999999999999999765432211111000000000   0


Q ss_pred             cccccc--CCcC----CCC---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhccc
Q 046595          302 KVKQCV--DPKL----NND---YPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPL  351 (363)
Q Consensus       302 ~~~~~~--~~~~----~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l  351 (363)
                      .+....  ....    ...   .....+.++.+|+.+||+.||.+|||+.|+++  .|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence            000000  0000    000   01133467899999999999999999999998  46655

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-52  Score=368.82  Aligned_cols=271  Identities=21%  Similarity=0.300  Sum_probs=202.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-C-CCeEEEEEccCCCCC-CchHHHHHHHHHHhcC---CCCccceeeeEEEe----
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-D-GTPAAIKKLDTSSAP-EPESDFAAQLSVVSRL---KHEHFVELLGYCME----  136 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~-~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~----  136 (363)
                      .++|++++.||+|+||+||+|++. + ++.||||++...... .....+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999863 4 567999998654322 2234566788777766   79999999998853    


Q ss_pred             -CCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCc
Q 046595          137 -SNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFK  215 (363)
Q Consensus       137 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~  215 (363)
                       ....+++|||+.++.+........        ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~  154 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPE--------PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQ  154 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCT--------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCC
T ss_pred             cCceEEEEEEeccCCchhhhhhccC--------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCC
Confidence             346789999999876654443322        1389999999999999999999999   9999999999999999999


Q ss_pred             eEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 046595          216 SKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       216 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      +||+|||++........   .....||+.|+|||++.+..|+.++|||||||++|||++|+.||....+.+....+....
T Consensus       155 ~kl~dfg~~~~~~~~~~---~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~  231 (305)
T d1blxa_         155 IKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI  231 (305)
T ss_dssp             EEECSCCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             eeecchhhhhhhccccc---CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhh
Confidence            99999999876544332   355789999999999999999999999999999999999999997654332222111100


Q ss_pred             ccccc----------cccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhccc
Q 046595          296 PRLSE----------DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPL  351 (363)
Q Consensus       296 ~~~~~----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l  351 (363)
                      .....          ..............+....++.+.+||.+||+.||++|||++|+++  .|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             CCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence            00000          0000000001111222344567899999999999999999999987  46555

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=8e-51  Score=359.18  Aligned_cols=270  Identities=16%  Similarity=0.197  Sum_probs=212.9

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCC-CccceeeeEEEeCCeeEEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKH-EHFVELLGYCMESNNRILV  143 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv  143 (363)
                      +.++|++++.||+|+||.||+|++. +|+.||||++......   ..+.+|++.++.++| +|++.+++++......++|
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            4578999999999999999999865 6889999998654332   346788889988865 8999999999999999999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecC-----CCceEE
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFD-----DFKSKI  218 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~-----~~~vkl  218 (363)
                      |||+ +++|.+++.....        .++..++..++.|++.||+|||++   ||+||||||+|||++.     ++.+||
T Consensus        80 me~~-~~~l~~~~~~~~~--------~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl  147 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCGR--------KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYV  147 (293)
T ss_dssp             EECC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred             EEec-CCCHHHHHHhhcc--------chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEE
Confidence            9998 6799999875432        389999999999999999999999   9999999999999974     678999


Q ss_pred             eeeccCCCCCccccc-----ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhh
Q 046595          219 ADFNLTNQSSDTAAR-----LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTW  293 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~  293 (363)
                      +|||+|+........     .......||+.|||||++.+..++.++|||||||++|||++|..||..............
T Consensus       148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~  227 (293)
T d1csna_         148 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER  227 (293)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred             cccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH
Confidence            999999765432221     123346799999999999999999999999999999999999999976544332221111


Q ss_pred             ccccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCCCCC
Q 046595          294 ATPRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKPAGP  359 (363)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~~~~  359 (363)
                      ...........     .+    ...+++++.+++..|+..+|++||+++.+.+.|++++++.....
T Consensus       228 i~~~~~~~~~~-----~l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~  284 (293)
T d1csna_         228 IGEKKQSTPLR-----EL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE  284 (293)
T ss_dssp             HHHHHHHSCHH-----HH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred             HHhccCCCChH-----Hh----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCC
Confidence            00000000000     11    12345679999999999999999999999999999887765543

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-51  Score=369.58  Aligned_cols=269  Identities=20%  Similarity=0.288  Sum_probs=201.0

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeCC----ee
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMESN----NR  140 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~  140 (363)
                      ++.+|++++.||+|+||+||+|.+ .+|+.||||++...........+.+|+.+|+.++||||+++++++....    ..
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            346899999999999999999975 5799999999976544444567889999999999999999999987643    23


Q ss_pred             EEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEee
Q 046595          141 ILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIAD  220 (363)
Q Consensus       141 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D  220 (363)
                      +++++|+.+|+|.+++....          +++..+..++.|++.||+|||++   ||+||||||+|||++.++.+||+|
T Consensus        86 ~~l~~~~~~g~L~~~l~~~~----------l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~D  152 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKTQH----------LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICD  152 (345)
T ss_dssp             EEEEEECCCEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred             EEEEEeecCCchhhhhhcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcc
Confidence            55566777899999997543          89999999999999999999999   999999999999999999999999


Q ss_pred             eccCCCCCccccc-ccccccccccCCCCccccc-cCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 046595          221 FNLTNQSSDTAAR-LHSTRVLGTFGYHAPEYAM-TGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL  298 (363)
Q Consensus       221 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  298 (363)
                      ||++......... ......+||+.|+|||++. +..++.++||||+||++|+|++|+.||......+............
T Consensus       153 fG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~  232 (345)
T d1pmea_         153 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP  232 (345)
T ss_dssp             CTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             cCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCC
Confidence            9999765443322 2234567999999999985 4567899999999999999999999997654332222111111000


Q ss_pred             cccc--------ccccc-CCcCCCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 046595          299 SEDK--------VKQCV-DPKLNNDY-----PPKAIAKLAAVAALCVQYEADFRPNMTIVVKA  347 (363)
Q Consensus       299 ~~~~--------~~~~~-~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  347 (363)
                      ....        ..... ........     ....+.++.+|+.+||+.||++|||++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000        00000 00000000     11234568999999999999999999999973

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-50  Score=359.09  Aligned_cols=267  Identities=20%  Similarity=0.260  Sum_probs=196.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEe--------C
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCME--------S  137 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~  137 (363)
                      ++|++.+.||+|+||+||+|++ .+|+.||||++...... .....+.+|+.+|+.++||||+++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            6899999999999999999986 47999999998665433 334678999999999999999999998755        3


Q ss_pred             CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceE
Q 046595          138 NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSK  217 (363)
Q Consensus       138 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk  217 (363)
                      ...++||||+.++.+..+.....         .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+|
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~~---------~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~k  157 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVLV---------KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLK  157 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTTC---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEE
T ss_pred             ceEEEEEeccCCCccchhhhccc---------ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEE
Confidence            45789999998866655544333         388999999999999999999999   999999999999999999999


Q ss_pred             EeeeccCCCCCccccc--ccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhc
Q 046595          218 IADFNLTNQSSDTAAR--LHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWA  294 (363)
Q Consensus       218 l~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~  294 (363)
                      |+|||++.........  ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||....+......+...
T Consensus       158 l~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~  237 (318)
T d3blha1         158 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL  237 (318)
T ss_dssp             ECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             eeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999655432221  122335799999999998765 6899999999999999999999999765433322222111


Q ss_pred             cccccccc--------cccccCCcCCCCCCH-------HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          295 TPRLSEDK--------VKQCVDPKLNNDYPP-------KAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       295 ~~~~~~~~--------~~~~~~~~~~~~~~~-------~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                      ........        ...............       .....+.+||.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            11111110        000011011111111       11346788999999999999999999996

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.6e-50  Score=356.61  Aligned_cols=267  Identities=16%  Similarity=0.229  Sum_probs=201.8

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCcc-ceeeeEEEeCCeeEEE
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF-VELLGYCMESNNRILV  143 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv  143 (363)
                      +.++|++.+.||+|+||.||+|++ .+|+.||||++.....   ...+..|+++++.++|+|+ +.+..++.+....++|
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv   81 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   81 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence            346899999999999999999976 4689999999876432   2357889999999987665 5555666778888999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeec---CCCceEEee
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLF---DDFKSKIAD  220 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~---~~~~vkl~D  220 (363)
                      |||+.+ +|...+.....        .+++..+..++.|++.||+|||++   +|+||||||+|||++   .+..+||+|
T Consensus        82 me~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~D  149 (299)
T d1ckia_          82 MELLGP-SLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIID  149 (299)
T ss_dssp             EECCCC-BHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECC
T ss_pred             EEEcCC-chhhhhhhccC--------CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeec
Confidence            999954 77666654321        389999999999999999999999   999999999999875   456799999


Q ss_pred             eccCCCCCccccc-----ccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 046595          221 FNLTNQSSDTAAR-----LHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWAT  295 (363)
Q Consensus       221 fg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~  295 (363)
                      ||+|+........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||................
T Consensus       150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~  229 (299)
T d1ckia_         150 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS  229 (299)
T ss_dssp             CSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH
T ss_pred             cCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh
Confidence            9999765443221     12344679999999999999999999999999999999999999997654433222111000


Q ss_pred             ccccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhccccccCC
Q 046595          296 PRLSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVKALQPLLNSKP  356 (363)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~l~~l~~~~~  356 (363)
                      .......     .    ......++.++.+++..||+.||++||++++|.+.|+.+..+..
T Consensus       230 ~~~~~~~-----~----~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~  281 (299)
T d1ckia_         230 EKKMSTP-----I----EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  281 (299)
T ss_dssp             HHHHHSC-----H----HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             cccCCCC-----h----hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence            0000000     0    00112345679999999999999999999999999988765543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-50  Score=364.10  Aligned_cols=267  Identities=22%  Similarity=0.299  Sum_probs=199.4

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeCC-----
Q 046595           66 LTSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMESN-----  138 (363)
Q Consensus        66 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----  138 (363)
                      +.++|++.+.||+|+||+||+|.+. +|+.||||++...... ...+.+.+|+.+|+.++||||+++++++...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            4568999999999999999999864 6999999999764332 22457889999999999999999999987654     


Q ss_pred             -eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceE
Q 046595          139 -NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSK  217 (363)
Q Consensus       139 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vk  217 (363)
                       ..++||||+ +.+|..++....          +++..+..++.|++.||.|||++   ||+||||||+|||++.++.+|
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~~~----------l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~k  161 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKHEK----------LGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELK  161 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred             ceEEEEEecc-cccHHHHHHhcc----------ccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccc
Confidence             469999999 557888776543          99999999999999999999999   999999999999999999999


Q ss_pred             EeeeccCCCCCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccc
Q 046595          218 IADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATP  296 (363)
Q Consensus       218 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~  296 (363)
                      |+|||++......     .+...||+.|+|||++.+. .++.++|||||||++|+|++|+.||.................
T Consensus       162 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~  236 (346)
T d1cm8a_         162 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG  236 (346)
T ss_dssp             ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             cccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccC
Confidence            9999998765432     3456799999999998764 578999999999999999999999976543322111111000


Q ss_pred             ccccc---------------ccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhcccc
Q 046595          297 RLSED---------------KVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPLL  352 (363)
Q Consensus       297 ~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l~  352 (363)
                      .....               .........+ .......+..+.+||.+||..||.+|||++++++  .|+.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             CCCHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             CCcHHHHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            00000               0000000000 1112234566889999999999999999999998  466553

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-49  Score=358.17  Aligned_cols=268  Identities=24%  Similarity=0.265  Sum_probs=197.0

Q ss_pred             CCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCccceeeeEEEeC------CeeE
Q 046595           69 NFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHFVELLGYCMES------NNRI  141 (363)
Q Consensus        69 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~  141 (363)
                      +|+..++||+|+||+||+|++. +|+.||||++.....     ...+|+.+|++++||||+++++++...      ...+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            6888999999999999999865 699999999976432     234799999999999999999998543      3468


Q ss_pred             EEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC-ceEEee
Q 046595          142 LVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF-KSKIAD  220 (363)
Q Consensus       142 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~D  220 (363)
                      |||||+.++.+..+.....      ....+++.++..++.|++.||+|||++   ||+||||||+|||++.++ .+||+|
T Consensus        96 lv~Ey~~~~~~~~l~~~~~------~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~D  166 (350)
T d1q5ka_          96 LVLDYVPETVYRVARHYSR------AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCD  166 (350)
T ss_dssp             EEEECCSEEHHHHHHHHHH------TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECC
T ss_pred             EEEeccCCccHHHHHhhhh------ccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEec
Confidence            9999998753333322111      012389999999999999999999999   999999999999999765 899999


Q ss_pred             eccCCCCCcccccccccccccccCCCCcccccc-CCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc-
Q 046595          221 FNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMT-GQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL-  298 (363)
Q Consensus       221 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~-  298 (363)
                      ||++........   .....||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||......+....+....... 
T Consensus       167 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~  243 (350)
T d1q5ka_         167 FGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT  243 (350)
T ss_dssp             CTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             ccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCCh
Confidence            999876543322   234679999999998775 478999999999999999999999997654332221111000000 


Q ss_pred             -----------cccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhccccc
Q 046595          299 -----------SEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPLLN  353 (363)
Q Consensus       299 -----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l~~  353 (363)
                                 .....................+.++.+|+.+||+.||++|||+.|+++  .|+++.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             HHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             HHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence                       000000000000111112345567999999999999999999999996  4666544

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-49  Score=349.47  Aligned_cols=269  Identities=19%  Similarity=0.228  Sum_probs=208.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC-chHHHHHHHHHHhcCCCCccceeeeEEEeCCeeEEEEe
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLGYCMESNNRILVYQ  145 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  145 (363)
                      ++|++.+.||+|+||+||+|++. +++.||||+++...... ....+.+|+.+++.++||||+++++++.+....+++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            47999999999999999999864 78999999997654333 35788999999999999999999999999999999999


Q ss_pred             cccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          146 FATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       146 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      ++.+++|..++....         .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||.+.
T Consensus        82 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~  149 (292)
T d1unla_          82 FCDQDLKKYFDSCNG---------DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLAR  149 (292)
T ss_dssp             CCSEEHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             ecccccccccccccc---------ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhh
Confidence            999999988887654         288999999999999999999999   99999999999999999999999999997


Q ss_pred             CCCcccccccccccccccCCCCccccccCC-CCccCceehhHHHHHHHHhCCCCCCCCCCcccc-chhhhccccccc---
Q 046595          226 QSSDTAARLHSTRVLGTFGYHAPEYAMTGQ-ITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQ-SLVTWATPRLSE---  300 (363)
Q Consensus       226 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~-~~~~~~~~~~~~---  300 (363)
                      ........  .....+++.|+|||.+.+.. ++.++|||||||++|||++|+.||......... ..+.........   
T Consensus       150 ~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (292)
T d1unla_         150 AFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW  227 (292)
T ss_dssp             ECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred             cccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhh
Confidence            65543322  23446788999999887664 689999999999999999999997543322111 100000000000   


Q ss_pred             ---------cccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhcc
Q 046595          301 ---------DKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQP  350 (363)
Q Consensus       301 ---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~  350 (363)
                               ...................++.+.+|+.+||+.||.+|||++|+++  .|++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~  288 (292)
T d1unla_         228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD  288 (292)
T ss_dssp             TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred             hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence                     0000000011112223345667899999999999999999999987  4544

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=9.2e-49  Score=352.05  Aligned_cols=262  Identities=15%  Similarity=0.244  Sum_probs=200.1

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-CCccceeeeEEEeC--CeeEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVELLGYCMES--NNRILV  143 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv  143 (363)
                      ++|++++.||+|+||+||+|++ .+++.||||+++.    ...+++.+|+.+|+.++ ||||+++++++...  ...++|
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~----~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH----HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            4799999999999999999986 4689999999864    23567899999999995 99999999998754  568999


Q ss_pred             EecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCC-ceEEeeec
Q 046595          144 YQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDF-KSKIADFN  222 (363)
Q Consensus       144 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Dfg  222 (363)
                      |||+.+++|..+..            .+++.++..++.||+.||.|||++   ||+||||||+|||++.++ .+||+|||
T Consensus       111 ~e~~~~~~L~~~~~------------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG  175 (328)
T d3bqca1         111 FEHVNNTDFKQLYQ------------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWG  175 (328)
T ss_dssp             EECCCSCBGGGTTT------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGG
T ss_pred             EeecCCCcHHHHhc------------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccc
Confidence            99999999987653            289999999999999999999999   999999999999998654 69999999


Q ss_pred             cCCCCCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchh----------
Q 046595          223 LTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLV----------  291 (363)
Q Consensus       223 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~----------  291 (363)
                      +|........   .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||............          
T Consensus       176 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~  252 (328)
T d3bqca1         176 LAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL  252 (328)
T ss_dssp             GCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred             cceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchh
Confidence            9876544322   3456789999999998765 5799999999999999999999999755432111000          


Q ss_pred             -hhccc--cccccccccc--------cCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhccc
Q 046595          292 -TWATP--RLSEDKVKQC--------VDPKLNNDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPL  351 (363)
Q Consensus       292 -~~~~~--~~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l  351 (363)
                       .+...  ..........        .............+.++.+||.+||+.||++|||++|+++  .++.+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v  325 (328)
T d3bqca1         253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  325 (328)
T ss_dssp             HHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred             hhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence             00000  0000000000        0011111112334567899999999999999999999987  44443

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=354.84  Aligned_cols=253  Identities=23%  Similarity=0.321  Sum_probs=204.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEeC----CCCeEEEEEccCCC---CCCchHHHHHHHHHHhcCCC-CccceeeeEEEeCCe
Q 046595           68 SNFGTKALIGEGSYGRVFYAKLT----DGTPAAIKKLDTSS---APEPESDFAAQLSVVSRLKH-EHFVELLGYCMESNN  139 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~---~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~  139 (363)
                      ++|++.+.||+|+||+||+|+..    +|+.||||++....   .....+.+.+|+.++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            57999999999999999999742    48899999986532   22334678899999999966 899999999999999


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEe
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA  219 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~  219 (363)
                      .+++|||+.+|+|.+++.....         +.+..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~---------~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~  171 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRER---------FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLT  171 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEES
T ss_pred             eeeeeecccccHHHHHHHhccc---------ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEe
Confidence            9999999999999999976653         78899999999999999999999   99999999999999999999999


Q ss_pred             eeccCCCCCcccccccccccccccCCCCccccccC--CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhcccc
Q 046595          220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG--QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPR  297 (363)
Q Consensus       220 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~  297 (363)
                      |||+++......... .....|++.|+|||.+.+.  .++.++|||||||+||+|++|+.||...........+.-..  
T Consensus       172 DFG~a~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~--  248 (322)
T d1vzoa_         172 DFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--  248 (322)
T ss_dssp             CSSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--
T ss_pred             eccchhhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--
Confidence            999987655433322 3346799999999998754  46889999999999999999999997664433222111000  


Q ss_pred             ccccccccccCCcCCCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 046595          298 LSEDKVKQCVDPKLNNDYPPKAIAKLAAVAALCVQYEADFRP-----NMTIVVK  346 (363)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  346 (363)
                               .  .....++..++.++.+++.+||+.||++||     |++|+++
T Consensus       249 ---------~--~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         249 ---------L--KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ---------H--HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ---------c--cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                     0  011223445677899999999999999999     4888886

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-48  Score=351.98  Aligned_cols=262  Identities=19%  Similarity=0.228  Sum_probs=192.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEeC-CCCeEEEEEccCCCCCC-chHHHHHHHHHHhcCCCCccceeeeEEEe------CC
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKLT-DGTPAAIKKLDTSSAPE-PESDFAAQLSVVSRLKHEHFVELLGYCME------SN  138 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~  138 (363)
                      .++|++.++||+|+||+||+|++. +|+.||||++....... ...++.+|+.++++++||||+++++++..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            368999999999999999999865 69999999997654322 23568899999999999999999999864      36


Q ss_pred             eeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEE
Q 046595          139 NRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKI  218 (363)
Q Consensus       139 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl  218 (363)
                      ..|+||||+.++ |.+.+..           .+++..+..++.|++.||.|||++   ||+||||||+|||++.++.+|+
T Consensus        96 ~~~iv~Ey~~~~-l~~~~~~-----------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl  160 (355)
T d2b1pa1          96 DVYLVMELMDAN-LCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKI  160 (355)
T ss_dssp             EEEEEEECCSEE-HHHHHTS-----------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEE
T ss_pred             eeEEEEeccchH-HHHhhhc-----------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceee
Confidence            789999999774 5555532           289999999999999999999999   9999999999999999999999


Q ss_pred             eeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhh------
Q 046595          219 ADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVT------  292 (363)
Q Consensus       219 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~------  292 (363)
                      +|||+++.......   .....||+.|+|||++.+..++.++||||+||++|+|++|+.||...........+.      
T Consensus       161 ~df~~~~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~  237 (355)
T d2b1pa1         161 LDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP  237 (355)
T ss_dssp             CCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             echhhhhccccccc---cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCC
Confidence            99999876544322   345679999999999999999999999999999999999999997553222111110      


Q ss_pred             ----h------------ccccccccccccccCCcCC---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 046595          293 ----W------------ATPRLSEDKVKQCVDPKLN---NDYPPKAIAKLAAVAALCVQYEADFRPNMTIVVK  346 (363)
Q Consensus       293 ----~------------~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  346 (363)
                          |            ..+................   .......+..+.+|+.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             CHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                0            0000000000001100111   1112345778999999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-49  Score=354.98  Aligned_cols=267  Identities=23%  Similarity=0.324  Sum_probs=199.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCC-CchHHHHHHHHHHhcCCCCccceeeeEEEeC-----Ce
Q 046595           67 TSNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAP-EPESDFAAQLSVVSRLKHEHFVELLGYCMES-----NN  139 (363)
Q Consensus        67 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~  139 (363)
                      .++|++.+.||+|+||+||+|++ .+|+.||||++...... .....+.+|+.+|+.++||||+++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            45899999999999999999985 47999999999764332 2235788999999999999999999988643     34


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCCCceEEe
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFKSKIA  219 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~~~vkl~  219 (363)
                      .+++++|+.+|+|.+++....          +++.++..++.||+.||.|||++   ||+||||||+|||++.++.+|++
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~~----------l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~  163 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL  163 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             eEEEEEeecCCchhhhccccc----------ccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCcccccccccccccc
Confidence            467778888999999996543          99999999999999999999999   99999999999999999999999


Q ss_pred             eeccCCCCCcccccccccccccccCCCCccccccC-CCCccCceehhHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 046595          220 DFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTG-QITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTWATPRL  298 (363)
Q Consensus       220 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  298 (363)
                      |||++......     .....|++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+.......+.......
T Consensus       164 dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~  238 (348)
T d2gfsa1         164 DFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP  238 (348)
T ss_dssp             CC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99998765433     3346789999999987765 56899999999999999999999997554322211111000000


Q ss_pred             cc--------cccccccC---CcCCCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--Hhccc
Q 046595          299 SE--------DKVKQCVD---PKLNNDY---PPKAIAKLAAVAALCVQYEADFRPNMTIVVK--ALQPL  351 (363)
Q Consensus       299 ~~--------~~~~~~~~---~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~l~~l  351 (363)
                      ..        ........   ......+   ....+.++.+||.+||+.||.+|||++|+++  .|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence            00        00000000   0000000   0123466899999999999999999999998  56554

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.8e-42  Score=313.11  Aligned_cols=269  Identities=17%  Similarity=0.203  Sum_probs=190.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-CCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-----------CCccceeeeEEE
Q 046595           68 SNFGTKALIGEGSYGRVFYAKL-TDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-----------HEHFVELLGYCM  135 (363)
Q Consensus        68 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~  135 (363)
                      ++|+++++||+|+||+||+|+. .+|+.||||+++...  ...+.+.+|+.+++.++           |+||+++++++.
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence            4699999999999999999986 479999999997521  22356778888888775           578999998876


Q ss_pred             eC--CeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-cCCCCeEEecccCCceeecC
Q 046595          136 ES--NNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHE-KVQPPIVHRDVRSSNVLLFD  212 (363)
Q Consensus       136 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nill~~  212 (363)
                      ..  ...+++++++..+...........      ...+++..+..++.|++.||.|||+ .   ||+||||||+||||+.
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~  161 (362)
T d1q8ya_          91 HKGPNGVHVVMVFEVLGENLLALIKKYE------HRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEI  161 (362)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHHHTT------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEE
T ss_pred             eccccceeeeeeeccccccccccccccc------ccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeec
Confidence            43  455666776655433222221111      1238899999999999999999998 6   8999999999999986


Q ss_pred             CC------ceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHHHHHHhCCCCCCCCCCcc
Q 046595          213 DF------KSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKG  286 (363)
Q Consensus       213 ~~------~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~  286 (363)
                      ++      .++++|||.+......     .....||+.|+|||++.+..++.++||||+||++++|++|+.||.......
T Consensus       162 ~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~  236 (362)
T d1q8ya_         162 VDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS  236 (362)
T ss_dssp             EETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccc
Confidence            54      4999999998654332     345679999999999999999999999999999999999999997543221


Q ss_pred             ccchh------hhccccccc---------------cccccccCC----------cCCCCCCHHHHHHHHHHHHhccCCCC
Q 046595          287 QQSLV------TWATPRLSE---------------DKVKQCVDP----------KLNNDYPPKAIAKLAAVAALCVQYEA  335 (363)
Q Consensus       287 ~~~~~------~~~~~~~~~---------------~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~~p  335 (363)
                      .....      .........               .........          ..........+.++.+|+.+||..||
T Consensus       237 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP  316 (362)
T d1q8ya_         237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP  316 (362)
T ss_dssp             --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred             ccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence            11000      000000000               000000000          01223456778899999999999999


Q ss_pred             CCCCCHHHHHH--Hhcccc
Q 046595          336 DFRPNMTIVVK--ALQPLL  352 (363)
Q Consensus       336 ~~RPs~~~vl~--~l~~l~  352 (363)
                      .+|||++|+++  .|++..
T Consensus       317 ~~Rpta~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         317 RKRADAGGLVNHPWLKDTL  335 (362)
T ss_dssp             TTCBCHHHHHTCGGGTTCT
T ss_pred             hHCcCHHHHhcCcccCCCC
Confidence            99999999998  355443

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=7.8e-27  Score=191.83  Aligned_cols=170  Identities=15%  Similarity=0.123  Sum_probs=119.1

Q ss_pred             CCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCC-----C-------c-----hHHHHHHHHHHhcCCCCccceeeeE
Q 046595           71 GTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAP-----E-------P-----ESDFAAQLSVVSRLKHEHFVELLGY  133 (363)
Q Consensus        71 ~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~-----~-------~-----~~~~~~e~~~l~~l~h~~i~~~~~~  133 (363)
                      .+++.||+|+||.||+|...+|+.||||+++.....     .       .     ......|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            467789999999999999888999999987542211     0       0     1234467888999999999988765


Q ss_pred             EEeCCeeEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccCCCCeEEecccCCceeecCC
Q 046595          134 CMESNNRILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDD  213 (363)
Q Consensus       134 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nill~~~  213 (363)
                      .    ..+++|||+.+..+.+                ++......++.|++.+|.|||++   ||+||||||+|||++++
T Consensus        83 ~----~~~lvme~~~~~~~~~----------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~  139 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR----------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE  139 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG----------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT
T ss_pred             c----CCEEEEEeeccccccc----------------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC
Confidence            3    2379999998865433                23344567899999999999999   99999999999999865


Q ss_pred             CceEEeeeccCCCCCcccccccccccccccCCCCccccccCCCCccCceehhHHHH
Q 046595          214 FKSKIADFNLTNQSSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVL  269 (363)
Q Consensus       214 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l  269 (363)
                       .++|+|||+|...............+.   . -.+ +....|+.++|+||+.--+
T Consensus       140 -~~~liDFG~a~~~~~~~~~~~l~rd~~---~-~~~-~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         140 -GIWIIDFPQSVEVGEEGWREILERDVR---N-IIT-YFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             -EEEECCCTTCEETTSTTHHHHHHHHHH---H-HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred             -CEEEEECCCcccCCCCCcHHHHHHHHH---H-HHH-HHcCCCCCcccHHHHHHHH
Confidence             589999999865433221100000000   0 001 1235788999999986443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.87  E-value=5.6e-09  Score=88.20  Aligned_cols=149  Identities=15%  Similarity=0.100  Sum_probs=100.9

Q ss_pred             HHHHHHhcCCCCCCeeeccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-CCccceeeeEEEeCCe
Q 046595           61 DELNRLTSNFGTKALIGEGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVELLGYCMESNN  139 (363)
Q Consensus        61 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~  139 (363)
                      .++..+.+.|++.+..+-++.+.||+... ++..+++|....... .....+.+|...++.+. +--+.+++.+....+.
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcc-cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            46777778888776655455578998875 466678887654322 22335677888877764 4346778888888889


Q ss_pred             eEEEEecccCCChhhhhcCCCCCCCCCCCCCcCHHHHHHHHHHHHHHHHHhhccC-------------------------
Q 046595          140 RILVYQFATMGSLHDVLHGRKGVQGAEPGPVLTWNQRVKVAYGAAKGLEFLHEKV-------------------------  194 (363)
Q Consensus       140 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-------------------------  194 (363)
                      .++||++++|.++.+......           .   ...++.++...+..||+..                         
T Consensus        85 ~~lv~~~l~G~~~~~~~~~~~-----------~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYEDEQ-----------S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL  150 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTTCS-----------C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred             eEEEEEecccccccccccccc-----------c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHh
Confidence            999999999988766543211           1   1223444455555555431                         


Q ss_pred             -------------------------------CCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          195 -------------------------------QPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       195 -------------------------------~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                                                     ...++|+|+.|.||++++++.+-|+||+.+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                           0138999999999999987767799999753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.52  E-value=1.6e-07  Score=78.52  Aligned_cols=74  Identities=14%  Similarity=0.044  Sum_probs=53.4

Q ss_pred             eeccC-CceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCC--CCccceeeeEEEeCCeeEEEEecccCCCh
Q 046595           76 IGEGS-YGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK--HEHFVELLGYCMESNNRILVYQFATMGSL  152 (363)
Q Consensus        76 lg~G~-~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~g~L  152 (363)
                      +..|. -+.||+....++..+++|......    ...+..|...++.+.  .-.+.+++.+..+.+..++||++++|.++
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            34444 367899988888889999865432    234677888777763  33467788888888889999999988665


Q ss_pred             h
Q 046595          153 H  153 (363)
Q Consensus       153 ~  153 (363)
                      .
T Consensus        94 ~   94 (255)
T d1nd4a_          94 L   94 (255)
T ss_dssp             T
T ss_pred             c
Confidence            3

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.19  E-value=4e-06  Score=74.54  Aligned_cols=77  Identities=17%  Similarity=0.122  Sum_probs=50.0

Q ss_pred             CeeeccCCceEEEEEeCC-CCeEEEEEccC------CCCCCchHHHHHHHHHHhcCC-C--CccceeeeEEEeCCeeEEE
Q 046595           74 ALIGEGSYGRVFYAKLTD-GTPAAIKKLDT------SSAPEPESDFAAQLSVVSRLK-H--EHFVELLGYCMESNNRILV  143 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~-~~~~avK~~~~------~~~~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~~~~~lv  143 (363)
                      +.||.|....||++...+ ++.+++|.-..      ...+....+...|...|+.+. +  ..+.+++.+  +....++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            368999999999998654 67889986432      112233456677888887662 2  345666654  45567899


Q ss_pred             EecccCCCh
Q 046595          144 YQFATMGSL  152 (363)
Q Consensus       144 ~e~~~~g~L  152 (363)
                      ||++.+..+
T Consensus       110 mE~L~~~~~  118 (392)
T d2pula1         110 MEDLSHLKI  118 (392)
T ss_dssp             ECCCTTSEE
T ss_pred             EeccCCccc
Confidence            999976543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.73  E-value=0.00029  Score=60.03  Aligned_cols=165  Identities=18%  Similarity=0.175  Sum_probs=84.3

Q ss_pred             ccCHHHHHHHhcCCCCCCeee-----ccCCceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCC-----Cc
Q 046595           57 QIKLDELNRLTSNFGTKALIG-----EGSYGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKH-----EH  126 (363)
Q Consensus        57 ~~~~~~~~~~~~~y~~~~~lg-----~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h-----~~  126 (363)
                      .++.+++..+.++|.+++...     .|---+.|+.+..+| .+++|+......   ...+..|+.++..|..     |.
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~---~~~l~~~~~~l~~L~~~g~pvp~   77 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPL   77 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred             CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC---HHHHHHHHHHHHhhhhccccccc
Confidence            356788899999998876554     455577899987655 489998755322   2345566666666632     22


Q ss_pred             cceee---eEEEeCCeeEEEEecccCCChhh--------------hhcCCC-CCCCCCCCCC-----------------c
Q 046595          127 FVELL---GYCMESNNRILVYQFATMGSLHD--------------VLHGRK-GVQGAEPGPV-----------------L  171 (363)
Q Consensus       127 i~~~~---~~~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~-~~~~~~~~~~-----------------~  171 (363)
                      .+...   .+.........++.++.+.....              .++... ..........                 .
T Consensus        78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (316)
T d2ppqa1          78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE  157 (316)
T ss_dssp             BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred             cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence            22111   11223445556666665533211              000000 0000000000                 0


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcc-CCCCeEEecccCCceeecCCCceEEeeeccCC
Q 046595          172 TWNQRVKVAYGAAKGLEFLHEK-VQPPIVHRDVRSSNVLLFDDFKSKIADFNLTN  225 (363)
Q Consensus       172 ~~~~~~~i~~~i~~~l~~lH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~  225 (363)
                      ........+......+.-.+.. ...|+||+|+.++||+++.+...-|+||+.+.
T Consensus       158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            0001111122222222222211 12389999999999999988777899999763

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.55  E-value=0.00012  Score=62.99  Aligned_cols=68  Identities=10%  Similarity=0.030  Sum_probs=45.4

Q ss_pred             CceEEEEEeCCCCeEEEEEccCCCCCCchHHHHHHHHHHhcCCCCcc-----cee--eeEEEeCCeeEEEEecccCC
Q 046595           81 YGRVFYAKLTDGTPAAIKKLDTSSAPEPESDFAAQLSVVSRLKHEHF-----VEL--LGYCMESNNRILVYQFATMG  150 (363)
Q Consensus        81 ~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~--~~~~~~~~~~~lv~e~~~~g  150 (363)
                      --.||+++..+|+.|++|+.....  ...+.+..|...+..|...+|     +..  -.........+.+++++.|.
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~--~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCC--CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            468999999999999999986532  235667788888877742211     111  11234466778899988764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.51  E-value=0.00018  Score=63.66  Aligned_cols=72  Identities=18%  Similarity=0.224  Sum_probs=48.5

Q ss_pred             CeeeccCCceEEEEEeCC--------CCeEEEEEccCCCCCCchHHHHHHHHHHhcCC-CCccceeeeEEEeCCeeEEEE
Q 046595           74 ALIGEGSYGRVFYAKLTD--------GTPAAIKKLDTSSAPEPESDFAAQLSVVSRLK-HEHFVELLGYCMESNNRILVY  144 (363)
Q Consensus        74 ~~lg~G~~g~V~~~~~~~--------~~~~avK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~  144 (363)
                      +.|+.|-.-.+|++...+        .+.|++++.-.   ........+|..+++.+. +.-..++++++.+    .+|+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~---~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN---PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS---CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC---cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            467888889999997653        34566666542   223446678999988884 4334577776532    6889


Q ss_pred             ecccCCCh
Q 046595          145 QFATMGSL  152 (363)
Q Consensus       145 e~~~~g~L  152 (363)
                      +|++|.+|
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987544